PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fachal, L; Gomez-Caamano, A; Barnett, GC; Peleteiro, P; Carballo, AM; Calvo-Crespo, P; Kerns, SL; Sanchez-Garcia, M; Lobato-Busto, R; Dorling, L; Elliott, RM; Dearnaley, DP; Sydes, MR; Hall, E; Burnet, NG; Carracedo, A; Rosenstein, BS; West, CML; Dunning, AM; Vega, A				Fachal, Laura; Gomez-Caamano, Antonio; Barnett, Gillian C.; Peleteiro, Paula; Carballo, Ana M.; Calvo-Crespo, Patricia; Kerns, Sarah L.; Sanchez-Garcia, Manuel; Lobato-Busto, Ramon; Dorling, Leila; Elliott, Rebecca M.; Dearnaley, David P.; Sydes, Matthew R.; Hall, Emma; Burnet, Neil G.; Carracedo, Angel; Rosenstein, Barry S.; West, Catharine M. L.; Dunning, Alison M.; Vega, Ana			A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1	NATURE GENETICS			English	Article							ERECTILE DYSFUNCTION; RADIATION TOXICITY; POLYMORPHISMS; PROSTATE; RADIOGENOMICS; DROSOPHILA; THERAPY	There is increasing evidence supporting the role of genetic variants in the development of radiation-induced toxicity(1). However, previous candidate gene association studies failed to elucidate the common genetic variation underlying this phenotype(2), which could emerge years after the completion of treatment(3). We performed a genome-wide association study on a Spanish cohort of 741 individuals with prostate cancer treated with external beam radiotherapy (EBRT). The replication cohorts consisted of 633 cases from the UK4 and 368 cases from North Americas. One locus comprising TANC1 (lowest unadjusted P value for overall late toxicity = 6.85 x 10(-9), odds ratio (OR) = 6.61, 95% confidence interval (CI) = 2.23-19.63) was replicated in the second stage (lowest unadjusted P value for overall late toxicity = 2.08 x 10(-4), OR = 6.17,95% CI = 2.25-16.95; P-combined = 4.16 x 10(-10)). The inclusion of the third cohort gave unadjusted P-combined = 4.64 x 10(-11). These results, together with the role of TANC1 in regenerating damaged muscle, suggest that the TANC1 locus influences the development of late radiation-induced damage.	[Fachal, Laura; Carracedo, Angel; Vega, Ana] Serv Galego Saucle SERGAS, Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain; [Fachal, Laura; Carracedo, Angel; Vega, Ana] Univ Santiago Compostela, CIBERER, Grp Med Xenom, Santiago De Compostela, Spain; [Gomez-Caamano, Antonio; Peleteiro, Paula; Carballo, Ana M.; Calvo-Crespo, Patricia] SERGAS, USC Univ Hosp Complex, Dept Radiat Oncol, Santiago De Compostela, Spain; [Barnett, Gillian C.; Dorling, Leila; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Strangeways Res Lab, Cambridge, England; [Kerns, Sarah L.; Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA; [Sanchez-Garcia, Manuel; Lobato-Busto, Ramon] USC Univ Hosp Complex, SERGAS, Dept Med Phys, Santiago De Compostela, Spain; [Elliott, Rebecca M.; West, Catharine M. L.] Univ Manchester, Manchester Acad, Christie Hosp, Hlth Sci Ctr,Inst Canc Sci, Manchester, Lancs, England; [Dearnaley, David P.] Inst Canc Res, Sutton, Surrey, England; [Sydes, Matthew R.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Hall, Emma] MRC, Clin Trials Unit, London, England; [Burnet, Neil G.] Inst Canc Res, Clin Trials & Stat Unit, London SW3 6JB, England; [Carracedo, Angel] Univ Cambridge, Hosp NHS Fdn Trust, Ctr Oncol, Dept Oncol, Cambridge, England; [Carracedo, Angel] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; University of Cambridge; Icahn School of Medicine at Mount Sinai; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Medical Research Council Clinical Trials Unit; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; King Abdulaziz University	Vega, A (corresponding author), Serv Galego Saucle SERGAS, Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain.	ana.vega@usc.es	Vega, Ana/R-4758-2019; Fachal, Laura/N-5560-2014; Burnet, Neil/L-1025-2019; Dearnaley, David P/J-2318-2014; Carracedo, Angel/D-4257-2012; West, Catharine/J-4152-2012; Sydes, Matthew/C-3373-2008	Fachal, Laura/0000-0002-7256-9752; Dearnaley, David P/0000-0002-3954-2806; Carracedo, Angel/0000-0003-1085-8986; West, Catharine/0000-0002-0839-3449; Sydes, Matthew/0000-0002-9323-1371; Dunning, Alison Margaret/0000-0001-6651-7166; Hall, Emma/0000-0001-5999-5020; Gomez-Caamano, Antonio/0000-0002-9773-4590; Sanchez-Garcia, Manuel/0000-0002-0968-9743	CEGEN (Spanish National Genotyping Center); Instituto de Salud Carlos III [FIS PI10/00164, PI13/02030]; Fondo Europeo de Desarrollo Regional [FEDER 2007-2013, PI13/01136]; Isabel Barreto program from Xunta de Galicia; Fondo Social Europeo; ESTRO Technology Transfer Grant; Cancer Research UK; Experimental Cancer Medicine Centre funding; National Institute for Health Research (NIHR) Royal Marsden NHS Foundation Trust; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK [CRUK/06/16, SP2312/021, C8262/A7253]; UK Department of Health; NIHR Cancer Research Network; American Cancer Society [RSGT-05-200-01-CCE]; US Department of Defense [PC074201]; US National Institutes of Health [1R01CA134444]; Instituto de Salud Carlos III; King Abdulaziz University grant [1-117-1434-HiCi]; Innopharma and the Botin Foundation; NATIONAL CANCER INSTITUTE [R01CA134444] Funding Source: NIH RePORTER; Cancer Research UK [18504, 7253, 16565, 10588] Funding Source: researchfish; Medical Research Council [1366822, MC_U122861330, MC_UU_12023/6] Funding Source: researchfish; MRC [MC_UU_12023/6, MC_U122861330] Funding Source: UKRI	CEGEN (Spanish National Genotyping Center); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional(European Commission); Isabel Barreto program from Xunta de Galicia; Fondo Social Europeo(European Social Fund (ESF)European Commission); ESTRO Technology Transfer Grant; Cancer Research UK(Cancer Research UK); Experimental Cancer Medicine Centre funding; National Institute for Health Research (NIHR) Royal Marsden NHS Foundation Trust; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK(Cancer Research UK); UK Department of Health; NIHR Cancer Research Network; American Cancer Society(American Cancer Society); US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); King Abdulaziz University grant; Innopharma and the Botin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to all participating patients for their cooperation. We thank I. Quintela from CEGEN (Spanish National Genotyping Center) for her support as Affymetrix genotyping platform manager. We also thank the Galician Supercomputation Centre for providing computing infrastructures and the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai for providing computational resources and staff expertise. This work was funded by grants from the Instituto de Salud Carlos III (FIS PI10/00164 and PI13/02030) and the Fondo Europeo de Desarrollo Regional (FEDER 2007-2013). L.F. is supported by the Isabel Barreto program from Xunta de Galicia and Fondo Social Europeo and was granted by an ESTRO Technology Transfer Grant (2012). The RAPPER group is supported by Cancer Research UK and Experimental Cancer Medicine Centre funding. Investigators from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust acknowledge support from the National Institute for Health Research (NIHR) Royal Marsden NHS Foundation Trust and The Institute of Cancer Research Biomedical Research Centre. Sample and data collection within the CHHiP trial (CRUK/06/16) were supported by Cancer Research UK (SP2312/021 and C8262/A7253) and the UK Department of Health, with patient recruitment at participating sites supported by the NIHR Cancer Research Network. B.S.R. and S.L.K. are funded by grants RSGT-05-200-01-CCE from the American Cancer Society; PC074201 from the US Department of Defense and 1R01CA134444 from the US National Institutes of Health. A.C. acknowledges support from the Instituto de Salud Carlos III and the Fondo Europeo de Desarrollo Regional (PI13/01136, FEDER 2007-2013), a King Abdulaziz University grant (1-117-1434-HiCi), Innopharma and the Botin Foundation. The research collaboration leading to this paper was developed under the framework of the Radiogenomics Consortium.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreassen CN, 2012, RADIOTHER ONCOL, V105, P337, DOI 10.1016/j.radonc.2012.11.004; Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018; Avirneni-Vadlamudi U, 2012, J CLIN INVEST, V122, P403, DOI 10.1172/JCI59877; Barnett GC, 2011, CLIN ONCOL-UK, V23, P613, DOI 10.1016/j.clon.2011.03.001; Barnett GC, 2014, RADIOTHER ONCOL, V111, P178, DOI 10.1016/j.radonc.2014.02.012; Barnett GC, 2012, RADIOTHER ONCOL, V105, P289, DOI 10.1016/j.radonc.2012.10.017; Barnett GC, 2012, INT J RADIAT ONCOL, V82, P1065, DOI 10.1016/j.ijrobp.2011.03.015; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Bentzen, 1994, Semin Radiat Oncol, V4, P68, DOI 10.1016/S1053-4296(05)80034-7; Bentzen SM, 2003, SEMIN RADIAT ONCOL, V13, P189, DOI 10.1016/S1053-4296(03)00036-5; Burnet NG, 2013, CLIN ONCOL-UK, V25, P431, DOI 10.1016/j.clon.2013.04.001; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerns SL, 2014, RADIOTHER ONCOL, V110, P182, DOI 10.1016/j.radonc.2013.07.011; Kerns SL, 2013, RADIOTHER ONCOL, V107, P372, DOI 10.1016/j.radonc.2013.05.001; Kerns SL, 2013, J UROLOGY, V190, P102, DOI 10.1016/j.juro.2013.01.096; Kerns SL, 2013, INT J RADIAT ONCOL, V85, pE21, DOI 10.1016/j.ijrobp.2012.08.003; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Matzinger O, 2009, EUR J CANCER, V45, P2825, DOI 10.1016/j.ejca.2009.07.009; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rau A, 2001, DEVELOPMENT, V128, P5061; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Talbot CJ, 2012, BRIT J CANCER, V107, P748, DOI 10.1038/bjc.2012.290; West C, 2010, INT J RADIAT ONCOL, V76, P1295, DOI 10.1016/j.ijrobp.2009.12.017; West CM, 2011, GENOME MED, V3, DOI 10.1186/gm268; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	34	95	103	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					891	894		10.1038/ng.3020	http://dx.doi.org/10.1038/ng.3020			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24974847				2022-12-17	WOS:000339704400020
J	Foth, BJ; Tsai, IJ; Reid, AJ; Bancroft, AJ; Nichol, S; Tracey, A; Holroyd, N; Cotton, JA; Stanley, EJ; Zarowiecki, M; Liu, JZ; Huckvale, T; Cooper, PJ; Grencis, RK; Berriman, M				Foth, Bernardo J.; Tsai, Isheng J.; Reid, Adam J.; Bancroft, Allison J.; Nichol, Sarah; Tracey, Alan; Holroyd, Nancy; Cotton, James A.; Stanley, Eleanor J.; Zarowiecki, Magdalena; Liu, Jimmy Z.; Huckvale, Thomas; Cooper, Philip J.; Grencis, Richard K.; Berriman, Matthew			Whipworm genome and dual-species transcriptome analyses provide molecular insights into an intimate host-parasite interaction	NATURE GENETICS			English	Article							TRANSMITTED HELMINTH INFECTIONS; NEMATODE PARASITE; DRAFT GENOME; DNASE II; RESISTANCE; GENES; TRICHURIASIS; KARYOTYPE; MECHANISM; PROTEINS	Whipworms are common soil-transmitted helminths that cause debilitating chronic infections in man. These nematodes are only distantly related to Caenorhabditis elegans and have evolved to occupy an unusual niche, tunneling through epithelial cells of the large intestine. We report here the whole-genome sequences of the human-infective Trichuris trichiura and the mouse laboratory model Trichuris muris. On the basis of whole-transcriptome analyses, we identify many genes that are expressed in a sex- or life stage-specific manner and characterize the transcriptional landscape of a morphological region with unique biological adaptations, namely, bacillary band and stichosome, found only in whipworms and related parasites. Using RNA sequencing data from whipworm-infected mice, we describe the regulated T helper 1 (T(H)1)-like immune response of the chronically infected cecum in unprecedented detail. In silico screening identified numerous new potential drug targets against trichuriasis. Together, these genomes and associated functional data elucidate key aspects of the molecular host-parasite interactions that define chronic whipworm infection.	[Foth, Bernardo J.; Tsai, Isheng J.; Reid, Adam J.; Nichol, Sarah; Tracey, Alan; Holroyd, Nancy; Cotton, James A.; Stanley, Eleanor J.; Zarowiecki, Magdalena; Liu, Jimmy Z.; Huckvale, Thomas; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Tsai, Isheng J.] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan; [Bancroft, Allison J.; Grencis, Richard K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Cooper, Philip J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Cooper, Philip J.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecc, Escuela Biol, Quito, Ecuador	Wellcome Trust Sanger Institute; University of Miyazaki; University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool; Pontificia Universidad Catolica del Ecuador	Berriman, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	richard.grencis@manchester.ac.uk; mb4@sanger.ac.uk	Tsai, Isheng Jason/ABB-8273-2021; Tsai, Isheng J/H-6606-2014; Berriman, Matthew/A-7618-2011; Zarowiecki, Magdalena/ABD-2858-2021; Zarowiecki, Magdalena/F-5037-2013; Cotton, James A/B-8806-2008	Tsai, Isheng Jason/0000-0002-2123-5058; Berriman, Matthew/0000-0002-9581-0377; Zarowiecki, Magdalena/0000-0001-6102-7731; Cotton, James A/0000-0001-5475-3583; Cooper, Philip/0000-0002-6770-6871; Reid, Adam/0000-0002-5926-7768; Huckvale, Thomas/0000-0001-7066-2577	Wellcome Trust Sanger Institute [098051, WT100290MA, WT083620MA]; Wellcome Trust [088862/Z/09/Z]	Wellcome Trust Sanger Institute(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Maizels for initially proposing a T muris genome project, C. Anderson and T. Raine for sharing their unpublished method for enrichment analysis of IBD-associated genes, S. Thompson for preparing parasite material, T. Kikuchi and Z. Hance for preparing genomic DNA, H.M. Bennett for preparing RNA, K.L. Brooks and H. Beasley for manually curating gene models, M. Dunn for generating optical map data, N. Rawlings for helpful discussions, A. Coghlan for supporting bioinformatics analysis and M. Aslett for data submission to the European Molecular Biology Laboratory (EMBL). This work was funded by the Wellcome Trust through their support of the Wellcome Trust Sanger Institute (grant 098051) and through an Investigator Award (WT100290MA) and Programme grant (WT083620MA) to R.K.G. The collection of samples in Ecuador was supported by the Wellcome Trust (grant 088862/Z/09/Z).	BANCROFT AJ, 1994, EUR J IMMUNOL, V24, P3113, DOI 10.1002/eji.1830241230; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bien J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-10; Bos NA, 2001, GUT, V48, P762, DOI 10.1136/gut.48.6.762; Bowcutt R, 2011, PARASITE IMMUNOL, V33, P411, DOI 10.1111/j.1365-3024.2011.01300.x; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Crow YJ, 2010, EUR J IMMUNOL, V40, P2376, DOI 10.1002/eji.201040829; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; DRAKE LJ, 1994, PARASITOLOGY, V109, P623, DOI 10.1017/S0031182000076502; Else KJ, 1996, INFECT IMMUN, V64, P2950, DOI 10.1128/IAI.64.8.2950-2954.1996; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grencis RK, 2004, CLIN REV ALLERG IMMU, V26, P51, DOI 10.1385/CRIAI:26:1:51; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Helmby H, 2001, J EXP MED, V194, P355, DOI 10.1084/jem.194.3.355; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Johnston WL, 2010, CURR BIOL, V20, P1932, DOI 10.1016/j.cub.2010.09.059; Jouvin MH, 2012, J ALLERGY CLIN IMMUN, V130, P3, DOI 10.1016/j.jaci.2012.05.028; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koyama K, 2000, PARASITE IMMUNOL, V22, P13, DOI 10.1046/j.1365-3024.2000.00270.x; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Levison SE, 2010, INFLAMM BOWEL DIS, V16, P2065, DOI 10.1002/ibd.21326; Levison SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-127; Liu MF, 2008, DNA CELL BIOL, V27, P223, DOI 10.1089/dna.2007.0691; Lynch EA, 2003, J IMMUNOL, V171, P4965, DOI 10.4049/jimmunol.171.10.4965; Marcilla A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001513; Mitreva M, 2008, PARASITOLOGY, V135, P869, DOI 10.1017/S0031182008004472; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; MUTAFOVA T, 1982, Z PARASITENKD, V67, P115, DOI 10.1007/BF00929519; Ota E, 2006, TOXICON, V48, P1002, DOI 10.1016/j.toxicon.2006.08.005; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; SCRAGG JN, 1978, AM J TROP MED HYG, V27, P255, DOI 10.4269/ajtmh.1978.27.255; SPAKULOVA M, 1994, J HELMINTHOL, V68, P67, DOI 10.1017/S0022149X0001350X; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Tarr DEK, 2005, TRENDS PARASITOL, V21, P224, DOI 10.1016/j.pt.2005.03.009; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115	51	95	97	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					693	700		10.1038/ng.3010	http://dx.doi.org/10.1038/ng.3010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24929830	Green Published, Green Accepted, hybrid			2022-12-17	WOS:000338093800009
J	Stelzer, Y; Sagi, I; Yanuka, O; Eiges, R; Benvenisty, N				Stelzer, Yonatan; Sagi, Ido; Yanuka, Ofra; Eiges, Rachel; Benvenisty, Nissim			The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome	NATURE GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; GLOBAL ANALYSIS; GENE; DIFFERENTIATION; IDENTIFICATION; ANTISENSE; ANGELMAN; REVEALS; CLUSTER	Parental imprinting is a form of epigenetic regulation that results in parent-of-origin differential gene expression. To study Prader-Willi syndrome (PWS), a developmental imprinting disorder, we generated case-derived induced pluripotent stem cells (iPSCs) harboring distinct aberrations in the affected region on chromosome 15. In studying PWS-iPSCs and human parthenogenetic iPSCs, we unexpectedly found substantial upregulation of virtually all maternally expressed genes (MEGs) in the imprinted DLK1-DIO3 locus on chromosome 14. Subsequently, we determined that IPW, a long noncoding RNA in the critical region of the PWS locus, is a regulator of the DLKI-DIO3 region, as its overexpression in PWS and parthenogenetic iPSCs resulted in downregulation of MEGs in this locus. We further show that gene expression changes in the DLK1-DIO3 region coincide with chromatin modifications rather than DNA methylation levels. Our results suggest that a subset of PWS phenotypes may arise from dysregulation of an imprinted locus distinct from the PWS region.	[Stelzer, Yonatan; Sagi, Ido; Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Eiges, Rachel] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Stem Cell Res Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il		eiges, rachel/0000-0001-8139-0933	Israel Science Foundation-Morasha Foundation [1252/12]; Israel Ministry of Science and Technology Infrastructure [3-9693]	Israel Science Foundation-Morasha Foundation; Israel Ministry of Science and Technology Infrastructure	Fibroblasts obtained from an individual with PWS harboring complete mUPD of chromosome 15 were kindly donated by V. Gross-Tour (Multidisciplinary Prader-Willi Syndrome Clinic, Child Neurology Unit, Shaare Zedek Medical Center). This research was partially funded by the Israel Science Foundation-Morasha Foundation (grant 1252/12) and by the Israel Ministry of Science and Technology Infrastructure (grant 3-9693).	Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Falk MJ, 2005, PEDIATR NEUROL, V32, P116, DOI 10.1016/j.pediatrneurol.2004.07.007; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hordijk R, 1999, J MED GENET, V36, P782, DOI 10.1136/jmg.36.10.782; Hosoki K, 2009, J PEDIATR-US, V155, P900, DOI 10.1016/j.jpeds.2009.06.045; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Stelzer Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3724; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vassena R, 2012, HUM MOL GENET, V21, P3366, DOI 10.1093/hmg/dds168; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Yang JY, 2010, J BIOL CHEM, V285, P40303, DOI 10.1074/jbc.M110.183392; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033	32	95	95	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					551	557		10.1038/ng.2968	http://dx.doi.org/10.1038/ng.2968			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24816254				2022-12-17	WOS:000336870700010
J	To, MD; Wong, CE; Karnezis, AN; Del Rosario, R; Di Lauro, R; Balmain, A				To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Di Lauro, Roberto; Balmain, Allan			Kras regulatory elements and exon 4A determine mutation specificity in lung cancer	NATURE GENETICS			English	Article							K-RAS 4A; MOUSE SKIN CARCINOGENESIS; TUMOR SUSCEPTIBILITY; HA-RAS; N-RAS; MICE; GENE; PROGRESSION; ACTIVATION; EXPRESSION	Kras is the most frequently mutated ras family member in lung carcinomas(1,2), whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model(3), we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development(4,5), it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele(6,7). Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications(8); therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.	[To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; [Di Lauro, Roberto] Staz Zool Anton Dohrn, I-80121 Naples, Italy; [Di Lauro, Roberto] Inst Genet Res Gaetano Salvatore IRGS, I-83031 Ariano Irpino, Italy	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Stazione Zoologica Anton Dohrn di Napoli	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Di Lauro, Roberto/A-2746-2012	Di Lauro, Roberto/0000-0001-9493-3036	Sandler Foundation Postdoctoral Research Fellowship [CA111834, CA084244]; Swiss National Science Foundation (SNSF); Associazione Italiana per la ricerca sul cancro (AIRC); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE [R01CA111834, U01CA084244] Funding Source: NIH RePORTER	Sandler Foundation Postdoctoral Research Fellowship; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Associazione Italiana per la ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA111834 and CA084244 (A. B.). M. D. T. was supported in part by a Sandler Foundation Postdoctoral Research Fellowship. C. E. W. was supported by the Swiss National Science Foundation (SNSF). R. D. L. was supported by a grant of Associazione Italiana per la ricerca sul cancro (AIRC). A. B. acknowledges support from the Bruce and Davina Isackson Foundation and from the Barbara Bass Bakar Chair of Cancer Genetics. Phospho-Akt was provided by D. Stokoe (University of California San Francisco), and primary antibodies against CCA/CC10 were a gift from A. Mukherjee (National Institute of Child Health and Human Development, US National Institutes of Health).	BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BOS JL, 1989, CANCER RES, V49, P4682; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Nagase H, 2003, CANCER RES, V63, P4849; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Patek CE, 2008, EXP CELL RES, V314, P1105, DOI 10.1016/j.yexcr.2007.11.004; Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang M, 2005, EXP LUNG RES, V31, P165, DOI 10.1080/01902140490495543; Wang Y, 2001, EXP LUNG RES, V27, P255, DOI 10.1080/019021401300054028; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	95	96	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1240	1244		10.1038/ng.211	http://dx.doi.org/10.1038/ng.211			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758463	Green Accepted			2022-12-17	WOS:000259651000026
J	Li, MZ; Elledge, SJ				Li, MZ; Elledge, SJ			MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules	NATURE GENETICS			English	Article							LAC OPERATOR DNA; ESCHERICHIA-COLI; CLONING; PLASMID; REPLACEMENT; MUTAGENESIS; EXPRESSION; PROMOTER; VECTOR; SYSTEM	We describe a highly engineered in vivo cloning method, mating-assisted genetically integrated cloning (MAGIC), that facilitates the rapid construction of recombinant DNA molecules. MAGIC uses bacterial mating, in vivo site-specific endonuclease cleavage and homologous recombination to catalyze the transfer of a DNA fragment between a donor vector in one bacterial strain and a recipient plasmid in a separate bacterial strain. Recombination events are genetically selected and result in placement of the gene of interest under the control of new regulatory elements with high efficiency. MAGIC eliminates the need for restriction enzymes, DNA ligases, preparation of DNA and all in vitro manipulations required for subcloning and allows the rapid construction of multiple constructs with minimal effort. We show that MAGIC can generate constructs for expression in multiple organisms. As this new method requires only the simple mixing of bacterial strains, it represents a substantial advance in high-throughput recombinant DNA production that will save time, effort and expense in functional genomics studies.	Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst,Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu						BACKMAN K, 1978, CELL, V13, P65, DOI 10.1016/0092-8674(78)90138-1; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bethke B, 1997, NUCLEIC ACIDS RES, V25, P2828, DOI 10.1093/nar/25.14.2828; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gumbiner-Russo LM, 2001, GENE, V273, P97, DOI 10.1016/S0378-1119(01)00565-0; Haldimann A, 1998, J BACTERIOL, V180, P1277, DOI 10.1128/JB.180.5.1277-1286.1998; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HASHIMOTO T, 1976, J BACTERIOL, V127, P1561, DOI 10.1128/JB.127.3.1561-1563.1976; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; KAISER K, 1980, MOL GEN GENET, V179, P555, DOI 10.1007/BF00271745; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MARIANS KJ, 1976, NATURE, V263, P744, DOI 10.1038/263744a0; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Nebert D W, 2000, Ann N Y Acad Sci, V919, P148; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Siegel RW, 2004, GENOME RES, V14, P1119, DOI 10.1101/gr.1821804; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	33	95	106	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					311	319		10.1038/ng1505	http://dx.doi.org/10.1038/ng1505			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731760				2022-12-17	WOS:000227297800024
J	Zhu, L; Lee, HO; Jordan, CRS; Cantrell, VA; Southard-Smith, EM; Shin, MK				Zhu, L; Lee, HO; Jordan, CRS; Cantrell, VA; Southard-Smith, EM; Shin, MK			Spatiotemporal regulation of endothelin receptor-B by SOX10 in neural crest-derived enteric neuron precursors	NATURE GENETICS			English	Article							MOUSE MODEL; DOMINANT-MEGACOLON; AGANGLIONIC BOWEL; PROGENITOR CELLS; MIGRATION; GENE; RET; MUTATION; EDNRB; HAPLOINSUFFICIENCY	Hirschsprung disease (HSCR) is a multigenic, congenital disorder that affects 1 in 5,000 newborns and is characterized by the absence of neural crest derived enteric ganglia in the colon(1). One of the primary genes affected in HSCR encodes the G protein coupled endothelin receptor-B (EDNRB)(2,3). The expression of Ednrb is required at a defined time period during the migration of the precursors of the enteric nervous system (ENS) into the colon(4). In this study, we describe a conserved spatiotemporal ENS enhancer of Ednrb. This 1-kb enhancer is activated as the ENS precursors approach the colon, and partial deletion of this enhancer at the endogenous Ednrb locus results in pigmented mice that die postnatally from megacolon. We identified binding sites for SOX10, an SRY-related transcription factor associated with HSCR5, in the Ednrb ENS enhancer, and mutational analyses of these sites suggested that SOX10 may have multiple roles in regulating Ednrb in the ENS.	Fox Chase Canc Ctr, Cellular & Dev Biol Program, Philadelphia, PA 19111 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Med Genet, Nashville, TN 37232 USA	Fox Chase Cancer Center; Princeton University; Vanderbilt University	Shin, MK (corresponding author), Fox Chase Canc Ctr, Cellular & Dev Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Myung.Shin@fccc.edu	Southard-Smith, Michelle/C-3488-2012	Southard-Smith, E Michelle/0000-0003-4718-5869	NIDDK NIH HHS [R01 DK060047-03, R01 DK060047-01A1, R01 DK060047, R01 DK060047-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060047] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Newgreen DF, 1995, ACTA ANAT, V154, P243; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROTHMAN TP, 1993, DEV BIOL, V159, P559, DOI 10.1006/dbio.1993.1264; Rothman TP, 1996, DEV BIOL, V178, P498, DOI 10.1006/dbio.1996.0234; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shin MK, 1997, P NATL ACAD SCI USA, V94, P13105, DOI 10.1073/pnas.94.24.13105; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Wu JJ, 1999, DEVELOPMENT, V126, P1161	30	95	99	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					732	737		10.1038/ng1371	http://dx.doi.org/10.1038/ng1371			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15170213	Bronze			2022-12-17	WOS:000222354100024
J	Hagan, CR; Sheffield, RF; Rudin, CM				Hagan, CR; Sheffield, RF; Rudin, CM			Human Alu element retrotransposition induced by genotoxic stress	NATURE GENETICS			English	Article							TRANSCRIPTION; SEQUENCES; REPEATS; SINES	Alu elements are found exclusively in primate species and comprise over 10% of the human genome. To better define the mechanisms responsible for Alu replication, we introduced a human Alu element into mouse cells. We report that Alu retrotransposition can be induced in mouse cells by exposure to the topoisomerase II inhibitor etoposide and is mediated in trans by endogenous mouse long interspersed elements (LINEs).	Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Rudin, CM (corresponding author), Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA.		Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465				Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Felix CA, 1998, LEUKEMIA, V12, P976, DOI 10.1038/sj.leu.2401026; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1	14	95	97	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					219	220		10.1038/ng1259	http://dx.doi.org/10.1038/ng1259			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14578886				2022-12-17	WOS:000186273300016
J	Schaner, P; Richards, N; Wadhwa, A; Aksentijevich, I; Kastner, D; Tucker, P; Gumucio, D				Schaner, P; Richards, N; Wadhwa, A; Aksentijevich, I; Kastner, D; Tucker, P; Gumucio, D			Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states	NATURE GENETICS			English	Letter							FAMILIAL MEDITERRANEAN-FEVER; GENE; MEFV; SUBSTITUTION; INHERITANCE; FREQUENCY; SELECTION	Familiar Mediterranean fever (FMF; MIM 249100) is an autosomal recessive disease characterized by recurrent attacks of fever with synovial, pleural or peritoneal inflammation(1). The disease is caused by mutations in the gene encoding the pyrin protein(2-4), Human population studies have revealed extremely high allele frequencies for several different pyrin mutations, leading to the conclusion that the mutant alleles confer a selective advantage(5-7). Here we examine the ret finger protein (rfp) domain (which contains most of the disease-causing mutations) of pyrin during primate evolution. Amino acids that cause human disease are often present as wild type in other species. This is true at positions 653 (a novel mutation), 680, 681. 726. 744 and 761, For several of these human mutations, the mutant represents the reappearance of an ancestral amino acid state. Examination of lineage-specific d(N)/d(S) ratios revealed a pattern consistent with the signature of episodic positive selection, Our data, together with previous human population studies, indicate that selective pressures may have caused functional evolution of pyrin in humans and other primates.	Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; NIAMSD, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Gumucio, D (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dgumucio@umich.edu	Aksentijevich, Ivona/AAF-1335-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041083] Funding Source: NIH RePORTER; NICHD NIH HHS [T32-HD07505] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akar E, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<71::AID-HUMU8>3.0.CO;2-3; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Chae JJ, 2000, MAMM GENOME, V11, P428, DOI 10.1007/s003350010082; DANIELS M, 1995, AM J MED GENET, V55, P311, DOI 10.1002/ajmg.1320550313; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Swofford D. L, 2002, PAUP 4 0 PHYLOGENETI; Tunca M, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00990-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; YANG ZH, 1999, PAML PHYLOGENETIC AN; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319	24	95	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					318	321		10.1038/85893	http://dx.doi.org/10.1038/85893			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242116				2022-12-17	WOS:000167304200026
J	Riazuddin, S; Castelein, CM; Ahmed, ZM; Lalwani, AK; Mastroianni, MA; Naz, S; Smith, TN; Liburd, NA; Friedman, TB; Griffith, AJ; Riazuddin, S; Wilcox, ER				Riazuddin, S; Castelein, CM; Ahmed, ZM; Lalwani, AK; Mastroianni, MA; Naz, S; Smith, TN; Liburd, NA; Friedman, TB; Griffith, AJ; Riazuddin, S; Wilcox, ER			Dominant modifier DFNM1 suppresses recessive deafness DFNB26	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; HEARING IMPAIRMENT; GENE; MUTATION; EXISTENCE; PROTEIN; FORM	More than 50% of severe childhood deafness is genetically determined, approximately 70% of which occurs without other abnormalities and is thus termed nonsyndromic(1,2). So far, 30 nonsyndromic recessive deafness loci have been mapped and the defective genes at 6 loci, DFNB1, DFNB2, DFNB3, DFNB4, DFNB9 and DFNB21, have been identified, encoding connexin-26 (ref. 3), myosin VIIA (ref. 4), myosin XV (ref. 5), pendrin(6) otoferlin(7) and alpha -tectorin(8), respectively. Here we map a new recessive nonsyndromic deafness locus, DFNB26, to a 1.5-cM interval of chromosome 4q31 in a consanguineous Pakistani family. A maximum rod score of 8.10 at theta =0 was obtained with D4S1610 when only the 8 affected individuals in this family were included in the calculation. There are seven unaffected family members who are also homozygous for the DFNB26-linked haplotype and thus are non-penetrant. A dominant modifier, DFNM1. that suppresses deafness in the 7 nonpenetrant individuals was mapped to a 5.6-cM region on chromosome 1q24 with a rod score of 4.31 at theta =0 for D1S2815.	NIDCD, Genet Mol Lab, NIH, Rockville, MD 20852 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; Univ Calif San Francisco, Dept Otolaryngol, Lab Mol Otol, San Francisco, CA 94143 USA; NIDCD, Neurootol Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Wilcox, ER (corresponding author), NIDCD, Genet Mol Lab, NIH, Rockville, MD 20852 USA.	wilcoxe@nidcd.nih.gov	Naz, Sadaf/C-3911-2019	Naz, Sadaf/0000-0002-1912-0235	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, Z01DC000035, Z01DC000048] Funding Source: NIH RePORTER; NIDCD NIH HHS [Z01DC00035] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; BORK JM, IN PRESS AM J HUM GE; Bridges CB, 1919, J EXP ZOOL, V28, P337, DOI 10.1002/jez.1400280302; Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914; Cheng NC, 1996, HUM MOL GENET, V5, P309, DOI 10.1093/hmg/5.3.309; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; Friedman T, 2000, CURR OPIN NEUROBIOL, V10, P487, DOI 10.1016/S0959-4388(00)00120-3; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ikeda A, 1999, HUM MOL GENET, V8, P1761, DOI 10.1093/hmg/8.9.1761; KEISELL DP, 1997, NATURE, V387, P80; KERN MJ, 1994, GENOMICS, V19, P334, DOI 10.1006/geno.1994.1066; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sertie AL, 1999, AM J HUM GENET, V65, P433, DOI 10.1086/302491; SLYNN G, 1990, NUCLEIC ACIDS RES, V18, P681, DOI 10.1093/nar/18.3.681; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635	31	95	99	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					431	434		10.1038/82558	http://dx.doi.org/10.1038/82558			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101839				2022-12-17	WOS:000165671700014
J	Evans, AL; Muller, U				Evans, AL; Muller, U			Stereocilia defects in the sensory hair cells of the inner ear in mice deficient in integrin alpha 8 beta 1	NATURE GENETICS			English	Article							KIDNEY MORPHOGENESIS; OSTEOPONTIN; EXPRESSION; DEAFNESS; REGENERATION; FIBRONECTIN; ADHESION; RECEPTOR; TENASCIN; GENES	The mammalian inner ear contains organs for the detection of sound and acceleration, the cochlea and the vestibule, respectively. Mechanosensory hair cells within the neuroepithelia of these organs transduce mechanical force generated by sound waves or head movements into neuronal signals. Defects in hair cells lead to deafness and balance defects(1-3). Hair cells have stereocilia that are indispensable for mechanosensation, but the molecular mechanisms regulating stereocilia formation are poorly understood(4-6). We show here that integrin alpha 8 beta 1, its ligand fibronectin and the integrin-regulated focal adhesion kinase (FAK) co-localize to the apical hair-cell surface where stereocilia are forming. In mice homozygous for a targeted mutation of Itga8 (encoding the alpha 8 subunit; ref. 7), this co-localization is perturbed and hair cells in the utricle, a vestibular subcompartment, lack stereocilia or contain malformed stereocilia. Most integrin-alpha 8 beta 1-deficient mice die soon after birth due to kidney defects. Many of the survivors have difficulty balancing, consistent with the structural defects of the inner ear. Our data suggest that integrin alpha 8 beta 1, and potentially other integrins, regulates hair-cell differentiation and stereocilia maturation. Mutations affecting matrix molecules cause inherited forms of inner ear disease(1-3,8) and integrins may mediate some effects of matrix molecules in the ear: thus, mutations in integrin genes may lead to inner-ear diseases as well.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Evans, AL (corresponding author), Friedrich Miescher Inst, CH-4002 Basel, Switzerland.							Corwin JT, 1998, P NATL ACAD SCI USA, V95, P12080, DOI 10.1073/pnas.95.21.12080; CORWIN JT, 1991, ANNU REV NEUROSCI, V14, P301, DOI 10.1146/annurev.neuro.14.1.301; Cosgrove D, 1996, HEARING RES, V100, P21, DOI 10.1016/0378-5955(96)00114-1; Cremers FPM, 1998, CURR OPIN NEUROL, V11, P11, DOI 10.1097/00019052-199802000-00003; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Legan PK, 1997, SEMIN CELL DEV BIOL, V8, P217, DOI 10.1006/scdb.1997.0145; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; LOPEZ CA, 1995, HEARING RES, V85, P210, DOI 10.1016/0378-5955(95)00046-7; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; MULLER U, 1995, MOL BIOL CELL, V6, P433; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; TAKEMURA T, 1994, HEARING RES, V79, P99, DOI 10.1016/0378-5955(94)90131-7; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; VARNUMFINNEY B, 1995, NEURON, V14, P1213, DOI 10.1016/0896-6273(95)90268-6; Whitlon DS, 1999, J COMP NEUROL, V406, P361, DOI 10.1002/(SICI)1096-9861(19990412)406:3<361::AID-CNE5>3.0.CO;2-O; Zheng JL, 1997, J NEUROSCI, V17, P8270	26	95	97	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2000	24	4					424	428		10.1038/74286	http://dx.doi.org/10.1038/74286			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742111				2022-12-17	WOS:000086192800026
J	Marra, M; Hillier, L; Kucaba, T; Allen, M; Barstead, R; Beck, C; Blistain, A; Bonaldo, M; Bowers, Y; Bowles, L; Cardenas, M; Chamberlain, A; Chappell, J; Clifton, S; Favello, A; Geisel, S; Gibbons, M; Harvey, N; Hill, F; Jackson, Y; Kohn, S; Lennon, G; Mardis, E; Martin, J; Mila, L; McCann, R; Morales, R; Pape, D; Person, B; Prange, C; Ritter, E; Soares, M; Schurk, R; Shin, T; Steptoe, M; Swaller, T; Theising, B; Underwood, K; Wylie, T; Yount, T; Wilson, R; Waterston, R				Marra, M; Hillier, L; Kucaba, T; Allen, M; Barstead, R; Beck, C; Blistain, A; Bonaldo, M; Bowers, Y; Bowles, L; Cardenas, M; Chamberlain, A; Chappell, J; Clifton, S; Favello, A; Geisel, S; Gibbons, M; Harvey, N; Hill, F; Jackson, Y; Kohn, S; Lennon, G; Mardis, E; Martin, J; Mila, L; McCann, R; Morales, R; Pape, D; Person, B; Prange, C; Ritter, E; Soares, M; Schurk, R; Shin, T; Steptoe, M; Swaller, T; Theising, B; Underwood, K; Wylie, T; Yount, T; Wilson, R; Waterston, R			An encyclopedia of mouse genes	NATURE GENETICS			English	Article							EXPRESSED SEQUENCE TAGS; CAENORHABDITIS-ELEGANS; HUMAN GENOME; CDNA LIBRARY; MUTAGENESIS; DISCOVERY; FAMILIES; RICE; MAP	The laboratory mouse is the premier model system for studies of mammalian development due to the powerful classical genetic analysis(1) possible (see also the Jackson Laboratory web site, http://www.jax.org/) and the ever-expanding collection of molecular tools(2,3). To enhance the utility of the mouse system, we initiated a program to generate a large database of expressed sequence tags (ESTs) that can provide rapid access to genes(4-16). Of particular significance was the possibility that cDNA libraries could be prepared from very early stages of development, a situation unrealized in human EST projects(7,12). We report here the development of a comprehensive database of ESTs for the mouse. The project, initiated in March 1996, has focused on 5' end sequences from directionally cloned, oligo-dT primed cDNA libraries. As of 23 October 1998, 352,040 sequences had been generated, annotated and deposited in dbEST, where they comprised 93% of the total ESTs available for mouse. EST data are versatile and have been applied to gene identification(17), comparative sequence analysis(18,19), comparative gene mapping and candidate disease gene identification(20), genome sequence annotation(21,22), microarray development(23) and the development of gene-based map resources(24).	Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA; Univ Iowa, Iowa City, IA 52242 USA; Univ Calif Lawrence Livermore Natl Lab, IMAGE Consortium, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; Genelogic Inc, Genom, Gaithersburg, MD 20878 USA	Washington University (WUSTL); Oklahoma Medical Research Foundation; University of Iowa; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System	Marra, M (corresponding author), Washington Univ, Genome Sequencing Ctr, 4444 Forest Pk Blvd, St Louis, MO 63108 USA.		Lennon, Greg/T-4717-2019; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Marra, Marco A/B-5987-2008	Wilson, Richard K./0000-0002-1992-1358; Marra, Marco A/0000-0001-7146-7175				ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Ajioka JW, 1998, GENOME RES, V8, P18, DOI 10.1101/gr.8.1.18; Bailey LC, 1998, GENOME RES, V8, P362, DOI 10.1101/gr.8.4.362; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Brown SDM, 1996, TRENDS GENET, V12, P433, DOI 10.1016/0168-9525(96)30094-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOULGATTE R, 1995, GENOME RES, V5, P272, DOI 10.1101/gr.5.3.272; Jiang J, 1998, GENOME RES, V8, P268, DOI 10.1101/gr.8.3.268; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; Nelson PS, 1998, GENOMICS, V47, P12, DOI 10.1006/geno.1997.5035; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; Sasaki N, 1998, GENOMICS, V49, P167, DOI 10.1006/geno.1998.5209; SASAKI T, 1994, PLANT J, V6, P615, DOI 10.1046/j.1365-313X.1994.6040615.x; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sonnhammer ELL, 1997, GENOMICS, V46, P200, DOI 10.1006/geno.1997.4989; Sutherland HF, 1998, GENOMICS, V52, P37, DOI 10.1006/geno.1998.5414; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Yamamoto K, 1997, PLANT MOL BIOL, V35, P135, DOI 10.1023/A:1005735322577; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	30	95	98	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					191	194		10.1038/5976	http://dx.doi.org/10.1038/5976			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988271				2022-12-17	WOS:000078399500021
J	Eicher, EM; Washburn, LL; Schork, NJ; Lee, BK; Shown, EP; Xu, XL; Dredge, RD; Pringle, MJ; Page, DC				Eicher, EM; Washburn, LL; Schork, NJ; Lee, BK; Shown, EP; Xu, XL; Dredge, RD; Pringle, MJ; Page, DC			Sex-determining genes on mouse autosomes identified by linkage analysis of C57BL/6J-Y-POS sex reversal	NATURE GENETICS			English	Letter							Y-CHROMOSOME; MICE; TESTIS; SRY; PROTEIN		CASE WESTERN RESERVE UNIV, DEPT EPIDEMIOL & BIOSTAT, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT GENET, CLEVELAND, OH 44106 USA; MIT, HOWARD HUGHES MED INST, CAMBRIDGE, MA 02142 USA; MIT, WHITEHEAD INST, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA	Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Eicher, EM (corresponding author), JACKSON LAB, 600 MAIN ST, BAR HARBOR, ME 04609 USA.			Schork, Nicholas/0000-0003-0920-5013	NICHD NIH HHS [HD22532] Funding Source: Medline; NIGMS NIH HHS [GM20919] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020919, R01GM020919] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beamer W G, 1978, Basic Life Sci, V12, P195; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BOGAN JS, 1994, CELL, V76, P603, DOI 10.1016/0092-8674(94)90501-0; Burgoyne PS, 1993, GONADAL DEV FUNCTION, P17; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; EICHER EM, 1994, NAT GENET, V6, P221, DOI 10.1038/ng0394-221; EICHER EM, 1988, PHILOS T R SOC B, V322, P109, DOI 10.1098/rstb.1988.0118; EICHER EM, 1986, ANNU REV GENET, V20, P327, DOI 10.1146/annurev.ge.20.120186.001551; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; EICHER EM, 1980, CYTOGENET CELL GENET, V28, P104, DOI 10.1159/000131518; EICHER EM, 1995, T B ROY SOC, V350, P2623; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; GOODFELLOW PN, 1992, SERONO SYM, V94, P5; HACKER A, 1995, DEVELOPMENT, V121, P1603; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Nadeau J H, 1991, Mamm Genome, V1 Spec No, pS461, DOI 10.1007/BF00656504; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; PALMER SJ, 1991, DEVELOPMENT, V113, P709; PRINGLE MJ, 1996, INFERTILITY MALE; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SOKAL RR, 1981, BIOMERY; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; WASHBURN LL, 1983, NATURE, V303, P338, DOI 10.1038/303338a0; WASHBURN LL, 1989, GENETICS, V123, P173; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	29	95	95	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1996	14	2					206	209		10.1038/ng1096-206	http://dx.doi.org/10.1038/ng1096-206			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841197				2022-12-17	WOS:A1996VL44600031
J	RUGG, EL; MCLEAN, WHI; ALLISON, WE; LUNNY, DP; MACLEOD, RI; FELIX, DH; LANE, EB; MUNRO, CS				RUGG, EL; MCLEAN, WHI; ALLISON, WE; LUNNY, DP; MACLEOD, RI; FELIX, DH; LANE, EB; MUNRO, CS			A MUTATION IN THE MUCOSAL KERATIN K4 IS ASSOCIATED WITH ORAL WHITE SPONGE NEVUS	NATURE GENETICS			English	Note							EXPRESSION		EDINBURGH DENT HOSP,DEPT ORAL MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND; GLASGOW DENT HOSP,DEPT ORAL MED,GLASGOW G2 3JZ,LANARK,SCOTLAND; SO GEN HOSP,DEPT DERMATOL,GLASGOW G51 4TF,LANARK,SCOTLAND	University of Edinburgh; University of Glasgow; University of Glasgow	RUGG, EL (corresponding author), UNIV DUNDEE,INST MED SCI,CANC RES CAMPAIGN LABS,DEPT ANAT & PHYSIOL,CANC RES CAMPAIGN,DUNDEE DD1 4HN,SCOTLAND.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALOI FG, 1988, DERMATOLOGICA, V177, P323, DOI 10.1159/000248588; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; COOPER DN, 1993, HUM GENE MUTAT; FRITHIOF L, 1976, ORAL SURG ORAL MED O, V41, P607, DOI 10.1016/0030-4220(76)90313-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HATZFELD M, 1991, J CELL SCI, V99, P351; JORGENSON RJ, 1981, ARCH DERMATOL, V117, P73, DOI 10.1001/archderm.117.2.73; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; MCDONAGH AJG, 1990, CLIN EXP DERMATOL, V15, P152, DOI 10.1111/j.1365-2230.1990.tb02056.x; MCGINNIS JP, 1975, ORAL SURG ORAL MED O, V40, P644, DOI 10.1016/0030-4220(75)90374-6; MCKUSICK VA, 1995, OMIM ON LINE MENDELI; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; MCLEAN WHI, 1994, HUM MOL GENET, V3, P1031, DOI 10.1093/hmg/3.6.1031; MISCHKE D, 1989, NUCLEIC ACIDS RES, V17, P7984, DOI 10.1093/nar/17.19.7984; RICHARD G, 1995, NAT GENET, V11, P453, DOI 10.1038/ng1295-453; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; YOON SJ, 1994, GENOMICS, V24, P502, DOI 10.1006/geno.1994.1659	21	95	97	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					450	452		10.1038/ng1295-450	http://dx.doi.org/10.1038/ng1295-450			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493030				2022-12-17	WOS:A1995TH62900027
J	Lavallee, VP; Baccelli, I; Krosl, J; Wilhelm, B; Barabe, F; Gendron, P; Boucher, G; Lemieux, S; Marinier, A; Meloche, S; Hebert, J; Sauvageau, G				Lavallee, Vincent-Philippe; Baccelli, Irsne; Krosl, Jana; Wilhelm, Brian; Barabe, Frederic; Gendron, Patrick; Boucher, Genevieve; Lemieux, Sebastien; Marinier, Anne; Meloche, Sylvain; Hebert, Josee; Sauvageau, Guy			The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias	NATURE GENETICS			English	Article							PARTIAL TANDEM DUPLICATION; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION PROFILE; ACQUIRED-RESISTANCE; PATHWAY MUTATIONS; MEK INHIBITION; PU.1 MUTATIONS; DISTINCT; CANCER	Using next-generation sequencing of primary acute myeloid leukemia (AML) specimens, we identified to our knowledge the first unifying genetic network common to the two subgroups of KMT2A (MLL)-rearranged leukemia, namely having MLL fusions or partial tandem duplications. Within this network, we experimentally confirmed upregulation of the gene with the most subtype-specific increase in expression, LOC100289656, and identified cryptic MLL fusions, including a new MLL-ENAH fusion. We also identified a subset of MLL fusion specimens carrying mutations in SPI1 accompanied by inactivation of its transcriptional network, as well as frequent RAS pathway mutations, which sensitized the leukemias to synthetic lethal interactions between MEK and receptor tyrosine kinase inhibitors. This transcriptomics-based characterization and chemical interrogation of human MLL-rearranged AML was a valuable approach for identifying complementary features that define this disease.	[Lavallee, Vincent-Philippe; Baccelli, Irsne; Krosl, Jana; Wilhelm, Brian; Barabe, Frederic; Gendron, Patrick; Boucher, Genevieve; Lemieux, Sebastien; Marinier, Anne; Hebert, Josee; Sauvageau, Guy] Univ Montreal, Leucegene Project, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Hebert, Josee; Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada; [Wilhelm, Brian; Hebert, Josee; Sauvageau, Guy] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; [Barabe, Frederic] Ctr Hosp Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Barabe, Frederic] Hop Enfants Jesus, Quebec City, PQ, Canada; [Barabe, Frederic] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Lemieux, Sebastien] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ, Canada; [Marinier, Anne] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Hebert, Josee; Sauvageau, Guy] Maisonneuve Rosemont Hosp, Quebec Leukemia Cell Bank, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Leucegene Project, Inst Res Immunol & Canc, Montreal, PQ, Canada.	josee.hebert@umontreal.ca; guy.sauvageau@umontreal.ca		Boucher, Genevieve/0000-0001-6389-9007; Sauvageau, Guy/0000-0002-4333-7266; Gendron, Patrick/0000-0001-9829-2600; Lemieux, Sebastien/0000-0001-5477-1386	Genome Canada; Genome Quebec; Amorchem; Canadian Cancer Society Research Institute (CCSRI); Industrielle-Alliance (Universite de Montreal); Canada Research Chair program; Cancer Research Network of the Fonds de Recherche du Quebec-Sante; Canada Foundation for Innovation (CFI); NanoQuebec; RMGA; Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT); Hopital Maisonneuve-Rosemont Foundation; Cole Foundation; Human Frontier Science Program	Genome Canada(Genome Canada); Genome Quebec; Amorchem; Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Industrielle-Alliance (Universite de Montreal); Canada Research Chair program(Canada Research Chairs); Cancer Research Network of the Fonds de Recherche du Quebec-Sante; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); NanoQuebec; RMGA; Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT); Hopital Maisonneuve-Rosemont Foundation; Cole Foundation; Human Frontier Science Program(Human Frontier Science Program)	We thank M. Draoui for project coordination, S. Corneau for sample coordination and I. Boivin for data validation as well as M. Arteau and R. Lambert at the IRIC genomics platform for RNA sequencing. We acknowledge the dedicated work of the Quebec Leukemia Cell Bank (BCLQ) staff, namely G. d'Angelo for morphological diagnoses, C. Rondeau and S. Lavallee; M. Marquis for qRT-PCR validations, and H. Chaker for FISH analyses on AML samples. We thank J. Duchaine and D. Salois at the IRIC high-throughput screening platform. This work was mostly supported by Genome Canada and Genome Quebec with supplementary funds from Amorchem and the Canadian Cancer Society Research Institute (CCSRI). Contribution was provided by Ministeres de l'Economie, de l'Innovation et des Exportations du Quebec and the Leukemia Lymphoma Society of Canada. G.S. and J.H. are recipients of research chairs from Industrielle-Alliance (Universite de Montreal) and the Canada Research Chair program, respectively. BCLQ is supported by grants from the Cancer Research Network of the Fonds de Recherche du Quebec-Sante. RNA sequencing read mapping and transcript quantification were performed on the supercomputer Briaree from Universite de Montreal, managed by Calcul Quebec and Compute Canada. The operation of this supercomputer is funded by the Canada Foundation for Innovation (CFI), NanoQuebec, RMGA and Fonds de Recherche du Quebec-Nature et Technologies (FRQ-NT). V.P.L. is supported by a postdoctoral fellowship jointly supported by the Hopital Maisonneuve-Rosemont Foundation and the Cole Foundation. I.B. is supported by a postdoctoral fellowship from the Human Frontier Science Program.	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Borthakur G, 2012, BLOOD, V120; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dohner K, 2003, BLOOD, V102, P3850, DOI 10.1182/blood-2003-08-2654; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Groschel S, 2013, J CLIN ONCOL, V31, P95, DOI 10.1200/JCO.2011.41.5505; Grossmann V, 2013, LEUKEMIA, V27, P1933, DOI 10.1038/leu.2013.90; Grossmann V, 2012, BLOOD, V120, P2963, DOI 10.1182/blood-2012-03-419622; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Kampen KR, 2014, LEUKEMIA, V28, P589, DOI 10.1038/leu.2013.342; KERN DH, 1988, CANCER RES, V48, P117; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuhn Michael W M, 2015, Haematologica, V100, pe190, DOI 10.3324/haematol.2014.115337; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lamandin C, 2002, BLOOD, V100, P4680, DOI 10.1182/blood-2002-08-2563; Lavallee VP, 2015, BLOOD, V125, P140, DOI 10.1182/blood-2014-07-591529; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2003, P NATL ACAD SCI USA, V100, P14275, DOI 10.1073/pnas.2335924100; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Pabst C, 2014, NAT METHODS, V11, P436, DOI 10.1038/nmeth.2847; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Kladniew BR, 2014, CHEM-BIOL INTERACT, V214, P57, DOI 10.1016/j.cbi.2014.02.013; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Sandhofer N, 2015, LEUKEMIA, V29, P828, DOI 10.1038/leu.2014.305; Steudel C, 2003, GENE CHROMOSOME CANC, V37, P237, DOI 10.1002/gcc.10219; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vegesna VA, 2002, LEUKEMIA RES, V26, P451, DOI 10.1016/S0145-2126(01)00150-3; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhou J, 2014, LEUKEMIA, V28, P1436, DOI 10.1038/leu.2013.384	43	94	98	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1030	+		10.1038/ng.3371	http://dx.doi.org/10.1038/ng.3371			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26237430				2022-12-17	WOS:000360394100013
J	Simons, C; Rash, LD; Crawford, J; Ma, LL; Cristofori-Armstrong, B; Miller, D; Ru, KL; Baillie, GJ; Alanay, Y; Jacquinet, A; Debray, FG; Verloes, A; Shen, J; Yesil, G; Guler, S; Yuksel, A; Cleary, JG; Grimmond, SM; McGaughran, J; King, GF; Gabbett, MT; Taft, RJ				Simons, Cas; Rash, Lachlan D.; Crawford, Joanna; Ma, Linlin; Cristofori-Armstrong, Ben; Miller, David; Ru, Kelin; Baillie, Gregory J.; Alanay, Yasemin; Jacquinet, Adeline; Debray, Francois-Guillaume; Verloes, Alain; Shen, Joseph; Yesil, Gozde; Guler, Serhat; Yuksel, Adnan; Cleary, John G.; Grimmond, Sean M.; McGaughran, Julie; King, Glenn F.; Gabbett, Michael T.; Taft, Ryan J.			Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy	NATURE GENETICS			English	Article							SEVERE MENTAL-RETARDATION; DE-NOVO MUTATION; MISSENSE MUTATIONS; DRAVET SYNDROME; SCN1A MUTATION; ABSENT NAILS; K+ CHANNEL; ENCEPHALOPATHIES; INFANCY; HALLUX	Temple-Baraitser syndrome (TBS) is a multisystem developmental disorder characterized by intellectual disability, epilepsy, and hypoplasia or aplasia of the nails of the thumb and great toe(1,2). Here we report damaging de novo mutations in KCNH1 (encoding a protein called ether a go-go, EAG1 or K(V)10.1), a voltage-gated potassium channel that is predominantly expressed in the central nervous system (CNS), in six individuals with TBS. Characterization of the mutant channels in both Xenopus laevis oocytes and human HEK293T cells showed a decreased threshold of activation and delayed deactivation, demonstrating that TBS-associated KCNH1 mutations lead to deleterious gain of function. Consistent with this result, we find that two mothers of children with TBS, who have epilepsy but are otherwise healthy, are low-level (10% and 27%) mosaic carriers of pathogenic KCNH1 mutations. Consistent with recent reports(3-8), this finding demonstrates that the etiology of many unresolved CNS disorders, including epilepsies, might be explained by pathogenic mosaic mutations.	[Simons, Cas; Rash, Lachlan D.; Crawford, Joanna; Ma, Linlin; Cristofori-Armstrong, Ben; Miller, David; Ru, Kelin; Baillie, Gregory J.; Grimmond, Sean M.; King, Glenn F.; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Miller, David] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Ctr Clin Gen, Darlinghurst, NSW 2010, Australia; [Alanay, Yasemin] Acibadem Univ, Sch Med, Dept Pediat, Istanbul, Turkey; [Jacquinet, Adeline; Debray, Francois-Guillaume] Ctr Hosp Univ, Ctr Human Genet, Liege, Belgium; [Jacquinet, Adeline; Debray, Francois-Guillaume] Univ Liege, Liege, Belgium; [Verloes, Alain] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Verloes, Alain] Hop Robert Debre, INSERM, UMR 1141, F-75019 Paris, France; [Shen, Joseph] Childrens Hosp Cent Calif, Madera, CA USA; [Yesil, Gozde; Guler, Serhat; Yuksel, Adnan] Bezmialem Vakif Univ, Sch Med, Dept Med Genet, Istanbul, Turkey; [Cleary, John G.] Real Time Gen Ltd, Hamilton, New Zealand; [Grimmond, Sean M.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland; [McGaughran, Julie; Gabbett, Michael T.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [McGaughran, Julie] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gabbett, Michael T.] Griffith Univ, Sch Med, Gold Coast, Qld, Australia; [Taft, Ryan J.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrated Syst Biol, Washington, DC 20052 USA; [Taft, Ryan J.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Taft, Ryan J.] Illumina Inc, San Diego, CA USA	University of Queensland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Acibadem University; University of Liege; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Bezmialem Vakif University; University of Glasgow; Royal Brisbane & Women's Hospital; University of Queensland; Griffith University; George Washington University; George Washington University; Illumina	Simons, C (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	c.simons@imb.uq.edu.au; rtaft@illumina.com	King, Glenn F/J-5059-2012; Simons, Cas/A-7905-2011; YESIL, GOZDE/ABE-1615-2020; Crawford, Joanna/F-9135-2013; Rash, Lachlan D/A-3858-2010; Shen, Joseph/AAY-5083-2020; Alanay, Yasemin/A-1516-2016; /AAK-8500-2021; Güler, Serhat/AAC-9709-2021; McGaughran, Julie/A-2563-2012; Baillie, Gregory J/F-9478-2013; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Gabbett, Michael T/C-3228-2012; Cabrera, Mariel/GMX-2706-2022	King, Glenn F/0000-0002-2308-2200; Simons, Cas/0000-0003-3147-8042; YESIL, GOZDE/0000-0003-1964-6306; Crawford, Joanna/0000-0003-0786-6889; Rash, Lachlan D/0000-0003-3616-0279; Shen, Joseph/0000-0002-5604-7639; Alanay, Yasemin/0000-0003-0683-9731; Güler, Serhat/0000-0002-8965-6668; Baillie, Gregory J/0000-0002-6130-250X; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Gabbett, Michael T/0000-0002-5828-315X; Yuksel, Adnan/0000-0002-7275-8254; Ma, Linlin/0000-0002-4716-5158; Cristofori-Armstrong, Ben/0000-0003-0235-2029; McGaughran, Julie/0000-0002-0926-7858	Australian Research Council Discovery Early-Career Research Award; Australian National Health and Medical Research Council (NHMRC); Centre Hospitalier Universitaire of Liege, Belgium; University of Queensland Foundation Research Excellence Award; Fund Invest for Scientific Research (FIRS)	Australian Research Council Discovery Early-Career Research Award(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre Hospitalier Universitaire of Liege, Belgium; University of Queensland Foundation Research Excellence Award(University of Queensland); Fund Invest for Scientific Research (FIRS)	We would like to thank the patients and their families for their participation in this study. Computational support was provided by the NeCTAR Genomics Virtual Laboratory and QRIScloud programs. We thank the Queensland Centre for Medical Genomics and Institute for Molecular Bioscience sequencing facility teams for their assistance with this project and J. Lynch for providing access to his patch-clamp facilities. We also wish to thank J. Vandenberg for his helpful discussion of results. R.J.T. was supported by an Australian Research Council Discovery Early-Career Research Award. L.M. is supported by an Australian National Health and Medical Research Council (NHMRC) C.J. Martin fellowship. A.J. and F.-G.D. were supported by a Fund Invest for Scientific Research (FIRS) grant from Centre Hospitalier Universitaire of Liege, Belgium. This work was supported in part by a University of Queensland Foundation Research Excellence Award and a donation by Joan and Graham J. Crawford.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; D'Adamo MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00134; Depienne C, 2010, J MED GENET, V47, P404, DOI 10.1136/jmg.2009.074328; Gabbett MT, 2008, AM J MED GENET A, V146A, P450, DOI 10.1002/ajmg.a.32129; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Jacquinet A, 2010, AM J MED GENET A, V152A, P2322, DOI 10.1002/ajmg.a.33574; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marini C, 2006, EPILEPSIA, V47, P1737, DOI 10.1111/j.1528-1167.2006.00675.x; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898; Selmer KK, 2009, CLIN GENET, V76, P398, DOI 10.1111/j.1399-0004.2009.01208.x; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; TEMPLE IK, 1991, AM J MED GENET, V41, P173, DOI 10.1002/ajmg.1320410207; Tian CA, 2014, CHEM BIOL DRUG DES, V83, P1, DOI 10.1111/cbdd.12237; Ufartes R, 2013, HUM MOL GENET, V22, P2247, DOI 10.1093/hmg/ddt076; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Yesil G, 2014, AM J MED GENET A, V164, P848, DOI 10.1002/ajmg.a.36344; Zhang J, 2012, AM J PHYSIOL-CELL PH, V303, pC115, DOI 10.1152/ajpcell.00326.2011	37	94	96	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					73	+		10.1038/ng.3153	http://dx.doi.org/10.1038/ng.3153			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25420144				2022-12-17	WOS:000346990400014
J	Morrison, AC; Voorman, A; Johnson, AD; Liu, XM; Yu, J; Li, A; Muzny, D; Yu, FL; Rice, K; Zhu, CS; Bis, J; Heiss, G; O'Donnell, CJ; Psaty, BM; Cupples, LA; Gibbs, R; Boerwinkle, E				Morrison, Alanna C.; Voorman, Arend; Johnson, Andrew D.; Liu, Xiaoming; Yu, Jin; Li, Alexander; Muzny, Donna; Yu, Fuli; Rice, Kenneth; Zhu, Chengsong; Bis, Joshua; Heiss, Gerardo; O'Donnell, Christopher J.; Psaty, Bruce M.; Cupples, L. Adrienne; Gibbs, Richard; Boerwinkle, Eric		Cohorts Heart Aging Res Genetic	Whole-genome sequence-based analysis of high-density lipoprotein cholesterol	NATURE GENETICS			English	Article							COMMON SNPS; ASSOCIATION; ANNOTATION; DISEASE; HDL; OREGANNO; MUTATION; DATABASE; FAMILY; LIPIDS	We describe initial steps for interrogating whole-genome sequence data to characterize the genetic architecture of a complex trait, levels of high-density lipoprotein cholesterol (HDL-C). We report whole-genome sequencing and analysis of 962 individuals from the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) studies. From this analysis, we estimate that common variation contributes more to heritability of HDL-C levels than rare variation, and screening for mendelian variants for dyslipidemia identified individuals with extreme HDL-C levels. Whole-genome sequencing analyses highlight the value of regulatory and non-protein-coding regions of the genome in addition to protein-coding regions.	[Morrison, Alanna C.; Liu, Xiaoming; Li, Alexander; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Voorman, Arend; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Johnson, Andrew D.; O'Donnell, Christopher J.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA USA; [Johnson, Andrew D.; O'Donnell, Christopher J.] NHLBI, Div Intramural Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Yu, Jin; Muzny, Donna; Yu, Fuli; Gibbs, Richard; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhu, Chengsong] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Bis, Joshua; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Bis, Joshua; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Bis, Joshua; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine; Kansas State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Group Health Cooperative; Boston University	Boerwinkle, E (corresponding author), Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA.	eric.boerwinkle@uth.tmc.edu	Johnson, Andrew D/G-6520-2013; Liu, Xiaoming/C-2743-2008; Yu, Jin/E-3732-2013	Johnson, Andrew D/0000-0001-6369-5178; Liu, Xiaoming/0000-0001-8285-5528; Morrison, Alanna/0000-0001-6381-4296; Yu, Jin/0000-0002-2990-6602; Cupples, L. Adrienne/0000-0003-0273-7965	NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, RC2HL102419-02, N01-HC-85239, N01-HC-85079]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [AG-023629, AG-15928, AG-20098, AG-027058]; NHLBI FHS [N01-HC-25195]; National Heart, Lung, and Blood Institute [N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C, HL080295, HL087652, HL105756]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085081, N01HC025195, N01HC085079, N01HC085085, N01HC045133, N01HC055222, N01HC085082, N01HC015103, N01HC085080, N01HC085086, N01HC075150, N01HC085083, N01HC085084] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, ZIAHL006170, U01HL080295, ZIAHL006002, ZIAHL006175, R01HL080295, R01HL072810, RC2HL102419, R01HL087652, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG027058, R01AG015928, R56AG020098, R56AG023629, R01AG023629] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI FHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Atherosclerosis Risk in Communities (ARIC) Study: This ARIC study is carried out as a collaborative study supported by NHLBI contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C. The authors thank the staff and participants of the ARIC study for their important contributions. Ancillary study support has been provided by NHLBI-sponsored project RC2HL102419-02.; Cardiovascular Health Study (CHS): This CHS research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133 and HHSN268201200036C and by NHLBI grants HL080295, HL087652 and HL105756, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG-023629, AG-15928, AG-20098 and AG-027058 from the National Institute on Aging (NIA). See also https://chs-nhlbi. org/CHSOverview.; Framingham Heart Study (FHS) of the NHLBI of the US National Institutes of Health and Boston University School of Medicine: This work was supported by the NHLBI FHS (contract N01-HC-25195).	Brousseau ME, 2000, J LIPID RES, V41, P433; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Dachet C, 2000, ARTERIOSCL THROM VAS, V20, P507, DOI 10.1161/01.ATV.20.2.507; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Papp AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031930; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rhyne J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-1; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weers PMM, 2011, J LIPID RES, V52, P35, DOI 10.1194/jlr.M007500; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	23	94	97	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					899	U29		10.1038/ng.2671	http://dx.doi.org/10.1038/ng.2671			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23770607	Green Accepted			2022-12-17	WOS:000322374900012
J	Alcazar, R; Garcia, AV; Kronholm, I; de Meaux, J; Koornneef, M; Parker, JE; Reymond, M				Alcazar, Ruben; Garcia, Ana V.; Kronholm, Ilkka; de Meaux, Juliette; Koornneef, Maarten; Parker, Jane E.; Reymond, Matthieu			Natural variation at Strubbelig Receptor Kinase 3 drives immune-triggered incompatibilities between Arabidopsis thaliana accessions	NATURE GENETICS			English	Article							MPK4 ACTIVATION; RESISTANCE; EDS1; MEKK1	Accumulation of genetic incompatibilities within species can lead to reproductive isolation and, potentially, speciation. In this study, we show that allelic variation at SRF3 (Strubbelig Receptor Family 3), encoding a receptor-like kinase, conditions the occurrence of incompatibility between Arabidopsis thaliana accessions. The geographical distribution of SRF3 alleles reveals that allelic forms causing epistatic incompatibility with a Landsberg erecta allele at the RPP1 resistance locus are present in A. thaliana accessions in central Asia. Incompatible SRF3 alleles condition for an enhanced early immune response to pathogens as compared to the resistance-dampening effect of compatible SRF3 forms in isogenic backgrounds. Variation in disease susceptibility suggests a basis for the molecular patterns of a recent selective sweep detected at the SRF3 locus in central Asian populations.	[Alcazar, Ruben; Kronholm, Ilkka; de Meaux, Juliette; Koornneef, Maarten; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Garcia, Ana V.; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Max Planck Society; Max Planck Society	Reymond, M (corresponding author), INRA AgroParisTech, Ctr Versailles Grignon, Inst Jean Pierre Bourgin, UMR1318, Route St Cyr,RD10, Versailles, France.	reymond@mpiz-koeln.mpg.de	Alcazar, Ruben/E-7720-2010; Alcazar, Ruben/S-6391-2019	Koornneef, Maarten/0000-0002-7759-4869; Kronholm, Ilkka/0000-0002-4126-0250; Alcazar, Ruben/0000-0002-3567-7586; de Meaux, Juliette/0000-0002-2942-4750				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], GENETICS ORIGIN SPEC; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bechtold N, 1998, METH MOL B, V82, P259; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Fay JC, 2000, GENETICS, V155, P1405; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Muller H.J., 1942, BIOL S, V6, P71; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Wakeley J, 2001, GENETICS, V159, P893; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	37	94	97	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1135	+		10.1038/ng.704	http://dx.doi.org/10.1038/ng.704			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037570				2022-12-17	WOS:000284578800019
J	Berger, AH; Niki, M; Morotti, A; Taylor, BS; Socci, ND; Viale, A; Brennan, C; Szoke, J; Motoi, N; Rothman, PB; Teruya-Feldstein, J; Gerald, WL; Ladanyi, M; Pandolfi, PP				Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Taylor, Barry S.; Socci, Nicholas D.; Viale, Agnes; Brennan, Cameron; Szoke, Janos; Motoi, Noriko; Rothman, Paul B.; Teruya-Feldstein, Julie; Gerald, William L.; Ladanyi, Marc; Pandolfi, Pier Paolo			Identification of DOK genes as lung tumor suppressors	NATURE GENETICS			English	Article							BRONCHIOALVEOLAR STEM-CELLS; ACTIVATED PROTEIN-KINASE; NEGATIVE REGULATORS; DOCKING PROTEIN; MAP KINASE; CANCER; CARCINOMA; LEUKEMIA; RECEPTOR; FAMILY	Genome-wide analyses of human lung adenocarcinoma have identified regions of consistent copy-number gain or loss, but in many cases the oncogenes and tumor suppressors presumed to reside in these loci remain to be determined. Here we identify the downstream of tyrosine kinase (Dok) family members Dok1, Dok2 and Dok3 as lung tumor suppressors. Single, double or triple compound loss of these genes in mice results in lung cancer, with penetrance and latency dependent on the number of lost Dok alleles. Cancer development is preceded by an aberrant expansion and signaling profile of alveolar type II cells and bronchioalveolar stem cells. In human lung adenocarcinoma, we identify DOK2 as a target of copy-number loss and mRNA downregulation and find that DOK2 suppresses lung cancer cell proliferation in vitro and in vivo. Given the genomic localization of DOK2, we propose it as an 8p21.3 haploinsufficient human lung tumor suppressor.	[Berger, Alice H.; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Berger, Alice H.; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Pandolfi, Pier Paolo] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA; [Berger, Alice H.; Niki, Masaru; Morotti, Alessandro; Szoke, Janos; Motoi, Noriko; Teruya-Feldstein, Julie; Gerald, William L.; Ladanyi, Marc; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; [Berger, Alice H.; Pandolfi, Pier Paolo] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Niki, Masaru; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Lab, New York, NY USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Brennan, Cameron; Gerald, William L.; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of Iowa; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Morotti, Alessandro/J-7590-2018; Ladanyi, Marc/AAG-8585-2019; Motoi, Noriko/A-9718-2009; Motoi, Noriko/AAO-5642-2020; Brennan, Cameron/R-7082-2019	Morotti, Alessandro/0000-0002-8407-2903; Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Brennan, Cameron/0000-0003-4064-8891	National Cancer Institute [CA-129243, CA-64593]; Society of MSKCC; Thomas G. Labrecque Foundation; NATIONAL CANCER INSTITUTE [R01CA142787, P01CA129243, R01CA132591, P01CA064593] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society of MSKCC; Thomas G. Labrecque Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Politi, H. E. Varmus, L. F. Cai, C. F. Kim, T. Motoi, R. Hobbs, J. Clohessy, T. Yung, A. Carracedo, K. Ito, Pandolfi lab members, members of the Memorial Sloan-Kettering Cancer Center (MSKCC) Lung Cancer Oncogenome Group and members of the Dana-Farber/Harvard Cancer Center Lung Cancer Research Program for advice and discussion; B. Clarkson (MSKCC) for reagents and discussion; M. Asher, T. Matos and A. Egia for histology services and immunohistochemistry; and the MSKCC, University of Iowa, and Dana-Farber Cancer Institute flow cytometry core facilities for technical assistance. This work was funded by National Cancer Institute grants and CA-129243 (to M. L.) CA-64593 (to P. P. P.) and by the Steps for Breath Fund from the Society of MSKCC and the Thomas G. Labrecque Foundation (to M. N.).	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Cong F, 1999, MOL CELL BIOL, V19, P8314; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; EMI M, 1992, CANCER RES, V52, P5368; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Inoue A, 2007, J BIOCHEM, V142, P257, DOI 10.1093/jb/mvm127; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kashiwada M, 2006, J IMMUNOL, V176, P3958, DOI 10.4049/jimmunol.176.7.3958; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lau SK, 2002, APPL IMMUNOHISTO M M, V10, P97, DOI 10.1097/00022744-200206000-00001; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MACOSKA JA, 1995, CANCER RES, V55, P5390; Ng CH, 2007, BLOOD, V110, P259, DOI 10.1182/blood-2006-10-055194; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; OHATA H, 1993, GENE CHROMOSOME CANC, V7, P85, DOI 10.1002/gcc.2870070204; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Scholnick SB, 1996, J NATL CANCER I, V88, P1676, DOI 10.1093/jnci/88.22.1676; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wistuba II, 1999, CANCER RES, V59, P1973; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	41	94	96	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					216	U27		10.1038/ng.527	http://dx.doi.org/10.1038/ng.527			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20139980	Green Accepted			2022-12-17	WOS:000274912400009
J	Martinez, AM; Schuettengruber, B; Sakr, S; Janic, A; Gonzalez, C; Cavalli, G				Martinez, Anne-Marie; Schuettengruber, Bernd; Sakr, Samy; Janic, Ana; Gonzalez, Cayetano; Cavalli, Giacomo			Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling	NATURE GENETICS			English	Article							POLYCOMB GROUP PROTEINS; DROSOPHILA-MELANOGASTER; IMAGINAL DISCS; CELL FATE; ASYMMETRIC DIVISION; PCG PROTEINS; STEM-CELLS; GROWTH; GENES; CANCER	Polycomb Group (PcG) proteins silence critical developmental genes and modulate cell proliferation. Using the Drosophila melanogaster eye as a model system, we show that cells with mutations in the gene locus (ph) that encodes the PcG protein Polyhomeotic (PH) overproliferate and lose both the ability to differentiate and their normal polarity. They invade the neighboring tissues and, when combined with an activated form of the Ras proto-oncogene, they trigger the formation of metastases. PcG proteins bind to multiple genes in the Notch pathway and control their transcription as well as Notch signaling. The massive cell-autonomous overproliferation of ph mutant cell clones can be rescued by ectopic expression of a dominant negative form of Notch or by RNA interference (RNAi)-mediated repression of Notch. Conversely, overexpression of ph induces a small-eye phenotype that is rescued by activation of Notch signaling. These data show that ph is a tumor suppressor locus that controls cellular proliferation by silencing multiple Notch signaling components.	[Martinez, Anne-Marie; Schuettengruber, Bernd; Sakr, Samy; Cavalli, Giacomo] CNRS, Inst Genet Humaine, Montpellier, France; [Martinez, Anne-Marie] Univ Montpellier 2, Fac Sci, Montpellier, France; [Janic, Ana; Gonzalez, Cayetano] Inst Res Biomed, Cell Div Grp, Barcelona, Spain; [Janic, Ana; Gonzalez, Cayetano] Inst Catalana Rec & Estudis Avancats, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Cavalli, G (corresponding author), CNRS, Inst Genet Humaine, Montpellier, France.	Anne-Marie.Martinez@igh.cnrs.fr; Giacomo.Cavalli@igh.cnrs.fr	martinez, Anne-marie A.M/R-2751-2017; Gonzalez, Cayetano/K-3055-2019; Janic, Ana/AAR-4783-2020; cavalli, giacomo/Z-2754-2019; Gonzalez, Cayetano/K-3933-2019; Cavalli, Giacomo/A-7958-2008	martinez, Anne-marie A.M/0000-0001-8562-7627; Gonzalez, Cayetano/0000-0002-5259-3608; Janic, Ana/0000-0002-4200-2560; cavalli, giacomo/0000-0003-3709-3469; Cavalli, Giacomo/0000-0003-3709-3469; Schuettengruber, Bernd/0000-0001-7338-4648	CNRS; Human Frontier Science Program Organization; European Union; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Ministere de l'Enseignement Superieur; ICREA Funding Source: Custom	CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program Organization(Human Frontier Science Program); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministere de l'Enseignement Superieur; ICREA(ICREA)	We are grateful to N. Azpiazu, M. Dominguez, F. Maschat, J. Treisman, L. Jan, S. Artavanis-Tsakonas, J.-M. Dura, Y.N. Jan, J. Muller, M. O'Connor, F. Schweisguth, T. Xu, the Bloomington Stock Center ( Indiana University) and the Developmental Studies Hybridoma Bank ( University of Iowa) for fly stocks and antibodies see Supplementary Acknowledgments for details). We thank C. Cazevieille, N. Lautredou and C. Duperray for technical assistance. We also thank F. Bantignies for his contribution on PC foci analysis, T. Sexton for critical reading of the manuscript and members of the Cavalli lab for discussion. G.C.'s research was supported by grants from the CNRS, the Human Frontier Science Program Organization, the European Union FP6 (Network of Excellence the Epigenome and STREP 3D Genome), the Agence Nationale de la Recherche, the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale and the Ministere de l'Enseignement Superieur.	Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Deshpande AM, 2007, ONCOGENE, V26, P1714, DOI 10.1038/sj.onc.1209988; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; HADORN E, 1978, GENETICS BIOL DROS C, V2, P557; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pagliarini Raymond A, 2003, Methods Mol Biol, V223, P349; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tokimasa S, 2001, EXP HEMATOL, V29, P93, DOI 10.1016/S0301-472X(00)00620-2; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	54	94	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1076	U47		10.1038/ng.414	http://dx.doi.org/10.1038/ng.414			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19749760				2022-12-17	WOS:000270330400009
J	van Steensel, B				van Steensel, B			Mapping of genetic and epigenetic regulatory networks using microarrays	NATURE GENETICS			English	Article							GENOME-WIDE LOCATION; DNA METHYLATION; BINDING-SITES; TRANSCRIPTION FACTOR; TARGET GENES; IN-VIVO; C-MYC; EXPRESSION; YEAST; IDENTIFICATION	The highly coordinated expression of thousands of genes in an organism is regulated by the concerted action of hundreds of transcription factors and chromatin proteins, as well as by epigenetic mechanisms. Understanding the architecture of these vastly complex regulatory networks is one of the main challenges in the postgenomic era. New microarray-based techniques have become available for the genome-wide mapping of in vivo protein-DNA interactions and epigenetic marks. Data sets obtained with these techniques begin to offer the first comprehensive views of genetic and epigenetic regulatory networks.	Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	van Steensel, B (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl						Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hatada I, 2002, J HUM GENET, V47, P448, DOI 10.1007/s100380200063; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; KOLLER D, 2005, NAT GENET, V37, P38; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LODEN M, IN PRESS CHROM RES; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ren B, 2004, METHOD ENZYMOL, V376, P304; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2004, METHOD ENZYMOL, V376, P289; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Shi HD, 2003, CANCER RES, V63, P2164; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, BIOTECHNIQUES, V35, P346; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Weil MR, 2004, GENOME RES, V14, P1374, DOI 10.1101/gr.1396104; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Yan PS, 2001, CANCER RES, V61, P8375; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	75	94	103	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S18	S24		10.1038/ng1559	http://dx.doi.org/10.1038/ng1559			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920525	Bronze			2022-12-17	WOS:000229590000005
J	Engel, N; West, AG; Felsenfeld, G; Bartolomei, MS				Engel, N; West, AG; Felsenfeld, G; Bartolomei, MS			Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations	NATURE GENETICS			English	Article							IMPRINTED EXPRESSION; SEQUENCE UPSTREAM; PROTEIN CTCF; METHYLATION; GENE; IGF2; INSULATOR; ELEMENT; REGION; DELETION	Imprinted expression at the H19-Igf2 locus depends on a differentially methylated domain (DMD) that acts both as a maternal-specific, methylation-sensitive insulator and as a paternal-specific site of hypermethylation. Four repeats in the DMD bind CCCTC-binding factor ( CTCF) on the maternal allele and have been proposed to attract methylation on the paternal allele. We introduced point mutations into the DMD to deplete the repeats of CpGs while retaining CTCF-binding and enhancer-blocking activity. Maternal inheritance of the mutations left H19 expression and Igf2 imprinting intact, consistent with the idea that the DMD acts as an insulator. Conversely, paternal inheritance of these mutations disrupted maintenance of DMD methylation, resulting in biallelic H19 expression. Furthermore, an insulator was established on the paternally inherited mutated allele in vivo, reducing Igf2 expression and resulting in a 40% reduction in size of newborn offspring. Thus, the nine CpG mutations in the DMD showed that the two parental-specific roles of the H19 DMD, methylation maintenance and insulator assembly, are antagonistic.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bartolomei, MS (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	bartolom@mail.med.upenn.edu		West, Adam/0000-0003-3502-7804; Engel, Nora/0000-0002-0618-3624	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainscough JFX, 2000, MECH DEVELOP, V91, P365, DOI 10.1016/S0925-4773(99)00289-0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Srivastava M, 2000, GENE DEV, V14, P1186; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	30	94	99	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					883	888		10.1038/ng1399	http://dx.doi.org/10.1038/ng1399			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273688				2022-12-17	WOS:000222974000023
J	Knight, JC; Keating, BJ; Kwiatkowski, DP				Knight, JC; Keating, BJ; Kwiatkowski, DP			Allele-specific repression of lymphotoxin-alpha activated B cell factor-1	NATURE GENETICS			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; GENE POLYMORPHISM; FACTOR-BETA; SEVERE SEPSIS; AMINO-ACID; BINDING; PROTEINS; ENHANCER; ASTHMA	Genetic variation at the human LTA locus, encoding lymphotoxin-alpha, is associated with susceptibility to myocardial infarction, asthma and other diseases. By detailed haplotypic analysis of the locus, we identified a single-nucleotide polymorphism (SNP) at LTA + 80 as a main predictor of LTA protein production by human B cells. We found that activated B-cell factor-1 (ABF-1) binds to this site in vitro and suppresses reporter gene expression, but only in the presence of the LTA +80A allele. Using haplotype-specific chromatin immunoprecipitation, we confirmed that ABF-1 is preferentially recruited to the low-producer allele in vivo. These findings provide a molecular model of how LTA expression may be genetically regulated by allele-specific recruitment of the transcriptional repressor ABF-1.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Knight, JC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	julian@well.ox.ac.uk	Knight, Julian/C-7242-2009; Knight, Julian Charles/W-2399-2019	Knight, Julian/0000-0002-0377-5536; Knight, Julian Charles/0000-0002-0377-5536; Kwiatkowski, Dominic/0000-0002-5023-0176				Albuquerque RV, 1998, CLIN EXP ALLERGY, V28, P578; Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; BADENHOOP K, 1992, J CLIN ENDOCR METAB, V74, P287, DOI 10.1210/jc.74.2.287; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Demeter J, 1997, BRIT J HAEMATOL, V97, P107, DOI 10.1046/j.1365-2141.1997.9912636.x; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lee SH, 1997, LUPUS, V6, P603, DOI 10.1177/096120339700600708; Majetschak M, 1999, ANN SURG, V230, P207, DOI 10.1097/00000658-199908000-00011; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PICOT F, 1993, EUR J IMMUNOL, V23, P224; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHIMURA T, 1994, CANCER, V73, P1184, DOI 10.1002/1097-0142(19940215)73:4<1184::AID-CNCR2820730410>3.0.CO;2-Y; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; Takahashi Y, 2000, GENE DEV, V14, P804; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Whichelow CE, 1996, EUR J IMMUNOGENET, V23, P425, DOI 10.1111/j.1744-313X.1996.tb00133.x; Wong J, 2001, DNA CELL BIOL, V20, P465, DOI 10.1089/104454901316976091; Yamaguchi E, 2001, CHEST, V119, P753, DOI 10.1378/chest.119.3.753	30	94	97	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					394	399		10.1038/ng1331	http://dx.doi.org/10.1038/ng1331			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15052269	Bronze			2022-12-17	WOS:000220647200024
J	Varley, H; Pickett, HA; Foxon, JL; Reddel, RR; Royle, NJ				Varley, H; Pickett, HA; Foxon, JL; Reddel, RR; Royle, NJ			Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells	NATURE GENETICS			English	Article							IMMORTALIZED HUMAN-CELLS; HUMAN XP/YP TELOMERE; HUMAN FIBROBLASTS; LENGTH; MAINTENANCE; RECOMBINATION; MECHANISM; DYNAMICS; CONTAIN; PATHWAY	Telomeres in most immortal cells(1-3) are maintained by the enzyme telomerase(4), allowing cells to divide indefinitely. Some telomerase-negative tumors and immortal cell lines maintain long heterogeneous telomeres by the ALT (alternative lengthening of telomeres) mechanism(5,6); such tumors are expected to be resistant to anti-telomerase drug therapies. Occasionally telomerase-negative Saccharomyces cerevisiae mutants survive, and 10% of them (type II survivors) have unstable telomeres(7,8). As in human ALT+ cells(9), short telomeres in yeast type II survivors lengthen abruptly; in yeast, this is dependent on the recombination proteins Rad52p and Rad50p(10). In human cells, ALT involves copying of sequence from a donor to a recipient telomere(11). We have characterized for the first time a class of complex telomere mutations seen only in ALT+ cells. The mutant telomeres are defined by the replacement of the progenitor telomere at a discrete point (fusion point) with a different telomere repeat array. Among 19 characterized fusion points, one occurred within the first six repeats of the telomere, indicating that these recombination-like events can occur anywhere within the telomere. One mutant telomere may have been involved in a secondary recombination-like mutation event, suggesting that these mutations are sporadic but ongoing in ALT+ cells. We also identified simple intra-allelic mutations at high frequency, which evidently contribute to telomere instability in ALT+ cells.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Childrens Med Res Inst, Canc Res Unit, Sydney, NSW, Australia	University of Leicester; Children's Medical Research Institute - Australia; University of Sydney	Royle, NJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107; Royle, Nicola/0000-0003-1174-6329				ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 1997, HUM MOL GENET, V6, P2291, DOI 10.1093/hmg/6.13.2291; Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Wright WE, 1996, DEV GENET, V18, P173; Yeager TR, 1999, CANCER RES, V59, P4175	28	94	97	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					301	305		10.1038/ng834	http://dx.doi.org/10.1038/ng834			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11919561				2022-12-17	WOS:000174157600015
J	Doxsey, S				Doxsey, S			The centrosome - a tiny organelle with big potential	NATURE GENETICS			English	News Item							POLO-LIKE KINASE; ORGANIZATION; EXPRESSION		Univ Massachusetts, Program Mol Med, Med Ctr, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Doxsey, S (corresponding author), Univ Massachusetts, Program Mol Med, Med Ctr, 373 Plantat St, Worcester, MA 01605 USA.							Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boveri T, 1914, ORIGIN MALIGNANT TUM; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Pihan GA, 1998, CANCER RES, V58, P3974; Smith L, 1998, NAT GENET, V19, P39, DOI 10.1038/ng0598-39; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	17	94	106	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					104	106		10.1038/2392	http://dx.doi.org/10.1038/2392			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771694				2022-12-17	WOS:000076231300003
J	Reiss, J; Cohen, N; Dorche, C; Mandel, H; Mendel, RR; Stallmeyer, B; Zabot, MT; Dierks, T				Reiss, J; Cohen, N; Dorche, C; Mandel, H; Mendel, RR; Stallmeyer, B; Zabot, MT; Dierks, T			Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; EARLY STEPS; BIOSYNTHESIS; MOLYBDOPTERIN; COMPLEMENTATION; REINITIATION; PROTEIN; LENGTH	All molybdoenzymes other than nitrogenase require molyb-dopterin as a metal-binding cofactor(1). Several genes necessary for the synthesis of the molybdenum cofactor (MoCo) have been characterized in bacteria(2,3) and plants(4). The proteins encoded by the Escherichia coli genes moaA and moaC catalyse the first steps in MoCo synthesis. The human homologues of these genes are therefore candidate genes for molybdenum cofactor deficiency, a rare and fatal disease(5). Using oligonucleotides complementary to a conserved region in the moaA gene, we have isolated a human cDNA derived from liver mRNA. This transcript contains an open reading frame (ORF) encoding the human moaA homologue and a second ORF encoding a human moaC homologue. Mutations can be found in the majority of MoCo-deficient patients that confirm the functional role of both ORFs in the corresponding gene MOCS1 (for 'molybdenum cofactor synthesis-step 1'). Northern-blot analysis detected only full-length transcripts containing both consecutive ORFs in various human tissues. The mRNA structure suggests a translation reinitiation mechanism for the second ORF, These data indicate the existence of a eukaryotic mRNA, which as a single and uniform transcript guides the synthesis of two different enzymatic polypeptides with disease-causing potential.	Univ Gottingen, Inst Humangenet, D-37073 Gottingen, Germany; Univ Gottingen, Biochem Abt 2, D-37073 Gottingen, Germany; Technion Israel Inst Technol, Dept Genet, Tamkin Human Mol Genet Res Facil, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Rambam Med Ctr, Dept Pediat, IL-31096 Haifa, Israel; Hop Debrousse, Serv Biochim, F-69322 Lyon 05, France; Tech Univ Braunschweig, Inst Bot, D-38106 Braunschweig, Germany	University of Gottingen; University of Gottingen; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; CHU Lyon; Braunschweig University of Technology	Reiss, J (corresponding author), Univ Gottingen, Inst Humangenet, Gosslerstr 12D, D-37073 Gottingen, Germany.		Dierks, Thomas/A-3596-2012; Stallmeyer, Birgit/AAE-3020-2020	Dierks, Thomas/0000-0001-6426-1339; 				BOUHIDEL K, 1994, NUCLEIC ACIDS RES, V22, P2370, DOI 10.1093/nar/22.12.2370; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; IRBY RB, 1994, J BIOL CHEM, V269, P23981; Johnson J.L, 1995, METABOLIC MOL BASES, V7th edition., P2271, DOI [10.1016/0168-9525(96)81407-7, DOI 10.1016/0168-9525(96)81407-7]; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Menendez C, 1996, FEBS LETT, V391, P101, DOI 10.1016/0014-5793(96)00712-0; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; REISS J, 1987, MOL GEN GENET, V206, P352, DOI 10.1007/BF00333594; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; Shalata A, 1998, AM J HUM GENET, V63, P148, DOI 10.1086/301916; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082	17	94	95	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					51	53		10.1038/1706	http://dx.doi.org/10.1038/1706			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731530				2022-12-17	WOS:000075671400018
J	Good, DJ; Porter, FD; Mahon, KA; Parlow, AF; Westphal, H; Kirsch, IR				Good, DJ; Porter, FD; Mahon, KA; Parlow, AF; Westphal, H; Kirsch, IR			Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene	NATURE GENETICS			English	Article							HORMONE-RELEASING HORMONE; DEVELOPING NERVOUS-SYSTEM; MESSENGER-RNA; NEUROPEPTIDE-Y; MOUSE; EXPRESSION; PITUITARY; DEFICIENCY; LETHALITY; NSCL-2	The family of basic helix-loop-helix (bHLH) genes comprises transcription factors involved in many aspects of growth and development. We have previously described two bHLH transcription factors, Nhlh1 and Nhlh2 (originally named NSCL1 and NSCL2)(1-3). The nucleotide and predicted protein sequences of Nhlh1 and Nhlh2 are homologous within their bHLH domain where there are only three conservative amino acid differences(2,3). During murine embryogenesis, Nhlh1 and Nhlh2 share an overlapping but distinct pattern of expression in the developing nervous system(1,2). To improve our understanding of the role of these genes during neurogenesis, we have generated mice containing targeted deletions of both genes and here describe our results for Nhlh2. Loss of Nhlh2 results in a disruption of the hypothalamic-pituitary axis in mice. Male Nhlh2-/- mice are microphallic, hypogonadal and infertile with alterations in circulating gonadotropins, a defect spermatogenesis and a loss of instinctual male sexual behaviour. Female Nhlh2-/- mice reared alone are hypogonadal, but when reared in the presence of males, their ovaries and uteri develop normally and they are fertile. Both male and female homozygotes exhibit progressive adult-onset obesity. Nhlh2 is expressed in the ventral-medial and lateral hypothalamus, Rathke's pouch and in the anterior lobe of the adult pituitary. Our results support a role for Nhlh2 in the onset of puberty and the regulation of body weight metabolism.	NCI, ACQUIRED GENE REARRANGEMENT SECT, NIH, BETHESDA, MD 20889 USA; NICHHD, LAB MAMMALIAN GENES & DEV, NIH, BETHESDA, MD 20889 USA; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, PITUITARY HORMONES & ANTISERA CTR, TORRANCE, CA 90509 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BRAY GA, 1989, VITAM HORM, V45, P1; Bronson F.H., 1983, P175; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; CHARLTON HM, 1992, PROG BRAIN RES, V93, P321; CONLON RA, 1992, DEVELOPMENT, V116, P357; CROWLEY WF, 1991, RECENT PROG HORM RES, V47, P27; CULLER MD, 1986, ENDOCRINOLOGY, V118, P609, DOI 10.1210/endo-118-2-609; DEYEBENES EG, 1995, BRAIN RES, V674, P112, DOI 10.1016/0006-8993(94)01429-L; GOBEL V, 1992, CELL GROWTH DIFFER, V3, P143; HALPIN DMG, 1986, J REPROD FERTIL, V78, P119, DOI 10.1530/jrf.0.0780119; HOGAN B, 1994, MANIPULATING MOUSE E; IKEDA M, 1995, BIOCHEM BIOPH RES CO, V207, P800, DOI 10.1006/bbrc.1995.1257; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KOVACIC N, 1972, ENDOCRINOLOGY, V91, P910, DOI 10.1210/endo-91-4-910; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIPKOWITZ S, 1992, J BIOL CHEM, V267, P21065; LOPEZ FJ, 1991, P NATL ACAD SCI USA, V88, P4508, DOI 10.1073/pnas.88.10.4508; LOVE PE, 1992, P NATL ACAD SCI USA, V89, P9929, DOI 10.1073/pnas.89.20.9929; MATOCHIK JA, 1994, BEHAV BRAIN RES, V60, P141, DOI 10.1016/0166-4328(94)90141-4; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; OATES E, 1984, J BIOL CHEM, V259, P7421; PARKINSON WL, 1990, AM J PHYSIOL, V259, pR829, DOI 10.1152/ajpregu.1990.259.4.R829; REHBEIN M, 1986, BIOL CHEM H-S, V367, P695, DOI 10.1515/bchm3.1986.367.2.695; RUGH R, 1990, MOUSE ITS REPROD DEV, P1; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; TAKEUCHI T, 1986, J CLIN INVEST, V77, P1038, DOI 10.1172/JCI112357; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WRAY S, 1988, PEPTIDES, V9, P1151, DOI 10.1016/0196-9781(88)90103-9; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	94	97	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					397	401		10.1038/ng0497-397	http://dx.doi.org/10.1038/ng0497-397			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090387				2022-12-17	WOS:A1997WQ38900020
J	SUZUKI, H; UEDA, R; TAKAHASHI, T; TAKAHASHI, T				SUZUKI, H; UEDA, R; TAKAHASHI, T; TAKAHASHI, T			ALTERED IMPRINTING IN LUNG-CANCER	NATURE GENETICS			English	Letter							CELL-LINES; GENE; ADENOCARCINOMA; ABNORMALITIES; EXPRESSION; P53		AICHI CANC CTR RES INST,IMMUNOL LAB,CHIKUSA KU,NAGOYA 464,JAPAN		SUZUKI, H (corresponding author), AICHI CANC CTR RES INST,CHEMOTHERAPY LAB,CHIKUSA KU,NAGOYA 464,JAPAN.		Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001				BROWN AL, 1986, J BIOL CHEM, V261, P3144; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; NAKANISHI Y, 1988, J CLIN INVEST, V82, P354, DOI 10.1172/JCI113594; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REEVE JG, 1992, J NATL CANCER I, V84, P628, DOI 10.1093/jnci/84.8.628; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; SHIRAISHI M, 1987, JPN J CANCER RES, V78, P1302; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAHASHI T, 1991, ONCOGENE, V6, P1775; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099	18	94	97	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					332	333		10.1038/ng0494-332	http://dx.doi.org/10.1038/ng0494-332			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054970				2022-12-17	WOS:A1994ND87000007
J	KNUDSON, AG				KNUDSON, AG			ALL IN THE (CANCER) FAMILY	NATURE GENETICS			English	Editorial Material							BECKWITH-WIEDEMANN SYNDROME; WILMS TUMOR LOCUS; BREAST-CANCER; TYPE-1 GENE; IDENTIFICATION; CHROMOSOME-11; MUTATIONS; RETINOBLASTOMA; SEGMENT				KNUDSON, AG (corresponding author), FOX CHASE CANC CTR,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.							AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; BISHOP DT, 1993, AM J HUM GENET, V52, P677; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; EMI M, 1993, NAT GENET, V5, P151, DOI 10.1038/ng1093-151; Escobar V, 1976, Birth Defects Orig Artic Ser, V12, P151; FAULKNER KW, 1983, J PEDIATR-US, V103, P600, DOI 10.1016/S0022-3476(83)80598-8; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRYER AE, 1987, LANCET, V1, P659; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GUNZ FW, 1979, J NATL CANCER I, V60, P1243; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; Knudson A. G., 1973, ADV CANCER RES, V17, P317; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LAWLOR KG, 1992, CELL GROWTH DIFFER, V3, P609; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PARRY DM, 1982, J NATL CANCER I, V68, P573; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; THUWE I, 1979, LANCET, V1, P504; TROFATTER JA, 1993, CELL, V72, P7791; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143	38	94	100	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					103	104		10.1038/ng1093-103	http://dx.doi.org/10.1038/ng1093-103			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252032				2022-12-17	WOS:A1993MA05600002
J	WHITE, RA; PETERS, LL; ADKISON, LR; KORSGREN, C; COHEN, CM; LUX, SE				WHITE, RA; PETERS, LL; ADKISON, LR; KORSGREN, C; COHEN, CM; LUX, SE			THE MURINE PALLID MUTATION IS A PLATELET STORAGE POOL DISEASE ASSOCIATED WITH THE PROTEIN 42 (PALLIDIN) GENE	NATURE GENETICS			English	Article							HUMAN-ERYTHROCYTE-MEMBRANE; CYTOPLASMIC DOMAIN; BAND 4.2; MOUSE MODEL; DEFICIENCY; ANKYRIN; CELLS; MICE	Pallid is one of 12 independent murine mutations with a prolonged bleeding time that are models for human platelet storage pool deficiencies in which several intracellular organelles are abnormal. We have mapped the murine gene for protein 4.2 (Epb4.2) to chromosome 2 where it co-localizes with pallid. Southern blot analyses suggest that pallid is a mutation in the Epb4.2 gene. Northern blot analyses demonstrate a smaller than normal Epb4.2 transcript in affected pallid tissues, such as kidney and skin. This is the first gene defect to be associated with a platelet storage pool deficiency, and may allow the identification of a novel structure or biological pathway that influences granulogenesis.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; MERCER UNIV,SCH MED,DEPT HUMAN GENET,MACON,GA 31207; TUFTS UNIV,SCH MED,BOSTON,MA 02115; ST ELIZABETH HOSP,DEPT BIOMED RES,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Mercer University; Tufts University	WHITE, RA (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02115, USA.			Peters, Luanne/0000-0002-0784-0534				ABO T, 1982, J CLIN INVEST, V70, P193, DOI 10.1172/JCI110592; AHMED F, 1989, EXPERIENTIA, V45, P1133, DOI 10.1007/BF01950180; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BOXER GJ, 1977, BRIT J HAEMATOL, V35, P521; CLARK EA, 1981, IMMUNOGENETICS, V12, P601, DOI 10.1007/BF01561700; CONBOY J, 1990, J CLIN INVEST, V86, P524, DOI 10.1172/JCI114739; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; DEPINHO RA, 1985, MEDICINE, V64, P192, DOI 10.1097/00005792-198505000-00004; Flaherty L, 1981, MOUSE BIOMEDICAL RES, P215; FRIEDRICHS B, 1989, EUR J CELL BIOL, V48, P121; GHANEM A, 1990, BRIT J HAEMATOL, V75, P414, DOI 10.1111/j.1365-2141.1990.tb04357.x; IDEGUCHI H, 1990, BRIT J HAEMATOL, V74, P347, DOI 10.1111/j.1365-2141.1990.tb02594.x; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; LANE PW, 1989, GENETIC VARIANTS STR, P825; LYON MF, 1953, J GENET, V51, P638, DOI 10.1007/BF02982950; Lyon ML, 1989, GENETIC VARIANTS STR, P773; MCCLUER RH, 1981, J BIOL CHEM, V256, P3112; MEISLER MH, 1978, J BIOL CHEM, V253, P3129; NOVAK EK, 1988, BRIT J HAEMATOL, V69, P371, DOI 10.1111/j.1365-2141.1988.tb02376.x; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1980, BIOCHEM GENET, V18, P549, DOI 10.1007/BF00484401; NOVAK EK, 1979, GENETICS, V92, P189; NOVAK EK, 1980, GENET RES, V35, P195, DOI 10.1017/S001667230001404X; ORN A, 1982, SCAND J IMMUNOL, V15, P305, DOI 10.1111/j.1365-3083.1982.tb00653.x; PETERS LL, 1991, J CELL BIOL, V114, P114; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PHILLIPS MA, 1992, J BIOL CHEM, V267, P2282; REDDINGTON M, 1987, BLOOD, V69, P1300; RISINGER MA, 1992, J BIOL CHEM, V267, P5680; Roberts E, 1931, SCIENCE, V74, P569, DOI 10.1126/science.74.1927.569; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; RYBICKI AC, 1988, J CLIN INVEST, V81, P893, DOI 10.1172/JCI113400; SILVER J, 1985, J HERED, V76, P436, DOI 10.1093/oxfordjournals.jhered.a110140; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNG LA, 1990, P NATL ACAD SCI USA, V87, P955, DOI 10.1073/pnas.87.3.955; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; SWANK RT, 1991, BLOOD, V78, P2036, DOI 10.1182/blood.V78.8.2036.bloodjournal7882036; THERIAULT LL, 1970, DEV BIOL, V23, P261, DOI 10.1016/0012-1606(70)90098-9; WHITE RA, 1992, MAMM GENOME, V3, P281, DOI 10.1007/BF00292156	43	94	95	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					80	83		10.1038/ng0992-80	http://dx.doi.org/10.1038/ng0992-80			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284644				2022-12-17	WOS:A1992JM64600021
J	Speidel, L; Forest, M; Shi, SN; Myers, SR				Speidel, Leo; Forest, Marie; Shi, Sinan; Myers, Simon R.			A method for genome-wide genealogy estimation for thousands of samples	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; POPULATION HISTORY; POSITIVE SELECTION; HUMAN ADAPTATION; INFERENCE; RECOMBINATION; EVOLUTION; SEQUENCES; NEANDERTHAL; ALLELE	Knowledge of genome-wide genealogies for thousands of individuals would simplify most evolutionary analyses for humans and other species, but has remained computationally infeasible. We have developed a method, Relate, scaling to >10,000 sequences while simultaneously estimating branch lengths, mutational ages and variable historical population sizes, as well as allowing for data errors. Application to 1,000 Genomes Project haplotypes produces joint genealogical histories for 26 human populations. Highly diverged lineages are present in all groups, but most frequent in Africa. Outside Africa, these mainly reflect ancient introgression from groups related to Neanderthals and Denisovans, while African signals instead reflect unknown events unique to that continent. Our approach allows more powerful inferences of natural selection than has previously been possible. We identify multiple regions under strong positive selection, and multi-allelic traits including hair color, body mass index and blood pressure, showing strong evidence of directional selection, varying among human groups.	[Speidel, Leo; Shi, Sinan; Myers, Simon R.] Univ Oxford, Dept Stat, Oxford, England; [Forest, Marie] Univ Quebec Montreal, Montreal, PQ, Canada; [Myers, Simon R.] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England	University of Oxford; University of Quebec; University of Quebec Montreal; University of Oxford; Wellcome Centre for Human Genetics	Myers, SR (corresponding author), Univ Oxford, Dept Stat, Oxford, England.; Myers, SR (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.	myers@stats.ox.ac.uk			Engineering and Physical Sciences Research Council [EP/G03706X/1]; Natural Sciences and Engineering Research Council of Canada (PGS D); Clarendon Scholarship; Wellcome Trust Investigator Award [098387/Z/12/Z, 212284/Z/18/Z]; Health Data Research UK; NIHR Oxford Biomedical Research Centre; Wellcome Trust Core Award [203141/Z/16/Z]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Sciences and Engineering Research Council of Canada (PGS D)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Clarendon Scholarship; Wellcome Trust Investigator Award(Wellcome Trust); Health Data Research UK; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust Core Award(Wellcome Trust)	We thank N. Barton, D. Falush, M. Przeworski, G. Sella, J. Terhorst, P. Palamara, G. Lunter, J. Marchini, S. Hu, C. B. Cole, T. Aid and C. E. West for helpful comments, ideas and suggestions. L. S. acknowledges the support provided through the Engineering and Physical Sciences Research Council (grant number EP/G03706X/1). M. F. acknowledges the support provided through the Natural Sciences and Engineering Research Council of Canada (PGS D) and the Clarendon Scholarship. S. R. M. acknowledges the support provided by the Wellcome Trust Investigator Award (grant number 098387/Z/12/Z and 212284/Z/18/Z). For computation we used the Oxford Biomedical Research Computing facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. Financial support was provided by the Wellcome Trust Core Award grant number 203141/Z/16/Z. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bae CJ, 2017, SCIENCE, V358, DOI 10.1126/science.aai9067; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Chheda H, 2017, EUR J HUM GENET, V25, P477, DOI 10.1038/ejhg.2016.205; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Edge MD, 2019, GENETICS, V211, P235, DOI 10.1534/genetics.118.301687; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Falush D, 2003, GENETICS, V164, P1567; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Goudarzi M, 2019, ELIFE, V8, DOI [10.7554/eLife.40815, 10.7554/eLife.39725]; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harris K, 2015, P NATL ACAD SCI USA, V112, P3439, DOI 10.1073/pnas.1418652112; HEIN J, 1990, MATH BIOSCI, V98, P185, DOI 10.1016/0025-5564(90)90123-G; Henderson D., 2018, DEMOGRAPHIC INFERENC, DOI [10.1101/382218, DOI 10.1101/382218]; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Kececioglu J, 1998, DISCRETE APPL MATH, V88, P239, DOI 10.1016/S0166-218X(98)00074-2; Kelleher J., 2018, INFERRING ANCESTRY E, DOI [10.1101/458067, DOI 10.1101/458067]; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Kiezun A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003301; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li N, 2003, GENETICS, V165, P2213; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; MARUYAMA T, 1974, GENET RES, V23, P137, DOI 10.1017/S0016672300014750; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; McVean GAT, 2005, PHILOS T R SOC B, V360, P1387, DOI 10.1098/rstb.2005.1673; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mirzaei S, 2017, BIOINFORMATICS, V33, P1021, DOI 10.1093/bioinformatics/btw735; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novick D, 2016, NEUROPSYCH DIS TREAT, V12, P2927, DOI 10.2147/NDT.S101151; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ragsdale AP, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008204; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401; Ruderfer DM, 2018, CELL, V173, P1705, DOI 10.1016/j.cell.2018.05.046; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Sadier A, 2014, TRENDS GENET, V30, P24, DOI 10.1016/j.tig.2013.08.006; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Simons YB, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002985; Sohail M, 2019, ELIFE, V8, DOI 10.7554/eLife.39702; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748; Teshima KM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-166; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang LS, 2001, J COMPUT BIOL, V8, P69, DOI 10.1089/106652701300099119; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Wu YF, 2011, IEEE ACM T COMPUT BI, V8, P182, DOI 10.1109/TCBB.2009.27; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhang G, 2013, APPL TRANSL GENOM, V2, P78, DOI 10.1016/j.atg.2013.10.002	71	93	92	4	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2019	51	9					1321	+		10.1038/s41588-019-0484-x	http://dx.doi.org/10.1038/s41588-019-0484-x			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV1AX		Green Submitted, Green Accepted			2022-12-17	WOS:000484010800008
J	Bolhaqueiro, ACF; Ponsioen, B; Bakker, B; Klaasen, SJ; Kucukkose, E; van Jaarsveld, RH; Vivie, J; Verlaan-Klink, I; Hami, N; Spierings, DCJ; Sasaki, N; Dutta, D; Boj, SF; Vries, RGJ; Lansdorp, PM; van de Wetering, M; van Oudenaarden, A; Clevers, H; Kranenburg, O; Foijer, F; Snippert, HJG; Kops, GJPL				Bolhaqueiro, Ana C. F.; Ponsioen, Bas; Bakker, Bjorn; Klaasen, Sjoerd J.; Kucukkose, Emre; van Jaarsveld, Richard H.; Vivie, Judith; Verlaan-Klink, Ingrid; Hami, Nizar; Spierings, Diana C. J.; Sasaki, Nobuo; Dutta, Devanjali; Boj, Sylvia F.; Vries, Robert G. J.; Lansdorp, Peter M.; van de Wetering, Marc; van Oudenaarden, Alexander; Clevers, Hans; Kranenburg, Onno; Foijer, Floris; Snippert, Hugo J. G.; Kops, Geert J. P. L.			Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids	NATURE GENETICS			English	Article							TUMOR EVOLUTION; DNA-DAMAGE; INTRATUMOR HETEROGENEITY; GENETIC INSTABILITY; SEGREGATION ERRORS; MIS-SEGREGATION; HUMAN COLON; IN-VITRO; ANEUPLOIDY; CELLS	Chromosome segregation errors cause aneuploidy and genomic heterogeneity, which are hallmarks of cancer in humans. A persistent high frequency of these errors (chromosomal instability (CIN)) is predicted to profoundly impact tumor evolution and therapy response. It is unknown, however, how prevalent CIN is in human tumors. Using three-dimensional live-cell imaging of patient-derived tumor organoids (tumor PDOs), we show that CIN is widespread in colorectal carcinomas regardless of background genetic alterations, including microsatellite instability. Cell-fate tracking showed that, although mitotic errors are frequently followed by cell death, some tumor PDOs are largely insensitive to mitotic errors. Single-cell karyotype sequencing confirmed heterogeneity of copy number alterations in tumor PDOs and showed that monoclonal lines evolved novel karyo-types over time in vitro. We conclude that ongoing CIN is common in colorectal cancer organoids, and propose that CIN levels and the tolerance for mitotic errors shape aneuploidy landscapes and karyotype heterogeneity.	[Bolhaqueiro, Ana C. F.; Klaasen, Sjoerd J.; van Jaarsveld, Richard H.; Vivie, Judith; Sasaki, Nobuo; Dutta, Devanjali; van Oudenaarden, Alexander; Clevers, Hans; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Hubrecht Inst KNAW, Oncode Inst, Utrecht, Netherlands; [Ponsioen, Bas; Verlaan-Klink, Ingrid; Hami, Nizar; Snippert, Hugo J. G.] Univ Med Ctr Utrecht, Ctr Mol Med, Oncode Inst, Utrecht, Netherlands; [Bakker, Bjorn; Spierings, Diana C. J.; Lansdorp, Peter M.; Foijer, Floris] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Kucukkose, Emre; Kranenburg, Onno] Univ Med Ctr, UMC Utrecht Canc Ctr, Dept Surg Oncol, Utrecht, BC, Canada; [Boj, Sylvia F.; Vries, Robert G. J.] Fdn Hubrecht Organoid Technol HUB, Utrecht, Netherlands; [Lansdorp, Peter M.] Univ British Columbia, Terry Fox Lab, BC Canc Agcy, Dept Med Genet, Vancouver, BC, Canada; [van de Wetering, Marc; Clevers, Hans] Princess Maxima Ctr Paediat Oncol, Oncode Inst, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; British Columbia Cancer Agency; University of British Columbia	Kops, GJPL (corresponding author), Univ Med Ctr Utrecht, Hubrecht Inst KNAW, Oncode Inst, Utrecht, Netherlands.; Snippert, HJG (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Oncode Inst, Utrecht, Netherlands.	H.J.G.Snippert@umcutrecht.nl; g.kops@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Sasaki, Nobuo/HDO-8251-2022; de Andrés San Cristóbal, Marta/ABF-5806-2021	Sasaki, Nobuo/0000-0002-8798-7244; Kucukkose, Emre/0000-0002-8983-9464; Bakker, Bjorn/0000-0003-3095-7287; Foijer, Floris/0000-0003-0989-3127; Lansdorp, Peter/0000-0001-7435-1071; van Jaarsveld, Richard H/0000-0001-5247-6965; Klaasen, Sjoerd/0000-0002-2915-3217	Dutch Cancer Society [KWF/HUBR-2015-7848]; gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO); FP7-MSCA-ITN-2013 grant (PloidyNet) [607722]; NWO TOP grant [91215003]; ERC	Dutch Cancer Society(KWF Kankerbestrijding); gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); FP7-MSCA-ITN-2013 grant (PloidyNet); NWO TOP grant; ERC(European Research Council (ERC)European Commission)	We thank members of the Kops, Snippert and Clevers laboratories for reagents, suggestions and discussions; Y. Bollen and E. Stelloo for help with bulk genome sequencing; S. Sonneveld and F. Ferreira for help with R; and R. Wardenaar for the modifications on the Aneufinder algorithm. We are grateful to the Hubrecht Imaging Centre, particularly to A. Graaf, the Hubrecht Flow Cytometry facility, the USEQ Utrecht sequencing facility, and the ERIBA FACS and DNA sequencing facilities. This work is part of the Oncode Institute, which is partly financed by the Dutch Cancer Society, and was funded by the gravitation program CancerGenomiCs.nl from the Netherlands Organisation for Scientific Research (NWO), by a grant from the Dutch Cancer Society (KWF/HUBR-2015-7848), by a FP7-MSCA-ITN-2013 grant (PloidyNet, 607722), an NWO TOP grant (grant 91215003 to F.F.), an ERC starting grant (to H.J.G.S.) and by an Advanced Grant (to P. M. L.).	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Bakhoum SF, 2014, CANCER DISCOV, V4, P1281, DOI 10.1158/2159-8290.CD-14-0403; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Buccitelli C, 2017, GENOME RES, V27, P501, DOI 10.1101/gr.212225.116; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Davis A, 2017, BBA-REV CANCER, V1867, P151, DOI 10.1016/j.bbcan.2017.01.003; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Knouse KA, 2018, CELL, V175, P200, DOI 10.1016/j.cell.2018.07.042; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lopez-Garcia C, 2017, CANCER CELL, V31, P79, DOI 10.1016/j.ccell.2016.11.001; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Lu YW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152673; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Mamlouk S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14093; Mitelman F, 2018, MITELMAN DATABASE CH; Morrissy AS, 2017, NAT GENET, V49, P780, DOI 10.1038/ng.3838; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8319; Navin NE, 2014, CELL REP, V6, P417, DOI 10.1016/j.celrep.2014.01.035; Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Roylance R, 2014, BREAST CANCER RES TR, V148, P221, DOI 10.1007/s10549-014-3153-x; Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sansregret L, 2018, NAT REV CLIN ONCOL, V15, P139, DOI 10.1038/nrclinonc.2017.198; Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schutte M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14262; Schukken KM, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700147; Shih IM, 2001, CANCER RES, V61, P818; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Soto M, 2017, CELL REP, V19, P2423, DOI 10.1016/j.celrep.2017.05.055; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Jaarsveld RH, 2016, TRENDS CANCER, V2, P561, DOI 10.1016/j.trecan.2016.09.003; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang ML, 2016, EMBO J, V35, P2285, DOI 10.15252/embj.201593103; 2013, NAT METHODS, V10, P407, DOI DOI 10.1038/NMETH.2413; 2017, NAT MED, V23, P1424, DOI DOI 10.1038/NM.4438; 2013, SCIENCE, V339, P543, DOI DOI 10.1126/SCIENCE.1227670	70	93	94	3	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					824	+		10.1038/s41588-019-0399-6	http://dx.doi.org/10.1038/s41588-019-0399-6			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK	31036964	Green Submitted			2022-12-17	WOS:000466842000010
J	Holt, KE; McAdam, P; Thai, PVK; Thuong, NTT; Ha, DTM; Lan, NN; Lan, NH; Nhu, NTQ; Hai, HT; Ha, VTN; Thwaites, G; Edwards, DJ; Nath, AP; Pham, K; Ascher, DB; Farrar, J; Khor, CC; Teo, YY; Inouye, M; Caws, M; Dunstan, SJ				Holt, Kathryn E.; McAdam, Paul; Phan Vuong Khac Thai; Nguyen Thuy Thuong Thuong; Dang Thi Minh Ha; Nguyen Ngoc Lan; Nguyen Huu Lan; Nguyen Thi Quynh Nhu; Hoang Thanh Hai; Vu Thi Ngoc Ha; Thwaites, Guy; Edwards, David J.; Nath, Artika P.; Pham, Kym; Ascher, David B.; Farrar, Jeremy; Khor, Chiea Chuen; Teo, Yik Ying; Inouye, Michael; Caws, Maxine; Dunstan, Sarah J.			Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam	NATURE GENETICS			English	Article							DRUG-RESISTANCE; LYMPHATIC EXPOSURE; PROTEIN STABILITY; GENETIC-DISEASE; MUTATIONS; GENOTYPE; EVOLUTION; VACCINE; SERVER; IDENTIFICATION	To examine the transmission dynamics of Mycobacterium tuberculosis (Mtb) isolated from tuberculosis patients in Ho Chi Minh City, Vietnam, we sequenced the whole genomes of 1,635 isolates and compared these with 3,144 isolates from elsewhere. The data identify an underlying burden of disease caused by the endemic Mtb lineage 1 associated with the activation of long-term latent infection, and a threefold higher burden associated with the more recently introduced Beijing lineage and lineage 4 Mtb strains. We find that Beijing lineage Mtb is frequently transferred between Vietnam and other countries, and detect higher levels of transmission of Beijing lineage strains within this host population than the endemic lineage 1 Mtb. Screening for parallel evolution of Beijing lineage-associated SNPs in other Mtb lineages as a signal of positive selection, we identify an alteration in the ESX-5 type VII-secreted protein EsxW, which could potentially contribute to the enhanced transmission of Beijing lineage Mtb in Vietnamese and other host populations.	[Holt, Kathryn E.; McAdam, Paul; Edwards, David J.; Ascher, David B.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Phan Vuong Khac Thai; Dang Thi Minh Ha; Nguyen Ngoc Lan; Nguyen Huu Lan] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Nguyen Thuy Thuong Thuong; Nguyen Thi Quynh Nhu; Hoang Thanh Hai; Vu Thi Ngoc Ha; Thwaites, Guy; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Thwaites, Guy; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Nath, Artika P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Nath, Artika P.; Inouye, Michael] Baker Heart & Diabet Inst, Syst Genom Lab, Melbourne, Vic, Australia; [Pham, Kym; Inouye, Michael] Univ Melbourne, Dept Clin Pathol, Parkville, Vic, Australia; [Khor, Chiea Chuen] Genome Inst Singapore, Singapore, Singapore; [Khor, Chiea Chuen] Singapore Eye Res Inst, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Inouye, Michael] Univ Cambridge, Strangeways Res Labs, Dept Publ Hlth & Primary Care, Cambridge, England; [Caws, Maxine] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Caws, Maxine] Birat Nepal Med Trust, Kathmandu, Nepal; [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia	University of Melbourne; University of Oxford; University of Oxford; University of Melbourne; University of Melbourne; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; University of Cambridge; Liverpool School of Tropical Medicine; University of Melbourne	Holt, KE (corresponding author), Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Dept Biochem & Mol Biol, Parkville, Vic, Australia.; Dunstan, SJ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia.	kholt@unimelb.edu.au; sarah.dunstan@unimelb.edu.au	Holt, Kathryn E/A-8108-2012; Dunstan, Sarah/AAO-9597-2020; Hải, Hoàng/GXA-2392-2022; Thwaites, Guy E/R-4993-2019; Farrar, Jeremy J./HGA-7610-2022	Holt, Kathryn E/0000-0003-3949-2471; Thwaites, Guy E/0000-0002-2858-2087; Inouye, Michael/0000-0001-9413-6520; McAdam, Paul/0000-0001-6465-9910; Dunstan, Sarah/0000-0001-7873-933X; Ascher, David/0000-0003-2948-2413; Caws, Maxine/0000-0002-9109-350X	National Health and Medical Research Council, Australia [1056689, 1061409, 1061435, 1072476]; A*STAR Biomedical Research Council, Singapore [12/1/21/24/6689]; Wellcome Trust UK [081814/Z/06/Z]; Major Overseas Program in Vietnam [089276/Z/09/Z, 106680/B/14/Z]; MRC [MR/L003120/1] Funding Source: UKRI	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); A*STAR Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Wellcome Trust UK(Wellcome Trust); Major Overseas Program in Vietnam; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the clinical staff who recruited patients into our study from the following District TB Units (DTUs) in HCMC, Vietnam: Districts 1, 4, 5, 6 and 8, Tan Binh, Binh Thanh and Phu Nhuan; and also our colleagues from Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, HCMC Vietnam. This work was supported by the National Health and Medical Research Council, Australia (project grant no. 1056689 to S.J.D., Fellowship no. 1061409 to K.E.H., Fellowship no. 1061435 to M.I., Fellowship no. 1072476 to D.B.A.), A*STAR Biomedical Research Council, Singapore (12/1/21/24/6689 to Y.Y.T.) and the Wellcome Trust UK (research training fellowship no. 081814/Z/06/Z to M.C.) and as part of their Major Overseas Program in Vietnam (089276/Z/09/Z to J.F. and 106680/B/14/Z to G.T.).	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Albanaz ATS, 2017, EXPERT OPIN DRUG DIS, V12, P553, DOI 10.1080/17460441.2017.1322579; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Baldwin SL, 2016, CLIN VACCINE IMMUNOL, V23, P137, DOI 10.1128/CVI.00458-15; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Brennan MJ, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00969-16, 10.1128/iai.00969-16]; Bukka A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00266; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Carver T, 2013, BRIEF BIOINFORM, V14, P203, DOI 10.1093/bib/bbr073; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Casey RT, 2017, MOL GENET GENOM MED, V5, P237, DOI 10.1002/mgg3.279; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan LDJ, 2016, MOL PHARMACEUT, V13, P1229, DOI 10.1021/acs.molpharmaceut.5b00749; Chan LJ, 2015, MOL PHARMACEUT, V12, P794, DOI 10.1021/mp5006189; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coppola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37793; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Groschel MI, 2016, NAT REV MICROBIOL, V14, P677, DOI 10.1038/nrmicro.2016.131; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Hazbon MH, 2008, ANTIMICROB AGENTS CH, V52, P3369, DOI 10.1128/AAC.00309-08; Houben RMGJ, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002152, 10.1371/journal.pmed.1002119]; Jafri M, 2015, CANCER DISCOV, V5, P723, DOI 10.1158/2159-8290.CD-14-1096; Jubb HC, 2017, PROG BIOPHYS MOL BIO, V128, P3, DOI 10.1016/j.pbiomolbio.2016.10.002; Kano FS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005177; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Knudsen NPH, 2014, P NATL ACAD SCI USA, V111, P1096, DOI 10.1073/pnas.1314973111; Kumar A, 2005, FEMS IMMUNOL MED MIC, V43, P185, DOI 10.1016/j.femsim.2004.08.013; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee CH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2554-y; Lewinsohn DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Maeda S, 2014, TUBERCULOSIS, V94, P649, DOI 10.1016/j.tube.2014.09.005; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mortimer TD, 2017, GENOME BIOL EVOL, V9, P398, DOI 10.1093/gbe/evx001; Nemethova M, 2016, EUR J HUM GENET, V24, P66, DOI 10.1038/ejhg.2015.60; NGUYEN VAT, 2012, PLOS ONE, V0007; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; Pandurangan AP, 2017, BIOCHEM SOC T, V45, P303, DOI 10.1042/BST20160422; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Thai PVK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3033-9; Phelan J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0575-9; Pires DEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19848; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Silvino ACR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160172; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah S, 2015, INFECT IMMUN, V83, P4349, DOI 10.1128/IAI.00827-15; Soardi FC, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0009-4; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stucki D, 2016, NAT GENET, V48, P1535, DOI 10.1038/ng.3704; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; Usher JL, 2015, JIMD REP, V24, P3, DOI 10.1007/8904_2014_380; Nguyen VAT, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0784-6; van Laarhoven A, 2013, INFECT IMMUN, V81, P3750, DOI 10.1128/IAI.00282-13; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Vijay S. V., 2017, FRONT MICROBIOL, V8, P1; White RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005977; Wlodarska M, 2015, CLIN MICROBIOL REV, V28, P523, DOI 10.1128/CMR.00124-14; World Health Organization, 2017, GLOB TUB REP 2017; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zumla A, 2012, J INFECT DIS, V205, pS141, DOI 10.1093/infdis/jir880	84	93	94	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					849	+		10.1038/s41588-018-0117-9	http://dx.doi.org/10.1038/s41588-018-0117-9			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29785015	Green Accepted, Green Submitted			2022-12-17	WOS:000433621000012
J	Walker, J; Gao, HB; Zhang, JY; Aldridge, B; Vickers, M; Higgins, JD; Feng, XQ				Walker, James; Gao, Hongbo; Zhang, Jingyi; Aldridge, Billy; Vickers, Martin; Higgins, James D.; Feng, Xiaoqi			Sexual-lineage-specific DNA methylation regulates meiosis in Arabidopsis	NATURE GENETICS			English	Article							GENE-EXPRESSION; CG METHYLATION; THALIANA; DIFFERENTIATION; PLANTS; DEMETHYLATION; EVOLUTION; CELLS; CROSSTALK; ELEMENTS	DNA methylation regulates eukaryotic gene expression and is extensively reprogrammed during animal development. However, whether developmental methylation reprogramming during the sporophytic life cycle of flowering plants regulates genes is presently unknown. Here we report a distinctive gene-targeted RNA-directed DNA methylation (RdDM) activity in the Arabidopsis thaliana male sexual lineage that regulates gene expression in meiocytes. Loss of sexual-lineage-specific RdDM causes mis-splicing of the MPS1 gene (also known as PRD2), thereby disrupting meiosis. Our results establish a regulatory paradigm in which de novo methylation creates a cell-lineage-specific epigenetic signature that controls gene expression and contributes to cellular function in flowering plants.	[Walker, James; Gao, Hongbo; Zhang, Jingyi; Aldridge, Billy; Vickers, Martin; Feng, Xiaoqi] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Higgins, James D.] Univ Leicester, Dept Genet, Leicester, Leics, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Leicester	Feng, XQ (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England.	xiaoqi.feng@jic.ac.uk		Aldridge, Billy/0000-0002-9404-3815; Walker, James/0000-0002-4289-6197; Feng, Xiaoqi/0000-0002-4008-1234; Zhang, Jingyi/0000-0002-5292-8279; Vickers, Martin/0000-0002-1543-4827	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/L025043/1]; BBSRC [BB/M01973X/1]; Sainsbury PhD Studentship; BBSRC [BB/L025043/1, BBS/E/J/000C0675, BBS/E/J/000PR9773] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9773, BBS/E/J/000C0675, BB/L025043/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sainsbury PhD Studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Zilberman for intellectual contributions to this work; D. Zilberman, C. Dean, K. Bomblies, V. Kumar, S. Brady and S. Kamoun for comments on the manuscript; H. Dickinson and J. Hellberg for developing the meiocyte isolation method; G. Oldroyd (Sainsbury Laboratory, Cambridge University) for the pGWB13-Bar vector; E. Fiume (Institut Jean-Pierre Bourgin, Paris) for the pMDC107-NTF vector; M. Hartley, M. Couchman and T. S. G. Olsson at the John Innes Centre Computing Infrastructure for Science Facility for bioinformatics support; and the Norwich Bioscience Institute Partnership Computing Infrastructure for Science group for High Performance Computing resources and the John Innes Centre Bioimaging Facility for assistance with microscopy. This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship (BB/L025043/1) to X.F., a BBSRC grant (BB/M01973X/1) to J.D.H. and a Sainsbury PhD Studentship to J.W.	Armstrong SJ, 2009, METHODS MOL BIOL, V558, P131, DOI 10.1007/978-1-60761-103-5_9; Baubec T, 2014, EMBO REP, V15, P446, DOI 10.1002/embr.201337915; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Catoni M, 2017, EMBO J, V36, P617, DOI 10.15252/embj.201695602; Chen CB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-280; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; De Muyt A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000654; Deal RB, 2011, NAT PROTOC, V6, P56, DOI 10.1038/nprot.2010.175; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Feng XQ, 2013, DEV CELL, V24, P215, DOI 10.1016/j.devcel.2013.01.014; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Hsieh PH, 2016, P NATL ACAD SCI USA, V113, P15132, DOI 10.1073/pnas.1619074114; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Jiang CF, 2014, GENOME RES, V24, P1821, DOI 10.1101/gr.177659.114; Jiang H, 2009, PLANT J, V59, P1001, DOI 10.1111/j.1365-313X.2009.03929.x; Kawakatsu T, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.58, 10.1038/NPLANTS.2016.58]; Kawashima T, 2014, NAT REV GENET, V15, P613, DOI 10.1038/nrg3685; Kim MY, 2014, TRENDS PLANT SCI, V19, P320, DOI 10.1016/j.tplants.2014.01.014; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-116; Lipka DB, 2014, CELL CYCLE, V13, P3476, DOI 10.4161/15384101.2014.973334; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; Martinez G, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.30, 10.1038/nplants.2016.30]; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Oliver C, 2016, GENETICS, V204, P543, DOI 10.1534/genetics.116.189217; Park K, 2016, P NATL ACAD SCI USA, V113, P15138, DOI 10.1073/pnas.1619047114; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Rodrigues JA, 2015, GENE DEV, V29, P2517, DOI 10.1101/gad.269902.115; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Slieker RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005583; SONOBE S, 1989, PROTOPLASMA, V148, P80, DOI 10.1007/BF02079325; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Wang XT, 2016, MOL PLANT, V9, P305, DOI 10.1016/j.molp.2015.09.016; Wibowo A, 2016, ELIFE, V5, DOI 10.7554/eLife.13546; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zemach A, 2010, CURR BIOL, V20, pR780, DOI 10.1016/j.cub.2010.07.007; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	54	93	96	7	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2018	50	1					130	+		10.1038/s41588-017-0008-5	http://dx.doi.org/10.1038/s41588-017-0008-5			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FT4XB	29255257	Green Published, Green Accepted			2022-12-17	WOS:000423157400016
J	Ongen, H; Brown, AA; Delaneau, O; Panousis, NI; Nica, AC; Dermitzakis, ET				Ongen, Halit; Brown, Andrew A.; Delaneau, Olivier; Panousis, Nikolaos I.; Nica, Alexandra C.; Dermitzakis, Emmanouil T.		GTEx Consortium	Estimating the causal tissues for complex traits and diseases	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; LIPID-METABOLISM; UNCERTAINTY; RELEVANCE; ONSET	How to interpret the biological causes underlying the predisposing markers identified through genome-wide association studies (GWAS) remains an open question. One direct and powerful way to assess the genetic causality behind GWAS is through analysis of expression quantitative trait loci (eQTLs). Here we describe a new approach to estimate the tissues behind the genetic causality of a variety of GWAS traits, using the cis-eQTLs in 44 tissues from the Genotype-Tissue Expression (GTEx) Consortium. We have adapted the regulatory trait concordance (RTC) score to measure the probability of eQTLs being active in multiple tissues and to calculate the probability that a GWAS-associated variant and an eQTL tag the same functional effect. By normalizing the GWAS-eQTL probabilities by the tissue-sharing estimates for eQTLs, we generate relative tissue-causality profiles for GWAS traits. Our approach not only implicates the gene likely mediating individual GWAS signals, but also highlights tissues where the genetic causality for an individual trait is likely manifested.	[Ongen, Halit; Brown, Andrew A.; Delaneau, Olivier; Panousis, Nikolaos I.; Nica, Alexandra C.; Dermitzakis, Emmanouil T.] Univ Geneva, Med Sch, Dept Genet Med & Dev, Geneva, Switzerland; [Ongen, Halit; Brown, Andrew A.; Delaneau, Olivier; Panousis, Nikolaos I.; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Ongen, Halit; Brown, Andrew A.; Delaneau, Olivier; Panousis, Nikolaos I.; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Geneva, Switzerland	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics	Ongen, H; Dermitzakis, ET (corresponding author), Univ Geneva, Med Sch, Dept Genet Med & Dev, Geneva, Switzerland.; Ongen, H; Dermitzakis, ET (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.; Ongen, H; Dermitzakis, ET (corresponding author), Swiss Inst Bioinformat, Geneva, Switzerland.	halit.ongen@unige.ch; emmanouil.dermitzakis@unige.ch	/AAR-2792-2021; Little, Roger/O-6191-2014; Liu, Yaping/A-8601-2018	Brown, Andrew/0000-0002-8087-3033; Dermitzakis, Emmanouil/0000-0002-9302-6490; Little, Roger/0000-0001-6831-0177; Ongen, Halit/0000-0002-4197-5790; Liu, Yaping/0000-0003-4165-7693; Delaneau, Olivier/0000-0002-3906-8446	US National Institutes of Health [NIH-R01MH101814]; European Commission Framework Programme 7 [UE7-SYSCOL-258236]; European Research Council [UE7-POPRNASEQ-260927]; Swiss National Science Foundation [31003A-149984, 31003A-170096]; Louis Jeantet Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission Framework Programme 7; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation	This research was supported by grants from the US National Institutes of Health (NIH-R01MH101814), European Commission Framework Programme 7 (UE7-SYSCOL-258236), the European Research Council (UE7-POPRNASEQ-260927), the Swiss National Science Foundation (31003A-149984 and 31003A-170096), and the Louis Jeantet Foundation. Computations were performed at the Vital-IT Centre for High-Performance Computing of the SIB Swiss Institute of Bioinformatics.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Delaneau O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15452; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; GTEx Consortium, NATURE; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hore V, 2016, NAT GENET, V48, P1094, DOI 10.1038/ng.3624; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	37	93	93	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1676	+		10.1038/ng.3981	http://dx.doi.org/10.1038/ng.3981			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29058715	Green Published, Green Submitted			2022-12-17	WOS:000416480600006
J	Li, LF; Li, YL; Jia, YL; Caicedo, AL; Olsen, KM				Li, Lin-Feng; Li, Ya-Ling; Jia, Yulin; Caicedo, Ana L.; Olsen, Kenneth M.			Signatures of adaptation in the weedy rice genome	NATURE GENETICS			English	Article							RED RICE; ORYZA-SATIVA; POPULATION-STRUCTURE; CLEARFIELD(TM) RICE; PARALLEL EVOLUTION; CROP DOMESTICATION; PERICARP COLOR; GENETICS; ORIGINS; TECHNOLOGY	Crop domestication provided the calories that fueled the rise of civilization(1-3). For many crop species, domestication was accompanied by the evolution of weedy crop relatives, which aggressively outcompete crops and reduce harvests(4-6). Understanding the genetic mechanisms that underlie the evolution of weedy crop relatives is critical for agricultural weed management and food security. Here we use whole-genome sequences to examine the origin and adaptation of the two major strains of weedy rice found in the United States. We find that de-domestication from cultivated ancestors has had a major role in their evolution, with relatively few genetic changes required for the emergence of weediness traits. Weed strains likely evolved both early and late in the history of rice cultivation and represent an under-recognized component of the domestication process. Genomic regions identified here that show evidence of selection can be considered candidates for future genetic and functional analyses for rice improvement.	[Li, Lin-Feng] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable, Guangzhou, Guangdong, Peoples R China; [Li, Lin-Feng; Olsen, Kenneth M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Li, Ya-Ling] Northeast Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Jia, Yulin] USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Caicedo, Ana L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Washington University (WUSTL); Northeast Normal University - China; United States Department of Agriculture (USDA); University of Massachusetts System; University of Massachusetts Amherst	Olsen, KM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.; Caicedo, AL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	caicedo@bio.umass.edu; kolsen@wustl.edu	Jia, Yulin/AAE-7090-2021; Jia, Yulin/T-8235-2019	Li, Yaling/0000-0002-4711-5353; Olsen, Kenneth/0000-0002-8338-3638; Jia, Yulin/0000-0002-2132-0498	National Science Foundation [IOS-1032023]; Division Of Integrative Organismal Systems [1032023] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Dyer and staff of the University greenhouse for assistance in growing plants and L. Small for technical laboratory assistance. We are grateful to members of the Olsen laboratory for helpful comments on this manuscript. This work is supported by the National Science Foundation Plant Genome Research Program (IOS-1032023). The USDA is an equal opportunity provider and employer.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Basu C, 2004, TRENDS PLANT SCI, V9, P391, DOI 10.1016/j.tplants.2004.06.003; Burgos NR, 2006, FIELD CROP RES, V99, P96, DOI 10.1016/j.fcr.2006.03.009; Burgos NR, 2014, PLANT PHYSIOL, V166, P1208, DOI 10.1104/pp.114.242719; Cui YX, 2016, G3-GENES GENOM GENET, V6, P4105, DOI 10.1534/g3.116.035881; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DEWET JMJ, 1975, ECON BOT, V29, P99, DOI 10.1007/BF02863309; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ellstrand NC, 2010, EVOL APPL, V3, P494, DOI 10.1111/j.1752-4571.2010.00140.x; Estorninos LE, 2005, WEED SCI, V53, P683, DOI 10.1614/WS-04-040R1.1; Gealy DR, 2012, WEED TECHNOL, V26, P517, DOI 10.1614/WT-D-11-00141.1; Gealy DR, 2005, CROP FERALITY AND VOLUNTEERISM, P323, DOI 10.1201/9781420037999.ch20; Grimm A, 2013, ECOL EVOL, V3, P4786, DOI 10.1002/ece3.848; Gu XY, 2011, GENETICS, V189, P1515, DOI 10.1534/genetics.111.131169; HILL JE, 1994, AUST J EXP AGR, V34, P1021, DOI 10.1071/EA9941021; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2016, EVOL APPL, V9, P857, DOI 10.1111/eva.12377; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merotto A, 2016, EVOL APPL, V9, P837, DOI 10.1111/eva.12387; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Pavlidis P, 2013, MOL BIOL EVOL, V30, P2224, DOI 10.1093/molbev/mst112; Pusadee T, 2013, GENET RESOUR CROP EV, V60, P335, DOI 10.1007/s10722-012-9839-1; Qi XS, 2015, MOL ECOL, V24, P3329, DOI 10.1111/mec.13256; Qiu J, 2014, PLANTA, V240, P1353, DOI 10.1007/s00425-014-2159-2; Reagon M, 2011, MOL ECOL, V20, P3743, DOI 10.1111/j.1365-294X.2011.05216.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Shivrain VK, 2007, CROP PROT, V26, P349, DOI 10.1016/j.cropro.2005.09.019; Shivrain VK, 2008, WEED SCI, V56, P807, DOI 10.1614/WS-08-026.1; Chauhan BS, 2013, CROP PROT, V48, P51, DOI 10.1016/j.cropro.2013.02.015; Song BK, 2014, MOL ECOL, V23, P5003, DOI 10.1111/mec.12922; Thurber CS, 2013, MOL ECOL, V22, P685, DOI 10.1111/mec.12147; Vigueira CC, 2013, J EVOLUTION BIOL, V26, P1738, DOI 10.1111/jeb.12171; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Ziska LH, 2015, ADV AGRON, V129, P181, DOI 10.1016/bs.agron.2014.09.003	49	93	97	9	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2017	49	5					811	+		10.1038/ng.3825	http://dx.doi.org/10.1038/ng.3825			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET1TI	28369039				2022-12-17	WOS:000400051400024
J	Okimoto, RA; Breitenbuecher, F; Olivas, VR; Wu, W; Gini, B; Hofree, M; Asthana, S; Hrustanovic, G; Flanagan, J; Tulpule, A; Blakely, CM; Haringsma, HJ; Simmons, AD; Gowen, K; Suh, J; Miller, VA; Ali, S; Schuler, M; Bivona, TG				Okimoto, Ross A.; Breitenbuecher, Frank; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Haringsma, Henry J.; Simmons, Andrew D.; Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj; Schuler, Martin; Bivona, Trever G.			Inactivation of Capicua drives cancer metastasis	NATURE GENETICS			English	Article							MATRIX METALLOPROTEINASES; DOWN-REGULATION; LUNG; ACTIVATION; MUTATIONS; REPRESSOR; TORSO	Metastasis is the leading cause of death in people with lung cancer, yet the molecular effectors underlying tumor dissemination remain poorly defined. Through the development of an in vivo spontaneous lung cancer metastasis model, we show that the developmentally regulated transcriptional repressor Capicua (CIC) suppresses invasion and metastasis. Inactivation of CIC relieves repression of its effector ETV4, driving ETV4-mediated upregulation of MMP24, which is necessary and sufficient for metastasis. Loss of CIC, or an increase in levels of its effectors ETV4 and MMP24, is a biomarker of tumor progression and worse outcomes in people with lung and/or gastric cancer. Our findings reveal CIC as a conserved metastasis suppressor, highlighting new anti-metastatic strategies that could potentially improve patient outcomes.	[Okimoto, Ross A.; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Tulpule, Asmin; Blakely, Collin M.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Okimoto, Ross A.; Wu, Wei; Gini, Beatrice; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Breitenbuecher, Frank; Schuler, Martin] Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Hofree, Matan] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hofree, Matan] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Haringsma, Henry J.; Simmons, Andrew D.] Clovis Oncol Inc, San Francisco, CA USA; [Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj] Fdn Med, Cambridge, MA USA; [Schuler, Martin] German Canc Consortium DKTK, Heidelberg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Duisburg Essen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Foundation Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	trever.bivona@ucsf.edu	Ali, Siraj/AAE-2958-2019; wu, wei/J-2797-2019	wu, wei/0000-0002-6556-067X; Hofree, Matan/0000-0001-8368-0299	A.P. Giannini Foundation; NIH Director's New Innovator Award [DP2 CA174497]; NIH/NCI [RO1 CA169338]; Pew-Stewart Foundation Trusts;  [NIHT32CA177555-01]; NATIONAL CANCER INSTITUTE [T32CA177555, R01CA169338, T32CA128583, DP2CA174497] Funding Source: NIH RePORTER	A.P. Giannini Foundation; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew-Stewart Foundation Trusts; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.A.O. was supported by the A.P. Giannini Foundation and NIHT32CA177555-01. T.G.B. acknowledges support from NIH Director's New Innovator Award DP2 CA174497, NIH/NCI RO1 CA169338, and the Pew-Stewart Foundation Trusts. We thank B. Hann (UCSF Preclinical Therapeutics Core) for helpful discussions. The lentiviral GFP-Luc vector was a kind gift from M. Jensen (Seattle Children's Research Institute, Seattle, Washington, USA).	Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Choi N, 2015, ONCOTARGET, V6, P23533, DOI 10.18632/oncotarget.4372; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkin Michael, 2001, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1902s12; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Futran AS, 2015, P NATL ACAD SCI USA, V112, P8590, DOI 10.1073/pnas.1501373112; Gleize V, 2015, ANN NEUROL, V78, P355, DOI 10.1002/ana.24443; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Grimm O, 2012, DEVELOPMENT, V139, P3962, DOI 10.1242/dev.084327; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Madero-Visbal RA, 2012, SURG ONCOL, V21, P23, DOI 10.1016/j.suronc.2010.07.008; Mordant P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026073; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schoppmann SF, 2014, CANCER INVEST, V32, P363, DOI 10.3109/07357907.2014.919304; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Szasz AM, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10337; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	31	93	95	5	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					87	96		10.1038/ng.3728	http://dx.doi.org/10.1038/ng.3728			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27869830	Green Submitted, Green Accepted			2022-12-17	WOS:000390976600014
J	Gutierrez-Achury, J; Zhernakova, A; Pulit, SL; Trynka, G; Hunt, KA; Romanos, J; Raychaudhuri, S; van Heel, DA; Wijmenga, C; de Balcker, PIW				Gutierrez-Achury, Javier; Zhernakova, Alexandra; Pulit, Sara L.; Trynka, Gosia; Hunt, Karen A.; Romanos, Jihane; Raychaudhuri, Soumya; van Heel, David A.; Wijmenga, Cisca; de Balcker, Paul I. W.			Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease	NATURE GENETICS			English	Article							HERITABILITY; HLA; ASSOCIATION; HAPLOTYPE; VARIANTS	Although dietary gluten is the trigger for celiac disease, risk is strongly influenced by genetic variation in the major histocompatibility complex (MHC) region. We fine mapped the MHC association signal to identify additional risk factors independent of the HLA-DQA1 and HLA-DQB1 alleles and observed five new associations that account for 18% of the genetic risk. Taking these new loci together with the 57 known non-MHC loci, genetic variation can now explain up to 48% of celiac disease heritability.	[Gutierrez-Achury, Javier; Zhernakova, Alexandra; Romanos, Jihane; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pulit, Sara L.; de Balcker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Trynka, Gosia] Wellcome Trust Sanger Inst, Cambridge, England; [Hunt, Karen A.; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Arthritis Res UK Epidemiol Unit, Manchester, Lancs, England; [de Balcker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; Utrecht University; Utrecht University Medical Center	Wijmenga, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	c.wijmenga@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020	Wijmenga, Cisca/0000-0002-5635-1614; Trynka, Gosia/0000-0002-6955-9529; Raychaudhuri, Soumya/0000-0002-1901-8265; Gutierrez-Achury, Javier/0000-0002-4971-1474; van Heel, David/0000-0002-0637-2265; Pulit, Sara/0000-0002-2502-3669; Zhernakova, Alexandra/0000-0002-4574-0841	Celiac Disease Consortium; European Research Council advanced grant (FP)/ERC [2012-322698]; Dutch Reumafonds [11-1-101]; Rosalind Franldin Fellowship from the University of Groningen; US National Institutes of Health [1R01AR062886]; VIDI award from the Netherlands Organization for Scientific Research (NWO) [016.126.354]; Doris Duke Clinical Scientist Development Award; MRC [G1001158] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759, R01AR062886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	Celiac Disease Consortium; European Research Council advanced grant (FP)/ERC; Dutch Reumafonds; Rosalind Franldin Fellowship from the University of Groningen; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIDI award from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Senior for carefully reading the manuscript and C. Gonzalez-Arevalo for the graphics. This study was funded by a grant from the Celiac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative (to C.W.), a European Research Council advanced grant (FP/2007-2013/ERC grant 2012-322698) (to C.W.), a grant from the Dutch Reumafonds (11-1-101) (to A.Z.) and a Rosalind Franldin Fellowship from the University of Groningen (to A.Z.). S.R. and P.I.W.d.B. received support from the US National Institutes of Health (1R01AR062886). P.I.W.d.B. holds a VIDI award from the Netherlands Organization for Scientific Research (NWO project 016.126.354). S.R. is also supported by a Doris Duke Clinical Scientist Development Award.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	15	93	97	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					577	578		10.1038/ng.3268	http://dx.doi.org/10.1038/ng.3268			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25894500	Green Submitted, Green Accepted			2022-12-17	WOS:000355386500006
J	Mercer, TR; Edwards, SL; Clark, MB; Neph, SJ; Wang, H; Stergachis, AB; John, S; Sandstrom, R; Li, GL; Sandhu, KS; Ruan, YJ; Nielsen, LK; Mattick, JS; Stamatoyannopoulos, JA				Mercer, Tim R.; Edwards, Stacey L.; Clark, Michael B.; Neph, Shane J.; Wang, Hao; Stergachis, Andrew B.; John, Sam; Sandstrom, Richard; Li, Guoliang; Sandhu, Kuljeet S.; Ruan, Yijun; Nielsen, Lars K.; Mattick, John S.; Stamatoyannopoulos, John A.			DNase I-hypersensitive exons colocalize with promoters and distal regulatory elements	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORIES; CHROMATIN; GENOME; GENE; NUCLEAR; LANDSCAPE; INTERACTOME; METHYLATION; COMPLEXITY; DYNAMICS	The precise splicing of genes confers an enormous transcriptional complexity to the human genome. The majority of gene splicing occurs cotranscriptionally, permitting epigenetic modifications to affect splicing outcomes. Here we show that select exonic regions are demarcated within the three-dimensional structure of the human genome. We identify a subset of exons that exhibit DNase I hypersensitivity and are accompanied by 'phantom' signals in chromatin immunoprecipitation and sequencing (ChIP-seq) that result from cross-linking with proximal promoter- or enhancer-bound factors. The capture of structural features by ChIP-seq is confirmed by chromatin interaction analysis that resolves local intragenic loops that fold exons close to cognate promoters while excluding intervening intronic sequences. These interactions of exons with promoters and enhancers are enriched for alternative splicing events, an effect reflected in cell type-specific periexonic DNase I hypersensitivity patterns. Collectively, our results connect local genome topography, chromatin structure and cis-regulatory landscapes with the generation of human transcriptional complexity by cotranscriptional splicing.	[Mercer, Tim R.; Clark, Michael B.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Mercer, Tim R.; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Edwards, Stacey L.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Edwards, Stacey L.] SE Queensland Inst Med Res, Brisbane, Qld, Australia; [Neph, Shane J.; Wang, Hao; Stergachis, Andrew B.; John, Sam; Sandstrom, Richard; Stamatoyannopoulos, John A.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Li, Guoliang; Sandhu, Kuljeet S.; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Mattick, John S.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Mattick, John S.] Univ New S Wales, Vincents Clin Sch, Kensington, NSW 2033, Australia	University of Queensland; University of Queensland; University of Queensland; University of Washington; University of Washington Seattle; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	j.mattick@garvan.org.au; jstam@u.washington.edu	Nielsen, Lars K/A-5519-2011; Li, Guoliang/D-8014-2012; Edwards, Stacey/A-4980-2011; Mercer, Tim/AAK-5060-2020; Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012	Nielsen, Lars K/0000-0001-8191-3511; Li, Guoliang/0000-0003-1601-6640; Mercer, Tim/0000-0001-8780-894X; Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Sandhu, Kuljeet/0000-0001-7632-6339; Sandstrom, Richard/0000-0002-3356-1547; Clark, Michael/0000-0002-2903-9537	Australian National Health and Medical Research Council [631668, 631381, 1021731]; Queensland State Government (National and International Research Alliance Program); National Breast Cancer Foundation Australia; National Human Genome Research Institute (NHGRI) [HG004456]; US National Institutes of Health (NHGRI) [U54HG004592, U54HG007599]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U01HG007599, R01HG004456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government (National and International Research Alliance Program); National Breast Cancer Foundation Australia; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the following funding sources: the Australian National Health and Medical Research Council (Australia Fellowships 631668 to J.S.M., T. R. M. and M. B. C. and 631381 and 1021731 to S. L. E.); the Queensland State Government (National and International Research Alliance Program to L.K.N.); the National Breast Cancer Foundation Australia (to S. L. E.); the National Human Genome Research Institute (NHGRI; ENCODE grant HG004456 to Y.R., G. L. and K. S. S.); and the US National Institutes of Health (NHGRI ENCODE grants U54HG004592 and U54HG007599 to J.A.S.).	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cheutin T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002465; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kim S, 2011, P NATL ACAD SCI USA, V108, P13564, DOI 10.1073/pnas.1109475108; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Melnik S, 2011, NAT METHODS, V8, P963, DOI [10.1038/NMETH.1705, 10.1038/nmeth.1705]; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pozzoli U, 2007, TRENDS GENET, V23, P20, DOI 10.1016/j.tig.2006.10.003; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Razin SV, 2011, NUCLEIC ACIDS RES, V39, P9085, DOI 10.1093/nar/gkr683; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054	59	93	96	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					852	U181		10.1038/ng.2677	http://dx.doi.org/10.1038/ng.2677			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23793028	Green Accepted			2022-12-17	WOS:000322374900006
J	Burton, H; Chowdhury, S; Dent, T; Hall, A; Pashayan, N; Pharoah, P				Burton, Hilary; Chowdhury, Susmita; Dent, Tom; Hall, Alison; Pashayan, Nora; Pharoah, Paul			Public health implications from COGS and potential for risk stratification and screening	NATURE GENETICS			English	Editorial Material							BREAST-CANCER; PROSTATE; SURVIVAL		[Burton, Hilary; Chowdhury, Susmita; Dent, Tom; Hall, Alison] PHG Fdn Fdn Genom & Populat Hlth, Cambridge, England; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London, England; [Pharoah, Paul] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Pharoah, Paul] Univ Cambridge, Dept Oncol, Cambridge, England	University of London; University College London; University of Cambridge; University of Cambridge	Burton, H (corresponding author), PHG Fdn Fdn Genom & Populat Hlth, Cambridge, England.	hilary.burton@phgfoundation.org	Pharoah, Paul/V-6658-2019	Pharoah, Paul/0000-0001-8494-732X; Pashayan, Nora/0000-0003-0843-2468	Cancer Research UK [13065] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Akizu N., 2015, NAT GENET, DOI [10.1038/ng.3256, DOI 10.1038/NG.3256, DOI 10.1038/NG.2592]; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Burton H., 2012, ITAL J PUBLIC HLTH, V9, P4; Chowdhury S, 2013, GENET MED, V15, P423, DOI 10.1038/gim.2012.167; Dent T, 2013, PUBLIC HEALTH GENOM, V16, P94, DOI 10.1159/000345941; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629	20	93	94	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					349	351		10.1038/ng.2582	http://dx.doi.org/10.1038/ng.2582			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23535723				2022-12-17	WOS:000316840600004
J	Witte, JS				Witte, John S.			Multiple prostate cancer risk variants on 8q24	NATURE GENETICS			English	Editorial Material							LOCUS		Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Witte, JS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	jwitte@ucsf.edu						Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Cher ML, 1996, CANCER RES, V56, P3091; Fisher RA., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Miller DC, 2006, JNCI-J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; VISAKORPI T, 1995, CANCER RES, V55, P342; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	12	93	98	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					579	580		10.1038/ng0507-579	http://dx.doi.org/10.1038/ng0507-579			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17460686				2022-12-17	WOS:000245971300009
J	Jasnos, L; Korona, R				Jasnos, Lukasz; Korona, Ryszard			Epistatic buffering of fitness loss in yeast double deletion strains	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; DELETERIOUS MUTATIONS; SEXUAL REPRODUCTION; METABOLIC NETWORK; RECOMBINATION; EVOLUTION; GENOME; SELECTION; GENES	Interactions between deleterious mutations have been insufficiently studied(1,2), despite the fact that their strength and direction are critical for understanding the evolution of genetic recombination(3,4) and the buildup of mutational load in populations(5,6). We compiled a list of 758 yeast gene deletions causing growth defects ( from the Munich Information Center for Protein Sequences database and ref. 7). Using BY4741 and BY4742 single- deletion strains, we carried out 639 random crosses and assayed growth curves of the resulting progeny. We show that the maximum growth rate averaged over strains lacking deletions and those with double deletions is higher than that of strains with single deletions, indicating a positive epistatic effect. This tendency is shared by genes belonging to a variety of functional classes. Based on our data and former theoretical work(8-10), we suggest that epistasis is likely to diminish the negative effects of mutations when the ability to produce biomass at high rates contributes significantly to fitness.	Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland	Jagiellonian University	Korona, R (corresponding author), Jagiellonian Univ, Inst Environm Sci, Gronostajowa 7, PL-30387 Krakow, Poland.	korona@eko.uj.edu.pl	Korona, Ryszard/J-7154-2015	Korona, Ryszard/0000-0002-4329-5908				Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; FELDMAN MW, 1980, P NATL ACAD SCI-BIOL, V77, P4838, DOI 10.1073/pnas.77.8.4838; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jasnos L, 2005, ANAL BIOCHEM, V344, P138, DOI 10.1016/j.ab.2005.04.034; Keightley PD, 1996, J THEOR BIOL, V182, P311, DOI 10.1006/jtbi.1996.0169; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sliwa P, 2005, P NATL ACAD SCI USA, V102, P17670, DOI 10.1073/pnas.0505517102; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SZATHMARY E, 1993, GENETICS, V133, P127; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931	30	93	94	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					550	554		10.1038/ng1986	http://dx.doi.org/10.1038/ng1986			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322879				2022-12-17	WOS:000245271200028
J	Nakamura, T; Yao, R; Ogawa, T; Suzuki, T; Ito, C; Tsunekawa, N; Inoue, K; Ajima, R; Miyasaka, T; Yoshida, Y; Ogura, A; Toshimori, K; Noce, T; Yamamoto, T; Noda, T				Nakamura, T; Yao, R; Ogawa, T; Suzuki, T; Ito, C; Tsunekawa, N; Inoue, K; Ajima, R; Miyasaka, T; Yoshida, Y; Ogura, A; Toshimori, K; Noce, T; Yamamoto, T; Noda, T			Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta	NATURE GENETICS			English	Article							ALPHA MUTANT MICE; CCR4-NOT COMPLEX; MESSENGER-RNA; STEM-CELLS; VITAMIN-A; RXR-ALPHA; COMPONENT; TRANSPLANTATION; SPERMATOGENESIS; YEAST	Spermatogenesis is a complex process that involves cooperation of germ cells and testicular somatic cells. Various genetic disorders lead to impaired spermatogenesis, defective sperm function and male infertility(1). Here we show that Cnot7(-/-) males are sterile owing to oligo-astheno-teratozoospermia, suggesting that Cnot7, a CCR4-associated transcriptional cofactor(2), is essential for spermatogenesis. Maturation of spermatids is unsynchronized and impaired in seminiferous tubules of Cnot7(-/-) mice. Transplantation of spermatogonial stem cells from male Cnot7(-/-) mice to seminiferous tubules of Kit mutant mice (Kit(W/W-v)) restores spermatogenesis, suggesting that the function of testicular somatic cells is damaged in the Cnot7(-/-) condition. The testicular phenotypes of Cnot7(-/-) mice are similar to those of mice deficient in retinoid X receptor beta (Rxrb)(3). We further show that Cnot7 binds the AF-1 domain of Rxrb and that Rxrb malfunctions in the absence of Cnot7. Therefore, Cnot7 seems to function as a coregulator of Rxrb in testicular somatic cells and is thus involved in spermatogenesis.	Univ Tokyo, Inst Med Sci, Inst Med Sci, Tokyo 1088639, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1708455, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanagawa 2360004, Japan; Chiba Univ, Grad Sch Med, Dept Anat & Dev Biol, Chiba 2608670, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; RIKEN, Bioresource Ctr, Tsukuba 3050074, Japan; Tohoku Univ, Sch Med, Ctr Translat & Adv Anim Res Human Dis, Sendai, Miyagi 9808575, Japan; RIKEN, Genom Sci Ctr, Mouse Funct Genom Res Grp, Kanagawa 2440804, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Yokohama City University; Chiba University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; Tohoku University; RIKEN	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Inst Med Sci, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp; tnoda@ims.u-tokyo.ac.jp	noce, toshiaki/L-1739-2013; Noda, Tetsuo/B-1667-2016; Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988; Ito, Chizuru/0000-0003-2697-0382				Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Creemers LB, 2002, BIOL REPROD, V66, P1579, DOI 10.1095/biolreprod66.6.1579; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Maleszewski M, 1996, MOL REPROD DEV, V44, P256, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;256::AID-MRD16&gt;3.0.CO;2-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 2003, BIOL REPROD, V68, P316, DOI 10.1095/biolreprod.102.004549; Ogonuki N, 2003, BIOL REPROD, V68, P1821, DOI 10.1095/biolreprod.102.011726; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tabuchi Y, 2002, J UROLOGY, V167, P1538, DOI 10.1016/S0022-5347(05)65359-1; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	30	93	97	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					528	533		10.1038/ng1344	http://dx.doi.org/10.1038/ng1344			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107851	Bronze			2022-12-17	WOS:000221183000029
J	Vrontou, S; Petrou, P; Meyer, BI; Galanopoulos, VK; Imai, K; Yanagi, M; Chowdhury, K; Scambler, PJ; Chalepakis, G				Vrontou, S; Petrou, P; Meyer, BI; Galanopoulos, VK; Imai, K; Yanagi, M; Chowdhury, K; Scambler, PJ; Chalepakis, G			Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice	NATURE GENETICS			English	Article							MEMBRANE-SPANNING PROTEOGLYCAN; DROSOPHILA-MELANOGASTER; EXTRACELLULAR-MATRIX; KIDNEY MORPHOGENESIS; EXPRESSION; DISEASE; MUTANTS; MODEL; NG2	Loss of tight association between epidermis and dermis underlies several blistering disorders and is frequently caused by impaired function of extracellular matrix (ECM) proteins(1,2). Here we describe a new protein in mouse, Fras1, that is specifically detected in a linear fashion underlying the epidermis and the basal surface of other epithelia in embryos. Loss of Fras1 function results in the formation of subepidermal hemorrhagic blisters as well as unilateral or bilateral renal agenesis during mouse embryogenesis. Postnatally, homozygous Fras1 mutants have fusion of the eyelids and digits and unilateral renal agenesis or dysplasia. The defects observed in Fras1(-/-) mice phenocopy those of the existing bl (blebbed) mouse mutants(3,4), which have been considered a model for the human genetic disorder Fraser syndrome(5,6). We show that bl/bl homozygous embryos are devoid of Fras1 protein, consistent with the finding that Fras1 is mutated in these mice(6). In sum, our data suggest that perturbations in the composition of the extracellular space underlying epithelia could account for the onset of the blebbed phenotype in mouse and Fraser syndrome manifestation in human.	FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Dev Genet, Neuherberg, Germany; Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; University College London	Chalepakis, G (corresponding author), FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.		Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628				Arin MJ, 2001, TRENDS MOL MED, V7, P422, DOI 10.1016/S1471-4914(01)02095-0; Bruckner-Tuderman L, 1998, J MOL MED-JMM, V76, P226, DOI 10.1007/s001090050213; Darling S, 1994, Clin Dysmorphol, V3, P91; Gustafsson E, 2000, EXP CELL RES, V261, P52, DOI 10.1006/excr.2000.5042; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; LYON MF, 1996, GENETIC VARIANTS STR; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; MCGREGOR L, 2003, NAT GENET, V34; MOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; SNYDER PB, 1986, P NATL ACAD SCI USA, V83, P3341, DOI 10.1073/pnas.83.10.3341; Spirito F, 2001, J BIOL CHEM, V276, P18828, DOI 10.1074/jbc.M100381200; Tillet E, 1997, J BIOL CHEM, V272, P10769; Willem M, 2002, DEVELOPMENT, V129, P2711; WINTER RM, 1990, CLIN GENET, V37, P494	21	93	95	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					209	214		10.1038/ng1168	http://dx.doi.org/10.1038/ng1168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12766770	Green Published			2022-12-17	WOS:000183200500029
J	Puri, PL; Bhakta, K; Wood, LD; Costanzo, A; Zhu, JY; Wang, JYJ				Puri, PL; Bhakta, K; Wood, LD; Costanzo, A; Zhu, JY; Wang, JYJ			A myogenic differentiation checkpoint activated by genotoxic stress	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR MYOD; CELL-CYCLE ARREST; HELIX-LOOP-HELIX; DNA-DAMAGE; SKELETAL MYOGENESIS; TYROSINE KINASE; MADS-BOX; C-ABL; MUSCLE; PROTEIN	Cell-cycle checkpoints help to protect the genomes of proliferating cells under genotoxic stress. In multicellular organisms, cell proliferation is often directed toward differentiation during development and throughout adult homeostasis. To prevent the formation of differentiated cells with genetic instability, we hypothesized that genotoxic stress may trigger a differentiation checkpoint. Here we show that exposure to genotoxic agents causes a reversible inhibition of myogenic differentiation. Muscle-specific gene expression is suppressed by DNA-damaging agents if applied prior to differentiation induction but not after the differentiation program is established. The myogenic determination factor, MyoD (encoded by Myod1), is a target of the differentiation checkpoint in myoblasts. The inhibition of MyoD by DNA damage requires a functional c-Abl tyrosine kinase (encoded by Abl1), but occurs in cells deficient for p53 (transformation-related protein 53, encoded by Trp53) or c-Jun (encoded by the oncogene Jun). These results support the idea that genotoxic stress can regulate differentiation, and identify a new biological function for DNA damage-activated signaling network.	Univ Roma La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, Dulbecco Telethon Inst, I-00161 Rome, Italy; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Sapienza University Rome; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Puri, PL (corresponding author), Univ Roma La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, Dulbecco Telethon Inst, Piazzale Aldo Moro 5, I-00161 Rome, Italy.	plorenzo@salk.edu; jywang@ucsd.edu	Costanzo, Antonio/D-3896-2012; Costanzo, Antonio/GZG-2433-2022; Wood, Laura/ABF-1531-2020	Costanzo, Antonio/0000-0001-9697-2557; Puri, Pier Lorenzo/0000-0003-4964-0095	NCI NIH HHS [R01 CA043054, R37 CA043054] Funding Source: Medline; Telethon [TCP00081] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043054, R37CA043054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALEMA S, 1994, SEMIN CANCER BIOL, V5, P147; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Buchdunger E, 1996, CANCER RES, V56, P100; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; KURABAYASHI M, 1994, J BIOL CHEM, V269, P6031; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, J CELL BIOCHEM, V66, P27, DOI 10.1002/(SICI)1097-4644(19970701)66:1<27::AID-JCB4>3.0.CO;2-#; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Smith L, 1998, NAT GENET, V19, P39, DOI 10.1038/ng0598-39; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang JYJ, 1998, CURR OPIN CELL BIOL, V10, P240, DOI 10.1016/S0955-0674(98)80146-4; WANG JYJ, 2000, INTEGRATIVE SIGNALIN; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	34	93	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					585	593		10.1038/ng1023	http://dx.doi.org/10.1038/ng1023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415271				2022-12-17	WOS:000179593000010
J	Stock, M; Lamatsch, DK; Steinlein, C; Epplen, JT; Grosse, WR; Hock, R; Klapperstuck, T; Lampert, KP; Scheer, U; Schmid, M; Schartl, M				Stock, M; Lamatsch, DK; Steinlein, C; Epplen, JT; Grosse, WR; Hock, R; Klapperstuck, T; Lampert, KP; Scheer, U; Schmid, M; Schartl, M			A bisexually reproducing all-triploid vertebrate	NATURE GENETICS			English	Article							POLYMORPHIC MICROSATELLITE LOCI; LAMPBRUSH CHROMOSOMES; ALBURNOIDES COMPLEX; FLOW-CYTOMETRY; BUFO; DIVERSITY; DNA; ELIMINATION; SEQUENCES; AMPHIBIA	Green toads are common in the Palaearctic region, where they have differentiated into several taxa(1,2). The toads exist with variable amounts of ploidy, similar to other anuran species(3) or reptiles(4). In vertebrate biology, the very rare occurrence of triploidy is coupled with infertility or unisexuality, or requires the coexistence of individuals of different ploidy in a reproductive community. The reproduction of naturally occurring triploids has been reported to occur only through parthenogenesis, gynogenesis or hybridogenesis. The bisexual reproduction of pure triploids has been considered to be impossible because of the problem of equally distributing three chromosome sets in meiosis. Here we report geographically isolated populations of green toads (Bufo viridis complex) that are all-triploid and reproduce bisexually.	Theodor Boveri Inst, Lehrstuhl Phyziol Chem 1, D-97074 Wurzburg, Germany; Univ Halle Wittenberg, Inst Zool, D-06099 Halle Saale, Saale, Germany; Biozentrum, Theodor Boveri Inst, Inst Humangenet, D-97074 Wurzburg, Germany; Biozentrum, Theodor Boveri Inst, Lehrstuhl Zool 1, D-97074 Wurzburg, Germany; Ruhr Univ Bochum, Abt Mol Humangenet, D-44780 Bochum, Germany; Univ Halle Wittenberg, Klin Dermatol & Venerol, D-06097 Halle Saale, Saale, Germany	University of Wurzburg; Martin Luther University Halle Wittenberg; University of Wurzburg; University of Wurzburg; Ruhr University Bochum; Martin Luther University Halle Wittenberg	Schartl, M (corresponding author), Theodor Boveri Inst, Lehrstuhl Phyziol Chem 1, D-97074 Wurzburg, Germany.		Stöck, Matthias/E-7245-2014	Stöck, Matthias/0000-0003-4888-8371; Schartl, Manfred/0000-0001-9882-5948; Epplen, Joerg T./0000-0002-6087-3327				Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; BICKHAM JW, 1993, COPEIA, P723; Borkin Leo J., 2001, Russian Journal of Herpetology, V8, P45; Borkin LJ, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P329; CALLAN HG, 1987, CHROMOSOMA, V95, P236, DOI 10.1007/BF00294780; Carmona JA, 1997, GENETICS, V146, P983; Castellano S, 1998, BIOL J LINN SOC, V63, P257, DOI 10.1006/bijl.1997.0189; CHEN H, 1995, BIOCHEM GENET, V33, P297, DOI 10.1007/BF02399929; GALL JG, 1991, METHOD CELL BIOL, V36, P149; Green DM, 1991, AMPHIBIAN CYTOGENETI; Gunther R., 1979, Mitteilungen aus dem Zoologischen Museum in Berlin, V55, P35; Klapperstuck T, 1996, CYTOMETRY, V25, P82, DOI 10.1002/(SICI)1097-0320(19960901)25:1<82::AID-CYTO9>3.0.CO;2-G; MEZHZHERIN SV, 1995, GENETIKA+, V31, P43; MORGAN GT, 1980, CHROMOSOMA, V80, P309, DOI 10.1007/BF00292687; OHTANI H, 1993, CHROMOSOMA, V102, P158, DOI 10.1007/BF00387730; PISANETS EM, 1978, DOKLADY AKAD NAUK B, V3, P280; Roth P., 1987, P335; Rowe G, 1997, MOL ECOL, V6, P401, DOI 10.1046/j.1365-294X.1997.00197.x; SCHARTL M, 1991, P NATL ACAD SCI USA, V88, P8759, DOI 10.1073/pnas.88.19.8759; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; SCRIBNER KT, 1994, MOL BIOL EVOL, V11, P737; Stock M, 1999, ITAL J ZOOL, V66, P215; Stock M., 2001, ZOOLOGICAL ABHANDLUN, V51, P253; STOCK M, 2001, THESIS M LUTHER U HA; Stock Matthias, 1997, Alytes (Paris), V15, P72; Sumida Masayuki, 1993, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V12, P133; Tikel D, 2000, MOL ECOL, V9, P1927, DOI 10.1046/j.1365-294x.2000.01074-6.x; UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678; VINOGRADOV AE, 1990, GENOME, V33, P619, DOI 10.1139/g90-092	30	93	100	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					325	328		10.1038/ng839	http://dx.doi.org/10.1038/ng839			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836500				2022-12-17	WOS:000174157600020
J	Rouault, TA				Rouault, TA			Iron on the brain	NATURE GENETICS			English	Editorial Material								Accumulations of iron are often detected in the brains of people suffering from neurodegenerative diseases. But it is often not known whether such accumulations contribute directly to disease progression. The identification of the genes mutated in two such disorders suggests that errors in iron metabolism do indeed have a key role.	NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rouault, TA (corresponding author), NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001602] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CURTIS ARJ, 2001, NAT GENET, V28, P327; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Overly CC, 1996, J NEUROSCI, V16, P6056; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Sheth S, 2000, ANNU REV MED, V51, P443, DOI 10.1146/annurev.med.51.1.443; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	9	93	105	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					299	300		10.1038/91036	http://dx.doi.org/10.1038/91036			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479580				2022-12-17	WOS:000170174800002
J	Van Etten, WJ; Steen, RG; Nguyen, H; Castle, AB; Slonim, DK; Ge, B; Nusbaum, C; Schuler, GD; Lander, ES; Hudson, TJ				Van Etten, WJ; Steen, RG; Nguyen, H; Castle, AB; Slonim, DK; Ge, B; Nusbaum, C; Schuler, GD; Lander, ES; Hudson, TJ			Radiation hybrid map of the mouse genome	NATURE GENETICS			English	Article								Radiation hybrid (RH) maps are a useful tool for genome analysis, providing a direct method for localizing genes and anchoring physical maps and genomic sequence along chromosomes, The construction of a comprehensive RH map for the human genome(1) has resulted in gene maps reflecting the location of more than 30,000 human genes(2,3). Here we report the first comprehensive RH map of the mouse genome. The map contains 2,486 loci screened against an RH panel of 93 cell lines(4). Most loci (93%) are simple sequence length polymorphisms (SSLPs) taken from the mouse genetic map, thereby providing direct integration between these two key maps, We performed RH mapping by a new and efficient approach in which we replaced traditional gel- or hybridization-based assays by a homogeneous 5'-nuclease assay(5) involving a single common probe for all genetic markers. The map provides essentially complete connectivity and coverage across the genome, and good resolution for ordering loci, with 1 centiRay (cR) corresponding to an average of approximately 100 kb, The RH map, together with an accompanying World-Wide Web server, makes it possible for any investigator to rapidly localize sequences in the mouse genome. Together with the previously constructed genetic map(6) and a YAC-based physical map reported in a companion paper(7), the fundamental maps required for mouse genomics are now available.	MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA; McGill Univ, Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA.			Slonim, Donna/0000-0003-3357-437X	NHGRI NIH HHS [HG01806] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Marra M, 1999, NAT GENET, V21, P191, DOI 10.1038/5976; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487	10	93	100	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1999	22	4					384	387		10.1038/11962	http://dx.doi.org/10.1038/11962			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	10431245				2022-12-17	WOS:000081772500023
J	Mara, M; Kucaba, T; Sekhon, M; Hillier, L; Martienssen, R; Chinwalla, A; Crockett, J; Fedele, J; Grover, H; Gund, C; McCombie, WR; McDonald, K; McPherson, J; Mudd, N; Parnell, L; Schein, J; Seim, R; Shelby, P; Waterston, R; Wilson, R				Mara, M; Kucaba, T; Sekhon, M; Hillier, L; Martienssen, R; Chinwalla, A; Crockett, J; Fedele, J; Grover, H; Gund, C; McCombie, WR; McDonald, K; McPherson, J; Mudd, N; Parnell, L; Schein, J; Seim, R; Shelby, P; Waterston, R; Wilson, R			zA map for sequence analysis of the Arabidopsis thaliana genome	NATURE GENETICS			English	Article							BAC LIBRARY; CLONES; YEAST; DNA	Arabidopsis thaliana has emerged as a model system for studies of plant genetics and development, and its genome has been targeted for sequencing(1) by an international consortium (the Arabidopsis Genome Initiative; http://genome-www. stanford.edu/Arabidopsis/agi.html). To support the genome-sequencing effort, we fingerprinted more than 20,000 BACs (ref. 2) from two high-quality publicly available libraries(3-5), generating an estimated 17-fold redundant coverage of the genome, and used the fingerprints to nucleate assembly of the data by computer. Subsequent manual revision of the assemblies resulted in the incorporation of 19,661 fingerprinted BACs into 169 ordered sets of overlapping clones ('contigs'), each containing at least 3 clones. These contigs are ideal for parallel selection of BACs for large-scale sequencing and have supported the generation of more than 5.8 Mb of finished genome sequence submitted to GenBank; analysis of the sequence has confirmed the integrity of contigs constructed using this fingerprint data. Placement of contigs onto chromosomes can now be performed, and is being pursued by groups involved in both sequencing and positional cloning studies. To our knowledge, these data provide the first example of whole-genome random PAC fingerprint analysis of a eucaryote, and have provided a model essential to efforts aimed at generating similar databases of fingerprint contigs to support sequencing of other complex genomes, including that of human.	Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Washington University (WUSTL); Cold Spring Harbor Laboratory	Mara, M (corresponding author), Washington Univ, Genome Sequencing Ctr, 4444 Forest Pk Blvd, St Louis, MO 63108 USA.	mmarra@alu.wustl.edu	Schein, Jacquie E/G-3674-2015; McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Marra, Marco A/B-5987-2008	McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Marra, Marco A/0000-0001-7146-7175; McCombie, W. Richard/0000-0003-1899-0682; Chinwalla, Asif/0000-0001-7831-3996				Bevan M, 1997, PLANT CELL, V9, P476, DOI 10.1105/tpc.9.4.476; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHOI S, 1995, WEEDS WORLD, V2, P17; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gregory SG, 1997, GENOME RES, V7, P1162, DOI 10.1101/gr.7.12.1162; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Mozo T, 1998, PLANT J, V16, P377, DOI 10.1046/j.1365-313x.1998.00299.x; Mozo T, 1998, MOL GEN GENET, V258, P562, DOI 10.1007/s004380050769; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; RILES L, 1993, GENETICS, V134, P81; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Wilson RK, 1997, GENOME ANAL, V1, P397; WONG GK, 1997, P NATL ACAD SCI USA, V13, P5225	20	93	105	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1999	22	3					265	270		10.1038/10327	http://dx.doi.org/10.1038/10327			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	10391214				2022-12-17	WOS:000081125900019
J	AnsariLari, MA; Liu, XM; Metzker, ML; Rut, AR; Gibbs, RA				AnsariLari, MA; Liu, XM; Metzker, ML; Rut, AR; Gibbs, RA			The extent of genetic variation in the CCR5 gene	NATURE GENETICS			English	Letter											AnsariLari, MA (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030, USA.				NIAID NIH HHS [P30 AI36211] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Metzker ML, 1996, SCIENCE, V271, P1420, DOI 10.1126/science.271.5254.1420; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g	16	93	99	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					221	222		10.1038/ng0797-221	http://dx.doi.org/10.1038/ng0797-221			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207783				2022-12-17	WOS:A1997XG60900013
J	McWhir, J; Schnieke, AE; Ansell, R; Wallace, H; Colman, A; Scott, AR; Kind, AJ				McWhir, J; Schnieke, AE; Ansell, R; Wallace, H; Colman, A; Scott, AR; Kind, AJ			Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background	NATURE GENETICS			English	Letter							TRANSCRIPTION FACTOR; ESTABLISHMENT; TRANSMISSION; EXPRESSION; REGION		PPL THERAPEUT,ROSLIN EH25 9PP,MIDLOTHIAN,SCOTLAND		McWhir, J (corresponding author), ROSLIN INST,DEPT MOL BIOL,ROSLIN EH25 9PS,MIDLOTHIAN,SCOTLAND.			Schnieke, Angelika/0000-0002-5761-9635				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; COWARD P, 1994, NAT GENET, V6, P245, DOI 10.1038/ng0394-245; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hogan B., 1986, MANIPULATING MOUSE E; HOOPER ML, 1990, EMBRYONAL STEM CELLS, P147; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; KAWASE E, 1994, INT J DEV BIOL, V38, P385; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SUEMORI H, 1987, DEV GROWTH DIFFER, V29, P133; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; THOMSEN DR, 1984, P NATL ACAD SCI-BIOL, V81, P659, DOI 10.1073/pnas.81.3.659; WHEELER MB, 1994, REPROD FERT DEVELOP, V6, P563, DOI 10.1071/RD9940563; Yeom YI, 1996, DEVELOPMENT, V122, P881	23	93	115	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					223	226		10.1038/ng1096-223	http://dx.doi.org/10.1038/ng1096-223			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841201				2022-12-17	WOS:A1996VL44600035
J	LEMERRER, M; ROUSSEAU, F; LEGEAIMALLET, L; LANDAIS, JC; PELET, A; BONAVENTURE, J; SANAK, M; WEISSENBACH, J; STOLL, C; MUNNICH, A; MAROTEAUX, P				LEMERRER, M; ROUSSEAU, F; LEGEAIMALLET, L; LANDAIS, JC; PELET, A; BONAVENTURE, J; SANAK, M; WEISSENBACH, J; STOLL, C; MUNNICH, A; MAROTEAUX, P			A GENE FOR ACHONDROPLASIA-HYPOCHONDROPLASIA MAPS TO CHROMOSOME 4P	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; BIRTH PREVALENCE RATES; HUNTINGTON DISEASE; SKELETAL DYSPLASIAS; SEQUENCE; REGION; FAMILY; LOCUS	Achondroplasia (ACH) is a frequent condition of unknown origin characterized by short-limbed dwarfism and macrocephaly. Milder forms, termed hypochondroplasias (HCH) result in short stature with radiological features similar to those observed in ACH. We report on the mapping of a gene causing ACH/HCH to human chromosome 4p16.3, by linkage to the iduronidase A (IDUA) locus, in 15 informative families (Z max = 3.01 at theta = 0 for ACH; Z max = 4.71 at theta = 0 for ACH/HCH). Multipoint linkage analysis provides evidence for mapping the disease locus telomeric to D4S412 (location score in log 10 = 4.60). Moreover, this study supports the view that ACH and HCH are genetically homogeneous in our series.	HOP ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANTS,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,CNRS,ER88,F-75743 PARIS 15,FRANCE; POLISH AMER CHILDRENS HOSP,DEPT MED GENET,KRAKOW,POLAND; GENETHON,F-91002 EVRY,FRANCE; INST PUERICULTURE,SERV GENET,F-67000 STRASBOURG,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	LEMERRER, M (corresponding author), HOP ENFANTS MALAD,SERV GENET,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Sanak, Marek/AAV-1628-2021; Legeai-Mallet, Laurence/E-6112-2016	Sanak, Marek/0000-0001-7635-8103; Legeai-Mallet, Laurence/0000-0003-4989-5856; PELET, Anastella/0000-0002-8353-1725				BOUVET JP, 1971, ANN GENET-PARIS, V14, P127; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARTER WA, 1992, AM J HUM GENET, V51, P841; GARDNER RJM, 1977, CLIN GENET, V11, P31; GUSELLA JF, 1992, GENOMICS, V13, P75, DOI 10.1016/0888-7543(92)90204-6; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; IWAMOTO M, 1991, J BIOL CHEM, V266, P461; KATO Y, 1990, J BIOL CHEM, V265, P5903; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAROTEAUX P, 1988, ARCH FR PEDIATR, V45, P105; Maroteaux P, 1964, Clin Orthop Relat Res, V33, P91; MAYNARD JA, 1981, J BONE JOINT SURG AM, V63, P969, DOI 10.2106/00004623-198163060-00015; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MULLIS PE, 1991, CLIN ENDOCRINOL, V14, P265; MURDOCH JL, 1970, ANN HUM GENET, V33, P227, DOI 10.1111/j.1469-1809.1970.tb01648.x; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OGILVIE D, 1986, J MED GENET, V23, P19, DOI 10.1136/jmg.23.1.19; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; OTT J, 1985, VARIABILITY RECOMBIN, P112; PADANILAM BJ, 1992, HUM MOL GENET, V1, P104; PARROT J, 1878, B SOC ANTROPOL, V1, P296; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; PULST SM, 1990, HUM GENET, V85, P12; PULST SM, 1991, AM J MED GENET, V10, P84; SCOTT HS, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348-a; SOMMER A, 1987, AM J MED GENET, V26, P949, DOI 10.1002/ajmg.1320260426; STANESCU R, 1990, AM J MED GENET, V37, P412, DOI 10.1002/ajmg.1320370323; STANESCU V, 1977, ARCH FR PEDIAT S, V34; STOLL C, 1989, CLIN GENET, V35, P88; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TOMMERUP M, 1993, HUM MOL GENET, V2, P1571; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WELSSENBACH J, 1992, NATURE, V359, P794; WILSON HG, 1981, HUM GENET, V59, P397; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674; 1913, NOU ICONOG SAPEL, V26, P157; 1924, B SOC MED HOP PARIS, V48, P1780	40	93	93	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					318	321						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012398				2022-12-17	WOS:A1994MZ56200023
J	BUREAU, JF; MONTAGUTELLI, X; BIHL, F; LEFEBVRE, S; GUENET, JL; BRAHIC, M				BUREAU, JF; MONTAGUTELLI, X; BIHL, F; LEFEBVRE, S; GUENET, JL; BRAHIC, M			MAPPING LOCI INFLUENCING THE PERSISTENCE OF THEILERS VIRUS IN THE MURINE CENTRAL-NERVOUS-SYSTEM	NATURE GENETICS			English	Article							INDUCED DEMYELINATING DISEASE; PCR-ANALYZED MICROSATELLITES; MOUSE GENOME; NUDE-MICE; SUSCEPTIBLE SJL/J; H-2D REGION; DA STRAIN; ENCEPHALOMYELITIS; GENE; IDENTIFICATION	Inbred strains of mice differ greatly in their susceptibility to the demyelinating disease caused by Theiler's Murine Encephalomyelitis Virus. In this murine disease, which is an animal model for the study of multiple sclerosis, demyelination depends on the persistent infection of the central nervous system. Previous studies identified a locus in the H-2D region of the major histocompatibility complex which controls susceptibility to the persistent infection, and also showed that other loci are involved. In order to identify these loci, we screened the genome of a set of backcross animals with a combination of polymorphic microsatellites and restriction enzymes sites. We now show that viral persistence is also controlled by a locus close to lfg on chromosome 10 and possibly by a locus near Mbp on chromosome 18.	INST PASTEUR,UNITE GENET MAMMIFERES,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	BUREAU, JF (corresponding author), INST PASTEUR,UNITE VIRUS LENTS,CNRS,UA1157,28 RUE DR ROUX,F-75724 PARIS 15,FRANCE.		Lefebvre, Suzie/D-5092-2017					AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; AUBERT C, 1987, MICROB PATHOGENESIS, V3, P319, DOI 10.1016/0882-4010(87)90002-7; BORROW P, 1992, J GEN VIROL, V73, P1861, DOI 10.1099/0022-1317-73-7-1861; BRINTON M, 1984, HOST GENES INFLUENCE, P71; BUREAU JF, 1992, J VIROL, V66, P4698, DOI 10.1128/JVI.66.8.4698-4704.1992; CLATCH RJ, 1985, J IMMUNOL, V135, P1408; CLATCH RJ, 1990, VIROLOGY, V176, P244, DOI 10.1016/0042-6822(90)90249-Q; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DIETRICH W, 1992, GENETICS, V131, P423; GERETY SJ, 1991, J IMMUNOL, V146, P2401; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HILLYARD AL, 1992, MOUSE GENOME, V90, P8; LANDER ES, 1989, GENETICS, V121, P185; LIPTON HL, 1976, SCIENCE, V192, P62, DOI 10.1126/science.176726; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MELVOLD RW, 1990, J VIROL, V64, P686, DOI 10.1128/JVI.64.2.686-690.1990; MELVOLD RW, 1987, J IMMUNOL, V138, P1429; MONTAGUTELLI X, 1990, J HERED, V81, P490, DOI 10.1093/oxfordjournals.jhered.a111033; MONTAGUTELLI X, 1991, MAMM GENOME, V1, P255, DOI 10.1007/BF00352333; OZDEN S, 1991, J HISTOCHEM CYTOCHEM, V39, P1305, DOI 10.1177/39.10.1940303; PATICK AK, 1990, J VIROL, V64, P5570, DOI 10.1128/JVI.64.11.5570-5576.1990; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1988, J IMMUNOL, V140, P2950; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; ROOS RP, 1984, ANN NEUROL, V15, P494, DOI 10.1002/ana.410150516; ROOS RP, 1982, J NEUROIMMUNOL, V2, P223, DOI 10.1016/0165-5728(82)90057-1; ROSENTHAL A, 1986, LAB INVEST, V54, P515; Sawyer WA, 1944, AM J HYG, V39, P337, DOI 10.1093/oxfordjournals.aje.a118911; SPINELLA DG, 1990, J IMMUNOL METHODS, V135, P209, DOI 10.1016/0022-1759(90)90274-Y; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; ZURBRIGGEN A, 1991, J VIROL, V65, P1023, DOI 10.1128/JVI.65.2.1023-1030.1991	33	93	93	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					87	91		10.1038/ng0993-87	http://dx.doi.org/10.1038/ng0993-87			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220433				2022-12-17	WOS:A1993LV56500023
J	JORDAN, SA; FARRAR, GJ; KENNA, P; HUMPHRIES, MM; SHEILS, DM; KUMARSINGH, R; SHARP, EM; SORIANO, N; AYUSO, C; BENITEZ, J; HUMPHRIES, P				JORDAN, SA; FARRAR, GJ; KENNA, P; HUMPHRIES, MM; SHEILS, DM; KUMARSINGH, R; SHARP, EM; SORIANO, N; AYUSO, C; BENITEZ, J; HUMPHRIES, P			LOCALIZATION OF AN AUTOSOMAL-DOMINANT RETINITIS-PIGMENTOSA GENE TO CHROMOSOME-7Q	NATURE GENETICS			English	Article							HUMAN COLOR-VISION; MOLECULAR-GENETICS; LINKAGE ANALYSIS; LOCI; ARM	Retinitis pigmentosa is a group of clinically and genetically heterogeneous retinopathies and a significant cause of worldwide visual handicap. We have typed DNA from members of a Spanish family segregating an autosomal dominant form of retinitis pigmentosa (adRP) using a large series of simple sequence polymorphic markers. Positive two-point lod scores have been obtained with fifteen markers including D7S480 (theta(max)=0.00, Z(max)=7.22). Multipoint analyses using a subset of these markers gave a lod score of 7.51 maximizing at D7S480. These data provide definitive evidence for the localisation of an adRP gene on chromsome 7q, and highlight the extensive genetic heterogeneity that exists in the autosomal dominant form of this disease.	FDN JIMENEZ DIAZ,DEPT GENET,E-28040 MADRID,SPAIN		JORDAN, SA (corresponding author), UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND.		Bateson, Jane Farrar/AAO-6147-2020; Farrar, G Jane/B-9832-2011	Kumar-Singh, Rajendra/0000-0002-7754-0713; Ayuso, Carmen/0000-0002-9242-7065	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BATEMAN JB, 1992, GENOMICS, V12, P601, DOI 10.1016/0888-7543(92)90454-Z; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; FARRAR FJ, 1992, GENOMICS, V14, P805; FARRAR GJ, 1990, GENOMICS, V8, P35; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; Freund C. L., 1992, American Journal of Human Genetics, V51, pA6; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P125; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUMPHRIES P, 1993, PROG RETIN RES, V12, P231, DOI 10.1016/0278-4327(93)90011-H; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; JORDAN SA, 1992, AM J HUM GENET, V50, P634; Jordan Siobhan A., 1992, Human Molecular Genetics, V1, P411, DOI 10.1093/hmg/1.6.411; KAJIWARA K, 1992, INVEST OPHTH VIS SCI, V33, P1396; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIOU GI, 1989, J BIOL CHEM, V264, P8200; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MARMOR MF, 1989, ARCH OPHTHALMOL-CHIC, V107, P816, DOI 10.1007/BF00154486; MASSOF RW, 1981, DOC OPHTHALMOL, V51, P28; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NGO JT, 1990, GENOMICS, V7, P84, DOI 10.1016/0888-7543(90)90521-U; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; OTT J, 1976, AM J HUM GENET, V28, P528; PEARSON PL, 1992, NUCLEIC ACIDS RES, V20, P2210; RICHARDS B, 1991, NUCLEIC ACIDS RES, V19, P5798; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEITZ CJ, 1992, AM J HUM GENET, V50, P498; WEITZ CJ, 1992, AM J HUM GENET, V51, P444; Zheng K., 1992, American Journal of Human Genetics, V51, pA250	36	93	97	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					54	58		10.1038/ng0593-54	http://dx.doi.org/10.1038/ng0593-54			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513324				2022-12-17	WOS:A1993LA33700013
J	COMPTON, JG; DIGIOVANNA, JJ; SANTUCCI, SK; KEARNS, KS; AMOS, CI; ABANGAN, DL; KORGE, BP; MCBRIDE, OW; STEINERT, PM; BALE, SJ				COMPTON, JG; DIGIOVANNA, JJ; SANTUCCI, SK; KEARNS, KS; AMOS, CI; ABANGAN, DL; KORGE, BP; MCBRIDE, OW; STEINERT, PM; BALE, SJ			LINKAGE OF EPIDERMOLYTIC HYPERKERATOSIS TO THE TYPE-II KERATIN GENE-CLUSTER ON CHROMOSOME-12Q	NATURE GENETICS			English	Article							CYTOKERATIN GENES; COMPLETE SEQUENCE; LOCALIZATION	We investigated the molecular genetics of epidermolytic hyperkeratosis (EHK), a dominant disorder characterized by epidermal blistering, hyperkeratosis, vacuolar degeneration and clumping of keratin filaments. Based on this pathology, we have excluded by linkage analysis several candidate genes for the disease; in contrast, complete linkage was obtained with the type II keratin, K1, on 12q11-q13. Linkage in this region of chromosome 12 was confirmed using several other markers, and multi-locus linkage analyses further supported this location. Keratins are excellent EHK gene candidates since their expression is specific to the suprabasal epidermal layers. In the pedigree studied here, a type II keratin gene, very probably K1, is implicated as the site of the molecular defect causing EHK.	NCI,DERMATOL BRANCH,BETHESDA,MD 20892; NCI,DIV CANC BIOL & DIAG,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				DiGiovanna, John J./0000-0002-2750-2313				ANTON-LAMPBRECHT I, 1983, J INVEST DERMATOL S, V81, P149; ANTONLAMPRECHT I, 1978, DERMATOLOGICA, V157, P65, DOI 10.1159/000250810; BARLETTA C, 1990, CYTOGENET CELL GENET, V54, P148, DOI 10.1159/000132979; BLANCHETBARDON C, 1977, ANN DERMATOL VENER, V104, P648; BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; COMPTON JG, 1988, MOUSE NEWS LETT, V80, P165; COULOMBE PA, 1991, J CELL BIOL, V115, P1661, DOI 10.1083/jcb.115.6.1661; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; GOLDSMITH LA, 1976, PROG MED GENET, V1, P185; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOYHEIM T, 1992, J INVEST DERMATOL, V98, P397; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; KIM IG, 1992, J BIOL CHEM, V367, P7710; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESSIN SR, 1988, J INVEST DERMATOL, V91, P572, DOI 10.1111/1523-1747.ep12477087; MCBRIDE OW, 1987, J BIOL CHEM, V262, P11163; MCKINLEYGRANT LJ, 1989, P NATL ACAD SCI USA, V86, P4848, DOI 10.1073/pnas.86.13.4848; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nadeau J H, 1991, Mamm Genome, V1 Spec No, pS461, DOI 10.1007/BF00656504; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P779, DOI 10.1093/nar/16.2.779; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P778, DOI 10.1093/nar/16.2.778; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; PEARSON RW, 1962, J INVEST DERMATOL, V39, P551, DOI 10.1038/jid.1962.156; PRIESTLEY L, 1990, HUM GENET, V85, P525; RIEGER M, 1985, EMBO J, V4, P2261, DOI 10.1002/j.1460-2075.1985.tb03924.x; ROMANO V, 1988, CYTOGENET CELL GENET, V48, P148, DOI 10.1159/000132612; RYYNANEN M, 1991, AM J HUM GENET, V49, P978; TAKAHASHI E, 1990, HUM GENET, V86, P14; WILLIAMS ML, 1987, DERMATOL CLIN, P155; YONEDA K, IN PRESS J BIOL CHEM; ZHOU XM, 1988, J BIOL CHEM, V263, P15584	36	93	96	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					301	305		10.1038/ng0792-301	http://dx.doi.org/10.1038/ng0792-301			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1284546				2022-12-17	WOS:A1992JC98400016
J	WAGSTAFF, J; KNOLL, JHM; GLATT, KA; SHUGART, YY; SOMMER, A; LALANDE, M				WAGSTAFF, J; KNOLL, JHM; GLATT, KA; SHUGART, YY; SOMMER, A; LALANDE, M			MATERNAL BUT NOT PATERNAL TRANSMISSION OF 15Q11-13-LINKED NONDELETION ANGELMAN SYNDROME LEADS TO PHENOTYPIC-EXPRESSION	NATURE GENETICS			English	Article							PRADER-WILLI SYNDROME; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; PROXIMAL 15Q	Angelman syndrome (AS) may result from either maternally inherited deletions of chromosome 15q11-13 or from paternal uniparental disomy for chromosome 15. This is in contrast to Prader-Willi syndrome (PWS), which is caused by either paternal deletion of this region or maternal disomy for chromosome 15. However, 40% of AS patients inherit an apparently intact copy of chromosome 15 from each parent. We now describe a family in which three sisters have given birth to four AS offspring who have no evidence of deletion or paternal disomy. We show that AS in this family is caused by a mutation in 15q11-13 that results in AS when transmitted from mother to child, but no phenotype when transmitted paternally. These results suggest that the loci responsible for AS and PWS, although closely linked, are distinct.	CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; CHILDRENS HOSP,COLUMBUS,OH 43205	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Columbia University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital				Knoll, Joan/0000-0001-6691-1710				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; BARAITSER M, 1987, CLIN GENET, V31, P323; BUTLER MG, 1983, LANCET, V1, P1285; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FEENER CA, 1991, AM J HUM GENET, V48, P621; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREENBERG F, 1987, AM J MED GENET, V28, P813, DOI 10.1002/ajmg.1320280405; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HULTEN M, 1991, LANCET, V338, P638, DOI 10.1016/0140-6736(91)90652-6; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NAKATSU Y, 1992, MAMM GENOME, V2, P69, DOI 10.1007/BF00570442; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NICHOLLS RD, 1989, MOUSE NEWS LETT, V84, P87; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308	29	93	93	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					291	294		10.1038/ng0792-291	http://dx.doi.org/10.1038/ng0792-291			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1338769				2022-12-17	WOS:A1992JC98400014
J	Kragesteen, BK; Spielmann, M; Paliou, C; Heinrich, V; Schopflin, R; Esposito, A; Annunziatella, C; Bianco, S; Chiariello, AM; Jerkovic, I; Harabula, I; Guckelberger, P; Pechstein, M; Wittler, L; Chan, WL; Franke, M; Lupianez, DG; Kraft, K; Timmermann, B; Vingron, M; Visel, A; Nicodemi, M; Mundlos, S; Andrey, G				Kragesteen, Bjort K.; Spielmann, Malte; Paliou, Christina; Heinrich, Verena; Schoepflin, Robert; Esposito, Andrea; Annunziatella, Carlo; Bianco, Simona; Chiariello, Andrea M.; Jerkovic, Ivana; Harabula, Izabela; Guckelberger, Philine; Pechstein, Michael; Wittler, Lars; Chan, Wing-Lee; Franke, Martin; Lupianez, Dario G.; Kraft, Katerina; Timmermann, Bernd; Vingron, Martin; Visel, Axel; Nicodemi, Mario; Mundlos, Stefan; Andrey, Guillaume			Dynamic 3D chromatin architecture contributes to enhancer specificity and limb morphogenesis	NATURE GENETICS			English	Article							PELVIC REDUCTION; PITX1; GENOME; HINDLIMB; DOMAINS; TRANSFORMATION; DETERMINES; LANDSCAPES; EXPRESSION; PRINCIPLES	The regulatory specificity of enhancers and their interaction with gene promoters is thought to be controlled by their sequence and the binding of transcription factors. By studying Pitx1, a regulator of hindlimb development, we show that dynamic changes in chromatin conformation can restrict the activity of enhancers. Inconsistent with its hindlimb-restricted expression, Pitx1 is controlled by an enhancer (Pen) that shows activity in forelimbs and hindlimbs. By Capture Hi-C and three-dimensional modeling of the locus, we demonstrate that forelimbs and hindlimbs have fundamentally different chromatin configurations, whereby Pen and Pitx1 interact in hindlimbs and are physically separated in forelimbs. Structural variants can convert the inactive into the active conformation, thereby inducing Pitx1 misexpression in forelimbs, causing partial arm-to-leg transformation in mice and humans. Thus, tissue-specific three-dimensional chromatin conformation can contribute to enhancer activity and specificity in vivo and its disturbance can result in gene misexpression and disease.	[Kragesteen, Bjort K.; Spielmann, Malte; Paliou, Christina; Schoepflin, Robert; Jerkovic, Ivana; Harabula, Izabela; Guckelberger, Philine; Pechstein, Michael; Franke, Martin; Lupianez, Dario G.; Kraft, Katerina; Mundlos, Stefan; Andrey, Guillaume] Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany; [Kragesteen, Bjort K.; Spielmann, Malte; Paliou, Christina; Schoepflin, Robert; Chan, Wing-Lee; Franke, Martin; Lupianez, Dario G.; Kraft, Katerina; Mundlos, Stefan; Andrey, Guillaume] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Kragesteen, Bjort K.; Paliou, Christina; Franke, Martin; Lupianez, Dario G.; Kraft, Katerina; Mundlos, Stefan; Andrey, Guillaume] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Kragesteen, Bjort K.; Jerkovic, Ivana] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Heinrich, Verena; Schoepflin, Robert; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Esposito, Andrea; Annunziatella, Carlo; Bianco, Simona; Chiariello, Andrea M.; Nicodemi, Mario] Univ Napoli Federico II, Dipartimento Fis, Complesso Univ Monte St Angelo, Naples, Italy; [Esposito, Andrea; Annunziatella, Carlo; Bianco, Simona; Chiariello, Andrea M.; Nicodemi, Mario] Ist Nazl Fis Nucl, Complesso Univ Monte St Angelo, Naples, Italy; [Esposito, Andrea; Nicodemi, Mario] Berlin Inst Hlth, MDC Berlin, Berlin, Germany; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Lupianez, Dario G.] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, Epigenet & Sex Dev Grp, Berlin, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, Berlin, Germany; [Visel, Axel] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Visel, Axel] Joint Genome Inst, US DOE, Walnut Creek, CA USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced	Mundlos, S; Andrey, G (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany.; Mundlos, S; Andrey, G (corresponding author), Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany.; Mundlos, S; Andrey, G (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.; Nicodemi, M (corresponding author), Univ Napoli Federico II, Dipartimento Fis, Complesso Univ Monte St Angelo, Naples, Italy.; Nicodemi, M (corresponding author), Ist Nazl Fis Nucl, Complesso Univ Monte St Angelo, Naples, Italy.; Nicodemi, M (corresponding author), Berlin Inst Hlth, MDC Berlin, Berlin, Germany.	nicodem@na.infn.it; mundlos@molgen.mpg.de; andrey@molgen.mpg.de	Mundlos, Stefan/ABH-9585-2020; Bianco, Simona/AAC-5344-2019; Franke, Martin/AAX-6027-2021; Franke, Martin/O-8986-2017; Lupiáñez, Darío G./AAH-3405-2019; Visel, Axel/A-9398-2009; Esposito, Andrea/CAJ-1360-2022; Chiariello, Andrea Maria/AAA-1544-2020; Andrey, Guillaume/AAL-4397-2020; Nicodemi, Mario/K-1815-2015; Spielmann, Malte/H-2230-2018	Bianco, Simona/0000-0001-5819-060X; Franke, Martin/0000-0002-4626-3290; Franke, Martin/0000-0002-4626-3290; Lupiáñez, Darío G./0000-0002-3165-036X; Visel, Axel/0000-0002-4130-7784; Esposito, Andrea/0000-0002-5903-8439; Chiariello, Andrea Maria/0000-0002-6112-0167; Jerkovic, Ivana/0000-0001-9707-8303; Annunziatella, Carlo/0000-0001-7175-4254; Nicodemi, Mario/0000-0002-8416-6416; Andrey, Guillaume/0000-0002-0911-4907; Kragesteen, Bjort Katrinardottir/0000-0002-9999-2067; Guckelberger, Philine/0000-0002-1057-2518; Spielmann, Malte/0000-0002-0583-4683; Mundlos, Stefan/0000-0002-9788-3166; Paliou, Christina/0000-0003-3383-2527	Deutsche Forschungsgemeinschaft [SP1532/2-1, MU 880/14]; Max Planck Foundation; Swiss National Science Foundation [P300PA_160964, P2ELP3_151960]; National Institutes of Health (NIH) [1U54DK107977-01]; CINECA ISCRA [HP10CRTY8P]; Einstein BIH Fellowship Award [EVF-BIH-2016-282]; NIH [R01HG003988, U54HG006997, R24HL123879, UM1HL098166]; Department of Energy [DE-AC02-05CH11231]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CINECA ISCRA(CINECA, Italy); Einstein BIH Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE))	We thank Judith Fiedler, Niclas Engemann and Karol Macura from the transgenic facility, Norbert Brieske for the WISH, and Myriam Hochradel from the sequencing core facility of the MPIMG. This study was supported by grants from the Deutsche Forschungsgemeinschaft (SP1532/2-1, MU 880/14) to M.S. and S.M., as well as the Max Planck Foundation to S.M. G.A. was supported by an early and advanced postdoc mobility grant from the Swiss National Science Foundation (P300PA_160964, P2ELP3_151960). M.N. acknowledges grants from the National Institutes of Health (NIH) (1U54DK107977-01), CINECA ISCRA (HP10CRTY8P), the Einstein BIH Fellowship Award (EVF-BIH-2016-282), and computer resources from the Istituto Nazionale di Fisica Nucleare, CINECA, and SCoPE at the University of Naples. A.V. was supported by NIH grants R01HG003988, U54HG006997, R24HL123879, and UM1HL098166. Work at the Lawrence Berkeley National Laboratory was performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Al-Qattan MM, 2013, GENE, V524, P65, DOI 10.1016/j.gene.2013.03.120; Alvarado DM, 2011, HUM MOL GENET, V20, P3943, DOI 10.1093/hmg/ddr313; Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Andrey G, 2017, METHODS MOL BIOL, V1468, P221, DOI 10.1007/978-1-4939-4035-6_15; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Barbieri M, 2017, NAT STRUCT MOL BIOL, V24, P515, DOI 10.1038/nsmb.3402; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Beccari L, 2016, GENE DEV, V30, P1172, DOI 10.1101/gad.281055.116; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco S, 2018, NAT GENET, V50, P662, DOI 10.1038/s41588-018-0098-8; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Domyan ET, 2016, ELIFE, V5, DOI 10.7554/eLife.12115; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Freire-Pritchett P, 2017, ELIFE, V6, DOI 10.7554/eLife.21926; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jain AK, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158360; Joshi O, 2015, CELL STEM CELL, V17, P748, DOI 10.1016/j.stem.2015.11.010; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mundlos S, 2000, METH MOL B, V136, P61; Nemec S, 2017, DEVELOPMENT, V144, P3325, DOI 10.1242/dev.154864; Nicodemi M, 2009, BIOPHYS J, V96, P2168, DOI 10.1016/j.bpj.2008.12.3919; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Symmons O, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0358; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Will AJ, 2017, NAT GENET, V49, P1539, DOI 10.1038/ng.3939; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1	60	92	93	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2018	50	10					1463	+		10.1038/s41588-018-0221-x	http://dx.doi.org/10.1038/s41588-018-0221-x			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV4DF	30262816	Green Submitted			2022-12-17	WOS:000446047000018
J	Zhu, ZZ; Lee, PH; Chaffin, MD; Chung, W; Loh, PR; Lu, Q; Christiani, DC; Liang, LM				Zhu, Zhaozhong; Lee, Phil H.; Chaffin, Mark D.; Chung, Wonil; Loh, Po-Ru; Lu, Quan; Christiani, David C.; Liang, Liming			A genome-wide cross-trait analysis from UK Biobank highlights the shared genetic architecture of asthma and allergic diseases	NATURE GENETICS			English	Article							TH2 CYTOKINES; RISK LOCI; HAY-FEVER; ASSOCIATION; METAANALYSIS; SUSCEPTIBILITY; MECHANISMS; EXPRESSION; IDENTIFICATION; ORGANIZATION	Clinical and epidemiological data suggest that asthma and allergic diseases are associated and may share a common genetic etiology. We analyzed genome-wide SNP data for asthma and allergic diseases in 33,593 cases and 76,768 controls of European ancestry from UK Biobank. Two publicly available independent genome-wide association studies were used for replication. We have found a strong genome-wide genetic correlation between asthma and allergic diseases (rg = 0.75, P = 6.84 x 10(-62)). Cross-trait analysis identified 38 genome-wide significant loci, including 7 novel shared loci. Computational analysis showed that shared genetic loci are enriched in immune/inflammatory systems and tissues with epithelium cells. Our work identifies common genetic architectures shared between asthma and allergy and will help to advance understanding of the molecular mechanisms underlying co-morbid asthma and allergic diseases.	[Zhu, Zhaozhong; Chung, Wonil; Loh, Po-Ru; Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Zhu, Zhaozhong; Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Zhu, Zhaozhong; Lee, Phil H.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Zhu, Zhaozhong; Lee, Phil H.] Harvard Med Sch, Boston, MA USA; [Lee, Phil H.; Chaffin, Mark D.; Loh, Po-Ru] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA USA; [Lee, Phil H.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA USA; [Lu, Quan] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Program Mol & Integrat Physiol Sci, Boston, MA USA; [Christiani, David C.] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Christiani, David C.] Harvard Med Sch, Boston, MA USA; [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Liang, LM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA.; Liang, LM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	lliang@hsph.harvard.edu		Loh, Po-Ru/0000-0001-5542-9064; Chung, Wonil/0000-0002-5766-6247	National Heart, Lung, and Blood Institute (NHLBI) [R01HL060710, R56HL134356, R01HL114769, AAF15-0097, R00MH101367]; National Institutes of Health; American Asthma Foundation; National Institute of Mental Health; MRC [MC_PC_12028] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710, R56HL134356, R01HL114769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH101367] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been conducted using the UK Biobank Resource under application number 16549. We would like to thank the participants and researchers from UK Biobank who significantly contributed or collected data. We thank the GABRIEL consortium and the EAGLE consortium for providing GWAS summary statistic data. We also thank W. Cookson and M. Moffatt their clinical advice, and D. Chasman, V. Anttila, S. Gazal, H. Shi, Y. Feng and M. Chen for their statistical advice. This study was supported by grants R01HL060710 (D.C.C.), R56HL134356 (D.C.C.), R01HL114769 (Q.L.), AAF15-0097 (Q.L.) and R00MH101367 (P.H.L.) from the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health, the American Asthma Foundation and the National Institute of Mental Health.	Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Amaral AFS, 2015, ALLERGY, V70, P328, DOI 10.1111/all.12557; Anthoni M, 2007, INT J BIOL SCI, V3, P477; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Belsky DW, 2013, LANCET RESP MED, V1, P453, DOI 10.1016/S2213-2600(13)70101-2; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bunyavanich S, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-48; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Dale M, 1999, GENOMICS, V57, P177, DOI 10.1006/geno.1999.5767; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Emdin CA, 2017, JAMA-J AM MED ASSOC, V317, P626, DOI 10.1001/jama.2016.21042; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo CC, 2010, CLIN IMMUNOL, V135, P483, DOI 10.1016/j.clim.2010.01.004; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hammerschlag AR, 2017, NAT GENET, V49, P1584, DOI 10.1038/ng.3888; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lane JM, 2017, NAT GENET, V49, P274, DOI 10.1038/ng.3749; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lenz HJ, 2007, ONCOLOGIST, V12, P601, DOI 10.1634/theoncologist.12-5-601; Leynaert Benedicte, 2000, Journal of Allergy and Clinical Immunology, V106, pS201; Li XN, 2012, J ALLERGY CLIN IMMUN, V129, P575, DOI 10.1016/j.jaci.2011.09.040; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lotem J, 2015, BBA-REV CANCER, V1855, P131, DOI 10.1016/j.bbcan.2015.01.004; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McLean W H Irwin, 2011, F1000 Med Rep, V3, P2, DOI 10.3410/M3-2; Meijer H, 2003, INFLAMM RES, V52, P404, DOI 10.1007/s00011-003-1197-1; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Novak N, 2001, CURR OPIN IMMUNOL, V13, P721, DOI 10.1016/S0952-7915(01)00285-0; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pariente PD, 1997, PHARMACOECONOMICS, V12, P585, DOI 10.2165/00019053-199712050-00009; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pawankar R, 2011, ASIA PAC ALLERGY, V1, P157, DOI 10.5415/apallergy.2011.1.3.157; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Seko A, 2002, JPN J CANCER RES, V93, P507, DOI 10.1111/j.1349-7006.2002.tb01285.x; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Wallace C, 2013, GENET EPIDEMIOL, V37, P802, DOI 10.1002/gepi.21765; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	83	92	94	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					857	+		10.1038/s41588-018-0121-0	http://dx.doi.org/10.1038/s41588-018-0121-0			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29785011	Green Submitted, Green Accepted			2022-12-17	WOS:000433621000013
J	Low, SK; Takahashi, A; Ebana, Y; Ozaki, K; Christophersen-, IE; Ellinor, PT; Ogishima, S; Yamamoto, M; Satoh, M; Sasaki, M; Yamaji, T; Iwasaki, M; Tsugane, S; Tanaka, K; Naito, M; Wakai, K; Tanaka, H; Furukawa, T; Kubo, M; Ito, K; Kamatani, Y; Tanaka, T				Low, Siew-Kee; Takahashi, Atsushi; Ebana, Yusuke; Ozaki, Kouichi; Christophersen-, Ingrid E.; Ellinor, Patrick T.; Ogishima, Soichi; Yamamoto, Masayuki; Satoh, Mamoru; Sasaki, Makoto; Yamaji, Taiki; Iwasaki, Motoki; Tsugane, Shoichiro; Tanaka, Keitaro; Naito, Mariko; Wakai, Kenji; Tanaka, Hideo; Furukawa, Tetsushi; Kubo, Michiaki; Ito, Kaoru; Kamatani, Yoichiro; Tanaka, Toshihiro		AFGen Consortium	Identification of six new genetic loci associated with atrial fibrillation in the Japanese population	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; DILATED CARDIOMYOPATHY; NEBULETTE MUTATIONS; CHROMOSOME 4Q25; COMMON VARIANTS; EARLY-ONSET; HEART; EXPRESSION; NEBULIN; RISK	Atrial fibrillation is the most common cardiac arrhythmia and leads to stroke. To investigate genetic loci associated with atrial fibrillation in the Japanese population, we performed a genome-wide association study (GWAS) that included 8,180 atrial fibrillation cases and 28,612 controls with follow-up in an additional 3,120 cases and 125,064 controls. We replicated previously reported loci and identified six new loci, near the KCND3, PPFIA4, SLC1A4-CEP68, HAND2, NEBL and SH3PXD2A genes. Five of the six new loci were specifically associated with atrial fibrillation in the Japanese population after comparing our data to those from individuals of European ancestry, suggesting that there might be different genetic factors affecting susceptibility across ancestry groups. Our study discovered variants in the HAND2, KCND3 and NEBL genes, which are relevant to atrial fibrillation susceptibility. The involvement of PPFIA4 and SH3PXD2A in axon guidance also suggested a role in disease pathogenesis. Our findings may contribute to a better understanding of atrial fibrillation susceptibility and pathogenesis.	[Low, Siew-Kee; Takahashi, Atsushi; Kamatani, Yoichiro] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Low, Siew-Kee] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Takahashi, Atsushi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Genom Med, Osaka, Japan; [Ebana, Yusuke; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan; [Ozaki, Kouichi; Ito, Kaoru; Tanaka, Toshihiro] RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Ozaki, Kouichi] Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Lab Med Genome Sci, Obu, Japan; [Christophersen-, Ingrid E.; Ellinor, Patrick T.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Christophersen-, Ingrid E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Christophersen-, Ingrid E.] Vestre Viken Hosp Trust, Baerum Hosp, Dept Med Res, Gjettum, Norway; [Ogishima, Soichi; Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Satoh, Mamoru; Sasaki, Makoto] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Yamaji, Taiki; Iwasaki, Motoki] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Epidemiol, Tokyo, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Tanaka, Hideo] Saga Univ, Fac Med, Dept Prevent Med, Saga, Japan; [Naito, Mariko; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan; [Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Tanaka, Hideo] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Nagoya, Aichi, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan	RIKEN; University of Sydney; National Cerebral & Cardiovascular Center - Japan; Tokyo Medical & Dental University (TMDU); RIKEN; National Center for Geriatrics & Gerontology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Tohoku University; Iwate Medical University; National Cancer Center - Japan; National Cancer Center - Japan; Saga University; Nagoya University; Aichi Cancer Center; Nagoya University; RIKEN; Tokyo Medical & Dental University (TMDU)	Kamatani, Y (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan.; Ito, K; Tanaka, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan.; Tanaka, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan.	kaoru.ito@riken.jp; yoichiro.kamatani@riken.jp; ttana.brc@tmd.ac.jp	Yamamoto, Masayuki/A-4873-2010; Tsugane, Shoichiro/A-2424-2015; Wakai, Kenji/I-7248-2014; NAITO, Mariko/I-7264-2014; Ito, Kaoru/AAZ-3440-2021; furukawa, tetsushi/ABD-3178-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Tsugane, Shoichiro/0000-0003-4105-2774; Wakai, Kenji/0000-0001-7388-7157; NAITO, Mariko/0000-0003-3794-2643; Ellinor, Patrick/0000-0002-2067-0533; Ebana, Yusuke/0000-0002-5162-0838; Christophersen, Ingrid Elisabeth/0000-0002-6141-4712; Ozaki, Kouichi/0000-0003-0028-1570	Naito Foundation Natural Science Scholarship; BioBank Japan project; Tohoku Medical Megabank project; Ministry of Education, Culture, Sports, Sciences and Technology Japan; Japan Agency for Medical Research and Development; National Cancer Research and Development Fund; Ministry of Health, Labour and Welfare of Japan; Japan Ministry of Education, Science, Sports, Culture and Technology [17015018, 221S0001]; JSPS KAKENHI from Japan Ministry of Education, Science, Sports, Culture and Technology [16H06277]; US National Institutes of Health [1RO1HL092577, R01HL128914, K24HL105780]; American Heart Association [13EIA14220013]; Fondation Leducq [14CVD01]; Grants-in-Aid for Scientific Research [15K08539, 16H06277] Funding Source: KAKEN	Naito Foundation Natural Science Scholarship; BioBank Japan project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku Medical Megabank project; Ministry of Education, Culture, Sports, Sciences and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Cancer Research and Development Fund; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Ministry of Education, Science, Sports, Culture and Technology; JSPS KAKENHI from Japan Ministry of Education, Science, Sports, Culture and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq(Leducq Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We express our heartfelt gratitude to all the participants in this study. We would like to express our gratefulness to the staff of TMM, J-MICC, JPHC and BBJ for their outstanding assistance. We extend our appreciation to N. Miyagawa and other members of the Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences for their support. This study was in part supported by the Naito Foundation Natural Science Scholarship to T.T. This study was also funded by the BioBank Japan project and the Tohoku Medical Megabank project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology Japan and the Japan Agency for Medical Research and Development. The JPHC Study has been supported by the National Cancer Research and Development Fund since 2010 and was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan from 1989 to 2010. The J-MICC Study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (17015018) and Innovative Areas (221S0001) and the JSPS KAKENHI Grant (16H06277) from the Japan Ministry of Education, Science, Sports, Culture and Technology. The following research institutions participated in the study: Chiba Cancer Center, University of Shizuoka, Nagoya City University, Aichi Cancer Center, Nagoya University, Shiga University of Medical Science, Kyoto Prefectural University of Medicine, University of Tokushima, Kyushu University, Saga University and Kagoshima University. This work was supported by grants from the US National Institutes of Health to P.T.E. (1RO1HL092577, R01HL128914, K24HL105780). P.T.E. is also supported by an Established Investigator Award from the American Heart Association (13EIA14220013) and by the Fondation Leducq (14CVD01).	Bang ML, 2015, CIRC J, V79, P2081, DOI 10.1253/circj.CJ-15-0854; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Duarri A, 2015, CELL MOL LIFE SCI, V72, P3387, DOI 10.1007/s00018-015-1894-2; Duarri A, 2013, NEUROGENETICS, V14, P257, DOI 10.1007/s10048-013-0370-0; Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Eulitz S, 2013, MOL BIOL CELL, V24, P3215, DOI 10.1091/mbc.E13-04-0202; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; KIRBY ML, 1983, DEV BIOL, V97, P433, DOI 10.1016/0012-1606(83)90100-8; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Moncman CL, 2002, EXP CELL RES, V273, P204, DOI 10.1006/excr.2001.5423; Morikawa Y, 2008, CIRC RES, V103, P1422, DOI 10.1161/CIRCRESAHA.108.180083; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Santiago-Medina M, 2015, DEVELOPMENT, V142, P486, DOI 10.1242/dev.108266; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Smets K, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0200-3; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	33	92	93	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					953	+		10.1038/ng.3842	http://dx.doi.org/10.1038/ng.3842			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	28416822				2022-12-17	WOS:000402062300022
J	Zhao, J; Ma, JY; Deng, Y; Kelly, JA; Kim, K; Bang, SY; Lee, HS; Li, QZ; Wakeland, EK; Qiu, R; Liu, MR; Guo, JP; Li, ZG; Tan, WF; Rasmussen, A; Lessard, CJ; Sivils, KL; Hahn, BH; Grossman, JM; Kamen, DL; Gilkeson, GS; Bae, SC; Gaffney, PM; Shen, N; Tsao, BP				Zhao, Jian; Ma, Jianyang; Deng, Yun; Kelly, Jennifer A.; Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Li, Quan-Zhen; Wakeland, Edward K.; Qiu, Rong; Liu, Mengru; Guo, Jianping; Li, Zhanguo; Tan, Wenfeng; Rasmussen, Astrid; Lessard, Christopher J.; Sivils, Kathy L.; Hahn, Bevra H.; Grossman, Jennifer M.; Kamen, Diane L.; Gilkeson, Gary S.; Bae, Sang-Cheol; Gaffney, Patrick M.; Shen, Nan; Tsao, Betty P.			A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NADPH OXIDASE ACTIVATION; GENOME-WIDE ASSOCIATION; PHOX HOMOLOGY DOMAIN; DELETION; INDIVIDUALS; SIGNATURE; 7Q11.23; CHINESE	Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a strong genetic component characterized by autoantibody production and a type 1 interferon signatures. Here we report a missense variant (g.74779296G>A; p.Arg90His) in NCF1, encoding the p47phox subunit of the phagocyte NADPH oxidase (NOX2), as the putative underlying causal variant that drives a strong SLE-associated signal detected by the lmmunochip in the GTF2IRD1-GTF2I region at 7q11.23 with a complex genomic structure. We show that the p.Arg90His substitution, which is reported to cause reduced reactive oxygen species (ROS) production(2), predisposes to SLE (odds ratio (OR) = 3.47 in Asians (P-meta = 3.1 x 10(-104)), OR = 2.61 in European Americans, OR = 2.02 in African Americans) and other autoimmune diseases, including primary Sjogren's syndrome (OR = 2.45 in Chinese, OR = 2.35 in European Americans) and rheumatoid arthritis (OR = 1.65 in Koreans). Additionally, decreased and increased copy numbers of NCF1 predispose to and protect against SLE, respectively. Our data highlight the pathogenic role of reduced NOX2-derived ROS levels in autoimmune diseases.	[Zhao, Jian; Deng, Yun; Kamen, Diane L.; Gilkeson, Gary S.; Tsao, Betty P.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Zhao, Jian; Deng, Yun; Hahn, Bevra H.; Grossman, Jennifer M.; Tsao, Betty P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Ma, Jianyang; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Rheumatol, Shanghai, Peoples R China; [Kelly, Jennifer A.; Rasmussen, Astrid; Lessard, Christopher J.; Sivils, Kathy L.; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Kim, Kwangwoo] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea; [Li, Quan-Zhen; Wakeland, Edward K.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Qiu, Rong; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai, Peoples R China; [Qiu, Rong; Shen, Nan] Chinese Acad Sci, Univ Chinese Acad Sci, SIBS, Shanghai, Peoples R China; [Liu, Mengru; Guo, Jianping; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Tan, Wenfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Lessard, Christopher J.; Sivils, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai, Peoples R China; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Translat Med, Shanghai, Peoples R China	Medical University of South Carolina; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University; Oklahoma Medical Research Foundation; Kyung Hee University; Hanyang University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Peking University; Nanjing Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center; Shanghai Jiao Tong University	Zhao, J; Tsao, BP (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.; Zhao, J; Tsao, BP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA.; Shen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Rheumatol, Shanghai, Peoples R China.; Shen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai, Peoples R China.; Shen, N (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, SIBS, Shanghai, Peoples R China.; Shen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai, Peoples R China.; Shen, N (corresponding author), Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA.; Shen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Translat Med, Shanghai, Peoples R China.	zhaoji@musc.edu; nanshensibs@gmail.com; tsaob@musc.edu	Shen, Nan/AGK-6807-2022; Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948; Tsao, Betty/0000-0001-7938-5975; Kim, Kwangwoo/0000-0001-8926-6216; Lessard, Christopher J./0000-0003-2440-3843; Gaffney, Patrick/0000-0002-1580-869X; Kelly, Jennifer/0000-0002-3203-2467; Bae, Sang-Cheol/0000-0003-4658-1093	US National Institutes of Health [R01AR043814, R21AR065626, R01AR056360, R01AR063124, U19AI082714, R01AR043274, R01DE015223, R01DE018209, R01AR050782, R01AR065953, P50AR0608040, P60AR062755]; Lupus Foundation of America; Alliance for Lupus Research; Sjogren's Syndrome Foundation; Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare in the Republic of Korea [HI13C2124, HI15C3182]; National Basic Research Program of China (973 program) [2014CB541902]; Key Research Program of Bureau of Frontier Sciences and Education Chinese Academy of Sciences grant [QYZDJ-SSW-SMC006]; Key Research Program of the Chinese Academy of Sciences grant [KJZD-EW-L01-3]; State Key Laboratory of Oncogenes and Related Genes grant [91-14-05]; National Natural Science Foundation of China [31630021]; Strategic Priority Research Program of the Chinese Academy of Sciences grant [XDA12020107]; Clinical and Translational Science Institute (CTSI) grants [UL1RR033176, UL1TR000124, UL1TR001450]; Spaulding-Paolozzi Autoimmunity Center of Excellence (MUSC); Endowment for Inflammation Research; SmartState(R) Center of Economic Excellence in Inflammation and Fibrosis Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082714, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043814, R01AR063124, R01AR065953, R21AR065626, R01AR050782, P50AR060804, P30AR053483, R01AR043274, R01AR056360, P60AR062755, P30AR072582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223, R01DE018209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510, U54GM104938, P30GM110766] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Foundation of America; Alliance for Lupus Research; Sjogren's Syndrome Foundation; Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare in the Republic of Korea; National Basic Research Program of China (973 program)(National Basic Research Program of China); Key Research Program of Bureau of Frontier Sciences and Education Chinese Academy of Sciences grant; Key Research Program of the Chinese Academy of Sciences grant; State Key Laboratory of Oncogenes and Related Genes grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences grant; Clinical and Translational Science Institute (CTSI) grants; Spaulding-Paolozzi Autoimmunity Center of Excellence (MUSC); Endowment for Inflammation Research; SmartState(R) Center of Economic Excellence in Inflammation and Fibrosis Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all subjects for their participation in this study. We thank E. Magdangal and Y. Shi for help with DNA preparation and organization. We also thank A. Lusis for valuable discussion and comments. This work was supported by US National Institutes of Health grants R01AR043814 (B.P.T.), R21AR065626 (B.P.T.), R01AR056360 (P.M.G.), R01AR063124 (P.M.G.), U19AI082714 (P.M.G.), R01AR043274 (K.L.S.), R01DE015223 (K.L.S.), R01DE018209 (K.L.S.), R01AR050782 (K.L.S.), R01AR065953 (C.J.L. and K.L.S.), P50AR0608040 (K.L.S. and C.J.L.), U19AI082714 (K.L.S. and C.J.L.) and P60AR062755 (D.L.K. and G.S.G.), the Lupus Foundation of America (B.P.T.), the Alliance for Lupus Research (B.P.T.), the Sjogren's Syndrome Foundation (K.L.S. and C.J.L.), Korea Healthcare Technology R&D Project of the Ministry for Health and Welfare in the Republic of Korea grants HI13C2124 (S.-C.B.) and HI15C3182 (K.K.), National Basic Research Program of China (973 program) grant 2014CB541902 (N.S.), Key Research Program of Bureau of Frontier Sciences and Education Chinese Academy of Sciences grant QYZDJ-SSW-SMC006 (N.S.), Key Research Program of the Chinese Academy of Sciences grant KJZD-EW-L01-3 (N.S.), State Key Laboratory of Oncogenes and Related Genes grant 91-14-05 (N.S.), National Natural Science Foundation of China grant 31630021 (N.S.), Strategic Priority Research Program of the Chinese Academy of Sciences grant XDA12020107 (N.S.). Clinical and Translational Science Institute (CTSI) grants UL1RR033176 (UCLA), UL1TR000124 (UCLA) and UL1TR001450 (MUSC), and funds from the Spaulding-Paolozzi Autoimmunity Center of Excellence (MUSC), the Richard M. Silver, MD, Endowment for Inflammation Research (B.P.T.) and the SmartState (R) Center of Economic Excellence in Inflammation and Fibrosis Research (B.P.T.). The funders had no role in study design, data collection, analysis and interpretation, writing of the report, or decision to submit the paper for publication.	Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Cachat J, 2015, CLIN SCI, V128, P635, DOI 10.1042/CS20140635; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Deng Y, 2014, CURR OPIN RHEUMATOL, V26, P482, DOI 10.1097/BOR.0000000000000086; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; Heyworth PG, 2002, BLOOD, V100, P1845, DOI 10.1182/blood-2002-03-0861; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kelkka T, 2014, ANTIOXID REDOX SIGN, V21, P2231, DOI 10.1089/ars.2013.5828; Li XJ, 2010, J BIOL CHEM, V285, P35169, DOI 10.1074/jbc.M110.164475; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Morris DL, 2016, NAT GENET, V48, P940, DOI 10.1038/ng.3603; Olsson LM, 2012, ANTIOXID REDOX SIGN, V16, P71, DOI 10.1089/ars.2011.4013; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	21	92	94	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					433	437		10.1038/ng.3782	http://dx.doi.org/10.1038/ng.3782			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	28135245	Green Accepted			2022-12-17	WOS:000394917800017
J	Niu, BF; Scott, AD; Sengupta, S; Bailey, MH; Batra, P; Ning, J; Wyczalkowski, MA; Liang, WW; Zhang, QY; McLellan, MD; Sun, SQ; Tripathi, P; Lou, C; Ye, K; Mashl, RJ; Wallis, J; Wendl, MC; Chen, F; Ding, L				Niu, Beifang; Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Batra, Prag; Ning, Jie; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Zhang, Qunyuan; McLellan, Michael D.; Sun, Sam Q.; Tripathi, Piyush; Lou, Carolyn; Ye, Kai; Mashl, R. Jay; Wallis, John; Wendl, Michael C.; Chen, Feng; Ding, Li			Protein-structure-guided discovery of functional mutations across 19 cancer types	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; DATA-BANK; IMPACT; NETWORKS; THERAPY; DRIVERS; GENOMES; GENES	Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots ( clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra-and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.	[Niu, Beifang; Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Batra, Prag; Ning, Jie; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Zhang, Qunyuan; McLellan, Michael D.; Sun, Sam Q.; Lou, Carolyn; Ye, Kai; Mashl, R. Jay; Wallis, John; Wendl, Michael C.; Ding, Li] Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA; [Scott, Adam D.; Sengupta, Sohini; Bailey, Matthew H.; Wyczalkowski, Matthew A.; Liang, Wen-Wei; Sun, Sam Q.; Lou, Carolyn; Mashl, R. Jay; Wendl, Michael C.; Ding, Li] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA; [Ning, Jie; Tripathi, Piyush; Chen, Feng; Ding, Li] Washington Univ, Div Nephrol, Dept Med, St Louis, MO 63130 USA; [Zhang, Qunyuan; Ye, Kai; Wendl, Michael C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63130 USA; [Chen, Feng; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA; [Chen, Feng] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA; [Niu, Beifang] Chinese Acad Sci, Dept High Performance Comp Technol & Applicat Dev, Comp Network Informat Ctr, Beijing, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Chinese Academy of Sciences; Computer Network Information Center, CAS	Ding, L (corresponding author), Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA.; Ding, L (corresponding author), Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA.; Chen, F; Ding, L (corresponding author), Washington Univ, Div Nephrol, Dept Med, St Louis, MO 63130 USA.; Chen, F; Ding, L (corresponding author), Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA.; Chen, F (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	fchen@wustl.edu; lding@genome.wustl.edu	Ye, Kai/B-3640-2012; Ye, Kai/GSD-9856-2022	Ye, Kai/0000-0002-2851-6741; Bailey, Matthew H./0000-0003-4526-9727; Wyczalkowski, Matthew/0000-0003-4197-551X; Scott, Adam/0000-0003-4066-6053; MCLELLAN, MICHAEL/0000-0002-2703-8784	National Cancer Institute [R01CA180006, R01CA178383]; National Human Genome Research Institute [U01HG006517]; US Department of Defense [PC130118 (W81XWH-14-1-0458)]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087960]; Precision Medicine Pathway at the Washington University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA178383, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087960] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US Department of Defense(United States Department of Defense); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Precision Medicine Pathway at the Washington University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Friesel (Maine Medical Center Research Institute) for NIH3T3 clone 2.2 cells. We thank K. Johnson, C. Kandoth, M. Bharadwaj, and K. Huang for suggestions on data analysis. We also thank M. Xie, R. Jayasinghe, and H. Greulich for suggestions on experiments. This work was supported by National Cancer Institute grants R01CA180006 and R01CA178383 and National Human Genome Research Institute grant U01HG006517 to L.D.F.C. is supported in part by US Department of Defense grant PC130118 (W81XWH-14-1-0458) and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK087960. M.H.B. is in part supported by the Precision Medicine Pathway at the Washington University School of Medicine.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts MJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1094; Carter H, 2010, CANCER BIOL THER, V10, P582, DOI 10.4161/cbt.10.6.12537; Choi YL, 2012, CARCINOGENESIS, V33, P956, DOI 10.1093/carcin/bgs099; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Dangalchev C, 2006, PHYSICA A, V365, P556, DOI 10.1016/j.physa.2005.12.020; de Biase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083607; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; FRIESEL R, 1989, MOL CELL BIOL, V9, P1857, DOI 10.1128/MCB.9.5.1857; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hardman WE, 2004, J NUTR, V134, p3427S, DOI 10.1093/jn/134.12.3427S; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kancha RK, 2009, CLIN CANCER RES, V15, P460, DOI 10.1158/1078-0432.CCR-08-1757; Kerner GSMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070346; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Niknafs N, 2013, HUM GENET, V132, P1235, DOI 10.1007/s00439-013-1325-0; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Ryslik GA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-231; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Teyra J, 2013, NAT METHODS, V10, P43, DOI 10.1038/nmeth.2300; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	37	92	92	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					827	+		10.1038/ng.3586	http://dx.doi.org/10.1038/ng.3586			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27294619	Green Accepted			2022-12-17	WOS:000380755100005
J	Styrkarsdottir, U; Thorleifsson, G; Helgadottir, HT; Bomer, N; Metrustry, S; Bierma-Zeinstra, S; Strijbosch, AM; Evangelou, E; Hart, D; Beekman, M; Jonasdottir, A; Sigurdsson, A; Eiriksson, FF; Thorsteinsdottir, M; Frigge, ML; Kong, A; Gudjonsson, SA; Magnusson, OT; Masson, G; Hofman, A; Arden, NK; Ingvarsson, T; Lohmander, S; Kloppenburg, M; Rivadeneira, F; Nelissen, RGHH; Spector, T; Uitterlinden, A; Slagboom, PE; Thorsteinsdottir, U; Jonsdottir, I; Valdes, AM; Meulenbelt, I; van Meurs, J; Jonsson, H; Stefansson, K				Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Helgadottir, Hafdis T.; Bomer, Nils; Metrustry, Sarah; Bierma-Zeinstra, S.; Strijbosch, Annelieke M.; Evangelou, Evangelos; Hart, Deborah; Beekman, Marian; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Eiriksson, Finnur F.; Thorsteinsdottir, Margret; Frigge, Michael L.; Kong, Augustine; Gudjonsson, Sigurjon A.; Magnusson, Olafur T.; Masson, Gisli; Hofman, Albert; Arden, Nigel K.; Ingvarsson, Thorvaldur; Lohmander, Stefan; Kloppenburg, Margreet; Rivadeneira, Fernando; Nelissen, Rob G. H. H.; Spector, Tim; Uitterlinden, Andre; Slagboom, P. Eline; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Valdes, Ana M.; Meulenbelt, Ingrid; van Meurs, Joyce; Jonsson, Helgi; Stefansson, Kari		TREAT OA Consortium; arcOGEN Consortium	Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RETINOIC ACID SYNTHESIS; KNEE OSTEOARTHRITIS; SUSCEPTIBILITY; HIP; INVOLVEMENT; POPULATION; IDENTIFY; RISK	Osteoarthritis is the most common form of arthritis and is a major cause of pain and disability in the elderly. To search for sequence variants that confer risk of osteoarthritis of the hand, we carried out a genome-wide association study (GWAS) in subjects with severe hand osteoarthritis, using variants identified through the whole-genome sequencing of 2,230 Icelanders. We found two significantly associated loci in the Icelandic discovery set: at 15q22 (frequency of 50.7%, odds ratio (OR) = 1.51, P = 3.99 x 10(-10)) in the ALDH1A2 gene and at 1p31 (frequency of 0.02%, OR = 50.6, P = 9.8 x 10(-10)). Among the carriers of the variant at 1p31 is a family with several members in whom the risk allele segregates with osteoarthritis. The variants within the ALDH1A2 gene were confirmed in replication sets from The Netherlands and the UK, yielding an overall association of OR = 1.46 and P= 1.1 x 10(-11) (rs3204689).	[Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Helgadottir, Hafdis T.; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Frigge, Michael L.; Kong, Augustine; Gudjonsson, Sigurjon A.; Magnusson, Olafur T.; Masson, Gisli; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland; [Bomer, Nils; Strijbosch, Annelieke M.; Beekman, Marian; Slagboom, P. Eline; Meulenbelt, Ingrid] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Metrustry, Sarah; Hart, Deborah; Spector, Tim] Kings Coll London, St Thomas Hosp, Dept Twin Res, London, England; [Bierma-Zeinstra, S.; Uitterlinden, Andre; van Meurs, Joyce] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Evangelou, Evangelos] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Beekman, Marian; Slagboom, P. Eline] Integrated Res Dev Determinants Ageing & Longev I, Leiden, Netherlands; [Beekman, Marian; Slagboom, P. Eline; Meulenbelt, Ingrid] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Eiriksson, Finnur F.; Thorsteinsdottir, Margret] Arctic Mass, Reykjavik, Iceland; [Thorsteinsdottir, Margret; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Arden, Nigel K.] Univ Oxford, Biomed Res Unit, NIHR, Oxford, England; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthoped Surg, Akureyri, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, Akureyri, Iceland; [Lohmander, Stefan] Lund Univ, Dept Orthoped, Lund, Sweden; [Kloppenburg, Margreet] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Kloppenburg, Margreet] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands; [Valdes, Ana M.] Univ Nottingham, City Hosp Nottingham, Acad Rheumatol, Nottingham NG7 2RD, England; [Jonsson, Helgi] Natl Univ Hosp Iceland, Dept Med, Reykjavik, Iceland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; University of Ioannina; Imperial College London; University of Iceland; Erasmus University Rotterdam; Erasmus MC; University of Oxford; University of Akureyri; Lund University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Landspitali National University Hospital	Stefansson, K (corresponding author), deCODE Genet Amgen, Reykjavik, Iceland.	unnur.tyrkarsdottir@decode.is; kstefans@decode.is	Lohmander, Stefan/AAL-8314-2021; Bierma-Zeinstra, Sita/AAF-2122-2019; Rivadeneira, Fernando/O-5385-2015; Beekman, Marian/L-3004-2019; Meulenbelt, Ingrid/F-4756-2011; Slagboom, P. Eline/R-4790-2016; Evangelou, Evangelos/C-3033-2013; Nelissen, Rob/AAD-8134-2020; Stefansson, Kari/AAE-7187-2019	Lohmander, Stefan/0000-0002-5424-9448; Rivadeneira, Fernando/0000-0001-9435-9441; Beekman, Marian/0000-0003-0585-6206; Meulenbelt, Ingrid/0000-0001-7786-7081; Slagboom, P. Eline/0000-0002-2875-4723; Evangelou, Evangelos/0000-0002-5488-2999; Nelissen, Rob/0000-0003-1228-4162; Jonsson, Helgi/0000-0003-0187-8985; Kong, Augustine/0000-0001-8193-5438; Valdes, Ana M./0000-0003-1141-4471; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Styrkarsdottir, Unnur/0000-0001-8146-8278; Bomer, Nils/0000-0001-5926-6960; van Meurs, Joyce/0000-0001-6245-2123; Helgadottir, Hafdis/0000-0003-4352-152X	European Union [200800 TREAT-0A]	European Union(European Commission)	We thank the subjects of the deCODE study, the Rotterdam study, the GARP LLS, RAAK and PAPRIKA studies, the TwinsUK and Chingford studies, and the MDC study for their valuable participation. This work was supported by European Union Framework Programme 7 grant 200800 TREAT-0A. Full acknowledgments are given in the Supplementary Note.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Betancourt MCC, 2012, P NATL ACAD SCI USA, V109, P8218, DOI 10.1073/pnas.1119899109; Dahaghin S, 2005, ARTHRITIS RHEUM, V52, P3520, DOI 10.1002/art.21375; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Evangelou E, 2014, ANN RHEUM DIS, V73, P2130, DOI 10.1136/annrheumdis-2012-203114; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; HART DJ, 1993, ANN RHEUM DIS, V52, P93, DOI 10.1136/ard.52.2.93; Haugen IK, 2011, ANN RHEUM DIS, V70, P1581, DOI 10.1136/ard.2011.150078; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Jonsson H, 2003, ARTHRITIS RHEUM, V48, P391, DOI 10.1002/art.10785; Jonsson Helgi, 2011, Open Rheumatol J, V5, P7, DOI 10.2174/1874312901105010007; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kraus VB, 2007, OSTEOARTHR CARTILAGE, V15, P120, DOI 10.1016/j.joca.2006.10.002; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Pittlik S, 2012, DEV DYNAM, V241, P1205, DOI 10.1002/dvdy.23805; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Riyazi N, 2005, ANN RHEUM DIS, V64, P438, DOI 10.1136/ard.2004.024661; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Underhill TM, 1998, MICROSC RES TECHNIQ, V43, P137, DOI 10.1002/(SICI)1097-0029(19981015)43:2<137::AID-JEMT7>3.3.CO;2-V; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2688, DOI 10.1002/art.27574; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	37	92	96	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					498	502		10.1038/ng.2957	http://dx.doi.org/10.1038/ng.2957			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24728293	Green Submitted			2022-12-17	WOS:000335422900019
J	Hammar, P; Wallden, M; Fange, D; Persson, F; Baltekin, O; Ullman, G; Leroy, P; Elf, J				Hammar, Petter; Wallden, Mats; Fange, David; Persson, Fredrik; Baltekin, Ozden; Ullman, Gustaf; Leroy, Prune; Elf, Johan			Direct measurement of transcription factor dissociation excludes a simple operator occupancy model for gene regulation	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; LAC REPRESSOR; MULTISCALE PRODUCTS; MOLECULE; CELLS; DISTRIBUTIONS; EXPRESSION; PROTEIN	Transcription factors mediate gene regulation by site-specific binding to chromosomal operators. It is commonly assumed that the level of repression is determined solely by the equilibrium binding of a repressor to its operator. However, this assumption has not been possible to test in living cells. Here we have developed a single-molecule chase assay to measure how long an individual transcription factor molecule remains bound at a specific chromosomal operator site. We find that the lac repressor dimer stays bound on average 5 min at the native lac operator in Escherichia coli and that a stronger operator results in a slower dissociation rate but a similar association rate. Our findings do not support the simple equilibrium model. The discrepancy with this model can, for example, be accounted for by considering that transcription initiation drives the system out of equilibrium. Such effects need to be considered when predicting gene activity from transcription factor binding strengths.	[Hammar, Petter; Wallden, Mats; Fange, David; Persson, Fredrik; Baltekin, Ozden; Ullman, Gustaf; Leroy, Prune; Elf, Johan] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, Uppsala, Sweden.	johan.elf@icm.uu.se	; Persson, Fredrik/F-3057-2011	elf, johan/0000-0001-5522-1810; Persson, Fredrik/0000-0002-5019-4312	European Research Council (ERC); Knut and Alice Wallenberg Foundation (KAW); Vetenskapsradet (VR); Foundation for Strategic Research (SSF); Gran Gustafsson Foundation	European Research Council (ERC)(European Research Council (ERC)); Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation); Vetenskapsradet (VR)(Swedish Research Council); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Gran Gustafsson Foundation	We thank K.S. Matthews for advice on LacI mutants, G.-W. Li for helpful comments, X.S. Xie (Harvard University) for the MalI-Venus strain and I. Barkefors for critical reading of the manuscript. This work was supported by the European Research Council (ERC), the Knut and Alice Wallenberg Foundation (KAW), Vetenskapsradet (VR), the Foundation for Strategic Research (SSF) and the Gran Gustafsson Foundation.	Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; CHANG WI, 1994, BIOCHEMISTRY-US, V33, P3607, DOI 10.1021/bi00178a018; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Garcia HG, 2012, CELL REP, V2, P150, DOI 10.1016/j.celrep.2012.06.004; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hermsen R, 2008, TRENDS GENET, V24, P216, DOI 10.1016/j.tig.2008.02.004; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Sadler BM, 1999, IEEE T INFORM THEORY, V45, P1043, DOI 10.1109/18.761341; Sanchez A, 2011, EMBO J, V30, P3940, DOI 10.1038/emboj.2011.273; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	25	92	92	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					405	+		10.1038/ng.2905	http://dx.doi.org/10.1038/ng.2905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24562187	Green Accepted			2022-12-17	WOS:000334510100020
J	Shi, YY; Li, L; Hu, ZB; Li, S; Wang, SX; Liu, JH; Wu, C; He, L; Zhou, JF; Li, ZQ; Hu, T; Chen, YL; Jia, Y; Wang, SS; Wu, L; Cheng, XD; Yang, ZJ; Yang, R; Li, X; Huang, KC; Zhang, QH; Zhou, H; Tang, FX; Chen, ZL; Shen, J; Jiang, J; Ding, H; Xing, H; Zhang, SL; Qu, PP; Song, XJ; Lin, ZQ; Deng, DR; Xi, L; Lv, WG; Han, XB; Tao, GS; Yan, LX; Han, ZD; Li, Z; Miao, XP; Pan, SD; Shen, YM; Wang, H; Liu, D; Gong, E; Li, Z; Zhou, LM; Luan, XM; Wang, CP; Song, Q; Wu, SF; Xu, HB; Shen, JW; Qiang, FL; Ma, G; Liu, L; Chen, XJ; Liu, JB; Wu, JP; Shen, Y; Wen, Y; Chu, MJ; Yu, J; Hu, XX; Fan, YJ; He, HY; Jiang, YM; Lei, ZY; Liu, C; Chen, JH; Zhang, Y; Yi, CJ; Chen, SY; Li, WJ; Wang, DW; Wang, ZH; Di, W; Shen, K; Lin, DX; Shen, HB; Feng, YJ; Xie, X; Ma, D				Shi, Yongyong; Li, Li; Hu, Zhibin; Li, Shuang; Wang, Shixuan; Liu, Jihong; Wu, Chen; He, Lin; Zhou, Jianfeng; Li, Zhiqiang; Hu, Ting; Chen, Yile; Jia, Yao; Wang, Shaoshuai; Wu, Li; Cheng, Xiaodong; Yang, Zhijun; Yang, Ru; Li, Xiong; Huang, Kecheng; Zhang, Qinghua; Zhou, Hang; Tang, Fangxu; Chen, Zhilan; Shen, Jian; Jiang, Jie; Ding, Hu; Xing, Hui; Zhang, Shulan; Qu, Pengpeng; Song, Xiaojie; Lin, Zhongqiu; Deng, Dongrui; Xi, Ling; Lv, Weiguo; Han, Xiaobing; Tao, Guangshi; Yan, Lixing; Han, Zhedong; Li, Zhuang; Miao, Xiaoping; Pan, Shandong; Shen, Yuanming; Wang, Hui; Liu, Dan; Gong, Ee; Li, Zheng; Zhou, Limei; Luan, Xiaomei; Wang, Chuping; Song, Qian; Wu, Sufang; Xu, Hongbin; Shen, Jiawei; Qiang, Fulin; Ma, Gang; Liu, Li; Chen, Xiaojun; Liu, Jibin; Wu, Jiangping; Shen, Yan; Wen, Yang; Chu, Minjie; Yu, Jiang; Hu, Xiaoxia; Fan, Yujuan; He, Hongying; Jiang, Yanming; Lei, Zhiying; Liu, Cui; Chen, Jianhua; Zhang, Yuan; Yi, Cunjian; Chen, Shuangyun; Li, Wenjin; Wang, Daowen; Wang, Zehua; Di, Wen; Shen, Keng; Lin, Dongxin; Shen, Hongbing; Feng, Youji; Xie, Xing; Ma, Ding			A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12	NATURE GENETICS			English	Article							T-CELL-ACTIVATION; NEF; COMPLEX; PAPILLOMAVIRUSES; STRATIFICATION; PROGRESSION; EXPRESSION; IMPUTATION; REGRESSION; GASDERMIN	To identify new genetic risk factors for cervical cancer, we conducted a genome-wide association study in the Han Chinese population. The initial discovery set included 1,364 individuals with cervical cancer (cases) and 3,028 female controls, and we selected a 'stringently matched samples' subset (829 cases and 990 controls) from the discovery set on the basis of principal component analysis; the follow-up stages included two independent sample sets (1,824 cases and 3,808 controls for follow-up 1 and 2,343 cases and 3,388 controls for follow-up 2). We identified strong evidence of associations between cervical cancer and two new loci: 4q12 (rs13117307, P-combined,P- stringently matched = 9.69 x 10(-9), per-allele odds ratio (OR)(stringently matched) = 1.26) and 17q12 (rs8067378, P-combined,P- stringently matched = 2.00 x 10(-8), per-allele ORstringently matched = 1.18). We additionally replicated an association between HLA-DPB1 and HLA-DPB2 (HLA-DPB1/2) at 6p21.32 and cervical cancer (rs4282438, Pcombined, stringently matched = 4.52 x 10(-27), per-allele ORstringently matched = 0.75). Our findings provide new insights into the genetic etiology of cervical cancer.	[Shi, Yongyong; Li, Shuang; Wang, Shixuan; Hu, Ting; Jia, Yao; Wang, Shaoshuai; Yang, Ru; Li, Xiong; Huang, Kecheng; Zhang, Qinghua; Zhou, Hang; Tang, Fangxu; Chen, Zhilan; Shen, Jian; Deng, Dongrui; Xi, Ling; Wang, Hui; Liu, Dan; Gong, Ee; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Shi, Yongyong; He, Lin; Li, Zhiqiang; Shen, Jiawei; Chen, Jianhua; Li, Wenjin] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Shi, Yongyong; He, Lin; Li, Zhiqiang; Shen, Jiawei] Shanghai Genome Pilot Inst Genom Hlth, Shanghai, Peoples R China; [Shi, Yongyong; He, Lin; Li, Zhiqiang; Shen, Jiawei] Shanghai Genome Pilot Inst Human Hlth, Shanghai, Peoples R China; [Shi, Yongyong; He, Lin; Li, Zhiqiang; Shen, Jiawei] Changning Mental Hlth Ctr, Shanghai, Peoples R China; [Li, Li; Yang, Zhijun; Li, Zhuang] Guangxi Prov Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China; [Hu, Zhibin; Jiang, Jie; Pan, Shandong; Wen, Yang; Chu, Minjie; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Jiang, Jie; Pan, Shandong; Wen, Yang; Chu, Minjie; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Liu, Jihong; Li, Zheng] Sun Yat Sen Univ, Ctr Canc, Dept Gynecol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Chen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhou, Jianfeng; Ding, Hu; Wang, Daowen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Hubei, Peoples R China; [Chen, Yile; Wu, Li] Hunan Prov Tumor Hosp, Dept Gynecol Oncol, Changsha, Hunan, Peoples R China; [Cheng, Xiaodong; Lv, Weiguo; Shen, Yuanming; Xie, Xing] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Hui] Hubei Univ Arts & Sci, Affiliated Hosp 1, Xiangyang Cent Hosp, Dept Obstet & Gynecol, Xiangyang, Peoples R China; [Zhang, Shulan; Luan, Xiaomei] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Qu, Pengpeng; Zhou, Limei] Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China; [Song, Xiaojie] Wuhan Med Ctr Women & Children, Wuhan, Peoples R China; [Lin, Zhongqiu] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Gynecol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Han, Xiaobing] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Peoples R China; [Tao, Guangshi] Cent South Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China; [Yan, Lixing; Han, Zhedong] Minist Hlth, Key Lab Blood Safety, Blood Ctr Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, Minist Educ,Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China; [Wang, Chuping] Huangshi Cent Hosp, Dept Obstet & Gynecol, Huangshi, Peoples R China; [Song, Qian] Xiaogan Cent Hosp, Dept Obstet & Gynecol, Xiaogan, Peoples R China; [Wu, Sufang; Feng, Youji] Hosp Fudan Univ, Dept Gynecol Obstet & Gynecol, Shanghai, Peoples R China; [Xu, Hongbin] Peoples Hosp Shenzhen, Dept Gynecol & Obstet, Shenzhen, Peoples R China; [Qiang, Fulin; Liu, Li; Chen, Xiaojun; Liu, Jibin] Nantong Tumor Hosp, Nantong, Peoples R China; [Ma, Gang] Guangxi Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Nanning, Peoples R China; [Wu, Jiangping; Shen, Yan] Nanjing Med Univ, Nanjing Matern & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Jiang] 181 Hosp Peoples Liberat Army, Maternal & Child Ctr, Guilin, Peoples R China; [Hu, Xiaoxia] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Obstet & Gynecol, Nanning, Peoples R China; [Fan, Yujuan] Guangxi Univ Med Sci, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanning, Peoples R China; [He, Hongying] Liuzhou Worker Hosp, Dept Obstet & Gynecol, Liuzhou, Peoples R China; [Jiang, Yanming] Peoples Hosp Liuzhou, Dept Obstet & Gynecol, Liuzhou, Peoples R China; [Lei, Zhiying] Youjiang Med Coll Nationalities, Dept Obstet & Gynecol, Affiliated Hosp, Baise, Peoples R China; [Liu, Cui] Red Cross Hosp Yulin City, Dept Obstet & Gynecol, Yulin, Peoples R China; [Chen, Jianhua] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Zhang, Yuan; Wang, Zehua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Yi, Cunjian] First Peoples Hosp Jingzhou City, Dept Obstet & Gynecol, Jinzhou, Peoples R China; [Chen, Shuangyun] Taihe Hosp Shiyan, Dept Gynecol Oncol, Shiyan, Peoples R China; [Di, Wen] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Shen, Keng] Chinese Acad Med Sci, Dept Obstet & Gynecol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Nanjing Medical University; Nanjing Medical University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Zhejiang University; Hubei University of Arts & Science; China Medical University; Sun Yat Sen University; Xi'an Jiaotong University; Central South University; Huazhong University of Science & Technology; Fudan University; Nanjing Medical University; Guangxi Medical University; Youjiang Medical University for Nationalities; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	shiyongyong@gmail.com; xiex@zju.edu.cn; dma@tjh.tjmu.edu.cn	xu, hong/GSD-8903-2022; Li, Zheng/B-3191-2017; Shi, Yongyong/GSO-1627-2022; Chen, Jianhua/AAS-8417-2020; li, xiong/ABG-2578-2020; miao, xiaoping/C-4336-2011; Li, Zhiqiang/AAI-4003-2021	Li, Zheng/0000-0002-6141-4990; Shi, Yongyong/0000-0003-1710-1505; li, xiong/0000-0003-0203-2973; miao, xiaoping/0000-0002-6818-9722; Li, Zhiqiang/0000-0002-0174-9254; Liu, Jihong/0000-0003-3464-2901; Shen, Hongbing/0000-0002-2581-5906; Wu, Chen/0000-0003-4954-1011; Lin, Dongxin/0000-0002-8723-8868; ding, hu/0000-0002-1814-1552; Zhou, Hang/0000-0003-2719-790X	Key Basic Research and Development Program Foundation of China (973 Program) from the Ministry of Science and Technology of China [2009CB521808, 2013CB911304]; National Natural Science Foundation of China [81230038, 81025011, 81090414, 30973472, 81071663, 81130022, 81121001, 81230052, 81272302, 31000553, 81172464, 81101964]; Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period [2008BAI57B01]; High-Tech Research and Development Program of China (863 Program) [2012AA020801, 2012AA02A515]; Fund of the Key Laboratory of Cancer Invasion and Metastasis from Hubei Province and Tongji Hospital [HB001, xkdy28]; Hubei Research and Development Program [2008BCC005, 2009BCC001, 2010BCB006]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1025]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Program for New Century Excellent Talents in University [NCET-09-0550]; Shanghai Rising-Star Program [12QA1401900]	Key Basic Research and Development Program Foundation of China (973 Program) from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period; High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fund of the Key Laboratory of Cancer Invasion and Metastasis from Hubei Province and Tongji Hospital; Hubei Research and Development Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program	This study was funded by the Fund of the Key Basic Research and Development Program Foundation of China (973 Program) from the Ministry of Science and Technology of China (2009CB521808 and 2013CB911304), grants from the National Natural Science Foundation of China (81230038, 81025011, 81090414, 30973472, 81071663, 81130022, 81121001, 81230052, 81272302, 31000553, 81172464 and 81101964), Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period (2008BAI57B01), the High-Tech Research and Development Program of China (863 Program) (2012AA020801 and 2012AA02A515) and the Fund of the Key Laboratory of Cancer Invasion and Metastasis from Hubei Province and Tongji Hospital (HB001 and xkdy28). This work was also partially supported by the Hubei Research and Development Program (2008BCC005, 2009BCC001 and 2010BCB006), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1025), the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026), the Program for New Century Excellent Talents in University (NCET-09-0550) and the Shanghai Rising-Star Program (12QA1401900). We thank all participants recruited for this study. We would like to thank S. Liu, G. Wu, Z. Wang, S. Xie, S. Chen, Q. Wu, Y. Lu, B. Cao, Y. Li, Q. Chen, D. Zhu, M. Gong, S. Sun, Y. Wang, Y. Qin, R. Yang, J. Feng, T. Wang, L. Shi, J. Jiang, F. Rong, W. Zhou, M. Qian, X. Wu, X. Xia, Y. Yan, Y. Fan, M. Cao, C. Sun, Q. Ling, J. Yang, B. Zhou, Z. Zeng, L. Tang, L. Yu, Y. Han, J. Zhou, Y. Fang, P. Chen and Y. Meng for their useful help.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; CHEN TM, 1993, CANCER RES, V53, P1167; Dalstein W, 2003, INT J CANCER, V106, P396, DOI 10.1002/ijc.11222; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Di Bonito P, 2009, VIROLOGY, V395, P45, DOI 10.1016/j.virol.2009.09.012; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivansson EL, 2011, GENES IMMUN, V12, P605, DOI 10.1038/gene.2011.40; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nicol AF, 2008, J CLIN PATHOL, V61, P84, DOI 10.1136/jcp.2007.047290; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sun Q, 2008, TRANSL ONCOL, V1, P73, DOI 10.1593/tlo.08112; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Villada IB, 2004, CANCER RES, V64, P8761, DOI 10.1158/0008-5472.CAN-04-2455; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wirtz Carla, 2012, Methods Mol Biol, V882, P87, DOI 10.1007/978-1-61779-842-9_6; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	41	92	102	1	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					918	U262		10.1038/ng.2687	http://dx.doi.org/10.1038/ng.2687			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23817570				2022-12-17	WOS:000322374900016
J	Tanikawa, C; Urabe, Y; Matsuo, K; Kubo, M; Takahashi, A; Ito, H; Tajima, K; Kamatani, N; Nakamura, Y; Matsuda, K				Tanikawa, Chizu; Urabe, Yuji; Matsuo, Keitaro; Kubo, Michiaki; Takahashi, Atsushi; Ito, Hidemi; Tajima, Kazuo; Kamatani, Naoyuki; Nakamura, Yusuke; Matsuda, Koichi			A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population	NATURE GENETICS			English	Article							STEM-CELL ANTIGEN; HELICOBACTER-PYLORI INFECTION; ABO BLOOD-GROUPS; PEPTIC-ULCER; GASTRIC-CANCER; PANCREATIC-CANCER; GENETIC-VARIATION; BLADDER-CANCER; RISK; DISEASE	Through a genome-wide association analysis with a total of 7,035 individuals with duodenal ulcer and 25,323 controls from Japan, we identified two susceptibility loci at the PSCA gene (encoding prostate stem cell antigen) at 8q24 and at the ABO blood group locus at 9q34. The C allele of rs2294008 at PSCA was associated with increased risk of duodenal ulcer (odds ratio (OR) = 1.84; P = 3.92 x 10(-33)) in a recessive model but was associated with decreased risk of gastric cancer (OR = 0.79; P = 6.79 x 10(-12)), as reported previously(1). The T allele of rs2294008 encodes a translation initiation codon upstream of the reported site and changes protein localization from the cytoplasm to the cell surface. rs505922 at ABO was also associated with duodenal ulcer in a recessive model (OR = 1.32; P = 1.15 x 10(-10)). Our findings demonstrate a role for genetic variants in the pathogenesis of duodenal ulcer.	[Tanikawa, Chizu; Urabe, Yuji; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Matsuo, Keitaro; Ito, Hidemi; Tajima, Kazuo] Aichi Canc Ctr, Div Epidemiol & Prevent, Res Inst, Toyoake, Aichi, Japan; [Kubo, Michiaki; Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Inst Phys & Chem Res, Kanagawa, Japan	University of Tokyo; Aichi Cancer Center; RIKEN	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Matsuo, Keitaro/H-6758-2019; Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Matsuo, Keitaro/0000-0003-1761-6314; Tanikawa, Chizu/0000-0003-4759-4793; Ito, Hidemi/0000-0002-8023-4581; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all the subjects and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan, who donated their DNA for this work. We also thank A. Matsui and H. Tagaya and the technical staff of the Laboratory for Genotyping Development at the Center for Genomic Medicine at RIKEN for their technical support. This work was conducted as a part of the BioBank Japan Project, which was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	AINLEY CC, 1986, GUT, V27, P648, DOI 10.1136/gut.27.6.648; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; ARAKI S, 1985, J EPIDEMIOL COMMUN H, V39, P82, DOI 10.1136/jech.39.1.82; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breslow N E, 1987, IARC Sci Publ, P1; CLARKE CA, 1955, BRIT MED J, V2, P643, DOI 10.1136/bmj.2.4940.643; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; FUJITA Y, 1978, JPN J HUM GENET, V23, P197, DOI 10.1007/BF01872469; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Hopkins RJ, 1996, GASTROENTEROLOGY, V110, P1244, DOI 10.1053/gast.1996.v110.pm8613015; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; KHUROO MS, 1989, GUT, V30, P930, DOI 10.1136/gut.30.7.930; KURATA J, 1994, J CLIN GASTROENTEROL, V18, P145, DOI 10.1097/00004836-199403000-00014; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Nakao M, 2011, CANCER SCI, V102, P1076, DOI 10.1111/j.1349-7006.2011.01907.x; Ohara T, 2003, HEPATO-GASTROENTEROL, V50, P1774; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raff AB, 2009, CANCER LETT, V277, P126, DOI 10.1016/j.canlet.2008.08.034; Raiha I, 1998, ARCH INTERN MED, V158, P698, DOI 10.1001/archinte.158.7.698; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SCHLEMPER RJ, 1993, SCAND J GASTROENTERO, V28, P33, DOI 10.3109/00365529309101573; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Tajima Kazuo, 2000, Asian Pac J Cancer Prev, V1, P35; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Walker MM, 1996, ALIMENT PHARM THERAP, V10, P119, DOI 10.1046/j.1365-2036.1996.22164012.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu TC, 2003, WORLD J GASTROENTERO, V9, P1752, DOI 10.3748/wjg.v9.i8.1752; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; WYATT JI, 1987, J CLIN PATHOL, V40, P841, DOI 10.1136/jcp.40.8.841; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	41	92	96	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					430	U241		10.1038/ng.1109	http://dx.doi.org/10.1038/ng.1109			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22387998				2022-12-17	WOS:000302130600018
J	Tiwari, VK; Stadler, MB; Wirbelauer, C; Paro, R; Schubeler, D; Beisel, C				Tiwari, Vijay K.; Stadler, Michael B.; Wirbelauer, Christiane; Paro, Renato; Schuebeler, Dirk; Beisel, Christian			A chromatin-modifying function of JNK during stem cell differentiation	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; HISTONE H3; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; MAP KINASES; PHOSPHORYLATION; LINEAGE; DNA	Signaling mediates cellular responses to extracellular stimuli. The c-Jun NH2-terminal kinase (JNK) pathway exemplifies one subgroup of the mitogen-activated protein (MAP) kinases, which, besides having established functions in stress response, also contribute to development by an unknown mechanism(1-4). We show by genome-wide location analysis that JNK binds to a large set of active promoters during the differentiation of stem cells into neurons. JNK-bound promoters are enriched with binding motifs for the transcription factor NF-Y but not for AP-1. NF-Y occupies these predicted sites, and overexpression of dominant-negative NF-YA reduces the JNK presence on chromatin. We find that histone H3 Ser10 (H3S10) is a substrate for JNK, and JNK-bound promoters are enriched for H3S10 phosphorylation. Inhibition of JNK signaling in post-mitotic neurons reduces phosphorylation at H3S10 and the expression of target genes. These results establish MAP kinase binding and function on chromatin at a novel class of target genes during stem cell differentiation.	[Tiwari, Vijay K.; Stadler, Michael B.; Wirbelauer, Christiane; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Paro, Renato; Beisel, Christian] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Paro, Renato; Schuebeler, Dirk] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	michael.stadler@fmi.ch; dirk@fmi.ch		Beisel, Christian/0000-0001-5360-2193; Tiwari, Vijay/0000-0003-0292-6635	Marie Curie International Incoming fellowship; EMBO; Deutsche Forschungsgemeinschaft (DFG); European Union Epigenome Network of Excellence (EU-NoE) Epigenesys; Novartis; ETH Zurich; Novartis Research Foundation; European Union ((EU-NoE) Epigenesys, Blueprint)); European Research Council [ERC-204264]; SystemsX.ch (Cell Plasticity)	Marie Curie International Incoming fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union Epigenome Network of Excellence (EU-NoE) Epigenesys; Novartis(Novartis); ETH Zurich(ETH Zurich); Novartis Research Foundation; European Union ((EU-NoE) Epigenesys, Blueprint)); European Research Council(European Research Council (ERC)European Commission); SystemsX.ch (Cell Plasticity)	We thank L. Hoerner, M. Seimiya and I. Nissen for technical assistance, N. Tiwari for help with reagents and critical suggestions, G. Christofori, M. Bentires-Alj and members of the Schubeler laboratory for comments to the manuscript, R. Davis (University of Massachusetts Medical School, Worcester, Massachusetts, USA) for providing wild-type NIH3T3 cells and those lacking JNK1 and JNK2, and R. Mantovani (University of Milan, Milan, Italy) for the wild-type and dominant-negative NF-Y constructs. We thank the facilities at the Friedrich Miescher Institute, especially T. Roloff. Illumina sequencing was carried out at the Quantitative Genomics Facility of the Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich. V. K. T. is supported by a Marie Curie International Incoming fellowship and an EMBO long-term postdoctoral fellowship. Research in the laboratory of R. P. is supported by the Deutsche Forschungsgemeinschaft (DFG), the European Union Epigenome Network of Excellence (EU-NoE) Epigenesys, Novartis and the ETH Zurich. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union ((EU-NoE) Epigenesys, Blueprint)), the European Research Council (ERC-204264) and SystemsX.ch (Cell Plasticity).	Alabert C, 2006, ONCOGENE, V25, P3387, DOI 10.1038/sj.onc.1209385; Amura CR, 2005, MOL CELL BIOL, V25, P10791, DOI 10.1128/MCB.25.24.10791-10802.2005; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Aplin AE, 2002, J CELL SCI, V115, P2781; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wood JL, 2001, J BIOL CHEM, V276, P21262, DOI 10.1074/jbc.M007520200; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	54	92	94	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					94	U134		10.1038/ng.1036	http://dx.doi.org/10.1038/ng.1036			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179133				2022-12-17	WOS:000298664000021
J	Lindstrom, S; Vachon, CM; Li, JM; Varghese, J; Thompson, D; Warren, R; Brown, J; Leyland, J; Audley, T; Wareham, NJ; Loos, RJF; Paterson, AD; Rommens, J; Waggott, D; Martin, LJ; Scott, CG; Pankratz, VS; Hankinson, SE; Hazra, A; Hunter, DJ; Hopper, JL; Southey, MC; Chanock, SJ; Silva, ID; Liu, JJ; Eriksson, L; Couch, FJ; Stone, J; Apicella, C; Czene, K; Kraft, P; Hall, P; Easton, DF; Boyd, NF; Tamimi, RM				Lindstroem, Sara; Vachon, Celine M.; Li, Jingmei; Varghese, Jajini; Thompson, Deborah; Warren, Ruth; Brown, Judith; Leyland, Jean; Audley, Tina; Wareham, Nicholas J.; Loos, Ruth J. F.; Paterson, Andrew D.; Rommens, Johanna; Waggott, Darryl; Martin, Lisa J.; Scott, Christopher G.; Pankratz, V. Shane; Hankinson, Susan E.; Hazra, Aditi; Hunter, David J.; Hopper, John L.; Southey, Melissa C.; Chanock, Stephen J.; Silva, Isabel dos Santos; Liu, JianJun; Eriksson, Louise; Couch, Fergus J.; Stone, Jennifer; Apicella, Carmel; Czene, Kamila; Kraft, Peter; Hall, Per; Easton, Douglas F.; Boyd, Norman F.; Tamimi, Rulla M.			Common variants in ZNF365 are associated with both mammographic density and breast cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RANDOMIZED-TRIAL; MENOPAUSE; FEATURES	High-percent mammographic density adjusted for age and body mass index is one of the strongest risk factors for breast cancer. We conducted a meta analysis of five genome-wide association studies of percent mammographic density and report an association with rs10995190 in ZNF365 (combined P = 9.6 x 10(-10)). Common variants in ZNF365 have also recently been associated with susceptibility to breast cancer.	[Lindstroem, Sara; Hankinson, Susan E.; Hazra, Aditi; Hunter, David J.; Kraft, Peter; Tamimi, Rulla M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lindstroem, Sara; Hazra, Aditi; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Vachon, Celine M.; Scott, Christopher G.; Pankratz, V. Shane] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Li, Jingmei; Eriksson, Louise; Czene, Kamila; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Li, Jingmei; Liu, JianJun] Genome Inst Singapore, Singapore, Singapore; [Varghese, Jajini; Thompson, Deborah; Brown, Judith; Leyland, Jean; Audley, Tina; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Genet Epidemiol, Cambridge, England; [Warren, Ruth] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; [Wareham, Nicholas J.; Loos, Ruth J. F.] MRC, Epidemiol Unit, Cambridge, England; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Paterson, Andrew D.; Rommens, Johanna] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Waggott, Darryl] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Martin, Lisa J.; Boyd, Norman F.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Hankinson, Susan E.; Hazra, Aditi; Hunter, David J.; Tamimi, Rulla M.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hankinson, Susan E.; Hazra, Aditi; Hunter, David J.; Tamimi, Rulla M.] Harvard Univ, Sch Med, Boston, MA USA; [Hopper, John L.; Stone, Jennifer; Apicella, Carmel] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Silva, Isabel dos Santos] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Tamimi, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	rulla.tamimi@channing.harvard.edu	Paterson, Andrew D/A-4088-2011; Loos, Ruth/GON-5877-2022; Stone, Jennifer/AAS-3805-2020; Liu, Jianjun/AAK-4989-2020; Paterson, Andrew/AAQ-7511-2020; Varghese, Jajini/GWU-5455-2022; Loos, Ruth J F/Q-2862-2016; Rommens, Johanna/AAT-7465-2021; Li, Jingmei/I-2904-2012	Paterson, Andrew D/0000-0002-9169-118X; Liu, Jianjun/0000-0002-3255-3019; Paterson, Andrew/0000-0002-9169-118X; Loos, Ruth J F/0000-0002-8532-5087; Li, Jingmei/0000-0001-8587-7511; Varghese, Jajini Susan/0000-0001-8189-5608; Czene, Kamila/0000-0002-3233-5695; Southey, Melissa/0000-0002-6313-9005; Scott, Christopher/0000-0003-1340-0647; Stone, Jennifer/0000-0001-5077-0124; dos Santos Silva, Isabel/0000-0002-6596-8798	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [CA131332, CA087969, CA049449, CA128931, CA116201, CA075016, CA122340, CA089393]; Breast Cancer Research Fund; National Cancer Institute's Cancer Markers of Susceptibility (CGEMS) initiative; Cancer Research UK; Marit and Hans Rausing's Initiative against Breast Cancer, National Institutes of Health; Susan Komen Foundation; Agency for Science, Technology and Research of Singapore (A*STAR); Campbell Family Institute for Breast Cancer Research; Ontario Ministry of Health and Long Term Care; NATIONAL CANCER INSTITUTE [R29CA075016, R01CA049449, R01CA131332, ZIACP010201, U01CA049449, P01CA087969, P50CA116201, R01CA122340, P50CA089393, R01CA128931] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research Council [MC_U106188470, MC_U106179471, G0701863] Funding Source: researchfish; MRC [G0701863, MC_U106188470] Funding Source: UKRI	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Fund; National Cancer Institute's Cancer Markers of Susceptibility (CGEMS) initiative; Cancer Research UK(Cancer Research UK); Marit and Hans Rausing's Initiative against Breast Cancer, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Campbell Family Institute for Breast Cancer Research; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Public Health Service Grants CA131332, CA087969, CA049449, CA128931, CA116201, CA075016, CA122340 and CA089393 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services and Breast Cancer Research Fund. The Nurses' Health Study (NHS) breast cancer cases and controls were genotyped with support from the National Cancer Institute's Cancer Markers of Susceptibility (CGEMS) initiative. Data evaluation of mammograms and analysis of the EPIC-Norfolk and SIBS studies was supported by Cancer Research UK. The SASBAC study was supported by Marit and Hans Rausing's Initiative against Breast Cancer, National Institutes of Health, Susan Komen Foundation and Agency for Science, Technology and Research of Singapore (A*STAR). Genotyping in the TORONTO/MELBOURNE subjects was supported by the Campbell Family Institute for Breast Cancer Research. Support was also provided by the Ontario Ministry of Health and Long Term Care.	Boyd N F, 2001, IARC Sci Publ, V154, P163; Boyd N F, 2001, Curr Oncol Rep, V3, P314, DOI 10.1007/s11912-001-0083-7; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 1997, JNCI-J NATL CANCER I, V89, P488, DOI 10.1093/jnci/89.7.488; Byng JW, 1996, EUR J CANCER PREV, V5, P319, DOI 10.1097/00008469-199610000-00003; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Duffy SW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2123; Knight JA, 1999, CANCER EPIDEM BIOMAR, V8, P123; SPICER DV, 1994, J NATL CANCER I, V86, P431, DOI 10.1093/jnci/86.6.431; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; Warren R, 2007, CLIN RADIOL, V62, P1052, DOI 10.1016/j.crad.2007.04.002; Yaffe M, 2005, GYNECOL ENDOCRINOL, V21, P17, DOI 10.1080/09513590400030004	14	92	93	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					185	187		10.1038/ng.760	http://dx.doi.org/10.1038/ng.760			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21278746	Green Accepted			2022-12-17	WOS:000287693800007
J	Wilbe, M; Jokinen, P; Truve, K; Seppala, EH; Karlsson, EK; Biagi, T; Hughes, A; Bannasch, D; Andersson, G; Hansson-Hamlin, H; Lohi, H; Lindblad-Toh, K				Wilbe, Maria; Jokinen, Paivi; Truve, Katarina; Seppala, Eija H.; Karlsson, Elinor K.; Biagi, Tara; Hughes, Angela; Bannasch, Danika; Andersson, Goran; Hansson-Hamlin, Helene; Lohi, Hannes; Lindblad-Toh, Kerstin			Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DUCK TOLLING RETRIEVER; AUTOIMMUNE-DISEASE; T-CELLS; DOGS; ACTIVATION; PROTEIN; PREDISPOSITION; CALCINEURIN; PHOSPHATASE	The unique canine breed structure makes dogs an excellent model for studying genetic diseases. Within a dog breed, linkage disequilibrium is extensive(1,2), enabling genome-wide association (GWA) with only around 15,000 SNPs and fewer individuals than in human studies(1,3). Incidences of specific diseases are elevated in different breeds, indicating that a few genetic risk factors might have accumulated through drift or selective breeding. In this study, a GWA study with 81 affected dogs (cases) and 57 controls from the Nova Scotia duck tolling retriever breed identified five loci associated with a canine systemic lupus erythematosus (SLE)-related disease complex that includes both antinuclear antibody (ANA)-positive immune-mediated rheumatic disease (IMRD) and steroid-responsive meningitis-arteritis (SRMA). Fine mapping with twice as many dogs validated these loci. Our results indicate that the homogeneity of strong genetic risk factors within dog breeds allows multigenic disorders to be mapped with fewer than 100 cases and 100 controls, making dogs an excellent model in which to identify pathways involved in human complex diseases.	[Karlsson, Elinor K.; Biagi, Tara; Lindblad-Toh, Kerstin] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA; [Karlsson, Elinor K.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Wilbe, Maria; Truve, Katarina; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, S-75007 Uppsala, Sweden; [Jokinen, Paivi; Seppala, Eija H.; Lohi, Hannes] Univ Helsinki, Dept Med Genet, Dept Vet Biosci, Folkhalsan Inst Genet,Program Mol Med,Biomedicum, Helsinki, Finland; [Hughes, Angela] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Bannasch, Danika] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Hansson-Hamlin, Helene] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Swedish University of Agricultural Sciences; University of Helsinki; University of California System; University of California Davis; University of California System; University of California Davis; Swedish University of Agricultural Sciences; Uppsala University	Lindblad-Toh, K (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA.	kersli@broadinstitute.org	Fiumefreddo, Andrea/T-2977-2019; Lohi, Hannes/F-4596-2011; Bannasch, Danika/GZL-8044-2022; Andersson, Goran/AAK-6564-2020	Lohi, Hannes/0000-0003-1087-5532; Andersson, Goran/0000-0001-5131-3144; Karlsson, Elinor/0000-0002-4343-3776; Hamlin, Helene/0000-0002-8015-4688; Bannasch, Danika/0000-0002-7614-7207; Truve, Katarina/0000-0002-2449-8283	NSDTRs; FORMAS; Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning; Swedish Foundation for Strategic Research; Swedish Research Council; Foundation of Thure F. and Karin Forsberg; Swedish Kennel Club; Swedish Nova Scotia Duck Tolling Retriever Club; AKC Canine Health Foundation; UC-Davis Center for Companion Animal Health; Sigrid Juselius Foundation; Biocentrum Helsinki; Academy of Finland; Jane and Aatos Erkko Foundation; European Science Foundation; Morris Animal Foundation; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	NSDTRs; FORMAS(Swedish Research Council Formas); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Thure F. and Karin Forsberg; Swedish Kennel Club; Swedish Nova Scotia Duck Tolling Retriever Club; AKC Canine Health Foundation; UC-Davis Center for Companion Animal Health; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; European Science Foundation(European Science Foundation (ESF)European Commission); Morris Animal Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the dog owners, breeders and veterinarians and the breed clubs of NSDTRs that have provided dog samples and are supporting this study. We thank L. Andersson for comments on the manuscript and U. Gustafson for assistance with DNA extraction. The work was supported by FORMAS, the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, the Swedish Foundation for Strategic Research, the Swedish Research Council, the Foundation of Thure F. and Karin Forsberg, the Swedish Kennel Club, the Swedish Nova Scotia Duck Tolling Retriever Club, AKC Canine Health Foundation, UC-Davis Center for Companion Animal Health, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Academy of Finland and the Jane and Aatos Erkko Foundation, and part of the work was funded by research grants from L. Peltonen and the Center of Excellence of Complex Disease Genetics of the Academy of Finland. K.L.-T. is the recipient of a EURYI award from the European Science Foundation. A. H. was partially supported by a fellowship from the Morris Animal Foundation.	Anfinsen KP, 2008, CAN J VET RES, V72, P350; Chung SA, 2007, AUTOIMMUNITY, V40, P582, DOI 10.1080/08916930701510848; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Han SL, 2000, EUR J IMMUNOL, V30, P1318, DOI 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G; Hansson-Hamlin H, 2006, VET CLIN PATH, V35, P397, DOI 10.1111/j.1939-165X.2006.tb00155.x; Hansson-Hamlin H, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-16; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Koskenmies S, 2008, LUPUS, V17, P337, DOI 10.1177/0961203307087403; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kyttaris VC, 2007, J IMMUNOL, V178, P1960, DOI 10.4049/jimmunol.178.3.1960; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Mariani Sara M, 2004, MedGenMed, V6, P18; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redman J, 2002, VET REC, V151, P712; Serfling E, 2006, EUR J IMMUNOL, V36, P2837, DOI 10.1002/eji.200536618; Sommers CL, 2008, INT IMMUNOL, V20, P811, DOI 10.1093/intimm/dxn039; Strang A. I., 1996, NOVA SCOTIA DUCK TOL; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6	30	92	94	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					250	U39		10.1038/ng.525	http://dx.doi.org/10.1038/ng.525			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101241				2022-12-17	WOS:000274912400015
J	Kun, A; Santos, M; Szathmary, E				Kun, A; Santos, M; Szathmary, E			Real ribozymes suggest a relaxed error threshold	NATURE GENETICS			English	Article							RNA; ADDITIVITY; EVOLUTION; PROTEIN	The error threshold for replication, the critical copying fidelity below which the fittest genotype deterministically disappears, limits the length of the genome that can be maintained by selection. Primordial replication must have been error- prone, and so early replicators are thought to have been necessarily short(1). The error threshold also depends on the fitness landscape. In an RNA world(2), many neutral and compensatory mutations can raise the threshold, below which the functional phenotype(3), rather than a particular sequence, is still present(4,5). Here we show, on the basis of comparative analysis of two extensively mutagenized ribozymes, that with a copying fidelity of 0.999 per digit per replication the phenotypic error threshold rises well above 7,000 nucleotides, which permits the selective maintenance of a functionally rich riboorganism(6) with a genome of more than 100 different genes, the size of a tRNA. This requires an order of magnitude of improvement in the accuracy of in vitro - generated polymerase ribozymes(7,8). Incidentally, this genome size coincides with that estimated for a minimal cell achieved by top- down analysis(9), omitting the genes dealing with translation.	Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary; Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Ecol & Theoret Biol, H-1117 Budapest, Hungary	Eotvos Lorand University; Autonomous University of Barcelona; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University	Szathmary, E (corresponding author), Collegium Budapest, Inst Adv Study, Szentharomsag 2, H-1014 Budapest, Hungary.	szathmary@colbud.hu	Santos, Mauro/A-8044-2008; Szathmáry, Eörs/A-5007-2011; Kun, Ádám/A-5571-2011; Szathmary, Eors/AAS-1202-2021	Santos, Mauro/0000-0002-6478-6570; Kun, Ádám/0000-0002-8409-8521; Szathmary, Eors/0000-0001-5227-2997				BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; BENNER SA, 1987, COLD SPRING HARB SYM, V52, P53, DOI 10.1101/SQB.1987.052.01.009; BUTCHER SE, 1994, BIOCHEMISTRY-US, V33, P992, DOI 10.1021/bi00170a018; BUTCHER SE, 1994, J MOL BIOL, V244, P52, DOI 10.1006/jmbi.1994.1703; Domingo Esteban, 1994, P161; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Lafontaine DA, 2002, BIOCHEM SOC T, V30, P1170, DOI 10.1042/bst0301170; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Muller UF, 2003, CHEM BIOL, V10, P799, DOI 10.1016/S1074-5521(03)00171-6; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; SANDBERG WS, 1993, P NATL ACAD SCI USA, V90, P8367, DOI 10.1073/pnas.90.18.8367; Santos M, 2004, J MOL EVOL, V59, P507, DOI 10.1007/s00239-004-2642-7; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; SMITH JM, 1983, PROC R SOC SER B-BIO, V219, P315, DOI 10.1098/rspb.1983.0076; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9	27	92	95	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					1008	1011		10.1038/ng1621	http://dx.doi.org/10.1038/ng1621			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16127452				2022-12-17	WOS:000231591900029
J	Kargul, GJ; Dudekula, DB; Qian, Y; Lim, MK; Jaradat, SA; Tanaka, TS; Carter, MG; Ko, MSH				Kargul, GJ; Dudekula, DB; Qian, Y; Lim, MK; Jaradat, SA; Tanaka, TS; Carter, MG; Ko, MSH			Verification and initial annotation of the NIA mouse 15K cDNA clone set	NATURE GENETICS			English	Letter							DATABASE; SEQUENCES		NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ko, MSH (corresponding author), NIA, Dev Genom & Aging Sect, Genet Lab, NIH, Baltimore, MD 21224 USA.	kom@grc.nia.nih.gov	Ko, Minoru S. H./B-7969-2009; Carter, Mark/B-5089-2010	Ko, Minoru S. H./0000-0002-3530-3015; Tanaka, Tetsuya/0000-0002-0406-0217; Dudekula, Dawood/0000-0002-4054-1827	NATIONAL INSTITUTE ON AGING [Z01AG000656] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; 2000, NATURE GENET, V25, P251	16	92	93	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2001	28	1					17	18		10.1038/ng0501-17	http://dx.doi.org/10.1038/ng0501-17			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326268				2022-12-17	WOS:000168413300008
J	Scharf, JM; Endrizzi, MG; Wetter, A; Huang, S; Thompson, TG; Zerres, K; Dietrich, WF; Wirth, B; Kunkel, LM				Scharf, JM; Endrizzi, MG; Wetter, A; Huang, S; Thompson, TG; Zerres, K; Dietrich, WF; Wirth, B; Kunkel, LM			Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics	NATURE GENETICS			English	Article							WERDNIG-HOFFMANN DISEASE; LARGE-SCALE DELETIONS; MOTOR-NEURON GENE; 5Q13 REGION; PROTEIN; SEVERITY; SMN; COPIES; ASSOCIATION; (C)BCD541	Spinal muscular atrophy (SMA) is a common recessive disorder characterized by the loss of lower motor neurons in the spinal cord. The disease has been classified into three types based on age of onset and severity(1). SMA I-III all map to chromosome 5q13 (refs 2,3), and nearly all patients display deletions or gene conversions of the survival motor neuron (SMN1) gene(4-7). Some correlation has been established between SMN protein levels and disease course(8-10): nevertheless, the genetic basis for SMA phenotypic variability remains unclear, and it has been postulated that the loss of an additional modifying factor contributes to the severity of type I SMA. Using comparative genomics to screen for such a factor among evolutionarily conserved sequences between mouse and human, we have identified a novel transcript, H4F5, which lies closer to SMN? than any previously identified gene in the region. A multi-copy microsatellite marker that is deleted in more than 90% of type I SMA chromosomes is embedded in an intron of this gene, indicating that H4F5 is also highly deleted in type I SMA chromosomes, and thus is a candidate phenotypic modifier for SMA.	Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Childrens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Bonn; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Kunkel, LM (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA.		Wirth, Brunhilde/H-3192-2019	Huang, Sidong/0000-0002-2838-4726; Wirth, Brunhilde/0000-0003-4051-5191	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 23740] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burglen L, 1997, AM J HUM GENET, V60, P72; Burlet P, 1996, J MED GENET, V33, P281, DOI 10.1136/jmg.33.4.281; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; Chen QF, 1998, GENOMICS, V48, P121, DOI 10.1006/geno.1997.5141; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Mortillaro MJ, 1998, J BIOL CHEM, V273, P8183, DOI 10.1074/jbc.273.14.8183; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Nishio H, 1997, NEUROLOGY, V48, P1266, DOI 10.1212/WNL.48.5.1266; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Scharf JM, 1996, GENOMICS, V38, P405, DOI 10.1006/geno.1996.0644; Schwartz M, 1997, HUM MOL GENET, V6, P99, DOI 10.1093/hmg/6.1.99; SELIG S, 1995, P NATL ACAD SCI USA, V92, P3702, DOI 10.1073/pnas.92.9.3702; THOMPSON TG, 1996, THESIS U CALIFORNIA; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273	30	92	102	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					83	86		10.1038/1753	http://dx.doi.org/10.1038/1753			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731538				2022-12-17	WOS:000075671400026
J	Gourdon, G; Radvanyi, F; Lia, AS; Duros, C; Blanche, M; Abitbol, M; Junien, C; HofmannRadvanyi, H				Gourdon, G; Radvanyi, F; Lia, AS; Duros, C; Blanche, M; Abitbol, M; Junien, C; HofmannRadvanyi, H			Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY PATIENTS; DNA MISMATCH REPAIR; CTG REPEAT; TRINUCLEOTIDE REPEAT; (CTG)(N) REPEAT; TRIPLET REPEAT; EXPANSION; GENE; SIZE; SEX	Myotonic dystrophy (DM) is associated with the expansion of a (CTG)n trinucleotide repeat in the 3' untranslated region (UTR) of the DM protein kinase gene (DMPK)(1). The (CTG)n repeat is polymorphic and varies in size between 5 and 37 repeats in unaffected individuals' whereas in affected patients there are between 50 and 4,000 CTGs(2,3), The size of the (CTC)n repeat, which increases through generations, generally correlates with clinical severity and age of onset(4). The instability of the CTG repeat appears to depend on its size as well as on the sex of the transmitting parent(5-9). Moreover, mitotic instability analysis of different human DM tissues shows length mosaicism between different cell lineages(3,6,10-14). The molecular mechanisms of triplet instability remain elusive. To investigate the role of genomic sequences in instability, we produced transgenic mice containing a 45-kb genomic segment with a 55-CTG repeat cloned from a mildly affected patient. In contrast to other mouse models containing CAG repeats within cDNAs, these mice showed both intergenerational and somatic repeat instability(15-17).	HOP NECKER ENFANTS MALAD,INSERM UR383,LAMY,F-75743 PARIS 15,FRANCE; INST CURIE,UMR 144,CNRS,PARIS,FRANCE; UNIV PARIS 05,FAC NECKER,CTR RECH THERAPEUT OPHTALMOL,F-75270 PARIS 06,FRANCE; HOP AMBROISE PARE,BIOCHIM LAB,BOULOGNE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP			Gourdon, Genevieve/F-2996-2013	Gourdon, Genevieve/0000-0002-3319-1347; Radvanyi, Francois/0000-0002-5696-6424				ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BARCELO JM, 1993, HUM MOL GENET, V2, P705, DOI 10.1093/hmg/2.6.705; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; GOURDON G, 1994, NUCLEIC ACIDS RES, V22, P4139, DOI 10.1093/nar/22.20.4139; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HARPER PS, 1992, AM J HUM GENET, V51, P10; HARRIS H, 1996, HUM MOL GENET, V5, P1417; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JANSEN G, 1994, AM J HUM GENET, V54, P575; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; WONG LJC, 1995, AM J HUM GENET, V56, P114	30	92	93	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					190	192		10.1038/ng0297-190	http://dx.doi.org/10.1038/ng0297-190			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020847				2022-12-17	WOS:A1997WF08700021
J	vonHaeseler, A; Sajantila, A; Paabo, S				vonHaeseler, A; Sajantila, A; Paabo, S			The genetical archaeology of the human genome	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA SEQUENCES; MAJOR HISTOCOMPATIBILITY COMPLEX; RECENT AFRICAN ORIGIN; II DRB GENES; CONVERGENT EVOLUTION; BALANCING SELECTION; D-LOOP; POLYMORPHISM; POPULATIONS; DIVERSITY	Palaentology and archaeology are disciplines that traditionally deal with the reconstruction of human origins and history. Recently, however, molecular genetics has come to make increasing contributions to this area. In particular, several data sets indicate that variation of the human gene pool originated in Africa within the last 200,000 years. Furthermore, the study of DNA sequences allows the detection of expansions in population size. Here we briefly summarize and exemplify how DNA sequences can be used to reconstruct the history of populations.			vonHaeseler, A (corresponding author), UNIV MUNICH,INST ZOOL,POB 202136,D-80021 MUNICH,GERMANY.		Sajantila, Antti/AAY-9084-2021; von Haeseler, Arndt/HCI-9958-2022	von Haeseler, Arndt/0000-0002-3366-4458; Sajantila, Antti/0000-0003-4117-5248				Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; Blanchard JL, 1996, MOL BIOL EVOL, V13, P537, DOI 10.1093/oxfordjournals.molbev.a025614; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1984, NEOLITHIC TRANSITION; CROUAUROY B, 1996, HUM MOL GENET, V8, P1131; DANDRADE R, 1996, AM ANTHROPOL, V98, P2; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Felsenstein J., 1993, PHYLOGENETIC INFEREN; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; FU YX, IN PRESS NATURE; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GUSTAFSSON K, 1994, IMMUNOGENETICS, V39, P355, DOI 10.1007/BF00189233; GUSTAFSSON K, 1990, P NATL ACAD SCI USA, V87, P9798, DOI 10.1073/pnas.87.24.9798; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HEDGES SB, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1738849; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Howell N, 1996, AM J HUM GENET, V59, P501; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; LI WH, 1991, GENETICS, V129, P513; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; MAJORAM P, 1994, GENETICS, V136, P673; MANDERSCHEID EJ, IN PRESS AM J PHYS A; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; NEI M, 1984, EVOL BIOL, V17, P73; Paabo S, 1996, AM J HUM GENET, V59, P493; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PESOLE G, 1992, MOL BIOL EVOL, V9, P587; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; RUVOLO M, 1994, P NATL ACAD SCI USA, V91, P8900, DOI 10.1073/pnas.91.19.8900; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; SAJANTILA A, IN PRESS P NATL ACAD; SHERRY ST, 1994, HUM BIOL, V66, P761; SLATKIN M, 1991, GENETICS, V129, P555; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; TAKAHATA N, 1992, GENETICS, V130, P925; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Tishkoff S. A., 1995, American Journal of Human Genetics, V57, pA42; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WATSON L, 1996, AM J HUM GENET, V59, P437; WEISS G, 1996, SCIENCE, V272, P1358; WILLS C, 1995, EVOLUTION, V49, P593, DOI 10.1111/j.1558-5646.1995.tb02296.x; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	58	92	91	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					135	140		10.1038/ng1096-135	http://dx.doi.org/10.1038/ng1096-135			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841181				2022-12-17	WOS:A1996VL44600015
J	ALBERTSEN, HM; SMITH, SA; MAZOYER, S; FUJIMOTO, E; STEVENS, J; WILLIAMS, B; RODRIGUEZ, P; CROPP, CS; SLIJEPCEVIC, P; CARLSON, M; ROBERTSON, M; BRADLEY, P; LAWRENCE, E; HARRINGTON, T; SHENG, ZM; HOOPES, R; STERNBERG, N; BROTHMAN, A; CALLAHAN, R; PONDER, BAJ; WHITE, R				ALBERTSEN, HM; SMITH, SA; MAZOYER, S; FUJIMOTO, E; STEVENS, J; WILLIAMS, B; RODRIGUEZ, P; CROPP, CS; SLIJEPCEVIC, P; CARLSON, M; ROBERTSON, M; BRADLEY, P; LAWRENCE, E; HARRINGTON, T; SHENG, ZM; HOOPES, R; STERNBERG, N; BROTHMAN, A; CALLAHAN, R; PONDER, BAJ; WHITE, R			A PHYSICAL MAP AND CANDIDATE GENES IN THE BRCA1 REGION ON CHROMOSOME 17Q12-21	NATURE GENETICS			English	Article							BREAST-OVARIAN-CANCER; POLYMERASE CHAIN-REACTION; FAMILIAL BREAST; YEAST; DNA; CLONING; SEQUENCES; LIBRARY; CDNA; PCR	We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1. The map comprises a contig of 137 overlapping yeast artificial chromosomes and P1 clones, onto which we have placed 112 PCR markers. We have localized more than 20 genes on this map, ten of which had not been mapped to the region previously, and have isolated 30 cDNA clones representing partial sequences of as yet unidentified genes. Two genes that lie within a narrow region defined by meiotic breakpoints in BRCA1 patients have been sequenced in breast cancer patients without revealing any deleterious mutations. These new reagents should facilitate the identification of BRCA1.	UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 1QP,ENGLAND; NCI,TUMOR IMMUNOL & BIOL LAB,BETHESDA,MD 20892; DUPONT MERCK PHARMACEUT CO,WILMINGTON,DE 19880	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); DuPont	ALBERTSEN, HM (corresponding author), UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112, USA.		Mazoyer, Sylvie/N-7559-2017	Mazoyer, Sylvie/0000-0002-2135-0160	NHGRI NIH HHS [R01-HG00367-04, R01-HG00339] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367, R01HG000339] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALBERTSEN LA, 1994, AM J HUM GENET, V54, P516; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; CROPP CS, 1994, CANCER RES, V54, P2548; EASTON DF, 1993, AM J HUM GENET, V52, P678; EISHOUBAGY N, 1992, EUR J BIOCHEM, V204, P491; ERNI M, 1993, NAT GENET, V5, P151; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KEISELL DP, 1993, HUM MOL GENET, V2, P1823; KOHRI K, 1993, BIOCHIM BIOPHYS ACTA, V1173, P345, DOI 10.1016/0167-4781(93)90136-2; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NIKAIDO T, 1990, CLIN EXP IMMUNOL, V79, P209; OCONNELL P, 1994, AM J HUM GENET, V54, P526; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SPRINKLE TJ, 1993, GENOMICS, V16, P542, DOI 10.1006/geno.1993.1227; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; TONIN P, 1993, GENOMICS, V18, P414, DOI 10.1006/geno.1993.1487; TRASK BJ, 1991, AM J HUM GENET, V48, P1; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; XU W, 1989, CYTOGENET CELL GENET, V51, P1111; [No title captured]	40	92	113	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					472	479		10.1038/ng0894-472	http://dx.doi.org/10.1038/ng0894-472			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951316				2022-12-17	WOS:A1994PA83200012
J	WERTHEIMER, E; LU, SP; BACKELJAUW, PF; DAVENPORT, ML; TAYLOR, SI				WERTHEIMER, E; LU, SP; BACKELJAUW, PF; DAVENPORT, ML; TAYLOR, SI			HOMOZYGOUS DELETION OF THE HUMAN INSULIN-RECEPTOR GENE RESULTS IN LEPRECHAUNISM	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS; MUTATIONS; CDNA	Homozygous inactivation of a gene, as is frequently performed to generate mouse models, provides an opportunity to elucidate the role that the gene plays in normal physiology. However, studies of human disease provide direct insight into the effect of inactivating mutations in man. In this investigation, we have identified a one year-old boy from a consanguineous pedigree who is homozygous for deletion of the insulin receptor gene resulting in leprechaunism. Contrary to previous predictions, the complete deletion of the insulin receptor gene is compatible with life.	NIDDKD, DIABET BRANCH, BETHESDA, MD 20892 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27399 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill								BARBETTI F, 1992, DIABETES, V41, P408, DOI 10.2337/diabetes.41.4.408; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CZECH MP, 1988, J BIOL CHEM, V263, P11017; DENTON RM, 1981, DIABETOLOGIA, V21, P347; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; LIU SJ, 1992, 1992 M MOUS MOL GEN, P265; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; RECHLER MM, 1990, HDB EXPT PHARM, V95, P263; RIFKIN H, 1963, DIABETES, V12, P31, DOI 10.2337/diab.12.1.31; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SHARMA PM, 1989, GENE, V77, P177, DOI 10.1016/0378-1119(89)90372-7; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; TEWARI DS, 1989, J BIOL CHEM, V264, P16238; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; YANGFENG TL, 1985, SCIENCE, V228, P728, DOI 10.1126/science.3873110	22	92	93	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					71	73		10.1038/ng0993-71	http://dx.doi.org/10.1038/ng0993-71			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	7693131				2022-12-17	WOS:A1993LV56500019
J	DELANEY, SJ; RICH, DP; THOMSON, SA; HARGRAVE, MR; LOVELOCK, PK; WELSH, MJ; WAINWRIGHT, BJ				DELANEY, SJ; RICH, DP; THOMSON, SA; HARGRAVE, MR; LOVELOCK, PK; WELSH, MJ; WAINWRIGHT, BJ			CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR SPLICE VARIANTS ARE NOT CONSERVED AND FAIL TO PRODUCE CHLORIDE CHANNELS	NATURE GENETICS			English	Article							MESSENGER-RNA TRANSCRIPTS; CODING SEQUENCES; CFTR GENE; EXPRESSION; MUTATIONS; DOMAIN; DELETION	In the human CFTR only the rare exon 4- splice variant is conserved in mice. We have discovered two novel murine variants, exon 5- and exon 11b+. The exon 5- variant represents up to 40% of mRNA in all CFTR-expressing tissues and leaves the reading frame intact. The exon 11b+ variant inserts a novel exon between exons 11 and 12 with expression restricted to the testis. Two variants of 11b have been found and both introduce premature stop codons. When we expressed human CFTR variants lacking either exon 5 or exon 9 in HeLa cells, they failed to generate cAMP-mediated chloride transport, due to defective intracellular processing. The lack of conservation of splice variants between species and the inability of the more abundant splice variants to generate protein that is correctly processed argue against a physiological role and may simply represent aberrant splicing that is tolerated by the cell and organism.	UNIV QUEENSLAND,CTR MOLEC BIOL & BIOTECHNOL,BRISBANE,QLD 4072,AUSTRALIA; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Queensland; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa				Hargrave, Murray/0000-0001-5797-9377; Wainwright, Brandon/0000-0003-0406-2092; Welsh, Michael/0000-0002-1646-6206				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; BREMER S, 1992, EUR J BIOCHEM, V206, P137, DOI 10.1111/j.1432-1033.1992.tb16911.x; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; CHU CS, 1992, EMBO J, V11, P379, DOI 10.1002/j.1460-2075.1992.tb05062.x; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Fonknechten N., 1992, Human Molecular Genetics, V1, P281, DOI 10.1093/hmg/1.4.281; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; PETCH LA, 1990, MOL CELL BIOL, V10, P2973, DOI 10.1128/MCB.10.6.2973; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; WAEBER G, 1991, MOL ENDOCRINOL, V5, P1431, DOI 10.1210/mend-5-10-1431; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	26	92	95	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					426	431		10.1038/ng0893-426	http://dx.doi.org/10.1038/ng0893-426			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	7691356				2022-12-17	WOS:A1993LQ17800024
J	Shih, DJH; Nayyar, N; Bihun, I; Dagogo-Jack, I; Gill, CM; Aquilanti, E; Bertalan, M; Kaplan, A; D'Andrea, MR; Chukwueke, U; Ippen, FM; Alvarez-Breckenridge, C; Camarda, ND; Lastrapes, M; McCabe, D; Kuter, B; Kaufman, B; Strickland, MR; Martinez-Gutierrez, JC; Nagabhushan, D; De Sauvage, M; White, MD; Castro, BA; Hoang, K; Kaneb, A; Batchelor, ED; Paek, SH; Park, SH; Martinez-Lage, M; Berghoff, AS; Merrill, P; Gerstner, ER; Batchelor, TT; Frosch, MP; Frazier, RP; Borger, DR; Iafrate, AJ; Johnson, BE; Santagata, S; Preusser, M; Cahill, DP; Carter, SL; Brastianos, PK				Shih, David J. H.; Nayyar, Naema; Bihun, Ivanna; Dagogo-Jack, Ibiayi; Gill, Corey M.; Aquilanti, Elisa; Bertalan, Mia; Kaplan, Alexander; D'Andrea, Megan R.; Chukwueke, Ugonma; Ippen, Franziska Maria; Alvarez-Breckenridge, Christopher; Camarda, Nicholas D.; Lastrapes, Matthew; McCabe, Devin; Kuter, Ben; Kaufman, Benjamin; Strickland, Matthew R.; Martinez-Gutierrez, Juan Carlos; Nagabhushan, Deepika; De Sauvage, Magali; White, Michael D.; Castro, Brandyn A.; Hoang, Kaitlin; Kaneb, Andrew; Batchelor, Emily D.; Paek, Sun Ha; Park, Sun Hye; Martinez-Lage, Maria; Berghoff, Anna S.; Merrill, Parker; Gerstner, Elizabeth R.; Batchelor, Tracy T.; Frosch, Matthew P.; Frazier, Ryan P.; Borger, Darrell R.; Iafrate, A. John; Johnson, Bruce E.; Santagata, Sandro; Preusser, Matthias; Cahill, Daniel P.; Carter, Scott L.; Brastianos, Priscilla K.			Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma	NATURE GENETICS			English	Article							EGFR MUTATION; CANCER; KRAS; PROGRESSION; ALIGNMENT; PATTERNS; YAP	Whole-exome sequencing of human brain metastases from lung adenocarcinoma uncovers new drivers by comparison of somatic alteration frequencies in brain metastasis cases to those in primary lung adenocarcinomas. Brain metastases from lung adenocarcinoma (BM-LUAD) frequently cause patient mortality. To identify genomic alterations that promote brain metastases, we performed whole-exome sequencing of 73 BM-LUAD cases. Using case-control analyses, we discovered candidate drivers of brain metastasis by identifying genes with more frequent copy-number aberrations in BM-LUAD compared to 503 primary LUADs. We identified three regions with significantly higher amplification frequencies in BM-LUAD, including MYC (12 versus 6%), YAP1 (7 versus 0.8%) and MMP13 (10 versus 0.6%), and significantly more frequent deletions in CDKN2A/B (27 versus 13%). We confirmed that the amplification frequencies of MYC,YAP1 and MMP13 were elevated in an independent cohort of 105 patients with BM-LUAD. Functional assessment in patient-derived xenograft mouse models validated the notion that MYC, YAP1 or MMP13 overexpression increased the incidence of brain metastasis. These results demonstrate that somatic alterations contribute to brain metastases and that genomic sequencing of a sufficient number of metastatic tumors can reveal previously unknown metastatic drivers.	[Shih, David J. H.; Lastrapes, Matthew; Carter, Scott L.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Shih, David J. H.; Camarda, Nicholas D.; Lastrapes, Matthew; McCabe, Devin; Carter, Scott L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shih, David J. H.; Nayyar, Naema; Bihun, Ivanna; Aquilanti, Elisa; Lastrapes, Matthew; McCabe, Devin; Kaufman, Benjamin; Carter, Scott L.; Brastianos, Priscilla K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Nayyar, Naema] UMass Med Sch, Program Mol Med, Worcester, MA USA; [Nayyar, Naema; Bihun, Ivanna; Dagogo-Jack, Ibiayi; Gill, Corey M.; Aquilanti, Elisa; Bertalan, Mia; Kaplan, Alexander; D'Andrea, Megan R.; Ippen, Franziska Maria; Lastrapes, Matthew; Kuter, Ben; Strickland, Matthew R.; Martinez-Gutierrez, Juan Carlos; Nagabhushan, Deepika; De Sauvage, Magali; White, Michael D.; Castro, Brandyn A.; Hoang, Kaitlin; Kaneb, Andrew; Batchelor, Emily D.; Brastianos, Priscilla K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Nayyar, Naema; Bihun, Ivanna; Gill, Corey M.; Bertalan, Mia; Kaplan, Alexander; D'Andrea, Megan R.; Ippen, Franziska Maria; Kuter, Ben; Strickland, Matthew R.; Martinez-Gutierrez, Juan Carlos; Nagabhushan, Deepika; De Sauvage, Magali; White, Michael D.; Castro, Brandyn A.; Hoang, Kaitlin; Kaneb, Andrew; Batchelor, Emily D.; Gerstner, Elizabeth R.; Batchelor, Tracy T.; Brastianos, Priscilla K.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gill, Corey M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Aquilanti, Elisa; Chukwueke, Ugonma; Camarda, Nicholas D.; Lastrapes, Matthew; McCabe, Devin; Kaufman, Benjamin; Strickland, Matthew R.; Johnson, Bruce E.; Carter, Scott L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Alvarez-Breckenridge, Christopher; Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Camarda, Nicholas D.; Kaufman, Benjamin; Martinez-Gutierrez, Juan Carlos; Paek, Sun Ha; Johnson, Bruce E.; Carter, Scott L.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA; [Martinez-Gutierrez, Juan Carlos] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Park, Sun Hye] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Paek, Sun Ha; Park, Sun Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Martinez-Lage, Maria; Frosch, Matthew P.; Frazier, Ryan P.; Borger, Darrell R.; Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Berghoff, Anna S.; Preusser, Matthias] Med Univ Vienna, Div Oncol, Comprehens Canc Ctr Vienna, Dept Med 1, Vienna, Austria; [Merrill, Parker; Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Santagata, Sandro] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Santagata, Sandro] Harvard Med Sch, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Massachusetts General Hospital; Medical University of Vienna; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Carter, SL (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Carter, SL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.; Carter, SL; Brastianos, PK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Brastianos, PK (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Brastianos, PK (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Carter, SL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Carter, SL (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA.	carter.scott@jimmy.harvard.edu; pbrastianos@mgh.harvard.edu	Frosch, Matthew P/ABD-7456-2021; Preusser, Matthias/C-8530-2011; Shih, David J. H./H-3186-2011	Frosch, Matthew P/0000-0002-3940-9861; Preusser, Matthias/0000-0003-3541-2315; Nayyar, Naema/0000-0003-3436-8404; Berghoff, Anna Sophie/0000-0001-9379-6797; D'Andrea, Megan/0000-0002-7371-4739; McCabe, Devin/0000-0002-2183-4368; Shih, David J. H./0000-0002-9802-4937; Ippen, Franziska Maria/0000-0001-6870-1784; Brastianos, Priscilla/0000-0003-4470-8425; Camarda, Nicholas/0000-0002-1853-0056; Gill, Corey/0000-0003-4494-1948; Martinez-Lage, Maria/0000-0002-5859-7562; de Sauvage, Magali/0000-0001-9486-945X	National Cancer Institute [1R01CA227156-01]; Damon Runyon Cancer Research Foundation; Conquer Cancer Foundation; Breast Cancer Research Foundation; Brain Science Foundation; American Brain Tumor Association; Wong Family Awards in Translational Oncology; Susan G. Komen for the Cure; Canadian Institutes of Health Research Fellowship; LUNGstrong Fund	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Conquer Cancer Foundation; Breast Cancer Research Foundation; Brain Science Foundation; American Brain Tumor Association; Wong Family Awards in Translational Oncology; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); LUNGstrong Fund	This work was supported by National Cancer Institute grant no. 1R01CA227156-01 (to P.K.B. and S.L.C.); the Damon Runyon Cancer Research Foundation (to P.K.B.); the Conquer Cancer Foundation (to P.K.B.); the Breast Cancer Research Foundation (to P.K.B.); the Brain Science Foundation (to P.K.B.); the American Brain Tumor Association (to P.K.B.); the Wong Family Awards in Translational Oncology (to S.L.C.); and the LUNGstrong Fund (to S.L.C.). P.K.B. is also supported by Susan G. Komen for the Cure and received institutional support from Massachusetts General Hospital. D.J.H.S. was supported by the Canadian Institutes of Health Research Fellowship. S.L.C. received institutional support from the Dana-Farber Cancer Institute. We thank the patients for providing tissue samples; L. Brown, J. Kim and W. Richards for assisting with sample collection; and G. Parmigiani, J. Miller, M. Yajima, C. Musco, C. Stewart, L. Lichtenstein, S. Lee, M. Babadi, D. Benjamin, B. Reardon and K. Korthauer for fruitful discussions.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Cagney DN, 2017, NEURO-ONCOLOGY, V19, P1511, DOI 10.1093/neuonc/nox077; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Davies JA, 1996, ACTA ANAT, V156, P187; Demichelis F, 2008, NUCLEIC ACIDS RES, V36, P2446, DOI 10.1093/nar/gkn089; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [10.18637/jss.v042.i08, DOI 10.18637/JSS.V042.I08]; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korthauer K, 2019, BIOSTATISTICS, V20, P367, DOI 10.1093/biostatistics/kxy007; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin JD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a027094; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Midha A, 2015, AM J CANCER RES, V5, P2892; Muller P., 2006, DEP BIOSTATISTICS WO; Nakatani K, 2017, J BIOCHEM, V161, P237, DOI 10.1093/jb/mvw074; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Soh J, 2015, ONCOL LETT, V10, P1775, DOI 10.3892/ol.2015.3414; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takamochi K, 2013, ONCOL LETT, V6, P1207, DOI 10.3892/ol.2013.1551; Tseng CH, 2017, ONCOTARGET, V8, P98384, DOI 10.18632/oncotarget.21642; Zhang Yue-Lun, 2016, Oncotarget, V7, P78985, DOI 10.18632/oncotarget.12587	43	91	91	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2020	52	4					371	+		10.1038/s41588-020-0592-7	http://dx.doi.org/10.1038/s41588-020-0592-7		MAR 2020	20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ6QL	32203465	Green Accepted			2022-12-17	WOS:000521529000002
J	Vesth, TC; Nybo, JL; Theobald, S; Frisvad, JC; Larsen, TO; Nielsen, KF; Hoof, JB; Brandl, J; Salamov, A; Riley, R; Gladden, JM; Phatale, P; Nielsen, MT; Lyhne, EK; Kogle, ME; Strasser, K; McDonnell, E; Barry, K; Clum, A; Chen, C; LaButti, K; Haridas, S; Nolan, M; Sandor, L; Kuo, A; Lipzen, A; Hainaut, M; Drula, E; Tsang, A; Magnuson, JK; Henrissat, B; Wiebenga, A; Simmons, BA; Makela, MR; de Vries, RP; Grigoriev, IV; Mortensen, UH; Baker, SE; Andersen, MR				Vesth, Tammi C.; Nybo, Jane L.; Theobald, Sebastian; Frisvad, Jens C.; Larsen, Thomas O.; Nielsen, Kristian F.; Hoof, Jakob B.; Brandl, Julian; Salamov, Asaf; Riley, Robert; Gladden, John M.; Phatale, Pallavi; Nielsen, Morten T.; Lyhne, Ellen K.; Kogle, Martin E.; Strasser, Kimchi; McDonnell, Erin; Barry, Kerrie; Clum, Alicia; Chen, Cindy; LaButti, Kurt; Haridas, Sajeet; Nolan, Matt; Sandor, Laura; Kuo, Alan; Lipzen, Anna; Hainaut, Matthieu; Drula, Elodie; Tsang, Adrian; Magnuson, Jon K.; Henrissat, Bernard; Wiebenga, Ad; Simmons, Blake A.; Makela, Miia R.; de Vries, Ronald P.; Grigoriev, Igor V.; Mortensen, Uffe H.; Baker, Scott E.; Andersen, Mikael R.			Investigation of inter- and intraspecies variation through genome sequencing of Aspergillus section Nigri	NATURE GENETICS			English	Article							OCHRATOXIN-A; NIGER; DEREPLICATION; EXTRACTION; PREDICTION; ALIGNMENT; PATHWAY; FUNGI; GENUS	Aspergillus section Nigri comprises filamentous fungi relevant to biomedicine, bioenergy, health, and biotechnology. To learn more about what genetically sets these species apart, as well as about potential applications in biotechnology and biomedicine, we sequenced 23 genomes de novo, forming a full genome compendium for the section (26 species), as well as 6 Aspergillus niger isolates. This allowed us to quantify both inter-and intraspecies genomic variation. We further predicted 17,903 carbohydrateactive enzymes and 2,717 secondary metabolite gene clusters, which we condensed into 455 distinct families corresponding to compound classes, 49% of which are only found in single species. We performed metabolomics and genetic engineering to correlate genotypes to phenotypes, as demonstrated for the metabolite aurasperone, and by heterologous transfer of citrate production to Aspergillus nidulans. Experimental and computational analyses showed that both secondary metabolism and regulation are key factors that are significant in the delineation of Aspergillus species.	[Vesth, Tammi C.; Nybo, Jane L.; Theobald, Sebastian; Frisvad, Jens C.; Larsen, Thomas O.; Nielsen, Kristian F.; Hoof, Jakob B.; Brandl, Julian; Nielsen, Morten T.; Lyhne, Ellen K.; Kogle, Martin E.; Mortensen, Uffe H.; Andersen, Mikael R.] Tech Univ Denmark, Dept Biotechnol & Bioengn, Lyngby, Denmark; [Salamov, Asaf; Riley, Robert; Barry, Kerrie; Clum, Alicia; Chen, Cindy; LaButti, Kurt; Haridas, Sajeet; Nolan, Matt; Sandor, Laura; Kuo, Alan; Lipzen, Anna; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Gladden, John M.; Phatale, Pallavi; Magnuson, Jon K.; Simmons, Blake A.; Baker, Scott E.] US DOE, Joint Genome Inst, Emeryville, CA 94608 USA; [Gladden, John M.] Sandia Natl Labs, Livermore, CA USA; [Phatale, Pallavi; Magnuson, Jon K.] Pacific Northwest Natl Lab, Chem & Biol Proc Dev Grp, Energy & Environm Directorate, Richland, WA USA; [Strasser, Kimchi; McDonnell, Erin; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Hainaut, Matthieu; Drula, Elodie; Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Marseille, France; [Hainaut, Matthieu; Drula, Elodie; Henrissat, Bernard] INRA, USC Architecture & Fonct Macromol Biol 1408, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Wiebenga, Ad; Makela, Miia R.; de Vries, Ronald P.] Westerdijk Fungal Biodivers Inst, Fungal Physiol, Utrecht, Netherlands; [Wiebenga, Ad; Makela, Miia R.; de Vries, Ronald P.] Univ Utrecht, Fungal Mol Physiol, Utrecht, Netherlands; [Simmons, Blake A.] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Makela, Miia R.] Univ Helsinki, Dept Microbiol, Helsinki, Finland; [Grigoriev, Igor V.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Baker, Scott E.] Pacific Northwest Natl Lab, Environm Mol Sci Div, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Riley, Robert] Amyris Inc, Emeryville, CA USA	Technical University of Denmark; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Concordia University - Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University; Utrecht University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Finland National Institute for Health & Welfare; University of Helsinki; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Andersen, MR (corresponding author), Tech Univ Denmark, Dept Biotechnol & Bioengn, Lyngby, Denmark.; Baker, SE (corresponding author), US DOE, Joint Genome Inst, Emeryville, CA 94608 USA.; Baker, SE (corresponding author), Pacific Northwest Natl Lab, Environm Mol Sci Div, Earth & Biol Sci Directorate, Richland, WA 99352 USA.	scott.baker@pnnl.gov; mr@bio.dtu.dk	Nielsen, Kristian Fog/C-7233-2011; Haridas, Sajeet/H-4018-2019; Mäkelä, Miia R./F-2181-2011; Riley, Robert/AAA-4531-2020; Simmons, Blake/N-6022-2016; Barry, Kerrie Whitelaw/AAA-5500-2020; Frisvad, Jens C/K-2818-2017; Mortensen, Uffe/AAQ-1150-2021; Baker, Scott E./ABB-1635-2020; Andersen, Mikael Rørdam/P-6743-2019; Henrissat, Bernard/J-2475-2012; Baker, Scott E/X-2065-2018; de Vries, Ronald/F-8125-2011; Hoof, Jakob Blaesbjerg/L-6019-2015	Nielsen, Kristian Fog/0000-0002-5848-0911; Haridas, Sajeet/0000-0002-0229-0975; Mäkelä, Miia R./0000-0003-0771-2329; Riley, Robert/0000-0003-0224-0975; Simmons, Blake/0000-0002-1332-1810; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Frisvad, Jens C/0000-0002-0573-4340; Baker, Scott E./0000-0001-5085-3106; Andersen, Mikael Rørdam/0000-0003-4794-6808; Henrissat, Bernard/0000-0002-3434-8588; Baker, Scott E/0000-0001-5085-3106; Brandl, Julian/0000-0002-3479-8642; de Vries, Ronald/0000-0002-4363-1123; Lipzen, Anna/0000-0003-2293-9329; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Hoof, Jakob Blaesbjerg/0000-0002-7650-9300; Grigoriev, Igor/0000-0002-3136-8903; DRULA, ELODIE/0000-0002-9168-5214; Nybo, Jane/0000-0001-5049-6436; Theobald, Sebastian/0000-0001-7042-8326; Vesth, Tammi Camilla/0000-0003-4182-1764	Villum Foundation/Villum Fonden [VKR023437]; Novo Nordisk Foundation [NNF13OC0004831, NNF13OC0005201]; Danish National Research Foundation [DNRF137]; US DOE, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Science of the US DOE [DE-AC02-05CH11231]	Villum Foundation/Villum Fonden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); US DOE, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Science of the US DOE(United States Department of Energy (DOE))	T.C.V., J.L. N., S.T., and M.R.A. acknowledge funding from The Villum Foundation/Villum Fonden, grant VKR023437. J. B. and M.R.A. acknowledge funding from the Novo Nordisk Foundation, grant NNF13OC0004831. M. R. A. and T.C.V. acknowledge funding from the Danish National Research Foundation (DNRF137) for the Center for Microbial Secondary Metabolites. J.C.F. acknowledges funding from the Novo Nordisk Foundation, grant NNF13OC0005201. Work performed at the US Department of Energy (DOE) Joint BioEnergy Institute is supported by the US DOE, Office of Science, Office of Biological and Environmental Research, through Contract No. DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US DOE. The work conducted by the US DOE Joint Genome Institute, a DOE Office of Science User Facility, is supported by the Office of Science of the US DOE under Contract No. DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US DOE. S. Mondo is acknowledged for GenBank submission of 20 of the genomes. I. Kjaerbolling is acknowledged for critical and constructive feedback on the manuscript and figures.	ABARCA ML, 1994, APPL ENVIRON MICROB, V60, P2650, DOI 10.1128/AEM.60.7.2650-2652.1994; Ali H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098212; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; [Anonymous], 2009, LIST COMMERCIAL ENZY; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benoit I, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0285-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Csardi G., 2006, INTERJOURNAL COMPLEX; Currie JN, 1917, J BIOL CHEM, V1917, P15, DOI DOI 10.1016/S0021-9258(18)86708-4; de Vries RP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1151-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Frandsen RJN, 2006, MOL MICROBIOL, V61, P1069, DOI 10.1111/j.1365-2958.2006.05295.x; Frisvad JC, 2007, J AGR FOOD CHEM, V55, P9727, DOI 10.1021/jf0718906; Frisvad JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094857; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grigoriev IV, 2006, APPL MYCOL BIOTECH, V6, P123; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Hossain AH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0527-2; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jurjevic Z, 2012, IMA FUNGUS, V3, P159, DOI 10.5598/imafungus.2012.03.02.08; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; Kis-Papo T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4745; Klitgaard A, 2014, ANAL BIOANAL CHEM, V406, P1933, DOI 10.1007/s00216-013-7582-x; KOZAKIEWICZ Z, 1992, Taxon, V41, P109, DOI 10.2307/1222500; Li L., 2014, NUCLEIC ACIDS RES, V37, pD233; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Meijer M, 2011, STUD MYCOL, P19, DOI 10.3114/sim.2011.69.02; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nielsen JC, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.44; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perrone G, 2007, STUD MYCOL, P53, DOI 10.3114/sim.2007.59.07; Perrone G, 2011, FUNGAL BIOL-UK, V115, P1138, DOI 10.1016/j.funbio.2011.07.008; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; RAJENDRAN C, 1980, P INDIAN AS-PLANT SC, V89, P185; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Samson RA, 2004, STUD MYCOL, P45; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sorensen A, 2012, CAN J MICROBIOL, V58, P1035, DOI [10.1139/W2012-076, 10.1139/w2012-076]; Sorensen A, 2011, CAN J MICROBIOL, V57, P638, DOI [10.1139/w11-052, 10.1139/W11-052]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Szollosi GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0335; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Visagie CM, 2014, STUD MYCOL, P63, DOI 10.1016/j.simyco.2014.07.002; Workman M., 2013, IND BIOTECHNOL, V9, P337, DOI DOI 10.1089/IND.2013.0025; Wosten H. A. B., 2007, MYCOLOGY S; Yamada O, 2016, DNA RES, V23, P507, DOI 10.1093/dnares/dsw032; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	69	91	112	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1688	+		10.1038/s41588-018-0246-1	http://dx.doi.org/10.1038/s41588-018-0246-1			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30349117	Green Published, Green Submitted, hybrid			2022-12-17	WOS:000451434400016
J	Aggarwala, V; Voight, BF				Aggarwala, Varun; Voight, Benjamin F.			An expanded sequence context model broadly explains variability in polymorphism levels across the human genome	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; NATURAL-SELECTION; DNA; 5-METHYLCYTOSINE; RATES; PATTERNS; REVEALS; GENES	The rate of single-nucleotide polymorphism varies substantially across the human genome and fundamentally influences evolution and incidence of genetic disease. Previous studies have only considered the immediately flanking nucleotides around a polymorphic site-the site's trinucleotide sequence context-to study polymorphism levels across the genome. Moreover, the impact of larger sequence contexts has not been fully clarified, even though context substantially influences rates of polymorphism. Using a new statistical framework and data from the 1000 Genomes Project, we demonstrate that a heptanucleotide context explains >81% of variability in substitution probabilities, highlighting new mutation-promoting motifs at ApT dinucleotide, CAAT and TACG sequences. Our approach also identifies previously undocumented variability in C-to-T substitutions at CpG sites, which is not immediately explained by differential methylation intensity. Using our model, we present informative substitution intolerance scores for genes and a new intolerance score for amino acids, and we demonstrate clinical use of the model in neuropsychiatric diseases.	[Aggarwala, Varun] Univ Penn, Perelman Sch Med, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Voight, BF (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Voight, BF (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	bvoight@upenn.edu		Voight, Benjamin/0000-0002-6205-9994; Aggarwala, Varun/0000-0002-5499-7745	Alfred P. Sloan Foundation [BR2012-087]; American Heart Association [13SDG14330006]; W.W. Smith Charitable Trust [H1201]; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders [R01DK101478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101478] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); American Heart Association(American Heart Association); W.W. Smith Charitable Trust; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Brown, M. Bucan, P. Babb, K. Siewert, K. Johnson, S. Bumgarner and two anonymous reviewers for helpful comments on the manuscript. B.F.V. is grateful for support of the work from the Alfred P. Sloan Foundation (BR2012-087), the American Heart Association (13SDG14330006), the W.W. Smith Charitable Trust (H1201) and the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders (R01DK101478).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; BLAKE RD, 1992, J MOL EVOL, V34, P189, DOI 10.1007/BF00162968; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Eyre-Walker A, 2014, G3-GENES GENOM GENET, V4, P1667, DOI 10.1534/g3.114.012849; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; GINSBURG D, 1992, BLOOD, V79, P2507; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hussin JG, 2015, NAT GENET, V47, P400, DOI 10.1038/ng.3216; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mugal CF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r58; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Panchin AY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-268; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	49	91	91	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					349	+		10.1038/ng.3511	http://dx.doi.org/10.1038/ng.3511			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26878723	Green Accepted			2022-12-17	WOS:000372908800005
J	Alakbarzade, V; Hameed, A; Quek, DQY; Chioza, BA; Baple, EL; Cazenave-Gassiot, A; Nguyen, LN; Wenk, MR; Ahmad, AQ; Sreekantan-Nair, A; Weedon, MN; Rich, P; Patton, MA; Warner, TT; Silver, DL; Crosby, AH				Alakbarzade, Vafa; Hameed, Abdul; Quek, Debra Q. Y.; Chioza, Barry A.; Baple, Emma L.; Cazenave-Gassiot, Amaury; Nguyen, Long N.; Wenk, Markus R.; Ahmad, Arshia Q.; Sreekantan-Nair, Ajith; Weedon, Michael N.; Rich, Phil; Patton, Michael A.; Warner, Thomas T.; Silver, David L.; Crosby, Andrew H.			A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome	NATURE GENETICS			English	Article							RAT	The major pathway by which the brain obtains essential omega-3 fatty acids from the circulation is through a sodium-dependent lysophosphatidylcholine (LPC) transporter (MFSD2A), expressed in the endothelium of the blood-brain barrier. Here we show that a homozygous mutation affecting a highly conserved MFSD2A residue (p.Ser339Leu) is associated with a progressive microcephaly syndrome characterized by intellectual disability, spasticity and absent speech. We show that the p.Ser339Leu alteration does not affect protein or cell surface expression but rather significantly reduces, although not completely abolishes, transporter activity. Notably, affected individuals displayed significantly increased plasma concentrations of LPCs containing mono-and polyunsaturated fatty acyl chains, indicative of reduced brain uptake, confirming the specificity of MFSD2A for LPCs having mono- and polyunsaturated fatty acyl chains. Together, these findings indicate an essential role for LPCs in human brain development and function and provide the first description of disease associated with aberrant brain LPC transport in humans.	[Alakbarzade, Vafa; Chioza, Barry A.; Baple, Emma L.; Sreekantan-Nair, Ajith; Weedon, Michael N.; Patton, Michael A.; Crosby, Andrew H.] Univ Exeter, RILD Wellcome Wolfson Ctr, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Alakbarzade, Vafa; Warner, Thomas T.] UCL, Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Inst Neurol Studies, London, England; [Hameed, Abdul] IBGE, Islamabad, Pakistan; [Quek, Debra Q. Y.; Nguyen, Long N.; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Baple, Emma L.] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Baple, Emma L.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Ahmad, Arshia Q.] IUPUI, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Ahmad, Arshia Q.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Rich, Phil] St George Hosp, Dept Neuroradiol, London, England; [Patton, Michael A.] St Georges Healthcare Natl Hlth Serv NHS Trust, Southwest Thames Reg Genet Serv, London, England	University of Exeter; University of London; University College London; National University of Singapore; University of Southampton; National University of Singapore; Indiana University System; Indiana University-Purdue University Indianapolis; St Georges University London	Crosby, AH (corresponding author), Univ Exeter, RILD Wellcome Wolfson Ctr, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.	david.silver@duke-nus.edu.sg; a.h.crosby@exeter.ac.uk	Chioza, Barry/C-1586-2008; Cazenave-Gassiot, Amaury/E-4536-2014; , WaNgtJ/AAR-7045-2020; Nguyen, Long/AAY-6172-2021; Crosby, Andrew H/E-2218-2015; Warner, Thomas T/A-1454-2013	Chioza, Barry/0000-0002-3546-1726; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Crosby, Andrew H/0000-0003-3667-9054; Warner, Thomas T/0000-0001-6195-6995; Weedon, Michael/0000-0002-6174-6135; Nguyen, Long N/0000-0002-9857-2239; Alakbarzade, Vafa/0000-0002-1661-4280; Silver, David/0000-0002-7289-9890	UK Medical Research Council [G1002279, G0900205, G1001931]; Newlife Foundation for disabled children; Singapore Ministry of Health's National Medical Research Council [CBRG/069/2014]; Singapore National Research Foundation Competitive Research Program [2007-04]; National University of Singapore's Life Sciences Institute; Medical Research Council [G1001931, G1002279] Funding Source: researchfish; MRC [G1001931, G1002279] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newlife Foundation for disabled children; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the families for participating in this research. The work was supported by UK Medical Research Council grants G1002279, G0900205 and G1001931 and by the Newlife Foundation for disabled children (to A.H.C., M.A.P. and E.L.B.), the Singapore Ministry of Health's National Medical Research Council grant CBRG/069/2014 (to D.L.S.), Singapore National Research Foundation Competitive Research Program grant 2007-04 (to M.R.W.) and the National University of Singapore's Life Sciences Institute (to M.R.W.).	BAISTED DJ, 1988, BIOCHEM J, V253, P693, DOI 10.1042/bj2530693; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Rozen S, 2000, Methods Mol Biol, V132, P365; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	12	91	92	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					814	+		10.1038/ng.3313	http://dx.doi.org/10.1038/ng.3313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005865				2022-12-17	WOS:000357090300021
J	Arnold, CD; Gerlach, D; Spies, D; Matts, JA; Sytnikova, YA; Pagani, M; Lau, NC; Stark, A				Arnold, Cosmas D.; Gerlach, Daniel; Spies, Daniel; Matts, Jessica A.; Sytnikova, Yuliya A.; Pagani, Michaela; Lau, Nelson C.; Stark, Alexander			Quantitative genome-wide enhancer activity maps for five Drosophila species show functional enhancer conservation and turnover during cis-regulatory evolution	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; MORPHOLOGICAL EVOLUTION; SEQ; GENE; DIVERGENCE; ELEMENTS; REVEALS	Phenotypic differences between closely related species are thought to arise primarily from changes in gene expression due to mutations in cis-regulatory sequences (enhancers). However, it has remained unclear how frequently mutations alter enhancer activity or create functional enhancers de novo. Here we use STARR-seq, a recently developed quantitative enhancer assay, to determine genome-wide enhancer activity profiles for five Drosophila species in the constant trans-regulatory environment of Drosophila melanogaster S2 cells. We find that the functions of a large fraction of D. melanogaster enhancers are conserved for their orthologous sequences owing to selection and stabilizing turnover of transcription factor motifs. Moreover, hundreds of enhancers have been gained since the D. melanogaster-Drosophila yakuba split about 11 million years ago without apparent adaptive selection and can contribute to changes in gene expression in vivo. Our finding that enhancer activity is often deeply conserved and frequently gained provides functional insights into regulatory evolution.	[Arnold, Cosmas D.; Gerlach, Daniel; Spies, Daniel; Pagani, Michaela; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Matts, Jessica A.; Sytnikova, Yuliya A.; Lau, Nelson C.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Matts, Jessica A.; Sytnikova, Yuliya A.; Lau, Nelson C.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Brandeis University; Brandeis University	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	stark@starklab.org	Sytnikova, Yuliya/J-6118-2017; Stark, Alexander/D-1473-2012; Spies, Daniel/ABA-3363-2021	Stark, Alexander/0000-0003-2611-0841; Spies, Daniel/0000-0003-0072-0799; Lau, Nelson/0000-0001-9907-1404; Sytnikova, Yuliya/0000-0002-8468-5101; Gerlach, Daniel/0000-0001-9338-3765	European Research Council (ERC) Starting Grant [242922]; Austrian Science Fund (FWF) [F4303-B09]; US National Institutes of Health [HD057298]; Searle Scholars foundation; Boehringer Ingelheim; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD057298, K99HD057298] Funding Source: NIH RePORTER	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars foundation; Boehringer Ingelheim(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Drosophila Species Stock Center (DSSC) at the University of California, San Diego for genomic DNA, I. Sinitsyn and L.M. Boryn for help with library cloning, M. Rath, K. Schernhuber and O. Frank for help with experiments, J.O. Yanez-Cuna and M.A. Zabidi for help with data analysis, and S. Westermann, L. Cochella, I. Crisostomo, J. Brennecke, J. Knoblich, U. Technau, K. Tessmar-Raible and F. Raible for comments on the manuscript. Deep sequencing was performed at the CSF (Campus Science Support Facilities) Next-Generation Sequencing Unit and the Brandeis Genomics Core Facility (laboratory of M. Rosbash). C.D.A. is supported by a European Research Council (ERC) Starting Grant (242922) awarded to A.S. This work was partly supported by the Austrian Science Fund (FWF), F4303-B09. The work of N.C.L. was supported by the Searle Scholars foundation and the US National Institutes of Health (HD057298). Basic research at IMP is supported by Boehringer Ingelheim.	Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Bardet AF, 2012, NAT PROTOC, V7, P45, DOI 10.1038/nprot.2011.420; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Kalay G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001222; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Matts JA, 2014, METHODS MOL BIOL, V1093, P123, DOI 10.1007/978-1-62703-694-8_10; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Paris M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003748; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Swanson CI, 2011, CURR BIOL, V21, P1186, DOI 10.1016/j.cub.2011.05.056; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	34	91	93	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					685	692		10.1038/ng.3009	http://dx.doi.org/10.1038/ng.3009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908250	Green Accepted			2022-12-17	WOS:000338093800008
J	Uslu, VV; Petretich, M; Ruf, S; Langenfeld, K; Fonseca, NA; Marioni, JC; Spitz, F				Uslu, Veil Vural; Petretich, Massimo; Ruf, Sandra; Langenfeld, Katja; Fonseca, Nuno A.; Marioni, John C.; Spitz, Francois			Long-range enhancers regulating Myc expression are required for normal facial morphogenesis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NONSYNDROMIC CLEFT-LIP; C-MYC; SUSCEPTIBILITY LOCI; SNP RS6983267; PALATE; MOUSE; TRANSCRIPTION; MORPHOLOGY; VARIANTS	Cleft lip with or without cleft palate (CL/P) is one of the most common congenital malformations observed in humans, with 1 occurrence in every 500-1,000 births(1,2). A 640-kb noncoding interval at 8q24 has been associated with increased risk of non-syndromic CL/P in humans(3-5), but the genes and pathways involved in this genetic susceptibility have remained elusive. Using a large series of rearrangements engineered over the syntenic mouse region, we show that this interval contains very remote cis-acting enhancers that control Myc expression in the developing face. Deletion of this interval leads to mild alteration of facial morphology in mice and, sporadically, to CUP. At the molecular level, we identify misexpression of several downstream genes, highlighting combined impact on the craniofacial developmental network and the general metabolic capacity of cells contributing to the future upper lip. This dual molecular etiology may account for the prominent influence of variants in the 8q24 region on human facial dysmorphologies.	[Uslu, Veil Vural; Petretich, Massimo; Ruf, Sandra; Langenfeld, Katja; Spitz, Francois] EMBL, Dev Biol Unit, Heidelberg, Germany; [Fonseca, Nuno A.; Marioni, John C.] EBI, EMBL, Cambridge, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Spitz, F (corresponding author), EMBL, Dev Biol Unit, Heidelberg, Germany.	spitz@embl.de	Fonseca, Nuno A./B-7801-2009	Fonseca, Nuno A./0000-0003-4832-578X; Marioni, John/0000-0001-9092-0852; Spitz, Francois/0000-0002-1960-829X	EMBL; Jeff Schell Darwin Trust; EMBL International PhD program	EMBL; Jeff Schell Darwin Trust; EMBL International PhD program	We thank B. Sleckman (Washington University, St. Louis) and A. Trumpp (DKFZ, Heidelberg) for providing the Myc<SUP>tm1Slek</SUP> strain. We thank members of the EMBL Laboratory Animal Resources Facility for animal welfare and husbandry; the EMBL Genomics Core Facility for advice and support in processing ChIP and RNA sequencing experiments; and Genome Biology Computational Support for help with the analyses. We thank members of the Spitz laboratory and colleagues at EMBL for sharing reagents and helpful comments. V.V.U. and M.P. were supported by PhD fellowships from the Jeff Schell Darwin Trust and the EMBL International PhD program, respectively. This work was supported by EMBL.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; KAROLYI J, 1988, TERATOLOGY, V37, P283, DOI 10.1002/tera.1420370314; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nelson DK, 2004, DEV BIOL, V267, P72, DOI 10.1016/j.ydbio.2003.10.033; Parsons TE, 2008, J ANAT, V212, P135, DOI 10.1111/j.1469-7580.2007.00845.x; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Terzian T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003300; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Watkins-Chow DE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003094; Wei K, 2007, GENESIS, V45, P382, DOI 10.1002/dvg.20304; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104	49	91	92	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					753	758		10.1038/ng.2971	http://dx.doi.org/10.1038/ng.2971			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24859337				2022-12-17	WOS:000338093800019
J	Mirzaa, GM; Parry, DA; Fry, AE; Giamanco, KA; Schwartzentruber, J; Vanstone, M; Logan, CV; Roberts, N; Johnson, CA; Singh, S; Kholmanskikh, SS; Adams, C; Hodge, RD; Hevner, RF; Bonthron, DT; Braun, KPJ; Faivre, L; Riviere, JB; St-Onge, J; Gripp, KW; Mancini, GMS; Pang, K; Sweeney, E; van Esch, H; Verbeek, N; Wieczorek, D; Steinraths, M; Majewski, J; Boycott, KM; Pilz, DT; Ross, ME; Dobyns, WB; Sheridan, EG				Mirzaa, Ghayda M.; Parry, David A.; Fry, Andrew E.; Giamanco, Kristin A.; Schwartzentruber, Jeremy; Vanstone, Megan; Logan, Clare V.; Roberts, Nicola; Johnson, Colin A.; Singh, Shawn; Kholmanskikh, Stanislav S.; Adams, Carissa; Hodge, Rebecca D.; Hevner, Robert F.; Bonthron, David T.; Braun, Kees P. J.; Faivre, Laurence; Riviere, Jean-Baptiste; St-Onge, Judith; Gripp, Karen W.; Mancini, Grazia M. S.; Pang, Ki; Sweeney, Elizabeth; van Esch, Hilde; Verbeek, Nienke; Wieczorek, Dagmar; Steinraths, Michelle; Majewski, Jacek; Boycott, Kym M.; Pilz, Daniela T.; Ross, M. Elizabeth; Dobyns, William B.; Sheridan, Eamonn G.		FORGE Canada Consortium	De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyriapolydactyly-hydrocephalus syndrome	NATURE GENETICS			English	Article							INTERMEDIATE PROGENITOR CELLS; CEREBRAL-CORTEX; AKT3	Activating mutations in genes encoding phosphatidylinositol 3-kinase (PI3K)-AKT pathway components cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH, OMIM 603387)(1-3). Here we report that individuals with MPPH lacking upstream PI3K-AKT pathway mutations carry de novo mutations in CCND2 (encoding cyclin D2) that are clustered around a residue that can be phosphorylated by glycogen synthase kinase 313 (GSK-3 beta)(4). Mutant CCND2 was resistant to proteasomal degradation in vitro compared to wild-type CCND2. The PI3K-AKT pathway modulates GSK-3 beta activity(4), and cells from individuals with PIK3CA, PIK3R2 or AKT3 mutations showed similar CCND2 accumulation. CCND2 was expressed at higher levels in brains of mouse embryos expressing activated AKT3. In utero electroporation of mutant CCND2 into embryonic mouse brains produced more proliferating transfected progenitors and a smaller fraction of progenitors exiting the cell cycle compared to cells electroporated with wild-type CCND2. These observations suggest that cyclin D2 stabilization, caused by CCND2 mutation or PI3K-AKT activation, is a unifying mechanism in PI3K-AKT-related megalencephaly syndromes.	[Mirzaa, Ghayda M.; Adams, Carissa; Hodge, Rebecca D.; Hevner, Robert F.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Mirzaa, Ghayda M.; Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Parry, David A.; Logan, Clare V.; Roberts, Nicola; Johnson, Colin A.; Sheridan, Eamonn G.] St James Univ Hosp, Wellcome Trust Brenner Bldg, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Fry, Andrew E.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Giamanco, Kristin A.; Singh, Shawn; Kholmanskikh, Stanislav S.] Weill Cornell Med Coll, Neurogenet & Dev Fell Family Brain & Mind Res Ins, New York, NY USA; [Schwartzentruber, Jeremy; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Vanstone, Megan; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Hodge, Rebecca D.; Hevner, Robert F.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hevner, Robert F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Braun, Kees P. J.] UMC Utrecht, Dept Child Neurol, Utrecht, Netherlands; [Faivre, Laurence] Univ Bourgogne, CHU Dijon, Hop Enfants, Ctr Genet, Dijon, France; [Faivre, Laurence] Univ Bourgogne, CHU Dijon, Hop Enfants, Ctr Reference Anomalies Dev & Syndromes Malformat, Dijon, France; [Riviere, Jean-Baptiste; St-Onge, Judith] Univ Bourgogne, Equipe Genet Anomalies Dev GAD, Dijon, France; [Gripp, Karen W.] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DC USA; [Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Expertise Ctr Neurodev Disorders, Rotterdam, Netherlands; [Pang, Ki] Royal Victoria Infirm, Dept Paediat Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Sweeney, Elizabeth] Liverpool Womens Natl Hlth Serv NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [van Esch, Hilde] Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Leuven, Belgium; [Verbeek, Nienke] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Steinraths, Michelle] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Saint James's University Hospital; Cardiff University; Cornell University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University Medical Center; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Nemours Alfred I. duPont Hospital for Children; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Newcastle University - UK; KU Leuven; University Hospital Leuven; Utrecht University; Utrecht University Medical Center; University of Duisburg Essen; University of British Columbia; University of Washington; University of Washington Seattle	Sheridan, EG (corresponding author), St James Univ Hosp, Wellcome Trust Brenner Bldg, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	mer2005@med.cornell.edu; e.sheridan@leeds.ac.uk	Fry, Andrew/AAN-2730-2020; Dobyns, William Brian/ABC-6525-2021; Wieczorek, Dagmar/AAU-6008-2021; Dobyns, William/AAI-2768-2020; Fry, Andrew/AFK-7448-2022; Van+Esch, Hilde/AAU-5688-2020; Scherer, Stephen W./B-3785-2013	Fry, Andrew/0000-0001-9778-6924; Wieczorek, Dagmar/0000-0003-2812-6492; Dobyns, William/0000-0002-7681-2844; Fry, Andrew/0000-0001-9778-6924; Scherer, Stephen W./0000-0002-8326-1999; Parry, David/0000-0003-0376-7736; Van Esch, Hilde/0000-0002-9604-5726; Faivre, Laurence/0000-0001-9770-444X; Johnson, Colin/0000-0002-2979-8234; Bernier, Francois/0000-0001-7063-4269; Schwartzentruber, Jeremy/0000-0002-6183-2092; Friedman, Jan/0000-0002-7482-9570; Logan, Clare/0000-0003-4323-1602; Bonthron, David/0000-0001-8132-8179	Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec and Genome British Columbia; National Institute of Neurological Disorders and Stroke (NINDS) of US National Institutes of Health [P01-NSO48120, NRSA F32 NS086173, R01NS058721]; Baily Thomas Charitable Fund; Sir Jules Thorn Charitable Trust; Great Ormond Street Children's Hospital Charity; MRC [MR/K011154/1, MR/L01629X/1] Funding Source: UKRI; Medical Research Council [MR/L01629X/1, MR/K011154/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1217] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS086173, R01NS058721, P01NS048120] Funding Source: NIH RePORTER	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec and Genome British Columbia; National Institute of Neurological Disorders and Stroke (NINDS) of US National Institutes of Health; Baily Thomas Charitable Fund; Sir Jules Thorn Charitable Trust; Great Ormond Street Children's Hospital Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the study patients and their families, without whose participation this work would not be possible. We thank M. O ' Driscoll (University of Sussex) for advice and help. This work was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), the Ontario Genomics Institute (OGI-049), Genome Quebec and Genome British Columbia (to K.M.B.). The work was selected for study by the FORGE Canada Steering Committee, consisting of K. Boycott (University of Ottawa), J. Friedman (University of British Columbia), J. Michaud (Universite de Montreal), F. Bernier (University of Calgary), M. Brudno (University of Toronto), B. Fernandez (Memorial University), B. Knoppers (McGill University), M. Samuels (Universite de Montreal) and S. Scherer (University of Toronto). Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the US National Institutes of Health under award numbers P01-NSO48120 (to M.E.R.), NRSA F32 NS086173 (to K.A.G.) and R01NS058721 (to W.B.D.), by The Baily Thomas Charitable Fund (to D.T.P.) and by the Sir Jules Thorn Charitable Trust and Great Ormond Street Children's Hospital Charity (to E.G.S.).	Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Glickstein SB, 2007, CEREB CORTEX, V17, P632, DOI 10.1093/cercor/bhk008; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Glickstein SB, 2009, J NEUROSCI, V29, P9614, DOI 10.1523/JNEUROSCI.2284-09.2009; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544	18	91	94	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					510	515		10.1038/ng.2948	http://dx.doi.org/10.1038/ng.2948			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705253	Green Submitted, Green Accepted			2022-12-17	WOS:000335422900021
J	Staton, AA; Knaut, H; Giraldez, AJ				Staton, Alison A.; Knaut, Holger; Giraldez, Antonio J.			miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration	NATURE GENETICS			English	Article							ZEBRAFISH GASTRULATION; MESSENGER-RNAS; MICRORNAS; EXPRESSION; EVOLUTION; TARGET; DROSOPHILA; SPECIFICATION; CONSEQUENCES; CANALIZATION	microRNAs (miRNAs) function as genetic rheostats to control gene output. Based on their role as modulators, it has been postulated that miRNAs canalize development and provide genetic robustness. Here, we uncover a previously unidentified regulatory layer of chemokine signaling by miRNAs that confers genetic robustness on primordial germ cell (PGC) migration. In zebrafish, PGCs are guided to the gonad by the ligand Sdf1a, which is regulated by the sequestration receptor Cxcr7b. We find that miR-430 regulates sdf1a and cxcr7 mRNAs. Using target protectors, we demonstrate that miR-430-mediated regulation of endogenous sdf1a (also known as cxcl12a) and cxcr7b (i) facilitates dynamic expression of sdf1a by clearing its mRNA from previous expression domains, (ii) modulates the levels of the decoy receptor Cxcr7b to avoid excessive depletion of Sdf1a and (iii) buffers against variation in gene dosage of chemokine signaling components to ensure accurate PGC migration. Our results indicate that losing miRNA-mediated regulation can expose otherwise buffered genetic lesions leading to developmental defects.	[Staton, Alison A.; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Knaut, Holger] NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA	Yale University; New York University; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu		Knaut, Holger/0000-0002-8399-8720; Giraldez, Antonio/0000-0002-6823-137X	US National Institutes of Health (NIH)/National Institute of General Medicine Sciences [T32 GM007223]; NIH [R01GM081602-03/03S1]; Yale Scholar program; Pew Scholars Program in Biomedical Sciences; Whitehead Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM081602] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Scholar program; Pew Scholars Program in Biomedical Sciences; Whitehead Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Patnode for fish husbandry, C. Takacs and C. Stahlhut for discussion and critical reading of the manuscript, H. Xue for analysis of the Sdf1a 3' UTR and D. Stemple for cxcr7b mutant zebrafish. This work was supported by the National Research Service Award US National Institutes of Health (NIH)/National Institute of General Medicine Sciences T32 GM007223 Training Grant (A. A. S.), NIH grants R01GM081602-03/03S1, the Yale Scholar program, the Pew Scholars Program in Biomedical Sciences (A.J.G.) and a Whitehead Fellowship Award (H.K.).	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fenyes F., 2010, ZFIN DIRECT DA UNPUB; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nair S, 2008, SCIENCE, V322, P89, DOI 10.1126/science.1160038; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Svoboda P, 2010, EMBO REP, V11, P590, DOI 10.1038/embor.2010.102; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022; Weidinger G, 2002, DEVELOPMENT, V129, P25; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	46	91	95	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					204	U45		10.1038/ng.758	http://dx.doi.org/10.1038/ng.758			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258340	Green Accepted			2022-12-17	WOS:000287693800010
J	Harada, M; Murakami, H; Okawa, A; Okimoto, N; Hiraoka, S; Nakahara, T; Akasaka, R; Shiraishi, Y; Futatsugi, N; Mizutani-Koseki, Y; Kuroiwa, A; Shirouzu, M; Yokoyama, S; Taiji, M; Iseki, S; Ornitz, DM; Koseki, H				Harada, Masayo; Murakami, Hirotaka; Okawa, Akihiko; Okimoto, Noriaki; Hiraoka, Shuichi; Nakahara, Taka; Akasaka, Ryogo; Shiraishi, Yo-ichi; Futatsugi, Noriyuki; Mizutani-Koseki, Yoko; Kuroiwa, Atsushi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Taiji, Makoto; Iseki, Sachiko; Ornitz, David M.; Koseki, Haruhiko			FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion	NATURE GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; MOUSE CORONAL SUTURE; HEPARAN-SULFATE; CHONDROCYTE DIFFERENTIATION; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BONE-DEVELOPMENT; RECEPTOR; BINDING; OSTEOGENESIS	The spontaneous dominant mouse mutant, Elbow knee synostosis (Eks), shows elbow and knee joint synosotsis, and premature fusion of cranial sutures. Here we identify a missense mutation in the Fgf9 gene that is responsible for the Eks mutation. Through investigation of the pathogenic mechanisms of joint and suture synostosis in Eks mice, we identify a key molecular mechanism that regulates FGF9 signaling in developing tissues. We show that the Eks mutation prevents homodimerization of the FGF9 protein and that monomeric FGF9 binds to heparin with a lower affinity than dimeric FGF9. These biochemical defects result in increased diffusion of the altered FGF9 protein (FGF9(Eks)) through developing tissues, leading to ectopic FGF9 signaling and repression of joint and suture development. We propose a mechanism in which the range of FGF9 signaling in developing tissues is limited by its ability to homodimerize and its affinity for extracellular matrix heparan sulfate proteoglycans.	[Harada, Masayo; Hiraoka, Shuichi; Mizutani-Koseki, Yoko; Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunl, Tsurumi Ku, Kanagawa 2300045, Japan; [Harada, Masayo] Chiba Univ, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Murakami, Hirotaka; Okawa, Akihiko] Chiba Univ, Grad Sch, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan; [Okimoto, Noriaki; Futatsugi, Noriyuki; Taiji, Makoto] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa 2300046, Japan; [Nakahara, Taka; Iseki, Sachiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Bunkyo Ku, Tokyo 1138549, Japan; [Akasaka, Ryogo; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Shiraishi, Yo-ichi; Kuroiwa, Atsushi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	RIKEN; Chiba University; Chiba University; RIKEN; Tokyo Medical & Dental University (TMDU); RIKEN; Nagoya University; University of Tokyo; Washington University (WUSTL)	Koseki, H (corresponding author), RIKEN, Res Ctr Allergy & Immunl, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	koseki@rcai.riken.jp	Okimoto, Noriaki/AAI-4656-2020; Taiji, Makoto/N-1077-2014; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Harada, Masayo/AAA-2691-2022; Koseki, Haruhiko/I-3825-2014; Nakahara, Taka/AAM-4112-2020	Okimoto, Noriaki/0000-0002-2956-1317; Taiji, Makoto/0000-0002-5317-0500; Yokoyama, Shigeyuki/0000-0003-3133-7338; Koseki, Haruhiko/0000-0001-8424-5854; Nakahara, Taka/0000-0002-4637-1072; Harada, Masayo/0000-0001-8916-5618; Kuroiwa, Atsushi/0000-0001-7710-4041; Ornitz, David/0000-0003-1592-7629	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analysis; Ministry of Education, Culture, Sports, Science and Technology of Japan; US National Institutes of Health [HD049808]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analysis; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported in part by the RIKEN Structural Genomics/ Proteomics Initiative (RSGI) and the National Project on Protein Structural and Functional Analysis, Ministry of Education, Culture, Sports, Science and Technology of Japan (S.Y.) and US National Institutes of Health grant HD049808 (D.M.O.).	CASE DA, 2004, AMBER, V8; Colvin JS, 1999, DEV DYNAM, V216, P72; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Hajihosseini MK, 2002, MECH DEVELOP, V113, P79, DOI 10.1016/S0925-4773(01)00656-6; Hecht HJ, 2001, ACTA CRYSTALLOGR D, V57, P378, DOI 10.1107/S0907444900020813; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Iseki S, 1997, DEVELOPMENT, V124, P3375; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Murakami H, 2002, MAMM GENOME, V13, P341, DOI 10.1007/s00335-001-2143-6; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; NARUMI T, 2006, 55 TFLOPS SIMULATION, DOI DOI 10.1145/1188455.11885064; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Storm EE, 1996, DEVELOPMENT, V122, P3969; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; TSANG M, 2004, SCI STKE; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P1892, DOI 10.1073/pnas.96.5.1892; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang O, 2001, DEVELOPMENT, V128, P3867; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Yoshida T, 2005, J ANAT, V206, P437, DOI 10.1111/j.1469-7580.2005.00411.x	43	91	91	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					289	298		10.1038/ng.316	http://dx.doi.org/10.1038/ng.316			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219044	Green Accepted			2022-12-17	WOS:000263640200009
J	Manolio, TA				Manolio, Teri A.			Cohort studies and the genetics of complex disease	NATURE GENETICS			English	Editorial Material								Three new studies identify nearly 20 new loci for serum lipid levels using predominantly a prospective cohort study design which also permits extensive and unbiased characterization of environmental exposures. Given the known, strong environmental influences on these traits, investigation of gene-environment interactions should be emphasized in attempts to understand the complete epidemiologic and genetic architecture of these complex traits.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Manolio, TA (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	manolio@nih.gov						Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lusis AJ, 2008, NAT GENET, V40, P129, DOI 10.1038/ng0208-129; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Ordovas JM, 2002, CIRCULATION, V106, P2315, DOI 10.1161/01.CIR.0000036597.52291.C9; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271	10	91	93	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					5	6		10.1038/ng0109-5	http://dx.doi.org/10.1038/ng0109-5			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19112455				2022-12-17	WOS:000262085300002
J	Ercan, S; Giresi, PG; Whittle, CM; Zhang, XM; Green, RD; Lieb, JD				Ercan, Sevinc; Giresi, Paul G.; Whittle, Christina M.; Zhang, Xinmin; Green, Roland D.; Lieb, Jason D.			X chromosome repression by localization of the C-elegans dosage compensation machinery to sites of transcription initiation	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; COMPLEX; GENOME; GENE; SEX; BINDING; ARRAY; TOOL	Among organisms with chromosome-based mechanisms of sex determination, failure to equalize expression of X-linked genes between the sexes is typically lethal. In C. elegans, XX hermaphrodites halve transcription from each X chromosome to match the output of XO males(1). Here, we mapped the binding location of the condensin homolog DPY-27 and the zinc finger protein SDC-3, two components of the C. elegans dosage compensation complex (DCC)(2,3). We observed strong foci of DCC binding on X, surrounded by broader regions of localization. Binding foci, but not adjacent regions of localization, were distinguished by clusters of a 10-bp DNA motif, suggesting a recruitment-and-spreading mechanism for X recognition. The DCC was preferentially bound upstream of genes, suggesting modulation of transcriptional initiation and polymerase-coupled spreading. Stronger DCC binding upstream of genes with high transcriptional activity indicated a mechanism for tuning DCC activity at specific loci. These data aid in understanding how proteins involved in higherorder chromosome dynamics can regulate transcription at individual loci.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carloina Ctr Genome Sci, Chapel Hill, NC 27599 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roche Holding; Roche NimbleGen	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, 202 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu		Lieb, Jason/0000-0001-7601-8061	NHGRI NIH HHS [U01 HG004270-01, U01 HG004270] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Davis TL, 1997, DEVELOPMENT, V124, P1019; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HODGKIN J, 1994, DEVELOPMENT, V120, P3681; HSU DR, 1995, DEVELOPMENT, V121, P3323; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li WQ, 1999, GENETICS, V152, P237; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; MEYER BJ, 2005, X CHROMOSOME DOSAGE; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nicoll M, 1997, NATURE, V388, P200, DOI 10.1038/40645; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439	30	91	94	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					403	408		10.1038/ng1983	http://dx.doi.org/10.1038/ng1983			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293863	Green Accepted, Green Submitted			2022-12-17	WOS:000244480000025
J	Siminovitch, KA				Siminovitch, KA			PTPN22 and autoimmune disease	NATURE GENETICS			English	Editorial Material							TYROSINE-PHOSPHATASE PEP; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISM; VARIANTS; GENE	Protein tyrosine phosphatases (PTPs) have diverse roles as negative regulators of stimulatory signaling cascades and are widely recognized as key to maintaining immune cellular homeostasis. Recent data implicating the PTP Lyp in susceptibility to four autoimmune diseases attests to the biological importance of PTP immune regulatory roles and to the etiologic relatedness of different autoimmune conditions.	Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Siminovitch, KA (corresponding author), Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.	ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013					Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chien WW, 2003, J BIOL CHEM, V278, P27413, DOI 10.1074/jbc.M304575200; Ferreiros-Vidal I, 2003, RHEUMATOLOGY, V42, P1380, DOI 10.1093/rheumatology/keg383; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hasegawa K, 1999, EUR J IMMUNOL, V29, P887, DOI 10.1002/(SICI)1521-4141(199903)29:03<887::AID-IMMU887>3.0.CO;2-9; HO P, 2004, ARTHRITIS RHEUM S, P5258; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; NEWMAN B, IN PRESS ARTH RHEUM; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710	15	91	97	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1248	1249		10.1038/ng1204-1248	http://dx.doi.org/10.1038/ng1204-1248			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565104				2022-12-17	WOS:000225354100005
J	Gerhold, DL; Jensen, RV; Gullans, SR				Gerhold, DL; Jensen, RV; Gullans, SR			Better therapeutics through microarrays	NATURE GENETICS			English	Review							MOLECULAR PHARMACOLOGY; EXPRESSION PROFILES; MECHANISM; GENES; CANCER; METABOLISM; PREDICTION; DISCOVERY; TOXICITY; SETS	DNA microarrays are an integral part of the process for therapeutic discovery, optimization and clinical validation. At an early stage, investigators use arrays to prioritize a few genes as potential therapeutic targets on the basis of various criteria. Subsequently, gene expression analysis assists in drug discovery and toxicology by eliminating poor compounds and optimizing the selection of promising leads. Integral to this process is the use of sophisticated statistics, mathematics and bioinformatics to define statistically valid observations and to deduce complex patterns of phenotypes and biological pathways. In short, microarrays are redefining the drug discovery process by providing greater knowledge at each step and by illuminating the complex workings of biological systems.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Funct Genom, Cambridge, MA 02139 USA; Merck Res Labs, Dept Mol Profiling, W Point, PA 19486 USA; Wesleyan Univ, Dept Phys, Middletown, CT 06459 USA	Harvard University; Brigham & Women's Hospital; Merck & Company; Wesleyan University	Gullans, SR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Funct Genom, 65 Landsdowne St, Cambridge, MA 02139 USA.			Gerhold, David/0000-0001-5739-730X				Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; Burczynski ME, 2000, TOXICOL SCI, V58, P399, DOI 10.1093/toxsci/58.2.399; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cho YS, 2001, P NATL ACAD SCI USA, V98, P9819, DOI 10.1073/pnas.171314398; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fryer RM, 2002, EXP NEPHROL, V10, P64; Gerhold D, 1996, BIOESSAYS, V18, P973, DOI 10.1002/bies.950181207; Gerhold D, 2001, PHYSIOL GENOMICS, V5, P161, DOI 10.1152/physiolgenomics.2001.5.4.161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HANSTEN PD, 2002, TOP 100 DRUG INTERAC; HEIMARK LD, 1987, CLIN PHARMACOL THER, V42, P388, DOI 10.1038/clpt.1987.168; Hu WY, 2002, J HYPERTENS, V20, P1323, DOI 10.1097/00004872-200207000-00019; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Pennie WD, 2001, TOXICOL LETT, V120, P353, DOI 10.1016/S0378-4274(01)00322-8; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; SARANG SS, 2002, PHYSL GENOM     0917; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; WHITLOCK JP, 1995, INDUCTION CYTOCHROME; Xu H, 2001, Biotechnol Annu Rev, V7, P131, DOI 10.1016/S1387-2656(01)07035-1; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	40	91	99	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			547	552		10.1038/ng1042	http://dx.doi.org/10.1038/ng1042			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454652				2022-12-17	WOS:000179742900017
J	Park, C; Falls, W; Finger, JH; Longo-Guess, CM; Ackerman, SL				Park, C; Falls, W; Finger, JH; Longo-Guess, CM; Ackerman, SL			Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation	NATURE GENETICS			English	Article							DEFICIENT FOLIA CDF; PREPULSE INHIBITION; ADHESION COMPLEX; CADHERIN; EXPRESSION; MUTATION; REGIONS; NUCLEUS; SYSTEM; MODEL	Mice homozygous for the cerebellar deficient folia (cdf) mutation are ataxic and have cerebellar hypoplasia and abnormal lobulation of the cerebellum. In the cerebella of cdf/cdf homozygous mice, approximately 40% of Purkinje cells are located ectopically in the white matter and inner granule-cell layer. Many hippocampal pyramidal cells are scattered in the plexiform layers, and those that are correctly positioned are less densely packed than are cells in wild-type mice. We show that fear conditioning and prepulse inhibition of the startle response are also disrupted in cdf/cdf mice. We identify a deletion on chromosome 6 that removes approximately 150 kb in the cdf critical region. The deletion includes part of Catna2, encoding alphaN-catenin, a protein that links the classical cadherins to the neuronal cytoskeleton. Expression of a Catna2 transgene in cdf/cdf mice restored normal cerebellar and hippocampal morphology, prepulse inhibition and fear conditioning. The findings suggest that catenin-cadherin cell-adhesion complexes are important in cerebellar and hippocampal lamination and in the control of startle modulation.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Vermont, Burlington, VT 05405 USA	Jackson Laboratory; University of Vermont	Ackerman, SL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Falls, William/D-1208-2013	Falls, William/0000-0002-9246-1474				Beierbach E, 2001, J COMP NEUROL, V436, P42; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Cook SA, 1997, MAMM GENOME, V8, P108, DOI 10.1007/s003359900368; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; DAVIS M, 1978, J EXP PSYCHOL ANIM B, V4, P95, DOI 10.1037//0097-7403.4.2.95; FALLS WA, IN PRESS CURRENT PRO; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Lynn RB, 1997, J AUTONOM NERV SYST, V62, P174, DOI 10.1016/S0165-1838(96)00125-7; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ozol K, 1999, J COMP NEUROL, V412, P95; Park C, 2000, GENOMICS, V69, P135, DOI 10.1006/geno.2000.6322; Park C, 2002, GENESIS, V32, P32, DOI 10.1002/gene.10024; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; SWERDLOW NR, 1993, BEHAV NEUROSCI, V107, P104, DOI 10.1037/0735-7044.107.1.104; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864	30	91	93	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					279	284		10.1038/ng908	http://dx.doi.org/10.1038/ng908			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089526				2022-12-17	WOS:000176494100016
J	Ferrigno, O; Virolle, T; Djabari, Z; Ortonne, JP; White, RJ; Aberdam, D				Ferrigno, O; Virolle, T; Djabari, Z; Ortonne, JP; White, RJ; Aberdam, D			Transposable B2SINE elements can provide mobile RNA polymerase II promoters	NATURE GENETICS			English	Article							HUMAN GENOME; TRANSCRIPTION; GENE; INITIATOR; SEQUENCE; DNA; ALU; USF; FAMILIES; REPEAT	Short interspersed elements (SINEs) are highly abundant components of mammalian genomes that are propagated by retrotransposition. SINEs are recognized as a causal agent of human disease and must also have had a profound influence in shaping eukaryotic genomes(1). The B2 SINE family constitutes approximately 0.7% of total mouse genomic DNA(ref, 2) and is also found at low abundance in humans(3) It resembles the Alufamily in several respects, such as its mechanism of propagation. BZ SINEs are derived from tRNA and are transcribed by RNA polymerase (pol) III to generate short transcripts that are not translated(4,5). We find here, however, that one B2 SINE also carries an active pol II promoter located outside the tRNA region. Indeed, a B2 element is responsible for the production of a mouse Lama3 transcript. The B2 pol Il promoters can be bound and stimulated by the transcription factor USF (for upstream stimulatory factor), as shown by transient transfection experiments. Moreover, this pol II activity does not preclude the pol III transcription necessary for retrotransposition(6). Dispersal of BZ SINEs by retrotransposition may therefore have provided numerous opportunities for creating regulated pol II transcription at novel genomic sites. This mechanism may have allowed the evolution of new transcription units and new genes.	Fac Med, INSERM, U385, Nice, France; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Glasgow	Aberdam, D (corresponding author), Fac Med, INSERM, U385, Nice, France.		Virolle, Thierry/E-5838-2016; ferrigno, olivier/GSN-8581-2022; Aberdam, Daniel/G-3299-2013	ferrigno, olivier/0000-0001-7544-4384; Aberdam, Daniel/0000-0002-4019-5418				ABERDAM D, 2000, LAMININS, P228; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; BRINI AT, 1993, J BIOL CHEM, V268, P1355; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; CHANDRASEKARAN B, 1992, IEEE EXPERT, V7, P2; Chen YL, 1998, T NONFERR METAL SOC, V8, P5; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; FEHLING HJ, 1995, IMMUNOGENETICS, V42, P275, DOI 10.1007/BF00176445; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Makalowski W., 1995, IMPACT SHORT INTERSP, P81; Marinoni JC, 1997, METHODS, V12, P235, DOI 10.1006/meth.1997.0476; Mayorov VI, 2000, MAMM GENOME, V11, P177, DOI 10.1007/s003350010033; Novina CD, 1996, TRENDS GENET, V12, P351, DOI 10.1016/0168-9525(96)10034-2; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; REHN M, 1994, J BIOL CHEM, V269, P13929; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAKAMOTO K, 1985, J MOL EVOL, V22, P134, DOI 10.1007/BF02101691; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; Vailly J, 1998, GENE THER, V5, P1322, DOI 10.1038/sj.gt.3300730; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	24	91	94	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					77	81		10.1038/88306	http://dx.doi.org/10.1038/88306			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326281				2022-12-17	WOS:000168413300021
J	Jin, LQ; Zeng, H; Chien, S; Otto, KG; Richard, RE; Emery, DW; Blau, CA				Jin, LQ; Zeng, H; Chien, S; Otto, KG; Richard, RE; Emery, DW; Blau, CA			In vivo selection using a cell-growth switch	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW CELLS; IN-VIVO; PROLIFERATION; TRANSDUCTION; EXPRESSION	A major obstacle to stem-cell gene therapy rests in the inability to deliver a gene into a therapeutically relevant fraction of stem cells'. One way to circumvent this obstacle is to use selection. Vectors containing two linked genes serve as the basis for selection. with one gene encoding a selectable product and the other, a therapeutic protein. Applying selection in vivo has the potential to bring a minor population of genetically corrected cells into the therapeutic range. But strategies for achieving in vivo selection have traditionally relied on genes that confer resistance to cytotoxic drugs(2,3) and are encumbered by toxicity. Here we describe a new system for in vivo selection that uses a 'cell-growth switch'. allowing a minor population of genetically modified cells to be inducibly amplified, thereby averting the risks associated with cytotoxic drugs. This system provides a general platform for conditionally expanding genetically modified cell populations in vivo. and may have widespread applications in gene and cell therapy.	Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Blau, CA (corresponding author), Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.				NHLBI NIH HHS [2P01HL53750] Funding Source: Medline; NIDDK NIH HHS [5R01DK52997, 1R01DK57525] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052997, R01DK057525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allay JA, 1998, NAT MED, V4, P1136, DOI 10.1038/2632; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; CHALLITA PM, 1994, P NATL ACAD SCI USA, V91, P2567, DOI 10.1073/pnas.91.7.2567; Cheng L, 1997, GENE THER, V4, P1013, DOI 10.1038/sj.gt.3300507; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; HAWLEY RG, 1994, GENE THER, V1, P136; HODGSON GS, 1973, CELL TISSUE KINET, V6, P199, DOI 10.1111/j.1365-2184.1973.tb01608.x; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Jin LQ, 1998, P NATL ACAD SCI USA, V95, P8093, DOI 10.1073/pnas.95.14.8093; Jin LQ, 1998, BLOOD, V91, P890, DOI 10.1182/blood.V91.3.890.890_890_897; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; SORRENTION BP, IN PRESS MOL BASIS B; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0	17	91	101	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					64	66		10.1038/79194	http://dx.doi.org/10.1038/79194			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973250				2022-12-17	WOS:000089078000019
J	Rossi, FMV; Guicherit, OM; Spicher, A; Kringstein, AM; Fatyol, K; Blakely, BT; Blau, HM				Rossi, FMV; Guicherit, OM; Spicher, A; Kringstein, AM; Fatyol, K; Blakely, BT; Blau, HM			Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; ANTIBIOTIC-RESISTANCE; RETROVIRAL VECTORS; PRIMARY MYOBLASTS; TET REPRESSOR; COMPLEX; SYSTEM; PROMOTERS; DESIGN	Continuous regulation is required to maintain a given cell state(1,2) or to allow it to change in response to the environment(3,4). Studies of the mechanisms underlying such regulation have often been hindered by the inability to control gene expression at will. Among the inducible systems available for regulating gene expression in eukaryotes(5-8), the tetracycline (tet) regulatable system has distinct advantages(9-11). It is highly specific, non-toxic and non-eukaryotic, and consequently does not have pleiotropic effects on host cell genes. Previously this system also had drawbacks, as it did not extinguish gene expression completely, precluding the study of toxic or growth-inhibitory gene products. We report here the development of a facile reversible tetracycline-inducible retroviral system (designated RetroTet-ART) in which activators and repressors together are expressed in cells. Gene expression can now be actively repressed in the absence of tet and induced in the presence of tet, as we have engineered distinct dimerization domains that allow co-expression of homodimeric tet-regulated transactivators and transrepressors in the same cells, without the formation of non-functional heterodimers. Using this system, we show that growth arrest by the cell cycle inhibitor p16 is reversible and dependent on its continuous expression.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.		Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA059717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521] Funding Source: NIH RePORTER; NCI NIH HHS [CA59717] Funding Source: Medline; NIA NIH HHS [AG09521] Funding Source: Medline; NICHD NIH HHS [HD18179] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; Bohl D, 1997, NAT MED, V3, P299, DOI 10.1038/nm0397-299; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Dupin E, 1998, CURR TOP DEV BIOL, V36, P1; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GALBRAITH DW, IN PRESS METH CELL B; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; KISKER C, 1995, J MOL BIOL, V247, P260, DOI 10.1006/jmbi.1994.0138; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NAKAUCHI H, 1985, P NATL ACAD SCI USA, V82, P5126, DOI 10.1073/pnas.82.15.5126; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Poulos NE, 1996, CANCER RES, V56, P1719; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Sah DWY, 1997, NAT BIOTECHNOL, V15, P574, DOI 10.1038/nbt0697-574; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SPICHER A, 1994, DEV BIOL, V164, P72, DOI 10.1006/dbio.1994.1181; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; ZHAO J, 1992, MICROBIOL IMMUNOL, V36, P1051, DOI 10.1111/j.1348-0421.1992.tb02109.x	31	91	97	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					389	393		10.1038/3871	http://dx.doi.org/10.1038/3871			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843215				2022-12-17	WOS:000077199600030
J	Gavrilov, DK; Shi, XY; Das, K; Gilliam, TC; Wang, CH				Gavrilov, DK; Shi, XY; Das, K; Gilliam, TC; Wang, CH			Differential SMN2 expression associated with SMA severity	NATURE GENETICS			English	Letter							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON GENE; PHENOTYPE; IDENTIFICATION; FAMILIES; DISEASE; EXON-6; NUMBER; COPIES		Univ Missouri, Dept Psychiat & Neurol, Mol Neurogenet Lab, Columbia, MO 65212 USA; Univ Missouri, Dept Biochem, Mol Neurogenet Lab, Columbia, MO 65212 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Columbia University	Wang, CH (corresponding author), Univ Missouri, Dept Psychiat & Neurol, Mol Neurogenet Lab, Columbia, MO 65212 USA.		Gavrilov, Dimitar/AAB-9453-2021					Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; FRANCIS J, IN PRESS P NATL ACAD; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Schwartz M, 1997, HUM MOL GENET, V6, P99, DOI 10.1093/hmg/6.1.99; TALBOT K, 1997, HUM MOL GENET, V6, P697; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; WANG CH, IN PRESS NEUROGENETI	15	91	92	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					230	231		10.1038/3030	http://dx.doi.org/10.1038/3030			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806538				2022-12-17	WOS:000076698100013
J	ROBIN, NH; FELDMAN, GJ; ARONSON, AL; MITCHELL, HF; WEKSBERG, R; LEONARD, CO; BURTON, BK; JOSEPHSON, KD; LAXOVA, R; ALECK, KA; ALLANSON, JE; GUIONALMEIDA, ML; MARTIN, RA; LEICHTMAN, LG; PRICE, RA; OPITZ, JM; MUENKE, M				ROBIN, NH; FELDMAN, GJ; ARONSON, AL; MITCHELL, HF; WEKSBERG, R; LEONARD, CO; BURTON, BK; JOSEPHSON, KD; LAXOVA, R; ALECK, KA; ALLANSON, JE; GUIONALMEIDA, ML; MARTIN, RA; LEICHTMAN, LG; PRICE, RA; OPITZ, JM; MUENKE, M			OPITZ-SYNDROME IS GENETICALLY HETEROGENEOUS, WITH ONE LOCUS ON XP22, AND A 2ND LOCUS ON 22Q11.2	NATURE GENETICS			English	Note							MICRODELETIONS; GENE; DELETIONS		UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PSYCHIAT,PHILADELPHIA,PA 19104; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616; GUNDERSON CLIN LTD,LA CROSSE REG GENET SERV,LA CROSSE,WI 54601; UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT,MADISON,WI 53705; UNIV ARIZONA,DEPT PEDIAT,PHOENIX,AZ 85010; UNIV ARIZONA,DEPT GENET,PHOENIX,AZ 85010; CHILDRENS HOSP EASTERN ONTARIO,DEPT GENET,OTTAWA,ON K1H 8L1,CANADA; UNIV SAO PAULO,HOSP PESQUISA & REABILITACAO LESOES LABIO PALATAI,BAURU,SP,BRAZIL; UNIV CALIF IRVINE,MED CTR,DEPT PEDIAT,ORANGE,CA 92613; EASTERN VIRGINIA MED SCH,DEPT PEDIAT,DIV GENET,NORFOLK,VA 23507; FDN DEV & MED GENET,HELENA,MT 59601	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utah System of Higher Education; University of Utah; Michael Reese Hospital & Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of Arizona; University of Ottawa; Children's Hospital of Eastern Ontario; Universidade de Sao Paulo; University of California System; University of California Irvine; Eastern Virginia Medical School				Muenke, Maximilian/0000-0002-7719-6545	NICHD NIH HHS [R29HD28732, 5T32HD07107] Funding Source: Medline; NIDDK NIH HHS [R01DK44073] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007107, R29HD028732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLANSON JE, 1988, AM J MED GENET, V31, P637, DOI 10.1002/ajmg.1320310319; AUBRY M, 1992, GENOMICS, V13, P641, DOI 10.1016/0888-7543(92)90135-F; BROOKS JK, 1992, AM J MED GENET, V43, P595, DOI 10.1002/ajmg.1320430318; Cohen M M Jr, 1979, Birth Defects Orig Artic Ser, V15, P85; CORDERO JF, 1978, AM J MED GENET, V2, P145, DOI 10.1002/ajmg.1320020205; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; FARDON PA, 1983, CLIN GENET, V24, P446; FRANZE A, 1991, GENOMICS, V7, P728; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P918, DOI 10.1002/ajmg.1320430603; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACPHERSON E, 1991, AM J HUM GENET S, V49, pA774; MARINO M, 1993, MAMM GENOME, V4, P252, DOI 10.1007/BF00417431; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P759; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P95; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; PAGE DC, 1990, GENOMICS, V7, P37, DOI 10.1016/0888-7543(90)90516-W; STOLL C, 1978, AM J MED GENET, V20, P221; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WITTWER B, 1994, AM J HUM GENET, V55, pA1207; [No title captured]	23	91	93	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					459	461		10.1038/ng1295-459	http://dx.doi.org/10.1038/ng1295-459			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493033				2022-12-17	WOS:A1995TH62900030
J	VILLAR, AJ; PEDERSEN, RA				VILLAR, AJ; PEDERSEN, RA			PARENTAL IMPRINTING OF THE MAS PROTOONCOGENE IN MOUSE	NATURE GENETICS			English	Article							GROWTH FACTOR-II; PATERNAL GENOMES; TGF-ALPHA; ONCOGENE; GENE; METHYLATION; EMBRYOGENESIS; ACTIVATION; EXPRESSION; RELAXATION	The Mas protooncogene on mouse chromosome 17 encodes a mitogenic G-protein-coupled cell surface receptor. We investigated the allele-specific expression pattern of the Mas gene on the basis of its proximity to the known imprinted gene for the insulin growth factor type II receptor (Igf2r). Phenotyping of mRNA demonstrated exclusive expression from the paternal allele in all embryonic tissues, including visceral yolk sac, between 11 and 12.5 days of gestation. By 13.5 days of gestation the paternal allele-specific expression of Mas was restricted to heart, tongue and visceral yolk sac, whereas all other tissues exhibited relaxation of the parental imprint. Our results demonstrate parental imprinting of Mas and suggest that the maternally inherited allele is transcriptionally repressed in a developmental and tissue-specific manner.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	VILLAR, AJ (corresponding author), UNIV CALIF SAN FRANCISCO, RADIOBIOL & ENVIRONM HLTH LAB, SAN FRANCISCO, CA 94143 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD026732] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26732] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDRAWIS NS, 1992, CELL BIOL INT REP, V16, P547, DOI 10.1016/S0309-1651(05)80053-0; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BIRCHMEIER C, 1986, COLD SPRING HARB SYM, V51, P993, DOI 10.1101/SQB.1986.051.01.113; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CEBRATHOMAS JA, 1992, GENOMICS, V13, P444, DOI 10.1016/0888-7543(92)90267-V; CEBRATHOMAS JA, 1992, GENOMICS, V14, P208; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GOLD JD, 1994, CURR TOP DEV BIOL, V29, P227; HANLEY MR, 1991, J CARDIOVASC PHARM, V18, pS7, DOI 10.1097/00005344-199100182-00003; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JANSSEN JWG, 1988, LEUKEMIA, V2, P318; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MARTIN KA, 1992, DEV BRAIN RES, V68, P75, DOI 10.1016/0165-3806(92)90249-V; McClelland M, 1987, Gene Amplif Anal, V5, P257; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; PEDERSEN RA, 1993, SERONO SYMP, P212; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; RE RN, 1987, AM J CARDIOL, V60, P1041; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLTER D, 1988, ANNU REV GENET, V22, P127; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; VANTVEER LJ, 1988, ONCOGENE RES, V3, P247; VANTVEER LJ, 1993, ONCOGENE, V8, P2673; VARMUZA S, 1994, TRENDS GENET, V10, P118, DOI 10.1016/0168-9525(94)90212-7; VILLAR AJ, 1994, MOL REPROD DEV, V37, P247, DOI 10.1002/mrd.1080370302; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	42	91	93	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					373	379		10.1038/ng1294-373	http://dx.doi.org/10.1038/ng1294-373			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894489				2022-12-17	WOS:A1994PV68200019
J	DURHAMPIERRE, D; GARDNER, JM; NAKATSU, Y; KING, RA; FRANCKE, U; CHING, A; AQUARON, R; DELMARMOL, V; BRILLIANT, MH				DURHAMPIERRE, D; GARDNER, JM; NAKATSU, Y; KING, RA; FRANCKE, U; CHING, A; AQUARON, R; DELMARMOL, V; BRILLIANT, MH			AFRICAN ORIGIN OF AN INTRAGENIC DELETION OF THE HUMAN-P GENE IN TYROSINASE POSITIVE OCULOCUTANEOUS ALBINISM	NATURE GENETICS			English	Article							MOUSE; LOCUS	Oculocutaneous albinism (OCA) is a genetically heterogeneous hypopigmentation disorder. One of the two major autosomal recessive forms involves the tyrosinase gene (OCA1), while the other form (OCA2) has recently been associated with alterations of the P gene on chromosome 15. OCA2 is about twice as common as OCA1 in African and African-American populations. We now describe an interstitial deletion that removes a single exon of the P gene. Tn a large family from an inbred population of tri-racial origin, all individuals with OCA2 were found to be homozygous for this allele. Moreover, the same mutant P allele was detected in several unrelated African American individuals with OCA2, but not in Caucasians with OCA2. The detection of the same allele in two unrelated Africans with OCA2 indicates an African origin for this allele.	FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111; UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; CHILDRENS HOSP,BIOL LAB,MARSEILLE,FRANCE; INST JULES BORDET,LOCE,B-1000 BRUSSELS,BELGIUM	Fox Chase Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut Jules Bordet			del marmol, veronique/AAZ-8117-2020	Nakatsu, Yoshimichi/0000-0001-7408-7071	NCI NIH HHS [CA06927] Funding Source: Medline; NIGMS NIH HHS [GM43840, GM22167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167, R01GM043840] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AQUARON R, 1990, OPHTHALMIC PAEDIAT G, V4, P255; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; HEARING VJ, 1973, J ULTRA MOL STRUCT R, V43, P88, DOI 10.1016/S0022-5320(73)90072-5; KROMBERG JGR, 1982, S AFR MED J, V61, P383; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RUSSELL ES, 1949, GENETICS, V34, P146; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; WITKOP CJ, 1972, AM J PHYS ANTHROPOL, V36, P397, DOI 10.1002/ajpa.1330360311; WITKOP CJ, 1973, J INVEST DERMATOL, V60, P443, DOI 10.1111/1523-1747.ep12702920; WITKOP CJ, 1970, AM J HUM GENET, V22, P55; [No title captured]	18	91	92	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					176	179		10.1038/ng0694-176	http://dx.doi.org/10.1038/ng0694-176			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920637				2022-12-17	WOS:A1994NQ03700018
J	ARNGRIMSSON, R; PURANDARE, S; CONNOR, M; WALKER, JJ; BJORNSSON, S; SOUBRIER, F; KOTELEVTSEV, YV; GEIRSSON, RT; BJORNSSON, H				ARNGRIMSSON, R; PURANDARE, S; CONNOR, M; WALKER, JJ; BJORNSSON, S; SOUBRIER, F; KOTELEVTSEV, YV; GEIRSSON, RT; BJORNSSON, H			ANGIOTENSINOGEN - A CANDIDATE GENE INVOLVED IN PREECLAMPSIA	NATURE GENETICS			English	Letter							BLOOD-PRESSURE; PREGNANCY; HYPERTENSION; ECLAMPSIA; WOMEN		UNIV GLASGOW,GLASGOW ROYAL INFIRM,DEPT OBSTET & GYNAECOL,GLASGOW,SCOTLAND; COLL FRANCE,INSERM,U36,F-75231 PARIS 05,FRANCE; NATL UNIV HOSP REYKJAVIK,DEPT OBSTET & GYNECOL,REYKJAVIK,ICELAND; AGR RES INST,DIV STAT,REYKJAVIK,ICELAND	University of Glasgow; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Landspitali National University Hospital	ARNGRIMSSON, R (corresponding author), UNIV GLASGOW,DUNCAN GUTHRIE INST MED GENET,GLASGOW G12 8QQ,SCOTLAND.		Kotelevtsev, Yuri V/R-1772-2016	Arngrimsson, Reynir/0000-0003-1142-2914; Walker, James/0000-0002-8922-083X; Kotelevtsev, Yuri/0000-0002-7255-7794				ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; CHESLEY LC, 1980, CLIN EXP HYPERTENS, V2, P777, DOI 10.3109/10641968009037142; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; Hughes EC, 1972, OBSTET GYNECOLOGIC T, P422; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KOTELEVTSEV YV, 1991, NUCLEIC ACIDS RES, V19, P6978, DOI 10.1093/nar/19.24.6978; LINDEBERG S, 1988, ACTA OBSTET GYN SCAN, V67, P605, DOI 10.3109/00016348809004272; MOUTQUIN JM, 1985, AM J OBSTET GYNECOL, V151, P191, DOI 10.1016/0002-9378(85)90010-9; SEIDMAN DS, 1991, BRIT J OBSTET GYNAEC, V98, P1009, DOI 10.1111/j.1471-0528.1991.tb15339.x; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859	14	91	97	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					114	115		10.1038/ng0693-114	http://dx.doi.org/10.1038/ng0693-114			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348146				2022-12-17	WOS:A1993LF81600006
J	SEIZINGER, BR				SEIZINGER, BR			NF1 - A PREVALENT CAUSE OF TUMORIGENESIS IN HUMAN CANCERS	NATURE GENETICS			English	Editorial Material							NEUROFIBROMATOSIS TYPE-1 GENE; BILATERAL ACOUSTIC NEUROFIBROMATOSIS; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; MUTATIONS; GAP; RETINOBLASTOMA; DELETIONS; SEQUENCE; ENCODES; DOMAIN				SEIZINGER, BR (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,ONCOL DRUG DISCOVERY,PRINCETON,NJ 08543, USA.							ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; GUTMANN DH, 1992, ANN NEUROL, V31, P555, DOI 10.1002/ana.410310515; HARBOUR JE, 1989, PEDIATR HEMATOL ONCO, V6, P319; JOHNSON MR, IN PRESS P NATN ACAD; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MCCORMICK F, 1989, CELL, V5, P1281; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; YOKOTA J, 1988, ONCOGENE, V3, P471	30	91	92	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					97	99		10.1038/ng0293-97	http://dx.doi.org/10.1038/ng0293-97			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	7848376				2022-12-17	WOS:A1993KL01000002
J	HYLAND, J; ALAKOKKO, L; ROYCE, P; STEINMANN, B; KIVIRIKKO, KI; MYLLYLA, R				HYLAND, J; ALAKOKKO, L; ROYCE, P; STEINMANN, B; KIVIRIKKO, KI; MYLLYLA, R			A HOMOZYGOUS STOP CODON IN THE LYSYL HYDROXYLASE GENE IN 2 SIBLINGS WITH EHLERS-DANLOS SYNDROME TYPE-VI	NATURE GENETICS			English	Article							DEFICIENT COLLAGEN; ASCORBIC-ACID; FAMILY	Ehlers-Danlos syndrome (EDS) is characterized by joint hypermobility, alterations in the skin and additional signs of connective tissue involvement. EDS type VI was the first connective tissue disorder for which a specific defect in collagen metabolism was identified, namely a deficiency of lysyl hydroxylase activity. We now report a homozygous single basepair substitution converting the CGA codon (Arg319) to a TGA termination codon in two siblings with EDS type VI. The healthy parents, who are first cousins, and two of the three healthy siblings of the patients are heterozygous. The mutation leads to an almost complete absence of lysyl hydroxylase activity in extracts derived from fibroblasts of the patients.	UNIV OULU,BIOCTR,COLLAGEN RES UNIT,SF-90220 OULU,FINLAND; UNIV OULU,DEPT MED BIOCHEM,SF-90220 OULU,FINLAND; UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8032 ZURICH,SWITZERLAND	University of Oulu; University of Oulu; University of Zurich								BYERS PH, 1989, METABOLIC BASIS INHE, V4, P2805; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; DEMBURE PP, 1984, AM J HUM GENET, V36, P783; ELSAS LJ, 1978, J PEDIATR-US, V92, P378, DOI 10.1016/S0022-3476(78)80423-5; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; HAUTALA T, 1992, BIOCHEM J, V284, P51; IHME A, 1983, EUR J CLIN INVEST, V13, P357, DOI 10.1111/j.1365-2362.1983.tb00113.x; JUDISCH GF, 1976, ARCH OPHTHALMOL-CHIC, V94, P1489; KIVIRIKKO KI, 1985, ANN NY ACAD SCI, V460, P187, DOI 10.1111/j.1749-6632.1985.tb51167.x; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1992, FOCUS POST TRANSLATI, P1; KIVIRIKKO KI, 1987, CONNECTIVE TISSUE DI; KRANE SM, 1972, P NATL ACAD SCI USA, V69, P2899, DOI 10.1073/pnas.69.10.2899; KRANE SM, 1982, AM ACADEMY ORTHOPAED, P61; KRANE SM, 1984, EXTRACELLULAR MATRIX, P413; KRANE SM, 1980, GENE FAMILIES COLLAG, P57; KRIEG T, 1979, HUM GENET, V46, P41, DOI 10.1007/BF00278900; McKusick V.A., 1972, CLIN GENET; MYLLYLA R, 1992, BIOCHEM J, V286, P923, DOI 10.1042/bj2860923; MYLLYLA R, 1991, J BIOL CHEM, V266, P2805; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; ROYCE PM, 1989, MATRIX, V9, P147, DOI 10.1016/S0934-8832(89)80033-2; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEINMANN B, 1992, CONNECTIVE TISSUE IT, P351; SUSSMAN M, 1974, J BONE JOINT SURG AM, VA 56, P1228, DOI 10.2106/00004623-197456060-00015; WENSTRUP RJ, 1989, J PEDIATR-US, V115, P405, DOI 10.1016/S0022-3476(89)80839-X	28	91	93	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					228	231		10.1038/ng1192-228	http://dx.doi.org/10.1038/ng1192-228			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345174				2022-12-17	WOS:A1992JW16500014
J	Zhao, SG; Chen, WS; Li, HL; Foye, A; Zhang, M; Sjostrom, M; Aggarwal, R; Playdle, D; Liao, A; Alumkal, JJ; Das, R; Chou, J; Hua, JJT; Barnard, TJ; Bailey, AM; Chow, ED; Perry, MD; Dang, H; Yang, R; Moussavi-Baygi, R; Zhang, L; Alshalalfa, M; Chang, SL; Houlahan, KE; Shiah, YJ; Beer, TM; Thomas, G; Chi, KN; Gleave, M; Zoubeidi, A; Reiter, RE; Rettig, MB; Witte, O; Kim, MY; Fong, L; Spratt, DE; Morgan, TM; Bose, R; Huang, FW; Li, H; Chesner, L; Shenoy, T; Goodarzi, H; Asangani, IA; Sandhu, S; Lang, JM; Mahajan, NP; Lara, PN; Evans, CP; Febbo, P; Batzoglou, S; Knudsen, KE; He, HSH; Huang, JT; Zwart, W; Costello, JF; Luo, JH; Tomlins, SA; Wyatt, AW; Dehm, SM; Ashworth, A; Gilbert, LA; Boutros, PC; Farh, K; Chinnaiyan, AM; Maher, CA; Small, EJ; Quigley, DA; Feng, FY				Zhao, Shuang G.; Chen, William S.; Li, Haolong; Foye, Adam; Zhang, Meng; Sjostrom, Martin; Aggarwal, Rahul; Playdle, Denise; Liao, Arnold; Alumkal, Joshi J.; Das, Rajdeep; Chou, Jonathan; Hua, Junjie T.; Barnard, Travis J.; Bailey, Adina M.; Chow, Eric D.; Perry, Marc D.; Dang, Ha X.; Yang, Rendong; Moussavi-Baygi, Ruhollah; Zhang, Li; Alshalalfa, Mohammed; Chang, S. Laura; Houlahan, Kathleen E.; Shiah, Yu-Jia; Beer, Tomasz M.; Thomas, George; Chi, Kim N.; Gleave, Martin; Zoubeidi, Amina; Reiter, Robert E.; Rettig, Matthew B.; Witte, Owen; Kim, M. Yvonne; Fong, Lawrence; Spratt, Daniel E.; Morgan, Todd M.; Bose, Rohit; Huang, Franklin W.; Li, Hui; Chesner, Lisa; Shenoy, Tanushree; Goodarzi, Hani; Asangani, Irfan A.; Sandhu, Shahneen; Lang, Joshua M.; Mahajan, Nupam P.; Lara, Primo N.; Evans, Christopher P.; Febbo, Phillip; Batzoglou, Serafim; Knudsen, Karen E.; He, Housheng H.; Huang, Jiaoti; Zwart, Wilbert; Costello, Joseph F.; Luo, Jianhua; Tomlins, Scott A.; Wyatt, Alexander W.; Dehm, Scott M.; Ashworth, Alan; Gilbert, Luke A.; Boutros, Paul C.; Farh, Kyle; Chinnaiyan, Arul M.; Maher, Christopher A.; Small, Eric J.; Quigley, David A.; Feng, Felix Y.			The DNA methylation landscape of advanced prostate cancer	NATURE GENETICS			English	Article							CPG ISLAND HYPERMETHYLATION; TET2 MUTATIONS; ANDROGEN RECEPTOR; TRANSCRIPTION FACTORS; EPIGENOMIC ANALYSIS; CLONAL EVOLUTION; GENE; GENOME; DNMT3A; HYPOMETHYLATION	Although DNA methylation is a key regulator of gene expression, the comprehensive methylation landscape of metastatic cancer has never been defined. Through whole-genome bisulfite sequencing paired with deep whole-genome and transcriptome sequencing of 100 castration-resistant prostate metastases, we discovered alterations affecting driver genes that were detectable only with integrated whole-genome approaches. Notably, we observed that 22% of tumors exhibited a novel epigenomic subtype associated with hypermethylation and somatic mutations inTET2,DNMT3B,IDH1andBRAF. We also identified intergenic regions where methylation is associated with RNA expression of the oncogenic driver genesAR,MYCandERG. Finally, we showed that differential methylation during progression preferentially occurs at somatic mutational hotspots and putative regulatory regions. This study is a large integrated study of whole-genome, whole-methylome and whole-transcriptome sequencing in metastatic cancer that provides a comprehensive overview of the important regulatory role of methylation in metastatic castration-resistant prostate cancer. Whole-genome bisulfite sequencing along with whole-genome and transcriptome sequencing of 100 prostate cancer metastases identifies genomic regions that are differentially methylated during disease progression and a novel epigenomic subtype.	[Zhao, Shuang G.; Spratt, Daniel E.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Zhao, Shuang G.; Morgan, Todd M.; Chinnaiyan, Arul M.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Zhao, Shuang G.; Chen, William S.; Li, Haolong; Zhang, Meng; Sjostrom, Martin; Das, Rajdeep; Chou, Jonathan; Barnard, Travis J.; Perry, Marc D.; Moussavi-Baygi, Ruhollah; Alshalalfa, Mohammed; Chang, S. Laura; Li, Hui; Chesner, Lisa; Feng, Felix Y.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Zhao, Shuang G.; Chen, William S.; Li, Haolong; Foye, Adam; Zhang, Meng; Sjostrom, Martin; Aggarwal, Rahul; Playdle, Denise; Das, Rajdeep; Chou, Jonathan; Barnard, Travis J.; Bailey, Adina M.; Perry, Marc D.; Moussavi-Baygi, Ruhollah; Zhang, Li; Fong, Lawrence; Bose, Rohit; Huang, Franklin W.; Li, Hui; Chesner, Lisa; Shenoy, Tanushree; Ashworth, Alan; Gilbert, Luke A.; Small, Eric J.; Quigley, David A.; Feng, Felix Y.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Morgan, Todd M.; Tomlins, Scott A.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Chen, William S.] Yale Sch Med, New Haven, CT USA; [Foye, Adam; Aggarwal, Rahul; Playdle, Denise; Chou, Jonathan; Bailey, Adina M.; Perry, Marc D.; Zhang, Li; Fong, Lawrence; Bose, Rohit; Huang, Franklin W.; Shenoy, Tanushree; Ashworth, Alan; Small, Eric J.; Feng, Felix Y.] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Liao, Arnold; Febbo, Phillip; Batzoglou, Serafim; Farh, Kyle] Illumina Inc, San Diego, CA USA; [Alumkal, Joshi J.; Beer, Tomasz M.; Thomas, George] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Alumkal, Joshi J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Hua, Junjie T.; He, Housheng H.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Chow, Eric D.; Goodarzi, Hani] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Chow, Eric D.] Univ Calif San Francisco, Ctr Adv Technol, San Francisco, CA 94143 USA; [Dang, Ha X.; Maher, Christopher A.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA; [Dang, Ha X.; Maher, Christopher A.] Washington Univ, Dept Internal Med, St Louis, MO 63110 USA; [Dang, Ha X.; Mahajan, Nupam P.; Maher, Christopher A.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Yang, Rendong] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Houlahan, Kathleen E.; Shiah, Yu-Jia] Ontario Inst Canc Res, Toronto, ON, Canada; [Houlahan, Kathleen E.; He, Housheng H.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Houlahan, Kathleen E.; Boutros, Paul C.] Univ Calif Los Angeles, Inst Precis Hlth, Dept Human Genet, Los Angeles, CA USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol Med Oncol, Portland, OR 97201 USA; [Thomas, George] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Chi, Kim N.; Gleave, Martin; Zoubeidi, Amina; Wyatt, Alexander W.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada; [Chi, Kim N.] British Columbia Canc Agcy, Vancouver Ctr, Vancouver, BC, Canada; [Reiter, Robert E.; Rettig, Matthew B.; Boutros, Paul C.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med & Urol, Los Angeles, CA 90024 USA; [Rettig, Matthew B.] VA Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA; [Witte, Owen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kim, M. Yvonne; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Morgan, Todd M.; Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Bose, Rohit; Goodarzi, Hani; Gilbert, Luke A.; Quigley, David A.; Feng, Felix Y.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Bose, Rohit] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Asangani, Irfan A.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Sandhu, Shahneen] Univ Melbourne, Peter MacCallum Canc Ctr, Victoria, Australia; [Lang, Joshua M.] Univ Wisconsin, Dept Med, Madison, WI USA; [Mahajan, Nupam P.] Washington Univ, Dept Surg, St Louis, MO 63110 USA; [Lara, Primo N.] Univ Calif Davis, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Lara, Primo N.; Evans, Christopher P.] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Evans, Christopher P.] Univ Calif Davis, Dept Urol Surg, Sacramento, CA 95817 USA; [Knudsen, Karen E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Huang, Jiaoti] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Zwart, Wilbert] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands; [Luo, Jianhua] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Dehm, Scott M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Med Sch, Ann Arbor, MI 48109 USA; [Maher, Christopher A.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Quigley, David A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Michigan System; University of Michigan; Yale University; University of California System; University of California San Francisco; Illumina; Oregon Health & Science University; Oregon Health & Science University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); University of Minnesota System; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of California System; University of California Los Angeles; Oregon Health & Science University; Oregon Health & Science University; University of British Columbia; British Columbia Cancer Agency; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Peter Maccallum Cancer Center; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Jefferson University; Duke University; Netherlands Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Washington University (WUSTL); University of California System; University of California San Francisco	Feng, FY (corresponding author), Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA.; Feng, FY (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Feng, FY (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	Felix.Feng@ucsf.edu	Hua, Junjie Tony/AAH-2163-2021; Das, Rajdeep/ABB-3238-2021; zhao, shuangling/HCI-6255-2022; Luo, jian/HGE-7331-2022; Das, Rajdeep/AAN-7566-2021	Das, Rajdeep/0000-0002-1041-4931; Morgan, Todd/0000-0002-1140-0603; Sjostrom, Martin/0000-0002-2629-9966; Goodarzi, Hani/0000-0002-9648-8949; Bose, Rohit/0000-0002-6785-0697; Thomas, George V/0000-0001-7416-8840; Sandhu, Shahneen/0000-0002-8660-4475; Zhang, Li/0000-0002-3617-2627; Perry, Marc/0000-0001-6476-2942	Stand Up To Cancer-Prostate Cancer Foundation Prostate Cancer Dream Team Award [SU2C-AACR-DT0812]; Movember Foundation; Prostate Cancer Foundation Young Investigator Awards; Prostate Cancer Foundation Challenge Awards; UCSF Benioff Initiative for Prostate Cancer Research award; National Institutes of Health (NIH)/National Cancer Institute (NCI) [1R01CA230516-01]; NIH/NCI [1R01CA227025, P30CA016042]; Prostate Cancer Foundation (PCF) [17CHAL06]; NIH [P50CA186786, R35CA231996, U01CA214170]; BRCA Foundation Young Investigator Award; Swedish Research Council (Vetenskapsradet) [2018-00382]; Swedish Society of Medicine (Svenska Lakaresallskapet); Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology; National Cancer Institute Early Detection Research Network [1U01CA214194-01];  [K99/R00 CA204602];  [DP2 CA239597]	Stand Up To Cancer-Prostate Cancer Foundation Prostate Cancer Dream Team Award; Movember Foundation; Prostate Cancer Foundation Young Investigator Awards; Prostate Cancer Foundation Challenge Awards; UCSF Benioff Initiative for Prostate Cancer Research award; National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation (PCF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRCA Foundation Young Investigator Award; Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Society of Medicine (Svenska Lakaresallskapet); Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology; National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	We thank the patients who selflessly contributed samples to this study and without whom this research would not have been possible. We would also like to acknowledge the assistance of Steven Kronenberg and Barbara Panning. This research was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Cancer Dream Team Award (SU2C-AACR-DT0812 to E.J.S.) and by the Movember Foundation. Stand Up To Cancer is a division of the Entertainment Industry Foundation. This research grant was administered by the American Association for Cancer Research, the scientific partner of SU2C. S.G.Z., D.A.Q., Hui Li, R.A., J.T.H., R.B. and R.Y. were funded by Prostate Cancer Foundation Young Investigator Awards. F.Y.F. was funded by Prostate Cancer Foundation Challenge Awards. Additional funding was provided by a UCSF Benioff Initiative for Prostate Cancer Research award. F.Y.F. and A.A. were supported by National Institutes of Health (NIH)/National Cancer Institute (NCI) 1R01CA230516-01. F.Y.F. and N.M. were supported by NIH/NCI 1R01CA227025 and Prostate Cancer Foundation (PCF) 17CHAL06. F.Y.F. and A.M.C. were supported by NIH P50CA186786. A.M.C. is supported by NIH R35CA231996 and U01CA214170. D.A.Q. was funded by a BRCA Foundation Young Investigator Award. M.S. was supported by the Swedish Research Council (Vetenskapsradet) with grant number 2018-00382 and the Swedish Society of Medicine (Svenska Lakaresallskapet). L.A.G. was supported by K99/R00 CA204602 and DP2 CA239597, as well as the Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology. P.C.B. was supported by the NIH/NCI under award number P30CA016042 and by an operating grant from the National Cancer Institute Early Detection Research Network (1U01CA214194-01).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Aggarwal RR, 2019, MOL CANCER RES, V17, P1235, DOI 10.1158/1541-7786.MCR-18-1101; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Bhasin JM, 2015, CELL REP, V13, P2135, DOI 10.1016/j.celrep.2015.10.078; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Boormans JL, 2013, INT J CANCER, V133, P335, DOI 10.1002/ijc.28025; Brinkman AB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09828-0; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Buscarlet M, 2017, BLOOD, V130, P753, DOI 10.1182/blood-2017-04-777029; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Faraway J, 2014, J LINEAR MODELS R; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gerhauser C, 2018, CANCER CELL, V34, P996, DOI 10.1016/j.ccell.2018.10.016; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Goldman M, 2015, NUCLEIC ACIDS RES, V43, pD812, DOI 10.1093/nar/gku1073; Hama N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03999-y; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Itzykson R, 2011, LEUKEMIA, V25, P1147, DOI 10.1038/leu.2011.71; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Klughammer J, 2018, NAT MED, V24, P1611, DOI 10.1038/s41591-018-0156-x; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kretzmer H, 2015, NAT GENET, V47, P1316, DOI 10.1038/ng.3413; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/B978-0-12-380866-0.60002-2, 10.1016/S0065-2660(10)70002-X]; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Li YY, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1390-8; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Massie CE, 2017, J STEROID BIOCHEM, V166, P1, DOI 10.1016/j.jsbmb.2016.04.009; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pacis A, 2019, P NATL ACAD SCI USA, V116, P6938, DOI 10.1073/pnas.1814700116; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Prensner JR, 2014, LANCET ONCOL, V15, P1469, DOI 10.1016/S1470-2045(14)71113-1; Qian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037225; Queiros AC, 2016, CANCER CELL, V30, P806, DOI 10.1016/j.ccell.2016.09.014; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Rasmussen KD, 2015, GENE DEV, V29, P910, DOI 10.1101/gad.260174.115; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roller E, 2016, BIOINFORMATICS, V32, P2375, DOI 10.1093/bioinformatics/btw163; Saghafinia S, 2018, CELL REP, V25, P1066, DOI 10.1016/j.celrep.2018.09.082; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Skvortsova K, 2019, CANCER CELL, V35, P297, DOI 10.1016/j.ccell.2019.01.004; Spencer DH, 2017, CELL, V168, P801, DOI 10.1016/j.cell.2017.01.021; Stelloo S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07270-2; Sun W, 2018, NUCLEIC ACIDS RES, V46, P3009, DOI 10.1093/nar/gky131; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; Teschendorff AE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10478; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; White NM, 2017, EUR UROL, V71, P257, DOI 10.1016/j.eururo.2016.07.012; Wong TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02858-0; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu JC, 2001, CANCER RES, V61, P1563; Yamazaki J, 2015, CANCER RES, V75, P2833, DOI 10.1158/0008-5472.CAN-14-0739; Yamazaki J, 2012, EPIGENETICS-US, V7, P201, DOI 10.4161/epi.7.2.19015; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu YP, 2013, AM J PATHOL, V183, P1960, DOI 10.1016/j.ajpath.2013.08.018; Zhang ZZ, 2019, GENOME RES, V29, P223, DOI 10.1101/gr.230243.117; Zhao SG, 2019, JNCI-J NATL CANCER I, V111, P301, DOI 10.1093/jnci/djy141; Zhao SG, 2017, JAMA ONCOL, V3, P1663, DOI 10.1001/jamaoncol.2017.0751; Zhou WD, 2018, NAT GENET, V50, P591, DOI 10.1038/s41588-018-0073-4	107	90	92	5	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2020	52	8					778	+		10.1038/s41588-020-0648-8	http://dx.doi.org/10.1038/s41588-020-0648-8		JUL 2020	14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV1BD	32661416	Green Accepted, Green Published			2022-12-17	WOS:000549723500001
J	Abakir, A; Giles, TC; Cristini, A; Foster, JM; Dai, N; Starczak, M; Rubio-Roldan, A; Li, MM; Eleftheriou, M; Crutchley, J; Flatt, L; Young, L; Gaffney, DJ; Denning, C; Dalhus, B; Emes, RD; Gackowski, D; Correa, IR; Garcia-Perez, JL; Klungland, A; Gromak, N; Ruzov, A				Abakir, Abdulkadir; Giles, Tom C.; Cristini, Agnese; Foster, Jeremy M.; Dai, Nan; Starczak, Marta; Rubio-Roldan, Alejandro; Li, Miaomiao; Eleftheriou, Maria; Crutchley, James; Flatt, Luke; Young, Lorraine; Gaffney, Daniel J.; Denning, Chris; Dalhus, Bjorn; Emes, Richard D.; Gackowski, Daniel; Correa, Ivan R., Jr.; Garcia-Perez, Jose L.; Klungland, Arne; Gromak, Natalia; Ruzov, Alexey			N-6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells	NATURE GENETICS			English	Article							R-LOOPS; DNA METHYLATION; REVEALS; REPLICATION; ACCURATE; SITES; WIDE	R-loops are nucleic acid structures formed by an RNA:DNA hybrid and unpaired single-stranded DNA that represent a source of genomic instability in mammalian cells(1-4). Here we show that N-6-methyladenosine (m(6)A) modification, contributing to different aspects of messenger RNA metabolism(5,6), is detectable on the majority of RNA:DNA hybrids in human pluripotent stem cells. We demonstrate that m(6)A-containing R-loops accumulate during G(2)/M and are depleted at G(0)/G(1) phases of the cell cycle, and that the m(6)A reader promoting mRNA degradation, YTHDF2 (ref. (7)), interacts with R-loop-enriched loci in dividing cells. Consequently, YTHDF2 knockout leads to increased R-loop levels, cell growth retardation and accumulation of gamma H2AX, a marker for DNA double-strand breaks, in mammalian cells. Our results suggest that m(6)A regulates accumulation of R-loops, implying a role for this modification in safeguarding genomic stability. N-6-methyladenosine (m(6)A) is prevalent at RNA:DNA hybrids in human pluripotent stem cells. The m(6)A reader YTHDF2 interacts with R-loop-enriched loci in dividing cells, and YTHDF2 loss leads to increased R-loop levels and accumulation of gamma H2AX.	[Abakir, Abdulkadir; Eleftheriou, Maria; Crutchley, James; Flatt, Luke; Young, Lorraine; Denning, Chris; Ruzov, Alexey] Univ Nottingham, Dept Stem Cell Biol, Nottingham, England; [Giles, Tom C.; Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Loughborough, England; [Giles, Tom C.] Univ Nottingham, Digital Res Serv, Loughborough, England; [Cristini, Agnese; Gromak, Natalia] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Foster, Jeremy M.; Dai, Nan; Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA USA; [Starczak, Marta; Gackowski, Daniel] Nicolaus Copernicus Univ Torun, Dept Clin Biochem, Bydgoszcz, Poland; [Rubio-Roldan, Alejandro; Garcia-Perez, Jose L.] Univ Granada, GENYO, Andalusian Reg Govt, Ctr Genom & Oncol Res Pfizer, Granada, Spain; [Li, Miaomiao; Dalhus, Bjorn; Klungland, Arne] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Li, Miaomiao; Klungland, Arne] Univ Oslo, Dept Mol Med, Oslo, Norway; [Gaffney, Daniel J.] Wellcome Sanger Inst, Cambridge, England; [Dalhus, Bjorn] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England; [Garcia-Perez, Jose L.] Univ Edinburgh, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Nottingham; University of Nottingham; University of Nottingham; University of Oxford; New England Biolabs; Nicolaus Copernicus University; Pfizer; University of Granada; University of Oslo; University of Oslo; Wellcome Trust Sanger Institute; University of Oslo; University of Nottingham; University of Edinburgh	Ruzov, A (corresponding author), Univ Nottingham, Dept Stem Cell Biol, Nottingham, England.; Gromak, N (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.; Klungland, A (corresponding author), Oslo Univ Hosp, Dept Microbiol, Oslo, Norway.; Klungland, A (corresponding author), Univ Oslo, Dept Mol Med, Oslo, Norway.	arne.klungland@medisin.uio.no; natalia.gromak@path.ox.ac.uk; alexey.ruzov@nottingham.ac.uk	Starczak, Marta/P-4773-2019; Dalhus, Bjørn/AAK-2895-2020; Rubio-Roldan, Alejandro/ADN-4329-2022; Center, Norwegian Transgenic/T-2512-2018; Ruzov, Alexey/AAF-3669-2020; Gackowski, Daniel/G-5693-2012	Starczak, Marta/0000-0003-4098-7412; Ruzov, Alexey/0000-0002-1247-6634; Gackowski, Daniel/0000-0002-7259-1511; Abakir, Abdulkadir H/0000-0001-5043-5529; Cristini, Agnese/0000-0003-0235-8770; Rubio Roldan, Alejandro/0000-0002-6775-4013; Gromak, Natalia/0000-0002-4158-3586; FOSTER, JEREMY/0000-0001-5107-6513; Young, Lorraine/0000-0001-5450-5723	BBSRC [BB/M012336/1, BB/N005759/1, BB/L013827/1] Funding Source: UKRI; MRC [MR/J007870/1, 1792340, MR/M017354/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abakir A, 2016, JOVE-J VIS EXP, DOI 10.3791/54416; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; [Anonymous], 2017, JOVE J VIS EXP SEP, DOI DOI 10.3791/56318; [Anonymous], 2015, 2015 5 INT C ELCT; [Anonymous], 2006, METH MOL B; [Anonymous], 2017, NAT COMMUN, DOI DOI 10.1038/S41467-017-00338-5; Benitez-Guijarro M, 2018, EMBO J, V37, DOI 10.15252/embj.201798506; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chang VY, 2013, PEDIATR BLOOD CANCER, V60, P570, DOI 10.1002/pbc.24316; Chedin F, 2016, TRENDS GENET, V32, P828, DOI 10.1016/j.tig.2016.10.002; Cristini A, 2018, CELL REP, V23, P1891, DOI 10.1016/j.celrep.2018.04.025; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Gackowski D, 2016, ANAL CHEM, V88, P12128, DOI 10.1021/acs.analchem.6b02900; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hamperl S, 2017, CELL, V170, P774, DOI 10.1016/j.cell.2017.07.043; Jachowicz JW, 2017, NAT GENET, V49, P1502, DOI 10.1038/ng.3945; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Liu JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13052; Lu WT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02893-x; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Mita P, 2018, ELIFE, V7, DOI 10.7554/eLife.30058; Mondo SJ, 2017, NAT GENET, V49, P964, DOI 10.1038/ng.3859; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; RIEDER CL, 1992, J CELL SCI, V102, P387; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Salas-Armenteros I, 2017, EMBO J, V36, P3532, DOI 10.15252/embj.201797208; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wheldon LM, 2014, CELL REP, V7, P1353, DOI 10.1016/j.celrep.2014.05.003; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	90	91	5	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2020	52	1					48	+		10.1038/s41588-019-0549-x	http://dx.doi.org/10.1038/s41588-019-0549-x			28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KH7IB	31844323	Green Accepted, Green Submitted			2022-12-17	WOS:000510822700010
J	Lindeboom, RGH; Vermeulen, M; Lehner, B; Supek, F				Lindeboom, Rik G. H.; Vermeulen, Michiel; Lehner, Ben; Supek, Fran			The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy	NATURE GENETICS			English	Article							RARE VARIANTS; MUTATIONS; THERAPY; INHIBITION; REVEALS; EXON; IDENTIFICATION; PHENOTYPES; INDUCTION; BLOCKADE	Premature termination codons (PTCs) can result in the production of truncated proteins or the degradation of messenger RNAs by nonsense-mediated mRNA decay (NMD). Which of these outcomes occurs can alter the effect of a mutation, with the engagement of NMD being dependent on a series of rules. Here, by applying these rules genome-wide to obtain a resource called NMDetective, we explore the impact of NMD on genetic disease and approaches to therapy. First, human genetic diseases differ in whether NMD typically aggravates or alleviates the effects of PTCs. Second, failure to trigger NMD is a cause of ineffective gene inactivation by CRISPR-Cas9 gene editing. Finally, NMD is a determinant of the efficacy of cancer immunotherapy, with only frameshifted transcripts that escape NMD predicting a response. These results demonstrate the importance of incorporating the rules of NMD into clinical decision-making. Moreover, they suggest that inhibiting NMD may be effective in enhancing cancer immunotherapy.	[Lindeboom, Rik G. H.; Vermeulen, Michiel] Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Oncode Inst,Dept Mol Biol, Nijmegen, Netherlands; [Lehner, Ben] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Syst Biol Program, Barcelona, Spain; [Lehner, Ben] Univ Pompeu Fabra, Barcelona, Spain; [Lehner, Ben; Supek, Fran] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Supek, Fran] Barcelona Inst Sci & Technol, Inst Recerca Biomed Barcelona, Barcelona, Spain	Radboud University Nijmegen; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Lehner, B (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat, Syst Biol Program, Barcelona, Spain.; Lehner, B (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Lehner, B; Supek, F (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain.; Supek, F (corresponding author), Barcelona Inst Sci & Technol, Inst Recerca Biomed Barcelona, Barcelona, Spain.	ben.lehner@crg.eu; fran.supek@irbbarcelona.org	Lehner, Ben/ABH-6562-2020; Vermeulen, Michiel/C-8883-2013; Supek, Fran/B-2359-2012; Lehner, Ben/L-3413-2014	Lehner, Ben/0000-0002-8817-1124; Vermeulen, Michiel/0000-0003-0836-6894; Supek, Fran/0000-0002-7811-6711; Lehner, Ben/0000-0002-8817-1124; Lindeboom, Rik/0000-0002-3660-504X	ERC Starting Grant HYPER-INSIGHT [757700]; ERC Consolidator Grant IR-DC [616434]; Oncode Institute - Dutch Cancer Society; Netherlands Organization for Scientific Research; Severo Ochoa Centres of Excellence programme; Spanish Ministry of Economy and Competitiveness [BFU2017-89488-P, BFU2017-89833-P]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2017 SGR 1322]; CERCA Program/Generalitat de Catalunya; Spanish Ministry of Economy, Industry and Competitiveness; Bettencourt Schueller Foundation; ICREA Research Professor programme	ERC Starting Grant HYPER-INSIGHT; ERC Consolidator Grant IR-DC; Oncode Institute - Dutch Cancer Society; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Severo Ochoa Centres of Excellence programme; Spanish Ministry of Economy and Competitiveness(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); CERCA Program/Generalitat de Catalunya(General Electric); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Bettencourt Schueller Foundation; ICREA Research Professor programme	This work was funded by the ERC Starting Grant HYPER-INSIGHT (757700, to F.S.) and the ERC Consolidator Grant IR-DC (616434, to B.L.). R.G.H.L. and M.V. are supported by the Oncode Institute, which is partly funded by the Dutch Cancer Society. M.V. also acknowledges support by the gravitation program Cancer GenomiCs.nl from the Netherlands Organization for Scientific Research. F.S. and B.L. are funded by the ICREA Research Professor programme. F.S. and B.L. acknowledge support of the Severo Ochoa Centres of Excellence programme to the IRB Barcelona and to the CRG, respectively. B.L. and F.S. were supported by the Spanish Ministry of Economy and Competitiveness (grant no. BFU2017-89488-P and BFU2017-89833-P, respectively). B.L. was further supported by the Bettencourt Schueller Foundation, Agencia de Gestio d'Ajuts Universitaris i de Recerca (no. 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. B.L. also acknowledges the support of the Spanish Ministry of Economy, Industry and Competitiveness to the EMBL partnership.	Allen F, 2019, NAT BIOTECHNOL, V37, P64, DOI 10.1038/nbt.4317; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balasubramanian S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00443-5; Banning A, 2018, BBA-MOL BASIS DIS, V1864, P668, DOI 10.1016/j.bbadis.2017.12.014; Bokhari A, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0079-x; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Coban-Akdemir Z, 2018, AM J HUM GENET, V103, P171, DOI 10.1016/j.ajhg.2018.06.009; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; HALL GW, 1994, BLOOD, V83, P2031; Hargadon KM, 2018, INT IMMUNOPHARMACOL, V62, P29, DOI 10.1016/j.intimp.2018.06.001; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hoek TA, 2019, MOL CELL, V75, P324, DOI 10.1016/j.molcel.2019.05.008; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15943; Huang LL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1386-9; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F., 2016, SINGLE CELL BIOL, V5; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Maher MC, 2012, HUM HERED, V74, P118, DOI 10.1159/000346826; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Spinner NB, 2001, HUM MUTAT, V17, P18, DOI 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	63	90	91	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2019	51	11					1645	+		10.1038/s41588-019-0517-5	http://dx.doi.org/10.1038/s41588-019-0517-5			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JK2ZE	31659324	Green Accepted			2022-12-17	WOS:000494714300013
J	Satizabal, CL; Adams, HHH; Hibar, DP; White, CC; Knol, MJ; Stein, JL; Scholz, M; Sargurupremraj, M; Jahanshad, N; Roshchupkin, GV; Smith, AV; Bis, JC; Jian, XQ; Luciano, M; Hofer, E; Teumer, A; van der Lee, SJ; Yang, JY; Yanek, LR; Lee, TV; Li, S; Hu, YH; Koh, JY; Eicher, JD; Desrivieres, S; Arias-Vasquez, A; Chauhan, G; Athanasiu, L; Rentera, ME; Kim, S; Hoehn, D; Armstrong, NJ; Chen, Q; Holmes, AJ; den Braber, A; Kloszewska, I; Andersson, M; Espeseth, T; Grimm, O; Abramovic, L; Alhusaini, S; Milaneschi, Y; Papmeyer, M; Axelsson, T; Ehrlich, S; Roiz-Santianez, R; Kraemer, B; Haberg, AK; Jones, HJ; Pike, GB; Stein, DJ; Stevens, A; Bralten, J; Vernooij, MW; Harris, TB; Filippi, I; Witte, AV; Guadalupe, T; Wittfeld, K; Mosley, TH; Becker, JT; Doan, NT; Hagenaars, SP; Saba, Y; Cuellar-Partida, G; Amin, N; Hilal, S; Nho, K; Mirza-Schreiber, N; Arfanakis, K; Becker, DM; Ames, D; Goldman, AL; Lee, PH; Boomsma, DI; Lovestone, S; Giddaluru, S; Le Hellard, S; Mattheisen, M; Bohlken, MM; Kasperaviciute, D; Schmaal, L; Lawrie, SM; Agartz, I; Walton, E; Tordesillas-Gutierrez, D; Davies, GE; Shin, J; Ipser, JC; Vinke, LN; Hoogman, M; Jia, TY; Burkhardt, R; Klein, M; Crivello, F; Janowitz, D; Carmichael, O; Haukvik, UK; Aribisala, BS; Schmidt, H; Strike, LT; Cheng, CY; Risacher, SL; Putz, B; Fleischman, DA; Assareh, AA; Mattay, VS; Buckner, RL; Mecocci, P; Dale, AM; Cichon, S; Boks, MP; Matarin, M; Penninx, BWJH; Calhoun, VD; Chakravarty, MM; Marquand, AF; Macare, C; Masouleh, SK; Oosterlaan, J; Amouyel, P; Hegenscheid, K; Rotter, JI; Schork, AJ; Liewald, DCM; de Zubicaray, GI; Wong, TY; Shen, L; Samann, PG; Brodaty, H; Roffman, JL; de Geus, EJC; Tsolaki, M; Erk, S; van Eijk, KR; Cavalleri, GL; van der Wee, NJA; McIntosh, AM; Gollub, RL; Bulayeva, KB; Bernard, M; Richards, JS; Himali, JJ; Loeffler, M; Rommelse, N; Hoffmann, W; Westlye, LT; Hernandez, MCV; Hansell, NK; van Erp, TGM; Wolf, C; Kwok, JBJ; Vellas, B; Heinz, A; Loohuis, LMO; Delanty, N; Ho, BC; Ching, CRK; Shumskaya, E; Singh, B; Hofman, A; van der Meer, D; Homuth, G; Psaty, BM; Bastin, ME; Montgomery, GW; Foroud, TM; Reppermund, S; Hottenga, JJ; Simmons, A; Meyer-Lindenberg, A; Cahn, W; Whelan, CD; van Donkelaar, MMJ; Yang, Q; Hosten, N; Green, RC; Thalamuthu, A; Mohnke, S; Pol, HEH; Lin, HH; Jack, CR; Schofield, PR; Muhleisen, TW; Maillard, P; Potkin, SG; Wen, W; Fletcher, E; Toga, AW; Gruber, O; Huentelman, M; Smith, GD; Launer, LJ; Nyberg, L; Jonsson, EG; Crespo-Facorro, B; Koen, N; Greve, DN; Uitterlinden, AG; Weinberger, DR; Steen, VM; Fedko, IO; Groenewold, NA; Niessen, WJ; Toro, R; Tzourio, C; Longstreth, WT; Ikram, MK; Smoller, JW; van Tol, MJ; Sussmann, JE; Paus, T; Lemaitre, H; Schroeter, ML; Mazoyer, B; Andreassen, OA; Holsboer, F; Depondt, C; Veltman, DJ; Turner, JA; Pausova, Z; Schumann, G; van Rooij, D; Djurovic, S; Deary, IJ; McMahon, KL; Muller-Myhsok, B; Brouwer, RM; Soininen, H; Pandolfo, M; Wassink, TH; Cheung, JW; Wolfers, T; Martinot, JL; Zwiers, MP; Nauck, M; Melle, I; Martin, NG; Kanai, R; Westman, E; Kahn, RS; Sisodiya, SM; White, T; Saremi, A; van Bokhoven, H; Brunner, HG; Volzke, H; Wright, MJ; van't Ent, D; Nothen, MM; Ophoff, RA; Buitelaar, JK; Fernandez, G; Sachdev, PS; Rietschel, M; van Haren, NEM; Fisher, SE; Beiser, AS; Francks, C; Saykin, AJ; Mather, KA; Romanczuk-Seiferth, N; Hartman, CA; DeStefano, AL; Heslenfeld, DJ; Weiner, MW; Walter, H; Hoekstra, PJ; Nyquist, PA; Franke, B; Bennett, DA; Grabe, HJ; Johnson, AD; Chen, C; van Duijn, CM; Lopez, OL; Fornage, M; Wardlaw, JM; Schmidt, R; DeCarli, C; De Jager, PL; Villringer, A; Debette, S; Gudnason, V; Medland, SE; Shulman, JM; Thompson, PM; Seshadri, S; Ikram, MA				Satizabal, Claudia L.; Adams, Hieab H. H.; Hibar, Derrek P.; White, Charles C.; Knol, Maria J.; Stein, Jason L.; Scholz, Markus; Sargurupremraj, Muralidharan; Jahanshad, Neda; Roshchupkin, Gennady, V; Smith, Albert, V; Bis, Joshua C.; Jian, Xueqiu; Luciano, Michelle; Hofer, Edith; Teumer, Alexander; van der Lee, Sven J.; Yang, Jingyun; Yanek, Lisa R.; Lee, Tom, V; Li, Shuo; Hu, Yanhui; Koh, Jia Yu; Eicher, John D.; Desrivieres, Sylvane; Arias-Vasquez, Alejandro; Chauhan, Ganesh; Athanasiu, Lavinia; Rentera, Miguel E.; Kim, Sungeun; Hoehn, David; Armstrong, Nicola J.; Chen, Qiang; Holmes, Avram J.; den Braber, Anouk; Kloszewska, Iwona; Andersson, Micael; Espeseth, Thomas; Grimm, Oliver; Abramovic, Lucija; Alhusaini, Saud; Milaneschi, Yuri; Papmeyer, Martina; Axelsson, Tomas; Ehrlich, Stefan; Roiz-Santianez, Roberto; Kraemer, Bernd; Haberg, Asta K.; Jones, Hannah J.; Pike, G. Bruce; Stein, Dan J.; Stevens, Allison; Bralten, Janita; Vernooij, Meike W.; Harris, Tamara B.; Filippi, Irina; Witte, A. Veronica; Guadalupe, Tulio; Wittfeld, Katharina; Mosley, Thomas H.; Becker, James T.; Nhat Trung Doan; Hagenaars, Saskia P.; Saba, Yasaman; Cuellar-Partida, Gabriel; Amin, Najaf; Hilal, Saima; Nho, Kwangsik; Mirza-Schreiber, Nazanin; Arfanakis, Konstantinos; Becker, Diane M.; Ames, David; Goldman, Aaron L.; Lee, Phil H.; Boomsma, Dorret, I; Lovestone, Simon; Giddaluru, Sudheer; Le Hellard, Stephanie; Mattheisen, Manuel; Bohlken, Marc M.; Kasperaviciute, Dalia; Schmaal, Lianne; Lawrie, Stephen M.; Agartz, Ingrid; Walton, Esther; Tordesillas-Gutierrez, Diana; Davies, Gareth E.; Shin, Jean; Ipser, Jonathan C.; Vinke, Louis N.; Hoogman, Martine; Jia, Tianye; Burkhardt, Ralph; Klein, Marieke; Crivello, Fabrice; Janowitz, Deborah; Carmichael, Owen; Haukvik, Unn K.; Aribisala, Benjamin S.; Schmidt, Helena; Strike, Lachlan T.; Cheng, Ching-Yu; Risacher, Shannon L.; Puetz, Benno; Fleischman, Debra A.; Assareh, Amelia A.; Mattay, Venkata S.; Buckner, Randy L.; Mecocci, Patrizia; Dale, Anders M.; Cichon, Sven; Boks, Marco P.; Matarin, Mar; Penninx, Brenda W. J. H.; Calhoun, Vince D.; Chakravarty, M. Mallar; Marquand, Andre F.; Macare, Christine; Masouleh, Shahrzad Kharabian; Oosterlaan, Jaap; Amouyel, Philippe; Hegenscheid, Katrin; Rotter, Jerome, I; Schork, Andrew J.; Liewald, David C. M.; de Zubicaray, Greig, I; Wong, Tien Yin; Shen, Li; Saemann, Philipp G.; Brodaty, Henry; Roffman, Joshua L.; de Geus, Eco J. C.; Tsolaki, Magda; Erk, Susanne; van Eijk, Kristel R.; Cavalleri, Gianpiero L.; van der Wee, Nic J. A.; McIntosh, Andrew M.; Gollub, Randy L.; Bulayeva, Kazima B.; Bernard, Manon; Richards, Jennifer S.; Himali, Jayandra J.; Loeffler, Markus; Rommelse, Nanda; Hoffmann, Wolfgang; Westlye, Lars T.; Hernandez, Maria C. Valdes; Hansell, Narelle K.; van Erp, Theo G. M.; Wolf, Christiane; Kwok, John B. J.; Vellas, Bruno; Heinz, Andreas; Loohuis, Loes M. Olde; Delanty, Norman; Ho, Beng-Choon; Ching, Christopher R. K.; Shumskaya, Elena; Singh, Baljeet; Hofman, Albert; van der Meer, Dennis; Homuth, Georg; Psaty, Bruce M.; Bastin, Mark E.; Montgomery, Grant W.; Foroud, Tatiana M.; Reppermund, Simone; Hottenga, Jouke-Jan; Simmons, Andrew; Meyer-Lindenberg, Andreas; Cahn, Wiepke; Whelan, Christopher D.; van Donkelaar, Marjolein M. J.; Yang, Qiong; Hosten, Norbert; Green, Robert C.; Thalamuthu, Anbupalam; Mohnke, Sebastian; Pol, Hilleke E. Hulshoff; Lin, Honghuang; Jack, Clifford R., Jr.; Schofield, Peter R.; Muehleisen, Thomas W.; Maillard, Pauline; Potkin, Steven G.; Wen, Wei; Fletcher, Evan; Toga, Arthur W.; Gruber, Oliver; Huentelman, Matthew; Smith, George Davey; Launer, Lenore J.; Nyberg, Lars; Jonsson, Erik G.; Crespo-Facorro, Benedicto; Koen, Nastassja; Greve, Douglas N.; Uitterlinden, Andre G.; Weinberger, Daniel R.; Steen, Vidar M.; Fedko, Iryna O.; Groenewold, Nynke A.; Niessen, Wiro J.; Toro, Roberto; Tzourio, Christophe; Longstreth, William T., Jr.; Ikram, M. Kamran; Smoller, Jordan W.; van Tol, Marie-Jose; Sussmann, Jessika E.; Paus, Tomas; Lemaitre, Herve; Schroeter, Matthias L.; Mazoyer, Bernard; Andreassen, Ole A.; Holsboer, Florian; Depondt, Chantal; Veltman, Dick J.; Turner, Jessica A.; Pausova, Zdenka; Schumann, Gunter; van Rooij, Daan; Djurovic, Srdjan; Deary, Ian J.; McMahon, Katie L.; Mueller-Myhsok, Bertram; Brouwer, Rachel M.; Soininen, Hilkka; Pandolfo, Massimo; Wassink, Thomas H.; Cheung, Joshua W.; Wolfers, Thomas; Martinot, Jean-Luc; Zwiers, Marcel P.; Nauck, Matthias; Melle, Ingrid; Martin, Nicholas G.; Kanai, Ryota; Westman, Eric; Kahn, Rene S.; Sisodiya, Sanjay M.; White, Tonya; Saremi, Arvin; van Bokhoven, Hans; Brunner, Han G.; Voelzke, Henry; Wright, Margaret J.; van't Ent, Dennis; Noethen, Markus M.; Ophoff, Roel A.; Buitelaar, Jan K.; Fernandez, Guilln; Sachdev, Perminder S.; Rietschel, Marcella; van Haren, Neeltje E. M.; Fisher, Simon E.; Beiser, Alexa S.; Francks, Clyde; Saykin, Andrew J.; Mather, Karen A.; Romanczuk-Seiferth, Nina; Hartman, Catharina A.; DeStefano, Anita L.; Heslenfeld, Dirk J.; Weiner, Michael W.; Walter, Henrik; Hoekstra, Pieter J.; Nyquist, Paul A.; Franke, Barbara; Bennett, David A.; Grabe, Hans J.; Johnson, Andrew D.; Chen, Christopher; van Duijn, Cornelia M.; Lopez, Oscar L.; Fornage, Myriam; Wardlaw, Joanna M.; Schmidt, Reinhold; DeCarli, Charles; De Jager, Philip L.; Villringer, Arno; Debette, Stephanie; Gudnason, Vilmundur; Medland, Sarah E.; Shulman, Joshua M.; Thompson, Paul M.; Seshadri, Sudha; Ikram, M. Arfan			Genetic architecture of subcortical brain structures in 38,851 individuals	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; BASAL GANGLIA; ALKALINE-PHOSPHATASE; ALZHEIMERS-DISEASE; PLASMA-PROTEIN; RISK LOCI; DROSOPHILA; METAANALYSIS; EXPRESSION	Subcortical brain structures are integral to motion, consciousness, emotions and learning. We identified common genetic variation related to the volumes of the nucleus accumbens, amygdala, brainstem, caudate nucleus, globus pallidus, putamen and thalamus, using genome-wide association analyses in almost 40,000 individuals from CHARGE, ENIGMA and UK Biobank. We show that variability in subcortical volumes is heritable, and identify 48 significantly associated loci (40 novel at the time of analysis). Annotation of these loci by utilizing gene expression, methylation and neuropathological data identified 199 genes putatively implicated in neurodevelopment, synaptic signaling, axonal transport, apoptosis, inflammation/infection and susceptibility to neurological disorders. This set of genes is significantly enriched for Drosophila orthologs associated with neurodevelopmental phenotypes, suggesting evolutionarily conserved mechanisms. Our findings uncover novel biology and potential drug targets underlying brain development and disease.	[Satizabal, Claudia L.] UT Hlth San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA; [Satizabal, Claudia L.] UT Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX 78229 USA; [Satizabal, Claudia L.; Himali, Jayandra J.; Lin, Honghuang; Beiser, Alexa S.; DeStefano, Anita L.; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Satizabal, Claudia L.; Himali, Jayandra J.; Beiser, Alexa S.; Debette, Stephanie; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Adams, Hieab H. H.; Knol, Maria J.; Roshchupkin, Gennady, V; van der Lee, Sven J.; Vernooij, Meike W.; Amin, Najaf; Hofman, Albert; Uitterlinden, Andre G.; Ikram, M. Kamran; van Duijn, Cornelia M.; Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Adams, Hieab H. H.; Roshchupkin, Gennady, V; Vernooij, Meike W.; Niessen, Wiro J.; White, Tonya; Ikram, M. Arfan] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Adams, Hieab H. H.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Hibar, Derrek P.; Stein, Jason L.; Jahanshad, Neda; Ching, Christopher R. K.; Whelan, Christopher D.; Cheung, Joshua W.; Saremi, Arvin; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, USC Mark & Mary Stevens Neuroimaging & Informat I, Imaging Genet Ctr, Los Angeles, CA USA; [White, Charles C.; De Jager, Philip L.] Broad Inst, Cell Circuits Program, Cambridge, MA USA; [White, Charles C.; De Jager, Philip L.] Columbia Univ, Dept Neurol, Med Ctr, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [Stein, Jason L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Stein, Jason L.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Scholz, Markus; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Scholz, Markus; Burkhardt, Ralph; Loeffler, Markus; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Sargurupremraj, Muralidharan; Chauhan, Ganesh; Debette, Stephanie] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, Team Vintage, INSERM,UMR 1219, Bordeaux, France; [Roshchupkin, Gennady, V; Niessen, Wiro J.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Smith, Albert, V] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Smith, Albert, V; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Smith, Albert, V; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Jian, Xueqiu; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Luciano, Michelle; Hagenaars, Saskia P.; Liewald, David C. M.; McIntosh, Andrew M.; Deary, Ian J.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Dept Psychol, Edinburgh, Midlothian, Scotland; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Teumer, Alexander; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Yang, Jingyun; Arfanakis, Konstantinos; Fleischman, Debra A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Yang, Jingyun; Fleischman, Debra A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Yanek, Lisa R.; Becker, Diane M.; Nyquist, Paul A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Lee, Tom, V; Shulman, Joshua M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Li, Shuo; Himali, Jayandra J.; Yang, Qiong; Beiser, Alexa S.; DeStefano, Anita L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hu, Yanhui] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Koh, Jia Yu; Cheng, Ching-Yu; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Eicher, John D.; Johnson, Andrew D.] NHLBI, Div Intramural Res, Populat Sci Branch, Framingham, MA USA; [Desrivieres, Sylvane; Jia, Tianye; Macare, Christine; Schumann, Gunter] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Arias-Vasquez, Alejandro; Richards, Jennifer S.; van Rooij, Daan; Buitelaar, Jan K.; Fernandez, Guilln] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Hoogman, Martine; Klein, Marieke; Shumskaya, Elena; van Donkelaar, Marjolein M. J.; Wolfers, Thomas; van Bokhoven, Hans; Brunner, Han G.; Franke, Barbara] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Rommelse, Nanda; Franke, Barbara] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Hoogman, Martine; Klein, Marieke; Marquand, Andre F.; Rommelse, Nanda; Shumskaya, Elena; van Donkelaar, Marjolein M. J.; van Rooij, Daan; Wolfers, Thomas; Zwiers, Marcel P.; van Bokhoven, Hans; Brunner, Han G.; Buitelaar, Jan K.; Fisher, Simon E.; Francks, Clyde; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Chauhan, Ganesh; Richards, Jennifer S.; Fernandez, Guilln] Indian Inst Sci, Ctr Brain Res, Bangalore, Karnataka, India; [Athanasiu, Lavinia; Espeseth, Thomas; Haukvik, Unn K.; Westlye, Lars T.; van der Meer, Dennis; Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, CoE NORMENT, Oslo, Norway; [Athanasiu, Lavinia; Nhat Trung Doan; Agartz, Ingrid; Westlye, Lars T.; van der Meer, Dennis; Jonsson, Erik G.; Andreassen, Ole A.; Melle, Ingrid] Univ Oslo, Inst Clin Med, CoE NORMENT, Oslo, Norway; [Rentera, Miguel E.] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Kim, Sungeun; Nho, Kwangsik] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [Hoehn, David; Mirza-Schreiber, Nazanin; Puetz, Benno; Saemann, Philipp G.; Holsboer, Florian; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Munich, Germany; [Armstrong, Nicola J.] Murdoch Univ, Math & Stat, Perth, WA, Australia; [Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT USA; [Holmes, Avram J.; Ehrlich, Stefan; Lee, Phil H.; Buckner, Randy L.; Roffman, Joshua L.; Gollub, Randy L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [den Braber, Anouk; Boomsma, Dorret, I; de Geus, Eco J. C.; Hottenga, Jouke-Jan; Fedko, Iryna O.; van't Ent, Dennis] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [den Braber, Anouk; Boomsma, Dorret, I; de Geus, Eco J. C.; Hottenga, Jouke-Jan; Fedko, Iryna O.; van't Ent, Dennis] Vrije Univ, Netherlands Twin Register, Amsterdam, Netherlands; [den Braber, Anouk; Boomsma, Dorret, I; de Geus, Eco J. C.; Hottenga, Jouke-Jan; van't Ent, Dennis] Amsterdam Neurosci, Amsterdam, Netherlands; [den Braber, Anouk] Vrije Univ Amsterdam, Dept Neurol, Amsterdam UMC, Amsterdam Neurosci,Alzheimer Ctr Amsterdam, Amsterdam, Netherlands; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Andersson, Micael; Nyberg, Lars] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Andersson, Micael; Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging UFBI, Umea, Sweden; [Espeseth, Thomas] Univ Oslo, Dept Psychol, Oslo, Norway; [Grimm, Oliver; Meyer-Lindenberg, Andreas; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Abramovic, Lucija; Bohlken, Marc M.; Boks, Marco P.; Cahn, Wiepke; Pol, Hilleke E. Hulshoff; Brouwer, Rachel M.; Kahn, Rene S.; van Haren, Neeltje E. M.] Univ Utrecht, Univ Med Ctr Utrecht, UMC Brain Ctr, Dept Psychiat, Utrecht, Netherlands; [Alhusaini, Saud; Delanty, Norman; Whelan, Christopher D.] Royal Coll Surgeons Ireland, Dublin, Ireland; [Alhusaini, Saud] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Milaneschi, Yuri; Penninx, Brenda W. J. H.; Veltman, Dick J.] Vrije Univ Amsterdam, Dept Psychiat, Amsterdam Neurosci, Med Ctr, Amsterdam, Netherlands; [Papmeyer, Martina; Lawrie, Stephen M.; McIntosh, Andrew M.; Sussmann, Jessika E.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Papmeyer, Martina] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Syst Neurosci Psychopathol, Bern, Switzerland; [Axelsson, Tomas] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Ehrlich, Stefan; Walton, Esther] Tech Univ Dresden, Div Psychol & Social Med & Dev Neurosci, Fac Med, Dresden, Germany; [Ehrlich, Stefan; Stevens, Allison; Gollub, Randy L.; Greve, Douglas N.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Roiz-Santianez, Roberto] Univ Cantabria IDIVAL, Univ Hosp Marques de Valdecilla, Sch Med, Dept Psychiat, Santander, Spain; [Roiz-Santianez, Roberto; Crespo-Facorro, Benedicto] Univ Cantabria IDIVAL, Univ Hosp Marques de Valdecilla, Sch Med, Dept Med, Santander, Spain; [Roiz-Santianez, Roberto; Tordesillas-Gutierrez, Diana; Crespo-Facorro, Benedicto] Ctr Invest Biomed Red Salud Mental, Santander, Spain; [Kraemer, Bernd; Gruber, Oliver] Heidelberg Univ, Dept Gen Psychiat, Sect Expt Psychopathol & Neuroimaging, Heidelberg, Germany; [Haberg, Asta K.] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol, Trondheim, Norway; [Jones, Hannah J.] Univ Bristol, Ctr Acad Mental Hlth, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Jones, Hannah J.; Smith, George Davey] Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Jones, Hannah J.] Univ Hosp Bristol NHS Fdn Trust, NIHR Bristol Biomed Res Ctr, Bristol, Avon, England; [Jones, Hannah J.] Univ Bristol, Bristol, Avon, England; [Pike, G. Bruce] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Pike, G. Bruce] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Stein, Dan J.; Ipser, Jonathan C.; Koen, Nastassja; Groenewold, Nynke A.] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Stein, Dan J.; Koen, Nastassja] South African Med Res Council, Unit Risk & Resilience Mental Disorders, Cape Town, South Africa; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Filippi, Irina; Lemaitre, Herve; Martinot, Jean-Luc] Paris Saclay Univ, INSERM, Res Unit Neuroimaging & Psychiat 1000, Gif Sur Yvette, France; [Filippi, Irina; Lemaitre, Herve; Martinot, Jean-Luc] Paris Descartes Univ, DIGITEO Labs, Gif Sur Yvette, France; [Witte, A. Veronica; Masouleh, Shahrzad Kharabian; Schroeter, Matthias L.; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Witte, A. Veronica; Villringer, Arno] Univ Leipzig, Fac Med, CRC Obes Mech 1052, Leipzig, Germany; [Guadalupe, Tulio] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Guadalupe, Tulio; Fisher, Simon E.; Francks, Clyde] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Wittfeld, Katharina; Janowitz, Deborah; Grabe, Hans J.] Univ Med Greifswald, Dept Psychiat, Greifswald, Germany; [Wittfeld, Katharina; Hoffmann, Wolfgang; Grabe, Hans J.] German Ctr Neurodegenerat Dis, Greifswald, Germany; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Becker, James T.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Becker, James T.; Lopez, Oscar L.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Becker, James T.; Lopez, Oscar L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Res Unit Genet Epidemiol, Graz, Austria; [Cuellar-Partida, Gabriel; Strike, Lachlan T.; Hansell, Narelle K.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Hilal, Saima; Chen, Christopher] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore; [Hilal, Saima; Chen, Christopher] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Mirza-Schreiber, Nazanin] German Res Ctr Environm Hlth, Inst Neurogen, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Arfanakis, Konstantinos] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Arfanakis, Konstantinos] Rush Univ, Med Ctr, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic, Australia; [Lee, Phil H.; Gollub, Randy L.; Green, Robert C.; Smoller, Jordan W.] Harvard Med Sch, Boston, MA 02115 USA; [Lee, Phil H.] Harvard Med Sch, Lurie Ctr Autism, Massachusetts Gen Hosp, Lexington, MA USA; [Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Genom Med, Boston, MA 02114 USA; [Lee, Phil H.; Smoller, Jordan W.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Boston, MA USA; [Boomsma, Dorret, I; de Geus, Eco J. C.; Hottenga, Jouke-Jan; Fedko, Iryna O.; van't Ent, Dennis] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Lovestone, Simon] Univ Oxford, Dept Psychiat, Oxford, England; [Lovestone, Simon] Kings Coll London, NIHR Dementia Biomed Res Unit, London, England; [Giddaluru, Sudheer; Le Hellard, Stephanie; Steen, Vidar M.; Djurovic, Srdjan] Univ Bergen, Dept Clin Sci, NORMENT, Bergen, Norway; [Giddaluru, Sudheer; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway; [Mattheisen, Manuel] Aarhus Univ, Ctr Integrated Sequencing, Aarhus, Denmark; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel] Lundbeck Fdn Initiat Integrat Psychiat Res iPSYCH, Aarhus, Denmark; [Mattheisen, Manuel; Agartz, Ingrid; Jonsson, Erik G.] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Mattheisen, Manuel] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Kasperaviciute, Dalia; Matarin, Mar; Sisodiya, Sanjay M.] UCL Queen Sq Inst Neurol, London, England; [Kasperaviciute, Dalia; Sisodiya, Sanjay M.] Chalfont Ctr Epilepsy, Gerrards Cross, Bucks, England; [Schmaal, Lianne] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Schmaal, Lianne] Orygen, Natl Ctr Excellence Youth Mental Hlth, Melbourne, Vic, Australia; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Res & Dev, Oslo, Norway; [Walton, Esther] Univ Bath, Dept Psychol, Bath, Avon, England; [Tordesillas-Gutierrez, Diana] Valdecilla Biomed Res Inst IDIVAL, Neuroimaging Unit, Technol Facil, Santander, Spain; [Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD USA; [Shin, Jean; Bernard, Manon; Pausova, Zdenka] Univ Toronto, Lospital Sick Children, Toronto, ON, Canada; [Vinke, Louis N.] Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA; [Burkhardt, Ralph] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany; [Crivello, Fabrice; Mazoyer, Bernard] Univ Bordeaux, Neurodegeneratives Dis Inst, CNRS UMR 5293, Bordeaux, France; [Carmichael, Owen] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Haukvik, Unn K.] Univ Oslo, Inst Clin Med, Dept Adult Psychiat, Oslo, Norway; [Aribisala, Benjamin S.; Hernandez, Maria C. Valdes; Bastin, Mark E.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Aribisala, Benjamin S.] Lagos State Univ, Dept Comp Sci, Ojo, Nigeria; [Strike, Lachlan T.; Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Cheng, Ching-Yu] Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program Eye ACP, Singapore, Singapore; [Fleischman, Debra A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Assareh, Amelia A.; Brodaty, Henry; Reppermund, Simone; Thalamuthu, Anbupalam; Wen, Wei; Sachdev, Perminder S.; Mather, Karen A.] Univ New South Wales, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia; [Mattay, Venkata S.; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Buckner, Randy L.] Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA; [Mecocci, Patrizia] Univ Perugia, Dept Med, Sect Gerontol & Geriatr, Perugia, Italy; [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, Basel, Switzerland; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Muehleisen, Thomas W.] Res Ctr Julich, Inst Neurosci & Med Struct & Funct Org Brain INM, Julich, Germany; [Matarin, Mar] UCL Inst Neurol, Reta Lila Weston Inst, London, England; [Matarin, Mar] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA; [Calhoun, Vince D.; Turner, Jessica A.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vince D.; Turner, Jessica A.] LBERI, Albuquerque, NM USA; [Calhoun, Vince D.; Turner, Jessica A.] Georgia State Univ, Triinst Ctr Translat Res Neuroimaging & Data Sci, Atlanta, GA 30303 USA; [Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Marquand, Andre F.; Shumskaya, Elena; Zwiers, Marcel P.] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Masouleh, Shahrzad Kharabian] Res Ctr Julich, Inst Neurosci & Med Brain & Behav INM 7, Julich, Germany; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Oosterlaan, Jaap] Univ Amsterdam, Amsterdam UMC, Amsterdam Reprod & Dev, Emma Neurosci Grp,Dept Pediat,Emma Childrens Hosp, Amsterdam, Netherlands; [Amouyel, Philippe] Univ Lille, RID AGE Risk Factors & Mol Determinants Aging Rel, LabEx DISTALZ U1167, Lille, France; [Amouyel, Philippe] Inserm U1167, Lille, France; [Amouyel, Philippe] Ctr Hosp Univ Lille, Lille, France; [Amouyel, Philippe] Inst Pasteur, Lille, France; [Hegenscheid, Katrin; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Rotter, Jerome, I] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst & Pediat, Torrance, CA 90509 USA; [Schork, Andrew J.] Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark; [Schork, Andrew J.; Huentelman, Matthew] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [de Zubicaray, Greig, I; McMahon, Katie L.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia; [de Zubicaray, Greig, I; McMahon, Katie L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Wong, Tien Yin] Duke NUS Med Sch, Acad Med Res Inst, Singapore, Singapore; [Shen, Li] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Brodaty, Henry] UNSW, Dementia Ctr Res Collaborat, Sydney, NSW, Australia; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Ahepa Univ Hosp, Dept Neurol 1, Thessaloniki, Greece; [Erk, Susanne; Mohnke, Sebastian; Walter, Henrik] Freie Univ Berliepartment Psychiat & Psychotherap, Div Mind & Brain Res D, Berlin, Germany; [Erk, Susanne; Mohnke, Sebastian; Walter, Henrik] Charite Univ Med Berlin, Berlin, Germany; [Erk, Susanne; Mohnke, Sebastian; Walter, Henrik] Humboldt Univ, Berlin, Germany; [Erk, Susanne; Mohnke, Sebastian; Walter, Henrik] Berlin Inst Hlth, Berlin, Germany; [van Eijk, Kristel R.] UMC Utrecht, Human Neurogenet Unit, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin, Ireland; [van der Wee, Nic J. A.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [van der Wee, Nic J. A.] Leiden Univ, Leiden Inst Brain & Cognit, Med Ctr, Leiden, Netherlands; [Bulayeva, Kazima B.] Dagestan State Univ, Dept Evolut & Genet, Makhachkala, Russia; [Richards, Jennifer S.; van Rooij, Daan; Hartman, Catharina A.; Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Hoffmann, Wolfgang] Univ Med Greifswald, Inst Community Med, Sect Epidemiol Hlth Care & Community Hlth, Greifswald, Germany; [Hernandez, Maria C. Valdes; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [van Erp, Theo G. M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Clin Translat Neurosci Lab, Irvine, CA 92717 USA; [van Erp, Theo G. M.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Wolf, Christiane] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Kwok, John B. J.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Kwok, John B. J.; Schofield, Peter R.; Mather, Karen A.] Neurosci Res Australia, Sydney, NSW, Australia; [Kwok, John B. J.] Univ New South Wales, Sydney, NSW, Australia; [Vellas, Bruno] Univ Toulouse, Dept Internal Med, INSERM U1027, Toulouse, France; [Vellas, Bruno] Univ Toulouse, Dept Geriatr Med, INSERM U1027, Toulouse, France; [Heinz, Andreas; Romanczuk-Seiferth, Nina] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany; [Loohuis, Loes M. Olde; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Delanty, Norman] Beaumont Hosp, Neurol Div, Dublin, Ireland; [Ho, Beng-Choon; Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Ching, Christopher R. K.] UCLA, Sch Med, Interdept Neurosci Grad Program, Los Angeles, CA USA; [Singh, Baljeet; Maillard, Pauline; Fletcher, Evan] Univ Calif Davis, Dept Neurol, Imaging Dementia & Aging Lab, Davis, CA 95616 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van der Meer, Dennis] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Psaty, Bruce M.] Kaiser Permanent Washington Hlth Res Inst, Seattle, WA USA; [Psaty, Bruce M.; Longstreth, William T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Med & Mol Genet, Indianapolis, IN 46202 USA; [Reppermund, Simone] UNSW Med, Dept Dev Disabil Neuropsychiat, Sch Psychiat, Sydney, NSW, Australia; [Simmons, Andrew] Kings Coll London, Biomed Res Unit Dementia, London, England; [Simmons, Andrew] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London, England; [Simmons, Andrew] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Schofield, Peter R.] UNSW, Sch Med Sci, Sydney, NSW, Australia; [Muehleisen, Thomas W.] Univ Basel, Dept Biomed, Basel, Switzerland; [Muehleisen, Thomas W.] Heinrich Heine Univ Dusseldorf, Cecile & Oskar Vogt Inst Brain Res, Dusseldorf, Germany; [Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Toga, Arthur W.] Univ Southern Calif, Keck Sch Med, USC Mark & Mary Stevens Neuroimaging & Informat I, Lab Neuro Imaging, Los Angeles, CA USA; [Nyberg, Lars] Umea Univ, Radiat Sci, Umea, Sweden; [Greve, Douglas N.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Inst Genet Med, Sch Med, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Niessen, Wiro J.] Delft Univ Technol, Fac Appl Sci, Imaging Phys, Delft, Netherlands; [Toro, Roberto] Inst Pasteur, Paris, France; [Tzourio, Christophe; Debette, Stephanie] CHU Bordeaux, Dept Neurol, Bordeaux, France; [Longstreth, William T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Ikram, M. Kamran] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [van Tol, Marie-Jose] Univ Groningen, Univ Med Ctr Groningen, Cognit Neurosci Ctr, Groningen, Netherlands; [Paus, Tomas] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Schroeter, Matthias L.] Univ Clin Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Holsboer, Florian] HMNC Brain Hlth, Munich, Germany; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Bruxelles, Dept Neurol, Hop Erasme, Brussels, Belgium; [Turner, Jessica A.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Neuroctr Neurol, Kuopio, Finland; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Nauck, Matthias; Voelzke, Henry] German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Kanai, Ryota] Araya, Dept Neuroinformat, Tokyo, Japan; [Kanai, Ryota] UCL, Inst Cognit Neurosci, London, England; [Kanai, Ryota] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Kahn, Rene S.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [White, Tonya; van Haren, Neeltje E. M.] Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Brunner, Han G.] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands; [Brunner, Han G.] GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Ophoff, Roel A.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia; [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Weiner, Michael W.] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco VA Med Ctr, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [van Duijn, Cornelia M.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Wardlaw, Joanna M.] Univ Edinburgh, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Dept Neurol, Sacramento, CA 95817 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shulman, Joshua M.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Framingham Heart Study; Boston University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern California; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Leipzig University; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Iceland; Icelandic Heart Association; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Edinburgh; Medical University of Graz; Medical University of Graz; Greifswald Medical School; Rush University; Rush University; Johns Hopkins University; Baylor College of Medicine; Boston University; Harvard University; Harvard Medical School; National University of Singapore; Singapore National Eye Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Indian Institute of Science (IISC) - Bangalore; University of Oslo; University of Oslo; QIMR Berghofer Medical Research Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Max Planck Society; Murdoch University; Yale University; Harvard University; Massachusetts General Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Medical University Lodz; Umea University; Umea University; University of Oslo; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; Royal College of Surgeons - Ireland; Yale University; Vrije Universiteit Amsterdam; Royal Infirmary of Edinburgh; University of Edinburgh; University of Bern; University Hospital of Bern; Uppsala University; Technische Universitat Dresden; Harvard University; Massachusetts General Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Ruprecht Karls University Heidelberg; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Calgary; University of Calgary; University of Cape Town; South African Medical Research Council; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; Leipzig University; Max Planck Society; Max Planck Society; Greifswald Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz; QIMR Berghofer Medical Research Institute; National University of Singapore; National University of Singapore; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Illinois Institute of Technology; Rush University; University of Melbourne; National Ageing Research Institute; Royal Melbourne Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oxford; University of London; King's College London; University of Bergen; University of Bergen; Haukeland University Hospital; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Karolinska Institutet; Stockholm County Council; University of London; University College London; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; Diakonhjemmet Hospital; University of Bath; Hospital Universitario Marques de Valdecilla (HUMV); University of Toronto; Boston University; University of Regensburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Oslo; University of Edinburgh; Lagos State University; University of Queensland; National University of Singapore; Rush University; University of New South Wales Sydney; Johns Hopkins University; Johns Hopkins University; Harvard University; University of Perugia; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Basel; University of Bonn; Helmholtz Association; Research Center Julich; University of London; University College London; University of London; University College London; University of New Mexico; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; University System of Georgia; Georgia State University; McGill University; McGill University; Radboud University Nijmegen; Helmholtz Association; Research Center Julich; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Greifswald Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Translational Genomics Research Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); National University of Singapore; University of Pennsylvania; University of New South Wales Sydney; Aristotle University of Thessaloniki; Ahepa University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Berlin Institute of Health; Utrecht University; Utrecht University Medical Center; Royal College of Surgeons - Ireland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Dagestan State University; University of Groningen; Radboud University Nijmegen; Greifswald Medical School; University of Edinburgh; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Wurzburg; University of Sydney; Neuroscience Research Australia; University of New South Wales Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health; Maastricht University; Greifswald Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Queensland; Indiana University System; Indiana University Bloomington; University of London; King's College London; University of London; King's College London; Karolinska Institutet; Harvard University; Brigham & Women's Hospital; Boston University; Mayo Clinic; University of New South Wales Sydney; University of Basel; Heinrich Heine University Dusseldorf; University of California System; University of California Irvine; University of Southern California; Umea University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Delft University of Technology; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Bordeaux; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; University of Toronto; Leipzig University; Universite Libre de Bruxelles; University System of Georgia; Georgia State University; University of Oslo; University of Munich; University of Liverpool; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Greifswald Medical School; German Centre for Cardiovascular Research; University of London; University College London; University of Sussex; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University; University of Queensland; University of Bonn; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Leiden University; Leiden University - Excl LUMC; University of Texas System; University of Texas Health Science Center Houston; University of Edinburgh; University of California System; University of California Davis; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Satizabal, CL (corresponding author), UT Hlth San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA.; Satizabal, CL (corresponding author), UT Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX 78229 USA.; Satizabal, CL (corresponding author), Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA.; Satizabal, CL (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Ikram, MA (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Ikram, MA (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands.	satizabal@uthscsa.edu; m.a.ikram@erasmusmc.nl	de Zubicaray, Greig/ABC-8955-2021; Hilal, Saima/D-6028-2016; Pike, Bruce/K-5562-2014; Boomsma, Dorret I/AAX-4470-2020; Mirza-Schreiber, Nazanin/AAD-1563-2022; Witte, A. Veronica/L-7765-2017; Mecocci, Patrizia/W-2116-2019; Rotter, Jerome/AAY-6598-2021; chen, qiang/GWZ-7308-2022; Romanczuk-Seiferth, Nina/AFN-0829-2022; DeCarli, Charles/B-5541-2009; Wardlaw, Joanna M/Y-3456-2019; Crivello, Fabrice/ABB-4531-2021; Lawrie, Stephen MacGregor/AAD-1607-2021; Maillard, Pauline/N-7600-2018; Hansell, Narelle K/A-4553-2016; Davey Smith, George/A-7407-2013; van Rooij, Daan/AAC-3526-2020; Westman, Eric/H-5771-2011; Sachdev, Perminder/ABC-1137-2020; Hernandez, María/GYU-3543-2022; Calhoun, Vince D./ACN-9399-2022; /ABD-6198-2020; Matarin, Mar/F-1771-2016; Shen, Li/AAB-6870-2021; Rentería, Miguel E./M-6671-2017; Medland, Sarah/AAT-7595-2020; van der Meer, Dennis/H-6663-2019; Strike, Lachlan T/R-3902-2018; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Francks, Clyde/AGU-8875-2022; Tzourio, christophe/B-4015-2009; Heinz, Andreas/ABB-7736-2020; Jack, Clifford R/F-2508-2010; Chen, Christopher/E-7023-2013; Sargurupremraj, Muralidharan/AHA-7680-2022; CHAUHAN, GANESH/AAI-5110-2021; Andreassen, Ole A./AAY-7531-2020; Francks, Clyde/E-1384-2012; Jia, Tianye/AAC-3925-2019; Armstrong, Nicola J./AAF-3045-2021; Walton, Esther/GSN-8429-2022; Bokhoven, J.H.L.M. van van/H-8015-2014; Mirza-Schreiber, Nazanin/AAD-1558-2022; Lemaitre, Herve/ABB-5427-2020; Wright, Margaret Jane/A-4560-2016; Ikram, M. Arfan/AAM-5225-2021; Risacher, Shannon/AAI-2141-2019; Turner, Jessica A/H-7282-2015; Wittfeld, Katharina/AFB-1549-2022; Vernooij, Meike Willemijn/E-4061-2016; Walton, Esther/P-9832-2019; Franke, Barbara/D-4836-2009; Arfanakis, Konstantinos/AAN-3148-2021; Stein, Dan/A-1752-2008; McIntosh, Andrew M/B-9379-2008; Wong, Tien Yin/AAC-9724-2020; Carmichael, Owen/N-1955-2017; Fisher, Simon E./E-9130-2012; Adams, Hieab/GLN-6421-2022; Ehrlich, Stefan/ABB-4650-2020; Johnson, Andrew D/G-6520-2013; van Haren, Neeltje/AAC-7656-2020; Bralten, Janita/AAB-9566-2019; Hoogman, Martine/G-8958-2015; Romanczuk-Seiferth, Nina/AFN-7029-2022; Hulshoff Pol, Hilleke Evertje/B-4795-2014; chen, qiang/HGU-5418-2022; Wolfers, Thomas/ABF-1461-2020; White, Tonya/AAU-2226-2021; Jahanshad, Neda/ABD-5944-2021; Buitelaar, J.K./AAY-7522-2020; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Yang, Jingyun/D-5361-2009; Desrivières, Sylvane/ABC-4336-2021; Cheng, Ching-Yu/Y-2229-2019; Zwiers, Marcel P/D-2968-2009; Walter, Henrik/O-2612-2013; Knol, Maria/AAP-9725-2020; Mattheisen, Manuel/S-3725-2019; Smith, Albert Vernon/AHC-3838-2022; Teumer, Alexander/S-7438-2019; Ho, Beng-Choon/D-6959-2011; Gruber, Oliver/AAY-5563-2020; de Geus, Eco/M-9318-2015; Gudnason, Vilmundur/K-6885-2015; debette, stephanie/T-4946-2019; Penninx, Brenda WJH/S-7627-2017	de Zubicaray, Greig/0000-0003-4506-0579; Hilal, Saima/0000-0001-5434-5635; Pike, Bruce/0000-0001-8924-683X; Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Mecocci, Patrizia/0000-0003-0729-5246; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Wardlaw, Joanna M/0000-0002-9812-6642; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Maillard, Pauline/0000-0003-3516-6345; Hansell, Narelle K/0000-0002-8229-9741; Davey Smith, George/0000-0002-1407-8314; Westman, Eric/0000-0002-3115-2977; Sachdev, Perminder/0000-0002-9595-3220; Calhoun, Vince D./0000-0001-9058-0747; Matarin, Mar/0000-0002-4717-5735; Rentería, Miguel E./0000-0003-4626-7248; Medland, Sarah/0000-0003-1382-380X; van der Meer, Dennis/0000-0002-0466-386X; Strike, Lachlan T/0000-0003-2885-5898; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Tzourio, christophe/0000-0002-6517-2984; Heinz, Andreas/0000-0001-5405-9065; Jack, Clifford R/0000-0001-7916-622X; Chen, Christopher/0000-0002-1047-9225; Francks, Clyde/0000-0002-9098-890X; Jia, Tianye/0000-0001-5399-2953; Armstrong, Nicola J./0000-0002-4477-293X; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Lemaitre, Herve/0000-0002-5952-076X; Wright, Margaret Jane/0000-0001-7133-4970; Turner, Jessica A/0000-0003-0076-8434; Wittfeld, Katharina/0000-0003-4383-5043; Walton, Esther/0000-0002-0935-2200; Franke, Barbara/0000-0003-4375-6572; Arfanakis, Konstantinos/0000-0001-9705-597X; Stein, Dan/0000-0001-7218-7810; McIntosh, Andrew M/0000-0002-0198-4588; Wong, Tien Yin/0000-0002-8448-1264; Fisher, Simon E./0000-0002-3132-1996; Ehrlich, Stefan/0000-0003-2132-4445; Johnson, Andrew D/0000-0001-6369-5178; van Haren, Neeltje/0000-0002-3090-7653; Bralten, Janita/0000-0003-1440-8675; Hoogman, Martine/0000-0002-1261-7628; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Wolfers, Thomas/0000-0002-7693-0621; White, Tonya/0000-0003-0271-1896; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Yang, Jingyun/0000-0002-3495-3710; Desrivières, Sylvane/0000-0002-9120-7060; Cheng, Ching-Yu/0000-0003-0655-885X; Zwiers, Marcel P/0000-0001-5483-2935; Knol, Maria/0000-0002-3597-1531; Mattheisen, Manuel/0000-0002-8442-493X; Smith, Albert Vernon/0000-0003-1942-5845; Teumer, Alexander/0000-0002-8309-094X; Ho, Beng-Choon/0000-0003-3976-1555; Carmichael, Owen/0000-0002-0576-0047; Westlye, Lars T./0000-0001-8644-956X; Cavalleri, Gianpiero/0000-0002-9802-0506; Hagenaars, Saskia/0000-0001-9697-8596; Jonsson, Erik/0000-0001-8368-6332; de Geus, Eco/0000-0001-6022-2666; Van Duijn, Cornelia/0000-0002-2374-9204; Chauhan, Ganesh/0000-0002-8564-5021; Vernooij, Meike/0000-0003-4658-2176; Ikram, Mohammad Arfan/0000-0003-0372-8585; Gudnason, Vilmundur/0000-0001-5696-0084; Groenewold, Nynke A./0000-0002-0865-8427; Fedko, Iryna/0000-0003-1962-916X; Seshadri, Sudha/0000-0001-6135-2622; Tsolaki, Magda/0000-0002-2072-8010; debette, stephanie/0000-0001-8675-7968; Thalamuthu, Anbupalam/0000-0002-7114-1260; den Braber, A./0000-0002-3377-2627; Mather, Karen Anne/0000-0003-4143-8941; Burkhardt, Ralph/0000-0003-1924-1202; /0000-0003-1391-9481; Walter, Henrik/0000-0002-9403-6121; Gollub, Randy L./0000-0002-9434-4044; Risacher, Shannon/0000-0002-3304-7943; Grimm, Oliver/0000-0002-0767-0301; Satizabal, Claudia L/0000-0002-1115-4430; van 't Ent, Dennis/0000-0003-2001-1375; Wen, Wei/0000-0003-2753-3870; Erk, Susanne/0000-0003-0961-3543; Villringer, Arno/0000-0003-2604-2404; Whelan, Christopher/0000-0003-0308-5583; Adams, Hieab/0000-0003-3687-2508; Wassink, Thomas/0000-0002-0952-8333; Penninx, Brenda WJH/0000-0001-7779-9672	Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Medical Research Council [MR/M013111/1, G1001245, MC_PC_17228, MR/S015132/1, MR/N027558/1, MC_UU_00011/1, MC_QA137853] Funding Source: Medline; NCATS NIH HHS [UL1 TR000153] Funding Source: Medline; NHLBI NIH HHS [R01 HL120393, R01 HL105756, U01 HL120393, U01 HL130114] Funding Source: Medline; NIA NIH HHS [T32 AG058507, R01 AG054076, U01 AG052409, P30 AG010129, P30 AG010161, R01 AG017917, R03 AG054936, R01 AG015819, U01 AG049505] Funding Source: Medline; NIGMS NIH HHS [U54 GM104940] Funding Source: Medline; NIMH NIH HHS [R00 MH101367, R01 MH119243] Funding Source: Medline; NINDS NIH HHS [UH3 NS100605, R01 NS087541] Funding Source: Medline; RCUK | MRC | Medical Research Foundation [MC_UU_00011/1] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Center for Research Resources (NCRR) [C06RR029965] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH) [K99MH102357, R01MH117601, R01MH111671, K99MH116115] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) [R01AG059874] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111671, K99MH116115, R01MH117601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG054936, U01AG052409, T32AG058507, R01AG017917, R01AG015819, R01AG059874] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012535] Funding Source: NIH RePORTER; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_UU_00011/1, G1001245, MR/S015132/1, MR/N027558/1, MR/M013111/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); RCUK | MRC | Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. Department of Health &amp; Human Services | NIH | National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH); U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abad MA, 2006, J NEUROSCI, V26, P12735, DOI 10.1523/JNEUROSCI.0575-06.2006; Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bennett DA, 2014, BIOCHEM PHARMACOL, V88, P617, DOI 10.1016/j.bcp.2014.01.037; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Desbuquois B, 2013, FEBS J, V280, P794, DOI 10.1111/febs.12080; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Donlon TA, 2017, AGING CELL, V16, P1016, DOI 10.1111/acel.12625; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Fabbro F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00157; Figueiro-Silva J, 2015, J NEUROSCI, V35, P5504, DOI 10.1523/JNEUROSCI.2548-14.2015; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Funayama A, 2011, J CARD FAIL, V17, P819, DOI 10.1016/j.cardfail.2011.05.011; Guan JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.546; Hibar DP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13624; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Hikosaka O, 2014, ANNU REV NEUROSCI, V37, P289, DOI 10.1146/annurev-neuro-071013-013924; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hsu SC, 2013, NEUROGENETICS, V14, P11, DOI 10.1007/s10048-012-0349-2; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Ingason A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.151; Jahanshahi M, 2015, NAT REV NEUROSCI, V16, P719, DOI 10.1038/nrn4038; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kellett KAB, 2011, INT J MOL EPIDEMIOL, V2, P114; Kjaer-Sorensen K, 2013, J BIOL CHEM, V288, P9982, DOI 10.1074/jbc.M112.426304; Krishnan N, 2015, J CLIN INVEST, V125, P3163, DOI 10.1172/JCI80323; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Li J, 2018, CLIN EXP IMMUNOL, V192, P82, DOI 10.1111/cei.13080; Liu XA, 2012, TRANSL NEUROSCI, V3, P355, DOI 10.2478/s13380-012-0044-7; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; Mao CX, 2014, DEVELOPMENT, V141, P1064, DOI 10.1242/dev.097774; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; MARSDEN CD, 1982, NEUROLOGY, V32, P514, DOI 10.1212/WNL.32.5.514; Martins-de-Souza D, 2012, J PROTEOME RES, V11, P2533, DOI 10.1021/pr2012279; Marygold SJ, 2016, METHODS MOL BIOL, V1478, P1, DOI 10.1007/978-1-4939-6371-3_1; Matulka K, 2013, CELL STEM CELL, V13, P706, DOI 10.1016/j.stem.2013.09.016; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McDonald AJ, 2017, J NEUROSCI RES, V95, P797, DOI 10.1002/jnr.23709; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; Peng K, 2010, NEUROSCI LETT, V484, P98, DOI 10.1016/j.neulet.2010.07.068; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Quick VBS, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.192; Renteria ME, 2014, GENES BRAIN BEHAV, V13, P821, DOI 10.1111/gbb.12177; Replogle JM, 2015, ANN NEUROL, V77, P469, DOI 10.1002/ana.24337; Ruderfer DM, 2018, CELL, V173, P1705, DOI 10.1016/j.cell.2018.05.046; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Santama N, 2004, J CELL SCI, V117, P4537, DOI 10.1242/jcs.01326; Scarpa JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006137; SCHMIDT R, 1994, NEUROEPIDEMIOLOGY, V13, P308, DOI 10.1159/000110396; Schneider JA, 2006, ANN NEUROL, V59, P166, DOI 10.1002/ana.20723; Sears JC, 2016, DEV BIOL, V418, P40, DOI 10.1016/j.ydbio.2016.08.018; Sebastian-Serrano A, 2015, COMPUT STRUCT BIOTEC, V13, P95, DOI 10.1016/j.csbj.2014.12.004; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Shulman JM, 2014, HUM MOL GENET, V23, P870, DOI 10.1093/hmg/ddt478; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Stratmann K, 2016, BRAIN PATHOL, V26, P371, DOI 10.1111/bpa.12289; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taglia I, 2015, NEUROL SCI, V36, P787, DOI 10.1007/s10072-015-2110-8; Takahashi K, 2008, J COMP NEUROL, V509, P180, DOI 10.1002/cne.21740; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Tobaben S, 2003, J BIOL CHEM, V278, P38376, DOI 10.1074/jbc.M301558200; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1800, DOI 10.1093/ije/dyv337; Vardy ERLC, 2012, NEURODEGENER DIS, V9, P31, DOI 10.1159/000329722; Verhaaren BFJ, 2015, CIRC-CARDIOVASC GENE, V8, P398, DOI 10.1161/CIRCGENETICS.114.000858; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wangler MF, 2017, DIS MODEL MECH, V10, P77, DOI 10.1242/dmm.027680; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yu MQ, 2014, INT J MOL SCI, V15, P19253, DOI 10.3390/ijms151019253; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zhang W, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav025; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18	101	90	91	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2019	51	11					1624	+		10.1038/s41588-019-0511-y	http://dx.doi.org/10.1038/s41588-019-0511-y			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JK2ZE	31636452	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000494714300011
J	Rakocevic, G; Semenyuk, V; Lee, WP; Spencer, J; Browning, J; Johnson, IJ; Arsenijevic, V; Nadj, J; Ghose, K; Suciu, MC; Ji, SG; Demir, G; Li, LZ; Toptas, BC; Dolgoborodov, A; Pollex, B; Spulber, I; Glotova, I; Komar, P; Stachyra, AL; Li, YL; Popovic, M; Kallberg, M; Jain, A; Kural, D				Rakocevic, Goran; Semenyuk, Vladimir; Lee, Wan-Ping; Spencer, James; Browning, John; Johnson, Ivan J.; Arsenijevic, Vladan; Nadj, Jelena; Ghose, Kaushik; Suciu, Maria C.; Ji, Sun-Gou; Demir, Gulfem; Li, Lizao; Toptas, Berke C.; Dolgoborodov, Alexey; Pollex, Bjorn; Spulber, Iosif; Glotova, Irina; Komar, Peter; Stachyra, Andrew L.; Li, Yilong; Popovic, Milos; Kallberg, Morten; Jain, Amit; Kural, Deniz			Fast and accurate genomic analyses using genome graphs	NATURE GENETICS			English	Article							SHORT READ ALIGNMENT; DISCOVERY; SEQUENCE; PROVIDES; QUALITY; LOCI; MAP	The human reference genome serves as the foundation for genomics by providing a scaffold for alignment of sequencing reads, but currently only reflects a single consensus haplotype, thus impairing analysis accuracy. Here we present a graph reference genome implementation that enables read alignment across 2,800 diploid genomes encompassing 12.6 million SNPs and 4.0 million insertions and deletions (indels). The pipeline processes one whole-genome sequencing sample in 6.5 h using a system with 36 CPU cores. We show that using a graph genome reference improves read mapping sensitivity and produces a 0.5% increase in variant calling recall, with unaffected specificity. Structural variations incorporated into a graph genome can be genotyped accurately under a unified framework. Finally, we show that iterative augmentation of graph genomes yields incremental gains in variant calling accuracy. Our implementation is an important advance toward fulfilling the promise of graph genomes to radically enhance the scalability and accuracy of genomic analyses.	[Rakocevic, Goran; Semenyuk, Vladimir; Lee, Wan-Ping; Spencer, James; Browning, John; Johnson, Ivan J.; Arsenijevic, Vladan; Nadj, Jelena; Ghose, Kaushik; Suciu, Maria C.; Ji, Sun-Gou; Demir, Gulfem; Li, Lizao; Toptas, Berke C.; Dolgoborodov, Alexey; Pollex, Bjorn; Spulber, Iosif; Glotova, Irina; Komar, Peter; Stachyra, Andrew L.; Li, Yilong; Popovic, Milos; Kallberg, Morten; Jain, Amit; Kural, Deniz] Seven Bridges Genom Inc, Cambridge, MA 02129 USA; [Rakocevic, Goran; Semenyuk, Vladimir; Spencer, James; Browning, John; Johnson, Ivan J.; Arsenijevic, Vladan; Nadj, Jelena; Ghose, Kaushik; Suciu, Maria C.; Ji, Sun-Gou; Demir, Gulfem; Li, Lizao; Toptas, Berke C.; Pollex, Bjorn; Glotova, Irina; Komar, Peter; Stachyra, Andrew L.; Li, Yilong; Popovic, Milos; Jain, Amit; Kural, Deniz] Totient Inc, Cambridge, MA 02140 USA		Kural, D (corresponding author), Seven Bridges Genom Inc, Cambridge, MA 02129 USA.; Kural, D (corresponding author), Totient Inc, Cambridge, MA 02140 USA.	deniz.kural@sbgenomics.com	Lee, Wan-Ping/ABD-4571-2021; Arsenijevic, Vladan/F-6901-2013	Lee, Wan-Ping/0000-0002-5305-1181; Ji, Sun-Gou/0000-0001-8652-6318; Ghose, Kaushik/0000-0003-2933-1260; Rakocevic, Goran/0000-0002-3411-0764; Stachyra, Andrew/0000-0001-5315-3260; Arsenijevic, Vladan/0000-0002-8740-0706	UK Department of Health grant SBRI Genomics Competition: Enabling Technologies for Genomic Sequence Data Analysis and Interpretation	UK Department of Health grant SBRI Genomics Competition: Enabling Technologies for Genomic Sequence Data Analysis and Interpretation	We are grateful for the members of the GA4GH Data Workgroup, Benchmarking, and Reference variation initiatives, in particular J. Zook, for insightful discussions and ideas. M. Huvet helped refine the treatment and presentation of ideas behind trio-based benchmarking. Research reported in this publication was supported in part by the UK Department of Health grant SBRI Genomics Competition: Enabling Technologies for Genomic Sequence Data Analysis and Interpretation administered by Genomics England.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antaki D, 2018, BIOINFORMATICS, V34, P1774, DOI 10.1093/bioinformatics/btx813; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Brandt DYC, 2015, G3-GENES GENOM GENET, V5, P931, DOI 10.1534/g3.114.015784; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Cleary J., 2015, BIORXIV, DOI [10.1101/023754, DOI 10.1101/023754]; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dilthey A, 2015, NAT GENET, V47, P682, DOI 10.1038/ng.3257; Durbin R, 1998, BIOL SEQUENCE ANAL P; Eggertsson HP, 2017, NAT GENET, V49, P1654, DOI 10.1038/ng.3964; Fakhro Khalid A, 2016, Hum Genome Var, V3, P16016, DOI 10.1038/hgv.2016.16; Garrison E., 2012, ARXIV12073907QBIO; Garrison E, 2018, NAT BIOTECHNOL, V36, P875, DOI 10.1038/nbt.4227; Haussler D, 2014, ARXIVQBIOGN14045010; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kural D, 2014, METHODS INTER INTRAS; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIVQBIOGN13033997V; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maretty L, 2017, NATURE, V548, P87, DOI 10.1038/nature23264; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nho Kwangsik, 2014, IEEE Int Conf Systems Biol, V2014, P59, DOI 10.1109/ISB.2014.6990432; Novak A. M., 2017, BIORXIV, DOI [10.1101/101378, DOI 10.1101/101378]; Novak AM, 2017, ALGORITHM MOL BIOL, V12, DOI 10.1186/s13015-017-0109-9; Paten B, 2017, GENOME RES, V27, P665, DOI 10.1101/gr.214155.116; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178, DOI 10.1101/201178]; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Siren J., 2018, ARXIVCSDS180503834; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; van Leeuwen EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7065; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	47	90	90	4	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					354	+		10.1038/s41588-018-0316-4	http://dx.doi.org/10.1038/s41588-018-0316-4			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30643257	Green Submitted			2022-12-17	WOS:000457314300022
J	Turcan, S; Makarov, V; Taranda, J; Wang, YX; Fabius, AWM; Wu, W; Zheng, YP; El-Amine, N; Haddock, S; Nanjangud, G; LeKaye, HC; Brennan, C; Cross, J; Huse, JT; Kelleher, NL; Osten, P; Thompson, CB; Chan, TA				Turcan, Sevin; Makarov, Vladimir; Taranda, Julian; Wang, Yuxiang; Fabius, Armida W. M.; Wu, Wei; Zheng, Yupeng; El-Amine, Nour; Haddock, Sara; Nanjangud, Gouri; LeKaye, H. Carl; Brennan, Cameron; Cross, Justin; Huse, Jason T.; Kelleher, Neil L.; Osten, Pavel; Thompson, Craig B.; Chan, Timothy A.			Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence	NATURE GENETICS			English	Article							INTEGRATED GENOMIC ANALYSIS; MOLECULE L1; IDH1; CELLS; EXPRESSION; MUTATION; TUMORS; GROWTH; DIFFERENTIATION; ACTIVATION	Mutations in IDH1 and IDH2 (encoding isocitrate dehydrogenase 1 and 2) drive the development of gliomas and other human malignancies. Mutant IDH1 induces epigenetic changes that promote tumorigenesis, but the scale and reversibility of these changes are unknown. Here, using human astrocyte and glioma tumorsphere systems, we generate a large-scale atlas of mutant-IDH1-induced epigenomic reprogramming. We characterize the reversibility of the alterations in DNA methylation, the histone landscape, and transcriptional reprogramming that occur following IDH1 mutation. We discover genome-wide coordinate changes in the localization and intensity of multiple histone marks and chromatin states. Mutant IDH1 establishes a CD24(+) population with a proliferative advantage and stem-like transcriptional features. Strikingly, prolonged exposure to mutant IDH1 results in irreversible genomic and epigenetic alterations. Together, these observations provide unprecedented high-resolution molecular portraits of mutant-IDH1-dependent epigenomic reprogramming. These findings have substantial implications for understanding of mutant IDH function and for optimizing therapeutic approaches to targeting IDH-mutant tumors.	[Turcan, Sevin; Makarov, Vladimir; Wang, Yuxiang; Fabius, Armida W. M.; Wu, Wei; Haddock, Sara; Huse, Jason T.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Taranda, Julian; El-Amine, Nour; Osten, Pavel] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Zheng, Yupeng] Sanofi Genzyme, Waltham, MA USA; [Haddock, Sara; Chan, Timothy A.] Weill Cornell Sch Med, New York, NY 10065 USA; [Nanjangud, Gouri] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core Facil, 1275 York Ave, New York, NY 10021 USA; [LeKaye, H. Carl] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA; [Cross, Justin] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA; [Turcan, Sevin] Univ Hosp Heidelberg, Dept Neurol, Heidelberg, Germany; [Fabius, Armida W. M.] Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Sanofi-Aventis; Genzyme Corporation; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Northwestern University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Turcan, S; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Weill Cornell Sch Med, New York, NY 10065 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA.; Turcan, S (corresponding author), Univ Hosp Heidelberg, Dept Neurol, Heidelberg, Germany.	sevin.turcan@med.uni-heidelberg.de; chant@mskcc.org	Turcan, Sevin/AAF-1095-2019; Chan, Timothy A/ABD-5850-2021; Brennan, Cameron/R-7082-2019	Turcan, Sevin/0000-0002-0885-5607; Brennan, Cameron/0000-0003-4064-8891; Haddock, Sara/0000-0002-5661-5317	US National Institutes of Health (NIH) [R01 CA177828, R01 MH096946]; MSKCC Brain Tumor Center; Sontag Foundation; PaineWebber Chair Endowment; NIH T32 grant [5T32CA160001]; MSKCC Society; NIH Cancer Center Support Grant [P30CA008748]; National Resource for Translational and Developmental Proteomics from National Institute of General Medical Sciences, NIH [P41 GM108569]; NATIONAL CANCER INSTITUTE [T32CA160001, R01CA177828, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096946] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Brain Tumor Center; Sontag Foundation; PaineWebber Chair Endowment; NIH T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Society; NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Resource for Translational and Developmental Proteomics from National Institute of General Medical Sciences, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the members of the Chan and Thompson laboratories for helpful discussions. This work was supported in part by the US National Institutes of Health (NIH; R01 CA177828) (T.A.C. and C.B.T.), the MSKCC Brain Tumor Center (S.T. and T.A.C.), the Sontag Foundation (T.A.C.), the PaineWebber Chair Endowment (T.A.C.), NIH T32 grant 5T32CA160001 (S.T.), the MSKCC Society (T.A.C.), the NIH (R01 MH096946) (P.O.), and NIH Cancer Center Support Grant P30CA008748 (G.N.). This research was carried out in collaboration with the National Resource for Translational and Developmental Proteomics under grant P41 GM108569 (N.L.K.) from the National Institute of General Medical Sciences, NIH.	Anders S, 2009, BIOINFORMATICS, V25, P1231, DOI 10.1093/bioinformatics/btp152; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Chiappinelli KB, 2016, CELL, V164, P1073, DOI 10.1016/j.cell.2015.10.020; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Feber A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r30; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Izumoto S, 1996, CANCER RES, V56, P1440; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mimeault M, 2014, CANCER EPIDEM BIOMAR, V23, P234, DOI 10.1158/1055-9965.EPI-13-0785; Mohanan V, 2013, CLIN EXP METASTAS, V30, P507, DOI 10.1007/s10585-012-9555-4; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/NMETH.1854, 10.1038/nmeth.1854]; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Scheie D, 2011, NEURO-ONCOLOGY, V13, P1225, DOI 10.1093/neuonc/nor114; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Sonoda Y, 2001, CANCER RES, V61, P4956; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Tateishi K, 2015, CANCER CELL, V28, P773, DOI 10.1016/j.ccell.2015.11.006; Team RC., 2022, R LANG ENV STAT COMP; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Turcan S, 2013, ONCOTARGET, V4, P1729, DOI 10.18632/oncotarget.1412; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zheng YP, 2016, CURR OPIN CHEM BIOL, V33, P142, DOI 10.1016/j.cbpa.2016.06.007; Zheng YP, 2014, PROTEOMICS, V14, P2190, DOI 10.1002/pmic.201400060	61	90	91	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2018	50	1					62	+		10.1038/s41588-017-0001-z	http://dx.doi.org/10.1038/s41588-017-0001-z			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FT4XB	29180699	Green Accepted			2022-12-17	WOS:000423157400010
J	Dunning, AM; Michailidou, K; Kuchenbaecker, KB; Thompson, D; French, JD; Beesley, J; Healey, CS; Kar, S; Pooley, KA; Lopez-Knowles, E; Dicks, E; Barrowdale, D; Sinnott-Armstrong, NA; Sallari, RC; Hillman, KM; Kaufmann, S; Sivakumaran, H; Marjaneh, MM; Lee, JS; Hills, M; Jarosz, M; Drury, S; Canisius, S; Bolla, MK; Dennis, J; Wang, Q; Hopper, JL; Southey, MC; Broeks, A; Schmidt, MK; Lophatananon, A; Muir, K; Beckmann, MW; Fasching, PA; dos-Santos-Silva, I; Peto, J; Sawyer, EJ; Tomlinson, I; Burwinkel, B; Marme, F; Guenel, P; Truong, T; Bojesen, SE; Flyger, H; Gonzalez-Neira, A; Perez, JIA; Anton-Culver, H; Eunjung, L; Arndt, V; Brenner, H; Meindl, A; Schmutzler, RK; Brauch, H; Hamann, U; Aittomaki, K; Blomqvist, C; Ito, H; Matsuo, K; Bogdanova, N; Dork, T; Lindblom, A; Margolin, S; Kosma, VM; Mannermaa, A; Tseng, CC; Wu, AH; Lambrechts, D; Wildiers, H; Chang-Claude, J; Rudolph, A; Peterlongo, P; Radice, P; Olson, JE; Giles, GG; Milne, RL; Haiman, CA; Henderson, BE; Goldberg, MS; Teo, SH; Yip, CH; Nord, S; Borresen-Dale, AL; Kristensen, V; Long, J; Zheng, W; Pylkas, K; Winqvist, R; Andrulis, IL; Knight, JA; Devilee, P; Seynaeve, C; Figueroa, J; Sherman, ME; Czene, K; Darabi, H; Hollestelle, A; van den Ouweland, AMW; Humphreys, K; Gao, YT; Shu, XO; Cox, A; Cross, SS; Blot, W; Cai, Q; Ghoussaini, M; Perkins, BJ; Shah, M; Choi, JY; Kang, D; Lee, SC; Hartman, M; Kabisch, M; Torres, D; Jakubowska, A; Lubinski, J; Brennan, P; Sangrajrang, S; Ambrosone, CB; Toland, AE; Shen, CY; Wu, PE; Orr, N; Swerdlow, A; McGuffog, L; Healey, S; Lee, A; Kapuscinski, M; John, EM; Terry, MB; Daly, MB; Goldgar, DE; Buys, SS; Janavicius, R; Tihomirova, L; Tung, N; Dorfling, CM; van Rensburg, EJ; Neuhausen, SL; Ejlertsen, B; Hansen, TVO; Osorio, A; Benitez, J; Rando, R; Weitzel, JN; Bonanni, B; Peissel, B; Manoukian, S; Papi, L; Ottini, L; Konstantopoulou, I; Apostolou, P; Garber, J; Rashid, MU; Frost, D; Izatt, L; Ellis, S; Godwin, AK; Arnold, N; Niederacher, D; Rhiem, K; Bogdanova-Markov, N; Sagne, C; Stoppa-Lyonnet, D; Damiola, F; Sinilnikova, OM; Mazoyer, S; Isaacs, C; Claes, KBM; De Leeneer, K; De la Hoya, M; Caldes, T; Nevanlinna, H; Khan, S; Mensenkamp, AR; Hooning, MJ; Rookus, MA; Kwong, A; Olah, E; Diez, O; Brunet, J; Pujana, MA; Gronwald, J; Huzarski, T; Barkardottir, RB; Laframboise, R; Soucy, P; Montagna, M; Agata, S; Teixeira, MR; Park, SK; Lindor, N; Couch, FJ; Tischkowitz, M; Foretova, L; Vijai, J; Offit, K; Singer, CF; Rappaport, C; Phelan, CM; Greene, MH; Mai, PL; Rennert, G; Imyanitov, EN; Hulick, PJ; Phillips, KA; Piedmonte, M; Mulligan, AM; Glendon, G; Bojesen, A; Thomassen, M; Caligo, MA; Yoon, SY; Friedman, E; Laitman, Y; Borg, A; Von Wachenfeldt, A; Ehrencrona, H; Rantala, J; Olopade, OI; Ganz, PA; Nussbaum, RL; Gayther, SA; Nathanson, KL; Domchek, SM; Arun, BK; Mitchell, G; Karlan, BY; Lester, J; Maskarinec, G; Woolcott, C; Scott, C; Stone, J; Apicella, C; Tamimi, R; Luben, R; Khaw, KT; Helland, A; Haakensen, V; Dowsett, M; Pharoah, PDP; Simard, J; Hall, P; Garcia-Closas, M; Vachon, C; Chenevix-Trench, G; Antoniou, AC; Easton, DF; Edwards, SL				Dunning, Alison M.; Michailidou, Kyriaki; Kuchenbaecker, Karoline B.; Thompson, Deborah; French, Juliet D.; Beesley, Jonathan; Healey, Catherine S.; Kar, Siddhartha; Pooley, Karen A.; Lopez-Knowles, Elena; Dicks, Ed; Barrowdale, Daniel; Sinnott-Armstrong, Nicholas A.; Sallari, Richard C.; Hillman, Kristine M.; Kaufmann, Susanne; Sivakumaran, Haran; Marjaneh, Mahdi Moradi; Lee, Jason S.; Hills, Margaret; Jarosz, Monika; Drury, Suzie; Canisius, Sander; Bolla, Manjeet K.; Dennis, Joe; Wang, Qin; Hopper, John L.; Southey, Melissa C.; Broeks, Annegien; Schmidt, Marjanka K.; Lophatananon, Artitaya; Muir, Kenneth; Beckmann, Matthias W.; Fasching, Peter A.; dos-Santos-Silva, Isabel; Peto, Julian; Sawyer, Elinor J.; Tomlinson, Ian; Burwinkel, Barbara; Marme, Frederik; Guenel, Pascal; Truong, Therese; Bojesen, Stig E.; Flyger, Henrik; Gonzalez-Neira, Anna; Perez, Jose I. A.; Anton-Culver, Hoda; Eunjung, Lee; Arndt, Volker; Brenner, Hermann; Meindl, Alfons; Schmutzler, Rita K.; Brauch, Hiltrud; Hamann, Ute; Aittomaki, Kristiina; Blomqvist, Carl; Ito, Hidemi; Matsuo, Keitaro; Bogdanova, Natasha; Dork, Thilo; Lindblom, Annika; Margolin, Sara; Kosma, Veli-Matti; Mannermaa, Arto; Tseng, Chiu-chen; Wu, Anna H.; Lambrechts, Diether; Wildiers, Hans; Chang-Claude, Jenny; Rudolph, Anja; Peterlongo, Paolo; Radice, Paolo; Olson, Janet E.; Giles, Graham G.; Milne, Roger L.; Haiman, Christopher A.; Henderson, Brian E.; Goldberg, Mark S.; Teo, Soo H.; Yip, Cheng Har; Nord, Silje; Borresen-Dale, Anne-Lise; Kristensen, Vessela; Long, Jirong; Zheng, Wei; Pylkas, Katri; Winqvist, Robert; Andrulis, Irene L.; Knight, Julia A.; Devilee, Peter; Seynaeve, Caroline; Figueroa, Jonine; Sherman, Mark E.; Czene, Kamila; Darabi, Hatef; Hollestelle, Antoinette; van den Ouweland, Ans M. W.; Humphreys, Keith; Gao, Yu-Tang; Shu, Xiao-Ou; Cox, Angela; Cross, Simon S.; Blot, William; Cai, Qiuyin; Ghoussaini, Maya; Perkins, Barbara J.; Shah, Mitul; Choi, Ji-Yeob; Kang, Daehee; Lee, Soo Chin; Hartman, Mikael; Kabisch, Maria; Torres, Diana; Jakubowska, Anna; Lubinski, Jan; Brennan, Paul; Sangrajrang, Suleeporn; Ambrosone, Christine B.; Toland, Amanda E.; Shen, Chen-Yang; Wu, Pei-Ei; Orr, Nick; Swerdlow, Anthony; McGuffog, Lesley; Healey, Sue; Lee, Andrew; Kapuscinski, Miroslav; John, Esther M.; Terry, Mary Beth; Daly, Mary B.; Goldgar, David E.; Buys, Saundra S.; Janavicius, Ramunas; Tihomirova, Laima; Tung, Nadine; Dorfling, Cecilia M.; van Rensburg, Elizabeth J.; Neuhausen, Susan L.; Ejlertsen, Bent; Hansen, Thomas V. O.; Osorio, Ana; Benitez, Javier; Rando, Rachel; Weitzel, Jeffrey N.; Bonanni, Bernardo; Peissel, Bernard; Manoukian, Siranoush; Papi, Laura; Ottini, Laura; Konstantopoulou, Irene; Apostolou, Paraskevi; Garber, Judy; Rashid, Muhammad Usman; Frost, Debra; Izatt, Louise; Ellis, Steve; Godwin, Andrew K.; Arnold, Norbert; Niederacher, Dieter; Rhiem, Kerstin; Bogdanova-Markov, Nadja; Sagne, Charlotte; Stoppa-Lyonnet, Dominique; Damiola, Francesca; Sinilnikova, Olga M.; Mazoyer, Sylvie; Isaacs, Claudine; Claes, Kathleen B. M.; De Leeneer, Kim; De la Hoya, Miguel; Caldes, Trinidad; Nevanlinna, Heli; Khan, Sofia; Mensenkamp, Arjen R.; Hooning, Maartje J.; Rookus, Matti A.; Kwong, Ava; Olah, Edith; Diez, Orland; Brunet, Joan; Pujana, Miquel Angel; Gronwald, Jacek; Huzarski, Tomasz; Barkardottir, Rosa B.; Laframboise, Rachel; Soucy, Penny; Montagna, Marco; Agata, Simona; Teixeira, Manuel R.; Park, Sue Kyung; Lindor, Noralane; Couch, Fergus J.; Tischkowitz, Marc; Foretova, Lenka; Vijai, Joseph; Offit, Kenneth; Singer, Christian F.; Rappaport, Christine; Phelan, Catherine M.; Greene, Mark H.; Mai, Phuong L.; Rennert, Gad; Imyanitov, Evgeny N.; Hulick, Peter J.; Phillips, Kelly-Anne; Piedmonte, Marion; Mulligan, Anna Marie; Glendon, Gord; Bojesen, Anders; Thomassen, Mads; Caligo, Maria A.; Yoon, Sook-Yee; Friedman, Eitan; Laitman, Yael; Borg, Ake; Von Wachenfeldt, Anna; Ehrencrona, Hans; Rantala, Johanna; Olopade, Olufunmilayo I.; Ganz, Patricia A.; Nussbaum, Robert L.; Gayther, Simon A.; Nathanson, Katherine L.; Domchek, Susan M.; Arun, Banu K.; Mitchell, Gillian; Karlan, Beth Y.; Lester, Jenny; Maskarinec, Gertraud; Woolcott, Christy; Scott, Christopher; Stone, Jennifer; Apicella, Carmel; Tamimi, Rulla; Luben, Robert; Khaw, Kay-Tee; Helland, Aslaug; Haakensen, Vilde; Dowsett, Mitch; Pharoah, Paul D. P.; Simard, Jacques; Hall, Per; Garcia-Closas, Montserrat; Vachon, Celine; Chenevix-Trench, Georgia; Antoniou, Antonis C.; Easton, Douglas F.; Edwards, Stacey L.		EMBRACE; GEMO Study Collaborators; HEBON; KConFab Investigators	Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BRCA2 MUTATION CARRIERS; BONE-MINERAL DENSITY; MAMMOGRAPHIC DENSITY; SUSCEPTIBILITY LOCUS; METAANALYSIS; MODIFIERS; REVEALS; DISEASE; WOMEN	We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen receptor a) in 118,816 subjects from three international consortia. We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER+ or ER-) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade. The best candidate causal variants for ER-tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	[Dunning, Alison M.; Healey, Catherine S.; Kar, Siddhartha; Dicks, Ed; Ghoussaini, Maya; Perkins, Barbara J.; Shah, Mitul; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Michailidou, Kyriaki; Kuchenbaecker, Karoline B.; Thompson, Deborah; Pooley, Karen A.; Barrowdale, Daniel; Bolla, Manjeet K.; Dennis, Joe; Wang, Qin; McGuffog, Lesley; Lee, Andrew; Frost, Debra; Ellis, Steve; Pharoah, Paul D. P.; Antoniou, Antonis C.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [French, Juliet D.; Beesley, Jonathan; Hillman, Kristine M.; Kaufmann, Susanne; Sivakumaran, Haran; Marjaneh, Mahdi Moradi; Lee, Jason S.; Healey, Sue; Chenevix-Trench, Georgia; Edwards, Stacey L.] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia; [Lopez-Knowles, Elena; Jarosz, Monika; Drury, Suzie; Dowsett, Mitch] Breakthrough Breast Canc Res Ctr, Breast Canc Res, London, England; [Lopez-Knowles, Elena; Hills, Margaret; Jarosz, Monika; Drury, Suzie; Dowsett, Mitch] Royal Marsden Hosp, Acad Biochem, London SW3 6JJ, England; [Sinnott-Armstrong, Nicholas A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Sallari, Richard C.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Canisius, Sander; Broeks, Annegien; Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Hopper, John L.; Giles, Graham G.; Milne, Roger L.; Apicella, Carmel] Univ Melbourne, Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Lophatananon, Artitaya; Muir, Kenneth] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Comprehens Canc Ctr Erlangen Nuremberg Metropolit, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA; [dos-Santos-Silva, Isabel; Peto, Julian] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Sawyer, Elinor J.] Kings Coll London, Guys Hosp, Div Canc Studies, Res Oncol, London, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Burwinkel, Barbara] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Guenel, Pascal; Truong, Therese] INSERM, Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, Villejuif, France; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Gonzalez-Neira, Anna] Spanish Natl Canc Ctr CNIO, Human Canc Genet Program, Madrid, Spain; [Perez, Jose I. A.] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Eunjung, Lee; Tseng, Chiu-chen; Wu, Anna H.; Haiman, Christopher A.; Henderson, Brian E.; Gayther, Simon A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Arndt, Volker; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Brauch, Hiltrud] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, D-80290 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Integrated Oncol, Cologne, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana; Rashid, Muhammad Usman] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Aittomaki, Kristiina] Helsinki Univ Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Oncol, Helsinki, Finland; [Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Aichi, Japan; [Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan; [Bogdanova, Natasha] Hannover Med Sch, Radiat Oncol Res Unit, Hannover, Germany; [Dork, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara; Von Wachenfeldt, Anna] Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Lambrechts, Diether] Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Wildiers, Hans] Univ Hosp Leuven, Dept Gen Med Oncol, Multidisciplinary Breast Ctr, Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, UCCH, Hamburg, Germany; [Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Radice, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Basis Genet Risk & Genet Testing, Milan, Italy; [Olson, Janet E.; Lindor, Noralane; Couch, Fergus J.; Scott, Christopher; Vachon, Celine] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Teo, Soo H.; Yoon, Sook-Yee] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Malaysia; [Teo, Soo H.; Yip, Cheng Har] Univ Malaya, Med Ctr, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Nord, Silje; Borresen-Dale, Anne-Lise; Kristensen, Vessela; Helland, Aslaug; Haakensen, Vilde] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Borresen-Dale, Anne-Lise; Kristensen, Vessela] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Oslo Univ Hosp, Dept Clin Mol Biol, Oslo, Norway; [Long, Jirong; Zheng, Wei; Shu, Xiao-Ou; Blot, William; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, NordLab Oulu Univ Hosp, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, NordLab Oulu Univ Hosp, Bioctr Oulu, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Northern Finland Lab Ctr NordLab, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Devilee, Peter] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands; [Devilee, Peter] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Seynaeve, Caroline; Hollestelle, Antoinette] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands; [Figueroa, Jonine; Sherman, Mark E.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Czene, Kamila; Darabi, Hatef; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [van den Ouweland, Ans M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Cox, Angela] Univ Sheffield, Sheffield Canc Res, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Choi, Ji-Yeob; Park, Sue Kyung] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Choi, Ji-Yeob; Park, Sue Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sue Kyung] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kang, Daehee; Lee, Soo Chin] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore; [Kang, Daehee; Lee, Soo Chin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Torres, Diana] Pontificia Univ Javerianar, Inst Human Genet, Bogota, Colombia; [Jakubowska, Anna; Lubinski, Jan; Gronwald, Jacek; Huzarski, Tomasz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Brennan, Paul] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Orr, Nick; Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Div Canc Studies, London SW3 6JB, England; [Swerdlow, Anthony; Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Kapuscinski, Miroslav] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Terry, Mary Beth] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Huntsman Canc Inst, Salt Lake City, UT USA; [Buys, Saundra S.] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Janavicius, Ramunas] State Res Inst Ctr Innovat Med, Vilnius, Lithuania; [Tihomirova, Laima] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Dept Med Oncol, Boston, MA 02215 USA; [Dorfling, Cecilia M.; van Rensburg, Elizabeth J.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Ejlertsen, Bent] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [Hansen, Thomas V. O.] Copenhagen Univ Hosp, Rigshosp, Ctr Genom Med, Copenhagen, Denmark; [Osorio, Ana; Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain; [Osorio, Ana; Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid, Spain; [Rando, Rachel] City Hope Clin Canc Genom Community Res Network, Duarte, CA USA; [Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Clin Canc Genet, Duarte, CA USA; [Bonanni, Bernardo] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Peissel, Bernard; Manoukian, Siranoush] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Med Genet, Via Venezian 1, I-20133 Milan, Italy; [Papi, Laura] Univ Florence, Dept Biomed Expt & Clin Sci, Unit Med Genet, Florence, Italy; [Ottini, Laura] Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Konstantopoulou, Irene; Apostolou, Paraskevi] Aghia Paraskevi Attikis, Natl Ctr Sci Res Demokritos, INRASTES Inst Nucl & Radiol Sci & Technol, Mol Diagnost Lab, Athens, Greece; [Garber, Judy] Dana Farber Canc Inst, Canc Risk & Prevent Clin, Boston, MA 02115 USA; [Rashid, Muhammad Usman] Shaukat Khanum Mem Canc Hosp & Res Ctr, Dept Basic Sci, Lahore, Pakistan; [Izatt, Louise] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Clin Genet, London, England; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Arnold, Norbert] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Gynaecol & Obstet, Campus Kiel, Kiel, Germany; [Niederacher, Dieter] Univ Dusseldorf, Dusseldorf, Germany; [Rhiem, Kerstin] Univ Hosp Cologne, Ctr Mol Med Cologne, Dept Obstet & Gynaecol, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Rhiem, Kerstin] Univ Hosp Cologne, Ctr Mol Med Cologne, Ctr Integrated Oncol, Cologne, Germany; [Bogdanova-Markov, Nadja] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Sagne, Charlotte; Damiola, Francesca; Sinilnikova, Olga M.; Mazoyer, Sylvie] Univ Lyon 1, CNRS UMR 5286, INSERM U1052, Ctr Rech Cancerol Lyon, F-69365 Lyon, France; [Stoppa-Lyonnet, Dominique] Inst Curie, Dept Tumour Biol, Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Sinilnikova, Olga M.] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitutionnelle Canc Frequent, Lyon, France; [Isaacs, Claudine] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Claes, Kathleen B. M.; De Leeneer, Kim] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [De la Hoya, Miguel; Caldes, Trinidad] Hosp Clin San Carlos, IdISSC, Mol Oncol Lab, Madrid, Spain; [Nevanlinna, Heli; Khan, Sofia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Khan, Sofia] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Mensenkamp, Arjen R.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Hooning, Maartje J.] Erasmus Univ, Med Ctr, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Kwong, Ava] Hong Kong Sanat & Hosp, Canc Genet Ctr, Hong Kong Hereditary Breast Canc Family Registry, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Olah, Edith] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Diez, Orland] Vall dHebron Univ Hosp, VHIO, Oncogenet Lab, Barcelona, Spain; [Brunet, Joan] Catalan Inst Oncol, IDIBGI, Hereditary Canc Program, Genet Counseling Unit, Girona, Spain; [Pujana, Miquel Angel] Catalan Inst Oncol, IDIBELL Bellvitge Biomed Res Inst, Breast Canc & Syst Biol Unit, Barcelona, Spain; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, Biomed Ctr BMC, Reykjavik, Iceland; [Laframboise, Rachel] Ctr Hosp Univ Quebec, Div Med Genet, Quebec City, PQ, Canada; [Laframboise, Rachel; Soucy, Penny; Simard, Jacques] Univ Laval, Quebec City, PQ, Canada; [Soucy, Penny; Simard, Jacques] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Montagna, Marco; Agata, Simona] IRCCS, IOV, Immunol & Mol Oncol Unit, Padua, Italy; [Teixeira, Manuel R.] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Tischkowitz, Marc] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Foretova, Lenka] Masaryk Univ, Masaryk Mem Canc Inst, Brno, Czech Republic; [Foretova, Lenka] Masaryk Univ, Fac Med, Brno, Czech Republic; [Vijai, Joseph; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Singer, Christian F.; Rappaport, Christine] Med Univ Vienna, Ctr Comprehens Canc, Dept Obstet & Gynecol, Vienna, Austria; [Phelan, Catherine M.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Greene, Mark H.; Mai, Phuong L.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, US NIH, Rockville, MD USA; [Rennert, Gad] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; [Rennert, Gad] Technion Israel Inst Technol, Bruce Rappaport Fac Med, POB 9649, IL-31096 Haifa, Israel; [Rennert, Gad] Clalit Natl Israeli Canc Control Ctr, Haifa, Israel; [Imyanitov, Evgeny N.] NN Petrov Oncol Res Inst, St Petersburg, Russia; [Hulick, Peter J.] NorthShore Univ Hlth Syst, Ctr Med Genet, Evanston, IL USA; [Phillips, Kelly-Anne] Peter MacCallum Canc Ctr, Div Canc Med, East Melbourne, Vic, Australia; [Piedmonte, Marion] Roswell Pk Canc Inst, Stat & Data Management Ctr, NRG Oncol, Buffalo, NY 14263 USA; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Bojesen, Anders] Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Caligo, Maria A.] Univ Pisa, Dept Lab Med, Sect Genet Oncol, Pisa, Italy; [Caligo, Maria A.] Univ Hosp Pisa, Pisa, Italy; [Yoon, Sook-Yee] Univ Malaya, Univ Malaya Med Ctr, Fac Med, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Friedman, Eitan; Laitman, Yael] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel; [Borg, Ake] Lund Univ, Dept Oncol, Lund, Sweden; [Ehrencrona, Hans] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ehrencrona, Hans] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Rantala, Johanna] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Olopade, Olufunmilayo I.] Univ Chicago, Med Ctr, Ctr Clin Canc Genet & Global Hlth, Chicago, IL 60637 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Med, Johnsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Johnsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Dept Med & Genet, San Francisco, CA 94143 USA; [Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Arun, Banu K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Mitchell, Gillian] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia; [Mitchell, Gillian] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Karlan, Beth Y.; Lester, Jenny] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Maskarinec, Gertraud] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Woolcott, Christy] Dalhousie Univ, Dept Obstet Gynaecol & Pediat, Halifax, NS, Canada; [Stone, Jennifer] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Perth, WA 6009, Australia; [Tamimi, Rulla] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Tamimi, Rulla] Harvard Univ, Sch Med, Boston, MA USA; [Tamimi, Rulla] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tamimi, Rulla] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, 665 Huntington Ave, Boston, MA 02115 USA; [Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol, Cambridge, England	University of Cambridge; University of Cambridge; QIMR Berghofer Medical Research Institute; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Stanford University; Massachusetts Institute of Technology (MIT); Netherlands Cancer Institute; University of Melbourne; University of Melbourne; University of Warwick; University of Manchester; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); University of California System; University of California Irvine; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Aichi Cancer Center; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; KU Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Mayo Clinic; Cancer Council Victoria; McGill University; McGill University; Royal Victoria Hospital; Universiti Malaya; University of Oslo; University of Oslo; University of Oslo; Vanderbilt University; University of Oulu; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; Shanghai Jiao Tong University; University of Sheffield; University of Sheffield; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Pomeranian Medical University; World Health Organization; International Agency for Research on Cancer (IARC); National Cancer Institute - Thailand; Roswell Park Cancer Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; China Medical University Taiwan; Academia Sinica - Taiwan; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Melbourne; Cancer Prevention Institute of California; Columbia University; Fox Chase Cancer Center; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; State Research Institute Centre for Innovative Medicine; Latvian Biomedical Research & Study Centre; Harvard University; Beth Israel Deaconess Medical Center; University of Pretoria; City of Hope; Beckman Research Institute of City of Hope; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); City of Hope; IRCCS European Institute of Oncology (IEO); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Florence; Sapienza University Rome; National Centre of Scientific Research "Demokritos"; Harvard University; Dana-Farber Cancer Institute; Shaukat Khanum Memorial Cancer Hospital & Research Centre; University of Kansas; University of Kansas Medical Center; University of Kiel; Schleswig Holstein University Hospital; Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; University of Munster; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UNICANCER; Centre Leon Berard; Georgetown University; Ghent University; Hospital Clinico San Carlos; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute; University of Hong Kong; National Institute of Oncology Hungary; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Landspitali National University Hospital; University of Iceland; University of Iceland; Laval University; Laval University; Laval University; IRCCS Istituto Oncologico Veneto (IOV); Portuguese Institute of Oncology; Universidade do Porto; Mayo Clinic; McGill University; Masaryk Memorial Cancer Institute; Masaryk University Brno; Masaryk University Brno; Memorial Sloan Kettering Cancer Center; Medical University of Vienna; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; N.N. Petrov Research Institute of Oncology; NorthShore University Health System; Peter Maccallum Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Roswell Park Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Odense University Hospital; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universiti Malaya; Chaim Sheba Medical Center; Lund University; Uppsala University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Chicago; University of Chicago Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Cedars Sinai Medical Center; Cancer Research Center of Hawaii; University of Hawaii System; Dalhousie University; University of Western Australia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Dunning, AM; Easton, DF; Edwards, SL (corresponding author), Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England.; Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.; Edwards, SL (corresponding author), QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia.	amd24@medschl.cam.ac.uk; dfe20@medschl.cam.ac.uk; stacey.edwards@qimrberghofer.edu.au	gao, yi/HCI-8298-2022; /AAM-5330-2020; zhang, weihua/GXV-1334-2022; Figueroa, Jonine/AFK-2752-2022; Yip, Cheng-Har/B-1909-2010; Hulick, Peter J/AAC-9444-2020; Yoon, Sook Yee/AAH-1182-2021; Schmidt, Marjanka K/G-9058-2011; Bojesen, Anders B/G-6308-2010; manoukian, siranoush/E-7132-2017; Brenner, Hermann/B-4627-2017; Mensenkamp, Arjen/L-4520-2015; Osorio, Ana/I-4324-2014; Tischkowitz, Marc/O-4452-2018; Arndt, Volker/AAI-7282-2020; Knight, Julia/A-6843-2012; Margolin, Sara/AAX-9034-2020; Zheng, Wei/O-3351-2013; Shen, CY/F-6271-2010; Gronwald, Jacek/A-4576-2017; Stone, Jennifer/AAS-3805-2020; Knight, Julia/R-5617-2019; Devilee, Peter/GXV-8005-2022; wildiers, hans/AAV-8158-2021; Fasching, Peter A/ABH-9912-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; Teixeira, Manuel António Rodrigues/E-4885-2011; Teixeira, Manuel AC/AAZ-7251-2020; Guenel, Pascal/AAS-7688-2021; Brenner, Hermann/ABE-6383-2020; Bonanni, Bernardo/AAM-7928-2020; Figueroa, Jonine/GWD-1322-2022; Matsuo, Keitaro/H-6758-2019; Hansen, Thomas v. O./J-9361-2014; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022; Imyanitov, Evgeny/ABG-8619-2021; Ehrencrona, Hans/M-5619-2014; Caligo, Adelaide Maria/K-4289-2018; Pujana, Miquel Angel/N-3127-2014; DEVILEE, PETER/ABR-2140-2022; de la Hoya, MIguel/Z-2911-2019; Teo, Soo-hwang/H-2353-2014; Peissel, Bernard/E-8187-2017; Lambrechts, Diether/AAJ-3167-2020; Figueroa, Jonine/AAG-1065-2022; Radice, Paolo/O-3119-2013; Guenel, Pascal/H-3728-2018; Dörk, Thilo/J-8620-2012; Mazoyer, Sylvie/N-7559-2017; Claes, Kathleen/AFR-6830-2022; Bogdanova, Natalia V./Y-2205-2019; Khaw, Kay-Tee/AAZ-3209-2021; Zheng, Wei/GQQ-8951-2022; Arnold, Norbert/E-3012-2010; Ehrencrona, Hans/Q-4621-2019; Lee, Soo Chin/S-9111-2016; truong, therese/A-2837-2013; Arndt, Volker/B-4999-2014; French, Juliet/AAV-4435-2020; montagna, marco/E-2225-2012; Lee, Jason/M-7522-2016; Luben, Robert N/H-5519-2015; Jakubowska, Anna/O-8050-2014; Flyger, Henrik/AAM-6494-2021; Gonzalez-Neira, Anna/C-5791-2015; Michailidou, Kyriaki/ABD-5122-2020; De Leeneer, Kim/AFS-1595-2022; Huzarski, Tomasz/AAQ-2161-2021; Peterlongo, Paolo/Q-4717-2018; Andrulis, Irene L./E-7267-2013; Pharoah, Paul/V-6658-2019; Hansen, Thomas/GWZ-2858-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Nord, Silje/R-5212-2016; Helland, Åslaug/H-3910-2015; van Rensburg, Elizabeth J./B-9104-2011; Edwards, Stacey/A-4980-2011; Kwong, Ava/D-8005-2013; Joseph, Vijai/J-9158-2013; benitez, javier/H-5232-2015; Konstantopoulou, Irene/B-5309-2009; Hartman, Mikael/B-4324-2011; Brunet, Joan/C-5292-2018	Figueroa, Jonine/0000-0002-5100-623X; Hulick, Peter J/0000-0001-8397-4078; Schmidt, Marjanka K/0000-0002-2228-429X; manoukian, siranoush/0000-0002-6034-7562; Brenner, Hermann/0000-0002-6129-1572; Mensenkamp, Arjen/0000-0003-3805-877X; Osorio, Ana/0000-0001-8124-3984; Tischkowitz, Marc/0000-0002-7880-0628; Arndt, Volker/0000-0001-9320-8684; Zheng, Wei/0000-0003-1226-070X; Gronwald, Jacek/0000-0002-3643-2871; Knight, Julia/0000-0002-7610-7635; Fasching, Peter A/0000-0003-4885-8471; Garcia-Closas, Montserrat/0000-0003-1033-2650; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Teixeira, Manuel AC/0000-0002-1959-0624; Guenel, Pascal/0000-0002-8359-518X; Brenner, Hermann/0000-0002-6129-1572; Figueroa, Jonine/0000-0002-5100-623X; Matsuo, Keitaro/0000-0003-1761-6314; Hansen, Thomas v. O./0000-0003-4635-2653; Ehrencrona, Hans/0000-0002-5589-3622; Caligo, Adelaide Maria/0000-0003-0589-1829; Pujana, Miquel Angel/0000-0003-3222-4044; Peissel, Bernard/0000-0001-9233-3571; Lambrechts, Diether/0000-0002-3429-302X; Figueroa, Jonine/0000-0002-5100-623X; Radice, Paolo/0000-0001-6298-4111; Guenel, Pascal/0000-0002-8359-518X; Dörk, Thilo/0000-0002-9458-0282; Claes, Kathleen/0000-0003-0841-7372; Arnold, Norbert/0000-0003-4523-8808; Ehrencrona, Hans/0000-0002-5589-3622; Lee, Soo Chin/0000-0002-5835-6419; truong, therese/0000-0002-2943-6786; Arndt, Volker/0000-0001-9320-8684; French, Juliet/0000-0002-9770-0198; montagna, marco/0000-0002-4929-2150; Lee, Jason/0000-0003-0879-934X; Luben, Robert N/0000-0002-5088-6343; Jakubowska, Anna/0000-0002-5650-0501; Gonzalez-Neira, Anna/0000-0002-5421-2020; Michailidou, Kyriaki/0000-0001-7065-1237; De Leeneer, Kim/0000-0002-9319-411X; Huzarski, Tomasz/0000-0003-3857-4854; Peterlongo, Paolo/0000-0001-6951-6855; Pharoah, Paul/0000-0001-8494-732X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Nord, Silje/0000-0002-3271-5356; Helland, Åslaug/0000-0002-5520-0275; Mulligan, Anna Marie/0000-0002-7239-5297; Kwong, Ava/0000-0002-6968-9489; Lopez Knowles, Elena/0000-0002-0893-3361; Lubinski, Jan/0000-0003-2931-3003; Joseph, Vijai/0000-0002-7933-151X; Margolin, Sara/0000-0002-5526-5570; Barrowdale, Daniel/0000-0003-1661-3939; Evans, Gareth/0000-0002-8482-5784; Cox, Angela/0000-0002-5138-1099; Brauch, Hiltrud/0000-0001-7531-2736; Damiola, Francesca/0000-0002-0238-1252; Stone, Jennifer/0000-0001-5077-0124; Lee, Eunjung/0000-0002-8287-6131; Papi, Laura/0000-0003-4552-9517; van Rensburg, Elizabeth/0000-0003-2077-230X; Kang, Daehee/0000-0003-4031-5878; de la Hoya, Miguel/0000-0002-8113-1410; Dunning, Alison Margaret/0000-0001-6651-7166; Hollestelle, Antoinette/0000-0003-1166-1966; OTTINI, LAURA/0000-0001-8030-0449; Foretova, Lenka/0000-0003-0494-2620; Winqvist, Robert/0000-0003-0932-9104; Simard, Jacques/0000-0001-6906-3390; diez, orland/0000-0001-7339-0570; Bojesen, Anders/0000-0003-4289-8595; Southey, Melissa/0000-0002-6313-9005; benitez, javier/0000-0002-0923-7202; Konstantopoulou, Irene/0000-0002-0470-0309; Devilee, Peter/0000-0002-8023-2009; Hartman, Mikael/0000-0001-5726-9965; Sivakumaran, Haran/0000-0002-4691-4989; Beesley, Jonathan/0000-0003-1942-325X; Rennert, Gad/0000-0002-8512-068X; Dowsett, Mitch/0000-0003-4122-744X; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Khan, Sofia/0000-0003-4185-8882; Thorne, Heather/0000-0003-3610-2511; Rashid, Muhammad Usman/0000-0002-7684-3122; Woolcott, Christy/0000-0002-4606-3125; Bojesen, Stig/0000-0002-4061-4133; Kar, Siddhartha P./0000-0002-2314-1426; Blomqvist, Carl/0000-0003-3041-1938; Ganz, Patricia/0000-0002-1841-4143; Long, Jirong/0000-0002-7433-9766; Swerdlow, Anthony/0000-0001-5550-4159; Mazoyer, Sylvie/0000-0002-2135-0160; Durocher, Francine/0000-0001-8012-4641; Phillips, Kelly-Anne/0000-0002-0475-1771; Brunet, Joan/0000-0003-1945-3512; Terry, Mary Beth/0000-0002-4106-5033	National Institute for Health Research (NIHR); European Community [223175 (HEALTH-F2-2009-223175)]; Cancer Research UK [C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565]; US National Institutes of Health (NIH) [CA128978, CA192393, CA116167, CA176785]; US National Institutes of Health (NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer) [CA116201]; Post-Cancer GWAS initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; Post-Cancer GWAS initiative (GAME-ON initiative); US Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR); Komen Foundation for the Cure; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; Cancer Research UK [16565, 11174, 10118, 14136, 16561] Funding Source: researchfish; Medical Research Council [G0401527, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10122, 03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [110135, 150147] Funding Source: researchfish; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; National Breast Cancer Foundation [ECF-12-04, PF-11-20, PRAC-13-04, IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U19CA148537, R01CA100374, UM1CA182910, R01CA116167, P30CA008748, ZIACP010126, U19CA148112, R37CA054281, R01CA192393, R01CA128978, P30CA006927, R01CA092447, R01CA077398, R01CA054281, R01CA132839, U01CA098758, U01CA116167, R01CA097396, UM1CA164920, U10CA180868, U19CA148065, R25CA090956, R01CA176785, P30CA016056, R01CA148667, P50CA116201, R01CA122340, U01CA063464, R01CA064277, UG1CA189867] Funding Source: NIH RePORTER; MRC [MR/N003284/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); European Community(European Commission); Cancer Research UK(Cancer Research UK); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Cancer GWAS initiative; Post-Cancer GWAS initiative (GAME-ON initiative); US Department of Defense(United States Department of Defense); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Ovarian Cancer Research Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; The Francis Crick Institute; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. This study would not have been possible without the contributions of the following: A. Berchuck (OCAC), R.A. Eeles, A. A. Al Olama, Z. Kote-Jarai and S. Benlloch (PRACTICAL), C. Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, the staff of the CNIO genotyping unit, D.C. Tessier, F. Bacot, D. Vincent, S. LaBoissiere, F. Robidoux and the staff of the McGill University and Genome Quebec Innovation Centre, S. F. Nielsen, B.G. Nordestgaard and the staff of the Copenhagen DNA laboratory, and J.M. Cunningham, S. A. Windebank, C. A. Hilker, J. Meyer and the staff of the Mayo Clinic Genotyping Core Facility. Normal human tissues from the Susan G. Komen for the Cure Tissue Bank at the Indiana University Simon Cancer Center (Indianapolis) were used in this study. We thank the contributors, including Indiana University who collected samples used in this study, as well as the donors and their families, whose help and participation made this work possible. We also acknowledge National Institute for Health Research (NIHR) support to the Royal Marsden Biomedical Research Centre. Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692 and C8197/A16565), the US National Institutes of Health (NIH; CA128978, CA192393, CA116167, CA176785 and an NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201)) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112, the GAME-ON initiative), the US Department of Defense (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. Full acknowledgments are given in the Supplementary Note.	Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Chenevix-Trench G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1670; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Crandall CJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2340; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Grabe Niels, 2002, In Silico Biology, V2, pS1; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hein R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042380; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020; Koller DL, 2013, J BONE MINER RES, V28, P547, DOI 10.1002/jbmr.1796; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Sherman ME, 2012, CANCER PREV RES, V5, P528, DOI 10.1158/1940-6207.CAPR-11-0234; Spencer AV, 2014, ANN HUM GENET, V78, P50, DOI 10.1111/ahg.12043; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Stone J, 2015, CANCER RES, V75, P2457, DOI 10.1158/0008-5472.CAN-14-2012; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Varghese JS, 2012, CANCER RES, V72, P1478, DOI 10.1158/0008-5472.CAN-11-3295; Veeraraghavan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5577; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Xiao R, 2011, GENET EPIDEMIOL, V35, P515, DOI 10.1002/gepi.20601; Yamamoto-Ibusuki M, 2015, EUR J HUM GENET, V23, P949, DOI 10.1038/ejhg.2014.219; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	46	90	91	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					374	+		10.1038/ng.3521	http://dx.doi.org/10.1038/ng.3521			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26928228	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000372908800009
J	Kretzmer, H; Bernhart, SH; Wang, W; Haake, A; Weniger, MA; Bergmann, AK; Betts, MJ; Carrillo-de-Santa-Pau, E; Doose, G; Gutwein, J; Richter, J; Hovestadt, V; Huang, BD; Rico, D; Juhling, F; Kolarova, J; Lu, QH; Otto, C; Wagener, R; Arnolds, J; Burkhardt, B; Claviez, A; Drexler, HG; Eberth, S; Eils, R; Flicek, P; Haas, S; Hummel, M; Karsch, D; Kerstens, HHD; Klapper, W; Kreuz, M; Lawerenz, C; Lenze, D; Loeffler, M; Lopez, C; MacLeod, RAF; Martens, JHA; Kulis, M; Martin-Subero, JI; Moller, P; Nagel, I; Picelli, S; Vater, I; Rohde, M; Rosenstiel, P; Rosolowski, M; Russell, RB; Schilhabel, M; Schlesner, M; Stadler, PF; Szczepanowski, M; Trumper, L; Stunnenberg, HG; Kuppers, R; Stunnenberg, HG; Lichter, P; Siebert, R; Hoffmann, S; Radlwimmer, B				Kretzmer, Helene; Bernhart, Stephan H.; Wang, Wei; Haake, Andrea; Weniger, Marc A.; Bergmann, Anke K.; Betts, Matthew J.; Carrillo-de-Santa-Pau, Enrique; Doose, Gero; Gutwein, Jana; Richter, Julia; Hovestadt, Volker; Huang, Bingding; Rico, Daniel; Juehling, Frank; Kolarova, Julia; Lu, Qianhao; Otto, Christian; Wagener, Rabea; Arnolds, Judith; Burkhardt, Birgit; Claviez, Alexander; Drexler, Hans G.; Eberth, Sonja; Eils, Roland; Flicek, Paul; Haas, Siegfried; Hummel, Michael; Karsch, Dennis; Kerstens, Hinrik H. D.; Klapper, Wolfram; Kreuz, Markus; Lawerenz, Chris; Lenze, Dido; Loeffler, Markus; Lopez, Cristina; MacLeod, Roderick A. F.; Martens, Joost H. A.; Kulis, Marta; Ignacio Martin-Subero, Jose; Moeller, Peter; Nagel, Inga; Picelli, Simone; Vater, Inga; Rohde, Marius; Rosenstiel, Philip; Rosolowski, Maciej; Russell, Robert B.; Schilhabel, Markus; Schlesner, Matthias; Stadler, Peter F.; Szczepanowski, Monika; Truemper, Lorenz; Stunnenberg, Hendrik G.; Kueppers, Ralf; Ammerpohl, Ole; Lichter, Peter; Siebert, Reiner; Hoffmann, Steve; Radlwimmer, Bernhard		ICGC MMML-Seq Project; BLUEPRINT Project	DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control	NATURE GENETICS			English	Article							GENOME; LANDSCAPE; GENES; ACTIVATION; MECHANISMS; DIAGNOSIS; REVEALS; CELLS	Although Burkitt lymphomas and follicular lymphomas both have features of germinal center B cells, they are biologically and clinically quite distinct. Here we performed whole-genome bisulfite, genome and transcriptome sequencing in 13 IG-MYC translocation-positive Burkitt lymphoma, nine BCL2 translocation-positive follicular lymphoma and four normal germinal center B cell samples. Comparison of Burkitt and follicular lymphoma samples showed differential methylation of intragenic regions that strongly correlated with expression of associated genes, for example, genes active in germinal center dark-zone and light-zone B cells. Integrative pathway analyses of regions differentially methylated in Burkitt and follicular lymphomas implicated DNA methylation as cooperating with somatic mutation of sphingosine phosphate signaling, as well as the TCF3-ID3 and SWI/SNF complexes, in a large fraction of Burkitt lymphomas. Taken together, our results demonstrate a tight connection between somatic mutation, DNA methylation and transcriptional control in key B cell pathways deregulated differentially in Burkitt lymphoma and other germinal center B cell lymphomas.	[Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Res Ctr Civilizat Dis LIFE, Transcriptome Bioinformat, D-04109 Leipzig, Germany; [Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Kretzmer, Helene; Bernhart, Stephan H.; Doose, Gero; Hovestadt, Volker; Juehling, Frank; Otto, Christian; Stadler, Peter F.; Hoffmann, Steve] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Wang, Wei; Hovestadt, Volker; Picelli, Simone; Lichter, Peter; Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Haake, Andrea; Bergmann, Anke K.; Gutwein, Jana; Richter, Julia; Kolarova, Julia; Lu, Qianhao; Wagener, Rabea; Nagel, Inga; Vater, Inga; Ammerpohl, Ole; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Weniger, Marc A.; Kueppers, Ralf] Univ Duisburg Essen, Inst Cell Biol Canc Res, Kiel, Germany; [Bergmann, Anke K.; Claviez, Alexander] Univ Hosp Schleswig Holstein, Dept Pediat, Kiel, Germany; [Betts, Matthew J.; Russell, Robert B.] Heidelberg Univ, Bioquant, Cell Networks, Heidelberg, Germany; [Carrillo-de-Santa-Pau, Enrique; Rico, Daniel] Spanish Natl Canc Res Ctr CNIO, Struct Biol & BioComputing Programme, Madrid, Spain; [Huang, Bingding; Eils, Roland; Lawerenz, Chris; Schlesner, Matthias] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Arnolds, Judith] Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany; [Burkhardt, Birgit] Univ Hosp Munster, Pediat Hematol & Oncol, Munster, Germany; [Drexler, Hans G.; Eberth, Sonja; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures DSM, Leibniz Inst, Braunschweig, Germany; [Eberth, Sonja; Truemper, Lorenz] Univ Gottingen, Dept Hematol & Oncol, D-37073 Gottingen, Germany; [Eils, Roland] Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Flicek, Paul] European Mol Biol Lab, European Bioinformat Inst, Hinxton, England; [Haas, Siegfried] Friedrich Ebert Hosp Neumunster, Clin Haematol, Neumunster, Germany; [Haas, Siegfried] Friedrich Ebert Hosp Neumunster, Clin Oncol & Nephrol, Neumunster, Germany; [Hummel, Michael; Lenze, Dido] Charite, Inst Pathol, D-13353 Berlin, Germany; [Karsch, Dennis] Univ Med Ctr, Dept Internal Med 2, Hematol & Oncol, Kiel, Germany; [Kerstens, Hinrik H. D.; Martens, Joost H. A.; Kulis, Marta; Szczepanowski, Monika; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Klapper, Wolfram] Univ Kiel, Hematopathol Sect, Kiel, Germany; [Kreuz, Markus; Loeffler, Markus; Rosolowski, Maciej] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Ignacio Martin-Subero, Jose] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Anat Patol Farmacol & Microbiol, Barcelona, Spain; [Moeller, Peter] Univ Ulm, Inst Pathol, Fac Med, D-89069 Ulm, Germany; [Rohde, Marius] Univ Hosp Giessen, Pediat Hematol & Oncol, Giessen, Germany; [Rosenstiel, Philip; Schilhabel, Markus] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol IZI, RNomics Grp, Leipzig, Germany; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Kiel; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Centro Nacional de Investigaciones Oncologicas (CNIO); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Munster; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Gottingen; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Radboud University Nijmegen; University of Kiel; Leipzig University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Ulm University; University Hospital of Giessen & Marburg; University of Kiel; Fraunhofer Gesellschaft; The Santa Fe Institute; Max Planck Society	Siebert, R (corresponding author), Univ Kiel, Inst Human Genet, Kiel, Germany.	rsiebert@medgen.uni-kiel.de; steve@bioinf.uni-leipzig.de; b.radlwimmer@dkfz.de	Stunnenberg, Hendrik G./D-6875-2012; Langenberger, David/AAF-3313-2020; Rosenstiel, Philip/A-5137-2009; Russell, Rob/AAH-9145-2019; Martens, Joost/D-4966-2012; Burkhardt, Birgit/AAS-9678-2021; Ammerpohl, Ole/G-2691-2010; Russell, Robert/GWU-6389-2022; Hoffmann, Steve/E-1438-2013; de Santa Pau, Enrique Carrillo/AAV-7544-2021; López, Cristina/W-4621-2017; Stadler, Peter F. F/L-7857-2015; Kretzmer, Helene/GSJ-2664-2022; Eils, Roland/B-6121-2009; Siebert, Reiner/A-8049-2010; Radlwimmer, Bernhard F/I-3229-2013; Klapper, Wolfram/S-6314-2016; López, Cristina/ABB-3519-2020; Bergmann, Anke/AAT-2509-2020; Rico, Daniel/I-2049-2013; Schlesner, Matthias/I-4030-2013	Stunnenberg, Hendrik G./0000-0002-0066-1576; Rosenstiel, Philip/0000-0002-9692-8828; Russell, Rob/0000-0002-1905-4717; Martens, Joost/0000-0003-2008-6537; Burkhardt, Birgit/0000-0002-1151-829X; Russell, Robert/0000-0002-7213-1398; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; López, Cristina/0000-0001-6644-1659; Stadler, Peter F. F/0000-0002-5016-5191; Kretzmer, Helene/0000-0002-0723-4980; Eils, Roland/0000-0002-0034-4036; Radlwimmer, Bernhard F/0000-0002-4553-7800; López, Cristina/0000-0001-6644-1659; Flicek, Paul/0000-0002-3897-7955; Rico, Daniel/0000-0002-6561-2310; Kreuz, Markus/0000-0002-0520-8391; Kulis, Marta/0000-0001-8104-9620; Otto, Christian/0000-0001-6231-9648; Kuppers, Ralf/0000-0002-6691-7191; Schlesner, Matthias/0000-0002-5896-4086; Hovestadt, Volker/0000-0002-3480-6649; , Stephan/0000-0002-5928-9449; Claviez, Alexander/0000-0002-1561-5185; Betts, Matthew/0000-0003-4583-9814; Hummel, Michael/0000-0001-6717-605X	German Ministry of Science and Education (BMBF) [01KU1002A-J, 036166B]; European Union [HEALTH-F5-2011-282510]; KinderKrebsInitiative Buchholz/Holm-Seppensen; LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University; European Union; European Regional Development Fund (ERDF); European Social Fund (ESF); Free State of Saxony; NGFNplus (BMBF) [01GS0883]; DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dr. Werner Jackstadt Foundation [S134-10.100]; MMML by the Deutsche Krebshilfe	German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); KinderKrebsInitiative Buchholz/Holm-Seppensen; LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); Free State of Saxony; NGFNplus (BMBF)(Federal Ministry of Education & Research (BMBF)); DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dr. Werner Jackstadt Foundation; MMML by the Deutsche Krebshilfe	This study has been supported by the German Ministry of Science and Education (BMBF) in the framework of the ICGC MMML-Seq project (01KU1002A-J) and the MMML-MYC-SYS project (036166B), the European Union in the framework of the BLUEPRINT Project (HEALTH-F5-2011-282510) and the KinderKrebsInitiative Buchholz/Holm-Seppensen and LIFE (Leipzig Research Center for Civilization Diseases), Leipzig University. LIFE is funded by the European Union, the European Regional Development Fund (ERDF), the European Social Fund (ESF) and the Free State of Saxony. WGBS was additionally supported by NGFNplus (BMBF, 01GS0883) and the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO). Former grant support of MMML by the Deutsche Krebshilfe (2003-2011) is gratefully acknowledged. J.R. is supported by the Dr. Werner Jackstadt Foundation in the framework of a Junior Excellence Research Group on 'Mechanisms of B-Cell Lymphomagenesis in the Senium as Basic Principle for the Development of Age-Adjusted Therapy Regimes' (S134-10.100).	Abraham BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-193; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Betts MJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1094; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Hahn MA, 2014, CANCER RES, V74, P3617, DOI 10.1158/0008-5472.CAN-13-3147; Hasselblatt M, 2014, ACTA NEUROPATHOL, V128, P453, DOI 10.1007/s00401-014-1323-x; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loeffler M, 2015, LEUKEMIA, V29, P456, DOI 10.1038/leu.2014.209; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Otto C, 2012, BIOINFORMATICS, V28, P1698, DOI 10.1093/bioinformatics/bts254; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Rohde M, 2014, GENE CHROMOSOME CANC, V53, P911, DOI 10.1002/gcc.22202; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Takuwa N, 2011, AM J CANCER RES, V1, P460; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zhang NR, 2012, STAT SINICA, V22, P1507, DOI 10.5705/ss.2010.257	55	90	91	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1316	+		10.1038/ng.3413	http://dx.doi.org/10.1038/ng.3413			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26437030	Green Accepted, Green Published			2022-12-17	WOS:000363988200015
J	Hatlestad, GJ; Akhavan, NA; Sunnadeniya, RM; Elam, L; Cargile, S; Hembd, A; Gonzalez, A; McGrath, JM; Lloyd, AM				Hatlestad, Gregory J.; Akhavan, Neda A.; Sunnadeniya, Rasika M.; Elam, Lee; Cargile, Scott; Hembd, Austin; Gonzalez, Antonio; McGrath, J. Mitchell; Lloyd, Alan M.			The beet Y locus encodes an anthocyanin MYB-like protein that activates the betalain red pigment pathway	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; IDENTIFICATION; EXPRESSION; EVOLUTION; BIOSYNTHESIS; SPECIFY; COMPLEX; FAMILY	Nearly all flowering plants produce red/violet anthocyanin pigments. Caryophyllales is the only order containing families that replace anthocyanins with unrelated red and yellow betalain pigments(1,2). Close biological correlation of pigmentation patterns suggested that betalains might be regulated by a conserved anthocyanin-regulating transcription factor complex consisting of a MYB, a bHLH and a WD repeat-containing protein (the MBW complex)(3). Here we show that a previously uncharacterized anthocyanin MYB-like protein, Beta vulgaris MYB1 (BvMYB1), regulates the betalain pathway in beets. Silencing BvMYB1 downregulates betalain biosynthetic genes and pigmentation, and overexpressing BvMYB1 upregulates them. However, unlike anthocyanin MYBs, BvMYB1 will not interact with bHLH members of heterologous anthocyanin MBW complexes because of identified nonconserved residues. BvMYB1 resides at the historic beet pigment-patterning locus, Y, required for red-fleshed beets(4). We show that Y and y express different levels of BvMYB1 transcripts. The co-option of a transcription factor regulating anthocyanin biosynthesis would be an important evolutionary event allowing betalains to largely functionally replace anthocyanins.	[Hatlestad, Gregory J.; Akhavan, Neda A.; Sunnadeniya, Rasika M.; Elam, Lee; Cargile, Scott; Hembd, Austin; Gonzalez, Antonio; Lloyd, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [McGrath, J. Mitchell] Michigan State Univ, USDA ARS, Sugarbeet & Bean Res Unit, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; Michigan State University; United States Department of Agriculture (USDA)	Lloyd, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	amlloyd@utexas.edu	McGrath, Mitch/S-7397-2019		US Department of Agriculture [2008-35301-19032]; US National Science Foundation [MCB-1122179]; Direct For Biological Sciences [1122179] Funding Source: National Science Foundation	US Department of Agriculture(United States Department of Agriculture (USDA)); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by US Department of Agriculture grant 2008-35301-19032 and US National Science Foundation grant MCB-1122179. We thank E. Huq, S. Sung and V. Symonds for comments on the manuscript and discussion, I. Goldman (University of Wisconsin-Madison) for the W357B beet cultivar and K. Keller for pigment analysis.	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Clement JS, 1996, BOT ACTA, V109, P360, DOI 10.1111/j.1438-8677.1996.tb00584.x; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Deplancke B., 2006, COLD SPRING HARB PRO, V2006; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Goldman IL, 2000, THEOR APPL GENET, V100, P337, DOI 10.1007/s001220050044; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Haldane JBS, 1931, GENETICS, V16, P0357; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller W, 1936, J AGRIC RES, V52, P0027; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kugler F, 2004, J AGR FOOD CHEM, V52, P2975, DOI 10.1021/jf035491w; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; McGrath JM, 2007, CROP SCI, V47, pS27, DOI 10.2135/cropsci2006-05-0339tpg; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; STAFFORD HA, 1994, PLANT SCI, V101, P91, DOI 10.1016/0168-9452(94)90244-5; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	29	90	107	5	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					92	+		10.1038/ng.3163	http://dx.doi.org/10.1038/ng.3163			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25436858				2022-12-17	WOS:000346990400018
J	Auer, PL; Teumer, A; Schick, U; O'Shaughnessy, A; Lo, KS; Chami, N; Carlson, C; de Denus, S; Dube, MP; Haessler, J; Jackson, RD; Kooperberg, C; Perreault, LPL; Nauck, M; Peters, U; Rioux, JD; Schmidt, F; Turcot, V; Volker, U; Volzke, H; Greinacher, A; Hsu, L; Tardif, JC; Diaz, GA; Reiner, AP; Lettre, G				Auer, Paul L.; Teumer, Alexander; Schick, Ursula; O'Shaughnessy, Andrew; Lo, Ken Sin; Chami, Nathalie; Carlson, Chris; de Denus, Simon; Dube, Marie-Pierre; Haessler, Jeff; Jackson, Rebecca D.; Kooperberg, Charles; Perreault, Louis-Philippe Lemieux; Nauck, Matthias; Peters, Ulrike; Rioux, John D.; Schmidt, Frank; Turcot, Valerie; Voelker, Uwe; Voelzke, Henry; Greinacher, Andreas; Hsu, Li; Tardif, Jean-Claude; Diaz, George A.; Reiner, Alexander P.; Lettre, Guillaume			Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits	NATURE GENETICS			English	Article							TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; RECEPTOR GENE; HUMAN GENOME; MUTATION; CELL; POPULATION; EXPRESSION; ERYTHROCYTOSIS	Hematological traits are important clinical parameters. To test the effects of rare and low-frequency coding variants on hematological traits, we analyzed hemoglobin concentration, hematocrit levels, white blood cell (WBC) counts and platelet counts in 31,340 individuals genotyped on an exome array. We identified several missense variants in CXCR2 associated with reduced WBC count (gene-based P = 2.6 x 10(-13)). In a separate family-based resequencing study, we identified a CXCR2 frameshift mutation in a pedigree with congenital neutropenia that abolished ligand-induced CXCR2 signal transduction and chemotaxis. We also identified missense or splice-site variants in key hematopoiesis regulators (EPO, TFR2, HBB, TUBB1 and SH283) associated with blood cell traits. Finally, we were able to detect associations between a rare somatic JAK2 mutation (encoding p.VaI617Phe) and platelet count (P = 3.9 x 10(-22)) as well as hemoglobin concentration (P = 0.002), hematocrit levels (P = 9.5 x 10(-7)) and WBC count (P = 3.1 x 10(-5)). In conclusion, exome arrays complement genome-wide association studies in identifying new variants that contribute to complex human traits.	[Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Auer, Paul L.; Schick, Ursula; Carlson, Chris; Haessler, Jeff; Kooperberg, Charles; Peters, Ulrike; Hsu, Li; Reiner, Alexander P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Teumer, Alexander; Schmidt, Frank; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [O'Shaughnessy, Andrew; Diaz, George A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Lo, Ken Sin; Chami, Nathalie; de Denus, Simon; Dube, Marie-Pierre; Perreault, Louis-Philippe Lemieux; Rioux, John D.; Turcot, Valerie; Tardif, Jean-Claude; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [de Denus, Simon; Dube, Marie-Pierre; Rioux, John D.; Tardif, Jean-Claude; Lettre, Guillaume] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [de Denus, Simon; Dube, Marie-Pierre; Rioux, John D.; Tardif, Jean-Claude; Lettre, Guillaume] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Nauck, Matthias; Reiner, Alexander P.] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Peters, Ulrike; Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Diaz, George A.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY USA	University of Wisconsin System; University of Wisconsin Milwaukee; Fred Hutchinson Cancer Center; Greifswald Medical School; Icahn School of Medicine at Mount Sinai; Universite de Montreal; Universite de Montreal; Universite de Montreal; University System of Ohio; Ohio State University; Greifswald Medical School; University of Washington; University of Washington Seattle; Greifswald Medical School; Greifswald Medical School; Icahn School of Medicine at Mount Sinai	Diaz, GA (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	george.diaz@mssm.edu; apreiner@u.washington.edu; guillaume.lettre@umontreal.ca	Diaz, George/AAF-6199-2021; Dubé, Marie-Pierre/B-9364-2008; Auer, Paul/AAC-5060-2019; Rioux, John D/A-9599-2015; Frank, ZIK FunGene Schmidt/B-6075-2009; Teumer, Alexander/S-7438-2019	Dubé, Marie-Pierre/0000-0001-8442-4393; Rioux, John D/0000-0001-7560-8326; Teumer, Alexander/0000-0002-8309-094X; Volker, Uwe/0000-0002-5689-3448; Chami, Nathalie/0000-0002-8547-6424; Schmidt, Frank/0000-0001-5406-3988	Centre of Excellence in Personalized Medicine (CEPMed); Fonds de Recherche du Quebec-Sante (FRQS); Canada Research Chair program and the MHI Foundation; National Heart, Lung, and Blood Institute; US Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; Exome Sequencing Project (NHLBI) [RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; Genetics and Epidemiology of Colorectal Cancer Consortium (NCI ) [CA137088]; Genomics and Randomized Trials Network (NHGRI) [UOI-HG005152]; National Cancer Institute [R25CA094880]; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03IS2061A, 03Z1CN22]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Federal State of Mecklenburg-West Pomerania; US National Institutes of Health [P0 1AI061093]; NATIONAL CANCER INSTITUTE [U01CA137088, P01CA053996, R25CA094880] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102924, R21HL121422, RC2HL102924, RC2HL102925, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005152] Funding Source: NIH RePORTER	Centre of Excellence in Personalized Medicine (CEPMed); Fonds de Recherche du Quebec-Sante (FRQS); Canada Research Chair program and the MHI Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; Exome Sequencing Project (NHLBI); Genetics and Epidemiology of Colorectal Cancer Consortium (NCI ); Genomics and Randomized Trials Network (NHGRI); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Federal State of Mecklenburg-West Pomerania; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all participants and staff of the MHI Biobank and acknowledge the technical support of the Beaulieu-Saucier MHI Pharmacogenomic Center. This work was supported by the Centre of Excellence in Personalized Medicine (CEPMed), Fonds de Recherche du Quebec-Sante (FRQS), the Canada Research Chair program and the MHI Foundation. The WHI program is funded by the National Heart, Lung, and Blood Institute, the US National Institutes of Health and the US Department of Health and Human Services (HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C). Exome chip data and analysis were supported through the Exome Sequencing Project (NHLBI RC2 HL-102924, RC2 HL-102925 and RC2 HL-102926), the Genetics and Epidemiology of Colorectal Cancer Consortium (NCI CA137088), the Genomics and Randomized Trials Network (NHGRI UOI-HG005152) and a National Cancer Institute training grant (R25CA094880). The authors thank the WHI investigators and staff for their dedication and the study participants for making the program possible. SHIP is part of the Community Medicine Research network of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants 01ZZ9603,01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania, and the network Greifswald Approach to Individualized Medicine (GANI_MED) funded by the Federal Ministry of Education and Research (grant 03IS2061A). Generation of ExomeChip data has been supported by the Federal Ministry of Education and Research (grant 03Z1CN22) and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the Center of Knowledge Interchange program of Siemens AG and the Cache Campus program of InterSystems. G.A.D. acknowledges support from US National Institutes of Health award P0 1AI061093.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Biasiotto G, 2008, HAEMATOLOGICA, V93, P309, DOI 10.3324/haematol.11942; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOHINJEC J, 1981, BLUT, V42, P191, DOI 10.1007/BF01026389; Cernelc P, 2000, PFLUG ARCH EUR J PHY, V440, pR81, DOI 10.1007/s004240000014; DELACHAPELLE A, 1993, LANCET, V341, P82, DOI 10.1016/0140-6736(93)92558-B; Forand A, 2013, BLOOD, V121, P666, DOI 10.1182/blood-2012-05-427302; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Macari ER, 2011, BLOOD, V117, P5987, DOI 10.1182/blood-2010-10-314096; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McMullin MF, 2011, AM J HEMATOL, V86, P962, DOI 10.1002/ajh.22154; Nails MA., 2011, PLOS GENET, V7; Oh ST, 2011, THER ADV HEMATOL, V2, P11, DOI 10.1177/2040620710393391; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pelucchi S, 2009, HAEMATOL-HEMATOL J, V94, P276, DOI 10.3324/haematol.13576; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sidon P, 2006, LEUKEMIA, V20, P1622, DOI 10.1038/sj.leu.2404292; Stasi R, 2012, SEMIN THROMB HEMOST, V38, P454, DOI 10.1055/s-0032-1305780; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Vannucchi AM, 2011, THER ADV HEMATOL, V2, P21, DOI 10.1177/2040620710394474; Xu XS, 2007, BLOOD, V109, P339, DOI 10.1182/blood-2006-03-009472; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	38	90	92	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					629	634		10.1038/ng.2962	http://dx.doi.org/10.1038/ng.2962			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24777453	Green Accepted			2022-12-17	WOS:000336870700022
J	Bard-Chapeau, EA; Nguyen, AT; Rust, AG; Sayadi, A; Lee, P; Chua, BQ; New, LS; de Jong, J; Ward, JM; Chin, CKY; Chew, V; Toh, C; Abastado, JP; Benoukraf, T; Soong, R; Bard, FA; Dupuy, AJ; Johnson, RL; Radda, GK; Chan, ECY; Wessels, LFA; Adams, DJ; Jenkins, NA; Copeland, NG				Bard-Chapeau, Emilie A.; Nguyen, Anh-Tuan; Rust, Alistair G.; Sayadi, Ahmed; Lee, Philip; Chua, Belinda Q.; New, Lee-Sun; de Jong, Johann; Ward, Jerrold M.; Chin, Christopher K. Y.; Chew, Valerie; Han Chong Toh; Abastado, Jean-Pierre; Benoukraf, Touati; Soong, Richie; Bard, Frederic A.; Dupuy, Adam J.; Johnson, Randy L.; Radda, George K.; Chan, Eric Chun Yong; Wessels, Lodewyk F. A.; Adams, David J.; Jenkins, Nancy A.; Copeland, Neal G.			Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model	NATURE GENETICS			English	Article							FINGER PROTEIN ZBTB20; REAL-TIME PCR; ADENOSINE KINASE; INTRATUMOR HETEROGENEITY; CANCER METABOLISM; PYRUVATE-KINASE; DOWN-REGULATION; LIVER; CELL; EXPRESSION	The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC.	[Bard-Chapeau, Emilie A.; Nguyen, Anh-Tuan; Sayadi, Ahmed; Chua, Belinda Q.; Ward, Jerrold M.; Chin, Christopher K. Y.; Bard, Frederic A.; Jenkins, Nancy A.; Copeland, Neal G.] ASTAR, Inst Mol & Cell Biol, Biopolis, Singapore, Singapore; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England; [Lee, Philip; Radda, George K.] Natl Univ Singapore, Singapore Bioimaging Consortium, Ctr Translat Med, Clin Imaging Res Ctr, Singapore 117548, Singapore; [New, Lee-Sun; Chan, Eric Chun Yong] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [de Jong, Johann; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Chew, Valerie; Abastado, Jean-Pierre] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Han Chong Toh] Natl Canc Ctr, Singapore, Singapore; [Benoukraf, Touati; Soong, Richie] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Dupuy, Adam J.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Wellcome Trust Sanger Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; Netherlands Cancer Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National Cancer Centre Singapore (NCCS); National University of Singapore; University of Iowa; University of Texas System; UTMD Anderson Cancer Center	Copeland, NG (corresponding author), Methodist Hosp, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	ncopeland@tmhs.org	Toh, Chee-Keong/AAC-9610-2020; Chan, Eric Chun Yong/E-7101-2013; Benoukraf, Touati/K-9978-2019; Bard, Frederic Andre Jean/G-9914-2011	Benoukraf, Touati/0000-0002-4789-8028; Dupuy, Adam/0000-0002-8561-4911; Soong, Richie/0000-0002-0152-1225; Bard, Frederic Andre Jean/0000-0002-3783-4805; Chan, Eric Chun Yong/0000-0001-6107-9072; de Jong, Johann/0000-0002-2097-0915; Rust, Alistair/0000-0001-7287-192X; Adams, David/0000-0001-9490-0306	Biomedical Research Council; Agency for Science, Technology and Research, Singapore; Cancer Prevention Research Institute of Texas (CPRIT); Wellcome Trust; Cancer Research UK; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Prevention Research Institute of Texas (CPRIT); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge K. Reifenberg at Johannes Gutenberg University, Germany, for giving us the HBsAg mouse strain (originated from F. Chisari). We also thank K. Rogers and S. Rogers at the Institute of Molecular and Cell Biology Histopathology core for their necropsy and histotechnology assistance. We thank P. Cheok, N. Lim and D. Chen for their help with mouse breeding and monitoring. This work was supported by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore and the Cancer Prevention Research Institute of Texas (CPRIT). A. G. R. and D.J.A. are supported by the Wellcome Trust and Cancer Research UK. N.A.J. and N. G. C. are both CPRIT Scholars in Cancer Research.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bernard F, 2009, LEUKEMIA, V23, P583, DOI 10.1038/leu.2008.228; Berquam-Vrieze KE, 2011, BLOOD, V118, P4646, DOI 10.1182/blood-2011-03-343947; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheng F, 2011, ONCOGENE, V30, P3599, DOI 10.1038/onc.2011.71; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eppig Janan T, 2007, Toxicol Pathol, V35, P456, DOI 10.1080/01926230701310536; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; JACKSON RC, 1978, BRIT J CANCER, V37, P701, DOI 10.1038/bjc.1978.107; Jee J, 2011, BIOINFORMATICS, V27, P1152, DOI 10.1093/bioinformatics/btr092; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kojima K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1345; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Morrow M, 2007, ONCOGENE, V26, P4404, DOI 10.1038/sj.onc.1210227; Nii A, 2009, HEPATOL RES, V39, P274, DOI 10.1111/j.1872-034X.2008.00457.x; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; QUEENER SF, 1971, CANCER RES, V31, P1004; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gky1069, 10.1093/nar/gks1189]; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder MA, 2010, CARDIOVASC RES, V86, P82, DOI 10.1093/cvr/cvp396; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhang GW, 2012, J INVEST SURG, V25, P93, DOI 10.3109/08941939.2011.606875; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008	87	90	92	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					24	+		10.1038/ng.2847	http://dx.doi.org/10.1038/ng.2847			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316982	Green Accepted			2022-12-17	WOS:000329113500008
J	Kurth, I; Klopocki, E; Stricker, S; van Oosterwijk, J; Vanek, S; Altmann, J; Santos, HG; van Harssel, JJT; de Ravel, T; Wilkie, AOM; Gal, A; Mundlos, S				Kurth, Ingo; Klopocki, Eva; Stricker, Sigmar; van Oosterwijk, Jolieke; Vanek, Sebastian; Altmann, Jens; Santos, Heliosa G.; van Harssel, Jeske J. T.; de Ravel, Thomy; Wilkie, Andrew O. M.; Gal, Andreas; Mundlos, Stefan			Duplications of noncoding elements 5 ' of SOX9 are associated with brachydactyly-anonychia	NATURE GENETICS			English	Letter									[Klopocki, Eva; van Oosterwijk, Jolieke; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Kurth, Ingo; Vanek, Sebastian; Gal, Andreas] Univ Klinikum Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Stricker, Sigmar; Mundlos, Stefan] Max Planck Inst Mol Genet, Dev & Dis Res Grp, Berlin, Germany; [Altmann, Jens] Berufsgenossenschaftliches Unfallkrankenhaus Hamb, Abt Handchirurg, Hamburg, Germany; [Santos, Heliosa G.] Fac Med, Serv Genet Med, Lisbon, Portugal; [van Harssel, Jeske J. T.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Ravel, Thomy] Katholieke Univ Leuven Hosp, Ctr Human Genet, Leuven, Belgium; [Wilkie, Andrew O. M.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Universidade de Lisboa; Utrecht University; Utrecht University Medical Center; KU Leuven; University Hospital Leuven; University of Oxford	Mundlos, S (corresponding author), Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Wilkie, Andrew/AAC-3820-2020; Mundlos, Stefan/ABH-9585-2020; Klopocki, Eva/B-6823-2017; Stricker, Sigmar/B-9169-2009	Wilkie, Andrew/0000-0002-2972-5481; Klopocki, Eva/0000-0003-1438-2081; Stricker, Sigmar/0000-0002-7174-5363; Mundlos, Stefan/0000-0002-9788-3166; Kurth, Ingo/0000-0002-5642-8378; de Ravel, Thomy/0000-0002-3361-3781; van Oosterwijk, Jolieke/0000-0003-2282-6121				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	5	90	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					862	863		10.1038/ng0809-862	http://dx.doi.org/10.1038/ng0809-862			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19639023				2022-12-17	WOS:000268432900002
J	Hofker, M; Wijmenga, C				Hofker, Marten; Wijmenga, Cisca			A supersized list of obesity genes	NATURE GENETICS			English	Editorial Material							VARIANTS; RISK; MASS; LOCI	Obesity genetics is making progress, as evidenced by the recent discovery of 15 new loci associated with body mass index. The function of the likely candidate genes in associated regions suggests a key role for the hypothalamus in the genetics of weight control.	[Hofker, Marten] Univ Med Ctr Groningen, Dept Med Biol, NL-9713 EX Groningen, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 EX Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9713 EX Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Hofker, M (corresponding author), Univ Med Ctr Groningen, Dept Med Biol, NL-9713 EX Groningen, Netherlands.	c.wijmenga@medgen.umcg.nl	Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614				Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Savage DB, 2003, DIABETES, V52, P910, DOI 10.2337/diabetes.52.4.910; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	10	90	94	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2009	41	2					139	140		10.1038/ng0209-139	http://dx.doi.org/10.1038/ng0209-139			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19174833				2022-12-17	WOS:000263091300002
J	Kouznetsova, A; Lister, L; Nordenskjold, M; Herbert, M; Hoog, C				Kouznetsova, Anna; Lister, Lisa; Nordenskjold, Magnus; Herbert, Mary; Hoog, Christer			Bi-orientation of achiasmatic chromosomes in meiosis I oocytes contributes to aneuploidy in mice	NATURE GENETICS			English	Article							SPINDLE-CHECKPOINT; NONDISJUNCTION; ASSOCIATION; MECHANISM; TENSION; MAD2	The spindle assembly checkpoint guards against chromosomal missegregation but does not induce arrest in oocytes that contain a few achiasmatic chromosomes ( univalents). We followed the fate of univalents in oocytes during the first meiotic division, and although these preserved a meiotic kinetochore structure, they were also bi-oriented in a mitotic manner. The hybrid chromosomal configuration attained by univalents allows them to evade the spindle assembly checkpoint and contribute to aneuploidy in oocytes.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Univ Newcastle, Int Ctr Life, N E England Stem Cell Inst, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Solna, Sweden; Karolinska Univ Hosp, Ctr Mol Med, S-17176 Solna, Sweden	Karolinska Institutet; Newcastle University - UK; Newcastle University - UK; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hoog, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	christer.hoog@ki.se	Kouznetsova, Anna/AAF-2312-2019	Kouznetsova, Anna/0000-0001-9059-4567; Nordenskjold, Magnus/0000-0002-4974-425X; Herbert, Mary/0000-0002-8488-2770				Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Kallio M, 2000, DEV BIOL, V225, P112, DOI 10.1006/dbio.2000.9818; Kuliev A, 2004, HUM REPROD UPDATE, V10, P401, DOI 10.1093/humupd/dmh036; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	15	90	95	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					966	968		10.1038/ng2065	http://dx.doi.org/10.1038/ng2065			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618286				2022-12-17	WOS:000248446900012
J	Bachtrog, D				Bachtrog, D			Evidence that positive selection drives Y-chromosome degeneration in Drosophila miranda	NATURE GENETICS			English	Article							NEO-Y; EVOLUTION; ACCUMULATION; HITCHHIKING; ADAPTATION; PATTERN; GENES	Why does the Y chromosome harbor so few functional loci? Evolutionary theory predicts that Y chromosomes degenerate because they lack genetic recombination(1). Both positive(2) and negative(1) selection models have been invoked to explain this degeneration, as both can result in the recurrent fixation of linked deleterious mutations on a nonrecombining Y chromosome. To distinguish between these models, I investigated patterns of nucleotide variability along 37 kb of the recently formed neo-Y chromosome in Drosophila miranda. Levels of nucleotide variability on this chromosome are 30 times lower than in highly recombining portions of the genome. Both positive and negative selection models can result in reduced variability levels, but their effects on the frequency spectrum of mutations differ. Using coalescent simulations, I show that the patterns of nucleotide variability on the neo-Y chromosome are unlikely under deleterious mutation models (including background selection and Muller's ratchet) but are expected under recent positive selection. These results implicate positive selection as an important force driving the degeneration of Y chromosomes; adaptation at a few loci, possibly increasing male fitness, occurs at the cost of most other genes on this chromosome.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Cornell Univ, Dept Genet & Mol Biol, Ithaca, NY 14853 USA	University of Edinburgh; Cornell University	Bachtrog, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Doris.Bachtrog@cornell.edu						Andolfatto P, 2001, GENETICS, V158, P657; Bachtrog D, 2003, GENETICS, V165, P1221; Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Drake JW, 1998, GENETICS, V148, P1667; Gordo I, 2002, GENETICS, V161, P835; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson Richard R., 1994, P140; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MUKAI T, 1972, GENETICS, V72, P335; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; RICE WR, 1987, GENETICS, V116, P161; SIMONSEN KL, 1995, GENETICS, V141, P413; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; TAJIMA F, 1989, GENETICS, V123, P585; Yi SJ, 2003, GENETICS, V164, P1369	24	90	91	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					518	522		10.1038/ng1347	http://dx.doi.org/10.1038/ng1347			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107853	Bronze			2022-12-17	WOS:000221183000027
J	Huttley, GA; Easteal, S; Southey, MC; Tesoriero, A; Giles, GG; McCredie, MRE; Hopper, JL; Venter, DJ				Huttley, GA; Easteal, S; Southey, MC; Tesoriero, A; Giles, GG; McCredie, MRE; Hopper, JL; Venter, DJ		Australian Breast Canc Family Stud	Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees	NATURE GENETICS			English	Article							BREAST-CANCER; NUCLEOTIDE SUBSTITUTION; SEQUENCE VARIANTS; AUSTRALIAN WOMEN; OVARIAN-CANCER; MEIOTIC CELLS; GENE BRCA1; POPULATION; SELECTION; SUSCEPTIBILITY	Mutations in BRCA1 (ref. 1) confer an increased risk of female breast cancer(2). In a genome-wide scan of linkage disequilibrium (LD), a high revel of LD was detected among microsatellite markers flanking BRCA1 (ref. 3), raising the prospect that positive natural selection may have acted on this gene. We have used the predictions of evolutionary genetic theory to investigate this further. Using phylogeny-based maximum likelihood analysis of the BRCA1 sequences from primates and other mammals, we found that the ratios of replacement to silent nucleotide substitutions on the human and chimpanzee lineages were not different from one another (P=0.8), were different from those of other primate lineages (P=0.004) and were greater than 1 (P=0.04). This is consistent with the historic occurrence of positive darwinian selection pressure on the BRCA1 protein in the human and chimpanzee lineages. Analysis of genetic variation in a sample of female Australians of Northern European origin showed evidence for Hardy-Weinberg (HW) disequilibrium at polymorphic sites in BRCA1, consistent with the possibility that natural selection is affecting genotype frequencies in modern Europeans. The clustering of between-species variation in the region of the gene encoding the RAD51-interaction domain of BRCA1 suggests the maintenance of genomic integrity as a possible target of selection.	Australian Natl Univ, John Curtin Sch Med Res, Human Genet Grp, Canberra, ACT 2601, Australia; Peter MacCallum Canc Inst, Dept Pathol, E Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Res Dept, E Melbourne, Vic, Australia; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Anticanc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; New S Wales Canc Council, Canc & Epidemiol Res Unit, Woolloomooloo, NSW, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic, Australia	Australian National University; John Curtin School of Medical Research; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Cancer Council New South Wales; University of Otago; University of Melbourne	Huttley, GA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Human Genet Grp, Canberra, ACT 2601, Australia.		Huttley, Gavin A/G-5169-2015	Huttley, Gavin A/0000-0001-7224-2074; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005; Easteal, Simon/0000-0002-0462-502X				[Anonymous], 1984, AM NAT; Batterham P, 1996, BIOESSAYS, V18, P841, DOI 10.1002/bies.950181011; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Clark AG, 2000, NATURE, V403, P261, DOI 10.1038/35002236; Dunning AM, 1997, HUM MOL GENET, V6, P285, DOI 10.1093/hmg/6.2.285; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Hacia JG, 1998, NAT GENET, V18, P155, DOI 10.1038/ng0298-155; Hopper JL, 1994, BREAST, V3, P79; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huttley GA, 1999, GENETICS, V152, P1711; KREITMAN M, 1995, ANNU REV ECOL SYST, V26, P403, DOI 10.1146/annurev.es.26.110195.002155; LEWONTIN RC, 1959, EVOLUTION, V13, P561, DOI 10.2307/2406136; Li W.H., 1997, MOL EVOLUTION; McCredie MRE, 1998, CANCER CAUSE CONTROL, V9, P189, DOI 10.1023/A:1008886328352; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Southey MC, 1998, J NATL CANCER I, V90, P532, DOI 10.1093/jnci/90.7.532; Swanson WJ, 1998, SCIENCE, V281, P710, DOI 10.1126/science.281.5377.710; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	33	90	97	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					410	413		10.1038/78092	http://dx.doi.org/10.1038/78092			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932184				2022-12-17	WOS:000088615000015
J	Bentley, DJ; Selfridge, J; Millar, JK; Samuel, K; Hole, N; Ansell, JD; Melton, DW				Bentley, DJ; Selfridge, J; Millar, JK; Samuel, K; Hole, N; Ansell, JD; Melton, DW			DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability	NATURE GENETICS			English	Letter							EMBRYONIC STEM-CELLS; BLOOMS-SYNDROME; STRAIN 46BR; GENE; REPLICATION; EXPRESSION; REPAIR; PATIENT; HYPERSENSITIVITY; INDUCTION		UNIV EDINBURGH,INST CELL & MOL BIOL,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,INST CELL ANIM & POPULAT BIOL,EDINBURGH EH9 3JT,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh				SELFRIDGE, JIM/0000-0003-2473-4386; Bentley, Darren/0000-0003-2136-9264				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; APPLEGREN N, 1995, J CELL BIOCHEM, V59, P91, DOI 10.1002/jcb.240590111; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; CHAN JYH, 1985, CARCINOGENESIS, V6, P1275, DOI 10.1093/carcin/6.9.1275; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Freshney M. G., 1994, P265; GARIBOLDI M, 1995, MOL CARCINOGEN, V14, P71, DOI 10.1002/mc.2940140202; HENDERSON LM, 1985, P NATL ACAD SCI USA, V82, P2044, DOI 10.1073/pnas.82.7.2044; JESSOP JK, 1995, GENE, V160, P307, DOI 10.1016/0378-1119(95)00222-R; LEHMANN AR, 1988, CANCER RES, V48, P6343; LONN U, 1989, CARCINOGENESIS, V10, P981, DOI 10.1093/carcin/10.6.981; LORIMORE SA, 1990, LEUKEMIA RES, V14, P481, DOI 10.1016/0145-2126(90)90036-9; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; METCALF D, 1971, HEMOPOIETIC COLONIES; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; MONTECUCCO A, 1995, NUCLEIC ACIDS RES, V23, P962, DOI 10.1093/nar/23.6.962; NOGUIEZ P, 1992, NUCLEIC ACIDS RES, V20, P3845, DOI 10.1093/nar/20.15.3845; PETRINI JHJ, 1995, MOL CELL BIOL, V15, P4303; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; STACEY A, 1994, MOL CELL BIOL, V14, P1009, DOI 10.1128/MCB.14.2.1009; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, J BIOL CHEM, V269, P10923; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEI YF, 1995, MOL CELL BIOL, V15, P3206; WU W, 1994, J BIOL CHEM, V54, P32	31	90	91	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					489	491		10.1038/ng0896-489	http://dx.doi.org/10.1038/ng0896-489			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696349				2022-12-17	WOS:A1996VB62000035
J	WHITSETT, JA; DEY, CR; STRIPP, BR; WIKENHEISER, KA; CLARK, JC; WERT, SE; GREGORY, RJ; SMITH, AE; COHN, JA; WILSON, JM; ENGELHARDT, J				WHITSETT, JA; DEY, CR; STRIPP, BR; WIKENHEISER, KA; CLARK, JC; WERT, SE; GREGORY, RJ; SMITH, AE; COHN, JA; WILSON, JM; ENGELHARDT, J			HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DIRECTED TO RESPIRATORY EPITHELIAL-CELLS OF TRANSGENIC MICE	NATURE GENETICS			English	Article							CHLORIDE CHANNELS; GENE; EXPRESSION; IDENTIFICATION; CLONING; MOUSE; CFTR	Human cystic fibrosis transmembrane conductance regulator (CFTR) was expressed in transgenic mice under the control of transcriptional elements derived from the human surfactant protein C (SP-C) gene. The hCFTR mRNA was expressed in lungs and testes: in the lung, we found hCFTR mRNA in bronchiolar and alveolar epithelial cells, and CFTR protein in respiratory epithelial cells. While the level of expression of hCFTR mRNA varied, hCFTR mRNA and protein were detected in pulmonary epithelial cells of several lines. Lung weight, morphology, somatic growth and reproductive capacity were not altered by expression hCFTR in lung and testes of the transgenics. Our findings suggest that hCFTR can be safely transferred to lung epithelial cells for CF therapy.	GENZYME CORP,FRAMINGHAM,MA 01701; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,DEPT BIOL CHEM,ANN ARBOR,MI 48109; DUKE UNIV,DEPT MED,DURHAM,NC 27710; DUKE UNIV,VET ADM MED CTR,DURHAM,NC 27710	Sanofi-Aventis; Genzyme Corporation; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	WHITSETT, JA (corresponding author), CHILDRENS HOSP,DIV PULM BIOL,CINCINNATI,OH 45229, USA.		Wilson, James M/F-9220-2011; Stripp, Barry/AAI-1467-2021	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277; Stripp, Barry/0000-0003-4348-2137				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DITULLIO P, 1992, BIO-TECHNOL, V10, P74, DOI 10.1038/nbt0192-74; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FIEDLER M, IN PRESS AM J PHYSL; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1991, AM PHYS SOC, pL349; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; KORFHAGEN TR, 1990, P NATL ACAD SCI USA, V87, P6122, DOI 10.1073/pnas.87.16.6122; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; MARINO C R, 1991, Gastroenterology, V100, pA287; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; TRESIZE AEO, 1991, NATURE, V353, P434; WELSH MJ, 1986, SCIENCE, V232, P1648, DOI 10.1126/science.2424085	23	90	91	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					13	20		10.1038/ng0992-13	http://dx.doi.org/10.1038/ng0992-13			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284640				2022-12-17	WOS:A1992JM64600009
J	Zhan, HY; Ahearn, TU; Lecarpentier, J; Barnes, D; Beesley, J; Qi, GH; Jiang, X; O'Mara, TA; Zhao, N; Bolla, MK; Dunning, AM; Dennis, J; Wang, Q; Abu Ful, Z; Aittomaki, K; Andrulis, IL; Anton-Culver, H; Arndt, V; Aronson, KJ; Arun, BK; Auer, PL; Azzollini, J; Barrowdale, D; Becher, H; Beckmann, MW; Behrens, S; Benitez, J; Bermisheva, M; Bialkowska, K; Blanco, A; Blomqvist, C; Bogdanova, NV; Bojesen, SE; Bonanni, B; Bondavalli, D; Borg, A; Brauch, H; Brenner, H; Briceno, I; Broeks, A; Brucker, SY; Bruning, T; Burwinkel, B; Buys, SS; Byers, H; Caldes, T; Caligo, MA; Calvello, M; Campa, D; Castelao, JE; Chang-Claude, J; Chanock, SJ; Christiaens, M; Christiansen, H; Chung, WK; Claes, KBM; Clarke, CL; Cornelissen, S; Couch, FJ; Cox, A; Cross, SS; Czene, K; Daly, MB; Devilee, P; Diez, O; Domchek, SM; Dork, T; Dwek, M; Eccles, DM; Ekici, AB; Evans, DG; Fasching, PA; Figueroa, J; Foretova, L; Fostira, F; Friedman, E; Frost, D; Gago-Dominguez, M; Gapstur, SM; Garber, J; Garcia-Saenz, JA; Gaudet, MM; Gayther, SA; Giles, GG; Godwin, AK; Goldberg, MS; Goldgar, DE; Gonzalez-Neira, A; Greene, MH; Gronwald, J; Guenel, P; Haberle, L; Hahnen, E; Haiman, CA; Hake, CR; Hall, P; Hamann, U; Harkness, EF; Heemskerk-Gerritsen, BAM; Hillemanns, P; Hogervorst, FBL; Holleczek, B; Hollestelle, A; Hooning, MJ; Hoover, RN; Hopper, JL; Howell, A; Huebner, H; Hulick, PJ; Imyanitov, EN; Isaacs, C; Izatt, L; Jager, A; Jakimovska, M; Jakubowska, A; James, P; Janavicius, R; Janni, W; John, EM; Jones, ME; Jung, A; Kaaks, R; Kapoor, PM; Karlan, BY; Keeman, R; Khan, S; Khusnutdinova, E; Kitahara, CM; Ko, YD; Konstantopoulou, I; Koppert, LB; Koutros, S; Kristensen, VN; Laenkholm, AV; Lambrechts, D; Larsson, SC; Laurent-Puig, P; Lazaro, C; Lazarova, E; Lejbkowicz, F; Leslie, G; Lesueur, F; Lindblom, A; Lissowska, J; Lo, WY; Loud, JT; Lubinski, J; Lukomska, A; MacInnis, RJ; Mannermaa, A; Manoochehri, M; Manoukian, S; Margolin, S; Martinez, ME; Matricardi, L; McGuffog, L; McLean, C; Mebirouk, N; Meindl, A; Menon, U; Miller, A; Mingazheva, E; Montagna, M; Mulligan, AM; Mulot, C; Muranen, TA; Nathanson, KL; Neuhausen, SL; Nevanlinna, H; Neven, P; Newman, WG; Nielsens, FC; Nikitina-Zake, L; Nodora, J; Offit, K; Olah, E; Olopade, OI; Olsson, H; Orr, N; Papi, L; Papp, J; Park-Simon, TW; Parsons, MT; Peissel, B; Peixoto, A; Peshkin, B; Peterlongo, P; Peto, J; Phillips, KA; Piedmonte, M; Plaseska-Karanfilska, D; Prajzendanc, K; Prentice, R; Prokofyeva, D; Rack, B; Radice, P; Ramus, SJ; Rantala, J; Rashid, MU; Rennert, G; Rennert, HS; Risch, HA; Romero, A; Rookus, MA; Rubner, M; Rudiger, T; Saloustros, E; Sampson, S; Sandler, DP; Sawyer, EJ; Scheuner, MT; Schmutzler, RK; Schneeweiss, A; Schoemaker, MJ; Schottker, B; Schurmann, P; Senter, L; Sharma, P; Sherman, ME; Shu, XO; Singer, CF; Smichkoska, S; Soucy, P; Southey, MC; Spinelli, JJ; Stone, J; Stoppa-Lyonnet, D; Swerdlow, AJ; Szabo, CI; Tamimi, RM; Tapper, WJ; Taylor, JA; Teixeira, MR; Terry, M; Thomassen, M; Thull, DL; Tischkowitz, M; Toland, AE; Tollenaar, RAEM; Tomlinson, I; Torres, D; Troester, MA; Truong, T; Tung, N; Untch, M; Vachon, CM; van den Ouweland, AMW; van der Kolk, LE; van Veen, EM; vanRensburg, EJ; Vega, A; Wappenschmidt, B; Weinberg, CR; Weitzel, JN; Wildiers, H; Winqvist, R; Wolk, A; Yang, XHR; Yannoukakos, D; Zheng, W; Zorn, KK; Milne, RL; Kraft, P; Simard, J; Pharoah, PDP; Michailidou, K; Antoniou, AC; Schmidt, MK; Chenevix-Trench, G; Easton, DF; Chatterjee, N; Garcia-Closas, M				Zhan, Haoyu; Ahearn, Thomas U.; Lecarpentier, Julie; Barnes, Daniel; Beesley, Jonathan; Qi, Guanghao; Jiang, Xia; O'Mara, Tracy A.; Zhao, Ni; Bolla, Manjeet K.; Dunning, Alison M.; Dennis, Joe; Wang, Qin; Abu Ful, Zumuruda; Aittomaki, Kristiina; Andrulis, Irene L.; Anton-Culver, Hoda; Arndt, Volker; Aronson, Kristan J.; Arun, Banu K.; Auer, Paul L.; Azzollini, Jacopo; Barrowdale, Daniel; Becher, Heiko; Beckmann, Matthias W.; Behrens, Sabine; Benitez, Javier; Bermisheva, Marina; Bialkowska, Katarzyna; Blanco, Ana; Blomqvist, Carl; Bogdanova, Natalia, V; Bojesen, Stig E.; Bonanni, Bernardo; Bondavalli, Davide; Borg, Ake; Brauch, Hiltrud; Brenner, Hermann; Briceno, Ignacio; Broeks, Annegien; Brucker, Sara Y.; Bruening, Thomas; Burwinkel, Barbara; Buys, Saundra S.; Byers, Helen; Caldes, Trinidad; Caligo, Maria A.; Calvello, Mariarosaria; Campa, Daniele; Castelao, Jose E.; Chang-Claude, Jenny; Chanock, Stephen J.; Christiaens, Melissa; Christiansen, Hans; Chung, Wendy K.; Claes, Kathleen B. M.; Clarke, Christine L.; Cornelissen, Sten; Couch, Fergus J.; Cox, Angela; Cross, Simon S.; Czene, Kamila; Daly, Mary B.; Devilee, Peter; Diez, Orland; Domchek, Susan M.; Doerk, Thilo; Dwek, Miriam; Eccles, Diana M.; Ekici, Arif B.; Evans, D. Gareth; Fasching, Peter A.; Figueroa, Jonine; Foretova, Lenka; Fostira, Florentia; Friedman, Eitan; Frost, Debra; Gago-Dominguez, Manuela; Gapstur, Susan M.; Garber, Judy; Garcia-Saenz, Jose A.; Gaudet, Mia M.; Gayther, Simon A.; Giles, Graham G.; Godwin, Andrew K.; Goldberg, Mark S.; Goldgar, David E.; Gonzalez-Neira, Anna; Greene, Mark H.; Gronwald, Jacek; Guenel, Pascal; Haeberle, Lothar; Hahnen, Eric; Haiman, Christopher A.; Hake, Christopher R.; Hall, Per; Hamann, Ute; Harkness, Elaine F.; Heemskerk-Gerritsen, Bernadette A. M.; Hillemanns, Peter; Hogervorst, Frans B. L.; Holleczek, Bernd; Hollestelle, Antoinette; Hooning, Maartje J.; Hoover, Robert N.; Hopper, John L.; Howell, Anthony; Huebner, Hanna; Hulick, Peter J.; Imyanitov, Evgeny N.; Isaacs, Claudine; Izatt, Louise; Jager, Agnes; Jakimovska, Milena; Jakubowska, Anna; James, Paul; Janavicius, Ramunas; Janni, Wolfgang; John, Esther M.; Jones, Michael E.; Jung, Audrey; Kaaks, Rudolf; Kapoor, Pooja Middha; Karlan, Beth Y.; Keeman, Renske; Khan, Sofia; Khusnutdinova, Elza; Kitahara, Cari M.; Ko, Yon-Dschun; Konstantopoulou, Irene; Koppert, Linetta B.; Koutros, Stella; Kristensen, Vessela N.; Laenkholm, Anne-Vibeke; Lambrechts, Diether; Larsson, Susanna C.; Laurent-Puig, Pierre; Lazaro, Conxi; Lazarova, Emilija; Lejbkowicz, Flavio; Leslie, Goska; Lesueur, Fabienne; Lindblom, Annika; Lissowska, Jolanta; Lo, Wing-Yee; Loud, Jennifer T.; Lubinski, Jan; Lukomska, Alicja; MacInnis, Robert J.; Mannermaa, Arto; Manoochehri, Mehdi; Manoukian, Siranoush; Margolin, Sara; Martinez, Maria Elena; Matricardi, Laura; McGuffog, Lesley; McLean, Catriona; Mebirouk, Noura; Meindl, Alfons; Menon, Usha; Miller, Austin; Mingazheva, Elvira; Montagna, Marco; Mulligan, Anna Marie; Mulot, Claire; Muranen, Taru A.; Nathanson, Katherine L.; Neuhausen, Susan L.; Nevanlinna, Heli; Neven, Patrick; Newman, William G.; Nielsens, Finn C.; Nikitina-Zake, Liene; Nodora, Jesse; Offit, Kenneth; Olah, Edith; Olopade, Olufunmilayo, I; Olsson, Hakan; Orr, Nick; Papi, Laura; Papp, Janos; Park-Simon, Tjoung-Won; Parsons, Michael T.; Peissel, Bernard; Peixoto, Ana; Peshkin, Beth; Peterlongo, Paolo; Peto, Julian; Phillips, Kelly-Anne; Piedmonte, Marion; Plaseska-Karanfilska, Dijana; Prajzendanc, Karolina; Prentice, Ross; Prokofyeva, Darya; Rack, Brigitte; Radice, Paolo; Ramus, Susan J.; Rantala, Johanna; Rashid, Muhammad U.; Rennert, Gad; Rennert, Hedy S.; Risch, Harvey A.; Romero, Atocha; Rookus, Matti A.; Ruebner, Matthias; Ruediger, Thomas; Saloustros, Emmanouil; Sampson, Sarah; Sandler, Dale P.; Sawyer, Elinor J.; Scheuner, Maren T.; Schmutzler, Rita K.; Schneeweiss, Andreas; Schoemaker, Minouk J.; Schoettker, Ben; Schuermann, Peter; Senter, Leigha; Sharma, Priyanka; Sherman, Mark E.; Shu, Xiao-Ou; Singer, Christian F.; Smichkoska, Snezhana; Soucy, Penny; Southey, Melissa C.; Spinelli, John J.; Stone, Jennifer; Stoppa-Lyonnet, Dominique; Swerdlow, Anthony J.; Szabo, Csilla, I; Tamimi, Rulla M.; Tapper, William J.; Taylor, Jack A.; Teixeira, Manuel R.; Terry, MaryBeth; Thomassen, Mads; Thull, Darcy L.; Tischkowitz, Marc; Toland, Amanda E.; Tollenaar, Rob A. E. M.; Tomlinson, Ian; Torres, Diana; Troester, Melissa A.; Truong, Therese; Tung, Nadine; Untch, Michael; Vachon, Celine M.; van den Ouweland, Ans M. W.; van der Kolk, Lizet E.; van Veen, Elke M.; vanRensburg, Elizabeth J.; Vega, Ana; Wappenschmidt, Barbara; Weinberg, Clarice R.; Weitzel, Jeffrey N.; Wildiers, Hans; Winqvist, Robert; Wolk, Alicja; Yang, Xiaohong R.; Yannoukakos, Drakoulis; Zheng, Wei; Zorn, Kristin K.; Milne, Roger L.; Kraft, Peter; Simard, Jacques; Pharoah, Paul D. P.; Michailidou, Kyriaki; Antoniou, Antonis C.; Schmidt, Marjanka K.; Chenevix-Trench, Georgia; Easton, Douglas F.; Chatterjee, Nilanjan; Garcia-Closas, Montserrat		kConFab Investigators; ABCTB Investigators; EMBRACE Study; GEMO Study Collaborators	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses	NATURE GENETICS			English	Article							MUTATION CARRIERS; RISK; HERITABILITY; METAANALYSIS; MODIFIERS; BRCA1	Genome-wide analysis identifies 32 loci associated with breast cancer susceptibility, accounting for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype(1-3). To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 x 10(-8)), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate < 0.05). Five loci showed associations (P < 0.05) in opposite directions between luminal and non-luminal subtypes. In silico analyses showed that these five loci contained cell-specific enhancers that differed between normal luminal and basal mammary cells. The genetic correlations between five intrinsic-like subtypes ranged from 0.35 to 0.80. The proportion of genome-wide chip heritability explained by all known susceptibility loci was 54.2% for luminal A-like disease and 37.6% for triple-negative disease. The odds ratios of polygenic risk scores, which included 330 variants, for the highest 1% of quantiles compared with middle quantiles were 5.63 and 3.02 for luminal A-like and triple-negative disease, respectively. These findings provide an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.	[Zhan, Haoyu; Ahearn, Thomas U.; Chanock, Stephen J.; Hoover, Robert N.; Koutros, Stella; Yang, Xiaohong R.; Garcia-Closas, Montserrat] NCI, Div Canc Epidemiol & Genet, US Dept HHS, NIH, Bethesda, MD 20892 USA; [Zhan, Haoyu; Qi, Guanghao; Zhao, Ni; Chatterjee, Nilanjan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Lecarpentier, Julie; Barnes, Daniel; Dunning, Alison M.; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Beesley, Jonathan; O'Mara, Tracy A.; Parsons, Michael T.; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Jiang, Xia; Tamimi, Rulla M.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA USA; [Bolla, Manjeet K.; Dennis, Joe; Wang, Qin; Leslie, Goska; McGuffog, Lesley; Peto, Julian; Pharoah, Paul D. P.; Michailidou, Kyriaki; Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Abu Ful, Zumuruda; Lejbkowicz, Flavio; Rennert, Gad; Rennert, Hedy S.] Carmel Hosp, Clalit Natl Canc Control Ctr, Haifa, Israel; [Abu Ful, Zumuruda; Lejbkowicz, Flavio; Rennert, Gad; Rennert, Hedy S.] Technion Fac Med, Haifa, Israel; [Aittomaki, Kristiina] Univ Helsinki, Helsinki Univ Hosp, Dept Clin Genet, Helsinki, Finland; [Andrulis, Irene L.] Mt Sinai Hosp, Fred A Litwin Ctr Canc Genet, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Anton-Culver, Hoda] Univ Calif Irvine, Genet Epidemiol Res Inst, Dept Epidemiol, Irvine, CA USA; [Arndt, Volker; Brenner, Hermann; Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Aronson, Kristan J.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Aronson, Kristan J.] Queens Univ, Canc Res Inst, Kingston, ON, Canada; [Arun, Banu K.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Auer, Paul L.; Prentice, Ross] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, 1124 Columbia St, Seattle, WA 98104 USA; [Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Azzollini, Jacopo; Manoukian, Siranoush; Peissel, Bernard] Fdn IRCCS Ist Nazl Tumori INT, Dept Med Oncol & Hematol, Unit Med Genet, Milan, Italy; [Barrowdale, Daniel; Frost, Debra] Univ Cambridge, Ctr Canc Genet Epidemiol, Cambridge, England; [Becher, Heiko; Prokofyeva, Darya] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany; [Beckmann, Matthias W.; Fasching, Peter A.; Huebner, Hanna] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr ER EMN, Dept Gynecol & Obstet, Erlangen, Germany; [Behrens, Sabine; Campa, Daniele; Chang-Claude, Jenny; Jung, Audrey; Kaaks, Rudolf; Kapoor, Pooja Middha] DKFZ, Div Canc Epidemiol, Heidelberg, Germany; [Benitez, Javier] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain; [Bermisheva, Marina; Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Fed Res Ctr, Ufa, Russia; [Bialkowska, Katarzyna; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan; Lukomska, Alicja; Prajzendanc, Karolina] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Blanco, Ana; Vega, Ana] Fdn Publ Galega Med Xen, Mol Med Unit, Santiago De Compostela, Spain; [Blanco, Ana; Vega, Ana] Complejo Hosp Univ Santiago, Inst Invest Sanitaria Santiago de Compostela IDIS, Serv Galego Saude SERGAS, Santiago De Compostela, Spain; [Blanco, Ana; Vega, Ana] CIBERER, Santiago De Compostela, Spain; [Blomqvist, Carl] Univ Helsinki, Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Blomqvist, Carl] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden; [Bogdanova, Natalia, V] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Bogdanova, Natalia, V; Doerk, Thilo; Hillemanns, Peter; Park-Simon, Tjoung-Won; Schuermann, Peter] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Bogdanova, Natalia, V; Christiansen, Hans] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Bojesen, Stig E.; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Programme, Madrid, Spain; [Bonanni, Bernardo; Bondavalli, Davide; Calvello, Mariarosaria] European Inst Oncol IEO IRCCS, Div Canc Prevent & Genet, Milan, Italy; [Borg, Ake] Lund Univ, Dept Oncol, Lund, Sweden; [Borg, Ake] Skane Univ Hosp, Lund, Sweden; [Brauch, Hiltrud; Lo, Wing-Yee] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud; Greene, Mark H.] Univ Tubingen, iFIT Cluster Excellence, Tubingen, Germany; [Brauch, Hiltrud; Brenner, Hermann] DKFZ, German Canc Consortium DKTK, Heidelberg, Germany; [Brenner, Hermann] DKFZ, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Briceno, Ignacio] Univ Sabana, Fac Med, Biosci Dept, Chia, Colombia; [Broeks, Annegien; Cornelissen, Sten; Keeman, Renske; Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Brucker, Sara Y.] Univ Tubingen, Dept Womens Hlth, Tubingen, Germany; [Bruening, Thomas] Ruhr Univ Bochum, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Burwinkel, Barbara] DKFZ, Mol Epidemiol Grp C080, Heidelberg, Germany; [Burwinkel, Barbara; Schneeweiss, Andreas] Heidelberg Univ, Univ Womens Clin Heidelberg, Mol Biol Breast Canc, Heidelberg, Germany; [Buys, Saundra S.] Huntsman Canc Inst, Dept Med, Salt Lake City, UT USA; [Byers, Helen; Evans, D. Gareth; Newman, William G.; van Veen, Elke M.] Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med,Manchester NIHR Biomed R, Manchester, Lancs, England; [Caldes, Trinidad; Garcia-Saenz, Jose A.] Hosp Clin San Carlos, Ctr Invest Biomed Red Canc CIBERONC, Inst Invest Sanitaria San Carlos IdISSC, Med Oncol Dept, Madrid, Spain; [Caligo, Maria A.] Univ Hosp Pisa, Dept Lab Med, Sect Mol Genet, Pisa, Italy; [Campa, Daniele] Univ Pisa, Dept Biol, Pisa, Italy; [Castelao, Jose E.] Xerencia Xest Integrada Vigo SERGAS, Oncol & Genet Unit, Inst Invest Sanitaria Galicia IISGS, Vigo, Spain; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg UCCH, Canc Epidemiol Grp, Hamburg, Germany; [Christiaens, Melissa; Neven, Patrick; Wildiers, Hans] Univ Hosp Leuven, Leuven Multidisciplinary Breast Ctr, Leuven Canc Inst, Dept Oncol, Leuven, Belgium; [Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, New York, NY USA; [Claes, Kathleen B. M.] Univ Ghent, Ctr Med Genet, Ghent, Belgium; [Clarke, Christine L.] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Cox, Angela] Univ Sheffield, Sheffield Inst Nucle Acids SInFoNiA, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England; [Czene, Kamila; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Clin Genet, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Devilee, Peter] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Diez, Orland] Vall dHebron Inst Oncol VHIO, Oncogenet Grp, Barcelona, Spain; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Dwek, Miriam] Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London, England; [Eccles, Diana M.] Univ Southampton, Canc Sci Acad Unit, Fac Med, Southampton, Hants, England; [Ekici, Arif B.] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr ER EMN, Inst Human Genet, Erlangen, Germany; [Evans, D. Gareth; Newman, William G.; van Veen, Elke M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Evolut & Genom Med, Manchester, Lancs, England; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Figueroa, Jonine] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Med Sch, Edinburgh, Midlothian, Scotland; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Fostira, Florentia; Konstantopoulou, Irene; Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, INRASTES, Athens, Greece; [Friedman, Eitan] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Ramat Gan, Israel; [Gago-Dominguez, Manuela] Complejo Hosp Univ Santiago, Galician Fdn Genom Med, SERGAS, IDIS,Genom Med Grp, Santiago De Compostela, Spain; [Gago-Dominguez, Manuela; Martinez, Maria Elena; Nodora, Jesse] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gapstur, Susan M.; Gaudet, Mia M.] Amer Canc Soc, Behav & Epidemiol Res Grp, Atlanta, GA 30329 USA; [Garber, Judy] Dana Farber Canc Inst, Canc Risk & Prevent Clin, Boston, MA 02115 USA; [Gayther, Simon A.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Gayther, Simon A.] Cedars Sinai Med Ctr, Cedars Sinai Genom Core, Los Angeles, CA 90048 USA; [Giles, Graham G.; MacInnis, Robert J.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Giles, Graham G.; Hopper, John L.; MacInnis, Robert J.; Phillips, Kelly-Anne; Stone, Jennifer; Milne, Roger L.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Giles, Graham G.; Southey, Melissa C.; Milne, Roger L.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Melbourne, Vic, Australia; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Goldberg, Mark S.] Univ Malaya, Canc Res Inst, Breast Canc Res Unit, Med Ctr, Kuala Lumpur, Malaysia; [Goldgar, David E.] Univ Utah, Huntsman Canc Inst, Dept Dermatol, Sch Med, Salt Lake City, UT USA; [Loud, Jennifer T.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, Univ Paris Saclay, Ctr Res Epidemiol & Populat Hlth CESP, INSERM, Paris, France; [Haeberle, Lothar; Ruebner, Matthias] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr ER EMN, Dept Gynaecol & Obstet, Erlangen, Germany; [Hahnen, Eric; Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, Fac Med, Ctr Familial Breast & Ovarian Canc, Ctr Integrated Oncol CIO, Cologne, Germany; [Hahnen, Eric; Schmutzler, Rita K.; Wappenschmidt, Barbara] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Hake, Christopher R.] Waukesha Mem Hosp Pro Hlth Care, Waukesha, WI USA; [Hall, Per; Margolin, Sara] Soder Sjukhuset, Dept Oncol, Stockholm, Sweden; [Hamann, Ute; Manoochehri, Mehdi; Rashid, Muhammad U.; Torres, Diana] DKFZ, Mol Genet Breast Canc, Heidelberg, Germany; [Harkness, Elaine F.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Harkness, Elaine F.] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Nightingale Breast Screening Ctr, Manchester, Lancs, England; [Heemskerk-Gerritsen, Bernadette A. M.; Hollestelle, Antoinette; Hooning, Maartje J.; Jager, Agnes] Erasmus MC Canc Inst, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [Hogervorst, Frans B. L.; van der Kolk, Lizet E.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Howell, Anthony] Univ Manchester, Div Canc Sci, Manchester, Lancs, England; [Hulick, Peter J.] NorthShore Univ Hlth Syst, Ctr Med Genet, Evanston, IL USA; [Imyanitov, Evgeny N.] NN Petrov Inst Oncol, St Petersburg, Russia; [Isaacs, Claudine] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, Clin Genet, London, England; [Jakimovska, Milena; Plaseska-Karanfilska, Dijana] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, North Macedonia; [Jakubowska, Anna; Wolk, Alicja] Pomeranian Med Univ, Independent Lab Mol Biol & Genet Diagnost, Szczecin, Poland; [James, Paul] Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, Melbourne, Vic, Australia; [Janavicius, Ramunas] Vilnius Univ Hosp Santariskiu Clin, Hematol Oncol & Transfus Med Ctr, Dept Mol & Regenerat Med, Vilnius, Lithuania; [Janavicius, Ramunas] State Res Inst Ctr Innovat Med, Vilnius, Lithuania; [Janni, Wolfgang; Rack, Brigitte] Univ Hosp Ulm, Dept Gynaecol & Obstet, Ulm, Germany; [John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Dept Med,Div Oncol, Stanford, CA 94305 USA; [Jones, Michael E.; Schoemaker, Minouk J.; Swerdlow, Anthony J.] Inst Canc Res, Div Genet & Epidemiol, London, England; [Kapoor, Pooja Middha] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Karlan, Beth Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Khan, Sofia; Muranen, Taru A.; Nevanlinna, Heli] Univ Helsinki, Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Khusnutdinova, Elza; Mingazheva, Elvira] Bashkir State Med Univ, Dept Genet & Fundamental Med, Ufa, Russia; [Kitahara, Cari M.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ko, Yon-Dschun] Johanniter Krankenhaus, Dept Internal Med, Evangel Kliniken Bonn, Bonn, Germany; [Koppert, Linetta B.] Erasmus MC Canc Inst, Dept Surg Oncol, Family Canc Clin, Rotterdam, Netherlands; [Kristensen, Vessela N.] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Canc Genet, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Laenkholm, Anne-Vibeke] Zealand Univ Hosp, Dept Surg Pathol, Slagelse, Denmark; [Lambrechts, Diether] VIB, VIB Ctr Canc Biol, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium; [Larsson, Susanna C.; Wolk, Alicja] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Larsson, Susanna C.; Wolk, Alicja] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Laurent-Puig, Pierre; Mulot, Claire] Univ Paris Sorbonne Cite, INSERM UMR S1147, Paris, France; [Lazaro, Conxi] CIBERONC, Catalan Inst Oncol ICO, Mol Diagnost Unit, Bellvitge Biomed Res Inst IDIBELL,Hereditary Canc, Barcelona, Spain; [Lazarova, Emilija; Smichkoska, Snezhana] Ss Cyril & Methodius Univ Skopje, Univ Clin Radiotherapy & Oncol, Med Fac, Skopje, North Macedonia; [Lesueur, Fabienne] INSERM U900, Genet Epidemiol Canc Team, Paris, France; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lindblom, Annika] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Oncol Inst, Warsaw, Poland; [Lo, Wing-Yee] Univ Tubingen, Tubingen, Germany; [Mannermaa, Arto] Univ Eastern Finland, Translat Canc Res Area, Kuopio, Finland; [Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, Dept Clin Pathol, Kuopio, Finland; [Margolin, Sara] Karolinska Inst, Dept Clin Sci & Educ, Soder Sjukhuset, Stockholm, Sweden; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Matricardi, Laura; Montagna, Marco] Veneto Inst Oncol IOV IRCCS, Immunol & Mol Oncol Unit, Padua, Italy; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Mebirouk, Noura] PSL Univ, Inst Curie, Mines ParisTech, INSERM U900,Genet Epidemiol Canc Team, Paris, France; [Meindl, Alfons] Ludwig Maximilian Univ Munich, Dept Gynecol & Obstet, Munich, Germany; [Menon, Usha] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, London, England; [Miller, Austin; Piedmonte, Marion] Roswell Park Canc Inst, NRG Oncol Stat & Data Management Ctr, Buffalo, NY 14263 USA; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Nielsens, Finn C.] Copenhagen Univ Hosp, Rigshosp, Ctr Genom Med, Copenhagen, Denmark; [Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Nodora, Jesse] University California San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Clin Genet Res Lab, 1275 York Ave, New York, NY 10021 USA; [Olah, Edith; Papp, Janos] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Olopade, Olufunmilayo, I] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA; [Olopade, Olufunmilayo, I] Univ Melbourne, Dept Clin Pathol, Melbourne, Vic, Australia; [Olsson, Hakan] Lund Univ, Dept Canc Epidemiol, Clin Sci, Lund, Sweden; [Olsson, Hakan] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA; [Orr, Nick] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Papi, Laura] Univ Florence, Dept Biomed Expt & Clin Sci, Unit Med Genet, Florence, Italy; [Peixoto, Ana; Teixeira, Manuel R.] Portuguese Oncol Inst, Dept Genet, Porto, Portugal; [Peshkin, Beth] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Peterlongo, Paolo] FIRC Inst Mol Oncol, IFOM, Genome Diagnost Program, Milan, Italy; [Peto, Julian] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Phillips, Kelly-Anne] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Phillips, Kelly-Anne] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Radice, Paolo] INT, Unit Mol Bases Genet Risk & Genet Testing, Dept Res, Milan, Italy; [Ramus, Susan J.] Univ NSW Sydney, Lowy Canc Res Ctr, Adult Canc Program, Sydney, NSW, Australia; [Ramus, Susan J.] Univ NSW Sydney, Fac Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Ramus, Susan J.] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Rantala, Johanna] Karolinska Inst, Clin Genet, Stockholm, Sweden; [Rashid, Muhammad U.] Shaukat Khanum Mem Canc Hosp & Res Ctr SKMCH&RC, Dept Basic Sci, Lahore, Pakistan; [Risch, Harvey A.] Yale Sch Publ Hlth, Chron Dis Epidemiol, New Haven, CT USA; [Romero, Atocha] Hosp Univ Puerta de Hierro, Med Oncol Dept, Madrid, Spain; [Romero, Atocha; Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, Porto, Portugal; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Ruediger, Thomas] Staedt Klinikum Karlsruhe, Inst Pathol, Karlsruhe, Germany; [Saloustros, Emmanouil] Univ Hosp Larissa, Dept Oncol, Larisa, Greece; [Sampson, Sarah] Manchester Univ NHS Fdn Trust, Prevent Breast Canc Ctr, Manchester, Lancs, England; [Sampson, Sarah] Manchester Univ NHS Fdn Trust, Nightingale Breast Screening Ctr, Manchester, Lancs, England; [Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, Durham, NC USA; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Res Oncol, London, England; [Scheuner, Maren T.] Univ Calif San Francisco, Canc Genet & Prevent Program, San Francisco, CA 94143 USA; [Schneeweiss, Andreas] Univ Hosp, NCT, Heidelberg, Germany; [Schneeweiss, Andreas] DKFZ, Heidelberg, Germany; [Senter, Leigha] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Human Genet,Clin Canc Genet Program, Columbus, OH 43210 USA; [Sharma, Priyanka] Univ Kansas, Med Ctr, Dept Internal Med, Div Oncol, Kansas City, KS 66103 USA; [Sherman, Mark E.] Mayo Clin, Dept Hlth Sci Res, Coll Med, Jacksonville, FL 32224 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Vanderbilt Ingram Canc Ctr, Dept Med,Sch Med,Div Epidemiol, Nashville, TN 37212 USA; [Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Singer, Christian F.] Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria; [Soucy, Penny; Simard, Jacques] Univ Laval, Ctr Hosp Univ Quebec, Genom Ctr, Res Ctr, Quebec City, PQ, Canada; [Spinelli, John J.] BC Canc, Populat Oncol, Vancouver, BC, Canada; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Stone, Jennifer] Curtin Univ, Curtin UWA Ctr Genet Origins Hlth & Dis, Perth, WA, Australia; [Stone, Jennifer] Univ Western Australia, Perth, WA, Australia; [Stoppa-Lyonnet, Dominique] Paris Descartes Sorbonne Paris Cite Univ, Dept Genet, INSERM U830, Inst Curie, Paris, France; [Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, London, England; [Szabo, Csilla, I] NCI, NHGRI, Bethesda, MD 20892 USA; [Tamimi, Rulla M.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Tamimi, Rulla M.] Harvard Med Sch, Boston, MA 02115 USA; [Tamimi, Rulla M.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Tapper, William J.] Univ Southampton, Fac Med, Southampton, Hants, England; [Taylor, Jack A.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Durham, NC USA; [Terry, MaryBeth] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Thull, Darcy L.] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Tischkowitz, Marc] McGill Univ, Dept Human Genet & Oncol, Program Canc Genet, Montreal, PQ, Canada; [Tischkowitz, Marc] Univ Cambridge, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Dept Med Genet, Cambridge, England; [Toland, Amanda E.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Tollenaar, Rob A. E. M.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [Tomlinson, Ian] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford, England; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Troester, Melissa A.] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Dept Med Oncol, Boston, MA 02215 USA; [Untch, Michael] Helios Clin Berlin Buch, Dept Gynecol & Obstet, Berlin, Germany; [Vachon, Celine M.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [van den Ouweland, Ans M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [vanRensburg, Elizabeth J.] Univ Pretoria, Dept Genet, Pretoria, South Africa; [Weinberg, Clarice R.] NIEHS, Biostat & Computat Biol Branch, NIH, Durham, NC USA; [Weitzel, Jeffrey N.] City Hope Natl Med Ctr, Clin Canc Genom, Duarte, CA USA; [Winqvist, Robert] Univ Oulu, Bioctr Oulu, Canc & Translat Med Res Unit, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Winqvist, Robert] Northern Finland Lab Ctr Oulu, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Winqvist, Robert] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Winqvist, Robert] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Zorn, Kristin K.] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Pittsburgh, PA 15213 USA; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Biostat Unit, Nicosia, Cyprus; [Michailidou, Kyriaki] Cyprus Sch Mol Med, Nicosia, Cyprus; [Schmidt, Marjanka K.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Chatterjee, Nilanjan] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge; QIMR Berghofer Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California Irvine; Helmholtz Association; German Cancer Research Center (DKFZ); Queens University - Canada; Queens University - Canada; University of Texas System; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Cambridge; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Pomeranian Medical University; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Helsinki; Helsinki University Central Hospital; Orebro University; Hannover Medical School; Hannover Medical School; University of Copenhagen; University of Copenhagen; University of Copenhagen; Centro Nacional de Investigaciones Oncologicas (CNIO); Lund University; Lund University; Skane University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Universidad de La Sabana; Netherlands Cancer Institute; Eberhard Karls University of Tubingen; Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Huntsman Cancer Institute; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; University of Hamburg; University Medical Center Hamburg-Eppendorf; KU Leuven; University Hospital Leuven; Columbia University; Columbia University; Ghent University; University of Sydney; Westmead Institute for Medical Research; Mayo Clinic; University of Sheffield; University of Sheffield; Karolinska Institutet; Fox Chase Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vall d'Hebron Institut d'Oncologia (VHIO); University of Pennsylvania; Pennsylvania Medicine; University of Westminster; University of Southampton; University of Erlangen Nuremberg; University of Manchester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Edinburgh; Masaryk Memorial Cancer Institute; National Centre of Scientific Research "Demokritos"; Chaim Sheba Medical Center; Complexo Hospitalario Universitario de Santiago de Compostela; University of California System; University of California San Diego; American Cancer Society; Harvard University; Dana-Farber Cancer Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cancer Council Victoria; University of Melbourne; Monash University; University of Kansas; University of Kansas Medical Center; McGill University; McGill University; Royal Victoria Hospital; Universiti Malaya; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Erlangen Nuremberg; University of Cologne; University of Cologne; University of Southern California; Sodersjukhuset Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Netherlands Cancer Institute; University of Manchester; NorthShore University Health System; N.N. Petrov Research Institute of Oncology; Georgetown University; Guy's & St Thomas' NHS Foundation Trust; Pomeranian Medical University; Peter Maccallum Cancer Center; Vilnius University Hospital Santariskiu Klinikos; State Research Institute Centre for Innovative Medicine; Ulm University; Stanford Cancer Institute; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Ruprecht Karls University Heidelberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; Bashkir State Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Oslo; University of Oslo; Flanders Institute for Biotechnology (VIB); KU Leuven; Karolinska Institutet; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Saints Cyril & Methodius University of Skopje; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Maria Sklodowska-Curie National Research Institute of Oncology; Eberhard Karls University of Tubingen; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Karolinska Institutet; Sodersjukhuset Hospital; University of California System; University of California San Diego; IRCCS Istituto Oncologico Veneto (IOV); Florey Institute of Neuroscience & Mental Health; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munich; Medical Research Council Clinical Trials Unit; University of London; University College London; Roswell Park Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; City of Hope; Beckman Research Institute of City of Hope; Rigshospitalet; University of Copenhagen; Latvian Biomedical Research & Study Centre; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center; National Institute of Oncology Hungary; University of Chicago; University of Melbourne; Lund University; Memorial Sloan Kettering Cancer Center; Queens University Belfast; University of Florence; Portuguese Institute of Oncology; Georgetown University; IFOM - FIRC Institute of Molecular Oncology; University of London; London School of Hygiene & Tropical Medicine; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; Karolinska Institutet; Shaukat Khanum Memorial Cancer Hospital & Research Centre; Yale University; Hospital Puerta de Hierro-Majadahonda; Universidade do Porto; Netherlands Cancer Institute; Municipal Hospital Karlsruhe; General University Hospital of Larissa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Kansas; University of Kansas Medical Center; Mayo Clinic; Vanderbilt University; Medical University of Vienna; Medical University of Vienna; Laval University; University of British Columbia; Curtin University; University of Western Australia; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Human Genome Research Institute (NHGRI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Southampton; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University; University of Southern Denmark; Odense University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University; University of Cambridge; University System of Ohio; Ohio State University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Pontificia Universidad Javeriana; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Erasmus University Rotterdam; Erasmus MC; University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); City of Hope; University of Oulu; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Netherlands Cancer Institute; Johns Hopkins University	Chatterjee, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.; Chatterjee, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	nchatte2@jnu.edu	Peterlongo, Paolo/Q-4717-2018; jager, agnes/V-6381-2017; Brüning, Thomas/G-8120-2015; Figueroa, Jonine/GWD-1322-2022; truong, therese/A-2837-2013; Figueroa, Jonine/AAG-1065-2022; Zheng, Wei/GQQ-8951-2022; Kitahara, Cari M/R-8267-2016; DEVILEE, PETER/ABR-2140-2022; Lesueur, Fabienne/R-2178-2017; Imyanitov, Evgeny/ABG-8619-2021; Romero, Atocha/AAS-2862-2021; Margolin, Sara/AAX-9034-2020; Fasching, Peter A/ABH-9912-2020; Gago-Dominguez, Manuela/AAP-6611-2021; Dörk, Thilo/J-8620-2012; Lambrechts, Diether/AAJ-3167-2020; Bogdanova, Natalia V./Y-2205-2019; Kraft, Peter/GQH-8448-2022; Ekici, Arif B/C-3971-2013; Garcia-Closas, Montserrat/AAZ-6930-2021; Jakubowska, Anna/O-8050-2014; Gonzalez-Neira, Anna/C-5791-2015; Lissowska, Jolanta/AAH-3252-2020; Huebner, Hanna/U-1003-2019; Claes, Kathleen/AFR-6830-2022; Teixeira, Manuel AC/AAZ-7251-2020; Becher, Heiko/ABI-1234-2020; GARCIA, CONXI LAZARO/Q-2410-2016; Devilee, Peter/GXV-8005-2022; Brenner, Hermann/ABE-6383-2020; van Veen, Elke/ABA-3250-2021; Larsson, Susanna C./F-6065-2015; montagna, marco/E-2225-2012; Evans, D Gareth/AAB-4308-2022; taylor, jack a/C-7154-2019; Teixeira, Manuel António Rodrigues/E-4885-2011; Romero-Alfonso, Atocha/AAC-9879-2021; Garcia-Saenz, Jose Angel/AAW-8662-2020; van Rensburg, Elizabeth J./B-9104-2011; Michailidou, Kyriaki/ABD-5122-2020; Chenevix-Trench, Georgia/AAV-2014-2020; Figueroa, Jonine/AFK-2752-2022; Brenner, Hermann/B-4627-2017; wildiers, hans/AAV-8158-2021; Caligo, Adelaide Maria/K-4289-2018; Guenel, Pascal/AAS-7688-2021; Heemskerk-Gerritsen, Bernadette Anna Maria/AAA-4155-2021; Konstantopoulou, Irene/B-5309-2009; Briceno Balcazar, Ignacio/N-3337-2017	Peterlongo, Paolo/0000-0001-6951-6855; jager, agnes/0000-0002-7713-1450; Brüning, Thomas/0000-0001-9560-5464; Figueroa, Jonine/0000-0002-5100-623X; truong, therese/0000-0002-2943-6786; Figueroa, Jonine/0000-0002-5100-623X; Kitahara, Cari M/0000-0001-6416-4432; Lesueur, Fabienne/0000-0001-7404-4549; Romero, Atocha/0000-0002-1634-7397; Fasching, Peter A/0000-0003-4885-8471; Dörk, Thilo/0000-0002-9458-0282; Lambrechts, Diether/0000-0002-3429-302X; Ekici, Arif B/0000-0001-6099-7066; Garcia-Closas, Montserrat/0000-0003-1033-2650; Jakubowska, Anna/0000-0002-5650-0501; Gonzalez-Neira, Anna/0000-0002-5421-2020; Lissowska, Jolanta/0000-0003-2695-5799; Huebner, Hanna/0000-0001-6889-1493; Claes, Kathleen/0000-0003-0841-7372; Teixeira, Manuel AC/0000-0002-1959-0624; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Brenner, Hermann/0000-0002-6129-1572; van Veen, Elke/0000-0001-8618-2332; Larsson, Susanna C./0000-0003-0118-0341; montagna, marco/0000-0002-4929-2150; Evans, D Gareth/0000-0002-8482-5784; taylor, jack a/0000-0001-5303-6398; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Garcia-Saenz, Jose Angel/0000-0001-6880-0301; Michailidou, Kyriaki/0000-0001-7065-1237; Chenevix-Trench, Georgia/0000-0002-1878-2587; Figueroa, Jonine/0000-0002-5100-623X; Brenner, Hermann/0000-0002-6129-1572; Caligo, Adelaide Maria/0000-0003-0589-1829; Guenel, Pascal/0000-0002-8359-518X; Heemskerk-Gerritsen, Bernadette Anna Maria/0000-0002-9724-6693; Peixoto, Ana/0000-0002-1404-5897; Rennert, Gad/0000-0002-8512-068X; Margolin, Sara/0000-0002-5526-5570; Jones, Michael/0000-0001-7479-3451; Muranen, Taru/0000-0002-5895-1808; Cox, Angela/0000-0002-5138-1099; Calvello, Mariarosaria/0000-0003-2113-8503; Stone, Jennifer/0000-0001-5077-0124; Beesley, Jonathan/0000-0003-1942-325X; Konstantopoulou, Irene/0000-0002-0470-0309; , IIS Galicia Sur/0000-0003-3812-7413; Briceno Balcazar, Ignacio/0000-0001-7300-6401; Simard, Jacques/0000-0001-6906-3390; Barrowdale, Daniel/0000-0003-1661-3939; Eccles, Diana M/0000-0002-9935-3169; Brauch, Hiltrud/0000-0001-7531-2736; Menon, Usha/0000-0003-3708-1732; Laenkholm, Anne-Vibeke/0000-0003-2166-8686; Dwek, Miriam/0000-0001-7184-2932; O'Mara, Tracy/0000-0002-5436-3232; Schoemaker, Minouk/0000-0001-8403-2234; Matricardi, Laura/0000-0002-0241-1810; Winqvist, Robert/0000-0003-0932-9104; Gago, Manuela/0000-0001-6713-4351; Khan, Sofia/0000-0003-4185-8882; Durocher, Francine/0000-0001-8012-4641; Bialkowska, Katarzyna/0000-0001-8489-6665; Bojesen, Stig/0000-0002-4061-4133; Castelao, Jose E/0000-0001-7110-1376; Barnes, Daniel/0000-0002-3781-7570; Olsson, Hakan/0000-0002-8794-9635; Saloustros, Emmanouil/0000-0002-0485-0120; Becher, Heiko/0000-0002-8808-6667; James, Paul/0000-0002-4361-4657	Federal funds from the National Cancer Institute Intramural Research Program, National Institutes of Health; government of Canada through Genome Canada; Canadian Institutes of Health Research [GPH-129344]; Ministere de l'Economie et de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; US National Institutes of Health (NIH) [1U19 CA148065, X01HG007492, HHSN268201200008I]; Cancer Research UK [C1287/A16563, C1287/A10710, C1287/A10118, C12292/A11174, C12292/A20861]; Odense University Hospital Research Foundation (Denmark); National RAMP;D Program for Cancer Control-Ministry of Health and Welfare (Republic of Korea) [1420190]; Italian Association for Cancer Research (AIRC) [IG16933]; Breast Cancer Research Foundation; National Health and Medical Research Council (Australia); German Cancer Aid [110837]; European Union [HEALTH-F2-2009-223175]; NIH [CA128978, CA116167, CA176785]; Post-Cancer GWAS initiative [1U19 CA148065, 1U19 CA148537, 1U19 CA148112]; NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer; Ministere de l'Economie, Innovation et Exportation du Quebec [PSR-SIIRI-701]; Komen Foundation for the Cure; Ovarian Cancer Research Fund; NIH Cancer Post-Cancer GWAS initiative [1U19 CA148065]; European Union via its Seventh Framework Programme [HEALTH-F2-2009-223175]; Horizon 2020 Research and Innovation Programme [633784, 634935]; NHGRI [1R01 HG010480-01];  [CA194393]; National Breast Cancer Foundation [ECF-17-010] Funding Source: researchfish	Federal funds from the National Cancer Institute Intramural Research Program, National Institutes of Health; government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economie et de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Odense University Hospital Research Foundation (Denmark); National RAMP;D Program for Cancer Control-Ministry of Health and Welfare (Republic of Korea); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Breast Cancer Research Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); German Cancer Aid(Deutsche Krebshilfe); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Cancer GWAS initiative; NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economie, Innovation et Exportation du Quebec; Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Ovarian Cancer Research Fund; NIH Cancer Post-Cancer GWAS initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union via its Seventh Framework Programme; Horizon 2020 Research and Innovation Programme; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; National Breast Cancer Foundation	We thank all of the individuals who took part in these studies, and all of the researchers, clinicians, technicians and administrative staff who enabled this work to be carried out. This project has been funded in part with Federal funds from the National Cancer Institute Intramural Research Program, National Institutes of Health. Genotyping for the OncoArray was funded by the government of Canada through Genome Canada and the Canadian Institutes of Health Research (GPH-129344), the Ministere de l'Economie et de la Science et de l'Innovation du Quebec through Genome Quebec, the Quebec Breast Cancer Foundation for the PERSPECTIVE project, the US National Institutes of Health (NIH) (1U19 CA148065 for the Discovery, Biology and Risk of Inherited Variants in Breast Cancer (DRIVE) project and X01HG007492 to the Center for Inherited Disease Research under contract HHSN268201200008I), Cancer Research UK (C1287/A16563), the Odense University Hospital Research Foundation (Denmark), the National R&D Program for Cancer Control-Ministry of Health and Welfare (Republic of Korea; 1420190), the Italian Association for Cancer Research (AIRC; IG16933), the Breast Cancer Research Foundation, the National Health and Medical Research Council (Australia) and German Cancer Aid (110837). Genotyping for the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710, C1287/A10118 and C12292/A11174), NIH grants (CA128978, CA116167 and CA176785) and the Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 (GAME-ON initiative)), an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Ministere de l'Economie, Innovation et Exportation du Quebec (PSR-SIIRI-701), the Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. Combination of the GWAS data was supported in part by the NIH Cancer Post-Cancer GWAS initiative (1U19 CA148065) (DRIVE, part of the GAME-ON initiative). Linkage disequilibrium score regression analysis was supported by grant CA194393. BCAC was funded by Cancer Research UK (C1287/A16563) and by the European Union via its Seventh Framework Programme (HEALTH-F2-2009-223175; COGS) and the Horizon 2020 Research and Innovation Programme (633784 (B-CAST) and 634935 (BRIDGES)). CIMBA was funded by Cancer Research UK (C12292/A20861 and C12292/A11174). N.C. was funded by NHGRI (1R01 HG010480-01). For a full description of funding and acknowledgments, see the Supplementary Note.	Ahearn T. U, 2019, COMMON BREAST CANC R, DOI DOI 10.1101/733402V1; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Beesley J, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1877-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chatterjee N, 2004, J AM STAT ASSOC, V99, P127, DOI 10.1198/016214504000000124; Curigliano G, 2017, ANN ONCOL, V28, P1700, DOI 10.1093/annonc/mdx308; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fachal L, 2020, NAT GENET, V52, P56, DOI 10.1038/s41588-019-0537-1; Ferreira MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08053-5; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Hendricks AE, 2014, EUR J HUM GENET, V22, P414, DOI 10.1038/ejhg.2013.144; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Pellacani D, 2016, CELL REP, V17, P2060, DOI 10.1016/j.celrep.2016.10.058; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Phelan CM, 2017, NAT GENET, V49, P680, DOI 10.1038/ng.3826; Spurdle AB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0474-y; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Udler MS, 2010, GENET EPIDEMIOL, V34, P463, DOI 10.1002/gepi.20504; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu L, 2018, NAT GENET, V50, P968, DOI 10.1038/s41588-018-0132-x; Zhang HY, 2021, BIOSTATISTICS, V22, P772, DOI 10.1093/biostatistics/kxz065	35	89	91	1	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2020	52	6					572	+		10.1038/s41588-020-0609-2	http://dx.doi.org/10.1038/s41588-020-0609-2		MAY 2020	19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV2FA	32424353	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000533846800005
J	Rauch, A; Haakonsson, AK; Madsen, JGS; Larsen, M; Forss, I; Madsen, MR; Van Hauwaert, EL; Wiwie, C; Jespersen, NZ; Tencerova, M; Nielsen, R; Larsen, BD; Rottger, R; Baumbach, J; Scheele, C; Kassem, M; Mandrup, S				Rauch, Alexander; Haakonsson, Anders K.; Madsen, Jesper G. S.; Larsen, Mette; Forss, Isabel; Madsen, Martin R.; Van Hauwaert, Elvira L.; Wiwie, Christian; Jespersen, Naja Z.; Tencerova, Michaela; Nielsen, Ronni; Larsen, Bjork D.; Roettger, Richard; Baumbach, Jan; Scheele, Camilla; Kassem, Moustapha; Mandrup, Susanne			Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis	NATURE GENETICS			English	Article							VISCERAL ADIPOSE-TISSUE; BONE-MARROW; PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; IN-VITRO; GENE; EXPRESSION; ASSOCIATION; ENHANCER; LOCI	Mesenchymal (stromal) stem cells (MSCs) constitute populations of mesodermal multipotent cells involved in tissue regeneration and homeostasis in many different organs. Here we performed comprehensive characterization of the transcriptional and epigenomic changes associated with osteoblast and adipocyte differentiation of human MSCs. We demonstrate that adipogenesis is driven by considerable remodeling of the chromatin landscape and de novo activation of enhancers, whereas osteogenesis involves activation of preestablished enhancers. Using machine learning algorithms for in silico modeling of transcriptional regulation, we identify a large and diverse transcriptional network of pro-osteogenic and antiadipogenic transcription factors. Intriguingly, binding motifs for these factors overlap with SNPs related to bone and fat formation in humans, and knockdown of single members of this network is sufficient to modulate differentiation in both directions, thus indicating that lineage determination is a delicate balance between the activities of many different transcription factors.	[Rauch, Alexander; Madsen, Jesper G. S.; Larsen, Mette; Forss, Isabel; Madsen, Martin R.; Van Hauwaert, Elvira L.; Nielsen, Ronni; Larsen, Bjork D.; Mandrup, Susanne] Univ Southern Denmark, Dept Biochem & Mol Biol, Funct Genom & Metab Res Unit, Odense, Denmark; [Haakonsson, Anders K.; Tencerova, Michaela; Kassem, Moustapha] Univ Southern Denmark, Dept Endocrinol & Metab, Mol Endocrinol & Stem Cell Res Unit KMEB, Odense Univ Hosp, Odense, Denmark; [Haakonsson, Anders K.; Tencerova, Michaela; Kassem, Moustapha] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Wiwie, Christian; Roettger, Richard; Baumbach, Jan] Univ Southern Denmark, Dept Math & Comp Sci, Odense, Denmark; [Jespersen, Naja Z.; Scheele, Camilla] Univ Hosp Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Jespersen, Naja Z.; Scheele, Camilla] Univ Hosp Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Jespersen, Naja Z.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Jespersen, Naja Z.] Odense Univ Hosp, Danish Diabet Acad, Odense, Denmark; [Scheele, Camilla] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Baumbach, Jan] Tech Univ Munich, TUM Sch Life Sci, Expt Bioinformat, Freising Weihenstephan, Germany	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Novo Nordisk Foundation; University of Copenhagen; Technical University of Munich	Mandrup, S (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Funct Genom & Metab Res Unit, Odense, Denmark.	s.mandrup@bmb.sdu.dk	Madsen, Jesper Grud Skat/O-9803-2019; Rauch, Alexander/AAY-5235-2021; Jespersen, Naja/AGY-9219-2022; Larsen, Bjørk D/Q-2178-2016; Scheele, Camilla/AAA-3599-2020; Tencerova, Michaela/G-8089-2017; Kassem, Moustapha/J-7688-2013	Madsen, Jesper Grud Skat/0000-0002-0518-0800; Rauch, Alexander/0000-0002-9429-7356; Larsen, Bjørk D/0000-0003-1754-770X; Scheele, Camilla/0000-0002-6055-9709; Tencerova, Michaela/0000-0001-8670-425X; Kassem, Moustapha/0000-0003-1557-0869; Roettger, Richard/0000-0003-4490-5947; Van Hauwaert, Elvira Laila/0000-0002-6248-0025; Nielsen, Ronni/0000-0001-6331-7660; Haakonsson, Anders Kristian/0000-0002-5076-3730; Forss, Isabel/0000-0003-3873-1696; Baumbach, Jan/0000-0002-0282-0462; Mandrup, Susanne/0000-0002-0961-5787	Villum Foundation; Danish Independent Research Council \ Natural Sciences; Novo Nordisk Foundation; Lundbeck Foundation; Danish National Research Foundation; EMBO Long-Term Fellowship [ALTF 1544-2011]; VILLUM Young Investigator grant [13154]; Novo Nordisk Foundation [NNF15OC0016284]	Villum Foundation(Villum Fonden); Danish Independent Research Council \ Natural Sciences; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); VILLUM Young Investigator grant(Villum Fonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank B. Klarlund Pedersen (Centre of Inflammation and Metabolism and Centre for Physical Activity Research, Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark) for providing primary stromal cells from muscle tissue; T. E. Andersen (Research Unit of Clinical Microbiology, Odense University Hospital and Department of Clinical Research University of Southern Denmark, Odense, Denmark) for EAhy926 cells; and B.S. Andresen (Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark) for PANC-1, A549 and SH-SY5Y cells. This work was carried out mainly at the Villum Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, SDU, with support from the Villum Foundation. The work was supported by grants from the Danish Independent Research Council vertical bar Natural Sciences, the Novo Nordisk Foundation and the Lundbeck Foundation and by the Danish National Research Foundation. The Novo Nordisk Foundation Center for Basic Metabolic Research is supported by an unconditional grant from the Novo Nordisk Foundation to the University of Copenhagen. A.R. was supported by an EMBO Long-Term Fellowship (ALTF 1544-2011). A.R., M.T. and N.Z.J. received a postdoc stipend and N.Z.J. and I.F. received a PhD stipend from the Danish Diabetes Academy supported by the Novo Nordisk Foundation. C.W. and J.B. were supported by a VILLUM Young Investigator grant (13154). M.K. was supported by the Novo Nordisk Foundation (NNF15OC0016284).	Aguilera CM, 2015, INT J MOL SCI, V16, P7723, DOI 10.3390/ijms16047723; Ahrends R, 2014, SCIENCE, V344, P1384, DOI 10.1126/science.1252079; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allum F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8211; Alves H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042908; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Broholm C, 2011, J APPL PHYSIOL, V111, P251, DOI 10.1152/japplphysiol.01399.2010; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Chu AY, 2017, NAT GENET, V49, P125, DOI 10.1038/ng.3738; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fujita K, 2014, OSTEOPOROSIS INT, V25, P887, DOI 10.1007/s00198-013-2529-9; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Jaager K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038833; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jun GR, 2017, ALZHEIMERS DEMENT, V13, P727, DOI 10.1016/j.jalz.2016.12.012; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lambertini E, 2009, CELL MOL LIFE SCI, V66, P3641, DOI 10.1007/s00018-009-0149-5; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Madsen JGS, 2018, GENOME RES, V28, P243, DOI 10.1101/gr.227231.117; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Miyamoto T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004476; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Onate B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-625; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Roforth MM, 2015, BONE, V76, P49, DOI 10.1016/j.bone.2015.03.017; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shafiee A, 2011, BIOTECHNOL LETT, V33, P1257, DOI 10.1007/s10529-011-0541-8; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Signorelli M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1203-6; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tam CS, 2011, INT J PEDIATR OBES, V6, pE360, DOI 10.3109/17477166.2011.575152; Tatrai P, 2012, BIOCHEM BIOPH RES CO, V422, P28, DOI 10.1016/j.bbrc.2012.04.088; Thompson B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148619; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Vishnubalaji R, 2012, CELL TISSUE RES, V347, P419, DOI 10.1007/s00441-011-1306-3; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wentworth JM, 2016, INT J OBESITY, V40, P706, DOI 10.1038/ijo.2015.223; Wu H, 2017, BBA-GENE REGUL MECH, V1860, P438, DOI 10.1016/j.bbagrm.2017.01.003; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	91	89	90	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					716	+		10.1038/s41588-019-0359-1	http://dx.doi.org/10.1038/s41588-019-0359-1			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30833796				2022-12-17	WOS:000462767500018
J	van Karnebeek, CDM; Bonafe, L; Wen, XY; Tarailo-Graovac, M; Balzano, S; Royer-Bertrand, B; Ashikov, A; Garavelli, L; Mammi, I; Turolla, L; Breen, C; Donnai, D; Cormier-Daire, V; Heron, D; Nishimura, G; Uchikawa, S; Campos-Xavier, B; Rossi, A; Hennet, T; Brand-Arzamendi, K; Rozmus, J; Harshman, K; Stevenson, BJ; Girardi, E; Superti-Furga, G; Dewan, T; Collingridge, A; Halparin, J; Ross, CJ; Van Allen, MI; Rossi, A; Engelke, UF; Kluijtmans, LAJ; van der Heeft, E; Renkema, H; de Brouwer, A; Huijben, K; Zijlstra, F; Heise, T; Boltje, T; Wasserman, WW; Rivolta, C; Unger, S; Lefeber, DJ; Wevers, RA; Superti-Furga, A				van Karnebeek, Clara D. M.; Bonafe, Luisa; Wen, Xiao-Yan; Tarailo-Graovac, Maja; Balzano, Sara; Royer-Bertrand, Beryl; Ashikov, Angel; Garavelli, Livia; Mammi, Isabella; Turolla, Licia; Breen, Catherine; Donnai, Dian; Cormier-Daire, Valerie; Heron, Delphine; Nishimura, Gen; Uchikawa, Shinichi; Campos-Xavier, Belinda; Rossi, Antonio; Hennet, Thierry; Brand-Arzamendi, Koroboshka; Rozmus, Jacob; Harshman, Keith; Stevenson, Brian J.; Girardi, Enrico; Superti-Furga, Giulio; Dewan, Tammie; Collingridge, Alissa; Halparin, Jessie; Ross, Colin J.; Van Allen, Margot I.; Rossi, Andrea; Engelke, Udo F.; Kluijtmans, Leo A. J.; van der Heeft, Ed; Renkema, Herma; de Brouwer, Arjan; Huijben, Karin; Zijlstra, Fokje; Heise, Torben; Boltje, Thomas; Wasserman, Wyeth W.; Rivolta, Carlo; Unger, Sheila; Lefeber, Dirk J.; Wevers, Ron A.; Superti-Furga, Andrea			NANS-mediated synthesis of sialic acid is required for brain and skeletal development	NATURE GENETICS			English	Article							INTELLECTUAL DISABILITY; ESSENTIAL NUTRIENT; MASS-SPECTROMETRY; DISORDERS; QUANTIFICATION; CLASSIFICATION; METABOLISM; MUTATIONS; DYSPLASIA; DIAGNOSIS	We identified biallelic mutations in NANS, the gene encoding the synthase for N-acetylneuraminic acid (NeuNAc; sialic acid), in nine individuals with infantile-onset severe developmental delay and skeletal dysplasia. Patient body fluids showed an elevation in N-acetyl-d-mannosamine levels, and patient-derived fibroblasts had reduced NANS activity and were unable to incorporate sialic acid precursors into sialylated glycoproteins. Knockdown of nansa in zebrafish embryos resulted in abnormal skeletal development, and exogenously added sialic acid partially rescued the skeletal phenotype. Thus, NANS-mediated synthesis of sialic acid is required for early brain development and skeletal growth. Normal sialylation of plasma proteins was observed in spite of NANS deficiency. Exploration of endogenous synthesis, nutritional absorption, and rescue pathways for sialic acid in different tissues and developmental phases is warranted to design therapeutic strategies to counteract NANS deficiency and to shed light on sialic acid metabolism and its implications for human nutrition.	[van Karnebeek, Clara D. M.; Rozmus, Jacob; Dewan, Tammie; Collingridge, Alissa; Halparin, Jessie; Ross, Colin J.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [van Karnebeek, Clara D. M.; Tarailo-Graovac, Maja; Ross, Colin J.; Wasserman, Wyeth W.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med, Vancouver, BC V5Z 1M9, Canada; [Bonafe, Luisa; Royer-Bertrand, Beryl; Campos-Xavier, Belinda; Superti-Furga, Andrea] Univ Lausanne, Lausanne Univ Hosp CHUV, Ctr Mol Dis, Lausanne, Switzerland; [Wen, Xiao-Yan; Brand-Arzamendi, Koroboshka] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Zebrafish Ctr Adv Drug Discovery, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Wen, Xiao-Yan; Brand-Arzamendi, Koroboshka] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tarailo-Graovac, Maja; Ross, Colin J.; Van Allen, Margot I.; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Balzano, Sara; Royer-Bertrand, Beryl; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Ashikov, Angel; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Garavelli, Livia] IRCCS S Maria Nuova Hosp, Clin Genet Unit, Reggio Emilia, Italy; [Mammi, Isabella] Osped Dolo, UO Ginecol Ostetricia, Ambulatorio Genet Med ULSS 13, Dolo, Italy; [Turolla, Licia] Local Hlth Author ULSS 9, Med Genet Unit, Treviso, Italy; [Breen, Catherine; Donnai, Dian] Univ Manchester, St Marys Hosp,Manchester Ctr Genom Med, Manchester Acad Hlth Sci Ctr,Inst Human Dev, Cent Manchester Univ Hosp NHS Fdn Trust,Fac Med &, Manchester M13 0JH, Lancs, England; [Cormier-Daire, Valerie; Heron, Delphine] Hop Necker Enfants Malad, Inst IMAGINE, Paris, France; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol, Tokyo, Japan; [Uchikawa, Shinichi] Natl Ctr Child Hlth & Dev, Dept Orthoped, Tokyo, Japan; [Rossi, Antonio] Univ Pavia, Biochem Unit, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy; [Hennet, Thierry] Univ Zurich, Dept Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Harshman, Keith] Univ Lausanne, Fac Biol & Med, Genom Technol Facil, Lausanne, Switzerland; [Stevenson, Brian J.] Univ Lausanne, Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Girardi, Enrico; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Rossi, Andrea] G Gaslini Childrens Hosp, Dept Neuroradiol, Genoa, Italy; [Engelke, Udo F.; Kluijtmans, Leo A. J.; van der Heeft, Ed; Renkema, Herma; Huijben, Karin; Zijlstra, Fokje; Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6525 ED Nijmegen, Netherlands; [de Brouwer, Arjan] Radboud Univ Nijmegen, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [Heise, Torben; Boltje, Thomas] Radboud Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands; [Unger, Sheila] Univ Lausanne, Univ Lausanne Hosp, Med Genet Serv, Lausanne, Switzerland; [Superti-Furga, Andrea] Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland	University of British Columbia; Child & Family Research Institute; University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of British Columbia; University of Lausanne; Radboud University Nijmegen; ULSS 3 Serenissima; Presidio Ospedaliero di Dolo; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Tokyo Metropolitan Children's Medical Center; National Center for Child Health & Development - Japan; University of Pavia; University of Zurich; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Genoa; IRCCS Istituto Giannina Gaslini; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	van Karnebeek, CDM (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.; van Karnebeek, CDM (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med, Vancouver, BC V5Z 1M9, Canada.; Superti-Furga, A (corresponding author), Univ Lausanne, Lausanne Univ Hosp CHUV, Ctr Mol Dis, Lausanne, Switzerland.; Wevers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6525 ED Nijmegen, Netherlands.; Superti-Furga, A (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland.	cvankarnebeek@cw.bc.ca; ron.wevers@radboudumc.nl; asuperti@unil.ch	Garavelli, Livia/AAA-8132-2021; Kluijtmans, Leo A/L-4437-2015; Girardi, Enrico/L-4033-2014; Lefeber, Dirk DJ/A-2146-2014; de Brouwer, Arjan PM/P-5949-2015; Rossi, Antonio/E-9935-2012; Renkema, Herma/L-1489-2015; Heise, Torben/E-1157-2017; Rossi, Andrea/A-4146-2011; Wevers, Ron A./H-8116-2014; Campos-Xavier, Belinda/P-9917-2019; Superti-Furga, Giulio/AAE-5681-2019; Ashikov, Angel/N-7714-2015; Boltje, Thomas/F-9695-2015; Girardi, Enrico/AAD-2260-2020; superti-furga, andrea/E-9162-2015; cormier-daire, valerie/H-6520-2017	Garavelli, Livia/0000-0002-7684-3982; Girardi, Enrico/0000-0003-3508-2723; Renkema, Herma/0000-0002-8174-6538; Heise, Torben/0000-0003-2949-0456; Rossi, Andrea/0000-0001-8575-700X; Wevers, Ron A./0000-0003-2278-9746; Campos-Xavier, Belinda/0000-0002-6271-0724; Ashikov, Angel/0000-0001-9679-7955; Girardi, Enrico/0000-0003-3508-2723; superti-furga, andrea/0000-0002-3543-7531; Turolla, Licia/0000-0001-8899-4588; Rivolta, Carlo/0000-0002-0733-9950; cormier-daire, valerie/0000-0002-2839-9856; Tarailo-Graovac, Maja/0000-0002-4472-8584; Wasserman, Wyeth/0000-0001-6098-6412; Ross, Colin/0000-0003-1476-7037; Unger, Sheila/0000-0002-9539-8941; Wen, Xiao-Yan/0000-0001-6728-0025; , Jacob/0000-0003-4036-2105	Leenaards Foundation in Lausanne, Switzerland; Faculty of Biology and Medicine of the University of Lausanne; BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC [SOF-195]; Rare Diseases Foundation; Rare Diseases Models and Mechanisms Network; Canadian Institutes of Health Research [301221]; Dutch Organization for Scientific Research, ZONMW [40-00506-98-9001]; Dutch Organization for Scientific Research, ZONMW (VIDI) [91713359]; Canadian Rare Disease Models and Mechanisms Network; Brain Canada Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Genome BC; Genome Canada (ABC4DE Project); Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland); Canadian Institutes of Health Research; Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada); Marie Sklodowska-Curie fellowship [MSCA-IF-661491]	Leenaards Foundation in Lausanne, Switzerland; Faculty of Biology and Medicine of the University of Lausanne; BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC; Rare Diseases Foundation; Rare Diseases Models and Mechanisms Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dutch Organization for Scientific Research, ZONMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Organization for Scientific Research, ZONMW (VIDI); Canadian Rare Disease Models and Mechanisms Network; Brain Canada Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Genome BC; Genome Canada (ABC4DE Project)(Genome Canada); Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada); Marie Sklodowska-Curie fellowship	This work has been supported by funding from the Leenaards Foundation in Lausanne, Switzerland; the Faculty of Biology and Medicine of the University of Lausanne; the BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC (grant SOF-195); the Rare Diseases Foundation; the Rare Diseases Models and Mechanisms Network; the Canadian Institutes of Health Research (grant 301221); and the Dutch Organization for Scientific Research, ZONMW (Medium Investment Grant 40-00506-98-9001 and VIDI Grant 91713359 to D.J.L.). The zebrafish studies were supported by funding to X.-Y.W. from the Canadian Rare Disease Models and Mechanisms Network, the Brain Canada Foundation, the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canada Foundation for Innovation (CFI). The informatics infrastructures were supported by Genome BC and Genome Canada (ABC4DE Project) as well as by the Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland). C.J.R. is funded by a Canadian Institutes of Health Research New Investigator Award. C.D.M.v.K. is a recipient of the Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada). E.G. is supported by a Marie Sklodowska-Curie fellowship (MSCA-IF-661491).	American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Bull C, 2015, ACS CHEM BIOL, V10, P2353, DOI 10.1021/acschembio.5b00501; CAMERA G, 1993, PEDIATR RADIOL, V23, P611, DOI 10.1007/BF02014981; Cotton TR, 2014, BBA-PROTEINS PROTEOM, V1844, P2257, DOI 10.1016/j.bbapap.2014.09.014; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Engelke UFH, 2006, NMR BIOMED, V19, P271, DOI 10.1002/nbm.1018; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; Genevieve D, 2005, EUR J HUM GENET, V13, P541, DOI 10.1038/sj.ejhg.5201339; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gunawan J, 2005, J BIOL CHEM, V280, P3555, DOI 10.1074/jbc.M411942200; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Jansen JC, 2016, AM J HUM GENET, V98, P310, DOI 10.1016/j.ajhg.2015.12.010; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Riemersma M, 2015, HUM MOL GENET, V24, P2241, DOI 10.1093/hmg/ddu742; Rohrig CH, 2017, CRIT REV FOOD SCI, V57, P1017, DOI 10.1080/10408398.2015.1040113; ROUGHLEY PJ, 1981, J BIOL CHEM, V256, P2699; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Salvador-Carulla L, 2011, WORLD PSYCHIATRY, V10, P175; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sprenger N, 2012, ADV NUTR, V3, p392S, DOI 10.3945/an.111.001479; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tarailo-Graovac M., N ENGL J ME IN PRESS; Valianpour F, 2004, CLIN CHEM, V50, P403, DOI 10.1373/clinchem.2003.027169; van der Ham M, 2010, J CHROMATOGR B, V878, P1098, DOI 10.1016/j.jchromb.2010.03.020; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191; Van Scherpenzeel M, 2015, TRANSL RES, V166, P639, DOI 10.1016/j.trsl.2015.07.005; Vincent K, 2013, J MOL GRAPH MODEL, V39, P108, DOI 10.1016/j.jmgm.2012.10.007; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	50	89	91	1	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					777	+		10.1038/ng.3578	http://dx.doi.org/10.1038/ng.3578			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27213289	Green Accepted			2022-12-17	WOS:000378840100015
J	Taal, HR; St Pourcain, B; Thiering, E; Das, S; Mook-Kanamori, DO; Warrington, NM; Kaakinen, M; Kreiner-Moller, E; Bradfield, JP; Freathy, RM; Geller, F; Guxens, M; Cousminer, DL; Kerkhof, M; Timpson, NJ; Ikram, MA; Beilin, LJ; Bonnelykke, K; Buxton, JL; Charoen, P; Chawes, BLK; Eriksson, J; Evans, DM; Hofman, A; Kemp, JP; Kim, CE; Klopp, N; Lahti, J; Lye, SJ; McMahon, G; Mentch, FD; Muller-Nurasyid, M; O'Reilly, PF; Prokopenko, I; Rivadeneira, F; Steegers, EAP; Sunyer, J; Tiesler, C; Yaghootkar, H; Breteler, MMB; Debette, S; Fornage, M; Gudnason, V; Launer, LJ; van der Lugt, A; Mosley, TH; Seshadri, S; Smith, AV; Vernooij, MW; Blakemore, AIF; Chiavacci, RM; Feenstra, B; Fernandez-Banet, J; Grant, SFA; Hartikainen, AL; van der Heijden, AJ; Iniguez, C; Lathrop, M; McArdle, WL; Molgaard, A; Newnham, JP; Palmer, LJ; Palotie, A; Pouta, A; Ring, SM; Sovio, U; Standl, M; Uitterlinden, AG; Wichmann, HE; Vissing, NH; DeCarli, C; van Duijn, CM; McCarthy, MI; Koppelman, GH; Estivill, X; Hattersley, AT; Melbye, M; Bisgaard, H; Pennell, CE; Widen, E; Hakonarson, H; Smith, GD; Heinrich, J; Jarvelin, MR; Jaddoe, VWV; Adair, LS; Ang, W; Atalay, M; van Beijsterveldt, T; Bergen, N; Benke, K; Berry, D; Coin, L; Davis, OSP; Elliott, P; Flexeder, C; Frayling, T; Gaillard, R; Groen-Blokhuis, M; Goh, LK; Haworth, CMA; Hadley, D; Hedebrand, J; Hinney, A; Hirschhorn, JN; Holloway, JW; Holst, C; Hottenga, JJ; Horikoshi, M; Huikari, V; Hypponen, E; Kilpelainen, TO; Kirin, M; Kowgier, M; Lakka, HM; Lange, LA; Lawlor, DA; Lehtimaki, T; Lewin, A; Lindgren, C; Lindi, V; Maggi, R; Marsh, J; Middeldorp, C; Millwood, I; Murray, JC; Nivard, M; Nohr, EA; Ntalla, I; Oken, E; Panoutsopoulou, K; Pararajasingham, J; Rodriguez, A; Salem, RM; Sebert, S; Siitonen, N; Strachan, DP; Taal, HR; Teo, YY; Valcarcel, B; White, S; Willemsen, G; Zeggini, E; Boomsma, DI; Cooper, C; Gillman, M; Hocher, B; Lakka, TA; Mohlke, KL; Dedoussis, GV; Ong, KK; Pearson, ER; Price, TS; Power, C; Raitakari, OT; Saw, SM; Scherag, A; Simell, O; Sorensen, TIA; Wilson, JF; Schmidt, R; Vrooman, HA; Sigurdsson, S; Ropele, S; Coker, LH; Longstreth, WT; Niessen, WJ; DeStefano, AL; Beiser, A; Zijdenbos, AP; Struchalin, M; Jack, CR; Nalls, MA; Au, R; Gudnason, H; Harris, TB; Meeks, WM; van Buchem, MA; Catellier, D; Windham, BG; Wolf, PA; Schmidt, H				Taal, H. Rob; St Pourcain, Beate; Thiering, Elisabeth; Das, Shikta; Mook-Kanamori, Dennis O.; Warrington, Nicole M.; Kaakinen, Marika; Kreiner-Moller, Eskil; Bradfield, Jonathan P.; Freathy, Rachel M.; Geller, Frank; Guxens, Monica; Cousminer, Diana L.; Kerkhof, Marjan; Timpson, Nicholas J.; Ikram, M. Arfan; Beilin, Lawrence J.; Bonnelykke, Klaus; Buxton, Jessica L.; Charoen, Pimphen; Chawes, Bo Lund Krogsgaard; Eriksson, Johan; Evans, David M.; Hofman, Albert; Kemp, John P.; Kim, Cecilia E.; Klopp, Norman; Lahti, Jari; Lye, Stephen J.; McMahon, George; Mentch, Frank D.; Mueller-Nurasyid, Martina; O'Reilly, Paul F.; Prokopenko, Inga; Rivadeneira, Fernando; Steegers, Eric A. P.; Sunyer, Jordi; Tiesler, Carla; Yaghootkar, Hanieh; Breteler, Monique M. B.; Debette, Stephanie; Fornage, Myriam; Gudnason, Vilmundur; Launer, Lenore J.; van der Lugt, Aad; Mosley, Thomas H., Jr.; Seshadri, Sudha; Smith, Albert V.; Vernooij, Meike W.; Blakemore, Alexandra I. F.; Chiavacci, Rosetta M.; Feenstra, Bjarke; Fernandez-Banet, Julio; Grant, Struan F. A.; Hartikainen, Anna-Liisa; van der Heijden, Albert J.; Iniguez, Carmen; Lathrop, Mark; McArdle, Wendy L.; Molgaard, Anne; Newnham, John P.; Palmer, Lyle J.; Palotie, Aarno; Pouta, Annneli; Ring, Susan M.; Sovio, Ulla; Standl, Marie; Uitterlinden, Andre G.; Wichmann, H-Erich; Vissing, Nadja Hawwa; DeCarli, Charles; van Duijn, Cornelia M.; McCarthy, Mark I.; Koppelman, Gerard H.; Estivill, Xavier; Hattersley, Andrew T.; Melbye, Mads; Bisgaard, Hans; Pennell, Craig E.; Widen, Elisabeth; Hakonarson, Hakon; Smith, George Davey; Heinrich, Joachim; Jarvelin, Marjo-Riitta; Jaddoe, Vincent W. V.; Adair, Linda S.; Ang, Wei; Atalay, Mustafa; van Beijsterveldt, Toos; Bergen, Nienke; Benke, Kelly; Berry, Diane; Coin, Lachlan; Davis, Oliver S. P.; Elliott, Paul; Flexeder, Claudia; Frayling, Tim; Gaillard, Romy; Groen-Blokhuis, Maria; Goh, Liang-Kee; Haworth, Claire M. A.; Hadley, Dexter; Hedebrand, Johannes; Hinney, Anke; Hirschhorn, Joel N.; Holloway, John W.; Holst, Claus; Hottenga, Jouke Jan; Horikoshi, Momoko; Huikari, Ville; Hypponen, Elina; Kilpelainen, Tuomas O.; Kirin, Mirna; Kowgier, Matthew; Lakka, Hanna-Maaria; Lange, Leslie A.; Lawlor, Debbie A.; Lehtimaki, Terho; Lewin, Alex; Lindgren, Cecilia; Lindi, Virpi; Maggi, Reedik; Marsh, Julie; Middeldorp, Christel; Millwood, Iona; Murray, Jeffrey C.; Nivard, Michel; Nohr, Ellen Aagaard; Ntalla, Ioanna; Oken, Emily; Panoutsopoulou, Kalliope; Pararajasingham, Jennifer; Rodriguez, Alina; Salem, Rany M.; Sebert, Sylvain; Siitonen, Niina; Strachan, David P.; Taal, H. Rob; Teo, Yik-Ying; Valcarcel, Beatriz; White, Scott; Willemsen, Gonneke; Zeggini, Eleftheria; Boomsma, Dorret I.; Cooper, Cyrus; Gillman, Matthew; Hocher, Berthold; Lakka, Timo A.; Mohlke, Karen L.; Dedoussis, George V.; Ong, Ken K.; Pearson, Ewan R.; Price, Thomas S.; Power, Chris; Raitakari, Olli T.; Saw, Seang-Mei; Scherag, Andre; Simell, Olli; Sorensen, Thorkild I. A.; Wilson, James F.; Schmidt, Reinhold; Vrooman, Henri A.; Sigurdsson, Sigurdur; Ropele, Stefan; Coker, Laura H.; Longstreth, W. T., Jr.; Niessen, Wiro J.; DeStefano, Anita L.; Beiser, Alexa; Zijdenbos, Alex P.; Struchalin, Maksim; Jack, Clifford R., Jr.; Nalls, Mike A.; Au, Rhoda; Gudnason, Haukur; Harris, Tamara B.; Meeks, William M.; van Buchem, Mark A.; Catellier, Diane; Windham, B. Gwen; Wolf, Philip A.; Schmidt, Helena		Cohorts Heart Aging Res Genetic Ep; Early Genetics Lifecourse Epidemio; Early Growth Genetics EGG Consorti	Common variants at 12q15 and 12q24 are associated with infant head circumference	NATURE GENETICS			English	Article							BRAIN-DEVELOPMENT; FETAL-GROWTH; INTELLIGENCE; MUTATIONS; GENE; SIZE; IDENTIFICATION; DEGENERATION; POPULATION; DISORDERS	To identify genetic variants associated with head circumference in infancy, we performed a meta-analysis of seven genome-wide association studies (GWAS) (N = 10,768 individuals of European ancestry enrolled in pregnancy and/or birth cohorts) and followed up three lead signals in six replication studies (combined N = 19,089). rs7980687 on chromosome 12q24 (P = 8.1 x 10(-9)) and rs1042725 on chromosome 12q15 (P = 2.8 x 10(-10)) were robustly associated with head circumference in infancy. Although these loci have previously been associated with adult height(1), their effects on infant head circumference were largely independent of height (P = 3.8 x 10(-7) for rs7980687 and P = 1.3 x 10(-7) for rs1042725 after adjustment for infant height). A third signal, rs11655470 on chromosome 17q21, showed suggestive evidence of association with head circumference (P = 3.9 x 10(-6)). SNPs correlated to the 17q21 signal have shown genome-wide association with adult intracranial volume(2), Parkinson's disease and other neurodegenerative diseases(3-5), indicating that a common genetic variant in this region might link early brain growth with neurological disease in later life.	[Timpson, Nicholas J.; Evans, David M.; Kemp, John P.; McMahon, George; Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Taal, H. Rob; Ikram, M. Arfan; Hofman, Albert; Rivadeneira, Fernando; Breteler, Monique M. B.; Vernooij, Meike W.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Jaddoe, Vincent W. V.; Bergen, Nienke; Gaillard, Romy; Taal, H. Rob; Struchalin, Maksim] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.; van der Heijden, Albert J.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Taal, H. Rob; Mook-Kanamori, Dennis O.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Thiering, Elisabeth; Tiesler, Carla; Standl, Marie; Wichmann, H-Erich; Heinrich, Joachim; Flexeder, Claudia] German Res Ctr Environm Hlth, Inst Epidemiol 1, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Das, Shikta; Charoen, Pimphen; O'Reilly, Paul F.; Sovio, Ulla; Coin, Lachlan; Lewin, Alex; Millwood, Iona; Rodriguez, Alina; Sebert, Sylvain; Valcarcel, Beatriz] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Pennell, Craig E.; Ang, Wei; Benke, Kelly; Kowgier, Matthew; Marsh, Julie; White, Scott] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Warrington, Nicole M.; Lye, Stephen J.; Palmer, Lyle J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kaakinen, Marika; Jarvelin, Marjo-Riitta; Huikari, Ville] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Pouta, Annneli; Jarvelin, Marjo-Riitta; Huikari, Ville] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kreiner-Moller, Eskil; Bonnelykke, Klaus; Chawes, Bo Lund Krogsgaard; Molgaard, Anne; Vissing, Nadja Hawwa; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Gentofte, Denmark; [Bradfield, Jonathan P.; Kim, Cecilia E.; Mentch, Frank D.; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon; Hadley, Dexter] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Freathy, Rachel M.; Yaghootkar, Hanieh; Frayling, Tim] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Geller, Frank; Feenstra, Bjarke; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Guxens, Monica] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Guxens, Monica; Sunyer, Jordi] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Guxens, Monica; Iniguez, Carmen; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Cousminer, Diana L.; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kerkhof, Marjan] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van der Lugt, Aad; Vernooij, Meike W.; Vrooman, Henri A.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; Netherlands Consortium Hlth Aging, Rotterdam, Netherlands; [Buxton, Jessica L.; Blakemore, Alexandra I. F.; Hypponen, Elina] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, London, England; Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Eriksson, Johan] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Folkhalsan Res Ctr, Biomedicum Helsinki, Helsinki, Finland; [Klopp, Norman] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Klopp, Norman] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Lahti, Jari] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Mueller-Nurasyid, Martina; Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Prokopenko, Inga; McCarthy, Mark I.; Horikoshi, Momoko] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.; Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; Pompeu Fabra Univ UPF, Dept Expt & Hlth Sci, Barcelona, Spain; Univ Munich, Div Metab Dis & Nutr Med, Dr Von Hauner Childrens Hosp, Munich, Germany; German Ctr Neurol Dis DZNE, Bonn, Germany; [Debette, Stephanie; Seshadri, Sudha; DeStefano, Anita L.; Beiser, Alexa; Au, Rhoda; Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Debette, Stephanie; DeStefano, Anita L.; Beiser, Alexa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Debette, Stephanie] INSERM, U708, Paris, France; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Inst Mol Med, Houston Hlth Sci Ctr, Houston, TX USA; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Human Genet Ctr, Houston Hlth Sci Ctr, Houston, TX USA; [Fornage, Myriam] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston Hlth Sci Ctr, Houston, TX USA; [Gudnason, Vilmundur; Smith, Albert V.; Sigurdsson, Sigurdur; Gudnason, Haukur] Iceland Res Inst, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Mosley, Thomas H., Jr.; Meeks, William M.; Windham, B. Gwen] Univ Mississippi, Med Ctr, Dept Med Geriatr, Jackson, MS 39216 USA; [Wolf, Philip A.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Fernandez-Banet, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; Ctr Publ Hlth Res CSISP, Div Environm & Hlth, Valencia, Spain; [Lathrop, Mark] Ctr Natl Genotypage, Comissariat Energie Atom, Evry, France; [Lathrop, Mark] Fdn Jean Dausset, CEPH, Paris, France; [McArdle, Wendy L.; Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; Broad Inst Harvard Univ & MIT, Cambridge, MA USA; [Panoutsopoulou, Kalliope; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Cambridge, England; [Pouta, Annneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Sovio, Ulla] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; Churchill Hosp, Oxford Natl Inst Hlth Res NIHR, Biomed Res Ctr, Oxford OX3 7LJ, England; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; UPF, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Spain; [Hattersley, Andrew T.] Univ Exeter, Peninsula NIHR Clin Res Facil, Peninsula Coll Med & Dent, Exeter, Devon, England; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth, London, England; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Atalay, Mustafa; Lindi, Virpi; Lakka, Timo A.] Univ Eastern Finland, Dept Physiol, Inst Biomed, Kuopio, Finland; [van Beijsterveldt, Toos; Groen-Blokhuis, Maria; Hottenga, Jouke Jan; Middeldorp, Christel; Nivard, Michel; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Berry, Diane; Power, Chris] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Davis, Oliver S. P.; Haworth, Claire M. A.; Pararajasingham, Jennifer; Price, Thomas S.] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Goh, Liang-Kee; Saw, Seang-Mei] Duke Natl Univ Singapore NUS, Grad Sch Med, Singapore, Singapore; [Goh, Liang-Kee; Teo, Yik-Ying; Saw, Seang-Mei] NUS, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hedebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Hirschhorn, Joel N.; Oken, Emily; Salem, Rany M.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Oken, Emily; Salem, Rany M.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Broad Inst, Metab Initiat, Cambridge, MA USA; Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Holst, Claus; Nohr, Ellen Aagaard; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Kilpelainen, Tuomas O.; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Kirin, Mirna; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Lakka, Hanna-Maaria] Univ Eastern Finland, Dept Publ Hlth, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Lange, Leslie A.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Sch Med, FIN-33101 Tampere, Finland; [Lindgren, Cecilia; Maggi, Reedik] Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Maggi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Murray, Jeffrey C.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Ntalla, Ioanna; Dedoussis, George V.] Harokopio Univ Athens, Dept Dietet Nutr, Athens, Greece; [Simell, Olli] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Siitonen, Niina; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Strachan, David P.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gillman, Matthew] Harvard Univ, Sch Med, Obes Prevent Program, Dept Populat Med, Boston, MA USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Hocher, Berthold] Charite, Inst Pharmacol, Ctr Cardiovasc Res, D-13353 Berlin, Germany; [Ong, Ken K.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Pearson, Ewan R.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol, Turku, Finland; Turku Univ Hosp, FIN-20520 Turku, Finland; Singapore Eye Res Inst, Singapore, Singapore; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Simell, Olli] Univ Turku, Dept Pediat, Turku, Finland; [Wilson, James F.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Schmidt, Reinhold; Ropele, Stefan; Au, Rhoda] Med Univ Graz, Dept Neurol, Graz, Austria; [Vrooman, Henri A.; Niessen, Wiro J.] Univ Med Ctr, Erasmus Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Coker, Laura H.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands; [Zijdenbos, Alex P.] Biospective Inc, Montreal, PQ, Canada; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Nalls, Mike A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Catellier, Diane] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	University of Bristol; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Imperial College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Western Australia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Oulu; University of Oulu; University of Copenhagen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Exeter; University of Plymouth; Statens Serum Institut; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Helsinki; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Mahidol University; Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University of Helsinki; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boston University; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Mississippi; University of Mississippi Medical Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); European Molecular Biology Laboratory (EMBL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Oulu; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; University of Bristol; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; University of California System; University of California Davis; University of Oxford; University of Groningen; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Exeter; University of Plymouth; Imperial College London; University of North Carolina; University of North Carolina Chapel Hill; University of Eastern Finland; Vrije Universiteit Amsterdam; University of London; University College London; University of London; King's College London; National University of Singapore; University of Duisburg Essen; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southampton; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Edinburgh; University of Eastern Finland; University of North Carolina; University of North Carolina Chapel Hill; Tampere University; Tampere University Hospital; Tampere University; University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; University of Oxford; University of Oxford; University of Iowa; Harokopio University Athens; Mid-Sweden University; University of Turku; University of London; University of Southampton; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; University of Dundee; University of Turku; University of Turku; National University of Singapore; Singapore National Eye Center; University of Duisburg Essen; University of Turku; University of Edinburgh; Medical University of Graz; Erasmus University Rotterdam; Erasmus MC; Wake Forest University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Delft University of Technology; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of North Carolina; University of North Carolina Chapel Hill; Medical University of Graz	Smith, GD (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England.	Julia.Mackay@bristol.ac.uk; heinrich@helmholtz-muenchen.de; m.jarvelin@imperial.ac.uk; v.jaddoe@erasmusmc.nl	Wilson, James F/A-5704-2009; Hypponen, Elina/B-2596-2014; van Buchem, Mark/AAC-9843-2022; DeCarli, Charles/B-5541-2009; Bisgaard, Hans/N-4761-2016; Thiering, Elisabeth/B-3342-2013; Hinney, Anke/D-6953-2011; Koppelman, Gerard/AAG-9187-2020; Middeldorp, Christel M/L-7728-2017; Debette, Stephanie/T-4946-2019; Guxens, Monica/T-2285-2018; Lahti, Jari/P-7987-2018; Warrington, Nicole/P-4868-2014; Vernooij, Meike Willemijn/E-4061-2016; Coin, Lachlan JM/A-9001-2014; Lehtimäki, Terho/AAD-1094-2022; Müller-Nurasyid, Martina/I-8735-2018; Schmidt, Reinhold/E-1137-2014; Kronow, Joern/B-1054-2011; Scherag, Andre/B-3805-2014; Lye, Stephen J/E-7269-2013; Iñiguez, Carmen/AAA-5866-2019; Buxton, Jessica L/I-4033-2014; Pennell, Craig/ABD-6902-2020; Ikram, M. Arfan/AAM-5225-2021; Smith, Albert Vernon/K-5150-2015; Kemp, John P./R-3091-2018; Palmer, Lyle John/N-1948-2019; Jack, Clifford R/F-2508-2010; Prokopenko, Inga/H-3241-2014; Dedoussis, George/AAN-7252-2021; Hocher, Berthold/AAC-3510-2020; Haworth, Claire M.A./C-7073-2009; Evans, David M/H-6325-2013; Davis, Oliver SP/B-9653-2008; Estivill, Xavier/A-3125-2013; Fox, Laura J/C-6249-2016; Gudnason, Vilmundur/AAE-7126-2019; Davey Smith, George/A-7407-2013; Buxton, Jessica/L-9849-2019; Breteler, Monique M.B./J-5058-2014; Rivadeneira, Fernando/O-5385-2015; Study, Raine/K-4517-2013; Blakemore, Alexandra I F/D-2253-2009; Lahti, Jari/P-2283-2019; Raitakari, Olli/AAQ-7389-2021; Wichmann, Heinz Erich/AAA-5695-2022; Palmer, Lyle John/K-3196-2014; Holloway, John W/B-5424-2009; St Pourcain, Beate/K-8004-2017; Price, Thomas S./B-7372-2008; Rodriguez, Alina/B-3541-2015; Timpson, Nicholas John/O-7548-2015; Catellier, Diane/AAN-2219-2021; Taal, Hendrik R/B-4847-2018; Coin, Lachlan/O-4976-2019; Heinrich, Joachim/N-1720-2013; Prokopenko, Inga/AAU-9895-2020; Gudnason, Vilmundur/K-6885-2015; Sovio, Ulla/H-8532-2019; Attrill, Lauren/V-1688-2018; Hadley, Dexter/ABB-7568-2021; Sunyer Deu, Jordi/G-6909-2014; McCarthy, Mark/M-3763-2015	Wilson, James F/0000-0001-5751-9178; Hypponen, Elina/0000-0003-3670-9399; van Buchem, Mark/0000-0003-1881-1998; Bisgaard, Hans/0000-0003-4131-7592; Hinney, Anke/0000-0001-5659-0706; Middeldorp, Christel M/0000-0002-6218-0428; Debette, Stephanie/0000-0001-8675-7968; Guxens, Monica/0000-0002-8624-0333; Lahti, Jari/0000-0002-4310-5297; Warrington, Nicole/0000-0003-4195-775X; Coin, Lachlan JM/0000-0002-4300-455X; Lehtimäki, Terho/0000-0002-2555-4427; Müller-Nurasyid, Martina/0000-0003-3793-5910; Lye, Stephen J/0000-0002-3305-4406; Iñiguez, Carmen/0000-0003-3471-4928; Buxton, Jessica L/0000-0002-0918-9335; Pennell, Craig/0000-0002-0937-6165; Smith, Albert Vernon/0000-0003-1942-5845; Kemp, John P./0000-0002-9105-2249; Palmer, Lyle John/0000-0002-1628-3055; Jack, Clifford R/0000-0001-7916-622X; Prokopenko, Inga/0000-0003-1624-7457; Dedoussis, George/0000-0002-7798-6221; Haworth, Claire M.A./0000-0002-8608-289X; Evans, David M/0000-0003-0663-4621; Davis, Oliver SP/0000-0002-6448-3684; Estivill, Xavier/0000-0002-0723-2256; Gudnason, Vilmundur/0000-0001-5696-0084; Davey Smith, George/0000-0002-1407-8314; Breteler, Monique M.B./0000-0002-0626-9305; Rivadeneira, Fernando/0000-0001-9435-9441; Blakemore, Alexandra I F/0000-0003-0661-564X; Lahti, Jari/0000-0002-4310-5297; Palmer, Lyle John/0000-0002-1628-3055; Holloway, John W/0000-0001-9998-0464; St Pourcain, Beate/0000-0002-4680-3517; Price, Thomas S./0000-0001-7356-2109; Rodriguez, Alina/0000-0003-1209-8802; Timpson, Nicholas John/0000-0002-7141-9189; Coin, Lachlan/0000-0002-4300-455X; Heinrich, Joachim/0000-0002-9620-1629; Gudnason, Vilmundur/0000-0001-5696-0084; Sovio, Ulla/0000-0002-0799-1105; Hadley, Dexter/0000-0003-0990-4674; Willemsen, Gonneke/0000-0003-3755-0236; Iniguez, Carmen/0000-0002-5156-0732; Geller, Frank/0000-0002-9238-3269; Lawlor, Debbie A/0000-0002-6793-2262; van Beijsterveldt, Toos/0000-0002-6617-4201; Cooper, Cyrus/0000-0003-3510-0709; O'Reilly, Paul/0000-0001-7515-0845; Pearson, Ewan/0000-0001-9237-8585; Kaakinen, Marika/0000-0002-9228-0462; Freathy, Rachel/0000-0003-4152-2238; Lewin, Alexandra/0000-0003-0081-7582; Feenstra, Bjarke/0000-0003-1478-649X; s, hema/0000-0002-3440-9475; Van Duijn, Cornelia/0000-0002-2374-9204; Lindgren, Cecilia/0000-0002-4903-9374; Sunyer Deu, Jordi/0000-0002-2602-4110; McCarthy, Mark/0000-0002-4393-0510; Nivard, Michel/0000-0003-2015-1888; Zeggini, Eleftheria/0000-0003-4238-659X; Thiering, Elisabeth/0000-0002-5429-9584; Fernandez Banet, Julio/0000-0003-0901-1286; Grant, Struan/0000-0003-2025-5302; Palotie, Aarno/0000-0002-2527-5874; Beiser, Alexa/0000-0001-8551-7778; Elliott, Paul/0000-0002-7511-5684; Marsh, Julie/0000-0001-8984-6907; Newnham, John/0000-0001-9983-7457; Scherag, Andre/0000-0002-9406-4704; Koppelman, Gerard/0000-0001-8567-3252; melbye, mads/0000-0001-8264-6785; Niessen, Wiro/0000-0002-5822-1995; Hocher, Berthold/0000-0001-8143-0579; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Lakka, Timo/0000-0002-9199-2871; Vernooij, Meike/0000-0003-4658-2176; Seshadri, Sudha/0000-0001-6135-2622; , Hanieh/0000-0001-9672-9477; Kreiner, Eskil/0000-0003-1204-2438; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Chawes, Bo/0000-0001-6846-6243; Hattersley, Andrew/0000-0001-5620-473X; Ikram, Mohammad Arfan/0000-0003-0372-8585; Sebert, Sylvain/0000-0001-6681-6983; Bonnelykke, Klaus/0000-0003-2003-1018; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland [104781, 120315, 129269, 1114194, 134839, 129287]; Biocentrum Helsinki; Biocenter, University of Oulu, Finland; British Heart Foundation; Canadian Institutes of Health Research [MOP 82893]; The Children's Hospital of Philadelphia; Cotswold Foundation; Darlington Trust; Dutch Asthma Foundation; Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; European Community [HEALTH-F4-2007-201413]; Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen; German Research Center for Environment and Health; Institute of Epidemiology I; Neuherberg; Instituto de Salud Carlos III [FIS PI081151, PS09/00432]; Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; UK MRC [G0500539, G0600331, G0600705]; Municipal Health Service Rotterdam; National Health and Medical Research Council of Australia [403981, 003209]; National Public Health Institute, Helsinki, Finland; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw) [SPI 56-464-14192, 904-61-090, 904-61-193, 912-03-031, 480-04-004, 400-05-717]; US NHLBI [5R01HL087679-02, 1RL1MH083268-01]; US NIH [1R01HD056465-01A1]; Peninsula NIHR Clinical Research Facility; RAINE Medical Research Foundation; Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst AMP; Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; Wellcome Trust [GR069224, 085541/Z/08/Z, WT083431MA, WT088431MA]; Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; ZonMW [21000074]; Dutch Kidney Foundation [C08.2251]; MRC UK [G0500539, PS0476]; MRC [MRC G0800582]; Netherlands Organisation for Health Research (ZonMw) [90700303, 916.10159]; MRC [G0801056, G0600331, G0800582, G0600705] Funding Source: UKRI; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; Medical Research Council [G0800582, G0600331, G0801056B, G0600705, G0801056, G9817803B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056465] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U22PS000476] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007270] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Biocenter, University of Oulu, Finland; British Heart Foundation(British Heart Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Children's Hospital of Philadelphia; Cotswold Foundation; Darlington Trust; Dutch Asthma Foundation; Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; European Community(European Commission); Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen; German Research Center for Environment and Health; Institute of Epidemiology I; Neuherberg; Instituto de Salud Carlos III; Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Municipal Health Service Rotterdam; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Public Health Institute, Helsinki, Finland; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); US NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peninsula NIHR Clinical Research Facility; RAINE Medical Research Foundation; Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst AMP; Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; Wellcome Trust(Wellcome TrustEuropean Commission); Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; ZonMW(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organisation for Health Research (ZonMw)(Netherlands Organization for Health Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Sayers for helpful discussions with respect to the conducted mediation analysis. Major funding for the research in this paper is from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 134839, 129287 and Center of Excellence in Complex Disease Genetics); Biocentrum Helsinki; Biocenter, University of Oulu, Finland; the British Heart Foundation; the Canadian Institutes of Health Research (grant MOP 82893); The Children's Hospital of Philadelphia (Institute Development Award); the Cotswold Foundation (Research Development Award); the Darlington Trust; the Dutch Asthma Foundation; the Dutch Ministry of the Environment; Erasmus Medical Center Rotterdam; Erasmus University Rotterdam; The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project and grant agreement HEALTH-F4-2007-201413; Exeter National Health Service (NHS) Research and Development; Fundacio La Marato de TV3 (Televisio de Catalunya); Helmholtz Zentrum Muenchen, the German Research Center for Environment and Health, Institute of Epidemiology I, Neuherberg; Instituto de Salud Carlos III (FIS PI081151 and PS09/00432); Institut fur Umweltmedizinische Forschung (IUF) Dusseldorf; Marien-Hospital Wesel; the UK MRC (G0500539, G0600331, PrevMetSyn/Salve/MRC and G0600705); the Municipal Health Service Rotterdam; the National Health and Medical Research Council of Australia (403981 and 003209); the National Public Health Institute, Helsinki, Finland; the Netherlands Organisation for Scientific Research (NWO) and the Netherlands Organisation for Health Research and Development (ZonMw) (grants SPI 56-464-14192, 904-61-090, 904-61-193, 912-03-031, 480-04-004 and 400-05-717); the US NHLBI (grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01)); the US NIH (grant 1R01HD056465-01A1); the Peninsula NIHR Clinical Research Facility; the RAINE Medical Research Foundation; the Rotterdam Homecare Foundation; South West NHS Research and Development; Stichting Astmabestrijding; Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR) Rotterdam; Technical University Munich; the Telethon Institute for Child Health Research; UFZ-Centre for Environmental Research Leipzig-Halle; University Hospital Oulu, Finland; University of Bristol; University of Leipzig; the Wellcome Trust (project grant GR069224); the Western Australian DNA Bank; the Western Australian Genetic Epidemiology Resource and ZonMW (grant 21000074). Data exchange and deposition has been facilitated by the SIMBioMS platform. Personal funding was provided by the Dutch Kidney Foundation (C08.2251 to H. R. T.), the MRC UK (G0500539, PrevMetSyn and PS0476 to S. Das), a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust grant 085541/Z/08/Z to R. M. F.), a MRC New Investigator Award (MRC G0800582 to D. M. E.) and Wellcome Trust 4-year PhD studentships (WT083431MA to J.P.K. and WT088431MA to J.L.B.). I. P. and J.F.-B. are in part supported by the European Community's ENGAGE grant HEALTH-F4-2007-201413, A. T. H. is employed as a core member of the Peninsula NIHR Clinical Research Facility and V.W.V.J. is funded by the Netherlands Organisation for Health Research (ZonMw 90700303 and 916.10159). Detailed acknowledgments by study are given in the Supplementary Note.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Conrad C, 2004, J NEUROCHEM, V89, P179, DOI 10.1046/j.1471-4159.2004.02320.x; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; COYLETHOMPSON CA, 1993, DEVELOPMENT, V119, P377; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FISCH RO, 1976, AM J DIS CHILD, V130, P481, DOI 10.1001/archpedi.1976.02120060027006; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsuchou H, 2010, ENDOCRINOLOGY, V151, P1221, DOI 10.1210/en.2009-1039; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; Ivanovic DM, 2000, NUTRITION, V16, P1056, DOI 10.1016/S0899-9007(00)00431-7; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Krestyaninova M, 2009, BIOINFORMATICS, V25, P2768, DOI 10.1093/bioinformatics/btp420; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Levecque C, 2004, J NEUROL NEUROSUR PS, V75, P478, DOI 10.1136/jnnp.2003.015750; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Samaranch L, 2010, J ALZHEIMERS DIS, V22, P1065, DOI 10.3233/JAD-2010-101011; Saunders CL, 2006, ANN HUM BIOL, V33, P415, DOI 10.1080/03014460600742062; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smit DJA, 2010, TWIN RES HUM GENET, V13, P370, DOI 10.1375/twin.13.4.370; Suzuki C, 2007, MOL CANCER THER, V6, P542, DOI 10.1158/1535-7163.MCT-06-0659; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Webb A, 2008, ARCH NEUROL-CHICAGO, V65, P1473, DOI 10.1001/archneur.65.11.1473; Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	43	89	89	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					532	+		10.1038/ng.2238	http://dx.doi.org/10.1038/ng.2238			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22504419	Green Published, Green Accepted, Green Submitted			2022-12-17	WOS:000303416300013
J	Wang, HB; Bauzon, F; Ji, P; Xu, XL; Sun, DQ; Locker, J; Sellers, RS; Nakayama, K; Nakayama, KI; Cobrinik, D; Zhu, L				Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Xu, Xiaoliang; Sun, Daqian; Locker, Joseph; Sellers, Rani S.; Nakayama, Keiko; Nakayama, Keiich I.; Cobrinik, David; Zhu, Liang			Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1(+/-) mice	NATURE GENETICS			English	Article							RB MUTANT MICE; TUMOR; RETINOBLASTOMA; P27(KIP1); CANCER; MOUSE; SUPPRESSION; APOPTOSIS; MUTATION; PROTEIN	Heterozygosity of the retinoblastoma gene Rb1 elicits tumorigenesis in susceptible tissues following spontaneous loss of the remaining functional allele. Inactivation of previously studied retinoblastoma protein (pRb) targets partially inhibited tumorigenesis in Rb1(+/-) mice(1-6). Here we report that inactivation of pRb target Skp2 (refs. 7,8) completely prevents spontaneous tumorigenesis in Rb1(+/-) mice. Targeted Rb1 deletion in melanotrophs ablates the entire pituitary intermediate lobe when Skp2 is inactivated. Skp2 inactivation does not inhibit aberrant proliferation of Rb1-deleted melanotrophs but induces their apoptotic death. Eliminating p27 phosphorylation on T187 in p27T187A knock-in mice reproduces the effects of Skp2 knockout, identifying p27 ubiquitination by SCFSkp2 ubiquitin ligase as the underlying mechanism for Skp2's essential tumorigenic role in this setting. RB1-deficient human retinoblastoma cells also undergo apoptosis after Skp2 knockdown; and ectopic expression of p27, especially the p27T187A mutant, induces apoptosis. These results reveal that Skp2 becomes an essential survival gene when susceptible cells incur Rb1 deficiency.	[Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Sun, Daqian; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol & Med, Bronx, NY USA; [Wang, Hongbo; Bauzon, Frederick; Ji, Peng; Sun, Daqian; Locker, Joseph; Sellers, Rani S.; Zhu, Liang] Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10467 USA; [Xu, Xiaoliang; Cobrinik, David] Weill Cornell Med Coll, Dyson Vis Res Inst, New York, NY USA; [Locker, Joseph; Sellers, Rani S.] Albert Einstein Comprehens Canc Ctr, Dept Pathol, Bronx, NY USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Funct Genom, Div Dev Genet, Sendai, Miyagi 980, Japan; [Nakayama, Keiich I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Dyson; Yeshiva University; Tohoku University; Kyushu University	Zhu, L (corresponding author), Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol & Med, Bronx, NY USA.	liang.zhu@einstein.yu.edu			NCI NIH HHS [R01 CA131421, R01 CA131421-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA131421] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [19057011] Funding Source: KAKEN	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Carneiro C, 2003, ONCOGENE, V22, P361, DOI 10.1038/sj.onc.1206163; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Ji P, 2007, MOL CANCER THER, V6, P684, DOI 10.1158/1535-7163.MCT-06-0538; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Leung SW, 2004, ONCOGENE, V23, P3296, DOI 10.1038/sj.onc.1207457; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi C, 2006, NAT GENET, V38, P118, DOI 10.1038/ng1703; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	26	89	93	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					83	U105		10.1038/ng.498	http://dx.doi.org/10.1038/ng.498			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19966802	Green Accepted, Bronze			2022-12-17	WOS:000273055100021
J	Suzuki, A; Yamada, R; Kochi, Y; Sawada, T; Okada, Y; Matsuda, K; Kamatani, Y; Mori, M; Shimane, K; Hirabayashi, Y; Takahashi, A; Tsunoda, T; Miyatake, A; Kubo, M; Kamatani, N; Nakamura, Y; Yamamoto, K				Suzuki, Akari; Yamada, Ryo; Kochi, Yuta; Sawada, Tetsuji; Okada, Yukinori; Matsuda, Koichi; Kamatani, Yoichiro; Mori, Mikako; Shimane, Kenichi; Hirabayashi, Yasuhiko; Takahashi, Atsushi; Tsunoda, Tatsuhiko; Miyatake, Akihiko; Kubo, Michiaki; Kamatani, Naoyuki; Nakamura, Yusuke; Yamamoto, Kazuhiko			Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; ASSOCIATION; SUSCEPTIBILITY; PTPN22; PADI4; POLYMORPHISM; METAANALYSIS; NUCLEOTIDE; FAMILIES	Rheumatoid arthritis is a chronic autoimmune inflammatory disease with a complex genetic etiology. Members of the signaling lymphocyte activation molecule (SLAM) family carry out pivotal functions in innate immunity and in conventional lymphocytes. We identified a linkage disequilibrium block associated with rheumatoid arthritis in the chromosome 1q region containing multiple SLAM family genes. In this block, the association peaked at two functional SNPs (rs3766379 and rs6682654) in CD244 in two independent rheumatoid arthritis cohorts from Japan (P = 3.23 x 10(-8) and P = 7.45 x 10(-8)). We also identified a Japanese cohort with systemic lupus erythematosus that had a similar genotype distribution as the rheumatoid arthritis cohorts. We demonstrated that the rheumatoid arthritis-susceptible alleles of rs3766379 and rs6682654 and their haplotype increased their expression in luciferase and allele-specific transcript quantification assays. CD244 is a genetic risk factor for rheumatoid arthritis and may have a role in the autoimmune process shared by rheumatoid arthritis and systemic lupus erythematosus.	[Suzuki, Akari; Yamada, Ryo; Kochi, Yuta; Mori, Mikako; Shimane, Kenichi; Yamamoto, Kazuhiko] RIKEN, Ctr Genom Med, Lab Autoimmune Dis, Tsurumi Ku, Kanagawa 2300045, Japan; [Yamada, Ryo; Okada, Yukinori] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Funct Genom,Minato Ku, Tokyo 1088639, Japan; [Sawada, Tetsuji; Mori, Mikako; Shimane, Kenichi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1130033, Japan; [Hirabayashi, Yasuhiko] Tohoku Univ, Grad Sch Med, Dept Rheumatol & Hematol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Tsurumi Ku, Kanagawa 2300045, Japan; [Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Tsurumi Ku, Kanagawa 2300045, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Chuo Ku, Osaka 5420086, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping, Tsurumi Ku, Kanagawa 2300045, Japan	RIKEN; University of Tokyo; University of Tokyo; Tohoku University; RIKEN; RIKEN; RIKEN	Yamamoto, K (corresponding author), RIKEN, Ctr Genom Med, Lab Autoimmune Dis, Tsurumi Ku, 1-7-22 Suehirocho, Kanagawa 2300045, Japan.	yamamoto-tky@umin.ac.jp	Sawed, Tetsuji/GRX-6582-2022; Tsunoda, Tatsuhiko/K-2061-2014; Yamamoto, Kazuhiko/N-5096-2015; Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Suzuki, Akari/N-5389-2015; Matsuda, Koichi/D-4597-2011	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Matsuda, Koichi/0000-0001-7292-2686; Yamada, Ryo/0000-0002-1587-630X	BioBank Japan Project; Japanese Millennium Project; Japanese Ministry of Health, Labor and Welfare	BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Millennium Project; Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank K. Kobayashi, M. Ohtake-Yamanaka, E. Kanno and all members of the rheumatoid arthritis team for their advice and technical assistance; H. Kawakami and T. Kawaguchi for their expertise in computer programming; and members of the Center for Genomic Medicine of RIKEN and the Biomedical Research Laboratories of Sankyo Co. Ltd. for helpful discussions and assistance in various aspects of this study. We are also grateful to members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan, the Pharma SNP Consortium in Japan and the BioBank Japan Project for supporting our study. This work was supported by grants from the Japanese Millennium Project and the Japanese Ministry of Health, Labor and Welfare.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Claus M, 2008, FRONT BIOSCI-LANDMRK, V13, P956, DOI 10.2741/2735; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Nakajima H, 2000, HUM IMMUNOL, V61, P39, DOI 10.1016/S0198-8859(99)00170-6; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Scofield RH, 2003, BLOOD, V101, P992, DOI 10.1182/blood-2002-04-1003; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Yamada R, 2005, MUTAT RES-FUND MOL M, V573, P136, DOI 10.1016/j.mrfmmm.2004.06.061; Yamamoto K, 2007, NEW ENGL J MED, V357, P1250, DOI 10.1056/NEJMe078174	30	89	91	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1224	1229		10.1038/ng.205	http://dx.doi.org/10.1038/ng.205			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794858				2022-12-17	WOS:000259651000023
J	Sung, LY; Gao, SR; Shen, HM; Yu, H; Song, YF; Smith, SL; Chang, CC; Inoue, K; Kuo, L; Lian, J; Li, A; Tian, XC; Tuck, DP; Weissman, SM; Yang, XZ; Cheng, T				Sung, Li-Ying; Gao, Shaorong; Shen, Hongmei; Yu, Hui; Song, Yifang; Smith, Sadie L.; Chang, Ching-Chien; Inoue, Kimiko; Kuo, Lynn; Lian, Jin; Li, Ao; Tian, X. Cindy; Tuck, David P.; Weissman, Sherman M.; Yang, Xiangzhong; Cheng, Tao			Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer	NATURE GENETICS			English	Article							CLONED MICE; P21(CIP1/WAF1); P18(INK4C); GENOME; MOUSE	Since the creation of Dolly via somatic cell nuclear transfer (SCNT) 1, more than a dozen species of mammals have been cloned using this technology(2). One hypothesis for the limited success of cloning via SCNT (1%-5%) 3 is that the clones are likely to be derived from adult stem cells(4). Support for this hypothesis comes from the findings that the reproductive cloning efficiency for embryonic stem cells is five to ten times higher than that for somatic cells as donors(5,6) and that cloned pups cannot be produced directly from cloned embryos derived from differentiated B and T cells or neuronal cells(7-10). The question remains as to whether SCNT-derived animal clones can be derived from truly differentiated somatic cells. We tested this hypothesis with mouse hematopoietic cells at different differentiation stages: hematopoietic stem cells, progenitor cells and granulocytes. We found that cloning efficiency increases over the differentiation hierarchy, and terminally differentiated postmitotic granulocytes yield cloned pups with the greatest cloning efficiency.	Univ Pittsburgh, Inst Canc, Canc Stem Cell Program, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Connecticut; University of Connecticut; University of Connecticut; Yale University; Yale University	Yang, XZ (corresponding author), Univ Pittsburgh, Inst Canc, Canc Stem Cell Program, Pittsburgh, PA 15213 USA.	xiangzhong.yang@uconn.edu; chengt@upmc.edu	Li, aoyu/GXV-4925-2022; Pillay, Nischalan/F-9536-2012; Li, Ao/GRR-5311-2022; Kuo, Lynn/AAQ-6409-2021	Kuo, Lynn/0000-0002-1903-4425; SUNG, LI-YING/0000-0003-1221-2476; Cheng, Tao/0000-0002-5925-2769; Marjani, Sadie/0000-0003-1241-8538	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080424] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL70561, R01 HL070561-05A2, R01 HL070561] Funding Source: Medline; NIAID NIH HHS [R01 AI080424] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gao SR, 2003, CLONING STEM CELLS, V5, P287, DOI 10.1089/153623003772032790; Gao SR, 2003, BIOL REPROD, V68, P595, DOI 10.1095/biolreprod.102.005819; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Smith AL, 2005, J GERONTOL A-BIOL, V60, P448, DOI 10.1093/gerona/60.4.448; Smyth MJ, 2005, J EXP MED, V201, P1973, DOI 10.1084/jem.20042280; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Tian X Cindy, 2003, Reprod Biol Endocrinol, V1, P98, DOI 10.1186/1477-7827-1-98; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yanagimachi R, 2002, MOL CELL ENDOCRINOL, V187, P241, DOI 10.1016/S0303-7207(01)00697-9; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	30	89	103	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1323	1328		10.1038/ng1895	http://dx.doi.org/10.1038/ng1895			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013394				2022-12-17	WOS:000241592700022
J	Need, AC; Motulsky, AG; Goldstein, DB				Need, AC; Motulsky, AG; Goldstein, DB			Priorities and standards in pharmacogenetic research	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; COMMON DISEASE GENES; LONG-QT SYNDROME; LINKAGE DISEQUILIBRIUM; RESISTANT SCHIZOPHRENIA; PULMONARY-HYPERTENSION; DRUG DEVELOPMENT; HUMAN GENOME; LUNG-CANCER; MUTATION	The current enthusiasm for pharmacogenetics draws much of its inspiration from the relatively few examples of polymorphisms that have marked and seemingly clinically relevant effects on drug response. In this regard, pharmacogenetic research has paralleled the study of human disease, which has enjoyed success in identifying mutations underlying mendelian conditions. Progress in deciphering the genetics of complex diseases, involving the interaction of multiple genes with each other and with the environment has been considerably less successful. In most instances, drug responses will probably also prove to be complex, influenced by both the environment and multiple genetic factors. For pharmacogenetics to deliver on its potential, this complexity will need to be recognized and accommodated, both in basic research and in clinical application of pharmacogenetics. As the attention of researchers begins to shift toward more systematic pharmacogenetic investigations, we suggest some priorities and standards for pharmacogenetic research.	Duke Univ, Ctr Populat Genom & Pharmacogenet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Need, AC (corresponding author), Duke Univ, Ctr Populat Genom & Pharmacogenet, Inst Genome Sci & Policy, 103 Res Dr,DUMC Box 3471, Durham, NC 27710 USA.		Goldstein, David/AAY-8125-2020	Need, Anna/0000-0003-3955-8207	NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acuna Gonzalo, 2002, Pharmacogenomics Journal, V2, P327, DOI 10.1038/sj.tpj.6500123; Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Belohlavkova S, 2001, J APPL PHYSIOL, V91, P755, DOI 10.1152/jappl.2001.91.2.755; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Camilleri M, 2002, GASTROENTEROLOGY, V123, P425, DOI 10.1053/gast.2002.34780; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Dervieux T, 2004, ARTHRITIS RHEUM-US, V50, P2766, DOI 10.1002/art.20460; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Duggan A, 2003, BRIT J PSYCHIAT, V182, P505, DOI 10.1192/bjp.182.6.505; Fischer OM, 2003, CURR OPIN CHEM BIOL, V7, P490, DOI 10.1016/S1367-5931(03)00082-6; Flowers CR, 2004, PHARMACOECONOMICS, V22, P481, DOI 10.2165/00019053-200422080-00001; Ford GA, 2000, BRIT J CLIN PHARMACO, V50, P77, DOI 10.1046/j.1365-2125.2000.00230.x; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Goldstein DB, 2003, NEW ENGL J MED, V348, P553, DOI 10.1056/NEJMe020173; Gross AS, 1996, BRIT J CLIN PHARMACO, V41, P311, DOI 10.1046/j.1365-2125.1996.03178.x; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Humbert M, 2002, EUR RESPIR J, V20, P518, DOI 10.1183/09031936.02.01762002; Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6; Jiang ZW, 2005, HUM MUTAT, V25, P196, DOI 10.1002/humu.20134; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Krajinovic M, 2004, PHARMACOGENOMICS J, V4, P66, DOI 10.1038/sj.tpj.6500224; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kumashiro R, 2003, HEPATOL RES, V26, P337, DOI 10.1016/S1386-6346(03)00165-7; Lesko LJ, 2004, NAT REV DRUG DISCOV, V3, P763, DOI 10.1038/nrd1499; Li H, 2001, ANN HUM GENET, V65, P189, DOI 10.1017/S0003480001008491; Liguori MJ, 2005, HEPATOLOGY, V41, P177, DOI 10.1002/hep.20514; Liu NJ, 2004, GENET EPIDEMIOL, V27, P385, DOI 10.1002/gepi.20026; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; McGough JJ, 2003, J AM ACAD CHILD PSY, V42, P684, DOI 10.1097/01.CHI.0000046850.56865.CB; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; Michalski C, 2002, J BIOL CHEM, V277, P43058, DOI 10.1074/jbc.M207735200; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nebert DW, 2004, EUR J PHARMACOL, V500, P267, DOI 10.1016/j.ejphar.2004.07.031; Ni W, 2004, J PHARMACOL EXP THER, V309, P845, DOI 10.1124/jpet.103.060806; Ovcharenko I, 2004, GENOME RES, V14, P1191, DOI 10.1101/gr.1773104; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; Rajput AH, 2002, MOVEMENT DISORD, V17, P289, DOI 10.1002/mds.10031; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Roses AD, 2005, DRUG DISCOV TODAY, V10, P177, DOI 10.1016/S1359-6446(04)03321-5; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; Shah Rashmi R, 2005, Expert Opin Drug Saf, V4, P103, DOI 10.1517/14740338.4.1.103; Shah RR, 2004, DRUG SAFETY, V27, P145, DOI 10.2165/00002018-200427030-00001; SHAH RR, IN PRESS P R SOC L B; SHORVON S, 2004, TREATMENT EPILEPSY; Soranzo N, 2004, GENOME RES, V14, P1333, DOI 10.1101/gr.1965304; Strauss JF, 2004, NATURE, V432, P43, DOI 10.1038/432043a; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Watanabe I, 2003, CLIN PHARMACOL THER, V73, P435, DOI 10.1016/S0009-9236(03)00014-6; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wolbrette Deborah L, 2004, Curr Cardiol Rep, V6, P379, DOI 10.1007/s11886-004-0041-8; Wong DR, 2005, CURR OPIN PHARMACOL, V5, P204, DOI 10.1016/j.coph.2005.02.001; Zembutsu H, 2002, CANCER RES, V62, P518; Zhang JY, 2003, DRUG METAB DISPOS, V31, P652, DOI 10.1124/dmd.31.5.652; Zhen XA, 2004, CANCER RES, V64, P2904, DOI 10.1158/0008-5472.CAN-03-3754	75	89	92	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					671	681		10.1038/ng1593	http://dx.doi.org/10.1038/ng1593			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15990888				2022-12-17	WOS:000230196400013
J	Chen, WSV; Delrow, J; Corrin, PD; Frazier, JP; Soriano, P				Chen, WSV; Delrow, J; Corrin, PD; Frazier, JP; Soriano, P			Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA; DEVELOPMENTAL GENES; EXPRESSION PATTERNS; FUNCTIONAL-ANALYSIS; GROWTH-FACTORS; MOUSE GENOME; MUTANT MICE; IN-VITRO; SCREEN	We developed a versatile, high-throughput genetic screening strategy by coupling gene mutagenesis and expression profiling technologies. Using a retroviral gene-trap vector optimized for efficient mutagenesis and cloning, we randomly disrupted genes in mouse embryonic stem (ES) cells and amplified them to construct a cDNA microarray. With this gene-trap array, we show that transcriptional target genes of platelet-derived growth factor (PDGF) can be efficiently and reliably identified in physiologically relevant cells and are immediately accessible to genetic studies to determine their in vivo roles and relative contributions to PDGF-regulated developmental processes. The same platform can be used to search for genes of specific biological relevance in a broad array of experimental settings, providing a fast track from gene identification to functional validation.	Fred Hutchinson Canc Res Ctr, Program Dev Biol, Div Basic Sci, Seattle, WA 98109 USA; Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan	Soriano, P (corresponding author), Fred Hutchinson Canc Res Ctr, Program Dev Biol, Div Basic Sci, Seattle, WA 98109 USA.	psoriano@fhcrc.org	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X				Abuin A, 2002, TRENDS BIOTECHNOL, V20, P36, DOI 10.1016/S0167-7799(01)01843-1; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bonaldo P, 1998, EXP CELL RES, V244, P125, DOI 10.1006/excr.1998.4208; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komada M, 2000, GENE DEV, V14, P1332; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SORIANO P, 1991, J VIROL, V65, P2314, DOI 10.1128/JVI.65.5.2314-2319.1991; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	42	89	96	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					304	312		10.1038/ng1306	http://dx.doi.org/10.1038/ng1306			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981515	Bronze			2022-12-17	WOS:000189250400022
J	Stoeckert, CJ; Causton, HC; Ball, CA				Stoeckert, CJ; Causton, HC; Ball, CA			Microarray databases: standards and ontologies	NATURE GENETICS			English	Editorial Material							EXPRESSION; CANCER; GENES	A single microarray can provide information on the expression of tens of thousands of genes. The amount of information generated by a microarray-based experiment is sufficiently large that no single study can be expected to mine each nugget of scientific information. As a consequence, the scale and complexity of microarray experiments require that computer software programs do much of the data processing, storage, visualization, analysis and transfer. The adoption of common standards and ontologies for the management and sharing of microarray data is essential and will provide immediate benefit to the research community.	Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Microarray Ctr, Ctr Clin Sci, London W12 0NN, England; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Pennsylvania; University of Pennsylvania; Imperial College London; Stanford University	Stoeckert, CJ (corresponding author), Univ Penn, Ctr Bioinformat, 423 Guardian Dr, Philadelphia, PA 19104 USA.	stoeckert@pcbi.upenn.edu		Causton, Helen/0000-0003-4630-6569				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Spellman PT, 2002, GENOME BIOL, V3; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Stoeckert C, 2001, BIOINFORMATICS, V17, P300, DOI 10.1093/bioinformatics/17.4.300; Waddell P J, 2000, Genome Inform Ser Workshop Genome Inform, V11, P129	13	89	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			469	473		10.1038/ng1028	http://dx.doi.org/10.1038/ng1028			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454640				2022-12-17	WOS:000179742900005
J	You, Y; Bergstrom, R; Klemm, M; Lederman, B; Nelson, H; Ticknor, C; Jaenisch, R; Schimenti, J				You, Y; Bergstrom, R; Klemm, M; Lederman, B; Nelson, H; Ticknor, C; Jaenisch, R; Schimenti, J			Chromosomal deletion complexes in mice by radiation of embryonic stem cells	NATURE GENETICS			English	Article							SEX-DETERMINING REGION; MOUSE CHROMOSOME-7; LETHAL MUTATIONS; GENE; LOCUS; INVERSIONS; ECTODERM; ENCODES; PROTEIN; DEFINE	Chromosomal deletions ('deficiencies') are powerful tools in the genetic analysis of complex genomes. They have been exploited extensively in Drosophila melanogaster, an organism in which deficiencies can be efficiently induced and selected(1). Spontaneous deletions in humans have facilitated the dissection of phenotypes in contiguous gene syndromes(2,3) and led to the positional cloning of critical genes(4,5). In mice, deletion complexes created by whole animal irradiation experiments have enabled a systematic characterization of functional units along defined chromosomal regions(6,7). However, classical mutagenesis in mice is logistically impractical for generating deletion sets on a genome-wide scale. Here, we report a high-throughput method for generating radiation-induced deletion complexes at defined regions in the genome using ES cells. Dozens of deletions of up to several centiMorgans, encompassing a specific locus, can be created in a single experiment and transmitted through the germline. The ability to rapidly create deletion complexes along chromosomes will facilitate systematic functional analyses of the mammalian genome.	JACKSON LAB, BAR HARBOR, ME 04609 USA; MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE CTR 9, CAMBRIDGE, MA 02142 USA; SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND	Jackson Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis; Sandoz								ASHBURNER M, 1989, DROSOPHILA LAB MAN; ASKEW GR, 1993, MOL CELL BIOL, V13, P4115, DOI 10.1128/MCB.13.7.4115; BELL JA, 1995, MAMM GENOME, V6, P389, DOI 10.1007/BF00355638; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; Hamvas R, 1996, MAMM GENOME, V6, pS281; HOLDENER BC, 1995, GENOMICS, V27, P447, DOI 10.1006/geno.1995.1076; HOLDENERKENNY B, 1992, BIOESSAYS, V14, P831, DOI 10.1002/bies.950141208; JOHNSON DR, 1974, GENETICS, V76, P795; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; RINCHIK EM, 1993, GENETICS, V135, P1117; RUSSELL LB, 1982, GENETICS, V100, P427; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHARAN SK, 1991, GENETICS, V129, P825; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941	24	89	92	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					285	288		10.1038/ng0397-285	http://dx.doi.org/10.1038/ng0397-285			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054943				2022-12-17	WOS:A1997WK38600020
J	ENGLE, EC; KUNKEL, LM; SPECHT, LA; BEGGS, AH				ENGLE, EC; KUNKEL, LM; SPECHT, LA; BEGGS, AH			MAPPING A GENE FOR CONGENITAL FIBROSIS OF THE EXTRAOCULAR-MUSCLES TO THE CENTROMERIC REGION OF CHROMOSOME-12	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; DNA	Congenital Fibrosis of the Extraocular Muscles (CFEOM) is an autosomal dominant, ocular disorder characterized by congenital, nonprogressive, bilateral ptosis and external ophthalmoplegia. The pathophysiology of this disorder is unknown and it is unclear if it has a primary neurogenic or myopathic etiology. We report linkage of this disorder, in two unrelated families, to markers in the pericentromeric region of human chromosome 12. D12S59 does not recombine with the disease giving a two-point lod score of 12.5 (theta = 0.00). D12S87 and D12S85 flank the CFEOM locus with two-point lod scores of 8.9 (theta = 0.03) and 5.4 (theta = 0.03) respectively, defining a region of 8 cM. These data establish a map location for CFEOM and demonstrate that this may be a genetically homogeneous disorder.	HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, CHILDRENS HOSP, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; HARVARD UNIV, CHILDRENS HOSP, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute				Beggs, Alan/0000-0001-8818-0568	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007264] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS07264] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; APPLETON RE, 1989, ARCH NEUROL-CHICAGO, V46, P579, DOI 10.1001/archneur.1989.00520410115035; Brodsky M C, 1989, J Pediatr Ophthalmol Strabismus, V26, P159; Brown HW., 1950, STRABISMUS OPHTHALMI, P205; CANNIZZARO LA, 1987, AM J HUM GENET, V41, P1; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CRAIG I, 1992, CYTOGENET CELL GENET, V61, P244, DOI 10.1159/000133416; CRAWFORD JS, 1970, CAN J OPHTHALMOLOGY, V5, P331; GUYER M, 1992, SCIENCE, V258, P67; HANSEN E, 1968, ACTA OPHTHALMOL, V46, P469; HARLEY RD, 1978, J PEDIAT OPHTH STRAB, V15, P346; HIATT RL, 1983, ANN OPHTHALMOL, V15, P1103; HOLT M, 1993, AM J HUM GENET, V53, P1016; HOUTMAN WA, 1986, OPHTHALMOLOGICA, V193, P207, DOI 10.1159/000309712; JONES C, 1984, HUM GENET, V66, P206, DOI 10.1007/BF00286602; Kalpakian B, 1986, J Pediatr Ophthalmol Strabismus, V23, P170; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KHODADOUST AA, 1967, ARCH OPHTHALMOL-CHIC, V78, P606, DOI 10.1001/archopht.1967.00980030608009; KOSMORSKY G, 1991, NEUROL CLIN, V9, P147, DOI 10.1016/S0733-8619(18)30308-6; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAUGHLIN RC, 1956, AM J OPHTHALMOL, V41, P432, DOI 10.1016/0002-9394(56)91259-4; LAWFORD JB, 1888, T OPHTHAL SOC UK, V8, P262; Leone CJ, 1972, OPHTHALMIC SURG, V3, P71; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; NEMET P, 1985, Metabolic Pediatric and Systemic Ophthalmology, V8, P172; ODA K, 1986, J NEUROL SCI, V74, P125, DOI 10.1016/0022-510X(86)90099-7; Ott J., 1991, ANAL HUMAN GENETIC L; PRENDERGAST RA, 1993, INVEST OPHTH VIS SCI, V34, P1120; RINGEL SP, 1978, ARCH OPHTHALMOL-CHIC, V96, P1067; ROWLAND LP, 1992, HDB CLIN NEUROLOGY, P287; Rumpf M., 1974, ANN OCUL, V207, P831; VILLASECA A, 1959, AM J OPHTHALMOL, V48, P751, DOI 10.1016/0002-9394(59)90618-X; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WU S, 1990, NUCLEIC ACIDS RES, V18, P3102, DOI 10.1093/nar/18.10.3102-a	36	89	96	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					69	73		10.1038/ng0594-69	http://dx.doi.org/10.1038/ng0594-69			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075644				2022-12-17	WOS:A1994NJ84200016
J	Schrode, N; Ho, SM; Yamamuro, K; Dobbyn, A; Huckins, L; Matos, MR; Cheng, E; Deans, PJM; Flaherty, E; Barretto, N; Topol, A; Alganem, K; Abadali, S; Gregory, J; Hoelzli, E; Phatnani, H; Singh, V; Girish, D; Aronow, B; Mccullumsmith, R; Hoffman, GE; Stahl, EA; Morishita, H; Sklar, P; Brennand, KJ				Schrode, Nadine; Ho, Seok-Man; Yamamuro, Kazuhiko; Dobbyn, Amanda; Huckins, Laura; Matos, Marliette R.; Cheng, Esther; Deans, P. J. Michael; Flaherty, Erin; Barretto, Natalie; Topol, Aaron; Alganem, Khaled; Abadali, Sonya; Gregory, James; Hoelzli, Emily; Phatnani, Hemali; Singh, Vineeta; Girish, Deeptha; Aronow, Bruce; Mccullumsmith, Robert; Hoffman, Gabriel E.; Stahl, Eli A.; Morishita, Hirofumi; Sklar, Pamela; Brennand, Kristen J.			Synergistic effects of common schizophrenia risk variants	NATURE GENETICS			English	Article							GENE-EXPRESSION; NEURONS; DISEASE; CRISPR; GENOME; TRANSCRIPTION; HERITABILITY; MUTATIONS; INSIGHTS; COMPLEX	The mechanisms by which common risk variants of small effect interact to contribute to complex genetic disorders are unclear. Here, we apply a genetic approach, using isogenic human induced pluripotent stem cells, to evaluate the effects of schizophrenia (SZ)-associated common variants predicted to function as SZ expression quantitative trait loci (eQTLs). By integrating CRISPR-mediated gene editing, activation and repression technologies to study one putative SZ eQTL (FURIN rs4702) and four top-ranked SZ eQTL genes (FURIN, SNAP91, TSNARE1 and CLCN3), our platform resolves pre- and postsynaptic neuronal deficits, recapitulates genotype-dependent gene expression differences and identifies convergence downstream of SZ eQTL gene perturbations. Our observations highlight the cell-type-specific effects of common variants and demonstrate a synergistic effect between SZ eQTL genes that converges on synaptic function. We propose that the links between rare and common variants implicated in psychiatric disease risk constitute a potentially generalizable phenomenon occurring more widely in complex genetic disorders.	[Schrode, Nadine; Dobbyn, Amanda; Huckins, Laura; Deans, P. J. Michael; Hoffman, Gabriel E.; Stahl, Eli A.; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA; [Schrode, Nadine; Dobbyn, Amanda; Huckins, Laura; Deans, P. J. Michael; Hoffman, Gabriel E.; Stahl, Eli A.; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Ho, Seok-Man; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Stem Cell & Regenerat Biol, New York, NY 10029 USA; [Ho, Seok-Man; Matos, Marliette R.; Cheng, Esther; Flaherty, Erin; Barretto, Natalie; Topol, Aaron; Abadali, Sonya] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Yamamuro, Kazuhiko; Morishita, Hirofumi; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Yamamuro, Kazuhiko; Morishita, Hirofumi; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Huckins, Laura; Hoffman, Gabriel E.; Stahl, Eli A.; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Pamela Sklar Div Psychiat Genom, New York, NY 10029 USA; [Flaherty, Erin; Sklar, Pamela; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Alganem, Khaled; Mccullumsmith, Robert] Univ Toledo, Dept Neurosci, Inst Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gregory, James; Hoelzli, Emily; Phatnani, Hemali] New York Genome Ctr, Ctr Genom Neurodegenerat Dis, New York, NY USA; [Singh, Vineeta; Girish, Deeptha; Aronow, Bruce] Cincinnati Childrens Hosp Med Ctr, UC Dept Pediat, Cincinnati, OH 45229 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Toledo; Cincinnati Children's Hospital Medical Center	Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Stem Cell & Regenerat Biol, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Pamela Sklar Div Psychiat Genom, New York, NY 10029 USA.; Brennand, KJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	kristen.brennand@mssm.edu	McCullumsmith, Robert/GYR-1547-2022; Huckins, Laura/GPX-8325-2022; Morishita, Hirofumi/J-9619-2015; Brennand, Kristen J/J-8704-2012	Huckins, Laura/0000-0002-5369-6502; Morishita, Hirofumi/0000-0002-1045-1337; Brennand, Kristen J/0000-0003-0993-5956; Barretto, Natalie/0000-0002-1208-0453; Cheng, Esther/0000-0003-2909-666X; Gregory, James/0000-0002-7733-3212; Rodriguez Matos, Marliette/0000-0003-2641-6541; Cheng, Esther/0000-0001-7383-2447; Hoelzli, Emily/0000-0001-6159-703X; Flaherty, Erin/0000-0003-1109-3313; Alganem, Khaled/0000-0002-7368-5763	NIH [R56 MH101454, R01 MH106056, U19 MH104172, U19 MH107367, R01 MH109897]; New York Stem Cell Foundation; project ALS [2017-03]; Common Fund of the Office of the Director of the NIH; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107916, R01MH106056, R56MH101454, R01MH107487, R01MH109897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; project ALS; Common Fund of the Office of the Director of the NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This manuscript is dedicated to Pamela Sklar, a scientist, mentor and friend who advanced the field of psychiatric genetics. This work was partially supported by NIH grants (nos. R56 MH101454 to K.J.B., E.S. and H.M., R01 MH106056 to K.J.B., U19 MH104172 and U19 MH107367 to B.A., and R01 MH109897 to P.S. and K.J.B.), the New York Stem Cell Foundation (to K.J.B.) and project ALS (grant no. 2017-03 to J.G. and H.P.). We thank the Neuroscience and Stem Cell Cores at ISMMS. This work was supported in part through the computational resources and staff expertise provided by the Scientific Computing unit at ISMMS. P. O'Reilly provided thoughtful feedback on the manuscript. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by National Cancer Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health and National Institute of Neurological Disorders and Stroke. The data used for the analyses described in this manuscript were obtained from the GTEx portal on 4 January 2019.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Ballouz S, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0455-8; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bowles KR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213374; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Canals I, 2018, NAT METHODS, V15, P693, DOI 10.1038/s41592-018-0103-2; Chun SK, 2017, NAT MED, V23, P39, DOI 10.1038/nm.4240; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dobbyn A, 2018, AM J HUM GENET, V102, P1169, DOI 10.1016/j.ajhg.2018.04.011; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Focking M, 2015, MOL PSYCHIATR, V20, P424, DOI 10.1038/mp.2014.63; Forrest MP, 2017, CELL STEM CELL, V21, P305, DOI 10.1016/j.stem.2017.07.008; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hall L. S, 2018, TRANSCRIPTOME WIDE A, DOI [10.1101/384560, DOI 10.1101/384560]; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Ho SM, 2017, STEM CELL REP, V9, P615, DOI 10.1016/j.stemcr.2017.06.012; Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019; Hoffman GE, 2019, MOL PSYCHIATR, V24, P49, DOI 10.1038/s41380-018-0029-1; Hoffman GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02330-5; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Hou Y, 2018, SCHIZOPHR RES, V199, P176, DOI 10.1016/j.schres.2018.02.040; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huckins LM, 2019, NAT GENET, V51, P659, DOI 10.1038/s41588-019-0364-4; Jaffe AE, 2018, NAT NEUROSCI, V21, P1117, DOI 10.1038/s41593-018-0197-y; Jia PL, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0154-2; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu XY, 2019, CELL, V177, P1022, DOI 10.1016/j.cell.2019.04.014; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; McMahon FJ, 2012, NEURON, V74, P773, DOI 10.1016/j.neuron.2012.05.004; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Petralia RS, 2013, NEUROMOL MED, V15, P49, DOI 10.1007/s12017-012-8194-x; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ripke S, 2017, EUR NEUROPSYCHOPHARM, V27, pS415, DOI 10.1016/j.euroneuro.2016.09.460; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubin AJ, 2019, CELL, V176, P361, DOI 10.1016/j.cell.2018.11.022; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Schwartzentruber J, 2018, NAT GENET, V50, P54, DOI 10.1038/s41588-017-0005-8; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Smith JJ, 2012, MOL BIOL EVOL, V29, P985, DOI 10.1093/molbev/msr267; Suk HJ, 2017, NEURON, V95, P1037, DOI 10.1016/j.neuron.2017.08.011; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takata A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14519; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tansey KE, 2016, MOL PSYCHIATR, V21, P1153, DOI 10.1038/mp.2015.170; Wainschtein P, 2019, RECOVERY TRAIT HERIT, DOI [DOI 10.1101/588020, 10.1101/588020v1]; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863; Wray NR, 2018, CELL, V173, P1573, DOI 10.1016/j.cell.2018.05.051; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/nmeth.4291, 10.1038/NMETH.4291]; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	74	88	90	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1475	+		10.1038/s41588-019-0497-5	http://dx.doi.org/10.1038/s41588-019-0497-5			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31548722	Green Accepted			2022-12-17	WOS:000489016400011
J	Kirk, JM; Kim, SO; Inoue, K; Smola, MJ; Lee, DM; Schertzer, MD; Wooten, JS; Baker, AR; Sprague, D; Collins, DW; Horning, CR; Wang, S; Chen, QD; Weeks, KM; Mucha, PJ; Calabrese, JM				Kirk, Jessime M.; Kim, Susan O.; Inoue, Kaoru; Smola, Matthew J.; Lee, David M.; Schertzer, Megan D.; Wooten, Joshua S.; Baker, Allison R.; Sprague, Daniel; Collins, David W.; Horning, Christopher R.; Wang, Shuo; Chen, Qidi; Weeks, Kevin M.; Mucha, Peter J.; Calabrese, J. Mauro			Functional classification of long non-coding RNAs by k-mer content	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; EVOLUTION; SEQUENCE; SECONDARY; DOMAINS; LNCRNA; TRANSCRIPTOMES; VISUALIZATION; PROTEINS; GENOMICS	The functions of most long non-coding RNAs (lncRNAs) are unknown. In contrast to proteins, lncRNAs with similar functions often lack linear sequence homology; thus, the identification of function in one lncRNA rarely informs the identification of function in others. We developed a sequence comparison method to deconstruct linear sequence relationships in lncRNAs and evaluate similarity based on the abundance of short motifs called k-mers. We found that lncRNAs of related function often had similar k-mer profiles despite lacking linear homology, and that k-mer profiles correlated with protein binding to lncRNAs and with their subcellular localization. Using a novel assay to quantify Xist-like regulatory potential, we directly demonstrated that evolutionarily unrelated lncRNAs can encode similar function through different spatial arrangements of related sequence motifs. K-mer-based classification is a powerful approach to detect recurrent relationships between sequence and function in lncRNAs.	[Kirk, Jessime M.; Kim, Susan O.; Inoue, Kaoru; Lee, David M.; Schertzer, Megan D.; Wooten, Joshua S.; Baker, Allison R.; Sprague, Daniel; Calabrese, J. Mauro] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kirk, Jessime M.; Kim, Susan O.; Inoue, Kaoru; Lee, David M.; Schertzer, Megan D.; Wooten, Joshua S.; Baker, Allison R.; Sprague, Daniel; Calabrese, J. Mauro] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kirk, Jessime M.] Univ North Carolina Chapel Hill, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Smola, Matthew J.; Weeks, Kevin M.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC USA; [Lee, David M.; Schertzer, Megan D.; Wooten, Joshua S.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Sprague, Daniel] Univ North Carolina Chapel Hill, Curriculum Pharmacol, Chapel Hill, NC USA; [Collins, David W.; Horning, Christopher R.; Wang, Shuo; Chen, Qidi] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Mucha, Peter J.] Univ North Carolina Chapel Hill, Carolina Ctr Interdisciplinary Appl Math, Dept Math, Chapel Hill, NC USA; [Kim, Susan O.; Inoue, Kaoru] NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Smola, Matthew J.] Ribometrix, Durham, NC USA; [Baker, Allison R.] Harvard Med Sch, PhD Program Biol & Biomed Sci, Boston, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School	Calabrese, JM (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Calabrese, JM (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jmcalabr@med.unc.edu		Inoue, Kaoru/0000-0002-3615-6192; Schertzer, Megan/0000-0003-4997-8221; Baker, Allison/0000-0003-2030-7379	National Institutes of Health (NIH) [UL1TR002489, GM121806, GM105785]; Basil O'Connor Award from the March of Dimes Foundation [5100683]; Eshelman Institute for Innovation; Lineberger Comprehensive Cancer Center; UNC Department of Pharmacology; James S. McDonnell Foundation 21st Century Science Initiative-Complex Systems Scholar Award Grant [220020315]; NIH MIRA award [R35 GM122532]; NIH training grant in bioinformatics and computational biology [T32 GM067553]; NIH training grant in genetics and molecular biology [T32 GM007092]; NSF [DGE-1144081]; NIH training grant in molecular and cellular biophysics [T32 GM08570];  [DGE-1650116]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553, R01GM105785, T32GM008570, T32GM007092, R35GM122532, R01GM121806] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor Award from the March of Dimes Foundation; Eshelman Institute for Innovation; Lineberger Comprehensive Cancer Center; UNC Department of Pharmacology; James S. McDonnell Foundation 21st Century Science Initiative-Complex Systems Scholar Award Grant; NIH MIRA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant in bioinformatics and computational biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant in genetics and molecular biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH training grant in molecular and cellular biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank UNC colleagues for discussions, and J. Cheng for help with TETRIS cloning. This work was supported by National Institutes of Health (NIH) Grants UL1TR002489, GM121806, and GM105785, Basil O'Connor Award no. 5100683 from the March of Dimes Foundation, and funds from the Eshelman Institute for Innovation, the Lineberger Comprehensive Cancer Center and the UNC Department of Pharmacology (J.M.C.), the James S. McDonnell Foundation 21st Century Science Initiative-Complex Systems Scholar Award Grant no. 220020315 (P.J.M.), and NIH MIRA award R35 GM122532 (K.M.W.). J.M.K. is an NSF Graduate Research Fellow (Grant DGE-1650116) and was supported in part by an NIH training grant in bioinformatics and computational biology (T32 GM067553). D.M.L. was supported in part by an NIH training grant in genetics and molecular biology (T32 GM007092). M.J.S. was an NSF Graduate Research Fellow (Grant DGE-1144081) and was supported in part by an NIH training grant in molecular and cellular biophysics (Grant T32 GM08570).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Busan S, 2017, RNA, V23, P1012, DOI 10.1261/rna.060194.116; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Carlevaro-Fita J, 2016, RNA, V22, P867, DOI 10.1261/rna.053561.115; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2015, RNA, V21, P605, DOI 10.1261/rna.050484.115; Eddy SR, 2014, ANNU REV BIOPHYS, V43, P433, DOI 10.1146/annurev-biophys-051013-022950; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu F, 2017, NAT CHEM BIOL, V13, P282, DOI [10.1038/NCHEMBIO.2272, 10.1038/nchembio.2272]; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Pervouchine DD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6903; Quinn JJ, 2016, GENE DEV, V30, P191, DOI 10.1101/gad.272187.115; R Core Team, 2019, R LANG ENV STAT COMP; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Smola MJ, 2016, P NATL ACAD SCI USA, V113, P10322, DOI 10.1073/pnas.1600008113; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Weir WH, 2017, ALGORITHMS, V10, DOI 10.3390/a10030093; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820	57	88	91	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2018	50	10					1474	+		10.1038/s41588-018-0207-8	http://dx.doi.org/10.1038/s41588-018-0207-8			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV4DF	30224646	Green Accepted			2022-12-17	WOS:000446047000019
J	Breslow, DK; Hoogendoorn, S; Kopp, AR; Morgens, DW; Vu, BK; Kennedy, MC; Han, K; Li, A; Hess, GT; Bassik, MC; Chen, JK; Nachury, MV				Breslow, David K.; Hoogendoorn, Sascha; Kopp, Adam R.; Morgens, David W.; Vu, Brandon K.; Kennedy, Margaret C.; Han, Kyuho; Li, Amy; Hess, Gaelen T.; Bassik, Michael C.; Chen, James K.; Nachury, Maxence V.			A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies	NATURE GENETICS			English	Article							EPSILON-TUBULIN; INTRAFLAGELLAR TRANSPORT; HUMAN-CELLS; CENTRIOLE ELONGATION; HUMAN INTERACTOME; CILIUM INTERFACE; JOUBERT SYNDROME; ESSENTIAL GENES; CANCER-THERAPY; DELTA-TUBULIN	Primary cilia organize Hedgehog signaling and shape embryonic development, and their dysregulation is the unifying cause of ciliopathies. We conducted a functional genomic screen for Hedgehog signaling by engineering antibiotic-based selection of Hedgehog-responsive cells and applying genome-wide CRISPR-mediated gene disruption. The screen can robustly identify factors required for ciliary signaling with few false positives or false negatives. Characterization of hit genes uncovered novel components of several ciliary structures, including a protein complex that contains delta-tubulin and epsilon-tubulin and is required for centriole maintenance. The screen also provides an unbiased tool for classifying ciliopathies and showed that many congenital heart disorders are caused by loss of ciliary signaling. Collectively, our study enables a systematic analysis of ciliary function and of ciliopathies, and also defines a versatile platform for dissecting signaling pathways through CRISPR-based screening.	[Breslow, David K.; Kennedy, Margaret C.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Breslow, David K.; Kopp, Adam R.; Vu, Brandon K.; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Hoogendoorn, Sascha; Chen, James K.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Morgens, David W.; Han, Kyuho; Li, Amy; Hess, Gaelen T.; Bassik, Michael C.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chen, James K.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Nachury, Maxence V.] UCSF, Dept Ophthalmol, San Francisco, CA 94131 USA	Yale University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco	Breslow, DK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Breslow, DK; Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Chen, JK (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.; Nachury, MV (corresponding author), UCSF, Dept Ophthalmol, San Francisco, CA 94131 USA.	david.breslow@yale.edu; jameschen@stanford.edu; maxence.nachury@ucsf.edu	Nachury, Maxence/H-3695-2019; Chen, James/G-9972-2011	Nachury, Maxence/0000-0003-4918-1562; Hess, Gaelen/0000-0002-3836-0277; Breslow, David/0000-0003-0245-3348; , Kyuho/0000-0003-4259-8736; Chen, James/0000-0002-9220-8436; Hoogendoorn, Sascha/0000-0002-1155-8697	NIH Pathway to Independence Award [K99/R00 HD082280]; Damon Runyon Dale F. Frey Award [DFS-11-14]; Stanford Center for Systems Biology; Stanford ChEM-H; NWO Rubicon Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship [DGE-114747]; Walter V. and Idun Berry Award; NIH [T32 HG000044, DP2 HD084069, R01 GM113100, R01 GM089933, P30 CA124435]; NIH shared instrument grant [S10RR025518]; National Center for Research Resources [S10 RR027425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD082280, K99HD082280] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425, S10RR025518, S10RR022448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089933, R01GM113100, P50GM107615] Funding Source: NIH RePORTER	NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Dale F. Frey Award; Stanford Center for Systems Biology; Stanford ChEM-H; NWO Rubicon Postdoctoral Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Walter V. and Idun Berry Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH shared instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge members of the laboratories of J.K.C. and M.V.N. for advice and technical support; S. van Dorp for assistance with image quantification; P. Beachy (Stanford) for NIH-3T3 cells, 8xGli-luciferase reporter plasmid, and ShhN-producing HEK293T cells; K. Anderson (Sloan Kettering) for antibody to SMO; G. Crabtree, K. C. Garcia, and A. Pyle for use of plate readers; N. Dimitrova for microscope use; C. Bustamante for use of an Illumina sequencer; R. Rohatgi (Stanford) for antibodies to EVC and IQCE and NIH-3T3 FlpIn cells; P. Jackson (Stanford) for IMCD3 FlpIn cells; J. Wang and T. Stearns (Stanford) for sharing unpublished results and cDNA for Cby1; and M. Scott for helpful discussions. This project was supported by NIH Pathway to Independence Award K99/R00 HD082280 (D.K.B.), Damon Runyon Dale F. Frey Award DFS-11-14 (D.K.B.), a seed grant from the Stanford Center for Systems Biology (D.K.B., S.H., and G.T.H.) and Stanford ChEM-H (M.C.B.), an NWO Rubicon Postdoctoral Fellowship (S.H.), National Science Foundation Graduate Research Fellowship DGE-114747 (D.W.M.), a Walter V. and Idun Berry Award (K.H.), and NIH T32 HG000044 (G.T.H.), DP2 HD084069 (M.C.B.), R01 GM113100 (J.K.C.), and R01 GM089933 (M.V.N.). Cell sorting/flow cytometry was done on instruments in the Stanford Shared FACS Facility, including an instrument supported by NIH shared instrument grant S10RR025518. Mass spectrometry analyses were conducted in the Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University Mass Spectrometry and the Stanford Cancer Institute Proteomics/Mass Spectrometry Shared Resource; these centers are supported by Award S10 RR027425 from the National Center for Research Resources and NIH P30 CA124435, respectively. We thank C. Carstens, B. Borgo, P. Sheffield, and L. Bruhn of Agilent Technologies for cilia-focused oligonucleotide sublibraries.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Bangs F, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028175; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Burke MC, 2014, J CELL BIOL, V207, P123, DOI 10.1083/jcb.201406140; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dupuis-Williams P, 2002, J CELL BIOL, V158, P1183, DOI 10.1083/jcb.200205028; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kanie T, 2017, DEV CELL, V42, P22, DOI 10.1016/j.devcel.2017.05.016; Kar A., 2017, WHOLE EXOME SEQUENCI; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YL, 2014, MOL BIOL CELL, V25, P2919, DOI 10.1091/mbc.E14-02-0735; Li FQ, 2016, MOL CELL BIOL, V36, P2668, DOI 10.1128/MCB.00160-16; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Loucks CM, 2015, HUM MUTAT, V36, P1015, DOI 10.1002/humu.22843; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Mojarad BA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170114; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nishijima Y, 2017, MOL BIOL CELL, V28, P1652, DOI 10.1091/mbc.E17-01-0017; O'Toole ET, 2003, MOL BIOL CELL, V14, P2999, DOI 10.1091/mbc.E02-11-0755; Oegema R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006809; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Panigrahi I, 2002, CLIN DYSMORPHOL, V11, P289, DOI 10.1097/00019605-200210000-00011; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Pimenta-Marques A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4866; Pusapati GV, 2014, DEV CELL, V28, P483, DOI 10.1016/j.devcel.2014.01.021; Roosing S, 2015, ELIFE, V4, DOI 10.7554/eLife.06602; Ross I, 2013, J CELL SCI, V126, P3441, DOI 10.1242/jcs.128694; Ruiz-Perez VL, 2009, AM J MED GENET C, V151C, P341, DOI 10.1002/ajmg.c.30226; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma A, 2016, DEV CELL, V37, P362, DOI 10.1016/j.devcel.2016.04.024; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Sollis E, 2016, HUM MOL GENET, V25, P546, DOI 10.1093/hmg/ddv495; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Turk E, 2015, CURR BIOL, V25, P2177, DOI 10.1016/j.cub.2015.06.063; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Van De Weghe JC, 2017, AM J HUM GENET, V101, P23, DOI 10.1016/j.ajhg.2017.05.010; Wang JT, 2017, ELIFE, V6, DOI [10.7554/eLife.29061.001, 10.7554/eLife.29061]; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Xu MC, 2017, AM J HUM GENET, V100, P592, DOI 10.1016/j.ajhg.2017.02.008; Zheng XD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11874; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	93	88	89	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3								10.1038/s41588-018-0054-7	http://dx.doi.org/10.1038/s41588-018-0054-7			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29459677	Green Accepted, Green Submitted			2022-12-17	WOS:000427933400022
J	Eppinga, RN; Hagemeijer, Y; Burgess, S; Hinds, DA; Stefansson, K; Gudbjartsson, DF; van Veldhuisen, DJ; Munroe, PB; Verweij, N; van der Harst, P				Eppinga, Ruben N.; Hagemeijer, Yanick; Burgess, Stephen; Hinds, David A.; Stefansson, Kari; Gudbjartsson, Daniel F.; van Veldhuisen, Dirk J.; Munroe, Patricia B.; Verweij, Niek; van der Harst, Pim			Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; PLACEBO-CONTROLLED TRIAL; WIDE ASSOCIATION; RISK-FACTOR; UK BIOBANK; FOLLOW-UP; OUTCOMES; HYPERTENSION; IVABRADINE; FAILURE	Resting heart rate is a heritable trait correlated with life span. Little is known about the genetic contribution to resting heart rate and its relationship with mortality. We performed a genome-wide association discovery and replication analysis starting with 19.9 million genetic variants and studying up to 265,046 individuals to identify 64 loci associated with resting heart rate (P < 5 x 10(-8)); 46 of these were novel. We then used the genetic variants identified to study the association between resting heart rate and all-cause mortality. We observed that a genetically predicted resting heart rate increase of 5 beats per minute was associated with a 20% increase in mortality risk (hazard ratio 1.20, 95% confidence interval 1.11-1.28, P = 8.20 x 10(-7)) translating to a reduction in life expectancy of 2.9 years for males and 2.6 years for females. Our findings provide evidence for shared genetic predictors of resting heart rate and all-cause mortality.	[Eppinga, Ruben N.; Hagemeijer, Yanick; van Veldhuisen, Dirk J.; Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Stefansson, Kari; Gudbjartsson, Daniel F.] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Dept Clin Pharmacol, London, England; [Munroe, Patricia B.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London, England; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, Pim] Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands	University of Groningen; University of Cambridge; University of Iceland; University of Iceland; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Groningen	van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.; van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; van der Harst, P (corresponding author), Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands.	p.van.der.harst@umcg.nl	Stefansson, Kari/AAE-7187-2019; Verweij, Niek/A-4499-2017; Verweij, Niek/ABC-6249-2021; Hagemeijer, Yanick/AAL-7611-2020	Verweij, Niek/0000-0002-4303-7685; Hagemeijer, Yanick/0000-0001-6036-3741; Gudbjartsson, Daniel/0000-0002-5222-9857; Burgess, Stephen/0000-0001-5365-8760; Hinds, David/0000-0002-4911-803X	Netherlands organization for health research and development (ZonMw) [90.700.441]; Wellcome Trust [100114]; NIHR Cardiovascular Biomedical Research Unit at Barts; London School of Medicine and Dentistry, Queen Mary University of London; Netherlands Heart Institute; Marie Sklodowska-Curie Global Fellowship [661395]; Medical Research Council [MC_qA137853] Funding Source: researchfish	Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cardiovascular Biomedical Research Unit at Barts; London School of Medicine and Dentistry, Queen Mary University of London; Netherlands Heart Institute; Marie Sklodowska-Curie Global Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was conducted using the UK Biobank Resource. This project is supported by the Netherlands organization for health research and development (ZonMw grant 90.700.441). S.B. is supported by the Wellcome Trust (grant 100114). P.B.M. acknowledges support from the NIHR Cardiovascular Biomedical Research Unit at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. N.V. is supported by Netherlands Heart Institute and Marie Sklodowska-Curie Global Fellowship (grant 661395).	Aladin AI, 2016, AM J HYPERTENS, V29, P251, DOI 10.1093/ajh/hpv095; AZBEL MY, 1994, P NATL ACAD SCI USA, V91, P12453, DOI 10.1073/pnas.91.26.12453; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Caetano J, 2015, EUR J INTERN MED, V26, P217, DOI 10.1016/j.ejim.2015.02.009; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Grassi G, 1998, J HYPERTENS, V16, P1635, DOI 10.1097/00004872-199816110-00010; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Jiang XJ, 2015, HEART, V101, P44, DOI 10.1136/heartjnl-2014-305685; Kanai M., 2016, J HUM GENET; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Levine HJ, 1997, J AM COLL CARDIOL, V30, P1104; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Reunanen A, 2000, J INTERN MED, V247, P231, DOI 10.1046/j.1365-2796.2000.00602.x; Schmidt-Nielsen K., 1975, ANIMAL PHYSL ADAPTAT; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797	32	88	88	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1557	1563		10.1038/ng.3708	http://dx.doi.org/10.1038/ng.3708			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798624	Green Submitted			2022-12-17	WOS:000389011100017
J	Saliba, J; Saint-Martin, C; Di Stefano, A; Lenglet, G; Marty, C; Keren, B; Pasquier, F; Della Valle, V; Secardin, L; Leroy, G; Mahfoudhi, E; Grosjean, S; Droin, N; Diop, M; Dessen, P; Charrier, S; Palazzo, A; Merlevede, J; Meniane, JC; Delaunay-Darivon, C; Fuseau, P; Isnard, F; Casadevall, N; Solary, E; Debili, N; Bernard, OA; Raslova, H; Najman, A; Vainchenker, W; Bellanne-Chantelot, C; Plo, I				Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Keren, Boris; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Leroy, Gwendoline; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Charrier, Sabine; Palazzo, Alberta; Merlevede, Jane; Meniane, Jean-Come; Delaunay-Darivon, Christine; Fuseau, Pascal; Isnard, Francoise; Casadevall, Nicole; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Najman, Albert; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle			Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; MYELOPROLIFERATIVE NEOPLASMS; SOMATIC MUTATIONS; ESSENTIAL THROMBOCYTHEMIA; CLONAL HEMATOPOIESIS; GENOMIC ABERRATIONS; NEGATIVE REGULATOR; GATA2 MUTATIONS; JAK2 HAPLOTYPE; IN-VITRO	No major predisposition gene for familial myeloproliferative neoplasms (MPN) has been identified. Here we demonstrate that the autosomal dominant transmission of a 700-kb duplication in four genetically related families predisposes to myeloid malignancies, including MPN, frequently progressing to leukemia. Using induced pluripotent stem cells and primary cells, we demonstrate that overexpression of ATG2B and GSKIP enhances hematopoietic progenitor differentiation, including of megakaryocytes, by increasing progenitor sensitivity to thrombopoietin (TPO). ATG2B and GSKIP cooperate with acquired JAK2, MPL and CALR mutations during MPN development. Thus, the germline duplication may change the fitness of cells harboring signaling pathway mutations and increases the probability of disease development.	[Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Casadevall, Nicole; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] INSERM, UMR 1170, Villejuif, France; [Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] Univ Paris 11, UMR 1170, Villejuif, France; [Saliba, Joseph; Saint-Martin, Cecile; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Della Valle, Veronique; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Droin, Nathalie; Diop, M'boyba; Dessen, Philippe; Palazzo, Alberta; Merlevede, Jane; Solary, Eric; Debili, Najet; Bernard, Olivier A.; Raslova, Hana; Vainchenker, William; Bellanne-Chantelot, Christine; Plo, Isabelle] Gustave Roussy, Villejuif, France; [Saliba, Joseph; Di Stefano, Antonio; Lenglet, Gaelle; Marty, Caroline; Pasquier, Florence; Secardin, Lise; Mahfoudhi, Emna; Grosjean, Sarah; Vainchenker, William; Plo, Isabelle] Lab Excellence GR Ex, Villejuif, France; [Saint-Martin, Cecile; Keren, Boris; Leroy, Gwendoline; Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Mahfoudhi, Emna] Inst Pasteur Tunis, Lab Hematol Mol & Cellulaire Salem Abbes, Belvedere, France; [Charrier, Sabine] Genethon, Evry, France; [Meniane, Jean-Come; Delaunay-Darivon, Christine] CHU Ft de France, Serv Med Interne, Fort De France, France; [Fuseau, Pascal] CHU Ft de France, Lab Hematol, Fort De France, France; [Isnard, Francoise; Najman, Albert] Hop St Antoine, AP HP, Dept Hematol Clin & Therapie Cellulaire, F-75571 Paris, France; [Isnard, Francoise; Bernard, Olivier A.; Najman, Albert; Bellanne-Chantelot, Christine] Univ Paris 06, Sorbonne Univ, Grp Rech Clin Myeloproliferat Aigues & Chron GRC, MYPAC, Paris, France; [Casadevall, Nicole] Hop St Antoine, AP HP, Lab Hematol, F-75571 Paris, France; [Vainchenker, William] Hop St Louis, AP HP, Consultat Immuno Hematol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Martinique; CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Vainchenker, W (corresponding author), INSERM, UMR 1170, Villejuif, France.	verpre@igr.fr; christine.bellanne-chantelot@aphp.fr; isabelle.plo@gustaveroussy.fr	Droin, Nathalie M/Y-5506-2018; MARTY, Caroline/I-1721-2017; Plo, Isabelle/AAT-6742-2021; Plo, Isabelle/C-9056-2017; Di Stefano, Antonio/M-1478-2018; Raslova, Hana/N-3562-2018	Droin, Nathalie M/0000-0002-6099-5324; MARTY, Caroline/0000-0003-4350-2302; Plo, Isabelle/0000-0002-5915-6910; Raslova, Hana/0000-0001-8846-5299; Solary, Eric/0000-0002-8629-1341; Vainchenker, William/0000-0003-4705-202X; Bernard, Olivier/0000-0002-0463-9747; CHARRIER, Sabine/0000-0001-9399-7492	Agence Nationale de la Recherche (ANR) [ANR-13-JVSV1-GERMPN-01]; Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre) [2012-SL220120605292]; Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing [AO9102LS]; Association de Recherche sur la Moelle Osseuse (ARMO); regional Programme Hospitalier de Recherche Clinique (PHRC) [AOR07014]; Association Laurette Fugain; program 'Investissements d'Avenir'; Ile-de-France Canceropole; ANR Molecular Medicine in Oncology (MMO) (program 'Investissements d'Avenir'); ARC; Fondation pour la Recherche Medicale (FRM); Ile-de-France region (Canceropole); Ile-de-France region (DIM Cellule Souche);  [INCa-DGOS-INSERM 6043]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre); Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing; Association de Recherche sur la Moelle Osseuse (ARMO); regional Programme Hospitalier de Recherche Clinique (PHRC); Association Laurette Fugain; program 'Investissements d'Avenir'(French National Research Agency (ANR)); Ile-de-France Canceropole(Region Ile-de-France); ANR Molecular Medicine in Oncology (MMO) (program 'Investissements d'Avenir')(French National Research Agency (ANR)); ARC(Australian Research Council); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Ile-de-France region (Canceropole)(Region Ile-de-France); Ile-de-France region (DIM Cellule Souche)(Region Ile-de-France); 	This work was supported by grants from Agence Nationale de la Recherche (ANR) (Blanc Megon 2009, Thrombocytosis 2011; ANR-13-JVSV1-GERMPN-01), Association pour la Recherche contre le Cancer (ARC) (Fondation ARC Libre 2012-SL220120605292), Groupe Information Sante (GIS)-Institute for Rare Diseases for High-Throughput Sequencing (AO9102LS), Association de Recherche sur la Moelle Osseuse (ARMO), regional Programme Hospitalier de Recherche Clinique (PHRC) AOR07014, Association Laurette Fugain and INCa-DGOS-INSERM 6043. Labex GR-Ex (I.P. and W.V.) is funded by the program 'Investissements d'Avenir'. G. Lenglet was supported by a postdoctoral fellowship from Ile-de-France Canceropole and ANR Molecular Medicine in Oncology (MMO) (funded by the program 'Investissements d'Avenir'). F.P. was supported by ARC. L.S. and J.S. were supported by doctoral grants from the Ile-de-France region (Canceropole and DIM Cellule Souche) and from Fondation pour la Recherche Medicale (FRM). C.M. was supported by ANR-13-JVSV1-GERMPN-01.	Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Bellanne-Chantelot C, 2008, LEUKEMIA, V22, P450, DOI 10.1038/sj.leu.2404896; Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; Bluteau D, 2014, J CLIN INVEST, V124, P580, DOI 10.1172/JCI71861; Cabagnols X, 2015, NEW ENGL J MED, V372, P688, DOI 10.1056/NEJMc1413718; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Chou ST, 2012, P NATL ACAD SCI USA, V109, P17573, DOI 10.1073/pnas.1211175109; Cui W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/365318; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harutyunyan AS, 2012, HEMATOL ONCOL CLIN N, V26, P1037, DOI 10.1016/j.hoc.2012.07.005; Jager R, 2014, AM J HEMATOL, V89, P1107, DOI 10.1002/ajh.23842; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2013, THER ADV HEMATOL, V4, P237, DOI 10.1177/2040620713489144; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg P, 2014, J EXP MED, V211, P2213, DOI 10.1084/jem.20131371; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Malak S, 2012, BLOOD CELL MOL DIS, V49, P170, DOI 10.1016/j.bcmd.2012.06.004; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; MANCINI M, 1993, CANCER GENET CYTOGEN, V66, P39, DOI 10.1016/0165-4608(93)90146-D; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; MERTENS F, 1990, LEUKEMIA, V4, P117; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Oddsson A, 2014, LEUKEMIA, V28, P1371, DOI 10.1038/leu.2014.48; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Rice KL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.39; Rumi E, 2014, BLOOD, V123, P2416, DOI 10.1182/blood-2014-01-550434; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Saliba J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074257; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Soda M, 2008, CELL SIGNAL, V20, P2317, DOI 10.1016/j.cellsig.2008.09.001; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Toze CL, 1997, BRIT J HAEMATOL, V98, P177, DOI 10.1046/j.1365-2141.1997.1863003.x; Krepischi ACV, 2012, FUTURE ONCOL, V8, P441, DOI [10.2217/fon.12.34, 10.2217/FON.12.34]; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yamada O, 2014, J CLIN ONCOL, V32, pE76, DOI 10.1200/JCO.2012.47.8669; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759	62	88	91	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1131	+		10.1038/ng.3380	http://dx.doi.org/10.1038/ng.3380			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CS3JR	26280900	Green Submitted			2022-12-17	WOS:000361969900008
J	Lopez-Serra, L; Kelly, G; Patel, H; Stewart, A; Uhlmann, F				Lopez-Serra, Lidia; Kelly, Gavin; Patel, Harshil; Stewart, Aengus; Uhlmann, Frank			The Scc2-Scc4 complex acts in sister chromatid cohesion and transcriptional regulation by maintaining nucleosome-free regions	NATURE GENETICS			English	Article							XENOPUS EGG EXTRACTS; REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE; YEAST CHROMOSOMES; NIPPED-B; GENOME; RSC; GENES; IDENTIFICATION; REPLICATION	The cohesin complex is at the heart of many chromosomal activities, including sister chromatid cohesion and transcriptional regulation(1-3). Cohesin loading onto chromosomes depends on the Scc2-Scc4 cohesin loader complex(4-6), but the chromatin features that form cohesin loading sites remain poorly understood. Here we show that the RSC chromatin remodeling complex recruits budding yeast Scc2-Scc4 to broad nucleosome-free regions, which the cohesin loader helps to maintain. Consequently, inactivation of either the cohesin loader or the RSC complex has similar effects on nucleosome positioning, gene expression and sister chromatid cohesion. These results show an intimate link between local chromatin structure and higher-order chromosome architecture. Our findings pertain to the similarities between two severe human disorders, Cornelia de Lange syndrome, which is caused by alterations in the human cohesin loader, and Coffin-Siris syndrome, which results from alterations in human RSC complex components(7-9). Both syndromes can arise from gene misregulation due to related changes in the nucleosome landscape.	[Lopez-Serra, Lidia; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [Kelly, Gavin; Patel, Harshil; Stewart, Aengus] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Kelly, Gavin/ABG-2715-2021	Kelly, Gavin/0000-0001-7219-560X; Patel, Harshil/0000-0003-2707-7940; Uhlmann, Frank/0000-0002-3527-6619	Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain); Marie Curie Intra-European Fellowship; European Research Council; Cancer Research UK [15671] Funding Source: researchfish	Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain); Marie Curie Intra-European Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	We thank P. Chambers at the Cancer Research UK Genome Variation Laboratory at St. James's University Hospital, Leeds, and N. Matthews from the Advanced Sequencing Facility at the Cancer Research UK London Research Institute for high-throughput sequencing. We thank C. Esnault, A. Lengronne and our laboratory members for discussions and comments on the manuscript. This work was supported by a Beca Postdoctoral del Ministerio de Ciencia y Tecnologia (Spain) and a Marie Curie Intra-European Fellowship (L.L.-S.) and the European Research Council (L.L.-S. and F.U.).	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Du J, 1998, GENETICS, V150, P987; Fasulo B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002878; FRYNS JP, 1986, CLIN GENET, V29, P263; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Morohashi N, 2006, EUKARYOT CELL, V5, P1925, DOI 10.1128/EC.00105-06; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Tsurusaki Y, 2014, CLIN GENET, V85, P548, DOI 10.1111/cge.12225; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	37	88	88	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1147	1151		10.1038/ng.3080	http://dx.doi.org/10.1038/ng.3080			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25173104	Green Accepted			2022-12-17	WOS:000342554100021
J	Lincecum, JM; Vieira, FG; Wang, MZ; Thompson, K; De Zutter, GS; Kidd, J; Moreno, A; Sanchez, R; Carrion, IJ; Levine, BA; Al-Nakhala, BM; Sullivan, SM; Gill, A; Perrin, S				Lincecum, John M.; Vieira, Fernando G.; Wang, Monica Z.; Thompson, Kenneth; De Zutter, Gerald S.; Kidd, Joshua; Moreno, Andrew; Sanchez, Ricardo; Carrion, Isarelis J.; Levine, Beth A.; Al-Nakhala, Bashar M.; Sullivan, Shawn M.; Gill, Alan; Perrin, Steven			From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD40 LIGAND; GENE-EXPRESSION; SPINAL-CORD; ALLOGRAFT-REJECTION; CELLS; ACTIVATION; BLOCKADE; GP39; MICE	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune responses. Furthermore, we observed that this pathway is upregulated in the blood of 56% of human patients with ALS. A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model. This work demonstrates that unbiased transcript profiling can identify cellular pathways responsive to therapeutic intervention in a preclinical model of human disease.	[Lincecum, John M.; Vieira, Fernando G.; Wang, Monica Z.; Thompson, Kenneth; De Zutter, Gerald S.; Kidd, Joshua; Moreno, Andrew; Sanchez, Ricardo; Carrion, Isarelis J.; Levine, Beth A.; Al-Nakhala, Bashar M.; Sullivan, Shawn M.; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA USA		Perrin, S (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	sperrin@als.net	Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418	ALS; Muscular Dystrophy Association/Augie's Quest; US Department of Defense; RGK Foundation	ALS; Muscular Dystrophy Association/Augie's Quest(Muscular Dystrophy Association); US Department of Defense(United States Department of Defense); RGK Foundation	We thank S. Appel, J. McCoy, S. Hesterlee and R. Goldstein for their thoughtful scientific discussions and contributions, R. Puchalski and the staff of the Allen Institute for Brain Science for the contribution of the in situ hybridization data, S. F. Scott, who lost his battle with ALS in 2009, for establishing the rigorous parameters required to test therapeutics in the SOD1<SUP>G93A</SUP> model, J. Heywood and his family for establishing ALS TDI and continuing to support our efforts and A. Nieto and L. Nieto for their dedication and financial support for the development of therapeutics for ALS. This work was supported by the Muscular Dystrophy Association/Augie's Quest, the US Department of Defense, the RGK Foundation and all our patients with ALS and their families.	Agrawal N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004032; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; DeCristofaro Marc F., 2008, V460, P185, DOI 10.1007/978-1-60327-048-9_9; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Gallon L, 1997, J IMMUNOL, V159, P4212; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Honey K, 1999, J IMMUNOL, V163, P4805; HUGHES R, 1992, MUSCLE NERVE, V15, P568, DOI 10.1002/mus.880150506; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kalled SL, 2001, LUPUS, V10, P9, DOI 10.1191/096120301668384751; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kinter J, 2008, Int MS J, V15, P51; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lacroix L, 2008, EXPERT REV MOL DIAGN, V8, P167, DOI 10.1586/14737159.8.2.167; Larsen CP, 1996, TRANSPLANTATION, V61, P4, DOI 10.1097/00007890-199601150-00002; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Ma J, 1996, J IMMUNOL, V157, P417; Merrick BA, 2004, CURR OPIN MOL THER, V6, P600; MOHAN C, 1995, J IMMUNOL, V154, P1470; Monk NJ, 2003, NAT MED, V9, P1275, DOI 10.1038/nm931; Nagelkerken L, 2004, J IMMUNOL, V173, P993, DOI 10.4049/jimmunol.173.2.993; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; ROY M, 1993, J IMMUNOL, V151, P2497; Ruderman Eric M., 2009, P27, DOI 10.1007/978-3-7643-8238-4_2; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; TROOST D, 1989, CLIN NEUROPATHOL, V8, P289	44	88	90	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					392	U45		10.1038/ng.557	http://dx.doi.org/10.1038/ng.557			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348957				2022-12-17	WOS:000277179500008
J	Hillmer, AM; Brockschmidt, FF; Hanneken, S; Eigelshoven, S; Steffens, M; Flaquer, A; Herms, S; Becker, T; Kortum, AK; Nyholt, DR; Zhao, ZZ; Montgomery, GW; Martin, NG; Muhleisen, TW; Alblas, MA; Moebus, S; Jockel, KH; Brocker-Preuss, M; Erbel, R; Reinartz, R; Betz, RC; Cichon, S; Propping, P; Baur, MP; Wienker, TF; Kruse, R; Nothen, MM				Hillmer, Axel M.; Brockschmidt, Felix F.; Hanneken, Sandra; Eigelshoven, Sibylle; Steffens, Michael; Flaquer, Antonia; Herms, Stefan; Becker, Tim; Kortuem, Anne-Katrin; Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.; Muehleisen, Thomas W.; Alblas, Margrieta A.; Moebus, Susanne; Joeckel, Karl-Heinz; Broecker-Preuss, Martina; Erbel, Raimund; Reinartz, Roman; Betz, Regina C.; Cichon, Sven; Propping, Peter; Baur, Max P.; Wienker, Thomas F.; Kruse, Roland; Noethen, Markus M.			Susceptibility variants for male-pattern baldness on chromosome 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; ALOPECIA; POLYMORPHISM	We carried out a genome-wide association study in 296 individuals with male-pattern baldness (androgenetic alopecia) and 347 controls. We then investigated the 30 best SNPs in an independent replication sample and found highly significant association for five SNPs on chromosome 20p11 (rs2180439 combined P = 2.7 x 10(-15)). No interaction was detected with the X-chromosomal androgen receptor locus, suggesting that the 20p11 locus has a role in a yet-to-be-identified androgen-independent pathway.	[Hillmer, Axel M.; Brockschmidt, Felix F.; Herms, Stefan; Muehleisen, Thomas W.; Alblas, Margrieta A.; Reinartz, Roman; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Hanneken, Sandra; Eigelshoven, Sibylle; Kortuem, Anne-Katrin; Kruse, Roland] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; [Steffens, Michael; Flaquer, Antonia; Becker, Tim; Baur, Max P.; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; [Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, Inst Med Bioinformat Biometry & Epidemiol, D-45122 Essen, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp Essen, Cent Lab Unit Res & Educ, Clin Endocrinol, D-45122 Essen, Germany; [Erbel, Raimund] Univ Duisburg Essen, W German Heart Ctr Essen, Clin Cardiol, D-45122 Essen, Germany; [Betz, Regina C.; Cichon, Sven; Propping, Peter; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany	University of Bonn; Heinrich Heine University Dusseldorf; University of Bonn; QIMR Berghofer Medical Research Institute; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Bonn	Hillmer, AM (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany.	axel.hillmer@uni-bonn.de	Nöthen, Markus/B-2027-2009; Hillmer, Axel M/B-7485-2015; Nyholt, Dale Robert/J-3174-2017; Montgomery, Grant W/B-7148-2008; Hillmer, Axel M/N-2927-2014; Cichon, Sven/B-9618-2014; Herms, Stefan/J-1949-2014; Betz, Regina C/E-8591-2011; Cichon, Sven/H-8803-2013	Nöthen, Markus/0000-0002-8770-2464; Hillmer, Axel M/0000-0002-3381-7266; Nyholt, Dale Robert/0000-0001-7159-3040; Montgomery, Grant W/0000-0002-4140-8139; Hillmer, Axel M/0000-0002-3381-7266; Cichon, Sven/0000-0002-9475-086X; Herms, Stefan/0000-0002-2786-8200; Betz, Regina C/0000-0001-5024-3623; Cichon, Sven/0000-0002-9475-086X; Reinartz, Roman/0000-0002-6417-9156; Martin, Nicholas/0000-0003-4069-8020; Steffens, Michael/0000-0002-6445-8593; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft; Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	We thank all probands for participating in the study and providing blood samples. This study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and Emmy Noether) and the Alfried Krupp von Bohlen und Halbach-Stiftung. The Heinz Nixdorf Recall cohort was established with the support of the Heinz Nixdorf Foundation (G. Schmidt, Chairman).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Paik JH, 2001, BRIT J DERMATOL, V145, P95, DOI 10.1046/j.1365-2133.2001.04289.x; RISCH N, 1996, SCIENCE, V273, P1517	15	88	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1279	1281		10.1038/ng.228	http://dx.doi.org/10.1038/ng.228			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849994				2022-12-17	WOS:000260501500016
J	Perlstein, EO; Ruderfer, DM; Roberts, DC; Schreiber, SL; Kruglyak, L				Perlstein, Ethan O.; Ruderfer, Douglas M.; Roberts, David C.; Schreiber, Stuart L.; Kruglyak, Leonid			Genetic basis of individual differences in the response to small-molecule drugs in yeast	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; SACCHAROMYCES-CEREVISIAE; CELL-LINES; PHOSPHATE TRANSPORTER; CANCER; POLYMORPHISMS; CYTOTOXICITY; EXPRESSION; RESISTANCE; DISCOVERY	Individual response to small-molecule drugs is variable; a drug that provides a cure for some may confer no therapeutic benefit or trigger an adverse reaction in others. To begin to understand such differences systematically, we treated 104 genotyped segregants from a cross between two yeast strains with a collection of 100 diverse small molecules. We used linkage analysis to identify 124 distinct linkages between genetic markers and response to 83 compounds. The linked markers clustered at eight genomic locations, or quantitative-trait locus 'hotspots', that contain one or more polymorphisms that affect response to multiple small molecules. We also experimentally verified that a deficiency in leucine biosynthesis caused by a deletion of LEU2 underlies sensitivity to niguldipine, which is structurally related to therapeutic calcium channel blockers, and that a natural coding-region polymorphism in the inorganic phosphate transporter PHO84 underlies sensitivity to two polychlorinated phenols that uncouple oxidative phosphorylation. Our results provide a step toward a systematic understanding of small-molecule drug action in genetically distinct individuals.	Harvard Univ, Broad Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87544 USA; Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87544 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Princeton University; Princeton University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University	Schreiber, SL (corresponding author), Harvard Univ, Broad Inst, Howard Hughes Med Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	stuart_schreiber@harvard.edu; leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Perlstein, Ethan/0000-0002-4734-4391	NIGMS NIH HHS [P50GM071508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENARI G, 2006, IN PRESS PLOS GENET; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; FOGEL S, 1988, J BASIC MICROB, V28, P147, DOI 10.1002/jobm.3620280302; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Hohmann S, 2005, CURR OPIN BIOTECH, V16, P356, DOI 10.1016/j.copbio.2005.04.006; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Le Morvan V, 2006, PHARMACOGENOMICS, V7, P843, DOI 10.2217/14622416.7.6.843; MARO B, 1982, EMBO J, V1, P1347, DOI 10.1002/j.1460-2075.1982.tb01321.x; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Moisan F, 2006, BRIT J CANCER, V95, P906, DOI 10.1038/sj.bjc.6603361; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Outeiro Tiago Fleming, 2006, Biotechnology Journal, V1, P258, DOI 10.1002/biot.200500043; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SOMERVILLE L, 1986, XENOBIOTICA, V16, P1017, DOI 10.3109/00498258609038980; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stoehlmacher J, 2004, BRIT J CANCER, V91, P344, DOI 10.1038/sj.bjc.6601975; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Tenreiro S, 2002, BIOCHEM BIOPH RES CO, V292, P741, DOI 10.1006/bbrc.2002.6703; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Urban TJ, 2006, GENOME RES, V16, P223, DOI 10.1101/gr.4356206; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; WEINBACH EUGENE C., 1957, PROC NATL ACAD SCI, V43, P393, DOI 10.1073/pnas.43.5.393; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yarosh DB, 2005, BIOMARKERS, V10, P188, DOI 10.1080/13547500500138732; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhou XF, 2005, DRUG METAB DISPOS, V33, P1220, DOI 10.1124/dmd.104.003558	45	88	93	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					496	502		10.1038/ng1991	http://dx.doi.org/10.1038/ng1991			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334364				2022-12-17	WOS:000245271200019
J	Kuroki, Y; Toyoda, A; Noguchi, H; Taylor, TD; Itoh, T; Kim, DS; Kim, DW; Choi, SH; Kim, IC; Choi, HH; Kim, YS; Satta, Y; Saitou, N; Yamada, T; Morishita, S; Hattori, M; Sakaki, Y; Park, HS; Fujiyama, A				Kuroki, Y; Toyoda, A; Noguchi, H; Taylor, TD; Itoh, T; Kim, DS; Kim, DW; Choi, SH; Kim, IC; Choi, HH; Kim, YS; Satta, Y; Saitou, N; Yamada, T; Morishita, S; Hattori, M; Sakaki, Y; Park, HS; Fujiyama, A			Comparative analysis of chimpanzee and human Y chromosomes unveils complex evolutionary pathway	NATURE GENETICS			English	Article							HUMAN X-CHROMOSOME; DNA-SEQUENCE; HUMAN GENOME; GREAT APES; MOLECULAR EVOLUTION; REGION; PRIMATES; DUPLICATIONS; EXPANSION; HISTORY	The mammalian Y chromosome has unique characteristics compared with the autosomes or X chromosomes. Here we report the finished sequence of the chimpanzee Y chromosome (PTRY), including 271 kb of the Y-specific pseudoautosomal region 1 and 12.7 Mb of the male-specific region of the Y chromosome. Greater sequence divergence between the human Y chromosome (HSAY) and PTRY (1.78%) than between their respective whole genomes (1.23%) confirmed the accelerated evolutionary rate of the Y chromosome. Each of the 19 PTRY protein-coding genes analyzed had at least one nonsynonymous substitution, and 11 genes had higher nonsynonymous substitution rates than synonymous ones, suggesting relaxation of selective constraint, positive selection or both. We also identified lineage-specific changes, including deletion of a 200-kb fragment from the pericentromeric region of HSAY, expansion of young Alu families in HSAY and accumulation of young L1 elements and long terminal repeat retrotransposons in PTRY. Reconstruction of the common ancestral Y chromosome reflects the dynamic changes in our genomes in the 5 - 6 million years since speciation.	Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305333, South Korea; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Kashiwa, Chiba 2770882, Japan; Mitsubishi Res Inst, Tokyo 1008141, Japan; Univ Sci & Technol, Taejon 305333, South Korea; Grad Univ Adv Studies, Hayama 2400193, Japan; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kitasato Univ, Sagamihara, Kanagawa 2288555, Japan; Natl Inst Informat, Tokyo 1018430, Japan	Korea Research Institute of Bioscience & Biotechnology (KRIBB); RIKEN; University of Tokyo; Mitsubishi Research Institute; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kitasato University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Park, HS (corresponding author), Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305333, South Korea.	hspark@kribb.re.kr; afujiyam@nii.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Taylor, Todd/A-7121-2009; Itoh, Takehiko/E-8873-2014	Hattori, Masahira/0000-0001-9467-0344; Taylor, Todd/0000-0003-4247-6253; Itoh, Takehiko/0000-0002-6113-557X; Morishita, Shinichi/0000-0002-6201-8885; Satta, Yoko/0000-0002-5305-493X				Archidiacono N, 1998, CHROMOSOMA, V107, P241, DOI 10.1007/s004120050303; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BONNER TI, 1982, J VIROL, V43, P914, DOI 10.1128/JVI.43.3.914-924.1982; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Ellis N, 2002, GENOME RES, V12, P339; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Erlandsson R, 2000, MOL BIOL EVOL, V17, P804, DOI 10.1093/oxfordjournals.molbev.a026359; Filatov DA, 2004, MOL BIOL EVOL, V21, P410, DOI 10.1093/molbev/msh032; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Gibbons R, 2004, J MOL BIOL, V339, P721, DOI 10.1016/j.jmb.2004.04.033; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Kittler R, 2003, EUR J HUM GENET, V11, P304, DOI 10.1038/sj.ejhg.5200960; KJELLMAN C, 1995, GENE, V161, P163, DOI 10.1016/0378-1119(95)00248-5; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1997, MOL EVOLUTION, P237; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; NAKAHORI Y, 1996, ARES SERONO S PUBLIC, P1; Ohno S., 1967, SEX CHROMOSOMES SEX; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Orti R, 1998, CYTOGENET CELL GENET, V83, P262, DOI 10.1159/000015201; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SAITOU N, 1994, MOL BIOL EVOL, V11, P504; Sakaki Y, 2003, COLD SPRING HARB SYM, V68, P455, DOI 10.1101/sqb.2003.68.455; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Waters PD, 2001, CYTOGENET CELL GENET, V92, P74, DOI 10.1159/000056872; Yamada Tomoyuki, 2004, J Bioinform Comput Biol, V2, P21, DOI 10.1142/S0219720004000454; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	52	88	93	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					158	+		10.1038/ng1729	http://dx.doi.org/10.1038/ng1729			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16388311				2022-12-17	WOS:000234953200009
J	Mehta, T; Tanik, M; Allison, DB				Mehta, T; Tanik, M; Allison, DB			Towards sound epistemological foundations of statistical methods for high-dimensional biology	NATURE GENETICS			English	Article							MICROARRAY EXPRESSION DATA; GENE-EXPRESSION; INFORMATION; DISSECTION; GUIDELINES; SELECTION; TESTS; BIAS		Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Elect & Comp Engn, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Ryals Publ Hlth Bldg,Suite 327,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399				Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Baggerly KA, 2003, PROTEOMICS, V3, P1667, DOI 10.1002/pmic.200300522; Bailey LR, 1999, AM J HUM GENET, V65, pA91; Balagurunathan Y, 2002, J BIOMED OPT, V7, P507, DOI 10.1117/1.1486246; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BEMOULLI J, 1713, ARS CONJECTANDI; Benes V, 2003, TRENDS BIOCHEM SCI, V28, P244, DOI 10.1016/S0968-0004(03)00068-9; BERRY WD, 1993, UNDERSTANDING REGRES, P3; Blashfield RK., 1988, HDB MULTIVARIATE EXP, P447, DOI [10.1007/978-1-4613-0893-5_14, DOI 10.1007/978-1-4613-0893-5_14]; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Catellier DJ, 2000, STAT MED, V19, P1101, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1101::AID-SIM415>3.3.CO;2-8; Cherepinsky V, 2003, P NATL ACAD SCI USA, V100, P9668, DOI 10.1073/pnas.1633770100; Davies PI, 2000, BIT, V40, P640, DOI 10.1023/A:1022384216930; EDWARDS AWF, 1969, NATURE, V222, P1233, DOI 10.1038/2221233a0; Ertas A, 2003, IEEE T EDUC, V46, P289, DOI 10.1109/TE.2002.808232; Evans GA, 2000, NAT BIOTECHNOL, V18, P127, DOI 10.1038/72480; Famili AF, 2004, BIOINFORMATICS, V20, P1535, DOI 10.1093/bioinformatics/bth124; Gadbury GL, 2003, J R STAT SOC C-APPL, V52, P365, DOI 10.1111/1467-9876.00410; GADBURY GL, IN PRESS STAT METHOD; Gracey AY, 2003, ANNU REV PHYSIOL, V65, P231, DOI 10.1146/annurev.physiol.65.092101.142716; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Headrick TC, 1999, PSYCHOMETRIKA, V64, P25, DOI 10.1007/BF02294317; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karian Z. A, 2000, FITTING STAT DISTRIB, P1; Kowalski J, 2004, BIOINFORMATICS, V20, P364, DOI 10.1093/bioinformatics/btg418; LAKATOS I, 1963, BRIT J PHILOS SCI, V14, P1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Malley JD, 2002, HUM HERED, V54, P174, DOI 10.1159/000070663; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Michaud DJ, 2003, BIOINFORMATICS, V19, P1140, DOI 10.1093/bioinformatics/btg132; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Perez-Enciso M, 2003, GENETICS, V164, P1597; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rockett JC, 2004, GENOMICS, V83, P541, DOI 10.1016/j.ygeno.2003.09.017; Roy T, 2002, J STAT COMPUT SIM, V72, P23; RUSSELL B, 1961, BASIC WRITINGS, P149; Singhal S, 2003, CANCER BIOL THER, V2, P383, DOI 10.4161/cbt.2.4.431; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Spence MA, 2003, AM J HUM GENET, V72, P1084, DOI 10.1086/374826; Tilstone C, 2003, NATURE, V424, P610, DOI 10.1038/424610a; Toda K, 2003, ANAL SCI, V19, P1529, DOI 10.2116/analsci.19.1529; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xu RH, 2003, BIOINFORMATICS, V19, P1284, DOI 10.1093/bioinformatics/btg155; Yang Dongyan, 2004, Am J Pharmacogenomics, V4, P53, DOI 10.2165/00129785-200404010-00006	49	88	92	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					943	947		10.1038/ng1422	http://dx.doi.org/10.1038/ng1422			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340433	Bronze			2022-12-17	WOS:000223658100017
J	Fraser, AG; Marcotte, EM				Fraser, AG; Marcotte, EM			A probabilistic view of gene function	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORKS; SMALL-WORLD; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; MODULES; DATABASE; YEAST	Cells are controlled by the complex and dynamic actions of thousands of genes. With the sequencing of many genomes, the key problem has shifted from identifying genes to knowing what the genes do; we need a framework for expressing that knowledge. Even the most rigorous attempts to construct ontological frameworks describing gene function (e.g., the Gene Ontology project) ultimately rely on manual curation and are thus labor-intensive and subjective. But an alternative exists: the field of functional genomics is piecing together networks of gene interactions, and although these data are currently incomplete and error-prone, they provide a glimpse of a new, probabilistic view of gene function. We outline such a framework, which revolves around a statistical description of gene interactions derived from large, systematically compiled data sets. In this probabilistic view, pleiotropy is implicit, all data have errors and the definition of gene function is an iterative process that ultimately converges on the correct functions. The relationships between the genes are defined by the data, not by hand. Even this comprehensive view fails to capture key aspects of gene function, not least their dynamics in time and space, showing that there are limitations to the model that must ultimately be addressed.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Texas, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Wellcome Trust Sanger Institute; University of Texas System; University of Texas Austin	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk; marcotte@icmb.utexas.edu		Marcotte, Edward/0000-0001-8808-180X; Fraser, Andrew/0000-0001-9939-6014				Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Clare A, 2002, BIOINFORMATICS, V18, P160, DOI 10.1093/bioinformatics/18.1.160; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen Ronald, 2002, Journal of Structural and Functional Genomics, V2, P71, DOI 10.1023/A:1020495201615; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Krause R, 2003, BIOINFORMATICS, V19, P1901, DOI 10.1093/bioinformatics/btg344; Manke T, 2003, J MOL BIOL, V333, P75, DOI 10.1016/j.jmb.2003.08.004; Marcotte E, 2001, Brief Bioinform, V2, P363, DOI 10.1093/bib/2.4.363; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Saito R, 2002, NUCLEIC ACIDS RES, V30, P1163, DOI 10.1093/nar/30.5.1163; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tjian R, 1996, PHILOS T R SOC B, V351, P491, DOI 10.1098/rstb.1996.0047; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906	58	88	91	1	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2004	36	6					559	564		10.1038/ng1370	http://dx.doi.org/10.1038/ng1370			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15167932	Bronze			2022-12-17	WOS:000221763700009
J	Le Stunff, C; Fallin, D; Bougneres, P				Le Stunff, C; Fallin, D; Bougneres, P			Paternal transmission of the very common class IINSVNTR alleles predisposes to childhood obesity	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS IDDM2; INSULIN GENE; VARIABLE NUMBER; MINISATELLITE; EXPRESSION; FETUS; TDT	To identify some of the genetic factors that contribute to obesity in children of Central European and North African descent, we studied the parental transmission of alleles at the insulin locus to offspring with early-onset obesity. A variable nucleotide tandem repeat (VNTR) polymorphism upstream of the insulin gene (INS) is associated with variations in the expression of INS and the nearby gene encoding insulin-like growth factor 2 (IGF2). We found an excess of paternal transmission of class I VNTR alleles to obese children: children who inherited a class I allele from their father (but not those inheriting it from their mother) had a relative risk of early-onset obesity of 1.8. Due to the frequency of class I alleles in this population, this risk concerns 65-70% of all infants. These results suggest that increased in utero expression of paternal INS or IGF2 due to the class I INS VNTR allele may predispose off spring to postnatal fat deposition.	Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University	Bougneres, P (corresponding author), Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France.	pbougneres@mageos.com	LE STUNFF, CATHERINE/Y-3270-2018	LE STUNFF, CATHERINE/0000-0001-8419-0451				Battaglia FC, 1998, DIABETES CARE, V21, pB70; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bundred P, 2001, BMJ-BRIT MED J, V322, P326, DOI 10.1136/bmj.322.7282.326; Catalano PM, 1998, DIABETES CARE, V21, pB85; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P169; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; DUNGER DB, 1998, NAT GENET, V19, P268; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; FREEMAN JV, 1995, INT J EPIDEMIOL, V24, P970, DOI 10.1093/ije/24.5.970; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; International Obesity Task Force, 1998, OB PREV MAN GLOB EP; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; TANIGUCHI A, 1986, J LIPID RES, V27, P925; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6	28	88	90	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					96	99		10.1038/ng707	http://dx.doi.org/10.1038/ng707			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528401				2022-12-17	WOS:000170781300026
J	Castellani, LW; Weinreb, A; Bodnar, J; Goto, AM; Doolittle, M; Mehrabian, M; Demant, P; Lusis, AJ				Castellani, LW; Weinreb, A; Bodnar, J; Goto, AM; Doolittle, M; Mehrabian, M; Demant, P; Lusis, AJ			Mapping a gene for combined hyperlipidaemia in a mutant mouse strain	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; RECOMBINANT CONGENIC STRAINS; TRAITS	Familiar combined hyperlipidaemia (FCHL) is a common, multifactorial disorder associated with elevated levels of plasma triglyceride, cholesterol, or both(1-3). A characteristic feature is increased secretion of very low density lipoproteins (VLDL) and apolipoprotein B (apoB; refs 3,4). Although FCHL is the most common cause of premature coronary artery disease (CAD), accounting for over 10% of cases, its aetiology remains largely unknown(3-6). One powerful approach to the dissection of complex genetic traits involves the use of animal models' We have identified a mouse strain, HcB-19/Dem (HcB-19), which exhibits hypertriglyceridaemia, hypercholesterolaemia and elevated levels of plasma apoB. Like FCHL patients, HcB-19 mice also exhibit increased secretion of triglyceride-rich lipoproteins, and their hyperlipidaemia becomes progressively more severe with age. It is likely that the hyperlipidaemia results from a mutation of a novel gene that arose during development of strain HcB-19. We mapped the hyperlipidaemia gene (Hyplip1) to the distal portion of mouse chromosome 3. This region is syntenic to human chromosome 1q21-q23, which has recently been shown to harbour a gene associated with FCHL in families from a Finnish isolate (see accompanying manuscript by Pajukanta et al., ref. 8).	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Wadsworth Vet Adm, Los Angeles, CA 90073 USA; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Netherlands Cancer Institute	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	jlusis@medicine.medsch.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042488, P01HL028481, R37HL042488] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42488, HL28481] Funding Source: Medline; NIGMS NIH HHS [GM08243] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; BRUNZELL JD, 1983, J LIPID RES, V24, P147; Collin GB, 1996, MAMM GENOME, V7, P68, DOI 10.1007/s003359900017; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DOOLITTLE MH, 1987, J LIPID RES, V28, P1326; FALCONER DS, 1991, INTRO QUANTITATIVE G; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; KHAN BV, 1990, BIOCHIM BIOPHYS ACTA, V1044, P297, DOI 10.1016/0005-2760(90)90073-7; Kwiterovich Peter O. Jr., 1993, Current Opinion in Lipidology, V4, P133, DOI 10.1097/00041433-199304000-00009; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; PAJVKANTA P, 1997, ARTERIOSCLER THROMB, V17, P841; Silver L.M., 1995, MOUSE GENETICS CONCE; VALERA A, 1994, J BIOL CHEM, V269, P6267; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; Welch CL, 1996, J LIPID RES, V37, P1406	18	88	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					374	377		10.1038/ng0498-374	http://dx.doi.org/10.1038/ng0498-374			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537422				2022-12-17	WOS:000072755500022
J	Guan, XY; Zhang, H; Bittner, M; Jiang, Y; Meltzer, P; Trent, J				Guan, XY; Zhang, H; Bittner, M; Jiang, Y; Meltzer, P; Trent, J			Chromosome arm painting probes	NATURE GENETICS			English	Letter							INSITU HYBRIDIZATION; GENERATION; LIBRARIES				Guan, XY (corresponding author), NIH,NATL CTR HUMAN GENOME RES,CANC GENET LAB,BETHESDA,MD 20892, USA.		Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805				COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; GUAN XY, 1994, GENOMICS, V22, P101, DOI 10.1006/geno.1994.1350; HARDAS BD, 1994, GENOMICS, V21, P359, DOI 10.1006/geno.1994.1277; HECHT BK, 1985, CANCER GENET CYTOGEN, V14, P205, DOI 10.1016/0165-4608(85)90186-4; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SUIJKERBUIJK RF, 1992, GENOMICS, V13, P355, DOI 10.1016/0888-7543(92)90253-O; ZHANG J, 1995, CANCER RES, V55, P4640	10	88	92	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					10	11		10.1038/ng0196-10	http://dx.doi.org/10.1038/ng0196-10			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528238				2022-12-17	WOS:A1996TM55500006
J	HEUTINK, P; ZGURICAS, J; VANOOSTERHOUT, L; BREEDVELD, GJ; TESTERS, L; SANDKUIJL, LA; SNIJDERS, PJLM; WEISSENBACH, J; LINDHOUT, D; HOVIUS, SER; OOSTRA, BA				HEUTINK, P; ZGURICAS, J; VANOOSTERHOUT, L; BREEDVELD, GJ; TESTERS, L; SANDKUIJL, LA; SNIJDERS, PJLM; WEISSENBACH, J; LINDHOUT, D; HOVIUS, SER; OOSTRA, BA			THE GENE FOR TRIPHALANGEAL THUMB MAPS TO THE SUBTELOMERIC REGION OF CHROMOSOME 7Q	NATURE GENETICS			English	Article							PATTERN-FORMATION; LINKAGE; EXPRESSION; MOUSE; EN-2; LOCALIZATION	Triphalangeal thumb is a developmental anomaly, sometimes dominantly transmitted, characterized by a long, finger-like thumb with three phalanges instead of two. The underlying genetic defect is unknown, but presumably involves genes that regulate the differentiation of the developing forelimb. In two large kindreds with triphalangeal thumb, evidence for linkage to the long arm of chromosome 7 was obtained with a maximum lod score of 12.61. Multipoint linkage and haplotype analysis placed the gene close to the telomere of the long arm. To our knowledge this is the first time that a human gene involved solely in the pathologic morphogenesis of the hand and feet has been localized.	ACAD HOSP ROTTERDAM DIJKZIGT,DEPT PLAST & RECONSTRUCT SURG,ROTTERDAM,NETHERLANDS; REG HLTH CARE CTR,ST WILLEBRORD,NETHERLANDS; GENETHON,HUMAN GENOME RES CTR,EVRY,FRANCE	Erasmus University Rotterdam; Erasmus MC	HEUTINK, P (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		Lindhout, Dick/AAH-5765-2019	Heutink, Peter/0000-0001-5218-1737; Lindhout, Dick/0000-0001-9580-624X				BROOK JD, IN PRESS NATURE GENE; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Green MC, 1964, MOUSE NEWS LETT, V31, P27; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HING AV, 1993, AM J HUM GENET, V53, P509; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; Lapidus PW., 1943, SURG GYNECOL OBSTET, V77, P178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOGAN C, 1989, GENOMICS, V4, P206, DOI 10.1016/0888-7543(89)90301-7; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; MARTIN GR, 1990, GENOMICS, V6, P302, DOI 10.1016/0888-7543(90)90570-K; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; NICOLAI JPA, 1988, J HAND SURG A, V13, P417; POOLE SJ, 1989, GENOMICS, V4, P225, DOI 10.1016/0888-7543(89)90324-8; QAZI Q, 1988, J MED GENET, V25, P505, DOI 10.1136/jmg.25.8.505; RADHAKRISHNA U, 1993, J MED GENET, V30, P296, DOI 10.1136/jmg.30.4.296; ROSEN DR, 1993, HUM MOL GENET, V2, P617, DOI 10.1093/hmg/2.5.617; SWEET HO, 1982, MOUSE NEWS LETT, V66, P66; TABIN CJ, 1992, DEVELOPMENT, V116, P289; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TENTAMY S, 1978, BIRTH DEFECTS, V14, P3; TURLEAU C, 1984, ANN GENET-PARIS, V27, P237; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WARM A, 1988, J MED GENET, V25, P337, DOI 10.1136/jmg.25.5.337; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Winter Robin M., 1993, European Journal of Human Genetics, V1, P96; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	32	88	90	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					287	292		10.1038/ng0394-287	http://dx.doi.org/10.1038/ng0394-287			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012392	Green Published			2022-12-17	WOS:A1994MZ56200017
J	POLYMEROPOULOS, MH; XIAO, H; SIKELA, JM; ADAMS, M; VENTER, JC; MERRIL, CR				POLYMEROPOULOS, MH; XIAO, H; SIKELA, JM; ADAMS, M; VENTER, JC; MERRIL, CR			CHROMOSOMAL DISTRIBUTION OF 320 GENES FROM A BRAIN CDNA LIBRARY	NATURE GENETICS			English	Article							HUMAN GENOME; ASSIGNMENT; MAP	We have determined the chromosomal assignment of 320 brain expressed genes by studying the segregation of polymerase chain reaction (PCR) products in human rodent somatic cell hybrids and by genetically mapping polymorphic cDNAs using the CEPH (Centre d'Etude du Polymophisme Humaine) reference pedigrees and database. These mapped genes can function as markers on the physical map of the human genome, as well as serve as candidate disease gene loci. Distribution of these genes to the human chromosomes correlates well with the GC content of the chromosomes. However, the distribution of these genes does not correlate well with the cytogenetic length of each chromosome.	UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262; INST GENOM RES,GAITHERSBURG,MD 20878	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; J. Craig Venter Institute	POLYMEROPOULOS, MH (corresponding author), NIMH,BIOCHEM GENET LAB,CTR NEUROSCI,WASHINGTON,DC 20032, USA.							ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; ROMANI M, 1990, GENE, V95, P231, DOI 10.1016/0378-1119(90)90366-Y; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837; 1993, CELL, V72, P971	19	88	88	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					381	386		10.1038/ng0893-381	http://dx.doi.org/10.1038/ng0893-381			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401586				2022-12-17	WOS:A1993LQ17800016
J	MURRAY, JC; BENNETT, SR; KWITEK, AE; SMALL, KW; SCHINZEL, A; ALWARD, WLM; WEBER, JL; BELL, GI; BUETOW, KH				MURRAY, JC; BENNETT, SR; KWITEK, AE; SMALL, KW; SCHINZEL, A; ALWARD, WLM; WEBER, JL; BELL, GI; BUETOW, KH			LINKAGE OF RIEGER SYNDROME TO THE REGION OF THE EPIDERMAL GROWTH-FACTOR GENE ON CHROMOSOME-4	NATURE GENETICS			English	Article							DELETION; INVITRO; EGF; POLYMORPHISMS; EXPRESSION; SEQUENCE; TOOTH; ARM; 4Q	Rieger syndrome is an autosomal dominant disorder of morphogenesis in which previous cytogenetic arrangements have suggested chromosome 4 as a candidate chromosome. Using a group of highly polymorphic short tandem repeat polymorphisms (STRP), including a new tetranucleotide repeat for epidermal growth factor (EGF), significant linkage of Rieger syndrome to 4q markers has been identified. Tight linkage to EGF supports its role as a candidate gene, although a recombinant in an unaffected individual has been identified. This study demonstrates the utility of using polymorphic STRP markers when only a limited number of small families are available for study.	UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; VITREO RETINAL SURG,EDINA,MN 55435; INST MED GENET,ZURICH,SWITZERLAND; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111	University of Iowa; Howard Hughes Medical Institute; University of Chicago; Fox Chase Cancer Center	MURRAY, JC (corresponding author), UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242, USA.		Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Kwitek, Anne/0000-0003-1024-4116				ABBOTT BD, 1988, DEV BIOL, V128, P300, DOI 10.1016/0012-1606(88)90293-X; AKAZAWA K, 1981, JPN J OPHTHALMOL, V25, P321; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; FURGUSON JG, 1987, ARCH OPHTHALMOL-CHIC, V105, P323; HEINEMANN MH, 1979, BRIT J OPHTHALMOL, V63, P40, DOI 10.1136/bjo.63.1.40; HERVE J, 1984, ANN PEDIATR-PARIS, V31, P77; JORGENSON RJ, 1978, AM J MED GENET, V2, P307, DOI 10.1002/ajmg.1320020310; JUMBLATT MM, 1988, INVEST OPHTH VIS SCI, V29, P586; KRONMILLER JE, 1991, DEV BIOL, V147, P485, DOI 10.1016/0012-1606(91)90307-O; LIGUTIC I, 1981, CLIN GENET, V20, P323; MILLS KA, IN PRESS GENOMICS; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; MOTEGI T, 1988, J MED GENET, V25, P628, DOI 10.1136/jmg.25.9.628; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; PARTANEN AM, 1985, DEV BIOL, V111, P84, DOI 10.1016/0012-1606(85)90437-3; RAYMOND GM, 1986, INVEST OPHTH VIS SCI, V27, P474; RHODES JA, 1987, DEV BIOL, V121, P247, DOI 10.1016/0012-1606(87)90156-4; SERVILLE F, 1977, HUM GENET, V39, P239, DOI 10.1007/BF00287019; SHIELDS MB, 1985, SURV OPHTHALMOL, V29, P387, DOI 10.1016/0039-6257(85)90205-X; SHIELDS MB, 1987, TXB GLAUCOMA, P199; Stathacopoulos R A, 1987, J Pediatr Ophthalmol Strabismus, V24, P198; TABBARA KF, 1973, CAN J OPHTHALMOL, V8, P488; VAUX C, 1992, J MED GENET, V29, P256, DOI 10.1136/jmg.29.4.256; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILCOX LM, 1978, AM J OPHTHALMOL, V86, P834, DOI 10.1016/0002-9394(78)90132-0	25	88	90	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					46	49		10.1038/ng0992-46	http://dx.doi.org/10.1038/ng0992-46			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303248				2022-12-17	WOS:A1992JM64600015
J	Zheng, J; Haberland, V; Baird, D; Walker, V; Haycock, PC; Hurle, MR; Gutteridge, A; Erola, P; Liu, Y; Luo, S; Robinson, J; Richardson, TG; Staley, JR; Elsworth, B; Burgess, S; Sun, BNB; Danesh, J; Runz, H; Maranville, JC; Martin, HM; Yarmolinsky, J; Laurin, C; Holmes, MV; Liu, JZ; Estrada, K; Santos, R; McCarthy, L; Waterworth, D; Nelson, MR; Smith, GD; Butterworth, AS; Hemani, G; Scott, RA; Gaunt, TR				Zheng, Jie; Haberland, Valeriia; Baird, Denis; Walker, Venexia; Haycock, Philip C.; Hurle, Mark R.; Gutteridge, Alex; Erola, Pau; Liu, Yi; Luo, Shan; Robinson, Jamie; Richardson, Tom G.; Staley, James R.; Elsworth, Benjamin; Burgess, Stephen; Sun, Benjamin B.; Danesh, John; Runz, Heiko; Maranville, Joseph C.; Martin, Hannah M.; Yarmolinsky, James; Laurin, Charles; Holmes, Michael V.; Liu, Jimmy Z.; Estrada, Karol; Santos, Rita; McCarthy, Linda; Waterworth, Dawn; Nelson, Matthew R.; Smith, George Davey; Butterworth, Adam S.; Hemani, Gibran; Scott, Robert A.; Gaunt, Tom R.			Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases	NATURE GENETICS			English	Article							ASSOCIATION; INSTRUMENTS; ACTIVATION; VARIANTS; TARGETS; GENES; GWAS	The human proteome is a major source of therapeutic targets. Recent genetic association analyses of the plasma proteome enable systematic evaluation of the causal consequences of variation in plasma protein levels. Here we estimated the effects of 1,002 proteins on 225 phenotypes using two-sample Mendelian randomization (MR) and colocalization. Of 413 associations supported by evidence from MR, 130 (31.5%) were not supported by results of colocalization analyses, suggesting that genetic confounding due to linkage disequilibrium is widespread in naive phenome-wide association studies of proteins. Combining MR and colocalization evidence incis-only analyses, we identified 111 putatively causal effects between 65 proteins and 52 disease-related phenotypes (https://www.epigraphdb.org/pqtl/).). Evaluation of data from historic drug development programs showed that target-indication pairs with MR and colocalization support were more likely to be approved, evidencing the value of this approach in identifying and prioritizing potential therapeutic targets.	[Zheng, Jie; Haberland, Valeriia; Baird, Denis; Walker, Venexia; Haycock, Philip C.; Erola, Pau; Liu, Yi; Luo, Shan; Robinson, Jamie; Richardson, Tom G.; Staley, James R.; Elsworth, Benjamin; Yarmolinsky, James; Laurin, Charles; Holmes, Michael V.; Hemani, Gibran; Gaunt, Tom R.] Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Zheng, Jie; Haberland, Valeriia; Baird, Denis; Walker, Venexia; Haycock, Philip C.; Smith, George Davey; Butterworth, Adam S.; Hemani, Gibran; Scott, Robert A.; Gaunt, Tom R.] Proteome MR Writing Grp, Bristol, Avon, England; [Hurle, Mark R.; Waterworth, Dawn; Nelson, Matthew R.] GlaxoSmithKline, Human Genet, Collegeville, PA USA; [Gutteridge, Alex; McCarthy, Linda; Scott, Robert A.] GlaxoSmithKline, Human Genet, Stevenage, Herts, England; [Luo, Shan] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Staley, James R.; Burgess, Stephen; Sun, Benjamin B.; Danesh, John; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Danesh, John; Butterworth, Adam S.] Addenbrookes Hosp, Sch Clin Med, BHF Ctr Res Excellence, Cambridge, England; [Danesh, John; Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Danesh, John; Butterworth, Adam S.] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Sch Clin Med, Cambridge, England; [Danesh, John; Butterworth, Adam S.] Hlth Data Res UK Cambridge, Wellcome Genome Campus, Hinxton, England; [Danesh, John; Butterworth, Adam S.] Univ Cambridge, Hinxton, England; [Danesh, John] Wellcome Sanger Inst, Dept Human Genet, Hinxton, England; [Runz, Heiko; Liu, Jimmy Z.; Estrada, Karol] Biogen, Translat Biol, Cambridge, MA USA; [Maranville, Joseph C.] Celgene Corp, Informat & Predict Sci, Cambridge, MA USA; [Martin, Hannah M.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Holmes, Michael V.] Univ Oxford, Populat Hlth Res Unit, Med Res Council, Oxford, England; [Holmes, Michael V.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Holmes, Michael V.] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Liu, Jimmy Z.] Oxford Univ Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Santos, Rita] GlaxoSmithKline, Funct Genom, Stevenage, Herts, England; [Smith, George Davey; Gaunt, Tom R.] NIHR Bristol Biomed Res Ctr, Bristol, Avon, England	University of Bristol; GlaxoSmithKline; GlaxoSmithKline; University of Hong Kong; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Biogen; Bristol-Myers Squibb; Celgene Corporation; University of Edinburgh; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Oxford; University of Oxford; University of Oxford; GlaxoSmithKline	Zheng, J; Gaunt, TR (corresponding author), Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England.; Zheng, J; Scott, RA; Gaunt, TR (corresponding author), Proteome MR Writing Grp, Bristol, Avon, England.; Scott, RA (corresponding author), GlaxoSmithKline, Human Genet, Stevenage, Herts, England.; Gaunt, TR (corresponding author), NIHR Bristol Biomed Res Ctr, Bristol, Avon, England.	jie.zheng@bristol.ac.uk; robert.a.scott@gsk.com; tom.gaunt@bristol.ac.uk	Haberland, Valeriia/AAW-1822-2021; Gaunt, Tom R/O-3918-2014; Luo, Shan/AIC-3411-2022; Holmes, Michael/AAA-2208-2021; Davey Smith, George/A-7407-2013	Haberland, Valeriia/0000-0002-3874-0683; Gaunt, Tom R/0000-0003-0924-3247; Luo, Shan/0000-0003-3368-9935; Davey Smith, George/0000-0002-1407-8314; Haycock, Philip/0000-0001-5001-3350; Burgess, Stephen/0000-0001-5365-8760; Baird, Denis/0000-0003-4600-6013; Maranville, Joseph/0000-0002-1688-1573; Richardson, Tom/0000-0002-7918-2040; Elsworth, Benjamin/0000-0001-7328-4233; Hemani, Gibran/0000-0003-0920-1055	Vice-Chancellor's Fellowship from the University of Bristol; UK Medical Research Council Integrative Epidemiology Unit [MC_UU_00011/1, MC_UU_00011/4]; GlaxoSmithKline; Biogen; Cancer Research Integrative Cancer Epidemiology Programme [C18281/A19169]; UK Medical Research Council [MR/L003120/1]; Wellcome [102215/2/13/2]; Turing Fellowship; Wellcome Trust; Royal Society [208806/Z/17/Z]; British Heart Foundation Intermediate Clinical Research Fellowship [FS/18/23/33512]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust; University of Bristol; Elizabeth Blackwell Institute for Health Research University of Bristol; Medical Research Council; Cancer Research UK (CRUK) [C18281/A19169]; Bau Tsu Zung Bau Kwan Yeun Hing Research and Clinical Fellowship from the University of Hong Kong [200008682.920006.20006.400.01]; NIHR Senior Investigator award; CRUK Population Research Postdoctoral Fellowship [C52724/A20138]; NIHR; NIHR BioResource; NIHR Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR) [BTRU-2014-10024]; British Heart Foundation [SP/09/002, RG/13/13/30194, RG/18/13/33946]; MRC [MC_UU_00011/4, MC_PC_19009, MR/L003120/1, MC_UU_00011/1, MC_UU_00002/7] Funding Source: UKRI	Vice-Chancellor's Fellowship from the University of Bristol; UK Medical Research Council Integrative Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Biogen(Biogen); Cancer Research Integrative Cancer Epidemiology Programme; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; Turing Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); British Heart Foundation Intermediate Clinical Research Fellowship; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust; University of Bristol; Elizabeth Blackwell Institute for Health Research University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (CRUK)(Cancer Research UK); Bau Tsu Zung Bau Kwan Yeun Hing Research and Clinical Fellowship from the University of Hong Kong(University of Hong Kong); NIHR Senior Investigator award; CRUK Population Research Postdoctoral Fellowship; NIHR(National Institute for Health Research (NIHR)); NIHR BioResource; NIHR Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Acknowledgements We are extremely grateful to all the families who took part in the ALSPAC study, the midwives for their help in recruiting them and the whole ALSPAC team, including interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. We acknowledge J. Bowden for statistical support and advice relating to MR-Egger regression. This publication is the work of the authors, and J. Zheng will serve as guarantor for the contents of this paper. J.Z. is funded by a Vice-Chancellor's Fellowship from the University of Bristol. This research was also funded by the UK Medical Research Council Integrative Epidemiology Unit (MC_UU_00011/1 and MC_UU_00011/4), GlaxoSmithKline, Biogen and the Cancer Research Integrative Cancer Epidemiology Programme (C18281/A19169). The UK Medical Research Council and Wellcome (grant no. 102215/2/13/2) and the University of Bristol provided core support for ALSPAC. A comprehensive list of grant funding is available on the ALSPAC website (https://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf/).T.R.G.holds a Turing Fellowship with the Alan Turing Institute. G.H. is funded by the Wellcome Trust and the Royal Society (208806/Z/17/Z). M.V.H. is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/23/33512) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. This work has been supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (G.D.S. and T.R.G.). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. This work was supported by the Elizabeth Blackwell Institute for Health Research University of Bristol and the Medical Research Council Proximity to Discovery award. P.E. is supported by Cancer Research UK (CRUK; C18281/A19169). S.L. is funded by the Bau Tsu Zung Bau Kwan Yeun Hing Research and Clinical Fellowship (200008682.920006.20006.400.01) from the University of Hong Kong. J.D. is funded by a NIHR Senior Investigator award. J.D. sits on the International Cardiovascular and Metabolic advisory board for Novartis (since 2010), the UK Biobank Steering Committee (since 2011), and is a member of the MRC International Advisory Group (ING) London (since 2013), the MRC High Throughput Science `Omics Panel', London (since 2013), the Scientific Advisory Committee for Sanofi (since 2013), the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis and the AstraZeneca Genomics advisory board (since 2018). P.C.H. is supported by CRUK Population Research Postdoctoral Fellowship C52724/A20138.; Participants in the INTERVAL randomized controlled trial were recruited with the active collaboration of NHS Blood and Transplant England (https://ww.nhsbt.nhs.uk/), which has supported fieldwork and other elements of the trial. DNA extraction and genotyping was co-funded by the NIHR, the NIHR BioResource (https://bioresource.nihr.ac.uk/) and the NIHR Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The academic coordinating centre for INTERVAL was supported by core funding from the NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR BTRU-2014-10024), UK Medical Research Council (MR/L003120/1), British Heart Foundation (SP/09/002; RG/13/13/30194; RG/18/13/33946) and the NIHR Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. A complete list of the investigators and contributors to the INTERVAL trial is provided in Di Angelantonio et al.59. The academic coordinating centre thank blood donor center staff and blood donors for participating in the INTERVAL trial.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Burgess S, 2017, GENET EPIDEMIOL, V41, P714, DOI 10.1002/gepi.22077; Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835; Chong M, 2019, CIRCULATION, V140, P819, DOI 10.1161/CIRCULATIONAHA.119.040180; Cichonska A, 2016, BIOINFORMATICS, V32, P1981, DOI 10.1093/bioinformatics/btw052; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Evans DM, 2015, ANNU REV GENOM HUM G, V16, P327, DOI 10.1146/annurev-genom-090314-050016; Evans DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003919; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; Folkersen L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006706; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Harrison RK, 2016, NAT REV DRUG DISCOV, V15, P817, DOI 10.1038/nrd.2016.184; Hashizume M, 2015, INT REV IMMUNOL, V34, P265, DOI 10.3109/08830185.2014.938325; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216; Hemani G, 2017, AUTOMATING MENDELIAN, DOI [10.1101/173682, DOI 10.1101/173682]; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hemani G, 2018, HUM MOL GENET, V27, pR195, DOI 10.1093/hmg/ddy163; Hemani G, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007081; Holmes MV, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.78; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Kim-Hellmuth S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00366-1; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Millwood IY, 2018, JAMA CARDIOL, V3, P34, DOI 10.1001/jamacardio.2017.4177; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Richardson TG, 2018, HUM MOL GENET, V27, P3293, DOI 10.1093/hmg/ddy210; Ridker PM, 2018, EUR HEART J, V39, P3499, DOI 10.1093/eurheartj/ehy310; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Solomon T, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002170; Stacey D, 2020, ELUCIDATING MECH GEN, DOI [10.1101/2020.03.16.20036822, DOI 10.1101/2020.03.16.20036822]; Suhre K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14357; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Swerdlow DI, 2016, INT J EPIDEMIOL, V45, P1600, DOI 10.1093/ije/dyw088; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Timpson NJ, 2016, INT J EPIDEMIOL, V45, P1617, DOI 10.1093/ije/dyw197; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wainberg M, 2019, NAT GENET, V51, P592, DOI 10.1038/s41588-019-0385-z; Wu Y, 2019, HUM MOL GENET, V28, P4162, DOI 10.1093/hmg/ddz263; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yao C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05512-x; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Zhao QY, 2020, ANN STAT, V48, P1742, DOI 10.1214/19-AOS1866; Zheng J, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy090; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	59	87	87	2	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2020	52	10					1122	+		10.1038/s41588-020-0682-6	http://dx.doi.org/10.1038/s41588-020-0682-6		SEP 2020	15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NV5GP	32895551	Green Accepted, Green Submitted			2022-12-17	WOS:000566900800001
J	Izzo, F; Lee, SC; Poran, A; Chaligne, R; Gaiti, F; Gross, B; Murali, RR; Deochand, SD; Ang, C; Jones, PW; Nam, AS; Kim, KT; Kothen-Hill, S; Schulman, RC; Ki, M; Lhoumaud, P; Skok, JA; Viny, AD; Levine, RL; Kenigsberg, E; Abdel-Wahab, O; Landau, DA				Izzo, Franco; Lee, Stanley C.; Poran, Asaf; Chaligne, Ronan; Gaiti, Federico; Gross, Baptiste; Murali, Rekha R.; Deochand, Sunil D.; Ang, Chelston; Jones, Philippa Wyndham; Nam, Anna S.; Kim, Kyu-Tae; Kothen-Hill, Steven; Schulman, Rafael C.; Ki, Michelle; Lhoumaud, Priscillia; Skok, Jane A.; Viny, Aaron D.; Levine, Ross L.; Kenigsberg, Ephraim; Abdel-Wahab, Omar; Landau, Dan A.			DNA methylation disruption reshapes the hematopoietic differentiation landscape	NATURE GENETICS			English	Article							CELL SELF-RENEWAL; TRANSCRIPTION FACTORS; CLONAL HEMATOPOIESIS; LINEAGE COMMITMENT; DNMT3A MUTATIONS; STEM-CELLS; RNA-SEQ; TET2; HETEROGENEITY; BINDING	Mutations in genes involved in DNA methylation (DNAme; for example, TET2 and DNMT3A) are frequently observed in hematological malignancies(1-3) and clonal hematopoiesis(4,5). Applying single-cell sequencing to murine hematopoietic stem and progenitor cells, we observed that these mutations disrupt hematopoietic differentiation, causing opposite shifts in the frequencies of erythroid versus myelomonocytic progenitors following Tet2 or Dnmt3a loss. Notably, these shifts trace back to transcriptional priming skews in uncommitted hematopoietic stem cells. To reconcile genome-wide DNAme changes with specific erythroid versus myelomonocytic skews, we provide evidence in support of differential sensitivity of transcription factors due to biases in CpG enrichment in their binding motif. Single-cell transcriptomes with targeted genotyping showed similar skews in transcriptional priming of DNMT3A-mutated human clonal hematopoiesis bone marrow progenitors. These data show that DNAme shapes the topography of hematopoietic differentiation, and support a model in which genome-wide methylation changes are transduced to differentiation skews through biases in CpG enrichment of the transcription factor binding motif. Single-cell analysis of mouse hematopoietic stem cells shows that mutations in DNA methylation genes change the frequencies of erythroid versus myelomonocytic progenitors, owing to differential CpG enrichment in transcription factor binding motifs.	[Izzo, Franco; Chaligne, Ronan; Gaiti, Federico; Gross, Baptiste; Murali, Rekha R.; Deochand, Sunil D.; Ang, Chelston; Jones, Philippa Wyndham; Nam, Anna S.; Kim, Kyu-Tae; Kothen-Hill, Steven; Schulman, Rafael C.; Landau, Dan A.] New York Genome Ctr, New York, NY 10013 USA; [Izzo, Franco; Poran, Asaf; Chaligne, Ronan; Gaiti, Federico; Gross, Baptiste; Murali, Rekha R.; Deochand, Sunil D.; Ang, Chelston; Jones, Philippa Wyndham; Nam, Anna S.; Kim, Kyu-Tae; Kothen-Hill, Steven; Schulman, Rafael C.; Landau, Dan A.] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA; [Lee, Stanley C.; Ki, Michelle; Viny, Aaron D.; Levine, Ross L.; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Lee, Stanley C.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Lhoumaud, Priscillia; Skok, Jane A.] New York Univ Langone Hlth, New York, NY USA; [Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Kenigsberg, Ephraim] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Landau, Dan A.] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Landau, DA (corresponding author), New York Genome Ctr, New York, NY 10013 USA.; Landau, DA (corresponding author), Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA.; Landau, DA (corresponding author), Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA.	dlandau@nygenome.org	Viny, Aaron/AAH-5964-2020; Kenigsberg, Ephraim/AAM-5690-2020; Skok, Jane/ABF-7249-2020	Viny, Aaron/0000-0001-7039-0110; Skok, Jane/0000-0002-4145-1516; Lee, Stanley/0000-0001-7110-2416; Gaiti, Federico/0000-0001-5111-8816; Izzo, Franco/0000-0002-5813-6504; Ang, Chelston/0000-0003-2122-8488; Chaligne, Ronan/0000-0003-4332-3291	Lymphoma Research Foundation; Marie Skodowska-Curie fellowships; ASH Scholar Award; Edward P. Evans Foundation; NIH K99/R00 Pathway to Independence Award [NCI R00 CA218896]; AACR Takeda Multiple Myeloma Fellowship; NCC National Cancer Center Postdoctoral fellowship; NIH/NHLBI [R01 HL128239]; Henry & Marilyn Taub Foundation; Leukemia and Lymphoma Society; National Institute of General Medical Sciences [1R35GM122515]; National Cancer Institute [K08 CA215317]; William Raveis Charitable Fund Fellowship of the Damon Runyon Cancer Research Foundation [DRG 117-15]; Burroughs Wellcome Fund Career Award for Medical Scientists; Pershing Square Sohn Prize for Young Investigators in Cancer Research; National Institutes of Health Director's New Innovator Award [DP2-CA239065]; Leukemia and Lymphoma Society Translational Research Program; National Heart Lung and Blood Institute [R01HL145283-01]; Stand Up To Cancer Innovative Research Grant [SU2C-AACR-IRG-0616];  [P30 CA008748]	Lymphoma Research Foundation; Marie Skodowska-Curie fellowships; ASH Scholar Award; Edward P. Evans Foundation; NIH K99/R00 Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR Takeda Multiple Myeloma Fellowship; NCC National Cancer Center Postdoctoral fellowship; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Henry & Marilyn Taub Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William Raveis Charitable Fund Fellowship of the Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Pershing Square Sohn Prize for Young Investigators in Cancer Research(Pershing Square Sohn Cancer Research Alliance); National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stand Up To Cancer Innovative Research Grant; 	R.C. is supported by Lymphoma Research Foundation and Marie Skodowska-Curie fellowships. S.C.L. is supported by the ASH Scholar Award, the Edward P. Evans Foundation Young Investigator Award and the NIH K99/R00 Pathway to Independence Award (no. NCI R00 CA218896). P.L. is supported by the AACR Takeda Multiple Myeloma Fellowship and the NCC National Cancer Center Postdoctoral fellowship. O.A.-W. is supported by grants from NIH/NHLBI (no. R01 HL128239), the Henry & Marilyn Taub Foundation, the Edward P. Evans Foundation and the Leukemia and Lymphoma Society. This work was also funded by grant no. P30 CA008748. J.A.S. is supported by National Institute of General Medical Sciences grant no. 1R35GM122515. A.D.V. is supported by a National Cancer Institute career development grant no. K08 CA215317, the William Raveis Charitable Fund Fellowship of the Damon Runyon Cancer Research Foundation (grant no. DRG 117-15) and an Evans MDS Young Investigator grant from the Edward P. Evans Foundation. D.A.L. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists, the Pershing Square Sohn Prize for Young Investigators in Cancer Research and the National Institutes of Health Director's New Innovator Award (no. DP2-CA239065). This work was enabled by the Weill Cornell Epigenomics Core and Flow Cytometry Core. This work was also supported by the Leukemia and Lymphoma Society Translational Research Program, National Heart Lung and Blood Institute (grant no. R01HL145283-01) and Stand Up To Cancer Innovative Research Grant (no. SU2C-AACR-IRG-0616).	Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cho BS, 2017, KOREAN J INTERN MED, V32, P248, DOI 10.3904/kjim.2016.244; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Emperle M, 2019, NUCLEIC ACIDS RES, V47, P11355, DOI 10.1093/nar/gkz911; Gaiti F, 2019, NATURE, V569, P576, DOI 10.1038/s41586-019-1198-z; Genovese G, 2015, NEW ENGL J MED, V372, P1071, DOI 10.1056/NEJMc1500684; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hwang HS, 2019, IMMUNOL INVEST, V48, P96, DOI 10.1080/08820139.2018.1497057; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kramer AC, 2017, LEUKEMIA, V31, P2479, DOI 10.1038/leu.2017.89; Kribelbauer JF, 2017, CELL REP, V19, P2383, DOI 10.1016/j.celrep.2017.05.069; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunimoto H, 2014, BLOOD, V123, P2897, DOI 10.1182/blood-2014-01-552471; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lhoumaud P, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1853-6; Li WJ, 2015, LEUKEMIA LYMPHOMA, V56, P1066, DOI 10.3109/10428194.2014.947607; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Mayle A, 2015, BLOOD, V125, P629, DOI 10.1182/blood-2014-08-594648; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nam AS, 2019, NATURE, V571, P355, DOI 10.1038/s41586-019-1367-0; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pan F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15102; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Pujato M, 2014, NUCLEIC ACIDS RES, V42, P13500, DOI 10.1093/nar/gku1228; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Shih AH, 2017, CANCER DISCOV, V7, P494, DOI 10.1158/2159-8290.CD-16-1049; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Stone A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8758; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun HY, 2019, METHODS MOL BIOL, V1935, P91, DOI 10.1007/978-1-4939-9057-3_6; Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Viner C, 2016, MODELING METHYL SENS, DOI [10.1101/043794, DOI 10.1101/043794]; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yang LB, 2016, CANCER CELL, V30, P363, DOI 10.1016/j.ccell.2016.07.015; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu VWC, 2017, CELL, V168, P944, DOI 10.1016/j.cell.2017.02.010; Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610	83	87	90	7	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2020	52	4					378	+		10.1038/s41588-020-0595-4	http://dx.doi.org/10.1038/s41588-020-0595-4		MAR 2020	28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ6QL	32203468	Green Accepted			2022-12-17	WOS:000521529000001
J	Fang, H; Beckmann, G; Bountra, C; Bowness, P; Burgess-Brown, N; Carpenter, L; Chen, LY; Damerell, D; Egner, U; Fujii, R; Howe, T; Jakobsson, PJ; Katopodis, A; Knight, JC; Marsden, BD; De Martino, J; Matthias, G; McVean, G; Mueller-Fahrnow, A; Malarstig, A; O'Callaghan, CA; Ostermann, N; Paez-cortez, JR; Peeters, PJ; Prinz, F; Soulard, P; Sundstrom, M; Yabuki, C; Vlach, J; De Wolf, H; Knezevic, B; Burnham, KL; Osgood, J; Sanniti, A; Lara, AL; Kasela, S; De Cesco, S; Wegner, JK; Handunnetthi, L; McCann, FE; Sekine, T; Brennan, PE; Sundstrom, Y; Milani, L; Berg, L; Gohlmann, HW; Fairfax, BP				Fang, Hai; Beckmann, Georg; Bountra, Chas; Bowness, Paul; Burgess-Brown, Nicola; Carpenter, Liz; Chen, Liye; Damerell, David; Egner, Ursula; Fujii, Ryo; Howe, Trevor; Jakobsson, Per-Johan; Katopodis, Andreas; Knight, Julian C.; Marsden, Brian D.; De Martino, Julie; Matthias, Gstaiger; McVean, Gilean; Mueller-Fahrnow, Anke; Malarstig, Anders; O'Callaghan, Chris A.; Ostermann, Nils; Paez-cortez, Jesus R.; Peeters, Pieter J.; Prinz, Florian; Soulard, Patricia; Sundstrom, Michael; Yabuki, Chiori; Vlach, Jaromir; De Wolf, Hans; Knezevic, Bogdan; Burnham, Katie L.; Osgood, Julie; Sanniti, Anna; Lara, Alicia Lledo; Kasela, Silva; De Cesco, Stephane; Wegner, Jorg K.; Handunnetthi, Lahiru; McCann, Fiona E.; Sekine, Takuya; Brennan, Paul E.; Sundstrom, Yvonne; Milani, Lili; Berg, Louise; Gohlmann, Hinrich W.; Fairfax, Benjamin P.		ULTRA-DD Consortium	A genetics-led approach defines the drug target landscape of 30 immune-related traits	NATURE GENETICS			English	Article							AUTOIMMUNE-DISEASES; GENOME; EXPRESSION; ARTHRITIS; ONTOLOGY; PATHWAY; MICE; GWAS; IDENTIFICATION; ACTIVATION	Most candidate drugs currently fail later-stage clinical trials, largely due to poor prediction of efficacy on early target selection(1). Drug targets with genetic support are more likely to be therapeutically valid(2,3), but the translational use of genome-scale data such as from genome-wide association studies for drug target discovery in complex diseases remains challenging(4-6). Here, we show that integration of functional genomic and immune-related annotations, together with knowledge of network connectivity, maximizes the informativeness of genetics for target validation, defining the target prioritization landscape for 30 immune traits at the gene and pathway level. We demonstrate how our genetics-led drug target prioritization approach (the priority index) successfully identifies current therapeutics, predicts activity in high-throughput cellular screens (including L1000, CRISPR, mutagenesis and patient-derived cell assays), enables prioritization of under-explored targets and allows for determination of target-level trait relationships. The priority index is an open-access, scalable system accelerating early-stage drug target selection for immune-mediated disease.	[Fang, Hai; Knight, Julian C.; McVean, Gilean; O'Callaghan, Chris A.; Knezevic, Bogdan; Burnham, Katie L.; Osgood, Julie; Sanniti, Anna; Lara, Alicia Lledo; Handunnetthi, Lahiru] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Howe, Trevor; Peeters, Pieter J.; De Wolf, Hans; Wegner, Jorg K.; Gohlmann, Hinrich W.] Janssen Res & Dev, Beerse, Belgium; [Kasela, Silva; Milani, Lili] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia; [De Cesco, Stephane; Brennan, Paul E.] Univ Oxford, Target Discovery Inst, Alzheimers Res UK, Oxford Drug Discovery Inst, Oxford, England; [Marsden, Brian D.; McCann, Fiona E.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Bowness, Paul; Chen, Liye; Sekine, Takuya] Univ Oxford, Botnar Res Ctr, Oxford, England; [Bountra, Chas; Burgess-Brown, Nicola; Carpenter, Liz; Damerell, David; Marsden, Brian D.; Brennan, Paul E.] Univ Oxford, Struct Genom Consortium, Oxford, England; [Bowness, Paul; Knight, Julian C.; O'Callaghan, Chris A.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford, England; [Jakobsson, Per-Johan; Sundstrom, Michael; Sundstrom, Yvonne; Berg, Louise] Karolinska Univ Hosp, Dept Med, Struct Genom Consortium, Stockholm, Sweden; [Jakobsson, Per-Johan; Sundstrom, Michael; Sundstrom, Yvonne; Berg, Louise] Karolinska Inst, Stockholm, Sweden; [Fairfax, Benjamin P.] Univ Oxford, MRC Weatherall Inst Mol Med, Dept Oncol, Oxford, England; [Beckmann, Georg; Egner, Ursula; Mueller-Fahrnow, Anke; Prinz, Florian] Bayer Pharma, Global Drug Discovery, Berlin, Germany; [Fujii, Ryo; Yabuki, Chiori] Takeda Pharmaceut, Fujisawa, Kanagawa, Japan; [Katopodis, Andreas; Ostermann, Nils] Novartis Pharmaceut, Novartis Inst BioMed Res, Basel, Switzerland; [De Martino, Julie; Soulard, Patricia; Vlach, Jaromir] Merck, Darmstadt, Germany; [Matthias, Gstaiger] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Malarstig, Anders] Pfizer Worldwide Res & Dev, Stockholm, Sweden; [Paez-cortez, Jesus R.] AbbVie Biores Ctr, Worcester, MA USA	University of Oxford; Wellcome Centre for Human Genetics; Johnson & Johnson; Janssen Pharmaceuticals; University of Tartu; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Oxford; Bayer AG; Bayer Healthcare Pharmaceuticals; Takeda Pharmaceutical Company Ltd; Novartis; Merck & Company; Merck & Company Germany; Swiss Federal Institutes of Technology Domain; ETH Zurich; Pfizer; AbbVie	Knight, JC (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.; Knight, JC (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford, England.	julian@well.ox.ac.uk	Bowness, Paul/AAH-2484-2019; Jakobsson, Per-Johan/ABC-5594-2021; Knight, Julian Charles/W-2399-2019	Knight, Julian Charles/0000-0002-0377-5536; Fang, Hai/0000-0003-3961-8572; Fairfax, Benjamin/0000-0001-7413-5002; Berg, Louise/0000-0001-6538-2837; Peeters, Pieter Johan/0000-0003-1252-8139; Wegner, Jorg Kurt/0000-0002-1852-9434; Handunnetthi, Lahiru/0000-0002-8242-3722; McCann, Fiona/0000-0001-8151-8781; De Cesco, Stephane/0000-0003-4443-4217	European Research Council (FP7/2007-2013), through an EU/EFPIA Innovative Medicines Initiative Joint Undertaking [ULTRA-DD 115766, 281824]; Arthritis Research UK [20773]; Wellcome Trust Investigator Award [204969/Z/16/Z]; NIHR Oxford Biomedical Research Centre; Estonian Research Council [PRG184]; Alzheimer's Research UK [ARUK-2018DDI-OX]; Boehringer Ingelheim; Bayer Pharma; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD) [115766]; Merck (Darmstadt, Germany); Novartis Pharma; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation; Takeda; Wellcome Trust [106169/ZZ14/Z]; Health Data Research UK; Wellcome Trust grants [090532/Z/09/Z, 203141/Z/16/Z, 201488/Z/16/Z]; AbbVie [1097737]; Janssen; MSD	European Research Council (FP7/2007-2013), through an EU/EFPIA Innovative Medicines Initiative Joint Undertaking; Arthritis Research UK(Versus Arthritis); Wellcome Trust Investigator Award(Wellcome Trust); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Estonian Research Council(Estonian Research Council); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Boehringer Ingelheim(Boehringer Ingelheim); Bayer Pharma; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD); Merck (Darmstadt, Germany)(Merck & Company); Novartis Pharma; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Health Data Research UK; Wellcome Trust grants(Wellcome Trust); AbbVie(AbbVie); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD	We thank A. Edwards for comments on the manuscript. This project was supported by: the European Research Council (FP7/2007-2013), through an EU/EFPIA Innovative Medicines Initiative Joint Undertaking (ULTRA-DD 115766 and 281824 to J.C.K.); Arthritis Research UK (20773 to J.C.K.); the Wellcome Trust Investigator Award (204969/Z/16/Z to J.C.K.); Wellcome Trust grants 090532/Z/09/Z and 203141/Z/16/Z (to the Wellcome Centre for Human Genetics core facility) and 201488/Z/16/Z (to B.P.F.); NIHR Oxford Biomedical Research Centre; Estonian Research Council (PRG184 to L.M.); Alzheimer's Research UK (ARUK-2018DDI-OX to P.E.B.); and Structural Genomics Consortium (charity number 1097737), which receives funds from AbbVie, Bayer Pharma, Boehringer Ingelheim, the Canada Foundation for Innovation, the Eshelman Institute for Innovation, Genome Canada, the Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant number 115766), Janssen, Merck (Darmstadt, Germany), MSD, Novartis Pharma, the Ontario Ministry of Economic Development and Innovation, Pfizer, the Sao Paulo Research Foundation, Takeda and the Wellcome Trust (106169/ZZ14/Z). For computation, we used the Oxford Biomedical Research Computing facility-a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute, supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR or Department of Health. Listed in the ULTRA-DD Consortium are Target Priorization Network (TPN) members (alphabetical order).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Banerjee S, 2017, DRUGS, V77, P521, DOI 10.1007/s40265-017-0701-9; Beeh KM, 2013, J ALLERGY CLIN IMMUN, V131, P866, DOI 10.1016/j.jaci.2012.12.1561; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boe A, 1999, CYTOKINE, V11, P1057, DOI 10.1006/cyto.1999.0502; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dargahi N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070078; De Wolf H, 2018, ASSAY DRUG DEV TECHN, V16, P162, DOI 10.1089/adt.2018.845; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0064-8; Fang H, 2014, BIOCHEM BIOPH RES CO, V443, P285, DOI 10.1016/j.bbrc.2013.11.103; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Guo YX, 2017, J IMMUNOL, V198, P4490, DOI 10.4049/jimmunol.1601988; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hedrich CM, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0685-1; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jonkers IH, 2017, HUM MOL GENET, V26, pR185, DOI 10.1093/hmg/ddx254; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kasela S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006643; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Lacey CA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00961-16; Lee WH, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002164; Loughin TM, 2004, COMPUT STAT DATA AN, V47, P467, DOI 10.1016/j.csda.2003.11.020; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Marigorta UM, 2017, NAT GENET, V49, P1517, DOI 10.1038/ng.3936; Meng XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02683-x; Mujtaba MG, 2005, J IMMUNOL, V175, P5077, DOI 10.4049/jimmunol.175.8.5077; Mungall CJ, 2017, NUCLEIC ACIDS RES, V45, pD712, DOI 10.1093/nar/gkw1128; Naranbhai V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8545; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Panes J, 2017, GUT, V66, P1049, DOI 10.1136/gutjnl-2016-312735; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sandborn WJ, 2017, NEW ENGL J MED, V376, P1723, DOI 10.1056/NEJMoa1606910; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Schwabe C, 2018, J CLIN PHARMACOL, V58, P1566, DOI 10.1002/jcph.1278; Singh N, 2016, DIS MODEL MECH, V9, P885, DOI 10.1242/dmm.024851; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Spalinger MR, 2018, CELL REP, V22, P1835, DOI 10.1016/j.celrep.2018.01.052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson MND, 2019, J CLIN INVEST, V129, P1193, DOI 10.1172/JCI123267; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Todd JA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002139; Tulunay A, 2015, GENES IMMUN, V16, P170, DOI 10.1038/gene.2014.64; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wang ZC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12846; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	66	87	87	2	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2019	51	7					1082	+		10.1038/s41588-019-0456-1	http://dx.doi.org/10.1038/s41588-019-0456-1			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG0PF	31253980	Green Accepted, Green Submitted			2022-12-17	WOS:000473491900006
J	Li, XB; Patena, W; Fauser, F; Jinkerson, RE; Saroussi, S; Meyer, MT; Ivanova, N; Robertson, JM; Yue, R; Zhang, R; Vilarrasa-Blasi, J; Wittkopp, TM; Ramundo, S; Blum, SR; Goh, A; Laudon, M; Srikumar, T; Lefebvre, PA; Grossman, AR; Jonikas, MC				Li, Xiaobo; Patena, Weronika; Fauser, Friedrich; Jinkerson, Robert E.; Saroussi, Shai; Meyer, Moritz T.; Ivanova, Nina; Robertson, Jacob M.; Yue, Rebecca; Zhang, Ru; Vilarrasa-Blasi, Josep; Wittkopp, Tyler M.; Ramundo, Silvia; Blum, Sean R.; Goh, Audrey; Laudon, Matthew; Srikumar, Tharan; Lefebvre, Paul A.; Grossman, Arthur R.; Jonikas, Martin C.			A genome-wide algal mutant library and functional screen identifies genes required for eukaryotic photosynthesis	NATURE GENETICS			English	Article							PSBA MESSENGER-RNA; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-I; ARABIDOPSIS-THALIANA; REPEAT PROTEIN; REVEALS; COMPLEX; EXPRESSION; DNA; ACCUMULATION	Photosynthetic organisms provide food and energy for nearly all life on Earth, yet half of their protein-coding genes remain uncharacterized(1,2). Characterization of these genes could be greatly accelerated by new genetic resources for unicellular organisms. Here we generated a genome-wide, indexed library of mapped insertion mutants for the unicellular alga Chlamydomonas reinhardtii. The 62,389 mutants in the library, covering 83% of nuclear protein-coding genes, are available to the community. Each mutant contains unique DNA barcodes, allowing the collection to be screened as a pool. We performed a genome-wide survey of genes required for photosynthesis, which identified 303 candidate genes. Characterization of one of these genes, the conserved predicted phosphatase-encoding gene CPL3, showed that it is important for accumulation of multiple photosynthetic protein complexes. Notably, 21 of the 43 higher-confidence genes are novel, opening new opportunities for advances in understanding of this biogeochemically fundamental process. This library will accelerate the characterization of thousands of genes in algae, plants, and animals.	[Li, Xiaobo; Patena, Weronika; Fauser, Friedrich; Meyer, Moritz T.; Robertson, Jacob M.; Goh, Audrey; Srikumar, Tharan; Jonikas, Martin C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Li, Xiaobo; Patena, Weronika; Fauser, Friedrich; Jinkerson, Robert E.; Saroussi, Shai; Ivanova, Nina; Robertson, Jacob M.; Yue, Rebecca; Zhang, Ru; Vilarrasa-Blasi, Josep; Wittkopp, Tyler M.; Blum, Sean R.; Grossman, Arthur R.; Jonikas, Martin C.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Li, Xiaobo] Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Hangzhou, Zhejiang, Peoples R China; [Wittkopp, Tyler M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Ramundo, Silvia] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Laudon, Matthew; Lefebvre, Paul A.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA; [Jinkerson, Robert E.] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Zhang, Ru] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Wittkopp, Tyler M.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Princeton University; Carnegie Institution for Science; Westlake University; Stanford University; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Riverside; Donald Danforth Plant Science Center; Salk Institute	Jonikas, MC (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Jonikas, MC (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	mjonikas@princeton.edu	Meyer, Moritz Thomas/AAP-2161-2021; Saroussi, Shai/Y-2163-2019; Vilarrasa-Blasi, Josep/AAB-9586-2021; Patena, Weronika/AAZ-3275-2020	Saroussi, Shai/0000-0003-0422-6165; Vilarrasa-Blasi, Josep/0000-0003-4328-4798; Patena, Weronika/0000-0002-8388-1303; Ramundo, Silvia/0000-0002-2703-1398; Jinkerson, Robert/0000-0001-9399-1613; Li, Xiaobo/0000-0003-3951-9646	National Science Foundation [MCB-1146621]; National Institutes of Health [DP2-GM-119137]; Simons Foundation; Howard Hughes Medical Institute [55108535]; German Academic Exchange Service (DAAD) research fellowship; Simons Foundation fellowships of the Life Sciences Research Foundation; EMBO long-term fellowship [ALTF 1450-2014, ALTF 563-2013]; Swiss National Science Foundation Advanced PostDoc Mobility Fellowship [P2GEP3_148531]; Westlake University startup fund	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Academic Exchange Service (DAAD) research fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); Simons Foundation fellowships of the Life Sciences Research Foundation; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation Advanced PostDoc Mobility Fellowship; Westlake University startup fund	We thank O. Vallon for helpful discussions; M. Cahn and G. Huntress for developing and improving the CLiP website; X. Ji at the Stanford Functional Genomics Facility and Z. Weng at the Stanford Center for Genomics and Personalized Medicine for deep sequencing services; A. Itakura for help in library pooling; S. Ghosh, K. Mendoza, M. LaVoie, L. Galhardo, X. Li, Y. Wang, and Q. Chen for technical assistance; K. Barton, W. Briggs, and Z.-Y. Wang for providing lab space; J. Ecker, L. Freeman Rosenzweig, and M. Kafri for constructive suggestions on the manuscript; and the Princeton Mass Spectrometry Facility for proteomics services. This project was supported by a grant from the National Science Foundation (MCB-1146621) awarded to M.C.J. and A.R.G., grants from the National Institutes of Health (DP2-GM-119137) and the Simons Foundation and Howard Hughes Medical Institute (55108535) awarded to M.C.J., a German Academic Exchange Service (DAAD) research fellowship to F.F., Simons Foundation fellowships of the Life Sciences Research Foundation to R.E.J. and J.V.-B., an EMBO long-term fellowship (ALTF 1450-2014 and ALTF 563-2013) to J.V.-B and S.R., a Swiss National Science Foundation Advanced PostDoc Mobility Fellowship (P2GEP3_148531) to S.R., and a Westlake University startup fund to X.L.	Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; BASSI R, 1992, J BIOL CHEM, V267, P25714; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern M, 2012, CURR PROTOC BIOINFOR, V13, P20; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Carlotto N, 2016, PLANT CELL ENVIRON, V39, P165, DOI 10.1111/pce.12603; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dent RM, 2015, PLANT J, V82, P337, DOI 10.1111/tpj.12806; Douchi D, 2016, PLANT CELL, V28, P1182, DOI 10.1105/tpc.15.00725; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Felder S, 2001, PLANT CELL, V13, P2127, DOI 10.1105/tpc.13.9.2127; Ferenczi A, 2017, P NATL ACAD SCI USA, V114, P13567, DOI 10.1073/pnas.1710597114; Gao H, 2006, P NATL ACAD SCI USA, V103, P6759, DOI 10.1073/pnas.0507287103; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; Greiner A, 2017, PLANT CELL, V29, P2498, DOI 10.1105/tpc.17.00659; Gutman BL, 2004, PLANT PHYSIOL, V135, P607, DOI 10.1104/pp.104.041491; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Heinnickel M, 2016, P NATL ACAD SCI USA, V113, P2774, DOI 10.1073/pnas.1524040113; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Kim EH, 2015, PLANT CELL, V27, P2956, DOI 10.1105/tpc.15.00707; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Krishnakumar V, 2015, NUCLEIC ACIDS RES, V43, pD1003, DOI 10.1093/nar/gku1200; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lefebvre-Legendre L, 2007, J BIOL CHEM, V282, P13250, DOI 10.1074/jbc.M610249200; LEVINE RP, 1960, P NATL ACAD SCI USA, V46, P972, DOI 10.1073/pnas.46.7.972; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XB, 2016, PLANT CELL, V28, P367, DOI 10.1105/tpc.15.00465; Link S, 2012, PLANT PHYSIOL, V160, P2202, DOI 10.1104/pp.112.205104; Liu XL, 2012, MOL PLANT, V5, P1082, DOI 10.1093/mp/sss012; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Martinis J, 2014, PLANT J, V77, P269, DOI 10.1111/tpj.12385; Marx C, 2015, EUKARYOT CELL, V14, P998, DOI 10.1128/EC.00096-15; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; MICHAELIS G, 1990, MOL GEN GENET, V223, P211, DOI 10.1007/BF00265056; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Rochaix JD, 1995, ANNU REV GENET, V29, P209, DOI 10.1146/annurev.ge.29.120195.001233; Rubin BE, 2015, P NATL ACAD SCI USA, V112, pE6634, DOI 10.1073/pnas.1519220112; SAGER R, 1958, NATURE, V182, P98, DOI 10.1038/182098a0; Saroussi SI, 2016, PLANT PHYSIOL, V170, P1975, DOI 10.1104/pp.15.02014; Schult K, 2007, PLANT CELL, V19, P1329, DOI 10.1105/tpc.106.042895; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Slaninova M, 2008, BIOLOGIA, V63, P941, DOI 10.2478/s11756-008-0146-4; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Suzuki Y, 2015, PLANT CELL PHYSIOL, V56, P863, DOI 10.1093/pcp/pcv012; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Wang HX, 2014, MOL CELL PROTEOMICS, V13, P2337, DOI 10.1074/mcp.M114.038281; Wang LY, 2016, P NATL ACAD SCI USA, V113, P12586, DOI 10.1073/pnas.1606519113; Wang YJ, 2006, P NATL ACAD SCI USA, V103, P10110, DOI 10.1073/pnas.0603402103; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	71	87	87	5	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					627	+		10.1038/s41588-019-0370-6	http://dx.doi.org/10.1038/s41588-019-0370-6			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30886426	Green Accepted, Green Submitted			2022-12-17	WOS:000462767500010
J	Suzuki, K; Akiyama, M; Ishigaki, K; Kanai, M; Hosoe, J; Shojima, N; Hozawa, A; Kadota, A; Kuriki, K; Naito, M; Tanno, K; Ishigaki, Y; Hirata, M; Matsuda, K; Iwata, N; Ikeda, M; Sawada, N; Yamaji, T; Iwasaki, M; Ikegawa, S; Maeda, S; Murakami, Y; Wakai, K; Tsugane, S; Sasaki, M; Yamamoto, M; Okada, Y; Kubo, M; Kamatani, Y; Horikoshi, M; Yamauchi, T; Kadowaki, T				Suzuki, Ken; Akiyama, Masato; Ishigaki, Kazuyoshi; Kanai, Masahiro; Hosoe, Jun; Shojima, Nobuhiro; Hozawa, Atsushi; Kadota, Aya; Kuriki, Kiyonori; Naito, Mariko; Tanno, Kozo; Ishigaki, Yasushi; Hirata, Makoto; Matsuda, Koichi; Iwata, Nakao; Ikeda, Masashi; Sawada, Norie; Yamaji, Taiki; Iwasaki, Motoki; Ikegawa, Shiro; Maeda, Shiro; Murakami, Yoshinori; Wakai, Kenji; Tsugane, Shoichiro; Sasaki, Makoto; Yamamoto, Masayuki; Okada, Yukinori; Kubo, Michiaki; Kamatani, Yoichiro; Horikoshi, Momoko; Yamauchi, Toshimasa; Kadowaki, Takashi			Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NOGO-B RECEPTOR; BODY-MASS INDEX; FASTING GLUCOSE; PROJECT; PROTEIN; DESIGN; ENHANCERS; MELLITUS; ATLAS	To understand the genetics of type 2 diabetes in people of Japanese ancestry, we conducted A meta-analysis of four genome-wide association studies (GWAS; 36,614 cases and 155,150 controls of Japanese ancestry). We identified 88 type 2 diabetes-associated loci (P < 5.0 x 10(-8)) with 115 independent signals (P < 5.0 x 10(-6)), of which 28 loci with 30 signals were novel. Twenty-eight missense variants were in linkage disequilibrium (r(2) > 0.6) with the lead variants. Among the 28 missense variants, three previously unreported variants had distinct minor allele frequency (MAF) spectra between people of Japanese and European ancestry (MAF(JPN) > 0.05 versus MAF(EUR) < 0.01), including missense variants in genes related to pancreatic acinar cells (GP2) and insulin secretion (GLP1R). Transethnic comparisons of the molecular pathways identified from the GWAS results highlight both ethnically shared and heterogeneous effects of a series of pathways on type 2 diabetes (for example, monogenic diabetes and beta cells).	[Suzuki, Ken; Hosoe, Jun; Shojima, Nobuhiro; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Suzuki, Ken; Akiyama, Masato; Ishigaki, Kazuyoshi; Kanai, Masahiro; Okada, Yukinori; Kamatani, Yoichiro] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Suzuki, Ken; Maeda, Shiro; Horikoshi, Momoko] RIKEN, Lab Endocrinol Metab & Kidney Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Suzuki, Ken; Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Osaka, Japan; [Akiyama, Masato] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Kanai, Masahiro] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Hozawa, Atsushi; Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Hozawa, Atsushi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Kadota, Aya] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga, Japan; [Kadota, Aya] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan; [Kuriki, Kiyonori] Univ Shizuoka, Lab Publ Hlth, Sch Food & Nutr Sci, Shizuoka, Japan; [Naito, Mariko; Wakai, Kenji] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Nagoya, Aichi, Japan; [Naito, Mariko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral Epidemiol, Hiroshima, Japan; [Tanno, Kozo] Iwate Med Univ, Div Clin Res & Epidemiol, Disaster Reconstruct Ctr, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Tanno, Kozo] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Morioka, Iwate, Japan; [Ishigaki, Yasushi] Iwate Med Univ, Disaster Reconstruct Ctr, Div Innovat & Educ, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Ishigaki, Yasushi] Iwate Med Univ, Dept Internal Med, Div Diabet Metab & Endocrinol, Morioka, Iwate, Japan; [Hirata, Makoto] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan; [Iwata, Nakao; Ikeda, Masashi] Fujita Hlth Univ, Dept Psychiat, Sch Med, Toyoake, Aichi, Japan; [Sawada, Norie; Yamaji, Taiki; Iwasaki, Motoki] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Epidemiol, Tokyo, Japan; [Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Ctr Integrat Med Sci, Tokyo, Japan; [Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Nishihara, Okinawa, Japan; [Maeda, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Nishihara, Okinawa, Japan; [Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Sasaki, Makoto] Iwate Med Univ, Disaster Reconstruct Ctr, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Sasaki, Makoto] Iwate Med Univ, Inst Biomed Sci, Div Ultrahigh Field MRI, Morioka, Iwate, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Osaka, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Kamatani, Yoichiro] Kyoto Univ, Kyoto McGill Int Collaborat Sch Genom Med, Grad Sch Med, Kyoto, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Prevent Diabet & Lifestyle Related Dis, Tokyo, Japan; [Kadowaki, Takashi] Teikyo Univ, Mizonokuchi Hosp, Fac Med, Dept Metab & Nutr, Tokyo, Japan	University of Tokyo; RIKEN; RIKEN; Osaka University; Kyushu University; Harvard University; Harvard Medical School; Tohoku University; Tohoku University; Shiga University of Medical Science; Shiga University of Medical Science; University of Shizuoka; Nagoya University; Hiroshima University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; University of Tokyo; University of Tokyo; Fujita Health University; National Cancer Center - Japan; RIKEN; University of the Ryukyus; University of the Ryukyus; University of Tokyo; National Cancer Center - Japan; Iwate Medical University; Iwate Medical University; Osaka University; RIKEN; Kyoto University; University of Tokyo; Teikyo University	Yamauchi, T; Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.; Kamatani, Y (corresponding author), RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Horikoshi, M (corresponding author), RIKEN, Lab Endocrinol Metab & Kidney Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Kamatani, Y (corresponding author), Kyoto Univ, Kyoto McGill Int Collaborat Sch Genom Med, Grad Sch Med, Kyoto, Japan.; Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Prevent Diabet & Lifestyle Related Dis, Tokyo, Japan.; Kadowaki, T (corresponding author), Teikyo Univ, Mizonokuchi Hosp, Fac Med, Dept Metab & Nutr, Tokyo, Japan.	yoichiro.kamatani@riken.jp; momoko.horikoshi@riken.jp; tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp	Ishigaki, Kazuyoshi/ABF-6926-2021; Tanno, Kozo/ABE-5165-2020; NAITO, Mariko/I-7264-2014; Horikoshi, Momoko/AAF-9034-2019; Tanno, Kozo/HDM-5952-2022; Akiyama, Masato/AHC-2589-2022; Yamamoto, Masayuki/A-4873-2010; Kanai, Masahiro/AAD-6726-2021; Ikegawa, Shiro/N-6895-2015	Tanno, Kozo/0000-0002-1264-0684; NAITO, Mariko/0000-0003-3794-2643; Tanno, Kozo/0000-0002-1264-0684; Yamamoto, Masayuki/0000-0002-9073-9436; Kanai, Masahiro/0000-0001-5165-4408; Ikegawa, Shiro/0000-0003-0316-2147; Shojima, Nobuhiro/0000-0002-4078-3308; Ikeda, Masashi/0000-0001-6237-2449; Suzuki, Ken/0000-0003-1065-3593; Ishigaki, Kazuyoshi/0000-0003-2881-0657; IWATA, Nakao/0000-0003-3189-6076; Hosoe, Jun/0000-0003-4244-8818	Japan Agency for Medical Research and Development (AMED) [17ek0109223h0001]; AMED [JP18dm0107097, JP18km0405201, JP18km0405208, JP18km0105003, JP18km0105004, JP18km0105001, JP18km0105002, JP18km0405203, JP18km0405001]; Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); AMED; Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) in the Platform Program for Promotion of Genome Medicine (P3GM) of AMED [JP18km0405202]; MEXT; National Cancer Center Research and Development Fund; Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI Grant from MEXT [16H06277];  [17015018];  [221S0001]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED; Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); AMED; Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) in the Platform Program for Promotion of Genome Medicine (P3GM) of AMED; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI Grant from MEXT; ; 	We acknowledge the staff of the BBJ Project, IMM, ToMMo, the JPHC Study and the J-MICC Study for their outstanding assistance in collecting samples and clinical information. We also acknowledge the members of the Genetic Study Group of the Investigation Committee on the Ossification of Spinal Ligaments for recruiting subjects to the ossification of the posterior longitudinal ligament GWAS used in this study, which was supported by the Japan Agency for Medical Research and Development (AMED) (17ek0109223h0001) (S.I.). The study of psychiatric disorders was supported by AMED under grants JP18dm0107097 (N.I., M. Ikeda and K.Y.), JP18km0405201 (N.I.) and JP18km0405208 (M. Ikeda). We are grateful to members of The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This research was funded by the Tailor-Made Medical Treatment Program (the BBJ Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and AMED (M. Kubo and Y.M.). This research was also supported by the Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) in the Platform Program for Promotion of Genome Medicine (P3GM) of AMED (T.K.), JP18km0405202. IMM is supported by MEXT and AMED (grants JP18km0105003 and JP18km0105004, M.S.) ToMMo is supported by MEXT and AMED (grants JP18km0105001, JP18km0105002, JP18km0405203 and JP18km0405001, M.Y.). The JPHC Study has been supported by the National Cancer Center Research and Development Fund since 2011 and was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan from 1989 to 2010 (S.T.). The J-MICC Study was supported by Grants-in-Aid for Scientific Research for Priority Areas of Cancer (17015018) and Innovative Areas (221S0001) and the JSPS KAKENHI Grant (16H06277) from MEXT (A.K., K.K., M.N. and K.W.).	Akiyama M, 2017, NAT GENET, V49, P1458, DOI 10.1038/ng.3951; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bonas-Guarch S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02380-9; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cogger KF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00561-0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Grarup N, 2018, DIABETOLOGIA, V61, P2005, DOI 10.1007/s00125-018-4659-2; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Imamura M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10531; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kanai M, 2016, J HUM GENET, V61, P861, DOI 10.1038/jhg.2016.72; Kobashi G, 2004, SPINE, V29, P1006, DOI 10.1097/00007632-200405010-00011; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Kwak SH, 2018, DIABETES, V67, P1892, DOI 10.2337/db18-0361; Logsdon CD, 2013, NAT REV GASTRO HEPAT, V10, P362, DOI 10.1038/nrgastro.2013.36; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Nakanishi N, 2002, DIABETOLOGIA, V45, P42, DOI 10.1007/s125-002-8243-1; Ogura Y, 2015, AM J HUM GENET, V97, P337, DOI 10.1016/j.ajhg.2015.06.012; Okada Y., 2015, RHEUMATOLOGY, V55, P186; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sathananthan A, 2010, DIABETES CARE, V33, P2074, DOI 10.2337/dc10-0200; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Scott RA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3744; Seino Y, 2014, DIABETES OBES METAB, V16, P739, DOI 10.1111/dom.12276; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Xue A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04951-w; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	57	87	88	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					379	+		10.1038/s41588-018-0332-4	http://dx.doi.org/10.1038/s41588-018-0332-4			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	30718926				2022-12-17	WOS:000459947200007
J	Speed, D; Balding, DJ				Speed, Doug; Balding, David J.			SumHer better estimates the SNP heritability of complex traits from summary statistics	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; SUSCEPTIBILITY LOCI; GENETIC-VARIATION; COMMON; RISK; ARCHITECTURE; DISEASES; ANNOTATION; INSIGHTS	We present SumHer, software for estimating confounding bias, SNP heritability, enrichments of heritability and genetic correlations using summary statistics from genome-wide association studies. The key difference between SumHer and the existing software LD Score Regression (LDSC) is that SumHer allows the user to specify the heritability model. We apply SumHer to results from 24 large-scale association studies (average sample size 121,000) using our recommended heritability model. We show that these studies tended to substantially over-correct for confounding, and as a result the number of genome-wide significant loci was under-reported by about a quarter. We also estimate enrichments for 24 categories of SNPs defined by functional annotations. A previous study using LDSC reported that conserved regions were 13-fold enriched, and found a further six categories with above threefold enrichment. By contrast, our analysis using SumHer finds that none of the categories have enrichment above twofold. SumHer provides an improved understanding of the genetic architecture of complex traits, which enables more efficient analysis of future genetic data.	[Speed, Doug] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Speed, Doug] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Speed, Doug; Balding, David J.] UCL, UCL Genet Inst, London, England; [Balding, David J.] Univ Melbourne, Sch BioSci, Melbourne Integrat Genom, Melbourne, Vic, Australia; [Balding, David J.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia	Aarhus University; Aarhus University; University of London; University College London; University of Melbourne; University of Melbourne	Speed, D (corresponding author), Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark.; Speed, D (corresponding author), Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark.	doug@aias.au.dk	Balding, David/G-9898-2011; Speed, Doug/AAM-1032-2021	Balding, David/0000-0002-1480-6115; Speed, Doug/0000-0002-0096-9765	UK Medical Research Council [MR/L012561/1]; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant [754513]; Aarhus University Research Foundation (AUFF); Independent Research Fund Denmark [7025-00094B]; NHGRI [U01HG006828, U01HG006830, U01HG006389, U01HG006382, U01HG006375, U01HG006379, U01HG006380, U01HG006388, U01HG006378, U01HG006385]; National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; dbGaP Project [14422, 15139]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER; MRC [MR/L012561/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant; Aarhus University Research Foundation (AUFF); Independent Research Fund Denmark; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); dbGaP Project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Price, H. Finucane, P. O'Reilly and M. Speed for helpful discussions. Access to the Wellcome Trust Case Control Consortium data was authorized as work related to the project 'Genome-wide association study of susceptibility and clinical phenotypes in epilepsy', access to eMERGE Network data was granted under dbGaP Project 14422, 'Comprehensive testing of SNP-based prediction models', while access to the Health and Retirement Study was granted under dbGaP Project 15139, 'Developing summary-statistic tools for analysing genetic association study data'. D.S. is funded by the UK Medical Research Council under grant no. MR/L012561/1, by the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 754513, by Aarhus University Research Foundation (AUFF) and the Independent Research Fund Denmark under Project no. 7025-00094B. The eMERGE Network was initiated and funded by NHGRI through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital); U01HG006830 (Children's Hospital of Philadelphia); U01HG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation and Pennsylvania State University); U01HG006382 (Geisinger Clinic); U01HG006375 (Group Health Cooperative); U01HG006379 (Mayo Clinic); U01HG006380 (Icahn School of Medicine at Mount Sinai); U01HG006388 (Northwestern University); U01HG006378 (Vanderbilt University Medical Center); and U01HG006385 (Vanderbilt University Medical Center serving as the Coordinating Center). The Health and Retirement Study genetic data is sponsored by the National Institute on Aging (grant nos. U01AG009740, RC2AG036495, and RC4AG039029) and was conducted by the University of Michigan. Analyses were performed with the use of the UCL Computer Science Cluster and the help of the CS Technical Support Group, as well as the use of the UCL Legion High-Performance Computing Facility (Legion@UCL) and associated support services.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DEMPSTER ER, 1950, GENETICS, V35, P212; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speed D, 2014, BRAIN, V137, P2680, DOI 10.1093/brain/awu206; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	56	87	88	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					277	+		10.1038/s41588-018-0279-5	http://dx.doi.org/10.1038/s41588-018-0279-5			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30510236	Green Submitted, Green Accepted			2022-12-17	WOS:000457314300014
J	Shema, E; Bernstein, BE; Buenrostro, JD				Shema, Efrat; Bernstein, Bradley E.; Buenrostro, Jason D.			Single-cell and single-molecule epigenomics to uncover genome regulation at unprecedented resolution	NATURE GENETICS			English	Article							CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; DNA METHYLATION; GENE-EXPRESSION; DYNAMICS; BINDING; PRINCIPLES; LINEAGE; VARIABILITY; LANDSCAPES	Recent advances in single-cell and single-molecule epigenomic technologies now enable the study of genome regulation and dynamics at unprecedented resolution. In this Perspective, we highlight some of these transformative technologies and discuss how they have been used to identify new modes of gene regulation. We also contrast these assays with recent advances in single-cell transcriptomics and argue for the essential role of epigenomic technologies in both understanding cellular diversity and discovering gene regulatory mechanisms. In addition, we provide our view on the next generation of biological tools that we expect will open new avenues for elucidating the fundamental principles of gene regulation. Overall, this Perspective motivates the use of these high-resolution epigenomic technologies for mapping cell states and understanding regulatory diversity at single-molecule resolution within single cells.	[Shema, Efrat; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shema, Efrat; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Shema, Efrat; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA USA; [Shema, Efrat; Bernstein, Bradley E.; Buenrostro, Jason D.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Buenrostro, Jason D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Shema, Efrat] Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Weizmann Institute of Science	Buenrostro, JD (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Buenrostro, JD (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	jason_buenrostro@harvard.edu	t, lf/AAJ-4924-2020; Shema, Efrat/AHC-5041-2022	Shema, Efrat/0000-0002-3718-593X	Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute; National Cancer Institute; NIH Common Fund; Harvard Society of Fellows; Broad Institute Fellowship; Allen Institute; NIH [R21HG009749]	Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society of Fellows; Broad Institute Fellowship; Allen Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Gaskell for insightful comments throughout the composition of this manuscript. E.S. is supported by the Jane Coffin Childs Memorial Fund for Medical Research. B.E.B. is an American Cancer Society Research Professor and is supported by funds from the National Human Genome Research Institute, the National Cancer Institute and the NIH Common Fund. J.D.B. acknowledges support from the Harvard Society of Fellows and Broad Institute Fellowship. J.D.B also acknowledges the Allen Institute and the NIH R21HG009749 for funding.	Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Clark SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03149-4; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lareau C. A., 2018, PREPRINT, DOI [10.1101/255224, DOI 10.1101/255224]; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Levo M, 2017, MOL CELL, V65, P604, DOI 10.1016/j.molcel.2017.01.007; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Liu Z, 2015, MOL CELL, V58, P644, DOI 10.1016/j.molcel.2015.02.033; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mooijman D, 2016, NAT BIOTECHNOL, V34, P852, DOI 10.1038/nbt.3598; Mulqueen RM, 2018, NAT BIOTECHNOL, V36, P428, DOI 10.1038/nbt.4112; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Pliner H., 2018, MOL CELL, V71; Prakadan SM, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.15; Preissl S, 2018, NAT NEUROSCI, V21, P432, DOI 10.1038/s41593-018-0079-3; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shema E, 2016, SCIENCE, V352, P717, DOI 10.1126/science.aad7701; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Woodworth MB, 2017, NAT REV GENET, V18, P230, DOI 10.1038/nrg.2016.159; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Zhou X, 2011, MOL CELL, V42, P826, DOI 10.1016/j.molcel.2011.05.025	72	87	89	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					19	25		10.1038/s41588-018-0290-x	http://dx.doi.org/10.1038/s41588-018-0290-x			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30559489				2022-12-17	WOS:000454108800008
J	Usher, CL; Handsaker, RE; Esko, T; Tuke, MA; Weedon, MN; Hastie, AR; Cao, H; Moon, JE; Kashin, S; Fuchsberger, C; Metspalu, A; Pato, CN; Pato, MT; McCarthy, MI; Boehnke, M; Altshuler, DM; Frayling, TM; Hirschhorn, JN; McCarroll, SA				Usher, Christina L.; Handsaker, Robert E.; Esko, Tonu; Tuke, Marcus A.; Weedon, Michael N.; Hastie, Alex R.; Cao, Han; Moon, Jennifer E.; Kashin, Seva; Fuchsberger, Christian; Metspalu, Andres; Pato, Carlos N.; Pato, Michele T.; McCarthy, Mark I.; Boehnke, Michael; Altshuler, David M.; Frayling, Timothy M.; Hirschhorn, Joel N.; McCarroll, Steven A.			Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; COPY NUMBER VARIATION; WIDE ASSOCIATION; MULTIGENE FAMILY; GENE; EVOLUTION; REPLICATION; DIVERSITY; VARIANTS; INSIGHTS	Hundreds of genes reside in structurally complex, poorly understood regions of the human genome(1-3). One such region contains the three amylase genes (AMY2B, AMY2A and AMY1) responsible for digesting starch into sugar. Copy number of AMY1 is reported to be the largest genomic influence on obesity(4), although genome-wide association studies for obesity have found this locus unremarkable. Using whole-genome sequence analysis(3,5), droplet digital PCR6 and genome mapping(7), we identified eight common structural haplotypes of the amylase locus that suggest its mutational history. We found that the AMY1 copy number in an individual's genome is generally even (rather than odd) and partially correlates with nearby SNPs, which do not associate with body mass index (BMI). We measured amylase gene copy number in 1,000 obese or lean Estonians and in 2 other cohorts totaling similar to 3,500 individuals. We had 99% power to detect the lower bound of the reported effects on BMI4, yet found no association.	[Usher, Christina L.; Handsaker, Robert E.; Esko, Tonu; Moon, Jennifer E.; Altshuler, David M.; Hirschhorn, Joel N.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02139 USA; [Handsaker, Robert E.; Esko, Tonu; Moon, Jennifer E.; Kashin, Seva; Altshuler, David M.; Hirschhorn, Joel N.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Handsaker, Robert E.; Kashin, Seva; McCarroll, Steven A.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Esko, Tonu; Moon, Jennifer E.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Esko, Tonu; Moon, Jennifer E.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Tuke, Marcus A.; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Sch Med, Genet Complex Traits, Exeter, Devon, England; [Hastie, Alex R.; Cao, Han] BioNano Genom, San Diego, CA USA; [Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Fuchsberger, Christian; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Pato, Carlos N.; Pato, Michele T.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Tartu; University of Exeter; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tartu; University of Southern California; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02139 USA.	joelh@broadinstitute.org; mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021; Fuchsberger, Christian/ABD-7127-2021; Altshuler, David M/A-4476-2009; McCarthy, Mark/M-3763-2015	Handsaker, Bob/0000-0002-3128-3547; Fuchsberger, Christian/0000-0002-5918-8947; Altshuler, David M/0000-0002-7250-4107; Esko, Tonu/0000-0003-1982-6569; Frayling, Timothy/0000-0001-8362-2603; McCarthy, Mark/0000-0002-4393-0510; Moon, Jennifer/0000-0003-3209-4702; Weedon, Michael/0000-0002-6174-6135	National Human Genome Research Institute [R01 HG006855]; Estonian Ministry of Science and Education [SF0180142s08]; Development Fund of the University of Tartu (SP1GVARENG); European Regional Development Fund [3.2.0304.11-0312, 313010]; US National Institutes of Health [R01 DK075787, DK062370]; European Research Council [SZ-50371-GLUCOSEGENES]; Wellcome Trust [WT097835MF]; Medical Research Council [G0601261, G0500070] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; MRC [G0601261, G0500070] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062370, U01DK062370, R01DK075787, P30DK020572, R01DK062370] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia); Development Fund of the University of Tartu (SP1GVARENG); European Regional Development Fund(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Human Genome Research Institute (R01 HG006855) to S.A.M. to support C.L.U., R.E.H. and S.A.M. Work by T.E. and A.M. was supported through the Estonian Genome Center of the University of Tartu (EGCUT) by Targeted Financing from the Estonian Ministry of Science and Education (SF0180142s08), the Development Fund of the University of Tartu (SP1GVARENG) and the European Regional Development Fund to the Centre of Excellence in Genomics (3.2.0304.11-0312) and through Framework Programme 7 grant 313010. T.E., A.M. and J.N.H. were further supported by the US National Institutes of Health (R01 DK075787). T.M.F. is supported by European Research Council funding (Framework Programme 7, SZ-50371-GLUCOSEGENES), M.A.T. and M.N.W. are supported by the Wellcome Trust Institutional Strategic Support Award (WT097835MF), and M.B. is supported by US National Institutes of Health grant DK062370.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantsilieris S, 2013, HUM MUTAT, V34, P1, DOI 10.1002/humu.22172; Cao HZ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-34; Carpenter D, 2015, HUM MOL GENET, V24, P3472, DOI 10.1093/hmg/ddv098; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GROOT PC, 1990, GENOMICS, V8, P97, DOI 10.1016/0888-7543(90)90230-R; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; GROOT PC, 1991, GENOMICS, V10, P779, DOI 10.1016/0888-7543(91)90463-O; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Mottus R, 2012, HEALTH PSYCHOL, V31, P806, DOI 10.1037/a0027041; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Foundation for Statistical Computing, 2021, R LANG ENV STAT COMP; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Tognon G, 2014, NUTR METAB CARDIOVAS, V24, P205, DOI 10.1016/j.numecd.2013.04.013; Zanda M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004367; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	51	87	87	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					921	+		10.1038/ng.3340	http://dx.doi.org/10.1038/ng.3340			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26098870	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000358674100018
J	Fortune, MD; Guo, H; Burren, O; Schofield, E; Walker, NM; Ban, M; Sawcer, SJ; Bowes, J; Worthington, J; Barton, A; Eyre, S; Todd, JA; Wallace, C				Fortune, Mary D.; Guo, Hui; Burren, Oliver; Schofield, Ellen; Walker, Neil M.; Ban, Maria; Sawcer, Stephen J.; Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve; Todd, John A.; Wallace, Chris			Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls	NATURE GENETICS			English	Article							TYPE-2 DIABETES RISK; SUSCEPTIBILITY LOCI; ASSOCIATION SIGNALS; CELIAC-DISEASE; GENOME; ARCHITECTURE; EXPRESSION; INSIGHTS	Determining whether potential causal variants for related diseases are shared can identify overlapping etiologies of multifactorial disorders. Colocalization methods disentangle shared and distinct causal variants. However, existing approaches require independent data sets. Here we extend two colocalization methods to allow for the shared-control design commonly used in comparison of genome-wide association study results across diseases. Our analysis of four autoimmune diseases-type 1 diabetes (T1D), rheumatoid arthritis, celiac disease and multiple sclerosis-identified 90 regions that were associated with at least one disease, 33 (37%) of which were associated with 2 or more disorders. Nevertheless, for 14 of these 33 shared regions, there was evidence that the causal variants differed. We identified new disease associations in 11 regions previously associated with one or more of the other 3 disorders. Four of eight T1D-specific regions contained known type 2 diabetes (T2D) candidate genes (COBL, GLIS3, RNLS and BCAR1), suggesting a shared cellular etiology.	[Fortune, Mary D.; Guo, Hui; Burren, Oliver; Schofield, Ellen; Walker, Neil M.; Todd, John A.; Wallace, Chris] Univ Cambridge, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Dept Med Genet,JDRF Wellcome Trust Diabet & Infla, Cambridge, England; [Guo, Hui] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester, Lancs, England; [Ban, Maria; Sawcer, Stephen J.] Addenbrookes Hosp, Univ Neurol Unit, Cambridge, England; [Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthritis Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res,Inst Inflammat & Repair, Manchester, Lancs, England; [Bowes, John; Worthington, Jane; Barton, Anne; Eyre, Steve] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Wallace, Chris] Cambridge Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England	University of Cambridge; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; University of Manchester; MRC Biostatistics Unit; University of Cambridge	Fortune, MD (corresponding author), Univ Cambridge, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Dept Med Genet,JDRF Wellcome Trust Diabet & Infla, Cambridge, England.	mary.fortune@cimr.cam.ac.uk; chris.wallace@cimr.cam.ac.uk	Todd, John A/A-3542-2010; eyre, stephen/K-3776-2017; Barton, Anne/N-2053-2014	Todd, John A/0000-0003-2740-8148; eyre, stephen/0000-0002-1251-6974; Fortune, Mary/0000-0002-6006-4343; Wallace, Chris/0000-0001-9755-1703; Guo, Hui/0000-0003-0282-6933; Sawcer, Stephen/0000-0001-7685-0974; Walker, Neil/0000-0001-9796-7688; Burren, Oliver/0000-0002-3388-5760; Barton, Anne/0000-0003-3316-2527; Schofield, Ellen/0000-0003-0648-1418	Wellcome Trust [099772, 089989, 091157, 068545/Z/02]; JDRF [9-2011-253]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Wellcome Trust Strategic Award [100140]; Eli Lilly and Company; UK Medical Research Council (MRC); MRC [G0000934]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); JDRF; NIDDK [U01DK062418]; Arthritis Foundation; US National Institutes of Health; Celiac Disease Consortium; Dutch government [BSIK03009]; Netherlands Organisation for Scientific Research (NWO) [918.66.620]; US National Institutes of Health [1R01CA141743]; Fondo de Investigacion Sanitaria [FIS08/1676, FIS07/0353]; UK Multiple Sclerosis Society; UK MRC; US National Multiple Sclerosis Society; Cambridge NIHR Biomedical Research Centre; DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Foundation for Strategic Research; Stockholm County Council; Karolinska Institutet; INSERM; Fondation d'Aide a la Recherche sur la Sclerose en Plaques; Association Francaise contre les Myopathies; Infrastructures en Biologie Sante et Agronomie (GIS-IBISA); German Ministry for Education and Research; German Competence Network Multiple Sclerosis; Deutsche Forschungsgemeinschaft; Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; Research Foundation Flanders; Research Fund KU Leuven; Belgian charcot Foundation; gemeinnutzige Hertie Stiftung; University Zurich; Danish Multiple Sclerosis Society; Danish Council for Strategic Research; Academy of Finland; Sigrid Juselius Foundation; Helsinki University; Italian Multiple Sclerosis Foundation; Fondazione Cariplo; Italian Ministry of University and Research; Torino Savings Bank Foundation; Italian Ministry of Health; Italian Institute of Experimental Neurology; Multiple Sclerosis Association of Oslo; Norwegian Research Council; South-Eastern Norwegian Health Authorities; Australian National Health and Medical Research Council; Dutch Multiple Sclerosis Foundation; Kaiser Permanente; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; Medical Research Council [G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275, NF-SI-0513-10143] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); JDRF(Juvenile Diabetes Research Foundation); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust Strategic Award(Wellcome Trust); Eli Lilly and Company(Eli Lilly); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); JDRF(Juvenile Diabetes Research Foundation); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Arthritis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Celiac Disease Consortium; Dutch government; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); UK Multiple Sclerosis Society; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); DeNDRon; Bibbi and Niels Jensens Foundation; Swedish Brain Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Foundation for Strategic Research; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation d'Aide a la Recherche sur la Sclerose en Plaques; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Infrastructures en Biologie Sante et Agronomie (GIS-IBISA); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Competence Network Multiple Sclerosis; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Munich Biotec Cluster M4; Fidelity Biosciences Research Initiative; Research Foundation Flanders(FWO); Research Fund KU Leuven(KU Leuven); Belgian charcot Foundation; gemeinnutzige Hertie Stiftung; University Zurich; Danish Multiple Sclerosis Society; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University; Italian Multiple Sclerosis Foundation; Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Torino Savings Bank Foundation; Italian Ministry of Health(Ministry of Health, Italy); Italian Institute of Experimental Neurology; Multiple Sclerosis Association of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norwegian Health Authorities; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dutch Multiple Sclerosis Foundation; Kaiser Permanente; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	M.D.F. is funded by the Wellcome Trust (099772). C.W. and H.G. are funded by the Wellcome Trust (089989).; This work was funded by the JDRF (9-2011-253), the Wellcome Trust (091157) and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140). ImmunoBase is supported by Eli Lilly and Company.; We thank the UK Medical Research Council (MRC) and Wellcome Trust for funding the collection of DNA for the British 1958 Birth Cohort (MRC grant G0000934 and Wellcome Trust grant 068545/Z/02). Control DNA samples were prepared and provided by S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton.; This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and the JDRF and supported by grant U01DK062418 from the NIDDK.; Collection of the rheumatoid arthritis data was funded by the Arthritis Foundation and the US National Institutes of Health.; We are grateful to G. Trynka and D. van Heel for use of the celiac disease data. Funding was provided by the Wellcome Trust, by grants from the Celiac Disease Consortium and an Innovative Cluster approved by the Netherlands Genomics Initiative, by the Dutch government (BSIK03009 to C.W.) and the Netherlands Organisation for Scientific Research (NWO; grant 918.66.620), and by US National Institutes of Health grant 1R01CA141743 and Fondo de Investigacion Sanitaria grants FIS08/1676 and FIS07/0353.; Multiple sclerosis data were provided by S. Sawcer and the International Multiple Sclerosis Genetics Consortium. Funding was provided by the US National Institutes of Health, the Wellcome Trust, the UK Multiple Sclerosis Society, the UK MRC, the US National Multiple Sclerosis Society, the Cambridge NIHR Biomedical Research Centre, DeNDRon, the Bibbi and Niels Jensens Foundation, the Swedish Brain Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Foundation for Strategic Research, the Stockholm County Council, Karolinska Institutet, INSERM, Fondation d'Aide a la Recherche sur la Sclerose en Plaques, Association Francaise contre les Myopathies, Infrastructures en Biologie Sante et Agronomie (GIS-IBISA), the German Ministry for Education and Research, the German Competence Network Multiple Sclerosis, Deutsche Forschungsgemeinschaft, Munich Biotec Cluster M4, the Fidelity Biosciences Research Initiative, Research Foundation Flanders, Research Fund KU Leuven, the, Belgian charcot Foundation, gemeinnutzige Hertie Stiftung, University Zurich, the Danish Multiple Sclerosis Society, the Danish Council for Strategic Research, the Academy of Finland, the Sigrid Juselius Foundation, Helsinki University, the Italian Multiple Sclerosis Foundation, Fondazione Cariplo, the Italian Ministry of University and Research, the Torino Savings Bank Foundation, the Italian Ministry of Health, the Italian Institute of Experimental Neurology, the Multiple Sclerosis Association of Oslo, the Norwegian Research Council, the South-Eastern Norwegian Health Authorities, the Australian National Health and Medical Research Council, the Dutch Multiple Sclerosis Foundation and Kaiser Permanente.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mero IL, 2010, EUR J HUM GENET, V18, P502, DOI 10.1038/ejhg.2009.195; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Scott R.A., 2014, GENOME WIDE ASS STUD; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Swafford ADE, 2011, DIABETES, V60, P1041, DOI 10.2337/db10-0446; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wallace C, 2013, GENET EPIDEMIOL, V37, P802, DOI 10.1002/gepi.21765; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098	32	87	87	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					839	+		10.1038/ng.3330	http://dx.doi.org/10.1038/ng.3330			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053495	Green Accepted, Green Submitted			2022-12-17	WOS:000357090300026
J	Okada, Y; Momozawa, Y; Ashikawa, K; Kanai, M; Matsuda, K; Kamatani, Y; Takahashi, A; Kubo, M				Okada, Yukinori; Momozawa, Yukihide; Ashikawa, Kyota; Kanai, Masahiro; Matsuda, Koichi; Kamatani, Yoichiro; Takahashi, Atsushi; Kubo, Michiaki			Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEROPOSITIVE RHEUMATOID-ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; HAPLOTYPE BLOCKS; LOCI; MHC; ALLELES; SUSCEPTIBILITY; IDENTIFICATION; HLA-DRB1	To fine map association signals of human leukocyte antigen (HLA) variants in the major histocompatibility complex (MHC) region, we constructed a Japanese population-specific reference panel (n = 908). We conducted trans-ancestry comparisons of linkage disequilibrium (LD) and haplotype structure for HLA variants using an entropy-based LD measurement,., and a visualization tool to capture high-dimensional variables. Our Japanese reference panel exhibited stronger LD between HLA genes than European or other East Asian populations, characterized by one population-specific common long-range HLA haplotype. We applied HLA imputation to genome-wide association study (GWAS) data for Graves' disease in Japanese (n = 9,003) and found that amino acid polymorphisms of multiple class I and class II HLA genes independently contribute to disease risk (HLA-DPB1, HLA-A, HLA-B and HLA-DRB1; P < 2.3 x 10(-6)), with the strongest impact at HLA-DPB1 (P = 1.6 x 10(-42)). Our study illustrates the value of population-specific HLA reference panels.	[Okada, Yukinori; Kanai, Masahiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori; Kamatani, Yoichiro; Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Momozawa, Yukihide; Ashikawa, Kyota] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Matsuda, Koichi] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Mol Med Lab, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; RIKEN; University of Tokyo	Okada, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan.	yokada.brc@tmd.ac.jp; michiaki.kubo@riken.jp	Kamatani, Yoichiro/N-5513-2015; Kubo, Michiaki/N-7947-2015; Momozawa, Yukihide/N-6453-2015; Kanai, Masahiro/AAD-6726-2021; Matsuda, Koichi/D-4597-2011	Kanai, Masahiro/0000-0001-5165-4408; Matsuda, Koichi/0000-0001-7292-2686	Japan Science and Technology Agency (JST); Japan Society of the Promotion of Science (JSPS); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Grants-in-Aid for Scientific Research [15K14429] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society of the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Gout Research Foundation; Tokyo Biochemical Research Foundation; Japan Rheumatism Foundation(Japan Rheumatism Foundation); Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Kumasaka who originally developed the Disentangler software. We acknowledge T. Aoi and C. Inai for technical assistance and the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International for supporting our study. Y.O. was supported by the Japan Science and Technology Agency (JST), the Japan Society of the Promotion of Science (JSPS), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, the Gout Research Foundation, the Tokyo Biochemical Research Foundation and the Japan Rheumatism Foundation. The BioBank Japan Project was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jin H, 2014, P NATL ACAD SCI USA, V111, P3787, DOI 10.1073/pnas.1401105111; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Nakabayashi K, 2011, J HUM GENET, V56, P772, DOI 10.1038/jhg.2011.99; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nothnagel M, 2005, AM J HUM GENET, V77, P988, DOI 10.1086/498175; Nothnagel M, 2002, HUM HERED, V54, P186, DOI 10.1159/000070664; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Okada Y, 2010, ANN RHEUM DIS, V69, P1569, DOI 10.1136/ard.2009.118018; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zhao SX, 2013, HUM MOL GENET, V22, P3347, DOI 10.1093/hmg/ddt183	34	87	88	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					798	+		10.1038/ng.3310	http://dx.doi.org/10.1038/ng.3310			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029868				2022-12-17	WOS:000357090300018
J	Wang, XK; Bledsoe, KL; Graham, RP; Asmann, YW; Viswanatha, DS; Lewis, JE; Lewis, JT; Chou, MM; Yaszemski, MJ; Jen, J; Westendorf, JJ; Oliveira, AM				Wang, Xiaoke; Bledsoe, Krista L.; Graham, Rondell P.; Asmann, Yan W.; Viswanatha, David S.; Lewis, Jean E.; Lewis, Jason T.; Chou, Margaret M.; Yaszemski, Michael J.; Jen, Jin; Westendorf, Jennifer J.; Oliveira, Andre M.			Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma	NATURE GENETICS			English	Article							WAARDENBURG SYNDROME; PAX3 FUNCTIONS; PAIRED DOMAIN; GENE; MUTATION; MOUSE; MELANOMA; TUMOR	Biphenotypic sinonasal sarcoma (SNS) is a newly described tumor of the nasal and paranasal areas. Here we report a recurrent chromosomal translocation in SNS, t(2;4)(q35;q31.1), resulting in a PAX3-MAML3 fusion protein that is a potent transcriptional activator of PAX3 response elements. The SNS phenotype is characterized by aberrant expression of genes involved in neuroectodermal and myogenic differentiation, closely simulating the developmental roles of PAX3.	[Wang, Xiaoke; Graham, Rondell P.; Viswanatha, David S.; Lewis, Jean E.; Lewis, Jason T.; Oliveira, Andre M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Bledsoe, Krista L.] Mayo Grad Sch, Dept Biochem & Mol Biol, Rochester, MN USA; [Asmann, Yan W.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Chou, Margaret M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chou, Margaret M.] Perelman Sch Med, Philadelphia, PA USA; [Yaszemski, Michael J.; Westendorf, Jennifer J.; Oliveira, Andre M.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Jen, Jin] Mayo Clin, Ctr Individualized Med, Med Genome Facil, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Mayo Clinic	Oliveira, AM (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	oliveira.andre@mayo.edu		Graham, Rondell/0000-0002-8686-4867	US National Institutes of Health [T32 CA148073]; Mayo Clinic DLMP [2012/13]; NATIONAL CANCER INSTITUTE [P30CA015083, T32CA148073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic DLMP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank A. Maran, K.L. Shogren, S.L. Segovis, J.L. Herrick and X. Li for logistical support in the performance of several of these experiments. We also express gratitude to L. Jin, M.R. Erickson-Johnson, B.R. Evers, C.W. Roth, R.N. Wehrs, A.R. Seys and M.L. Lonzo for technical support in the Molecular Anatomic Pathology Laboratory and Cytogenetics Laboratory, to T.J. Flotte and L.A. Gross in the Pathology Resource Core Laboratory, to K.C. Hailing and M.E. Brown for administration support, to T.L. Schmidt for secretarial assistance and to T.A. Bennett for editorial assistance. We also thank C.P. Kolbert and B.W. Eckloff at the Gene Expression Core and the Sequencing Core at the Mayo Medical Genome Facility for providing transcriptome sequencing and gene expression profiling services. This work was supported by Mayo Clinic DLMP 2012/13 Research Grants and by US National Institutes of Health grant T32 CA148073.	Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Chen Z, 2014, ONCOGENE, V33, P3869, DOI 10.1038/onc.2013.348; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gil Z, 2003, CANCER GENET CYTOGEN, V145, P139, DOI 10.1016/S0165-4608(03)00036-0; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lewis JT, 2012, AM J SURG PATHOL, V36, P517, DOI 10.1097/PAS.0b013e3182426886; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Medic S, 2011, BIOCHEM BIOPH RES CO, V411, P832, DOI 10.1016/j.bbrc.2011.07.053; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Nakazaki H, 2008, DEV BIOL, V316, P510, DOI 10.1016/j.ydbio.2008.01.008; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; TASSABEHJI M, 1994, HUM MOL GENET, V3, P1069, DOI 10.1093/hmg/3.7.1069; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wang QY, 2008, J CELL MOL MED, V12, P2281, DOI 10.1111/j.1582-4934.2008.00427.x; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2	20	87	93	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					666	668		10.1038/ng.2989	http://dx.doi.org/10.1038/ng.2989			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24859338	Green Accepted			2022-12-17	WOS:000338093800005
J	Mason, RP; Casu, M; Butler, N; Breda, C; Campesan, S; Clapp, J; Green, EW; Dhulkhed, D; Kyriacou, CP; Giorgini, F				Mason, Robert P.; Casu, Massimiliano; Butler, Nicola; Breda, Carlo; Campesan, Susanna; Clapp, Jannine; Green, Edward W.; Dhulkhed, Devyani; Kyriacou, Charalambos P.; Giorgini, Flaviano			Glutathione peroxidase activity is neuroprotective in models of Huntington's disease	NATURE GENETICS			English	Article							OXIDATIVE STRESS; KYNURENINE 3-MONOOXYGENASE; SELENOORGANIC COMPOUND; HYDROGEN-PEROXIDE; GENE LISTS; CELL-DEATH; EBSELEN; NEURODEGENERATION; INHIBITION; PROTEIN	Huntington's disease is a fatal neurodegenerative disorder caused by a CAG repeat expansion encoding a polyglutamine tract in the huntingtin (Htt) protein(1). Here we report a genome-wide overexpression suppressor screen in which we identified 317 ORFs that ameliorate the toxicity of a mutant Htt fragment in yeast and that have roles in diverse cellular processes, including mitochondrial import and copper metabolism. Two of these suppressors encode glutathione peroxidases (GPxs), which are conserved antioxidant enzymes that catalyze the reduction of hydrogen peroxide and lipid hydroperoxides(2). Using genetic and pharmacological approaches in yeast, mammalian cells and Drosophila, we found that GPx activity robustly ameliorates Huntington's disease-relevant metrics and is more protective than other antioxidant approaches tested here. Notably, we found that GPx activity, unlike many antioxidant treatments, does not inhibit autophagy, which is an important mechanism for clearing mutant Htt. Because previous clinical trials have indicated that GPx mimetics are well tolerated in humans, this study may have important implications for treating Huntington's disease.	[Mason, Robert P.; Casu, Massimiliano; Butler, Nicola; Breda, Carlo; Campesan, Susanna; Clapp, Jannine; Green, Edward W.; Dhulkhed, Devyani; Kyriacou, Charalambos P.; Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Giorgini, F (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	fg36@le.ac.uk		Giorgini, Flaviano/0000-0001-7881-9508; Breda, Carlo/0000-0002-6365-9828	CHDI Foundation, Inc.; Huntington's Disease Association; Medical Research Council [G0700090]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/J005169/1] Funding Source: researchfish; BBSRC [BB/J005169/1] Funding Source: UKRI; MRC [G0700090] Funding Source: UKRI	CHDI Foundation, Inc.; Huntington's Disease Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the CHDI Foundation, Inc. and the Huntington's Disease Association to F. G. and C. P. K. J.C. was funded by a New Investigator Research Grant from the Medical Research Council to F. G. (G0700090), and M. C. was supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council. We thank S. Macip for assistance with the FACS analysis. We thank E. D. Lynch for useful discussions related to this study and A. Winslow for advice on the autophagy protocol. We are grateful to L. M. Thompson (University of California, Irvine) for providing the PC12 cell lines and P. Taghert (Washington University, St. Louis), J.L. Marsh (University of California, Irvine), L. M. Thompson and R. Mockett (University of South Alabama) for providing transgenic fly lines. We thank M. Sherman and A. Meriin (Boston University School of Medicine, Boston) for providing yeast Htt constructs.	Allebrandt KV, 2013, MOL PSYCHIATR, V18, P122, DOI 10.1038/mp.2011.142; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Jones BE, 2000, AM J PHYSIOL-GASTR L, V278, pG693, DOI 10.1152/ajpgi.2000.278.5.G693; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; KISH SJ, 1986, NEUROCHEM PATHOL, V4, P23, DOI 10.1007/BF02834296; Klepac N, 2007, J NEUROL, V254, P1676, DOI 10.1007/s00415-007-0611-y; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V383, P303, DOI 10.1006/abbi.2000.2093; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ridet JL, 2006, NEUROBIOL DIS, V21, P29, DOI 10.1016/j.nbd.2005.06.003; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; SAFAYHI H, 1985, BIOCHEM PHARMACOL, V34, P2691, DOI 10.1016/0006-2952(85)90569-6; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schwartz EK, 2012, MOL CELL BIOL, V32, P3065, DOI 10.1128/MCB.00547-12; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Smith SME, 2012, CHEM BIOL, V19, P752, DOI 10.1016/j.chembiol.2012.04.015; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Valencia A, 2013, HUM MOL GENET, V22, P1112, DOI 10.1093/hmg/dds516; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; ZEMBOWICZ A, 1993, J PHARMACOL EXP THER, V267, P1112; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	48	87	90	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1249	U209		10.1038/ng.2732	http://dx.doi.org/10.1038/ng.2732			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23974869	Green Accepted			2022-12-17	WOS:000324989600024
J	Steinberg, KM; Antonacci, F; Sudmant, PH; Kidd, JM; Campbell, CD; Vives, L; Malig, M; Scheinfeldt, L; Beggs, W; Ibrahim, M; Lema, G; Nyambo, TB; Omar, SA; Bodo, JM; Froment, A; Donnelly, MP; Kidd, KK; Tishkoff, SA; Eichler, EE				Steinberg, Karyn Meltz; Antonacci, Francesca; Sudmant, Peter H.; Kidd, Jeffrey M.; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Scheinfeldt, Laura; Beggs, William; Ibrahim, Muntaser; Lema, Godfrey; Nyambo, Thomas B.; Omar, Sabah A.; Bodo, Jean-Marie; Froment, Alain; Donnelly, Michael P.; Kidd, Kenneth K.; Tishkoff, Sarah A.; Eichler, Evan E.			Structural diversity and African origin of the 17q21.31 inversion polymorphism	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; ADULT DEPRESSION; SEGMENTAL DUPLICATIONS; PARKINSON-DISEASE; COMMON INVERSION; KANSL1 CAUSE; HAPLOTYPE; MAPT; GENE; ASSOCIATION	The 17q21.31 inversion polymorphism exists either as direct (H1) or inverted (H2) haplotypes with differential predispositions to disease and selection. We investigated its genetic diversity in 2,700 individuals, with an emphasis on African populations. We characterize eight structural haplotypes due to complex rearrangements that vary in size from 1.08-1.49 Mb and provide evidence for a 30-kb H1-H2 double recombination event. We show that recurrent partial duplications of the KANSL1 gene have occurred on both the H1 and H2 haplotypes and have risen to high frequency in European populations. We identify a likely ancestral H2 haplotype (H2') lacking these duplications that is enriched among African hunter-gatherer groups yet essentially absent from West African populations. Whereas H1 and H2 segmental duplications arose independently and before human migration out of Africa, they have reached high frequencies recently among Europeans, either because of extraordinary genetic drift or selective sweeps.	[Steinberg, Karyn Meltz; Antonacci, Francesca; Sudmant, Peter H.; Kidd, Jeffrey M.; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Scheinfeldt, Laura; Beggs, William; Tishkoff, Sarah A.] Univ Penn, Dept Genet & Biol, Philadelphia, PA 19104 USA; [Ibrahim, Muntaser] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi, Kenya; [Bodo, Jean-Marie] Musee Homme Paris, MNHN, IRD, Unite Mixte Rech UMR 208, Paris, France; [Froment, Alain] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Donnelly, Michael P.; Kidd, Kenneth K.] Yale Univ, Dept Genet, New Haven, CT USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Pennsylvania; University of Khartoum; Muhimbili University of Health & Allied Sciences; Kenya Medical Research Institute; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Yale University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Antonacci, Francesca/F-5457-2013	Antonacci, Francesca/0000-0002-5833-6186; Scheinfeldt, Laura/0000-0001-6529-6701; Kidd, Jeffrey/0000-0002-9631-1465; Meltz Steinberg, Karyn/0000-0002-8676-3337; Sudmant, Peter/0000-0002-9573-8248	Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington [T32HG00035]; individual NRSA Fellowship [F32GM097807, F32HG006070]; Natural Sciences and Engineering Research Council of Canada Fellowship; Ruth L. Kirschstein NRSA training grant to Stanford University [T32HG000044]; US National Institutes of Health [HG002385, HG004120]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, F32HG006070, T32HG000044, P01HG004120, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097807] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); individual NRSA Fellowship; Natural Sciences and Engineering Research Council of Canada Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ruth L. Kirschstein NRSA training grant to Stanford University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Akey, M. Dennis and B. Dumont for helpful discussions and C. Alkan for computational assistance. We thank Z. Jiang for his initial work on the H1-H2 alignments. We are grateful to T. Brown for assistance with manuscript preparation, to C. Lee for technical assistance and to the anonymous reviewers of this paper who provided insightful comments. We thank the 1000 Genomes Project Consortium for access to unpublished sequence data for the 17q21.31 locus. K.M.S. was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington (T32HG00035) and an individual NRSA Fellowship (F32GM097807). C.D.C. was supported by an individual NRSA Fellowship (F32HG006070). P.H.S. was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship. J.M.K. was supported by a Ruth L. Kirschstein NRSA training grant to Stanford University (T32HG000044). This work was supported by the US National Institutes of Health (grants HG002385 and HG004120 to E.E.E.). E.E.E. is an Investigator of the Howard Hughes Medical Institute.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Dobzhansky T, 1938, GENETICS, V23, P28; DOBZHANSKY T, 1950, GENETICS, V35, P288; Donnelly MP, 2010, AM J HUM GENET, V86, P161, DOI 10.1016/j.ajhg.2010.01.007; Dubourg C, 2011, EUR J MED GENET, V54, P144, DOI 10.1016/j.ejmg.2010.11.003; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Goudet J., 2001, CLADISTICS; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Igartua C, 2010, CURR PROTOC HUM GENE, V18; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu ZC, 2007, NEUROSCI LETT, V414, P155, DOI 10.1016/j.neulet.2006.12.013; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rao PN, 2010, CYTOGENET GENOME RES, V129, P275, DOI 10.1159/000315901; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tobin JE, 2008, NEUROLOGY, V71, P28, DOI 10.1212/01.wnl.0000304051.01650.23; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	60	87	87	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					872	+		10.1038/ng.2335	http://dx.doi.org/10.1038/ng.2335			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22751100	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000306854700010
J	Begus-Nahrmann, Y; Lechel, A; Obenauf, AC; Nalapareddy, K; Peit, E; Hoffmann, E; Schlaudraff, F; Liss, B; Schirmacher, P; Kestler, H; Danenberg, E; Barker, N; Clevers, H; Speicher, MR; Rudolph, KL				Begus-Nahrmann, Yvonne; Lechel, Andre; Obenauf, Anna C.; Nalapareddy, Kodandaramireddy; Peit, Elvira; Hoffmann, Eva; Schlaudraff, Falk; Liss, Birgit; Schirmacher, Peter; Kestler, Hans; Danenberg, Esther; Barker, Nick; Clevers, Hans; Speicher, Michael R.; Rudolph, K. Lenhard			p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice	NATURE GENETICS			English	Article							DNA-DAMAGE; HUMAN FIBROBLASTS; LIFE-SPAN; CANCER; SENESCENCE; MECHANISM; RESISTANT; LENGTH; GENE; AGE	Telomere dysfunction limits the proliferative capacity of human cells and induces organismal aging by activation of p53 and p21 (refs. 1-6). Although deletion of p21 elongates the lifespan of telomere-dysfunctional mice(2), a direct analysis of p53 in telomere-related aging has been hampered by early tumor formation in p53 knockout mice(6). Here we analyzed the functional consequences of conditional p53 deletion(7). Intestinal deletion of p53 shortened the lifespan of telomere-dysfunctional mice without inducing tumor formation. In contrast to p21 deletion, the deletion of p53 impaired the depletion of chromosomal-instable intestinal stem cells in aging telomere-dysfunctional mice. These instable stem cells contributed to epithelial regeneration leading to an accumulation of chromosomal instability, increased apoptosis, altered epithelial cell differentiation and premature intestinal failure. Together, these results provide the first experimental evidence for an organ system in which p53-dependent mechanisms prevent tissue destruction in response to telomere dysfunction by depleting genetically instable stem cells.	[Begus-Nahrmann, Yvonne; Lechel, Andre; Nalapareddy, Kodandaramireddy; Peit, Elvira; Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany; [Begus-Nahrmann, Yvonne; Lechel, Andre; Nalapareddy, Kodandaramireddy; Peit, Elvira; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, Ulm, Germany; [Obenauf, Anna C.; Hoffmann, Eva; Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Kestler, Hans] Univ Ulm, Inst Neuroinformat, Ulm, Germany; [Danenberg, Esther; Barker, Nick; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands	Ulm University; Max Planck Society; Ulm University; Medical University of Graz; Ulm University; Ruprecht Karls University Heidelberg; Ulm University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Rudolph, KL (corresponding author), Univ Ulm, Inst Mol Med, Ulm, Germany.	lenhard.rudolph@uni-ulm.de	Barker, Nick/AAE-9833-2021; Lechel, André/AAQ-2041-2021; Barker, Nick/A-5535-2011; Speicher, Michael R/B-5362-2013; Kestler, Hans A./D-5799-2012; Barker, Nick/AAS-2774-2020	Barker, Nick/0000-0003-3566-4475; Lechel, André/0000-0003-0221-6959; Speicher, Michael R/0000-0003-0105-955X; Kestler, Hans A./0000-0002-4759-5254; Danenberg, Esther/0000-0002-1799-4457; liss, Birgit/0000-0002-6733-9207; Rudolph, Karl Lenhard/0000-0002-4839-2862; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Obenauf, Anna/0000-0002-9556-5914	Deutsche Forschungsgemeinschaft [KFO 167, RU745/10-1]; Deutsche Krebshilfe e. V.; European Union [202230]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); European Union(European Commission)	We thank S. Robine (Institute Curie-CNRS, Paris) for providing villin-Cre-ERT2 mice and A. Berns (The Netherlands Cancer Institute, Amsterdam) for providing conditional p53 knockout mice. We thank J. Jonkers ((The Netherlands Cancer Institute, Amsterdam) for providing the BAC clones for chromosome FISH. We thank G. Schatz (German Cancer Research Center, Heidelberg) for providing selfmade Cre antibody. We thank C. Ganes for critical reading of the manuscript. This project was supported by funding from the Deutsche Forschungsgemeinschaft (KFO 167, RU745/10-1), by the Deutsche Krebshilfe e. V. (consortium grant on tumor stem cells) and by the European Union (GENINCA, Telomarker). K. L. R. and M. R. S. are both supported by the European Union (GENINCA, contract number 202230).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Flores I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004934; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Riboni R, 1997, CANCER GENET CYTOGEN, V95, P130, DOI 10.1016/S0165-4608(96)00248-8; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	31	87	87	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1138	U125		10.1038/ng.426	http://dx.doi.org/10.1038/ng.426			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718028				2022-12-17	WOS:000270330400020
J	Akey, JM; Biswas, S; Leek, JT; Storey, JD				Akey, Joshua M.; Biswas, Shameek; Leek, Jeffrey T.; Storey, John D.			On the design and analysis of gene expression studies in human populations	NATURE GENETICS			English	Letter									Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	akeyj@u.washington.edu; jstorey@u.washington.edu	Storey, John/B-5282-2011; Longo, Kenneth A/A-5631-2010	Biswas, Shameek/0000-0002-9372-1143; Storey, John/0000-0001-5992-402X; Leek, Jeffrey/0000-0002-2873-2671; Akey, Joshua/0000-0002-4411-1330	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002913] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002913] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017	6	87	92	3	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					807	808		10.1038/ng0707-807	http://dx.doi.org/10.1038/ng0707-807			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17597765				2022-12-17	WOS:000247619800002
J	Altman, RB				Altman, Russ B.			PharmGKB: a logical home for knowledge relating genotype to drug response phenotype	NATURE GENETICS			English	Letter									Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Altman, RB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	russ.altman@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM061374, U01GM061374] Funding Source: NIH RePORTER; NIGMS NIH HHS [R24 GM061374, U01 GM061374] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425	1	87	89	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					426	426		10.1038/ng0407-426	http://dx.doi.org/10.1038/ng0407-426			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17392795	Green Accepted			2022-12-17	WOS:000245271200003
J	Herman, H; Lu, M; Anggraini, M; Sikora, A; Chang, YJ; Yoon, BJ; Soloway, PD				Herman, H; Lu, M; Anggraini, M; Sikora, A; Chang, YJ; Yoon, BJ; Soloway, PD			Trans allele methylation and paramutation-like effects in mice	NATURE GENETICS			English	Article							DNA METHYLATION; IMPRINTED GENE; MOUSE; LOCUS; MAIZE; RASGRF1	In mammals, imprinted genes have parent-of-origin specific patterns of DNA methylation that cause allele-specific expression. At Rasgrf1 (encoding RAS protein-specific guanine nucleotide-releasing factor 1), a repeated DNA element is needed to establish methylation and expression of the active paternal allele(1). At Igf2r (encoding insulin-like growth factor 2 receptor), a sequence called region 2 is needed for methylation of the active maternal allele(2,3). Here we show that replacing the Rasgrf1 repeats on the paternal allele with region 2 allows both methylation and expression of the paternal copy of Rasgrf1, indicating that sequences that control methylation can function ectopically. Paternal transmission of the mutated allele also induced methylation and expression in trans of the normally unmethylated and silent wild-type maternal allele. Once activated, the wild-type maternal Rasgrf1 allele maintained its activated state in the next generation independently of the paternal allele. These results recapitulate in mice several features in common with paramutation described in plants(4).	Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Padjadjaran State Univ, Dept Orthopaed Surg, Sch Med, Sadikin Gen Hosp, Bandung, Indonesia	Cornell University; Roswell Park Cancer Institute; Universitas Padjadjaran	Soloway, PD (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.		Yoon, Bong June/L-7126-2017; Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437	NCI NIH HHS [R01 CA098597-01, R01 CA098597] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett ST, 1997, NAT GENET, V17, P350, DOI 10.1038/ng1197-350; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Hatada I, 1997, J BIOL CHEM, V272, P9120, DOI 10.1074/jbc.272.14.9120; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; KENNISON JA, 2002, ADV GENET, V46, P699; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; PATTERSON GI, 1993, GENETICS, V135, P881; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Walker EL, 1998, GENETICS, V148, P1973; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	22	87	94	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					199	202		10.1038/ng1162	http://dx.doi.org/10.1038/ng1162			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12740578	Green Accepted			2022-12-17	WOS:000183200500027
J	May, CA; Shone, AC; Kalaydjieva, L; Sajantila, A; Jeffreys, AJ				May, CA; Shone, AC; Kalaydjieva, L; Sajantila, A; Jeffreys, AJ			Crossover clustering and rapid decay of linkage disequilibrium in the Xp/Yp pseudoautosomal gene SHOX	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HIGH-RESOLUTION ANALYSIS; HUMAN SEX-CHROMOSOMES; RECOMBINATION HOTSPOT; TURNER-SYNDROME; SHORT STATURE; REGION; DIVERSITY; PATTERNS; POPULATIONS	Crossover between the human sex chromosomes during male meiosis is restricted to the terminal pseudoautosomal pairing regions. An obligatory exchange occurs in PAR1, an Xp/Yp pseudoautosomal region of 2.6 Mb, which creates a male-specific recombination 'hot domain' with a recombination rate that is about 20 times higher than the genome average(1-3). Low-resolution analysis of PART suggests that crossovers are distributed fairly randomly(4). By contrast, linkage disequilibrium (LD)(5) and sperm crossover analyses(6) indicate that crossovers in autosomal regions tend to duster into 'hot spots' of 1-2 kb that lie between islands of disequilibrium of tens to hundreds of kilobases(7). To determine whether at high resolution this autosomal pattern also applies to PAR1, we have examined linkage disequilibrium over an interval of 43 kb around the gene SHOX8. Here we show that in northern European populations, disequilibrium decays rapidly with physical distance, which is consistent with this interval of PAR1 being recombination ally active in male meiosis. Analysis of a subregion of 9.9 kb in sperm shows, however, that crossovers are not distributed randomly, but instead cluster into an intense recombination hot spot that is very similar in morphology to autosomal hot spots. Thus, PAR1 crossover activity may be influenced by male-specific hot spots that are highly suitable for characterization by sperm DNA analysis.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Edith Cowan Univ, Ctr Human Genet, Perth, WA, Australia; Western Australia Inst Med Res, Perth, WA, Australia; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland	University of Leicester; Edith Cowan University; University of Helsinki	May, CA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cam5@lc.ac.uk	Sajantila, Antti/AAY-9084-2021	May, Celia/0000-0001-8541-2458; Sajantila, Antti/0000-0003-4117-5248				BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LEWONTIN RC, 1964, GENETICS, V49, P49; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Morton N. E., 1982, OUTLINE GENETIC EPID; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Schiebel K, 2000, CYTOGENET CELL GENET, V91, P224, DOI 10.1159/000056849; SLATKIN M, 1994, GENETICS, V137, P331; SU A, 1996, NUCLEIC ACIDS RES, V24, P1574; SVED J A, 1971, Theoretical Population Biology, V2, P125; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	29	87	97	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					272	275		10.1038/ng918	http://dx.doi.org/10.1038/ng918			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089524				2022-12-17	WOS:000176494100014
J	Corda, Y; Schramke, V; Longhese, MP; Smokvina, T; Paciotti, V; Brevet, V; Gilson, E; Geli, V				Corda, Y; Schramke, V; Longhese, MP; Smokvina, T; Paciotti, V; Brevet, V; Gilson, E; Geli, V			Interaction between Set1p and checkpoint protein Mec3p in DNA repair and telomere functions	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; GROUP GENE ENHANCER; BUDDING YEAST; TRITHORAX; LENGTH; DAMAGE; REPLICATION; SIR4	The yeast protein Set1p, inactivation of which alleviates telomeric position effect (TPE), contains a conserved SET domain present in chromosomal proteins involved in epigenetic control of transcription(1-2). Mec3p is required for efficient DNA-damage-dependent checkpoints at G1/S, intra-S and G2/M (refs 3-7). We show here that the SET domain of Set1p interacts with Mec3p. Deletion of SET1 increases the viability of mec3 Delta mutants after DNA damage (in a process that is mostly independent of Rad53p kinase, which has a central role in checkpoint control(8-9)) but does not significantly affect cell-cycle progression. Deletion of MEC3 enhances TPE and attenuates the set1 Delta-induced silencing defect. Furthermore, restoration of TPE in a set1 Delta mutant by overexpression of the isolated SET domain requires Mec3p. Finally, deletion of MEC3 results in telomere elongation, whereas cells with deletions of both SET1 and MEC3 do not have elongated telomeres. Our findings indicate that interactions between SET1 and MEC3 have a role in DNA repair and telomere function.	CNRS, Lab Ingn & Dynam Syst Macromol, F-13402 Marseille 20, France; Univ Milan, Dipartimento Genet & Biol Micorganismi, I-20133 Milan, Italy; Ecole Normale Super Lyon, CNRS, UMR 8510, Biol Cellulaire & Mol Lab, F-69364 Lyon, France	Centre National de la Recherche Scientifique (CNRS); University of Milan; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Geli, V (corresponding author), CNRS, Lab Ingn & Dynam Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.		Pia, Maria/AAK-2693-2020	Longhese, Maria Pia/0000-0003-1726-2034				Adams AK, 1996, MOL CELL BIOL, V16, P4614; Allen JB, 1994, GENE DEV, V8, P2416; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Fairhead C, 1996, YEAST, V12, P1439; GOLEMIS EA, 1990, CURRENT PROTOCOLS MO, V27, P1; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; LONGHESE MP, 1996, MOL CELL BIOL, V16, P3225; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Shore D, 1998, SCIENCE, V281, P1818, DOI 10.1126/science.281.5384.1818; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748	30	87	93	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					204	208		10.1038/5991	http://dx.doi.org/10.1038/5991			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988274				2022-12-17	WOS:000078399500024
J	Hacia, JG; Makalowski, W; Edgemon, K; Erdos, MR; Robbins, CM; Fodor, SPA; Brody, LC; Collins, FS				Hacia, JG; Makalowski, W; Edgemon, K; Erdos, MR; Robbins, CM; Fodor, SPA; Brody, LC; Collins, FS			Evolutionary sequence comparisons using high-density oligonucleotide arrays	NATURE GENETICS			English	Article							HYBRIDIZATION; BRCA1; STRATEGY; GENES	We explored the utility of high-density oligonucleotide arrays (DNA chips) for obtaining sequence information from homologous genes in closely related species. Orthologues of the human BRCA1 exon 11, all approximately 3.4 kb in length and ranging from 98.2% to 83.5% nucleotide identity, were subjected to hybridization-based and conventional dideoxysequencing analysis. Retrospective guidelines for identifying high-fidelity hybridization-based sequence calls were formulated based upon dideoxysequencing results. Prospective application of these rules yielded base-calling with at least 98.8% accuracy over orthologous sequence tracts shown to have approximately 99% identity. For higher primate sequences with greater than 97% nucleotide identity, base-calling was made with at least 99.91% accuracy covering a minimum of 97% of the sequence. Using a second-tier confirmatory hybridization chip strategy, shown in several cases to confirm the identity of predicted sequence changes, the complete sequence of the chimpanzee. gorilla and orangutan orthologues should be deducible solely through hybridization-based methodologies. Analysis of less highly conserved orthologues can still identify conserved nucleotide tracts of at least 15 nucleotides and can provide useful information for designing primers. DNA-chip based assays can be a valuable new technology for obtaining high-throughput cost-effective sequence information from related genomes.	Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; Affymetrix, Santa Clara, CA 95051 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Affymetrix	Collins, FS (corresponding author), Natl Human Genome Res Inst, NIH, Bldg 49-3A14, Bethesda, MD 20892 USA.		Makalowski, Wojciech/I-2843-2016	Makalowski, Wojciech/0000-0003-2303-9541	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG001323] Funding Source: NIH RePORTER; NHGRI NIH HHS [5POLHGO1323-03] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BROUDE NE, 1994, P NATL ACAD SCI USA, V91, P3072, DOI 10.1073/pnas.91.8.3072; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.3.CO;2-D; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hoheisel JD, 1996, NUCLEIC ACIDS RES, V24, P430, DOI 10.1093/nar/24.3.430; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Li W.H., 1997, MOL EVOLUTION; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; McConkey EH, 1997, TRENDS GENET, V13, P350, DOI 10.1016/S0168-9525(97)01226-2; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner N, 1997, NAT BIOTECHNOL, V15, P537, DOI 10.1038/nbt0697-537; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Szabo CI, 1996, HUM MOL GENET, V5, P1289, DOI 10.1093/hmg/5.9.1289; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	19	87	109	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					155	158		10.1038/ng0298-155	http://dx.doi.org/10.1038/ng0298-155			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462745				2022-12-17	WOS:000071779500024
J	RICHARD, G; DELAURENZI, V; DIDONA, B; BALE, SJ; COMPTON, JG				RICHARD, G; DELAURENZI, V; DIDONA, B; BALE, SJ; COMPTON, JG			KERATIN-13 POINT MUTATION UNDERLIES THE HEREDITARY MUCOSAL EPITHELIA DISORDER WHITE SPONGE NEVUS	NATURE GENETICS			English	Note							EXPRESSION; PATTERNS		NIAMSD,SKIN BIOL LAB,BETHESDA,MD 20892; UNIV ROMA TOR VERGATA,DEPT EXPTL MED,BIOCHEM LAB,IRCCS,IST DERMOPATICO IMMACOLATA,I-00167 ROME,ITALY; IRCCS,IST DERMOPATICO IMMACOLATA,I-00167 ROME,ITALY	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI)			; De Laurenzi, Vincenzo/K-7471-2016	Didona, Biagio/0000-0001-6635-0490; De Laurenzi, Vincenzo/0000-0002-7506-1743				ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; ANNEROTH G, 1975, ACTA DERM-VENEREOL, V55, P387; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; FRITHIOF L, 1976, ORAL SURG ORAL MED O, V41, P607, DOI 10.1016/0030-4220(76)90313-3; JORGENSON RJ, 1981, ARCH DERMATOL, V117, P73, DOI 10.1001/archderm.117.2.73; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LINDBERG K, 1990, DIFFERENTIATION, V45, P230, DOI 10.1111/j.1432-0436.1990.tb00477.x; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Metz J, 1979, Z Hautkr, V54, P604; MISCHKE D, 1989, NUCLEIC ACIDS RES, V17, P7984, DOI 10.1093/nar/17.19.7984; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORRIS R, 1988, ACTA CYTOL, V32, P357; OTT J, 1985, ANAL HUMAN GENETIC L; PARRY DAD, 1995, INTERMEDIATE FILAMEN; RICHARD G, 1994, J INVEST DERMATOL, V103, P665, DOI 10.1111/1523-1747.ep12398429; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROMANO V, 1992, GENOMICS, V14, P495, DOI 10.1016/S0888-7543(05)80250-2; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1995, J INVEST DERMATOL, V104, P430, DOI 10.1111/1523-1747.ep12666018; ROTHNAGEL JA, 1990, SCIENCE, V257, P1128; RUGG EL, NAT GENET, V11, P450; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; STEINERT PM, 1990, CELLULAR MOL BIOL IN, P353; YOON SJ, 1994, GENOMICS, V24, P502, DOI 10.1006/geno.1994.1659	25	87	89	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					453	455		10.1038/ng1295-453	http://dx.doi.org/10.1038/ng1295-453			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493031	Green Published			2022-12-17	WOS:A1995TH62900028
J	VELINOV, M; SLAUGENHAUPT, SA; STOILOV, I; SCOTT, CI; GUSELLA, JF; TSIPOURAS, P				VELINOV, M; SLAUGENHAUPT, SA; STOILOV, I; SCOTT, CI; GUSELLA, JF; TSIPOURAS, P			THE GENE FOR ACHONDROPLASIA MAPS TO THE TELOMERIC REGION OF CHROMOSOME 4P	NATURE GENETICS			English	Article							L-IDURONIDASE GENE; HOMOZYGOUS ACHONDROPLASIA; CANDIDATE REGION; II COLLAGEN; LOCUS; IDENTIFICATION; LOCALIZATION; POLYMORPHISM; CARTILAGE; MARKERS	Achondroplasia is the most common type of genetic dwarfism. It is characterized by disproportionate short stature and other skeletal anomalies resulting from a defect in the maturation of the chondrocytes in the growth plate of the cartilage. We have now mapped the achondroplasia gene near the telomere of the short arm of chromosome 4 (4p16.3), by family linkage studies using 14 pedigrees. A positive lod score of z=3.35 with no recombinants was obtained with an intragenic marker for IDUA. This localization wilt facilitate the positional cloning of the disease gene.	UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06030; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; ALFRED I DUPONT INST,DIV MED GENET,WILMINGTON,DE 19899	University of Connecticut; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nemours Alfred I. duPont Hospital for Children								ALITTO BA, 1992, MOL CELL PROBE, V6, P513; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; Collins Colin, 1992, Human Molecular Genetics, V1, P727; CORDONE M, 1993, PRENATAL DIAG, V13, P395, DOI 10.1002/pd.1970130512; DUYAO MP, 1993, HUM MOL GENET, V2, P673, DOI 10.1093/hmg/2.6.673; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; FRANCOMANO CA, 1988, AM J MED GENET, V29, P955, DOI 10.1002/ajmg.1320290433; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; HECHT JT, 1987, AM J HUM GENET, V41, P454; LANDER E, 1987, P NATL ACAD SCI USA, V85, P2363; LANGER LO, 1993, AM J MED GENET, V47, P772, DOI 10.1002/ajmg.1320470535; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; LOCKE PA, 1993, SOMAT CELL MOLEC GEN, V19, P95, DOI 10.1007/BF01233958; MACDONALD ME, 1991, SOMAT CELL MOLEC GEN, V17, P421, DOI 10.1007/BF01233067; MAGENIS RE, 1986, AM J HUM GENET, V39, P383; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MURRAY J, 1993, COOPERATIVE HUMAN LI, V1; OGILVIE D, 1986, J MED GENET, V23, P19, DOI 10.1136/jmg.23.1.19; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PAULI RM, 1983, AM J MED GENET, V16, P459, DOI 10.1002/ajmg.1320160404; PEDRINIMILLE A, 1982, J BONE JOINT SURG AM, V64, P39, DOI 10.2106/00004623-198264010-00007; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P161; SCOTT, 1988, CIBA GEIGY CLIN S, V40, P3; SCOTT HS, 1992, GENOMICS, V14, P1118, DOI 10.1016/S0888-7543(05)80145-4; SCOTT HS, 1990, AM J HUM GENET, V47, P802; SCOTT HS, 1993, AM J HUM GENET, V53, P973; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STANESCU R, 1990, AM J MED GENET, V37, P412, DOI 10.1002/ajmg.1320370323; SWEETMAN WA, 1992, AM J HUM GENET, V51, P841; Taylor S. A. M., 1992, Human Molecular Genetics, V1, P142, DOI 10.1093/hmg/1.2.142-a; TAYLOR SAM, 1992, NAT GENET, V2, P223, DOI 10.1038/ng1192-223; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TOMMERUP N, 1993, HUM MOL GENET, V2, P1571, DOI 10.1093/hmg/2.10.1571; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WANG H, 1986, AM J HUM GENET, V39, P393; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WEBER B, 1992, AM J HUM GENET, V47, P382; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	41	87	88	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					314	317		10.1038/ng0394-314	http://dx.doi.org/10.1038/ng0394-314			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012397				2022-12-17	WOS:A1994MZ56200022
J	RUGG, EL; MORLEY, SM; SMITH, FJD; BOXER, M; TIDMAN, MJ; NAVSARIA, H; LEIGH, IM; LANE, EB				RUGG, EL; MORLEY, SM; SMITH, FJD; BOXER, M; TIDMAN, MJ; NAVSARIA, H; LEIGH, IM; LANE, EB			MISSING LINKS - WEBER-COCKAYNE KERATIN MUTATIONS IMPLICATE THE L12 LINKER DOMAIN IN EFFECTIVE CYTOSKELETON FUNCTION	NATURE GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; AMINO-ACID-SEQUENCE; POLYMORPHIC KERATINS; SECONDARY-STRUCTURE; EXPRESSION; PCR; HYPERKERATOSIS; AMPLIFICATION; SEGREGATION; PATTERNS	We have identified mutations in keratins K5 (Arg331Cys) and K14 (Val270Met) in two kinships affected by the dominantly-inherited skin blistering disease, Weber-Cockayne epidermolysis bullosa simplex (EBS-WC). Linkage analysis, DNA sequencing and clinical and ultrastructural analysis are combined to provide the first detailed description of classical EBS-WC. Both phenotypes show similar blistering on trauma, indicating that both mutations compromise the structural resilience of the basal keratinocytes by affecting the keratin cytoskeleton. The location of these mutations in the L12 linker, which bisects the alpha-helical rod region of intermediate filament proteins, identifies another keratin mutation cluster leading to hereditary skin fragility syndromes.	EDINBURGH ROYAL INFIRM,DEPT DERMATOL,EDINBURGH EH3 9YW,SCOTLAND; NINEWELLS HOSP,DEPT PATHOL,MED GENET GRP,DUNDEE DD1 9SY,SCOTLAND; ROYAL LONDON HOSP,COLL MED,EXPTL DERMATOL LABS,LONDON E1 6BL,ENGLAND	Royal Infirmary of Edinburgh; University of Dundee; Barts Health NHS Trust; Royal London Hospital	RUGG, EL (corresponding author), UNIV DUNDEE,INST MED SCI,DEPT ANAT & PHYSIOL,CANC RES CAMPAIGN LABS,CRC CELL STRUCT RES GRP,DUNDEE DD1 4HN,SCOTLAND.							ANTONLAMPRECHT I, 1982, DERMATOLOGICA, V164, P221, DOI 10.1159/000250096; BAKER R, 1991, NUCLEIC ACIDS RES, V19, P4315, DOI 10.1093/nar/19.15.4315; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BONIFAS JM, 1992, J INVEST DERMATOL, V98, pA573; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P621; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; COULOMBE PA, 1990, J CELL BIOL; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEDDEDAHL T, 1990, MANAG BLISTERING DIS, V1, P189; GILL SR, 1990, J CELL BIOL, V111; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HOYHEIM B, 1992, J INVEST DERMATOL, V98, pA397; HUMPHRIES MM, 1993, HUM MUTAT, V2, P37, DOI 10.1002/humu.1380020107; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KORGE BP, 1992, J INVEST DERMATOL, V99, P697, DOI 10.1111/1523-1747.ep12614149; Lane E B, 1990, Semin Cancer Biol, V1, P165; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179; MCCORMICK MB, 1991, J CELL BIOL, V113, P1111, DOI 10.1083/jcb.113.5.1111; MCLEAN WHI, 1993, J INVEST DERMATOL, V100, P516; MCLEAN WHI, 1992, HUM MOL GENET, V1, P659, DOI 10.1093/hmg/1.8.659-a; MISCHKE D, 1987, J INVEST DERMATOL, V88, P191, DOI 10.1111/1523-1747.ep12525329; MISCHKE D, 1990, AM J HUM GENET, V46, P548; NIEMI KM, 1983, ARCH DERMATOL, V119, P138, DOI 10.1001/archderm.119.2.138; PRIESTLEY L, 1990, HUM GENET, V85, P525; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; RUGG E, IN PRESS BRIT J DERM; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sambrook J., 1989, MOL CLONING LAB MANU; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1993, J MOL BIOL; WANNER R, 1993, J INVEST DERMATOL; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WILD GA, 1986, EXP CELL RES, V162, P114, DOI 10.1016/0014-4827(86)90430-1	45	87	89	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					294	300		10.1038/ng1193-294	http://dx.doi.org/10.1038/ng1193-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7506097				2022-12-17	WOS:A1993MF12200023
J	INGLEHEARN, CF; CARTER, SA; KEEN, TJ; LINDSEY, J; STEPHENSON, AM; BASHIR, R; ALMAGHTHEH, M; MOORE, AT; JAY, M; BIRD, AC; BHATTACHARYA, SS				INGLEHEARN, CF; CARTER, SA; KEEN, TJ; LINDSEY, J; STEPHENSON, AM; BASHIR, R; ALMAGHTHEH, M; MOORE, AT; JAY, M; BIRD, AC; BHATTACHARYA, SS			A NEW LOCUS FOR AUTOSOMAL-DOMINANT RETINITIS-PIGMENTOSA ON CHROMOSOME-7P	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; GENE; MUTATIONS	Autosomal dominant retinitis pigmentosa (adRP) is known to result from mutations in two different retinal genes-rhodopsin and peripherin-while a third locus has been implicated by linkage data. However, families have been reported in which all three known loci have been excluded. We report linkage of adRP in one such family to two microsatellite markers on chromosome 7p. D7S435 has previously been localized to 7p13-15.1; D7S460, previously only localized to chromosome 7, maps to within 2 cM of D7S435 with a lod score of 12.15. Two point linkage analysis between these markers and adRP gave lod scores of 5.65 (theta = 0) and 4.19 (theta = 0.046) for D7S460 and D7S435, respectively. Multipoint analysis gave a maximum lod score of 8.22. These data strongly suggest a new adRP locus on chromosome 7p.	NEWCASTLE UNIV,DEPT HUMAN GENET,NEWCASTLE TYNE NE4 2AJ,ENGLAND; INST OPHTHALMOL,DEPT CLIN OPHTHALMOL,LONDON EC1V 2PD,ENGLAND; MOORFIELDS EYE HOSP,LONDON EC1V 2PD,ENGLAND	Newcastle University - UK; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	INGLEHEARN, CF (corresponding author), INST OPHTHALMOL,DEPT MOLEC GENET,BATH ST,LONDON EC1V 9EL,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BASHIR R, 1992, GENOMICS, V14, P191, DOI 10.1016/S0888-7543(05)80306-4; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P226; BIRD AC, 1988, AUST NZ J OPHTHALMOL, V16, P189, DOI 10.1111/j.1442-9071.1988.tb01209.x; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; JAY M, 1992, J MED GENET, V29, P906, DOI 10.1136/jmg.29.12.906; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESTER DH, 1990, AM J HUM GENET, V47, P536; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MASSOF RW, 1981, DOC OPHTHALMOL, V51, P289, DOI 10.1007/BF00143336; MISHRA SK, 1992, GENOMICS, V12, P326, DOI 10.1016/0888-7543(92)90381-2; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; MOORE AT, 1987, OPHTHAL S, V28, P3; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; ZHENG K, 1992, AM J HUM GENET S, V51, P986	25	87	88	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					51	53		10.1038/ng0593-51	http://dx.doi.org/10.1038/ng0593-51			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513323				2022-12-17	WOS:A1993LA33700012
J	Avsec, Z; Weilert, M; Shrikumar, A; Krueger, S; Alexandari, A; Dalal, K; Fropf, R; McAnany, C; Gagneur, J; Kundaje, A; Zeitlinger, J				Avsec, Ziga; Weilert, Melanie; Shrikumar, Avanti; Krueger, Sabrina; Alexandari, Amr; Dalal, Khyati; Fropf, Robin; McAnany, Charles; Gagneur, Julien; Kundaje, Anshul; Zeitlinger, Julia			Base-resolution models of transcription-factor binding reveal soft motif syntax	NATURE GENETICS			English	Article							CIS-REGULATORY MODULES; EMBRYONIC STEM-CELLS; CHIP-SEQ EXPERIMENTS; GENE-EXPRESSION; SELF-RENEWAL; ENHANCER-BINDING; DNA; ELEMENTS; NANOG; SOX2	The arrangement (syntax) of transcription factor (TF) binding motifs is an important part of the cis-regulatory code, yet remains elusive. We introduce a deep learning model, BPNet, that uses DNA sequence to predict base-resolution chromatin immunoprecipitation (ChIP)-nexus binding profiles of pluripotency TFs. We develop interpretation tools to learn predictive motif representations and identify soft syntax rules for cooperative TF binding interactions. Strikingly, Nanog preferentially binds with helical periodicity, and TFs often cooperate in a directional manner, which we validate using clustered regularly interspaced short palindromic repeat (CRISPR)-induced point mutations. Our model represents a powerful general approach to uncover the motifs and syntax of cis-regulatory sequences in genomics data.	[Avsec, Ziga; Gagneur, Julien] Tech Univ Munich, Dept Informat, Garching, Germany; [Avsec, Ziga] Ludwig Maximilians Univ Munchen, Grad Sch Quantitat Biosci, Munich, Germany; [Weilert, Melanie; Krueger, Sabrina; Dalal, Khyati; Fropf, Robin; McAnany, Charles; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shrikumar, Avanti; Alexandari, Amr; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Dalal, Khyati; Zeitlinger, Julia] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Avsec, Ziga] DeepMind, London, England	Technical University of Munich; University of Munich; Stowers Institute for Medical Research; Stanford University; University of Kansas; University of Kansas Medical Center; Stanford University	Zeitlinger, J (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Kundaje, A (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Zeitlinger, J (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.; Kundaje, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	akundaje@stanford.edu; jbz@stowers.org		Kundaje, Anshul/0000-0003-3084-2287; Gagneur, Julien/0000-0002-8924-8365				Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avsec Z, 2019, NAT BIOTECHNOL, V37, P592, DOI 10.1038/s41587-019-0140-0; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bar-Joseph Z, 2001, BIOINFORMATICS S1, V17, pS22, DOI [10.1093/bioinformatics/17.suppl_1.S22, DOI 10.1093/BIOINFORMATICS/17.SUPPL_1.S22]; Bogard N, 2019, CELL, V178, P91, DOI 10.1016/j.cell.2019.04.046; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Cai HN, 1996, P NATL ACAD SCI USA, V93, P9309, DOI 10.1073/pnas.93.18.9309; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Q, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003571; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chollet F., 2015, KERAS, DOI DOI 10.1038/NATURE083580; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Crocker J, 2017, CURR OPIN GENET DEV, V47, P91, DOI 10.1016/j.gde.2017.09.001; Cui F, 2014, NUCLEIC ACIDS RES, V42, P836, DOI 10.1093/nar/gkt943; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erceg J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004060; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Festuccia N, 2018, EMBO J, V37, DOI 10.15252/embj.201695476; Fiore C, 2016, GENOME RES, V26, P778, DOI 10.1101/gr.200733.115; Friman ET, 2019, ELIFE, V8, DOI 10.7554/eLife.50087; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghosh RP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11118-8; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Greenside P, 2018, BIOINFORMATICS, V34, P629, DOI 10.1093/bioinformatics/bty575; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hartonen T, 2016, BIOINFORMATICS, V32, P629, DOI 10.1093/bioinformatics/btw448; Hayashi Y, 2015, P NATL ACAD SCI USA, V112, P4666, DOI 10.1073/pnas.1502855112; He K., 2016, 2016 IEEE C COMP VIS, DOI DOI 10.1109/CVPR.2016.90; He QY, 2015, NAT BIOTECHNOL, V33, P395, DOI 10.1038/nbt.3121; He X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008155; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Istrail S, 2019, J COMPUT BIOL, V26, P653, DOI 10.1089/cmb.2019.0144; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Jankowski A, 2013, GENOME RES, V23, P1307, DOI 10.1101/gr.154922.113; Jha A., 2019, IMPROVING INTERPRETA, DOI [10.1101/700096, DOI 10.1101/700096]; Jin H, 2016, NUCLEIC ACIDS RES, V44, P2047, DOI 10.1093/nar/gkw101; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kelley DR, 2018, GENOME RES, V28, P739, DOI 10.1101/gr.227819.117; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; King DM, 2020, ELIFE, V9, DOI 10.7554/eLife.41279; Kingma D. P, 2014, 3 INT C LEARN REPR; KLEMENZ R, 1982, P NATL ACAD SCI-BIOL, V79, P6191, DOI 10.1073/pnas.79.20.6191; Koenecke N, 2017, GENOME RES, V27, P64, DOI 10.1101/gr.209486.116; Kuan PF, 2011, J AM STAT ASSOC, V106, P891, DOI 10.1198/jasa.2011.ap09706; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Labuhn M, 2018, NUCLEIC ACIDS RES, V46, P1375, DOI 10.1093/nar/gkx1268; Lanchantin J, 2017, BIOCOMPUT-PAC SYM, P254, DOI 10.1142/9789813207813_0025; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI Q, 1995, MOL CELL BIOL, V15, P4375; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002796; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lusk RW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000829; Mariani L, 2017, CELL SYST, V5, P187, DOI 10.1016/j.cels.2017.06.015; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Merino F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004287; Mistri TK, 2018, BIOCHEM J, V475, P1075, DOI 10.1042/BCJ20170418; Mistri TK, 2015, EMBO REP, V16, P1177, DOI 10.15252/embr.201540467; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moorthy SD, 2017, GENOME RES, V27, P246, DOI 10.1101/gr.210930.116; Morgunova E, 2017, CURR OPIN STRUC BIOL, V47, P1, DOI 10.1016/j.sbi.2017.03.006; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Mullins NP, 2017, J MOL BIOL, V429, P1544, DOI 10.1016/j.jmb.2016.12.001; Ng FSL, 2014, NUCLEIC ACIDS RES, V42, P13513, DOI 10.1093/nar/gku1254; Novo CL, 2018, CELL REP, V22, P2615, DOI 10.1016/j.celrep.2018.02.040; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Papagianni A, 2018, P NATL ACAD SCI USA, V115, P1807, DOI 10.1073/pnas.1713930115; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Quang D, 2019, METHODS, V166, P40, DOI 10.1016/j.ymeth.2019.03.020; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sayal R, 2016, ELIFE, V5, DOI 10.7554/eLife.08445; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shrikumar A, 2017, PMLR, V70, P3145, DOI DOI 10.1145/3292500.3330701; Shrikumar A, 2018, TF MODISCO V0 4 2 AL; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sun YJ, 2015, GENOME RES, V25, P1703, DOI 10.1101/gr.192542.115; Sundaram V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14550; Suryamohan K, 2015, WIRES DEV BIOL, V4, P59, DOI 10.1002/wdev.168; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Terooatea TW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw741; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Todd CD, 2019, ELIFE, V8, DOI 10.7554/eLife.44344; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Tseng A, 2020, ADV NEURAL INFORM PR, V33, P491, DOI [10.1101/2020.06.11.147272, DOI 10.1101/2020.06.11.147272]; van den Oord Aaron, 2016, ABS160903499 ARXIV; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Winter DR, 2013, GENOME RES, V23, P1118, DOI 10.1101/gr.150482.112; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Xie LQ, 2017, GENE DEV, V31, P1795, DOI 10.1101/gad.303321.117; Yamada N, 2019, BIOINFORMATICS, V35, P903, DOI 10.1093/bioinformatics/bty703; Yardimci GG, 2014, NUCLEIC ACIDS RES, V42, P11865, DOI 10.1093/nar/gku810; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong JL, 2016, GENOME RES, V26, P351, DOI 10.1101/gr.195602.115; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhu FJ, 2018, NATURE, V562, P76, DOI 10.1038/s41586-018-0549-5; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	135	86	86	8	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2021	53	3					354	+		10.1038/s41588-021-00782-6	http://dx.doi.org/10.1038/s41588-021-00782-6		FEB 2021	27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QT6UK	33603233	Green Accepted, Green Submitted			2022-12-17	WOS:000619509800001
J	van Arensbergen, J; Pagie, L; FitzPatrick, VD; de Haas, M; Baltissen, MP; Comoglio, F; van der Weide, RH; Teunissen, H; Vosa, U; Franke, L; de Wit, E; Vermeulen, M; Bussemaker, HJ; van Steensel, B				van Arensbergen, Joris; Pagie, Ludo; FitzPatrick, Vincent D.; de Haas, Marcel; Baltissen, Marijke P.; Comoglio, Federico; van der Weide, Robin H.; Teunissen, Hans; Vosa, Urmo; Franke, Lude; de Wit, Elzo; Vermeulen, Michiel; Bussemaker, Harmen J.; van Steensel, Bas			High-throughput identification of human SNPs affecting regulatory element activity	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-BINDING; GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; CHROMATIN STATES; READ ALIGNMENT; COMPLEX TRAITS; DNA-BINDING; PROMOTER; VARIANTS; DATABASE	Most of the millions of SNPs in the human genome are non-coding, and many overlap with putative regulatory elements. Genome-wide association studies (GWAS) have linked many of these SNPs to human traits or to gene expression levels, but rarely with sufficient resolution to identify the causal SNPs. Functional screens based on reporter assays have previously been of insufficient throughput to test the vast space of SNPs for possible effects on regulatory element activity. Here we leveraged the throughput and resolution of the survey of regulatory elements (SuRE) reporter technology to survey the effect of 5.9 million SNPs, including 57% of the known common SNPs, on enhancer and promoter activity. We identified more than 30,000 SNPs that alter the activity of putative regulatory elements, partially in a cell-type-specific manner. Integration of this dataset with GWAS results may help to pinpoint SNPs that underlie human traits.	[van Arensbergen, Joris; Pagie, Ludo; de Haas, Marcel; Comoglio, Federico; van der Weide, Robin H.; Teunissen, Hans; de Wit, Elzo; van Steensel, Bas] Netherlands Canc Inst, Oncode Inst, Div Gene Regulat, Amsterdam, Netherlands; [FitzPatrick, Vincent D.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [FitzPatrick, Vincent D.; Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Baltissen, Marijke P.; Vermeulen, Michiel] Radboud Univ Nijmegen, Dept Mol Biol, Oncode Inst, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Comoglio, Federico] Univ Cambridge, Dept Haematol, Cambridge, England; [Vosa, Urmo; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Vosa, Urmo] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia	Netherlands Cancer Institute; Columbia University; Columbia University; Radboud University Nijmegen; University of Cambridge; University of Groningen; University of Tartu	van Arensbergen, J; van Steensel, B (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Gene Regulat, Amsterdam, Netherlands.	joris.van.arensbergen@gmail.com; b.v.steensel@nki.nl	Vermeulen, Michiel/C-8883-2013; van der Weide, Robin H./GLV-1335-2022; Võsa, Urmo/AAJ-5928-2020	Vermeulen, Michiel/0000-0003-0836-6894; Võsa, Urmo/0000-0003-3476-1652; van der Weide, Robin Harm/0000-0002-6466-7280; de Wit, Elzo/0000-0003-2883-1415	ERC [694466, 637587]; NIH [R01HG003008]; Columbia University's Vagelos Precision Medicine Pilot Program; Swiss National Science Foundation postdoctoral fellowship [P2EZP3_165206]; Dutch Cancer Society (KWF); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University's Vagelos Precision Medicine Pilot Program; Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the NKI Genomics Core Facility and Research IT team for technical support, the RHPC facility of the Netherlands Cancer Institute for providing computational resources and members of our laboratories for helpful discussions. Supported by ERC Advanced Grant no. 694466 (to B.v.S.); ERC Starting Grant no. 637587 (to E.d.W.); NIH grant no. R01HG003008 and Columbia University's Vagelos Precision Medicine Pilot Program (to H.J.B.). F.C. was supported by a Swiss National Science Foundation postdoctoral fellowship (no. P2EZP3_165206). J.v.A., L.P., M.d.H., M.P.B., F.C., R.H.v.d.W., H.T., E.d.W., M.V. and B.v.S. are part of the Oncode Institute, which is partly funded by the Dutch Cancer Society (KWF).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen ZS, 2005, MOL PHARMACOL, V67, P545, DOI 10.1124/mol.104.007138; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edge P, 2017, GENOME RES, V27, P801, DOI 10.1101/gr.213462.116; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Gate RE, 2018, NAT GENET, V50, P1140, DOI 10.1038/s41588-018-0156-2; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064; La Corte ALC, 2011, HUM MUTAT, V32, P1326, DOI 10.1002/humu.21579; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1322-z; Liu X, 2017, CELL, V170, P1028, DOI 10.1016/j.cell.2017.08.003; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Makowski MM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04084-0; Makowski MM, 2016, PROTEOMICS, V16, P417, DOI 10.1002/pmic.201500327; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Maslah N, 2017, LEUKEMIA, V31, P1661, DOI 10.1038/leu.2017.139; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Miguel-Escalada I, 2015, CURR OPIN GENET DEV, V33, P71, DOI 10.1016/j.gde.2015.08.009; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Nguyen TA, 2016, GENOME RES, V26, P1023, DOI 10.1101/gr.204834.116; Nishizaki SS, 2017, TRENDS GENET, V33, P34, DOI 10.1016/j.tig.2016.10.008; Sawai H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26217-7; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; van Arensbergen J, 2017, NAT BIOTECHNOL, V35, P145, DOI 10.1038/nbt.3754; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Wen J, 2015, MOL CARCINOGEN, V54, P1275, DOI 10.1002/mc.22200; Westerink WMA, 2010, MUTAT RES-GEN TOX EN, V696, P21, DOI 10.1016/j.mrgentox.2009.12.007; Zhang P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04451-x; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6	56	86	86	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2019	51	7					1160	+		10.1038/s41588-019-0455-2	http://dx.doi.org/10.1038/s41588-019-0455-2			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG0PF	31253979	Green Accepted, Green Submitted			2022-12-17	WOS:000473491900015
J	Alvarez, MJ; Subramaniam, PS; Tang, LH; Grunn, A; Aburi, M; Rieckhof, G; Komissarova, EV; Hagan, EA; Bodei, L; Clemons, PA; Dela Cruz, FS; Dhall, D; Diolaiti, D; Fraker, DA; Ghavami, A; Kaemmerer, D; Karan, C; Kidd, M; Kim, KM; Kim, HC; Kunju, LP; Langel, U; Li, Z; Lee, J; Li, H; LiVolsi, V; Pfragner, R; Rainey, AR; Realubit, RB; Remotti, H; Regberg, J; Roses, R; Rustgi, A; Sepulveda, AR; Serra, S; Shi, CJ; Yuan, XP; Barberis, M; Bergamaschi, R; Chinnaiyan, AM; Detre, T; Ezzat, S; Frilling, A; Hommann, M; Jaeger, D; Kim, MK; Knudsen, BS; Kung, AL; Leahy, E; Metz, DC; Milsom, JW; Park, YS; Reidy-Lagunes, D; Schreiber, S; Washington, K; Wiedenmann, B; Modlin, I; Califano, A				Alvarez, Mariano J.; Subramaniam, Prem S.; Tang, Laura H.; Grunn, Adina; Aburi, Mahalaxmi; Rieckhof, Gabrielle; Komissarova, Elena V.; Hagan, Elizabeth A.; Bodei, Lisa; Clemons, Paul A.; Dela Cruz, Filemon S.; Dhall, Deepti; Diolaiti, Daniel; Fraker, Douglas A.; Ghavami, Afshin; Kaemmerer, Daniel; Karan, Charles; Kidd, Mark; Kim, Kyoung M.; Kim, Hee C.; Kunju, Lakshmi P.; Langel, Ulo; Li, Zhong; Lee, Jeeyun; Li, Hai; LiVolsi, Virginia; Pfragner, Roswitha; Rainey, Allison R.; Realubit, Ronald B.; Remotti, Helen; Regberg, Jakob; Roses, Robert; Rustgi, Anil; Sepulveda, Antonia R.; Serra, Stefano; Shi, Chanjuan; Yuan, Xiaopu; Barberis, Massimo; Bergamaschi, Roberto; Chinnaiyan, Arul M.; Detre, Tony; Ezzat, Shereen; Frilling, Andrea; Hommann, Merten; Jaeger, Dirk; Kim, Michelle K.; Knudsen, Beatrice S.; Kung, Andrew L.; Leahy, Emer; Metz, David C.; Milsom, Jeffrey W.; Park, Young S.; Reidy-Lagunes, Diane; Schreiber, Stuart; Washington, Kay; Wiedenmann, Bertram; Modlin, Irvin; Califano, Andrea			A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors	NATURE GENETICS			English	Article							REGULATORY NETWORKS; DRUG-SENSITIVITY; PROSTATE-CANCER; BREAST-CANCER; CELL-LINE; B-CELLS; BIOLOGY; GENES; ESTABLISHMENT; PROGRESSION	We introduce and validate a new precision oncology framework for the systematic prioritization of drugs targeting mechanistic tumor dependencies in individual patients. Compounds are prioritized on the basis of their ability to invert the concerted activity of master regulator proteins that mechanistically regulate tumor cell state, as assessed from systematic drug perturbation assays. We validated the approach on a cohort of 212 gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a rare malignancy originating in the pancreas and gastrointestinal tract. The analysis identified several master regulator proteins, including key regulators of neuroendocrine lineage progenitor state and immunoevasion, whose role as critical tumor dependencies was experimentally confirmed. Transcriptome analysis of GEP-NET-derived cells, perturbed with a library of 107 compounds, identified the HDAC class I inhibitor entinostat as a potent inhibitor of master regulator activity for 42% of metastatic GEP-NET patients, abrogating tumor growth in vivo. This approach may thus complement current efforts in precision oncology.	[Alvarez, Mariano J.; Subramaniam, Prem S.; Grunn, Adina; Aburi, Mahalaxmi; Komissarova, Elena V.; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY USA; [Alvarez, Mariano J.] DarwinHealth Inc, New York, NY USA; [Tang, Laura H.; Bodei, Lisa; Reidy-Lagunes, Diane] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Rieckhof, Gabrielle] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY USA; [Hagan, Elizabeth A.] Columbia Univ, Dept Urol, New York, NY USA; [Bodei, Lisa; Barberis, Massimo] European Inst Oncol, Div Pathol, Milan, Italy; [Clemons, Paul A.; Schreiber, Stuart] Broad Inst Harvard & MIT, Cambridge, MA USA; [Dela Cruz, Filemon S.; Diolaiti, Daniel; Rainey, Allison R.; Kung, Andrew L.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Dhall, Deepti; Yuan, Xiaopu; Knudsen, Beatrice S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Fraker, Douglas A.; LiVolsi, Virginia; Roses, Robert; Rustgi, Anil; Metz, David C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ghavami, Afshin; Leahy, Emer] PsychoGenics Inc, Tarrytown, NY USA; [Kaemmerer, Daniel; Hommann, Merten] Zent Klin, Dept Gen & Visceral Surg, Bad Berka, Germany; [Karan, Charles; Li, Hai; Realubit, Ronald B.] Columbia Univ, Sulzberger Columbia Genome Ctr, New York, NY USA; [Kidd, Mark] Wren Labs, Branford, CT USA; [Kim, Kyoung M.; Kim, Hee C.; Lee, Jeeyun; Park, Young S.] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Div Hematol Oncol,Sch Med, Seoul, South Korea; [Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kunju, Lakshmi P.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Langel, Ulo; Regberg, Jakob] Stockholm Univ, Dept Neurochem, Arrhenius Labs Nat Sci, Stockholm, Sweden; [Langel, Ulo] Univ Tartu, Inst Technol, Lab Mol Biotechnol, Tartu, Estonia; [Li, Zhong; Detre, Tony] Falconwood Fdn, New York, NY USA; [Pfragner, Roswitha] Med Univ Graz, Inst Pathophysiol & Immunol, Graz, Austria; [Remotti, Helen; Sepulveda, Antonia R.] Columbia Univ, Dept Pathol, New York, NY USA; [Serra, Stefano; Ezzat, Shereen] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Shi, Chanjuan; Washington, Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Bergamaschi, Roberto] SUNY Stony Brook, Div Colon & Rectal Surg, Stony Brook, NY 11794 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Frilling, Andrea] Imperial Coll London, London, England; [Jaeger, Dirk] Univ Med Ctr Heidelberg, Natl Ctr Tumor Dis Heidelberg, Med Oncol, Heidelberg, Germany; [Kim, Michelle K.] Mt Sinai Sch Med, New York, NY USA; [Milsom, Jeffrey W.] New York Presbyterian Hosp, Weill Cornell Med, Dept Surg, New York, NY USA; [Schreiber, Stuart] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wiedenmann, Bertram] Charite Univ Med Berlin, Div Gastroenterol, Dept Internal Med, Berlin, Germany; [Modlin, Irvin] Yale Univ, Sch Med, Gastrointestinal Surg, New Haven, CT 06520 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, JP Sulzberger Columbia Genome Ctr, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Memorial Sloan Kettering Cancer Center; New York University; NYU Langone Medical Center; Columbia University; IRCCS European Institute of Oncology (IEO); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Cedars Sinai Medical Center; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stockholm University; University of Tartu; Medical University of Graz; Columbia University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Imperial College London; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; Cornell University; NewYork-Presbyterian Hospital; Harvard University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Yale University; Columbia University; Columbia University; Columbia University; Columbia University	Modlin, I (corresponding author), Yale Univ, Sch Med, Gastrointestinal Surg, New Haven, CT 06520 USA.	imodlin@irvinmodlin.com; califano@cumc.columbia.edu	Bodei, Lisa/AAE-9798-2020; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Remotti, Helen/AAA-1671-2020; Barberis, Massimo/AAL-5446-2020; Lee, Jee Yun/C-9646-2011	Kung, Andrew L/0000-0002-9091-488X; Remotti, Helen/0000-0003-1555-9299; Califano, Andrea/0000-0003-4742-3679; Langel, Ulo/0000-0001-6107-0844; Komissarova, Elena V./0000-0001-6848-0635; Wiedenmann, Bertram/0000-0002-7890-2552	Falconwood Foundation; National Cancer Institute (NCI) Cancer Target Discovery and Development Program [U01CA217858]; NCI Outstanding Investigator Award [R35CA197745]; NCI Research Centers for Cancer Systems Biology Consortium [1U54CA209997]; NIH [S10OD012351, S10OD021764, G20 RR030860]; Swedish Cancer Foundation; NCI [3P50 CA095103]; SPORE in GI cancer; NATIONAL CANCER INSTITUTE [P50CA095103, R35CA197745, U01CA217858, P30CA008748, U54CA209997] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764] Funding Source: NIH RePORTER	Falconwood Foundation; National Cancer Institute (NCI) Cancer Target Discovery and Development Program; NCI Outstanding Investigator Award; NCI Research Centers for Cancer Systems Biology Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SPORE in GI cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the Falconwood Foundation for its generous support of research on neuroendocrine tumors, and the molecular pathology shared resources of the Herbert Irving Medical Center for tumor banking management/processing and histology support. This work was also supported by the National Cancer Institute (NCI) Cancer Target Discovery and Development Program (U01CA217858), an NCI Outstanding Investigator Award (R35CA197745) for A.C., the NCI Research Centers for Cancer Systems Biology Consortium (1U54CA209997), NIH instrumentation grants (S10OD012351 and S10OD021764), the NIH grant for the Biobank and Translational Research Core Facility at Cedars-Sinai (G20 RR030860), NCI 3P50 CA095103 and SPORE in GI cancer for K.W. and C.S., and support from the Swedish Cancer Foundation for J.R. and U.L.	Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bisikirska B, 2016, CANCER RES, V76, P664, DOI 10.1158/0008-5472.CAN-15-0828; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Califano A, 2017, NAT REV CANCER, V17, P116, DOI 10.1038/nrc.2016.124; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Commo F, 2015, ANN ONCOL, V26, P582, DOI 10.1093/annonc/mdu582; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davoli A, 2010, CANCER CHEMOTH PHARM, V65, P611, DOI 10.1007/s00280-009-1208-1; Diez M, 2013, ANN GASTROENTEROL, V26, P29; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Francis JM, 2013, NAT GENET, V45, P1483, DOI 10.1038/ng.2821; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Konishi T, 2007, GUT, V56, P863, DOI 10.1136/gut.2006.109157; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacConaill LE, 2014, J MOL DIAGN, V16, P660, DOI 10.1016/j.jmoldx.2014.06.004; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mitrofanova A, 2015, CELL REP, V12, P2060, DOI 10.1016/j.celrep.2015.08.051; Oberg K, 2005, BEST PRACT RES CL GA, V19, P753, DOI 10.1016/j.bpg.2005.06.002; Oberg K, 2016, ENDOCR CONNECT, V5, P174, DOI 10.1530/EC-16-0043; Pfragner R, 1996, INT J ONCOL, V8, P513; Pfragner R, 2009, ANTICANCER RES, V29, P1951; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Rajbhandari P, 2018, CANCER DISCOV, V8, P582, DOI 10.1158/2159-8290.CD-16-0861; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Rosai J, 2011, MODERN PATHOL, V24, pS53, DOI 10.1038/modpathol.2010.166; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Tannock IF, 2016, NEW ENGL J MED, V375, P1289, DOI 10.1056/NEJMsb1607705; Vijayvergia N, 2016, BRIT J CANCER, V115, P564, DOI 10.1038/bjc.2016.229; Walsh LA, 2017, CELL REP, V20, P1623, DOI 10.1016/j.celrep.2017.07.052; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	43	86	92	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					979	+		10.1038/s41588-018-0138-4	http://dx.doi.org/10.1038/s41588-018-0138-4			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29915428	Green Accepted, Green Submitted			2022-12-17	WOS:000437224400013
J	Ishigaki, K; Kochi, Y; Suzuki, A; Tsuchida, Y; Tsuchiya, H; Sumitomo, S; Yamaguchi, K; Nagafuchi, Y; Nakachi, S; Kato, R; Sakurai, K; Shoda, H; Ikari, K; Taniguchi, A; Yamanaka, H; Miya, F; Tsunoda, T; Okada, Y; Momozawa, Y; Kamatani, Y; Yamada, R; Kubo, M; Fujio, K; Yamamoto, K				Ishigaki, Kazuyoshi; Kochi, Yuta; Suzuki, Akari; Tsuchida, Yumi; Tsuchiya, Haruka; Sumitomo, Shuji; Yamaguchi, Kensuke; Nagafuchi, Yasuo; Nakachi, Shinichiro; Kato, Rika; Sakurai, Keiichi; Shoda, Hirofumi; Ikari, Katsunori; Taniguchi, Atsuo; Yamanaka, Hisashi; Miya, Fuyuki; Tsunoda, Tatsuhiko; Okada, Yukinori; Momozawa, Yukihide; Kamatani, Yoichiro; Yamada, Ryo; Kubo, Michiaki; Fujio, Keishi; Yamamoto, Kazuhiko			Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis	NATURE GENETICS			English	Article							ADAPTIVE IMMUNITY; WIDE ASSOCIATION; GENE-EXPRESSION; DISEASE; TRANSCRIPTOME; SUSCEPTIBILITY; PATHOGENESIS; AUTOIMMUNE; MONOCYTES; CYTOKINES	Recent evidence suggests that a substantial portion of complex disease risk alleles modify gene expression in a cell-specific manner1-4. To identify candidate causal genes and biological pathways of immune-related complex diseases, we conducted expression quantitative trait loci (eQTL) analysis on five subsets of immune cells (CD4(+) T cells, CD8(+) T cells, B cells, natural killer (NK) cells and monocytes) and unfractionated peripheral blood from 105 healthy Japanese volunteers. We developed a three-step analytical pipeline comprising (i) prediction of individual gene expression using our eQTL database and public epigenomic data, (ii) gene-level association analysis and (iii) prediction of cell-specific pathway activity by integrating the direction of eQTL effects. By applying this pipeline to rheumatoid arthritis data sets, we identified candidate causal genes and a cytokine pathway (upregulation of tumor necrosis factor (TNF) in CD4(+) T cells). Our approach is an efficient way to characterize the polygenic contributions and potential biological mechanisms of complex diseases.	[Ishigaki, Kazuyoshi; Kochi, Yuta; Suzuki, Akari; Yamaguchi, Kensuke; Okada, Yukinori; Yamada, Ryo; Yamamoto, Kazuhiko] RIKEN Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Ishigaki, Kazuyoshi; Tsuchida, Yumi; Tsuchiya, Haruka; Sumitomo, Shuji; Yamaguchi, Kensuke; Nagafuchi, Yasuo; Nakachi, Shinichiro; Kato, Rika; Sakurai, Keiichi; Shoda, Hirofumi; Fujio, Keishi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Ishigaki, Kazuyoshi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kochi, Yuta; Ikari, Katsunori; Miya, Fuyuki; Tsunoda, Tatsuhiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Ikari, Katsunori; Taniguchi, Atsuo; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan; [Momozawa, Yukihide; Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Stat Genet Ctr Genom Med, Kyoto, Japan	RIKEN; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); Tokyo Women's Medical University; RIKEN; Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University; RIKEN; Kyoto University	Kochi, Y (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan.; Kochi, Y (corresponding author), Japan Sci & Technol Agcy, CREST, Tokyo, Japan.	yuta.kochi@riken.jp	Nagafuchi, Yasuo/Y-9083-2019; Suzuki, Akari/N-5389-2015; Tsunoda, Tatsuhiko/K-2061-2014; Ishigaki, Kazuyoshi/ABF-6926-2021; Sumitomo, Shuji/N-5570-2019	Nagafuchi, Yasuo/0000-0002-1316-8035; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sumitomo, Shuji/0000-0003-4980-2664; Ishigaki, Kazuyoshi/0000-0003-2881-0657; Miya, Fuyuki/0000-0001-6758-2015; Yamada, Ryo/0000-0002-1587-630X	Takeda pharmaceutical Co., Ltd.; RIKEN; Japanese Ministry of Education, Culture, Sports, Sciences and Technology; Grants-in-Aid for Scientific Research [15H05670, 15H04965, 16K07211] Funding Source: KAKEN	Takeda pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); RIKEN; Japanese Ministry of Education, Culture, Sports, Sciences and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all the doctors and staff who participated in sample collection for eQTL analysis and the BioBank Japan Project and staff at the Laboratory for Genotyping Development. This research was supported by funding from Takeda pharmaceutical Co., Ltd. (Y. Kochi, K.F. and K. Yamamoto), and a grant from RIKEN (K. Ishigaki, Y. Kochi, A.S., Y.M., Y. Kamatani and M.K.). The BioBank Japan Project is supported by the Japanese Ministry of Education, Culture, Sports, Sciences and Technology.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Clarkson BD, 2015, J IMMUNOL, V194, P531, DOI 10.4049/jimmunol.1401320; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Efimov GA, 2016, P NATL ACAD SCI USA, V113, P3006, DOI 10.1073/pnas.1520175113; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2016, NAT REV RHEUMATOL, V12, P63, DOI 10.1038/nrrheum.2015.171; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pieper J, 2014, SCAND J IMMUNOL, V79, P149, DOI 10.1111/sji.12139; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tamura A, 2015, BIOCHEM BIOPH RES CO, V464, P654, DOI 10.1016/j.bbrc.2015.07.045; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	40	86	87	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1120	+		10.1038/ng.3885	http://dx.doi.org/10.1038/ng.3885			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28553958				2022-12-17	WOS:000404253300023
J	Morrissy, AS; Cavalli, FMG; Remke, M; Ramaswamy, V; Shih, DJH; Holgado, BL; Farooq, H; Donovan, LK; Garzia, L; Agnihotri, S; Kiehna, EN; Mercier, E; Mayoh, C; Papillon-Cavanagh, S; Nikbakht, H; Gayden, T; Torchia, J; Picard, D; Merino, DM; Vladoiu, M; Luu, B; Wu, X; Daniels, C; Horswell, S; Thompson, YY; Hovestadt, V; Northcott, PA; Jones, DTW; Peacock, J; Wang, X; Mack, SC; Reimand, J; Albrecht, S; Fontebasso, AM; Thiessen, N; Li, Y; Schein, JE; Lee, D; Carlsen, R; Mayo, M; Tse, K; Tam, A; Dhalla, N; Ally, A; Chuah, E; Cheng, Y; Plettner, P; Li, HI; Corbett, RD; Wong, T; Long, W; Loukides, J; Buczkowicz, P; Hawkins, CE; Tabori, U; Rood, BR; Myseros, JS; Packer, RJ; Korshunov, A; Lichter, P; Kool, M; Pfister, SM; Schuller, U; Dirks, P; Huang, A; Bouffet, E; Rutka, JT; Bader, GD; Swanton, C; Ma, Y; Moore, RA; Mungall, AJ; Majewski, J; Jones, SJM; Das, S; Malkin, D; Jabado, N; Marra, MA; Taylor, MD				Morrissy, A. Sorana; Cavalli, Florence M. G.; Remke, Marc; Ramaswamy, Vijay; Shih, David J. H.; Holgado, Borja L.; Farooq, Hamza; Donovan, Laura K.; Garzia, Livia; Agnihotri, Sameer; Kiehna, Erin N.; Mercier, Eloi; Mayoh, Chelsea; Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gayden, Tenzin; Torchia, Jonathon; Picard, Daniel; Merino, Diana M.; Vladoiu, Maria; Luu, Betty; Wu, Xiaochong; Daniels, Craig; Horswell, Stuart; Thompson, Yuan Yao; Hovestadt, Volker; Northcott, Paul A.; Jones, David T. W.; Peacock, John; Wang, Xin; Mack, Stephen C.; Reimand, Juri; Albrecht, Steffen; Fontebasso, Adam M.; Thiessen, Nina; Li, Yisu; Schein, Jacqueline E.; Lee, Darlene; Carlsen, Rebecca; Mayo, Michael; Tse, Kane; Tam, Angela; Dhalla, Noreen; Ally, Adrian; Chuah, Eric; Cheng, Young; Plettner, Patrick; Li, Haiyan I.; Corbett, Richard D.; Wong, Tina; Long, William; Loukides, James; Buczkowicz, Pawel; Hawkins, Cynthia E.; Tabori, Uri; Rood, Brian R.; Myseros, John S.; Packer, Roger J.; Korshunov, Andrey; Lichter, Peter; Kool, Marcel; Pfister, Stefan M.; Schueller, Ulrich; Dirks, Peter; Huang, Annie; Bouffet, Eric; Rutka, James T.; Bader, Gary D.; Swanton, Charles; Ma, Yusanne; Moore, Richard A.; Mungall, Andrew J.; Majewski, Jacek; Jones, Steven J. M.; Das, Sunit; Malkin, David; Jabado, Nada; Marra, Marco A.; Taylor, Michael D.			Spatial heterogeneity in medulloblastoma	NATURE GENETICS			English	Article							RENAL-CELL CARCINOMA; INTRATUMOR HETEROGENEITY; T-CELLS; SOLID TUMORS; IN-VITRO; LYMPHOCYTES; EVOLUTION; GROWTH; EXPRESSION; SUBTYPES	Spatial heterogeneity of transcriptional and genetic markers between physically isolated biopsies of a single tumor poses major barriers to the identification of biomarkers and the development of targeted therapies that will be effective against the entire tumor. We analyzed the spatial heterogeneity of multiregional biopsies from 35 patients, using a combination of transcriptomic and genomic profiles. Medulloblastomas (MBs), but not high-grade gliomas (HGGs), demonstrated spatially homogeneous transcriptomes, which allowed for accurate subgrouping of tumors from a single biopsy. Conversely, somatic mutations that affect genes suitable for targeted therapeutics demonstrated high levels of spatial heterogeneity in MB, malignant glioma, and renal cell carcinoma (RCC). Actionable targets found in a single MB biopsy were seldom clonal across the entire tumor, which brings the efficacy of monotherapies against a single target into question. Clinical trials of targeted therapies for MB should first ensure the spatially ubiquitous nature of the target mutation.	[Morrissy, A. Sorana; Cavalli, Florence M. G.; Remke, Marc; Ramaswamy, Vijay; Shih, David J. H.; Holgado, Borja L.; Farooq, Hamza; Donovan, Laura K.; Garzia, Livia; Vladoiu, Maria; Luu, Betty; Wu, Xiaochong; Daniels, Craig; Thompson, Yuan Yao; Peacock, John; Wang, Xin; Mack, Stephen C.; Das, Sunit; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Morrissy, A. Sorana; Cavalli, Florence M. G.; Remke, Marc; Ramaswamy, Vijay; Shih, David J. H.; Holgado, Borja L.; Farooq, Hamza; Donovan, Laura K.; Garzia, Livia; Torchia, Jonathon; Merino, Diana M.; Vladoiu, Maria; Luu, Betty; Wu, Xiaochong; Daniels, Craig; Thompson, Yuan Yao; Peacock, John; Wang, Xin; Mack, Stephen C.; Loukides, James; Hawkins, Cynthia E.; Tabori, Uri; Dirks, Peter; Huang, Annie; Bouffet, Eric; Rutka, James T.; Das, Sunit; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Remke, Marc; Picard, Daniel] Univ Hosp Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Remke, Marc; Picard, Daniel] Univ Hosp Dusseldorf, Fac Med, Dept Neuropathol, Dusseldorf, Germany; [Remke, Marc; Picard, Daniel] German Canc Consortium DKTK, Dept Pediat Neurooncogen, Dusseldorf, Germany; [Remke, Marc; Picard, Daniel] German Canc Res Ctr, Dusseldorf, Germany; [Ramaswamy, Vijay; Torchia, Jonathon; Merino, Diana M.; Tabori, Uri; Huang, Annie; Bouffet, Eric; Malkin, David] Hosp Sick Children, Dept Pediat, Div Haematol Oncol, Toronto, ON, Canada; [Shih, David J. H.; Farooq, Hamza; Torchia, Jonathon; Thompson, Yuan Yao; Peacock, John; Wang, Xin; Mack, Stephen C.; Rutka, James T.; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Garzia, Livia] McGill Univ, Ctr Hlth, Res Inst, Canc Res Program, Montreal, PQ, Canada; [Agnihotri, Sameer] Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Brain Tumour Ctr, Toronto, ON, Canada; [Kiehna, Erin N.; Dirks, Peter; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada; [Mercier, Eloi; Mayoh, Chelsea; Thiessen, Nina; Li, Yisu; Schein, Jacqueline E.; Lee, Darlene; Carlsen, Rebecca; Mayo, Michael; Tse, Kane; Tam, Angela; Dhalla, Noreen; Ally, Adrian; Chuah, Eric; Cheng, Young; Plettner, Patrick; Li, Haiyan I.; Corbett, Richard D.; Wong, Tina; Long, William; Ma, Yusanne; Moore, Richard A.; Mungall, Andrew J.; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gayden, Tenzin] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Papillon-Cavanagh, Simon; Nikbakht, Hamid; Gayden, Tenzin] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Merino, Diana M.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Horswell, Stuart] Canc Res UK London Res Inst, London, England; [Hovestadt, Volker; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Northcott, Paul A.; Jones, David T. W.; Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Reimand, Juri] Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada; [Reimand, Juri] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Reimand, Juri; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Albrecht, Steffen] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pathol, Montreal, PQ, Canada; [Fontebasso, Adam M.; Majewski, Jacek; Jabado, Nada] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Buczkowicz, Pawel; Hawkins, Cynthia E.] Hosp Sick Children, Div Pathol, Toronto, ON, Canada; [Rood, Brian R.] Childrens Natl Med Ctr, Div Pediat Oncol, Washington, DC 20010 USA; [Myseros, John S.] Childrens Natl Med Ctr, Div Pediat Neurosurg, Washington, DC 20010 USA; [Packer, Roger J.] Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Lichter, Peter; Pfister, Stefan M.] German Canc Consortium DKTK, Heidelberg, Germany; [Pfister, Stefan M.] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany; [Schueller, Ulrich] Univ Med Ctr, Inst Neuropathol, Hamburg, Germany; [Schueller, Ulrich] Childrens Canc Ctr, Res Inst, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr, Pediat Hematol & Oncol, Hamburg, Germany; [Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, London, England; [Swanton, Charles] UCL, Canc Res UK Lung Canc Ctr Excellence, London, England; [Jones, Steven J. M.; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jones, Steven J. M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Das, Sunit] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); British Columbia Cancer Agency; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cancer Research UK; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's National Health System; Children's National Health System; Children's National Health System; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Francis Crick Institute; Cancer Research UK; University of London; University College London; University of British Columbia; Simon Fraser University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Marra, MA (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.; Marra, MA (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mmarra@bcgsc.ca; mdtaylor@sickkids.ca	Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009; Jones, David T. W./Z-1963-2019; Papillon-Cavanagh, Simon/AAS-8749-2020; Northcott, Paul A/N-4022-2018; huang, dezhi/ABC-6566-2021; Bouffet, Eric/AAB-8999-2020; Wang, Xin/O-8779-2019; Wang, Xin/U-7221-2017; Malkin, David/AAW-8715-2021; Jabado, Nada/AAN-4026-2020; Mayoh, Chelsea/AAE-7349-2021; Bader, Gary/C-1176-2009; Hawkins, Cynthia/M-2571-2019; Mungall, Andrew J./U-7067-2018; Pfister, Stefan M/F-6860-2013; Reimand, Jüri/U-9264-2019; Shih, David J. H./AAE-8726-2019; Schein, Jacquie E/G-3674-2015; Jones, David TW/G-9588-2013	Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Northcott, Paul A/0000-0002-1220-5252; Wang, Xin/0000-0001-6292-3087; Wang, Xin/0000-0001-6292-3087; Mayoh, Chelsea/0000-0002-6398-3046; Bader, Gary/0000-0003-0185-8861; Mungall, Andrew J./0000-0002-0905-2742; Pfister, Stefan M/0000-0002-5447-5322; Reimand, Jüri/0000-0002-2299-2309; Shih, David J. H./0000-0002-9802-4937; Jones, David TW/0000-0002-2036-5141; Remke, Marc/0000-0002-9404-9993; Wang, Xin/0000-0001-8783-4080; Ramaswamy, Vijay/0000-0002-6557-895X; Donovan, Laura/0000-0001-5557-5539; Swanton, Charles/0000-0002-4299-3018; Nikbakht, Hamid/0000-0003-0209-5667; Mack, Stephen C./0000-0001-9620-4742; Morrissy, Sorana/0000-0001-8526-562X; Taylor, Michael/0000-0001-7009-3466; Schuller, Ulrich/0000-0002-8731-1121; Korshunov, Andrey/0000-0002-5257-3623; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Cavalli, Florence M. G./0000-0002-4409-9642	Genome Canada; Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; funds from The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; M.D.T.'s Garron Family Endowment; BC Childhood Cancer Parents Association; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; US National Institutes of Health [R01CA148699, R01CA159859]; Pediatric Brain Tumor Foundation; Brainchild; Ontario Institute for Cancer Research - Government of Ontario; Brain Tumour Foundation of Canada Impact Grant of the Canadian Cancer Society; Brain Canada; Health Canada [703202]; CureSearch for Children's Cancer; PedBrain Tumor Project - German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C]; B.R.A.I.N. Child and Megan's Walk; Canadian Institutes of Health Research (CIHR) [FDN-143288]; Dr. Mildred Scheel Foundation for Cancer Research/German Cancer Aid; Stephen Buttrum Brain Tumour Research Fellowship - Brain Tumour Foundation of Canada; CIHR; Alberta Innovates-Health Solutions; The Francis Crick Institute [10002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA159859, R01CA148699] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; funds from The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; M.D.T.'s Garron Family Endowment; BC Childhood Cancer Parents Association; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant; Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Brainchild; Ontario Institute for Cancer Research - Government of Ontario; Brain Tumour Foundation of Canada Impact Grant of the Canadian Cancer Society; Brain Canada; Health Canada; CureSearch for Children's Cancer; PedBrain Tumor Project - German Cancer Aid; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); B.R.A.I.N. Child and Megan's Walk; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Dr. Mildred Scheel Foundation for Cancer Research/German Cancer Aid; Stephen Buttrum Brain Tumour Research Fellowship - Brain Tumour Foundation of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MAGIC project (M.D.T. and M.A.M.) is financially supported by Genome Canada, Genome BC, Terry Fox Research Institute, Ontario Institute for Cancer Research, Pediatric Oncology Group Ontario, funds from The Family of Kathleen Lorette and the Clark H. Smith Brain Tumour Centre, Montreal Children's Hospital Foundation, Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre, Chief of Research Fund, Cancer Genetics Program, Garron Family Cancer Centre, B.R.A.I.N. Child, M.D.T.'s Garron Family Endowment, and the BC Childhood Cancer Parents Association. M.D.T. is supported by a Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113); Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.D.T. is also supported by The Garron Family Chair in Childhood Cancer Research, and grants from the Cure Search Foundation, the US National Institutes of Health (R01CA148699 and R01CA159859), The Pediatric Brain Tumor Foundation, The Terry Fox Research Institute, and Brainchild. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario, as well as The Brain Tumour Foundation of Canada Impact Grant of the Canadian Cancer Society and Brain Canada with the financial assistance of Health Canada (grant 703202 to M.D.T.). This work was also supported by a Program Project Grant from the Terry Fox Research Institute (to M.D.T.), a Grand Challenge Award from CureSearch for Children's Cancer (to M.D.T.), and the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF; grants 01KU1201A and MedSys 0315416C to S.M.P. and P.L.). We acknowledge the Labatt Brain Tumour Research Centre Tumour and Tissue Repository, which is supported by B.R.A.I.N. Child and Megan's Walk (M.D.T.). M.A.M. acknowledges support from the Canadian Institutes of Health Research (CIHR; FDN-143288). M.R. is supported by a fellowship from the Dr. Mildred Scheel Foundation for Cancer Research/German Cancer Aid. F.M.G.C. is supported by the Stephen Buttrum Brain Tumour Research Fellowship, granted by the Brain Tumour Foundation of Canada. V.R. is supported by a CIHR fellowship and an Alberta Innovates-Health Solutions Clinical Fellowship. For technical support and expertise in next-generation sequencing efforts, we thank The Centre for Applied Genomics (Toronto, Ontario, Canada). We thank S. Archer for technical writing, and C. Smith for artwork.	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Beuselinck B, 2015, CLIN CANCER RES, V21, P1329, DOI 10.1158/1078-0432.CCR-14-1128; Chinnasamy D, 2010, J CLIN INVEST, V120, P3953, DOI 10.1172/JCI43490; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Fraley C, 2012, MCLUST VERSION 4 R N; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Geldres C, 2014, CLIN CANCER RES, V20, P962, DOI 10.1158/1078-0432.CCR-13-2218; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Gulati S, 2014, EUR UROL, V66, P936, DOI 10.1016/j.eururo.2014.06.053; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Hong H, 2014, J IMMUNOTHER, V37, P93, DOI 10.1097/CJI.0000000000000018; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Kieran MW, 2014, NEURO-ONCOLOGY, V16, P1037, DOI 10.1093/neuonc/nou109; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lanitis E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049829; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pietsch T, 2014, ACTA NEUROPATHOL, V128, P137, DOI 10.1007/s00401-014-1276-0; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Remke M, 2013, CURR OPIN ONCOL, V25, P674, DOI 10.1097/CCO.0000000000000008; Shih DJH, 2014, J CLIN ONCOL, V32, P886, DOI 10.1200/JCO.2013.50.9539; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stein R, 2007, CLIN CANCER RES, V13, p5556S, DOI 10.1158/1078-0432.CCR-07-1167; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Tang XJ, 2014, J BIOMED RES, V28, P468, DOI [10.7555/JBR.28.20140066, 10.7555/JBR.27.20130002]; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thibodeau BJ, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.11.001; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang W, 2013, GENE THER, V20, P970, DOI 10.1038/gt.2013.19; Wu MR, 2015, GENE THER, V22, P675, DOI 10.1038/gt.2015.29	51	86	86	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2017	49	5					780	+		10.1038/ng.3838	http://dx.doi.org/10.1038/ng.3838			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET1TI	28394352	Green Accepted, Green Submitted			2022-12-17	WOS:000400051400018
J	Kim, D; Sung, YM; Park, J; Kim, S; Kim, J; Park, J; Ha, H; Bae, JY; Kim, S; Baek, D				Kim, Doyeon; Sung, You Me; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Park, Junhee; Ha, Haeok; Bae, Jung Yoon; Kim, SoHui; Baek, Daehyun			General rules for functional microRNA targeting	NATURE GENETICS			English	Article							MESSENGER-RNAS; MAMMALIAN MICRORNAS; BINDING-SITES; IDENTIFICATION; DETERMINANTS; STABILITY; ABUNDANCE; RECOGNITION; SPECIFICITY; REPRESSION	The functional rules for microRNA (miRNA) targeting remain controversial despite their biological importance because only a small fraction of distinct interactions, called site types, have been examined among an astronomical number of site types that can occur between miRNAs and their target mRNAs. To systematically discover functional site types and to evaluate the contradicting rules reported previously, we used large-scale transcriptome data and statistically examined whether each of approximately 2 billion site types is enriched in differentially downregulated mRNAs responding to overexpressed miRNAs. Accordingly, we identified seven non-canonical functional site types, most of which are novel, in addition to four canonical site types, while also removing numerous false positives reported by previous studies. Extensive experimental validation and significantly elevated 3' UTR sequence conservation indicate that these non-canonical site types may have biologically relevant roles. Our expanded catalog of functional site types suggests that the gene regulatory network controlled by miRNAs may be far more complex than currently understood.	[Kim, Doyeon; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Kim, SoHui; Baek, Daehyun] Inst for Basic Sci Korea, Ctr RNA Res, Seoul, South Korea; [Kim, Doyeon; Sung, You Me; Park, Jinman; Kim, Sukjun; Kim, Jongkyu; Park, Junhee; Ha, Haeok; Bae, Jung Yoon; Kim, SoHui; Baek, Daehyun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Baek, Daehyun] Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Baek, D (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul, South Korea.; Baek, D (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Baek, D (corresponding author), Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea.	baek@snu.ac.kr	Kim, Sukjun/AAV-8503-2021	Kim, Sukjun/0000-0002-3190-9829; Kim, Doyeon/0000-0003-1522-4341	Institute for Basic Science [IBS-R008-D1]; Ministry of Science ICT and Future Planning, Republic of Korea [NRF-2011-0014523, NRF-2014M3C9A3063541, F15SN01D1305, 2012M3A9D1054622]; Ministry of Health and Welfare, Republic of Korea [HI15C1578, HI15C3224]; TJ Park Science Fellowship of the POSCO TJ Park Foundation	Institute for Basic Science; Ministry of Science ICT and Future Planning, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); TJ Park Science Fellowship of the POSCO TJ Park Foundation	We thank V.N. Kim for generous research funding and insightful discussions, and we thank D.P. Bartel, J.W. Nam, S.W. Chi, and members of the Baek laboratory for helpful discussions. This work was supported by the Institute for Basic Science (IBS-R008-D1), the Ministry of Science ICT and Future Planning, Republic of Korea (NRF-2011-0014523, NRF-2014M3C9A3063541, F15SN01D1305, and 2012M3A9D1054622), the Ministry of Health and Welfare, Republic of Korea (HI15C1578 and HI15C3224), and the TJ Park Science Fellowship of the POSCO TJ Park Foundation.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Kim D, 2014, MOL CELLS, V37, P412, DOI 10.14348/molcells.2014.0100; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/nmeth.1608, 10.1038/NMETH.1608]; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Majoros WH, 2013, NAT METHODS, V10, P630, DOI 10.1038/nmeth.2489; Mayr C, 2016, TRENDS CELL BIOL, V26, P227, DOI 10.1016/j.tcb.2015.10.012; Melo SA, 2013, NAT CELL BIOL, V15, P139, DOI 10.1038/ncb2684; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	46	86	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1517	1526		10.1038/ng.3694	http://dx.doi.org/10.1038/ng.3694			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27776116	Green Submitted			2022-12-17	WOS:000389011100012
J	Lee, CS; Bhaduri, A; Mah, A; Johnson, WL; Ungewickell, A; Aros, CJ; Nguyen, CB; Rios, EJ; Siprashvili, Z; Straight, A; Kim, J; Aasi, SZ; Khavari, PA				Lee, Carolyn S.; Bhaduri, Aparna; Mah, Angela; Johnson, Whitney L.; Ungewickell, Alexander; Aros, Cody J.; Nguyen, Christie B.; Rios, Eon J.; Siprashvili, Zurab; Straight, Aaron; Kim, Jinah; Aasi, Sumaira Z.; Khavari, Paul A.			Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma	NATURE GENETICS			English	Article							CANCER GENOME; SKIN-CANCER; ANEUPLOIDY; PATTERNS; P53	Here we report the discovery of recurrent mutations concentrated at an ultraviolet signature hotspot in KNSTRN, which encodes a kinetochore protein, in 19% of cutaneous squamous cell carcinomas (SCCs). Cancer-associated KNSTRN mutations, most notably those encoding p.Ser24Phe, disrupt chromatid cohesion in normal cells, occur in SCC precursors, correlate with increased aneuploidy in primary tumors and enhance tumorigenesis in vivo. These findings suggest a role for KNSTRN mutagenesis in SCC development.	[Lee, Carolyn S.; Bhaduri, Aparna; Mah, Angela; Ungewickell, Alexander; Aros, Cody J.; Nguyen, Christie B.; Rios, Eon J.; Siprashvili, Zurab; Kim, Jinah; Aasi, Sumaira Z.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Johnson, Whitney L.; Straight, Aaron] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Lee, Carolyn/0000-0002-6511-3757; Straight, Aaron/0000-0001-5885-7881	US Veterans Affairs Office of Research and Development; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR43799]; NIH/NIAMS [K08 AR064732]; NIH/National Institute of General Medical Science (NIGMS) [GM074728]; American Cancer Society [120161-RSG]; National Science Foundation (NSF) [DGE-114747]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR043799, K08AR064732, R01AR043799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Institute of General Medical Science (NIGMS); American Cancer Society(American Cancer Society); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.G. Rheinwald (Dana-Farber/Harvard Cancer Center) for his generous gift of SCC cell lines. We thank A.E. Oro, H.Y. Chang, M. Diehn, M.P. Scott, S.E. Artandi, G.R. Crabtree and T. Waldman as well as A. Zehnder, X. Bao, B.K. Sun, R.J. Flockhart and V. Lopez-Pajares for presubmission review and helpful comments. This work was supported by the US Veterans Affairs Office of Research and Development and by US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) grant AR43799 to P.A.K. C.S.L. is the recipient of career award K08 AR064732 from the NIH/NIAMS. A.S. is supported by NIH/National Institute of General Medical Science (NIGMS) grant GM074728 and American Cancer Society grant 120161-RSG. W.L.J. is the recipient of National Science Foundation (NSF) graduate research fellowship grant DGE-114747.	BIESTERFELD S, 1995, BRIT J DERMATOL, V133, P557, DOI 10.1111/j.1365-2133.1995.tb02704.x; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	10	86	88	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1060	1062		10.1038/ng.3091	http://dx.doi.org/10.1038/ng.3091			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25194279	Green Accepted			2022-12-17	WOS:000342554100007
J	Wong, CC; Martincorena, I; Rust, AG; Rashid, M; Alifrangis, C; Alexandrov, LB; Tiffen, JC; Kober, C; Green, AR; Massie, CE; Nangalia, J; Lempidaki, S; Dohner, H; Dhner, K; Bray, SJ; McDermott, U; Papaemmanuil, E; Campbell, PJ; Adams, DJ				Wong, Chi C.; Martincorena, Inigo; Rust, Alistair G.; Rashid, Mamunur; Alifrangis, Constantine; Alexandrov, Ludmil B.; Tiffen, Jessamy C.; Kober, Christina; Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti; Lempidaki, Stella; Doehner, Hartmut; Dhner, Konstanze; Bray, Sarah J.; McDermott, Ultan; Papaemmanuil, Elli; Campbell, Peter J.; Adams, David J.		Chronic Myeloid Disorders Working	Inactivating CUX1 mutations promote tumorigenesis	NATURE GENETICS			English	Article							RECURRENT SOMATIC MUTATIONS; CCAAT DISPLACEMENT PROTEIN; DNA-BINDING; FREQUENT MUTATIONS; GENOMIC COMPLEXITY; GENETIC LANDSCAPE; DRIVER MUTATIONS; CELL CARCINOMA; CUT REPEATS; EXOME	A major challenge in cancer genetics is to determine which low-frequency somatic mutations are drivers of tumorigenesis. Here we interrogate the genomes of 7,651 diverse human cancers and find inactivating mutations in the homeodomain transcription factor gene CUX1 (cut-like homeobox 1) in similar to 1-5% of various tumors. Meta-analysis of CUX1 mutational status in 2,519 cases of myeloid malignancies reveals disruptive mutations associated with poor survival, highlighting the clinical significance of CUX1 loss. In parallel, we validate CUX1 as a bona fide tumor suppressor using mouse transposon-mediated insertional mutagenesis and Drosophila cancer models. We demonstrate that CUX1 deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition. Thus, our complementary approaches identify CUX1 as a pan-driver of tumorigenesis and uncover a potential strategy for treating CUX1-mutant tumors.	[Wong, Chi C.; Rust, Alistair G.; Rashid, Mamunur; Tiffen, Jessamy C.; Kober, Christina; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge, England; [Wong, Chi C.; Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Martincorena, Inigo; Alifrangis, Constantine; Alexandrov, Ludmil B.; Papaemmanuil, Elli; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Green, Anthony R.; Massie, Charles E.; Nangalia, Jyoti] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge, England; [Lempidaki, Stella; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Doehner, Hartmut; Dhner, Konstanze] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; Ulm University	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge, England.	da1@sanger.ac.uk	Döhner, Hartmut/C-8933-2016; Alexandrov, Ludmil/AAS-1454-2021	Döhner, Hartmut/0000-0003-2116-5536; Alexandrov, Ludmil/0000-0003-3596-4515; Rust, Alistair/0000-0001-7287-192X; Green, Anthony/0000-0002-9795-0218; Bray, Sarah/0000-0002-1642-599X; McDermott, Ultan/0000-0001-9032-4700; Massie, Charlie/0000-0003-2314-4843; Adams, David/0000-0001-9490-0306; Martincorena, Inigo/0000-0003-1122-4416	Cancer Research UK; Wellcome Trust; European Research Council; Medical Research Council; Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America; EMBO; Kay Kendall Leukaemia Fund Clinical Fellowship; MRC [G0800034, MR/L007177/1] Funding Source: UKRI; Cancer Research UK [16629, 13031] Funding Source: researchfish; Medical Research Council [G0800034, MR/L007177/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Research; Kay Kendall Leukaemia Fund; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); EMBO(European Molecular Biology Organization (EMBO)); Kay Kendall Leukaemia Fund Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PLKO.pig vector was a kind gift from I. Lemischka (Mount Sinai School of Medicine). Plasmids pXJ42 and pXJ myc-CUX1<SUP>p110</SUP>-HA were kindly provided by A. Nepveu (McGill University). We thank D. Pask, J. Carter, T. Hamilton and staff of the Sanger RSF for animal husbandry. C. C. W. and D. J. A. are supported by Cancer Research UK, The Wellcome Trust and the European Research Council. S. J. B. and S. L. are supported by the Medical Research Council. Work in the A. R. G. laboratory is supported by Leukemia and Lymphoma Research, Cancer Research UK, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia & Lymphoma Society of America. I. M. is supported by an EMBO Long-Term Fellowship. J.N. is supported by a Kay Kendall Leukaemia Fund Clinical Fellowship. U. M. is supported by a Cancer Research UK Clinician Scientist Fellowship.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goulet B, 2002, CANCER RES, V62, P6625; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulea L, 2012, GENE, V497, P18, DOI 10.1016/j.gene.2012.01.039; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schlenk RF, 2010, J CLIN ONCOL, V28, P4642, DOI 10.1200/JCO.2010.28.6856; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Terriente-Felix A, 2013, DEVELOPMENT, V140, P926, DOI 10.1242/dev.086785; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhai ZZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002582; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	72	86	87	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					33	+		10.1038/ng.2846	http://dx.doi.org/10.1038/ng.2846			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316979	Green Accepted			2022-12-17	WOS:000329113500009
J	Cordell, HJ; Bentham, J; Topf, A; Zelenika, D; Heath, S; Mamasoula, C; Cosgrove, C; Blue, G; Granados-Riveron, J; Setchfield, K; Thornborough, C; Breckpot, J; Soemedi, R; Martin, R; Rahman, TJ; Hall, D; van Engelen, K; Moorman, AFM; Zwinderman, AH; Barnett, P; Koopmann, TT; Adriaens, ME; Varro, A; George, AL; dos Remedios, C; Bishopric, NH; Bezzina, CR; O'Sullivan, J; Gewillig, M; Bu'Lock, FA; Winlaw, D; Bhattacharya, S; Devriendt, K; Brook, JD; Mulder, BJM; Mital, S; Postma, AV; Lathrop, GM; Farrall, M; Goodship, JA; Keavney, BD				Cordell, Heather J.; Bentham, Jamie; Topf, Ana; Zelenika, Diana; Heath, Simon; Mamasoula, Chrysovalanto; Cosgrove, Catherine; Blue, Gillian; Granados-Riveron, Javier; Setchfield, Kerry; Thornborough, Chris; Breckpot, Jeroen; Soemedi, Rachel; Martin, Ruairidh; Rahman, Thahira J.; Hall, Darroch; van Engelen, Klaartje; Moorman, Antoon F. M.; Zwinderman, Aelko H.; Barnett, Phil; Koopmann, Tamara T.; Adriaens, Michiel E.; Varro, Andras; George, Alfred L., Jr.; dos Remedios, Christobal; Bishopric, Nanette H.; Bezzina, Connie R.; O'Sullivan, John; Gewillig, Marc; Bu'Lock, Frances A.; Winlaw, David; Bhattacharya, Shoumo; Devriendt, Koen; Brook, J. David; Mulder, Barbara J. M.; Mital, Seema; Postma, Alex V.; Lathrop, G. Mark; Farrall, Martin; Goodship, Judith A.; Keavney, Bernard D.			Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16	NATURE GENETICS			English	Article							MSX1; TETRALOGY; MUTATION	We carried out a genome-wide association study (GWAS) of congenital heart disease (CHD). Our discovery cohort comprised 1,995 CHD cases and 5,159 controls and included affected individuals from each of the 3 major clinical CHD categories (with septal, obstructive and cyanotic defects). When all CHD phenotypes were considered together, no region achieved genome-wide significant association. However, a region on chromosome 4p16, adjacent to the MSX1 and STX18 genes, was associated (P = 9.5 x 10(-7)) with the risk of ostium secundum atrial septal defect (ASD) in the discovery cohort (N = 340 cases), and this association was replicated in a further 417 ASD cases and 2,520 controls (replication P = 5.0 x 10(-5); odds ratio (OR) in replication cohort = 1.40, 95% confidence interval (CI) = 1.19-1.65; combined P = 2.6 x 10(-10)). Genotype accounted for similar to 9% of the population-attributable risk of ASD.	[Cordell, Heather J.; Topf, Ana; Mamasoula, Chrysovalanto; Soemedi, Rachel; Martin, Ruairidh; Rahman, Thahira J.; Hall, Darroch; Goodship, Judith A.; Keavney, Bernard D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bentham, Jamie; Cosgrove, Catherine; Bhattacharya, Shoumo; Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Zelenika, Diana; Heath, Simon; Lathrop, G. Mark] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Zelenika, Diana; Lathrop, G. Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Heath, Simon] Ctr Nacl Anal Genom, Barcelona, Spain; [Blue, Gillian; Winlaw, David] Childrens Hosp Westmead, Westmead, NSW, Australia; [Granados-Riveron, Javier; Setchfield, Kerry; Brook, J. David] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Thornborough, Chris; Bu'Lock, Frances A.] Univ Hosp Leicester Natl Hlth Serv NHS Trust, East Midlands Congenital Heart Ctr, Leicester, Leics, England; [Breckpot, Jeroen; Devriendt, Koen] Univ Louvain, Ctr Human Genet, Leuven, Belgium; [van Engelen, Klaartje] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Moorman, Antoon F. M.; Barnett, Phil; Postma, Alex V.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aelko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Koopmann, Tamara T.; Adriaens, Michiel E.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Varro, Andras] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN USA; [dos Remedios, Christobal] Univ Sydney, Dept Anat, Bosch Inst, Muscle Res Unit, Sydney, NSW 2006, Australia; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Med Mol & Cellular Pharmacol, Miami, FL 33136 USA; [O'Sullivan, John] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Gewillig, Marc] Univ Louvain, Leuven, Belgium; [Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Mital, Seema] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Keavney, Bernard D.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	Newcastle University - UK; University of Oxford; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; University of Sydney; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Szeged University; Vanderbilt University; University of Sydney; University of Miami; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manchester	Keavney, BD (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	judith.goodship@ncl.ac.uk; bernard.keavney@manchester.ac.uk	Winlaw, David S/F-8365-2016; Varro, Andras/M-2647-2016; Winlaw, David/B-9405-2019; Bhattacharya, Shoumo/F-4127-2010; Postma, Alex V/H-4806-2019; Heath, Simon C/J-4138-2012	Winlaw, David S/0000-0001-8005-3361; Winlaw, David/0000-0001-8005-3361; Bhattacharya, Shoumo/0000-0002-5571-0478; Postma, Alex V/0000-0003-4874-2487; Heath, Simon C/0000-0002-9550-0897; Granados-Riveron, Javier T./0000-0002-0368-225X; Barnett, Phil/0000-0001-7420-6106; Adriaens, Michiel/0000-0002-4472-7119; Blue, Gillian M/0000-0002-1480-9535; Keavney, Bernard/0000-0001-9573-0812; Granados-Riveron, Javier Tadeo/0000-0001-5485-654X; Cordell, Heather/0000-0002-1879-5572; Bezzina, Connie/0000-0002-0633-3514; Gewillig, Marc/0000-0002-4595-5922; Brook, John David/0000-0002-5946-6740	Wellcome Trust [BH100708, 087436, 090532/Z/09/Z, 085475]; British Heart Foundation (BHF); European Union [HEALTH-F2-2008-223040]; SickKids Labatt Family Heart Centre Biobank; Netherlands Heart Foundation [NHS2010B175]; Heart Research UK; US National Institutes of Health [HL068880]; Agence Nationale de la Recherche (ANR) Labex project Medical Genomics; BHF Centre of Research Excellence in Oxford; European Community; UK Department of Health via a National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; British Heart Foundation [RG/13/10/30376, FS/12/55/29695, RG/07/010/23676, RG/10/17/28553, PG/07/045/22690] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068880] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation (BHF)(British Heart Foundation); European Union(European Commission); SickKids Labatt Family Heart Centre Biobank; Netherlands Heart Foundation(Netherlands Heart Foundation); Heart Research UK; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche (ANR) Labex project Medical Genomics(French National Research Agency (ANR)); BHF Centre of Research Excellence in Oxford; European Community(European Commission); UK Department of Health via a National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Our principal acknowledgment is of the individuals with CHD, their families and the healthy individuals who participated in the research. We acknowledge the contributions of C. de Gier-de Vries, L. M. Sneddon, M. Westerveld, C. Q. Simmons, T. Zhang, R. Hussein and V. Otero. This study was funded by the Wellcome Trust (grants BH100708 and 087436), the British Heart Foundation (BHF), the European Union Framework Programme 7 CHeartED Programme (HEALTH-F2-2008-223040), the SickKids Labatt Family Heart Centre Biobank (to S. M.), the Netherlands Heart Foundation (NHS2010B175 to T. T. K. and C. R. B.), Heart Research UK, the US National Institutes of Health (HL068880 to A. L. G.) and the Agence Nationale de la Recherche (ANR) Labex project Medical Genomics (to G. M. L.). M. F. acknowledges support from the Wellcome Trust core award (090532/Z/09/Z) and BHF Centre of Research Excellence in Oxford. S. B. and B. D. K. hold BHF Personal Chairs. This study makes use of data generated by the WTCCC2, funded by the Wellcome Trust under award 085475. Access to genotype data from the TwinsUK cohort was kindly provided by the Department of Twin Research and Genetic Epidemiology at King's College London. TwinsUK is funded by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013) and also receives support from the UK Department of Health via a National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TwinsUK SNP genotyping was performed by the Wellcome Trust Sanger Institute and the National Eye Institute via the US National Institutes of Health/Center for Integrated Disease Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Boogerd KJ, 2008, CARDIOVASC RES, V78, P485, DOI 10.1093/cvr/cvn049; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAMPBELL M, 1970, BRIT HEART J, V32, P820; Chen YH, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-75; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Goodship JA, 2012, CIRC-CARDIOVASC GENE, V5, P287, DOI 10.1161/CIRCGENETICS.111.962035; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Iinuma T, 2009, J CELL SCI, V122, P1680, DOI 10.1242/jcs.036103; Ishii M, 2005, DEVELOPMENT, V132, P4937, DOI 10.1242/dev.02072; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Soemedi R, 2012, HUM MOL GENET, V21, P1513, DOI 10.1093/hmg/ddr589; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Webb G, 2006, CIRCULATION, V114, P1645, DOI 10.1161/CIRCULATIONAHA.105.592055	27	86	87	4	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					822	U151		10.1038/ng.2637	http://dx.doi.org/10.1038/ng.2637			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23708191	Green Accepted			2022-12-17	WOS:000321005200020
J	Snape, K; Hanks, S; Ruark, E; Barros-Nunez, P; Elliott, A; Murray, A; Lane, AH; Shannon, N; Callier, P; Chitayat, D; Clayton-Smith, J; FitzPatrick, DR; Gisselsson, D; Jacquemont, S; Asakura-Hay, K; Micale, MA; Tolmie, J; Turnpenny, PD; Wright, M; Douglas, J; Rahman, N				Snape, Katie; Hanks, Sandra; Ruark, Elise; Barros-Nunez, Patricio; Elliott, Anna; Murray, Anne; Lane, Andrew H.; Shannon, Nora; Callier, Patrick; Chitayat, David; Clayton-Smith, Jill; FitzPatrick, David R.; Gisselsson, David; Jacquemont, Sebastien; Asakura-Hay, Keiko; Micale, Mark A.; Tolmie, John; Turnpenny, Peter D.; Wright, Michael; Douglas, Jenny; Rahman, Nazneen			Mutations in CEP57 cause mosaic variegated aneuploidy syndrome	NATURE GENETICS			English	Article							HUMAN CANCER; PROTEIN	Using exome sequencing and a variant prioritization strategy that focuses on loss-of-function variants, we identified biallelic, loss-of-function CEP57 mutations as a cause of constitutional mosaic aneuploidies. CEP57 is a centrosomal protein and is involved in nucleating and stabilizing microtubules. Our findings indicate that these and/or additional functions of CEP57 are crucial for maintaining correct chromosomal number during cell division.	[Snape, Katie; Hanks, Sandra; Ruark, Elise; Elliott, Anna; Murray, Anne; Douglas, Jenny; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Barros-Nunez, Patricio] Inst Mexicano Seguro Social, Div Genet, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico; [Lane, Andrew H.] SUNY Stony Brook, Div Pediat Endocrinol, Stony Brook, NY 11794 USA; [Shannon, Nora] City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; [Callier, Patrick] CHU Dijon, Cytogenet Serv, Dijon, France; [Chitayat, David] Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Chitayat, David] Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Clayton-Smith, Jill] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Manchester M13 0JH, Lancs, England; [FitzPatrick, David R.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Gisselsson, David] Lund Univ, Dept Clin Genet, Univ & Reg Labs, Skane Univ Hosp, Lund, Sweden; [Jacquemont, Sebastien] CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; [Asakura-Hay, Keiko] Tayside Univ Hosp Natl Hlth Serv NHS Trust, Ninewells Hosp & Med Sch, Dundee, Scotland; [Micale, Mark A.] Royal Oak & Oakland Univ, William Beaumont Sch Med, William Beaumont Hosp, Dept Anat Pathol, Rochester, MI USA; [Tolmie, John] Royal Hosp Sick Children, Dept Clin Genet, Ferguson Smith Ctr, Glasgow G3 8SJ, Lanark, Scotland; [Turnpenny, Peter D.] Royal Devon & Exeter Healthcare NHS Trust, Peninsula Clin Genet Serv, Exeter, Devon, England; [Turnpenny, Peter D.] Royal Devon & Exeter Healthcare NHS Trust, Peninsula Med Sch, Exeter, Devon, England; [Wright, Michael] Newcastle Upon Tyne Hosp Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England	University of London; Institute of Cancer Research - UK; Instituto Mexicano del Seguro Social; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Nottingham; CHU Dijon Bourgogne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Manchester; University of Edinburgh; Lund University; Skane University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Dundee; Beaumont Health; University of Glasgow; University of Exeter; University of Exeter; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	Jacquemont, Sebastien/AAS-5060-2021; Snape, Katie/AAA-8101-2022; Rahman, Nazneen/B-8890-2012; FitzPatrick, David R/C-7301-2013; Rahman, Nazneen/D-2802-2013	Jacquemont, Sebastien/0000-0001-6838-8767; Barros-Nunez, Jaime Patricio/0000-0002-6607-5553; Rahman, Nazneen/0000-0003-4376-0440; FitzPatrick, David R./0000-0003-4861-969X	Michael and Betty Kadoorie Cancer Genetics Research Programme; NHS; Cancer Research UK [C8620_A9024, C8620_A8857]; Institute of Cancer Research (UK); MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: researchfish	Michael and Betty Kadoorie Cancer Genetics Research Programme; NHS; Cancer Research UK(Cancer Research UK); Institute of Cancer Research (UK)(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to all the families that participated in this study and to A. Zachariou, M. Warren-Perry, R. Linger, D. Dudakia and J. Bull for assistance in their recruitment. We thank D. Leongamornlert for assistance with exome sequencing, A. Renwick, S. Seal, G. Bowden, D. Hughes and C. Turnbull for assistance in Solexa optimization and validation experiments and B. Ebbs for DNA extraction and for running the ABI sequencer. We thank K. Tatton-Brown for assistance with clinical review of cases, A. I. Vasquez and J. Swansbury for the karyotyping and A. Strydom for secretarial assistance with the manuscript. K. S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme. We acknowledge NHS funding to the National Institute for Health Research Biomedical Research Centre. This work was supported by Cancer Research UK (grants C8620_A9024 and C8620_A8857) and the Institute of Cancer Research (UK).	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garcia-Castillo H, 2008, AM J MED GENET A, V146A, P1687, DOI 10.1002/ajmg.a.32315; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Lane AH, 2002, AM J MED GENET, V110, P273, DOI 10.1002/ajmg.10462; Meunier S, 2009, TRAFFIC, V10, P1765, DOI 10.1111/j.1600-0854.2009.00985.x; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Suijkerbuijk SJE, 2010, CANCER RES, V70, P4891, DOI 10.1158/0008-5472.CAN-09-4319; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878	13	86	89	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					527	529		10.1038/ng.822	http://dx.doi.org/10.1038/ng.822			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552266	Green Accepted			2022-12-17	WOS:000291017000008
J	Bradley, J; Baltus, A; Skaletsky, H; Royce-Tolland, M; Dewar, K; Page, DC				Bradley, J; Baltus, A; Skaletsky, H; Royce-Tolland, M; Dewar, K; Page, DC			An X-to-autosome retrogene is required for spermatogenesis in mice	NATURE GENETICS			English	Article							SPERMATOGONIAL DEPLETION JSD; PROCESSED PSEUDOGENES; GENE; RETROPOSON; TESTIS; MOUSE; IDENTIFICATION; EXPRESSION; PROTEIN; PROLIFERATION	We identified the gene carrying the juvenile spermatogonial depletion mutation (jsd), a recessive spermatogenic defect mapped to mouse chromosome 1 (refs. 1,2). We localized jsd to a 272-kb region and resequenced this area to identify the underlying mutation: a frameshift that severely truncates the predicted protein product of a 2.3-kb genomic open reading frame. This gene, Utp14b, evidently arose through reverse transcription of an mRNA from an X-linked gene and integration of the resulting cDNA into an intron of an autosomal gene, whose promoter and 5' untranslated exons are shared with Utp14b. To our knowledge, Utp14b is the first protein-coding retrogene to be linked to a recessive mammalian phenotype. The X-linked progenitor of Utp14b is the mammalian ortholog of yeast Utp14, which encodes a protein required for processing of pre-rRNA(3) and hence for ribosome assembly. Our findings substantiate the hypothesis(4) that mammalian spermatogenesis is supported by autosomal retrogenes that evolved from X-linked housekeeping genes to compensate for silencing of the X chromosome during male meiosis(5-7). We find that Utp14b-like retrogenes arose independently and were conserved during evolution in at least four mammalian lineages. This recurrence implies a strong selective pressure, perhaps to enable ribosome assembly in male meiotic cells.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.							ASHWORTH A, 1990, EMBO J, V9, P1529, DOI 10.1002/j.1460-2075.1990.tb08271.x; Banks KG, 2003, GENOMICS, V82, P254, DOI 10.1016/S0888-7543(03)00155-1; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; Boettger-Tong HL, 2000, BIOL REPROD, V63, P1185, DOI 10.1095/biolreprod63.4.1185; Boettger-Tong HL, 2001, BIOCHEM BIOPH RES CO, V288, P1129, DOI 10.1006/bbrc.2001.5899; Chen HH, 2002, GENOMICS, V80, P140, DOI 10.1006/geno.2002.6808; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; HANDEL MA, 1994, CYTOGENET CELL GENET, V66, P83, DOI 10.1159/000133672; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Kojima Y, 1997, Int J Urol, V4, P500, DOI 10.1111/j.1442-2042.1997.tb00293.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARDON G, 1990, MOL CELL BIOL, V10, P681, DOI 10.1128/MCB.10.2.681; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nagase T., 1996, DNA RES, V3; Ohta H, 2001, INT J ANDROL, V24, P15, DOI 10.1046/j.1365-2605.2001.00257.x; RICHLER C, 1994, MOL BIOL CELL, V5, P1341, DOI 10.1091/mbc.5.12.1341; SARGENT CA, 1994, HUM MOL GENET, V3, P1317, DOI 10.1093/hmg/3.8.1317; Scanlan M J, 2001, Cancer Immun, V1, P4; Sedlacek Z, 1999, GENOMICS, V61, P125, DOI 10.1006/geno.1999.5931; Tohda A, 2001, BIOL REPROD, V65, P532, DOI 10.1095/biolreprod65.2.532; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; VANIN EF, 1984, BIOCHIM BIOPHYS ACTA, V782, P231, DOI 10.1016/0167-4781(84)90057-5; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	31	86	90	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2004	36	8					872	876		10.1038/ng1390	http://dx.doi.org/10.1038/ng1390			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15258580				2022-12-17	WOS:000222974000021
J	Taketo, MM				Taketo, MM			Shutting down Wnt signal-activated cancer	NATURE GENETICS			English	Editorial Material							BETA-CATENIN; COLORECTAL-CANCER; MUTATIONS; PATHWAY; AXIN; APC	New evidence suggests that Wnt signaling can be suppressed or further activated by upstream signals, even though the pathway seems to be constitutively activated by downstream mutations in cancer cells.	Kyoto Univ, Sch Med, Dept Pharmacol, Kyoto 606, Japan	Kyoto University	Taketo, MM (corresponding author), Kyoto Univ, Sch Med, Dept Pharmacol, Kyoto 606, Japan.	taketo@mfour.med.kyoto-u.ac.jp						Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Sparks AB, 1998, CANCER RES, V58, P1130; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WANG Z, 2003, CANCER RES, V63, P5243; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110	13	86	90	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2004	36	4					320	322		10.1038/ng0404-320	http://dx.doi.org/10.1038/ng0404-320			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15054482	Bronze			2022-12-17	WOS:000220647200004
J	Rustin, P				Rustin, P			Mitochondria, from cell death to proliferation	NATURE GENETICS			English	News Item							GENE; MUTATIONS; APOPTOSIS		Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rustin, P (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France.	rustin@necker.fr						Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOURGERON T, 1994, J CLIN INVEST, V93, P2514, DOI 10.1172/JCI117261; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Oberley LW, 2001, ANTIOXID REDOX SIGN, V3, P461, DOI 10.1089/15230860152409095; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523	13	86	88	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					352	353		10.1038/ng0402-352	http://dx.doi.org/10.1038/ng0402-352			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925557				2022-12-17	WOS:000174682000007
J	Shemer, R; Hershko, AY; Perk, J; Mostoslavsky, R; Tsuberi, B; Cedar, H; Buiting, K; Razin, A				Shemer, R; Hershko, AY; Perk, J; Mostoslavsky, R; Tsuberi, B; Cedar, H; Buiting, K; Razin, A			The imprinting box of the Prader-Willi/Angelman syndrome domain	NATURE GENETICS			English	Article							IGF2R GENE; SNRPN GENE; METHYLATION; ANTISENSE; MUTATION; PATTERN; WILLI	A subset of mammalian genes is monoallelically expressed in a parent-of-origin manner. These genes are subject to an imprinting process that epigenetically marks alleles according to their parental origin during gametogenesis. Imprinted genes can be organized in clusters as exemplified by the 2-Mb domain on human chromosome 15q11-q13 and its mouse orthologue on chromosome 7c (ref. 1). Loss of this 2-Mb domain on the paternal or maternal allele results in two neurogenetic disorders, Prader-Willi syndrome (PWS) or Angelman syndrome (AS), respectively. Microdeletions on the paternal allele share a 4.3-kb short region of overlap (SRO), which includes the SNRPN promoter/exon1. cause PWS and silence paternally expressed genes(2). Microdeletions on the maternal allele share a 0.88-kb SRO located 35 kb upstream to the SNRPN promoter(3), cause AS and alleviate repression of genes on the maternal allele(4). Individuals carrying both AS and PWS deletions on the paternal allele show a PWS phenotype and genotype. These observations suggest that cis elements within the AS-SRO and PWS-SRO constitute an imprinting box that regulates the entire domain on both chromosomes. Here we show that a minitransgene composed of a 200-bp Snrpn promoter/exon1 and a 1-kb sequence located approximately 35 kb upstream to the SNRPN promoter confer imprinting as judged by differential methylation, parent-of-origin-specific transcription and asynchronous replication.	Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem & Human Genet, IL-91010 Jerusalem, Israel; Univ Clin, Inst Human Genet, Essen, Germany	Hebrew University of Jerusalem; University of Duisburg Essen	Razin, A (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem & Human Genet, IL-91010 Jerusalem, Israel.							Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	12	86	87	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					440	443		10.1038/82571	http://dx.doi.org/10.1038/82571			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101841				2022-12-17	WOS:000165671700016
J	Cox, GA; Mahaffey, CL; Nystuen, A; Letts, VA; Frankel, WN				Cox, GA; Mahaffey, CL; Nystuen, A; Letts, VA; Frankel, WN			The mouse fidgetin gene defines a new role for AAA family proteins in mammalian development	NATURE GENETICS			English	Letter							ENCODES; SUBUNIT; ATPASE; DOMAIN	The mouse mutation fidget arose spontaneously in a heterogeneous albino stock(1). This mutant mouse is characterized by a side-to-side head-shaking and circling behaviour, due to reduced or absent semicircular canals(2). Fidget mice also have small eyes, associated with cell-cycle delay and insufficient growth of the retinal neural epithelium(3,4) and lower penetrance skeletal abnormalities, including pelvic girdle dysgenesis, skull bone fusions and polydactyly(2,5). By positional cloning, we found the gene mutated in fidget mice, fidgetin (Fign), which encodes a new member of the 'meiotic'(6) or subfamily-7 (SF7; ref. 7) group of ATPases associated with diverse cellular activities (AAA proteins). We also discovered two closely related mammalian genes. AAA proteins are molecular chaperones that facilitate a variety of functions, including membrane fusion, proteolysis, peroxisome biogenesis. endosome sorting and meiotic spindle formation(8), but functions for the SF7 AAA proteins are largely unknown. Fidgetin is the first mutant AAA protein found in a mammalian developmental mutant, thus defining a new role for these proteins in embryonic development.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.				NIDCD NIH HHS [DC03611] Funding Source: Medline; NINDS NIH HHS [NS32801] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032801, R01NS032801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003611] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beyer A, 1997, PROTEIN SCI, V6, P2043; Brown NL, 1998, DEVELOPMENT, V125, P4821; CARTER TC, 1950, HEREDITY, V4, P373, DOI 10.1038/hdy.1950.29; CLARKMAQUIRE S, 1994, GENETICS, V136, P53; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; Goudet J., 2001, CLADISTICS; Gruneberg H, 1943, J GENET, V45, P22, DOI 10.1007/BF02982771; GRUNEBERG HANS, 1955, JOUR GENETICS, V53, P515, DOI 10.1007/BF02981671; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Kaufmann MH, 1992, ATLAS MOUSE DEV; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KONYUKHO.BV, 1972, GENETIKA+, V8, P79; KONYUKHOV BV, 1976, DEV BIOL, V54, P13, DOI 10.1016/0012-1606(76)90282-7; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; Muller JMM, 1999, J BIOL CHEM, V274, P10154, DOI 10.1074/jbc.274.15.10154; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Swaffield JC, 1997, J MOL EVOL, V45, P549, DOI 10.1007/PL00006259; Truslove G. M., 1956, Journal of Genetics, V54, P64, DOI 10.1007/BF02981704; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	21	86	89	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					198	202		10.1038/79923	http://dx.doi.org/10.1038/79923			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017077				2022-12-17	WOS:000089638800018
J	El Meziane, A; Lehtinen, SK; Hance, N; Nijtmans, LGJ; Dunbar, D; Holt, IJ; Jacobs, HT				El Meziane, A; Lehtinen, SK; Hance, N; Nijtmans, LGJ; Dunbar, D; Holt, IJ; Jacobs, HT			A tRNA suppressor mutation in human mitochondria	NATURE GENETICS			English	Article							PROTEIN-SYNTHESIS; TRANSFER-RNAS; DNA; ENCEPHALOMYOPATHIES; ANTICODON; DISEASES; MYOPATHY; PEDIGREE; DEAFNESS; DEFECTS	Mitochondrial mutations are associated with a wide spectrum of human diseases(1,2). A common class of point mutations affects tRNA genes, and mutations in the tRNA-leu(UUR) gene (MTTL1) are the most frequently detected. In earlier studies, we showed that lung carcinoma cybrid cells containing high levels (greater than 95%) of mutated mtDNA from a patient with the pathological nucleotide pair (np) 3243 tRNA-leu(UUR) mutation can remain genotypically stable over time, and exhibit severe defects in mitochondrial respiratory metabolism(3,4). From such a cybrid containing 99% mutated mtDNA, we have isolated a spontaneous derivative that retains mutant mtDNA at this level but which has nevertheless reverted to the wild-type phenotype, based on studies of respiration, growth in selective media, mitochondrial protein synthesis and biogenesis of mitochondrial membrane complexes. The cells are heteroplasmic for a novel anticodon mutation in tRNA-leu(CUN) at np 12300, predicted to generate a suppressor tRNA capable of decoding UUR leucine codons. The suppressor mutation represents approximately 10% of the total mtDNA, but was undetectable in a muscle biopsy sample taken from the original patient or in the parental cybrid. These results indicate that the primary biochemical defect in cells with high levels of np 3243 mutated mtDNA is the inability to translate UUR leucine codons.	Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; Univ Cadi Ayyad, Fac Sci & Tech, Dept Biol, Marrakech, Morocco; Univ Dundee, Sch Med, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Tampere University; Cadi Ayyad University of Marrakech; University of Dundee; University of Glasgow	Jacobs, HT (corresponding author), Univ Tampere, Inst Med Technol, POB 607, FIN-33101 Tampere, Finland.		Jacobs, Howard T/G-2434-2011; Dunbar, Donald R/A-7093-2012	holt, ian/0000-0001-5468-0193; Jacobs, Howard/0000-0003-1895-6003				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CARBON J, 1970, J MOL BIOL, V52, P571, DOI 10.1016/0022-2836(70)90420-1; Chiu YH, 1997, GENETICS, V145, P707; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123; Fadic R, 1996, SEMIN NEUROL, V16, P11, DOI 10.1055/s-2008-1040954; HECKMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P3159, DOI 10.1073/pnas.77.6.3159; JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x; Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murgola Emanuel J., 1995, P491; Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9; PAGES D, 1991, NUCLEIC ACIDS RES, V19, P867, DOI 10.1093/nar/19.4.867; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Yokoyama Shigeyuki, 1995, P207	25	86	87	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					350	353						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537417				2022-12-17	WOS:000072755500017
J	HARRY, JL; KOOPMAN, P; BRENNAN, FE; GRAVES, JAM; RENFREE, MB				HARRY, JL; KOOPMAN, P; BRENNAN, FE; GRAVES, JAM; RENFREE, MB			WIDESPREAD EXPRESSION OF THE TESTIS-DETERMINING GENE SRY IN A MARSUPIAL	NATURE GENETICS			English	Letter							SEX-DETERMINING REGION; Y-CHROMOSOME; MOUSE TESTIS; DIFFERENTIATION; ZFY	Total RNA was extracted from pooled tammar fetuses and neonatal gonads and analysed for SRY expression using reverse transcription and polymerase chain reaction (RT-PCR). In the tammar, the gonadal primordium is first apparent at day 21 of the 26.5 day gestation. By day 25 the cytoplasmic:nuclear ratio in male pre-Sertoli cells is greater than in female cells, but it is not until two days post-partum that seminiferous cords are obvious with putative Leydig cells appearing in the interstitium(9). We initially tested for the presence of SRY transcripts from the day after the genital ridge is established (day 22 of gestation) until two days after the development of seminiferous tubules (day 4 post partum). Surprisingly, SRY expression was detected throughout this entire developmental period in male fetal tissue and in gonads from male pouch young (Fig. 1a). We therefore extended our sampling period from day 19 of gestation (early head-fold; similar to 20 somites) to 40 days after birth and established that in the tammar SRY is expressed from at least 6 days before the appearance of Sertoli cells until long after the immature testis has bully differentiated (Fig. 1b). Thus, expression of the tammar SRY gene does not result in immediate Sertoli cell differentiation.	UNIV QUEENSLAND, CTR MOLEC BIOL & BIOTECHNOL, ST LUCIA, QLD 4072, AUSTRALIA; LA TROBE UNIV, DEPT GENET & HUMAN VARIAT, BUNDOORA, VIC 3083, AUSTRALIA	University of Queensland; La Trobe University	HARRY, JL (corresponding author), UNIV MELBOURNE, DEPT ZOOL, MELBOURNE, VIC 3052, AUSTRALIA.		Koopman, Peter A/C-9416-2009; Graves, Jennifer A.M./A-1387-2008	Koopman, Peter A/0000-0001-6939-0914; Graves, Jennifer/0000-0001-6480-7856; Renfree, Marilyn/0000-0002-4589-0436				Ao Asangla, 1994, Zygote, V2, P281; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BOYER TR, 1994, BIOCHEM BIOPH RES CO, V198, P492, DOI 10.1006/bbrc.1994.1072; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CLEPET C, 1993, HUM MOL GENET, V2, P2007, DOI 10.1093/hmg/2.12.2007; FIDDLER M, 1995, AM J MED GENET, V55, P80, DOI 10.1002/ajmg.1320550121; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LOVELLBADGE R, 1993, PHILOS T R SOC B, V339, P159, DOI 10.1098/rstb.1993.0012; O WS, 1988, NATURE, V331, P716; Renfree Marilyn B., 1994, P213; SHARMAN GB, 1970, J REPROD FERTIL, V21, P57; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; ZWINGMAN T, 1993, P NATL ACAD SCI USA, V90, P814, DOI 10.1073/pnas.90.3.814	18	86	86	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1995	11	3					347	349		10.1038/ng1195-347	http://dx.doi.org/10.1038/ng1195-347			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581465				2022-12-17	WOS:A1995TC63900030
J	PENA, SDJ; SANTOS, FR; BIANCHI, NO; BRAVI, CM; CARNESE, FR; ROTHHAMMER, F; GERELSAIKHAN, T; MUNKHTUJA, B; OYUNSUREN, T				PENA, SDJ; SANTOS, FR; BIANCHI, NO; BRAVI, CM; CARNESE, FR; ROTHHAMMER, F; GERELSAIKHAN, T; MUNKHTUJA, B; OYUNSUREN, T			A MAJOR FOUNDER Y-CHROMOSOME HAPLOTYPE IN AMERINDIANS	NATURE GENETICS			English	Letter							MITOCHONDRIAL		IMBICE, LA PLATA, BUENOS AIRES, ARGENTINA; UNIV BUENOS AIRES, FAC FILOSOFIA & LETRAS, SECC ANTROPOL BIOL, BUENOS AIRES, DF, ARGENTINA; UNIV CHILE, FAC MED, DEPT BIOL CELULAR & GENET, SANTIAGO 7, CHILE; MONGOLIAN ACAD SCI, INST BIOTECHNOL, ULAANBAATAR, MONGOLIA	University of Buenos Aires; Universidad de Chile; Mongolian Academy of Sciences	PENA, SDJ (corresponding author), UNIV FED MINAS GERAIS, DEPT BIOQUIM & IMUNOL, CAIXA POSTAL 486, BR-30161970 BELO HORIZONTE, MG, BRAZIL.		Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750				BAILLIET G, 1994, AM J HUM GENET, V55, P27; CANN RL, 1994, AM J HUM GENET, V55, P7; CHAKRABORTY R, 1975, AM J PHYS ANTHROPOL, V42, P507, DOI 10.1002/ajpa.1330420319; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; GOMOLKA M, 1994, HUM GENET, V93, P592; PROUS A, 1991, ARQUEOLOGIA BRASILLE; REED TE, 1968, AM J HUM GENET, V20, P579; ROEWER L, 1993, EXS, V67, P221; SANTOS FR, 1993, HUM GENET, V90, P655; SANTOS FR, IN PRESS GENE; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; [No title captured]	13	86	89	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					15	16		10.1038/ng0995-15	http://dx.doi.org/10.1038/ng0995-15			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550307				2022-12-17	WOS:A1995RR72800009
J	GOUDIE, DR; YUILLE, MAR; LEVERSHA, MA; FURLONG, RA; CARTER, NP; LUSH, MJ; AFFARA, NA; FERGUSONSMITH, MA				GOUDIE, DR; YUILLE, MAR; LEVERSHA, MA; FURLONG, RA; CARTER, NP; LUSH, MJ; AFFARA, NA; FERGUSONSMITH, MA			MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMATA (ESS1) MAPPED TO CHROMOSOME 9Q22-Q31 IN FAMILIES WITH COMMON ANCESTRY	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; DNA-SEQUENCES; HUMAN GENOME; POLYMORPHISMS; PROGRAM; PROBES; CDNA	A gene (ESS1) predisposing to the development of multiple invasive but self-healing skin tumours (squamous cell epitheliomata) is tightly linked to the polymorphic DNA marker D9S53 (9q31) with a maximum lod score of 9.02 at a recombination fraction of 0.03. Multipoint linkage analysis demonstrates that the disease locus is most likely to lie between D9S58 (9q22.3-31) and ASSP3 (9q11-q22). Comparison of markers associated with ESS1 in independently ascertained families suggests a common origin of the disease and defines the location of ESS1. Haplotype studies indicate that the disease locus is most likely to lie between D9S29 (9q31) and D9S1 (9q22.1-q22.2).			GOUDIE, DR (corresponding author), UNIV CAMBRIDGE,IMPERIAL CANC RES FUND,GENET & TUMOUR VIRUS PATHOL UNIT,CAMBRIDGE CB2 1QP,ENGLAND.							ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BOARD PG, 1986, GENE, V44, P127, DOI 10.1016/0378-1119(86)90051-X; CARTER NP, 1991, T ROY MICROSCOP SOC, V1, P511; COTTER F, 1989, GENOMICS, V5, P470, DOI 10.1016/0888-7543(89)90011-6; DAIGER SP, 1984, AM J HUM GENET, V36, P736; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FAN YS, 1990, P NATL ACAD SCI USA, V87, P6223, DOI 10.1073/pnas.87.16.6223; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; Ferguson-Smith J., 1934, BRIT J DERMATOL, V46, P267, DOI 10.1111/j.1365-2133.1934.tb09778.x; FERGUSON-SMITH M A, 1971, Birth Defects Original Article Series, V7, P157; FERGUSONSMITH J, 1948, BRIT J DERMATOL, V60, P315; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, GENOMICS, V3, P361; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; OTT J, 1976, AM J HUM GENET, V28, P528; PANDOLFO M, 1988, NUCLEIC ACIDS RES, V16, P7213, DOI 10.1093/nar/16.14.7213; POVEY S, IN PRESS ANN HUM GEN; REIS, 1992, LANCET, V339, P617; Sambrook J., 1989, MOL CLONING; VIEGASPEQUIGNOT E, 1989, P NATL ACAD SCI USA, V86, P582, DOI 10.1073/pnas.86.2.582; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; Yuille M. A. R., 1992, Human Molecular Genetics, V1, P351, DOI 10.1093/hmg/1.5.351-a; YUILLE MAR, 1991, NUCLEIC ACIDS RES, V19, P5097, DOI 10.1093/nar/19.18.5097-a; YUILLE MAR, 1992, ANN HUM GENET, V56, P213	34	86	86	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					165	169		10.1038/ng0293-165	http://dx.doi.org/10.1038/ng0293-165			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499949				2022-12-17	WOS:A1993KL01000015
J	REEDERS, ST				REEDERS, ST			MULTILOCUS POLYCYSTIC DISEASE	NATURE GENETICS			English	Editorial Material							KIDNEY-DISEASE; PRENATAL-DIAGNOSIS				REEDERS, ST (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536, USA.							BERNSTEIN J, 1987, AM J PATHOL, V129, P92; BERNSTEIN J, 1990, CYSTIC KIDNEY, P147; BILLER DS, 1990, AM J HUM GENET, V47, pA48; BOULTER CA, IN PRESS CONTRIB NEP; DAVISSON MT, 1991, GENOMICS, V9, P778, DOI 10.1016/0888-7543(91)90376-P; DUNNILL MS, 1977, J CLIN PATHOL, V30, P868, DOI 10.1136/jcp.30.9.868; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; FRYER AE, 1987, LANCET, V1, P659; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HENRIKSEN P, 1988, J COMP PATHOL, V99, P101, DOI 10.1016/0021-9975(88)90109-0; KASPAREITRITTINGHAUSEN J, 1989, VET PATHOL, V26, P195, DOI 10.1177/030098588902600302; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; KRIINEN K, 1987, J MED GENET, V24, P474; LELLEY KA, 1991, J AM SOC NEPH, V2, P84; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; RAMSAY M, 1988, HUM GENET, V79, P73, DOI 10.1007/BF00291714; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; REEDERS ST, 1986, LANCET, V2, P6; REEDERS ST, 1990, CYSTIC KIDNEY, P117; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; SOMLO S, 1992, GENOMICS, V13, P152, DOI 10.1016/0888-7543(92)90215-E; TAKAHASHI H, 1986, J UROLOGY, V135, P1280, DOI 10.1016/S0022-5347(17)46074-5; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; WILSON PD, 1991, AM J PHYSIOL, V260, pF420, DOI 10.1152/ajprenal.1991.260.3.F420; ZERRES K, 1984, HUM GENET, V68, P104, DOI 10.1007/BF00279301	27	86	89	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					235	237		10.1038/ng0792-235	http://dx.doi.org/10.1038/ng0792-235			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1338768				2022-12-17	WOS:A1992JC98400003
J	Chen, ZY; Zhang, Y				Chen, Zhiyuan; Zhang, Yi			Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development	NATURE GENETICS			English	Article							GENE; EXPRESSION; CONSERVATION; CHROMATIN; WIDE	How maternal factors in oocytes trigger zygotic genome activation (ZGA) is a long-standing question in developmental biology. Recent studies in 2-cell-like embryonic stem cells (2C-like cells) suggest that transcription factors of the DUX family are key regulators of ZGA in placental mammals(1,2). To characterize the role of DUX in ZGA, we generated Dux cluster knockout (KO) mouse lines. Unexpectedly, we found that both Dux zygotic KO (Z-KO) and maternal and zygotic KO (MZ-KO) embryos can survive to adulthood despite showing reduced developmental potential. Furthermore, transcriptome profiling of the MZ-KO embryos revealed that loss of DUX has minimal effects on ZGA and most DUX targets in 2C-like cells are normally activated in MZ-KO embryos. Thus, contrary to the key function of DUX in inducing 2C-like cells, our data indicate that DUX has only a minor role in ZGA and that loss of DUX is compatible with mouse development.	[Chen, Zhiyuan; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Chen, Zhiyuan; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chen, Zhiyuan; Zhang, Yi] Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA 02115 USA; [Zhang, Yi] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu		Chen, Zhiyuan/0000-0002-6756-1895; Zhang, Yi/0000-0002-2789-0811	US National Institutes of Health (NIH) [R01HD092465]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092465] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank A. Inoue for training Z.C. to manipulate mouse embryos and for advice on generating the Dux KO mouse lines. We acknowledge X. Fu, C. Zhang, X. Wu and W. Zhang for helpful discussion. We thank N. Djekidel for his advice on bioinformatic analyses. This project was supported by the US National Institutes of Health (NIH) (R01HD092465) and Howard Hughes Medical Institute. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Han JX, 2014, RNA BIOL, V11, P829, DOI 10.4161/rna.29624; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Inoue A, 2018, GENE DEV, V32, P1525, DOI 10.1101/gad.318675.118; Inoue K, 2017, CELL REP, V19, P949, DOI 10.1016/j.celrep.2017.04.018; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Jin Y, 2015, BIOINFORMATICS, V31, P3593, DOI 10.1093/bioinformatics/btv422; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lu FL, 2015, NATL SCI REV, V2, P217, DOI 10.1093/nsr/nwv009; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Terrones D, 2018, NAT GENET, V50, P106, DOI 10.1038/s41588-017-0016-5; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Whiddon JL, 2017, NAT GENET, V49, P935, DOI 10.1038/ng.3846; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	31	85	86	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2019	51	6					947	+		10.1038/s41588-019-0418-7	http://dx.doi.org/10.1038/s41588-019-0418-7			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB1AY	31133747	Green Accepted			2022-12-17	WOS:000469996900006
J	Oudelaar, AM; Davies, JOJ; Hanssen, LLP; Telenius, JM; Schwessinger, R; Liu, Y; Brown, JM; Downes, DJ; Chiariello, AM; Bianco, S; Nicodemi, M; Buckle, VJ; Dekker, J; Higgs, DR; Hughes, JR				Oudelaar, A. Marieke; Davies, James O. J.; Hanssen, Lars L. P.; Telenius, Jelena M.; Schwessinger, Ron; Liu, Yu; Brown, Jill M.; Downes, Damien J.; Chiariello, Andrea M.; Bianco, Simona; Nicodemi, Mario; Buckle, Veronica J.; Dekker, Job; Higgs, Douglas R.; Hughes, Jim R.			Single-allele chromatin interactions identify regulatory hubs in dynamic compartmentalized domains	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; PHENOTYPIC ROBUSTNESS; HYPERSENSITIVE SITES; GENOME; COHESIN; ORGANIZATION; IDENTIFICATION; COMPLEXITY; PRINCIPLES; RESOLUTION	The promoters of mammalian genes are commonly regulated by multiple distal enhancers, which physically interact within discrete chromatin domains. How such domains form and how the regulatory elements within them interact in single cells is not understood. To address this we developed Tri-C, a new chromosome conformation capture (3C) approach, to characterize concurrent chromatin interactions at individual alleles. Analysis by Tri-C identifies heterogeneous patterns of single-allele interactions between CTCF boundary elements, indicating that the formation of chromatin domains likely results from a dynamic process. Within these domains, we observe specific higher-order structures that involve simultaneous interactions between multiple enhancers and promoters. Such regulatory hubs provide a structural basis for understanding how multiple cis-regulatory elements act together to establish robust regulation of gene expression.	[Oudelaar, A. Marieke; Davies, James O. J.; Hanssen, Lars L. P.; Telenius, Jelena M.; Schwessinger, Ron; Brown, Jill M.; Downes, Damien J.; Buckle, Veronica J.; Higgs, Douglas R.; Hughes, Jim R.] Univ Oxford, MRC Mol Haematol Unit, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford, England; [Oudelaar, A. Marieke; Telenius, Jelena M.; Schwessinger, Ron] Univ Oxford, MRC WIMM Ctr Computat Biol, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford, England; [Liu, Yu; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Chiariello, Andrea M.; Bianco, Simona; Nicodemi, Mario] Univ Napoli Federico II, Dipartimento Fis, Complesso Monte St Angelo, Naples, Italy; [Chiariello, Andrea M.; Bianco, Simona; Nicodemi, Mario] INFN Napoli, Complesso Monte St Angelo, Naples, Italy; [Dekker, Job] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Oxford; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Howard Hughes Medical Institute	Hughes, JR (corresponding author), Univ Oxford, MRC Mol Haematol Unit, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford, England.; Hughes, JR (corresponding author), Univ Oxford, MRC WIMM Ctr Computat Biol, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford, England.	jim.hughes@imm.ox.ac.uk	Bianco, Simona/AAC-5344-2019; Schwessinger, Ron/AAU-9904-2021; Davies, James/AAP-9555-2020; Chiariello, Andrea Maria/AAA-1544-2020; Nicodemi, Mario/K-1815-2015	Bianco, Simona/0000-0001-5819-060X; Schwessinger, Ron/0000-0001-7829-8503; Davies, James/0000-0002-4108-4357; Chiariello, Andrea Maria/0000-0002-6112-0167; Hanssen, Lars/0000-0002-2551-2278; Telenius, Jelena/0000-0003-4353-3854; LIU, YU/0000-0001-8359-6732; Brown, Jill/0000-0002-8884-2047; Nicodemi, Mario/0000-0002-8416-6416; Oudelaar, Aukje Marieke/0000-0002-4016-6158	Wellcome Trust [105281/Z/14/Z, 106130/Z/14/Z]; Medical Research Council [MR/N00969X/1, MR/R008108]; National Institutes of Health [R01 HG003143]; MRC [MR/R008108/1, MC_UU_00016/14, MC_UU_12009/1, MC_UU_00016/1, MC_UU_12009/15, MC_PC_15069, MC_U137961144, G1000801, MR/N00969X/1, MC_UU_00016/4, MC_UU_12009/4, MC_U137961145] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Wellcome Trust (Wellcome Trust Genomic Medicine and Statistics PhD Programme, reference 105281/Z/14/Z, A.M.O.; Wellcome Trust Strategic Award, reference 106130/Z/14/Z, D.R.H. and J.R.H.), the Medical Research Council (MRC Core Funding and Project Grant, reference MR/N00969X/1, V.J.B. and J.R.H.; MRC Clinician Scientist Fellowship, reference MR/R008108, J.O.J.D.) and the National Institutes of Health (reference R01 HG003143, J.D.). J.D. is an investigator of the Howard Hughes Medical Institute. We thank D. Hay and M. Kassouf for advice and R. Gibbons and H. Ayyub for help with Oxford Nanopore MinION sequencing.	Allahyar A, 2018, NAT GENET, V50, P1151, DOI 10.1038/s41588-018-0161-5; Ay F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1236-7; Barbieri M, 2017, NAT STRUCT MOL BIOL, V24, P515, DOI 10.1038/nsmb.3402; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Brown JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06248-4; Cattoni DI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01962-x; Chiariello AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29775; Darrow EM, 2016, P NATL ACAD SCI USA, V113, pE4504, DOI 10.1073/pnas.1609643113; Davies J.O.J., 2015, NAT METH, V86, P1202; Davies JOJ, 2017, NAT METHODS, V14, P125, DOI 10.1038/nmeth.4146; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gavrilov AA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1322; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Hanssen LLP, 2017, NAT CELL BIOL, V19, P952, DOI 10.1038/ncb3573; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jiang TT, 2016, NUCLEIC ACIDS RES, V44, P8714, DOI 10.1093/nar/gkw568; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kruse K, 2016, BIOINFORMATICS, V32, P3190, DOI 10.1093/bioinformatics/btw368; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marieke Oudelaar A., 2018, PROTOC EXCHANGE, DOI [10.1038/protex.2018.113, DOI 10.1038/PROTEX.2018.113]; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Olivares-Chauvet P, 2016, NATURE, V540, P296, DOI 10.1038/nature20158; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Oudelaar AM, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1194; Oudelaar AM, 2017, HUM MOL GENET, V26, pR208, DOI 10.1093/hmg/ddx306; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Quinodoz SA, 2018, CELL, V174, P744, DOI 10.1016/j.cell.2018.05.024; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rhodes J, 2017, ELIFE, V6, DOI 10.7554/eLife.30000; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schwartzman O, 2016, NAT METHODS, V13, P685, DOI 10.1038/nmeth.3922; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004	52	85	87	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1744	+		10.1038/s41588-018-0253-2	http://dx.doi.org/10.1038/s41588-018-0253-2			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30374068	Green Submitted, Green Accepted			2022-12-17	WOS:000451434400022
J	Grarup, N; Moltke, I; Andersen, MK; Dalby, M; Vitting-Seerup, K; Kern, T; Mahendran, Y; Jorsboe, E; Larsen, CVL; Dahl-Petersen, IK; Gilly, A; Suveges, D; Dedoussis, G; Zeggini, E; Pedersen, O; Andersson, R; Bjerregaard, P; Jorgensen, ME; Albrechtsen, A; Hansen, T				Grarup, Niels; Moltke, Ida; Andersen, Mette K.; Dalby, Maria; Vitting-Seerup, Kristoffer; Kern, Timo; Mahendran, Yuvaraj; Jorsboe, Emil; Larsen, Christina V. L.; Dahl-Petersen, Inger K.; Gilly, Arthur; Suveges, Daniel; Dedoussis, George; Zeggini, Eleftheria; Pedersen, Oluf; Andersson, Robin; Bjerregaard, Peter; Jorgensen, Marit E.; Albrechtsen, Anders; Hansen, Torben			Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes	NATURE GENETICS			English	Article							INSULIN-RESISTANCE; ASSOCIATION; QUANTIFICATION; INDIVIDUALS; GLUCOSE; INDEX	We have identified a variant in ADCY3 (encoding adenylate cyclase 3) associated with markedly increased risk of obesity and type 2 diabetes in the Greenlandic population. The variant disrupts a splice acceptor site, and carriers have decreased ADCY3 RNA expression. Additionally, we observe an enrichment of rare ADCY3 loss-of-function variants among individuals with type 2 diabetes in trans-ancestry cohorts. These findings provide new information on disease etiology relevant for future treatment strategies.	[Grarup, Niels; Andersen, Mette K.; Kern, Timo; Mahendran, Yuvaraj; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Moltke, Ida; Dalby, Maria; Vitting-Seerup, Kristoffer; Jorsboe, Emil; Andersson, Robin; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Vitting-Seerup, Kristoffer] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Larsen, Christina V. L.; Dahl-Petersen, Inger K.; Bjerregaard, Peter; Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Larsen, Christina V. L.; Bjerregaard, Peter; Jorgensen, Marit E.] Univ Greenland, Greenland Ctr Hlth Res, Nuuk, Greenland; [Gilly, Arthur; Suveges, Daniel; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Dedoussis, George] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece; [Jorgensen, Marit E.] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Wellcome Trust Sanger Institute; Harokopio University Athens; Steno Diabetes Center; University of Southern Denmark	Hansen, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.; Albrechtsen, A (corresponding author), Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark.; Jorgensen, ME (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.; Jorgensen, ME (corresponding author), Univ Greenland, Greenland Ctr Hlth Res, Nuuk, Greenland.; Jorgensen, ME (corresponding author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.; Hansen, T (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.	marit.eika.joergensen@regionh.dk; albrecht@binf.ku.dk; torben.hansen@sund.ku.dk	Moltke, Ida/C-6158-2011; Andersson, Robin/B-5311-2009; Bjerregaard, Peter/ABD-8894-2020; Vitting-Seerup, Kristoffer/AAE-4069-2021; Pedersen, Oluf/Z-1731-2019; Albrechtsen, Anders/K-4281-2013; Grarup, Niels/K-2807-2015; Vitting-Seerup, Kristoffer/C-9008-2015; Pedersen, Oluf/AAG-8015-2020; Dedoussis, George/AAN-7252-2021	Moltke, Ida/0000-0001-7052-8554; Andersson, Robin/0000-0003-1516-879X; Bjerregaard, Peter/0000-0001-7153-8447; Pedersen, Oluf/0000-0002-3321-3972; Albrechtsen, Anders/0000-0001-7306-031X; Grarup, Niels/0000-0001-5526-1070; Vitting-Seerup, Kristoffer/0000-0002-6450-0608; Dedoussis, George/0000-0002-7798-6221; Kern, Timo/0000-0001-7139-9766; Jorgensen, Marit Eika/0000-0001-8356-5565; Jorsboe, Emil/0000-0002-0593-7906; Hansen, Torben/0000-0001-8748-3831; Suveges, Daniel/0000-0003-4133-0447; Andersen, Mette korre/0000-0001-8227-1469; Larsen, Christina Viskum Lytken/0000-0002-6245-4222; Dahl-Petersen, Inger/0000-0002-3157-8847	Danish Council for Independent Research [11-120909, DFF-4090-00244, 6108-00038B, DFF-4181-00383]; Steno Diabetes Center Copenhagen; Simon Fougner Hartmanns Familiefond; Lundbeck Foundation [R215-2015-4174]; Novo Nordisk Foundation [NNF15OC0017918, NNF16OC0019986, NNFCC0018486]; European Research Council (ERC) under the European Union's Horizon research and innovation programme [638173]; Karen Elise Jensen's Foundation; Department of Health in Greenland; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research [Grarup Group, Pedersen Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF17SH0027192, NNF15SA0018486, NNF15OC0017918, NNF17OC0028136, NNF16OC0019986] Funding Source: researchfish; Steno Diabetes Center Copenhagen (SDCC) [SDCC 3. B Epidemiology] Funding Source: researchfish	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Steno Diabetes Center Copenhagen; Simon Fougner Hartmanns Familiefond; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC)); Karen Elise Jensen's Foundation; Department of Health in Greenland; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Steno Diabetes Center Copenhagen (SDCC)	We gratefully acknowledge the participants in the Greenlandic health surveys. We thank J. Flannick (Broad Institute) for help with obtaining the AMP-T2D exome sequencing data. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk). This project was also funded by the Danish Council for Independent Research (Sapere Aude DFF-Ung Eliteforsker grant 11-120909 from FSS to I.M.; DFF-4090-00244 from FNU to I.M.; Sapere Aude DFF-Forskningsleder 6108-00038B from FNU to R.A.; DFF-4181-00383 to A.A.), the Steno Diabetes Center Copenhagen (http://www.steno.dk), Simon Fougner Hartmanns Familiefond to N.G., the Lundbeck Foundation (R215-2015-4174) to A.A., the Novo Nordisk Foundation (NNF15OC0017918 to N.G.; NNF16OC0019986 to N.G.; NNFCC0018486 to T.H.) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 638173) to R.A. The Greenlandic health surveys (IHIT and B99) were supported by Karen Elise Jensen's Foundation, the Department of Health in Greenland, NunaFonden, the Medical Research Council of Denmark, the Medical Research Council of Greenland and the Commission for Scientific Research in Greenland.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andersen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006119; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bjerregaard P., 2003, INT J CIRCUMPOLAR S1, V62, P1; Bjerregaard P, 2010, INUIT HLTH TRANSITIO; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Laakso M, 2017, J LIPID RES, V58, P481, DOI 10.1194/jlr.O072629; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066883; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Panoutsopoulou K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6345; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pedersen CET, 2017, GENETICS, V205, P787, DOI 10.1534/genetics.116.193821; Philipsen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123062; Pitman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110226; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tong T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34179; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaisse C, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028217; Vitting-Seerup K, 2017, MOL CANCER RES, V15, P1206, DOI 10.1158/1541-7786.MCR-16-0459; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Warrington NM, 2015, INT J EPIDEMIOL, V44, P700, DOI 10.1093/ije/dyv077; World Health Organization, 1999, DEF DIAGN CLASS DIAB; Xu TR, 2013, CELL SIGNAL, V25, P2413, DOI 10.1016/j.cellsig.2013.07.025; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	39	85	90	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					172	+		10.1038/s41588-017-0022-7	http://dx.doi.org/10.1038/s41588-017-0022-7			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29311636	Green Submitted, Green Accepted			2022-12-17	WOS:000424519200006
J	Takeuchi, M; Mizuki, N; Meguro, A; Ombrello, MJ; Kirino, Y; Satorius, C; Le, J; Blake, M; Erer, B; Kawagoe, T; Ustek, D; Tugal-Tutkun, I; Seyahi, E; Ozyazgan, Y; Sousa, I; Davatchi, F; Francisco, V; Shahram, F; Abdollahi, BS; Nadji, A; Shafiee, NM; Ghaderibarmi, F; Ohno, S; Ueda, A; Ishigatsubo, Y; Gadina, M; Oliveira, SA; Gul, A; Kastner, DL; Remmers, EF				Takeuchi, Masaki; Mizuki, Nobuhisa; Meguro, Akira; Ombrello, Michael J.; Kirino, Yohei; Satorius, Colleen; Le, Julie; Blake, Mary; Erer, Burak; Kawagoe, Tatsukata; Ustek, Duran; Tugal-Tutkun, Ilknur; Seyahi, Emire; Ozyazgan, Yilmaz; Sousa, Ines; Davatchi, Fereydoun; Francisco, Vania; Shahram, Farhad; Abdollahi, Bahar Sadeghi; Nadji, Abdolhadi; Shafiee, Niloofar Mojarad; Ghaderibarmi, Fahmida; Ohno, Shigeaki; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki; Gadina, Massimo; Oliveira, Sofia A.; Gul, Ahmet; Kastner, Daniel L.; Remmers, Elaine F.			Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MHC CLASS-I; CROHNS-DISEASE; GENE POLYMORPHISMS; FUT2; RISK; LEPROSY; HLA-B-ASTERISK-51; IL23R-IL12RB2	We analyzed 1,900 Turkish Behcet's disease cases and 1,779 controls genotyped with the Immunochip. The most significantly associated SNP was rs1050502, a tag SNP for HLA-B*51. In the Turkish discovery set, we identified three new risk loci, IL1A-IL18, IRF8, and CEBPB-PTPN1, with genomewide significance (P < 5 x 10(-8)) by direct genotyping and ADO-EGR2 by imputation. We replicated the ADO-EGR2, IRF8, and CEBPB-PTPN1 loci by genotyping 969 Iranian cases and 826 controls. Imputed data in 608 Japanese cases and 737 controls further replicated ADO-EGR2 and IRF8, and meta analysis additionally identified R1PK2 and LACC1. The disease associated allele of rs4402765, the lead marker at 11.1A-ILIB, was associated with both decreased IL-1 alpha and increased IL-1 beta production. ABO non-secretor genotypes for two ancestry specific FUT2 SNPs showed strong disease association (P = 5.89 x 10(-15)). Our findings extend the list of susceptibility genes shared with Crohn's disease and leprosy and implicate mucosal factors and the innate immune response to microbial exposure in Behcet's disease susceptibility.	[Takeuchi, Masaki; Satorius, Colleen; Le, Julie; Erer, Burak; Kastner, Daniel L.; Remmers, Elaine F.] NHGRI, Inflammatory Dis Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Takeuchi, Masaki; Mizuki, Nobuhisa; Meguro, Akira; Kawagoe, Tatsukata] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Yokohama, Kanagawa, Japan; [Ombrello, Michael J.] NIAMSD, Translat Genet & Genom Unit, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Kirino, Yohei; Ueda, Atsuhisa; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Stem Cell & Immune Regulat, Yokohama, Kanagawa, Japan; [Blake, Mary; Gadina, Massimo] NIAMSD, Translat Immunol Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Ustek, Duran] Istanbul Univ, Inst Expt Med, Dept Genet, Istanbul, Turkey; [Tugal-Tutkun, Ilknur] Istanbul Univ, Istanbul Fac Med, Dept Ophthalmol, Istanbul, Turkey; [Seyahi, Emire] Istanbul Univ, Cerrahpasa Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey; [Ozyazgan, Yilmaz] Istanbul Univ, Cerrahpasa Fac Med, Dept Ophthalmol, Istanbul, Turkey; [Sousa, Ines; Francisco, Vania; Oliveira, Sofia A.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Sousa, Ines; Francisco, Vania; Oliveira, Sofia A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Davatchi, Fereydoun; Shahram, Farhad; Abdollahi, Bahar Sadeghi; Nadji, Abdolhadi; Shafiee, Niloofar Mojarad; Ghaderibarmi, Fahmida] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran; [Ohno, Shigeaki] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Gul, Ahmet] Istanbul Univ, Istanbul Fac Med, Div Rheumatol, Dept Internal Med, Istanbul, Turkey	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Istanbul University; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Tehran University of Medical Sciences; Hokkaido University; Istanbul University	Kastner, DL; Remmers, EF (corresponding author), NHGRI, Inflammatory Dis Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; elaine.remmers@nih.gov	Seyahi, Emire/AAD-1769-2021; Kirino, Yohei/B-3701-2009; erer, burak/AAR-5866-2021; Gul, Ahmet/AAT-7787-2020; SEYAHI, EMIRE/AAB-3576-2020; Shahram, Farhad/A-7071-2019	Kirino, Yohei/0000-0002-9488-661X; Gul, Ahmet/0000-0001-8219-3720; Shahram, Farhad/0000-0003-1830-6203; Ombrello, Michael/0000-0003-3322-4089; Remmers, Elaine F/0000-0002-9522-1249	Intramural Research Programs of the National Human Genome Research Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Fellowship for Japanese Biomedical and Behavioral Researchers at the NIH from the Japan Society for the Promotion of Science Research; Japan Foundation for Applied Enzymology; Japan Society for the Promotion of Science [26713036]; Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation; SENSHIN Medical Research Foundation; Yokohama Foundation for Advancement of Medical Science; Portuguese Fundacao para a Ciencia e a Tecnologia (Investigator-FCT) [CMUP-ERI/TPE/0028/2013, SFRH/BPD/70008/2010]; Research Committee of the Tehran University of Medical Sciences [132/714]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041181, Z01AR041083, ZIAAR041198] Funding Source: NIH RePORTER	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fellowship for Japanese Biomedical and Behavioral Researchers at the NIH from the Japan Society for the Promotion of Science Research; Japan Foundation for Applied Enzymology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for the Promotion of Medical Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Yokohama Foundation for Advancement of Medical Science; Portuguese Fundacao para a Ciencia e a Tecnologia (Investigator-FCT); Research Committee of the Tehran University of Medical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Programs of the National Human Genome Research Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases. We thank all the patients, the healthy controls, and medical staff for their enthusiastic support during this research study. M.T. is supported by a Fellowship for Japanese Biomedical and Behavioral Researchers at the NIH from the Japan Society for the Promotion of Science Research and a grant from the Japan Foundation for Applied Enzymology. Y.K. is supported by grants from the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (grant 26713036), the Kanae Foundation for the Promotion of Medical Science, the Takeda Science Foundation, the SENSHIN Medical Research Foundation, and the Yokohama Foundation for Advancement of Medical Science. This research was also supported by the Portuguese Fundacao para a Ciencia e a Tecnologia (grant CMUP-ERI/TPE/0028/2013, fellowship SFRH/BPD/70008/2010 to I.S., and an Investigator-FCT contract to S.A.O.) and the Research Committee of the Tehran University of Medical Sciences (grant 132/714). We thank A.F. Wilson for insightful comments on this manuscript.	Barland CO, 2004, J INVEST DERMATOL, V122, P330, DOI 10.1046/j.0022-202X.2004.22203.x; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Caso F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/107421; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gul A, 2012, ANN RHEUM DIS, V71, P563, DOI 10.1136/annrheumdis-2011-155143; Gul A, 2012, OCUL IMMUNOL INFLAMM, V20, P37, DOI 10.3109/09273948.2011.634978; Hatemi G, 2008, ANN RHEUM DIS, V67, P1656, DOI 10.1136/ard.2007.080432; Hatemi I, 2008, CLIN EXP RHEUMATOL, V26, pS91; Hu DY, 2014, J GASTROEN HEPATOL, V29, P1778, DOI 10.1111/jgh.12599; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kappen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119085; Kim EH, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0086-z; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Li H, 2013, HUM GENET, V132, P293, DOI 10.1007/s00439-012-1250-7; Liang L, 2013, INVEST OPHTH VIS SCI, V54, P402, DOI 10.1167/iovs.12-11047; Liu H, 2015, NAT GENET, V47, P267, DOI 10.1038/ng.3212; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; OHNO S, 1973, LANCET, V2, P1383; Ombrello MJ, 2014, P NATL ACAD SCI USA, V111, P8867, DOI 10.1073/pnas.1406575111; Ortiz-Fernandez L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161305; Patel N, 2014, GUT, V63, P1831, DOI 10.1136/gutjnl-2014-307859; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rupp C, 2014, ALIMENT PHARM THER, V39, P873, DOI 10.1111/apt.12663; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; Xavier JM, 2015, ANN RHEUM DIS, V74, P618, DOI 10.1136/annrheumdis-2013-204475; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zierhut M, 2003, CELL MOL LIFE SCI, V60, P1903, DOI 10.1007/s00018-003-2333-3	42	85	90	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					438	443		10.1038/ng.3786	http://dx.doi.org/10.1038/ng.3786			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	28166214	Green Accepted			2022-12-17	WOS:000394917800018
J	Hore, V; Vinuela, A; Buil, A; Knight, J; McCarthy, MI; Small, K; Marchini, J				Hore, Victoria; Vinuela, Ana; Buil, Alfonso; Knight, Julian; McCarthy, Mark I.; Small, Kerrin; Marchini, Jonathan			Tensor decomposition for multiple-tissue gene expression experiments	NATURE GENETICS			English	Article							IDENTIFICATION; REGULATOR; PHENOTYPES; THOUSANDS; COMPONENT; HUMANS; FUSION; EQTLS; LOCI; RNA	Genome-wide association studies of gene expression traits and other cellular phenotypes have successfully identified links between genetic variation and biological processes. The majority of discoveries have uncovered cis-expression quantitative trait locus (eQTL) effects via mass univariate testing of SNPs against gene expression in single tissues. Here we present a Bayesian method for multiple-tissue experiments focusing on uncovering gene networks linked to genetic variation. Our method decomposes the 3D array (or tensor) of gene expression measurements into a set of latent components. We identify sparse gene networks that can then be tested for association against genetic variation across the genome. We apply our method to a data set of 845 individuals from the TwinsUK cohort with gene expression measured via RNA-seq analysis in adipose, lymphoblastoid cell lines (LCLs) and skin. We uncover several gene networks with a genetic basis and clear biological and statistical significance. Extensions of this approach will allow integration of different omics, environmental and phenotypic data sets.	[Hore, Victoria; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford, England; [Vinuela, Ana; Small, Kerrin] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Buil, Alfonso] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Knight, Julian; McCarthy, Mark I.; Marchini, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Oxford; University of London; King's College London; University of Geneva; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Marchini, J (corresponding author), Univ Oxford, Dept Stat, Oxford, England.; Marchini, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	marchini@stats.ox.ac.uk	Knight, Julian Charles/W-2399-2019; Viñuela, Ana/L-5015-2019; Marchini, Jonathan/ABE-9024-2020; McCarthy, Mark/M-3763-2015	Knight, Julian Charles/0000-0002-0377-5536; Viñuela, Ana/0000-0003-3771-8537; Marchini, Jonathan/0000-0003-0610-8322; Small, Kerrin/0000-0003-4566-0005; McCarthy, Mark/0000-0002-4393-0510	Wellcome Trust; European Community; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; European Union [259749]; EPSRC through Life Sciences Interface program of the University of Oxford's Doctoral Training Center; ERC [617306]; Engineering and Physical Sciences Research Council [1104931] Funding Source: researchfish; Medical Research Council [MR/L01999X/1] Funding Source: researchfish; MRC [MR/L01999X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; European Union(European Commission); EPSRC through Life Sciences Interface program of the University of Oxford's Doctoral Training Center(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to A. Dahl, W. Kretzschmar, K. Sharp, L. Elliot and S. Myers for helpful discussions about the method and interpretation of the results. The TwinsUK cohort was funded by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust and the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. SNP genotyping was performed by the Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. A.V. and A.B. were supported by European Union Framework Programme 7 grant EuroBATS (259749). V.H. acknowledges the EPSRC for funding through a studentship at the Life Sciences Interface program of the University of Oxford's Doctoral Training Center. J.M. acknowledges support from the ERC (grant 617306).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoff PD, 2011, COMPUT STAT DATA AN, V55, P530, DOI 10.1016/j.csda.2010.05.020; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Khan S. A., 2014, PREPRINT; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lemire M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7326; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050; MITCHELL TJ, 1988, J AM STAT ASSOC, V83, P1023, DOI 10.2307/2290129; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pai AA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004857; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sun SL, 2013, NEURAL COMPUT APPL, V23, P2031, DOI 10.1007/s00521-013-1362-6; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yao C, 2015, CIRCULATION, V131, P536, DOI 10.1161/CIRCULATIONAHA.114.010696; Yener B, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-63; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	42	85	85	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1094	+		10.1038/ng.3624	http://dx.doi.org/10.1038/ng.3624			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27479908	Green Accepted, Green Submitted			2022-12-17	WOS:000382398800024
J	Sveinbjornsson, G; Gudbjartsson, DF; Halldorsson, BV; Kristinsson, KG; Gottfredsson, M; Barrett, JC; Gudmundsson, LJ; Blondal, K; Gylfason, A; Gudjonsson, SA; Helgadottir, HT; Jonasdottir, A; Jonasdottir, A; Karason, A; Kardum, LB; Knezevic, J; Kristjansson, H; Kristjansson, M; Love, A; Luo, Y; Magnusson, OT; Sulem, P; Kong, A; Masson, G; Thorsteinsdottir, U; Dembic, Z; Nejentsev, S; Blondal, T; Jonsdottir, I; Stefansson, K				Sveinbjornsson, Gardar; Gudbjartsson, Daniel F.; Halldorsson, Bjarni V.; Kristinsson, Karl G.; Gottfredsson, Magnus; Barrett, Jeffrey C.; Gudmundsson, Larus J.; Blondal, Kai; Gylfason, Arnaldur; Gudjonsson, Sigurjon Axel; Helgadottir, Hafdis T.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Karason, Ari; Kardum, Ljiljana Bulat; Knezevic, Jelena; Kristjansson, Helgi; Kristjansson, Mar; Love, Arthur; Luo, Yang; Magnusson, Olafur T.; Sulem, Patrick; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Dembic, Zlatko; Nejentsev, Sergey; Blondal, Thorsteinn; Jonsdottir, Ingileif; Stefansson, Kari			HLA class II sequence variants influence tuberculosis risk in populations of European ancestry	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CELIAC-DISEASE; SUSCEPTIBILITY; MHC; MOLECULES; CELLS; DQ	Mycobacterium tuberculosis infections cause 9 million new tuberculosis cases and 1.5 million deaths annually'. To identify variants conferring risk of tuberculosis, we tested 28.3 million variants identified through whole-genome sequencing of 2,636 Icelanders for association with tuberculosis (8,162 cases and 277,643 controls), pulmonary tuberculosis (PTB) and M. tuberculosis infection. We found association of three variants in the region harboring genes encoding the class II human leukocyte antigens (HLAs): rs557011 [T] (minor allele frequency (MAF) = 40.2%), associated with M. tuberculosis infection (odds ratio (OR) = 1.14, P = 3.1 x 10(-13)) and PTB (OR =1.25, P = 5.8 x 10(-12)), and rs9271378[G] (MAF = 32.5%), associated with PTB (OR = 0.78, P = 2.5 x 10(-12)) both located between HLA-DQA1 and HLA-DRB1 and a missense variant encoding p.Ala210Thr in HLA-DQA1 (MAF = 19.1%, rs9272785), associated with M. tuberculosis infection (P = 9.3 x 10(-9), OR = 1.14). We replicated association of these variants with PTB in samples of European ancestry from Russia and Croatia (P < 5.9 x 10(-4)). These findings show that the HLA class II region contributes to genetic risk of tuberculosis, possibly through reduced presentation of protective M. tuberculosis antigens to T cells.	[Sveinbjornsson, Gardar; Gudbjartsson, Daniel F.; Halldorsson, Bjarni V.; Gudmundsson, Larus J.; Gylfason, Arnaldur; Gudjonsson, Sigurjon Axel; Helgadottir, Hafdis T.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Karason, Ari; Kristjansson, Helgi; Magnusson, Olafur T.; Sulem, Patrick; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Sveinbjornsson, Gardar; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, Sch Sci & Engn, Reykjavik, Iceland; [Kristinsson, Karl G.; Gottfredsson, Magnus; Kristjansson, Helgi; Love, Arthur; Thorsteinsdottir, Unnur; Jonsdottir, Ingileif; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Kristinsson, Karl G.] Natl Univ Hosp Iceland, Dept Clin Microbiol, Landspitali, Reykjavik, Iceland; [Gottfredsson, Magnus; Kristjansson, Mar] Natl Univ Hosp Iceland, Dept Infect Dis, Landspitali, Reykjavik, Iceland; [Barrett, Jeffrey C.; Luo, Yang] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Blondal, Kai; Blondal, Thorsteinn] Primary Hlth Care Capital Area, Div Communicable Dis Prevent & Control, Reykjavik, Iceland; [Kardum, Ljiljana Bulat] Univ Rijeka, Dept Pulmonol, Clin Internal Med, Clin Hosp Ctr, Rijeka, Croatia; [Knezevic, Jelena; Dembic, Zlatko] Univ Oslo, Fac Dent, Dept Oral Biol, Mol Genet Lab, Oslo, Norway; [Knezevic, Jelena] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Love, Arthur] Natl Univ Hosp Iceland, Landspitali, Dept Virol, Reykjavik, Iceland; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Jonsdottir, Ingileif] Natl Univ Hosp Iceland, Landspitali, Dept Immunol, Reykjavik, Iceland	University of Iceland; Reykjavik University; University of Iceland; Wellcome Trust Sanger Institute; University of Rijeka; University of Oslo; Rudjer Boskovic Institute; Landspitali National University Hospital; University of Cambridge; Landspitali National University Hospital	Jonsdottir, I; Stefansson, K (corresponding author), Amgen Inc, deCODE Genet, Reykjavik, Iceland.; Jonsdottir, I; Stefansson, K (corresponding author), Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland.; Jonsdottir, I (corresponding author), Natl Univ Hosp Iceland, Landspitali, Dept Immunol, Reykjavik, Iceland.	ingileif.jonsdottir@decode.is; kstefans@decode.is	Dembic, Zlatko/ABG-7997-2020; Gottfredsson, Magnus/AAD-9086-2020; Stefansson, Kari/AAE-7187-2019	Dembic, Zlatko/0000-0002-9970-6497; Gottfredsson, Magnus/0000-0003-2465-0422; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Halldorsson, Bjarni/0000-0003-0756-0767; Sveinbjornsson, Gardar/0000-0003-2429-9468; Knezevic, Jelena/0000-0002-3152-3563; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgadottir, Hafdis/0000-0003-4352-152X; Barrett, Jeffrey/0000-0002-1152-370X; Masson, Gisli/0000-0003-0493-8242	US National Institute of Allergy and Infectious Diseases [HHSN266200400064C]; UK Wellcome Trust [088838/Z/09/Z, 095198/Z/10/Z]; EU Framework Programme 7 Collaborative (University of Cambridge) [201483]; European Research Council Starting [260477]; Royal Society [UF0763346, RG090638]; Wellcome Trust Senior Research fellowship; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK Wellcome Trust(Wellcome Trust); EU Framework Programme 7 Collaborative (University of Cambridge); European Research Council Starting(European Research Council (ERC)); Royal Society(Royal Society of London); Wellcome Trust Senior Research fellowship(Wellcome Trust); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors thank the study participants and the staff at the Patient Recruitment Center and the deCODE genetics core facilities. We thank S. Balen (University of Rijeka) and M. Balija (Croatian Institute for Transfusion Medicine) for assistance in the collection of blood samples, S. Grle-Popovic for assistance in collection of blood samples of tuberculosis patients treated at the University Hospital Center, Zagreb, and J. Pavelic (Ruder Bo'SkoviC Institute) for providing resources and advice. This work was supported:by the US National Institute of Allergy and Infectious Diseases grant HHSN266200400064C (deCODE Genetics, A. Kong, K.G.K., M.G., M.K.), UK Wellcome Trust grants 088838/Z/09/Z and 095198/Z/10/Z (S.N.), EU Framework Programme 7 Collaborative grant 201483 (University of Cambridge and S.N.), European Research Council Starting grant 260477 and Royal Society grants UF0763346 and RG090638 (S.N.). S.N. is also supported by a Wellcome Trust Senior Research fellowship and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre.	Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; Arlehamn CSL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00124; Arlehamn CSL, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018465; Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556; Bothamley GH, 2008, EUR RESPIR J, V32, P1023, DOI 10.1183/09031936.00011708; Busch R, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.9; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/EPI.12.18, 10.2217/epi.12.18]; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cho KJ, 2015, P NATL ACAD SCI USA, V112, P10449, DOI 10.1073/pnas.1507981112; Cobat A, 2015, J INFECT DIS, V211, P317, DOI 10.1093/infdis/jiu446; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fox GJ, 2013, ADV EXP MED BIOL, V783, P1, DOI 10.1007/978-1-4614-6111-1_1; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; Meyer CG, 2014, SEMIN IMMUNOL, V26, P445, DOI 10.1016/j.smim.2014.09.005; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Rider LG, 2007, AUTOIMMUN REV, V6, P241, DOI 10.1016/j.autrev.2006.08.009; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Sigurdsson S., 1976, LAEKNABLADID, V62, P3; Sigurdsson Sigurdur, 2005, Laeknabladid, V91, P69; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; World Health Organization, 2014, WHOHTMTB201408; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3	35	85	87	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					318	322		10.1038/ng.3498	http://dx.doi.org/10.1038/ng.3498			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829749	Green Accepted			2022-12-17	WOS:000370902600017
J	Mancuso, N; Rohland, N; Rand, KA; Tandon, A; Allen, A; Quinque, D; Mallick, S; Li, H; Stram, A; Sheng, X; Kote-Jarai, Z; Easton, DF; Eeles, RA; Le Marchand, L; Lubwama, A; Stram, D; Watya, S; Conti, DV; Henderson, B; Haiman, CA; Pasaniuc, B; Reich, D				Mancuso, Nicholas; Rohland, Nadin; Rand, Kristin A.; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Stram, Alex; Sheng, Xin; Kote-Jarai, Zsofia; Easton, Douglas F.; Eeles, Rosalind A.; Le Marchand, Loic; Lubwama, Alex; Stram, Daniel; Watya, Stephen; Conti, David V.; Henderson, Brian; Haiman, Christopher A.; Pasaniuc, Bogdan; Reich, David		PRACTICAL Consortium	The contribution of rare variation to prostate cancer heritability	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; LOW-FREQUENCY; SEQUENCE VARIANTS; COMPLEX TRAIT; MULTIPLE LOCI; RISK; 8Q24; COMMON; IDENTIFICATION	We report targeted sequencing of 63 known prostate cancer risk regions in a multi-ancestry study of 9,237 men and use the data to explore the contribution of low-frequency variation to disease risk. We show that SNPs with minor allele frequencies (MAFs) of 0.1-1% explain a substantial fraction of prostate cancer risk in men of African ancestry. We estimate that these SNPs account for 0.12 (standard error (s.e.) = 0.05) of variance in risk (similar to 42% of the variance contributed by SNPs with MAF of 0.1-50%). This contribution is much larger than the fraction of neutral variation due to SNPs in this class, implying that natural selection has driven down the frequency of many prostate cancer risk alleles; we estimate the coupling between selection and allelic effects at 0.48 (95% confidence interval [0.19, 0.78]) under the Eyre-Walker model. Our results indicate that rare variants make a disproportionate contribution to genetic risk for prostate cancer and suggest the possibility that rare variants may also have an outsize effect on other common traits.	[Mancuso, Nicholas; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rohland, Nadin; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Rohland, Nadin; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Reich, David] Broad Inst, Cambridge, MA USA; [Rand, Kristin A.; Stram, Alex; Sheng, Xin; Stram, Daniel; Conti, David V.; Henderson, Brian; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Rand, Kristin A.; Stram, Daniel; Conti, David V.; Henderson, Brian; Haiman, Christopher A.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA; [Lubwama, Alex; Watya, Stephen] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; University of Southern California; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research Center of Hawaii; University of Hawaii System; Makerere University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	christopher.haiman@med.usc.edu; pasaniuc@ucla.edu; reich@genetics.med.harvard.edu	Li, Heng/D-9344-2011; Mancuso, Nicholas/GLQ-8627-2022	Li, Heng/0000-0003-4874-2874; Pasaniuc, Bogdan/0000-0002-0227-2056; Eeles, Rosalind/0000-0002-3698-6241; batra, Jyotsna/0000-0003-4646-6247; Mancuso, Nicholas/0000-0002-9352-5927	US National Institutes of Health [R01 CA165862, U19 CA148537, UM1 CA164973, RC2 CA148085, U01 CA1326792, R21 CA182821, U01 CA188392, CA128978]; European Community [223175]; Cancer Research UK [C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565]; Post-Cancer GWAS initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; US Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR); Komen Foundation; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [U19CA148065, U19CA148537, R01CA128978, U19CA148112] Funding Source: NIH RePORTER; Cancer Research UK [17528, 15007, 16563] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Cancer Research UK(Cancer Research UK); Post-Cancer GWAS initiative; US Department of Defense(United States Department of Defense); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work is supported in part by the US National Institutes of Health (R01 CA165862, U19 CA148537, UM1 CA164973, RC2 CA148085, U01 CA1326792, R21 CA182821 and U01 CA188392). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Many of the risk regions examined were discovered through contributions from: P. Hall (COGS), D.F.E., P. Pharoah, K. Michailidou, M.K. Bolla and Q. Wang (BCAC), A. Berchuck (OCAC), R.A.E., D.F.E., A.A. Al Olama, Z.K.-J. and S. Benlloch (PRACTICAL), G. Chenevix-Trench, A. Antoniou, L. McGuffog, F. Couch and K. Offit (CIMBA), J. Dennis, A.M. Dunning, A. Lee, E. Dicks, C. Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, J. Benitez, A. Gonzalez-Neira and the staff of the CNIO genotyping unit, J. Simard, D.V.C. Tessier, F. Bacot, D. Vincent, S. LaBoissiere, F. Robidoux and the staff of the McGill University and Genome Quebec Innovation Centre, S.E. Bojesen, S.F. Nielsen, B.G. Nordestgaard and the staff of the Copenhagen DNA laboratory, and J.M. Cunningham, S.A. Windebank, C.A. Hilker, J. Meyer and the staff of the Mayo Clinic Genotyping Core Facility. Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118,C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692 and C8197/A16565), the US National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112-GAME-ON initiative), the US Department of Defense (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. D.R. is an Investigator of the Howard Hughes Medical Institute.	Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Baran Y, 2013, AM J HUM GENET, V92, P882, DOI 10.1016/j.ajhg.2013.04.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhatia G, 2015, BIORXIV, DOI [10.1101/022418, DOI 10.1101/022418]; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cropp CD, 2014, PROSTATE, V74, P1579, DOI 10.1002/pros.22871; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomella LG, 2011, CAN J UROL, V18, P5875; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hazelett DJ, 2013, CELL CYCLE, V12, P379, DOI 10.4161/cc.23201; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Huffman JE, 2015, BLOOD, V126, pE19, DOI 10.1182/blood-2015-02-624551; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin K, 2011, PROSTATE SPECIFIC AN; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Melnikow J, 2013, MED CARE, V51, P301, DOI 10.1097/MLR.0b013e31828a67d3; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang L, 2013, AM J MED GENET B, V162B, P419, DOI 10.1002/ajmg.b.32169; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	59	85	86	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					30	+		10.1038/ng.3446	http://dx.doi.org/10.1038/ng.3446			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569126	Green Submitted, Green Accepted			2022-12-17	WOS:000367255300010
J	Iles, MM; Law, MH; Stacey, SN; Han, JL; Fang, SY; Pfeiffer, R; Harland, M; MacGregor, S; Taylor, JC; Aben, KK; Akslen, LA; Avril, MF; Azizi, E; Bakker, B; Benediktsdottir, KR; Bergman, W; Scarra, GB; Brown, KM; Calista, D; Chaudru, V; Fargnoli, MC; Cust, AE; Demenais, F; de Waal, AC; Debniak, T; Elder, DE; Friedman, E; Galan, P; Ghiorzo, P; Gillanders, EM; Goldstein, AM; Gruis, NA; Hansson, J; Helsing, P; Hocevar, M; Hoiom, V; Hopper, JL; Ingvar, C; Janssen, M; Jenkins, MA; Kanetsky, PA; Kiemeney, LA; Lang, JL; Lathrop, GM; Leachman, S; Lee, JE; Lubinski, J; Mackie, RM; Mann, GJ; Martin, NG; Mayordomo, JI; Molven, A; Mulder, S; Nagore, E; Novakovic, S; Okamoto, I; Olafsson, JH; Olsson, H; Pehamberger, H; Peris, K; Grasa, MP; Planelles, D; Puig, S; Puig-Butille, JA; Randerson-Moor, J; Requena, C; Rivoltini, L; Rodolfo, M; Santinami, M; Sigurgeirsson, B; Snowden, H; Song, FJ; Sulem, P; Thorisdottir, K; Tuominen, R; Van Belle, P; van der Stoep, N; van Rossum, MM; Wei, QY; Wendt, J; Zelenika, D; Zhang, MF; Landi, MT; Thorleifsson, G; Bishop, DT; Amos, CI; Hayward, NK; Stefansson, K; Bishop, JAN; Barrett, JH				Iles, Mark M.; Law, Matthew H.; Stacey, Simon N.; Han, Jiali; Fang, Shenying; Pfeiffer, Ruth; Harland, Mark; MacGregor, Stuart; Taylor, John C.; Aben, Katja K.; Akslen, Lars A.; Avril, Marie-Francoise; Azizi, Esther; Bakker, Bert; Benediktsdottir, Kristrun R.; Bergman, Wilma; Scarra, Giovanna Bianchi; Brown, Kevin M.; Calista, Donato; Chaudru, Valerie; Fargnoli, Maria Concetta; Cust, Anne E.; Demenais, Florence; Waal, Anne C. de; Debniak, Tadeusz; Elder, David E.; Friedman, Eitan; Galan, Pilar; Ghiorzo, Paola; Gillanders, Elizabeth M.; Goldstein, Alisa M.; Gruis, Nelleke A.; Hansson, Johan; Helsing, Per; Hocevar, Marko; Hoiom, Veronica; Hopper, John L.; Ingvar, Christian; Janssen, Marjolein; Jenkins, Mark A.; Kanetsky, Peter A.; Kiemeney, Lambertus A.; Lang, Julie; Lathrop, G. Mark; Leachman, Sancy; Lee, Jeffrey E.; Lubinski, Jan; Mackie, Rona M.; Mann, Graham J.; Martin, Nicholas G.; Mayordomo, Jose I.; Molven, Anders; Mulder, Suzanne; Nagore, Eduardo; Novakovic, Srdjan; Okamoto, Ichiro; Olafsson, Jon H.; Olsson, Haan; Pehamberger, Hubert; Peris, Ketty; Grasa, Maria Pilar; Planelles, Dolores; Puig, Susana; Puig-Butille, Joan Anton; Randerson-Moor, Juliette; Requena, Celia; Rivoltini, Licia; Rodolfo, Monica; Santinami, Mario; Sigurgeirsson, Bardur; Snowden, Helen; Song, Fengju; Sulem, Patrick; Thorisdottir, Kristin; Tuominen, Rainer; Van Belle, Patricia; van der Stoep, Nienke; van Rossum, Michelle M.; Wei, Qingyi; Wendt, Judith; Zelenika, Diana; Zhang, Mingfeng; Landi, Maria Teresa; Thorleifsson, Gudrnar; Bishop, D. Timothy; Amos, Christopher I.; Hayward, Nicholas K.; Stefansson, Kari; Bishop, Julia A. Newton; Barrett, Jennifer H.		Q-MEGA AMFS Investigators; GenoMEL Consortium	A variant in FTO shows association with melanoma risk not due to BMI	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; CUTANEOUS MELANOMA; PHENOTYPIC CHARACTERISTICS; SUSCEPTIBILITY LOCI; IDENTIFIES 3; GENE; OBESITY; METAANALYSIS; PREDISPOSES	We report the results of an association study of melanoma that is based on the genome-wide imputation of the genotypes of 1,353 cases and 3,566 controls of European origin conducted by the GenoMEL consortium. This revealed an association between several SNPs in intron 8 of the FTO gene, including rs16953002, which replicated using 12,313 cases and 55,667 controls of European ancestry from Europe, the USA and Australia (combined P = 3.6 x 10(-12), per-allele odds ratio for allele A = 1.16). In addition to identifying a new melanomasusceptibility locus, this is to our knowledge the first study to identify and replicate an association with SNPs in FTO not related to body mass index (BMI). These SNPs are not in intron 1 (the BMI-related region) and exhibit no association with BMI. This suggests FTO's function may be broader than the existing paradigm that FTO variants influence multiple traits only through their associations with BMI and obesity.	[Harland, Mark; Taylor, John C.; Randerson-Moor, Juliette; Snowden, Helen; Bishop, D. Timothy; Bishop, Julia A. Newton; Barrett, Jennifer H.] St James Univ Hosp, Leeds Canc Res UK Ctr, Leeds Inst Mol Med, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Law, Matthew H.; MacGregor, Stuart; Martin, Nicholas G.; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Stacey, Simon N.; Sulem, Patrick; Thorleifsson, Gudrnar; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Han, Jiali; Song, Fengju; Zhang, Mingfeng] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Han, Jiali] Harvard Univ, Sch Med, Boston, MA USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fang, Shenying; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Pfeiffer, Ruth; Goldstein, Alisa M.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Aben, Katja K.; Kiemeney, Lambertus A.] Ctr Comprehens Canc, Nijmegen, Netherlands; [Aben, Katja K.; Waal, Anne C. de; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Akslen, Lars A.; Molven, Anders] Univ Bergen, Gade Inst, Ctr Canc Biomarkers, Bergen, Norway; [Iles, Mark M.; Akslen, Lars A.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Avril, Marie-Francoise] Univ Paris 05, Serv Dermatol, Hop Cochin, AP HP, Paris, France; [Azizi, Esther] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Dermatol & Oncogenet, IL-52621 Tel Hashomer, Israel; [Azizi, Esther; Friedman, Eitan] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Oncogenet Unit, IL-52621 Tel Hashomer, Israel; [Bakker, Bert; van der Stoep, Nienke] Leiden Univ, Med Ctr, Dept Clin Genet, Ctr Human & Clin Genet, Leiden, Netherlands; [Benediktsdottir, Kristrun R.; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Bergman, Wilma; Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Scarra, Giovanna Bianchi; Ghiorzo, Paola] Univ Genoa, Dept Internal Med & Med Specialties, Genoa, Italy; [Scarra, Giovanna Bianchi; Ghiorzo, Paola] San Martino Ist Sci Tumori, Ist Ricovero & Cura Carattere Sci, Lab Genet Rare Hereditary Canc, Genoa, Italy; [Brown, Kevin M.] NCI, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD USA; [Calista, Donato] Maurizio Bufalini Hosp, Dermatol Unit, Cesena, Italy; [Chaudru, Valerie] INSERM, UMR 946, Genet Variat & Human Dis Unit, Paris, France; [Chaudru, Valerie] Univ Evry Val dEssonne, Evry, France; [Chaudru, Valerie; Demenais, Florence; Lathrop, G. Mark] Fdn Jean Dausset, CEPH, Paris, France; [Fargnoli, Maria Concetta; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy; [Cust, Anne E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, Sorbonne Paris Cite, Paris, France; [Waal, Anne C. de; van Rossum, Michelle M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Szczecin, Poland; [Elder, David E.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Galan, Pilar] Univ Paris 13, Res Unit Nutr Epidemiol, INSERM, U557,Inst Sci Rech Agron,INRA U1125, Bobigny, France; [Gillanders, Elizabeth M.] NCI, Epidemiol & Genet Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Hansson, Johan; Hoiom, Veronica; Tuominen, Rainer] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden; [Helsing, Per] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Dermatol, N-0027 Oslo, Norway; [Hocevar, Marko] Inst Oncol, Dept Surg Oncol, Ljubljana, Slovenia; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Mol Environm Genet & Analyt MEGA Epidemiol, Melbourne, Vic, Australia; [Ingvar, Christian] Lund Univ, Dept Surg, Lund, Sweden; [Janssen, Marjolein; Mulder, Suzanne] ServiceXS BV, Leiden, Netherlands; [Kanetsky, Peter A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Lang, Julie] Univ Glasgow, Dept Med Genet, Glasgow, Lanark, Scotland; [Lathrop, G. Mark; Zelenika, Diana] Comis Nacl Energia Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Leachman, Sancy] Univ Utah, Sch Med, Dept Dermatol, Huntsman Canc Inst, Salt Lake City, UT USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Mackie, Rona M.] Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Mann, Graham J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; [Mann, Graham J.] Melanoma Inst Australia, Sydney, NSW, Australia; [Mayordomo, Jose I.; Grasa, Maria Pilar] Univ Zaragoza, Zaragoza, Spain; [Nagore, Eduardo; Requena, Celia] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Novakovic, Srdjan] Inst Oncol, Dept Mol Diagnost, Ljubljana, Slovenia; [Okamoto, Ichiro; Wendt, Judith] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Olafsson, Jon H.; Sigurgeirsson, Bardur; Thorisdottir, Kristin] Univ Iceland, Fac Med, Dept Dermatol, Reykjavik, Iceland; [Olsson, Haan] Lund Univ, Dept Oncol, Lund, Sweden; [Olsson, Haan] Lund Univ, Dept Canc Epidemiol, Lund, Sweden; [Pehamberger, Hubert; Planelles, Dolores] Ctr Blood Transfus, Lab Histocompatibil Mol Biol, Valencia, Spain; [Puig, Susana; Puig-Butille, Joan Anton] Univ Barcelona, Melanoma Unit, Dept Dermatol, Hosp Clin,Inst Invest Biorned August Pi Sune, Barcelona, Spain; [Puig, Susana; Puig-Butille, Joan Anton] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Raras, Barcelona, Spain; [Rivoltini, Licia; Rodolfo, Monica] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ist N, Immunotherapy Human Tumors Unit, Milan, Italy; [Santinami, Mario] Fdn IRCCS Ist Nazl Tumori, Melanoma & Sarcoma Surg Unit, Milan, Italy; [Song, Fengju] Tianjin Med Univ Canc Inst & Hosp, Dept Epidemiol, Tianjin, Peoples R China; [Van Belle, Patricia] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Amos, Christopher I.] Dartmouth Coll, Dept Community & Family Med, Geisel Coll Med, Hanover, NH 03755 USA	Saint James's University Hospital; University of Leeds; QIMR Berghofer Medical Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen; University of Bergen; University of Bergen; Haukeland University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Iceland; Landspitali National University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Genoa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ospedale Maurizio Bufalini; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; University of L'Aquila; University of Sydney; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Pomeranian Medical University; University of Pennsylvania; Pennsylvania Medicine; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska University Hospital; University of Oslo; National Hospital Norway; Institute of Oncology - Slovenia; University of Melbourne; Lund University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Radboud University Nijmegen; University of Glasgow; CEA; UDICE-French Research Universities; Universite Paris Saclay; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Glasgow; University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; University of Zaragoza; Instituto Valenciano De Oncologia; Institute of Oncology - Slovenia; Medical University of Vienna; University of Iceland; Lund University; Lund University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Fondazione IRCCS Istituto Nazionale Tumori Milan; Tianjin Medical University; University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Iles, MM (corresponding author), Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.	m.m.iles@leeds.ac.uk	Nagore, Eduardo/Z-2126-2019; Calista, Donato/AAM-1567-2020; Kiemeney, Lambertus A./D-3357-2009; Martin, Nicholas/R-9235-2019; Mayordomo, Jose/K-3453-2013; hayward, nicholas k/C-1367-2015; Scarrà, Giovanna Bianchi/G-8933-2014; hayward, nick/AAV-8802-2020; Akslen, Lars A./AAG-6097-2021; Law, Matthew H./AAJ-4066-2021; Bakker, Egbert/D-3525-2009; Aben, Katja KH/G-9686-2016; Akslen, Lars A/C-1202-2017; Sigurgeirsson, Bárður/B-6130-2011; Puig, Susana/AAB-2091-2020; Requena, Celia/Z-2344-2019; Pilar, Galan/F-2908-2017; Macgregor, Stuart/C-6442-2009; rivoltini, licia/I-2450-2012; PLANELLES, DOLORES/F-2689-2015; rodolfo, monica/H-2671-2012; Mulder, S.F./L-4536-2015; Sigurgeirsson, Bardur/AAP-7755-2020; Höiom, Veronica/F-4153-2012; Demenais, Florence/G-3298-2013; Mann, Graham J/G-4758-2014; Jenkins, Mark/P-7803-2015; Ghiorzo, Paola/CAG-0673-2022; de Waal, Anne/F-9379-2016; Cust, Anne/J-1797-2019; Stefansson, Kari/AAE-7187-2019; Rossum, M.M./L-4614-2015; Ingvar, Christian/AAE-9841-2019; Santinami, Mario/I-3795-2017; PLANELLES, DOLORES/AAS-5437-2020	Nagore, Eduardo/0000-0003-3433-8707; Kiemeney, Lambertus A./0000-0002-2368-1326; Martin, Nicholas/0000-0003-4069-8020; hayward, nicholas k/0000-0003-4760-1033; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; Akslen, Lars A./0000-0003-2710-9543; Law, Matthew H./0000-0002-4303-8821; Bakker, Egbert/0000-0002-2843-7357; Aben, Katja KH/0000-0002-0214-2147; Akslen, Lars A/0000-0003-2710-9543; Puig, Susana/0000-0003-1337-9745; Pilar, Galan/0000-0003-1706-3107; Macgregor, Stuart/0000-0001-6731-8142; rivoltini, licia/0000-0002-2409-6225; PLANELLES, DOLORES/0000-0001-6433-4825; rodolfo, monica/0000-0002-9196-0298; Demenais, Florence/0000-0001-8361-0936; Mann, Graham J/0000-0003-1301-405X; Jenkins, Mark/0000-0002-8964-6160; Ghiorzo, Paola/0000-0002-3651-8173; Cust, Anne/0000-0002-5331-6370; Santinami, Mario/0000-0001-8436-4757; PLANELLES, DOLORES/0000-0001-6433-4825; Novakovic, Srdjan/0000-0002-8888-4810; Lubinski, Jan/0000-0003-2931-3003; Aitken, Joanne Frances/0000-0001-6859-2186; Sigurgeirsson, Bardur/0000-0002-9733-9742; Peris, Ketty/0000-0002-5237-0463; Randerson-Moor, Juliette/0000-0003-0303-0072; Barrett, Jenny/0000-0002-1720-7724; Iles, Mark/0000-0002-2603-6509; Olsson, Hakan/0000-0002-8794-9635; Newton-Bishop, Julia/0000-0001-9147-6802; Fargnoli, Maria Concetta/0000-0002-7249-2556; Bishop, Tim/0000-0002-8752-8785; Tuominen, Rainer/0000-0002-5871-3682; Fang, Shenying/0000-0002-0604-793X; Gruis, Nelleke/0000-0002-5210-9150	European Commission under the 6th Framework Programme [LSHC-CT-2006-018702]; Cancer Research UK Programme Awards [C588/A4994 and C588/A10589]; Cancer Research UK [C8216/A6129]; Leeds Cancer Research UK Centre [C37059/A11941]; US National Institutes of Health (NIH [CA83115]; intramural Research Program of the NIH; US National Cancer Institute (NCI); Division of Cancer Epidemiology and Genetics; Wellcome Trust [076113]; Swedish Cancer Society; Gunnar Nilsson Foundation; European Research Council [ERC-2011-AdG 294576]; Italian Ministry of Education, University and Research Progetti di Ricerca di Interesse Nazionale [2008W8JTPA_002]; Intergruppo Melanoma Italian; Mara Naum foundation; INCa [INCa-PL016]; Ligue Nationale Contre Le Cancer [PRE05/ FD, PRE 09/FD]; Programme Hospitaller de Recherche Clinique [AOM-07-195]; European Biobanking and Biomolecular Resources Research Infrastructure Netherlands hub [C018]; Fond de Investigaciones Sanitarias, Spain [P.I. 09/01393]; Centro de Investigaciones Biomedicas en Red (CIBER); Comprehensive Cancer Center, Oslo University Hospital [SE0728]; Norwegian Cancer Society [71512-PR-2006-0356]; Jubilaumsfonds of the Osterreichische Nationalbank [12161, 13036]; Hans und Blanca Moser Stiftung; NIH RO1 [CA65558-02]; Department of Health and Human Services; Intramural Research Program of NIH; NCI Division of Cancer Epidemiology and Genetics; NIH NCI [CA83115, P30CA023108, 2P50CA093459, CA88363, CAl22838, CA87969, CA055075, CA100264, CA133996, CA49449]; Marit Peterson Fund for Melanoma Research; Cancer Institute New South Wales; National Health and Medical Research Council; Dutch Cancer Society Koningin Wilhemina Fonds (KWF) Kankerbestrijding; Radboud University Medical Centre; Melanoma Research Alliance; National Health and Medical Research Council of Australia (NHMRC) [200071, 241944, 339462, 380385, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496675, 496739, 552485, 552498]; Cancer Councils New South Wales; Victoria and Queensland; Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC); Cerylid Biosciences (Melbourne); Australian Cancer Research Foundation; The Wellcome Trust [WT084766/Z/08/Z]; NHMRC; Career Development award from the NHMRC [496674, 613705]; Cancer Australia [1011143]; Cancer Research UK [10589] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA049449, R01CA049449, R01CA122838, P01CA087969, P50CA093459, ZIACP004410, R01CA088363, R01CA133996, P30CA016520, P30CA023108, R01CA092824, R01CA065558, R01CA083115, R01CA100264] Funding Source: NIH RePORTER	European Commission under the 6th Framework Programme(European Commission); Cancer Research UK Programme Awards; Cancer Research UK(Cancer Research UK); Leeds Cancer Research UK Centre; US National Institutes of Health (NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Foundation; European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Education, University and Research Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Intergruppo Melanoma Italian; Mara Naum foundation; INCa(Institut National du Cancer (INCA) France); Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); Programme Hospitaller de Recherche Clinique; European Biobanking and Biomolecular Resources Research Infrastructure Netherlands hub; Fond de Investigaciones Sanitarias, Spain; Centro de Investigaciones Biomedicas en Red (CIBER); Comprehensive Cancer Center, Oslo University Hospital; Norwegian Cancer Society(Norwegian Cancer Society); Jubilaumsfonds of the Osterreichische Nationalbank; Hans und Blanca Moser Stiftung; NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marit Peterson Fund for Melanoma Research; Cancer Institute New South Wales; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dutch Cancer Society Koningin Wilhemina Fonds (KWF) Kankerbestrijding; Radboud University Medical Centre; Melanoma Research Alliance; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Councils New South Wales(Cancer Council New South Wales); Victoria and Queensland; Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cerylid Biosciences (Melbourne); Australian Cancer Research Foundation; The Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Career Development award from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M.I. McCarthy and C.M. Lindgren for assistance with the results of the GIANT study. The GenoMEL study was funded by the European Commission under the 6th Framework Programme (contract number LSHC-CT-2006-018702), by Cancer Research UK Programme Awards (C588/A4994 and C588/A10589), by a Cancer Research UK Project Grant (C8216/A6129), by the Leeds Cancer Research UK Centre (C37059/A11941) and by a grant from the US National Institutes of Health (NIH; CA83115). This research was also supported by the intramural Research Program of the NIH, US National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics. Genotyping of most of the samples collected in France that were included in GenoMEL was done at Centre National de Genotypage, Institut de Genomique-Commissariat a rEnergie Atomique and was supported by the Ministere de rEnseignement Superieur et de la Recherche and Institut National du Cancer (INCa). This study used data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs); funding for the project was provided by the Wellcome Trust under award 076113. We thank the EGEA cooperative group for giving access to data of the EGEA study (see URLs). We acknowledge that the biological specimens of the French Familial Melanoma Study Group were obtained from the Institut Gustave Roussy and Fondation Jean Dausset-CEPH Biobanks. Work in Stockholm was funded by the Swedish Cancer Society and Karolinska Institutet research funds. Work in Lund was funded by the Swedish Cancer Society, the Gunnar Nilsson Foundation and the European Research Council (ERC-2011-AdG 294576-risk factors cancer). Work in Genoa was funded by the Italian Ministry of Education, University and Research Progetti di Ricerca di Interesse Nazionale (2008W8JTPA_002), Intergruppo Melanoma Italian and Mara Naum foundation. Work in Paris was funded by grants from INCa (INCa-PL016) and Ligue Nationale Contre Le Cancer (PRE05/ FD and PRE 09/FD) to F. Demenais, and Programme Hospitaller de Recherche Clinique (AOM-07-195) to M.-F. Avril and F. Demenais. Work in Leiden was funded by a grant provided by European Biobanking and Biomolecular Resources Research Infrastructure Netherlands hub (C018). Research at the Melanoma Unit in Barcelona is partially funded by grants from Fond de Investigaciones Sanitarias P.I. 09/01393, Spain and by the Centro de Investigaciones Biomedicas en Red (CIBER) de Enfermedades Raras of the Institut de Salud Carlos III, Spain; by the Agenda de Gestio d'Ajuts Universitaris i de Recerca 2009 SGR-1337 of the Catalan Government, Spain. Work in Norway was funded by grants from the Comprehensive Cancer Center, Oslo University Hospital (SE0728) and the Norwegian Cancer Society (71512-PR-2006-0356). Work in Vienna was supported by the Jubilaumsfonds of the Osterreichische Nationalbank (project numbers 12161 and 13036) and the Hans und Blanca Moser Stiftung. The Italian study was partially supported by a NIH RO1 grant CA65558-02 (to M.T. Landi), Department of Health and Human Services and by the Intramural Research Program of NIH, NCI Division of Cancer Epidemiology and Genetics. Work at the MD Anderson Cancer Center was supported by the NIH NCI (P30CA023108 and 2P50CA093459) and by the Marit Peterson Fund for Melanoma Research. A. Cust is supported by fellowships from the Cancer Institute New South Wales and the National Health and Medical Research Council.; Work in Nijmegen, The Netherlands, was funded by the Dutch Cancer Society Koningin Wilhemina Fonds (KWF) Kankerbestrijding and by the Radboud University Medical Centre. The Q-MEGA study was supported by the Melanoma Research Alliance, the NIH NCI (CA88363, CA83115, CAl22838, CA87969, CA055075, CA100264, CA133996 and CA49449), the National Health and Medical Research Council of Australia (NHMRC) (200071, 241944, 339462, 380385, 389927,389875, 389891, 389892,389938, 443036, 442915, 442981, 496610, 496675, 496739, 552485, 552498), the Cancer Councils New South Wales, Victoria and Queensland, the Cancer Institute New South Wales, the Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC), Cerylid Biosciences (Melbourne), the Australian Cancer Research Foundation, The Wellcome Trust (WT084766/Z/08/Z) and donations from Neville and Shirley Hawkins. N.K.H. was supported by the NHMRC Fellowships scheme. SM was supported by a Career Development award from the NHMRC (496674, 613705). M.H.L. is supported by Cancer Australia grant 1011143.	Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brennan P, 2009, INT J EPIDEMIOL, V38, P971, DOI 10.1093/ije/dyp162; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon-Albright L A, 1991, Important Adv Oncol, P39; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doney ASF, 2009, CIRC-CARDIOVASC GENE, V2, P255, DOI 10.1161/CIRCGENETICS.108.822320; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Hubacek JA, 2012, NEPHROL DIAL TRANSPL, V27, P1030, DOI 10.1093/ndt/gfr418; Hubacek JA, 2010, CLIN CHIM ACTA, V411, P1069, DOI 10.1016/j.cca.2010.03.037; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Pothiawala S, 2012, CANCER CAUSE CONTROL, V23, P717, DOI 10.1007/s10552-012-9941-x; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sallman Almen M., 2012, INT J OBES LOND, DOI DOI 10.1038/0.2012.57; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	39	85	86	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					428	432		10.1038/ng.2571	http://dx.doi.org/10.1038/ng.2571			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23455637	Green Accepted			2022-12-17	WOS:000316840600014
J	Pillay, N; Plagnol, V; Tarpey, PS; Lobo, SB; Presneau, N; Szuhai, K; Halai, D; Berisha, F; Cannon, SR; Mead, S; Kasperaviciute, D; Palmen, J; Talmud, PJ; Kindblom, LG; Amary, MF; Tirabosco, R; Flanagan, AM				Pillay, Nischalan; Plagnol, Vincent; Tarpey, Patrick S.; Lobo, Samira B.; Presneau, Nadege; Szuhai, Karoly; Halai, Dina; Berisha, Fitim; Cannon, Stephen R.; Mead, Simon; Kasperaviciute, Dalia; Palmen, Jutta; Talmud, Philippa J.; Kindblom, Lars-Gunnar; Amary, M. Fernanda; Tirabosco, Roberto; Flanagan, Adrienne M.			A common single-nucleotide variant in T is strongly associated with chordoma	NATURE GENETICS			English	Article							BRACHYURY; EXPRESSION; CANCER; GENE	Chordoma is a rare malignant bone tumor that expresses the transcription factor T. We conducted an association study of 40 individuals with chordoma and 358 ancestry-matched controls, with replication in an independent cohort. Whole-exome and Sanger sequencing of T exons showed strong association of the common nonsynonymous SNP rs2305089 with chordoma risk (allelic odds ratio (OR) = 6.1, 95% confidence interval (Cl) = 3.1-12.1; P = 4.4 x 10(-9)), a finding that is exceptional in cancers with a non-Mendelian mode of inheritance.	[Pillay, Nischalan; Presneau, Nadege; Flanagan, Adrienne M.] UCL, Inst Canc, London, England; [Cannon, Stephen R.] Royal Natl Orthopaed Hosp, Bone Tumour Unit, Stanmore HA7 4LP, Middx, England; [Plagnol, Vincent] UCL, UCL Genet Inst, London, England; [Tarpey, Patrick S.] Wellcome Trust Sanger Inst, Cambridge, England; [Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Mead, Simon] UCL, Inst Neurol, Prion Unit, MRC, London, England; [Kasperaviciute, Dalia] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Palmen, Jutta; Talmud, Philippa J.] UCL, Inst Cardiovasc Sci, London, England; [Kindblom, Lars-Gunnar] Royal Orthopaed Hosp, Dept Histopathol, Birmingham B31 2AP, W Midlands, England	University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Wellcome Trust Sanger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; University of London; University College London; University of London; University College London; Royal Orthopaedic Hospital	Flanagan, AM (corresponding author), UCL, Inst Canc, London, England.	a.flanagan@ucl.ac.uk	Amary, Fernanda/AAI-7339-2020; Mead, Simon/E-9414-2011; Szuhai, Karoly/A-1100-2008	Mead, Simon/0000-0002-4326-1468; Szuhai, Karoly/0000-0002-1228-4245; Plagnol, Vincent/0000-0002-5597-9215; Pillay, Nischalan/0000-0003-0579-4105; Talmud, Philippa/0000-0002-5560-1933; Flanagan, Adrienne/0000-0002-2832-1303	Skeletal Cancer Action Trust (SCAT), UK; Pathological Society; Chordoma Foundation; Rosetrees Foundation; Wellcome Trust Sanger Institute [98051]; UCL Experimental Cancer Centre; MRC [MC_U123160651] Funding Source: UKRI; Medical Research Council [MC_U123160651] Funding Source: researchfish	Skeletal Cancer Action Trust (SCAT), UK; Pathological Society; Chordoma Foundation; Rosetrees Foundation(Rosetrees Trust); Wellcome Trust Sanger Institute(Wellcome Trust); UCL Experimental Cancer Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the study subjects for participating in the research and to the clinicians and support staff in the London Sarcoma Service involved in their care. We thank S. McLaren, C. Latimer, K. Raine and A. Butler at the The Wellcome Trust Sanger Institute for assistance with the exome sequencing. We are also grateful to L. Game (Head of Genomics Laboratory, MRC Clinical Sciences Centre) for assistance with aCGH scanning. We are particularly grateful to B. Liegl (Medical University of Graz) for providing us with the chordoma cell line, MUG-Chor1. The research was funded by the Skeletal Cancer Action Trust (SCAT), UK, The Pathological Society (N. Pillay), The Chordoma Foundation, The Rosetrees Foundation and the Wellcome Trust Sanger Institute (grant 98051). The research was part of the RNOH Musculoskeletal Research Programme and Biobank and the UCL Hospital (UCLH)/UCL Comprehensive Biomedical Research Programme and was supported by the UCL Experimental Cancer Centre.	Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Papapetrou C, 1997, FEBS LETT, V409, P201, DOI 10.1016/S0014-5793(97)00506-1; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tirabosco R, 2008, AM J SURG PATHOL, V32, P572, DOI 10.1097/PAS.0b013e31815b693a; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	15	85	86	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1185	1187		10.1038/ng.2419	http://dx.doi.org/10.1038/ng.2419			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23064415				2022-12-17	WOS:000310495800007
J	Esteban, MA; Pei, DQ				Esteban, Miguel A.; Pei, Duanqing			Vitamin C improves the quality of somatic cell reprogramming	NATURE GENETICS			English	Editorial Material							PLURIPOTENT STEM-CELLS	The reprogramming of somatic cells to a pluripotent state is prone to errors that could hamper the use of this technology. A new study now shows that vitamin C enhances the quality of somatic cell reprogramming in mice, highlighting the possibility that further manipulation of culture conditions could improve this technology for regenerative medicine.	[Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou, Guangdong, Peoples R China; [Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences	Esteban, MA (corresponding author), Chinese Acad Sci, Stem Cell & Canc Biol Grp, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou, Guangdong, Peoples R China.	esteban@gibh.org; pei_duanqing@gibh.ac.cn						Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Frei B, 2008, P NATL ACAD SCI USA, V105, P11037, DOI 10.1073/pnas.0806433105; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	15	85	93	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					366	367		10.1038/ng.2222	http://dx.doi.org/10.1038/ng.2222			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22456737				2022-12-17	WOS:000302130600007
J	Cha, PC; Takahashi, A; Hosono, N; Low, SK; Kamatani, N; Kubo, M; Nakamura, Y				Cha, Pei-Chieng; Takahashi, Atsushi; Hosono, Naoya; Low, Siew-Kee; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke			A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids	NATURE GENETICS			English	Article							EXTRACELLULAR-MATRIX; EXPRESSION; PATHOGENESIS; LEIOMYOMAS; NUCLEOTIDE; ETIOLOGY	Uterine fibroids are a common benign tumor of the female genital tract. We conducted a genome-wide association study in which 457,044 SNPs were analyzed in 1,607 individuals with clinically diagnosed uterine fibroids and 1,428 female controls. SNPs showing suggestive associations (P < 5 x 10(-5)) were further genotyped in 3,466 additional cases and 3,245 female controls. Three loci on chromosomes 10q24.33, 22q13.1 and 11p15.5 revealed genome-wide significant associations with uterine fibroids. The SNPs showing the most significant association in a combination analysis at each of these loci were rs7913069 (P = 8.65 x 10(-14), odds ratio (OR) = 1.47), rs12484776 (P = 2.79 x 10(-12), OR = 1.23) and rs2280543 (P = 3.82 x 10(-12), OR = 1.39), respectively. Subsequent fine mapping of these regions will be necessary to pinpoint the causal variants. Our findings should shed light on the pathogenesis of uterine fibroids.	[Cha, Pei-Chieng; Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Lab Mol Med, Ctr Human Genome, Tokyo, Japan; [Takahashi, Atsushi; Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN; RIKEN	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Lab Mol Med, Ctr Human Genome, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015	Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We extend our heartfelt gratitude to all subjects who kindly participated in the current study. We also thank the BioBank Japan for providing DNA samples and clinical information. Finally, we acknowledge members of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, for their excellent technical assistance. This work was supported by Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bonatz G, 1998, AM J OBSTET GYNECOL, V179, P591, DOI 10.1016/S0002-9378(98)70050-X; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; El-Gharib MN, 2010, J OBSTET GYNAECOL RE, V36, P101, DOI 10.1111/j.1447-0756.2009.01099.x; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Luo X, 2008, SEMIN REPROD MED, V26, P500, DOI 10.1055/s-0028-1096130; Malik M, 2010, SEMIN REPROD MED, V28, P168, DOI 10.1055/s-0030-1251475; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parazzini F, 1996, EPIDEMIOLOGY, V7, P440, DOI 10.1097/00001648-199607000-00018; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Storbeck CJ, 2004, MUSCLE NERVE, V29, P553, DOI 10.1002/mus.20000; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; TRELOAR SA, 1992, AM J OBSTET GYNECOL, V167, P82, DOI 10.1016/S0002-9378(11)91632-9; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004	24	85	87	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					447	+		10.1038/ng.805	http://dx.doi.org/10.1038/ng.805			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21460842				2022-12-17	WOS:000289972600014
J	Martinez-Garcia, E; Licht, JD				Martinez-Garcia, Eva; Licht, Jonathan D.			Deregulation of H3K27 methylation in cancer	NATURE GENETICS			English	Editorial Material							SOMATIC MUTATIONS; EZH2 EXPRESSION; REPRESSION; CELLS	A new study now reports recurrent somatic mutation of EZH2, a histone methyltransferase that modifies H3K27, in diffuse large B-cell lymphoma (DLBCL). There is now evidence for both increased and decreased activity of enzymes controlling H3K27 methylation in cancer, suggesting that a precise balance of this methylation is critical for normal cell growth.	[Martinez-Garcia, Eva; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Martinez-Garcia, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.	j-licht@northwestern.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NATIONAL CANCER INSTITUTE [R01CA123204] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA123204] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	15	85	95	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					100	101		10.1038/ng0210-100	http://dx.doi.org/10.1038/ng0210-100			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20104248				2022-12-17	WOS:000274084400004
J	Hudson, TJ				Hudson, TJ			Wanted: regulatory SNPs	NATURE GENETICS			English	Editorial Material							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN GENOME; MOUSE GENOME; GENE; SUSCEPTIBILITY; SEQUENCE	Reliable identification of genetic variants that affect gene regulation is still a challenge in genomics and is expected to have an important role in the molecular characterization of complex traits. A new study describes a robust functional assay that detects the presence of cis-acting polymorphisms that regulate gene transcription.	McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada	McGill University	Hudson, TJ (corresponding author), McGill Univ, Montreal, PQ H3A 1A4, Canada.							Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	14	85	90	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					439	440		10.1038/ng0403-439	http://dx.doi.org/10.1038/ng0403-439			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12665861	Bronze			2022-12-17	WOS:000181928600005
J	Singh, N; Ebrahimi, FAW; Gimelbrant, AA; Ensminger, AW; Tackett, MR; Qi, PM; Gribnau, J; Chess, A				Singh, N; Ebrahimi, FAW; Gimelbrant, AA; Ensminger, AW; Tackett, MR; Qi, PM; Gribnau, J; Chess, A			Coordination of the random asynchronous replication of autosomal loci	NATURE GENETICS			English	Article							ALLELIC EXCLUSION; EXPRESSION; SYSTEM; GENES; INTERLEUKIN-2; PATTERNS; MOUSE	Random monoallelic expression and asynchronous replication define an unusual class of autosomal mammalian genes. We show that every cell has randomly chosen either the maternal or paternal copy of each given autosome pair, such that alleles of these genes scattered across the chosen chromosome replicate earlier than the alleles on the homologous chromosome. Thus, chromosome-pair non-equivalence, rather than being limited to X-chromosome inactivation, is a fundamental property of mouse chromosomes.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chess, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Ebrahimi, Farzad/Q-8829-2016	Ebrahimi, Farzad/0000-0001-9091-4647; Ensminger, Alexander/0000-0003-0824-3704; Gimelbrant, Alexander/0000-0001-6986-0285				CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	15	85	86	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					339	341		10.1038/ng1102	http://dx.doi.org/10.1038/ng1102			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577058				2022-12-17	WOS:000181312700008
J	Bressler, J; Tsai, TF; Wu, MY; Tsai, SF; Ramirez, MA; Armstrong, D; Beaudet, AL				Bressler, J; Tsai, TF; Wu, MY; Tsai, SF; Ramirez, MA; Armstrong, D; Beaudet, AL			The SNRPN promoter is not required for genomic imprinting of the PraderWilli/Angelman domain in mice	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; EMBRYONIC STEM-CELLS; MOUSE NECDIN GENE; ANGELMAN-SYNDROME; DNA METHYLATION; REGION; EXPRESSION; LETHALITY; MUTATIONS; DELETION	In mice and humans, the locus encoding the gene for small nuclear ribonucleoprotein N (SNRPN/Snrpn), as well as other loci in the region are subject to genomic imprinting. The SNRPN promoter is embedded in a maternally methylated CpG island, is expressed only from the paternal chromosome and lies within an imprinting center that is required for switching to and/or maintenance of the paternal epigenotype. We show here that a 0.9-kb deletion of exon 1 of mouse Snrpn did not disrupt imprinting or elicit any obvious phenotype. although it did allow the detection of previously unknown upstream exons. In contrast, a larger, overlapping 4.8-kb deletion caused a partial or mosaic imprinting defect and perinatal lethality when paternally inherited.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan	Baylor College of Medicine; Baylor College of Medicine; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Tsai, Shih-Feng/E-3997-2010		NICHD NIH HHS [HD-37283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abuin A, 1996, MOL CELL BIOL, V16, P1851; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; DELOS ST, 2000, AM J HUM GENET, V67, P1067; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FergusonSmith AC, 1996, NAT GENET, V14, P119, DOI 10.1038/ng1096-119; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Glenn CC, 1996, AM J HUM GENET, V58, P335; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Huq AHMM, 1997, GENOME RES, V7, P642, DOI 10.1101/gr.7.6.642; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; REIS A, 1994, AM J HUM GENET, V54, P741; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Sambrook J, 1989, MOL CLONING LAB MANU; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tilghman SM, 1998, NAT GENET, V18, P206, DOI 10.1038/ng0398-206; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	49	85	87	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					232	240		10.1038/90067	http://dx.doi.org/10.1038/90067			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431693				2022-12-17	WOS:000169656400015
J	MAIER, E; HOHEISEL, JD; MCCARTHY, L; MOTT, R; GRIGORIEV, AV; MONACO, AP; LARIN, Z; LEHRACH, H				MAIER, E; HOHEISEL, JD; MCCARTHY, L; MOTT, R; GRIGORIEV, AV; MONACO, AP; LARIN, Z; LEHRACH, H			COMPLETE COVERAGE OF THE SCHIZOSACCHAROMYCES-POMBE GENOME IN YEAST ARTIFICIAL CHROMOSOMES	NATURE GENETICS			English	Article							S-POMBE; DNA; INTEGRATION; FRAGMENTS; SEQUENCE; DIVISION; CLONING; TYPE-1; REPEAT; CYCLE	The genome of the fission yeast, Schizosaccharomyces pombe, consists of some 14 million base pairs of DNA contained in three chromosomes. On account of its excellent genetics we used it as a test system for a strategy designed to map mammalian chromosomes and genomes. Data obtained from hybridization fingerprinting established an ordered library of 1,248 yeast artificial chromosome clones with an average size of 535 kilobases. The clones fall into three contigs completely representing the three chromosomes of the organism. This work provides a high resolution physical and clone map of the genome, which has been related to available genetic and physical map information.	JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,INST MOLEC MED,HUMAN GENET LAB,OXFORD OX3 9DU,ENGLAND	University of Oxford	MAIER, E (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Monaco, Anthony P/A-4495-2010; Monaco, Zoia L/C-5762-2011	Monaco, Anthony P/0000-0001-7480-3197; Grigoriev, Andrey/0000-0002-3227-532X; Mott, Richard/0000-0002-1022-9330				ALLSHIRE RC, 1987, CELL, V50, P391, DOI 10.1016/0092-8674(87)90493-4; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOOHER R, 1989, CELL, V57, P1009, DOI 10.1016/0092-8674(89)90339-5; BROUGHTON BC, 1991, MOL GEN GENET, V228, P470, DOI 10.1007/BF00260641; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; FAN JB, 1991, NUCLEIC ACIDS RES, V19, P6289, DOI 10.1093/nar/19.22.6289; FAN JB, 1989, NUCLEIC ACIDS RES, V17, P2801, DOI 10.1093/nar/17.7.2801; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; KAUFER NF, 1985, NATURE, V318, P78, DOI 10.1038/318078a0; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; KOHLI J, 1977, GENETICS, V87, P471; KOHLI J, 1987, CURR GENET, V11, P575, DOI 10.1007/BF00393919; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEHRACH H., 1990, GENOME ANAL, P39; LEVIN HL, 1990, MOL CELL BIOL, V10, P6791, DOI 10.1128/MCB.10.12.6791; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Munz P, 1989, MOL BIOL FISSION YEA, P1; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PRESS WH, 1988, NUMERICAL RECIPES C, P343; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; RUSSELL P, 1986, CELL, V45, P781, DOI 10.1016/0092-8674(86)90550-7; SCHAAK J, 1982, NUCLEIC ACIDS RES, V10, P2851, DOI 10.1093/nar/10.9.2851; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6	31	85	89	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					273	277		10.1038/ng0792-273	http://dx.doi.org/10.1038/ng0792-273			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302023				2022-12-17	WOS:A1992JC98400011
J	MARTINGALLARDO, A; MCCOMBIE, WR; GOCAYNE, JD; FITZGERALD, MG; WALLACE, S; LEE, BMB; LAMERDIN, J; TRAPP, S; KELLEY, JM; LIU, LI; DUBNICK, M; JOHNSTONDOW, LA; KERLAVAGE, AR; DEJONG, P; CARRANO, A; FIELDS, C; VENTER, JC				MARTINGALLARDO, A; MCCOMBIE, WR; GOCAYNE, JD; FITZGERALD, MG; WALLACE, S; LEE, BMB; LAMERDIN, J; TRAPP, S; KELLEY, JM; LIU, LI; DUBNICK, M; JOHNSTONDOW, LA; KERLAVAGE, AR; DEJONG, P; CARRANO, A; FIELDS, C; VENTER, JC			AUTOMATED DNA SEQUENCING AND ANALYSIS OF 106 KILOBASES FROM HUMAN CHROMOSOME-19Q13.3	NATURE GENETICS			English	Article							REPAIR GENE ERCC-1; HUMAN GENOME; ALU FAMILY; CYCLIC-AMP; TRANSCRIPTION; PROTEIN; REGION; IDENTIFICATION; ORGANIZATION; LIBRARIES	A total of 116,118 basepairs (bp) derived from three cosmids spanning the ERCC1 locus of human chromosome 19q13.3 have been sequenced with automated fluorescence-based sequencers and analysed by polymerase chain reaction amplification and computer methods. The assembled sequence forms two contigs totalling 105,831 bp, which contain a human fosB proto-oncogene, a gene encoding a protein phosphatase, two genes of unknown function and the previously-characterized ERCC1 DNA repair gene. This light band region has a high average density of 1.4 Alu repeats per kilobase. Human chromosome light bands could therefore contain up to 75,000 genes and 1.5 million Alu repeats.	NINCDS,RECEPTOR BIOCHEM & MOLEC BIOL SECT,BETHESDA,MD 20892; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,LIVERMORE,CA 94551; APPL BIOSYST INC,FOSTER CITY,CA 94404	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Thermo Fisher Scientific; Applied Biosystems			Lee, Brian/F-8380-2013	Lee, Brian/0000-0002-0269-7812; McCombie, W. Richard/0000-0003-1899-0682; Fields, Chris/0000-0002-4812-0744; Kerlavage, Anthony/0000-0002-3954-9653				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARNES DE, IN PRESS GENOMICS; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANSCOMB E, 1990, GENOMICS, V8, P351, DOI 10.1016/0888-7543(90)90293-4; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CARRANO AV, 1989, GENOME, V31, P1059, DOI 10.1139/g89-182; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DUBNICK M, IN PRESS COMP APPL B; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; FICHANT GA, 1991, J MOL BIOL, V220, P659, DOI 10.1016/0022-2836(91)90108-I; FIELDS C, 1990, COMP APPL BIOSCI, V6, P261; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MCCOMBIE W R, 1991, Methods (Orlando), V3, P33; MCCOMBIE WR, IN PRESS DNA SEQUENC; MOLDERS H, 1987, ONCOGENE, V1, P377; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; PAULSON KE, 1985, NATURE, V316, P359, DOI 10.1038/316359a0; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUNDERS AM, 1990, GENOMICS, V6, P324, DOI 10.1016/0888-7543(90)90573-D; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SLAGEL V, 1987, MOL BIOL EVOL, V4, P19; SMEETS H, 1990, AM J HUM GENET, V46, P492; SMEETS HJM, 1991, GENOMICS, V9, P257, DOI 10.1016/0888-7543(91)90250-I; SODERLUND C, 1992, P HAWAII INT C SYSTE, P653; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VANDUIN M, 1987, NUCLEIC ACIDS RES, V15, P9195, DOI 10.1093/nar/15.22.9195; VANDUIN M, 1989, MOL CELL BIOL, V9, P1794, DOI 10.1128/MCB.9.4.1794; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	50	85	91	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					34	39		10.1038/ng0492-34	http://dx.doi.org/10.1038/ng0492-34			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301997				2022-12-17	WOS:A1992JC97800009
J	Cai, N; Revez, JA; Adams, MJ; Andlauer, TFM; Breen, G; Byrne, EM; Clarke, TK; Forstner, AJ; Grabe, HJ; Hamilton, SP; Levinson, DF; Lewis, CM; Lewis, G; Martin, NG; Milaneschi, Y; Mors, O; Muller-Myhsok, B; Penninx, BWJH; Perlis, RH; Pistis, G; Potash, JB; Preisig, M; Shi, JX; Smoller, JW; Streit, F; Tiemeier, H; Uher, R; Van der Auwera, S; Viktorin, A; Weissman, MM; Kendler, KS; Flint, J				Cai, Na; Revez, Joana A.; Adams, Mark J.; Andlauer, Till F. M.; Breen, Gerome; Byrne, Enda M.; Clarke, Toni-Kim; Forstner, Andreas J.; Grabe, Hans J.; Hamilton, Steven P.; Levinson, Douglas F.; Lewis, Cathryn M.; Lewis, Glyn; Martin, Nicholas G.; Milaneschi, Yuri; Mors, Ole; Mueller-Myhsok, Bertram; Penninx, Brenda W. J. H.; Perlis, Roy H.; Pistis, Giorgio; Potash, James B.; Preisig, Martin; Shi, Jianxin; Smoller, Jordan W.; Streit, Fabien; Tiemeier, Henning; Uher, Rudolf; Van der Auwera, Sandra; Viktorin, Alexander; Weissman, Myrna M.; Kendler, Kenneth S.; Flint, Jonathan		MDD Working Grp Psychiat Genomics	Minimal phenotyping yields genome-wide association signals of low specificity for major depression	NATURE GENETICS			English	Article							STRESSFUL LIFE EVENTS; GENETIC ARCHITECTURE; MENTAL-HEALTH; RISK-FACTORS; PSYCHIATRIC-DISORDERS; UNITED-STATES; FIELD TRIALS; HERITABILITY; LOCI; SYMPTOMS	Minimal phenotyping refers to the reliance on the use of a small number of self-reported items for disease case identification, increasingly used in genome-wide association studies (GWAS). Here we report differences in genetic architecture between depression defined by minimal phenotyping and strictly defined major depressive disorder (MDD): the former has a lower genotype-derived heritability that cannot be explained by inclusion of milder cases and a higher proportion of the genome contributing to this shared genetic liability with other conditions than for strictly defined MDD. GWAS based on minimal phenotyping definitions preferentially identifies loci that are not specific to MDD, and, although it generates highly predictive polygenic risk scores, the predictive power can be explained entirely by large sample sizes rather than by specificity for MDD. Our results show that reliance on results from minimal phenotyping may bias views of the genetic architecture of MDD and impede the ability to identify pathways specific to MDD. Genetic analyses of depression based on minimal phenotyping identify nonspecific genetic risk factors shared between major depressive disorder (MDD) and other psychiatric conditions, suggesting that this approach may have limited ability to identify pathways specific to MDD.	[Cai, Na] Wellcome Genome Campus, Wellcome Sanger Inst, Hinxton, England; [Cai, Na] Wellcome Genome Campus, European Bioinformat Inst EMBL EBI, Hinxton, England; [Revez, Joana A.; Byrne, Enda M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Adams, Mark J.; Clarke, Toni-Kim] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Andlauer, Till F. M.; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Andlauer, Till F. M.] Tech Univ Munich, Sch Med, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Breen, Gerome] Kings Coll London, NIHR Maudsley Biomed Res Ctr, London, England; [Breen, Gerome; Lewis, Cathryn M.] Kings Coll London, Social Genet & Dev Psychiat Ctr, London, England; [Forstner, Andreas J.] Univ Basel, Dept Biomed, Basel, Switzerland; [Forstner, Andreas J.] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Forstner, Andreas J.] Univ Hosp Bonn, Bonn, Germany; [Forstner, Andreas J.] Univ Marburg, Ctr Human Genet, Marburg, Germany; [Grabe, Hans J.; Van der Auwera, Sandra] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Hamilton, Steven P.] Kaiser Permanente Northern Calif, Dept Psychiat, San Francisco, CA USA; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England; [Lewis, Glyn] UCL, Div Psychiat, London, England; [Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet & Computat Biol, Brisbane, Qld, Australia; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Vrije Univ, LaDept Psychiat, Amsterdam UMC, Amsterdam, Netherlands; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] GGZinGeest, Amsterdam, Netherlands; [Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, Risskov, Denmark; [Mors, Ole] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Copenhagen, Denmark; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Perlis, Roy H.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Perlis, Roy H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Pistis, Giorgio; Preisig, Martin] Lausanne Univ Hosp, Dept Psychiat, Lausanne, Switzerland; [Pistis, Giorgio; Preisig, Martin] Univ Lausanne, Lausanne, Switzerland; [Potash, James B.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, PNGU, Boston, MA 02114 USA; [Smoller, Jordan W.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Streit, Fabien] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Tiemeier, Henning] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Uher, Rudolf] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Viktorin, Alexander] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weissman, Myrna M.] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY USA; [Weissman, Myrna M.] New York State Psychiat Inst & Hosp, Div Translat Epidemiol, New York, NY 10032 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Cai, Na] Helmholtz Zentrum Munchen, Helmholtz Pioneer Campus, Neuherberg, Germany	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Queensland; University of Edinburgh; Max Planck Society; Technical University of Munich; University of London; King's College London; University of London; King's College London; University of Basel; University of Bonn; University of Bonn; Philipps University Marburg; Greifswald Medical School; Kaiser Permanente; Stanford University; University of London; King's College London; University of London; University College London; QIMR Berghofer Medical Research Institute; University of Amsterdam; Vrije Universiteit Amsterdam; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Munich; University of Liverpool; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Dalhousie University; Karolinska Institutet; Columbia University; New York State Psychiatry Institute; Virginia Commonwealth University; University of California System; University of California Los Angeles; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Cai, N (corresponding author), Wellcome Genome Campus, Wellcome Sanger Inst, Hinxton, England.; Cai, N (corresponding author), Wellcome Genome Campus, European Bioinformat Inst EMBL EBI, Hinxton, England.; Cai, N (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Pioneer Campus, Neuherberg, Germany.	na.cai@helmholtz-muenchen.de	Revez, Joana/ABA-2920-2020; Clarke, Toni/AAE-7069-2019; Colaus, PsyColaus/K-6607-2013; Lewis, Glyn/E-9944-2012; Tiemeier, Henning/H-6534-2019; Cai, Na/I-2977-2019; Uher, Rudolf/A-5477-2008; Andlauer, Till/AAV-1893-2020; Breen, Gerome/A-5540-2010; Byrne, Enda/J-6068-2014; Penninx, Brenda WJH/S-7627-2017; Lewis, Cathryn/A-5225-2010; Webb, Bradley/B-1459-2009	Revez, Joana/0000-0003-3204-5396; Clarke, Toni/0000-0002-7745-6351; Lewis, Glyn/0000-0001-5205-8245; Tiemeier, Henning/0000-0002-4395-1397; Cai, Na/0000-0001-7496-2075; Uher, Rudolf/0000-0002-2998-0546; Andlauer, Till/0000-0002-2917-5889; Viktorin, Alexander/0000-0003-2141-2816; Preisig, Martin/0000-0001-5689-4259; Breen, Gerome/0000-0003-2053-1792; Grabe, Hans J/0000-0003-3684-4208; Byrne, Enda/0000-0002-9491-7797; Penninx, Brenda WJH/0000-0001-7779-9672; Lewis, Cathryn/0000-0002-8249-8476; Adams, Mark James/0000-0002-3599-6018; Webb, Bradley/0000-0002-0576-5366	ESPOD Fellowship from European Bioinformatics (EMBL-EBI); Wellcome Sanger Institute; Swedish Brain Foundation; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London Maudsley Foundation Trust and King's College London; US National Institute of Mental Health (NIMH); Templeton Foundation; Sackler Foundation; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401, 33CS30-177535/1]; US NIMH; US National Institute of Drug Abuse [U01 MH109528, U01 MH1095320]	ESPOD Fellowship from European Bioinformatics (EMBL-EBI); Wellcome Sanger Institute; Swedish Brain Foundation; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London Maudsley Foundation Trust and King's College London; US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Templeton Foundation; Sackler Foundation; GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	We thank O. Weissbrod, A. Dahl, H. Shi and V. Zuber for insightful discussions. N.C. is supported by the ESPOD Fellowship from European Bioinformatics (EMBL-EBI) and Wellcome Sanger Institute. A.V. is supported by the Swedish Brain Foundation. C.M.L. and G.B. are funded by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London Maudsley Foundation Trust and King's College London. In the last 3 years, M.M.W. has received research funds from the US National Institute of Mental Health (NIMH), the Templeton Foundation and the Sackler Foundation and has received royalties for publication of books on interpersonal psychotherapy from Perseus Press and Oxford University Press, on other topics from the American Psychiatric Association Press and royalties on the social adjustment scale from Multihealth Systems. The CoLaus vertical bar PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne and the Swiss National Science Foundation (grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401 and 33CS30-177535/1). The PGC has received major funding from the US NIMH and the US National Institute of Drug Abuse (U01 MH109528 and U01 MH1095320). This research was conducted using the UK Biobank resource under application no. 28709 and with the support and collaboration from all investigators who make up the MDD Working Group of the PGC (full list in the Supplementary Note). We are greatly indebted to the hundreds of thousands of individuals who have shared their life experiences with the UK Biobank and PGC investigators.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Adams MJ, 2019, INT J EPIDEMIOL, DOI [10.1101/471433, DOI 10.1101/471433]; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; [Anonymous], 2016, 2011 CENS AGGR DAT, DOI [10.5257/census/aggregate-2011-1, DOI 10.5257/CENSUS/AGGREGATE-2011-1]; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Berardi D, 2005, PSYCHOTHER PSYCHOSOM, V74, P225, DOI 10.1159/000085146; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; BRESLAU N, 1985, PSYCHIAT RES, V15, P219, DOI 10.1016/0165-1781(85)90079-4; BROMET EJ, 1986, ARCH GEN PSYCHIAT, V43, P435; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clarke DE, 2013, AM J PSYCHIAT, V170, P43, DOI 10.1176/appi.ajp.2012.12070998; Corfield EC, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.99; Coyne J C, 1991, J Am Board Fam Pract, V4, P207; Davis KAS, 2018, BJPSYCH OPEN, V4, P83, DOI 10.1192/bjo.2018.12; DEMPSTER ER, 1950, GENETICS, V35, P212; Direk N, 2017, BIOL PSYCHIAT, V82, P322, DOI 10.1016/j.biopsych.2016.11.013; Druss BG, 2007, ARCH GEN PSYCHIAT, V64, P1196, DOI 10.1001/archpsyc.64.10.1196; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.01.027, 10.1016/j.neuron.2014.02.033]; Fluharty M, 2017, NICOTINE TOB RES, V19, P3, DOI 10.1093/ntr/ntw140; Foley DL, 2001, PSYCHOL MED, V31, P1413, DOI 10.1017/S0033291701004755; Freimer NB, 2019, NAT REV GENET, V20, P129, DOI 10.1038/s41576-018-0078-y; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Gibbons RD, 2013, J CLIN PSYCHIAT, V74, P669, DOI 10.4088/JCP.12m08338; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Howard DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03819-3; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; KELLER MB, 1995, AM J PSYCHIAT, V152, P843; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kendler KS, 2019, PSYCHOL MED, V49, P2745, DOI 10.1017/S003329171800377X; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lam M, 2020, BIOINFORMATICS, V36, P930, DOI 10.1093/bioinformatics/btz633; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lu JT, 2014, NEW ENGL J MED, V371, P593, DOI 10.1056/NEJMp1400788; Marcus SC, 2010, ARCH GEN PSYCHIAT, V67, P1265, DOI 10.1001/archgenpsychiatry.2010.151; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McIntosh AM, 2019, NEURON, V102, P91, DOI 10.1016/j.neuron.2019.03.022; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Mullins N, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0803-9; Nevin RL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-376; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Peterson RE, 2018, AM J PSYCHIAT, V175, P545, DOI 10.1176/appi.ajp.2017.17060621; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011, Nat Genet, V43, P977, DOI 10.1038/ng.943; RICE JP, 1992, ARCH GEN PSYCHIAT, V49, P824; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Shi HWB, 2017, AM J HUM GENET, V101, P737, DOI 10.1016/j.ajhg.2017.09.022; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; SPITZER RL, 1979, AM J PSYCHIAT, V136, P815; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sullivan PF, 2018, AM J PSYCHIAT, V175, P15, DOI 10.1176/appi.ajp.2017.17030283; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Trzaskowski M, 2019, AM J MED GENET B, V180, P439, DOI 10.1002/ajmg.b.32713; Turley P, 2018, NAT GENET, V50, P229, DOI 10.1038/s41588-017-0009-4; Weissbrod O, 2018, AM J HUM GENET, V103, P89, DOI 10.1016/j.ajhg.2018.06.002; WEISSMAN MM, 1978, ACTA PSYCHIAT SCAND, V57, P219, DOI 10.1111/j.1600-0447.1978.tb06888.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wootton RE, 2020, PSYCHOL MED, V50, P2435, DOI 10.1017/S0033291719002678; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3	82	84	86	1	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2020	52	4					437	+		10.1038/s41588-020-0594-5	http://dx.doi.org/10.1038/s41588-020-0594-5		MAR 2020	22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ6QL	32231276	Green Submitted, Green Accepted			2022-12-17	WOS:000522382900002
J	Dietlein, F; Weghorn, D; Taylor-Weiner, A; Richters, A; Reardon, B; Liu, D; Lander, ES; Van Allen, EM; Sunyaev, SR				Dietlein, Felix; Weghorn, Donate; Taylor-Weiner, Amaro; Richters, Andre; Reardon, Brendan; Liu, David; Lander, Eric S.; Van Allen, Eliezer M.; Sunyaev, Shamil R.			Identification of cancer driver genes based on nucleotide context	NATURE GENETICS			English	Article							RNA-BINDING PROTEINS; SOMATIC MUTATIONS; DNA-POLYMERASE; MOLECULAR CLASSIFICATION; CHROMATIN ORGANIZATION; NETWORK ANALYSIS; STRUCTURAL BASIS; P-VALUES; DATABASE; LANDSCAPE	MutPanning is a new method to detect cancer driver genes that identifies genes with an excess of mutations in unusual nucleotide contexts. Applying this to whole-exome sequencing data from 11,873 tumor-normal pairs identifies 460 driver genes. Cancer genomes contain large numbers of somatic mutations but few of these mutations drive tumor development. Current approaches either identify driver genes on the basis of mutational recurrence or approximate the functional consequences of nonsynonymous mutations by using bioinformatic scores. Passenger mutations are enriched in characteristic nucleotide contexts, whereas driver mutations occur in functional positions, which are not necessarily surrounded by a particular nucleotide context. We observed that mutations in contexts that deviate from the characteristic contexts around passenger mutations provide a signal in favor of driver genes. We therefore developed a method that combines this feature with the signals traditionally used for driver-gene identification. We applied our method to whole-exome sequencing data from 11,873 tumor-normal pairs and identified 460 driver genes that clustered into 21 cancer-related pathways. Our study provides a resource of driver genes across 28 tumor types with additional driver genes identified according to mutations in unusual nucleotide contexts.	[Dietlein, Felix; Taylor-Weiner, Amaro; Reardon, Brendan; Liu, David; Van Allen, Eliezer M.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dietlein, Felix; Taylor-Weiner, Amaro; Richters, Andre; Reardon, Brendan; Liu, David; Lander, Eric S.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Weghorn, Donate; Sunyaev, Shamil R.] Harvard Med Sch, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [Weghorn, Donate; Sunyaev, Shamil R.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Weghorn, Donate] Ctr Genom Regulat, Barcelona, Spain; [Richters, Andre] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Massachusetts Institute of Technology (MIT)	Dietlein, F; Van Allen, EM (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Dietlein, F; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Sunyaev, SR (corresponding author), Harvard Med Sch, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA.; Sunyaev, SR (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.	Felix_Dietlein@dfci.harvard.edu; EliezerM_VanAllen@dfci.harvard.edu; ssunyaev@rics.bwh.harvard.edu	Liu, David/ABF-1275-2020; Weghorn, Donate/AGZ-9573-2022	Liu, David/0000-0003-0346-5033; Weghorn, Donate/0000-0001-7722-8618; Van Allen, Eliezer/0000-0002-0201-4444	EMBO Long-Term Fellowship Program [ALTF 502-2016]; Claudia Adams Barr Program for Innovative Cancer Research; AWS Cloud Credits for Research Program; National Institutes of Health [K08 CA188615, R01 CA227388, R21 CA242861, R01 MH101244, R35 GM127131, U01 HG009088]; Phillip A. Sharp Innovation in Collaboration Award; ASPIRE Award of The Mark Foundation for Cancer Research	EMBO Long-Term Fellowship Program; Claudia Adams Barr Program for Innovative Cancer Research; AWS Cloud Credits for Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phillip A. Sharp Innovation in Collaboration Award; ASPIRE Award of The Mark Foundation for Cancer Research	We thank G. Getz and C. Cotsapas for their valuable comments and suggestions. We thank M. Reich and T. Liefeld for adding MutPanning as a module to the GenePattern platform. The results presented in this study are in part based on data generated by the TCGA Research Network: https://www.cancer.gov/tcga. F.D. was supported by the EMBO Long-Term Fellowship Program (grant no. ALTF 502-2016), the Claudia Adams Barr Program for Innovative Cancer Research and the AWS Cloud Credits for Research Program. E.M.V.A. and S.R.S received funding from the National Institutes of Health (grants nos K08 CA188615, R01 CA227388 and R21 CA242861 to E.M.V.A. and grants nos R01 MH101244, R35 GM127131 and U01 HG009088 to S.R.S.). E.M.V.A acknowledges support through the Phillip A. Sharp Innovation in Collaboration Award. F.D. and E.M.V.A. were further supported through the ASPIRE Award of The Mark Foundation for Cancer Research.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Cairns J, 2018, EMBO REP, V19, DOI 10.15252/embr.201744767; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chakravorty D, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1652-6; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen YH, 2012, CELL REP, V2, P1197, DOI 10.1016/j.celrep.2012.10.012; Cheng DT, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0271-4; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cowen L, 2017, NAT REV GENET, V18, P551, DOI 10.1038/nrg.2017.38; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/NMETH.3440, 10.1038/nmeth.3440]; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Ewens WJ, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346174; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fredriksson NJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006773; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ganai RA, 2016, MOL CELL, V62, P745, DOI 10.1016/j.molcel.2016.05.003; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao NN, 2013, PROTEIN PEPTIDE LETT, V20, P481, DOI 10.2174/092986613805290336; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Goodman MF, 1998, GENETICS, V148, P1475; Grau J, 2015, BIOINFORMATICS, V31, P2595, DOI 10.1093/bioinformatics/btv153; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hess JM, 2019, CANCER CELL, V36, P288, DOI 10.1016/j.ccell.2019.08.002; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12096; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Izarzugaza JMG, 2009, PROTEINS, V77, P892, DOI 10.1002/prot.22512; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar R, 2015, BIOINFORMATICS, V31, P2583, DOI 10.1093/bioinformatics/btv190; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Morrison G, 2016, EMBO J, V35, P356, DOI 10.15252/embj.201592116; Mularoni L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0994-0; Murphy M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28299; Neelamraju Y, 2018, RNA BIOL, V15, P115, DOI 10.1080/15476286.2017.1391436; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Porta-Pardo E, 2014, BIOINFORMATICS, V30, P3109, DOI 10.1093/bioinformatics/btu499; Porter Andrew P, 2016, Small GTPases, V7, P123, DOI 10.1080/21541248.2016.1173767; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reich M, 2017, CELL SYST, V5, P149, DOI 10.1016/j.cels.2017.07.003; Rheinbay E., 2017, DISCOVERY CHARACTERI, DOI [10.1101/237313, DOI 10.1101/237313]; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Shiraishi Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005657; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sulima SO, 2017, CANCER DISCOV, V7, P1069, DOI 10.1158/2159-8290.CD-17-0550; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Taylor-Weiner A, 2018, NAT METHODS, V15, P531, DOI 10.1038/s41592-018-0036-9; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weghorn D, 2017, NAT GENET, V49, P1785, DOI 10.1038/ng.3987; Wilson KF, 2013, TRENDS MOL MED, V19, P74, DOI 10.1016/j.molmed.2012.10.011; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zhang JJ, 2011, DATABASE-OXFORD, DOI [10.1093/database/bar026, 10.1155/2011/958381]; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	98	84	85	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2020	52	2					208	+		10.1038/s41588-019-0572-y	http://dx.doi.org/10.1038/s41588-019-0572-y		FEB 2020	28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KM6MD	32015527	Green Submitted, Green Accepted			2022-12-17	WOS:000510822800002
J	Mascher, M; Schreiber, M; Scholz, U; Graner, A; Reif, JC; Stein, N				Mascher, Martin; Schreiber, Mona; Scholz, Uwe; Graner, Andreas; Reif, Jochen C.; Stein, Nils			Genebank genomics bridges the gap between the conservation of crop diversity and plant breeding	NATURE GENETICS			English	Article							GENETIC DIVERSITY; WHEAT; RESISTANCE; SELECTION; TRAITS; EXPLOITATION; OPTIMIZATION; COLLECTIONS; ADAPTATION; ACCESSIONS	Genebanks have the long-term mission of preserving plant genetic resources as an agricultural legacy for future crop improvement. Operating procedures for seed storage and plant propagation have been in place for decades, but there is a lack of effective means for the discovery and transfer of beneficial alleles from landraces and wild relatives into modern varieties. Here, we review the prospects of using molecular passport data derived from genomic sequence information as a universal monitoring tool at the single-plant level within and between genebanks. Together with recent advances in breeding methodologies, the transformation of genebanks into bio-digital resource centers will facilitate the selection of useful genetic variation and its use in breeding programs, thus providing easy access to past crop diversity. We propose linking catalogs of natural genetic variation and enquiries into biological mechanisms of plant performance as a long-term joint research goal of genebanks, plant geneticists and breeders.	[Mascher, Martin; Schreiber, Mona; Scholz, Uwe; Graner, Andreas; Reif, Jochen C.; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Stein, Nils] Georg August Univ, Dept Crop Sci, Ctr Integrated Breeding Res CiBreed, Gottingen, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Gottingen	Mascher, M; Stein, N (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany.; Mascher, M (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.; Stein, N (corresponding author), Georg August Univ, Dept Crop Sci, Ctr Integrated Breeding Res CiBreed, Gottingen, Germany.	mascher@ipk-gatersleben.de; stein@ipk-gatersleben.de	Schreiber, Mona/AAV-5372-2021; Schreiber, Mona/AAY-7024-2020; Stein, Nils/F-7507-2017	Schreiber, Mona/0000-0002-6771-6914; Stein, Nils/0000-0003-3011-8731; Mascher, Martin/0000-0001-6373-6013; Scholz, Uwe/0000-0001-6113-3518; Graner, Andreas/0000-0003-3246-6393; Reif, Jochen/0000-0002-6742-265X	German Federal Ministry of Research and Education (BMBF) [FKZ 031B0190, FKZ 031B0184, FKZ 031A536A]; Leibniz Association [SAW-2015-IPK-1]	German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Leibniz Association	This work was supported by grants from the German Federal Ministry of Research and Education (BMBF) to N.S., J.C.R., U.S. and M.M. (FKZ 031B0190; 'SHAPE'; FKZ 031B0184 'Genebank 2.0'; FKZ 031A536A 'de.NBI') and a grant from the Leibniz Association to N.S., A.G., U.S., J.C.R. and M.M. (SAW-2015-IPK-1 'BRIDGE'). We thank M. Oppermann for tracing the origin of the Ethiopian accessions.	Akdemir D, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0116-6; Alamerew S, 2004, GENET RESOUR CROP EV, V51, P559, DOI 10.1023/B:GRES.0000024164.80444.f0; ALBERCH P, 1991, GENETICA, V84, P5, DOI 10.1007/BF00123979; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Blancke S, 2017, TRENDS BIOTECHNOL, V35, P185, DOI 10.1016/j.tibtech.2016.12.004; Bohm J, 2017, THEOR APPL GENET, V130, P861, DOI 10.1007/s00122-017-2856-x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Corwin JA, 2016, MOL PLANT MICROBE IN, V29, P287, DOI 10.1094/MPMI-09-15-0196-R; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Cwiek-Kupczynska H, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0144-4; Davidson EH, 2010, REGULATORY GENOME GE; FAO, 2010, 2 FAO; FRANKEL OH, 1974, GENETICS, V78, P53; Gaynor RC, 2017, CROP SCI, V57, P2372, DOI 10.2135/cropsci2016.09.0742; Gruber K, 2017, NATURE, V544, pS8, DOI 10.1038/544S8a; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Lemmon ZH, 2016, GENOME RES, V26, P1676, DOI 10.1101/gr.207837.116; Li TD, 2018, NAT BIOTECHNOL, V36, P1160, DOI 10.1038/nbt.4273; Longin CFH, 2014, TRENDS PLANT SCI, V19, P631, DOI 10.1016/j.tplants.2014.06.012; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Marden E, 2018, NAT PLANTS, V4, P2, DOI 10.1038/s41477-017-0087-4; Mascher M, 2016, NAT GENET, V48, P1089, DOI 10.1038/ng.3611; Milner SG, 2019, NAT GENET, V51, P319, DOI 10.1038/s41588-018-0266-x; Navarro JAR, 2017, NAT GENET, V49, P476, DOI 10.1038/ng.3784; Nelson PT, 2008, CROP SCI, V48, P85, DOI 10.2135/cropsci2007.05.0287; Nelson R, 2018, NAT REV GENET, V19, P21, DOI 10.1038/nrg.2017.82; Oppermann M, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav021; Parzies HK, 2000, HEREDITY, V84, P476, DOI 10.1046/j.1365-2540.2000.00705.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peres S, 2016, STUD HIST PHI PART C, V55, P96, DOI 10.1016/j.shpsc.2015.09.002; Phippen WB, 1997, THEOR APPL GENET, V94, P227, DOI 10.1007/s001220050404; Pistorius Robin, 1997, SCI PLANTS POLITICS; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Selby P, 2019, BIOINFORMATICS, V35, P4147, DOI 10.1093/bioinformatics/btz190; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; SIMMONDS NW, 1962, BIOL REV, V37, P422, DOI 10.1111/j.1469-185X.1962.tb01620.x; Strigens A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057234; Swarts K, 2017, SCIENCE, V357, P512, DOI 10.1126/science.aam9425; van Treuren R, 2001, THEOR APPL GENET, V103, P144, DOI 10.1007/s001220100537; VANHINTUM TJL, 1995, GENET RESOUR CROP EV, V42, P135, DOI 10.1007/BF02539517; von Bothmer R, 2003, DEV PL GEN, V7, P9; Watson A, 2018, NAT PLANTS, V4, P23, DOI 10.1038/s41477-017-0083-8; Weiss CL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160239; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wulff BBH, 2018, SCIENCE, V361, P451, DOI 10.1126/science.aat5119; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; Yu XQ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.150, 10.1038/nplants.2016.150]; Zhao YS, 2015, P NATL ACAD SCI USA, V112, P15624, DOI 10.1073/pnas.1514547112; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272	54	84	84	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2019	51	7					1076	1081		10.1038/s41588-019-0443-6	http://dx.doi.org/10.1038/s41588-019-0443-6			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG0PF	31253974				2022-12-17	WOS:000473491900005
J	Liu, BX; Gloudemans, MJ; Rao, AS; Ingelsson, E; Montgomery, SB				Liu, Boxiang; Gloudemans, Michael J.; Rao, Abhiram S.; Ingelsson, Erik; Montgomery, Stephen B.			Abundant associations with gene expression complicate GWAS follow-up	NATURE GENETICS			English	Letter							GENOME-WIDE ASSOCIATION; EQTL		[Liu, Boxiang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Liu, Boxiang; Gloudemans, Michael J.; Rao, Abhiram S.; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Gloudemans, Michael J.] Stanford Univ, Biomed Informat Training Program, Sch Med, Stanford, CA 94305 USA; [Rao, Abhiram S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Liu, BX (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Liu, BX; Montgomery, SB (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Montgomery, SB (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	jollier.liu@gmail.com; smontgom@stanford.edu		Gloudemans, Michael/0000-0002-9924-9943; Liu, Boxiang/0000-0002-2595-4463; Montgomery, Stephen/0000-0002-5200-3903	Stanford Center for Evolution and Human Genomics fellowship; National Key R&D Program of China [2016YFD0400800]; Baidu Research; NLM training grant [T15 LM 007033]; Stanford Graduate Fellowship; Edward Mallinckrodt Jr. Foundation;  [R01DK106236];  [R33HL120757];  [U01HG009431];  [R01MH101814];  [R01HG008150];  [R01HL142015];  [U01HG009080]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK116074] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Stanford Center for Evolution and Human Genomics fellowship; National Key R&D Program of China; Baidu Research; NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Stanford Graduate Fellowship(Stanford University); Edward Mallinckrodt Jr. Foundation; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	B.L. is supported by the Stanford Center for Evolution and Human Genomics fellowship and National Key R&D Program of China, 2016YFD0400800 and Baidu Research. M.J.G. is funded by NLM training grant T15 LM 007033 and a Stanford Graduate Fellowship. E.I. is supported by R01DK106236. S.B.M. is supported by R33HL120757 (NHLBI), U01HG009431 (NHGRI; ENCODE4), R01MH101814 (NIH Common Fund; GTEx Program), R01HG008150 (NHGRI; Non-Coding Variants Program), R01HL142015 (NHLBI; TOPMED), U01HG009080 (NHGRI; GSPAC) and the Edward Mallinckrodt Jr. Foundation. We acknowledge A. Shcherbina for support in this project and N. Cyr for support with graphical illustration.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Liu B., 2018, BIORXIV, DOI [10.1101/446799, DOI 10.1101/446799]; Liu BX, 2018, AM J HUM GENET, V103, P377, DOI 10.1016/j.ajhg.2018.08.001; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; McRae AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35871-w; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Zhao W, 2017, NAT GENET, V49, P1450, DOI 10.1038/ng.3943; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	15	84	85	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					768	+		10.1038/s41588-019-0404-0	http://dx.doi.org/10.1038/s41588-019-0404-0			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK	31043754	Green Accepted			2022-12-17	WOS:000466842000002
J	Lu, XF; Peloso, GM; Liu, DJJ; Wu, Y; Zhang, H; Zhou, W; Li, J; Tang, CSM; Dorajoo, R; Li, HX; Long, JR; Guo, XQ; Xu, M; Spracklen, CN; Chen, Y; Liu, XZ; Zhang, Y; Khor, CC; Liu, JJ; Sun, L; Wang, LY; Gao, YT; Hu, Y; Yu, K; Wang, YQ; Cheung, CYY; Wang, FJ; Huang, JF; Fan, Q; Cai, QY; Chen, SF; Shi, JX; Yang, XL; Zhao, WT; Sheu, WHH; Cherny, SS; He, MA; Feranil, AB; Adair, LS; Gordon-Larsen, P; Du, SF; Varma, R; Chen, YDI; Shu, XO; Lam, KSL; Wong, TY; Ganesh, SK; Mo, ZN; Hveem, K; Fritsche, LG; Nielsen, JB; Tse, HF; Huo, Y; Cheng, CY; Chen, YE; Zheng, W; Tai, ES; Gao, W; Lin, X; Huang, W; Abecasis, G; Kathiresan, S; Mohlke, KL; Wu, TC; Sham, PC; Gu, DF; Willer, CJ				Lu, Xiangfeng; Peloso, Gina M.; Liu, Dajiang J.; Wu, Ying; Zhang, He; Zhou, Wei; Li, Jun; Tang, Clara Sze-man; Dorajoo, Rajkumar; Li, Huaixing; Long, Jirong; Guo, Xiuqing; Xu, Ming; Spracklen, Cassandra N.; Chen, Yang; Liu, Xuezhen; Zhang, Yan; Khor, Chiea Chuen; Liu, Jianjun; Sun, Liang; Wang, Laiyuan; Gao, Yu-Tang; Hu, Yao; Yu, Kuai; Wang, Yiqin; Cheung, Chloe Yu Yan; Wang, Feijie; Huang, Jianfeng; Fan, Qiao; Cai, Qiuyin; Chen, Shufeng; Shi, Jinxiu; Yang, Xueli; Zhao, Wanting; Sheu, Wayne H-H; Cherny, Stacey Shawn; He, Meian; Feranil, Alan B.; Adair, Linda S.; Gordon-Larsen, Penny; Du, Shufa; Varma, Rohit; Chen, Yii-Der Ida; Shu, Xiao-Ou; Lam, Karen Siu Ling; Wong, Tien Yin; Ganesh, Santhi K.; Mo, Zengnan; Hveem, Kristian; Fritsche, Lars G.; Nielsen, Jonas Bille; Tse, Hung-fat; Huo, Yong; Cheng, Ching-Yu; Chen, Y. Eugene; Zheng, Wei; Tai, E. Shyong; Gao, Wei; Lin, Xu; Huang, Wei; Abecasis, Goncalo; Kathiresan, Sekar; Mohlke, Karen L.; Wu, Tangchun; Sham, Pak Chung; Gu, Dongfeng; Willer, Cristen J.		GLGC Consortium	Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LOW-FREQUENCY; BLOOD-LIPIDS; MYOCARDIAL-INFARCTION; SEQUENCE VARIANTS; RARE VARIANTS; RISK; CHOLESTEROL; GENE; TRIGLYCERIDES	Most genome-wide association studies have been of European individuals, even though most genetic variation in humans is seen only in non-European samples. To search for novel loci associated with blood lipid levels and clarify the mechanism of action at previously identified lipid loci, we used an exome array to examine protein-coding genetic variants in 47,532 East Asian individuals. We identified 255 variants at 41 loci that reached chip-wide significance, including 3 novel loci and 14 East Asian-specific coding variant associations. After a meta-analysis including >300,000 European samples, we identified an additional nine novel loci. Sixteen genes were identified by protein-altering variants in both East Asians and Europeans, and thus are likely to be functional genes. Our data demonstrate that most of the low-frequency or rare coding variants associated with lipids are population specific, and that examining genomic data across diverse ancestries may facilitate the identification of functional genes at associated loci.	[Lu, Xiangfeng; Wang, Laiyuan; Huang, Jianfeng; Chen, Shufeng; Yang, Xueli; Gu, Dongfeng] Chinese Acad Med Sci, Dept Epidemiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Lu, Xiangfeng; Wang, Laiyuan; Huang, Jianfeng; Chen, Shufeng; Yang, Xueli; Gu, Dongfeng] Peking Union Med Coll, Beijing, Peoples R China; [Lu, Xiangfeng; Zhang, He; Ganesh, Santhi K.; Nielsen, Jonas Bille; Chen, Y. Eugene; Willer, Cristen J.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Lu, Xiangfeng; Zhang, He; Ganesh, Santhi K.; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Peloso, Gina M.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Liu, Dajiang J.] Penn State Univ, Inst Personalized Med, Dept Publ Hlth Sci, University Pk, PA 16802 USA; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zhou, Wei; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Li, Jun; Yu, Kuai; He, Meian; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [Tang, Clara Sze-man] Univ Hong Kong, Li KaShing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tang, Clara Sze-man] Univ Hong Kong, Karolinska Inst Collaborat Regenerat Med, Li Dak Sum Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Dorajoo, Rajkumar; Khor, Chiea Chuen; Liu, Jianjun] Genome Inst Singapore, Agcy Sci Technol & Res, Singapore, Singapore; [Li, Huaixing; Sun, Liang; Hu, Yao; Wang, Yiqin; Wang, Feijie; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutrit Sci, Shanghai, Peoples R China; [Li, Huaixing; Sun, Liang; Hu, Yao; Wang, Yiqin; Wang, Feijie; Lin, Xu] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Long, Jirong; Cai, Qiuyin; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Guo, Xiuqing; Chen, Yii-Der Ida] Harbor UCLA Med Ctr, LABioMed, Inst Translat Genom & Populat Sci, Los Angeles, CA USA; [Xu, Ming] Peking Univ Third Hosp, Dept Cardiol, Inst Vasc Med, Key Lab Mol Cardiovasc Sci,Minist Educ, Beijing, Peoples R China; [Chen, Yang; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Med Sci Res Ctr, Nanning, Peoples R China; [Chen, Yang; Mo, Zengnan] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Peoples R China; [Zhang, Yan; Huo, Yong] Peking Univ, Hosp 1, Dept Cardiol, Beijing, Peoples R China; [Khor, Chiea Chuen; Wong, Tien Yin] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, Singapore, Singapore; [Khor, Chiea Chuen; Fan, Qiao; Zhao, Wanting] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Sch Med, Dept Epidemiol, Shanghai Canc Inst,Renji Hosp, Shanghai, Peoples R China; [Cheung, Chloe Yu Yan; Tse, Hung-fat] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Jianfeng] Shenzhen Univ, Affiliated Hosp 3, Community Hlth Ctr, Shenzhen, Peoples R China; [Fan, Qiao; Wong, Tien Yin; Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Gen, Shanghai, Peoples R China; [Sheu, Wayne H-H] Taichung Vet Gen Hosp, Div Endocrine Metab, Dept Internal Med, Taichung, Taiwan; [Cherny, Stacey Shawn; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey Shawn; Sham, Pak Chung] Univ Hong Kong, Li KaShing Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey Shawn; Sham, Pak Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Feranil, Alan B.] Univ San Carlos, USC Off Populat Studies Fdn, Cebu, Philippines; [Feranil, Alan B.] Univ San Carlos, Dept Anthropol Sociol & Hist, Cebu, Philippines; [Adair, Linda S.; Gordon-Larsen, Penny; Du, Shufa] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Gordon-Larsen, Penny; Du, Shufa] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Varma, Rohit] Univ Southern Calif, Keck Sch Med, Dept Ophthalmol, USC Eye Inst, Los Angeles, CA 90033 USA; [Lam, Karen Siu Ling; Tse, Hung-fat] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Li KaShing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Karen Siu Ling] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Wong, Tien Yin; Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Wong, Tien Yin; Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore, Singapore; [Hveem, Kristian; Fritsche, Lars G.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Hveem, Kristian; Fritsche, Lars G.] Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Hveem, Kristian] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med, Levanger, Norway; [Fritsche, Lars G.; Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Tse, Hung-fat] Univ Hong Kong, Hong Kong Guangdong Joint Lab Stem Cell & Regener, Hong Kong, Hong Kong, Peoples R China; [Cheng, Ching-Yu] Ophthalmol & Visual Sci Acad Clin Program, Duke NUS Med Sch, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Huazhong University of Science & Technology; University of Hong Kong; University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Peking University; Guangxi Medical University; Guangxi Medical University; Peking University; National University of Singapore; National University of Singapore; Singapore National Eye Center; Shanghai Jiao Tong University; University of Hong Kong; Shenzhen University; National University of Singapore; Taichung Veterans General Hospital; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of San Carlos; University of San Carlos; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of Hong Kong; University of Hong Kong; National University of Singapore; National University of Singapore; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; University of Hong Kong; National University of Singapore; National University of Singapore; Harvard University; Massachusetts General Hospital	Gu, DF (corresponding author), Chinese Acad Med Sci, Dept Epidemiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.; Gu, DF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Willer, CJ (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.; Sham, PC (corresponding author), Univ Hong Kong, Li KaShing Fac Med, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China.; Sham, PC (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	pcsham@hku.hk; gudongfeng@vip.sina.coM; cristen@umich.edu	Cheng, Ching-Yu/Y-2229-2019; Tse, Hung-Fat/C-4426-2009; gao, yi/HCI-8298-2022; Wong, Tien Yin/AAC-9724-2020; Hu, Yao/L-1424-2019; Liu, Jianjun/AAK-4989-2020; Gao, Yu/HGE-1937-2022; Cherny, Stacey S/B-3315-2008; Hveem, Kristian/AFV-4683-2022; Yang, Xueli/AAW-4792-2021; Zheng, Wei/GQQ-8951-2022; Gao, Y./GWZ-3665-2022; Fritsche, Lars G/AAF-9387-2019	Cheng, Ching-Yu/0000-0003-0655-885X; Tse, Hung-Fat/0000-0002-9578-7808; Wong, Tien Yin/0000-0002-8448-1264; Liu, Jianjun/0000-0002-3255-3019; Cherny, Stacey S/0000-0002-0269-3352; Fritsche, Lars G/0000-0002-2110-1690; Long, Jirong/0000-0002-7433-9766; Tai, E Shyong/0000-0003-2929-8966; mo, zengnan/0000-0002-3047-3138; Liu, Dajiang/0000-0001-6553-858X; Willer, Cristen/0000-0001-5645-4966; Nielsen, Jonas Bille/0000-0002-6654-2852; Gao, Wei/0000-0003-3541-9568; Cheung, Chloe Yu Yan/0000-0002-7884-5295; Wang, Yiqin/0000-0003-4714-774X; Gordon-Larsen, Penny/0000-0001-5322-4188; Zhang, He/0000-0001-9198-6503; Dorajoo, Rajkumar/0000-0001-6608-2051; Tang, Clara/0000-0003-0265-2638; Tse, Hung Fat/0000-0003-4665-7887; Lu, Xiangfeng/0000-0003-4088-2338	CAMS Innovation Fund for Medical Sciences [2016-I2M-1-009, 2017-I2M-1-004, 2016-I2M-1-011]; National Science Foundation of China [81422043, 91439202, 81370002, 81773537, 81230069]; National Institutes of Health [HL135824, HL127564]; Hong Kong Research Grants Council [TRS T12/705/11, GRF 17128515]; National Heart, Lung, and Blood Institute of the National Institutes of Health [K01HL125751]; FOGARTY INTERNATIONAL CENTER [D43TW009077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108427, R35HL135824, R01HL127564, K01HL125751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK104371] Funding Source: NIH RePORTER	CAMS Innovation Fund for Medical Sciences; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the participants of this study for their contributions. X. Lu is supported by the CAMS Innovation Fund for Medical Sciences (grants 2016-I2M-1-009, 2017-I2M-1-004, and 2016-I2M-1-011) and the National Science Foundation of China (grants 81422043, 91439202, 81370002, 81773537, and 81230069). C.J.W. is supported by the National Institutes of Health (grant HL135824). S.K. and C.J.W. are supported by the National Institutes of Health (grant HL127564). P.C.S. was supported by the Hong Kong Research Grants Council (grants TRS T12/705/11 and GRF 17128515). G.M.P. is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (award K01HL125751). We thank P. Marshall for professional editing. Additional acknowledgments of funding sources for the primary studies are provided in Supplementary Note 1.	Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Johansson A, 2010, OBESITY, V18, P803, DOI 10.1038/oby.2009.359; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lambert NG, 2016, PROG RETIN EYE RES, V54, P64, DOI 10.1016/j.preteyeres.2016.04.003; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Liu DJ, 2017, NAT GENET; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Rosenson RS, 2014, J AM COLL CARDIOL, V64, P2525, DOI 10.1016/j.jacc.2014.09.042; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Spracklen CN, 2017, HUM MOL GENET, V26, P1770, DOI 10.1093/hmg/ddx062; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10206; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wierzbicki AS, 2012, CURR OPIN LIPIDOL, V23, P345, DOI 10.1097/MOL.0b013e3283541cfc; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams GSB, 2015, J MOL CELL CARDIOL, V78, P35, DOI 10.1016/j.yjmcc.2014.10.019; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379	30	84	91	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1722	+		10.1038/ng.3978	http://dx.doi.org/10.1038/ng.3978			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29083407	Green Submitted, Green Accepted			2022-12-17	WOS:000416480600011
J	Riaz, N; Havel, JJ; Kendall, SM; Makarov, V; Walsh, LA; Desrichard, A; Weinhold, N; Chan, TA				Riaz, Nadeem; Havel, Jonathan J.; Kendall, Sviatoslav M.; Makarov, Vladimir; Walsh, Logan A.; Desrichard, Alexis; Weinhold, Nils; Chan, Timothy A.			Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy	NATURE GENETICS			English	Article							CTLA-4 BLOCKADE; PD-1 BLOCKADE; CELL; NIVOLUMAB; SENSITIVITY	Immune checkpoint blockade has shown significant promise as an anticancer treatment, yet the determinants of response are not completely understood. Here we show that somatic mutations in SERPINB3 and SERPINB4 are associated with survival after anti-CTLA4 immunotherapy in two independent cohorts of patients with melanoma (n = 174). Interestingly, serpins are homologs of the well-known ovalbumin antigen and are associated with autoimmunity. Our findings have implications for the personalization of immunotherapy.	[Riaz, Nadeem; Havel, Jonathan J.; Kendall, Sviatoslav M.; Makarov, Vladimir; Walsh, Logan A.; Desrichard, Alexis; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Riaz, Nadeem; Weinhold, Nils; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Chan, Timothy A/ABD-5850-2021	Havel, Jonathan/0000-0003-0951-510X; Walsh, Logan/0000-0001-8771-2577; Desrichard, Alexis/0000-0002-1335-7813; Kendall, Sviatoslav/0000-0002-5368-5109; Riaz, Nadeem/0000-0001-9873-5862	Pershing Square Sohn Cancer Research grant; Frederick Adler Chair; Stand Up 2 Cancer; the STARR Cancer Consortium; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Pershing Square Sohn Cancer Research grant(Pershing Square Sohn Cancer Research Alliance); Frederick Adler Chair; Stand Up 2 Cancer; the STARR Cancer Consortium; NIH/NCI Cancer Center Support Grant; Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Wolchok, T. Merghoub, J. Yuan, P. Wong, and A. Snyder for collaborative interactions. We thank the Integrated Genomics Operation and the Ludwig Immune Monitoring Facility at Memorial Sloan Kettering for technical assistance. We thank A. Heguy and the Genome Technology Center at New York University and L. Mangarin for assistance with validation sequencing. This work was funded by a Pershing Square Sohn Cancer Research grant (T.A.C.), the Frederick Adler Chair (T.A.C.), Stand Up 2 Cancer (T.A.C.), the STARR Cancer Consortium (T.A.C.), and in part through NIH/NCI Cancer Center Support Grant P30 CA008748. Research supported by a Stand Up To Cancer - Cancer Research Institute Cancer Immunology Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Catanzaro JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4729; El-Rachkidy RG, 2008, J INVEST DERMATOL, V128, P2219, DOI 10.1038/jid.2008.71; Gatto M, 2013, CLIN REV ALLERG IMMU, V45, P267, DOI 10.1007/s12016-013-8353-3; Guan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep07857; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holen E, 1996, CLIN EXP ALLERGY, V26, P1080, DOI 10.1046/j.1365-2222.1996.d01-412.x; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lysvand H, 2014, BBA-MOL BASIS DIS, V1842, P734, DOI 10.1016/j.bbadis.2014.02.005; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Munz C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00009; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011	24	84	90	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1327	1329		10.1038/ng.3677	http://dx.doi.org/10.1038/ng.3677			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668655	Green Accepted			2022-12-17	WOS:000386543400008
J	Adamo, A; Atashpaz, S; Germain, PL; Zanella, M; D'Agostino, G; Albertin, V; Chenoweth, J; Micale, L; Fusco, C; Unger, C; Augello, B; Palumbo, O; Hamilton, B; Carella, M; Donti, E; Pruneri, G; Selicorni, A; Biamino, E; Prontera, P; Mckay, R; Merla, G; Testa, G				Adamo, Antonio; Atashpaz, Sina; Germain, Pierre-Luc; Zanella, Matteo; D'Agostino, Giuseppe; Albertin, Veronica; Chenoweth, Josh; Micale, Lucia; Fusco, Carmela; Unger, Christian; Augello, Bartolomeo; Palumbo, Orazio; Hamilton, Brad; Carella, Massimo; Donti, Emilio; Pruneri, Giancarlo; Selicorni, Angelo; Biamino, Elisa; Prontera, Paolo; Mckay, Ronald; Merla, Giuseppe; Testa, Giuseppe			7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages	NATURE GENETICS			English	Article							WILLIAMS-BEUREN-SYNDROME; DIRECTED DIFFERENTIATION; SYNDROME REGION; CRANIOFACIAL DEVELOPMENT; MENTAL-RETARDATION; DEMETHYLASE JMJD3; HUMAN BRAIN; ABNORMALITIES; DUPLICATION; AUTISM	Cell reprogramming promises to make characterization of the impact of human genetic variation on health and disease experimentally tractable by enabling the bridging of genotypes to phenotypes in developmentally relevant human cell lineages. Here we apply this paradigm to two disorders caused by symmetrical copy number variations of 7q11.23, which display a striking combination of shared and symmetrically opposite phenotypes-Williams-Beuren syndrome and 7q-microduplication syndrome. Through analysis of transgene-free patient-derived induced pluripotent stem cells and their differentiated derivatives, we find that 7q11.23 dosage imbalance disrupts transcriptional circuits in disease-relevant pathways beginning in the pluripotent state. These alterations are then selectively amplified upon differentiation of the pluripotent cells into disease-relevant lineages. A considerable proportion of this transcriptional dysregulation is specifically caused by dosage imbalances in GTF2I, which encodes a key transcription factor at 7q11.23 that is associated with the LSD1 repressive chromatin complex and silences its dosage-sensitive targets.	[Adamo, Antonio; Atashpaz, Sina; Germain, Pierre-Luc; Zanella, Matteo; D'Agostino, Giuseppe; Albertin, Veronica; Pruneri, Giancarlo; Testa, Giuseppe] IRCCS, European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Chenoweth, Josh; Mckay, Ronald] Lieber Inst Brain Dev, Baltimore, MD USA; [Micale, Lucia; Augello, Bartolomeo; Palumbo, Orazio; Carella, Massimo; Merla, Giuseppe] IRCCS, Casa Sollievo Sofferenza Hosp, Med Genet Unit, San Giovanni Rotondo, Italy; [Unger, Christian] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Hamilton, Brad] Stemgent, Cambridge, MA USA; [Donti, Emilio; Prontera, Paolo] Univ Perugia, Hosp Santa Maria Misericordia, Med Genet Unit, I-06100 Perugia, Italy; [Selicorni, Angelo] Azienda Osped San Gerardo, Fdn MBBM, Genet Clin Pediatr, UOS, Monza, Italy; [Biamino, Elisa] Univ Turin, Dept Pediat, I-10124 Turin, Italy; [Testa, Giuseppe] Univ Milan, Dept Hlth Sci, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Casa Sollievo Della Sofferenza; University of Sheffield; Hospital Santa Maria della Misericordia; University of Perugia; University of Turin; University of Milan	Testa, G (corresponding author), IRCCS, European Inst Oncol, Dept Expt Oncol, Milan, Italy.	giuseppe.testa@ieo.eu	Fusco, Carmela/H-2964-2016; Micale, Lucia/K-3909-2016; merla, giuseppe/K-4627-2012; Pruneri, Giancarlo/AAC-7767-2022; Germain, Pierre-Luc/K-9326-2016; Prontera, Paolo/AAC-3911-2022; PALUMBO, ORAZIO/C-1133-2014; Augello, Bartolomeo/B-1927-2017; Carella, Massimo/A-2804-2014	Fusco, Carmela/0000-0001-7794-6046; merla, giuseppe/0000-0001-5078-928X; Pruneri, Giancarlo/0000-0002-7963-7172; Germain, Pierre-Luc/0000-0003-3418-4218; PALUMBO, ORAZIO/0000-0001-6583-3482; Augello, Bartolomeo/0000-0001-7475-6976; Prontera, Paolo/0000-0003-4960-9223; Carella, Massimo/0000-0002-6830-6829; D'Agostino, Giuseppe Alessandro/0000-0001-8315-7406; Unger, Christian/0000-0002-4216-3575; Atashpaz, Sina/0000-0003-0566-5629; Zanella, Matteo/0000-0002-1614-4370; Micale, Lucia/0000-0003-3604-194X; Adamo, Antonio/0000-0003-1080-3547; Testa, Giuseppe/0000-0002-9104-0918	Telethon Network of Genetic Biobanks [GTB12001G, GTB12001A]; European Research Council [616441-DISEASEAVATARS]; Italian Ministry of Health; EPIGEN Flagship Project of the Italian National Research Council; Jerome-Lejeune Foundation; ERA-NET Neuron Program; Umberto Veronesi Foundation; Federation of European Biochemical Societies (FEBS); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon Network of Genetic Biobanks(Fondazione Telethon); European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy); EPIGEN Flagship Project of the Italian National Research Council; Jerome-Lejeune Foundation; ERA-NET Neuron Program; Umberto Veronesi Foundation(Fondazione Umberto Veronesi); Federation of European Biochemical Societies (FEBS); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank the AFSW (Associazione Famiglie Sindrome di Williams) and AISW (Associazione Italiana Sindrome di Williams) for agreeing to participate and making this study possible and the Genomic and Genetic Disorder Biobank, Galliera Genetic Bank and members of the Telethon Network of Genetic Biobanks (project numbers GTB12001G and GTB12001A), along with the EuroBioBank network, for providing us with specimens. We also thank scientists at the Drug Discovery Unit, Drug Development Program (DDU-DDP) of the European Institute of Oncology (IEO) for sharing with us the two LSD1 inhibitors used in this study; A. Bachi, A. Cattaneo and P. Soffiantini from the Mass Spectrometry service of the FIRC (Fondazione Italians per la Ricerca sul Cancro) Institute of Molecular Oncology (IFOM); F. Pisati for processing of the teratomas; P. Andrews (University of Sheffield) for sharing two control iPSC lines (CTL2-C1 and CTL2-C2; reprogrammed from CRL-2429 fibroblasts); G. Mostoslavsky and the Center for Regenerative Medicine of Boston University for sharing the BU1Cr3-1 line; G. Barbagiovanni for help with FACS profiling and analysis; and L. Marelli along with all other members of the Testa laboratory for discussion. This work was funded by the European Research Council (consolidator grant number 616441-DISEASEAVATARS to G.T.), the Italian Ministry of Health (Ricerca Corrente to G.T. and G.M. and Bando Giovani Ricercatori 2008 and 2009 to G.T.), the EPIGEN Flagship Project of the Italian National Research Council (G.T.), the Jerome-Lejeune Foundation (G.T. and G.M.), the ERA-NET Neuron Program (G.T.), the Umberto Veronesi Foundation (S.A. and G.D.) and the Federation of European Biochemical Societies (FEBS; fellowship awarded to A.A. to work in the laboratory of G.T.).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Antonell A, 2010, HUM GENET, V128, P27, DOI 10.1007/s00439-010-0817-4; Barnett C, 2012, MECH DEVELOP, V129, P324, DOI 10.1016/j.mod.2012.06.001; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Campuzano V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002458; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Cobourne MT, 2009, DEV BIOL, V331, P38, DOI 10.1016/j.ydbio.2009.04.021; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Fan AX, 2014, NUCLEIC ACIDS RES, V42, P7625, DOI 10.1093/nar/gku467; Ferrero GB, 2010, EUR J HUM GENET, V18, P33, DOI 10.1038/ejhg.2009.108; Fusco C, 2014, EUR J HUM GENET, V22, P64, DOI 10.1038/ejhg.2013.101; Ge X, 2012, CIRCULATION, V126, P1695, DOI 10.1161/CIRCULATIONAHA.112.116996; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gothelf D, 2006, NEUROLOGY, V66, P390, DOI 10.1212/01.wnl.0000196643.35395.5f; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; KRUSE K, 1992, J PEDIATR-US, V121, P902, DOI 10.1016/S0022-3476(05)80336-1; Kurosaka H, 2014, J CLIN INVEST, V124, P1660, DOI 10.1172/JCI72688; Lazebnik MB, 2009, J BIOL CHEM, V284, P36234, DOI 10.1074/jbc.C109.063115; Letra A, 2010, AM J MED GENET A, V152A, P1701, DOI 10.1002/ajmg.a.33482; Leung A, 2013, STEM CELL REP, V1, P451, DOI 10.1016/j.stemcr.2013.10.003; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Makeyev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044443; Makeyev AV, 2011, CLEFT PALATE-CRAN J, V48, P109, DOI 10.1597/09-093; Malenfant P, 2012, J AUTISM DEV DISORD, V42, P1459, DOI 10.1007/s10803-011-1389-4; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Mervis CB, 2012, AM J HUM GENET, V90, P1064, DOI 10.1016/j.ajhg.2012.04.012; Metzis V, 2013, HUM MOL GENET, V22, P5026, DOI 10.1093/hmg/ddt353; Ming GL, 2011, J NEUROSCI, V31, P16070, DOI 10.1523/JNEUROSCI.4218-11.2011; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; O'Leary J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023868; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Osborne LR, 2010, AM J MED GENET C, V154C, P209, DOI 10.1002/ajmg.c.30257; Pankau R, 1996, AM J MED GENET, V63, P301, DOI 10.1002/(SICI)1096-8628(19960503)63:1<301::AID-AJMG49>3.0.CO;2-P; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Phillips HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037685; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Prontera P, 2014, J AUTISM DEV DISORD, V44, P2608, DOI 10.1007/s10803-014-2117-7; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Sabaratnam M, 2000, EUR CHILD ADOLES PSY, V9, P307, DOI 10.1007/s007870070035; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Singh S, 2007, BIRTH DEFECTS RES A, V79, P35, DOI 10.1002/bdra.20320; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Wang KS, 2012, J PSYCHIATR NEUROSCI, V37, P46, DOI 10.1503/jpn.100173; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Zhao XY, 2014, CYTOKINE GROWTH F R, V25, P35, DOI 10.1016/j.cytogfr.2013.12.010	65	84	89	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					132	141		10.1038/ng.3169	http://dx.doi.org/10.1038/ng.3169			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CA1TQ	25501393				2022-12-17	WOS:000348694700008
J	Takeda, H; Wei, ZB; Koso, H; Rust, AG; Yew, CCK; Mann, MB; Ward, JM; Adams, DJ; Copeland, NG; Jenkins, NA				Takeda, Haruna; Wei, Zhubo; Koso, Hideto; Rust, Alistair G.; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Adams, David J.; Copeland, Neal G.; Jenkins, Nancy A.			Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression	NATURE GENETICS			English	Article							NEGATIVE REGULATOR; COLORECTAL-CANCER; STEM-CELLS; P53; SUPPRESSOR; WNT; MUTATIONS; SCREEN; LRIG1; TRANSCRIPTION	To provide a more comprehensive understanding of the genes and evolutionary forces driving colorectal cancer (CRC) progression, we performed Sleeping Beauty (SB) transposon mutagenesis screens in mice carrying sensitizing mutations in genes that act at different stages of tumor progression. This approach allowed us to identify a set of genes that appear to be highly relevant for CRC and to provide a better understanding of the evolutionary forces and systems properties of CRC. We also identified six genes driving malignant tumor progression and a new human CRC tumor-suppressor gene, ZNF292, that might also function in other types of cancer. Our comprehensive CRC data set provides a resource with which to develop new therapies for treating CRC.	[Takeda, Haruna; Koso, Hideto; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Copeland, Neal G.; Jenkins, Nancy A.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore; [Takeda, Haruna] Kanazawa Med Univ, Sch Med, Dept Oncol Pathol, Kanazawa, Ishikawa, Japan; [Wei, Zhubo; Mann, Michael B.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX USA; [Koso, Hideto] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, Cambs, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Kanazawa Medical University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Tokyo; Wellcome Trust Sanger Institute	Jenkins, NA (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore.	njenkins2@houstonmethodist.org	Mann, Michael Bruce/M-4674-2019	Mann, Michael Bruce/0000-0002-7515-6515; KOSO, HIDETO/0000-0002-8986-7617; Rust, Alistair/0000-0001-7287-192X; Adams, David/0000-0001-9490-0306	Biomedical Research Council; Agency for Science, Technology and Research (A-STAR), Singapore; Cancer Prevention Research Institute of Texas (CPRIT); Cancer Research UK; Wellcome Trust; Cancer Research UK [13031] Funding Source: researchfish	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Cancer Prevention Research Institute of Texas (CPRIT); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	We thank K. Rogers, S. Rogers and the Institute of Molecular and Cell Biology histopathology core for performing the histopathological analysis; M.M. Taketo (Kyoto University) for supplying Smad4<SUP>KO</SUP> mice and S. Robin (Institute Curie) for supplying Vil1-creER<SUP>T2</SUP> mice; Y. Ito for helpful discussions and encouragement; and, P. Goh, P. Cheok, N. Lim,.D. Chen and C. Wee for monitoring mice and animal technical assistance. The Biomedical Research Council, Agency for Science, Technology and Research (A-STAR), Singapore, and the Cancer Prevention Research Institute of Texas (CPRIT) supported this research. N.G.C. and N.A.J. are both CPRIT Scholars in Cancer Research. D.J.A. and A.G.R. are supported by Cancer Research UK and the Wellcome Trust.	Ahn J, 2011, ONCOGENE, V30, P445, DOI 10.1038/onc.2010.424; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BOS JL, 1989, CANCER RES, V49, P4682; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Das TK, 2013, ONCOGENE, V32, P3184, DOI 10.1038/onc.2012.326; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meek DW, 2011, MOL CELL BIOCHEM, V356, P133, DOI 10.1007/s11010-011-0966-3; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Pinto D, 2005, BIOL CELL, V97, P185; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Singh H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.16; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Yoshio T, 2010, CARCINOGENESIS, V31, P1185, DOI 10.1093/carcin/bgq065; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	55	84	85	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					142	150		10.1038/ng.3175	http://dx.doi.org/10.1038/ng.3175			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA1TQ	25559195				2022-12-17	WOS:000348694700009
J	MacAlister, CA; Park, SJ; Jiang, K; Marcel, F; Bendahmane, A; Izkovich, Y; Eshed, Y; Lippman, ZB				MacAlister, Cora A.; Park, Soon Ju; Jiang, Ke; Marcel, Fabien; Bendahmane, Abdelhafid; Izkovich, Yinon; Eshed, Yuval; Lippman, Zachary B.			Synchronization of the flowering transition by the tomato TERMINATING FLOWER gene	NATURE GENETICS			English	Article							FLORAL MERISTEM; REGULATE GROWTH; ORTHOLOG; IDENTITY; SIGNALS; PROTEIN; FAMILY; EXPRESSION; FLORIGEN; GENOME	The transition to flowering is a major determinant of plant architecture, and variation in the timing of flowering can have profound effects on inflorescence architecture, flower production and yield. Here, we show that the tomato mutant terminating flower (tmf) flowers early and converts the multiflowered inflorescence into a solitary flower as a result of precocious activation of a conserved floral specification complex encoded by ANANTHA (AN) and FALSIFLORA (FA). Without TMF, the coordinated flowering process is disrupted, causing floral identity genes, such as AN and members of the SEPALLATA (SEP) family, to activate precociously, while the expression of flowering transition genes, such as FRUITFULL (FUL), is delayed. Indeed, driving AN expression precociously is sufficient to cause early flowering, and this expression transforms multiflowered inflorescences into normal solitary flowers resembling those of the Solanaceae species petunia and tobacco. Thus, by timing AN activation, TMF synchronizes flower formation with the gradual reproductive transition, which, in turn, has a key role in determining simple versus complex inflorescences.	[MacAlister, Cora A.; Park, Soon Ju; Jiang, Ke; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Marcel, Fabien; Bendahmane, Abdelhafid] Univ Evry Val dEssonne, Unit Innovat & Dev Agr 1165, Unite Rech Genome Vegetale, Inst Natl Rech Agron,Ctr Natl Rech Sci,ERL 8196, Evry, France; [Izkovich, Yinon; Eshed, Yuval] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu		Eshed, Yuval/0000-0001-8290-0018; Lippman, Zachary/0000-0001-7668-9025; MacAlister, Cora/0000-0003-1470-0596	Tomato Genetics Resource Center (TGRC) at the University of California, Davis; European Research Council (ERC); European Union [FOOD-CT-2006-016214]; Israel Science Foundation [1294-10]; Binational Agricultural Research & Development Fund [IS-4249-09]; International Human Frontier Science Program Organization	Tomato Genetics Resource Center (TGRC) at the University of California, Davis(University of California System); European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); Israel Science Foundation(Israel Science Foundation); Binational Agricultural Research & Development Fund; International Human Frontier Science Program Organization(Human Frontier Science Program)	We thank A. Aharoni for allowing screening of the population from which tmf2-D was derived. We also thank the Tomato Genetics Resource Center (TGRC) at the University of California, Davis, for germplasm, J. Van Eck for generating transgenic plants and DuPont Pioneer for funding. The work in the laboratory of A. Aharoni was supported by European Research Council (ERC) project SAMIT (Framework Programme 7). The tomato TILLING project is supported by funding from the European Union SOL Integrated Project FOOD-CT-2006-016214 to A.B. C.A.M. is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. This research was supported by research grant 1294-10 from the Israel Science Foundation and Binational Agricultural Research & Development Fund IS-4249-09 to Y.E. and a Career Development Award from The International Human Frontier Science Program Organization to Z.B.L.	Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; BELL AD, 1993, PLANT FORM ILLUSTRAT; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Cheng XD, 2009, GENETICS, V181, P1183, DOI 10.1534/genetics.108.099150; Child A., 1979, BIOL TAXONOMY SOLANA, P345; Cho EN, 2011, P NATL ACAD SCI USA, V108, P2154, DOI 10.1073/pnas.1018542108; Danert S, 1958, ABHANDLUNGEN DTSCH A, V6, P1; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Egeyan M., 1973, TGC REPORT, V23, P24; FRIJTERS D, 1978, ANN BOT-LONDON, V42, P549, DOI 10.1093/oxfordjournals.aob.a085490; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Rickett H. W., 1944, BOT REV, V10, P187, DOI 10.1007/BF02861094; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Souer E, 2008, PLANT CELL, V20, P2033, DOI 10.1105/tpc.108.060871; Takeda S, 2011, PLANT J, V66, P1066, DOI 10.1111/j.1365-313X.2011.04571.x; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Uimari A, 2004, P NATL ACAD SCI USA, V101, P15817, DOI 10.1073/pnas.0406844101; Weberling F, 1989, MORPHOLOGY FLOWERS I; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yoshida A, 2009, P NATL ACAD SCI USA, V106, P20103, DOI 10.1073/pnas.0907896106; Zhao L, 2004, PLANT J, V37, P694, DOI 10.1111/j.1365-313X.2003.01993.x	39	84	90	10	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1393	1398		10.1038/ng.2465	http://dx.doi.org/10.1038/ng.2465			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143603				2022-12-17	WOS:000311713200022
J	Manjarrez-Orduno, N; Marasco, E; Chung, SA; Katz, MS; Kiridly, JF; Simpfendorfer, KR; Freudenberg, J; Ballard, DH; Nashi, E; Hopkins, TJ; Graham, DSC; Lee, AT; Coenen, MJH; Franke, B; Swinkels, DW; Graham, RR; Kimberly, RP; Gaffney, PM; Vyse, TJ; Behrens, TW; Criswell, LA; Diamond, B; Gregersen, PK				Manjarrez-Orduno, Nataly; Marasco, Emiliano; Chung, Sharon A.; Katz, Matthew S.; Kiridly, Jenna F.; Simpfendorfer, Kim R.; Freudenberg, Jan; Ballard, David H.; Nashi, Emil; Hopkins, Thomas J.; Graham, Deborah S. Cunninghame; Lee, Annette T.; Coenen, Marieke J. H.; Franke, Barbara; Swinkels, Dorine W.; Graham, Robert R.; Kimberly, Robert P.; Gaffney, Patrick M.; Vyse, Timothy J.; Behrens, Timothy W.; Criswell, Lindsey A.; Diamond, Betty; Gregersen, Peter K.			CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation	NATURE GENETICS			English	Article							VARIANT; PTPN22; AUTOIMMUNITY; THRESHOLDS; TOLERANCE; ALLELE; ITGAM; LYN	The c-Src tyrosine kinase, Csk, physically interacts with the intracellular phosphatase Lyp (encoded by PTPN22) and can modify the activation state of downstream Src kinases, such as Lyn, in lymphocytes. We identified an association of CSK with systemic lupus erythematosus (SLE) and refined its location to the intronic polymorphism rs34933034 (odds ratio (OR) = 1.32; P = 1.04 x 10(-9)). The risk allele at this SNP is associated with increased CSK expression and augments inhibitory phosphorylation of Lyn. In carriers of the risk allele, there is increased B-cell receptor (BCR)-mediated activation of mature B cells, as well as higher concentrations of plasma immunoglobulin M (IgM), relative to individuals with the non-risk haplotype. Moreover, the fraction of transitional B cells is doubled in the cord blood of carriers of the risk allele, due to an expansion of late transitional cells in a stage targeted by selection mechanisms. This suggests that the Lyp-Csk complex increases susceptibility to lupus at multiple maturation and activation points in B cells.	[Manjarrez-Orduno, Nataly; Marasco, Emiliano; Nashi, Emil; Diamond, Betty] N Shore Long Isl Jewish LIJ, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Disorders, Manhasset, NY USA; [Manjarrez-Orduno, Nataly; Katz, Matthew S.; Kiridly, Jenna F.; Simpfendorfer, Kim R.; Freudenberg, Jan; Ballard, David H.; Hopkins, Thomas J.; Lee, Annette T.; Gregersen, Peter K.] N Shore LIJ, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA USA; [Graham, Deborah S. Cunninghame; Vyse, Timothy J.] Kings Coll London, Sch Med, Div Genet & Mol Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Coenen, Marieke J. H.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Dis, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Graham, Robert R.; Behrens, Timothy W.] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, Oklahoma City, OK 73104 USA	Northwell Health; Northwell Health; University of California System; University of California San Francisco; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; University of Alabama System; University of Alabama Birmingham; Roche Holding; Genentech; Oklahoma Medical Research Foundation	Diamond, B (corresponding author), N Shore Long Isl Jewish LIJ, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Disorders, Manhasset, NY USA.	bdiamond@nshs.edu; pgregers@nshs.edu	Coenen, Marieke/A-2159-2010; Simpfendorfer, Kim R/AAG-1940-2019; Swinkels, Dorine W./H-8098-2014; Marasco, Emiliano/J-3627-2016; Franke, Barbara/D-4836-2009	Coenen, Marieke/0000-0001-8796-2031; Simpfendorfer, Kim R/0000-0002-1906-2899; Swinkels, Dorine W./0000-0002-1040-9446; Marasco, Emiliano/0000-0001-5346-3357; Franke, Barbara/0000-0003-4375-6572; Kimberly, Robert/0000-0002-5330-3086; Manjarrez Orduno, Nataly/0000-0002-7569-1673; Gaffney, Patrick/0000-0002-1580-869X; Ballard, David/0000-0002-2587-4818	US National Institutes of Health (NIH) [RC2AR059092]; Alliance for Lupus Research; Kirkland Scholar Award; NIH/National Center for Research Resources (NCRR) [5 M01 RR-00079, P01 AR49084, UL1 TR000165]; NIH/National Center for Advancing Translational Sciences [KL2TR000143]; American College of Rheumatology;  [N01AR62277]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143, UL1TR000165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084, P60AR053308, RC2AR058959, RC2AR059092, N01AR62277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Kirkland Scholar Award; NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Center for Advancing Translational Sciences; American College of Rheumatology(General Electric); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the volunteers who participated in this study; the Genotype and Phenotype (GaP) registry; M. Keogh, M. DeFranco, C. Mason, C. Metz and the Biorepository at the Feinstein Institute for Medical Research (FIMR) for recruiting subjects and collecting samples; H. Borrero for technical assistance; and the Biostatistics Unit of the FIMR and M. Akerman for assistance. This work was supported by US National Institutes of Health (NIH) grant RC2AR059092; The Alliance for Lupus Research, a Kirkland Scholar Award and NIH/National Center for Research Resources (NCRR) grant 5 M01 RR-00079 (L.A.C.); P01 AR49084 and UL1 TR000165 (R.P.K.); and NIH/National Center for Advancing Translational Sciences grant KL2TR000143 and an American College of Rheumatology Physician Scientist Development Award (S.A.C.). The principal investigators of the Nijmegen Biomedical Study are L.A.L.M. Kiemeney, M. den Heijer, A.L.M. Verbeek, D.W. Swinkels and B. Franke. We thank the Lupus Family Registry and Repository (LFRR) investigators, J.B. Harley, K.L. Moser Sivils, M.H. Weisman and D.J. Wallace, funded by N01AR62277 (K.L.M.S. and J.B.H.).	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hasegawa M, 2001, J IMMUNOL, V167, P2469, DOI 10.4049/jimmunol.167.5.2469; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Lu R, 2009, GENES IMMUN, V10, P397, DOI 10.1038/gene.2009.19; Martin JE, 2012, HUM MOL GENET, V21, P2825, DOI 10.1093/hmg/dds099; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	18	84	85	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1227	1230		10.1038/ng.2439	http://dx.doi.org/10.1038/ng.2439			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23042117	Green Accepted, Green Submitted			2022-12-17	WOS:000310495800014
J	Zhang, SQ; Jiang, T; Li, M; Zhang, X; Ren, YQ; Wei, SC; Sun, LD; Cheng, H; Li, Y; Yin, XY; Hu, ZM; Wang, ZY; Liu, Y; Guo, BR; Tang, HY; Tang, XF; Ding, YT; Wang, JB; Li, P; Wu, BY; Wang, W; Yuan, XF; Hou, JS; Ha, WW; Wang, WJ; Zhai, YJ; Wang, J; Qian, FF; Zhou, FS; Chen, G; Zuo, XB; Zheng, XD; Sheng, YJ; Gao, JP; Liang, B; Li, P; Zhu, J; Xiao, FL; Wang, PG; Cui, Y; Li, H; Liu, SX; Gao, M; Fan, X; Shen, SK; Zeng, M; Sun, GQ; Xu, Y; Hu, JC; He, TT; Li, YR; Yang, HM; Wang, J; Yu, ZY; Zhang, HF; Hu, X; Yang, K; Wang, J; Zhao, SX; Zhou, YW; Liu, JJ; Du, WD; Zhang, L; Xia, K; Yang, S; Wang, J; Zhang, XJ				Zhang, Sheng-Quan; Jiang, Tao; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Hu, Zheng-Mao; Wang, Zhen-Ying; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Zhou, Fu-Sheng; Chen, Gang; Zuo, Xian-Bo; Zheng, Xiao-Dong; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Sun, Guang-Qing; Xu, Yu; Hu, Jing-Chu; He, Ting-Ting; Li, Ying-Rui; Yang, Huan-Ming; Wang, Jian; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Zhang, Li; Xia, Kun; Yang, Sen; Wang, Jun; Zhang, Xue-Jun			Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis	NATURE GENETICS			English	Article							MEVALONATE KINASE-DEFICIENCY; PERIODIC FEVER SYNDROME; SHORT READ ALIGNMENT; HYPERIMMUNOGLOBULINEMIA-D; GENETIC-ASPECTS; LOCUS; 12Q23.2-24.1; SPECTRUM; DISEASE	Disseminated superficial actinic porokeratosis (DSAP) is an autosomal dominantly inherited epidermal keratinization disorder whose etiology remains unclear. We performed exome sequencing in one unaffected and two affected individuals from a DSAP family. The mevalonate kinase gene (MVK) emerged as the only candidate gene located in previously defined linkage regions after filtering against existing SNP databases, eight HapMap exomes and 1000 Genomes Project data and taking into consideration the functional implications of the mutations. Sanger sequencing in 57 individuals with familial DSAP and 25 individuals with sporadic DSAP identified MVK mutations in 33% and 16% of these individuals (cases), respectively. All 14 MVK mutations identified in our study were absent in 676 individuals without DSAP. Our functional studies in cultured primary keratinocytes suggest that MVK has a role in regulating calcium-induced keratinocyte differentiation and could protect keratinocytes from apoptosis induced by type A ultraviolet radiation. Our results should help advance the understanding of DSAP pathogenesis.	[Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhang, Sheng-Quan; Li, Min; Zhang, Xin; Ren, Yun-Qing; Wei, Sheng-Cai; Sun, Liang-Dan; Cheng, Hui; Li, Yang; Yin, Xian-Yong; Liu, Yuan; Guo, Bi-Rong; Tang, Hua-Yang; Tang, Xian-Fa; Ding, Yan-Tao; Wang, Jian-Bo; Li, Ping; Wu, Bao-Yu; Wang, Wen; Yuan, Xiang-Feng; Hou, Jun-Sheng; Ha, Wei-Wei; Wang, Wen-Ju; Zhai, Yu-Juan; Wang, Jing; Qian, Fang-Fang; Zhou, Fu-Sheng; Chen, Gang; Zuo, Xian-Bo; Zheng, Xiao-Dong; Sheng, Yu-Jun; Gao, Jin-Ping; Liang, Bo; Li, Pan; Zhu, Jun; Xiao, Feng-Li; Wang, Pei-Guang; Cui, Yong; Li, Hui; Liu, Sheng-Xiu; Gao, Min; Fan, Xing; Shen, Song-Ke; Zeng, Ming; Yu, Zhong-Yi; Zhang, Hui-Feng; Hu, Xin; Yang, Ke; Wang, Jie; Zhao, Shi-Xiang; Zhou, You-Wen; Liu, Jian-Jun; Du, Wei-Dong; Yang, Sen; Zhang, Xue-Jun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Jiang, Tao; Sun, Guang-Qing; Xu, Yu; Hu, Jing-Chu; He, Ting-Ting; Li, Ying-Rui; Yang, Huan-Ming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Hu, Zheng-Mao; Xia, Kun] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Wang, Zhen-Ying; Zhang, Li] Shandong Univ, Prov Hosp, Dept Dermatol, Jinan, Shandong, Peoples R China; [Liu, Jian-Jun] Anhui Med Univ, Inst Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Xue-Jun] Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Beijing Genomics Institute (BGI); Central South University; Shandong University; Anhui Medical University; Anhui Medical University	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.	wangj@genomics.org.cn; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022; Wang, Jun/A-7261-2013; Cui, Yong/AAF-9300-2020; Liu, Jianjun/AAK-4989-2020; Chen, Gang/G-2722-2010; XIA, KUN/AAO-3525-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Liu, Jianjun/0000-0002-3255-3019; Hu, Jingchu/0000-0001-6144-7226; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Ministry of Education of China [IRT-1046]	Ministry of Education of China(Ministry of Education, China)	We thank the individuals and their families who participated in this project. This study was funded by Ministry of Education of China (IRT-1046).	ANDERSON DE, 1969, ARCH DERMATOL, V99, P408, DOI 10.1001/archderm.99.4.408; Bader-Meunier B, 2011, PEDIATRICS, V128, pE152, DOI 10.1542/peds.2010-3639; Bouwstra JA, 2006, BBA-BIOMEMBRANES, V1758, P2080, DOI 10.1016/j.bbamem.2006.06.021; CHERNOSKY ME, 1986, ARCH DERMATOL, V122, P869, DOI 10.1001/archderm.122.8.869; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Edmondson SR, 2001, J INVEST DERMATOL, V116, P491, DOI 10.1046/j.0022-202x.2001.temp.doc.x; Frank J, 2007, HUM MUTAT, V28, P1241, DOI 10.1002/humu.20587; Frank J, 2007, J INVEST DERMATOL, V127, P2058, DOI 10.1038/sj.jid.5700783; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; GOERTTLER EA, 1975, HUMANGENETIK, V26, P291; Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13; Houten SM, 2000, BBA-MOL CELL BIOL L, V1529, P19, DOI 10.1016/S1388-1981(00)00135-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu P, 2008, HUM GENET, V123, P507, DOI 10.1007/s00439-008-0504-x; Luan J, 2011, HUM GENET, V129, P329, DOI 10.1007/s00439-010-0929-x; Mandey SHL, 2006, HUM MUTAT, V27, P796, DOI 10.1002/humu.20361; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; OTSUKA F, 1991, J CANCER RES CLIN, V117, P55, DOI 10.1007/BF01613197; Sasson M, 1996, DERMATOL SURG, V22, P339, DOI 10.1111/j.1524-4725.1996.tb00327.x; Shen CS, 2002, BRIT J DERMATOL, V147, P498, DOI 10.1046/j.1365-2133.2002.04853.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu LQ, 2004, BRIT J DERMATOL, V150, P999, DOI 10.1111/j.1365-2133.2004.05912.x; Xia JH, 2000, J INVEST DERMATOL, V114, P1071, DOI 10.1046/j.1523-1747.2000.00978.x; Xia K, 2002, BRIT J DERMATOL, V147, P650, DOI 10.1046/j.1365-2133.2002.05058.x; Zhang ZH, 2005, BRIT J DERMATOL, V152, P658, DOI 10.1111/j.1365-2133.2005.06443.x; Zhang Zhenghua, 2004, Hum Mutat, V24, P438, DOI 10.1002/humu.9283; Zhao YW, 2011, J INVEST DERMATOL, V131, P1045, DOI 10.1038/jid.2011.41	34	84	99	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1156	+		10.1038/ng.2409	http://dx.doi.org/10.1038/ng.2409			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22983302				2022-12-17	WOS:000309550200019
J	Zimon, M; Baets, J; Almeida-Souza, L; De Vriendt, E; Nikodinovic, J; Parman, Y; Battaloglu, E; Matur, Z; Guergueltcheva, V; Tournev, I; Auer-Grumbach, M; De Rijk, P; Petersen, BS; Muller, T; Fransen, E; Van Damme, P; Loscher, WN; Barisic, N; Mitrovic, Z; Previtali, SC; Topaloglu, H; Bernert, G; Beleza-Meireles, A; Todorovic, S; Savic-Pavicevic, D; Ishpekova, B; Lechner, S; Peeters, K; Ooms, T; Hahn, AF; Zuchner, S; Timmerman, V; Van Dijck, P; Rasic, VM; Janecke, AR; De Jonghe, P; Jordanova, A				Zimon, Magdalena; Baets, Jonathan; Almeida-Souza, Leonardo; De Vriendt, Els; Nikodinovic, Jelena; Parman, Yesim; Battaloglu, Esra; Matur, Zeliha; Guergueltcheva, Velina; Tournev, Ivailo; Auer-Grumbach, Michaela; De Rijk, Peter; Petersen, Britt-Sabina; Mueller, Thomas; Fransen, Erik; Van Damme, Philip; Loescher, Wolfgang N.; Barisic, Nina; Mitrovic, Zoran; Previtali, Stefano C.; Topaloglu, Haluk; Bernert, Guenther; Beleza-Meireles, Ana; Todorovic, Slobodanka; Savic-Pavicevic, Dusanka; Ishpekova, Boryana; Lechner, Silvia; Peeters, Kristien; Ooms, Tinne; Hahn, Angelika F.; Zuechner, Stephan; Timmerman, Vincent; Van Dijck, Patrick; Rasic, Vedrana Milic; Janecke, Andreas R.; De Jonghe, Peter; Jordanova, Albena			Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia	NATURE GENETICS			English	Article							GENERATED LYSYL-ADENYLATE; HISTIDINE; SUPPORTS; MICE	Inherited peripheral neuropathies are frequent neuromuscular disorders known for their clinical and genetic heterogeneity. In 33 families, we identified 8 mutations in HINT1 (encoding histidine triad nucleotide-binding protein 1) by combining linkage analyses with next-generation sequencing and subsequent cohort screening of affected individuals. Our study provides evidence that loss of functional HINT1 protein results in a distinct phenotype of autosomal recessive axonal neuropathy with neuromyotonia.	[Zimon, Magdalena; De Vriendt, Els; Peeters, Kristien; Ooms, Tinne; Jordanova, Albena] Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium; [Zimon, Magdalena; Baets, Jonathan; Almeida-Souza, Leonardo; De Vriendt, Els; Peeters, Kristien; Ooms, Tinne; Timmerman, Vincent; De Jonghe, Peter; Jordanova, Albena] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Almeida-Souza, Leonardo; Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; [Nikodinovic, Jelena; Todorovic, Slobodanka; Rasic, Vedrana Milic] Univ Belgrade, Clin Neurol & Psychiat Children & Youth, Belgrade, Serbia; [Parman, Yesim; Matur, Zeliha] Istanbul Univ, Dept Neurol, Istanbul Fac Med, Istanbul, Turkey; [Battaloglu, Esra] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Guergueltcheva, Velina; Tournev, Ivailo; Ishpekova, Boryana] Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; [Tournev, Ivailo; Ishpekova, Boryana] New Bulgarian Univ, Dept Cognit Sci & Psychol, Sofia, Bulgaria; [Auer-Grumbach, Michaela] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [De Rijk, Peter] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Petersen, Britt-Sabina] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Mueller, Thomas; Janecke, Andreas R.] Innsbruck Med Univ, Dept Pediat 2, Innsbruck, Austria; [Fransen, Erik] Univ Antwerp, Dept Mol Genet, B-2020 Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, StatUA Ctr Stat, B-2020 Antwerp, Belgium; [Van Damme, Philip] Univ Louvain, LIND, Louvain, Belgium; [Van Damme, Philip] VIB, Vesalius Res Ctr, Louvain, Belgium; [Van Damme, Philip] Univ Louvain, Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Loescher, Wolfgang N.] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Barisic, Nina] Univ Zagreb, Dept Paediat, Sch Med, Univ Hosp Ctr Zagreb, Zagreb 41000, Croatia; [Mitrovic, Zoran] Univ Hosp Ctr Zagreb, Dept Neurol, Natl Ctr Neuromuscular Dis, Zagreb, Croatia; [Previtali, Stefano C.] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy; [Previtali, Stefano C.] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Topaloglu, Haluk] Hacettepe Univ, Fac Med, Dept Paediat Neurol, TR-06100 Ankara, Turkey; [Bernert, Guenther] Gottfried von Preyersches Kinderspital, Dept Paediat, Vienna, Austria; [Beleza-Meireles, Ana] Univ Aveiro, Autonomous Sect Hlth Sci, P-3800 Aveiro, Portugal; [Beleza-Meireles, Ana] Coimbra Paediat Hosp, Dept Genet, Ctr Hosp, Coimbra, Portugal; [Beleza-Meireles, Ana] Univ Coimbra CHUC EPE, Coimbra, Portugal; [Savic-Pavicevic, Dusanka] Univ Belgrade, Fac Biol, PCR Ctr, Belgrade, Serbia; [Lechner, Silvia; Janecke, Andreas R.] Innsbruck Med Univ, Div Human Genet, Innsbruck, Austria; [Hahn, Angelika F.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada; [Zuechner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genet, Miami, FL 33136 USA; [Van Dijck, Patrick] Univ Louvain, VIB, Dept Mol Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Rasic, Vedrana Milic] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jordanova, Albena] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Belgrade; Istanbul University; Bogazici University; Medical University Sofia; New Bulgarian University; Medical University of Graz; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Kiel; Medical University of Innsbruck; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Medical University of Innsbruck; University of Zagreb; University of Zagreb; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hacettepe University; Universidade de Aveiro; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Belgrade; Medical University of Innsbruck; London Health Sciences Centre; Western University (University of Western Ontario); University of Miami; Flanders Institute for Biotechnology (VIB); University of Belgrade; Medical University Sofia	Jordanova, A (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Mol Neurogen Grp, B-2610 Antwerp, Belgium.	peter.dejonghe@molgen.vib-ua.be; albena.jordanova@molgen.vib-ua.be	Matur, Zeliha/AAE-9246-2020; Savic-Pavicevic, Dusanka L/R-1255-2016; TOPALOGLU, HALUK AYDIN/I-9318-2013; Van Damme, Philip/A-6464-2009; Timmerman, Vincent/O-7283-2019; Jordanova, Albena/H-8323-2015; Fransen, Erik/C-4102-2015; Savic-Pavicevic, Dusanka/O-5543-2019; Battaloğlu, Esra/AAF-1559-2020; Löscher, Britt-Sabina/I-1671-2012; Previtali, Stefano/Z-1962-2019; Janecke, Andreas/AAA-5227-2019; Almeida-Souza, Leonardo/C-3437-2011; De Rijk, Peter/GXH-9837-2022	Matur, Zeliha/0000-0002-3895-0410; Savic-Pavicevic, Dusanka L/0000-0002-2079-4077; Van Damme, Philip/0000-0002-4010-2357; Timmerman, Vincent/0000-0002-2162-0933; Jordanova, Albena/0000-0002-3833-3754; Fransen, Erik/0000-0001-7785-4790; Savic-Pavicevic, Dusanka/0000-0002-2079-4077; Löscher, Britt-Sabina/0000-0001-9022-9017; Previtali, Stefano/0000-0003-2546-4357; Almeida-Souza, Leonardo/0000-0002-7169-1238; De Rijk, Peter/0000-0001-8558-9288; Janecke, Andreas/0000-0001-7155-0315; Zimon, Magdalena/0000-0001-7255-6639; Beleza-Meireles, Ana/0000-0002-5583-9175; Loscher, Wolfgang/0000-0002-7593-3222	University of Antwerp (in part by IWS BOF) [23064]; Fund for Scientific Research-Flanders; Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office (BELSPO) [P6/43]; Methusalem Excellence Grant of the Flemish Government; Association Belge Contre les Maladies Neuromusculaires (ABMM); VIB TechWatch Fund; Medizinische Forschungsfonds Tirol (MFF Tirol); US National Institue of Neurological Disorders and Stroke (NINDS) [R01NS075764, U54NS065712-03, R01NS052767]; Austrian Science Fond (FWF) [P23223-B19]; Ministry of Science and Technology of the Republic of Serbia [17 3016, 17 508]; PhD fellowship; clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen); Austrian Science Fund (FWF) [P 23223] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052767, R01NS075764, U54NS065712] Funding Source: NIH RePORTER	University of Antwerp (in part by IWS BOF); Fund for Scientific Research-Flanders(FWO); Medical Foundation Queen Elisabeth (GSKE); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); Methusalem Excellence Grant of the Flemish Government; Association Belge Contre les Maladies Neuromusculaires (ABMM); VIB TechWatch Fund; Medizinische Forschungsfonds Tirol (MFF Tirol); US National Institue of Neurological Disorders and Stroke (NINDS); Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Ministry of Science and Technology of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); PhD fellowship; clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the study participants and their families for their cooperation. We thank A. Suls, N. Avonce, G. Milternberger-Milteny, B. Ramirez Escorcia, W. Glassee, E. Ydens and C. Claes for their expert help with some of the experiments; the VIB Genetic Service Facility for sequencing and cell maintenance support; and C. Brenner (University of Iowa) for providing the BY8-5c yeast strain. This work was supported by the University of Antwerp (in part by IWS BOF 2008 23064 to A.J. and P.D.J.); the Fund for Scientific Research-Flanders (to A.J., P.D.J. and V.T.); the Medical Foundation Queen Elisabeth (GSKE; to P.D.J. and V.T.); the Interuniversity Attraction Poles P6/43 program of the Belgian Federal Science Policy Office (BELSPO; to A.J., P.D.J. and V.T.); the Methusalem Excellence Grant of the Flemish Government; the Association Belge Contre les Maladies Neuromusculaires (ABMM; to A.J., J.B., P.D.J. and V.T.); the VIB TechWatch Fund (to A.J. and P.D.J.), the Medizinische Forschungsfonds Tirol (MFF Tirol) (to S.L. and A.R.J.), the US National Institue of Neurological Disorders and Stroke (NINDS; R01NS075764, U54NS065712-03 and R01NS052767 to S.Z.), the Austrian Science Fond (FWF; P23223-B19 to M.A.-G.) and the Ministry of Science and Technology of the Republic of Serbia (17 3016 and 17 508 to V.M.R. and D.S.-P.). J.B., M.Z. and K.P. are supported by a PhD fellowship, and P. Van Damme is supported by a clinical investigatorship of the Fund for Scientific Research Flanders (FWO-Vlaanderen). All patients or their legal representatives signed an informed consent form prior to enrollment. This study was approved by local institutional review boards.	Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou TF, 2007, J BIOL CHEM, V282, P15137, DOI 10.1074/jbc.M606972200; Chou TF, 2007, J BIOL CHEM, V282, P4719, DOI 10.1074/jbc.M610530200; de Planell-Saguer M, 2009, HUM MOL GENET, V18, P2115, DOI 10.1093/hmg/ddp134; Dolot R, 2011, ACTA CRYSTALLOGR D, V67, P601, DOI 10.1107/S0907444911015605; HAHN AF, 1991, J NEUROL NEUROSUR PS, V54, P230, DOI 10.1136/jnnp.54.3.230; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Ozga M, 2010, J BIOL CHEM, V285, P40809, DOI 10.1074/jbc.M110.162065; Parks KP, 2004, PHYSIOL GENOMICS, V20, P12, DOI 10.1152/physiolgenomics.00204.2004; SKRE H, 1974, CLIN GENET, V6, P98; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200	15	84	94	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2012	44	10					1080	1083		10.1038/ng.2406	http://dx.doi.org/10.1038/ng.2406			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22961002				2022-12-17	WOS:000309550200005
J	Berezikov, E; Liu, N; Flynt, AS; Hodges, E; Rooks, M; Hannon, GJ; Lai, EC				Berezikov, Eugene; Liu, Na; Flynt, Alex S.; Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.; Lai, Eric C.			Evolutionary flux of canonical micrornAs and mirtrons in Drosophila	NATURE GENETICS			English	Letter							IDENTIFICATION; RNAS		[Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Berezikov, Eugene] InteRNA Genom, Bilthoven, Netherlands; [Liu, Na; Flynt, Alex S.; Lai, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA; [Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Berezikov, E (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	e.berezikov@hubrecht.eu; laie@mskcc.org	Berezikov, Eugene/D-3363-2013; Hannon, Gregory/AAB-3568-2019; Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Berezikov, Eugene/0000-0002-1145-2884; Lai, Eric/0000-0002-8432-5851; Hodges, Emily/0000-0001-6513-610X	NHGRI NIH HHS [U01 HG004261, U01-HG004261] Funding Source: Medline; NIGMS NIH HHS [R01-GM083300, R01 GM083300, R01 GM077581] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300, R01GM077581] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807	15	84	129	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					6	9		10.1038/ng0110-6	http://dx.doi.org/10.1038/ng0110-6			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	20037610	Green Accepted, Bronze			2022-12-17	WOS:000273055100005
J	Ruzankina, Y; Schoppy, DW; Asare, A; Clark, CE; Vonderheide, RH; Brown, EJ				Ruzankina, Yaroslava; Schoppy, David W.; Asare, Amma; Clark, Carolyn E.; Vonderheide, Robert H.; Brown, Eric J.			Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53	NATURE GENETICS			English	Article							EARLY EMBRYONIC LETHALITY; CELL-CYCLE; P53; TUMORIGENESIS; SENESCENCE; PATHWAY; LEADS; DEFICIENCY; ACTIVATION; PHENOTYPES	Trp53 loss of function has previously been shown to rescue tissue maintenance and developmental defects resulting from DNA damage or DNA-repair gene mutations(1-12). Here, we report that p53 deficiency severely exacerbates tissue degeneration caused by mosaic deletion of the essential genome maintenance regulator Atr. Combined loss of Atr and p53 (Trp53(-/-)Atr(mKO)) led to severe defects in hair follicle regeneration, localized inflammation (Mac1(+)Gr1(+) infiltrates), accelerated deterioration of the intestinal epithelium and synthetic lethality in adult mice. Tissue degeneration in Trp53(-/-)Atr(mKO) mice was characterized by the accumulation of cells maintaining high levels of DNA damage. Moreover, the elevated frequency of these damaged cells in both progenitor and downstream compartments in Trp53(-/-)Atr(mKO) skin coincided with delayed compensatory tissue renewal from residual ATR-expressing cells. Together, our results indicate that the combined loss of Atr and Trp53 in adult mice leads to the accumulation of highly damaged cells, which, consequently, impose a barrier to regeneration from undamaged progenitors.	[Ruzankina, Yaroslava; Schoppy, David W.; Asare, Amma; Clark, Carolyn E.; Vonderheide, Robert H.; Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Brown, EJ (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu		Asare, Amma/0000-0002-4865-6864	US National Institute on Aging [R01AG027376, F30AG034027]; Abramson Family Cancer Research Institute; NATIONAL INSTITUTE ON AGING [R01AG027376, F30AG034027] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abramson Family Cancer Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to G. Beatty, K. Cimprich, G. Cotsarelis and A. Bhandoola for reagents, protocols and helpful advice, and J. Wang and other members of the AFCRI Histology Core for tissue processing. These studies were supported by the US National Institute on Aging (R01AG027376 and F30AG034027) and the Abramson Family Cancer Research Institute.	Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 2000, CANCER RES, V60, P5002; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wlodarski P, 1998, BLOOD, V91, P2998, DOI 10.1182/blood.V91.8.2998.2998_2998_3006; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	33	84	85	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1144	U132		10.1038/ng.441	http://dx.doi.org/10.1038/ng.441			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19718024	Green Accepted			2022-12-17	WOS:000270330400021
J	Katajisto, P; Vaahtomeri, K; Ekman, N; Ventela, E; Ristimaki, A; Bardeesy, N; Feil, R; DePinho, RA; Makela, TP				Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Bardeesy, Nabeel; Feil, Robert; DePinho, Ronald A.; Makela, Tomi P.			LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis	NATURE GENETICS			English	Article							PEUTZ-JEGHERS-SYNDROME; SMOOTH-MUSCLE; GROWTH-FACTORS; TGF-BETA; DIFFERENTIATION; FIBROBLASTS; CANCER; MYOFIBROBLASTS; LUNG	Germline mutations in STK11 (also known as LKB1) are found in individuals with Peutz-Jeghers syndrome (PJS)(1) manifesting with gastrointestinal polyps that contain a prominent stromal component. Epithelia in polyps of Stk11(+/-) mice can retain a functional copy of Stk11 (refs. 2,3), and loss of heterozygosity is not an obligate feature of human polyps(4), raising the possibility of non-epithelial origins in tumorigenesis. Here we show that either monoallelic or biallelic loss of murine Stk11 limited to Tagln-expressing mesenchymal cells results in premature postnatal death as a result of gastrointestinal polyps indistinguishable from those in PJS. Stk11-deficient mesenchymal cells produced less TGF beta, and defective TGF beta signaling to epithelial cells coincided with epithelial proliferation. We also noted TGF beta signaling defects in polyps of individuals with PJS, suggesting that the identified stromal-derived mechanism of tumor suppression is also relevant in PJS.	[Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland; [Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Ctr Appl Canc Sci Belfer Inst Inno, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Ctr Appl Canc Sci Belfer Inst Innovat Ca, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet,Ctr Appl Canc Sci Belfer Inst Innovat, Boston, MA 02115 USA	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Makela, TP (corresponding author), Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland.	tomi.makela@helsinki.fi	Feil, Robert/B-8918-2014; makela, tomi/B-3734-2009	Feil, Robert/0000-0002-7335-4841; makela, tomi/0000-0002-4869-8044; Katajisto, Pekka/0000-0002-3033-4189; Vaahtomeri, Kari/0000-0001-7829-3518; DePinho, Ronald/0000-0002-5625-577X				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesten LSM, 2006, CELL DEATH DIFFER, V13, P2089, DOI 10.1038/sj.cdd.4401973; Entius MM, 1997, GUT, V41, P320, DOI 10.1136/gut.41.3.320; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hernan I, 2004, CLIN GENET, V66, P58, DOI 10.1111/j.0009-9163.2004.00266.x; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kuemmerle JF, 1997, GASTROENTEROLOGY, V113, P817, DOI 10.1016/S0016-5085(97)70176-8; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; KUROKOWA M, 1987, BIOCHEM BIOPH RES CO, V142, P775, DOI 10.1016/0006-291X(87)91481-1; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	25	84	92	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					455	459		10.1038/ng.98	http://dx.doi.org/10.1038/ng.98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311138				2022-12-17	WOS:000254388100017
J	Derti, A; Roth, FP; Church, GM; Wu, CT				Derti, Adnan; Roth, Frederick P.; Church, George M.; Wu, C-ting			Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; VERTEBRATE; GENE; SEQUENCES; TRANSVECTION; POLYMORPHISM; ENHANCER; GENOMES; REGIONS; MOUSE	An earlier search in the human, mouse and rat genomes for sequences that are 100% conserved in orthologous segments and >= 200 bp in length identified 481 distinct sequences(1). These human-mouse-rat sequences, which represent ultraconserved elements (UCEs), are believed to be important for functions involving DNA binding, RNA processing and the regulation of transcription and development. In vivo and additional computational studies of UCEs and other highly conserved sequences are consistent with these functional associations, with some observations indicating enhancer-like activity for these elements(1-9). Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants. Notably, of the UCEs that are found in segmental duplications or copy number variants, the majority overlap exons, indicating, along with other findings presented, that UCEs overlapping exons represent a distinct subset.	Harvard Univ, Sch Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Dana-Farber Cancer Institute	Wu, CT (corresponding author), Harvard Univ, Sch Med, Div Genet, Boston, MA 02115 USA.	twu@genetics.med.harvard.edu	Roth, Frederick P/H-6308-2011	Roth, Frederick/0000-0002-6628-649X; church, george/0000-0001-6232-9969	NHGRI NIH HHS [HG0017115, HG003224] Funding Source: Medline; NIGMS NIH HHS [GM61936] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061936] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Goode DK, 2005, GENOMICS, V86, P172, DOI 10.1016/j.ygeno.2005.04.006; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kennison JA, 2002, ADV GENET, V46, P399; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	28	84	87	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1216	1220		10.1038/ng1888	http://dx.doi.org/10.1038/ng1888			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16998490				2022-12-17	WOS:000241251100024
J	Tanaka, H; Bergstrom, DA; Yao, MC; Tapscott, SJ				Tanaka, H; Bergstrom, DA; Yao, MC; Tapscott, SJ			Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SHORT INVERTED REPEATS; HAMSTER CELLS; SOLID TUMORS; FUSION GENE; CHROMOSOMES; TETRAHYMENA; MECHANISMS; EXPRESSION; INDUCTION	Breakage-fusion-bridge cycles contribute to chromosome instability and generate large DNA palindromes that facilitate gene amplification in human cancers. The prevalence of large DNA palindromes in cancer is not known. Here, by using a new microarray-based approach called genome-wide analysis of palindrome formation, we show that palindromes occur frequently and are widespread in human cancers. Individual tumors seem to have a nonrandom distribution of palindromes in their genomes, and a subset of palindromic loci is associated with gene amplification. This indicates that the location of palindromes in the cancer genome can serve as a structural platform that supports subsequent gene amplification. Genome-wide analysis of palindrome formation is a new approach to identify structural chromosome aberrations associated with cancer.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Academia Sinica - Taiwan	Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Mailstop C3-168,1100 Fairview Ave N, Seattle, WA 98109 USA.	mcyao@imb.sinica.edu.tw; stapscot@fhcrc.org	Tanaka, Hisashi/ABE-7637-2020	Tanaka, Hisashi/0000-0001-9223-4186; Tapscott, Stephen/0000-0002-0319-0968				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albrecht EB, 2000, MOL BIOL CELL, V11, P873, DOI 10.1091/mbc.11.3.873; Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barber G, 2004, CALL CENT MAG, V17, P10; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; BUTLER DK, 1995, MOL CELL BIOL, V15, P7117; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Fan X, 2003, AM J PATHOL, V162, P1763, DOI 10.1016/S0002-9440(10)64311-8; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; FORD M, 1986, CELL, V45, P425, DOI 10.1016/0092-8674(86)90328-4; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Graf L, 2002, BLOOD, V100, P1509, DOI 10.1182/blood-2002-03-0844; Grondin K, 1996, MOL CELL BIOL, V16, P3587; HECHT F, 1984, SCIENCE, V226, P1445, DOI 10.1126/science.6438800; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; ISHHOROWICZ D, 1980, J MOL BIOL, V142, P231, DOI 10.1016/0022-2836(80)90047-9; Kuwahara Y, 2004, GENE CHROMOSOME CANC, V41, P125, DOI 10.1002/gcc.20075; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; MA C, 1988, MOL CELL BIOL, V8, P2316, DOI 10.1128/MCB.8.6.2316; MA C, 1993, GENE DEV, V7, P605, DOI 10.1101/gad.7.4.605; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; RUIZ JC, 1988, MOL CELL BIOL, V8, P4302, DOI 10.1128/MCB.8.10.4302; Shlomit R, 2000, CANCER GENET CYTOGEN, V121, P67, DOI 10.1016/S0165-4608(00)00218-1; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; SMITH KA, 1992, P NATL ACAD SCI USA, V89, P5427, DOI 10.1073/pnas.89.12.5427; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swisshelm K, 1999, GENE, V226, P285, DOI 10.1016/S0378-1119(98)00553-8; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P8772, DOI 10.1073/pnas.132275999; Tlsty TD, 1997, CURR TOP MICROBIOL, V221, P37; TOLEDO F, 1992, EMBO J, V11, P2665, DOI 10.1002/j.1460-2075.1992.tb05332.x; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559; YonedaKato N, 1996, ONCOGENE, V12, P265	49	84	86	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					320	327		10.1038/ng1515	http://dx.doi.org/10.1038/ng1515			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711546				2022-12-17	WOS:000227297800025
J	Wright, AF; Jacobson, SG; Cideciyan, AV; Roman, AJ; Shu, XH; Vlachantoni, D; McInnes, RR; Riemersma, RA				Wright, AF; Jacobson, SG; Cideciyan, AV; Roman, AJ; Shu, XH; Vlachantoni, D; McInnes, RR; Riemersma, RA			Lifespan and mitochondrial control of neurodegeneration	NATURE GENETICS			English	Article							HYDROGEN-PEROXIDE PRODUCTION; FREE-RADICAL PRODUCTION; ONE-HIT MODEL; CELL-DEATH; OXIDATIVE STRESS; SUPEROXIDE; APOPTOSIS; MECHANISMS; LONGEVITY; MEMBRANES	We examine the allometric (comparative scaling) relationships between rates of neurodegeneration resulting from equivalent mutations in a diverse group of genes from five mammalian species with different maximum lifespan potentials. In both retina and brain, rates of neurodegeneration vary by as much as two orders of magnitude and are strongly correlated with maximum lifespan potential and rates of formation of mitochondrial reactive oxygen and nitrogen species (RONS). Cell death in these disorders is directly or indirectly regulated by the intrinsic mitochondrial cell death pathway. Mitochondria are the main source of RONS production and integrate cellular stress signals to coordinate the intrinsic pathway. We propose that these two functions are intimately related and that steady-state RONS-mediated signaling or damage to the mitochondrial stress-integration machinery is the principal factor setting the probability of cell death in response to a diverse range of cellular stressors. This provides a new and unifying framework for investigating neurodegenerative disorders.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Hosp Sick Children, Program Genet & Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Edinburgh, Dept Biochem, Cardiovasc Res Unit, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Tromso, Dept Med Physiol, N-9001 Tromso, Norway	University of Edinburgh; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Edinburgh; UiT The Arctic University of Tromso	Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	alan.wright@hgu.mrc.ac.uk	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X				Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antebi A, 2004, DEV CELL, V6, P315, DOI 10.1016/S1534-5807(04)00068-1; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Clarke G, 2001, HUM MOL GENET, V10, P2269, DOI 10.1093/hmg/10.20.2269; Comfort A., 1979, BIOL SENESCENCE; Daiger Stephen P, 2004, Novartis Found Symp, V255, P17; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Hafezi F, 2000, BRIT J OPHTHALMOL, V84, P922, DOI 10.1136/bjo.84.8.922; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Katz, 1972, BIOL DATA BOOK; KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PAMPLONA R, 2002, ANN NY ACAD SCI, V959, P476; Partridge L, 1997, BETWEEN ZEUS AND THE SALMON, P78; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Schmidt-Nielsen K, 1984, SCALING WHY IS ANIMA; Shiva S, 2004, BIOCHEM SOC SYMP, V71, P107; SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I; SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; Wolf BB, 2002, CURR BIOL, V12, pR177, DOI 10.1016/S0960-9822(02)00736-4; Yu L, 2004, CELL CYCLE, V3, P1124	50	84	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1153	1158		10.1038/ng1448	http://dx.doi.org/10.1038/ng1448			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15514669	Bronze			2022-12-17	WOS:000224832800016
J	Matin, A; Collin, GB; Asada, Y; Varnum, D; Nadeau, JH				Matin, A; Collin, GB; Asada, Y; Varnum, D; Nadeau, JH			Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain	NATURE GENETICS			English	Article							MOUSE CHROMOSOME-18; GENETIC DISSECTION; COMPLEX TRAITS; MICE; TERATOMAS; MUTATION; DEFICIENCY; MAPS	The identification of genes that control susceptibility to testicular germ-cell tumours (TGCTs), the most common cancer affecting young men(1), has been difficult. In laboratory mice, TGCTs arise from primordial germ cells(2,3) in only the 129 inbred strains(4), and susceptibility is under multigenic control. The spontaneously arising mutation Ter (ref. 5) on mouse chromosome 18 (refs 6,7) increases TGCT frequency(5,8) on a 129/Sv background. We originally used Ter in genetic crosses to identify loci that control tumorigenesis. A genome scan of tumour-bearing progeny from backcrosses between the 129/Sv-Ter/+ and MOLF/Ei strains provided modest evidence that MOLF-derived alleles on chromosome 19 enhance development of bilateral TGCTs (ref. 9). To obtain independent evidence for linkage to the MOLF chromosome, we made an autosomal chromosome substitution strain (CSS; or 'consomic strain') in which chromosome 19 of 129/SV+/+ was replaced by its MOLF-derived homologue. The unusually high frequency of TGCTs in this CSS (even in the absence of the Ter mutation) provides evidence confirming the genome survey results, identifies linkage for a naturally occurring strain variant allele that confers susceptibility to TGCTs and illustrates the power of CSSs in complex trait analysis.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Nihon Univ, Sch Dent, Dept Pedodont, Chiba, Japan	Case Western Reserve University; University Hospitals of Cleveland; University Hospitals of Cleveland; Jackson Laboratory; Nihon University	Nadeau, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.				NCI NIH HHS [CA75056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2012, BIOMETRY PRINCIPLES; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; Bonhomme F., 1996, GENETIC VARIANTS STR, P1577; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Collin GB, 1996, MAMM GENOME, V7, P68, DOI 10.1007/s003359900017; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; Moriwaki Kazuo, 1994, pXIII; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Poirier C, 1998, MAMM GENOME, V8, pS353, DOI 10.1007/s003359900664; SAKURAI T, 1994, MAMM GENOME, V5, P333, DOI 10.1007/BF00356550; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; SILVER LM, 1995, MOUSE GENETICS CONCE, P15; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1961, J NATL CANCER I, V27, P443; STEVENS LC, 1962, J NATL CANCER I, V28, P247; STEVENS LC, 1957, J NATL CANCER I, V18, P719; Stevens LC, 1983, COLD SPRING HARB C C, P23; Threadgill DW, 1997, MAMM GENOME, V8, P441, DOI 10.1007/s003359900464	23	84	89	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					237	240		10.1038/13874	http://dx.doi.org/10.1038/13874			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508525				2022-12-17	WOS:000082827500028
J	Jessen, JR; Willett, CE; Lin, S				Jessen, JR; Willett, CE; Lin, S			Artificial chromosome transgenesis reveals long-distance negative regulation of rag1 in zebrafish	NATURE GENETICS			English	Letter							PROMOTER; GENES; RECOMBINATION; EXPRESSION; IDENTIFICATION; MICE		Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Massachusetts Institute of Technology (MIT)	Jessen, JR (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007463, R01AI008054] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR13227-01] Funding Source: Medline; NIAID NIH HHS [2RO1 AI08054, 9T32 AI07463] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; Brown ST, 1997, J IMMUNOL, V158, P5071; Chess A, 1998, ADV IMMUNOL, V69, P437, DOI 10.1016/S0065-2776(08)60613-6; Driever W, 1996, DEVELOPMENT, V123, P37; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; Haffter P, 1996, DEVELOPMENT, V123, P1; Jessen JR, 1998, P NATL ACAD SCI USA, V95, P5121, DOI 10.1073/pnas.95.9.5121; Kurioka H, 1996, MOL IMMUNOL, V33, P1059, DOI 10.1016/S0161-5890(96)00062-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Willett CE, 1997, IMMUNOGENETICS, V45, P394, DOI 10.1007/s002510050221; Zarrin AA, 1997, J IMMUNOL, V159, P4382	15	84	88	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					15	16		10.1038/12609	http://dx.doi.org/10.1038/12609			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471489				2022-12-17	WOS:000082337300007
J	Liu, F; Massague, J; Altaba, ARI				Liu, F; Massague, J; Altaba, ARI			Carboxy-terminally truncated Gli3 proteins associate with Smads	NATURE GENETICS			English	Letter							MUTATIONS		NYU, Sch Med, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	New York University; New York University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Altaba, ARI (corresponding author), NYU, Sch Med, Skirball Inst, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	j-massague@ski.mskcc.org; ria@saturn.med.nyu.edu		Ruiz i Altaba, Ariel/0000-0003-2292-3933; Massague, Joan/0000-0001-9324-8408	NCI NIH HHS [CA34610] Funding Source: Medline; NINDS NIH HHS [NS37352] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034610, R37CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037352] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Ding Q, 1998, DEVELOPMENT, V125, P2533; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Lee J, 1997, DEVELOPMENT, V124, P2537; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matise MP, 1998, DEVELOPMENT, V125, P2759; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; Sasaki H, 1997, DEVELOPMENT, V124, P1313	14	84	87	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					325	326		10.1038/3793	http://dx.doi.org/10.1038/3793			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843199				2022-12-17	WOS:000077199600013
J	Arguello, JR; Little, AM; Pay, AL; Gallardo, D; Rojas, I; Marsh, SGE; Goldman, JM; Madrigal, JA				Arguello, JR; Little, AM; Pay, AL; Gallardo, D; Rojas, I; Marsh, SGE; Goldman, JM; Madrigal, JA			Mutation detection and typing of polymorphic loci through double-strand conformation analysis	NATURE GENETICS			English	Article							REGULATOR CFTR GENE; GENOMIC DNA; CYSTIC-FIBROSIS; HLA-A; AMPLIFICATION; SEQUENCE; ALLELES	Variations, such as nucleotide substitutions, deletions and insertions, within genes can affect the function of the gene product and in some cases be deleterious. Screening for known allelic variation is important for determining disease and gene associations'. Techniques which target specific mutations such as restriction enzyme polymorphism and oligonucleotide probe or PCR primer reactivity are useful for the detection of specific mutations, but these techniques are not generally effective for the identification of new mutations. Approaches for measuring changes in DNA conformation have been developed, based on the principle that DNA fragments which differ in nucleotide composition exhibit different mobilities after separation by polyacrylamide gel electrophoresis (PAGE; refs 2,3). Here we describe a conformation-based mutation detection system, double-strand conformation analysis (DSCA), which provides a simple means to detect genetic variants and to type complex polymorphic loci, We demonstrate the application of DSCA to detect genetic polymorphisms such as a single-nucleotide difference within DNA fragments of up to 979 base pairs in length. We present the application of DSCA in detecting four different mutations in the cystic fibrosis gene (CFTR) and 131 different alleles encoded by HLA class I genes.	Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; Royal Free Hosp, Dept Haematol, London NW3 2QG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London W12 0NN, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London	Madrigal, JA (corresponding author), Royal Free Hosp, Anthony Nolan Res Inst, Pond St, London NW3 2QG, England.		Marsh, Steven GE/C-1638-2008	Marsh, Steven GE/0000-0003-2855-4120; Stevens, Andrea/0000-0002-2892-7065; Gallardo, David/0000-0003-1615-4592				Arguello R, 1997, NUCLEIC ACIDS RES, V25, P2236, DOI 10.1093/nar/25.11.2236; BLASCZYK R, 1995, TISSUE ANTIGENS, V46, P86, DOI 10.1111/j.1399-0039.1995.tb02483.x; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Dykes CW, 1996, BRIT J CLIN PHARMACO, V42, P683, DOI 10.1046/j.1365-2125.1996.00473.x; LAU M, 1994, INT CELL EXCHANGE, P467; MARSH SGE, 1997, P 12 INT HIST WORKSH, V1, P26; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Savage DA, 1996, TISSUE ANTIGENS, V47, P284, DOI 10.1111/j.1399-0039.1996.tb02555.x; VERLINGUE C, 1994, HUM GENET, V93, P429; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIMMERMAN PA, 1993, NUCLEIC ACIDS RES, V21, P4541, DOI 10.1093/nar/21.19.4541	12	84	91	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					192	194		10.1038/ng0298-192	http://dx.doi.org/10.1038/ng0298-192			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462755				2022-12-17	WOS:000071779500034
J	THOMPSON, TG; DIDONATO, CJ; SIMARD, LR; INGRAHAM, SE; BURGHES, AHM; CRAWFORD, TO; ROCHETTE, C; MENDELL, JR; WASMUTH, JJ				THOMPSON, TG; DIDONATO, CJ; SIMARD, LR; INGRAHAM, SE; BURGHES, AHM; CRAWFORD, TO; ROCHETTE, C; MENDELL, JR; WASMUTH, JJ			A NOVEL CDNA DETECTS HOMOZYGOUS MICRODELETIONS IN GREATER-THAN 50-PERCENT OF TYPE-I SPINAL MUSCULAR-ATROPHY PATIENTS	NATURE GENETICS			English	Article							21-HYDROXYLASE DEFICIENCY; CELL-CYCLE; GENE; REGION; CHROMOSOME-5; ASSIGNMENT; DELETION; LINKAGE; FORMS; MAP	Spinal muscular atrophy (SMA) is the second most common lethal, autosomal recessive disease in Caucasians (after cystic fibrosis). Childhood SMAs are divided into three groups (type I, II and III), which are allelic variants of the same locus in a region of similar to 850 kb in chromosome 5q12-q13, containing multiple copies of a novel, chromosome 5-specific repeat as well as many atypical pseudogenes. This has hampered the identification of candidate genes. We have identified several coding sequences unique to the SMA region. A genomic fragment detected by one cDNA is homozygously deleted in 17/29 (58%) of type I SMA patients. Of 235 unaffected individuals examined, only two showed the deletion and both are carriers of SMA. Our results suggest that deletion of at least part of this novel gene is directly related to the phenotype of SMA.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT BIOCHEM MED,COLUMBUS,OH 43210; HOP ST JUSTINE,MONTREAL,PQ H3T 1C5,CANADA; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	University of California System; University of California Irvine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal; Johns Hopkins University			Ingraham, Susan/B-4565-2012; Crawford, Thomas/E-6307-2012	Burghes, Arthur/0000-0001-9031-1555; Simard, Louise/0000-0003-0391-8821	NICHD NIH HHS [HD 24061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARREDONDOVEGA FX, 1984, CYTOGENET CELL GENET, V37, P403; BEIT KT, 1984, CELL, V36, P907; BRETON C, 1993, MOL BRAIN RES, V18, P297, DOI 10.1016/0169-328X(93)90093-5; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; BRUNSTOWICZ L, 1990, NATURE, V344, P540; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DANESINO C, 1981, HUM GENET, V56, P371, DOI 10.1007/BF00274695; DANIELS RJ, 1992, GENOMICS, V12, P335, DOI 10.1016/0888-7543(92)90382-3; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; KLYEN PW, 1993, P NATL ACAD SCI USA, V90, P6801; MEIKI J, 1994, SCIENCE, V264, P1474; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; PANG S, 1988, PEDIATRICS, V81, P866; PEARN J, 1980, LANCET, V1, P919; PEARN JH, 1982, ADV NEUROL, P121; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PREDEUTOUR F, 1994, GENOMICS, V19, P31; SARGENT CA, 1991, CYTOGENET CELL GENET, V56, P1901; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; SELIG S, IN PRESS EMBO J; SHEN LM, 1994, J BIOL CHEM, V269, P8466; SHIPLEY JM, 1993, AM J HUM GENET, V52, P517; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; Wirth B., 1994, American Journal of Human Genetics, V55, pA207; [No title captured]	40	84	84	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					56	62		10.1038/ng0195-56	http://dx.doi.org/10.1038/ng0195-56			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704025				2022-12-17	WOS:A1995PZ91300015
J	TSUKUROV, O; BOEHMER, A; FLYNN, J; NICOLAI, JP; HAMEL, BCJ; TRAILL, S; ZALESKE, D; MANKIN, HJ; YEON, H; HO, C; TABIN, C; SEIDMAN, JG; SEIDMAN, C				TSUKUROV, O; BOEHMER, A; FLYNN, J; NICOLAI, JP; HAMEL, BCJ; TRAILL, S; ZALESKE, D; MANKIN, HJ; YEON, H; HO, C; TABIN, C; SEIDMAN, JG; SEIDMAN, C			A COMPLEX BILATERAL POLYSYNDACTYLY DISEASE LOCUS MAPS TO CHROMOSOME 7Q36	NATURE GENETICS			English	Article							GENE; FAMILIES; LINKAGE; EN-2	We demonstrate that the gene responsible for a congenital limb deformity (polysyndactyly) maps to chromosome 7q36 in a large family. Pre- and postaxial anomalies of the extremities are inherited in this family as an autosomal dominant trait. The disease locus is closely linked to D7S550 (maximum lod score = 6.85, theta = 0). This region is homologous to a segment of mouse chromosome 5, where the mutations hammer toe (HM) and hemimelic extra toes (HX) have been mapped. These data suggest that human chromosome 7q36 and the homologous region of mouse chromosome 5 contain genes involved in limb pattern formation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,PEDIAT ORTHOPED UNIT,BOSTON,MA; MASSACHUSETTS GEN HOSP,DEPT ORTHOPED,BOSTON,MA 02114; ERASMUS UNIV ROTTERDAM,DEPT ENDOCRINOL & REPROD,3000 DR ROTTERDAM,NETHERLANDS; CHILDRENS HOSP,DEPT PEDIAT,ROTTERDAM,NETHERLANDS; REG CTR PLAST RECONSTRUCT & HAND SURG,ARNHEM,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Radboud University Nijmegen; Harvard University; Brigham & Women's Hospital								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BAILER MG, 1987, AM J HUM GENET, V28, P723; BERRY R, 1989, AM J MED GENET, V34, P358, DOI 10.1002/ajmg.1320340312; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; DICKIE MM, 1968, MOUSE NEWS LETT, V38, P24; DOLYLY G, 1817, HOLY BIBLE; Green MC, 1964, MOUSE NEWS LETT, V31, P27; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HELMS C, 1992, GENOMICS, V14, P1041, DOI 10.1016/S0888-7543(05)80128-4; HING AV, 1993, AM J HUM GENET, V53, P509; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P375; MARTIN GR, 1990, GENOMICS, V6, P302, DOI 10.1016/0888-7543(90)90570-K; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McKusick V.A., 1992, MENDELIAN INHERITANC; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; NICOLAI JPA, 1988, J HAND SURG-AM, V13A, P405, DOI 10.1016/S0363-5023(88)80019-4; NICOLAI JPA, 1986, J HAND SURG-AM, V11A, P293, DOI 10.1016/S0363-5023(86)80075-2; POOLE SJ, 1989, GENOMICS, V4, P225, DOI 10.1016/0888-7543(89)90324-8; RICHARDS EJ, 1992, CURRENT PROTOCOLS MO; SCOTTEMUAKPOR AB, 1976, HUM HERED, V26, P198, DOI 10.1159/000152803; SWEET HO, 1982, MOUSE NEWS LETT, V66, P66; Temtamy SA, 1978, GENETICS HAND MALFOR; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; [No title captured]	28	84	93	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					282	286		10.1038/ng0394-282	http://dx.doi.org/10.1038/ng0394-282			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012391				2022-12-17	WOS:A1994MZ56200016
J	BALLABIO, A				BALLABIO, A			THE RISE AND FALL OF POSITIONAL CLONING	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; COMPLEMENTARY-DNA; IDENTIFICATION; PROTEIN; REGION; MOLECULES; SEQUENCE; HOMOLOGY; ADHESION; ENCODES		BAYLOR COLL MED, CTR HUMAN GENOME, HOUSTON, TX 77030 USA	Baylor College of Medicine	BALLABIO, A (corresponding author), BAYLOR COLL MED, INST MOLEC GENET, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.		BALLABIO, Andrea/AAL-2672-2020	BALLABIO, Andrea/0000-0003-1381-4604				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHEN Z, 1993, NAT GENET, V1, P204; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KOWK K, 1985, BIOCHEMISTRY-US, V24, P556; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; POLYMEROPOULOS MH, IN PRESS NATURE GENE; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SARGENT CA, 1993, HUM MOL GENET, V2, P97, DOI 10.1093/hmg/2.2.97; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WALKER AP, 1993, HUM MOL GENET, V2, P107, DOI 10.1093/hmg/2.2.107; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	53	84	86	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1993	3	4					277	279		10.1038/ng0493-277	http://dx.doi.org/10.1038/ng0493-277			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981743				2022-12-17	WOS:A1993KW25700003
J	CARTIER, M; BREITMAN, ML; TSUI, LC				CARTIER, M; BREITMAN, ML; TSUI, LC			A FRAMESHIFT MUTATION IN THE GAMMA-E-CRYSTALLIN GENE OF THE ELO MOUSE	NATURE GENETICS			English	Article							EYE LENS OBSOLESCENCE; LINKAGE ANALYSIS; LOCUS; PROTEINS; CATARACT	The murine Elo (eye lens obsolesence) mutation confers a dominant phenotype characterized by malformation of the eye lens. The mutation maps to chromosome 1, in close proximity to the gamma-E-crystallin gene which is the 3'-most member of the gamma-crystallin gene cluster. We have analysed the sequence of this gene from the Elo mouse and identified a single nucleotide deletion which destroys the fourth and last "Greek key" motif of the protein. This mutation is tightly associated with the phenotype, as no recombination was detected in 274 meioses. In addition, the mutant mRNA is present in the affected lens, providing further support for our hypothesis that the deletion is responsible for the dominant Elo phenotype.	HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto			Tsui, Lap-chee/A-1081-2010					BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; DAVIS LG, 1986, BASIC METHODS MOL BI, P130; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; GORING DR, 1992, EXP EYE RES, V54, P785, DOI 10.1016/0014-4835(92)90034-P; GRAW J, 1991, GENE, V104, P265, DOI 10.1016/0378-1119(91)90260-I; HOGAN B, 1986, MANIPULATING MOUSE E, P175; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MASAKI S, 1988, EXP EYE RES, V47, P727, DOI 10.1016/0014-4835(88)90040-1; MASAKI S, 1989, GENOMICS, V5, P259, DOI 10.1016/0888-7543(89)90055-4; MCAVOY JW, 1980, DIFFERENTIATION, V17, P137, DOI 10.1111/j.1432-0436.1980.tb01091.x; ODA SI, 1980, EXP EYE RES, V31, P673, DOI 10.1016/S0014-4835(80)80051-0; ODA SI, 1980, JPN J GENET, V55, P71, DOI 10.1266/jjg.55.71; PARMELEE JT, 1988, J CELL PHYSIOL, V134, P491, DOI 10.1002/jcp.1041340323; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; QUINLAN P, 1987, GENE DEV, V1, P637, DOI 10.1101/gad.1.7.637; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SKOW LC, 1988, BIOCHEM GENET, V26, P557, DOI 10.1007/BF02399601; WATANABE K, 1980, EXP EYE RES, V31, P683, DOI 10.1016/S0014-4835(80)80052-2; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; YOSHIKI A, 1991, DEVELOPMENT, V113, P1293; ZIGLER JS, 1981, OPHTHALMIC RES, V13, P237, DOI 10.1159/000265154	25	84	85	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					42	45		10.1038/ng0992-42	http://dx.doi.org/10.1038/ng0992-42			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303247				2022-12-17	WOS:A1992JM64600014
J	Craig, JE; Han, XK; Qassim, A; Hassall, M; Bailey, JNC; Kinzy, TG; Khawaja, AP; An, JY; Marshall, H; Gharahkhani, P; Igo, RP; Graham, SL; Healey, PR; Ong, JS; Zhou, T; Siggs, O; Law, MH; Souzeau, E; Ridge, B; Hysi, PG; Burdon, KP; Mills, RA; Landers, J; Ruddle, JB; Agar, A; Galanopoulos, A; White, AJR; Willoughby, CE; Andrew, NH; Best, S; Vincent, AL; Goldberg, I; Radford-Smith, G; Martin, NG; Montgomery, GW; Vitart, V; Hoehn, R; Wojciechowski, R; Jonas, JB; Aung, T; Pasquale, LR; Cree, AJ; Sivaprasad, S; Vallabh, NA; Viswanathan, AC; Pasutto, F; Haines, JL; Klaver, CCW; van Duijn, CM; Casson, RJ; Foster, PJ; Khaw, PT; Hammond, CJ; Mackey, DA; Mitchell, P; Lotery, AJ; Wiggs, JL; Hewitt, AW; MacGregor, S				Craig, Jamie E.; Han, Xikun; Qassim, Ayub; Hassall, Mark; Bailey, Jessica N. Cooke; Kinzy, Tyler G.; Khawaja, Anthony P.; An, Jiyuan; Marshall, Henry; Gharahkhani, Puya; Igo, Robert P., Jr.; Graham, Stuart L.; Healey, Paul R.; Ong, Jue-Sheng; Zhou, Tiger; Siggs, Owen; Law, Matthew H.; Souzeau, Emmanuelle; Ridge, Bronwyn; Hysi, Pirro G.; Burdon, Kathryn P.; Mills, Richard A.; Landers, John; Ruddle, Jonathan B.; Agar, Ashish; Galanopoulos, Anna; White, Andrew J. R.; Willoughby, Colin E.; Andrew, Nicholas H.; Best, Stephen; Vincent, Andrea L.; Goldberg, Ivan; Radford-Smith, Graham; Martin, Nicholas G.; Montgomery, Grant W.; Vitart, Veronique; Hoehn, Rene; Wojciechowski, Robert; Jonas, Jost B.; Aung, Tin; Pasquale, Louis R.; Cree, Angela Jane; Sivaprasad, Sobha; Vallabh, Neeru A.; Viswanathan, Ananth C.; Pasutto, Francesca; Haines, Jonathan L.; Klaver, Caroline C. W.; van Duijn, Cornelia M.; Casson, Robert J.; Foster, Paul J.; Khaw, Peng Tee; Hammond, Christopher J.; Mackey, David A.; Mitchell, Paul; Lotery, Andrew J.; Wiggs, Janey L.; Hewitt, Alex W.; MacGregor, Stuart		NEIGHBORHOOD Consortium; UK Biobank Eye Vision Consortium	Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; OPEN-ANGLE GLAUCOMA; PREVALENCE; VARIANTS; MULTIPLE	Multitrait genome-wide analysis of glaucoma and related phenotypes identifies new risk loci and enables development of a polygenic risk score to predict disease susceptibility and key clinical outcomes. Glaucoma, a disease characterized by progressive optic nerve degeneration, can be prevented through timely diagnosis and treatment. We characterize optic nerve photographs of 67,040 UK Biobank participants and use a multitrait genetic model to identify risk loci for glaucoma. A glaucoma polygenic risk score (PRS) enables effective risk stratification in unselected glaucoma cases and modifies penetrance of the MYOC variant encoding p.Gln368Ter, the most common glaucoma-associated myocilin variant. In the unselected glaucoma population, individuals in the top PRS decile reach an absolute risk for glaucoma 10 years earlier than the bottom decile and are at 15-fold increased risk of developing advanced glaucoma (top 10% versus remaining 90%, odds ratio = 4.20). The PRS predicts glaucoma progression in prospectively monitored, early manifest glaucoma cases (P = 0.004) and surgical intervention in advanced disease (P = 3.6 x 10(-)(6)). This glaucoma PRS will facilitate the development of a personalized approach for earlier treatment of high-risk individuals, with less intensive monitoring and treatment being possible for lower-risk groups.	[Craig, Jamie E.; Qassim, Ayub; Hassall, Mark; Marshall, Henry; Zhou, Tiger; Siggs, Owen; Souzeau, Emmanuelle; Ridge, Bronwyn; Mills, Richard A.; Landers, John; Andrew, Nicholas H.] Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA, Australia; [Han, Xikun; An, Jiyuan; Gharahkhani, Puya; Ong, Jue-Sheng; Law, Matthew H.; Radford-Smith, Graham; Martin, Nicholas G.; Viswanathan, Ananth C.; MacGregor, Stuart] Queensland Inst Med Res, Berghofer Med Res Inst, Brisbane, Qld, Australia; [Han, Xikun] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Bailey, Jessica N. Cooke; Kinzy, Tyler G.; Igo, Robert P., Jr.; Haines, Jonathan L.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Inst Computat Biol, Cleveland, OH USA; [Khawaja, Anthony P.; Viswanathan, Ananth C.; Foster, Paul J.; Khaw, Peng Tee] Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Khawaja, Anthony P.; Viswanathan, Ananth C.; Foster, Paul J.; Khaw, Peng Tee] UCL Inst Ophthalmol, London, England; [Graham, Stuart L.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Healey, Paul R.; White, Andrew J. R.] Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Sydney, NSW, Australia; [Healey, Paul R.; White, Andrew J. R.] Univ Sydney, Westmead Clin Sch, Clin Ophthalmol & Eye Hlth, Sydney, NSW, Australia; [Hysi, Pirro G.; Hammond, Christopher J.] Kings Coll London, St Thomas Hosp, Dept Ophthalmol, London, England; [Burdon, Kathryn P.; Mackey, David A.; Hewitt, Alex W.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Ruddle, Jonathan B.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Agar, Ashish] Prince Wales Hosp Randwick, Dept Ophthalmol, Sydney, NSW, Australia; [Galanopoulos, Anna] Royal Adelaide Hosp, South Australian Inst Ophthalmol, Adelaide, SA, Australia; [Willoughby, Colin E.] Ulster Univ, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland; [Willoughby, Colin E.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Best, Stephen] Auckland Dist Hlth Board, Greenlane Clin Ctr, Eye Dept, Auckland, New Zealand; [Vincent, Andrea L.] Univ Auckland, Dept Ophthalmol, Auckland, New Zealand; [Goldberg, Ivan] Univ Sydney, Sydney Eye Hosp, Fac Med & Hlth, Discipline Ophthalmol, Sydney, NSW, Australia; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Vitart, Veronique] Univ Edinburgh, Med Res Council, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Hoehn, Rene] Univ Bern, Univ Hosp Bern, Inselspital, Dept Ophthalmol, Bern, Switzerland; [Hoehn, Rene] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Wojciechowski, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol & Med, Baltimore, MD USA; [Wojciechowski, Robert] NHGRI, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Aung, Tin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Pasquale, Louis R.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA; [Cree, Angela Jane; Lotery, Andrew J.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Sivaprasad, Sobha] Moorfields Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Vallabh, Neeru A.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England; [Vallabh, Neeru A.] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [Pasutto, Francesca] Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Casson, Robert J.] Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Vis Sci, Perth, WA, Australia; [Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Sydney, NSW, Australia; [Mitchell, Paul] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Wiggs, Janey L.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Flinders Medical Centre; Flinders University South Australia; QIMR Berghofer Medical Research Institute; University of Queensland; Case Western Reserve University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Macquarie University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Tasmania; Menzies Institute for Medical Research; Centre for Eye Research Australia; University of Melbourne; Royal Adelaide Hospital; Ulster University; Auckland District Health Board; University of Auckland; University of Sydney; University of Queensland; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Bern; University Hospital of Bern; Johannes Gutenberg University of Mainz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ruprecht Karls University Heidelberg; National University of Singapore; Singapore National Eye Center; Icahn School of Medicine at Mount Sinai; University of Southampton; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Erlangen Nuremberg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Adelaide; Lions Eye Institute; University of Western Australia; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Han, XK (corresponding author), Queensland Inst Med Res, Berghofer Med Res Inst, Brisbane, Qld, Australia.; Han, XK (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	Xikun.Han@qimrberghofer.edu.au	Radford-Smith, Graham/H-2792-2013; An, Jiyuan/ABD-2471-2020; Macgregor, Stuart/C-6442-2009; Fingert, John/AAX-4750-2021; Vallabh, Neeru/AAU-5130-2020; Burdon, Kathryn/AAD-2334-2022; White, Andrew JR/E-8462-2013; Sivaprasad, S./D-6876-2015; Foster, Paul/V-7288-2019; Mackey, David A/H-5340-2014; Han, Xikun/AAN-9012-2020; Souzeau, Emmanuelle/AAB-5608-2022; Law, Matthew H./AAJ-4066-2021; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Ong, Jue Sheng/B-3595-2018	Radford-Smith, Graham/0000-0002-2047-6239; Macgregor, Stuart/0000-0001-6731-8142; Fingert, John/0000-0002-0377-0479; Vallabh, Neeru/0000-0002-0109-4112; Burdon, Kathryn/0000-0001-8217-1249; Sivaprasad, S./0000-0001-8952-0659; Foster, Paul/0000-0002-4755-177X; Mackey, David A/0000-0001-7914-4709; Han, Xikun/0000-0002-3823-7308; Souzeau, Emmanuelle/0000-0002-2015-6577; Law, Matthew H./0000-0002-4303-8821; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Siggs, Owen/0000-0003-2840-4851; Lotery, Andrew/0000-0001-5541-4305; Craig, Jamie/0000-0001-9955-9696; Marshall, Henry/0000-0002-4425-2272; Willoughby, Colin/0000-0002-1246-4166; Mills, Richard/0000-0002-7386-2571; Graham, Stuart/0000-0001-7519-969X; Ong, Jue Sheng/0000-0002-6062-710X; Gharahkhani, Puya/0000-0002-4203-5952; Khaw, Sir Peng Tee/0000-0002-8087-2268; Khawaja, Anthony/0000-0001-6802-8585; Hysi, Pirro/0000-0001-5752-2510; Hassall, Mark M./0000-0002-6180-7954; Qassim, Ayub/0000-0002-2911-2941; Van Duijn, Cornelia/0000-0002-2374-9204	Welsh Assembly Government; British Heart Foundation; Diabetes UK; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology; Fight for Sight charity; Moorfields Eye Charity; Macular Society; International Glaucoma Association; Alcon Research Institute; National Health and Medical Research Council (NHMRC) of Australia [1107098, 1116360, 1116495, 1023911, 1150144, 1147571]; Ophthalmic Research Institute of Australia; BrightFocus Foundation; UK and Eire Glaucoma Society; Royal Liverpool University Hospital; NHMRC [APP1154543, APP1154824, APP1059954, APP1154513, APP1103329, 1063061]; Australian Research Council [FT130101902]; National Institutes of Health [R01 EY015473, P30 EY014104, R01 EY022305]; University of Queensland; Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship; MRC [MC_PC_12028, MC_UU_00007/10] Funding Source: UKRI	Welsh Assembly Government; British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology; Fight for Sight charity; Moorfields Eye Charity; Macular Society; International Glaucoma Association; Alcon Research Institute(Novartis); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; BrightFocus Foundation(BrightFocus Foundation); UK and Eire Glaucoma Society; Royal Liverpool University Hospital; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Queensland(University of Queensland); Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was conducted using the UK Biobank Resource (application no. 25331) and publicly available data from the IGGC. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and Northwest Regional Development Agency. It also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. The eye and vision dataset has been developed with additional funding from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, Fight for Sight charity, Moorfields Eye Charity, Macular Society, International Glaucoma Association and Alcon Research Institute. This work was also supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (nos. 1107098, 1116360, 1116495, 1023911, 1150144, 1147571), the Ophthalmic Research Institute of Australia, the BrightFocus Foundation, the UK and Eire Glaucoma Society and charitable funds from the Royal Liverpool University Hospital. S.M., J.E.C., K.P.B., D.A.M. and A.W.H. are supported by NHMRC Fellowships (APP1154543, APP1154824, APP1059954, APP1154513, APP1103329). S.M. was supported by an Australian Research Council Future Fellowship (FT130101902). L.R.P. is supported by National Institutes of Health grant no. R01 EY015473. X.H. is supported by the University of Queensland Research Training Scholarship and Queensland Institute of Medical Research Berghofer PhD Top Up Scholarship. We thank D. Whiteman, R. Neale and C. Olson for providing access to the QSkin samples for use as controls as part of NHMRC grant no. 1063061. We thank S. Wood, J. Pearson and S. Gordon from the Queensland Institute of Medical Research Berghofer Research Institute for their support. The NEIGHBORHOOD consortium is supported by National Institutes of Health grant nos. P30 EY014104, R01 EY015473 and R01 EY022305.	BENGTSSON B, 1976, ACTA OPHTHALMOL, V54, P804; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chan MPY, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3889; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Choquet H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04555-4; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; Gao XR, 2018, HUM MOL GENET, V27, P2205, DOI 10.1093/hmg/ddy111; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gharahkhani P, 2015, INVEST OPHTH VIS SCI, V56, P5087, DOI 10.1167/iovs.15-17305; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Han XK, 2019, HUM MOL GENET, V28, P3680, DOI 10.1093/hmg/ddz193; Han XK, 2019, JAMA OPHTHALMOL, V137, P28, DOI 10.1001/jamaophthalmol.2018.4477; Hewitt AW, 2008, HUM MUTAT, V29, P207, DOI 10.1002/humu.20634; Huang LL, 2019, SCI CHINA LIFE SCI, V62, P153, DOI 10.1007/s11427-018-9430-2; Khawaja AP, 2018, NAT GENET, V50, P778, DOI 10.1038/s41588-018-0126-8; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; King R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007145; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lecarpentier J, 2017, J CLIN ONCOL, V35, P2240, DOI 10.1200/JCO.2016.69.4935; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lopes MC, 2013, INVEST OPHTH VIS SCI, V54, P1260, DOI 10.1167/iovs.12-10463; MacGregor S, 2018, NAT GENET, V50, P1067, DOI 10.1038/s41588-018-0176-y; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Olsen CM, 2012, INT J EPIDEMIOL, V41, P929, DOI 10.1093/ije/dys107; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; R Core Team, 2017, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Souzeau E, 2012, CLIN EXP OPHTHALMOL, V40, P569, DOI 10.1111/j.1442-9071.2011.02742.x; Springelkamp H, 2017, HUM MOL GENET, V26, P438, DOI 10.1093/hmg/ddw399; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Turley P, 2018, NAT GENET, V50, P229, DOI 10.1038/s41588-017-0009-4; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang K, 2017, NAT GENET, V49, P1319, DOI 10.1038/ng.3931; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2017, DIAGNOSIS PRIMARY OP, V10; Wiggs JL, 2013, J GLAUCOMA, V22, P517, DOI 10.1097/IJG.0b013e31824d4fd8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1216-0; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	51	83	83	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2020	52	2					160	+		10.1038/s41588-019-0556-y	http://dx.doi.org/10.1038/s41588-019-0556-y		JAN 2020	14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KM6MD	31959993	Green Accepted, Green Submitted			2022-12-17	WOS:000508324400003
J	Park, HJ; Ji, P; Kim, S; Xia, Z; Rodriguez, B; Li, L; Su, JZ; Chen, KF; Masamha, CP; Baillat, D; Fontes-Garfias, CR; Shyu, AB; Neilson, JR; Wagner, EJ; Li, W				Park, Hyun Jung; Ji, Ping; Kim, Soyeon; Xia, Zheng; Rodriguez, Benjamin; Li, Lei; Su, Jianzhong; Chen, Kaifu; Masamha, Chioniso P.; Baillat, David; Fontes-Garfias, Camila R.; Shyu, Ann-Bin; Neilson, Joel R.; Wagner, Eric J.; Li, Wei			3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk	NATURE GENETICS			English	Article							ALTERNATIVE CLEAVAGE; EXPRESSION ANALYSIS; BREAST-CANCER; POLYADENYLATION; UPDATE; IDENTIFICATION; CONSEQUENCES; RESOURCE; TARGETS	Widespread mRNA 3' UTR shortening through alternative polyadenylation(1) promotes tumor growth in vivo(2). A prevailing hypothesis is that it induces proto-oncogene expression in cis through escaping microRNA-mediated repression. Here we report a surprising enrichment of 3' UTR shortening among transcripts that are predicted to act as competingendogenous RNAs (ceRNAs) for tumor-suppressor genes. Our model-based analysis of the trans effect of 3' UTR shortening (MAT3UTR) reveals a significant role in altering ceRNA expression. MAT3UTR predicts many trans-targets of 3' UTR shortening, including PTEN, a crucial tumor-suppressor gene(3) involved in ceRNA crosstalk(4) with nine 3' UTRshortening genes, including EPS15 and NFIA. Knockdown of NUDT21, a master 3' UTR-shortening regulator(2), represses tumor-suppressor genes such as PHF6 and LARP1 in trans in a miRNA-dependent manner. Together, the results of our analysis suggest a major role of 3' UTR shortening in repressing tumor-suppressor genes in trans by disrupting ceRNA crosstalk, rather than inducing proto-oncogenes in cis.	[Park, Hyun Jung; Xia, Zheng; Rodriguez, Benjamin; Li, Lei; Su, Jianzhong; Chen, Kaifu; Li, Wei] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Park, Hyun Jung; Xia, Zheng; Rodriguez, Benjamin; Li, Lei; Su, Jianzhong; Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Park, Hyun Jung] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Ji, Ping; Baillat, David; Fontes-Garfias, Camila R.; Wagner, Eric J.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Kim, Soyeon] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA; [Masamha, Chioniso P.] Butler Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Indianapolis, IN 46208 USA; [Shyu, Ann-Bin] Univ Texas, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX USA; [Neilson, Joel R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; Butler University; University of Texas System; Baylor College of Medicine	Li, W (corresponding author), Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Li, W (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Wagner, EJ (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	ejwagner@utmb.edu; WL1@bcm.edu	Xia, Zheng/AAC-5360-2022; Li, Lei/S-9028-2016; Kim, Soyeon/R-1511-2018	Xia, Zheng/0000-0003-3364-8324; Li, Lei/0000-0003-3924-2544; Fontes-Garfias, Camila/0000-0002-1912-8413; Su, Jianzhong/0000-0002-1172-7411; Neilson, Joel R./0000-0002-3408-608X; Kim, Soyeon/0000-0003-1573-2733	US National Institutes of Health (NIH) [R01HG007538, R01CA193466, U54CA217297]; Cancer Prevention Research Institute of Texas (CPRIT) grant [RP150292]; CPRIT [RP100107, RP140800]; Welch Foundation [AU-1889]; NIH [RO1GM046454]; Houston Endowment, Inc.; NATIONAL CANCER INSTITUTE [R01CA193466, U54CA217297] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454, R35GM127109] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K01LM012877] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT) grant; CPRIT; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Endowment, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by US National Institutes of Health (NIH) grants R01HG007538, R01CA193466 and U54CA217297, Cancer Prevention Research Institute of Texas (CPRIT) grant RP150292 to W.L., CPRIT RP100107 to E.J.W. and A.-B.S., CPRIT RP140800 and Welch Foundation AU-1889 to E.J.W., and NIH RO1GM046454 and the Houston Endowment, Inc. to A.-B.S.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Bayerlova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144014; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Kim S, 2017, STAT BIOSCI, V9, P217, DOI 10.1007/s12561-016-9169-5; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05406; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mets E, 2014, HAEMATOLOGICA, V99, P1326, DOI 10.3324/haematol.2013.099515; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Mueller AA, 2013, CURR OPIN CELL BIOL, V25, P222, DOI 10.1016/j.ceb.2012.12.008; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YF, 2016, TRENDS GENET, V32, P211, DOI 10.1016/j.tig.2016.02.001; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	38	83	85	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					783	+		10.1038/s41588-018-0118-8	http://dx.doi.org/10.1038/s41588-018-0118-8			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29785014	Green Accepted			2022-12-17	WOS:000433621000005
J	Toriyama, M; Lee, CJ; Taylor, SP; Duran, I; Cohn, DH; Bruel, AL; Tabler, JM; Drew, K; Kelly, MR; Kim, S; Park, TJ; Braun, DA; Pierquin, G; Biver, A; Wagner, K; Malfroot, A; Panigrahi, I; Franco, B; Al-Lami, HA; Yeung, Y; Choi, YJ; Duffourd, Y; Faivre, L; Riviere, JB; Chen, J; Liu, KJ; Marcotte, EM; Hildebrandt, F; Thauvin-Robinet, C; Krakow, D; Jackson, PK; Wallingford, JB				Toriyama, Michinori; Lee, Chanjae; Taylor, S. Paige; Duran, Ivan; Cohn, Daniel H.; Bruel, Ange-Line; Tabler, Jacqueline M.; Drew, Kevin; Kelly, Marcus R.; Kim, Sukyoung; Park, Tae Joo; Braun, Daniela A.; Pierquin, Ghislaine; Biver, Armand; Wagner, Kerstin; Malfroot, Anne; Panigrahi, Inusha; Franco, Brunella; Al-Lami, Hadeel Adel; Yeung, Yvonne; Choi, Yeon Ja; Duffourd, Yannis; Faivre, Laurence; Riviere, Jean-Baptiste; Chen, Jiang; Liu, Karen J.; Marcotte, Edward M.; Hildebrandt, Friedhelm; Thauvin-Robinet, Christel; Krakow, Deborah; Jackson, Peter K.; Wallingford, John B.		Univ Washington Ctr Mendelian Geno	The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery	NATURE GENETICS			English	Article							PLANAR CELL POLARITY; CILIARY VESICLE DOCKING; IFT-A COMPLEX; JOUBERT SYNDROME; TUBULIN TRANSPORT; KINESIN-II; GENE; FUZZY; CILIOGENESIS; MECHANISMS	Cilia use microtubule-based intraflagellar transport (IFT) to organize intercellular signaling. Ciliopathies are a spectrum of human diseases resulting from defects in cilia structure or function. The mechanisms regulating the assembly of ciliary multiprotein complexes and the transport of these complexes to the base of cilia remain largely unknown. Combining proteomics, in vivo imaging and genetic analysis of proteins linked to planar cell polarity (Inturned, Fuzzy and Wdpcp), we identified and characterized a new genetic module, which we term CPLANE (ciliogenesis and planar polarity effector), and an extensive associated protein network. CPLANE proteins physically and functionally interact with the poorly understood ciliopathy-associated protein Jbts17 at basal bodies, where they act to recruit a specific subset of IFT-A proteins. In the absence of CPLANE, defective IFT-A particles enter the axoneme and IFT-B trafficking is severely perturbed. Accordingly, mutation of CPLANE genes elicits specific ciliopathy phenotypes in mouse models and is associated with ciliopathies in human patients.	[Toriyama, Michinori; Lee, Chanjae; Tabler, Jacqueline M.; Drew, Kevin; Kim, Sukyoung; Park, Tae Joo; Marcotte, Edward M.; Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Bruel, Ange-Line; Duffourd, Yannis; Faivre, Laurence; Riviere, Jean-Baptiste; Thauvin-Robinet, Christel] Burgundy Univ, Fac Med, FHU TRANSLAD, Genet Dev Anomalies EA4271GAD, Dijon, France; [Kelly, Marcus R.; Jackson, Peter K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab, Stanford, CA 94305 USA; [Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA USA; [Pierquin, Ghislaine] Univ Hosp Ctr, Clin Genet Ctr, Liege, Belgium; [Biver, Armand] Ctr Hosp, Pediat Unit, Luxembourg, Luxembourg; [Wagner, Kerstin] Ctr Hosp, Cardiol Pediat Unit, Luxembourg, Luxembourg; [Malfroot, Anne] Univ Ziekenhuis Brussel, Clin Pediat Resp Dis, Brussels, Belgium; [Malfroot, Anne] Univ Ziekenhuis Brussel, Travel Clin, Infectious Dis, Brussels, Belgium; [Malfroot, Anne] Univ Ziekenhuis Brussel, Cyst Fibrosis Clin, Brussels, Belgium; [Panigrahi, Inusha] Pediat Ctr Pigmer, Dept Pediat Adv, Chandigarh, India; [Franco, Brunella] Univ Naples Federico II, Dept Med Translat Sci, Div Pediat, Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Al-Lami, Hadeel Adel; Yeung, Yvonne; Liu, Karen J.] Kings Coll London, Inst Dent, Dept Craniofacial & Stem Cell Biol, London WC2R 2LS, England; [Choi, Yeon Ja; Chen, Jiang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Choi, Yeon Ja; Chen, Jiang] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA; [Faivre, Laurence] CHU Dijon, Children Hosp, FHU TRANSLAD, Clin Genet Ctr, Dijon, France; [Faivre, Laurence] CHU Dijon, Children Hosp, FHU TRANSLAD, Eastern Referral Ctr Dev Anomalies & Malformat Sy, Dijon, France; [Riviere, Jean-Baptiste; Thauvin-Robinet, Christel] CHU Dijon, PTB, FHU TRANSLAD, Mol Genet Lab, Dijon, France; [Park, Tae Joo] UNIST, Ulsan, South Korea	University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Luxembourg Hospital Center; Luxembourg Hospital Center; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of London; King's College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Ulsan National Institute of Science & Technology (UNIST)	Wallingford, JB (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	wallingford@austin.utexas.edu	Duran, Ivan/M-3185-2016; Braun, Daniela A/R-2259-2017; Krakow, Deborah/B-5778-2009; Park, Tae Joo/G-1460-2011; Duran, Ivan/ADN-5665-2022; Al-Lami, Hadeel Adel/ABE-8854-2020; Panigrahi, Inusha/L-6965-2018; FRANCO, Brunella/S-2882-2018; Liu, Karen/F-2870-2010	Duran, Ivan/0000-0001-6097-0402; Braun, Daniela A/0000-0003-3146-1566; Krakow, Deborah/0000-0001-9906-4968; Park, Tae Joo/0000-0003-3176-177X; Duran, Ivan/0000-0001-6097-0402; Al-Lami, Hadeel Adel/0000-0002-3757-1822; Panigrahi, Inusha/0000-0001-7375-9892; FRANCO, Brunella/0000-0001-5588-4569; Faivre, Laurence/0000-0001-9770-444X; TORIYAMA, Michinori/0000-0003-2551-4334; Blue, Elizabeth/0000-0002-0633-0305; Liu, Karen/0000-0002-2483-2165; Jackson, Peter/0000-0002-1742-2539; Drew, Kevin/0000-0002-1260-4413; Marcotte, Edward/0000-0001-8808-180X; Kelly, Marcus/0000-0003-3670-8126	Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NHGRI; NHLBI [1U54 HG006493, HL117164]; Uehara Memorial Foundation Fellowship; NIDCR NRSA; French Rare Diseases Foundation; French Ministry of Health (PHRC national) [2010-A01014-35]; Regional Council of Burgundy; NIDDK [DK1068306]; NIAMS [AR061485]; BBSRC [BB/K010492/1]; MRC [MR/L017237/1]; NIH; NSF; CPRIT; Welch Foundation [F-1515]; March of Dimes [R01 AR066124]; Joseph Drown Foundation; NIH/NCATS UCLA CTSI grant [UL1TR000124, R01 AR062651]; NIGMS [GM114276, GM104853]; Baxter Laboratory; Stanford Department of Research; Biotechnology and Biological Sciences Research Council [BB/K010492/1] Funding Source: researchfish; Medical Research Council [MR/L017237/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117164, RC2HL102925, UC2HL102923, RC2HL102926, RC2HL102923, UC2HL102926, UC2HL103010, RC2HL103010, RC2HL102924, UC2HL102924, UC2HL102925] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061485, R01AR066124, R01AR062651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106408, F32GM112495, R01GM114276, R01GM121565, R01GM086627, R01GM104853] Funding Source: NIH RePORTER	Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Uehara Memorial Foundation Fellowship; NIDCR NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); French Rare Diseases Foundation; French Ministry of Health (PHRC national); Regional Council of Burgundy(Region Bourgogne-Franche-Comte); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CPRIT; Welch Foundation(The Welch Foundation); March of Dimes(March of Dimes); Joseph Drown Foundation; NIH/NCATS UCLA CTSI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Baxter Laboratory; Stanford Department of Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients and their families, the IntegraGen society for exome analysis and the NHLBI GO Exome Sequencing Project, which produced and provided exome variant calls for comparison: Lung GO Sequencing Project (HL-102923), WHI Sequencing Project (HL-102924), Broad GO Sequencing Project (HL-102925), Seattle GO Sequencing Project (HL-102926) and Heart GO Sequencing Project (HL-103010). We thank the Biological Resources Center-Ferdinand Cabanne (Dijon, France) for fibroblast centralization and storage. Sequencing was provided by the University of Washington Center for Mendelian Genomics (UW CMG) and was funded by the NHGRI and NHLBI (grant 1U54 HG006493) to D. Nickerson, J. Shendure and M. Bamshad. This work was supported by grants from the following: Uehara Memorial Foundation Fellowship to M.T.; an NIDCR NRSA to J.M.T.; the French Rare Diseases Foundation, the French Ministry of Health (PHRC national 2010-A01014-35 to C.T.-R.) and the Regional Council of Burgundy to C.T.-R.; NIDDK (DK1068306) to F.H., who is a Howard Hughes Medical Institute investigator, a Doris Duke Distinguished Clinical Scientist and the Warren E. Grupe Professor; NIAMS (AR061485) to J.C.; BBSRC (BB/K010492/1) and MRC (MR/L017237/1) to K.J.L.; NIH, NSF, CPRIT and the Welch Foundation (F-1515) to E.M.M.; R01 AR066124, March of Dimes and the Joseph Drown Foundation, NIH/NCATS UCLA CTSI grant UL1TR000124 to D.K.; R01 AR062651 to D.H.C.; NIGMS (GM114276), Baxter Laboratory, the Stanford Department of Research and NIGMS (GM114276) to P.K.J.; and NIGMS (GM104853) and NHLBI (HL117164) to J.B.W., who was a Howard Hughes Medical Institute Early Career Scientist.	ADLER PN, 1994, GENETICS, V137, P829; Alazami AM, 2012, HUM MUTAT, V33, P1423, DOI 10.1002/humu.22134; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Brooks Eric R, 2013, Cilia, V2, P13, DOI 10.1186/2046-2530-2-13; Brooks ER, 2012, J CELL BIOL, V198, P37, DOI 10.1083/jcb.201204072; Butler MT, 2015, DEVELOPMENT, V142, P3429, DOI 10.1242/dev.121384; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Collier S, 1997, DEVELOPMENT, V124, P4029; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Cui C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001720; Damerla RR, 2015, HUM MOL GENET, V24, P3994, DOI 10.1093/hmg/ddv137; Diggle CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004577; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Giles RH, 2014, NAT PROTOC, V9, P2725, DOI 10.1038/nprot.2014.181; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Harris JA, 2016, MOL BIOL CELL, V27, P295, DOI 10.1091/mbc.E15-08-0608; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hsieh YC, 1999, AM J MED GENET, V86, P278, DOI 10.1002/(SICI)1096-8628(19990917)86:3<278::AID-AJMG16>3.0.CO;2-C; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kobayashi D, 2012, DIFFERENTIATION, V83, pS23, DOI 10.1016/j.diff.2011.11.009; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lee Chanjae, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4957; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lopez E, 2014, HUM GENET, V133, P367, DOI 10.1007/s00439-013-1385-1; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Panigrahi I, 2013, CLIN DYSMORPHOL, V22, P109, DOI 10.1097/MCD.0b013e32835fe161; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saari J, 2015, AM J MED GENET A, V167, P421, DOI 10.1002/ajmg.a.36852; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sive HL, 2000, EARLY DEV XENOPUS LA; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; Wang Y, 2014, DEV BIOL, V394, P156, DOI 10.1016/j.ydbio.2014.07.013; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	76	83	94	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					648	+		10.1038/ng.3558	http://dx.doi.org/10.1038/ng.3558			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27158779	Green Accepted, Green Submitted			2022-12-17	WOS:000376744200012
J	Zhou, XM; Wang, BS; Pan, Q; Zhang, JB; Kumar, S; Sun, XQ; Liu, ZJ; Pan, HJ; Lin, Y; Liu, GJ; Zhan, W; Li, MZ; Ren, BP; Ma, XY; Ruan, H; Cheng, C; Wang, DW; Shi, FL; Hui, YY; Tao, YJ; Zhang, CL; Zhu, PF; Xiang, ZF; Jiang, WK; Chang, J; Wang, HL; Cao, ZS; Jiang, Z; Li, BG; Yang, G; Roos, C; Garber, PA; Bruford, MW; Li, RQ; Li, M				Zhou, Xuming; Wang, Boshi; Pan, Qi; Zhang, Jinbo; Kumar, Sudhir; Sun, Xiaoqing; Liu, Zhijin; Pan, Huijuan; Lin, Yu; Liu, Guangjian; Zhan, Wei; Li, Mingzhou; Ren, Baoping; Ma, Xingyong; Ruan, Hang; Cheng, Chen; Wang, Dawei; Shi, Fanglei; Hui, Yuanyuan; Tao, Yujing; Zhang, Chenglin; Zhu, Pingfen; Xiang, Zuofu; Jiang, Wenkai; Chang, Jiang; Wang, Hailong; Cao, Zhisheng; Jiang, Zhi; Li, Baoguo; Yang, Guang; Roos, Christian; Garber, Paul A.; Bruford, Michael W.; Li, Ruiqiang; Li, Ming			Whole-genome sequencing of the snub-nosed monkey provides insights into folivory and evolutionary history	NATURE GENETICS			English	Article							GENE; PLATEAU; AFRICAN; CHINA; RAT	Colobines are a unique group of Old World monkeys that principally eat leaves and seeds rather than fruits and insects. We report the sequencing at 146x coverage, de novo assembly and analyses of the genome of a male golden snub-nosed monkey (Rhinopithecus roxellana) and resequencing at 30x coverage of three related species (Rhinopithecus bieti, Rhinopithecus brelichi and Rhinopithecus strykeri). Comparative analyses showed that Asian colobines have an enhanced ability to derive energy from fatty acids and to degrade xenobiotics. We found evidence for functional evolution in the colobine RNASE1 gene, encoding a key secretory RNase that digests the high concentrations of bacterial RNA derived from symbiotic microflora. Demographic reconstructions indicated that the profile of ancient effective population sizes for R. roxellana more closely resembles that of giant panda rather than its congeners. These findings offer new insights into the dietary adaptations and evolutionary history of colobine primates.	[Zhou, Xuming; Wang, Boshi; Liu, Zhijin; Liu, Guangjian; Ren, Baoping; Cheng, Chen; Shi, Fanglei; Zhu, Pingfen; Chang, Jiang; Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhou, Xuming; Wang, Boshi; Liu, Guangjian; Cheng, Chen; Zhu, Pingfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Pan, Qi; Zhang, Jinbo; Sun, Xiaoqing; Lin, Yu; Zhan, Wei; Ma, Xingyong; Ruan, Hang; Wang, Dawei; Hui, Yuanyuan; Jiang, Wenkai; Wang, Hailong; Cao, Zhisheng; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Kumar, Sudhir] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Pan, Huijuan] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China; [Tao, Yujing] Beijing Wildlife Pk, Beijing, Peoples R China; [Zhang, Chenglin] Beijing Zoo, Beijing, Peoples R China; [Xiang, Zuofu] Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China; [Li, Baoguo] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China; [Yang, Guang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Roos, Christian] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL USA; [Garber, Paul A.] Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL USA; [Bruford, Michael W.] Cardiff Univ, Cardiff Sch Biosci, Biodivers & Ecol Proc Grp, Cardiff CF10 3AX, S Glam, Wales	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Beijing Forestry University; Sichuan Agricultural University; Central South University of Forestry & Technology; Northwest University Xi'an; Nanjing Normal University; Deutsches Primatenzentrum (DPZ); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Cardiff University	Li, M (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	lirq@novogene.cn; Iim@ioz.ac.cn	Bruford, Michael W/D-3750-2009; Ruan, Hang/AAI-7367-2021; zhang, jin/GXV-9154-2022; Kumar, Sudhir/F-1411-2011; Ren, Baoping/HGE-5822-2022; Bruford, Michael/Y-7463-2019; Zhang, Cheng/GRS-8698-2022	Bruford, Michael W/0000-0001-6357-6080; Ruan, Hang/0000-0001-7506-3805; Kumar, Sudhir/0000-0002-9918-8212; Bruford, Michael/0000-0001-6357-6080; 	National Key Technology R&D Program of China [2013BAD03B02]; Natural Science Foundation of China [31270420, 41371071, 31372185, 31130061]; Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Q-7-2]; US National Institutes of Health [HG002096-12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002096] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by grants from the National Key Technology R&D Program of China (2013BAD03B02), the Natural Science Foundation of China (31270420, 41371071, 31372185 and 31130061), the Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Q-7-2) and the US National Institutes of Health (HG002096-12).	Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dickinson DP, 2002, DNA CELL BIOL, V21, P47, DOI 10.1089/10445490252810311; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Kay Robin N. B., 1994, P229; Kumar S, 2011, TRENDS GENET, V27, P377, DOI 10.1016/j.tig.2011.06.004; Li BG, 2002, INT J PRIMATOL, V23, P1227, DOI 10.1023/A:1021122819845; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li TY, 2007, SCI CHINA SER D, V50, P1202, DOI 10.1007/s11430-007-0059-z; Liedigk R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037418; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Mailund T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001319; MATSUBARA Y, 1986, P NATL ACAD SCI USA, V83, P6543, DOI 10.1073/pnas.83.17.6543; Mau M, 2011, AM J PRIMATOL, V73, P896, DOI 10.1002/ajp.20958; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Milton K, 1998, INT J PRIMATOL, V19, P513, DOI 10.1023/A:1020364523213; Milton K., 1987, FOOD EVOLUTION THEOR, P93; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Quan G, 2002, RES GOLDEN MONKEY; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schienman JE, 2006, MOL BIOL EVOL, V23, P1465, DOI 10.1093/molbev/msl025; Sillen A, 1998, HUM MUTAT, V12, P377, DOI 10.1002/(SICI)1098-1004(1998)12:6<377::AID-HUMU3>3.0.CO;2-I; Sun YB, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006064; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xiang ZF, 2009, BIOL CONSERV, V142, P469, DOI 10.1016/j.biocon.2008.11.019; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu L, 2010, MOL BIOL EVOL, V27, P121, DOI 10.1093/molbev/msp216; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	40	83	95	7	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1303	1310		10.1038/ng.3137	http://dx.doi.org/10.1038/ng.3137			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU		Green Accepted, hybrid			2022-12-17	WOS:000345547300011
J	Lane, AA; Chapuy, B; Lin, CY; Tivey, T; Li, HB; Townsend, EC; van Bodegom, D; Day, TA; Wu, SC; Liu, HY; Yoda, A; Alexe, G; Schinzel, AC; Sullivan, TJ; Malinge, S; Taylor, JE; Stegmaier, K; Jaffe, JD; Bustin, M; te Kronnie, G; Izraeli, S; Harris, MH; Stevenson, KE; Neuberg, D; Silverman, LB; Sallan, SE; Bradner, JE; Hahn, WC; Crispino, JD; Pellman, D; Weinstock, DM				Lane, Andrew A.; Chapuy, Bjoern; Lin, Charles Y.; Tivey, Trevor; Li, Hubo; Townsend, Elizabeth C.; van Bodegom, Diederik; Day, Tovah A.; Wu, Shuo-Chieh; Liu, Huiyun; Yoda, Akinori; Alexe, Gabriela; Schinzel, Anna C.; Sullivan, Timothy J.; Malinge, Sebastien; Taylor, Jordan E.; Stegmaier, Kimberly; Jaffe, Jacob D.; Bustin, Michael; te Kronnie, Geertruy; Izraeli, Shai; Harris, Marian H.; Stevenson, Kristen E.; Neuberg, Donna; Silverman, Lewis B.; Sallan, Stephen E.; Bradner, James E.; Hahn, William C.; Crispino, John D.; Pellman, David; Weinstock, David M.			Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION; STEM; CRLF2; GENE; PROTEINS	Down syndrome confers a 20-fold increased risk of B cell acute lymphoblastic leukemia (B-ALL)1, and polysomy 21 is most frequent somatic aneuploidy among all B-ALLs(2). Yet the mechanistic links between chromosome 21 triplication and B-ALL remain undefined. Here we show that germline triplication of only 31 genes orthologous to human chromosome 21q22 confers mouse progenitor B cell self renewal in vitro, maturation defects in vivo and B-ALL with either the BCR-ABL fusion protein or CRLF2 with activated JAK2. Chromosome 21q22 triplication suppresses histone H3 Lys27 trimethylation (H3K27me3) in progenitor B cells and B-ALLs, and 'bivalent' genes with both H3K27me3 and H3K4me3 at their promoters in wild-type progenitor B cells are preferentially overexpressed in triplicated cells. Human B-ALLs with polysomy 21 are distinguished by their overexpression of genes marked with H3K27me3 in multiple cell types. Overexpression of HMGN1, a nucleosome remodeling protein encoded on chromosome 21q22 (refs. 3-5), suppresses H3K27me3 and promotes both B cell proliferation in vitro and B-ALL in vivo.	[Lane, Andrew A.; Chapuy, Bjoern; Lin, Charles Y.; Tivey, Trevor; Townsend, Elizabeth C.; van Bodegom, Diederik; Day, Tovah A.; Wu, Shuo-Chieh; Liu, Huiyun; Yoda, Akinori; Schinzel, Anna C.; Bradner, James E.; Hahn, William C.; Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Hubo; Alexe, Gabriela; Silverman, Lewis B.; Sallan, Stephen E.; Pellman, David] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Schinzel, Anna C.; Taylor, Jordan E.; Stegmaier, Kimberly; Jaffe, Jacob D.; Hahn, William C.; Weinstock, David M.] Broad Inst, Cambridge, MA USA; [Sullivan, Timothy J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Microarray Core, Boston, MA 02115 USA; [Malinge, Sebastien] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Bustin, Michael] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [te Kronnie, Geertruy] Univ Padua, Dept Pediat, Padua, Italy; [Izraeli, Shai] Chaim Sheba Med Ctr, Dept Pediat Hematooncol, Ramat Gan, Israel; [Izraeli, Shai] Tel Aviv Univ, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Harris, Marian H.] Childrens Hosp Boston, Dept Pathol, Boston, MA USA; [Stevenson, Kristen E.; Neuberg, Donna] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Crispino, John D.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua; Chaim Sheba Medical Center; Tel Aviv University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Howard Hughes Medical Institute	Lane, AA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	andrew_lane@dfci.harvard.edu; dweinstock@partners.org	Malinge, Sebastien/AAK-1158-2021; Kronnie, Geertruy te/L-1014-2016; Malinge, Sebastien/AAP-9452-2021; Malinge, Sebastien/B-3507-2014; Harris, Marian/R-7049-2019; Kronnie, Geertruij te/O-5251-2019; Bustin, Michael/G-6155-2015	Malinge, Sebastien/0000-0002-9533-7778; Malinge, Sebastien/0000-0002-9533-7778; Bustin, Michael/0000-0002-5147-7242; /0000-0001-5636-1006; Lane, Andrew/0000-0001-7380-0226; te Kronnie, Geertruy/0000-0001-7143-4795; Crispino, John/0000-0002-8182-8306; Tivey, Trevor/0000-0003-2124-5528	Conquer Cancer Foundation; Lauri Strauss Leukemia Foundation; Leukemia and Lymphoma Society; Alex Lemonade Stand Foundation; US Department of Defense; Israel Science Foundation; US Israel Binational Foundation; Stellato Fund; US National Institutes of Health/National Cancer Institute [CA15198-01, CA172387-A01]; NATIONAL CANCER INSTITUTE [ZIABC011154, K08CA181340, R01CA151898, R01CA172387] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116324] Funding Source: NIH RePORTER	Conquer Cancer Foundation; Lauri Strauss Leukemia Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex Lemonade Stand Foundation; US Department of Defense(United States Department of Defense); Israel Science Foundation(Israel Science Foundation); US Israel Binational Foundation(US-Israel Binational Science Foundation); Stellato Fund; US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Kopp and A. Schlauch for technical assistance, M. Busslinger (Research Institute of Molecular Pathology, Vienna) for the Pax5<SUP>+/-</SUP> mice and M. Oshimura (Tottori University) for A9 cells carrying human chromosome 21. This research was supported by the Conquer Cancer Foundation (.A.A.L.), the Lauri Strauss Leukemia Foundation (A.A.L.), the Leukemia and Lymphoma Society (A.A.L.), the Alex Lemonade Stand Foundation (A.A.L., H. Li and D.P.), the US Department of Defense (C.Y.L.), the Israel Science Foundation (S.I.), the US Israel Binational Foundation (J.D.C. and S.I.), the Stellato Fund (D.M.W.), US National Institutes of Health/National Cancer Institute R01 awards CA15198-01 and CA172387-A01 (D.M.W.) and a Translational Research Award from the Leukemia and Lymphoma Society (J.D.C. and D.M.W.).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bustin M, 1995, DNA CELL BIOL, V14, P997, DOI 10.1089/dna.1995.14.997; Cabelof DC, 2009, BLOOD, V114, P2753, DOI 10.1182/blood-2008-11-190330; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Heerema NA, 2007, GENE CHROMOSOME CANC, V46, P684, DOI 10.1002/gcc.20451; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; LACOBUCCI I, 2008, BLOOD, V112, P3847; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Rabin KR, 2009, ONCOLOGIST, V14, P164, DOI 10.1634/theoncologist.2008-0217; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Roy A, 2012, P NATL ACAD SCI USA, V109, P17579, DOI 10.1073/pnas.1211405109; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006; Wetzler M, 2004, BRIT J HAEMATOL, V124, P275, DOI 10.1046/j.1365-2141.2003.04736.x; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107	31	83	84	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					618	623		10.1038/ng.2949	http://dx.doi.org/10.1038/ng.2949			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747640	Green Submitted, Green Accepted			2022-12-17	WOS:000336870700020
J	Justice, CM; Yagnik, G; Kim, Y; Peter, I; Jabs, EW; Erazo, M; Ye, XQ; Ainehsazan, E; Shi, LS; Cunningham, ML; Kimonis, V; Roscioli, T; Wall, SA; Wilkie, AOM; Stoler, J; Richtsmeier, JT; Heuze, Y; Sanchez-Lara, PA; Buckley, MF; Druschel, CM; Mills, JL; Caggana, M; Romitti, PA; Kay, DM; Senders, C; Taub, PJ; Klein, OD; Boggan, J; Zwienenberg-Lee, M; Naydenov, C; Kim, J; Wilson, AF; Boyadjiev, SA				Justice, Cristina M.; Yagnik, Garima; Kim, Yoonhee; Peter, Inga; Jabs, Ethylin Wang; Erazo, Monica; Ye, Xiaoqian; Ainehsazan, Edmond; Shi, Lisong; Cunningham, Michael L.; Kimonis, Virginia; Roscioli, Tony; Wall, Steven A.; Wilkie, Andrew O. M.; Stoler, Joan; Richtsmeier, Joan T.; Heuze, Yann; Sanchez-Lara, Pedro A.; Buckley, Michael F.; Druschel, Charlotte M.; Mills, James L.; Caggana, Michele; Romitti, Paul A.; Kay, Denise M.; Senders, Craig; Taub, Peter J.; Klein, Ophir D.; Boggan, James; Zwienenberg-Lee, Marike; Naydenov, Cyrill; Kim, Jinoh; Wilson, Alexander F.; Boyadjiev, Simeon A.			A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; GENETIC-BASIS; NEURAL CREST; MSX2 GENE; MUTATIONS; CILIA; TWIST; RISK; FAMILY	Sagittal craniosynostosis is the most common form of craniosynostosis, affecting approximately one in 5,000 newborns. We conducted, to our knowledge, the first genome-wide association study for nonsyndromic sagittal craniosynostosis (sNSC) using 130 non-Hispanic case-parent trios of European ancestry (NHW). We found robust associations in a 120-kb region downstream of BMP2 flanked by rs1884302 (P = 1.13 x 10(-14), odds ratio (OR) = 4.58) and rs6140226 (P = 3.40 x 10(-11), OR = 0.24) and within a 167-kb region of BBS9 between rs10262453 (P = 1.61 x 10(-10), OR = 0.19) and rs17724206 (P = 1.50 x 10(-8), OR = 0.22). We replicated the associations to both loci (rs1884302, P = 4.39 x 10(-31) and rs10262453, P= 3.50 x 10(-14)) in an independent NHW population of 172 unrelated probands with sNSC and 548 controls. Both BMP2 and BBS9 are genes with roles in skeletal development that warrant functional studies to further understand the etiology of sNSC.	[Yagnik, Garima; Kim, Jinoh; Boyadjiev, Simeon A.] Univ Calif Davis, Dept Pediat, Genet Sect, Sacramento, CA 95817 USA; [Justice, Cristina M.; Kim, Yoonhee; Wilson, Alexander F.] NHGRI, Genometr Sect, Inherited Dis Res Branch, Div Intramural Res,US Natl Inst Hlth NIH, Baltimore, MD USA; [Peter, Inga; Jabs, Ethylin Wang; Erazo, Monica; Ye, Xiaoqian; Ainehsazan, Edmond; Shi, Lisong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Cunningham, Michael L.] Seattle Childrens Res Inst, Seattle, WA USA; [Kimonis, Virginia] Univ Calif Irvine, Dept Pediat, Div Genet, Irvine, CA 92717 USA; [Roscioli, Tony] Univ New S Wales, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Wall, Steven A.; Wilkie, Andrew O. M.] John Radcliffe Hosp, Craniofacial Unit, Oxford Univ Hosp Natl Hlth Serv Trust, Oxford OX3 9DU, England; [Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Stoler, Joan] Harvard Univ, Div Genet, Childrens Hosp Boston, Boston, MA 02115 USA; [Richtsmeier, Joan T.; Heuze, Yann] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Sanchez-Lara, Pedro A.] Univ So Calif, Childrens Hosp Los Angeles, Dept Pathol & Pediat, Los Angeles, CA USA; [Buckley, Michael F.] SE Area Lab Serv, Dept Haematol & Genet, Sydney, NSW, Australia; [Druschel, Charlotte M.] New York State Dept Hlth, Congenital Malformat Registry, Albany, NY USA; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Caggana, Michele; Kay, Denise M.] New York State Dept Hlth, Div Genet, Wadsworth Ctr, Albany, NY USA; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Senders, Craig] Univ Calif Davis, Dept Otolaryngol, Sacramento, CA 95817 USA; [Taub, Peter J.] Mt Sinai Med Ctr, Kravis Childrens Hosp, Div Plast & Reconstruct Surg, New York, NY 10029 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Boggan, James; Zwienenberg-Lee, Marike] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [Naydenov, Cyrill] Med Univ Sofia, Dept Chem & Biochem, Sofia, Bulgaria	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California Irvine; University of New South Wales Sydney; University of Sydney; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Harvard University; Boston Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Children's Hospital Los Angeles; University of Southern California; State University of New York (SUNY) System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center; University of Iowa; University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Medical University Sofia	Boyadjiev, SA (corresponding author), Univ Calif Davis, Dept Pediat, Genet Sect, Sacramento, CA 95817 USA.	simeon.boyd@ucdmc.ucdavis.edu	Wilson, Alexander F./Q-6910-2019; HEUZE, Yann/A-9371-2011; Wilkie, Andrew/AAC-3820-2020; Sanchez, Pedro/HHM-5713-2022; Kim, Jinoh/AAF-9178-2020; Sanchez, Pedro/P-1377-2018; Sanchez-Lara, Pedro A./AAP-5644-2021	Wilkie, Andrew/0000-0002-2972-5481; Sanchez, Pedro/0000-0003-1181-7828; Kim, Jinoh/0000-0003-2841-147X; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Justice, Cristina/0000-0002-6190-6821; Jabs, Ethylin/0000-0001-8983-5466; Heuze, Yann/0000-0002-0660-9613; Klein, Ophir/0000-0002-6254-7082; Mills, James/0000-0003-4496-332X; Kay, Denise/0000-0002-9928-2698; buckley, michael/0000-0002-8298-8758	Children's Miracle Network Endowed Chair; National Institute of Dental and Craniofacial Research (NIDCR)/NIH [K23 DE00462, R03 DE016342, R01 DE016886]; National Center for Research Resources/NIH [M01-RR00052]; Zlatka; Anton; Alec Boyadjiev; US Centers for Disease Control and Prevention (CDC) [5 R01 DD000350]; Wellcome Trust [093329]; CDC [5U01DD000492]; NIDCR/NIH [R21DE022419]; Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Robert Wood Johnson Foundation [3R37DE012711-13S1]; Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program [NIH K12-HD05954]; NIDCR/NIH; American Recovery and Reinvestment Act [R01 DE018500, 3R01 DE018500-02S1]; National Center for Advancing Translational Sciences [NIH UL1TR000067]; Division of Intramural Research Program of the National Human Genome Research Institute, NIH; NIH [HHSN268200782096C];  [R01 DE018227];  [HHSN267200703431C];  [NICHD N01-DK-7-3431]; CENTERS FOR DISEASE CONTROL AND PREVENTION [R01DD000350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000492] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018227, R01DE022988, R01DE018500, R01DE016886, R37DE012711, R21DE022419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016342, K23DE000462] Funding Source: NIH RePORTER	Children's Miracle Network Endowed Chair; National Institute of Dental and Craniofacial Research (NIDCR)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Zlatka; Anton; Alec Boyadjiev; US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program; NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Recovery and Reinvestment Act; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Division of Intramural Research Program of the National Human Genome Research Institute, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank all families who contributed to this study. S.A.B. is partially funded through a Children's Miracle Network Endowed Chair and through grants K23 DE00462, R03 DE016342 and R01 DE016886 from the National Institute of Dental and Craniofacial Research (NIDCR)/NIH and M01-RR00052 from the National Center for Research Resources/NIH and was fully supported by Zlatka, Anton and Alec Boyadjiev. Partial funding was also obtained from grants to E.W.J. (US Centers for Disease Control and Prevention (CDC) 5 R01 DD000350), M.L.C. (R01 DE018227), A.O.M.W. (Wellcome Trust 093329), P.A.R. (CDC 5U01DD000492), J.K. (NIDCR/NIH R21DE022419), J.L.M. (Intramural Research Program (IRP) of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); IRP HHSN267200703431C; NICHD N01-DK-7-3431), P.A.S.-L. (Robert Wood Johnson Foundation 3R37DE012711-13S1 and Children's Hospital Los Angeles-University of Southern California Child Health Research Career Development Program; NIH K12-HD05954), J.T.R. (NIDCR/NIH and the American Recovery and Reinvestment Act R01 DE018500 and 3R01 DE018500-02S1) and I.P. (National Center for Advancing Translational Sciences, NIH UL1TR000067). This project was also supported in part by the Division of Intramural Research Program of the National Human Genome Research Institute, NIH (C.M.J., Y.K. and A.F.W). Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to Johns Hopkins University, contract number HHSN268200782096C. We thank B. Wilson, N. Issac, C. Nauta, E. Goude, E. Cherkez, L. Peters and J. Harrison for patient recruitment, C. Boehm and A. Scott for coordination of discovery-phase genotyping, C. Stevens, A. Stoner, J.L. Liu, A. Gearhart, A. Atkins and E. McGrath for bench work, D. Mortlock for bioinformatic analysis and informative discussion and J. Graham (Cedars-Sinai Hospital, Los Angeles, California, USA), J. Bernstein (Stanford University, Palo Alto, California, USA), J. Marsh (Washington University, St. Louis, Missouri, USA), J. Panchal (University of Oklahoma Health Science Center, Oklahoma, USA), T. Tollefson (University of California Davis, Sacramento, California, USA) and M. Passos-Bueno (University of Sao Paolo, Brazil) for contributing clinical information and biospecimens for this project.	Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Choi DS, 1997, DEVELOPMENT, V124, P1745; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Gardner JS, 1998, INT J EPIDEMIOL, V27, P64, DOI 10.1093/ije/27.1.64; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Johnson D, 2000, EUR J HUM GENET, V8, P571, DOI 10.1038/sj.ejhg.5200499; Kallen K, 1999, TERATOLOGY, V60, P146; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Kim SD, 2012, FEBS LETT, V586, P1516, DOI 10.1016/j.febslet.2012.04.010; Kimonis Virginia, 2007, Semin Pediatr Neurol, V14, P150, DOI 10.1016/j.spen.2007.08.008; Kolar JC, 2011, J CRANIOFAC SURG, V22, P47, DOI 10.1097/SCS.0b013e3181f6c2fb; Lajeunie E, 1998, AM J MED GENET, V75, P211, DOI 10.1002/(SICI)1096-8628(19980113)75:2<211::AID-AJMG19>3.0.CO;2-S; Lajeunie E, 2005, J NEUROSURG, V103, P353, DOI 10.3171/ped.2005.103.4.0353; Lajeunie E, 1996, AM J MED GENET, V62, P282, DOI 10.1002/(SICI)1096-8628(19960329)62:3<282::AID-AJMG15>3.0.CO;2-G; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Marinaki AM, 2001, BLOOD, V97, P3327, DOI 10.1182/blood.V97.11.3327; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Melville H, 2010, AM J MED GENET A, V152A, P3007, DOI 10.1002/ajmg.a.33703; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sanchez-Lara PA, 2010, AM J MED GENET A, V152A, P394, DOI 10.1002/ajmg.a.33246; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seto ML, 2007, AM J MED GENET A, V143A, P678, DOI 10.1002/ajmg.a.31630; Spruijt L, 2005, AM J MED GENET A, V139A, P45, DOI 10.1002/ajmg.a.30923; Stankiewicz P, 2001, AM J MED GENET, V103, P56, DOI 10.1002/ajmg.1512; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Vissers LELM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002278; Weber I., 2001, European Journal of Human Genetics, V9, pP0409; Wilkie AOM, 2007, AM J MED GENET A, V143A, P1941, DOI 10.1002/ajmg.a.31905; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yagnik G, 2012, HUM MUTAT, V33, P1626, DOI 10.1002/humu.22166; Zeiger JS, 2002, J CRANIOFAC SURG, V13, P602, DOI 10.1097/00001665-200209000-00002; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401	52	83	85	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1360	1364		10.1038/ng.2463	http://dx.doi.org/10.1038/ng.2463			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23160099	Green Submitted, Green Accepted			2022-12-17	WOS:000311713200016
J	Boettger, LM; Handsaker, RE; Zody, MC; McCarroll, SA				Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.			Structural haplotypes and recent evolution of the human 17q21.31 region	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; POPULATION-SCALE; PHASE INFERENCE; DISEASE; POLYMORPHISM; DROSOPHILA; INVERSION; COMPLEX	Structurally complex genomic regions are not yet well understood. One such locus, human chromosome 17q21.31, contains a megabase-long inversion polymorphism(1), many uncharacterized copy-number variations (CNVs) and markers that associate with female fertility(1), female meiotic recombination(1-3) and neurological disease(4,5). Additionally, the inverted H2 form of 17q21.31 seems to be positively selected in Europeans(1). We developed a population genetics approach to analyze complex genome structures and identified nine segregating structural forms of 17q21.31. Both the H1 and H2 forms of the 17q21.31 inversion polymorphism contain independently derived, partial duplications of the KANSL1 gene; these duplications, which produce novel KANSL1 transcripts, have both recently risen to high allele frequencies (26% and 19%) in Europeans. An older H2 form lacking such a duplication is present at low frequency in European and central African hunter-gatherer populations. We further show that complex genome structures can be analyzed by imputation from SNPs.	[Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Boettger, Linda M.; Handsaker, Robert E.; Zody, Michael C.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Boettger, Linda M.] Harvard Univ, Sch Med, Program Genet & Genom, Grad Program Biol & Biomed Sci, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; McCarroll, Steven/0000-0002-6954-8184	Smith Family Award for Excellence in Biomedical Research; National Human Genome Research Institute [U01HG005208]; Harvard Medical School Department of Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005208] Funding Source: NIH RePORTER	Smith Family Award for Excellence in Biomedical Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Harvard Medical School Department of Genetics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	J. Korn provided an early version of software for visualizing haplotype diversity. N. Rohland and T. Mullen contributed expertise on laboratory experiments. We thank N. Patterson, D. Reich, D. Altshuler, E. Lander, B. Browning, J. Korn, J. Gray, C. Patil, G. Genovese, A. Sekar and S. Grossman for helpful conversations and/or comments on the manuscript. This work was supported by a Smith Family Award for Excellence in Biomedical Research to S.A.M., by the National Human Genome Research Institute (U01HG005208) and by startup resources from the Harvard Medical School Department of Genetics.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Quinlan AR, 2012, TRENDS GENET, V28, P43, DOI 10.1016/j.tig.2011.10.002; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yu L, 2010, GENESIS, V48, P161, DOI 10.1002/dvg.20600; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	31	83	88	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2012	44	8					881	+		10.1038/ng.2334	http://dx.doi.org/10.1038/ng.2334			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22751096	Green Accepted			2022-12-17	WOS:000306854700011
J	Akamatsu, S; Takata, R; Haiman, CA; Takahashi, A; Inoue, T; Kubo, M; Furihata, M; Kamatani, N; Inazawa, J; Chen, GK; Le Marchand, L; Kolonel, LN; Katoh, T; Yamano, Y; Yamakado, M; Takahashi, H; Yamada, H; Egawa, S; Fujioka, T; Henderson, BE; Habuchi, T; Ogawa, O; Nakamura, Y; Nakagawa, H				Akamatsu, Shusuke; Takata, Ryo; Haiman, Christopher A.; Takahashi, Atsushi; Inoue, Takahiro; Kubo, Michiaki; Furihata, Mutsuo; Kamatani, Naoyuki; Inazawa, Johji; Chen, Gary K.; Le Marchand, Loic; Kolonel, Laurence N.; Katoh, Takahiko; Yamano, Yuko; Yamakado, Minoru; Takahashi, Hiroyuki; Yamada, Hiroki; Egawa, Shin; Fujioka, Tomoaki; Henderson, Brian E.; Habuchi, Tomonori; Ogawa, Osamu; Nakamura, Yusuke; Nakagawa, Hidewaki			Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEQUENCE VARIANTS; ALLELIC LOSS; LOCI; GENE; IDENTIFICATION; REPLICATION; MUTATION; REGION; WDR11	We have previously reported multiple loci associated with prostate cancer susceptibility in a Japanese population using a genome-wide association study (GWAS). To identify additional prostate cancer susceptibility loci, we genotyped nine SNPs that were nominally associated with prostate cancer (P < 1 x 10(-4)) in our previous GWAS in three independent studies of prostate cancer in Japanese men (2,557 individuals with prostate cancer (cases) and 3,003 controls). In a meta-analysis of our previous GWAS and the replication studies, which included a total of 7,141 prostate cancer cases and 11,804 controls from a single ancestry group, three new loci reached genome-wide significance on chromosomes 11q12 (rs1938781; P = 1.10 x 10(-10); FAM111A-FAM111B), 10q26 (rs2252004; P = 1.98 x 10(-8)) and 3p11.2 (rs2055109; P = 3.94 x 10(-8)). We also found suggestive evidence of association at a previously reported prostate cancer susceptibility locus at 2p11 (rs2028898; P = 1.08 x 10(-7)). The identification of three new susceptibility loci should provide additional insight into the pathogenesis of prostate cancer and emphasizes the importance of conducting GWAS in diverse populations.	[Akamatsu, Shusuke; Takata, Ryo; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan; [Akamatsu, Shusuke; Inoue, Takahiro; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Takata, Ryo; Fujioka, Tomoaki] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan; [Haiman, Christopher A.; Chen, Gary K.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Tokyo, Japan; [Furihata, Mutsuo] Kochi Med Sch, Dept Pathol, Nankoku, Kochi, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Katoh, Takahiko] Kumamoto Univ, Fac Hlth Sci, Dept Publ Hlth, Kumamoto, Japan; [Yamano, Yuko] Showa Univ, Sch Med, Dept Hyg & Prevent Med, Tokyo 142, Japan; [Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan; [Takahashi, Hiroyuki] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan; [Yamada, Hiroki; Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Habuchi, Tomonori] Akita Univ, Sch Med, Dept Urol, Akita 010, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	RIKEN; Kyoto University; Iwate Medical University; University of Southern California; RIKEN; RIKEN; Kochi University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Cancer Research Center of Hawaii; University of Hawaii System; Kumamoto University; Showa University; Mitsui Memorial Hospital; Jikei University; Jikei University; Akita University; University of Tokyo	Nakagawa, H (corresponding author), RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan.	hidewaki@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015		BioBank Japan Project; Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Japan Society for the Promotion of Science [22390306]; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; US National Institutes of Health (NIH) [HG004726, CA148537, CA54281, CA63464]; NATIONAL CANCER INSTITUTE [R37CA054281, U19CA148537, R01CA054281, R01CA063464, U01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22390306, 22134002] Funding Source: KAKEN	BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the staff of the Laboratory for Genotyping Development at the Center for Genomic Medicine at RIKEN for their contribution to SNP genotyping, and K. Nakano and K. Watanabe for their technical assistance. We also thank Y. Mitobe and M. Kishida for sample management and clinical data collection. We are grateful to the members of the BioBank Japan Project and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government and was supported in part by a research grant from the Japan Society for the Promotion of Science (22390306 to H.N.), by the Princess Takamatsu Cancer Research Fund and by the Takeda Science Foundation. The Multiethnic Cohort (MEC) was supported by grants from the US National Institutes of Health (NIH; HG004726, CA148537, CA54281 and CA63464). S.A. is a Japan Society for the Promotion of Science Research Fellow.	Akamatsu S, 2010, HUM MOL GENET, V19, P4265, DOI 10.1093/hmg/ddq350; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ben-Batalla I, 2010, J CLIN INVEST, V120, P4289, DOI 10.1172/JCI42015; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; Chernova OB, 2001, ONCOGENE, V20, P5378, DOI 10.1038/sj.onc.1204694; Clayton RN, 1997, HORM RES, V47, P185, DOI 10.1159/000185463; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Ittmann M, 1996, CANCER RES, V56, P2143; Katoh M, 2003, INT J ONCOL, V22, P1155; Katoh M, 2003, INT J MOL MED, V11, P579; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lange EM, 2012, PROSTATE, V72, P147, DOI 10.1002/pros.21414; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mendoza S, 2005, CANCER GENET CYTOGEN, V158, P142, DOI 10.1016/j.cancergencyto.2004.08.035; Mutucumarana VP, 2000, J BIOL CHEM, V275, P32572, DOI 10.1074/jbc.M006808200; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	28	83	87	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					426	U234		10.1038/ng.1104	http://dx.doi.org/10.1038/ng.1104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22366784				2022-12-17	WOS:000302130600017
J	Choi, JK; Kim, YJ				Choi, Jung Kyoon; Kim, Young-Joon			Epigenetic regulation and the variability of gene expression	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; EUKARYOTIC GENOME; YEAST; IDENTIFICATION; REPRESSION; MACHINERY; LANDSCAPE; COMPLEXES	We characterized the genetic variability of gene expression in terms of trans and cis variability for each yeast transcript. Genes that are highly regulated by nucleosomes showed a high degree of trans variability. From the expression profiles of mutants for various chromatin modifiers, we found that transvariable genes are distinctly regulated at the chromatin level. The effect of chromatin regulators was highly significant, even when compared with that of transcription factors. The DNA-binding activities of transcription factors had a low influence on trans variability. In the case of the basal transcription factor TBP and TBP- associated factor TAF1, expression variability was coupled with the histone acetyltransferase activities of TAF1 and other factors, rather than with the binding of TBP to DNA. Additionally, we found that the correlation of TATA-box presence and expression variability could be explained in terms of chromatin regulation. The lack of activating histone modifications may subject TATA- containing promoters to chromatin regulation processes. Our results propose that epigenetic regulation has a central role in the variation and evolution of gene expression.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Genome Regulat Ctr, Seoul 120749, South Korea; [Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Yonsei University; Yonsei University	Kim, YJ (corresponding author), Yonsei Univ, Genome Regulat Ctr, 134 Sinchon Dong, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011					Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Durant M, 2006, MOL CELL BIOL, V26, P2791, DOI 10.1128/MCB.26.7.2791-2802.2006; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	31	83	84	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					141	147		10.1038/ng.2007.58	http://dx.doi.org/10.1038/ng.2007.58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18227874				2022-12-17	WOS:000252732900009
J	Kern, AD; Kondrashov, FA				Kern, AD; Kondrashov, FA			Mechanisms and convergence of compensatory evolution in mammalian mitochondrial tRNAs	NATURE GENETICS			English	Article							MUTATIONS; SUBSTITUTIONS; NUCLEAR	The function of protein and RNA molecules depends on complex epistatic interactions between sites. Therefore, the deleterious effect of a mutation can be suppressed by a compensatory second-site substitution(1,2). In relating a list of 86 pathogenic mutations in human tRNAs encoded by mitochondrial genes to the sequences of their mammalian orthologs, we noted that 52 pathogenic mutations were present in normal tRNAs of one or several nonhuman mammals. We found at least five mechanisms of compensation for 32 pathogenic mutations that destroyed a Watson-Crick pair in one of the four tRNA stems: restoration of the affected Watson-Crick interaction (25 cases), strengthening of another pair (4 cases), creation of a new pair (8 cases), changes of multiple interactions in the affected stem (11 cases) and changes involving the interaction between the loop and stem structures (3 cases). A pathogenic mutation and its compensating substitution are fixed in a lineage in rapid succession, and often a compensatory interaction evolves convergently in different clades. At least 10%, and perhaps as many as 50%, of all nucleotide substitutions in evolving mammalian tRNAs participate in such interactions, indicating that the evolution of tRNAs proceeds along highly epistatic fitness ridges.	Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Kondrashov, FA (corresponding author), Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, Davis, CA 95616 USA.	kondrashov@ucdavis.edu	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694				Andreu AL, 2003, J NEUROL, V250, P1403, DOI 10.1007/s00415-003-0281-3; Burch CL, 1999, GENETICS, V151, P921; Chen Y, 1999, GENES GENET SYST, V74, P271, DOI 10.1266/ggs.74.271; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; GILLESPIE JH, 1986, GENETICS, V113, P1077; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; Innan H, 2001, GENETICS, V159, P389; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; LODISH H, 2000, MOL CELL BIOL, P265; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Orr HA, 2001, EVOLUTION, V55, P1085; Parsch J, 2000, GENETICS, V154, P909; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillier ERM, 1998, GENETICS, V148, P1993; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820; ZUKER M, 1999, NATO ASI SER, P1	29	83	86	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1207	1212		10.1038/ng1451	http://dx.doi.org/10.1038/ng1451			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502829	Bronze			2022-12-17	WOS:000224832800025
J	Lipkin, SM; Rozek, LS; Rennert, G; Yang, W; Chen, PC; Hacia, J; Hunt, N; Shin, B; Fodor, S; Kokoris, M; Greenson, JK; Fearon, E; Lynch, H; Collins, F; Gruber, SB				Lipkin, SM; Rozek, LS; Rennert, G; Yang, W; Chen, PC; Hacia, J; Hunt, N; Shin, B; Fodor, S; Kokoris, M; Greenson, JK; Fearon, E; Lynch, H; Collins, F; Gruber, SB			The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer	NATURE GENETICS			English	Article							MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; MSH6 MUTATIONS; COLON-CANCER; MUTL; EXPRESSION; GENE; IDENTIFICATION; ASHKENAZI; FAMILIES	Most susceptibility to colorectal cancer (CRC) is not accounted for by known risk factors. Because MLH1, MSH2 and MSH6 mutations underlie high-penetrance CRC susceptibility in hereditary nonpolyposis colon cancer (HNPCC), we hypothesized that attenuated alleles might also underlie susceptibility to sporadic CRC. We looked for gene variants associated with HNPCC in Israeli probands with familial CRC unstratified with respect to the microsatellite instability (MSI) phenotype. Association studies identified a new MLH1 variant (415G-->C, resulting in the amino acid substitution D132H) in similar to1.3% of Israeli individuals with CRC self-described as Jewish, Christian and Muslim. MLH1 415C confers clinically significant susceptibility to CRC. In contrast to classic HNPCC, CRCs associated with MLH1 415C usually do not have the MSI defect, which is important for clinical mutation screening. Structural and functional analyses showed that the normal ATPase function of MLH1 is attenuated, but not eliminated, by the MLH1 415G-->C mutation. The new MLH1 variant confers a high risk of CRC and identifies a previously unrecognized mechanism in microsatellite-stable tumors. These studies suggest that variants of mismatch repair proteins with attenuated function may account for a higher proportion of susceptibility to sporadic microsatellite-stable CRC than previously assumed.	Univ Calif Irvine, Dept Med, Div Oncol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Div Oncol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Div Epidemiol, Irvine, CA 92697 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; NIDDKD, Mol Struct Sect, Bethesda, MD 20892 USA; Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA; Affymetrix Corp, Santa Clara, CA 95051 USA; BioCaptus, Bothell, WA 99164 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Creighton Univ, Hereditary Canc Inst, Omaha, NE USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California; Affymetrix; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Creighton University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lipkin, SM (corresponding author), Univ Calif Irvine, Dept Med, Div Oncol, Irvine, CA 92697 USA.	slipkin@uci.edu; sgruber@med.umich.edu	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Rennert, Gad/0000-0002-8512-068X; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Boland CR, 1998, CANCER RES, V58, P5248; Charames GS, 2000, HUM GENET, V107, P623, DOI 10.1007/s004390000417; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Gazzoli I, 2003, MOL CELL BIOL, V23, P7992, DOI 10.1128/MCB.23.22.7992-8007.2003; Greenson JK, 2003, AM J SURG PATHOL, V27, P563, DOI 10.1097/00000478-200305000-00001; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P3865, DOI 10.1093/nar/26.16.3865; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kokoris M, 2000, MOL DIAGN, V5, P329; Kolodner RD, 1999, CANCER RES, V59, P5068; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; Liu ZJ, 1999, MAR BIOTECHNOL, V1, P437, DOI 10.1007/PL00011800; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Peterlongo P, 2003, INT J CANCER, V107, P571, DOI 10.1002/ijc.11415; Quaresima B, 2003, BIOCHEM J, V371, P183, DOI 10.1042/BJ20021205; Samowitz WS, 2002, J CLIN ONCOL, V20, P3178, DOI 10.1200/JCO.2002.20.14.3178; Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203; Scholz B, 2003, NUCLEIC ACIDS RES, V31, P1426, DOI 10.1093/nar/gkg229; Shiri-Sverdlov R, 2000, HUM MUTAT, V16, P491, DOI 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.3.CO;2-A; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Szabo CI, 2004, CANCER RES, V64, P840, DOI 10.1158/0008-5472.CAN-03-2678; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773	30	83	89	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					694	699		10.1038/ng1374	http://dx.doi.org/10.1038/ng1374			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184898	Bronze			2022-12-17	WOS:000222354100018
J	Soong, NW; Nomura, L; Pekrun, K; Reed, M; Sheppard, L; Dawes, G; Stemmer, WPC				Soong, NW; Nomura, L; Pekrun, K; Reed, M; Sheppard, L; Dawes, G; Stemmer, WPC			Molecular breeding of viruses	NATURE GENETICS			English	Article							EVOLUTION; RETROVIRUSES; GLYCOSYLATION; DIVERSITY; RECEPTOR; PROTEIN; FAMILY	Genetic recombination is a major force driving the evolution of many viruses. Recombination between two copackaged retroviral genomes may occur at rates as high as 40% per replication cycle(1). This enables genetic information to be shuffled rapidly leading to recombinants with new patterns of mutations and phenotypes. The in vitro process of DNA shuffling(2,3) (molecular breeding) mimics this mechanism on a vastly parallel and accelerated scale. Multiple homologous parental sequences are recombined in parallel, leading to a diverse library of complex recombinants from which desired improvements can be selected. Different proteins and enzymes have been improved using DNA shuffling(4-6). We report here the first application of molecular breeding to viruses. A single round of shuffling envelope sequences from six murine leukaemia viruses (MLV) followed by selection yielded a chimaeric clone with a completely new tropism for Chinese Hamster Ovary (CHOK1) cells. The composition and properties of the selected clone indicated that this particular permutation of parental sequences cannot be readily attained by natural retroviral recombination. This example demonstrates that molecular breeding can enhance the inherently high evolutionary potential of retroviruses to obtain desired phenotypes. It can be an effective tool, when information is limited, to optimize viruses for gene therapy and vaccine applications when multiple complex functions must be simultaneously balanced.	Maxygen Inc, Redwood City, CA USA		Soong, NW (corresponding author), Maxygen Inc, Redwood City, CA USA.							Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; DEUTSCHERT SL, 1996, J BIOL CHEM, V261, P96; EIDEN MV, 1994, J VIROL, V68, P626, DOI 10.1128/JVI.68.2.626-631.1994; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; KATZ RA, 1990, ANNU REV GENET, V24, P409, DOI 10.1146/annurev.ge.24.120190.002205; Masuda M, 1996, J VIROL, V70, P8534, DOI 10.1128/JVI.70.12.8534-8539.1996; MILLER DG, 1992, J VIROL, V66, P78, DOI 10.1128/JVI.66.1.78-84.1992; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Patten PA, 1997, CURR OPIN BIOTECH, V8, P724, DOI 10.1016/S0958-1669(97)80127-9; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Wang H, 1996, J VIROL, V70, P6884, DOI 10.1128/JVI.70.10.6884-6891.1996	16	83	96	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					436	439		10.1038/78132	http://dx.doi.org/10.1038/78132			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932190				2022-12-17	WOS:000088615000021
J	Barr, FG				Barr, FG			Translocations, cancer and the puzzle of specificity	NATURE GENETICS			English	Article							HUMAN LEUKEMIA; FUSION GENE; ABL; PROTEIN; HEMATOPOIESIS; RECOMBINATION; FIBROBLASTS; ONCOGENES; SEQUENCE; CELLS	The finding of acquired chromosomal translocations that are consistently associated with specific tumour types supports the premise of lineage-specific mechanisms of tumorigenesis. We review the evidence indicating that the specificity of these translocations and the corresponding gene fusions is related to biological constraints at the level of recombination, expression, and protein function. A dynamic relationship between the gene fusion and the cellular environment is proposed in which the environment influences the selection of oncogenic fusions and the oncogenic fusion in turn influences the cellular environment.	Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Barr, FG (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA.	barrfg@mail.med.upenn.edu						Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Barr FG, 1997, J PEDIAT HEMATOL ONC, V19, P483, DOI 10.1097/00043426-199711000-00001; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; DALEY GQ, 1991, ADV CANCER RES, V57, P151; David G, 1997, ONCOGENE, V14, P1547, DOI 10.1038/sj.onc.1200989; DeiTos AP, 1997, VIRCHOWS ARCH, V431, P83; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; HALUSKA FG, 1990, MOL GENETICS CANC DI, P143; HLSTERKAMP N, 1991, TRANSGENIC RES, V1, P45; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kuroda M, 1997, AM J PATHOL, V151, P735; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; NUCIFORA G, 1995, BLOOD, V86, P1; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHORE SK, 1994, J BIOL CHEM, V269, P5413; VONCKEN JW, 1995, BLOOD, V86, P4603, DOI 10.1182/blood.V86.12.4603.bloodjournal86124603; Wang P, 1997, P NATL ACAD SCI USA, V94, P12018, DOI 10.1073/pnas.94.22.12018; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	36	83	88	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					121	124		10.1038/475	http://dx.doi.org/10.1038/475			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620766				2022-12-17	WOS:000073865100017
J	Foote, SJ; Burt, RA; Baldwin, TM; Presente, A; Roberts, AW; Laural, YL; Lew, AM; Marshall, VM				Foote, SJ; Burt, RA; Baldwin, TM; Presente, A; Roberts, AW; Laural, YL; Lew, AM; Marshall, VM			Mouse loci for malaria-induced mortality and the control of parasitaemia	NATURE GENETICS			English	Letter							LINKAGE ANALYSIS; GENETIC-MAP; CROSSES				Foote, SJ (corresponding author), ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, MELBOURNE, VIC 3050, AUSTRALIA.		Burt, Rachel/I-7874-2012; Roberts, Andrew W/C-6736-2012; Foote, Simon J/F-2802-2013; Lew, Andrew M/C-7248-2013	Burt, Rachel/0000-0001-8827-8266; Roberts, Andrew W/0000-0002-7341-5720; Lew, Andrew M/0000-0002-2198-8164; Foote, Simon/0000-0002-9142-2107				CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; DIETRICH W, 1992, GENETICS, V131, P423; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; KINGSLEY DM, 1989, GENETICS, V123, P165; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NEUMANN PE, 1990, GENETICS, V126, P277; RICHTERICH P, 1993, METHOD ENZYMOL, V218, P187; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHERER G, 1989, GENOMICS, V5, P275, DOI 10.1016/0888-7543(89)90058-X; SINGER MF, 1964, GENETICS, V50, P285; STEVENSON M, 1984, J CELL BIOCHEM, V24, P91, DOI 10.1002/jcb.240240108; STEVENSON MM, 1988, CURR TOP MICROBIOL, V137, P323	16	83	85	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1997	17	4					380	381		10.1038/ng1297-380	http://dx.doi.org/10.1038/ng1297-380			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398834				2022-12-17	WOS:A1997YJ92400013
J	FELSENSTEIN, KM; HUNIHAN, LW; ROBERTS, SB				FELSENSTEIN, KM; HUNIHAN, LW; ROBERTS, SB			ALTERED CLEAVAGE AND SECRETION OF A RECOMBINANT BETA-APP BEARING THE SWEDISH FAMILIAL ALZHEIMERS-DISEASE MUTATION	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; PLACENTAL ALKALINE-PHOSPHATASE; GENE-EXPRESSION; CELLS; DERIVATIVES; FRAGMENTS; REPORTER	Mutations within the beta-amyloid precursor protein gene cosegregate with the early-onset form of familial Alzheimer's Disease (FAD). It is not known how these mutations result in disease; however, one early-onset AD mutation in a Swedish kindred increases potentially amyloidogenic fragments and beta-protein production in cells expressing the mutant beta-APP. Using a novel recombinant reporter system we found a qualitative change in the secreted product, from cleavage within the beta-protein sequence to cleavage near the N-terminal region of the beta-protein, even though the total amount of secreted mutant product is similar to wild-type. The results suggest that the increased formation of potentially amyloidogenic fragments in cells expressing the Swedish FAD occurs by enzymatic cleavage in the secretory pathway. Alterations in the secretory process may predispose an individual to AD.			FELSENSTEIN, KM (corresponding author), BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,DEPT BIOPHYS & MOLEC BIOL,CNS,5 RES PKWY,WALLINGFORD,CT 06492, USA.							ANDERSON JP, 1989, EMBO J, V8, P3627, DOI 10.1002/j.1460-2075.1989.tb08536.x; ANDERSON JP, 1992, J NEUROCHEM, V59, P2328; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLEMMONS DJ, 1992, LAB ANIM SCI, V4, P307; DORNER AJ, 1990, METHOD ENZYMOL, V185, P577; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FELSENSTEIN KM, 1993, NEUROSCI LETT, V152, P185, DOI 10.1016/0304-3940(93)90514-L; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P855; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARDY J, 1991, LANCET, V337, P1342; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; SAHASRABUDHE SR, 1992, J BIOL CHEM, V267, P25602; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WELDEMANN A, 1989, J BIOL CHEM, V266, P16960	36	83	85	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					251	256		10.1038/ng0394-251	http://dx.doi.org/10.1038/ng0394-251			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012386				2022-12-17	WOS:A1994MZ56200011
J	Wu, SZ; Al-Eryani, G; Roden, DL; Junankar, S; Harvey, K; Andersson, A; Thennavan, A; Wang, CF; Torpy, JR; Bartonicek, N; Wang, TP; Larsson, L; Kaczorowski, D; Weisenfeld, NI; Uytingco, CR; Chew, JG; Bent, ZW; Chan, CL; Gnanasambandapillai, V; Dutertre, CA; Gluch, L; Hui, MN; Beith, J; Parker, A; Robbins, E; Segara, D; Cooper, C; Mak, C; Chan, B; Warrier, S; Ginhoux, F; Millar, E; Powell, JE; Williams, SR; Liu, XS; O'Toole, S; Lim, E; Lundeberg, J; Perou, CM; Swarbrick, A				Wu, Sunny Z.; Al-Eryani, Ghamdan; Roden, Daniel Lee; Junankar, Simon; Harvey, Kate; Andersson, Alma; Thennavan, Aatish; Wang, Chenfei; Torpy, James R.; Bartonicek, Nenad; Wang, Taopeng; Larsson, Ludvig; Kaczorowski, Dominik; Weisenfeld, Neil, I; Uytingco, Cedric R.; Chew, Jennifer G.; Bent, Zachary W.; Chan, Chia-Ling; Gnanasambandapillai, Vikkitharan; Dutertre, Charles-Antoine; Gluch, Laurence; Hui, Mun N.; Beith, Jane; Parker, Andrew; Robbins, Elizabeth; Segara, Davendra; Cooper, Caroline; Mak, Cindy; Chan, Belinda; Warrier, Sanjay; Ginhoux, Florent; Millar, Ewan; Powell, Joseph E.; Williams, Stephen R.; Liu, X. Shirley; O'Toole, Sandra; Lim, Elgene; Lundeberg, Joakim; Perou, Charles M.; Swarbrick, Alexander			A single-cell and spatially resolved atlas of human breast cancers	NATURE GENETICS			English	Article							MOLECULAR PORTRAITS; LANDSCAPE; FIBROBLASTS; SUBTYPES; TREM2; SEQ	Breast cancers are complex cellular ecosystems where heterotypic interactions play central roles in disease progression and response to therapy. However, our knowledge of their cellular composition and organization is limited. Here we present a single-cell and spatially resolved transcriptomics analysis of human breast cancers. We developed a single-cell method of intrinsic subtype classification (SCSubtype) to reveal recurrent neoplastic cell heterogeneity. Immunophenotyping using cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) provides high-resolution immune profiles, including new PD-L1/PD-L2(+) macrophage populations associated with clinical outcome. Mesenchymal cells displayed diverse functions and cell-surface protein expression through differentiation within three major lineages. Stromal-immune niches were spatially organized in tumors, offering insights into antitumor immune regulation. Using single-cell signatures, we deconvoluted large breast cancer cohorts to stratify them into nine clusters, termed 'ecotypes', with unique cellular compositions and clinical outcomes. This study provides a comprehensive transcriptional atlas of the cellular architecture of breast cancer. A multi-omic atlas of breast cancers, integrating single-cell RNA sequencing, spatial transcriptomics and immunophenotyping, identifies nine ecotypes associated with cellular heterogeneity and prognosis.	[Wu, Sunny Z.; Al-Eryani, Ghamdan; Roden, Daniel Lee; Junankar, Simon; Harvey, Kate; Torpy, James R.; Bartonicek, Nenad; Wang, Taopeng; Hui, Mun N.; O'Toole, Sandra; Lim, Elgene; Swarbrick, Alexander] Garvan Inst Med Res, Kinghorn Canc Ctr & Canc Res Theme, Darlinghurst, NSW, Australia; [Wu, Sunny Z.; Al-Eryani, Ghamdan; Roden, Daniel Lee; Junankar, Simon; Torpy, James R.; Bartonicek, Nenad; Wang, Taopeng; Parker, Andrew; Lim, Elgene; Swarbrick, Alexander] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Andersson, Alma; Larsson, Ludvig; Lundeberg, Joakim] KTH Royal Inst Technol, Dept Gene Technol, Sci Life Lab, Solna, Sweden; [Thennavan, Aatish; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Wang, Chenfei; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Data Sci, Boston, MA USA; [Kaczorowski, Dominik; Chan, Chia-Ling; Gnanasambandapillai, Vikkitharan; Powell, Joseph E.] Garvan Inst Med Res, Garvan Weizmann Ctr Cellular Genom, Sydney, NSW, Australia; [Weisenfeld, Neil, I; Uytingco, Cedric R.; Chew, Jennifer G.; Bent, Zachary W.; Williams, Stephen R.] 10x Genom, Pleasanton, CA USA; [Dutertre, Charles-Antoine] Gustave Roussy Canc Campus, Villejuif, France; [Dutertre, Charles-Antoine] INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Villejuif, France; [Gluch, Laurence] Strathfield Breast Ctr, Strathfield, NSW, Australia; [Hui, Mun N.; Beith, Jane] Chris OBrien Lifehouse, Camperdown, NSW, Australia; [Parker, Andrew; Segara, Davendra; Lim, Elgene] 5t Vincents Hosp, Darlinghurst, NSW, Australia; [Robbins, Elizabeth; O'Toole, Sandra] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Pathol, New South Wales Hlth Pathol, Camperdown, NSW, Australia; [Cooper, Caroline] Princess Alexandra Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Cooper, Caroline] Univ Queensland, Fac Med, Southside Clin Unit, Brisbane, Qld, Australia; [Mak, Cindy; Chan, Belinda; Warrier, Sanjay] Chris OBrien Lifehouse, Dept Breast Surg, Camperdown, NSW, Australia; [Mak, Cindy; Warrier, Sanjay] Univ Sydney, Royal Prince Alfred Inst Acad Surg, Sydney, NSW, Australia; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Millar, Ewan] St George Hosp, New South Wales Hlth Pathol, Dept Anat Pathol, Kogarah, NSW, Australia; [Millar, Ewan] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Millar, Ewan; O'Toole, Sandra] Western Sydney Univ, Fac Med & Hlth Sci, Campbelltown, NSW, Australia; [Powell, Joseph E.] Univ New South Wales, Cellular Genom Futures Inst, Sydney, NSW, Australia; [O'Toole, Sandra] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Royal Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Garvan Institute of Medical Research; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; University of Sydney; University of Queensland; University of Sydney; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; St George Hospital; University of New South Wales Sydney; University of Sydney; Western Sydney University; University of New South Wales Sydney; University of Sydney	Swarbrick, A (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr & Canc Res Theme, Darlinghurst, NSW, Australia.; Swarbrick, A (corresponding author), Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia.	a.swarbrick@garvan.org.au	Andersson, Alma/ABG-4801-2021; huang, dezhi/ABC-6566-2021; Perou, Charles M/H-9934-2014; Wu, Sunny Z./AAV-1870-2021	Andersson, Alma/0000-0002-4773-9975; Perou, Charles M/0000-0001-9827-2247; Wu, Sunny Z./0000-0002-6153-0449; Torpy, James/0000-0002-5392-1642; Lim, Elgene/0000-0001-8065-8838; Junankar, Simon/0000-0002-3965-8278; Harvey, Kate/0000-0002-2155-5203; Wang, Taopeng/0000-0002-9184-609X; Al-Eryani, Ghamdan/0000-0002-1137-1726; Swarbrick, Alexander/0000-0002-3051-5676; Powell, Joseph/0000-0002-5070-4124; Roden, Daniel/0000-0003-2393-5805				Ali HR, 2020, NAT CANCER, V1, P163, DOI 10.1038/s43018-020-0026-6; Andersson A, SPATIAL DECONVOLUTIO, DOI [10.1101/2020.07.14.200600(2020, DOI 10.1101/2020.07.14.200600(2020]; Andersson A, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01247-y; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Cazet AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05220-6; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dushyanthen S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0431-3; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Glajcar A, 2019, VIRCHOWS ARCH, V475, P13, DOI 10.1007/s00428-019-02568-y; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Kim C, 2018, CELL, V173, P879, DOI 10.1016/j.cell.2018.03.041; Kim HK, 2019, CANCER RES TREAT, V51, P737, DOI 10.4143/crt.2018.342; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kryczek I, 2005, CANCER RES, V65, P465; Kumar A, 2017, CELL REP, V19, P1902, DOI 10.1016/j.celrep.2017.05.019; Lakins MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03347-0; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Leruste A, 2019, CANCER CELL, V36, P597, DOI 10.1016/j.ccell.2019.10.008; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Medler TR, 2018, CANCER CELL, V34, P561, DOI 10.1016/j.ccell.2018.09.003; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Nakamura K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00356-8; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Picornell AC, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5849-0; Pliner HA, 2019, NAT METHODS, V16, P983, DOI 10.1038/s41592-019-0535-3; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsoucas D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10802-z; Ubezio B, 2016, ELIFE, V5, DOI 10.7554/eLife.12167; Wagner J, 2019, CELL, V177, P1330, DOI 10.1016/j.cell.2019.03.005; Wu SZ, 2020, EMBO J, V39, DOI 10.15252/embj.2019104063; Yamada S, 2002, CLIN EXP IMMUNOL, V130, P424, DOI 10.1046/j.1365-2249.2002.02012.x; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003	62	82	84	36	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2021	53	9					1334	+		10.1038/s41588-021-00911-1	http://dx.doi.org/10.1038/s41588-021-00911-1			40	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UO4LE	34493872	Green Accepted			2022-12-17	WOS:000694666000013
J	Lambert, SA; Gil, L; Jupp, S; Ritchie, SC; Xu, Y; Buniello, A; McMahon, A; Abraham, G; Chapman, M; Parkinson, H; Danesh, J; MacArthur, JAL; Inouye, M				Lambert, Samuel A.; Gil, Laurent; Jupp, Simon; Ritchie, Scott C.; Xu, Yu; Buniello, Annalisa; McMahon, Aoife; Abraham, Gad; Chapman, Michael; Parkinson, Helen; Danesh, John; MacArthur, Jacqueline A. L.; Inouye, Michael			The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation	NATURE GENETICS			English	Article									[Lambert, Samuel A.; Ritchie, Scott C.; Xu, Yu; Abraham, Gad; Inouye, Michael] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge Baker Syst Genom Initiat, Cambridge, England; [Lambert, Samuel A.; Gil, Laurent; Ritchie, Scott C.; Xu, Yu; Chapman, Michael; Danesh, John; Inouye, Michael] Univ Cambridge, British Heart Fdn Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Lambert, Samuel A.; Gil, Laurent; Chapman, Michael; Parkinson, Helen; Danesh, John; Inouye, Michael] Hlth Data Res UK Cambridge, Wellcome Genome Campus, Cambridge, England; [Lambert, Samuel A.; Gil, Laurent; Chapman, Michael; Parkinson, Helen; Danesh, John; Inouye, Michael] Univ Cambridge, Cambridge, England; [Lambert, Samuel A.; Jupp, Simon; Buniello, Annalisa; McMahon, Aoife; Parkinson, Helen; MacArthur, Jacqueline A. L.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Gil, Laurent; Chapman, Michael; Danesh, John] Welkome Sanger Inst, Hinxton, England; [Ritchie, Scott C.; Danesh, John; Inouye, Michael] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Ritchie, Scott C.; Danesh, John; Inouye, Michael] Univ Cambridge, Dept Clin Med, British Heart Fdn Cambridge Ctr Res Excellence, Cambridge, England; [Abraham, Gad; Inouye, Michael] Baker Heart & Diabet Inst, Cambridge Baker Syst Genom Initiat, Melbourne, Vic, Australia; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Inouye, Michael] Alan Turing Inst, London, England	University of Cambridge; University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Cambridge; University of Cambridge	Lambert, SA; Inouye, M (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge Baker Syst Genom Initiat, Cambridge, England.; Lambert, SA; Inouye, M (corresponding author), Univ Cambridge, British Heart Fdn Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England.; Lambert, SA; Inouye, M (corresponding author), Hlth Data Res UK Cambridge, Wellcome Genome Campus, Cambridge, England.; Lambert, SA; Inouye, M (corresponding author), Univ Cambridge, Cambridge, England.; Lambert, SA; MacArthur, JAL (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Hinxton, England.; Inouye, M (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England.; Inouye, M (corresponding author), Univ Cambridge, Dept Clin Med, British Heart Fdn Cambridge Ctr Res Excellence, Cambridge, England.; Inouye, M (corresponding author), Baker Heart & Diabet Inst, Cambridge Baker Syst Genom Initiat, Melbourne, Vic, Australia.; Inouye, M (corresponding author), Alan Turing Inst, London, England.	sl925@medschl.cam.ac.uk; jalm@ebi.ac.uk; mi336@medschl.cam.ac.uk	Lambert, Samuel/ABA-7732-2021	Lambert, Samuel/0000-0001-8222-008X; McMahon, Aoife/0000-0003-0978-0309; Gil, Laurent/0000-0002-9475-4502; Parkinson, Helen/0000-0003-3035-4195; Chapman, Michael/0000-0002-4582-6303; Inouye, Michael/0000-0001-9413-6520; Buniello, Annalisa/0000-0002-4623-8642; Ritchie, Scott/0000-0002-8454-9548	UK Biobank Project [7439]; UK Medical Research Council [MR/L003120/1]; British Heart Foundation [RG/13/13/30194, RG/18/13/33946]; National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust); Health Data Research UK - UK Medical Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation; Wellcome; Munz Chair of Cardiovascular Prediction and Prevention; Victorian Government's Operational Infrastructure Support (OIS) program; National Human Genome Research Institute of the National Institutes of Health [U41HG007823]; European Molecular Biology Laboratory; National Institute for Health Research Senior Investigator Award; Canadian Institutes of Health Research postdoctoral fellowship [MFE-171279]; Engineering and Physical Sciences Research Council [EP/P020259/1]; Science and Technology Facilities Council	UK Biobank Project; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust); Health Data Research UK - UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation(British Heart Foundation); Wellcome; Munz Chair of Cardiovascular Prediction and Prevention; Victorian Government's Operational Infrastructure Support (OIS) program; National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Molecular Biology Laboratory; National Institute for Health Research Senior Investigator Award; Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We wish to thank all the authors of publications in the PGS Catalog for making their data available and indexable in our database, and all those who responded to our inquiries and requests for data. We thank P. L. Whetzel for implementing the links from the NHGRI-EBI GWAS Catalog publication, study and trait pages to the PGS Catalog. We also wish to acknowledge E. Tinsley, S. Saverimuttu and members of the laboratory of M.I. for curation support. This work makes use of data from UK Biobank Project no. 7439.; This work was supported by core funding from the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194 and RG/18/13/33946) and the National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust). This work was also supported by Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome. M.I. was supported by the Munz Chair of Cardiovascular Prediction and Prevention. This study was supported by the Victorian Government's Operational Infrastructure Support (OIS) program. Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under award U41HG007823. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, we acknowledge funding from the European Molecular Biology Laboratory. J.D. holds a British Heart Foundation Professorship and is funded by a National Institute for Health Research Senior Investigator Award. M.I. and S.R. are supported by the National Institute for Health Research (Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust). S.A.L. is supported by a Canadian Institutes of Health Research postdoctoral fellowship (MFE-171279). This work was performed by using resources provided by the Cambridge Service for Data Driven Discovery (CSD3) operated by the University of Cambridge Research Computing Service (http://www.csd3.cam.ac.uk), provided by Dell EMC and Intel, by using Tier-2 funding from the Engineering and Physical Sciences Research Council (capital grant EP/P020259/1) and DiRAC funding from the Science and Technology Facilities Council (http://www.dirac.ac.uk).The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Abraham G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13848-1; Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; [Anonymous], 2010, LANCET, V376, P1800, DOI 10.1016/S0140-6736(10)62149-6; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cassim AM, 2019, PROG LIPID RES, V73, P1, DOI 10.1016/j.plipres.2018.11.002; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chereji RV, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1398-0; Choi SW, 2020, NAT PROTOC, V15, P2759, DOI 10.1038/s41596-020-0353-1; Dikilitas O, 2020, AM J HUM GENET, V106, P707, DOI 10.1016/j.ajhg.2020.04.002; Dorotea D, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0053-x; Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fritsche LG, 2020, AM J HUM GENET, V107, P815, DOI 10.1016/j.ajhg.2020.08.025; ICDA Organizing Committee and Working Groups, INT COMM DIS ALL REC; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Jupp S., 2015, P 8 INT C SEM WEB AP, V1546, P118; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Kuchenbaecker K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12026-7; Lambert SA, 2019, HUM MOL GENET, V28, pR133, DOI 10.1093/hmg/ddz187; Li HY, 2017, GENET MED, V19, P30, DOI 10.1038/gim.2016.43; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mills MC, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0261-x; Natarajan P, 2018, J AM COLL CARDIOL, V72, P1894, DOI 10.1016/j.jacc.2018.08.1041; Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reisberg S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179238; Richardson TG, 2019, ELIFE, V8, DOI 10.7554/eLife.43657; Rosenberg NA, 2019, EVOL MED PUBLIC HLTH, P26, DOI 10.1093/emph/eoy036; Seibert TM, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5757; Sharp SA, 2019, DIABETES CARE, V42, P200, DOI 10.2337/dc18-1785; Tada H, 2016, EUR HEART J, V37, P561, DOI 10.1093/eurheartj/ehv462; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; Wand H, 2021, NATURE, V591, P211, DOI 10.1038/s41586-021-03243-6; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wray NR, 2019, GENETICS, V211, P1131, DOI 10.1534/genetics.119.301859; Wunnemann F, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.119.002481; Zheutlin AB, 2019, AM J PSYCHIAT, V176, P846, DOI 10.1176/appi.ajp.2019.18091085	43	82	81	2	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2021	53	4					420	425		10.1038/s41588-021-00783-5	http://dx.doi.org/10.1038/s41588-021-00783-5		MAR 2021	6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL1CA	33692568	Green Submitted			2022-12-17	WOS:000627231100001
J	Corces, MR; Shcherbina, A; Kundu, S; Gloudemans, MJ; Fresard, L; Granja, JM; Louie, BH; Eulalio, T; Shams, S; Bagdatli, ST; Mumbach, MR; Liu, BX; Montine, KS; Greenleaf, WJ; Kundaje, A; Montgomery, SB; Chang, HY; Montine, TJ				Corces, M. Ryan; Shcherbina, Anna; Kundu, Soumya; Gloudemans, Michael J.; Fresard, Laure; Granja, Jeffrey M.; Louie, Bryan H.; Eulalio, Tiffany; Shams, Shadi; Bagdatli, S. Tansu; Mumbach, Maxwell R.; Liu, Boxiang; Montine, Kathleen S.; Greenleaf, William J.; Kundaje, Anshul; Montgomery, Stephen B.; Chang, Howard Y.; Montine, Thomas J.			Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HUMAN HEMATOPOIESIS; OPEN CHROMATIN; METAANALYSIS; EXPRESSION; GENES; IDENTIFICATION; INTERROGATION; HERITABILITY	Genome-wide association studies of neurological diseases have identified thousands of variants associated with disease phenotypes. However, most of these variants do not alter coding sequences, making it difficult to assign their function. Here, we present a multi-omic epigenetic atlas of the adult human brain through profiling of single-cell chromatin accessibility landscapes and three-dimensional chromatin interactions of diverse adult brain regions across a cohort of cognitively healthy individuals. We developed a machine-learning classifier to integrate this multi-omic framework and predict dozens of functional SNPs for Alzheimer's and Parkinson's diseases, nominating target genes and cell types for previously orphaned loci from genome-wide association studies. Moreover, we dissected the complex inverted haplotype of the MAPT (encoding tau) Parkinson's disease risk locus, identifying putative ectopic regulatory interactions in neurons that may mediate this disease association. This work expands understanding of inherited variation and provides a roadmap for the epigenomic dissection of causal regulatory variation in disease. Single-cell chromatin profiling of different brain regions identifies cell-type-specific regulatory elements, and helps to predict functional SNPs for Alzheimer's and Parkinson's diseases.	[Corces, M. Ryan; Gloudemans, Michael J.; Fresard, Laure; Louie, Bryan H.; Eulalio, Tiffany; Liu, Boxiang; Montine, Kathleen S.; Montgomery, Stephen B.; Montine, Thomas J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Corces, M. Ryan; Granja, Jeffrey M.; Louie, Bryan H.; Shams, Shadi; Bagdatli, S. Tansu; Mumbach, Maxwell R.; Greenleaf, William J.; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Shcherbina, Anna; Gloudemans, Michael J.; Eulalio, Tiffany] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Shcherbina, Anna; Kundu, Soumya; Granja, Jeffrey M.; Shams, Shadi; Bagdatli, S. Tansu; Mumbach, Maxwell R.; Greenleaf, William J.; Kundaje, Anshul; Montgomery, Stephen B.; Chang, Howard Y.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kundu, Soumya; Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Program Biophys, Stanford, CA 94305 USA; [Liu, Boxiang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Liu, Boxiang] Baidu Res, Sunnyvale, CA USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Baidu; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Montine, TJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu; tmontine@stanford.edu	Corces, M. Ryan/ABG-6947-2020	Corces, M. Ryan/0000-0001-7465-7652; Kundaje, Anshul/0000-0003-3084-2287; Eulalio, Tiffany/0000-0002-7084-9646	National Institutes of Health (NIH) [NS062684, AG057707, AG053959, AG047366, HG007735, HG009431, AG066490, AG059918]; NIH [AG005136, AG019610, S10OD018220, S10OD025212]; American Society of Hematology Scholar Award; Stanford BioX Bowes fellowship; National Library of Medicine training grant [5T15LM007033-36]; Stanford Graduate Fellowship	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; Stanford BioX Bowes fellowship; National Library of Medicine training grant; Stanford Graduate Fellowship(Stanford University)	This work was supported by National Institutes of Health (NIH) grant nos. NS062684, AG057707, AG053959, AG047366 (to T.J.M.), HG007735 (to H.Y.C.), HG009431 (to S.B.M./A.K.), AG066490 (to S.B.M.) and AG059918 (to M.R.C.). Additional support for patient sample collection was provided by NIH grant nos. AG005136 and AG019610. Sequencing data for this project were generated on an Illumina HiSeq 4000 System supported in part by NIH grant no. S10OD018220. Additional resources at the Stanford Center for Genomics and Personalized Medicine Sequencing Center were supported by NIH grant no. S10OD025212. M.R.C. is supported by the American Society of Hematology Scholar Award. A.S. is supported by the Stanford BioX Bowes fellowship. M.J.G. and T.E. are supported by a National Library of Medicine training grant no. 5T15LM007033-36. M.J.G. is additionally supported by a Stanford Graduate Fellowship. H.Y.C. is an Investigator of the Howard Hughes Medical Institute.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Allen M, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt268; Amiri A, 2018, SCIENCE, V362, P1268, DOI 10.1126/science.aat6720; Amlie-Wolf A, 2018, NUCLEIC ACIDS RES, V46, P8740, DOI 10.1093/nar/gky686; Andrew RJ, 2019, J BIOL CHEM, V294, P4477, DOI 10.1074/jbc.RA118.006379; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; [Anonymous], 2014, GENOME BIOL, DOI DOI 10.1186/S13059-014-0550-8; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; Beevers JE, 2017, STEM CELL REP, V9, P587, DOI 10.1016/j.stemcr.2017.06.005; Bhattacharyya S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11950-y; Bromberg Y, 2008, BIOINFORMATICS, V24, pI207, DOI 10.1093/bioinformatics/btn268; Bryois J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05379-y; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Efthymiou AG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0184-x; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fulco CP, 2019, NAT GENET, V51, P1664, DOI 10.1038/s41588-019-0538-0; Fullard JF, 2018, GENOME RES, V28, P1243, DOI 10.1101/gr.232488.117; Fullard JF, 2017, HUM MOL GENET, V26, P1942, DOI 10.1093/hmg/ddx103; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Ghandi M, 2016, BIOINFORMATICS, V32, P2205, DOI 10.1093/bioinformatics/btw203; Granja JM, 2019, NAT BIOTECHNOL, V37, P1458, DOI 10.1038/s41587-019-0332-7; Granja JM, 2020, ARCHR INTEGRATIVE SC, DOI [10.1101/2020.04.28.066498, DOI 10.1101/2020.04.28.066498]; Harvey CT, 2015, BIOINFORMATICS, V31, P1235, DOI 10.1093/bioinformatics/btu802; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemonnot AL, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00233; Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874; Huin V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12955-7; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Kondo T, 2000, DEVELOPMENT, V127, P2989; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krueger Felix, 2016, F1000Res, V5, P1479, DOI 10.12688/f1000research.9037.2; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kumasaka N, 2019, NAT GENET, V51, P128, DOI 10.1038/s41588-018-0278-6; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Lai MC, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0224-6; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Larsson M, 2011, AM J HUM GENET, V89, P334, DOI 10.1016/j.ajhg.2011.07.011; Lecours C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00282; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Li MF, 2018, SCIENCE, V362, P1264, DOI 10.1126/science.aat7615; Li ZQ, 2017, NAT GENET, V49, P1576, DOI 10.1038/ng.3973; Ma J, 2015, MOL NEUROBIOL, V51, P820, DOI 10.1007/s12035-014-8811-9; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; McKeown MR, 2017, CANCER DISCOV, V7, P1136, DOI 10.1158/2159-8290.CD-17-0399; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Nakatani H, 2013, J NEUROSCI, V33, P9752, DOI 10.1523/JNEUROSCI.0805-13.2013; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Nott A, 2019, SCIENCE, V366, P1134, DOI 10.1126/science.aay0793; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pascale E, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00096; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajarajan P, 2018, SCIENCE, V362, P1269, DOI 10.1126/science.aat4311; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Sey NYA, 2020, NAT NEUROSCI, V23, P583, DOI 10.1038/s41593-020-0603-0; Shrikumar A, 2019, BIOINFORMATICS, V35, pI173, DOI 10.1093/bioinformatics/btz322; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Song M, 2019, NAT GENET, V51, P1252, DOI 10.1038/s41588-019-0472-1; Stage Eddie, 2016, Alzheimers Dement (Amst), V5, P53, DOI 10.1016/j.dadm.2016.12.003; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Trevino AE, 2020, SCIENCE, V367, P404, DOI 10.1126/science.aay1645; Ulirsch JC, 2019, NAT GENET, V51, P683, DOI 10.1038/s41588-019-0362-6; Valenca GT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157452; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Xu W, 2015, MOL NEUROBIOL, V52, P399, DOI 10.1007/s12035-014-8878-3; Zillikens MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00031-7; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	90	82	82	4	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2020	52	11					1158	+		10.1038/s41588-020-00721-x	http://dx.doi.org/10.1038/s41588-020-00721-x		OCT 2020	30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OL8FK	33106633	Green Accepted, Green Submitted			2022-12-17	WOS:000584366100004
J	Calderon, D; Nguyen, MLT; Mezger, A; Kathiria, A; Muller, F; Nguyen, V; Lescano, N; Wu, BJ; Trombetta, J; Ribado, JV; Knowles, DA; Gao, ZY; Blaeschke, F; Parent, AV; Burt, TD; Anderson, MS; Criswell, LA; Greenleaf, WJ; Marson, A; Pritchard, JK				Calderon, Diego; Nguyen, Michelle L. T.; Mezger, Anja; Kathiria, Arwa; Mueller, Fabian; Nguyen, Vinh; Lescano, Ninnia; Wu, Beijing; Trombetta, John; Ribado, Jessica, V; Knowles, David A.; Gao, Ziyue; Blaeschke, Franziska; Parent, Audrey, V; Burt, Trevor D.; Anderson, Mark S.; Criswell, Lindsey A.; Greenleaf, William J.; Marson, Alexander; Pritchard, Jonathan K.			Landscape of stimulation-responsive chromatin across diverse human immune cells	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DNA-BINDING; LOCI; ACTIVATION; IDENTIFICATION; ARCHITECTURE; SENSITIVITY; ANNOTATION; ENHANCERS; DISCOVERY	A hallmark of the immune system is the interplay among specialized cell types transitioning between resting and stimulated states. The gene regulatory landscape of this dynamic system has not been fully characterized in human cells. Here we collected assay for transposase-accessible chromatin using sequencing (ATAC-seq) and RNA sequencing data under resting and stimulated conditions for up to 32 immune cell populations. Stimulation caused widespread chromatin remodeling, including response elements shared between stimulated B and T cells. Furthermore, several autoimmune traits showed significant heritability in stimulation-responsive elements from distinct cell types, highlighting the importance of these cell states in autoimmunity. Allele-specific read mapping identified variants that alter chromatin accessibility in particular conditions, allowing us to observe evidence of function for a candidate causal variant that is undetected by existing large-scale studies in resting cells. Our results provide a resource of chromatin dynamics and highlight the need to characterize the effects of genetic variation in stimulated cells.	[Calderon, Diego] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Nguyen, Michelle L. T.; Blaeschke, Franziska; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Nguyen, Michelle L. T.; Nguyen, Vinh; Lescano, Ninnia; Blaeschke, Franziska; Parent, Audrey, V; Anderson, Mark S.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Mezger, Anja; Kathiria, Arwa; Mueller, Fabian; Wu, Beijing; Trombetta, John; Ribado, Jessica, V; Knowles, David A.; Gao, Ziyue; Greenleaf, William J.; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Mezger, Anja] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Knowles, David A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Gao, Ziyue; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Blaeschke, Franziska; Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Burt, Trevor D.] Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA USA; [Burt, Trevor D.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Criswell, Lindsey A.; Marson, Alexander] Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94143 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Greenleaf, William J.; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marson, Alexander] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Karolinska Institutet; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Stanford University	Marson, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Greenleaf, WJ; Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Marson, A (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Criswell, LA; Marson, A (corresponding author), Univ Calif San Francisco, Rosalind Russell Ephraim P Engleman Rheumatol Res, San Francisco, CA 94143 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Greenleaf, WJ; Marson, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	lindsey.criswell@ucsf.edu; wjg@stanford.edu; alexander.marson@ucsf.edu; pritch@stanford.edu	Anderson, Mark/AAZ-4992-2020; Müller, Fabian/HGD-0719-2022	Anderson, Mark/0000-0002-3093-4758; Müller, Fabian/0000-0001-5809-2321; Burt, Trevor/0000-0001-7933-529X	Diabetes Research Center [NIH P30 DK063720, 1S10OD021822-01]; National Institutes of Health (NIH) [S10OD018220]; Chan Zuckerberg Biohub; UCSF Center for Advanced Technology; National Library of Medicine training grant [T15LM007033]; Swedish Research Council [2015-06403]; Care-forRare Foundation; NIH/National Institute of General Medical Sciences [P50 GM082250]; NIH [1R01HG008140, P30AR070155, DP3DK111914-01, P50HG007735, UM1HG009442, U19AI057266]; Howard Hughes Medical Institute; Rheumatology Research Foundation; UCSF-Stanford Arthritis Center of Excellence (Arthritis Foundation); Rita Allen Foundation; Human Frontiers Science Program [RGY006S]; Burroughs Wellcome Fund; National Multiple Sclerosis Society [CA 1074-A-21]; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009442, P50HG007735, R01HG008140, RM1HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, P50AI150476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021822] Funding Source: NIH RePORTER	Diabetes Research Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Biohub; UCSF Center for Advanced Technology; National Library of Medicine training grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Care-forRare Foundation; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rheumatology Research Foundation; UCSF-Stanford Arthritis Center of Excellence (Arthritis Foundation); Rita Allen Foundation; Human Frontiers Science Program(Human Frontier Science Program); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Yao for helping process the samples, C. J. Ye and members of the Greenleaf, Marson and Pritchard laboratories for helpful conversations and manuscript feedback. We relied on the Flow Cytometry Core at UCSF, which was supported by Diabetes Research Center grant nos. NIH P30 DK063720 and 1S10OD021822-01, and sequencing data generated by the Stanford Functional Genomics Facility on an Illumina HiSeq 4000 that was purchased with funds from the National Institutes of Health (NIH) under award no. S10OD018220. Sequencing that was generated on an Illumina NovaSeq was supported by the Chan Zuckerberg Biohub. Some of the computing for this project was performed on the Sherlock cluster. Sequencing of the ChIP-seq libraries was supported by the UCSF Center for Advanced Technology. We thank Stanford University and the Stanford Research Computing Center for providing computational resources and support that contributed to these research results. Support for D.C. was provided by National Library of Medicine training grant no. T15LM007033. A. Mezger is supported by the Swedish Research Council (grant no. 2015-06403). F.B. was supported by the Care-forRare Foundation and NIH/National Institute of General Medical Sciences funding for the HIV Accessory & Regulatory Complexes Center (no. P50 GM082250; A.Marson). This work was supported by NIH grants (no. 1R01HG008140-J.P. serves as principal investigator with subcontract to A. Marson and L.A.C. at UCSF; no. P30AR070155 to L.A.C.; no. DP3DK111914-01 to A. Marson; no. P50HG007735 to W.J.G.; no. UM1HG009442 to W.J.G.; no. U19AI057266 to W.J.G.), the Howard Hughes Medical Institute (J.K.P.), the Rheumatology Research Foundation (L.A.C.), the UCSF-Stanford Arthritis Center of Excellence (L.A.C.) (supported in part by the Arthritis Foundation), the Rita Allen Foundation (W.J.G.), the Human Frontiers Science Program grant no. RGY006S (W.J.G.), the Burroughs Wellcome Fund (A. Marson) and the National Multiple Sclerosis Society (A. Marson; no. CA 1074-A-21). Both W.J.G. and A. Marson are supported by the Chan Zuckerberg Biohub. Additionally, A. Marson holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund, has received funding from the Innovative Genomics Institute and is supported by the Parker Institute for Cancer Immunotherapy.	Alasoo K, 2018, NAT GENET, V50, P424, DOI 10.1038/s41588-018-0046-7; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Banovich NE, 2018, GENOME RES, V28, P122, DOI 10.1101/gr.224436.117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calderon D, 2017, AM J HUM GENET, V101, P686, DOI 10.1016/j.ajhg.2017.09.009; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gate RE, 2018, NAT GENET, V50, P1140, DOI 10.1038/s41588-018-0156-2; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; Hess K, 2004, INT IMMUNOL, V16, P1711, DOI 10.1093/intimm/dxh172; HODGKIN PD, 1991, CELL IMMUNOL, V134, P14, DOI 10.1016/0008-8749(91)90327-8; Housley WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9223; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kim-Hellmuth S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00366-1; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Van Belle K, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5281823; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; van der Veeken J, 2016, CELL, V166, P977, DOI 10.1016/j.cell.2016.07.006; Walsh AM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0948-6; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; WORTIS HH, 1995, P NATL ACAD SCI USA, V92, P3348, DOI 10.1073/pnas.92.8.3348; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706	63	82	82	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1494	+		10.1038/s41588-019-0505-9	http://dx.doi.org/10.1038/s41588-019-0505-9			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31570894	Green Submitted, Green Accepted			2022-12-17	WOS:000489016400013
J	Lilue, JT; Doran, AG; Fiddes, IT; Abrudan, M; Armstrong, J; Bennett, R; Chow, W; Collins, J; Collins, S; Czechanski, A; Danecek, P; Diekhans, M; Dolle, DD; Dunn, M; Durbin, R; Earl, D; Ferguson-Smith, A; Flicek, P; Flint, J; Frankish, A; Fu, BY; Gerstein, M; Gilbert, J; Goodstadt, L; Harrow, J; Howe, K; Ibarra-Soria, X; Kolmogorov, M; Lelliott, CJ; Logan, DW; Loveland, J; Mathews, CE; Mott, R; Muir, P; Nachtweide, S; Navarro, FCP; Odom, DT; Park, N; Pelan, S; Pham, SK; Quail, M; Reinholdt, L; Romoth, L; Shirley, L; Sisu, C; Sjoberg-Herrera, M; Stanke, M; Steward, C; Thomas, M; Threadgold, G; Thybert, D; Torrance, J; Wong, K; Wood, J; Yalcin, B; Yang, FT; Adams, DJ; Paten, B; Keane, TM				Lilue, Jingtao; Doran, Anthony G.; Fiddes, Ian T.; Abrudan, Monica; Armstrong, Joel; Bennett, Ruth; Chow, William; Collins, Joanna; Collins, Stephan; Czechanski, Anne; Danecek, Petr; Diekhans, Mark; Dolle, Dirk-Dominik; Dunn, Matt; Durbin, Richard; Earl, Dent; Ferguson-Smith, Anne; Flicek, Paul; Flint, Jonathan; Frankish, Adam; Fu, Beiyuan; Gerstein, Mark; Gilbert, James; Goodstadt, Leo; Harrow, Jennifer; Howe, Kerstin; Ibarra-Soria, Ximena; Kolmogorov, Mikhail; Lelliott, Chris J.; Logan, Darren W.; Loveland, Jane; Mathews, Clayton E.; Mott, Richard; Muir, Paul; Nachtweide, Stefanie; Navarro, Fabio C. P.; Odom, Duncan T.; Park, Naomi; Pelan, Sarah; Pham, Son K.; Quail, Mike; Reinholdt, Laura; Romoth, Lars; Shirley, Lesley; Sisu, Cristina; Sjoberg-Herrera, Marcela; Stanke, Mario; Steward, Charles; Thomas, Mark; Threadgold, Glen; Thybert, David; Torrance, James; Wong, Kim; Wood, Jonathan; Yalcin, Binnaz; Yang, Fengtang; Adams, David J.; Paten, Benedict; Keane, Thomas M.			Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci	NATURE GENETICS			English	Article							COLLABORATIVE CROSS; GENETIC-ANALYSIS; NK CELLS; MICE; EXPRESSION; SUSCEPTIBILITY; IDENTIFICATION; INFLAMMASOMES; ANNOTATION; RESISTANCE	We report full-length draft de novo genome assemblies for 16 widely used inbred mouse strains and find extensive strain-specific haplotype variation. We identify and characterize 2,567 regions on the current mouse reference genome exhibiting the greatest sequence diversity. These regions are enriched for genes involved in pathogen defence and immunity and exhibit enrichment of transposable elements and signatures of recent retrotransposition events. Combinations of alleles and genes unique to an individual strain are commonly observed at these loci, reflecting distinct strain phenotypes. We used these genomes to improve the mouse reference genome, resulting in the completion of 10 new gene structures. Also, 62 new coding loci were added to the reference genome annotation. These genomes identified a large, previously unannotated, gene (Efcab3-like) encoding 5,874 amino acids. Mutant Efcab3-like mice display anomalies in multiple brain regions, suggesting a possible role for this gene in the regulation of brain development.	[Lilue, Jingtao; Doran, Anthony G.; Bennett, Ruth; Flicek, Paul; Frankish, Adam; Loveland, Jane; Thybert, David; Keane, Thomas M.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Lilue, Jingtao; Doran, Anthony G.; Abrudan, Monica; Chow, William; Collins, Joanna; Danecek, Petr; Dolle, Dirk-Dominik; Dunn, Matt; Durbin, Richard; Flicek, Paul; Frankish, Adam; Fu, Beiyuan; Gilbert, James; Harrow, Jennifer; Howe, Kerstin; Ibarra-Soria, Ximena; Lelliott, Chris J.; Logan, Darren W.; Loveland, Jane; Park, Naomi; Pelan, Sarah; Quail, Mike; Shirley, Lesley; Steward, Charles; Thomas, Mark; Threadgold, Glen; Torrance, James; Wong, Kim; Wood, Jonathan; Yang, Fengtang; Adams, David J.; Keane, Thomas M.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Fiddes, Ian T.; Armstrong, Joel; Diekhans, Mark; Earl, Dent; Paten, Benedict] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Collins, Stephan; Yalcin, Binnaz] Univ Strasbourg, Ctr Natl Rech Sci UMR7104, Inst Natl Sante & Rech Med U964, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Collins, Stephan] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, Dijon, France; [Czechanski, Anne; Reinholdt, Laura] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Durbin, Richard; Ferguson-Smith, Anne] Univ Cambridge, Dept Genet, Cambridge, England; [Flint, Jonathan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Gerstein, Mark; Muir, Paul; Navarro, Fabio C. P.; Sisu, Cristina] Yale Univ, Yale Computat Biol & Bioinformat, New Haven, CT USA; [Goodstadt, Leo] OxFORD Asset Management, OxAM House, Oxford, England; [Kolmogorov, Mikhail] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Mott, Richard] UCL, Genet Inst, London, England; [Nachtweide, Stefanie; Romoth, Lars; Stanke, Mario] Univ Greifswald, Inst Math & Comp Sci, Greifswald, Germany; [Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England; [Odom, Duncan T.] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Pham, Son K.] BioTuring Inc, San Diego, CA USA; [Sisu, Cristina] Brunel Univ London, Dept Biosci, Uxbridge, Middx, England; [Sjoberg-Herrera, Marcela] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Thybert, David] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England; [Keane, Thomas M.] Univ Nottingham, Sch Life Sci, Nottingham, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Jackson Laboratory; University of Cambridge; University of California System; University of California Los Angeles; Yale University; University of California System; University of California San Diego; State University System of Florida; University of Florida; University of London; University College London; Ernst Moritz Arndt Universitat Greifswald; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); Brunel University; Pontificia Universidad Catolica de Chile; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; University of Nottingham	Keane, TM (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England.; Keane, TM (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England.; Keane, TM (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.	tk2@ebi.ac.uk	Yalcin, Binnaz/P-5482-2016; Stanke, Mario/P-7876-2019; Yalcin, Binnaz/ABB-7735-2020; Yang, Fan/GYU-4249-2022; Ibarra-Soria, Ximena/ABF-1624-2021; Sisu, Cristina/K-8994-2019; Kolmogorov, Mikhail/GLR-8863-2022; Durbin, Richard/AAE-7178-2019	Yalcin, Binnaz/0000-0002-1924-6807; Stanke, Mario/0000-0001-8696-0384; Yalcin, Binnaz/0000-0002-1924-6807; Sisu, Cristina/0000-0001-9371-0797; Durbin, Richard/0000-0002-9130-1006; Mott, Richard/0000-0002-1022-9330; Dolle, Dirk-Dominik/0000-0003-1786-6452; Loveland, Jane/0000-0002-7669-2934; Chow, William/0000-0002-9056-201X; Lilue, Jingtao/0000-0002-1958-0231; Torrance, James/0000-0002-6117-8190; Steward, Charles/0000-0001-8829-5349; Czechanski, Anne/0000-0003-3210-4210; Odom, Duncan/0000-0001-6201-5599; Wong, Kim/0000-0002-0984-1477; Howe, Kerstin/0000-0003-2237-513X; Sjoberg Herrera, Marcela K./0000-0001-7173-048X; Yang, Fengtang/0000-0002-3573-2354; Abrudan, Monica/0000-0003-0228-4353; Frankish, Adam/0000-0002-4333-628X; Adams, David/0000-0001-9490-0306; Bennett, Esther Ruth/0000-0002-9009-4607; Keane, Thomas/0000-0001-7532-6898; Thybert, David/0000-0001-7806-7318; Ferguson-Smith, Anne/0000-0002-7608-5894; Harrow, Jennifer/0000-0003-0338-3070; Flicek, Paul/0000-0002-3897-7955; Logan, Darren/0000-0003-1545-5510	Medical Research Council [MR/L007428/1]; BBSRC [BB/M000281/1]; Wellcome Trust [WT108749/Z/15/Z, WT098051, WT202878/B/16/Z, 202878/A/16/Z]; Cancer Research-UK [20412]; CONICYT/FONDECYT/REGULAR [1171004]; European Commission (EUFP7 BLUEPRINT grant) [HEALTH-F5-2011-282510]; European Research Council [615584]; National Human Genome Research Institute [U41HG007234]; European Molecular Biology Laboratory; European Union [HEALTH-F4-2010-241504];  [R01 DK074656]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074656] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011102, U42OD010921] Funding Source: NIH RePORTER; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR9818] Funding Source: UKRI; MRC [MR/R017565/1, MR/L007428/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Cancer Research-UK(Cancer Research UK); CONICYT/FONDECYT/REGULAR(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Commission (EUFP7 BLUEPRINT grant); European Research Council(European Research Council (ERC)European Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Molecular Biology Laboratory; European Union(European Commission); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MR/L007428/1), BBSRC (BB/M000281/1), and the Wellcome Trust. D.J.A. is supported by Cancer Research-UK and the Wellcome Trust. M.K.S. was supported by a research grant from CONICYT/FONDECYT/REGULAR No. 1171004 and the European Commission (EUFP7 BLUEPRINT grant HEALTH-F5-2011-282510). D.T.O. work was supported by Cancer Research UK (20412), the Wellcome Trust (202878/A/16/Z), and the European Research Council (615584). P.F. was supported by the Wellcome Trust (grant numbers WT108749/Z/15/Z, WT098051, WT202878/B/16/Z), the National Human Genome Research Institute (U41HG007234), and the European Molecular Biology Laboratory. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F4-2010-241504 (EURATRANS). C.E.M. is supported by R01 DK074656. We thank members of the Sanger Institute Mouse Pipelines teams (Mouse Informatics, Molecular Technologies, Genome Engineering Technologies, Mouse Production Team, Mouse Phenotyping) and the Research Support Facility for the provision and management of the mice. We thank V. Vancollie for assistance with phenotyping data.	Americo JL, 2010, J VIROL, V84, P8172, DOI 10.1128/JVI.00621-10; Arbogast T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006886; Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Boniotto M, 2012, HUM IMMUNOL, V73, P196, DOI 10.1016/j.humimm.2011.10.014; Boroviak K, 2016, GENESIS, V54, P78, DOI 10.1002/dvg.22915; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Cai Y, 2014, AM J PHYSIOL-LUNG C, V306, pL10, DOI 10.1152/ajplung.00037.2013; Capewell P, 2015, PARASITOLOGY, V142, pS108, DOI 10.1017/S0031182014000602; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Doran AG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1024-y; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Ewing AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r22; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Fiddes I. T., 2017, COMP ANNOTATION TOOL, DOI [10.1101/231118, DOI 10.1101/231118]; Flint J, 2008, NATURE, V456, P724, DOI 10.1038/nature07630; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Ibarra-Soria X, 2017, ELIFE, V6, DOI 10.7554/eLife.21476; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kelada SNP, 2014, AM J RESP CELL MOL, V51, P436, DOI 10.1165/rcmb.2013-0501OC; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Konig S, 2016, BIOINFORMATICS, V32, P3388, DOI 10.1093/bioinformatics/btw494; Kolmogorov M, 2018, CHROMOSOME ASSEMBLY; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Liebenauer LL, 1996, PHYSIOL BEHAV, V60, P403, DOI 10.1016/S0031-9384(96)80011-4; Lilue JT, 2013, ELIFE, V2, DOI 10.7554/eLife.01298; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loviglio MN, 2017, MOL PSYCHIATR, V22, P836, DOI 10.1038/mp.2016.84; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mikhaleva Anna, 2016, Curr Protoc Mouse Biol, V6, P307, DOI 10.1002/cpmo.12; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; O'Sullivan T, 2011, J IMMUNOL, V187, P3538, DOI 10.4049/jimmunol.1100413; Park N., 2013, METHODS NEXT GENER S, V1, P10, DOI DOI 10.2478/MNGS-2013-0001; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Patierno Steven R, 2002, Clin Prostate Cancer, V1, P118, DOI 10.3816/CGC.2002.n.014; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Saraiva LR, 2016, P NATL ACAD SCI USA, V113, pE3300, DOI 10.1073/pnas.1605973113; Sastalla I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-188; Schrider DR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003242; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Ye Z, 2006, TRANSPL P, V38, P2168, DOI 10.1016/j.transproceed.2006.06.096; Zhang H, 2011, MOL IMMUNOL, V48, P539, DOI 10.1016/j.molimm.2010.10.015; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116	78	82	82	1	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2018	50	11					1574	+		10.1038/s41588-018-0223-8	http://dx.doi.org/10.1038/s41588-018-0223-8			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY2UB	30275530	Green Submitted, Green Accepted, hybrid			2022-12-17	WOS:000448398000013
J	MacGregor, S; Ong, JS; An, JY; Han, XK; Zhou, T; Siggs, OM; Law, MH; Souzeau, E; Sharma, S; Lynn, DJ; Beesley, J; Sheldrick, B; Mills, RA; Landers, J; Ruddle, JB; Graham, SL; Healey, PR; White, AJR; Casson, RJ; Best, S; Grigg, JR; Goldberg, I; Powell, JE; Whiteman, DC; Radford-Smith, GL; Martin, NG; Montgomery, GW; Burdon, KP; Mackey, DA; Gharahkhani, P; Craig, JE; Hewitt, AW				MacGregor, Stuart; Ong, Jue-Sheng; An, Jiyuan; Han, Xikun; Zhou, Tiger; Siggs, Owen M.; Law, Matthew H.; Souzeau, Emmanuelle; Sharma, Shiwani; Lynn, David J.; Beesley, Jonathan; Sheldrick, Bronwyn; Mills, Richard A.; Landers, John; Ruddle, Jonathan B.; Graham, Stuart L.; Healey, Paul R.; White, Andrew J. R.; Casson, Robert J.; Best, Stephen; Grigg, John R.; Goldberg, Ivan; Powell, Joseph E.; Whiteman, David C.; Radford-Smith, Graham L.; Martin, Nicholas G.; Montgomery, Grant W.; Burdon, Kathryn P.; Mackey, David A.; Gharahkhani, Puya; Craig, Jamie E.; Hewitt, Alex W.			Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; COMMON VARIANTS; MUTATIONS; RISK; HERITABILITY; ATLAS; ABCA1; GENE	Intraocular pressure (IOP) is currently the sole modifiable risk factor for primary open-angle glaucoma (POAG), one of the leading causes of blindness worldwide(1). Both IOP and POAG are highly heritable(2). We report a combined analysis of participants from the UK Biobank (n = 103,914) and previously published data from the International Glaucoma Genetic Consortium (n = 29,578)(3,4) that identified 101 statistically independent genome-wide-significant SNPs for IOP, 85 of which have not been previously reported(4-12). We examined these SNPs in 11,018 glaucoma cases and 126,069 controls, and 53 SNPs showed evidence of association. Gene-based tests implicated an additional 22 independent genes associated with IOP. We derived an allele score based on the IOP loci and loci influencing optic nerve head morphology. In 1,734 people with advanced glaucoma and 2,938 controls, participants in the top decile of the allele score were at increased risk (odds ratio (OR) = 5.6; 95% confidence interval (CI): 4.1-7.6) of glaucoma relative to the bottom decile.	[MacGregor, Stuart; Ong, Jue-Sheng; An, Jiyuan; Han, Xikun; Law, Matthew H.; Beesley, Jonathan; Whiteman, David C.; Martin, Nicholas G.; Gharahkhani, Puya] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Zhou, Tiger; Siggs, Owen M.; Souzeau, Emmanuelle; Sharma, Shiwani; Sheldrick, Bronwyn; Mills, Richard A.; Landers, John; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Bedford Pk, SA, Australia; [Lynn, David J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Lynn, David J.] South Australian Hlth & Med Res Inst, EMBL Australia Grp, Infect & Immun Theme, Adelaide, SA, Australia; [Lynn, David J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia; [Ruddle, Jonathan B.; Hewitt, Alex W.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Graham, Stuart L.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Healey, Paul R.; White, Andrew J. R.] Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Sydney, NSW, Australia; [Healey, Paul R.; Grigg, John R.; Goldberg, Ivan] Univ Sydney, Sydney Eye Hosp, Fac Med & Hlth Sci, Discipline Ophthalmol, Sydney, NSW, Australia; [Casson, Robert J.] Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia; [Best, Stephen] Auckland Dist Hlth Board, Greenlane Clin Ctr, Eye Dept, Auckland, New Zealand; [Powell, Joseph E.] Garvan Inst Med Res, Garvan Weizmann Ctr Cellular Genom, Sydney, NSW, Australia; [Powell, Joseph E.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Radford-Smith, Graham L.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Burdon, Kathryn P.; Mackey, David A.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia	QIMR Berghofer Medical Research Institute; Flinders Medical Centre; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; Centre for Eye Research Australia; University of Melbourne; Macquarie University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Adelaide; Auckland District Health Board; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Queensland; University of Tasmania; Menzies Institute for Medical Research; University of Western Australia	MacGregor, S (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	stuart.macgregor@qimrberghofer.edu.au	An, Jiyuan/ABD-2471-2020; Han, Xikun/AAN-9012-2020; Radford-Smith, Graham/H-2792-2013; Mackey, David A/H-5340-2014; Law, Matthew H./AAJ-4066-2021; Burdon, Kathryn/AAD-2334-2022; Gharahkhani, Puya/AAA-6912-2020; Ong, Jue Sheng/B-3595-2018; Whiteman, David C/P-2728-2014; Souzeau, Emmanuelle/AAB-5608-2022; White, Andrew JR/E-8462-2013; Burdon, Kathryn/A-5026-2009; Grigg, John/A-6851-2013; Macgregor, Stuart/C-6442-2009	Han, Xikun/0000-0002-3823-7308; Radford-Smith, Graham/0000-0002-2047-6239; Mackey, David A/0000-0001-7914-4709; Law, Matthew H./0000-0002-4303-8821; Burdon, Kathryn/0000-0001-8217-1249; Gharahkhani, Puya/0000-0002-4203-5952; Ong, Jue Sheng/0000-0002-6062-710X; Whiteman, David C/0000-0003-2563-9559; Souzeau, Emmanuelle/0000-0002-2015-6577; Burdon, Kathryn/0000-0001-8217-1249; Grigg, John/0000-0002-6763-8119; Macgregor, Stuart/0000-0001-6731-8142; Lynn, David/0000-0003-4664-1404; Siggs, Owen/0000-0003-2840-4851; Sharma, Shiwani/0000-0002-0828-025X; Graham, Stuart/0000-0001-7519-969X; Beesley, Jonathan/0000-0003-1942-325X; Craig, Jamie/0000-0001-9955-9696; Mills, Richard/0000-0002-7386-2571; Powell, Joseph/0000-0002-5070-4124; Hewitt, Alex/0000-0002-5123-5999	National Health and Medical Research Council (NHMRC) of Australia [1107098, 1116360, 1116495, 1023911]; Ophthalmic Research Institute of Australia; BrightFocus Foundation; Australian Research Council Future Fellowship; NHMRC Fellowships; EMBL Australia group leader award	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; BrightFocus Foundation(BrightFocus Foundation); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); EMBL Australia group leader award	This work was conducted by using the UK Biobank Resource (application number 25331) and publicly available data from the International Glaucoma Genetics Consortium. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (1107098 (J.E.C.), 1116360 (D.A.M.), 1116495 (J.E.C.) and 1023911 (D.A.M.)), the Ophthalmic Research Institute of Australia and the BrightFocus Foundation. S.M. is supported by an Australian Research Council Future Fellowship. K.P.B., J.E.C. and A.W.H. are supported by NHMRC Fellowships. D.J.L. is supported by an EMBL Australia group leader award. We thank S. Wood and J. Pearson from QIMR Berghofer for IT support.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Bakshi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32894; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Bycroft C., 2017, PREPRINT, DOI [10.1101/166298, DOI 10.1101/166298]; Chan MPY, 2016, OPHTHALMOLOGY, V123, P771, DOI 10.1016/j.ophtha.2015.11.031; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Khan AO, 2012, OPHTHALMIC GENET, V33, P196, DOI 10.3109/13816810.2012.681097; Khor CC, 2016, NAT GENET, V48, P556, DOI 10.1038/ng.3540; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Larsson M, 2011, AM J HUM GENET, V89, P334, DOI 10.1016/j.ajhg.2011.07.011; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Souzeau E, 2012, CLIN EXP OPHTHALMOL, V40, P569, DOI 10.1111/j.1442-9071.2011.02742.x; Springelkamp H, 2017, HUM MOL GENET, V26, P438, DOI 10.1093/hmg/ddw399; Springelkamp H, 2015, HUM MOL GENET, V24, P2689, DOI 10.1093/hmg/ddv027; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Sweeney E, 2003, J MED GENET, V40, P153, DOI 10.1136/jmg.40.3.153; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Vollrath D, 1998, HUM MOL GENET, V7, P1091, DOI 10.1093/hmg/7.7.1091; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Weinreb RN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.67; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	48	82	83	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2018	50	8					1067	+		10.1038/s41588-018-0176-y	http://dx.doi.org/10.1038/s41588-018-0176-y			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GO9JP	30054594	Green Accepted			2022-12-17	WOS:000440423400004
J	Donaghey, J; Thakurela, S; Charlton, J; Chen, JS; Smith, ZD; Gu, HC; Pop, R; Clement, K; Stamenova, EK; Karnik, R; Kelley, DR; Gifford, CA; Cacchiarelli, D; Rinn, JL; Gnirke, A; Ziller, MJ; Meissner, A				Donaghey, Julie; Thakurela, Sudhir; Charlton, Jocelyn; Chen, Jennifer S.; Smith, Zachary D.; Gu, Hongcang; Pop, Ramona; Clement, Kendell; Stamenova, Elena K.; Karnik, Rahul; Kelley, David R.; Gifford, Casey A.; Cacchiarelli, Davide; Rinn, John L.; Gnirke, Andreas; Ziller, Michael J.; Meissner, Alexander			Genetic determinants and epigenetic effects of pioneer-factor occupancy	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FOXA; EMBRYONIC STEM-CELLS; DNA DEMETHYLATION; GUT ENDODERM; DEVELOPMENTAL COMPETENCE; REGULATORY ELEMENTS; COMPACTED CHROMATIN; MAMMALIAN LIVER; CHIP-SEQ; IN-VITRO	Transcription factors (TFs) direct developmental transitions by binding to target DNA sequences, influencing gene expression and establishing complex gene-regultory networks. To systematically determine the molecular components that enable or constrain TF activity, we investigated the genomic occupancy of FOXA2, GATA4 and OCT4 in several cell types. Despite their classification as pioneer factors, all three TFs exhibit cell-type-specific binding, even when supraphysiologically and ectopically expressed. However, FOXA2 and GATA4 can be distinguished by low enrichment at loci that are highly occupied by these factors in alternative cell types. We find that expression of additional cofactors increases enrichment at a subset of these sites. Finally, FOXA2 occupancy and changes to DNA accessibility can occur in G(1)-arrested cells, but subsequent loss of DNA methylation requires DNA replication.	[Donaghey, Julie; Thakurela, Sudhir; Smith, Zachary D.; Gu, Hongcang; Clement, Kendell; Stamenova, Elena K.; Karnik, Rahul; Gifford, Casey A.; Cacchiarelli, Davide; Rinn, John L.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Donaghey, Julie; Thakurela, Sudhir; Charlton, Jocelyn; Chen, Jennifer S.; Smith, Zachary D.; Pop, Ramona; Clement, Kendell; Karnik, Rahul; Kelley, David R.; Gifford, Casey A.; Cacchiarelli, Davide; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Charlton, Jocelyn; Meissner, Alexander] Max Planck Inst Mol Genet, Dept Genome Regulat, Berlin, Germany; [Ziller, Michael J.] Max Planck Inst Psychiat, Dept Translat Psychiat, Munich, Germany; [Gifford, Casey A.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Cacchiarelli, Davide] Telethon Inst Genet & Med TIGEM, Armenise Harvard Lab Integrat Genom, Pozzuoli, Italy; [Rinn, John L.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Max Planck Society; University of California System; University of California San Francisco; The J David Gladstone Institutes; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Colorado System; University of Colorado Boulder	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Meissner, A (corresponding author), Max Planck Inst Mol Genet, Dept Genome Regulat, Berlin, Germany.	meissner@molgen.mpg.de	Cacchiarelli, Davide/AAC-2693-2022; Thakurela, Sudhir/AAU-6339-2021; Clement, Kendell/AAZ-6854-2021	Cacchiarelli, Davide/0000-0002-9621-6716; Thakurela, Sudhir/0000-0003-1285-8680; Chen, Jennifer/0000-0002-7808-2670; Gu, Hongcang/0000-0002-1439-7606; Gifford, Casey/0000-0002-7757-573X; Clement, Kendell/0000-0003-3808-0811; Karnik, Rahul/0000-0002-0400-635X	BMBF [01ZX1504]; Max-Planck-Society; New York Stem Cell Foundation; NIH [1P50HG006193]; Max Planck Society; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society(Max Planck Society); New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all members of the laboratory of A.M., specifically A. Tsankov for advice and experimental support. M.J.Z. is supported by BMBF grant 01ZX1504 and the Max-Planck-Society. A.M. is supported as a New York Stem Cell Foundation Robertson Investigator. This work was supported by the New York Stem Cell Foundation, NIH grant 1P50HG006193 and the Max Planck Society.	Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bossard P, 1998, DEVELOPMENT, V125, P4909; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Liu ZY, 2017, MOL CELL, V65, P589, DOI 10.1016/j.molcel.2017.01.017; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2013, EMBO J, V32, P318, DOI 10.1038/emboj.2012.349; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stark R., 2011, R PACKAGE VERSION, V100, P1; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Tuteja G, 2008, NUCLEIC ACIDS RES, V36, P4149, DOI 10.1093/nar/gkn366; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang A, 2015, CELL STEM CELL, V16, P386, DOI 10.1016/j.stem.2015.02.013; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2016, NAT GENET, V48, P1003, DOI 10.1038/ng.3635	49	82	83	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					250	+		10.1038/s41588-017-0034-3	http://dx.doi.org/10.1038/s41588-017-0034-3			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29358654	Green Published, Green Accepted			2022-12-17	WOS:000424519200016
J	Zhang, Y; Xiang, YL; Yin, QZ; Du, ZH; Peng, X; Wang, QJ; Fidalgo, M; Xia, WK; Li, YY; Zhao, ZA; Zhang, WH; Ma, J; Xu, F; Wang, JL; Li, L; Xie, W				Zhang, Yu; Xiang, Yunlong; Yin, Qiangzong; Du, Zhenhai; Peng, Xu; Wang, Qiujun; Fidalgo, Miguel; Xia, Weikun; Li, Yuanyuan; Zhao, Zhen-ao; Zhang, Wenhao; Ma, Jing; Xu, Feng; Wang, Jianlong; Li, Lei; Xie, Wei			Dynamic epigenomic landscapes during early lineage specification in mouse embryos	NATURE GENETICS			English	Article							NOVO DNA METHYLATION; EARLY SOMITE STAGE; REGULATORY REGIONS; STEM-CELLS; EXTRAEMBRYONIC LINEAGES; CHROMATIN ARCHITECTURE; MAMMALIAN DEVELOPMENT; TRANSCRIPTION FACTORS; EPIGENETIC MEMORY; HUMAN GENOME	In mammals, all somatic development originates from lineage segregation in early embryos. However, the dynamics of transcriptomes and epigenomes acting in concert with initial cell fate commitment remains poorly characterized. Here we report a comprehensive investigation of transcriptomes and base-resolution methylomes for early lineages in peri-and postimplantation mouse embryos. We found allele-specific and lineage-specific de novo methylation at CG and CH sites that led to differential methylation between embryonic and extraembryonic lineages at promoters of lineage regulators, gene bodies, and DNA-methylation valleys. By using Hi-C experiments to define chromatin architecture across the same developmental period, we demonstrated that both global demethylation and remethylation in early development correlate with chromatin compartments. Dynamic local methylation was evident during gastrulation, which enabled the identification of putative regulatory elements. Finally, we found that de novo methylation patterning does not strictly require implantation. These data reveal dynamic transcriptomes, DNA methylomes, and 3D chromatin landscapes during the earliest stages of mammalian lineage specification.	[Zhang, Yu; Xiang, Yunlong; Yin, Qiangzong; Du, Zhenhai; Wang, Qiujun; Xia, Weikun; Li, Yuanyuan; Zhang, Wenhao; Ma, Jing; Xie, Wei] Tsinghua Univ, Sch Life Sci, Ctr Stem Cell Biol & Regenerat Med, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Xiang, Yunlong; Du, Zhenhai; Wang, Qiujun; Xia, Weikun; Zhang, Wenhao; Xie, Wei] Tsinghua Univ, THU PKU Ctr Life Sci, Beijing, Peoples R China; [Peng, Xu; Xu, Feng] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Fidalgo, Miguel; Wang, Jianlong] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Fidalgo, Miguel; Wang, Jianlong] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY USA; [Zhao, Zhen-ao; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore	Tsinghua University; Tsinghua University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Institute of Zoology, CAS; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Xie, W (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Stem Cell Biol & Regenerat Med, MOE Key Lab Bioinformat, Beijing, Peoples R China.; Xie, W (corresponding author), Tsinghua Univ, THU PKU Ctr Life Sci, Beijing, Peoples R China.	xiewei121@tsinghua.edu.cn	Fidalgo, Miguel/I-7006-2019; Wang, Jianlong/AAG-9425-2020; Xia, Weikun/GXG-7930-2022; Wang, Jianlong/GQR-1191-2022; Zhang, Wenhao/AGZ-7068-2022	Fidalgo, Miguel/0000-0003-1134-2674; Wang, Jianlong/0000-0002-1317-6457; Zhang, Wenhao/0000-0002-3739-0415; Li, Lei/0000-0001-5478-5681; Xu, Feng/0000-0003-2016-7521	National Key R&D Program of China [2016YFC0900301, 2017YFC1001401]; National Basic Research Program of China [2015CB856201]; National Natural Science Foundation of China [31422031]; THU-PKU Center for Life Sciences; Beijing Advanced Innovation Center for Structural Biology; Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore; NIH [R01GM095942, R21HD087722]; New York State Department of Health (NYSTEM) [C028103, C028121]; Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087722] Funding Source: NIH RePORTER	National Key R&D Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); THU-PKU Center for Life Sciences; Beijing Advanced Innovation Center for Structural Biology; Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM); Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to members of the Xie laboratory for helpful comments during preparation of the manuscript. We thank J. Na for critical reading of the manuscript. This work was supported by the National Key R&D Program of China (2016YFC0900301 to W. Xie; 2017YFC1001401 to L.L.), the National Basic Research Program of China (2015CB856201 to W. Xie), the National Natural Science Foundation of China (31422031 to W. Xie), the THU-PKU Center for Life Sciences (W. Xie), Beijing Advanced Innovation Center for Structural Biology (W. Xie), and the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore (F.X.). W. Xie is a Howard Hughes Medical Institute (HHMI) International Research Scholar. J. W. was funded by grants from the NIH (R01GM095942 and R21HD087722) and the Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM) (C028103 and C028121), and is a recipient of an Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award.	Akdemir KC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0767-1; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ANG SL, 1993, DEVELOPMENT, V119, P1301; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; BEDDINGTON R, 1987, P43; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bossard P, 1998, DEVELOPMENT, V125, P4909; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Du ZH, 2017, NATURE, V547, P232, DOI 10.1038/nature23263; Gao F, 2017, CELL RES, V27, P526, DOI 10.1038/cr.2017.25; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Iwafuchi-Doi M, 2012, DEVELOPMENT, V139, P3926, DOI 10.1242/dev.085936; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LIBBUS BL, 1980, ANAT REC, V197, P317, DOI 10.1002/ar.1091970306; LIBBUS BL, 1980, ANAT EMBRYOL, V159, P235, DOI 10.1007/BF00304981; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morris SA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1671; Nagy A., 2006, CSH PROTOC; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Peat JR, 2014, CELL REP, V9, P1990, DOI 10.1016/j.celrep.2014.11.034; Peng X, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku818; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Schroeder DI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005442; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2017, NATURE, V549, P543, DOI 10.1038/nature23891; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zylicz JJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09571	73	82	85	7	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2018	50	1					96	+		10.1038/s41588-017-0003-x	http://dx.doi.org/10.1038/s41588-017-0003-x			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FT4XB	29203909				2022-12-17	WOS:000423157400013
J	Wang, ZM; McGlynn, KA; Rajpert-De Meyts, E; Bishop, DT; Chung, CC; Dalgaard, MD; Greene, MH; Gupta, R; Grotmol, T; Haugen, TB; Karlsson, R; Litchfield, K; Mitra, N; Nielsen, K; Pyle, LC; Schwartz, SM; Thorsson, V; Vardhanabhuti, S; Wiklund, F; Turnbull, C; Chanock, SJ; Kanetsky, PA; Nathanson, KL				Wang, Zhaoming; McGlynn, Katherine A.; Rajpert-De Meyts, Ewa; Bishop, D. Timothy; Chung, Charles C.; Dalgaard, Marlene D.; Greene, Mark H.; Gupta, Ramneek; Grotmol, Tom; Haugen, Trine B.; Karlsson, Robert; Litchfield, Kevin; Mitra, Nandita; Nielsen, Kasper; Pyle, Louise C.; Schwartz, Stephen M.; Thorsson, Vesteinn; Vardhanabhuti, Saran; Wiklund, Fredrik; Turnbull, Clare; Chanock, Stephen J.; Kanetsky, Peter A.; Nathanson, Katherine L.		Testicular Canc Consortium	Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor	NATURE GENETICS			English	Article							CARCINOMA IN-SITU; SUSCEPTIBILITY LOCI; CANCER INCIDENCE; FAMILIAL RISK; EXPRESSION; HERITABILITY; RELATIVES; COMPONENT; VARIANTS; DISEASE	The international Testicular Cancer Consortium (TECAC) combined five published genome-wide association studies of testicular germ cell tumor (TGCT; 3,558 cases and 13,970 controls) to identify new susceptibility loci. We conducted a fixed-effects meta-analysis, including, to our knowledge, the first analysis of the X chromosome. Eight new loci mapping to 2q14.2, 3q26.2, 4q35.2, 7q36.3, 10q26.13, 15q21.3, 15q22.31, and Xq28 achieved genome-wide significance (P < 5 x 10(-8)). Most loci harbor biologically plausible candidate genes. We refined previously reported associations at 9p24.3 and 19p12 by identifying one and three additional independent SNPs, respectively. In aggregate, the 39 independent markers identified to date explain 37% of father-to-son familial risk, 8% of which can be attributed to the 12 new signals reported here. Our findings substantially increase the number of known TGCT susceptibility alleles, move the field closer to a comprehensive understanding of the underlying genetic architecture of TGCT, and provide further clues to the etiology of TGCT.	[Wang, Zhaoming; McGlynn, Katherine A.; Chung, Charles C.; Greene, Mark H.; Schwartz, Stephen M.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Rajpert-De Meyts, Ewa; Dalgaard, Marlene D.] Copenhagen Univ Hosp, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Canc & Pathol, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Dalgaard, Marlene D.; Gupta, Ramneek; Nielsen, Kasper] Tech Univ Denmark, Dept Bio & Hlth Informat, Kongens Lyngby, Denmark; [Grotmol, Tom] Canc Registry Norway, Oslo, Norway; [Haugen, Trine B.] Oslo & Akershus Univ, Fac Hlth Sci, Coll Appl Sci, Oslo, Norway; [Karlsson, Robert; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Litchfield, Kevin; Turnbull, Clare] Inst Canc Res, Div Genet & Epidemiol, London, England; [Mitra, Nandita] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Pyle, Louise C.; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Med, Philadelphia, PA 19104 USA; [Pyle, Louise C.] Childrens Hosp Philadelphia, Div Human Genet & Metab, Philadelphia, PA 19104 USA; [Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Thorsson, Vesteinn] Inst Syst Biol, Seattle, WA USA; [Vardhanabhuti, Saran] Harvard Univ, Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Turnbull, Clare] Genom England, London, England; [Kanetsky, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Wang, Zhaoming] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rigshospitalet; University of Copenhagen; University of Leeds; Technical University of Denmark; University of Oslo; Oslo Metropolitan University (OsloMet); Karolinska Institutet; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fred Hutchinson Cancer Center; Institute for Systems Biology (ISB); Harvard University; Harvard T.H. Chan School of Public Health; H Lee Moffitt Cancer Center & Research Institute; University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital	Nathanson, KL (corresponding author), Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Med, Philadelphia, PA 19104 USA.; Nathanson, KL (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	knathans@exchange.upenn.edu	Kiemeney, Lambertus A./D-3357-2009; zhang, hongling/R-3737-2017; Turnbull, Clare/AAA-6596-2019; Pyle, Louise C/AAR-3513-2021; Wang, Zhaoming/R-5527-2018; Rajpert-De Meyts, Ewa/H-6526-2019; Gupta, Ramneek/G-7278-2012	Kiemeney, Lambertus A./0000-0002-2368-1326; Pyle, Louise C/0000-0002-8933-9320; Wang, Zhaoming/0000-0001-7556-3869; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Gietema, Jourik/0000-0003-0629-7354; Greene, Mark/0000-0003-1852-9239; Bishop, Tim/0000-0002-8752-8785; Lessel, Davor/0000-0003-4496-244X; Litchfield, Kevin/0000-0002-3725-0914; Nielsen, Kasper/0000-0002-5510-7767; Gupta, Ramneek/0000-0001-6841-6676; Cortessis, Victoria/0000-0002-2339-1089; Haugen, Trine Berit/0000-0002-8814-3393; Turnbull, Clare/0000-0002-1734-5772; Ferlin, Alberto/0000-0001-5817-8141	NCI Clinical Genetics Branch Familial Testicular Cancer Project [NCI 02-C-0178, NCT-00039598]; National Institutes of Health [U01CA164947]; Intramural Research Program of the National Cancer Institute; IMS, Inc. [HHSN26120130003C]; Abramson Cancer Center at the University of Pennsylvania; National Institute of Health [CA114478, T32-GM008638]; Institute of Cancer Research; Cancer Research UK [C588/A19167]; Movember Foundation; Norwegian Cancer Society [418975-71081-PR-2006-0387, PK01-20070375]; Nordic Cancer Union [S-12/07]; Swedish Cancer Society [2008/708, 2010/808, 2011/484, CAN2012/823]; Villum Kann Rasmussen Foundation; NABIIT grant from Danish Strategic Research Council; Novo Nordisk Foundation; Danish Cancer Society; Danish and Swedish Childhood Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA114478, ZIACP010126, P30CA016520, U01CA164947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008638] Funding Source: NIH RePORTER; MRC [G0700491] Funding Source: UKRI; Cancer Research UK [19167, 10589] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish	NCI Clinical Genetics Branch Familial Testicular Cancer Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); IMS, Inc.; Abramson Cancer Center at the University of Pennsylvania; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); Movember Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Nordic Cancer Union; Swedish Cancer Society(Swedish Cancer Society); Villum Kann Rasmussen Foundation(Villum Fonden); NABIIT grant from Danish Strategic Research Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish and Swedish Childhood Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does the mention of trade names, commercial products, or organizations indicate endorsement by the US government. We thank B. Weathers for her coordination of TECAC, J. Pluta for biostatistical assistance, and K. D'Andrea for expert assistance with SNP genotyping. We thank D.R. Stewart and J.T. Loud for critical support of the NCI Clinical Genetics Branch Familial Testicular Cancer Project (NCI 02-C-0178; NCT-00039598). We also thank all previous contributors to the GWAS analyzed in this study, including N. Weinhold, D. Edsgard, H. Leffers, and A. Juul, N.E. Skakkebaek, and S. Brunak from the Danish study.; The Testicular Cancer Consortium is supported by National Institutes of Health grant U01CA164947 to K.L.N., P.A.K., and S.M.S. A portion of this work was supported by the Intramural Research Program of the National Cancer Institute and by support services contract HHSN26120130003C with IMS, Inc. The Penn GWAS (Penn) was supported by the Abramson Cancer Center at the University of Pennsylvania and National Institute of Health grant CA114478 to K.L.N. and P.A.K. The UK testicular cancer study was supported by the Institute of Cancer Research, Cancer Research UK, and made use of control data generated by the Wellcome Trust Case Control Consortium 2 (WTCCC2). C.T. is supported by the Movember Foundation. K.L. is supported by a PhD fellowship from Cancer Research UK. L.C.P. is supported by the National Institutes of Health (T32-GM008638). The contribution from the University of Leeds was funded by Cancer Research UK (C588/A19167). The Norwegian/Swedish study was supported by the Norwegian Cancer Society (grants 418975-71081-PR-2006-0387 and PK01-20070375); the Nordic Cancer Union (grant S-12/07), and the Swedish Cancer Society (grants 2008/708, 2010/808, 2011/484, and CAN2012/823). The Danish GWAS was supported by the Villum Kann Rasmussen Foundation, a NABIIT grant from the Danish Strategic Research Council, the Novo Nordisk Foundation, the Danish Cancer Society, and the Danish and Swedish Childhood Cancer Foundation.	Ahopelto K, 2016, CANCER BIOL THER, V17, P163, DOI 10.1080/15384047.2015.1121347; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bromen K, 2004, CANCER EPIDEM BIOMAR, V13, P1316; Chia VM, 2009, INT J CANCER, V124, P952, DOI 10.1002/ijc.23971; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Crockford GP, 2006, HUM MOL GENET, V15, P443, DOI 10.1093/hmg/ddi459; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; Heimdal K, 1996, BRIT J CANCER, V73, P970, DOI 10.1038/bjc.1996.174; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Howlader N, 2015, SEER CANC STAT REV 1; Jayachandran A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2185-5; Jiao S, 2014, HUM MOL GENET, V23, P3898, DOI 10.1093/hmg/ddu087; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kayser G, 2011, PATHOLOGY, V43, P719, DOI 10.1097/PAT.0b013e32834c352b; Kim JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5588; Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010; Kristiansen W, 2015, HUM MOL GENET, V24, P4138, DOI 10.1093/hmg/ddv129; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9690; Litchfield K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13889; Litchfield K, 2015, HUM MOL GENET, V24, P1169, DOI 10.1093/hmg/ddu511; Mancuso N, 2016, NAT GENET, V48, P30, DOI 10.1038/ng.3446; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Schwaab J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-363; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Sonneveld DJA, 1999, EUR J CANCER, V35, P1368, DOI 10.1016/S0959-8049(99)00140-9; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Trabert B, 2015, ANDROLOGY-US, V3, P4, DOI 10.1111/andr.293; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; Wong YH, 2010, J NEUROSCI, V30, P4428, DOI 10.1523/JNEUROSCI.0473-10.2010; Yokoi F, 2003, J BIOCHEM, V133, P607, DOI 10.1093/jb/mvg078; Znaor A, 2014, EUR UROL, V65, P1095, DOI 10.1016/j.eururo.2013.11.004	50	82	83	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1141	+		10.1038/ng.3879	http://dx.doi.org/10.1038/ng.3879			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28604732	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000404253300026
J	Bellott, DW; Skaletsky, H; Cho, TJ; Brown, L; Locke, D; Chen, N; Galkina, S; Pyntikova, T; Koutseva, N; Graves, T; Kremitzki, C; Warren, WC; Clark, AG; Gaginskaya, E; Wilson, RK; Page, DC				Bellott, Daniel W.; Skaletsky, Helen; Cho, Ting -Jan; Brown, Laura; Locke, Devin; Chen, Nancy; Galkina, Svetlana; Pyntikova, Tatyana; Koutseva, Natalia; Graves, Tina; Kremitzki, Colin; Warren, Wesley C.; Clark, Andrew G.; Gaginskaya, Elena; Wilson, Richard K.; Page, David C.			Avian W and mammalian Y chromosomes convergently retained dosage-sensitive regulators	NATURE GENETICS			English	Article							HOMOMORPHIC SEX-CHROMOSOMES; HUMAN X-CHROMOSOME; CHICKEN Z; PURIFYING SELECTION; EVOLUTIONARY STRATA; GENE ACQUISITION; EXPRESSION; EMBRYOS; ABNORMALITIES; DEGENERATION	After birds diverged from mammals, different ancestral autosomes evolved into sex chromosomes in each lineage. In birds, females are ZW and males are ZZ, but in mammals females are XX and males are XY. We sequenced the chicken W chromosome, compared its gene content with our reconstruction of the ancestral autosomes, and followed the evolutionary trajectory of ancestral W-linked genes across birds. Avian W chromosomes evolved in parallel with mammalian Y chromosomes, preserving ancestral genes through selection to maintain the dosage of broadly expressed regulators of key cellular processes. We propose that, like the human Y chromosome, the chicken W chromosome is essential for embryonic viability of the heterogametic sex. Unlike other sequenced sex chromosomes, the chicken W chromosome did not acquire and amplify genes specifically expressed in reproductive tissues. We speculate that the pressures that drive the acquisition of reproduction-related genes on sex chromosomes may be specific to the male germ line.	[Bellott, Daniel W.; Skaletsky, Helen; Cho, Ting -Jan; Brown, Laura; Pyntikova, Tatyana; Koutseva, Natalia; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Bellott, Daniel W.; Page, David C.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Skaletsky, Helen; Brown, Laura; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Locke, Devin; Graves, Tina; Kremitzki, Colin; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Chen, Nancy; Clark, Andrew G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Chen, Nancy] Cornell Lab Ornithol, Ithaca, NY USA; [Chen, Nancy] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Galkina, Svetlana; Gaginskaya, Elena] St Petersburg State Univ, St Petersburg, Russia; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Washington University (WUSTL); Cornell University; Cornell University; University of California System; University of California Davis; Saint Petersburg State University; Cornell University	Page, DC (corresponding author), Whitehead Inst, Cambridge, MA 02142 USA.; Page, DC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Page, DC (corresponding author), Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Chen, Nancy/GSD-8813-2022; Galkina, Svetlana A./J-2493-2013; Gaginskaya, Elena/C-9963-2013; Galkina, Svetlana/P-2308-2019; Wilson, Richard K./AAF-4139-2019; Galkina, Svetlana/AAK-7179-2021	Galkina, Svetlana A./0000-0002-7034-2466; Gaginskaya, Elena/0000-0003-4967-9053; Galkina, Svetlana/0000-0002-7034-2466; Wilson, Richard K./0000-0002-1992-1358; Kremitzki, Colin/0000-0001-9175-3136; Chen, Nancy/0000-0001-8966-3449; Locke, Devin/0000-0002-2527-0475; Clark, Andrew/0000-0001-7159-8511	National Institutes of Health; Howard Hughes Medical Institute; Russian Foundation of Basic Research [16-04-01823a]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007587, R01HG000257, R01HG007852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Delany (University of California, Davis) for UCD001 DNA, A. Vignal and M. Morrison (INRA Toulouse) for ChickRH6 radiation hybrid panel DNA, M. Lovett (Washington University, St. Louis) for chicken embryonic fibroblasts, C. Friedman and B. Trask for flow-sorted chicken W chromosomes, F. McCarthy for permission to use the Chickspress RNA-seq data set (PRJNA204941), and the "Chromas" Saint-Petersburg University Resource Center and L. Rapoport for technical assistance. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute. S.G. and E.G. were supported by the Russian Foundation of Basic Research (grant 16-04-01823a).	Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; BLOOM SE, 1972, CHROMOSOMA, V37, P309, DOI 10.1007/BF00319873; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; CONWAY SJ, 1994, MAMM GENOME, V5, P203, DOI 10.1007/BF00360546; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dunford A, 2017, NAT GENET, V49, P10, DOI 10.1038/ng.3726; FECHHEIMER NS, 1981, POULTRY SCI, V60, P1365, DOI 10.3382/ps.0601365; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Handley LL, 2004, GENETICS, V167, P367, DOI 10.1534/genetics.167.1.367; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Kaiser VB, 2011, GENOME BIOL EVOL, V3, P1329, DOI 10.1093/gbe/evr103; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Li SB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0557-1; Mank JE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017715; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Moghadam HK, 2012, P NATL ACAD SCI USA, V109, P8207, DOI 10.1073/pnas.1202721109; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Skromne I, 2001, DEVELOPMENT, V128, P2915; Smeds L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8330; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110; White MA, 2015, MOL BIOL EVOL, V32, P1981, DOI 10.1093/molbev/msv078; Wright AE, 2014, EVOLUTION, V68, P3281, DOI 10.1111/evo.12493; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yazdi HP, 2014, MOL BIOL EVOL, V31, P1444, DOI 10.1093/molbev/msu101; Zhang JL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0062-9; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852; Zhou Q, 2014, SCIENCE, V346, P1332, DOI 10.1126/science.1246338; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	53	82	88	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					387	394		10.1038/ng.3778	http://dx.doi.org/10.1038/ng.3778			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	28135246	Green Accepted, Green Submitted			2022-12-17	WOS:000394917800012
J	Shaw, ND; Brand, H; Kupchinsky, ZA; Bengani, H; Plummer, L; Jones, TI; Erdin, S; Williamson, KA; Rainger, J; Stortchevoi, A; Samocha, K; Curra, BB; Dunican, DS; Collins, RL; Willer, JR; Lek, A; Lek, M; Nassan, M; Pereira, S; Kammin, T; Lucente, D; Silva, A; Seabra, CM; Chiang, C; Ana, Y; Ansari, M; Rainger, JK; Joss, S; Smith, JC; Lippincott, MF; Singh, SS; Patel, N; Jing, JW; Law, JR; Ferraro, N; Verloes, M; Rauch, A; Steindl, K; Zweier, M; Scheer, I; Sato, D; Okamoto, N; Jacobsen, C; Tryggestad, J; Chernausek, S; Schimmenti, LA; Brasseur, B; Cesaretti, C; Garcia-Ortiz, JE; Buitrago, TP; Silva, OP; Hoffman, JD; Muhlbauer, W; Ruprecht, KW; Loeys, BL; Shino, M; Kaind, AM; Cho, CH; Morton, CC; Meehan, RR; van Heyningen, V; Liao, EC; Balasubramanian, R; Hall, JE; Seminara, SB; Macarthur, D; Moore, SA; Yoshiura, K; Gusella, JF; Marsh, JA; Graham, JM; Lin, AE; Katsanis, N; Jones, PL; Crowley, WF; Davis, EE; FitzPatrick, DR; Talkowski, ME				Shaw, Natalie D.; Brand, Harrison; Kupchinsky, Zachary A.; Bengani, Hemant; Plummer, Lacey; Jones, Takako I.; Erdin, Serkan; Williamson, Kathleen A.; Rainger, Joe; Stortchevoi, Alexei; Samocha, Kaitlin; Curra, Benjamin B.; Dunican, Donncha S.; Collins, Ryan L.; Willer, Jason R.; Lek, Angela; Lek, Monkol; Nassan, Malik; Pereira, Shahrin; Kammin, Tammy; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Ansari, Morad; Rainger, Jacqueline K.; Joss, Shelagh; Smith, Jill Clayton; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Law, Jennifer R.; Ferraro, Nalton; Verloes, Main; Rauch, Anita; Steindl, Katharina; Zweier, Markus; Scheer, Ianina; Sato, Daisuke; Okamoto, Nobuhiko; Jacobsen, Christina; Tryggestad, Jeanie; Chernausek, Steven; Schimmenti, Lisa A.; Brasseur, Benjamin; Cesaretti, Claudia; Garcia-Ortiz, Jose E.; Pineda Buitrago, Tatiana; Perez Silva, Orlando; Hoffman, Jodi D.; Muehlbauer, Wolfgang; Ruprecht, Klaus W.; Loeys, Bart L.; Shino, Masato; Kaind, Angela M.; Cho, Chie-Hee; Morton, Cynthia C.; Meehan, Richard R.; van Heyningen, Veronica; Liao, Eric C.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Macarthur, Daniel; Moore, Steven A.; Yoshiura, Koh-ichiro; Gusella, James F.; Marsh, Joseph A.; Graham, John M., Jr.; Lin, Angela E.; Katsanis, Nicholas; Jones, Peter L.; Crowley, William F., Jr.; Davis, Erica E.; FitzPatrick, David R.; Talkowski, Michael E.			SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome	NATURE GENETICS			English	Article							X INACTIVATION; CHROMOSOME; EXPRESSION; DOMAIN; FSHD1; GNRH; METHYLATION; INHERITANCE; HYPOPLASIA; PREDICTION	Arhinia, or absence of the nose, is a rare malformation of unknown etiology that is often accompanied by ocular and reproductive defects. Sequencing of 40 people with arhinia revealed that 84% of probands harbor a missense mutation localized to a constrained region of SMCHD1 encompassing the ATPase domain. SMCHD1 mutations cause facioscapulohumeral muscular dystrophy type 2 (FSHD2) via a trans-acting loss-of function epigenetic mechanism. We discovered shared mutations and comparable DNA hypomethylation patterning between these distinct disorders. CRISPR/Cas9-mediated alteration of smchd1 in zebrafish yielded arhinia-relevant phenotypes. Transcriptome and protein analyses in arhinia probands and controls showed no differences in SMCHD1 mRNA or protein abundance but revealed regulatory changes in genes and pathways associated with craniofacial patterning. Mutations in SMCHD1 thus contribute to distinct phenotypic spectra, from craniofacial malformation and reproductive disorders to muscular dystrophy, which we speculate to be consistent with oligogenic mechanisms resulting in pleiotropic outcomes.	[Shaw, Natalie D.; Brand, Harrison; Plummer, Lacey; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Crowley, William F., Jr.] Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, Harvard Reprod Endocrine Sci Ctr, Boston, MA 02114 USA; [Shaw, Natalie D.; Brand, Harrison; Plummer, Lacey; Lippincott, Margaret F.; Singh, Sylvia S.; Patel, Nirav; Jing, Jenny W.; Balasubramanian, Ravikumar; Hall, Janet E.; Seminara, Stephanie B.; Crowley, William F., Jr.] Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, NICHD Ctr Excellence Translat Res Fertil & Infert, Boston, MA 02114 USA; [Shaw, Natalie D.; Hall, Janet E.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Brand, Harrison; Erdin, Serkan; Stortchevoi, Alexei; Curra, Benjamin B.; Collins, Ryan L.; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Brand, Harrison; Erdin, Serkan; Stortchevoi, Alexei; Curra, Benjamin B.; Collins, Ryan L.; Lucente, Diane; Silva, Alexandra; Seabra, Catarina M.; Chiang, Colby; Ana, Yu; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Brand, Harrison; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Samocha, Kaitlin; Lek, Monkol; Jacobsen, Christina; Liao, Eric C.; Lin, Angela E.; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02115 USA; [Brand, Harrison; Erdin, Serkan; Samocha, Kaitlin; Lek, Monkol; Morton, Cynthia C.; Macarthur, Daniel; Gusella, James F.; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kupchinsky, Zachary A.; Willer, Jason R.; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA; [Bengani, Hemant; Williamson, Kathleen A.; Rainger, Joe; Dunican, Donncha S.; Ansari, Morad; Rainger, Jacqueline K.; Meehan, Richard R.; van Heyningen, Veronica; Marsh, Joseph A.; FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Jones, Takako I.; Jones, Peter L.] Univ Massachusetts Med Sch, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Samocha, Kaitlin; Lek, Monkol; Macarthur, Daniel] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Collins, Ryan L.] Harvard Med Sch, Div Med Sci, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Lek, Angela; Gusella, James F.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Nassan, Malik] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Pereira, Shahrin; Kammin, Tammy; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Seabra, Catarina M.] Univ Porto, GABBA Program, Oporto, Portugal; [Joss, Shelagh] South Glasgow Univ Hosp, West Scotland Genet Serv, Glasgow, Lanark, Scotland; [Smith, Jill Clayton] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Fac Med & Human Sci,Inst Human Dev, Manchester, Lancs, England; [Law, Jennifer R.] Univ N Carolina, Div Pediat Endocrinol, Chapel Hill, NC 27514 USA; [Ferraro, Nalton] Boston Childrens Hosp, Dept Oral & Maxillofacial Surg, Boston, MA USA; [Verloes, Main] Robert Debre Hosp, Dept Genet, Paris, France; [Rauch, Anita; Steindl, Katharina; Zweier, Markus] Univ Zurich, Clin Res Prior Program Rare Dis, Inst Med Genet, Schlieren, Switzerland; [Rauch, Anita; Steindl, Katharina; Zweier, Markus] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, Schlieren, Switzerland; [Scheer, Ianina] Childrens Hosp, Dept Diagnost Imaging, Zurich, Switzerland; [Sato, Daisuke] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Jacobsen, Christina] Boston Childrens Hosp, Div Endocrinol & Genet, Boston, MA 02115 USA; [Tryggestad, Jeanie] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Schimmenti, Lisa A.] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN 55905 USA; [Schimmenti, Lisa A.] Mayo Clin, Dep Clin Genom, Rochester, MN 55905 USA; [Brasseur, Benjamin] Univ Miami, Leonard M Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL 33146 USA; [Cesaretti, Claudia] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Med Genet Unit, Milan, Italy; [Garcia-Ortiz, Jose E.] Inst Mexicano Seguro Social, Ctr Invest Biomed Occidente, Div Genet, Guadalajara, Mexico; [Pineda Buitrago, Tatiana] San Jose State Univ, Fdn Hosp Infantil, Bogota, Colombia; [Perez Silva, Orlando] Acad Nacl Med Colombia, Bogota, Colombia; [Hoffman, Jodi D.] Tufts Med Ctr, Div Genet, Boston, MA 02111 USA; [Hoffman, Jodi D.] Tufts Med Ctr, Div Maternal Fetal Med, Boston, MA 02111 USA; [Muehlbauer, Wolfgang] ATOS Klin, Dept Plast & Aesthet Surg, Munich, Germany; [Ruprecht, Klaus W.] Univ Hosp Saarland, Dept Ophthalmol, Homburg, Germany; [Loeys, Bart L.] Univ Antwerp, Ctr Med Genet, Antwerp, Belgium; [Loeys, Bart L.] Univ Antwerp Hosp, Antwerp, Belgium; [Shino, Masato] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Gunma, Japan; [Kaind, Angela M.] Charite, Biol & Neurobiol, Berlin, Germany; [Kaind, Angela M.] Berlin Inst Hlth, Berlin, Germany; [Cho, Chie-Hee] Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Liao, Eric C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Liao, Eric C.] Massachusetts Gen Hosp, Div Plast & Reconstruct Surg, Boston, MA 02114 USA; [Liao, Eric C.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Macarthur, Daniel; Talkowski, Michael E.] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA; [Moore, Steven A.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki, Japan; [Graham, John M., Jr.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Lin, Angela E.] MassGeneral Hosp Children, Med Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; University of Edinburgh; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Universidade do Porto; University of Manchester; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; Hokkaido University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Harvard University; Boston Children's Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; Mayo Clinic; University of Miami; IRCCS Ca Granda Ospedale Maggiore Policlinico; Instituto Mexicano del Seguro Social; Tufts Medical Center; Tufts Medical Center; Universitatsklinikum des Saarlandes; University of Antwerp; University of Antwerp; Gunma University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Bern; University Hospital of Bern; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iowa; Nagasaki University; Cedars Sinai Medical Center	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Davis, EE (corresponding author), Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA.; FitzPatrick, DR (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Talkowski, ME (corresponding author), Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA.	erica.davis@duke.edu; david.fitzpatrick@igmm.ed.ac.uk; talkowski@chgr.mgh.harvard.edu	Wang, Guilin/G-8794-2018; Seabra, Catarina/ABA-5591-2020; Erdin, Serkan/AAE-4288-2019; VAN HEYNINGEN, Veronica/GYE-0531-2022; Hall, Janet E/F-3516-2019; Loeys, Bart/B-3236-2017; Erdin, Serkan/B-4988-2008; Rauch, Anita/C-5568-2014; Cesaretti, Claudia/K-2633-2018; Graham, John M./J-1429-2019; shaw, natalie/C-3761-2019	Hall, Janet E/0000-0003-4644-3061; Loeys, Bart/0000-0003-3703-9518; Erdin, Serkan/0000-0001-6587-2625; Rauch, Anita/0000-0003-2930-3163; Cesaretti, Claudia/0000-0002-6819-0846; shaw, natalie/0000-0002-0847-9170; Liao, Eric/0000-0001-6385-7448; Moore, Steven/0000-0002-6353-7900; Ansari, Morad/0000-0002-8905-5379; Meehan, Richard/0000-0001-6471-6882; Marsh, Joseph/0000-0003-4132-0628; van Heyningen, Veronica/0000-0003-0359-0141; Lippincott, Margaret/0000-0002-3533-1999; , steven/0000-0003-4538-8793; Davis, Erica/0000-0002-2412-8397; Schimmenti, Lisa/0000-0003-3154-4249; Seabra, Catarina/0000-0003-2862-1979; Collins, Ryan/0000-0003-1268-9995; Willer, Jason/0000-0002-5869-3992; Talkowski, Michael/0000-0003-2889-0992; MacArthur, Daniel/0000-0002-5771-2290; Rainger, Joe/0000-0003-1091-5100; Samocha, Kaitlin/0000-0002-1704-3352; Kaindl, Angela/0000-0001-9454-206X; FitzPatrick, David R./0000-0003-4861-969X	National Institutes of Health ((NIH)) [R00MH095867, R01HD081256, P01GM061354, T32HD007396, P50HD028138]; MGH Robert and Laura Reynolds Research Scholar Award [R01HD043341]; March of Dimes [FY15-255]; Medical Research Council [MR/M02122X/1]; German Research Foundation [SFB665]; Berlin Institute of Health (BIH) [CRG1]; Medical Research Council (MRC) Human Genetics Unit award [MC_PC_U127574433]; University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund;  [K23HD073304-02];  [1SI2ES025429-01];  [P50DK096415];  [R01AR062587];  [U54-NS053672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081256, U54HD060848, T32HD007396, K23HD073304, R01HD043341, F32HD085857, K23HD077043, P50HD028138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093, MC_PC_U127574433, MC_PC_U127561093, MC_U127527199, MC_PC_U127527199] Funding Source: researchfish; Fight for Sight [1590/91] Funding Source: researchfish; MRC [MC_U127561093, MR/M02122X/1, MC_U127527199, MC_PC_U127527199, MC_PC_U127561093, MC_PC_U127574433] Funding Source: UKRI	National Institutes of Health ((NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Robert and Laura Reynolds Research Scholar Award; March of Dimes(March of Dimes); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation(German Research Foundation (DFG)); Berlin Institute of Health (BIH); Medical Research Council (MRC) Human Genetics Unit award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all participants, family members and clinical staff for their generous contributions of time and materials to this research. We thank T. Gillis, J. Ruliera, C. Hanscom, C. Antolik and M. Anderson for technical assistance. This project was funded by grants from the National Institutes of Health ((NIH) R00MH095867 and R01HD081256 to M.E.T.; P01GM061354 to M.E.T., J.F.G., C.C.M. and E.C.L.; T32HD007396 to H. Brand; P50HD028138 to W.F.C., S.B.S., M.E.T., N.K. and E.E.D.; R01HD043341 and MGH Robert and Laura Reynolds Research Scholar Award to S.B.S.; K23HD073304-02 and 1SI2ES025429-01 to N.D.S.; P50DK096415 to N.K. and R01AR062587 to P.L.J.); the March of Dimes (FY15-255 to M.E.T.); the Medical Research Council (MR/M02122X/1 to J.A.M.); the German Research Foundation (SFB665 to A.M.K.) and the Berlin Institute of Health (BIH-CRG1 to A.M.K.). D.R.F., R.R.M. (MC_PC_U127574433), D.S.D., H. Bengani, K.A.W., J.R., J.K.R. and J.A.M. are funded by program grants from the Medical Research Council (MRC) Human Genetics Unit award to the University of Edinburgh. M.A. is funded by the University of Edinburgh Institute of Genomics and Molecular Medicine Translational Initiative Fund. S.A.M. is supported by U54-NS053672, which funds the Iowa, Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. N.K. is supported as a Distinguished Jean and George Brumley Professor at Duke University, and M.E.T. is supported as the Desmond and Ann Heathwood MGH Research Scholar.	Abraham E, 2009, GEN COMP ENDOCR, V164, P151, DOI 10.1016/j.ygcen.2009.01.012; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; BOSMA JF, 1981, J CRAN GENET DEV BIO, V1, P153; Calandra P, 2016, J MED GENET, V53, P348, DOI 10.1136/jmedgenet-2015-103436; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chassaing N, 2016, GENOME RES, V26, P474, DOI 10.1101/gr.196048.115; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen KL, 2016, BIOCHEM J, V473, P1733, DOI 10.1042/BCJ20160189; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; Cho CH, 2006, ORAL MAXILLOFAC SURG, V10, P106, DOI 10.1007/s10006-006-0680-6; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gordon C. T., 2016, NAT GENET; Hall JG, 2009, BIRTH DEFECTS RES A, V85, P677, DOI 10.1002/bdra.20611; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Jones TI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0072-6; Jones TI, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-23; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemmers RJLF, 2015, HUM MUTAT, V36, P679, DOI 10.1002/humu.22792; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; Liu CQ, 2016, HUM MOL GENET, V25, P1382, DOI 10.1093/hmg/ddw020; Mould AW, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-19; Parhar IS, 2002, PROG BRAIN RES, V141, P3; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schmidt-Sidor B, 2009, FOLIA NEUROPATHOL, V47, P371; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Solomon B. D., GENEREVIEWS; Solomon BD, 2009, AM J MED GENET A, V149A, P2543, DOI 10.1002/ajmg.a.33081; Steven C, 2003, GEN COMP ENDOCR, V133, P27, DOI 10.1016/S0016-6480(03)00144-8; Thiele H, 1996, AM J MED GENET, V63, P310, DOI 10.1002/(SICI)1096-8628(19960503)63:1<310::AID-AJMG51>3.0.CO;2-N; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; van den Boogaard ML, 2016, AM J HUM GENET, V98, P1020, DOI 10.1016/j.ajhg.2016.03.013; van den Boogaard ML, 2016, EUR J HUM GENET, V24, P78, DOI 10.1038/ejhg.2015.55; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; Whitlock KE, 2006, MOL CELL ENDOCRINOL, V254, P39, DOI 10.1016/j.mce.2006.04.038; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	52	82	83	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					238	248		10.1038/ng.3743	http://dx.doi.org/10.1038/ng.3743			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067909	Green Accepted, Green Submitted			2022-12-17	WOS:000393148600012
J	Youssef, HM; Eggert, K; Kopplu, R; Alqudah, AM; Poursarebani, N; Fazeli, A; Sakuma, S; Tagiri, A; Rutten, T; Govind, G; Lundqvist, U; Graner, A; Komatsuda, T; Sreenivasulu, N; Schnurbusch, T				Youssef, Helmy M.; Eggert, Kai; Kopplu, Ravi; Alqudah, Ahmad M.; Poursarebani, Naser; Fazeli, Arash; Sakuma, Shun; Tagiri, Akemi; Rutten, Twan; Govind, Geetha; Lundqvist, Udda; Graner, Andreas; Komatsuda, Takao; Sreenivasulu, Nese; Schnurbusch, Thorsten			VRS2 regulates hormone-mediated inflorescence patterning in barley	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; AUXIN BIOSYNTHESIS; GENES; CYTOKININ; DOMESTICATION; GIBBERELLINS; MORPHOLOGY; HOMOLOG; RICE; CELL	Plant architecture has clear agronomic and economic implications for crops such as wheat and barley, as it is a critical factor for determining grain yield. Despite this, only limited molecular information is available about how grain-bearing inflorescences, called spikes, are formed and maintain their regular, distichous pattern. Here we elucidate the molecular and hormonal role of Six-rowed spike 2 (Vrs2), which encodes a SHORT INTERNODES (SHI) transcriptional regulator during barley inflorescence and shoot development. We show that Vrs2 is specifically involved in floral organ patterning and phase duration by maintaining hormonal homeostasis and gradients during normal spike development and similarly influences plant stature traits. Furthermore, we establish a link between the SHI protein family and sucrose metabolism during organ growth and development that may have implications for deeper molecular insights into inflorescence and plant architecture in crops.	[Youssef, Helmy M.; Eggert, Kai; Kopplu, Ravi; Alqudah, Ahmad M.; Poursarebani, Naser; Sakuma, Shun; Rutten, Twan; Govind, Geetha; Graner, Andreas; Sreenivasulu, Nese; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Youssef, Helmy M.] Cairo Univ, Fac Agr, Giza, Egypt; [Fazeli, Arash] Ilam Univ, Dept Agron & Plant Breeding, Fac Agr, Ilam, Iran; [Sakuma, Shun] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa, Japan; [Tagiri, Akemi; Komatsuda, Takao] NIAS, Tsukuba, Ibaraki, Japan; [Govind, Geetha] Reliance Corp Pk, Reliance R&D Ctr, Ghansoli, Navi Mumbai, India; [Lundqvist, Udda] Nord Genet Resource Ctr NordGen, Alnarp, Sweden; [Sreenivasulu, Nese] IRRI, Grain Qual & Nutr Ctr, Manila, Philippines	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Egyptian Knowledge Bank (EKB); Cairo University; Yokohama City University; National Institute of Agrobiological Sciences - Japan; CGIAR; International Rice Research Institute (IRRI)	Youssef, HM; Schnurbusch, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.; Youssef, HM (corresponding author), Cairo Univ, Fac Agr, Giza, Egypt.	Youssef@ipk-gatersleben.de; thor@ipk-gatersleben.de	Alqudah, Ahmad M./I-7062-2012; Sakuma, Shun/AAH-6260-2020; Sakuma, Shun/C-5719-2019; Koppolu, Ravi/AAJ-6633-2021; Schnurbusch, Thorsten/B-2249-2009; Sreenivasulu, Nese/E-8600-2011; Govind, Geetha/AAB-3203-2021	Alqudah, Ahmad M./0000-0002-0436-9724; Sakuma, Shun/0000-0003-1622-5346; Sakuma, Shun/0000-0003-1622-5346; Schnurbusch, Thorsten/0000-0002-5267-0677; Sreenivasulu, Nese/0000-0002-3998-038X; Govind, Geetha/0000-0003-0450-0814; Koppolu, Ravi/0000-0001-8566-9501; Youssef, Helmy/0000-0003-4957-4040; Rutten, Twan/0000-0001-5891-6503; Graner, Andreas/0000-0003-3246-6393; Tagiri, Akemi/0000-0002-6445-2335	Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan [TRS1002]; HEISENBERG Program of the German Research Foundation (DFG) [SCHN 768/8-1, SCHN 768/9-1]	Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan; HEISENBERG Program of the German Research Foundation (DFG)(German Research Foundation (DFG))	We thank the US Department of Agriculture-Agricultural Research Service (USDA-ARS); the National Small Grains Collection, Aberdeen (ID); the Nordic Genetic Resources Center (NordGen), Alnarp, Sweden; and the IPK Genebank, Germany, for providing the mutants and germ plasm for haplotype analysis. We thank J. Thiel for help with the quantitative real-time PCR analyses; S. Beier and M. Mascher for bioinformatics support; the IBGSC for prepublication access to barley sequence information of chromosome 5H; and S. Konig, I. Walde, H. Ibrahim, C. Trautewig, M. Piirschel, K. Lipfert, H. Ernst, B. Kettig, D. Bohmert and Y.A.T. Moya for excellent technical support. We also would like to thank the anonymous reviewers for their constructive and supportive evaluations while improving this manuscript. This work was supported by grants from the Genomics for Agricultural Innovation Program of the Ministry of Agriculture, Forestry, and Fisheries of Japan, grant TRS1002, to T.K. and the HEISENBERG Program of the German Research Foundation (DFG), grants SCHN 768/8-1 and SCHN 768/9-1, to.T.S.	Baylis T, 2013, NEW PHYTOL, V197, P737, DOI 10.1111/nph.12084; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Boden SA, 2014, PLANT CELL, V26, P1557, DOI 10.1105/tpc.114.123794; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.010388; Gaillochet C, 2015, CURR OPIN PLANT BIOL, V23, P91, DOI 10.1016/j.pbi.2014.11.002; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; King RW, 2006, PLANT PHYSIOL, V141, P498, DOI 10.1104/pp.106.076760; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Kuusk S, 2006, PLANT J, V47, P99, DOI 10.1111/j.1365-313X.2006.02774.x; Matsoukas IG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00218; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Staldal V, 2012, PLANT MOL BIOL, V78, P545, DOI 10.1007/s11103-012-9888-z; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Wang Q, 2014, PLANT CELL, V26, P2068, DOI 10.1105/tpc.114.123059; Wang Y, 2014, PLANT CELL, V26, P2055, DOI 10.1105/tpc.114.123083; Yuo T, 2012, J EXP BOT, V63, P5223, DOI 10.1093/jxb/ers182; Zhang DB, 2014, ANNU REV PLANT BIOL, V65, P553, DOI 10.1146/annurev-arplant-050213-040104; Zhang R, 2008, J INTEGR PLANT BIOL, V50, P1070, DOI 10.1111/j.1744-7909.2008.00729.x; Zhu HF, 2005, PLANT MOL BIOL, V59, P581, DOI 10.1007/s11103-005-0183-0	29	82	88	6	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					157	161		10.1038/ng.3717	http://dx.doi.org/10.1038/ng.3717			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841879				2022-12-17	WOS:000390976600023
J	Wang, CL; Zhan, XW; Bragg-Gresham, J; Kang, HM; Stambolian, D; Chew, EY; Branham, KE; Heckenlively, J; Fulton, R; Wilson, RK; Mardis, ER; Lin, XH; Swaroop, A; Zollner, S; Abecasis, GR				Wang, Chaolong; Zhan, Xiaowei; Bragg-Gresham, Jennifer; Kang, Hyun Min; Stambolian, Dwight; Chew, Emily Y.; Branham, Kari E.; Heckenlively, John; Fulton, Robert; Wilson, Richard K.; Mardis, Elaine R.; Lin, Xihong; Swaroop, Anand; Zoellner, Sebastian; Abecasis, Goncalo R.		FUSION Study	Ancestry estimation and control of population stratification for sequence-based association studies	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; MACULAR DEGENERATION; GENETIC-VARIATION; STRUCTURED POPULATIONS; CANDIDATE GENES; COMPLEX TRAITS; RARE VARIANTS; LARGE-SCALE; DISEASE	Estimating individual ancestry is important in genetic association studies where population structure leads to false positive signals, although assigning ancestry remains challenging with targeted sequence data. We propose a new method for the accurate estimation of individual genetic ancestry, based on direct analysis of off-target sequence reads, and implement our method in the publicly available LASER software. We validate the method using simulated and empirical data and show that the method can accurately infer worldwide continental ancestry when used with sequencing data sets with whole-genome shotgun coverage as low as 0.001x. For estimates of fine-scale ancestry within Europe, the method performs well with coverage of 0.1x. On an even finer scale, the method improves discrimination between exome-sequenced study participants originating from different provinces within Finland. Finally, we show that our method can be used to improve case-control matching in genetic association studies and to reduce the risk of spurious findings due to population structure.	[Wang, Chaolong; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Chaolong; Zhan, Xiaowei; Bragg-Gresham, Jennifer; Kang, Hyun Min; Zoellner, Sebastian; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Stambolian, Dwight] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Chew, Emily Y.] NEI, Div Epidemiol & Clin Res, Bethesda, MD USA; [Branham, Kari E.; Heckenlively, John] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48105 USA; [Fulton, Robert; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD USA; [Zoellner, Sebastian] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan	Wang, CL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	chaolong@umich.edu; goncalo@umich.edu	Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Branham, Kari/AAA-8336-2022	Wilson, Richard K./0000-0002-1992-1358; Wang, Chaolong/0000-0003-3945-1012; Swaroop, Anand/0000-0002-1975-1141; Branham, Kari/0000-0002-2492-254X	Howard Hughes Medical Institute International Student Research Fellowship; US National Institutes of Health [DK062370, HG000376, HG005552, HG006513, EY022005, HG007022, HG005855, HG003079, CA076404, CA134294]; National Eye Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [P01CA134294, R37CA076404, R01CA076404, R29CA076404] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000475, ZIAEY000485, R01EY022005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005855, RC2HG005552, R29HG000376, R01HG007022, U01HG006513, R01HG000376, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062370, R01DK062370] Funding Source: NIH RePORTER	Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank investigators from the FUSION study and the GoT2D Sequencing Project for generously sharing whole-genome and deep exome sequence data for 941 individuals before publication and the D2D, Finrisk 2002, Health 2000, Action LADA and Saviatipale studies for providing some of the FUSIONsequenced DNA. We thank J.Z. Li for his assistance with the HGDP data set, H. Stringham and A. Locke for assistance with the FUSION data set and M. Brooks for organizing the macular degeneration samples. C.W. acknowledges funding support from a Howard Hughes Medical Institute International Student Research Fellowship. This study is supported by the US National Institutes of Health (DK062370, HG000376, HG005552, HG006513, EY022005, HG007022, HG005855, HG003079, CA076404 and CA134294) and by the National Eye Institute Intramural Research Program.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Guan WH, 2009, GENET EPIDEMIOL, V33, P508, DOI 10.1002/gepi.20403; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miclaus K, 2009, GENET EPIDEMIOL, V33, P488, DOI 10.1002/gepi.20401; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; SCHONEMANN PH, 1970, PSYCHOMETRIKA, V35, P245, DOI 10.1007/BF02291266; Shen PD, 2011, P NATL ACAD SCI USA, V108, P6549, DOI 10.1073/pnas.1018981108; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863	52	82	83	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					409	+		10.1038/ng.2924	http://dx.doi.org/10.1038/ng.2924			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24633160	Green Accepted			2022-12-17	WOS:000334510100021
J	Fujimoto, A; Nakagawa, H; Hosono, N; Nakano, K; Abe, T; Boroevich, KA; Nagasaki, M; Yamaguchi, R; Shibuya, T; Kubo, M; Miyano, S; Nakamura, Y; Tsunoda, T				Fujimoto, Akihiro; Nakagawa, Hidewaki; Hosono, Naoya; Nakano, Kaoru; Abe, Tetsuo; Boroevich, Keith A.; Nagasaki, Masao; Yamaguchi, Rui; Shibuya, Tetsuo; Kubo, Michiaki; Miyano, Satoru; Nakamura, Yusuke; Tsunoda, Tatsuhiko			Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing	NATURE GENETICS			English	Article							COPY-NUMBER; SHORT-READ; RARE VARIANTS; GENE; SNPS; SUSCEPTIBILITY; ASSOCIATION; GENERATION; ALIGNMENT; ALLELE	We report the analysis of a Japanese male using high-throughput sequencing to x40 coverage. More than 99% of the sequence reads were mapped to the reference human genome. Using a Bayesian decision method, we identified 3,132,608 single nucleotide variations (SNVs). Comparison with six previously reported genomes revealed an excess of singleton nonsense and nonsynonymous SNVs, as well as singleton SNVs in conserved non-coding regions. We also identified 5,319 deletions smaller than 10 kb with high accuracy, in addition to copy number variations and rearrangements. De novo assembly of the unmapped sequence reads generated around 3 Mb of novel sequence, which showed high similarity to non-reference human genomes and the human herpesvirus 4 genome. Our analysis suggests that considerable variation remains undiscovered in the human genome and that whole-genome sequencing is an invaluable tool for obtaining a complete understanding of human genetic variation.	[Fujimoto, Akihiro; Nakagawa, Hidewaki; Hosono, Naoya; Nakano, Kaoru; Abe, Tetsuo; Boroevich, Keith A.; Kubo, Michiaki; Nakamura, Yusuke; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Fujimoto, Akihiro; Miyano, Satoru; Tsunoda, Tatsuhiko] RIKEN, Computat Sci Res Program, Data Anal Fus Team, Tokyo, Japan; [Nagasaki, Masao; Yamaguchi, Rui; Shibuya, Tetsuo; Miyano, Satoru; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan	RIKEN; RIKEN; University of Tokyo	Tsunoda, T (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	hidewaki@ims.u-tokyo.ac.jp; tsunoda@src.riken.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Nagasaki, Masao/0000-0002-4292-8785; Boroevich, Keith/0000-0001-7095-7332; Miyano, Satoru/0000-0002-1753-6616	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K.Misawa for comments on the manuscript. This study was supported in part by the National Project on 'Next-generation Integrated Living Matter Simulation' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The super-computing resource was provided by the Human Genome Center, University of Tokyo, Japan (http://sc.hgc.jp/shirokane.html).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Tsend-Ayush E, 2004, GENOMICS, V83, P193, DOI 10.1016/j.ygeno.2003.08.012; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	49	82	90	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					931	U39		10.1038/ng.691	http://dx.doi.org/10.1038/ng.691			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972442				2022-12-17	WOS:000283540500009
J	Marsh, V; Winton, DJ; Williams, GT; Dubois, N; Trumpp, A; Sansom, OJ; Clarke, AR				Marsh, Victoria; Winton, Douglas J.; Williams, Geraint T.; Dubois, Nicole; Trumpp, Andreas; Sansom, Owen J.; Clarke, Alan R.			Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation	NATURE GENETICS			English	Article							GENE-EXPRESSION; DEFICIENCY; CRE; NEOPLASIA; DELETION; LEADS; RECOMBINATION; PROSTATE; DEFECTS; CANCER	PTEN acts as a tumor suppressor in a range of tissue types and has been implicated in the regulation of intestinal stem cells. To study Pten function in the intestine, we used various conditional transgenic strategies to specifically delete Pten from the mouse intestinal epithelium. We show that Pten loss specifically within the adult or embryonic epithelial cell population does not affect the normal architecture or homeostasis of the epithelium. However, loss of Pten in the context of Apc deficiency accelerates tumorigenesis through increased activation of Akt, leading to rapid development of adenocarcinoma. We conclude that Pten is redundant in otherwise normal intestinal epithelium and epithelial stem cells but, in the context of activated Wnt signaling, suppresses progression to adenocarcinoma through modulation of activated Akt levels.	[Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Marsh, Victoria; Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Winton, Douglas J.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Williams, Geraint T.] Cardiff Univ, Wales Coll Med, Cardiff CF14 4XN, S Glam, Wales; [Dubois, Nicole; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Epalinges, Switzerland	Beatson Institute; Cardiff University; CRUK Cambridge Institute; University of Cambridge; Cardiff University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Parry, Lee/A-9623-2011; Clarke, Alan R/A-6256-2008; Trumpp, Andreas/Z-2141-2019; clarke, alan r/P-2820-2014	Parry, Lee/0000-0002-4467-9196; Trumpp, Andreas/0000-0002-6212-3466; Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X	Cancer Research UK; Wales Gene Park; Swiss National Science Foundation; Swiss Cancer League; EU; Medical Research Council [G0301154] Funding Source: researchfish; MRC [G0301154] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Wales Gene Park; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Bishop, L. Pietzka and D. Scarborough for technical assistance and R. Kemp for assistance with the epithelial extraction protocol. Villin-CreER<SUP>T2</SUP> mice were provided by S. Robine (Center National de la Recherche Scientifique/ Institut Curie). This work was supported by Cancer Research UK and the Wales Gene Park and by grants to A.T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU FP6 INTACT program and the EU FP7 program 'Eurosystem'.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Bjerknes M, 2005, NAT GENET, V37, P1016, DOI 10.1038/ng1005-1016; CARLSON GJ, 1984, AM J SURG PATHOL, V8, P763, DOI 10.1097/00000478-198410000-00005; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jansen M, 2006, GUT, V55, P1, DOI 10.1136/gut.2005.069062; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Li DM, 1997, CANCER RES, V57, P2124; Li G, 2002, DEVELOPMENT, V129, P4159; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Merg A, 2004, AM J MED GENET C, V129C, P44, DOI 10.1002/ajmg.c.30020; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sansom OJ, 2005, ONCOGENE, V24, P8205, DOI 10.1038/sj.onc.1208956; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2003, ONCOGENE, V22, P7130, DOI 10.1038/sj.onc.1206850; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	39	82	85	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1436	1444		10.1038/ng.256	http://dx.doi.org/10.1038/ng.256			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19011632				2022-12-17	WOS:000261215900020
J	Richards, JB; Yuan, X; Geller, F; Waterworth, D; Bataille, V; Glass, D; Song, K; Waeber, G; Vollenweider, P; Aben, KKH; Kiemeney, LA; Walters, B; Soranzo, N; Thorsteinsdottir, U; Kong, A; Rafnar, T; Deloukas, P; Sulem, P; Stefansson, H; Stefansson, K; Spector, TD; Mooser, V				Richards, J. Brent; Yuan, Xin; Geller, Frank; Waterworth, Dawn; Bataille, Veronique; Glass, Daniel; Song, Kijoung; Waeber, Gerard; Vollenweider, Peter; Aben, Katja K. H.; Kiemeney, Lambertus A.; Walters, Bragi; Soranzo, Nicole; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Deloukas, Panos; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari; Spector, Tim D.; Mooser, Vincent			Male-pattern baldness susceptibility locus at 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; HAIR FOLLICLE; ALOPECIA; POLYMORPHISM; ASSOCIATION; RISK	We conducted a genome-wide association study for androgenic alopecia in 1,125 men and identified a newly associated locus at chromosome 20p11.22, confirmed in three independent cohorts (n = 1,650; OR = 1.60, P = 1.1 x 10(-14) for rs1160312). The one man in seven who harbors risk alleles at both 20p11.22 and AR (encoding the androgen receptor) has a sevenfold-increased odds of androgenic alopecia (OR = 7.12, P = 3.7 x 10(-15)).	[Richards, J. Brent; Bataille, Veronique; Glass, Daniel; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Richards, J. Brent] McGill Univ, Fac Med, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Yuan, Xin; Waterworth, Dawn; Song, Kijoung; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, King Of Prussia, PA 19406 USA; [Geller, Frank; Walters, Bragi; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Waeber, Gerard; Vollenweider, Peter] CHUV Univ Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Comprehens Canc Ctr IKO, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 GA Nijmegen, Netherlands; [Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of London; King's College London; McGill University; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Wellcome Trust Sanger Institute	Spector, TD (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.	tim.spector@kcl.ac.uk	Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Richards, J Brent/AAF-4225-2019; Walters, G. Bragi/L-4215-2013; Deloukas, Panos/B-2922-2013; Colaus, PsyColaus/K-6607-2013; Stefansson, Kari/AAE-7187-2019	Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Richards, J Brent/0000-0002-3746-9086; Walters, G. Bragi/0000-0002-5415-6487; Deloukas, Panos/0000-0001-9251-070X; Stefansson, Hreinn/0000-0002-9331-6666; Waeber, Gerard/0000-0003-4193-788X; Kong, Augustine/0000-0001-8193-5438; Soranzo, Nicole/0000-0003-1095-3852; Geller, Frank/0000-0002-9238-3269	GlaxoSmithKline; deCODE Genetics; Wellcome Trust; NIHR Biomedical Research Centre; Chronic Disease Research Foundation; Canadian Institutes of Health Research; EU [018827]	GlaxoSmithKline(GlaxoSmithKline); deCODE Genetics; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Chronic Disease Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EU(European Commission)	We wish to acknowledge the cooperation and dedication of the study participants and the personnel at the recruitment centers and core facilities. We would like to acknowledge the genotyping contributions of D. Smyth and J. Todd. This study was funded in part by GlaxoSmithKline; deCODE Genetics; the Wellcome Trust; NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London); the Chronic Disease Research Foundation; the Canadian Institutes of Health Research (J. B. R.) and the Sixth Framework Program of the EU contract number 018827 (Polygene).	CASH TF, 1993, J AM ACAD DERMATOL, V29, P568, DOI 10.1016/0190-9622(93)70223-G; Domashenko A, 2000, NAT BIOTECHNOL, V18, P420, DOI 10.1038/74480; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; LI LN, 1995, NAT MED, V1, P705, DOI 10.1038/nm0795-705; Littman AJ, 2005, ANN EPIDEMIOL, V15, P771, DOI 10.1016/j.annepidem.2005.02.013; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Olsen E.A., 1994, DISORDERS HAIR GROWT, P257; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1	14	82	84	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1282	1284		10.1038/ng.255	http://dx.doi.org/10.1038/ng.255			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849991	Green Accepted, Green Published			2022-12-17	WOS:000260501500017
J	Damian, D; Gorfine, M				Damian, D; Gorfine, M			Statistical concerns about the GSEA procedure	NATURE GENETICS			English	Letter									Beyond Genom, Waltham, MA 02154 USA; Bar Ilan Univ, Dept Math & Stat, IL-52900 Ramat Gan, Israel	Bar Ilan University	Damian, D (corresponding author), Beyond Genom, Waltham, MA 02154 USA.	ddamian@beyondgenomics.com	Gorfine, Malka/AAD-1468-2022; Gorfine, Malka/AAV-1242-2021					Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180	1	82	84	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					663	663		10.1038/ng0704-663a	http://dx.doi.org/10.1038/ng0704-663a			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15226741	Bronze			2022-12-17	WOS:000222354100002
J	Xu, X; Leo, C; Jang, YJ; Chan, E; Padilla, D; Huang, BCB; Lin, T; Gururaja, T; Hitoshi, Y; Lorens, JB; Anderson, DC; Sikic, B; Luo, Y; Payan, DG; Nolan, GP				Xu, X; Leo, C; Jang, YJ; Chan, E; Padilla, D; Huang, BCB; Lin, T; Gururaja, T; Hitoshi, Y; Lorens, JB; Anderson, DC; Sikic, B; Luo, Y; Payan, DG; Nolan, GP			Dominant effector genetics in mammalian cells	NATURE GENETICS			English	Article							HEAT-SHOCK-FACTOR; VIRUS-X PROTEIN; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PROTEASOME INHIBITORS; SUPPRESSOR ELEMENTS; PHAGE DISPLAY; SUBUNIT-ZETA; EXPRESSION; ACTIVATION	We have expressed libraries of peptides in mammalian cells to select for trans-dominant effects on intracellular signaling systems. As an example-and to reveal pharmacologically relevant points in pathways that lead to Taxol resistance-we selected for peptide motifs that confer resistance to Taxol-induced cell death. Of several peptides selected, one, termed RGP8.5, was linked to upregulation of expression of the gene ABCB1 (also known as MDR1, for multiple drug resistance) in HeLa cells. Our data indicate that trans-dominant effector peptides can point to potential mechanisms by which signaling systems operate. Such tools may be useful in functional genomic analysis of signaling pathways in mammalian disease processes.	Rigel Inc, San Francisco, CA USA; Stanford Univ, Dept Microbiol & Immunol, Dept Mol Pharmacol, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med Oncol, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Xu, X (corresponding author), Rigel Inc, San Francisco, CA USA.		Nolan, Garry/AAE-7903-2019; Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349; Nolan, Garry/0000-0002-8862-9043				Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; BELLOREUSS E, 1994, AM J PHYSIOL-CELL PH, V267, pC1351, DOI 10.1152/ajpcell.1994.267.5.C1351; Blum JH, 2000, P NATL ACAD SCI USA, V97, P2241, DOI 10.1073/pnas.040573397; BODENMULLER H, 1986, EMBO J, V5, P1825, DOI 10.1002/j.1460-2075.1986.tb04433.x; Cabilly S, 1999, MOL BIOTECHNOL, V12, P143, DOI 10.1385/MB:12:2:143; Caponigro G, 1998, P NATL ACAD SCI USA, V95, P7508, DOI 10.1073/pnas.95.13.7508; CASTRO B, 1975, TETRAHEDRON LETT, V14, P1219; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Doong SL, 1998, J HEPATOL, V29, P872, DOI 10.1016/S0168-8278(98)80113-X; Dumontet C, 1996, CANCER RES, V56, P1091; Gallagher WM, 1997, ONCOGENE, V14, P185; Gao YH, 2000, J CLIN INVEST, V106, P439, DOI 10.1172/JCI9826; Groettrup M, 1999, DRUG DISCOV TODAY, V4, P63, DOI 10.1016/S1359-6446(98)01292-6; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Gururaja TL, 1996, PEPTIDE RES, V9, P283; Gururaja TL, 2000, CHEM BIOL, V7, P515, DOI 10.1016/S1074-5521(00)00137-X; HART SM, 1993, LEUKEMIA LYMPHOMA, V11, P239, DOI 10.3109/10428199309087001; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Huang JK, 1996, J VIROL, V70, P5582, DOI 10.1128/JVI.70.8.5582-5591.1996; Huang Y, 1997, LEUKEMIA, V11, P253, DOI 10.1038/sj.leu.2400557; Jorgensen L, 1999, MOL BIOL REP, V26, P119, DOI 10.1023/A:1006965602142; Kania MA, 1996, EUR J BIOCHEM, V236, P510, DOI 10.1111/j.1432-1033.1996.00510.x; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kaye Stanley B., 1998, Current Opinion in Oncology, V10, pS15; Kim SH, 1997, CANCER LETT, V115, P9, DOI 10.1016/S0304-3835(97)04725-3; Klimka A, 1999, BRIT J CANCER, V80, P1214, DOI 10.1038/sj.bjc.6690488; Kundu B, 1999, Prog Drug Res, V53, P89; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEE JS, 1994, MOL PHARMACOL, V46, P627; Leith C, 1998, Curr Opin Hematol, V5, P287; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Mechetner E, 1998, CLIN CANCER RES, V4, P389; MIYAZAKI M, 1992, BIOCHEM BIOPH RES CO, V187, P677, DOI 10.1016/0006-291X(92)91248-O; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Petit F, 1997, BIOCHEM J, V326, P93, DOI 10.1042/bj3260093; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Tsurumi C, 1996, Nihon Rinsho, V54, P861; Volm M, 1998, ANTICANCER RES, V18, P2905; Wong DWS, 1998, ANN NY ACAD SCI, V864, P555, DOI 10.1111/j.1749-6632.1998.tb10379.x; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; YAMAGUCHI M, 1995, CANCER, V76, P2351, DOI 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1	47	82	91	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					23	29		10.1038/83717	http://dx.doi.org/10.1038/83717			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137994				2022-12-17	WOS:000166187900011
J	Fisher, S; Halpern, ME				Fisher, S; Halpern, ME			Patterning the zebrafish axial skeleton requires early chordin function	NATURE GENETICS			English	Article							BONE MORPHOGENETIC PROTEINS; SONIC HEDGEHOG; EMBRYO; GENE; ORGANIZER; MICE; MSX2; EXPRESSION; INDUCTION; DOMAINS	Members of the bone morphogenetic protein (BMP) family actively promote ventral cell fates, such as epidermis and blood, in the vertebrate gastrula. More dorsally, the organizer region counteracts BMP signalling through secretion of BMP-binding antagonists chordin and noggin, allowing dorsally derived tissues such as neurectoderm and semitic muscle to develop(1). BMPs also function in skeletal development and regeneration of bone following injury(2). Noggin antagonism is thought to prevent osteogenesis at sites of joint formation(3), whereas chordin has not yet been implicated in skeletogenesis. Analyses of zebrafish mutants have confirmed the action of chordin (chd) in opposing ventralizing signals at gastrulation(4-6). Some ventralized mutants recover and develop into fertile adults, thereby revealing a requirement for chd function for the later processes of fin and caudal skeletal patterning. We observe in mutants the misexpression of genes encoding BMPs and putative downstream genes, and ectopic sclerotomal cells. Through injections of chd mRNA into the early embryo, we restored wild-type gene expression patterns, and the resultant fish, although genotypically mutant, developed normal axial skeletons and fins. Our results demonstrate that chordin function during gastrulation is important for the correct morphogenesis of the adult zebrafish skeleton.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Fisher, S (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001851] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01851-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Connors SA, 1999, DEVELOPMENT, V126, P3119; Fisher S, 1997, DEVELOPMENT, V124, P1301; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Maeda R, 1997, DEVELOPMENT, V124, P2553; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Miller-Bertaglio V, 1999, DEV BIOL, V214, P72, DOI 10.1006/dbio.1999.9384; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Thomsen GH, 1997, TRENDS GENET, V13, P209, DOI 10.1016/S0168-9525(97)01117-7; Westerfield M, 1995, ZEBRAFISH BOOK; Winograd J, 1997, HUM MOL GENET, V6, P369, DOI 10.1093/hmg/6.3.369	30	82	82	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					442	446		10.1038/70557	http://dx.doi.org/10.1038/70557			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581032				2022-12-17	WOS:000084023900021
J	Subramani, S				Subramani, S			PEX genes on the rise	NATURE GENETICS			English	Editorial Material							PEROXISOMAL TARGETING SIGNAL; PROTEIN IMPORT DEFICIENCIES; MAMMALIAN-CELL MUTANT; SACCHAROMYCES-CEREVISIAE; DISORDERS; RECEPTOR; MEMBER; FAMILY; COMPLEMENTATION; THIOLASE				Subramani, S (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.							ALBERTINI M, IN PRESS CELL; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; Subramani S, 1996, CURR OPIN CELL BIOL, V8, P513, DOI 10.1016/S0955-0674(96)80029-9; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WALTON PA, 1992, MOL CELL BIOL, V12, P531, DOI 10.1128/MCB.12.2.531; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; Wiemer E A, 1994, Mol Genet Med, V4, P119; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	32	82	82	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					331	333		10.1038/ng0497-331	http://dx.doi.org/10.1038/ng0497-331			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090374				2022-12-17	WOS:A1997WQ38900006
J	PRONK, JC; GIBSON, RA; SAVOIA, A; WIJKER, M; MORGAN, NV; MELCHIONDA, S; FORD, D; TEMTAMY, S; ORTEGA, JJ; JANSEN, S; HAVENGA, C; COHN, RJ; DERAVEL, TJ; ROBERTS, I; WESTERVELD, A; EASTON, DF; JOENJE, H; MATHEW, CG; ARWERT, F				PRONK, JC; GIBSON, RA; SAVOIA, A; WIJKER, M; MORGAN, NV; MELCHIONDA, S; FORD, D; TEMTAMY, S; ORTEGA, JJ; JANSEN, S; HAVENGA, C; COHN, RJ; DERAVEL, TJ; ROBERTS, I; WESTERVELD, A; EASTON, DF; JOENJE, H; MATHEW, CG; ARWERT, F			LOCALIZATION OF THE FANCONI-ANEMIA COMPLEMENTATION GROUP-A GENE TO CHROMOSOME 16Q24.3	NATURE GENETICS			English	Letter							ANEMIA	Fanconi anaemia (FA) is an autosomal recessive disorder associated with diverse developmental abnormalities, bone-marrow failure and predisposition to cancer(1). FA cells show increased chromosome breakage and hypersensitivity to DNA cross-linking agents such as diepoxybutane and mitomycin C. Somatic-cell hybridisation analysis of FA cell lines has demonstrated the existence of at least five complementation groups (FA-A to FA-E)(2,3), the most common of which is FA-A(4). This genetic heterogeneity has been a major obstacle to the positional cloning of FA genes by classical linkage analysis. The FAC gene was cloned by functional complementation(5), and localised to chromosome 9q22.3 (ref. 2), but this approach has thus far failed to yield the genes for the other complementation groups. We have established a panel of families classified as FA-A by complementation analysis, and used them to search for the FAA gene by linkage analysis. We excluded the previous assignment by linkage(6) of an FA gene to chromosome 20q, and obtained conclusive evidence for linkage of FAA to microsatellite markers on chromosome 16q24.3. Strong evidence of allelic association with the disease was detected with the marker D16S303 in the Afrikaner population of South Africa, indicating the presence of a founder effect.	UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND; IRCCS,OSPED CASA SOLLIEVO SOFFERENZA,SERV GENET MED,SAN GIOVANNI ROTO,ITALY; INST CANC RES,EPIDEMIOL SECT,SURREY,ENGLAND; NATL RES CTR,DEPT HUMAN GENET,CAIRO,EGYPT; HOSP INFANTIL VALL HEBRON,HEMATOL & BMT UNIT,BARCELONA,SPAIN; UNIV ORANGE FREE STATE,SCH MED,DEPT HUMAN GENET,BLOEMFONTEIN,SOUTH AFRICA; UNIV ORANGE FREE STATE,SCH MED,DEPT PAEDIAT,BLOEMFONTEIN,SOUTH AFRICA; S AFRICAN INST MED RES,DEPT HUMAN GENET,WITWATERSRAND,SOUTH AFRICA; S AFRICAN INST MED RES,DEPT PAEDIAT,WITWATERSRAND,SOUTH AFRICA; UNIV WITWATERSRAND,WITWATERSRAND 2050,SOUTH AFRICA; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON,ENGLAND; UNIV AMSTERDAM,ACAD MED CTR,DEPT HUMAN GENET,1105 AZ AMSTERDAM,NETHERLANDS	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; IRCCS Casa Sollievo Della Sofferenza; University of London; Institute of Cancer Research - UK; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hospital Universitari Vall d'Hebron; University of the Free State; University of the Free State; University of Witwatersrand; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam	PRONK, JC (corresponding author), FREE UNIV AMSTERDAM,DEPT HUMAN GENET,AMSTERDAM,NETHERLANDS.		Savoia, Anna/AIC-4560-2022; Morgan, Neil V/A-5475-2009; Savoia, Anna/B-6463-2014; Mathew, Christopher G/G-3434-2015	Savoia, Anna/0000-0002-2407-2696; Morgan, Neil V/0000-0001-6433-5692; Savoia, Anna/0000-0002-2407-2696; Mathew, Christopher G/0000-0003-4178-1838; temtamy, samia/0000-0002-6452-823X; Gibson, Rachel/0000-0002-1338-1290; Cohn, Richard/0000-0002-2400-1353	Telethon [E.0033] Funding Source: Medline	Telethon(Fondazione Telethon)		AUERBACH AD, 1989, BLOOD, V73, P391; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; DOGGETT NA, 1995, CYTOGENET CELL GENET, V68, P166, DOI 10.1159/000133909; DUCKWORTHRYSIEC.G, 1985, SOMAT CELL MOLEC GEN, V11, P35; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOENJE H, IN PRESS BLOOD; JOENJE H, 1995, ACTA HAEMATOLOGICA, V93, P250; JORDE LB, 1995, AM J HUM GENET, V56, P11; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; NIKALI K, 1995, AM J HUM GENET, V56, P1088; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; ROSENDORFF J, 1987, AM J MED GENET, V27, P793, DOI 10.1002/ajmg.1320270408; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V358, P434, DOI 10.1038/358434a0	18	82	85	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					338	340		10.1038/ng1195-338	http://dx.doi.org/10.1038/ng1195-338			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581462				2022-12-17	WOS:A1995TC63900027
J	CHEN, H; CHRAST, R; ROSSIER, C; GOS, A; ANTONARAKIS, SE; KUDOH, J; YAMAKI, A; SHINDOH, N; MAEDA, H; MINOSHIMA, S; SHIMIZU, N				CHEN, H; CHRAST, R; ROSSIER, C; GOS, A; ANTONARAKIS, SE; KUDOH, J; YAMAKI, A; SHINDOH, N; MAEDA, H; MINOSHIMA, S; SHIMIZU, N			SINGLE-MINDED AND DOWN-SYNDROME	NATURE GENETICS			English	Letter							GENE ENCODES; RECEPTOR; PROTEIN; MIDLINE; CLONING		UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,HUMAN MOLEC GENET LAB,CH-1211 GENEVA,SWITZERLAND; CANTONAL HOSP,DIV MED GENET,GENEVA,SWITZERLAND; KEIO UNIV,SCH MED,DEPT MOLEC BIOL,SHINJUKU KU,TOKYO 160,JAPAN	University of Geneva; University of Geneva; Keio University			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Chrast, Roman/0000-0003-4189-3514				ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; MURALIDHAR MG, 1993, MECH DEVELOP, V41, P129, DOI 10.1016/0925-4773(93)90043-W; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; Patterson D, 1993, Prog Clin Biol Res, V384, P33; SEMENZA GL, 1989, P NATL ACAD SCI USA, V86, P2301, DOI 10.1073/pnas.86.7.2301	14	82	84	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					9	10		10.1038/ng0595-9	http://dx.doi.org/10.1038/ng0595-9			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647800				2022-12-17	WOS:A1995QX57300008
J	Urbut, SM; Wang, G; Carbonetto, P; Stephens, M				Urbut, Sarah M.; Wang, Gao; Carbonetto, Peter; Stephens, Matthew			Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions	NATURE GENETICS			English	Article							FALSE DISCOVERY RATE; GENE-EXPRESSION; CAUSAL VARIANTS; EMPIRICAL BAYES; ASSOCIATION	We introduce new statistical methods for analyzing genomic data sets that measure many effects in many conditions (for example, gene expression changes under many treatments). These new methods improve on existing methods by allowing for arbitrary correlations in effect sizes among conditions. This flexible approach increases power, improves effect estimates and allows for more quantitative assessments of effect-size heterogeneity compared to simple shared or condition-specific assessments. We illustrate these features through an analysis of locally acting variants associated with gene expression (cis expression quantitative trait loci (eQTLs)) in 44 human tissues. Our analysis identifies more eQTLs than existing approaches, consistent with improved power. We show that although genetic effects on expression are extensively shared among tissues, effect sizes can still vary greatly among tissues. Some shared eQTLs show stronger effects in subsets of biologically related tissues (for example, brain-related tissues), or in only one tissue (for example, testis). Our methods are widely applicable, computationally tractable for many conditions and available online.	[Urbut, Sarah M.] Univ Chicago, Pritzker Sch Med, Growth & Dev Training Program, Chicago, IL 60637 USA; [Urbut, Sarah M.; Wang, Gao; Carbonetto, Peter; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Carbonetto, Peter] Univ Chicago, Res Comp Ctr, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Stephens, M (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.; Stephens, M (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.	mstephens@uchicago.edu		Stephens, Matthew/0000-0001-5397-9257; Urbut, Sarah/0000-0002-1135-9647; Carbonetto, Peter/0000-0003-1144-6780	National Institutes of Health (NIH) [MH090951, HG02585]; Gordon and Betty Moore Foundation [GBMF 4559]; NIH [T32HD007009]; Common Fund of the Office of the Director of the NIH; National Cancer Institute (NCI); National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NCI/SAIC-Frederick (SAIC-F) [10XS170, 10XS171, X10S172]; SAIC-F [10ST1035, HHSN261200800001E]; University of Miami [DA006227, DA033684]; University of Geneva [MH090941, MH101814]; University of Chicago [MH090951, MH090937, MH101820, MH101825]; University of North Carolina at Chapel Hill [MH090936, MH101819]; Harvard University [MH090948]; Stanford University [MH101782]; Washington University in St. Louis [MH101810]; University of Pennsylvania [MH101822];  [HHSN268201000029C];  [N01MH000028]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101822, R01MH101810, R01MH101782] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund of the Office of the Director of the NIH; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI/SAIC-Frederick (SAIC-F); SAIC-F; University of Miami; University of Geneva; University of Chicago(University of Chicago); University of North Carolina at Chapel Hill; Harvard University; Stanford University(Stanford University); Washington University in St. Louis; University of Pennsylvania; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) grants MH090951 and HG02585 to M.S., and by a grant from the Gordon and Betty Moore Foundation (GBMF 4559) to M.S. S.M.U. was supported by NIH grant T32HD007009. Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the NIH. Additional funds were provided by the National Cancer Institute (NCI), National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. Donors were enrolled at Biospecimen Source Sites funded by NCI/SAIC-Frederick (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care (X10S172). The Laboratory, Data Analysis, and Coordinating Center was funded through a contract (HHSN268201000029C) to the Broad Institute. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplement to University of Miami grants DA006227 and DA033684 and to contract N01MH000028. Statistical methods development grants were made to the University of Geneva (MH090941 and MH101814), the University of Chicago (MH090951, MH090937, MH101820 and MH101825), the University of North Carolina at Chapel Hill (MH090936 and MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University in St. Louis (MH101810) and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 17 October 2015.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blischak JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16882; Bovy J, 2011, ANN APPL STAT, V5, P1657, DOI 10.1214/10-AOAS439; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Engelhardt BE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001117; Ferguson JP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1660; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Han B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002555; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Larribe F, 2011, STAT SINICA, V21, P43; Lebrec JJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1503; Li G, 2018, BIOSTATISTICS, V19, P391, DOI 10.1093/biostatistics/kxx048; Moyerbrailean GA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005875; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wei YY, 2015, BIOSTATISTICS, V16, P31, DOI 10.1093/biostatistics/kxu038; Wen XQ, 2014, ANN APPL STAT, V8, P176, DOI 10.1214/13-AOAS695; Wen XQ, 2010, ANN APPL STAT, V4, P1158, DOI 10.1214/10-AOAS338; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]	39	81	81	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					187	+		10.1038/s41588-018-0268-8	http://dx.doi.org/10.1038/s41588-018-0268-8			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30478440	Green Submitted, Green Accepted			2022-12-17	WOS:000454108800026
J	Verbitsky, M; Westland, R; Perez, A; Kiryluk, K; Liu, QX; Krithivasan, P; Mitrotti, A; Fasel, DA; Batourina, E; Sampson, MG; Bodria, M; Werth, M; Kao, C; Martino, J; Capone, VP; Vivante, A; Shril, S; Kil, BH; Marasa, M; Zhang, JY; Na, YJ; Lim, TY; Ahram, D; Weng, PL; Heinzen, EL; Carrea, A; Piaggio, G; Gesualdo, L; Manca, V; Masnata, G; Gigante, M; Cusi, D; Izzi, C; Scolari, F; van Wijk, JAE; Saraga, M; Santoro, D; Conti, G; Zamboli, P; White, H; Drozdz, D; Zachwieja, K; Miklaszewska, M; Tkaczyk, M; Tomczyk, D; Krakowska, A; Sikora, P; Jarmolinski, T; Borszewska-Kornacka, MK; Pawluch, R; Szczepanska, M; Adamczyk, P; Mizerska-Wasiak, M; Krzemien, G; Szmigielska, A; Zaniew, M; Dobson, MG; Darlow, JM; Puri, P; Barton, DE; Furth, SL; Warady, BA; Gucev, Z; Lozanovski, VJ; Tasic, V; Pisani, I; Allegri, L; Rodas, LM; Campistol, JM; Jeanpierre, C; Alam, S; Casale, P; Wong, CS; Lin, FM; Miranda, DM; Oliveira, EA; Simoes-e-Silva, AC; Barasch, JM; Levy, B; Wu, N; Hildebrandt, F; Ghiggeri, GM; Latos-Bielenska, A; Materna-Kiryluk, A; Zhang, F; Hakonarson, H; Papaioannou, VE; Mendelsohn, CL; Gharavi, AG; Sanna-Cherchi, S				Verbitsky, Miguel; Westland, Rik; Perez, Alejandra; Kiryluk, Krzysztof; Liu, Qingxue; Krithivasan, Priya; Mitrotti, Adele; Fasel, David A.; Batourina, Ekaterina; Sampson, Matthew G.; Bodria, Monica; Werth, Max; Kao, Charlly; Martino, Jeremiah; Capone, Valentina P.; Vivante, Asaf; Shril, Shirlee; Kil, Byum Hee; Marasa, Maddalena; Zhang, Jun Y.; Na, Young-Ji; Lim, Tze Y.; Ahram, Dina; Weng, Patricia L.; Heinzen, Erin L.; Carrea, Alba; Piaggio, Giorgio; Gesualdo, Loreto; Manca, Valeria; Masnata, Giuseppe; Gigante, Maddalena; Cusi, Daniele; Izzi, Claudia; Scolari, Francesco; van Wijk, Joanna A. E.; Saraga, Marijan; Santoro, Domenico; Conti, Giovanni; Zamboli, Pasquale; White, Hope; Drozdz, Dorota; Zachwieja, Katarzyna; Miklaszewska, Monika; Tkaczyk, Marcin; Tomczyk, Daria; Krakowska, Anna; Sikora, Przemyslaw; Jarmolinski, Tomasz; Borszewska-Kornacka, Maria K.; Pawluch, Robert; Szczepanska, Maria; Adamczyk, Piotr; Mizerska-Wasiak, Malgorzata; Krzemien, Grazyna; Szmigielska, Agnieszka; Zaniew, Marcin; Dobson, Mark G.; Darlow, John M.; Puri, Prem; Barton, David E.; Furth, Susan L.; Warady, Bradley A.; Gucev, Zoran; Lozanovski, Vladimir J.; Tasic, Velibor; Pisani, Isabella; Allegri, Landino; Rodas, Lida M.; Campistol, Josep M.; Jeanpierre, Cecile; Alam, Shumyle; Casale, Pasquale; Wong, Craig S.; Lin, Fangming; Miranda, Debora M.; Oliveira, Eduardo A.; Simoes-e-Silva, Ana Cristina; Barasch, Jonathan M.; Levy, Brynn; Wu, Nan; Hildebrandt, Friedhelm; Ghiggeri, Gian Marco; Latos-Bielenska, Anna; Materna-Kiryluk, Anna; Zhang, Feng; Hakonarson, Hakon; Papaioannou, Virginia E.; Mendelsohn, Cathy L.; Gharavi, Ali G.; Sanna-Cherchi, Simone			The copy number variation landscape of congenital anomalies of the kidney and urinary tract	NATURE GENETICS			English	Article							RENAL REPLACEMENT THERAPY; CANDIDATE GENES; VITAMIN-A; BRANCHING MORPHOGENESIS; GENOMIC DISORDERS; DIGEORGE-SYNDROME; RARE VARIANTS; MUTATIONS; DISEASE; DELETION	Congenital anomalies of the kidney and urinary tract (CAKUT) are a major cause of pediatric kidney failure. We performed a genome-wide analysis of copy number variants (CNVs) in 2,824 cases and 21,498 controls. Affected individuals carried a significant burden of rare exonic (that is, affecting coding regions) CNVs and were enriched for known genomic disorders (GD). Kidney anomaly (KA) cases were most enriched for exonic CNVs, encompassing GD-CNVs and novel deletions; obstructive uropathy (OU) had a lower CNV burden and an intermediate prevalence of GD-CNVs; and vesicoureteral reflux (VUR) had the fewest GD-CNVs but was enriched for novel exonic CNVs, particularly duplications. Six loci (1q21, 4p16.1-p16.3, 16p11.2, 16p13.11, 17q12 and 22q11.2) accounted for 65% of patients with GD-CNVs. Deletions at 17q12, 4p16.1-p16.3 and 22q11.2 were specific for KA; the 16p11.2 locus showed extensive pleiotropy. Using a multidisciplinary approach, we identified TBX6 as a driver for the CAKUT subphenotypes in the 16p11.2 microdeletion syndrome.	[Verbitsky, Miguel; Westland, Rik; Perez, Alejandra; Kiryluk, Krzysztof; Liu, Qingxue; Krithivasan, Priya; Mitrotti, Adele; Fasel, David A.; Werth, Max; Martino, Jeremiah; Capone, Valentina P.; Kil, Byum Hee; Marasa, Maddalena; Zhang, Jun Y.; Na, Young-Ji; Lim, Tze Y.; Ahram, Dina; White, Hope; Barasch, Jonathan M.; Gharavi, Ali G.; Sanna-Cherchi, Simone] Columbia Univ, Dept Med, Div Nephrol, New York, NY 10032 USA; [Westland, Rik; van Wijk, Joanna A. E.] Amsterdam UMC, Dept Pediat Nephrol, Amsterdam, Netherlands; [Batourina, Ekaterina; Mendelsohn, Cathy L.] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA; [Sampson, Matthew G.] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI USA; [Bodria, Monica; Carrea, Alba; Piaggio, Giorgio; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Div Nephrol, Dialysis, Transplantat, Genoa, Italy; [Bodria, Monica; Carrea, Alba; Piaggio, Giorgio; Ghiggeri, Gian Marco] Ist Giannina Gaslini, Lab Pathophysiol Uremia, Genoa, Italy; [Kao, Charlly; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Kao, Charlly; Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vivante, Asaf; Shril, Shirlee; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA USA; [Vivante, Asaf] Chaim Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Pediat Dept B, Tel Hashomer, Israel; [Vivante, Asaf] Chaim Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Pediat Nephrol Unit, Tel Hashomer, Israel; [Vivante, Asaf] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Weng, Patricia L.] Univ Calif Los Angeles, Med Ctr, Dept Pediat Nephrol, Los Angeles, CA 90024 USA; [Weng, Patricia L.] Univ Calif Los Angeles, Med Ctr Santa Monica, Los Angeles, CA USA; [Heinzen, Erin L.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY USA; [Gesualdo, Loreto; Gigante, Maddalena] Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Sect, Bari, Italy; [Manca, Valeria; Masnata, Giuseppe] Azienda Osped Brotzu, Dept Pediat Urol, Cagliari, Italy; [Cusi, Daniele] Natl Res Council Italy, Bio4dreams Sci Unit, Inst Biomed Technol Milano, Milan, Italy; [Izzi, Claudia] Spedali Civil Brescia, Dipartimento Ostetr & Ginecol, Brescia, Italy; [Izzi, Claudia] Spedali Civil Brescia, Div Nefrol ASST 2, Brescia, Italy; [Izzi, Claudia] Presidio Montichiari, Brescia, Italy; [Scolari, Francesco] Univ Brescia, Cattedra Nefrol, Div Nefrol 2, Azienda Osped Spedali Civili Brescia Presidio Mon, Brescia, Italy; [Saraga, Marijan] Univ Hosp Split, Dept Pediat, Split, Croatia; [Saraga, Marijan] Univ Split, Sch Med, Split, Croatia; [Santoro, Domenico] Univ Messina, Dipartimento Med Clin & Sperimentale, Messina, Italy; [Conti, Giovanni] Azienda Osped Univ G Martino, Dept Pediat Nephrol, Messina, Italy; [Zamboli, Pasquale] Univ Campania Luigi Vanvitell, Div Nephrol, Naples, Italy; [Drozdz, Dorota; Zachwieja, Katarzyna] Jagiellonian Univ, Coll Med, Dialysis Unit, Dept Pediat Nephrol & Hypertens, Krakow, Poland; [Miklaszewska, Monika] Jagiellonian Univ, Coll Med, Dept Pediat Nephrol, Krakow, Poland; [Tkaczyk, Marcin; Tomczyk, Daria; Krakowska, Anna] Polish Mothers Mem Hosp, Dept Pediat Immunol & Nephrol, Res Inst, Lodz, Poland; [Sikora, Przemyslaw] Med Univ Lublin, Dept Pediat Nephrol, Lublin, Poland; [Jarmolinski, Tomasz] Miedzyrzecki Hosp, Childrens Dept, Miedzyrzecz, Poland; [Borszewska-Kornacka, Maria K.; Pawluch, Robert; Szczepanska, Maria; Adamczyk, Piotr] Med Univ Silesia, Dept Pediat, Sch Med, Div Dent Zabrze, Katowice, Poland; [Mizerska-Wasiak, Malgorzata; Krzemien, Grazyna; Szmigielska, Agnieszka] Med Univ Warsaw, Dept Pediat & Nephrol, Warsaw, Poland; [Zaniew, Marcin] Univ Zielona Gora, Dept Pediat, Zielona Gora, Poland; [Dobson, Mark G.; Darlow, John M.; Barton, David E.] Our Ladys Childrens Hosp Crumlin, Dept Clin Genet, Dublin, Ireland; [Dobson, Mark G.; Darlow, John M.; Puri, Prem] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Puri, Prem] Natl Childrens Hosp Tallaght, Dublin, Ireland; [Barton, David E.] Univ Coll Dublin, UCD Sch Med, Our Ladys Childrens Hosp Crumlin, Dublin, Ireland; [Furth, Susan L.] Univ Penn, Dept Pediat, Perelman Sch Med, Childrens Hosp Philadelphia CHOP,Div Nephrol, Philadelphia, PA 19104 USA; [Furth, Susan L.] Univ Penn, Dept Epidemiol, Perelman Sch Med, Childrens Hosp Philadelphia CHOP,Div Nephrol, Philadelphia, PA 19104 USA; [Warady, Bradley A.] Univ Missouri, Sch Med, Dept Pediat, Div Nephrol,Childrens Mercy Kansas City, Kansas City, MO 64108 USA; [Gucev, Zoran; Lozanovski, Vladimir J.; Tasic, Velibor] Univ Childrens Hosp, Med Fac Skopje, Skopje, North Macedonia; [Lozanovski, Vladimir J.] Heidelberg Univ, Univ Clin Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Pisani, Isabella; Allegri, Landino] Univ Parma, Dept Med & Surg, Parma, Italy; [Rodas, Lida M.; Campistol, Josep M.] ICNU Nephrol & Urol Dept, Barcelona, Spain; [Jeanpierre, Cecile] Paris Descartes Univ, Lab Hereditary Kidney Dis, Imagine Inst, Sorbonne Paris Cite,Inserm,UMR 1163, Paris, France; [Alam, Shumyle; Casale, Pasquale] Columbia Univ Coll Phys & Surg, Dept Pediat Urol, 630 W 168th St, New York, NY 10032 USA; [Casale, Pasquale] Kravis Childrens Hosp, Mt Sinai Med Ctr, New York, NY USA; [Wong, Craig S.] Univ New Mexico, Childrens Hosp, Div Pediat Nephrol, Albuquerque, NM 87131 USA; [Lin, Fangming] Columbia Univ, Dept Pediat, Div Pediat Nephrol, New York, NY 10027 USA; [Miranda, Debora M.; Oliveira, Eduardo A.; Simoes-e-Silva, Ana Cristina] Univ Fed Minas Gerais, Dept Pediat, Unit Pediat Nephrol, Interdisciplinary Lab Med Invest,Fac Med, Belo Horizonte, MG, Brazil; [Levy, Brynn] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Wu, Nan] Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing Key Lab Genet Res Skeletal Deform, Med Res Ctr Orthoped,Dept Orthoped Surg, Beijing, Peoples R China; [Wu, Nan] Chinese Acad Med Sci, Beijing, Peoples R China; [Wu, Nan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Latos-Bielenska, Anna; Materna-Kiryluk, Anna] Poznan Univ Med Sci, Dept Med Genet, Poznan, Poland; [Latos-Bielenska, Anna; Materna-Kiryluk, Anna] NZOZ Ctr Med Genet GENESIS, Poznan, Poland; [Zhang, Feng] Fudan Univ, Obstet & Gynecol Hosp, Shanghai, Peoples R China; [Papaioannou, Virginia E.] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA	Columbia University; University of Amsterdam; Columbia University; University of Michigan System; University of Michigan; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Columbia University; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Split; University of Split; University of Messina; AOU Policlinico Gaetano Martino; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Mother's Memorial Hospital - Research Institute; Medical University of Lublin; Medical University Silesia; Medical University of Warsaw; University of Zielona Gora; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University College Dublin; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Ruprecht Karls University Heidelberg; University of Parma; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Columbia University; Icahn School of Medicine at Mount Sinai; University of New Mexico; Columbia University; Universidade Federal de Minas Gerais; Columbia University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Baylor College of Medicine; Poznan University of Medical Sciences; Fudan University; Columbia University	Gharavi, AG; Sanna-Cherchi, S (corresponding author), Columbia Univ, Dept Med, Div Nephrol, New York, NY 10032 USA.; Mendelsohn, CL (corresponding author), Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA.; Papaioannou, VE (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA.	vep1@cumc.columbia.edu; clm20@cumc.columbia.edu; ag2239@cumc.columbia.edu; ss2517@cumc.columbia.edu	Conti, Giovanni/AAF-1059-2020; Zhang, Feng/C-7735-2009; Izzi, Claudia/GZG-8769-2022; Barton, David E/B-9460-2008; Saraga, Marijan/E-7647-2017; Oliveira, Eduardo A/B-5476-2009; Shril, Shirlee/Q-5825-2016; Clinic, Hospital/AAH-1838-2022; Lozanovski, Vladimir J/AAP-9781-2020; Simões e Silva, Ana Cristina/A-4409-2013; Mendelsohn, Cathy/H-4280-2016; bodria, monica/K-2115-2016; Izzi, Claudia/AAB-7004-2022; Piaggio, Giorgio/AAA-7344-2020; Clinic, Hospital/AFL-9702-2022; Sikora, Przemyslaw/ABE-1814-2021; Miranda, Debora/AAQ-1952-2020; scolari, francesco/AAC-5957-2022; MASNATA, GIUSEPPE/K-9006-2016; Tkaczyk, Marcin/S-9468-2016; Sampson, Matthew/U-4501-2017; Gigante, Maddalena/R-4369-2016	Zhang, Feng/0000-0003-4556-8276; Clinic, Hospital/0000-0002-5071-6862; Lozanovski, Vladimir J/0000-0002-7332-3973; Simões e Silva, Ana Cristina/0000-0001-9222-3882; Mendelsohn, Cathy/0000-0002-4026-4073; bodria, monica/0000-0001-9690-9945; Piaggio, Giorgio/0000-0003-3814-9997; Clinic, Hospital/0000-0002-5071-6862; Sikora, Przemyslaw/0000-0002-5698-6863; Miranda, Debora/0000-0002-7081-8401; Barton, David E/0000-0002-2031-9719; Jarmolinski, Tomasz/0000-0002-3441-6165; Scolari, Francesco/0000-0003-0233-9705; MASNATA, GIUSEPPE/0000-0001-5136-3563; Szczepanska, Maria/0000-0002-6772-1983; weng, patricia/0000-0003-2020-2729; Westland, Rik/0000-0003-4960-4078; Cusi, Daniele/0000-0002-1006-7597; Tkaczyk, Marcin/0000-0003-1753-7560; Adamczyk, Piotr/0000-0001-9557-221X; Sampson, Matthew/0000-0001-9560-076X; Fasel, David/0000-0002-0815-2370; Gigante, Maddalena/0000-0001-8228-7639; Izzi, Claudia/0000-0001-6253-3185; Ghiggeri, Gian Marco/0000-0003-3659-9062	National Institutes of Health (NIH) [1R01DK103184, 1R21DK098531, UL1 TR000040, 2R01DK080099, 3U54DK104309, R37HD033082, 1R01DK105124]; American Heart Association [13GRNT14680075]; Italian Ministry of Health [RF-2010-2307403]; NIH Young Investigators Finalized Research [RF-2010-2307403]; Fondazione Malattie Renali nel Bambino; National Children's Research Centre; Irish Health Research Board [HRA-POR-2014-693]; GIS-Institut des Maladies Rares [AAE07007KSA]; Polish Ministry of Health; Polish Kidney Genetics Network (POLYGENES); Polish Registry of Congenital Malformations (PRCM); NZOZ Center for Medical Genetics (GENESIS); National Institute of Diabetes and Digestive and Kidney Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute [U01DK66143, U01DK66174, U01DK082194, U01DK66116, RO1DK082394]; Paul Marks Scholar Award; CNPq [460334/2014-0]; FAPEMIG [PPM-005555-15]; Kolff Postdoc Fellowship Abroad grant from the Dutch Kidney Foundation [15OKK95]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066116, R01DK103184, U01DK082194, U54DK104309, U01DK066143, U24DK066116, U01DK066174, R01DK105124, R01DK080099, R01DK088767, R01DK095044] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Italian Ministry of Health(Ministry of Health, Italy); NIH Young Investigators Finalized Research; Fondazione Malattie Renali nel Bambino; National Children's Research Centre; Irish Health Research Board; GIS-Institut des Maladies Rares; Polish Ministry of Health; Polish Kidney Genetics Network (POLYGENES); Polish Registry of Congenital Malformations (PRCM); NZOZ Center for Medical Genetics (GENESIS); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Paul Marks Scholar Award; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Kolff Postdoc Fellowship Abroad grant from the Dutch Kidney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all patients and family members for participating in this study. We thank J. R. Lupski for critical review of this manuscript. This work was supported by grants (1R01DK103184, 1R21DK098531 and UL1 TR000040, to S.S.-C.; 2R01DK080099, to A.G.G.; 3U54DK104309, to A.G.G., C.L.M. and J.M.B.; R37HD033082, to V.E.P.; and 1R01DK105124 to K.K.) from the National Institutes of Health (NIH); a grant-in-aid (13GRNT14680075, to S.S.-C.) from the American Heart Association; a grant (RF-2010-2307403, to S.S.-C. and G.M.G.) from the Joint Italian Ministry of Health and NIH Young Investigators Finalized Research; a grant (to G.M.G.) from the Fondazione Malattie Renali nel Bambino; grants to D.E.B. and P.P. from the National Children's Research Centre and the Irish Health Research Board (HRA-POR-2014-693); a grant (AAE07007KSA, to C.J.) from the GIS-Institut des Maladies Rares; by the Polish Ministry of Health (to A.M.K. and A.L.-B.); by the Polish Kidney Genetics Network (POLYGENES), the Polish Registry of Congenital Malformations (PRCM) and the NZOZ Center for Medical Genetics (GENESIS); by grants (to the Chronic Kidney Disease in Children Study) from the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; by grants (U01DK66143, U01DK66174, U01DK082194, U01DK66116 and RO1DK082394) from the National Heart, Lung, and Blood Institute; and by the Paul Marks Scholar Award (to S.S.-C.); CNPq grant 460334/2014-0 and FAPEMIG grant PPM-005555-15 (to D. M. M., E.A.O. and A.C.S.-e.-S.); and a Kolff Postdoc Fellowship Abroad grant (15OKK95, to R.W.) from the Dutch Kidney Foundation. S.S.-C. is supported as the Florence Irving Assistant Professor of Medicine at Columbia University. We thank D.B. Goldstein for providing infrastructure for whole-exome sequencing at the Institute for Genomic Medicine (IGM) at Columbia University, and for critical review of the manuscript. Acknowledgments to the investigators who contributed of whole-exome sequencing data for 15,469 controls from the IGM warehouse can be found in the Supplementary Note.	Abe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130231; Al-Kateb H, 2014, AM J MED GENET A, V164, P1118, DOI 10.1002/ajmg.a.36401; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Batourina E, 2002, NAT GENET, V32, P109, DOI 10.1038/ng952; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bekheirnia MR, 2017, GENET MED, V19, P412, DOI 10.1038/gim.2016.131; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; Chesnaye NC, 2017, LANCET, V389, P2128, DOI 10.1016/S0140-6736(17)30063-6; Concepcion D, 2017, BIOL OPEN, V6, P1065, DOI 10.1242/bio.026203; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; COWELL H R, 1974, Birth Defects Original Article Series, V10, P142; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; Fasel D., 2015, J AM SOC NEPHROL, V26, p443A; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fontes MIB, 2016, AM J MED GENET A, V170, P766, DOI 10.1002/ajmg.a.37494; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; Georgas KM, 2015, DEVELOPMENT, V142, P1893, DOI 10.1242/dev.117903; Goh ESY, 2012, AM J MED GENET A, V158A, P1579, DOI 10.1002/ajmg.a.35399; Golzio C, 2013, CURR OPIN GENET DEV, V23, P240, DOI 10.1016/j.gde.2013.04.013; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Goodyer P. R., 2004, PEDIAT NEPHROLOGY, P83; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Grisaru S, 2000, PEDIATR NEPHROL, V14, P146, DOI 10.1007/s004670050031; Hadjantonakis AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002511; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Heidet L, 2010, CLIN J AM SOC NEPHRO, V5, P1079, DOI 10.2215/CJN.06810909; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hoskins BE, 2008, NEPHROL DIAL TRANSPL, V23, P777, DOI 10.1093/ndt/gfm685; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kim Yoon-Myung, 2016, Korean J Pediatr, V59, pS25, DOI 10.3345/kjp.2016.59.11.S25; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Lata S, 2018, ANN INTERN MED, V168, P100, DOI 10.7326/M17-1319; Lefebvre M, 2017, CLIN GENET, V91, P908, DOI 10.1111/cge.12918; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lopez-Rivera E, 2017, NEW ENGL J MED, V376, P742, DOI 10.1056/NEJMoa1609009; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MacEwen GD, 2005, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000163115.10049.a7; MACEWEN GD, 1972, J BONE JOINT SURG AM, VA 54, P1451, DOI 10.2106/00004623-197254070-00007; Madariaga L, 2013, CLIN J AM SOC NEPHRO, V8, P1179, DOI 10.2215/CJN.10221012; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Materna-Kiryluk A, 2014, PEDIATR NEPHROL, V29, P257, DOI 10.1007/s00467-013-2625-2; Mattina T, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-9; McKinney W., 2010, P 9 PYTH SCI C AUST, P56, DOI [10.25080/Majora-92bf1922-00a, DOI 10.25080/MAJORA-92BF1922-00A]; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Nicolaou N, 2016, KIDNEY INT, V89, P476, DOI 10.1038/ki.2015.319; Nicolaou N, 2015, NAT REV NEPHROL, V11, P720, DOI 10.1038/nrneph.2015.140; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Ozgun MT, 2007, FETAL DIAGN THER, V22, P229, DOI 10.1159/000098724; Portnoi MF, 2009, EUR J MED GENET, V52, P88, DOI 10.1016/j.ejmg.2009.02.008; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sampson MG, 2010, AM J MED GENET A, V152A, P2618, DOI 10.1002/ajmg.a.33628; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2018, J CLIN INVEST, V128, P4, DOI 10.1172/JCI95300; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schimmenti LA, 1997, AM J HUM GENET, V60, P869; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serra-Juhe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045530; Short KM, 2016, NAT REV NEPHROL, V12, P754, DOI 10.1038/nrneph.2016.157; dos Santos ACS, 2014, BIRTH DEFECTS RES C, V102, P374, DOI 10.1002/bdrc.21084; South ST, 2013, GENET MED, V15, P901, DOI 10.1038/gim.2013.129; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Trachoo O, 2013, EUR J MED GENET, V56, P319, DOI 10.1016/j.ejmg.2013.03.011; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Verbitsky M, 2017, J AM SOC NEPHROL, V28, P2303, DOI 10.1681/ASN.2016101108; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Vivante A, 2015, AM J HUM GENET, V97, P291, DOI 10.1016/j.ajhg.2015.07.001; Vivante A, 2014, PEDIATR NEPHROL, V29, P695, DOI 10.1007/s00467-013-2684-4; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weber S, 2011, NEPHROL DIAL TRANSPL, V26, P136, DOI 10.1093/ndt/gfq400; Westland R, 2015, KIDNEY INT, V88, P1402, DOI 10.1038/ki.2015.239; Westland R, 2014, J AM SOC NEPHROL, V25, P1408, DOI 10.1681/ASN.2013080886; Westland R, 2014, CLIN J AM SOC NEPHRO, V9, P978, DOI 10.2215/CJN.08900813; Westland R, 2013, PEDIATRICS, V131, pE478, DOI 10.1542/peds.2012-2088; Westland R, 2011, NEPHROL DIAL TRANSPL, V26, P1533, DOI 10.1093/ndt/gfq844; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Wuhl E, 2013, CLIN J AM SOC NEPHRO, V8, P67, DOI 10.2215/CJN.03310412; Yamamoto T, 2006, AM J MED GENET A, V140A, P88, DOI 10.1002/ajmg.a.31055; Yu L, 2012, J MED GENET, V49, P650, DOI 10.1136/jmedgenet-2012-101135	100	81	89	2	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					117	+		10.1038/s41588-018-0281-y	http://dx.doi.org/10.1038/s41588-018-0281-y			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30578417	Green Accepted, Green Published			2022-12-17	WOS:000454108800019
J	Westra, HJ; Martinez-Bonet, M; Onengut-Gumuscu, S; Lee, A; Luol, Y; Teslovich, N; Worthington, J; Martin, J; Huizinga, T; Klareskog, L; Rantapaa-Dahlqvist, S; Chen, WM; Quinlan, A; Todd, JA; Eyre, S; Nigrovic, PA; Regersen, PKG; Rich, SS; Raychaudhuri, S				Westra, Harm-Jan; Martinez-Bonet, Marta; Onengut-Gumuscu, Suna; Lee, Annette; Luol, Yang; Teslovich, Nikola; Worthington, Jane; Martin, Javier; Huizinga, Tom; Klareskog, Lars; Rantapaa-Dahlqvist, Solbritt; Chen, Wei-Min; Quinlan, Aaron; Todd, John A.; Eyre, Steve; Nigrovic, Peter A.; Regersen, Peter K. G.; Rich, Stephen S.; Raychaudhuri, Soumya			Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFLAMMATORY-BOWEL-DISEASE; BURROWS-WHEELER TRANSFORM; SUSCEPTIBILITY LOCI; CELL-TYPES; TYROSINE-PHOSPHATASE; GENOTYPE IMPUTATION; COMPLEX TRAIT; RISK LOCI	To define potentially causal variants for autoimmune disease, we fine-mapped(1,2) 76 rheumatoid arthritis (11,475 cases,15,870 controls)(3) and type 1 diabetes loci (9,334 cases, 11,111 controls)(4). After sequencing 799 1-kilobase regulatory (H3K4me3) regions within these loci in 568 individuals, we observed accurate imputation for 89% of common variants. We defined credible sets of <= 5 causal variants at 5 rheumatoid arthritis and 10 type 1 diabetes loci. We identified potentially causal missense variants at DNASE1L3, PTPN22, SH2B3, and TYK2, and noncoding variants at MEG3, CD28-CTLA4, and IL2RA. We also identified potential candidate causal variants at SIRPG and TNFAIP3. Using functional assays, we confirmed allele-specific protein binding and differential enhancer activity for three variants: the CD28-CTLA4 rs117701653 SNP, MEG3 rs34552516 indel, and TNFAIP3 rs35926684 indel.	[Westra, Harm-Jan; Luol, Yang; Teslovich, Nikola; Raychaudhuri, Soumya] Harvard Med Sch, Ctr Data Sci, Brigham & Womens Hosp, Boston, MA 02115 USA; [Westra, Harm-Jan; Luol, Yang; Teslovich, Nikola; Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Westra, Harm-Jan; Luol, Yang; Teslovich, Nikola; Raychaudhuri, Soumya] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Westra, Harm-Jan; Martinez-Bonet, Marta; Luol, Yang; Teslovich, Nikola; Nigrovic, Peter A.; Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Onengut-Gumuscu, Suna; Chen, Wei-Min; Quinlan, Aaron; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Onengut-Gumuscu, Suna; Chen, Wei-Min; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Lee, Annette; Regersen, Peter K. G.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Worthington, Jane; Eyre, Steve; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Manchester, Lancs, England; [Worthington, Jane; Eyre, Steve] Manchester Univ NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Huizinga, Tom] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars] Karolinska Univ Hosp, Stockholm, Sweden; [Rantapaa-Dahlqvist, Solbritt] Umea Univ, Dept Publ Hlth & Clin Med, Div Rheumatol, Umea, Sweden; [Quinlan, Aaron] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Quinlan, Aaron] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Todd, John A.] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, JDRF Wellcome Diabet & Inflammat Lab, Oxford, England; [Nigrovic, Peter A.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Raychaudhuri, Soumya] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Groningen; University of Virginia; University of Virginia; Northwell Health; University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Raychaudhuri, S (corresponding author), Harvard Med Sch, Ctr Data Sci, Brigham & Womens Hosp, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Manchester, Lancs, England.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.	soumya@broadinstitute.org	Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Martín, María/HDL-9512-2022; Todd, John/A-3542-2010	Martin, Javier/0000-0002-2202-0622; Martinez Bonet, Marta/0000-0003-0715-403X; Quinlan, Aaron/0000-0003-1756-0859; Todd, John/0000-0003-2740-8148; Rich, Stephen/0000-0003-3872-7793; Raychaudhuri, Soumya/0000-0002-1901-8265	National Institutes of Health [U01GM092691, UH2AR067677, 1U01HG009088, 1R01AR063759, R01DK096926]; Doris Duke Charitable Foundation [2013097]; Netherlands Organization for Scientific Research [825.14.019]; Wellcome [107212/Z/15/Z, 203141/Z/16/Z]; Juvenile Diabetes Research Foundation [5-SRA-2015-130-A-N]; Feinstein Institute; Rheumatology Research Foundation Disease Targeted Research Grant; Fundacion Bechara; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International; NIH [P30 AR070253, R01 AR065538];  [U01DK062418]; ESRC [ES/S008349/1] Funding Source: UKRI; MRC [MR/N01104X/2, MR/N01104X/1, G1001799] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Feinstein Institute; Rheumatology Research Foundation Disease Targeted Research Grant; Fundacion Bechara; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported in part by funding from the National Institutes of Health (U01GM092691, UH2AR067677, 1U01HG009088, and 1R01AR063759 to S.R.), and Doris Duke Charitable Foundation Grant number 2013097. This work is part of the research program Rubicon ALW with project number 825.14.019 (H.-J.W.), which is partly financed by the Netherlands Organization for Scientific Research. Further support was provided by Wellcome (107212/Z/15/Z) and the Juvenile Diabetes Research Foundation (5-SRA-2015-130-A-N) to the Diabetes and Inflammation Laboratory, and by Wellcome (203141/Z/16/Z) to the Wellcome Centre for Human Genetics (J.A.T.). P.K.G. was supported in part by the Feinstein Institute and a generous gift from E.L. Greenland. P.A.N. is supported by a Rheumatology Research Foundation Disease Targeted Research Grant, NIH P30 AR070253 and R01 AR065538, and the Fundacion Bechara. S.S.R., W.-M.C. and S.O. were supported in part by funding from the National Institutes of Health (R01DK096926). This research makes use of resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development and Juvenile Diabetes Research Foundation International, and is supported by grant U01DK062418 (S.S.R.).	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jostins L, 2016, BIOINFORMATICS, V32, P1898, DOI 10.1093/bioinformatics/btw075; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McGovern A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1078-x; Nettleship JE, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-13; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Ueki M, 2009, CLIN CHIM ACTA, V407, P20, DOI 10.1016/j.cca.2009.06.022; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Yang JJ, 2017, AM J HUM GENET, V101, P404, DOI 10.1016/j.ajhg.2017.08.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zochling J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0438-8	65	81	81	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2018	50	10					1366	+		10.1038/s41588-018-0216-7	http://dx.doi.org/10.1038/s41588-018-0216-7			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV4DF	30224649	Green Submitted, Green Accepted			2022-12-17	WOS:000446047000008
J	Rodriguez-Terrones, D; Gaume, X; Ishiuchi, T; Weiss, A; Kopp, A; Kruse, K; Penning, A; Vaquerizas, JM; Brino, L; Torres-Padilla, ME				Rodriguez-Terrones, Diego; Gaume, Xavier; Ishiuchi, Takashi; Weiss, Amelie; Kopp, Arnaud; Kruse, Kai; Penning, Audrey; Vaquerizas, Juan M.; Brino, Laurent; Torres-Padilla, Maria-Elena			A molecular roadmap for the emergence of early-embryonic-like cells in culture	NATURE GENETICS			English	Article							POLYCOMB REPRESSIVE COMPLEX; PLURIPOTENT STEM-CELLS; GROUND-STATE; CHROMATIN; GENES; EXPRESSION; ZSCAN4; PREIMPLANTATION; INHIBITION; PROTEINS	Unlike pluripotent cells, which generate only embryonic tissues, totipotent cells can generate a full organism, including extraembryonic tissues. A rare population of cells resembling 2-cell-stage embryos arises in pluripotent embryonic stem (ES) cell cultures. These 2-cell-like cells display molecular features of totipotency and broader developmental plasticity. However, their specific nature and the process through which they arise remain outstanding questions. Here we identified intermediate cellular states and molecular determinants during the emergence of 2-cell-like cells. By deploying a quantitative single-cell expression approach, we identified an intermediate population characterized by expression of the transcription factor ZSCAN4 as a precursor of 2-cell-like cells. By using a small interfering RNA (siRNA) screen, we identified epigenetic regulators of 2-cell-like cell emergence, including the non-canonical PRC1 complex PRC1.6 and the EP400-TIP60 complex. Our data shed light on the mechanisms that underlie exit from the ES cell state toward the formation of early-embryonic-like cells in culture and identify key epigenetic pathways that promote this transition.	[Rodriguez-Terrones, Diego; Gaume, Xavier; Ishiuchi, Takashi; Penning, Audrey; Torres-Padilla, Maria-Elena] Helmholtz Zentrum Munchen, Inst Epigenet & Stem Cells IES, Munich, Germany; [Rodriguez-Terrones, Diego; Gaume, Xavier; Weiss, Amelie; Kopp, Arnaud; Brino, Laurent] CNRS, Inst Genet & Biol Mol & Cellulaire, INSERM, U964, Strasbourg, France; [Kruse, Kai; Vaquerizas, Juan M.] Max Planck Inst Mol Biomed, Munster, Germany; [Torres-Padilla, Maria-Elena] Ludwig Maximilians Univ Munchen, Fac Biol, Munich, Germany; [Ishiuchi, Takashi] Kyushu Univ, Med Inst Bioregulat, Div Epigenet & Dev, Fukuoka, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society; University of Munich; Kyushu University	Torres-Padilla, ME (corresponding author), Helmholtz Zentrum Munchen, Inst Epigenet & Stem Cells IES, Munich, Germany.; Torres-Padilla, ME (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol, Munich, Germany.	torres-padilla@helmholtz-muenchen.de	Vaquerizas, Juan M/AAY-2339-2020; Rodriguez-Terrones, Diego/AAE-6131-2020; Ishiuchi, Takashi/AAE-9742-2021; Vaquerizas, Juan M/F-2676-2011	Vaquerizas, Juan M/0000-0002-6583-6541; Rodriguez-Terrones, Diego/0000-0001-6306-5942; Vaquerizas, Juan M/0000-0002-6583-6541; Brino, laurent/0000-0002-9036-1461; Kruse, Kai/0000-0002-7951-7357; Ishiuchi, Takashi/0000-0001-8346-4596	EpiGeneSys NoE, ERC-Stg 'NuclearPotency' [280840]; EMBO Young Investigator Programme; Fondation Schlumberger pour l'Education et la Recherche (Torres-Padilla); Helmholtz Association; Max Planck Society; Epigenesys NoE; Uehara Memorial Foundation; Human Frontier Science Programme [LT000015/2012-l]; DGECI fellowship from the National University of Mexico [2890/2014]	EpiGeneSys NoE, ERC-Stg 'NuclearPotency'; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); Fondation Schlumberger pour l'Education et la Recherche (Torres-Padilla); Helmholtz Association(Helmholtz Association); Max Planck Society(Max Planck SocietyFoundation CELLEX); Epigenesys NoE; Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Programme(Human Frontier Science Program); DGECI fellowship from the National University of Mexico	We thank A. Smith (Wellcome Trust/MRC Stem Cell Institute) for providing the knock-in REX1 reporter cell line, M. Ko (Keio University) for the Zscan4c promoter plasmid, R. Enriquez-Gasca for providing a classification of MERVLs before publication, D. Reinberg (New York University Langone School of Medicine) for the rabbit antibody to PRDM14, A. Ettinger for time-lapse analysis, C. Ebel, D. Pich, T. Hofer and W. Hammerschmidt for help and access to FACS, the INGESTEM infrastructure for access to the IGBMC high-throughput high-content screening workstation, C. Thibault, F. Recillas-Targa and M. Zurita-Ortega for helpful discussions and A. Burton for critical reading of the manuscript. M.-E.T.-P. acknowledges funding from EpiGeneSys NoE, ERC-Stg 'NuclearPotency' (280840), the EMBO Young Investigator Programme, the Fondation Schlumberger pour l'Education et la Recherche (2016-Torres-Padilla) and the Helmholtz Association. J.M.V. acknowledges funding from the Max Planck Society and Epigenesys NoE. T.I. was a recipient of postdoctoral fellowships from the Uehara Memorial Foundation and the Human Frontier Science Programme (LT000015/2012-l). D.R.-T. was partially supported by a DGECI fellowship (2890/2014) from the National University of Mexico.	Alexandrova S, 2016, DEVELOPMENT, V143, P24, DOI 10.1242/dev.124602; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Boskovic A, 2014, GENE DEV, V28, P1042, DOI 10.1101/gad.238881.114; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Eid A, 2016, EPIGENETICS-US, V11, P389, DOI 10.1080/15592294.2016.1172160; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gonzalez JM, 2016, STEM CELL REP, V7, P177, DOI 10.1016/j.stemcr.2016.07.009; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Ishiuchi T, 2013, CURR OPIN GENET DEV, V23, P512, DOI 10.1016/j.gde.2013.06.006; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Krepelova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088933; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liu ZY, 2017, MOL CELL, V65, P589, DOI 10.1016/j.molcel.2017.01.017; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pradhan SK, 2016, MOL CELL, V61, P27, DOI 10.1016/j.molcel.2015.10.039; Ramachandran P, 2013, BIOINFORMATICS, V29, P444, DOI 10.1093/bioinformatics/btt001; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; TSUNODA Y, 1983, J REPROD FERTIL, V69, P315, DOI 10.1530/jrf.0.0690315; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu G, 2016, CURR TOP DEV BIOL, V117, P301, DOI 10.1016/bs.ctdb.2015.10.014; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	75	81	81	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2018	50	1					106	+		10.1038/s41588-017-0016-5	http://dx.doi.org/10.1038/s41588-017-0016-5			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FT4XB	29255263	Green Accepted, Green Submitted			2022-12-17	WOS:000423157400014
J	Lin, ZM; Li, S; Feng, C; Yang, S; Wang, HJ; Ma, DH; Zhang, J; Gou, MT; Bu, DF; Zhang, TJ; Kong, XH; Wang, XT; Sarig, O; Ren, Y; Dai, LL; Liu, HK; Zhang, JG; Li, F; Hu, YY; Padalon-Brauch, G; Vodo, D; Zhou, F; Chen, T; Deng, HT; Sprecher, E; Yang, Y; Tang, X				Lin, Zhimiao; Li, Shuo; Feng, Cheng; Yang, Shang; Wang, Huijun; Ma, Danhui; Zhang, Jing; Gou, Mengting; Bu, Dingfang; Zhang, Tengjiang; Kong, Xiaohui; Wang, Xintong; Sarig, Ofer; Ren, Yali; Dai, Lanlan; Liu, Hankui; Zhang, Jianguo; Li, Fei; Hu, Yongyan; Padalon-Brauch, Gilly; Vodo, Dan; Zhou, Feng; Chen, Ting; Deng, Haiteng; Sprecher, Eli; Yang, Yong; Tang, Xu			Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility	NATURE GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; PROTEASOME PATHWAY; MUSCULAR-DYSTROPHY; BTB/KELCH PROTEIN; KAINATE RECEPTORS; GENE FAMILY; DEGRADATION; EPITHELIA; DISEASE; DOMAIN	Skin integrity is essential for protection from external stress and trauma. Defects in structural proteins such as keratins cause skin fragility, epitomized by epidermolysis bullosa (EB), a life-threatening disorder. Here we show that dominant mutations of KLHL24, encoding a cullin 3-RBX1 ubiquitin ligase substrate receptor, cause EB. We have identified start-codon mutations in the KLHL24 gene in five patients with EB. These mutations lead to truncated KLHL24 protein lacking the initial 28 amino acids (KLHL24-Delta N28). KLHL24-Delta N28 is more stable than its wild-type counterpart owing to abolished autoubiquitination. We have further identified keratin 14 (KRT14) as a KLHL24 substrate and found that KLHL24-Delta N28 induces excessive ubiquitination and degradation of KRT14. Using a knock-in mouse model, we have confirmed that the K1h124 mutations lead to stabilized K1h124-Delta N28 and cause Krt14 degradation. Our findings identify a new disease-causing mechanism due to dysregulation of autoubiquitination and open new avenues for the treatment of related disorders.	[Lin, Zhimiao; Feng, Cheng; Wang, Huijun; Zhang, Jing; Bu, Dingfang; Wang, Xintong; Yang, Yong] Peking Univ, Dept Dermatol, Hosp 1, Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China; [Li, Shuo; Yang, Shang; Ma, Danhui; Gou, Mengting; Zhang, Tengjiang; Kong, Xiaohui; Tang, Xu] Tsinghua Univ, Sch Pharmaceut Sci, Sch Med, Tsinghua Peking Ctr Life Sci,Ctr Infect Dis Res, Beijing, Peoples R China; [Wang, Huijun; Zhang, Jing; Yang, Yong] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Sarig, Ofer; Padalon-Brauch, Gilly; Vodo, Dan; Sprecher, Eli] Tel Aviv Univ, Dept Dermatol, Tel Aviv Sourasky Med Ctr, Dept Human Mol Genet & Biochem,Sackler Fac Med, Tel Aviv, Israel; [Ren, Yali] Peking Univ, Hosp 1, Electron Microscopy Lab, Beijing, Peoples R China; [Dai, Lanlan; Liu, Hankui; Zhang, Jianguo] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Fei; Chen, Ting] Natl Inst Biol Sci, Beijing, Peoples R China; [Hu, Yongyan] Peking Univ, Hosp 1, Lab Anim Facil, Beijing, Peoples R China; [Zhou, Feng] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai, Peoples R China; [Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Deng, Haiteng] Tsinghua Univ, Ctr Biomed Anal, Beijing, Peoples R China	Peking University; Tsinghua University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Peking University; Beijing Genomics Institute (BGI); National Institute of Biological Sciences, Beijing; Peking University; Fudan University; Tsinghua University; Tsinghua University	Yang, Y (corresponding author), Peking Univ, Dept Dermatol, Hosp 1, Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China.; Tang, X (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Sch Med, Tsinghua Peking Ctr Life Sci,Ctr Infect Dis Res, Beijing, Peoples R China.; Yang, Y (corresponding author), Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.	dryongyang@bjmu.edu.cn; xutan@tsinghua.edu.cn	Tan, Xu/E-7170-2011; wang, hui/GRS-4730-2022	Tan, Xu/0000-0003-4861-4573; Zhang, Jianguo/0000-0003-0723-1701; Hankui, Liu/0000-0001-7826-0388; Feng, Cheng/0000-0002-8785-2681; Yang, Shang/0000-0001-6671-7571; li, shuo/0000-0003-1152-5593; Deng, Haiteng/0000-0001-9496-1280	National Natural Science Foundation of China [81201220, 81271744, 31670777]; Young Thousand Talents Program of China; China National Funds for Distinguished Young Scientists [81425020]; China National Funds for Excellent Young Scientists [81522037]; Beijing Nova Program [Z151100000315044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Thousand Talents Program of China; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); China National Funds for Excellent Young Scientists; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	We thank J. Jin, G. Ou, L. Yu, G. Xu and N. Zheng for advice and support, A. Elia, M. Emanuele and S. Elledge for critical reading of the manuscript, and all the patients and their families for participating in this study. This work was supported by the National Natural Science Foundation of China (grants 81201220 to Z.L. 81271744 to Y.Y. and 31670777 to X.T.), the Young Thousand Talents Program of China to X.T., China National Funds for Distinguished Young Scientists (grant 81425020 to Y.Y.), China National Funds for Excellent Young Scientists (grant 81522037 to Z.L.) and the Beijing Nova Program (grant Z151100000315044 to Z.L.).	Arin MJ, 2001, TRENDS MOL MED, V7, P422, DOI 10.1016/S1471-4914(01)02095-0; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Bruckner-Tuderman L, 2012, J INVEST DERMATOL, V132, pE2, DOI [10.1038/skinbio.2012.2, DOI 10.1038/SKINBIO.2012.2]; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Gadd MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131218; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; Harper JW, 2012, MOL CELL PROTEOMICS, V11, P1541, DOI 10.1074/mcp.R112.021154; Has C, 2014, ANNU REV GENOM HUM G, V15, P245, DOI 10.1146/annurev-genom-090413-025540; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Loffek S, 2010, HUM MUTAT, V31, P466, DOI 10.1002/humu.21222; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rogel Micah R, 2010, Proc Am Thorac Soc, V7, P71, DOI 10.1513/pats.200908-089JS; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rugg EL, 2007, J INVEST DERMATOL, V127, P574, DOI 10.1038/sj.jid.5700571; Schumacher FR, 2014, BIOCHEM J, V460, P237, DOI 10.1042/BJ20140153; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uitto J, 2007, EXP CELL RES, V313, P1995, DOI 10.1016/j.yexcr.2007.03.029; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wu WJ, 2013, SCI CHINA LIFE SCI, V56, P373, DOI 10.1007/s11427-013-4458-4; Yamazaki S, 2012, INT J MOL MED, V29, P165, DOI 10.3892/ijmm.2011.826; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	46	81	93	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1508	1516		10.1038/ng.3701	http://dx.doi.org/10.1038/ng.3701			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798626				2022-12-17	WOS:000389011100011
J	Mascher, M; Schuenemann, VJ; Davidovich, U; Marom, N; Himmelbach, A; Hubner, S; Korol, A; David, M; Reiter, E; Riehl, S; Schreiber, M; Vohr, SH; Green, RE; Dawson, IK; Russell, J; Kilian, B; Muehlbauer, GJ; Waugh, R; Fahima, T; Krause, J; Weiss, E; Stein, N				Mascher, Martin; Schuenemann, Verena J.; Davidovich, Uri; Marom, Nimrod; Himmelbach, Axel; Hubner, Sariel; Korol, Abraham; David, Michal; Reiter, Ella; Riehl, Simone; Schreiber, Mona; Vohr, Samuel H.; Green, Richard E.; Dawson, Ian K.; Russell, Joanne; Kilian, Benjamin; Muehlbauer, Gary J.; Waugh, Robbie; Fahima, Tzion; Krause, Johannes; Weiss, Ehud; Stein, Nils			Genomic analysis of 6,000-year-old cultivated grain illuminates the domestication history of barley	NATURE GENETICS			English	Article							ANCIENT DNA; GENETIC-EVIDENCE; HORDEUM-VULGARE; EVOLUTION; ADMIXTURE; REVEALS; ORIGIN; LANDRACES; SEQUENCES; FRAMEWORK	The cereal grass barley was domesticated about 10,000 years before the present in the Fertile Crescent and became a founder crop of Neolithic agriculture(1). Here we report the genome sequences of five 6,000-year-old barley grains excavated at a cave in the Judean Desert close to the Dead Sea. Comparison to whole-exome sequence data from a diversity panel of present-day barley accessions showed the close affinity of ancient samples to extant landraces from the Southern Levant and Egypt, consistent with a proposed origin of domesticated barley in the Upper Jordan Valley. Our findings suggest that barley landraces grown in present-day Israel have not experienced major lineage turnover over the past six millennia, although there is evidence for gene flow between cultivated and sympatric wild populations. We demonstrate the usefulness of ancient genomes from desiccated archaeobotanical remains in informing research into the origin, early domestication and subsequent migration of crop species.	[Mascher, Martin; Himmelbach, Axel; Schreiber, Mona; Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Schuenemann, Verena J.; Reiter, Ella; Riehl, Simone; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Schuenemann, Verena J.; Riehl, Simone; Krause, Johannes] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Davidovich, Uri] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Marom, Nimrod] Univ Haifa, Zinman Inst Archaeol, Lab Archaeozool, Haifa, Israel; [Hubner, Sariel] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Hubner, Sariel] Tel Hai Coll, Dept Biotechnol, Upper Galilee, Israel; [Korol, Abraham; Fahima, Tzion] Univ Haifa, Inst Evolut, Haifa, Israel; [Korol, Abraham; Fahima, Tzion] Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel; [David, Michal; Weiss, Ehud] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Vohr, Samuel H.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dawson, Ian K.; Russell, Joanne; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Waugh, Robbie] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Krause, Johannes] Max Planck Inst Sci Human Hist, Jena, Germany; [Kilian, Benjamin] Bayer CropSci, BCS Breeding & Trait Dev, Ghent, Belgium	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Hebrew University of Jerusalem; University of Haifa; University of British Columbia; Tel Hai Academy College; University of Haifa; University of Haifa; Bar Ilan University; University of California System; University of California Santa Cruz; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Dundee; Bayer AG; Bayer CropScience	Stein, N (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Seeland, Germany.; Krause, J (corresponding author), Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany.; Krause, J (corresponding author), Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany.; Fahima, T (corresponding author), Univ Haifa, Inst Evolut, Haifa, Israel.; Fahima, T (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Haifa, Israel.; Weiss, E (corresponding author), Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel.; Krause, J (corresponding author), Max Planck Inst Sci Human Hist, Jena, Germany.	fahima@research.haifa.ac.il; krause@shh.mpg.de; ehud.weiss@biu.ac.il; stein@ipk-gatersleben.de	Weiss, Ehud/AAJ-3619-2020; Riehl, Simone/AAI-5815-2020; Schreiber, Mona/AAV-5372-2021; Krause, Johannes/AFP-2642-2022; Stein, Nils/F-7507-2017; Schreiber, Mona/AAY-7024-2020	Weiss, Ehud/0000-0002-9730-4726; Riehl, Simone/0000-0002-1744-0032; Krause, Johannes/0000-0001-9144-3920; Stein, Nils/0000-0003-3011-8731; Schreiber, Mona/0000-0002-6771-6914; Davidovich, Uri/0000-0001-5947-1534; Dawson, Ian/0000-0003-4245-6973; Green, Richard/0000-0003-0516-5827; Kilian, Benjamin/0000-0002-9145-6980; Marom, Nimrod/0000-0002-1057-154X; Dawson, Ian/0000-0003-1345-3642; Mascher, Martin/0000-0001-6373-6013; Himmelbach, Axel/0000-0001-7338-0946; Fahima, Tzion/0000-0001-5555-0040; Vohr, Samuel/0000-0002-4338-3756	Israel Science Foundation [1179/13]; Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota; Triticeae Coordinated Agricultural Project [USDA-NIFA 2011-68002-30029]; IPK Gatersleben; Scottish government; University of Dundee; Irene Levi Sela CARE Foundation	Israel Science Foundation(Israel Science Foundation); Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota; Triticeae Coordinated Agricultural Project; IPK Gatersleben; Scottish government; University of Dundee; Irene Levi Sela CARE Foundation	We gratefully acknowledge B. Schafer for providing photographs of barley spikes and A. Fiebig for sequence data submission. This work was supported by a grant of the Israel Science Foundation (1179/13) to E.W., funding from the Endowed Chair in Molecular Genetics Applied to Crop Improvement at the University of Minnesota and the Triticeae Coordinated Agricultural Project, USDA-NIFA 2011-68002-30029 to G.J.M., and core funding of IPK Gatersleben to N.S. and M.M. R.W., J.R. and I.K.D. were supported by Research Programme funding from the Scottish government and the University of Dundee (R.W.). N.M. and U.D. acknowledge a grant from the Irene Levi Sela CARE Foundation.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arend D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-214; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bilgic H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151974; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; da Fonseca RR, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.3, 10.1038/nplants.2014.3]; Dickson A.D., 1978, BARLEY ORIGIN BOT CU; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Frumin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13308; Giuffra E, 2000, GENETICS, V154, P1785; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Himmelbach A., 2014, BIO-PROTOCOL, V4, pe1166, DOI DOI 10.21769/BioProtoc.1166; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kistler L., 2015, THERMAL AGE CYTOSINE; Kistler L, 2012, METHODS MOL BIOL, V840, P71, DOI 10.1007/978-1-61779-516-9_10; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Li CX, 2011, J ARCHAEOL SCI, V38, P115, DOI 10.1016/j.jas.2010.08.016; Li H., 2013, ARXIV; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meiri M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03035; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palmer SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006301; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Russell J., 2016, NAT GENET; Russell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086021; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schick, 2002, ATIQOT, V41, P223; Schiffels S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10408; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Snir A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131422; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Van Zeist W, 1984, PALAEOHISTORIA, V24, P165; Weiss CL, 2015, ELIFE, V4, DOI 10.7554/eLife.10005.001; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	59	81	84	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1089	+		10.1038/ng.3611	http://dx.doi.org/10.1038/ng.3611			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428749	Green Submitted			2022-12-17	WOS:000382398800023
J	Sharon, E; Sibener, LV; Battle, A; Fraser, HB; Garcia, KC; Pritchard, JK				Sharon, Eilon; Sibener, Leah V.; Battle, Alexis; Fraser, Hunter B.; Garcia, K. Christopher; Pritchard, Jonathan K.			Genetic variation in MHC proteins is associated with T cell receptor expression biases	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; AMINO-ACIDS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; THYMIC SELECTION; GERMLINE BIAS; IMMUNE-SYSTEM; CLASS-I; RECOGNITION; REPERTOIRE	In each individual, a highly diverse T cell receptor (TCR) repertoire interacts with peptides presented by major histocompatibility complex (MHC) molecules. Despite extensive research, it remains controversial whether germline-encoded TCR-MHC contacts promote TCR-MHC specificity and, if so, whether differences exist in TCR V gene compatibilities with different MHC alleles. We applied expression quantitative trait locus (eQTL) mapping to test for associations between genetic variation and TCR V gene usage in a large human cohort. We report strong trans associations between variation in the MHC locus and TCR V gene usage. Fine-mapping of the association signals identifies specific amino acids from MHC genes that bias V gene usage, many of which contact or are spatially proximal to the TCR or peptide in the TCR-peptide-MHC complex. Hence, these MHC variants, several of which are linked to autoimmune diseases, can directly affect TCR-MHC interaction. These results provide the first examples of trans-QTL effects mediated by protein-protein interactions and are consistent with intrinsic TCR-MHC specificity.	[Sharon, Eilon; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sharon, Eilon; Fraser, Hunter B.; Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol Physiol, Stanford, CA 94305 USA; [Sibener, Leah V.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Sibener, Leah V.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Garcia, K. Christopher; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Pritchard, JK (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Pritchard, JK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.; Garcia, KC; Pritchard, JK (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu; pritch@stanford.edu		Sharon, Eilon/0000-0002-1262-350X	NIH [HG0070736, 1R01GM097171-01A1, RO1AI03867, U19AI057229]; Howard Hughes Medical Institute; EMBO Long-Term Fellowship; National Science Foundation Graduate Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103867, R01AI048540, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Golan, D. Knowles, A. Fu, M. Birnbaum, M. Gee, J. Mendoza, A. Bhaskar and T. Raj for helpful discussions and the anonymous referees for valuable comments. This work was supported by NIH grants HG0070736, 1R01GM097171-01A1, RO1AI03867 and U19AI057229, the Howard Hughes Medical Institute, the EMBO Long-Term Fellowship and a National Science Foundation Graduate Research Fellowship.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blevins SJ, 2016, P NATL ACAD SCI USA, V113, pE1276, DOI 10.1073/pnas.1522069113; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Castro CD, 2015, IMMUNOL REV, V267, P30, DOI 10.1111/imr.12327; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Garcia KC, 2012, TRENDS IMMUNOL, V33, P429, DOI 10.1016/j.it.2012.05.005; Garcia KC, 2012, IMMUNITY, V36, P887, DOI 10.1016/j.immuni.2012.05.018; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GULWANIAKOLKAR B, 1995, J IMMUNOL, V154, P3843; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Ishwaran H, 2005, J AM STAT ASSOC, V100, P764, DOI 10.1198/016214505000000051; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Klarenbeek PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140815; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MCDEVITT HO, 1974, LANCET, V1, P1269; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; MITCHELL TJ, 1988, J AM STAT ASSOC, V83, P1023, DOI 10.2307/2290129; Miyadera H, 2015, J HUM GENET, V60, P697, DOI 10.1038/jhg.2015.100; Murray JS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00268; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Parrish HL, 2016, P NATL ACAD SCI USA, V113, P3000, DOI 10.1073/pnas.1518499113; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Roudier J, 2000, ARTHRITIS RES, V2, P217, DOI 10.1186/ar91; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sinclair C, 2013, P NATL ACAD SCI USA, V110, pE2905, DOI 10.1073/pnas.1304859110; SOTTINI A, 1991, EUR J IMMUNOL, V21, P2455, DOI 10.1002/eji.1830211023; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Wallace C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005272; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zvyagin IV, 2014, P NATL ACAD SCI USA, V111, P5980, DOI 10.1073/pnas.1319389111	68	81	83	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					995	+		10.1038/ng.3625	http://dx.doi.org/10.1038/ng.3625			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27479906	Green Accepted			2022-12-17	WOS:000382398800009
J	Liu, H; Irwanto, A; Fu, X; Yu, GQ; Yu, YX; Sun, YH; Wang, C; Wang, ZZ; Okada, Y; Low, HQ; Li, Y; Liany, H; Chen, MF; Bao, FF; Li, JH; You, JB; Zhang, QL; Liu, J; Chu, TS; Andiappan, AK; Wang, N; Niu, GY; Liu, DC; Yu, XL; Zhang, L; Tian, HQ; Zhou, GZ; Rotzschke, O; Chen, SM; Zhang, XJ; Liu, JJ; Zhang, FR				Liu, Hong; Irwanto, Astrid; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Okada, Yukinori; Low, Huiqi; Li, Yi; Liany, Herty; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Zhang, Qilin; Liu, Jian; Chu, Tongsheng; Andiappan, Anand Kumar; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Tian, Hongqing; Zhou, Guizhi; Rotzschke, Olaf; Chen, Shumin; Zhang, Xuejun; Liu, Jianjun; Zhang, Furen			Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; HIGH-RESOLUTION; POPULATION; HLA; IDENTIFICATION; IMPUTATION; VISUALIZATION; METAANALYSIS; INFERENCE	Genome-wide association studies (GWAS) have led to the discovery of several susceptibility loci for leprosy with robust evidence, providing biological insight into the role of host genetic factors in mycobacterial infection. However, the identified loci only partially explain disease heritability, and additional genetic risk factors remain to be discovered. We performed a 3-stage GWAS of leprosy in the Chinese population using 8,313 cases and 16,017 controls. Besides confirming all previously published loci, we discovered six new susceptibility loci, and further gene prioritization analysis of these loci implicated BATF3, CCDC88B and CIITA-SOCS1 as new susceptibility genes for leprosy. A systematic evaluation of pleiotropic effects demonstrated a high tendency for leprosy susceptibility loci to show association with autoimmunity and inflammatory diseases. Further analysis suggests that molecular sensing of infection might have a similar pathogenic role across these diseases, whereas immune responses have discordant roles in infectious and inflammatory diseases.	[Liu, Hong; Tian, Hongqing] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan 250100, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Liu, Jian; Chu, Tongsheng; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Zhou, Guizhi; Chen, Shumin; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Liu, Hong; Zhang, Qilin; Zhang, Furen] Shandong Univ, Sch Med, Jinan 250100, Peoples R China; [Liu, Hong; Fu, Xi'an; Yu, Gongqi; Yu, Yongxiang; Sun, Yonghu; Wang, Chuan; Wang, Zhenzhen; Chen, Mingfei; Bao, Fangfang; Li, Jinghui; You, Jiabao; Liu, Jian; Chu, Tongsheng; Wang, Na; Niu, Guiye; Liu, Dianchang; Yu, Xiulu; Zhang, Lin; Zhou, Guizhi; Chen, Shumin; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Peoples R China; [Irwanto, Astrid; Low, Huiqi; Li, Yi; Liany, Herty; Liu, Jianjun] Agcy Sci Technol & Res Singapore, Genome Inst Singapore, Human Genet, Singapore, Singapore; [Irwanto, Astrid; Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Okada, Yukinori] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Andiappan, Anand Kumar; Rotzschke, Olaf] Singapore Immunol Network, Singapore, Singapore; [Tian, Hongqing; Zhang, Furen] Natl Clin Key Project Dermatol & Venereol, Jinan, Peoples R China; [Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Zhang, Xuejun] Minist Educ & Anhui Prov, Key Lab Gene Resource Utilizat Severe Dis, Hefei, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Anhui Medical University	Zhang, FR (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com	zhang, xuan/AAN-9914-2020; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; Roetzschke, Olaf/GXH-0012-2022; zhang, xuan/GQO-8953-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022; Liu, Jianjun/AAK-4989-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; Liu, Jianjun/0000-0002-3255-3019; Andiappan, Anand Kumar/0000-0002-8442-1544; Sun, Yonghu/0000-0003-4553-2871	National Natural Science Foundation of China [81371721, 81271746, 31200933, 81101187]; National 863 Program of China [2014AA020505]; Shandong Provincial Advanced Taishan Scholar Construction Project; Agency for Science, Technology and Research of Singapore; Singapore International Graduate Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Shandong Provincial Advanced Taishan Scholar Construction Project; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore International Graduate Award	We thank the individuals who participated in this project. This work was funded by grants from the National Natural Science Foundation of China (81371721, 81271746, 31200933 and 81101187), the National 863 Program of China (2014AA020505), the Shandong Provincial Advanced Taishan Scholar Construction Project and the Agency for Science, Technology and Research of Singapore. A.I. was supported by the Singapore International Graduate Award.	Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P365; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Casanova JL, 2009, J EXP MED, V206, P1839, DOI 10.1084/jem.20091683; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Coulombe F, 2009, LANCET, V374, P769, DOI 10.1016/S0140-6736(09)61576-2; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fischer A, 2012, AM J RESP CRIT CARE, V186, P877, DOI 10.1164/rccm.201204-0708OC; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Liu H, 2013, HUM MOL GENET, V22, P4430, DOI 10.1093/hmg/ddt286; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; RANI R, 1993, TISSUE ANTIGENS, V42, P133, DOI 10.1111/j.1399-0039.1993.tb02179.x; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; SCHAUF V, 1985, TISSUE ANTIGENS, V26, P243; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TODD JR, 1990, REV INFECT DIS, V12, P63; Vanderborght PR, 2007, GENES IMMUN, V8, P320, DOI 10.1038/sj.gene.6364390; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	50	81	84	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					267	+		10.1038/ng.3212	http://dx.doi.org/10.1038/ng.3212			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25642632				2022-12-17	WOS:000350327900019
J	Gross, AM; Orosco, RK; Shen, JP; Egloff, AM; Carter, H; Hofree, M; Choueiri, M; Coffey, CS; Lippman, SM; Hayes, DN; Cohen, EE; Grandis, JR; Nguyen, QT; Ideker, T				Gross, Andrew M.; Orosco, Ryan K.; Shen, John P.; Egloff, Ann Marie; Carter, Hannah; Hofree, Matan; Choueiri, Michel; Coffey, Charles S.; Lippman, Scott M.; Hayes, D. Neil; Cohen, Ezra E.; Grandis, Jennifer R.; Nguyen, Quyen T.; Ideker, Trey			Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss	NATURE GENETICS			English	Article							SQUAMOUS-CELL CARCINOMA; SURVIVAL; LANDSCAPE; DISCOVERY; GENE	Head and neck squamous cell carcinoma (HNSCC) is characterized by aggressive behavior with a propensity for metastasis and recurrence. Here we report a comprehensive analysis of the molecular and clinical features of HNSCC that govern patient survival. We find that TP53 mutation is frequently accompanied by loss of chromosome 3p and that the combination of these events is associated with a surprising decrease in survival time (1.9 years versus >5 years for TP53 mutation alone). The TP53-3p interaction is specific to chromosome 3p and validates in HNSCC and pan-cancer cohorts. In human papillomavirus (HPV)-positive tumors, in which HPV inactivates TP53, 3p deletion is also common and is associated with poor outcomes. The TP53-3p event is modified by mir-548k expression, which decreases survival further, and is mutually exclusive with mutations affecting RAS signaling. Together, the identified markers underscore the molecular heterogeneity of HNSCC and enable a new multi-tiered classification of this disease.	[Gross, Andrew M.; Ideker, Trey] Univ Calif, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Orosco, Ryan K.; Coffey, Charles S.; Lippman, Scott M.; Nguyen, Quyen T.] Univ Calif San Diego, Div Head & Neck Surg, San Diego, CA USA; [Shen, John P.; Carter, Hannah; Choueiri, Michel; Lippman, Scott M.; Cohen, Ezra E.; Ideker, Trey] Univ Calif, Dept Med, La Jolla, CA USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Hofree, Matan; Ideker, Trey] Univ Calif, Dept Comp Sci & Engn, La Jolla, CA USA; [Lippman, Scott M.; Cohen, Ezra E.; Nguyen, Quyen T.; Ideker, Trey] Univ Calif, Moores Canc Ctr, La Jolla, CA USA; [Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Ideker, T (corresponding author), Univ Calif, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.	tideker@ucsd.edu	Orosco, Ryan K/AAR-7252-2021; Carter, Hannah/R-8425-2017	Orosco, Ryan K/0000-0002-7885-4327; Hofree, Matan/0000-0001-8368-0299; Ideker, Trey/0000-0002-1708-8454; Cohen, Ezra/0000-0002-9872-6242; Coffey, Charles/0000-0002-4513-3400; Carter, Hannah/0000-0002-1729-2463	US National Institutes of Health [P50 GM085764, U24 CA184427, P41 GM103504, T32 DC000028, P50 CA097190, K07 CA137140, DP5 OD017937-01]; US National Institutes of Health (Burroughs Welcome Fund CAMS); US National Institutes of Health (American Cancer Society); Marsha Rivkin Center for Ovarian Cancer Research; Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award; NATIONAL CANCER INSTITUTE [U24CA184427, R01CA158448, P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR031228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000028] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017937] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Burroughs Welcome Fund CAMS); US National Institutes of Health (American Cancer Society); Marsha Rivkin Center for Ovarian Cancer Research; Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The results published here are based upon data generated by the TCGA Research Network. We thank K. Messer and A. Tward for helpful discussions. We gratefully acknowledge support for this study from the US National Institutes of Health (P50 GM085764, U24 CA184427 and P41 GM103504 to T.I.; T32 DC000028 to R.K.O.; Burroughs Welcome Fund CAMS to Q.T.N.; P50 CA097190 and The American Cancer Society to J.R.G.; K07 CA137140 to A.M.E.; DP5 OD017937-01 to H.C.). J.P.S. is supported in part by grants from the Marsha Rivkin Center for Ovarian Cancer Research and a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cox D.R., 1984, ANAL SURVIVAL DATA; Farshadpour F, 2011, HEAD NECK-J SCI SPEC, V33, P817, DOI 10.1002/hed.21549; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Meredith S.D., 1995, HEAD NECK SURG, V121, P790; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mroz EA, 2013, CANCER-AM CANCER SOC, V119, P3034, DOI 10.1002/cncr.28150; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Partridge M, 1999, BRIT J CANCER, V79, P1821, DOI 10.1038/sj.bjc.6690290; Partridge M, 1996, BRIT J CANCER, V73, P366, DOI 10.1038/bjc.1996.62; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Rosin MP, 2000, CLIN CANCER RES, V6, P357; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	31	81	83	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					939	+		10.1038/ng.3051	http://dx.doi.org/10.1038/ng.3051			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25086664	Green Accepted, Green Submitted			2022-12-17	WOS:000341579400006
J	van der Zanden, LFM; van Rooij, IALM; Feitz, WFJ; Knight, J; Donders, ART; Renkema, KY; Bongers, EMHF; Vermeulen, SHHM; Kiemeney, LALM; Veltman, JA; Arias-Vasquez, A; Zhang, XF; Markljung, E; Qiao, LA; Baskin, LS; Nordenskjold, A; Roeleveld, N; Franke, B; Knoers, NVAM				van der Zanden, Loes F. M.; van Rooij, Iris A. L. M.; Feitz, Wout F. J.; Knight, Jo; Donders, A. Rogier T.; Renkema, Kirsten Y.; Bongers, Ernie M. H. F.; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A. L. M.; Veltman, Joris A.; Arias-Vasquez, Alejandro; Zhang, Xufeng; Markljung, Ellen; Qiao, Liang; Baskin, Laurence S.; Nordenskjold, Agneta; Roeleveld, Nel; Franke, Barbara; Knoers, Nine V. A. M.			Common variants in DGKK are strongly associated with risk of hypospadias	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ANDROGEN RECEPTOR GENE; POLYMORPHISM; DNA; IDENTIFICATION; CRYPTORCHIDISM; MICROARRAYS; LINKAGE	Hypospadias is a common congenital malformation of the male external genitalia. We performed a genome-wide association study using pooled DNA from 436 individuals with hypospadias (cases) and 494 controls of European descent and selected the highest ranked SNPs for individual genotyping in the discovery sample, an additional Dutch sample of 133 cases and their parents, and a Swedish series of 266 cases and 402 controls. Individual genotyping of two SNPs (rs1934179 and rs7063116) in DGKK, encoding diacylglycerol kinase., produced compelling evidence for association with hypospadias in the discovery sample (allele-specific odds ratio (OR) = 2.5, P = 2.5 x 10(-11) and OR = 2.3, P = 2.9 x 10(-9), respectively) and in the Dutch (OR = 3.9, P = 2.4 x 10(-5) and OR = 3.8, P = 3.4 x 10(-5)) and Swedish (OR = 2.5, P = 2.6 x 10(-8) and OR = 2.2, P = 2.7 x 10(-6)) replication samples. Expression studies showed expression of DGKK in preputial tissue of cases and controls, which was lower in carriers of the risk allele of rs1934179 (P = 0.047). We propose DGKK as a major risk gene for hypospadias.	[van der Zanden, Loes F. M.; Renkema, Kirsten Y.; Bongers, Ernie M. H. F.; Vermeulen, Sita H. H. M.; Veltman, Joris A.; Arias-Vasquez, Alejandro; Franke, Barbara; Knoers, Nine V. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van der Zanden, Loes F. M.; van Rooij, Iris A. L. M.; Donders, A. Rogier T.; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A. L. M.; Roeleveld, Nel] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Feitz, Wout F. J.; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Knight, Jo] Kings Coll London, Sch Med, Div Genet & Mol Med, London WC2R 2LS, England; [Knight, Jo] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Zhang, Xufeng; Markljung, Ellen; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Zhang, Xufeng; Markljung, Ellen; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Qiao, Liang; Baskin, Laurence S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; University of London; King's College London; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital	Franke, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	b.franke@antrg.umcn.nl	Feitz, W.F.J./H-8028-2014; Vasquez, Alejandro Arias/E-4762-2012; zhang, xu/GRX-9733-2022; Renkema, Kirsten Y./V-2385-2019; Vermeulen, Sita H./L-4716-2015; Iris ALM Rooij, van/A-5705-2014; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; Vasquez, A. Arias/L-4175-2015; van der Zanden, Loes/M-4795-2015; Knight, Jo/F-4946-2011; Donders, A.R.T./L-4277-2015; Veltman, Joris A/F-5128-2010; zhang, xu/GYE-3558-2022; Bongers, M.H.F./L-4214-2015; Kiemeney, Lambertus A./D-3357-2009; Roeleveld, Nel/B-4242-2008; Franke, Barbara/D-4836-2009	Vasquez, Alejandro Arias/0000-0002-4786-0169; Vermeulen, Sita H./0000-0003-4913-8601; Iris ALM Rooij, van/0000-0002-9519-966X; van der Zanden, Loes/0000-0003-3914-7491; Donders, A.R.T./0000-0002-0484-1419; Veltman, Joris A/0000-0002-3218-8250; Kiemeney, Lambertus A./0000-0002-2368-1326; Roeleveld, Nel/0000-0002-3390-4466; Franke, Barbara/0000-0003-4375-6572; Nordenskjold, Agneta/0000-0001-6638-4631; Knight, Joanne/0000-0002-7148-1660; Renkema, Kirsten/0000-0003-3922-9382	Radboud University Nijmegen Medical Centre; Urology Foundation; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust	Radboud University Nijmegen Medical Centre; Urology Foundation; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust	We thank all cases and parents for their cooperation in this study. We are grateful to the Microarray Facility Nijmegen of the Department of Human Genetics (RUNMC), in particular to M. Steehouwer, for performing the microarray experiments, and to T. Vrijenhoek and J. Hehir-Kwa for their assistance in data analysis. We would also like to thank everyone involved in the data collection, S. van der Velde-Visser, C. Beumer, K. Kwak, J. Knoll, R. de Gier, B. Kortmann, A. Paauwen, K. Kho, J. Driessen and the anesthesiologists of OR 18. Finally, we are grateful to M. Coenen, J. Groothuismink, R. Makkinje and M. Schijvenaars for their practical guidance. This research is performed within a PhD project supported by the Radboud University Nijmegen Medical Centre and with extra budget from the Urology Foundation 1973. J. Knight is funded by the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Aschim EL, 2004, J CLIN ENDOCR METAB, V89, P5105, DOI 10.1210/jc.2004-0293; Ban S, 2008, HUM REPROD, V23, P1466, DOI 10.1093/humrep/den098; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beleza-Meireles A, 2006, J ENDOCRINOL INVEST, V29, P5, DOI 10.1007/BF03349170; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; Beleza-Meireles A, 2007, J CLIN ENDOCR METAB, V92, P3712, DOI 10.1210/jc.2007-0543; Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Fredell L, 2002, J UROLOGY, V167, P1423, DOI 10.1016/S0022-5347(05)65334-7; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Radpour R, 2007, J ANDROL, V28, P164, DOI 10.2164/jandrol.106.000927; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thai HTT, 2005, J CLIN ENDOCR METAB, V90, P6695, DOI 10.1210/jc.2005-0446; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Wang YP, 2004, EUR J HUM GENET, V12, P706, DOI 10.1038/sj.ejhg.5201232; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513	26	81	82	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					48	U63		10.1038/ng.721	http://dx.doi.org/10.1038/ng.721			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21113153	Green Submitted			2022-12-17	WOS:000285683500014
J	Rizzuto, R; Pozzan, T				Rizzuto, R; Pozzan, T			When calcium goes wrong: genetic alterations of a ubiquitous signaling route	NATURE GENETICS			English	Review							CENTRAL CORE DISEASE; HYPOKALEMIC PERIODIC PARALYSIS; STATIONARY NIGHT BLINDNESS; RYANODINE RECEPTOR GENE; SPINOCEREBELLAR ATAXIA TYPE-6; CA2+ RELEASE CHANNELS; HAILEY-HAILEY-DISEASE; MALIGNANT-HYPERTHERMIA; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE	In all eukaryotic cells, the cytosolic concentration of calcium ions ([Ca2+](c)) is tightly controlled by complex interactions among transporters, pumps, channels and binding proteins. Finely tuned changes in [Ca2+](c) modulate a variety of intracellular functions, and disruption of Ca2+ handling leads to cell death. Here we review the human genetic diseases associated with perturbations in the Ca2+ signaling machinery. Despite the importance of Ca2+ in physiology and pathology, the number of known genetic diseases that can be attributed to defects in proteins directly involved in Ca2+ homeostasis is limited to few examples, which will be discussed. This paucity in contrast with the wide molecular repertoire may depend on the extreme severity of the phenotype (leading to death in utero) or, conversely, on functional compensation due to redundancy. In the latter case, it stands to reason that other genetic defects in calcium signaling have yet to be identified owing to their subtle phenotype.	Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, Interdisciplinary Ctr Study Inflammat, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy	University of Ferrara; University of Ferrara; University of Padua	Rizzuto, R (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Via Borsari 46, I-44100 Ferrara, Italy.		Rizzuto, Rosario/B-6312-2008	Rizzuto, Rosario/0000-0001-7044-5097				Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; BRODY IA, 1969, NEW ENGL J MED, V281, P187, DOI 10.1056/NEJM196907242810403; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Clapham DE, 2002, J GEN PHYSIOL, V120, P217, DOI 10.1085/jgp.20028618; Da Silva MRD, 2002, J CLIN ENDOCR METAB, V87, P4881, DOI 10.1210/jc.2002-020698; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; KARPATI G, 1986, ANN NEUROL, V20, P38, DOI 10.1002/ana.410200108; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Margolis Russell L, 2002, Curr Neurol Neurosci Rep, V2, P447, DOI 10.1007/s11910-002-0072-8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Periz G, 1999, EMBO J, V18, P5983, DOI 10.1093/emboj/18.21.5983; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Priori SG, 2001, CIRCULATION, V103, P196; Quane KA, 1997, BRIT J ANAESTH, V79, P332, DOI 10.1093/bja/79.3.332; Rajabally YA, 2002, MUSCLE NERVE, V25, P453, DOI 10.1002/mus.10069; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sternberg D, 2001, BRAIN, V124, P1091, DOI 10.1093/brain/124.6.1091; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Tiso N, 2002, BIOCHEM BIOPH RES CO, V299, P594, DOI 10.1016/S0006-291X(02)02689-X; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	67	81	83	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					135	141		10.1038/ng0603-135	http://dx.doi.org/10.1038/ng0603-135			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12776115				2022-12-17	WOS:000183200500015
J	Graeber, TG; Eisenberg, D				Graeber, TG; Eisenberg, D			Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN MONOCYTES; GROWTH; CHEMOKINES; PATTERNS; CELLS; OLIGONUCLEOTIDE; ACTIVATION; PREDICTION; RECEPTORS	Many biological signaling pathways involve autocrine ligand-receptor loops; misregulation of these signaling loops can contribute to cancer phenotypes. Here we present an algorithm for detecting such loops from gene expression profiles. Our method is based on the hypothesis that for some autocrine pathways, the ligand and receptor are regulated by coupled mechanisms at the level of transcription, and thus ligand-receptor pairs comprising such a loop should have correlated mRNA expression. Using our database of experimentally known ligand-receptor signaling partners, we found examples of ligand-receptor pairs with significantly correlated expression in five cancer-based gene expression datasets. The correlated ligand-receptor pairs we identified are consistent with known autocrine signaling events in cancer cells. In addition, our algorithm predicts new autocrine signaling loops that can be verified experimentally. Chemokines were commonly members of these potential autocrine pathways. Our analysis also revealed ligand-receptor pairs with expression patterns that may indicate cellular mechanisms for preventing autocrine signaling.	Univ Calif Los Angeles, Howard Hughes Med Inst, Lab Struct Biol & Mol Med, Dept Energy, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Lab Struct Biol & Mol Med, Dept Energy, Los Angeles, CA 90095 USA.			Graeber, Thomas/0000-0001-8574-9181				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Capsoni F, 1998, CELL IMMUNOL, V189, P51, DOI 10.1006/cimm.1998.1349; Carr MW, 1996, IMMUNITY, V4, P179, DOI 10.1016/S1074-7613(00)80682-2; DAWSON T, 1995, BRIT J CANCER, V71, P1136, DOI 10.1038/bjc.1995.222; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERIKSTEIN BK, 1993, BRIT J HAEMATOL, V83, P392, DOI 10.1111/j.1365-2141.1993.tb04662.x; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; JIANG YL, 1992, J IMMUNOL, V148, P2423; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2000, PHARMACOL REV, V52, P145; PENG BH, 1995, LEUKEMIA RES, V19, P159, DOI 10.1016/0145-2126(94)00129-X; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; Stroeken PJM, 1998, CANCER RES, V58, P1569; Tanaka Y, 1998, BLOOD, V91, P3909; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; VADDI K, 1994, J IMMUNOL, V153, P4721; Wang JM, 1998, J IMMUNOL METHODS, V220, P1, DOI 10.1016/S0022-1759(98)00128-8; Warzocha K, 1998, BRIT J CANCER, V77, P2357, DOI 10.1038/bjc.1998.391; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; ZHOU P, 1995, CLIN IMMUNOL IMMUNOP, V74, P84, DOI 10.1006/clin.1995.1012	30	81	87	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					295	300		10.1038/ng755	http://dx.doi.org/10.1038/ng755			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685206				2022-12-17	WOS:000171911000015
J	Ueijma, H; Lee, MP; Cui, H; Feinberg, AP				Ueijma, H; Lee, MP; Cui, H; Feinberg, AP			Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios	NATURE GENETICS			English	Article							COLORECTAL-CANCER; RELAXATION; TISSUE		Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA.		Feinberg, Andrew/AAY-7666-2020; Cui, Hengmi/A-2598-2008	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [R01 CA054358] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Greenwood AD, 1996, GENOME RES, V6, P336, DOI 10.1101/gr.6.4.336; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ohlsson R., 1995, GENOMIC IMPRINTING C; Pushnova EA, 1998, ANAL BIOCHEM, V260, P24, DOI 10.1006/abio.1998.2682; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; TAKEDA S, 1993, HUM MUTAT, V2, P112, DOI 10.1002/humu.1380020209; Yun K, 1999, J PATHOL, V187, P518, DOI 10.1002/(SICI)1096-9896(199904)187:5<518::AID-PATH276>3.0.CO;2-3; 1995, ABI PRISM DNA SEQUEN	13	81	86	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					375	376		10.1038/78040	http://dx.doi.org/10.1038/78040			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932175				2022-12-17	WOS:000088615000007
J	Wallace, DC; Melov, S				Wallace, DC; Melov, S			Radicals r'aging	NATURE GENETICS			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; ZN SUPEROXIDE-DISMUTASE; LIFE-SPAN; DROSOPHILA-MELANOGASTER; MICE; OVEREXPRESSION; MUTANT		Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA	Emory University	Wallace, DC (corresponding author), Emory Univ, Ctr Mol Med, 1462 Clifton Rd, Atlanta, GA 30322 USA.		Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834				BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BROWN RH, 1996, MOL GENETIC BASIS NE, P797; CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264; CHANOK SJ, 1994, J BIOL CHEM, V269, P25419; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Radi Rafael, 1997, P57; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; SMONIAN NA, 1996, ANN REV PHARM TOXICO, V36, P83; STAVELEY BE, 1990, GENOME, V33, P967; Wallace D., 1996, MOL GENETIC BASIS NE, P237; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	18	81	81	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					105	106		10.1038/448	http://dx.doi.org/10.1038/448			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620757				2022-12-17	WOS:000073865100002
J	GELB, BD; EDELSON, JG; DESNICK, RJ				GELB, BD; EDELSON, JG; DESNICK, RJ			LINKAGE OF PYCNODYSOSTOSIS TO CHROMOSOME 1Q21 BY HOMOZYGOSITY MAPPING	NATURE GENETICS			English	Note							RECEPTOR; GENE; INTERLEUKIN-6; ILLNESS		MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029; MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029; PORIYA GOVT HOSP,DEPT ORTHOPED,TIBERIAS,ISRAEL	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD 28822] Funding Source: Medline; NIDDK NIH HHS [R01 DK 31775] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDREN L., 1962, ACTA CHIR SCAND, V124, P496; BALENA R, 1994, EMBO J, V13, P1189; CRAIG RW, 1994, GENOMICS, V23, P457, DOI 10.1006/geno.1994.1523; EDELSON JG, 1992, CLIN ORTHOPAEDICS, V280, P263; FREY JB, 1994, TOULOUSELAUTREC LIFE; GREENSPAN A, 1991, SKELETAL RADIOL, V20, P561, DOI 10.1007/BF01106087; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Herrmann J, 1975, Birth Defects Orig Artic Ser, V11, P76; HOGGARD N, 1994, CYTOGENET CELL GENET, V67, P168; HOYLAND JA, 1994, J BONE MINER RES, V9, P75; KISHIMOTO T, 1992, INT J IMMUNOPHARMACO, V14, P431; KLUCK PMC, 1993, HUM GENET, V90, P542; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOFTUS LS, 1991, BRIT MED J, V303, P1589, DOI 10.1136/bmj.303.6817.1589; MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7; MAROTEAUX P, 1962, PRESSE MED, V70, P999; MAROTEAUX P, 1965, J AMER MED ASSOC, V191, P715, DOI 10.1001/jama.1965.03080090029007; MAROTEAUX P, 1993, PRESSE MED, V23, P1635; MCKUSICK VA, 1991, NATURE, V352, P280; MCKUSICK VA, 1965, SCI AM, V213, P88, DOI 10.1038/scientificamerican0865-88; OSHEA JG, 1987, MED J AUSTRALIA, V147, P586; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VERMA RS, 1995, HUMAN CHROMOSOMES PR, P134; WOLF PL, 1994, CLIN CHEM, V40, P328	30	81	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					235	237		10.1038/ng0695-235	http://dx.doi.org/10.1038/ng0695-235			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663521				2022-12-17	WOS:A1995RA85700024
J	KRISTJANSSON, K; CHONG, SS; VANDENVEYVER, IB; SUBRAMANIAN, S; SNABES, MC; HUGHES, MR				KRISTJANSSON, K; CHONG, SS; VANDENVEYVER, IB; SUBRAMANIAN, S; SNABES, MC; HUGHES, MR			PREIMPLANTATION SINGLE-CELL ANALYSES OF DYSTROPHIN GENE DELETIONS USING WHOLE GENOME AMPLIFICATION	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; X-CHROMOSOME; Y-CHROMOSOME; DNA; SPERM; GLOBIN; PCR	Primer extension preamplification (PEP) increases the scope and capacity of single cell genetic diagnosis by generating sufficient template to perform multiple subsequent DNA analyses using the polymerase chain reaction. We report the simultaneous analysis of single cells at five commonly deleted dystrophin exons and at the ZFX/ZFY loci. Ninety three percent of PEP reactions with single amniocytes, chorionic villus cells and blastomeres were successful, and a blinded analysis of single lymphoblasts from affected males resulted in 93% diagnostic accuracy, demonstrating its applicability in preimplantation prevention of Duchenne muscular dystrophy. Transfer of unaffected male embryos and improved diagnostic reliability are achieved with the ability to perform replicate multilocus analyses from the same blastomere.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OBSTET & GYNECOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			Van den Veyver, Ignatia B/AAF-4510-2021; Chong, Samuel S./D-8098-2015	Van den Veyver, Ignatia B/0000-0002-0651-5924; Chong, Samuel S./0000-0002-1872-5937				BEGGS AH, 1990, HUM GENET, V86, P45; BOEHNKE M, 1989, AM J HUM GENET, V45, P21; CHAMBERLAIN JS, 1991, METHOD MOL BIOL, V9, P299; Chamberlain JS, 1990, CURRENT NEUROLOGY, V10, P65; CHONG SS, 1993, HUM MOL GENET, V2, P1187, DOI 10.1093/hmg/2.8.1187; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; GRIFFIN DK, 1992, HUM GENET, V89, P18, DOI 10.1007/BF00207035; GRIFO JA, 1992, JAMA-J AM MED ASSOC, V268, P727, DOI 10.1001/jama.268.6.727; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HANDYSIDE AH, 1992, NEW ENGL J MED, V327, P905, DOI 10.1056/NEJM199209243271301; HUBERT R, 1992, AM J HUM GENET, V51, P985; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONTOGIANNI EH, 1991, 1ST P S PREIMPL GEN, P139; LI A, 1988, NATURE, V335, P414; NAVIDI W, 1992, AM J HUM GENET, V50, P347; NAVIDI W, 1991, HUM REPROD, V6, P836, DOI 10.1093/oxfordjournals.humrep.a137438; PICKERING SJ, 1992, HUM REPROD, V7, P630, DOI 10.1093/oxfordjournals.humrep.a137710; WITKOWSKI J, 1990, J CHILD NEUROL, V4, P251; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; 1992, JAMA-J AM MED ASSOC, V267, P2609	20	81	88	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					19	23		10.1038/ng0194-19	http://dx.doi.org/10.1038/ng0194-19			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136827				2022-12-17	WOS:A1994MQ17700008
J	JONES, CT; MORRIS, S; YATES, CM; MOFFOOT, A; SHARPE, C; BROCK, DJH; STCLAIR, D				JONES, CT; MORRIS, S; YATES, CM; MOFFOOT, A; SHARPE, C; BROCK, DJH; STCLAIR, D			MUTATION IN CODON-713 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE PRESENTING WITH SCHIZOPHRENIA	NATURE GENETICS			English	Article							ALZHEIMERS-DISEASE	Following reports of mutations of codon 717 in exon 17 of the amyloid precursor protein (APP) gene in early-onset familial Alzheimer's disease, we screened exon 17 for new mutations in presenile dementia. The majority of the 105 patients screened had definite or probable Alzheimer's disease, but we also included atypical cases and some chronic schizophrenics. We identified a single abnormal case - a chronic schizophrenic with cognitive defects. Sequencing revealed a C to T nucleotide substitution which produces an alanine to valine change at codon 713. We were unable to detect the mutation in the remaining members of the original cohort nor in a further 100 chronic schizophrenics and 100 non-demented controls. Nonetheless, the position of the mutation in a critical portion of the APP gene suggests that it may well prove to be pathogenic.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,HUMAN GENET UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; ROYAL EDINBURGH & ASSOC HOSP,MRC,BRAIN METAB UNIT,EDINBURGH EH10 5HF,SCOTLAND; UNIV EDINBURGH,ROYAL EDINBURGH HOSP,DEPT PSYCHIAT,EDINBURGH EH10 5HF,SCOTLAND	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh			St Clair, David/AAN-2412-2021		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BRIND AM, 1990, J HEPATOL, V10, P240, DOI 10.1016/0168-8278(90)90059-Z; BRUTON CJ, 1990, PSYCHOL MED, V20, P285, DOI 10.1017/S0033291700017608; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HARDY J, 1991, LANCET, V337, P1342; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Jellinger K., 1985, PATHOCHEMICAL MARKER; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; McKahnn G., 1984, NEUROLOGY, V34, P939; MEDORI R, 1992, NEW ENGL J MED, V326, P44; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SPITZER RL, 1987, RES DIAGNOSTIC CRITE; STEVENS JR, 1982, ARCH GEN PSYCHIAT, V39, P1131; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503	26	81	99	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					306	309		10.1038/ng0792-306	http://dx.doi.org/10.1038/ng0792-306			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1307241				2022-12-17	WOS:A1992JC98400017
J	JOHNSON, R; JACKSON, IJ				JOHNSON, R; JACKSON, IJ			LIGHT IS A DOMINANT MOUSE MUTATION RESULTING IN PREMATURE CELL-DEATH	NATURE GENETICS			English	Article							MOLECULAR-BASIS; BROWN LOCUS; TYROSINASE; EXPRESSION	Light is a dominant mutant allele of the mouse brown locus which results in hairs pigmented only at their tips. The phenotype is due to premature melanocyte death. We have sequenced the tyrosinase-related protein-1 cDNA encoded at this locus from Light mice and found that it contains a single base alteration from wild-type, causing an Arg to Cys change in the protein. To further elucidate the mutant phenotype, we studied the expression of melanocyte specific genes in the skin of Light mice. We have demonstrated premature melanocyte death, but only in pigmented mice, indicating that the cell death is mediated through the inherent cytotoxicity of pigment production.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh				Jackson, Ian/0000-0001-6526-0688				ABBOTT C, 1991, GENOMICS, V11, P471, DOI 10.1016/0888-7543(91)90160-G; ECKERT KA, 1991, PCR PRACTICAL APPROA, P225; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; JACKSON IJ, 1991, BIOESSAYS, V13, P439, DOI 10.1002/bies.950130903; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; JACKSON IJ, 1990, GENETICS, V91, P451; KING RA, 1991, MOL BIOL MED, V8, P19; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; LERNER AB, 1978, JAMA-J AM MED ASSOC, V239, P1183, DOI 10.1001/jama.239.12.1183; MACDOWELL EC, 1950, J HERED, V41, P35, DOI 10.1093/oxfordjournals.jhered.a106079; MINTY AJ, 1981, J BIOL CHEM, V256, P1006; MORSE HC, 1985, CELL, V41, P439, DOI 10.1016/S0092-8674(85)80017-9; Muller H.J, 1932, P 6 INT C GEN, V1, P213; PAWELEK J, 1980, NATURE, V286, P617, DOI 10.1038/286617a0; PAWELEK JM, 1978, NATURE, V276, P627, DOI 10.1038/276627a0; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; SHIBAHARA S, 1986, NUCLEIC ACIDS RES, V14, P2413, DOI 10.1093/nar/14.6.2413; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; ZDARSKY E, 1990, GENETICS, V126, P443	24	81	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					226	229		10.1038/ng0692-226	http://dx.doi.org/10.1038/ng0692-226			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303241				2022-12-17	WOS:A1992JC98200019
J	Sakaue, S; Kanai, M; Tanigawa, Y; Karjalainen, J; Kurki, M; Koshiba, S; Narita, A; Konuma, T; Yamamoto, K; Akiyama, M; Ishigaki, K; Suzuki, A; Suzuki, K; Obara, W; Yamaji, K; Takahashi, K; Asai, S; Takahashi, Y; Suzuki, T; Shinozaki, N; Yamaguchi, H; Minami, S; Murayama, S; Yoshimori, K; Nagayama, S; Obata, D; Higashiyama, M; Masumoto, A; Koretsune, Y; Ito, K; Terao, C; Yamauchi, T; Komuro, I; Kadowaki, T; Tamiya, G; Yamamoto, M; Nakamura, Y; Kubo, M; Murakami, Y; Yamamoto, K; Kamatani, Y; Palotie, A; Rivas, MA; Daly, MJ; Matsuda, K; Okada, Y				Sakaue, Saori; Kanai, Masahiro; Tanigawa, Yosuke; Karjalainen, Juha; Kurki, Mitja; Koshiba, Seizo; Narita, Akira; Konuma, Takahiro; Yamamoto, Kenichi; Akiyama, Masato; Ishigaki, Kazuyoshi; Suzuki, Akari; Suzuki, Ken; Obara, Wataru; Yamaji, Ken; Takahashi, Kazuhisa; Asai, Satoshi; Takahashi, Yasuo; Suzuki, Takao; Shinozaki, Nobuaki; Yamaguchi, Hiroki; Minami, Shiro; Murayama, Shigeo; Yoshimori, Kozo; Nagayama, Satoshi; Obata, Daisuke; Higashiyama, Masahiko; Masumoto, Akihide; Koretsune, Yukihiro; Ito, Kaoru; Terao, Chikashi; Yamauchi, Toshimasa; Komuro, Issei; Kadowaki, Takashi; Tamiya, Gen; Yamamoto, Masayuki; Nakamura, Yusuke; Kubo, Michiaki; Murakami, Yoshinori; Yamamoto, Kazuhiko; Kamatani, Yoichiro; Palotie, Aarno; Rivas, Manuel A.; Daly, Mark J.; Matsuda, Koichi; Okada, Yukinori			A cross-population atlas of genetic associations for 220 human phenotypes	NATURE GENETICS			English	Article							LD SCORE REGRESSION; RISK SCORES; HERITABILITY; TUBERCULOSIS; ARCHITECTURE; PROJECT; DESIGN; CANCER; ACIDS	Current genome-wide association studies do not yet capture sufficient diversity in populations and scope of phenotypes. To expand an atlas of genetic associations in non-European populations, we conducted 220 deep-phenotype genome-wide association studies (diseases, biomarkers and medication usage) in BioBank Japan (n = 179,000), by incorporating past medical history and text-mining of electronic medical records. Meta-analyses with the UK Biobank and FinnGen (n(total) = 628,000) identified similar to 5,000 new loci, which improved the resolution of the genomic map of human traits. This atlas elucidated the landscape of pleiotropy as represented by the major histocompatibility complex locus, where we conducted HLA fine-mapping. Finally, we performed statistical decomposition of matrices of phenome-wide summary statistics, and identified latent genetic components, which pinpointed responsible variants and biological mechanisms underlying current disease classifications across populations. The decomposed components enabled genetically informed subtyping of similar diseases (for example, allergic diseases). Our study suggests a potential avenue for hypothesis-free re-investigation of human diseases through genetics.	[Sakaue, Saori; Kanai, Masahiro; Konuma, Takahiro; Yamamoto, Kenichi; Suzuki, Ken; Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka, Japan; [Sakaue, Saori; Akiyama, Masato; Ishigaki, Kazuyoshi; Terao, Chikashi; Kamatani, Yoichiro; Okada, Yukinori] RIKEN, Lab Stat & Translat Genet, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Sakaue, Saori; Ishigaki, Kazuyoshi] Harvard Med Sch, Ctr Data Sci, Boston, MA 02115 USA; [Sakaue, Saori; Ishigaki, Kazuyoshi] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sakaue, Saori; Ishigaki, Kazuyoshi] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Sakaue, Saori; Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Ishigaki, Kazuyoshi; Palotie, Aarno; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Kanai, Masahiro] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Kanai, Masahiro; Karjalainen, Juha; Kurki, Mitja; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Tanigawa, Yosuke; Rivas, Manuel A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Koshiba, Seizo; Narita, Akira; Tamiya, Gen; Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Koshiba, Seizo; Tamiya, Gen; Yamamoto, Masayuki] Adv Res Ctr Innovat Next Generat Med INGEM, Sendai, Miyagi, Japan; [Yamamoto, Kenichi] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan; [Yamamoto, Kenichi; Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan; [Akiyama, Masato] Kyushu Univ, Grad Sch Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka, Fukuoka, Japan; [Suzuki, Akari; Yamamoto, Kazuhiko] RIKEN, Lab Autoimmune Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Obara, Wataru] Iwate Med Univ, Dept Urol, Morioka, Iwate, Japan; [Yamaji, Ken] Juntendo Univ, Dept Internal Med & Rheumatol, Grad Sch Med, Tokyo, Japan; [Takahashi, Kazuhisa] Juntendo Univ, Dept Resp Med, Grad Sch Med, Tokyo, Japan; [Asai, Satoshi] Nihon Univ, Dept Biomed Sci, Div Pharmacol, Sch Med, Tokyo, Japan; [Asai, Satoshi; Takahashi, Yasuo] Nihon Univ, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials, Sch Med, Tokyo, Japan; [Suzuki, Takao; Shinozaki, Nobuaki] Tokushukai Grp, Tokyo, Japan; [Yamaguchi, Hiroki] Nippon Med Sch, Dept Hematol, Tokyo, Japan; [Minami, Shiro] Nippon Med Sch, Dept Bioregulat, Kawasaki, Kanagawa, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Tokyo, Japan; [Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Yoshimori, Kozo] Fukujuji Hosp, Japan AntiTB Assoc, Tokyo, Japan; [Nagayama, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan; [Obata, Daisuke] Shiga Univ Med Sci, Ctr Clin Res & Adv Med, Otsu, Shiga, Japan; [Higashiyama, Masahiko] Osaka Int Canc Inst, Dept Gen Thorac Surg, Osaka, Japan; [Masumoto, Akihide] Aso Iizuka Hosp, Fukuoka, Fukuoka, Japan; [Koretsune, Yukihiro] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; [Ito, Kaoru] RIKEN, Lab Cardiovasc Genom & Informat, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kadowaki, Takashi] Toranomon Gen Hosp, Tokyo, Japan; [Tamiya, Gen; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Tamiya, Gen] RIKEN, Ctr Adv Intelligence Project, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Human Genome Ctr, Inst Med Sci, Tokyo, Japan; [Nakamura, Yusuke] Japanese Fdn Canc Res, Canc Precis Med Ctr, Tokyo, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan; [Kamatani, Yoichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Complex Trait Genom, Tokyo, Japan; [Palotie, Aarno; Okada, Yukinori] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno; Okada, Yukinori] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Palotie, Aarno; Okada, Yukinori] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan; [Okada, Yukinori] Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan	Osaka University; RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Helsinki; Stanford University; Tohoku University; Osaka University; Osaka University; Kyushu University; RIKEN; Iwate Medical University; Juntendo University; Juntendo University; Nihon University; Nihon University; Nippon Medical School; Nippon Medical School; Tokyo Metropolitan Institute of Gerontology; Fukujuji Hospital; Japanese Foundation for Cancer Research; Shiga University of Medical Science; Osaka National Hospital; RIKEN; University of Tokyo; University of Tokyo; Toranomon Hospital; Tohoku University; RIKEN; University of Tokyo; Japanese Foundation for Cancer Research; RIKEN; University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Tokyo; Osaka University	Okada, Y (corresponding author), Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka, Japan.; Okada, Y (corresponding author), RIKEN, Lab Stat & Translat Genet, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Okada, Y (corresponding author), Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan.; Okada, Y (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.; Okada, Y (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Okada, Y (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Matsuda, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan.; Okada, Y (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Integrated Frontier Res Med Sci Div, Suita, Osaka, Japan.	ssakaue@bwh.harvard.edu; kmatsuda@edu.k.u-tokyo.ac.jp; yokada@sg.med.osaka-u.ac.jp	Ishigaki, Kazuyoshi/ABF-6926-2021; Kurki, Mitja/GWM-5671-2022; Suzuki, Akari/N-5389-2015; Kanai, Masahiro/AAD-6726-2021; Yamamoto, Masayuki/A-4873-2010; Akiyama, Masato/AHC-2589-2022; Tanigawa, Yosuke/AAI-7931-2020	Kanai, Masahiro/0000-0001-5165-4408; Yamamoto, Masayuki/0000-0002-9073-9436; Tanigawa, Yosuke/0000-0001-9759-157X; Narita, Akira/0000-0002-9076-0710; Sakaue, Saori/0000-0003-3618-9717; Palotie, Aarno/0000-0002-2527-5874	Tailor-Made Medical Treatment program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Business Finland [HUS 4685/31/2016, UH 4386/31/2016]; AbbVie; AstraZeneca; Biogen; Celgene; Genentech; GSK; MSD; Pfizer; Sanofi; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; JCR Grant for Promoting Basic Rheumatology; Nakajima Foundation Fellowship; Masason Foundation; Funai Overseas Scholarship from the Funai Foundation for Information Technology; Stanford University School of Medicine; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [R01HG010140]; NIH Center for Multi-and Cross-population Mapping of Mendelian and Complex Diseases grant [5U01 HG009080]; Japan Society for the Promotion of Science (JSPS) KAKENHI [19H01021, 20K21834]; AMED [JP21km0405211, JP21ek0109413, JP21ek0410075, JP21gm4010006, JP21km0405217]; JST Moonshot RD [JPMJMS2021]; Takeda Science Foundation; Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University	Tailor-Made Medical Treatment program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Business Finland; AbbVie(AbbVie); AstraZeneca(AstraZeneca); Biogen(Biogen); Celgene(Bristol-Myers SquibbCelgene Corporation); Genentech(Roche HoldingGenentech); GSK(GlaxoSmithKline); MSD; Pfizer(Pfizer); Sanofi; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; JCR Grant for Promoting Basic Rheumatology; Nakajima Foundation Fellowship; Masason Foundation; Funai Overseas Scholarship from the Funai Foundation for Information Technology; Stanford University School of Medicine; National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Center for Multi-and Cross-population Mapping of Mendelian and Complex Diseases grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; JST Moonshot RD; Takeda Science Foundation(Takeda Science Foundation (TSF)); Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University	We thank all the participants of BioBank Japan, UK Biobank and FinnGen. We thank K. Watanabe for her input in the analysis of phenotypic correlations and pleiotropy. This research was supported by the Tailor-Made Medical Treatment program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Japan Agency for Medical Research and Development (AMED). The FinnGen project is funded by two grants from Business Finland (grant nos. HUS 4685/31/2016 and UH 4386/31/2016) and nine industry partners (AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GSK, MSD, Pfizer and Sanofi). The following biobanks are acknowledged for collecting the FinnGen project samples: Auria Biobank (https://www.auria.fi/biopankki/), THL Biobank (https://thl.fi/fi/web/thl-biopank), Helsinki Biobank (https://www.terveyskyla.fi/helsinginbiopankki/), Northern Finland Biobank Borealis (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki), Finnish Clinical Biobank Tampere (https://www.tays.fi/biopankki), Biobank of Eastern Finland (https://ita-suomenbiopankki.fi), Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (https://www.bloodservice.fi/Research%20Projects/biobanking) and Terveystalo Biobank Finland (https://www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/).S.S.was in part supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders and the JCR Grant for Promoting Basic Rheumatology. M. Kanai was supported by a Nakajima Foundation Fellowship and the Masason Foundation. Y. Tanigawa is in part supported by a Funai Overseas Scholarship from the Funai Foundation for Information Technology and the Stanford University School of Medicine. M.A.R. is in part supported by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) under award no. R01HG010140, and an NIH Center for Multi-and Cross-population Mapping of Mendelian and Complex Diseases grant (no. 5U01 HG009080). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Y.O. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant nos. 19H01021, 20K21834) and AMED (grant nos. JP21km0405211, JP21ek0109413, JP21ek0410075, JP21gm4010006 and JP21km0405217), JST Moonshot R&D Grant Number JPMJMS2021, Takeda Science Foundation and the Bioinformatics Initiative of Osaka University Graduate School of Medicine, Osaka University.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Akiyama M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12276-5; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Baldini C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00121; Berger D, 1999, MLO Med Lab Obs, V31, P28; Brown BC, 2016, AM J HUM GENET, V99, P76, DOI 10.1016/j.ajhg.2016.05.001; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burren O. S., 2020, INFORMED DIMENSION R, DOI [10.1101/2020.01.14.905869v3, DOI 10.1101/2020.01.14.905869V3]; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Canela-Xandri O, 2018, NAT GENET, V50, P1593, DOI 10.1038/s41588-018-0248-z; Chasman DI, 2020, AM J HUM GENET, V106, P646, DOI 10.1016/j.ajhg.2020.03.011; Claussnitzer M, 2020, NATURE, V577, P179, DOI [10.1038/d41586-019-03833-5, 10.1038/s41586-019-1879-7]; Coombs R.R.A., 1963, CLIN ASPECTS IMMUNOL, Vpublication, P317; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Taliun SAG, 2020, NAT GENET, V52, P550, DOI 10.1038/s41588-020-0622-5; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Hagiya H, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S095026881800290X; Hirata J, 2019, NAT GENET, V51, P470, DOI 10.1038/s41588-018-0336-0; Ishigaki K, 2020, NAT GENET, V52, P669, DOI 10.1038/s41588-020-0640-3; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meuleman W, 2020, NATURE, V584, P244, DOI 10.1038/s41586-020-2559-3; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Nakao M, 2011, CANCER SCI, V102, P1076, DOI 10.1111/j.1349-7006.2011.01907.x; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Organizacion Mundial de la Salud, 2016, INT STAT CLASS DIS R; Pendergrass SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226771; Portincasa P, 2012, HEPATOLOGY, V55, P1313, DOI 10.1002/hep.25604; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi H, 2017, HUM MOL GENET, V26, P4752, DOI 10.1093/hmg/ddx365; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Rueger S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007371; Sakaue S, 2020, NAT MED, V26, P542, DOI 10.1038/s41591-020-0785-8; Sakaue S, 2019, BIOINFORMATICS, V35, P3821, DOI 10.1093/bioinformatics/btz166; Shi HWB, 2017, AM J HUM GENET, V101, P737, DOI 10.1016/j.ajhg.2017.09.022; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Sveinbjornsson G, 2016, NAT GENET, V48, P318, DOI 10.1038/ng.3498; Tadaka S, 2018, NUCLEIC ACIDS RES, V46, pD551, DOI 10.1093/nar/gkx978; Tanigawa Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11953-9; Verma A, 2018, AM J HUM GENET, V102, P592, DOI 10.1016/j.ajhg.2018.02.017; VESSEY DA, 1978, BIOCHEM J, V174, P621, DOI 10.1042/bj1740621; Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WHO, 2019, 10 HLTH ISS WHO WILL; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu YD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09572-5; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y	64	80	80	4	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2021	53	10					1415	+		10.1038/s41588-021-00931-x	http://dx.doi.org/10.1038/s41588-021-00931-x		SEP 2021	28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WC0OE	34594039				2022-12-17	WOS:000702232800006
J	Li, Y; Xia, LJ; Tan, KF; Ye, XD; Zuo, ZX; Li, MC; Xiao, R; Wang, ZH; Liu, XN; Deng, MQ; Cui, JR; Yang, MT; Luo, QZ; Liu, S; Cao, X; Zhu, HR; Liu, TQ; Hu, JX; Shi, JF; Xiao, S; Xia, LX				Li, Yuan; Xia, Linjian; Tan, Kaifen; Ye, Xidong; Zuo, Zhixiang; Li, Minchun; Xiao, Rui; Wang, Zihan; Liu, Xiaona; Deng, Mingqiang; Cui, Jinru; Yang, Mengtian; Luo, Qizhi; Liu, Sun; Cao, Xin; Zhu, Haoran; Liu, Tianqi; Hu, Jiaxin; Shi, Junfang; Xiao, Shan; Xia, Laixin			N-6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2	NATURE GENETICS			English	Article							NUCLEAR-RNA; HETEROCHROMATIN; METHYLATION; EXPRESSION; LANDSCAPE; STABILITY; PROTEINS; IMPACTS; STATE	METTL3-induced deposition ofN(6)-methyladenosine (m(6)A) in RNA correlates with removal of H3K9me2 genome wide. The m(6)A reader YTHDC1 recruits the H3K9me2 demethylase KDM3B to chromatin. A dynamic epigenome is critical for appropriate gene expression in development and health(1-5). Central to this is the intricate process of transcription(6-11), which integrates cellular signaling with chromatin changes, transcriptional machinery and modifications to messenger RNA, such asN(6)-methyladenosine (m(6)A), which is co-transcriptionally incorporated. The integration of these aspects of the dynamic epigenome, however, is not well understood mechanistically. Here we show that the repressive histone mark H3K9me2 is specifically removed by the induction of m(6)A-modified transcripts. We demonstrate that the methyltransferase METTL3/METTL14 regulates H3K9me2 modification. We observe a genome-wide correlation between m(6)A and occupancy by the H3K9me2 demethylase KDM3B, and we find that the m(6)A reader YTHDC1 physically interacts with and recruits KDM3B to m(6)A-associated chromatin regions, promoting H3K9me2 demethylation and gene expression. This study establishes a direct link between m(6)A and dynamic chromatin modification and provides mechanistic insight into the co-transcriptional interplay between RNA modifications and histone modifications.	[Li, Yuan; Xia, Linjian; Tan, Kaifen; Ye, Xidong; Li, Minchun; Wang, Zihan; Liu, Xiaona; Deng, Mingqiang; Cui, Jinru; Yang, Mengtian; Liu, Sun; Cao, Xin; Zhu, Haoran; Liu, Tianqi; Hu, Jiaxin; Shi, Junfang; Xiao, Shan; Xia, Laixin] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Peoples R China; [Zuo, Zhixiang] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Xiao, Rui] Wuhan Univ, Zhongnan Hosp, Frontier Sci Ctr Immunol & Metab, Med Res Inst, Wuhan, Peoples R China; [Xiao, Rui] Wuhan Univ, Zhongnan Hosp, Dept Hematol, Wuhan, Peoples R China; [Luo, Qizhi] Southern Med Univ, Sch Forens Med, Dept Forens Toxicol, Guangzhou, Peoples R China	Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University; Wuhan University; Wuhan University; Southern Medical University - China	Xiao, S; Xia, LX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Peoples R China.	asdfg@smu.edu.cn; xialx@smu.edu.cn	LUO, QI/GQH-7209-2022; Zuo, Zhixiang/M-4441-2016	Zuo, Zhixiang/0000-0002-2492-2689; shaw, shan/0000-0002-4012-7650; Xia, Laixin/0000-0003-2735-9518; Xiao, Rui/0000-0002-9477-1054	National Key R&D Program of China [2018YFC1004103, 2019YFA0802300]; Natural Science Foundation of China [31722034, 81771643, 31801234, 31970595]; Pearl River S&T Nova Program of Guangzhou [201806010009]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou	We thank K. Yen for discussion and critical reading of the manuscript. This work was supported by the National Key R&D Program of China (grant nos. 2018YFC1004103 and 2019YFA0802300), the Natural Science Foundation of China (grant nos. 31722034, 81771643, 31801234 and 31970595) and Pearl River S&T Nova Program of Guangzhou (grant no. 201806010009).	Abakir A, 2020, NAT GENET, V52, P48, DOI 10.1038/s41588-019-0549-x; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Conrad T, 2017, METHODS MOL BIOL, V1468, P1, DOI 10.1007/978-1-4939-4035-6_1; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ebata KT, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0143-3; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang HL, 2019, NATURE, V567, P414, DOI 10.1038/s41586-019-1016-7; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu TQ, 2017, FASEB J, V31, P2185, DOI 10.1096/fj.201601217R; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nicetto D, 2019, CURR OPIN GENET DEV, V55, P1, DOI 10.1016/j.gde.2019.04.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Sendinc E, 2019, MOL CELL, V75, P620, DOI 10.1016/j.molcel.2019.05.030; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wan L, 2013, P NATL ACAD SCI USA, V110, P10646, DOI 10.1073/pnas.1220921110; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Xiao S, 2019, NAT CELL BIOL, V21, P651, DOI 10.1038/s41556-019-0315-4; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yang X, 2019, CELL RES, V29, P1035, DOI 10.1038/s41422-019-0235-7; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; Zeng Y, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006092; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	53	80	81	8	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2020	52	9					870	+		10.1038/s41588-020-0677-3	http://dx.doi.org/10.1038/s41588-020-0677-3		AUG 2020	21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ1LH	32778823				2022-12-17	WOS:000558893600001
J	Jimenez-Sanchez, A; Cybulska, P; Mager, KL; Koplev, S; Cast, O; Couturier, DL; Memon, D; Selenica, P; Nikolovski, I; Mazaheri, Y; Bykov, Y; Geyer, FC; Macintyre, G; Gavarro, LM; Drews, RM; Gill, MB; Papanastasiou, AD; Sosa, RE; Soslow, RA; Walther, T; Shen, R; Chi, DS; Park, KJ; Hollmann, T; Reis-Filho, JS; Markowetz, F; Beltrao, P; Vargas, HA; Zamarin, D; Brenton, JD; Snyder, A; Weigelt, B; Sala, E; Miller, ML				Jimenez-Sanchez, Alejandro; Cybulska, Paulina; Mager, Katherine LaVigne; Koplev, Simon; Cast, Oliver; Couturier, Dominique-Laurent; Memon, Danish; Selenica, Pier; Nikolovski, Ines; Mazaheri, Yousef; Bykov, Yonina; Geyer, Felipe C.; Macintyre, Geoff; Gavarro, Lena Morrill; Drews, Ruben M.; Gill, Michael B.; Papanastasiou, Anastasios D.; Sosa, Ramon E.; Soslow, Robert A.; Walther, Tyler; Shen, Ronglai; Chi, Dennis S.; Park, Kay J.; Hollmann, Travis; Reis-Filho, Jorge S.; Markowetz, Florian; Beltrao, Pedro; Vargas, Hebert Alberto; Zamarin, Dmitriy; Brenton, James D.; Snyder, Alexandra; Weigelt, Britta; Sala, Evis; Miller, Martin L.			Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy	NATURE GENETICS			English	Article							ADENOID CYSTIC CARCINOMA; COMPREHENSIVE ANALYSIS; T-CELLS; EXPRESSION; MUTATIONS; THERAPY; REVEALS; MICROENVIRONMENTS; INFLAMMATION; PROGRESSION	In metastatic cancer, the degree of heterogeneity of the tumor microenvironment (TME) and its molecular underpinnings remain largely unstudied. To characterize the tumor-immune interface at baseline and during neoadjuvant chemotherapy (NACT) in high-grade serous ovarian cancer (HGSOC), we performed immunogenomic analysis of treatment-naive and paired samples from before and after treatment with chemotherapy. In treatment-naive HGSOC, we found that immune-cell-excluded and inflammatory microenvironments coexist within the same individuals and within the same tumor sites, indicating ubiquitous variability in immune cell infiltration. Analysis of TME cell composition, DNA copy number, mutations and gene expression showed that immune cell exclusion was associated with amplification of Myc target genes and increased expression of canonical Wnt signaling in treatment-naive HGSOC. Following NACT, increased natural killer (NK) cell infiltration and oligoclonal expansion of T cells were detected. We demonstrate that the tumor-immune microenvironment of advanced HGSOC is intrinsically heterogeneous and that chemotherapy induces local immune activation, suggesting that chemotherapy can potentiate the immunogenicity of immune-excluded HGSOC tumors. Immunogenomic analyses of advanced high-grade serous ovarian cancer samples before and after neoadjuvant chemotherapy show that the tumor-immune microenvironment is intrinsically heterogeneous and that chemotherapy induces local immune activation.	[Jimenez-Sanchez, Alejandro; Koplev, Simon; Cast, Oliver; Couturier, Dominique-Laurent; Memon, Danish; Macintyre, Geoff; Gavarro, Lena Morrill; Drews, Ruben M.; Gill, Michael B.; Markowetz, Florian; Brenton, James D.; Sala, Evis; Miller, Martin L.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Jimenez-Sanchez, Alejandro] Mem Sloan Kettering Canc Ctr, Dept Computat & Syst Biol, 1275 York Ave, New York, NY 10021 USA; [Cybulska, Paulina; Mager, Katherine LaVigne; Chi, Dennis S.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Memon, Danish; Beltrao, Pedro] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Selenica, Pier; Geyer, Felipe C.; Papanastasiou, Anastasios D.; Soslow, Robert A.; Park, Kay J.; Hollmann, Travis; Reis-Filho, Jorge S.; Weigelt, Britta] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Nikolovski, Ines; Sosa, Ramon E.; Vargas, Hebert Alberto; Sala, Evis] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Mazaheri, Yousef] Mem Sloan Kettering Canc Ctr, Dept Med Phys & Radiol, 1275 York Ave, New York, NY 10021 USA; [Bykov, Yonina; Walther, Tyler; Zamarin, Dmitriy; Snyder, Alexandra] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Macintyre, Geoff] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Sala, Evis] Univ Cambridge, Li Ka Shing Ctr, Dept Radiol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; European Molecular Biology Laboratory (EMBL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); Memorial Sloan Kettering Cancer Center; CRUK Cambridge Institute; University of Cambridge	Miller, ML (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England.	martin.miller@cruk.cam.ac.uk	Papanastasiou, Anastasios/AAP-5296-2021; Koplev, Simon/GNX-5619-2022; Brenton, James D/B-3174-2008; Selenica, Pier/GQY-8678-2022; Memon, Danish/ABE-1094-2021	Koplev, Simon/0000-0002-8586-5614; Brenton, James D/0000-0002-5738-6683; Memon, Danish/0000-0002-1365-0710; Beltrao, Pedro/0000-0002-2724-7703; Cast, Oliver/0000-0002-5880-7726; Couturier, Dominique-Laurent/0000-0001-5774-5036; Jimenez-Sanchez, Alejandro/0000-0003-1879-7057; Morrill Gavarro, Lena/0000-0002-2242-4010	Marsha Rivkin Organization, Memorial Sloan Kettering Cancer Center, Translational and Integrative Medicine Research Fund (MSKCC); Kaleidoscope of Hope; Kaleidoscope of Hope grant; MSK Cancer Center Support Grant of the National Cancer Institute at the National Institutes of Health [P30 CA008748]; Ovarian Cancer Research Alliance Liz Tilberis Award; Wellcome Trust; Cancer Research UK [C14303/A17197, A22905, A19274, A15973]; Brown Performance Innovation in Cancer Informatics Discovery Award [BD523775]; Target Ovarian Cancer Translational Project Grant (Cambridge) [MM18]; Mark Foundation for Cancer Research; Cancer Research UK Cambridge Centre [C9685/A25177]; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT); NIH/NCI Cancer Center Support Grant [P30 CA008748]; Breast Cancer Research Foundation; Department of Defense Congressionally Directed Medical Research Programs [W81XWH-15-1-0547, GC229671]; EMBL-EBI; NIHR Cambridge Biomedical Research Centre (EBPOD); University of Cambridge Harding Distinguished Postgraduate Scholars Programme; University of Cambridge; Hutchison Whampoa Limited; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation	Marsha Rivkin Organization, Memorial Sloan Kettering Cancer Center, Translational and Integrative Medicine Research Fund (MSKCC); Kaleidoscope of Hope; Kaleidoscope of Hope grant; MSK Cancer Center Support Grant of the National Cancer Institute at the National Institutes of Health; Ovarian Cancer Research Alliance Liz Tilberis Award; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Brown Performance Innovation in Cancer Informatics Discovery Award; Target Ovarian Cancer Translational Project Grant (Cambridge); Mark Foundation for Cancer Research; Cancer Research UK Cambridge Centre; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIH/NCI Cancer Center Support Grant; Breast Cancer Research Foundation; Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense); EMBL-EBI; NIHR Cambridge Biomedical Research Centre (EBPOD); University of Cambridge Harding Distinguished Postgraduate Scholars Programme; University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation	We thank D. Pe'er for her support to A.J.-S. in finalizing this project. We thank J. Conejo-Garcia for providing the UPK10 cell line. We acknowledge T. Wu for his insightful comments on the manuscript. A.S. was supported by grants from the Marsha Rivkin Organization, Memorial Sloan Kettering Cancer Center, Translational and Integrative Medicine Research Fund (MSKCC) and Kaleidoscope of Hope. This work has been supported in part by a Kaleidoscope of Hope grant (H.A.V. and B.W.) and an MSK Cancer Center Support Grant of the National Cancer Institute at the National Institutes of Health (P30 CA008748). D.Z. received funding from the Ovarian Cancer Research Alliance Liz Tilberis Award. L.M.G. was supported by a Wellcome Trust grant through the Mathematical Genomics and Medicine programme. M.L.M. was supported by a Cancer Research UK core grant (C14303/A17197), a Brown Performance Innovation in Cancer Informatics Discovery Award (BD523775) and the Target Ovarian Cancer Translational Project Grant (Cambridge-MM18). J.D.B. was supported by a Cancer Research UK core grant (A22905). J.D.B. and E.S. were supported by the Mark Foundation for Cancer Research and Cancer Research UK Cambridge Centre (C9685/A25177). A.J.-S. was supported by a doctoral fellowship from the Cancer Research UK Cambridge Institute and the Mexican National Council of Science and Technology (CONACyT). Research by A.J.-S. was funded in part through the NIH/NCI Cancer Center Support Grant (P30 CA008748). J.S.R.-F. is funded in part by a Breast Cancer Research Foundation grant and by Department of Defense Congressionally Directed Medical Research Programs (W81XWH-15-1-0547; GC229671). D.M. was supported by the joint EMBL-EBI and NIHR Cambridge Biomedical Research Centre (EBPOD) postdoctoral program. F.M. was supported by a Cancer Research UK core grant (A19274). R.M.D. is supported by a doctoral fellowship from the Cancer Research UK Cambridge Institute. O.C. was supported by a doctoral fellowship from the University of Cambridge Harding Distinguished Postgraduate Scholars Programme. D.-L.C. was supported by a Cancer Research UK core grant (C14303/A17197). B.W. is funded in part by Breast Cancer Research Foundation and Cycle for Survival grants. G.M. would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. G.M. was funded by Cancer Research UK grants (C14303/A17197, A19274 and A15973) and by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation.	Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; [Anonymous], 2017, JLSRF, V3, pA104; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Becht E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1070-5; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bohm S, 2016, CLIN CANCER RES, V22, P3025, DOI 10.1158/1078-0432.CCR-15-2657; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grabosch S, 2019, ONCOGENE, V38, P2380, DOI 10.1038/s41388-018-0581-9; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hirata E, 2015, CANCER CELL, V27, P574, DOI 10.1016/j.ccell.2015.03.008; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iglewicz B., 1993, DETECT HANDLE OUTLIE; Janssen LME, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0283-9; Jimenez-Sanchez A, 2019, CANCER RES, V79, P6238, DOI 10.1158/0008-5472.CAN-18-3560; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kirsch I, 2015, MOL ONCOL, V9, P2063, DOI 10.1016/j.molonc.2015.09.003; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Larraguibel J, 2015, MOL BIOL CELL, V26, P2375, DOI 10.1091/mbc.E14-12-1648; Lee JD, 2016, ANN STAT, V44, P907, DOI 10.1214/15-AOS1371; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; Macintyre G, 2018, NAT GENET, V50, P1262, DOI 10.1038/s41588-018-0179-8; Martelotto LG, 2015, J PATHOL, V237, P179, DOI 10.1002/path.4573; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narzisi G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0023-9; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pareja F, 2019, JNCI-J NATL CANCER I, V111, P737, DOI 10.1093/jnci/djy216; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Patel SA, 2018, IMMUNITY, V48, P417, DOI 10.1016/j.immuni.2018.03.007; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Reuben A, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0013-8; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Saito T, 2015, MUTAGENESIS, V30, P297, DOI 10.1093/mutage/geu072; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Selenica P, 2019, MOL ONCOL, V13, P1684, DOI 10.1002/1878-0261.12490; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Sheskin D.J., 2003, HDB PARAMETRIC NONPA; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Sridharan V, 2016, CANCER IMMUNOL RES, V4, P679, DOI 10.1158/2326-6066.CIR-16-0031; Stanske M, 2018, NEOPLASIA, V20, P280, DOI 10.1016/j.neo.2018.01.007; Stevens JR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5236-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor J, 2018, CAN J STAT, V46, P41, DOI 10.1002/cjs.11313; TheGeneOntologyConsortium, 2017, Nucleic Acids Res, V45, pD331, DOI 10.1093/nar/gkw1108; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Wang YK, 2017, NAT GENET, V49, P856, DOI 10.1038/ng.3849; Weigelt Britta, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.18.00410; Yarilin D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09534; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	91	80	80	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2020	52	6					582	+		10.1038/s41588-020-0630-5	http://dx.doi.org/10.1038/s41588-020-0630-5		JUN 2020	16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV2FA	32483290	Green Submitted, Green Accepted			2022-12-17	WOS:000537037100001
J	Enache, OM; Rendo, V; Abdusamad, M; Lam, D; Davison, D; Pale, S; Currimjee, N; Hess, J; Pantel, S; Nag, A; Thorner, AR; Doench, JG; Vazquez, F; Beroukhim, R; Golub, TR; Ben-David, U				Enache, Oana M.; Rendo, Veronica; Abdusamad, Mai; Lam, Daniel; Davison, Desiree; Pale, Sangita; Currimjee, Naomi; Hess, Julian; Pantel, Sasha; Nag, Anwesha; Thorner, Aaron R.; Doench, John G.; Vazquez, Francisca; Beroukhim, Rameen; Golub, Todd R.; Ben-David, Uri			Cas9 activates the p53 pathway and selects for p53-inactivating mutations	NATURE GENETICS			English	Article							CANCER; FRAMEWORK; DATABASE	Cas9 is commonly introduced into cell lines to enable CRISPR-Cas9-mediated genome editing. Here, we studied the genetic and transcriptional consequences of Cas9 expression itself. Gene expression profiling of 165 pairs of human cancer cell lines and their Cas9-expressing derivatives revealed upregulation of the p53 pathway upon introduction of Cas9, specifically in wild-type TP53 (TP53-WT) cell lines. This was confirmed at the messenger RNA and protein levels. Moreover, elevated levels of DNA repair were observed in Cas9-expressing cell lines. Genetic characterization of 42 cell line pairs showed that introduction of Cas9 can lead to the emergence and expansion of p53-inactivating mutations. This was confirmed by competition experiments in isogenic TP53-WT and TP53-null (TP53(-/-)) cell lines. Lastly, Cas9 was less active in TP53-WT than in TP53-mutant cell lines, and Cas9-induced p53 pathway activation affected cellular sensitivity to both genetic and chemical perturbations. These findings may have broad implications for the proper use of CRISPR-Cas9-mediated genome editing. Cas9 expression induces DNA damage and activates the p53 pathway, and it can lead to the selection of cells with p53-inactivating mutations. Cas9 is less active in wild-type TP53 cell lines than in TP53-mutant cell lines.	[Enache, Oana M.; Abdusamad, Mai; Lam, Daniel; Davison, Desiree; Hess, Julian; Vazquez, Francisca; Beroukhim, Rameen; Golub, Todd R.; Ben-David, Uri] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Rendo, Veronica; Pale, Sangita; Currimjee, Naomi; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pantel, Sasha; Doench, John G.] Broad Inst Harvard & MIT, Genet Perturbat Platform, Cambridge, MA 02142 USA; [Nag, Anwesha; Thorner, Aaron R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen; Golub, Todd R.] Harvard Med Sch, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ben-David, Uri] Tel Aviv Univ, Fac Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Tel Aviv University	Ben-David, U (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.; Ben-David, U (corresponding author), Tel Aviv Univ, Fac Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.	ubendavid@tauex.tau.ac.il	Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020; Vazquez, Francisca/ABC-4620-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Pal, Sangita/0000-0002-4892-841X; Enache, Oana/0000-0002-9541-0058; Rendo, Veronica/0000-0002-2983-4020	NIH [R01 CA18828, CA215489, CA219943]; Gray Matters Brain Cancer Foundation; Pediatric Brain Tumor Foundation; HHMI; HFSP; Azrieli Foundation; Richard Eimert Research Fund on Solid Tumors; Tel-Aviv University Cancer Biology Research Center; Israel Cancer Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gray Matters Brain Cancer Foundation; Pediatric Brain Tumor Foundation; HHMI(Howard Hughes Medical Institute); HFSP(Human Frontier Science Program); Azrieli Foundation; Richard Eimert Research Fund on Solid Tumors; Tel-Aviv University Cancer Biology Research Center; Israel Cancer Association	We thank A. Subramanian, D. Root, T. Natoli, C. Kadoch, S. Cassel and C. Collings for helpful discussions; X. Lu, A. Giacomelli, K. Labella, K. Sanson and W. Hahn for contributing reagents; M. Ducar and S. Drinan for assistance with the OncoPanel assay; and F. Piccioni for assistance with Cas9 cell line generation. This work was supported by the NIH (R01 CA18828, CA215489 and CA219943 to R.B.), the Gray Matters Brain Cancer Foundation (R.B.), Pediatric Brain Tumor Foundation (R.B.), HHMI (T.R.G.) and HFSP (U.B.-D.). Research in the the laboratory of U.B.-D. is supported by the Azrieli Foundation, the Richard Eimert Research Fund on Solid Tumors, the Tel-Aviv University Cancer Biology Research Center, and the Israel Cancer Association.	[Anonymous], 2010, R LANG ENV STAT COMP; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Ben-David U, 2019, NAT REV CANCER, V19, P97, DOI 10.1038/s41568-018-0095-3; Ben-David U, 2018, NATURE, V560, P325, DOI 10.1038/s41586-018-0409-3; Ben-David U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12160; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dempster JM, 2019, EXTRACTING BIOL INSI, DOI [10.1101/720243, DOI 10.1101/720243, 10.1101/720243v1]; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Elkon R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r43; Enache OM, 2019, BIOINFORMATICS, V35, P1427, DOI 10.1093/bioinformatics/bty784; Giacomelli AO, 2018, NAT GENET, V50, P1381, DOI 10.1038/s41588-018-0204-y; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kung CP, 2015, MOL CANCER RES, V13, P250, DOI 10.1158/1541-7786.MCR-14-0385; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Piras F, 2017, EMBO MOL MED, V9, P1198, DOI 10.15252/emmm.201707922; Schiroli G, 2019, CELL STEM CELL, V24, P551, DOI 10.1016/j.stem.2019.02.019; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Sinha S., 2019, INTEGRATED COMPUTATI, P407767, DOI [10.1101/407767, DOI 10.1101/407767]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Wang Wei, 2017, J Cancer Metastasis Treat, V3, P45, DOI 10.20517/2394-4722.2017.03; Wu YX, 2019, NAT MED, V25, P776, DOI 10.1038/s41591-019-0401-y; Zacharias J, 2011, HUM GENE THER, V22, P1445, DOI 10.1089/hum.2011.006	38	80	83	10	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2020	52	7					662	+		10.1038/s41588-020-0623-4	http://dx.doi.org/10.1038/s41588-020-0623-4		MAY 2020	17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MH0XT	32424350	Green Accepted			2022-12-17	WOS:000533846800003
J	Hysi, PG; Choquet, H; Khawaja, AP; Wojciechowski, R; Tedja, MS; Yin, J; Simcoe, MJ; Patasova, K; Mahroo, OA; Thai, KK; Cumberland, PM; Melles, RB; Verhoeven, VJM; Vitart, V; Segre, A; Stone, RA; Wareham, N; Hewitt, AW; Mackey, DA; Klaver, CCW; MacGregor, S; Khaw, PT; Foster, PJ; Guggenheim, JA; Rahi, JS; Jorgenson, E; Hammond, CJ				Hysi, Pirro G.; Choquet, Helene; Khawaja, Anthony P.; Wojciechowski, Robert; Tedja, Milly S.; Yin, Jie; Simcoe, Mark J.; Patasova, Karina; Mahroo, Omar A.; Thai, Khanh K.; Cumberland, Phillippa M.; Melles, Ronald B.; Verhoeven, Virginie J. M.; Vitart, Veronique; Segre, Ayellet; Stone, Richard A.; Wareham, Nick; Hewitt, Alex W.; Mackey, David A.; Klaver, Caroline C. W.; MacGregor, Stuart; Khaw, Peng T.; Foster, Paul J.; Guggenheim, Jeremy A.; Rahi, Jugnoo S.; Jorgenson, Eric; Hammond, Christopher J.		Consortium Refractive Error Myop; UK Eye Vision Consortium; 23andMe Inc	Meta-analysis of 542,934 subjects of European ancestry identifies new genes and mechanisms predisposing to refractive error and myopia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY RESEARCH; QUALITY-CONTROL; ADULT HEALTH; SUSCEPTIBILITY; HERITABILITY; MULTIPLE; ALBINISM; VSX1; MUTATIONS	Refractive errors, in particular myopia, are a leading cause of morbidity and disability worldwide. Genetic investigation can improve understanding of the molecular mechanisms that underlie abnormal eye development and impaired vision. We conducted a meta-analysis of genome-wide association studies (GWAS) that involved 542,934 European participants and identified 336 novel genetic loci associated with refractive error. Collectively, all associated genetic variants explain 18.4% of heritability and improve the accuracy of myopia prediction (area under the curve (AUC) = 0.75). Our results suggest that refractive error is genetically heterogeneous, driven by genes that participate in the development of every anatomical component of the eye. In addition, our analyses suggest that genetic factors controlling circadian rhythm and pigmentation are also involved in the development of myopia and refractive error. These results may enable the prediction of refractive error and the development of personalized myopia prevention strategies in the future. Meta-analysis of genome-wide association studies of 542,934 individuals identifies 336 novel loci associated with refractive error and implicates eye development, circadian rhythm and pigmentation pathways in controlling myopia.	[Hysi, Pirro G.; Patasova, Karina; Mahroo, Omar A.; Hammond, Christopher J.] Kings Coll London, Sch Life Course Sci, Sect Ophthalmol, London, England; [Hysi, Pirro G.; Simcoe, Mark J.; Hammond, Christopher J.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Hysi, Pirro G.; Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL, UCL Great Ormond St Inst Child Hlth, London, England; [Choquet, Helene; Yin, Jie; Thai, Khanh K.; Jorgenson, Eric] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Khawaja, Anthony P.; Mahroo, Omar A.; Khaw, Peng T.; Foster, Paul J.; Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Khawaja, Anthony P.; Mahroo, Omar A.; Khaw, Peng T.; Foster, Paul J.; Rahi, Jugnoo S.] UCL Inst Ophthalmol, London, England; [Khawaja, Anthony P.; Wareham, Nick] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Wojciechowski, Robert] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Wojciechowski, Robert] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Tedja, Milly S.; Verhoeven, Virginie J. M.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Tedja, Milly S.; Verhoeven, Virginie J. M.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL, UCL Great Ormond St Inst Child Hlth, Ulverscroft Vis Res Grp, London, England; [Melles, Ronald B.] Kaiser Permanente Northern Calif, Dept Ophthalmol, Redwood City, CA USA; [Verhoeven, Virginie J. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Vitart, Veronique] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Segre, Ayellet] Harvard Med Sch, Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02115 USA; [Stone, Richard A.] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hewitt, Alex W.; Mackey, David A.] Royal Hobart Hosp, Dept Ophthalmol, Hobart, Tas, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA, Australia; [Klaver, Caroline C. W.] Radboud Univ Nijmegen, Dept Ophthalmol, Med Ctr, Rotterdam, Netherlands; [Klaver, Caroline C. W.] Inst Mol & Clin Ophthalmol Basel, Basel, Switzerland; [MacGregor, Stuart] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Foster, Paul J.] UCL Inst Ophthalmol, Div Genet & Epidemiol, London, England; [Guggenheim, Jeremy A.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, Wales; [Rahi, Jugnoo S.] Great Ormond St Hosp NHS Fdn Trust, Biomed Res Ctr, Dept Ophthalmol, London, England; [Rahi, Jugnoo S.] Great Ormond St Hosp NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London; Kaiser Permanente; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Kaiser Permanente; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Pennsylvania; Pennsylvania Medicine; Royal Hobart Hospital; Lions Eye Institute; University of Western Australia; Radboud University Nijmegen; QIMR Berghofer Medical Research Institute; University of London; University College London; Cardiff University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Hysi, PG (corresponding author), Kings Coll London, Sch Life Course Sci, Sect Ophthalmol, London, England.; Hysi, PG (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.; Hysi, PG (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, London, England.	pirro.hysi@kcl.ac.uk	Macgregor, Stuart/C-6442-2009; Mackey, David A/H-5340-2014; Wojciechowski, Robert/L-4970-2017	Macgregor, Stuart/0000-0001-6731-8142; Mackey, David A/0000-0001-7914-4709; Foster, Paul/0000-0002-4755-177X; Rahi, Jugnoo/0000-0002-5718-9209; Guggenheim, Jeremy/0000-0001-5164-340X; Simcoe, Mark/0000-0003-2432-0810; Wojciechowski, Robert/0000-0002-9593-4652; Khaw, Sir Peng Tee/0000-0002-8087-2268; Khawaja, Anthony/0000-0001-6802-8585; Yin, Jie/0000-0002-4990-0777; Mahroo, Omar/0000-0003-1254-0832; Hysi, Pirro/0000-0001-5752-2510; Melles, Ronald/0000-0003-1027-4083; Choquet, Helene/0000-0001-9839-8667; Tedja, Milly/0000-0003-0356-9684	National Institute for Health Research (NIHR); Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; UK NIHR [BRC3_026]; Moorfields Eye Charity [ST 15 11 E]; Fight for Sight [1507/1508]; Macular Society; International Glaucoma Association (IGA, Ashford UK); Alcon Research Institute; UK Medical Research Council (MRC) [MC_UU_00007/10]; US National Institute on Aging; National Institute of Mental Health; National Institute of Health Common Fund [RC2 AG036607]; National Eye Institute [NEI R01 EY027004, R01EY020483]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK116738]; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [648268]; Netherlands Organisation for Scientific Research (NWO) [91815655, 91617076]; National Health and Medical Research Council (NHMRC) of Australia [1150144, 1116360, 1154543, 1121979]; MRC [G1000143, MC_PC_13048]; Cancer Research UK [C864/A14136]; Moorfields Eye Charity grant; Richard Desmond Charitable Trust; National Institute for Health Research; Biomedical Research Centre for Ophthalmology; National Eye Institute of the National Institutes of Health [R21EY029309]; Fight for Sight PhD studentship; FfS ECI fellowship; TFC Frost Charitable Trust; UK Biobank [669, 17615]; NIHR Biomedical Research Centres at Moorfields Eye Hospital; UCL Institute of Ophthalmology, and at the UCL Institute of Child Health and Great Ormond Street Hospital; NIHR Senior Investigator; Ulverscroft Foundation; Wellcome Trust [206619_Z_17_Z]; NIHR Biomedical Research Centre at Moorfields Eye Hospital; MRC [MC_UU_00007/10, MC_UU_12015/1, MR/N003284/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; UK NIHR(National Institute for Health Research (NIHR)); Moorfields Eye Charity; Fight for Sight; Macular Society; International Glaucoma Association (IGA, Ashford UK); Alcon Research Institute(Novartis); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health Common Fund; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Moorfields Eye Charity grant; Richard Desmond Charitable Trust; National Institute for Health Research(National Institute for Health Research (NIHR)); Biomedical Research Centre for Ophthalmology; National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Fight for Sight PhD studentship; FfS ECI fellowship; TFC Frost Charitable Trust; UK Biobank; NIHR Biomedical Research Centres at Moorfields Eye Hospital; UCL Institute of Ophthalmology, and at the UCL Institute of Child Health and Great Ormond Street Hospital; NIHR Senior Investigator; Ulverscroft Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre at Moorfields Eye Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P.T.K. and P.J.F oversaw the UK Biobank eye data acquisition with support from the National Institute for Health Research (NIHR), Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The UK Biobank Eye and Vision Consortium was supported by grants from UK NIHR (BRC3_026), Moorfields Eye Charity (ST 15 11 E), Fight for Sight (1507/1508), The Macular Society, The International Glaucoma Association (IGA, Ashford UK) and Alcon Research Institute. V.V. is supported by a core UK Medical Research Council (MRC) grant MC_UU_00007/10. 23andMe thanks research participants and employees of 23andMe for making this work possible (a list of contributing staff is available in the Supplementary Note). Genotyping of the GERA cohort was funded by the US National Institute on Aging, the National Institute of Mental Health and the National Institute of Health Common Fund (RC2 AG036607); data analyses were funded by the National Eye Institute (NEI R01 EY027004, E.J.) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK116738, E.J.). The CREAM GWAS meta-analysis was supported by the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant 648268 to C.C.W.K), the Netherlands Organisation for Scientific Research (NWO, 91815655 to C.C.W.K) and the National Eye Institute (R01EY020483). V.J.M.V. acknowledges funding from the Netherlands Organisation for Scientific Research (NWO, grant 91617076). S.M. acknowledges support from the National Health and Medical Research Council (NHMRC) of Australia (grants 1150144, 1116360, 1154543, 1121979). EPIC-Norfolk infrastructure and core functions are supported by the MRC (G1000143) and Cancer Research UK (C864/A14136). Genotyping was funded by the MRC (MC_PC_13048). A.K.P. is supported by a Moorfields Eye Charity grant. P.J.F. received support from the Richard Desmond Charitable Trust, the National Institute for Health Research to Moorfields Eye Hospital and the Biomedical Research Centre for Ophthalmology. RW and PGH were supported by the National Eye Institute of the National Institutes of Health under award number R21EY029309. M.J.S. is a recipient of a Fight for Sight PhD studentship. K.P. is a recipient of a Fight for Sight PhD studentship. P.G.H. is the recipient of a FfS ECI fellowship. P.G.H. and C.J.H. acknowledge the TFC Frost Charitable Trust Support for the KCL Department of Ophthalmology. Statistical analyses were run in King's College London on the Rosalind HPC LINUX Clusters and cloud servers. The UK Biobank data were accessed as part of the UK Biobank projects 669 and 17615. J.S.R. is supported in part by the NIHR Biomedical Research Centres at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, and at the UCL Institute of Child Health and Great Ormond Street Hospital, and is an NIHR Senior Investigator. P.M.C. was funded by the Ulverscroft Foundation. O.A.M is supported by Wellcome Trust grant 206619_Z_17_Z and the NIHR Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carnes MU, 2018, EXP EYE RES, V167, P91, DOI 10.1016/j.exer.2016.11.021; Chakraborty R, 2018, OPHTHAL PHYSL OPT, V38, P217, DOI 10.1111/opo.12453; Chow RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8; Clark AM, 2008, BRAIN RES, V1192, P99, DOI 10.1016/j.brainres.2007.06.007; Colognato H, 2007, DEVELOPMENT, V134, P1723, DOI 10.1242/dev.02819; Cuellar-Partida G, 2015, HUM MOL GENET, V24, P5060, DOI 10.1093/hmg/ddv211; Cumberland PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139780; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; Fabian-Jessing BK, 2018, AM J MED GENET A, V176, P1587, DOI 10.1002/ajmg.a.38836; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hysi PG, 2018, NAT GENET, V50, P652, DOI 10.1038/s41588-018-0100-5; Hysi PG, 2014, JAMA OPHTHALMOL, V132, P50, DOI 10.1001/jamaophthalmol.2013.6022; Jean D, 1998, MECH DEVELOP, V76, P3, DOI 10.1016/S0925-4773(98)00117-8; Karouta C, 2015, INVEST OPHTH VIS SCI, V56, P299, DOI 10.1167/iovs.14-15499; Khawaja AP, 2018, NAT GENET, V50, P778, DOI 10.1038/s41588-018-0126-8; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Ma MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091086; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Miyake M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7689; Mohammad S, 2015, INVEST OPHTH VIS SCI, V56, P4611, DOI 10.1167/iovs.15-16856; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Mountjoy E, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2022; Oliveira J, 2008, CLIN GENET, V74, P502, DOI 10.1111/j.1399-0004.2008.01068.x; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pozarickij A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0387-5; Pybus M, 2014, NUCLEIC ACIDS RES, V42, pD903, DOI 10.1093/nar/gkt1188; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Ratnapriya R, 2019, NAT GENET, V51, P606, DOI 10.1038/s41588-019-0351-9; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113; Rohde K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/946075; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Stone RA, 2011, INVEST OPHTH VIS SCI, V52, P5765, DOI 10.1167/iovs.10-6727; Struck M. C., 2015, CURRENT OPHTHALMOLOG, V3, P232, DOI [10. 1007/s40135-015-0083-7, DOI 10.1007/s40135-015-0083-7]; Tedja MS, 2018, NAT GENET, V50, P834, DOI 10.1038/s41588-018-0127-7; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; TROILO D, 1987, CURR EYE RES, V6, P993, DOI 10.3109/02713688709034870; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Yahalom C, 2012, BRIT J OPHTHALMOL, V96, P537, DOI 10.1136/bjophthalmol-2011-300072; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zadnik K, 2004, OPTOMETRY VISION SCI, V81, P819, DOI 10.1097/01.OPX.0000145028.53923.67; Zhang Y, 2018, NAT GENET, V50, P1318, DOI 10.1038/s41588-018-0193-x; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	79	80	84	4	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2020	52	4					401	+		10.1038/s41588-020-0599-0	http://dx.doi.org/10.1038/s41588-020-0599-0		MAR 2020	20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ6QL	32231278	Green Accepted, Green Submitted			2022-12-17	WOS:000522382900001
J	Li, N; Lin, B; Wang, H; Li, XM; Yang, FF; Ding, XH; Yan, JB; Chu, ZH				Li, Ning; Lin, Bao; Wang, Hong; Li, Xiaoming; Yang, Fangfang; Ding, Xinhua; Yan, Jianbing; Chu, Zhaohui			Natural variation in ZmFBL41 confers banded leaf and sheath blight resistance in maize	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; F-BOX PROTEIN; WALL-DEGRADING ENZYMES; TRANSCRIPTION FACTOR; RHIZOCTONIA-SOLANI; DISEASE RESISTANCE; TRIGGERED IMMUNITY; DEFENSE RESPONSES; RICE	Rhizoctonia solani is a widely distributed phytopathogen that causes banded leaf and sheath blight in maize and sheath blight in rice. Here, we identified an F-box protein (ZmFBL41) that confers resistance to banded leaf and sheath blight through a genome-wide association study in maize. Rice overexpressing ZmFBL41 showed elevated susceptibility to R. solani. Two amino acid substitutions in this allele prevent its interaction with ZmCAD, which encodes the final enzyme in the monolignol biosynthetic pathway, resulting in the inhibition of ZmCAD degradation and, consequently, the accumulation of lignin and restriction of lesion expansion. Knocking out the ZmCAD-homologous gene OsCAD8B in rice enhanced susceptibility to R. solani. The results reveal a susceptibility mechanism in which R. solani targets the host proteasome to modify the secondary metabolism of the plant cell wall for its invasion. More importantly, it provides an opportunity to generate R. solani-resistant varieties of different plant species.	[Li, Ning; Lin, Bao; Li, Xiaoming; Yang, Fangfang; Ding, Xinhua; Chu, Zhaohui] Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Hong; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Ding, Xinhua] Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An, Shandong, Peoples R China; [Wang, Hong] Hebei Agr Univ, Coll Agron, Key Lab Northern China Crop Germplasm Resources, Baoding, Peoples R China	Shandong Agricultural University; Huazhong Agricultural University; Shandong Agricultural University; Hebei Agricultural University	Chu, ZH (corresponding author), Shandong Agr Univ, Coll Agron, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	yjianbing@mail.hzau.edu.cn; zchu@sdau.edu.cn	ding, xinhua/AAV-2612-2020; Chu, Zhaohui/AAX-9925-2021	ding, xinhua/0000-0002-6510-5992; Chu, Zhaohui/0000-0001-8320-7872; Li, Ning/0000-0001-6168-9604	National Key Research and Development Program of China [2016YFD0101003, 2016YFD0100903]; National Natural Science Foundation of China [31601279]; Key Research and Development Program of Shandong Province [2017GNC10104, 2018GNC110018]; Shandong Modern Agricultural Technology and Industry system [SDAIT-17-06]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; Shandong Modern Agricultural Technology and Industry system	We thank B. Liu and Y. Zhang from Shandong Agricultural University for seed propagation of maize transposon-insertion lines. This study was supported by the National Key Research and Development Program of China (2016YFD0101003 and 2016YFD0100903), the National Natural Science Foundation of China (31601279), the Key Research and Development Program of Shandong Province (2017GNC10104 and 2018GNC110018) and the Shandong Modern Agricultural Technology and Industry system (SDAIT-17-06).	Bacete L, 2018, PLANT J, V93, P614, DOI 10.1111/tpj.13807; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cao YF, 2008, PHYSIOL PLANTARUM, V134, P440, DOI 10.1111/j.1399-3054.2008.01149.x; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chezem WR, 2017, PLANT CELL, V29, P1907, DOI 10.1105/tpc.16.00954; Ding JQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0589-z; Duplan V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00042; Escudero V, 2017, PLANT J, V92, P386, DOI 10.1111/tpj.13660; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Furlan G, 2017, PLANT CELL, V29, P726, DOI 10.1105/tpc.16.00654; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Gou MY, 2012, PLANT J, V69, P411, DOI 10.1111/j.1365-313X.2011.04799.x; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Gowda M, 2015, THEOR APPL GENET, V128, P1957, DOI 10.1007/s00122-015-2559-0; Hammoudi V, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007157; Huang JH, 2018, PLANT J, V95, P504, DOI 10.1111/tpj.13965; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jia FJ, 2013, MOL GENET GENOMICS, V288, P559, DOI 10.1007/s00438-013-0769-1; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Jun SY, 2017, PLANT PHYSIOL, V174, P2128, DOI 10.1104/pp.17.00576; Kim HS, 2002, PLANT CELL, V14, P1469, DOI 10.1105/tpc.001867; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Lakshman DK, 2016, J AGR FOOD CHEM, V64, P3101, DOI 10.1021/acs.jafc.5b05735; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li N, 2018, PLANT BIOTECHNOL J, V16, P771, DOI 10.1111/pbi.12827; Li WT, 2017, CELL, V170, P114, DOI 10.1016/j.cell.2017.06.008; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; Lionetti V, 2017, PLANT PHYSIOL, V173, P1844, DOI 10.1104/pp.16.01185; Lu GH, 2006, J INTEGR PLANT BIOL, V48, P1233, DOI 10.1111/j.1744-7909.2006.00289.x; Ma QH, 2018, PLANT PATHOL, V67, P642, DOI 10.1111/ppa.12767; Ma X., 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP34919; Mahuku G, 2016, THEOR APPL GENET, V129, P1217, DOI 10.1007/s00122-016-2698-y; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Mammadov J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2171-3; Paccanaro MC, 2017, MOL PLANT MICROBE IN, V30, P886, DOI 10.1094/MPMI-07-17-0179-R; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Piisila M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0434-4; Richa K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00596; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHA XY, 1989, INT RICE RES NEWSL, V15, P7; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; Tang JD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1874-9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tong MXZ, 2017, NEW PHYTOL, V215, P1516, DOI 10.1111/nph.14678; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang HH, 2015, PLANT MOL BIOL, V89, P157, DOI 10.1007/s11103-015-0360-8; Wang J, 2017, PLANT SCI, V263, P142, DOI 10.1016/j.plantsci.2017.07.004; Wang XL, 2016, NAT GENET, V48, P1233, DOI 10.1038/ng.3636; Wang X, 2017, PLANT J, V89, P250, DOI 10.1111/tpj.13380; Wang Y, 2012, MOL BREEDING, V30, P293, DOI 10.1007/s11032-011-9619-1; Wen WW, 2016, TRENDS GENET, V32, P459, DOI 10.1016/j.tig.2016.05.003; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wibberg D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2561-1; Xiao YJ, 2017, MOL PLANT, V10, P359, DOI 10.1016/j.molp.2016.12.008; Xu C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1743; Yang FF, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1181-5; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; Zhang YW, 2017, PLANT J, V91, P714, DOI 10.1111/tpj.13599; Zhao MJ, 2006, CROP SCI, V46, P1039, DOI 10.2135/cropsci2005.0166; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu XG, 2018, MOL PLANT PATHOL, V19, P2590, DOI 10.1111/mpp.12731	76	80	91	16	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1540	+		10.1038/s41588-019-0503-y	http://dx.doi.org/10.1038/s41588-019-0503-y			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31570888				2022-12-17	WOS:000489016400017
J	Xu, M; Yao, YY; Chen, H; Zhang, SS; Cao, SM; Zhang, Z; Luo, B; Liu, ZW; Li, ZL; Xiang, T; He, GP; Feng, QS; Chen, LZ; Guo, X; Jia, WH; Chen, MY; Zhang, X; Xie, SH; Peng, RJ; Chang, ET; Pedergnana, V; Feng, L; Bei, JX; Xu, RH; Zeng, MS; Ye, WM; Adami, HO; Lin, XH; Zhai, WW; Zeng, YX; Liu, JJ				Xu, Miao; Yao, Youyuan; Chen, Hui; Zhang, Shanshan; Cao, Su-Mei; Zhang, Zhe; Luo, Bing; Liu, Zhiwei; Li, Zilin; Xiang, Tong; He, Guiping; Feng, Qi-Sheng; Chen, Li-Zhen; Guo, Xiang; Jia, Wei-Hua; Chen, Ming-Yuan; Zhang, Xiao; Xie, Shang-Hang; Peng, Roujun; Chang, Ellen T.; Pedergnana, Vincent; Feng, Lin; Bei, Jin-Xin; Xu, Rui-Hua; Zeng, Mu-Sheng; Ye, Weimin; Adami, Hans-Olov; Lin, Xihong; Zhai, Weiwei; Zeng, Yi-Xin; Liu, Jianjun			Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma	NATURE GENETICS			English	Article							DNA-BINDING PROTEIN; WIDE ASSOCIATION; LYTIC CYCLE; RELATEDNESS; PERFORMANCE; EXPRESSION; DIVERSITY; SIGNATURE; ALIGNMENT; BURKITTS	Epstein-Barr virus (EBV) infection is ubiquitous worldwide and is associated with multiple cancers, including nasopharyngeal carcinoma (NPC). The importance of EBV viral genomic variation in NPC development and its striking epidemic in southern China has been poorly explored. Through large-scale genome sequencing of 270 EBV isolates and two-stage association study of EBV isolates from China, we identify two non-synonymous EBV variants within BALF2 that are strongly associated with the risk of NPC (odds ratio (OR) = 8.69, P = 9.69 x 10(-25) for SNP 162476_C; OR = 6.14, P= 2.40 x 10(-32) for SNP 163364_T). The cumulative effects of these variants contribute to 83% of the overall risk of NPC in southern China. Phylogenetic analysis of the risk variants reveals a unique origin in Asia, followed by clonal expansion in NPC-endemic regions. Our results provide novel insights into the NPC endemic in southern China and also enable the identification of high-risk individuals for NPC prevention.	[Xu, Miao; Yao, Youyuan; Zhang, Shanshan; Cao, Su-Mei; Xiang, Tong; He, Guiping; Feng, Qi-Sheng; Chen, Li-Zhen; Guo, Xiang; Jia, Wei-Hua; Chen, Ming-Yuan; Zhang, Xiao; Xie, Shang-Hang; Peng, Roujun; Feng, Lin; Bei, Jin-Xin; Xu, Rui-Hua; Zeng, Mu-Sheng; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Guangdong Key Lab, Guangzhou, Guangdong, Peoples R China; [Xu, Miao; Li, Zilin; Lin, Xihong] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Yao, Youyuan] Zhejiang Canc Hosp, Key Lab Head & Neck Canc Translat Res Zhejiang Pr, Dept Comprehens Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Chen, Hui; Pedergnana, Vincent; Zhai, Weiwei; Liu, Jianjun] ASTAR, Human Genet, Genome Inst Singapore, Singapore, Singapore; [Zhang, Zhe] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Peoples R China; [Luo, Bing] Qingdao Univ, Dept Med Microbiol, Med Coll, Qingdao, Shandong, Peoples R China; [Liu, Zhiwei; Ye, Weimin; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Guo, Xiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China; [Chang, Ellen T.] Exponent, Ctr Hlth Sci, Menlo Pk, CA USA; [Chang, Ellen T.] Stanford Canc Inst, Stanford, CA USA; [Adami, Hans-Olov] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Zhai, Weiwei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Liu, Jianjun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore	State Key Lab Oncology South China; Sun Yat Sen University; Harvard University; Harvard T.H. Chan School of Public Health; Zhejiang Cancer Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Guangxi Medical University; Qingdao University; Karolinska Institutet; Sun Yat Sen University; Exponent; Stanford Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; National University of Singapore	Zeng, YX (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Guangdong Key Lab, Guangzhou, Guangdong, Peoples R China.; Zhai, WW; Liu, JJ (corresponding author), ASTAR, Human Genet, Genome Inst Singapore, Singapore, Singapore.; Zhai, WW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.; Zhai, WW (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.; Liu, JJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.	weiweizhai@ioz.ac.cn; zengyx@sysucc.org.cn; liuj3@gis.a-star.edu.sg	Bei, Jin-Xin/AAO-1259-2020; Liu, Jianjun/AAK-4989-2020; Li, Zilin/AAB-1216-2019; Chen, Ming/GVU-8412-2022; Xu, Rui-Hua/AAW-4766-2021; Liu, Zhiwei/AAM-5300-2020; xu, rui/GRX-5734-2022	Liu, Jianjun/0000-0002-3255-3019; Xu, Rui-Hua/0000-0001-9771-8534; Liu, Zhiwei/0000-0002-0136-651X; Zhang, Shanshan/0000-0002-9033-3786; Pedergnana, Vincent/0000-0002-7852-5339; Zhai, Weiwei/0000-0001-7938-0226	National Natural Science Foundation of China [81430059, 81872228]; National Key R&D Program of China [2016YF0902000, 2018YFC1406902, 2018YFC0910400]; National Cancer Institute at the US National Institutes of Health (NIH) [R01CA115873-01, R35-CA197449, P01-CA134294, U01-HG009088, U19-CA203654]; Agency of Science, Technology and Research (A*STAR), Singapore; NATIONAL CANCER INSTITUTE [P01CA134294, U19CA203654, R35CA197449] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009088] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Cancer Institute at the US National Institutes of Health (NIH); Agency of Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all of the participants for their generous support of the current study. We would also thank R. Sun, C. Wang, H. Chen, J. Shen and C. Jie for helpful discussions on viral biology and genetic statistical, evolutionary and phylogenetic analyses, W.-S. Liu and X. Zuo for providing code support, Z. Lin (Tulane University) for kindly sharing EBV genome annotation files and J.-Y. Shao from Sun Yat-sen University Cancer Center for providing the MassArray iPlex platform. This work was supported by the National Natural Science Foundation of China (81430059 to Y.-X.Z. and 81872228 to M.X.), the National Key R&D Program of China (2016YF0902000 to Y.-X.Z., and 2018YFC1406902 and 2018YFC0910400 to W.Z.), the National Cancer Institute at the US National Institutes of Health (NIH) (R01CA115873-01 to H.-O.A. and Y.-X.Z., and R35-CA197449, P01-CA134294, U01-HG009088 and U19-CA203654 to X.L.) and the Agency of Science, Technology and Research (A*STAR), Singapore (to J.L.).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bei JX, 2016, CANCER EPIDEM BIOMAR, V25, P188, DOI 10.1158/1055-9965.EPI-15-0144; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coghill AE, 2018, CLIN CANCER RES, V24, P1305, DOI 10.1158/1078-0432.CCR-17-1929; Correia S, 2017, J VIROL, V91, DOI 10.1128/JVI.00375-17; Cui Q, 2016, HUM MOL GENET, V25, P3626, DOI 10.1093/hmg/ddw200; Dahlqwist E, 2016, EUR J EPIDEMIOL, V31, P575, DOI 10.1007/s10654-016-0137-7; DECAUSSIN G, 1995, J VIROL, V69, P7309, DOI 10.1128/JVI.69.11.7309-7314.1995; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Epstein A, 2015, CURR TOP MICROBIOL, V390, P3, DOI 10.1007/978-3-319-22822-8_1; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hui KF, 2019, INT J CANCER, V144, P3031, DOI 10.1002/ijc.32049; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kwok H, 2014, J VIROL, V88, P10662, DOI 10.1128/JVI.01665-14; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lin Z, 2013, J VIROL, V87, P1172, DOI 10.1128/JVI.02517-12; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Mumtsidu E, 2008, J STRUCT BIOL, V161, P172, DOI 10.1016/j.jsb.2007.10.014; NERI A, 1991, BLOOD, V77, P1092; Palser AL, 2015, J VIROL, V89, P5222, DOI 10.1128/JVI.03614-14; Paramita DK, 2007, J MED VIROL, V79, P1710, DOI 10.1002/jmv.20987; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; ROWE M, 1989, J VIROL, V63, P1031, DOI 10.1128/JVI.63.3.1031-1039.1989; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Tang MZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003103; Tso KKY, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-29; Weiss ER, 2018, J VIROL, V92, DOI 10.1128/JVI.01466-17; Xue WQ, 2018, CANCER MED-US, V7, P3453, DOI 10.1002/cam4.1597; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; Zeng Y, 1997, VIROLOGY, V239, P285, DOI 10.1006/viro.1997.8891; Zhang LF, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0018-6; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	47	80	83	4	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2019	51	7					1131	+		10.1038/s41588-019-0436-5	http://dx.doi.org/10.1038/s41588-019-0436-5			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG0PF	31209392	Green Accepted, Green Submitted			2022-12-17	WOS:000473491900012
J	Small, KS; Todorcevic, M; Civelek, M; Moustafa, JSES; Wang, X; Simon, MM; Fernandez-Tajes, J; Mahajan, A; Horikoshi, M; Hugill, A; Glastonbury, CA; Quaye, L; Neville, MJ; Sethi, S; Yon, M; Pan, C; Che, N; Vinuela, A; Tsai, PC; Nag, A; Buil, A; Thorleifsson, G; Raghavan, A; Ding, Q; Morris, AP; Bell, JT; Thorsteinsdottir, U; Stefansson, K; Laakso, M; Dahlman, I; Arner, P; Gloyn, AL; Musunuru, K; Lusis, AJ; Cox, RD; Karpe, F; McCarthy, MI				Small, Kerrin S.; Todorcevic, Marijana; Civelek, Mete; Moustafa, Julia S. El-Sayed; Wang, Xiao; Simon, Michelle M.; Fernandez-Tajes, Juan; Mahajan, Anubha; Horikoshi, Momoko; Hugill, Alison; Glastonbury, Craig A.; Quaye, Lydia; Neville, Matt J.; Sethi, Siddharth; Yon, Marianne; Pan, Calvin; Che, Nam; Vinuela, Ana; Tsai, Pei-Chien; Nag, Abhishek; Buil, Alfonso; Thorleifsson, Gudmar; Raghavan, Avanthi; Ding, Qiurong; Morris, Andrew P.; Bell, Jordana T.; Thorsteinsdottir, Unnur; Stefansson, Kari; Laakso, Markku; Dahlman, Ingrid; Arner, Peter; Gloyn, Anna L.; Musunuru, Kiran; Lusis, Aldons J.; Cox, Roger D.; Karpe, Fredrik; McCarthy, Mark I.			Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition	NATURE GENETICS			English	Article							SCALE ASSOCIATION ANALYSIS; ADIPOSE GENE-EXPRESSION; INSULIN-RESISTANCE; DNA METHYLATION; TRANSCRIPTION FACTORS; FAT DISTRIBUTION; MESSENGER-RNA; LOCI; IDENTIFICATION; OBESITY	Individual risk of type 2 diabetes (T2D) is modified by perturbations to the mass, distribution and function of adipose tissue. To investigate the mechanisms underlying these associations, we explored the molecular, cellular and whole-body effects of T2D-associated alleles near KLF14. We show that KLF14 diabetes-risk alleles act in adipose tissue to reduce KLF14 expression and modulate, in trans, the expression of 385 genes. We demonstrate, in human cellular studies, that reduced KLF14 expression increases pre-adipocyte proliferation but disrupts lipogenesis, and in mice, that adipose tissue-specific deletion of Klf14 partially recapitulates the human phenotype of insulin resistance, dyslipidemia and T2D. We show that carriers of the KLF14 T2D risk allele shift body fat from gynoid stores to abdominal stores and display a marked increase in adipocyte cell size, and that these effects on fat distribution, and the T2D association, are female specific. The metabolic risk associated with variation at this imprinted locus depends on the sex both of the subject and of the parent from whom the risk allele derives.	[Small, Kerrin S.; Glastonbury, Craig A.; Quaye, Lydia; Vinuela, Ana; Tsai, Pei-Chien; Nag, Abhishek; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Todorcevic, Marijana; Horikoshi, Momoko; Neville, Matt J.; Gloyn, Anna L.; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Civelek, Mete] Univ Virginia, Dept Biomed Engn, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Civelek, Mete; Che, Nam; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Cardiovasc Inst,Dept Med, Philadelphia, PA 19104 USA; [Simon, Michelle M.; Sethi, Siddharth] MRC, Harwell Inst, Biocomp, Oxford, England; [Fernandez-Tajes, Juan; Mahajan, Anubha; Horikoshi, Momoko; Morris, Andrew P.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Hugill, Alison; Yon, Marianne; Cox, Roger D.] MRC, Harwell Inst, Genet Type Diabet 2, Oxford, England; [Neville, Matt J.; Gloyn, Anna L.; Karpe, Fredrik; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England; [Pan, Calvin; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Buil, Alfonso] Univ Geneva, Med Sch, Dept Genet Med & Dev, Geneva, Switzerland; [Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Raghavan, Avanthi] Harvard Med Sch, Boston, MA USA; [Ding, Qiurong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, CAS Key Lab Nutr & Metab, Shanghai, Peoples R China; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Dahlman, Ingrid; Arner, Peter] Karolinska Inst, Dept Med, Stockholm, Sweden; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of London; King's College London; University of Oxford; University of Virginia; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; MRC Harwell; University of Oxford; Wellcome Centre for Human Genetics; MRC Harwell; University of Oxford; University of California System; University of California Los Angeles; University of Geneva; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Liverpool; University of Iceland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Karolinska Institutet; University of California System; University of California Los Angeles	Small, KS (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.; McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.; McCarthy, MI (corresponding author), Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England.	kerrin.small@kcl.ac.uk; mark.mccarthy@drl.ox.ac.uk	Stefansson, Kari/AAE-7187-2019; Bell, Jordana/AAH-7312-2019; Horikoshi, Momoko/AAF-9034-2019; Viñuela, Ana/L-5015-2019	Viñuela, Ana/0000-0003-3771-8537; Gloyn, Anna/0000-0003-1205-1844; Todorcevic, Marijana/0000-0002-3100-8799; Arner, Peter/0000-0002-6208-6220; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Dahlman, Ingrid/0000-0003-3819-5977	MRC grant [MR/J010642/1]; MRC New Investigator Award [MR/L01999X/1]; Wellcome [090532, 106130, 098381, 203141]; NIDDK [U01-DK105535]; MRC [MR/L020149/1, MC_U142661184]; British Heart Foundation [RG/17/1/32663]; NIH [R00 HL121172, R01-DK099571, NIH P01HL28481]; Academy of Finland [77299, 124243]; Finnish Heart Foundation; Finnish Diabetes Foundation; Commission of the European Community [HEALTH-F2-2007-201681]; European Union Framework Programme 7 grant EuroBATS [259749]; Wellcome; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR); King's College London; Resource for Genetic Epidemiology Research in Adult Health and Aging [RC2 AG033067]; Robert Wood Johnson Foundation; Wayne and Gladys Valley Foundation; Ellison Medical Foundation; Medical Research Council [MC_U142661184, MR/L020149/1, MR/L01999X/1, MR/J010642/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; MRC [MR/J010642/1, MR/L01999X/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R00HL121172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK105535, R01DK099571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033067] Funding Source: NIH RePORTER	MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation; Commission of the European Community(European Commission); European Union Framework Programme 7 grant EuroBATS; Wellcome; European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London(General Electric); Resource for Genetic Epidemiology Research in Adult Health and Aging; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Wayne and Gladys Valley Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by MRC grant MR/J010642/1 to K.S.S., R.D.C., F.K. and M.I.M. K.S.S. is supported by an MRC New Investigator Award (MR/L01999X/1). M.I.M. is a Wellcome Senior Investigator and is supported by Wellcome (090532, 106130, 098381, 203141), NIDDK (U01-DK105535) and the MRC (MR/L020149/1). F.K. is supported by the British Heart Foundation (RG/17/1/32663). M.C. is supported by NIH Award R00 HL121172. A.L.G. is a Wellcome Senior Fellow in Basic Biomedical Science (095101/Z/10/Z and 200837/Z/16/Z). K.M. is supported by NIH award R01-DK099571, and A.J.L. is supported by NIH award NIH P01HL28481. R.D.C. is supported by MRC MC_U142661184. J.F. was a Marie Curie Fellow. M.L. is supported by Academy of Finland grants 77299 and 124243, the Finnish Heart Foundation, the Finnish Diabetes Foundation, and Commission of the European Community HEALTH-F2-2007-201681. A.V. and A.B. were supported by the European Union Framework Programme 7 grant EuroBATS (259749). Some computations were performed at the Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics (SIB; http://www.vital-it.ch/). The TwinsUK study was funded by Wellcome and European Community's Seventh Framework Programme (FP7/2007-2013). The TwinsUK study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. We acknowledge excellent technical support for animal husbandry (Mary Lyon Centre), genotyping, histology and pathology. We thank the volunteers from the Oxford Biobank, NIHR Oxford Biomedical Research Centre, for their participation. The Oxford Biobank (http://www.oxfordbiobank.org.uk) is also part of the NIHR National Bioresource, which supported the recalling process of the volunteers. GERA data came from a grant, the Resource for Genetic Epidemiology Research in Adult Health and Aging (RC2 AG033067; C. Schaefer and N. Risch, principal investigators), awarded to the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the UCSF Institute for Human Genetics. The RPGEH was supported by grants from the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, and the Ellison Medical Foundation. This research utilized data from the UK Biobank Resource under application 9161.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Civelek M, 2017, AM J HUM GENET, V100, P428, DOI 10.1016/j.ajhg.2017.01.027; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Dahlman I, 2016, DIABETES, V65, P433, DOI 10.2337/db15-0828; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; GARVEY WT, 1991, J CLIN INVEST, V87, P1072, DOI 10.1172/JCI115068; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guo YH, 2015, J CLIN INVEST, V125, P3819, DOI 10.1172/JCI79048; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; HIRSCH J, 1968, J LIPID RES, V9, P110; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Keildson S, 2014, DIABETES, V63, P1154, DOI 10.2337/db13-1301; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Najafabadi HS, 2015, BIOINFORMATICS, V31, P2879, DOI 10.1093/bioinformatics/btv284; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Naranbhai V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8545; Neville MJ, 2011, OBESITY, V19, P888, DOI 10.1038/oby.2010.257; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Parsons MJ, 2015, CELL, V162, P607, DOI 10.1016/j.cell.2015.06.060; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Ronn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	61	80	80	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					572	+		10.1038/s41588-018-0088-x	http://dx.doi.org/10.1038/s41588-018-0088-x			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR		Green Accepted, Green Submitted			2022-12-17	WOS:000429529300017
J	Chen, JJ; Guccini, I; Di Mitri, D; Brina, D; Revandkar, A; Sarti, M; Pasquini, E; Alajati, A; Pinton, S; Losa, M; Civenni, G; Catapano, CV; Sgrignani, J; Cavalli, A; D'Antuono, R; Asara, JM; Morandi, A; Chiarugi, P; Crotti, S; Agostini, M; Montopoli, M; Masgras, I; Rasola, A; Garcia-Escudero, R; Delaleu, N; Rinaldi, A; Bertoni, F; de Bono, J; Carracedo, A; Alimonti, A				Chen, Jingjing; Guccini, Ilaria; Di Mitri, Diletta; Brina, Daniela; Revandkar, Ajinkya; Sarti, Manuela; Pasquini, Emiliano; Alajati, Abdullah; Pinton, Sandra; Losa, Marco; Civenni, Gianluca; Catapano, Carlo V.; Sgrignani, Jacopo; Cavalli, Andrea; D'Antuono, Rocco; Asara, John M.; Morandi, Andrea; Chiarugi, Paola; Crotti, Sara; Agostini, Marco; Montopoli, Monica; Masgras, Ionica; Rasola, Andrea; Garcia-Escudero, Ramon; Delaleu, Nicolas; Rinaldi, Andrea; Bertoni, Francesco; de Bono, Johann; Carracedo, Arkaitz; Alimonti, Andrea			Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer	NATURE GENETICS			English	Article							LIPOPROTEIN RECEPTOR PROMOTER; STEROL REGULATORY ELEMENT; HISTONE ACETYLATION; METABOLIC SWITCH; OXIDATIVE STRESS; EPITHELIAL-CELLS; NUCLEAR-PROTEIN; ZINC INHIBITION; TCA CYCLE; MITOCHONDRIA	The mechanisms by which mitochondrial metabolism supports cancer anabolism remain unclear. Here, we found that genetic and pharmacological inactivation of pyruvate dehydrogenase A1 (PDHA1), a subunit of the pyruvate dehydrogenase complex (PDC), inhibits prostate cancer development in mouse and human xenograft tumor models by affecting lipid biosynthesis. Mechanistically, we show that in prostate cancer, PDC localizes in both the mitochondria and the nucleus. Whereas nuclear PDC controls the expression of sterol regulatory element-binding transcription factor (SREBF)-target genes by mediating histone acetylation, mitochondrial PDC provides cytosolic citrate for lipid synthesis in a coordinated manner, thereby sustaining anabolism. Additionally, we found that PDHA1 and the PDC activator pyruvate dehydrogenase phosphatase 1 (PDP1) are frequently amplified and overexpressed at both the gene and protein levels in prostate tumors. Together, these findings demonstrate that both mitochondrial and nuclear PDC sustain prostate tumorigenesis by controlling lipid biosynthesis, thus suggesting this complex as a potential target for cancer therapy.	[Chen, Jingjing; Guccini, Ilaria; Di Mitri, Diletta; Brina, Daniela; Revandkar, Ajinkya; Sarti, Manuela; Pasquini, Emiliano; Alajati, Abdullah; Pinton, Sandra; Losa, Marco; Civenni, Gianluca; Catapano, Carlo V.; Rinaldi, Andrea; Bertoni, Francesco; Alimonti, Andrea] Univ Svizzera Italiana, Oncol Inst Southern Switzerland, Inst Oncol Res, Bellinzona, Switzerland; [Chen, Jingjing; Revandkar, Ajinkya; Alimonti, Andrea] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Sgrignani, Jacopo; Cavalli, Andrea] Univ Svizzera Italiana, Inst Res Biomed, Computat Struct Biol, Bellinzona, Switzerland; [D'Antuono, Rocco] Univ Svizzera Italiana, Inst Res Biomed, Imaging Facil, Bellinzona, Switzerland; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Med Sch, Boston, MA USA; [Morandi, Andrea; Chiarugi, Paola] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Crotti, Sara; Agostini, Marco] Inst Paediat Res Citta Speranza, Nanoinspired Biomed Lab, Padua, Italy; [Agostini, Marco] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Surg Clin, Padua, Italy; [Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Masgras, Ionica; Rasola, Andrea] Univ Padua, Inst Neurosci, CNR, Padua, Italy; [Masgras, Ionica; Rasola, Andrea] Univ Padua, Dept Biomed Sci, Padua, Italy; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol, Mol Oncol Unit, Madrid, Spain; [Garcia-Escudero, Ramon] Univ Hosp 12 Octubre, Biomed Res Inst I 12, Madrid, Spain; [Garcia-Escudero, Ramon; Carracedo, Arkaitz] Ctr Invest Biomed Red Canc, Madrid, Spain; [Delaleu, Nicolas] Univ Bergen, Dept Clin Sci, Roegelmann Res Lab, Bergen, Norway; [de Bono, Johann] Royal Marsden NHS Fdn Trust, Div Canc Therapeut, Drug Dev Unit, London, England; [de Bono, Johann] Royal Marsden NHS Fdn Trust, Div Clin Studies, London, England; [de Bono, Johann] Inst Canc Res, London, England; [Carracedo, Arkaitz] CIC BioGUNE, Bizkaia Technol Pk, Bizkaia, Spain; [Carracedo, Arkaitz] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Carracedo, Arkaitz] Univ Basque Country, Biochem & Mol Biol Dept, Bilbao, Spain; [Alimonti, Andrea] Univ Padua, Venetian Inst Mol Med, Dept Med, Padua, Italy	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; University of Lausanne; Universita della Svizzera Italiana; Universita della Svizzera Italiana; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Florence; Fondazione Citta della Speranza; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Bergen; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; CIC bioGUNE; Basque Foundation for Science; University of Basque Country; University of Padua; Veneto Institute Molecular Medicine	Alimonti, A (corresponding author), Univ Svizzera Italiana, Oncol Inst Southern Switzerland, Inst Oncol Res, Bellinzona, Switzerland.; Alimonti, A (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.; Alimonti, A (corresponding author), Univ Padua, Venetian Inst Mol Med, Dept Med, Padua, Italy.	andrea.alimonti@ior.iosi.ch	Morandi, Andrea/AAC-1901-2022; D'Antuono, Rocco/HDM-4063-2022; Carracedo, Arkaitz/F-7029-2011; agostini, marco ma/K-2449-2018; Chiarugi, Paola/CDD-7988-2022; Garcia-Escudero, Ramon/A-2735-2012; Crotti, Sara/AAA-7091-2020; Sgrignani, Jacopo/D-5747-2011; Di Mitri, Diletta/AAA-4273-2019; Masgras, Ionica/ABG-9245-2021; Montopoli, Monica/W-9666-2019; Bertoni, Francesco/G-6922-2014; GUCCINI, Ilaria/E-8262-2018	Morandi, Andrea/0000-0002-9222-5332; D'Antuono, Rocco/0000-0003-0180-6500; Carracedo, Arkaitz/0000-0001-5957-1260; agostini, marco ma/0000-0001-7578-1233; Garcia-Escudero, Ramon/0000-0001-5640-6542; Crotti, Sara/0000-0001-6602-5153; Sgrignani, Jacopo/0000-0002-8633-1032; Masgras, Ionica/0000-0002-9768-460X; Bertoni, Francesco/0000-0001-5637-8983; Chiarugi, Paola/0000-0001-7655-2969; Catapano, Carlo V./0000-0002-7079-557X; Civenni, Gianluca/0000-0003-1921-161X; Cavalli, Andrea/0000-0003-4063-4502; Alimonti, Andrea/0000-0002-9362-2313; GUCCINI, Ilaria/0000-0002-3644-0679; Rasola, Andrea/0000-0003-4522-3008; Pasquini, Emiliano/0000-0001-9158-9671; Chen, Jingjing/0000-0001-6994-0074; MONTOPOLI, MONICA/0000-0001-6182-4132; de Bono, Johann S/0000-0002-2034-595X; DI MITRI, DILETTA/0000-0002-9626-4259	NIH [P01-CA120964, P30-CA006516]; AIRC Investigator Grant [19104]; CARIPARO Pediatric Research Grant; Fondazione Umberto Veronesi; Associazione Italiana Ricerca sul Cancro; Fondazione Cassa di Risparmio di Firenze [19515]; AIRC [8797]; Department of Education of the Basque Government [IKERTALDE IT1106-16]; BBVA Foundation; MINECO [SAF2016-79381-R, SEV-2016-0644]; European Research Council [336343, PoC 754627]; FEDER funds; Swiss National Science Foundation (SNF) grant Ambizione [PZ00P3_136612/1]; European Research Council Starting Grant [ERCsg 261342]; European Society for Medical Oncology (ESMO) Translational Research Award; Dr. Josef Steiner Cancer Research Award; Swiss Bridge Award; Fondazione IBSA fellowship award; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC Investigator Grant(Fondazione AIRC per la ricerca sul cancro); CARIPARO Pediatric Research Grant(Fondazione Cariparo); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); AIRC(Fondazione AIRC per la ricerca sul cancro); Department of Education of the Basque Government; BBVA Foundation(BBVA Foundation); MINECO(Spanish Government); European Research Council(European Research Council (ERC)European Commission); FEDER funds(European Commission); Swiss National Science Foundation (SNF) grant Ambizione(Swiss National Science Foundation (SNSF)); European Research Council Starting Grant(European Research Council (ERC)); European Society for Medical Oncology (ESMO) Translational Research Award; Dr. Josef Steiner Cancer Research Award; Swiss Bridge Award; Fondazione IBSA fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the IOR/IRB animal core facility for technical assistance and animal work, and M. Yuan and S.B. Breitkopf for help with metabolomic analysis. The mass spectrometry work was partially supported by NIH grants P01-CA120964 (J.M.A.) and P30-CA006516 (J.M.A.). Cholesterol measurements in prostate cancer cell lines were supported by an AIRC Investigator Grant (IG 2016 ID 19104) and a CARIPARO Pediatric Research Grant. The work of A. M. was funded by Fondazione Umberto Veronesi and Associazione Italiana Ricerca sul Cancro and Fondazione Cassa di Risparmio di Firenze (grant 19515 to P.C. and A.M.) and AIRC (grant 8797 to P.C.). We thank E. Ragazzi (Department of Pharmaceutical and Pharmacological Sciences, University of Padova) for multivariate statistical analysis. The work of A. Carracedo was supported by the Department of Education of the Basque Government (IKERTALDE IT1106-16), the BBVA Foundation, the MINECO (SAF2016-79381-R (FEDER/EU), Severo Ochoa Excellence Accreditation SEV-2016-0644) and the European Research Council (Starting Grant 336343, PoC 754627). The participation of A. Carracedo as part of CIBERONC was cofunded with FEDER funds. This work was supported by a Swiss National Science Foundation (SNF) grant Ambizione (PZ00P3_136612/1), a European Research Council Starting Grant (ERCsg 261342), a European Society for Medical Oncology (ESMO) Translational Research Award to A. Alimonti, a Dr. Josef Steiner Cancer Research Award and a Swiss Bridge Award to A. Alimonti, and a Fondazione IBSA fellowship award to J.C. We thank N.J. Maitland (University of York) and D. Peeper (Netherlands Cancer Institute) for providing reagents.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; AVIDOR Y, 1956, BIOCHEM J, V63, P613, DOI 10.1042/bj0630613; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Breitkopf SB, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1157-8; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; CHARI-BITRON A., 1959, BIOCHEM JOUR, V71, P572; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Costello LC, 2000, ENDOCR RES, V26, P23, DOI 10.1080/07435800009040143; Costello LC, 1997, J BIOL CHEM, V272, P28875, DOI 10.1074/jbc.272.46.28875; COSTELLO LC, 1981, ENZYME, V26, P281, DOI 10.1159/000459195; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Delaleu N, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4362; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; MAGER J, 1954, NATURE, V173, P126, DOI 10.1038/173126a0; Maitland NJ, 2001, RADIAT RES, V155, P133, DOI 10.1667/0033-7587(2001)155[0133:IVMTSC]2.0.CO;2; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Stevenson J, 2014, BIOCHEM J, V461, P435, DOI 10.1042/BJ20131404; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; WANG XD, 1993, J BIOL CHEM, V268, P14497; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011; [No title captured], DOI DOI 10.1007/BFB0031008	61	80	82	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					219	+		10.1038/s41588-017-0026-3	http://dx.doi.org/10.1038/s41588-017-0026-3			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29335542	Green Accepted, Green Submitted			2022-12-17	WOS:000424519200013
J	Litchfield, K; Levy, M; Orlando, G; Loveday, C; Law, PJ; Migliorini, G; Holroyd, A; Broderick, P; Karlsson, R; Haugen, TB; Kristiansen, W; Nsengimana, J; Fenwick, K; Assiotis, I; Kote-Jarai, Z; Dunning, AM; Muir, K; Peto, J; Eeles, R; Easton, DF; Dudakia, D; Orr, N; Pashayan, N; Bishop, DT; Reid, A; Huddart, RA; Shipley, J; Grotmol, T; Wiklund, F; Houlston, RS; Turnbull, C				Litchfield, Kevin; Levy, Max; Orlando, Giulia; Loveday, Chey; Law, Philip J.; Migliorini, Gabriele; Holroyd, Amy; Broderick, Peter; Karlsson, Robert; Haugen, Trine B.; Kristiansen, Wenche; Nsengimana, Jeremie; Fenwick, Kerry; Assiotis, Ioannis; Kote-Jarai, ZSofia; Dunning, Alison M.; Muir, Kenneth; Peto, Julian; Eeles, Rosalind; Easton, Douglas F.; Dudakia, Darshna; Orr, Nick; Pashayan, Nora; Bishop, D. Timothy; Reid, Alison; Huddart, Robert A.; Shipley, Janet; Grotmol, Tom; Wiklund, Fredrik; Houlston, Richard S.; Turnbull, Clare		UK Testicular Canc Collaboration; PRACTICAL Consortium	Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CANCER-RISK; GENOTYPE IMPUTATION; BREAST-CANCER; CHROMATIN; VARIANTS; PROTEIN; SPECIFICATION; CONSERVATION; METAANALYSIS	Genome-wide association studies (GWAS) have transformed understanding of susceptibility to testicular germ cell tumors (TGCTs), but much of the heritability remains unexplained. Here we report a new GWAS, a meta-analysis with previous GWAS and a replication series, totaling 7,319 TGCT cases and 23,082 controls. We identify 19 new TGCT risk loci, roughly doubling the number of known TGCT risk loci to 44. By performing in situ Hi-C in TGCT cells, we provide evidence for a network of physical interactions among all 44 TGCT risk SNPs and candidate causal genes. Our findings implicate widespread disruption of developmental transcriptional regulators as a basis of TGCT susceptibility, consistent with failed primordial germ cell differentiation as an initiating step in oncogenesis(1). Defective microtubule assembly and dysregulation of KIT-MAPK signaling also feature as recurrently disrupted pathways. Our findings support a polygenic model of risk and provide insight into the biological basis of TGCT.	[Litchfield, Kevin; Levy, Max; Orlando, Giulia; Loveday, Chey; Law, Philip J.; Migliorini, Gabriele; Holroyd, Amy; Broderick, Peter; Kote-Jarai, ZSofia; Eeles, Rosalind; Dudakia, Darshna; Houlston, Richard S.; Turnbull, Clare] Inst Canc Res, Div Genet & Epidemiol, London, England; [Karlsson, Robert; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Haugen, Trine B.; Kristiansen, Wenche] Fac Hlth Sci, Oslo, Norway; [Haugen, Trine B.; Kristiansen, Wenche] Akershus Univ, Coll Appl Sci, Oslo, Norway; [Nsengimana, Jeremie] Leeds Inst Canc & Pathol, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Fenwick, Kerry; Assiotis, Ioannis] Inst Canc Res, Tumour Profiling Unit, London, England; [Dunning, Alison M.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Peto, Julian] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, London, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Orr, Nick] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London, England; [Reid, Alison] Royal Marsden NHS Fdn Trust, Acad Urooncol Unit, Sutton, Surrey, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Sutton, Surrey, England; [Shipley, Janet] Inst Canc Res, Div Mol Pathol, London, England; [Grotmol, Tom] Canc Registry Norway, Oslo, Norway; [Turnbull, Clare] Queen Mary Univ, William Harvey Res Inst, London, England; [Turnbull, Clare] Guys & St Thomas Fdn NHS Trust, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; Oslo Metropolitan University (OsloMet); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Warwick; University of Manchester; University of London; London School of Hygiene & Tropical Medicine; Royal Marsden NHS Foundation Trust; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oslo; University of London; Queen Mary University London	Turnbull, C (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London, England.; Turnbull, C (corresponding author), Queen Mary Univ, William Harvey Res Inst, London, England.; Turnbull, C (corresponding author), Guys & St Thomas Fdn NHS Trust, London, England.	clare.turnbull@icr.ac.uk	Nsengimana, Jeremie/AGK-5625-2022; Nsengimana, Jeremie/AAP-3185-2020; Turnbull, Clare/AAA-6596-2019	Levy, Max/0000-0001-5078-1747; Houlston, Richard/0000-0002-5268-0242; Litchfield, Kevin/0000-0002-3725-0914; huddart, robert/0000-0003-3604-1990; Karlsson, Robert/0000-0002-8949-2587; Eeles, Rosalind/0000-0002-3698-6241; Haugen, Trine Berit/0000-0002-8814-3393; Turnbull, Clare/0000-0002-1734-5772; Pashayan, Nora/0000-0003-0843-2468; batra, Jyotsna/0000-0003-4646-6247; Broderick, Peter/0000-0002-8348-5829; Bishop, Tim/0000-0002-8752-8785; Shipley, Janet/0000-0001-6748-8678; Law, Philip/0000-0001-9663-4611	National Health Service; US National Institutes of Health (NIH) [U19 CA 148537, X01HG007492, HHSN268201200008I]; NIH NCI [U01 CA188392]; Cancer Research UK [C5047/A7357, C1287/A10118, C1287/A16563, C5047/A3354, C5047/A10692, C16913/A6135, C1298/A8362]; European Commission [223175 (HEALTH-F2-2009-223175)]; NIH Cancer Post-Cancer GWAS initiative grant [1 U19 CA 148537-01]; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; Prostate Action; Orchid Cancer Appeal; National Cancer Research Network UK; National Cancer Research Institute (NCRI) UK; NIHR; Royal Marsden NHS Foundation Trust; Swedish Cancer Society [CAN2011/484, CAN2012/823]; Norwegian Cancer Society [418975-71081-PR-2006-0387, PK01-20070375]; Nordic Cancer Union [S-12/07]; Movember Foundation; Cancer Research UK; Cancer Research UK [13065, 15007, 16563, 17528, 19167, 10118, 10589] Funding Source: researchfish; Medical Research Council [G1001799, MR/N01104X/1, MR/N01104X/2, G0700491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U19CA148537, U01CA188392] Funding Source: NIH RePORTER; MRC [G1001799, MR/N01104X/2, G0700491, MR/N01104X/1] Funding Source: UKRI	National Health Service; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH Cancer Post-Cancer GWAS initiative grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; Prostate Action; Orchid Cancer Appeal; National Cancer Research Network UK; National Cancer Research Institute (NCRI) UK; NIHR(National Institute for Health Research (NIHR)); Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Swedish Cancer Society(Swedish Cancer Society); Norwegian Cancer Society(Norwegian Cancer Society); Nordic Cancer Union; Movember Foundation; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects with TGCT and the clinicians involved in their care for participation in this study. We thank the patients and all clinicians forming part of the UK Testicular Cancer Collaboration (UKTCC) for their participation in this study. This study would not have been possible without the contributions of M.K. Bolla (Breast Cancer Association Consortium (BCAC)), Q. Wang (BCAC), K. Michailido (BCAC), J. Dennis (BCAC), P. Hall (Collaborative Oncological Gene-environment Study (COGS)); D.F. Easton (BCAC), A. Berchuck (Ovarian Cancer Association Consortium), R. Eeles (PRACTICAL), G. Chenevix-Trench (The Consortium of Investigators of Modifiers of BRCA1/2), J. Dennis, P. Pharoah, A. Dunning, K. Muir, J. Peto, A. Lee and E. Dicks. We also thank the following for their contributions to this project: J. Simard, P. Kraft, C. Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory; and K.F. Doheny and the staff of the Center for Inherited Disease Research (CIDR) genotyping facility. The results published here are based in part on data generated by the TCGA Research Network. This study makes use of data generated by the Wellcome Trust Case Control Consortium 2 (WTCCC2). We acknowledge the contribution of E. Rapley and M. Stratton to the generation of previously published UK GWAS case data. We thank all the individuals who took part in these studies and all the researchers, clinicians, technicians and administrative staff who have enabled this work to be carried out. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. We thank the UK Genetics of Prostate Cancer Study (UKGPCS) study teams for the recruitment of the UKGPCS controls. Genotyping of the OncoArray was funded by the US National Institutes of Health (NIH) (U19 CA 148537 for Elucidating Loci Involved in Prostate cancer Susceptibility (ELLIPSE) project and X01HG007492 to the Center for Inherited Disease Research (CIDR) under contract number HHSN268201200008I). Additional analytical support was provided by NIH NCI U01 CA188392. The PRACTICAL consortium was supported by Cancer Research UK Grants C5047/A7357, C1287/A10118, C1287/A16563, C5047/A3354, C5047/A10692 and C16913/A6135; the European Commission's Seventh Framework Programme grant agreement 223175 (HEALTH-F2-2009-223175) (D.F.E., R.E. and Z.K.-J.); and the NIH Cancer Post-Cancer GWAS initiative grant 1 U19 CA 148537-01 (the GAME-ON initiative). We thank the following for funding support: the Institute of Cancer Research and the Everyman Campaign, the Prostate Cancer Research Foundation, Prostate Research Campaign UK (now Prostate Action), the Orchid Cancer Appeal, the National Cancer Research Network UK and the National Cancer Research Institute (NCRI) UK. We are grateful for NIHR funding to the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust. We acknowledge funding from the Swedish Cancer Society (CAN2011/484 and CAN2012/823), the Norwegian Cancer Society (grants 418975-71081-PR-2006-0387 and PK01-20070375) and the Nordic Cancer Union (grant S-12/07). This study was supported by the Movember Foundation and the Institute of Cancer Research. K.L. is supported by a PhD fellowship from Cancer Research UK. R.S.H. and P.B. are supported by Cancer Research UK (C1298/A8362 Bobby Moore Fund for Cancer Research UK).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; [Anonymous], TEST CANC STAT; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colin E, 2014, AM J HUM GENET, V95, P637, DOI 10.1016/j.ajhg.2014.10.011; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Cuppen Edwin, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4841; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jinks RN, 2015, BRAIN, V138, P2173, DOI 10.1093/brain/awv153; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Kharazmi E, 2015, EUR UROL, V68, P283, DOI 10.1016/j.eururo.2014.12.031; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kristiansen W, 2015, HUM MOL GENET, V24, P4138, DOI 10.1093/hmg/ddv129; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Le Cornet C, 2014, EUR J CANCER, V50, P831, DOI 10.1016/j.ejca.2013.11.035; Litchfield K, 2015, ANDROLOGY-US, V3, P34, DOI 10.1111/andr.304; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9690; Litchfield K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13889; Litchfield K, 2015, HUM MOL GENET, V24, P1169, DOI 10.1093/hmg/ddu511; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma W, 2014, MOL REPROD DEV, V81, P1019, DOI 10.1002/mrd.22422; Manku G, 2016, ANDROLOGY-US, V4, P95, DOI 10.1111/andr.12122; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McGlynn KA, 2005, J CLIN ONCOL, V23, P5757, DOI 10.1200/JCO.2005.08.227; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Monda G, 2012, MOL CELL, V45, P680, DOI 10.1016/j.molcel.2012.01.013; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Scales M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107497; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	70	80	82	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1133	+		10.1038/ng.3896	http://dx.doi.org/10.1038/ng.3896			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28604728	Green Accepted, Green Submitted			2022-12-17	WOS:000404253300025
J	Visscher, PM; Yang, J				Visscher, Peter M.; Yang, Jian			A plethora of pleiotropy across complex traits	NATURE GENETICS			English	Editorial Material								A new analysis has identified hundreds of loci that are associated with multiple traits or diseases by comparing genome-wide association study (GWAS) data for 42 complex traits. The study uses the power of GWAS to provide evidence of pairs of traits with a likely causal relationship.	[Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Visscher, PM (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	peter.visscher@uq.edu.au; jian.yang@uq.edu.au	Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020	Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760				Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lynch M, 1998, GENETICS ANAL QUANTI; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	9	80	80	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					707	708		10.1038/ng.3604	http://dx.doi.org/10.1038/ng.3604			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27350602				2022-12-17	WOS:000378840100005
J	Dooley, J; Tian, L; Schonefeldt, S; Delghingaro-Augusto, V; Garcia-Perez, JE; Pasciuto, E; Di Marino, D; Carr, EJ; Oskolkov, N; Lyssenko, V; Franckaert, D; Lagou, V; Overbergh, L; Vandenbussche, J; Allemeersch, J; Chabot-Roy, G; Dahlstrom, JE; Laybutt, DR; Petrovsky, N; Socha, L; Gevaert, K; Jetten, AM; Lambrechts, D; Linterman, MA; Goodnow, CC; Nolan, CJ; Lesage, S; Schlenner, SM; Liston, A				Dooley, James; Tian, Lei; Schonefeldt, Susann; Delghingaro-Augusto, Viviane; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Di Marino, Daniele; Carr, Edward J.; Oskolkov, Nikolay; Lyssenko, Valeriya; Franckaert, Dean; Lagou, Vasiliki; Overbergh, Lut; Vandenbussche, Jonathan; Allemeersch, Joke; Chabot-Roy, Genevieve; Dahlstrom, Jane E.; Laybutt, D. Ross; Petrovsky, Nikolai; Socha, Luis; Gevaert, Kris; Jetten, Anton M.; Lambrechts, Diether; Linterman, Michelle A.; Goodnow, Chris C.; Nolan, Christopher J.; Lesage, Sylvie; Schlenner, Susan M.; Liston, Adrian			Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSGENIC MOUSE MODEL; MOLECULAR-DYNAMICS; DNA; EXPRESSION; ORGAN; MICE; RNA; INSULITIS	Type 1 (T1D) and type 2 (T2D) diabetes share pathophysiological characteristics, yet mechanistic links have remained elusive. T1D results from autoimmune destruction of pancreatic beta cells, whereas beta cell failure in T2D is delayed and progressive. Here we find a new genetic component of diabetes susceptibility in T1D non-obese diabetic (NOD) mice, identifying immune-independent beta cell fragility. Genetic variation in Xrcc4 and Glis3 alters the response of NOD beta cells to unfolded protein stress, enhancing the apoptotic and senescent fates. The same transcriptional relationships were observed in human islets, demonstrating the role of beta cell fragility in genetic predisposition to diabetes.	[Dooley, James; Tian, Lei; Schonefeldt, Susann; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Franckaert, Dean; Lagou, Vasiliki; Schlenner, Susan M.; Liston, Adrian] VIB, Ctr Biol Dis, Leuven, Belgium; [Dooley, James; Tian, Lei; Schonefeldt, Susann; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Franckaert, Dean; Lagou, Vasiliki; Schlenner, Susan M.; Liston, Adrian] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Delghingaro-Augusto, Viviane; Dahlstrom, Jane E.; Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Di Marino, Daniele] Univ Svizzera Italiana, Dept Informat, Lugano, Switzerland; [Carr, Edward J.; Linterman, Michelle A.] Babraham Inst, Lymphocyte Signaling & Dev Inst Strateg Programme, Cambridge, England; [Oskolkov, Nikolay; Lyssenko, Valeriya] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Lyssenko, Valeriya] Steno Diabet Ctr, Dept Translat Pathophysiol, DK-2820 Gentofte, Denmark; [Lagou, Vasiliki] Univ Leuven, Dept Neurosci, Leuven, Belgium; [Overbergh, Lut] Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [Vandenbussche, Jonathan; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Vandenbussche, Jonathan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Allemeersch, Joke] Univ Leuven, VIB Nucle Core, Leuven, Belgium; [Chabot-Roy, Genevieve; Lesage, Sylvie] Hop Maison Neuve Rosemont, Immunol Oncol Sect, Montreal, PQ H1T 2M4, Canada; [Chabot-Roy, Genevieve; Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Dahlstrom, Jane E.] Canberra Hosp, Dept Anat Pathol, Garran, ACT, Australia; [Laybutt, D. Ross; Goodnow, Chris C.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW, Australia; [Petrovsky, Nikolai] Flinders Univ S Australia, Dept Endocrinol, Adelaide, SA 5001, Australia; [Socha, Luis] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Jetten, Anton M.] NIEHS, Immun Inflammat & Dis Lab, US Natl Inst Hlth, POB 12233, Res Triangle Pk, NC 27709 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Leuven, Belgium; [Nolan, Christopher J.] Canberra Hosp, Dept Endocrinol, Garran, ACT, Australia	Flanders Institute for Biotechnology (VIB); KU Leuven; Australian National University; Universita della Svizzera Italiana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Lund University; Steno Diabetes Center; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite de Montreal; Universite de Montreal; Australian National University; Canberra Hospital; Garvan Institute of Medical Research; University of New South Wales Sydney; Flinders University South Australia; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Flanders Institute for Biotechnology (VIB); KU Leuven; Australian National University; Canberra Hospital	Liston, A (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; Liston, A (corresponding author), Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	adrian.liston@vib.be	Linterman, Michelle/AAN-4210-2021; Nolan, Christopher J/B-2026-2008; Liston, Adrian/G-8606-2013; Delghingaro-Augusto, Viviane/AAG-8696-2019; Jetten, Anton/C-3736-2019; Lambrechts, Diether/AAJ-3167-2020; Goodnow, Christopher C/V-8108-2018; Overbergh, Lut/AAC-3515-2020; Petrovsky, Nikolai/P-1912-2017; Gevaert, Kris/AAE-4212-2019; Pasciuto, Emanuela/AAP-2982-2020; Oskolkov, Nikolay/AAH-2349-2019; Di Marino, Daniele/AAB-9653-2019; Di Marino, Daniele/ABB-2333-2020; Gevaert, Kris/D-6489-2017; Schlenner, Susan/P-7905-2017; Dahlstrom, Jane/E-4683-2018	Linterman, Michelle/0000-0001-6047-1996; Nolan, Christopher J/0000-0002-6964-3819; Liston, Adrian/0000-0002-6272-4085; Delghingaro-Augusto, Viviane/0000-0002-5107-2384; Jetten, Anton/0000-0003-0954-4445; Lambrechts, Diether/0000-0002-3429-302X; Goodnow, Christopher C/0000-0001-5296-6155; Petrovsky, Nikolai/0000-0002-1580-5245; Gevaert, Kris/0000-0002-4237-0283; Di Marino, Daniele/0000-0001-6961-3129; Gevaert, Kris/0000-0002-4237-0283; Schlenner, Susan/0000-0002-8553-3388; Dahlstrom, Jane/0000-0001-5608-693X; Carr, Edward/0000-0001-9343-4593; Lesage, Sylvie/0000-0002-0968-2795; Dooley, James/0000-0003-3154-4708; Pasciuto, Emanuela/0000-0002-5391-9585; Lagou, Vasiliki/0000-0003-3165-8940	VIB; European Research Council (ERC); Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council of Australia [1028108]; Swedish Research Council [2009-1039]; BBSRC [BBS/E/B/000C0409] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0409] Funding Source: researchfish; National Institute for Health Research [ACF-2014-14-003] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016416] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485] Funding Source: NIH RePORTER	VIB; European Research Council (ERC)(European Research Council (ERC)European Commission); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the VIB, European Research Council (ERC) and a Juvenile Diabetes Research Foundation (JDRF) Career Development Award (A.L.) and by the National Health and Medical Research Council of Australia (project grant 1028108; C.J.N.). N.O. and V. Lyssenko acknowledge support by a Strategic Research Grant from the Swedish Research Council (2009-1039).	Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Ceriotti M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020601; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; HILL SW, 1980, EUR J IMMUNOL, V10, P384, DOI 10.1002/eji.1830100513; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kornete M, 2013, AUTOIMMUNITY, V46, P259, DOI 10.3109/08916934.2012.752462; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Leiter EH, 2007, DIABETES OBES METAB, V9, P14, DOI 10.1111/j.1463-1326.2007.00770.x; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Planas R, 2010, IMMUNOL LETT, V133, P55, DOI 10.1016/j.imlet.2010.08.001; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Puebla-Osorio N, 2014, ONCOGENE, V33, P2748, DOI 10.1038/onc.2013.234; Raj DBTG, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.74; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tavana O, 2010, DIABETES, V59, P135, DOI 10.2337/db09-0792; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WICK G, 1986, IMMUNOL REV, V94, P113, DOI 10.1111/j.1600-065X.1986.tb01167.x; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	76	80	80	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					519	+		10.1038/ng.3531	http://dx.doi.org/10.1038/ng.3531			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26998692	Green Accepted			2022-12-17	WOS:000374834100011
J	Akizu, N; Cantagrel, V; Zaki, MS; Al-Gazali, L; Wang, X; Rosti, RO; Dikoglu, E; Gelot, AB; Rosti, B; Vaux, KK; Scott, EM; Silhavy, JL; Schroth, J; Copeland, B; Schaffer, AE; Gordts, PLSM; Esko, JD; Buschman, MD; Field, SJ; Napolitano, G; Abdel-Salam, GM; Ozgul, RK; Sagiroglu, MS; Azam, M; Ismail, S; Aglan, M; Selim, L; Mahmoud, IG; Abdel-Hadi, S; El Badawy, A; Sadek, AA; Mojahedi, F; Kayserili, H; Masri, A; Bastaki, L; Temtamy, S; Muller, U; Desguerre, I; Casanova, JL; Dursun, A; Gunel, M; Gabriel, SB; de Lonlay, P; Gleeson, JG				Akizu, Naiara; Cantagrel, Vincent; Zaki, Maha S.; Al-Gazali, Lihadh; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Gelot, Antoinette Bernabe; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Gordts, Philip L. S. M.; Esko, Jeffrey D.; Buschman, Matthew D.; Field, Seth J.; Napolitano, Gennaro; Abdel-Salam, Ghada M.; Ozgul, R. Koksal; Sagiroglu, Mahmut Samil; Azam, Matloob; Ismail, Samira; Aglan, Mona; Selim, Laila; Mahmoud, Iman G.; Abdel-Hadi, Sawsan; El Badawy, Amera; Sadek, Abdelrahim A.; Mojahedi, Faezeh; Kayserili, Hulya; Masri, Amira; Bastaki, Laila; Temtamy, Samia; Mueller, Ulrich; Desguerre, Isabelle; Casanova, Jean-Laurent; Dursun, Ali; Gunel, Murat; Gabriel, Stacey B.; de Lonlay, Pascale; Gleeson, Joseph G.			Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction	NATURE GENETICS			English	Article							NEURODEGENERATIVE DISEASE; INTELLECTUAL DISABILITY; ATAXIA; SUPPRESSION; DISCOVERY; DEATH; MODEL	Pediatric-onset ataxias often present clinically as developmental delay and intellectual disability, with prominent cerebellar atrophy as a key neuroradiographic finding. Here we describe a new clinically distinguishable recessive syndrome in 12 families with cerebellar atrophy together with ataxia, coarsened facial features and intellectual disability, due to truncating mutations in the sorting nexin gene SNX14, encoding a ubiquitously expressed modular PX domain-containing sorting factor. We found SNX14 localized to lysosomes and associated with phosphatidylinositol (3,5)-bisphosphate, a key component of late endosomes/lysosomes. Patient-derived cells showed engorged lysosomes and a slower autophagosome clearance rate upon autophagy induction by starvation. Zebrafish morphants for snx14 showed dramatic loss of cerebellar parenchyma, accumulation of autophagosomes and activation of apoptosis. Our results characterize a unique ataxia syndrome due to biallelic SNX14 mutations leading to lysosome-autophagosome dysfunction.	[Akizu, Naiara; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10021 USA; [Akizu, Naiara; Wang, Xin; Rosti, Rasim Ozgur; Dikoglu, Esra; Rosti, Basak; Vaux, Keith K.; Scott, Eric M.; Silhavy, Jennifer L.; Schroth, Jana; Copeland, Brett; Schaffer, Ashleigh E.; Casanova, Jean-Laurent; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Akizu, Naiara; Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Cantagrel, Vincent] Hop Necker Enfants Malad, INSERM, Inst Imagine, U1163, Paris, France; [Zaki, Maha S.; Abdel-Salam, Ghada M.; Ismail, Samira; Aglan, Mona; Temtamy, Samia] Natl Res Ctr, Dept Clin Genet, Human Genet & Genome Res Div, Cairo, Egypt; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Pediat, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates; [Gelot, Antoinette Bernabe] Hop Armand Trousseau, Assistance Publ Hop Paris, UF Genet Dev, Dept Genet,Neuropathol, Paris, France; [Gelot, Antoinette Bernabe] INSERM, Inst Neurobiol Mediterranee INMED, U901, F-13258 Marseille, France; [Gordts, Philip L. S. M.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Buschman, Matthew D.; Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Napolitano, Gennaro] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ozgul, R. Koksal] Hacettepe Univ, Inst Child Hlth, Pediat Metab, Ankara, Turkey; [Sagiroglu, Mahmut Samil] Tubitak Bilgem Uekae, Gebze, Turkey; [Azam, Matloob] Wah Med Coll, Wah, Pakistan; [Selim, Laila; Mahmoud, Iman G.; Abdel-Hadi, Sawsan; El Badawy, Amera] Cairo Univ, Childrens Hosp, Dept Pediat Neurol, Cairo, Egypt; [Sadek, Abdelrahim A.] Sohag Univ, Fac Med, Pediat Neurol Dept, Sohag, Egypt; [Mojahedi, Faezeh] Mashhad Med Genet Counseling Ctr, Mashhad, Iran; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Med Genet Dept, Istanbul, Turkey; [Masri, Amira] Univ Jordan, Dept Pediat, Div Child Neurol, Amman, Jordan; [Bastaki, Laila] Matern Hosp, Kuwait Med Genet Ctr, Safat, Kuwait; [Desguerre, Isabelle] Paris Descartes Univ, Necker Enfants Malad Hosp, Dept Pediat Neurol, Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Inst Imagine, Genet Humaine Malad Infect, INSERM,U1163, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Dursun, Ali] Hacettepe Univ, Fac Med, Pediat Metab, TR-06100 Ankara, Turkey; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Gunel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gabriel, Stacey B.] Broad Inst MIT & Harvard, Cambridge, MA USA; [de Lonlay, Pascale] Paris Descartes Univ, Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Reference Ctr Inherited Metab Dis, Paris, France; [Gleeson, Joseph G.] New York Genome Ctr, New York, NY USA	Rockefeller University; Howard Hughes Medical Institute; Scripps Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); United Arab Emirates University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Hacettepe University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Sohag University; Istanbul University; University of Jordan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Hacettepe University; Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, 1230 York Ave, New York, NY 10021 USA.	jogleeson@rockefeller.edu	masri, amira/C-4570-2015; Wang, Xin/A-8119-2017; OZGUL, RIZA KOKSAL/J-1569-2013; Napolitano, Gennaro/O-5377-2016; Zaki, Maha S/B-9361-2013; Kayserili, Hülya/M-3791-2015; Vaux, Keith/R-2716-2019; Abdel-Salam, Ghada/W-1718-2017; Mahmoud, Iman Gamal El Din/Y-6497-2019; Vincent, Cantagrel/H-8698-2017; Dursun, Ali/AAA-1586-2020; Casanova, Jean-Laurent/I-3418-2017; Wang, Guilin/G-8794-2018; Kayserili, Hülya/AAA-5593-2021	masri, amira/0000-0001-6103-8713; Vaux, Keith/0000-0001-8738-5940; Abdel-Salam, Ghada/0000-0003-2893-8802; Mahmoud, Iman Gamal El Din/0000-0003-4853-1874; Vincent, Cantagrel/0000-0002-5180-4848; Dursun, Ali/0000-0003-1104-9902; Kayserili, Hülya/0000-0003-0376-499X; temtamy, samia/0000-0002-6452-823X; Gelot, Antoinette/0000-0002-3032-014X; aglan, mona/0000-0002-0908-0639; Copeland, Brett/0000-0003-2933-6061; ismail, samira/0000-0002-0406-8251; Selim, laila/0000-0002-6548-6545; Schaffer, Ashleigh/0000-0002-1164-697X; Napolitano, Gennaro/0000-0002-8615-4654; Gordts, Philip/0000-0001-7224-4328; Buschman, Matthew/0000-0002-2949-5815; Ozgul, Riza Koksal/0000-0002-0283-635X; Field, Seth/0000-0002-8893-4806; Casanova, Jean-Laurent/0000-0002-7782-4169; Zaki, Maha/0000-0001-7840-0002	US National Institutes of Health [P01HD070494, R01NS048453]; Howard Hughes Medical Institute; US National Institutes of Health grant [K99NS089859-01]; Broad Institute grant [U54HG003067]; Yale Center for Mendelian Disorders grant [U54HG006504]; INSERM; Paris Descartes University; Giles Foundation; Candidoser Association; Scientific and Technology Research Council of Turkey (TUBITAK-SBAG) [111S217]; Turkey Republic Ministry of Development [TRMOD, 108S420]; Scientific and Technology Research Council of Turkey (TUBITAK-BILGEM-UEKAE) [K030-T439]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, K99NS089859, R01NS052455] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute grant; Yale Center for Mendelian Disorders grant; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University; Giles Foundation; Candidoser Association; Scientific and Technology Research Council of Turkey (TUBITAK-SBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkey Republic Ministry of Development(Turkiye Cumhuriyeti Kalkinma Bakanligi); Scientific and Technology Research Council of Turkey (TUBITAK-BILGEM-UEKAE)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Itan and B. Boisson for sequencing, T. Meerloo and A. Schmitt for electron microscopy support, the Sanford Burnham Institute for iPSC reprogramming, and A.M. Cuervo and M. Farquhar for comments and suggestions. Analysis was performed by the University of California San Diego Glycotechnology Core and the University of California San Diego Microscopy Imaging Core. This work was supported by US National Institutes of Health grants P01HD070494 and R01NS048453 and the Howard Hughes Medical Institute (to J.G.G.), US National Institutes of Health grant K99NS089859-01 (to N.A.), Broad Institute grant U54HG003067, Yale Center for Mendelian Disorders grant U54HG006504 (to M.G.), INSERM, Paris Descartes University, the St. Giles Foundation, and the Candidoser Association and Howard Hughes Medical Institute (to J.-L.C.), the Scientific and Technology Research Council of Turkey (grant TUBITAK-SBAG, 111S217, grant TUBITAK-BILGEM-UEKAE, K030-T439) and the Turkey Republic Ministry of Development (grant TRMOD, 108S420) (to A.D.).	Aker M, 2012, J MED GENET, V49, P221, DOI 10.1136/jmedgenet-2011-100520; Bargal R, 2002, NEUROPEDIATRICS, V33, P199, DOI 10.1055/s-2002-34496; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Clements P.R., 2012, CURR PROTOC HUM GENE, V10; Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Deik A, 2014, MUSCLE NERVE, V49, P768, DOI 10.1002/mus.24146; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Gordts PLSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038330; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Heiseke A, 2008, TRAFFIC, V9, P1116, DOI 10.1111/j.1600-0854.2008.00750.x; Huang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098383; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Paton L, 2014, J BIOL CHEM, V289, P26709, DOI 10.1074/jbc.M114.586156; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Roda RH, 2014, J CLIN NEUROSCI, V21, P1627, DOI 10.1016/j.jocn.2013.11.048; Sousa SB, 2014, AM J MED GENET A, V164, P10, DOI 10.1002/ajmg.a.36235; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Thomas AC, 2014, AM J HUM GENET, V95, P611, DOI 10.1016/j.ajhg.2014.10.007; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhao YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-30	38	80	84	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					528	U137		10.1038/ng.3256	http://dx.doi.org/10.1038/ng.3256			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25848753	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000353635800017
J	Thauvin-Robinet, C; Lee, JS; Lopez, E; Herranz-Perez, V; Shida, T; Franco, B; Jego, L; Ye, F; Pasquier, L; Loget, P; Gigot, N; Aral, B; Lopes, CAM; St-Onge, J; Bruel, AL; Thevenon, J; Gonzalez-Granero, S; Alby, C; Munnich, A; Vekemans, M; Huet, F; Fry, AM; Saunier, S; Riviere, JB; Attie-Bitach, T; Garcia-Verdugo, JM; Faivre, L; Megarbane, A; Nachury, MV				Thauvin-Robinet, Christel; Lee, Jaclyn S.; Lopez, Estelle; Herranz-Perez, Vicente; Shida, Toshinobu; Franco, Brunella; Jego, Laurence; Ye, Fan; Pasquier, Laurent; Loget, Philippe; Gigot, Nadege; Aral, Bernard; Lopes, Carla A. M.; St-Onge, Judith; Bruel, Ange-Line; Thevenon, Julien; Gonzalez-Granero, Susana; Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Huet, Frederic; Fry, Andrew M.; Saunier, Sophie; Riviere, Jean-Baptiste; Attie-Bitach, Tania; Garcia-Verdugo, Jose Manuel; Faivre, Laurence; Megarbane, Andre; Nachury, Maxence V.			The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator of centriole elongation	NATURE GENETICS			English	Article							HUMAN-CELLS; BIOGENESIS; PROTEIN; COMPLEX; LENGTH; CILIA; CYCLE; CPAP; ORGANIZATION; DUPLICATION	Centrioles are microtubule-based, barrel-shaped structures that initiate the assembly of centrosomes and cilia(1,2). How centriole length is precisely set remains elusive. The microcephaly protein CPAP (also known as MCPH6) promotes procentriole growth(3-5), whereas the oral-facial-digital (OFD) syndrome protein OFD1 represses centriole elongation(6,7). Here we uncover a new subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two affected families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2CD3 colocalizes with OFD1 at the distal end of centrioles, and C2CD3 physically associates with OFD1. However, whereas OFD1 deletion leads to centriole hyperelongation, loss of C2CD3 results in short centrioles without subdistal and distal appendages. Because C2CD3 overexpression triggers centriole hyperelongation and OFD1 antagonizes this activity, we propose that C2CD3 directly promotes centriole elongation and that OFD1 acts as a negative regulator of C2CD3. Our results identify regulation of centriole length as an emerging pathogenic mechanism in ciliopathies.	[Thauvin-Robinet, Christel; Lopez, Estelle; Jego, Laurence; Gigot, Nadege; Aral, Bernard; St-Onge, Judith; Bruel, Ange-Line; Thevenon, Julien; Huet, Frederic; Riviere, Jean-Baptiste; Faivre, Laurence] Univ Bourgogne, Fed Hosp Univ, Equipe Accueil Genet Anomalies Dev 4271, Dijon, France; [Thauvin-Robinet, Christel; Thevenon, Julien; Huet, Frederic; Faivre, Laurence] Ctr Hosp Univ Dijon, Reference Malad Rares Anomalies Dev & Syndromes, Dijon, France; [Lee, Jaclyn S.; Shida, Toshinobu; Ye, Fan; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cell Physiol, Stanford, CA 94305 USA; [Herranz-Perez, Vicente; Gonzalez-Granero, Susana; Garcia-Verdugo, Jose Manuel] Univ Valencia, Inst Cavanilles, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Lab Neurobiol Comparada, Valencia, Spain; [Herranz-Perez, Vicente; Gonzalez-Granero, Susana; Garcia-Verdugo, Jose Manuel] Univ Valencia, Inst Invest Sanitaria Hosp Fe, Unidad Mixta Esclerosis Multiple Neurorregen, Valencia, Spain; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Franco, Brunella] Univ Naples Federico II, Dept Med Translat Sci, Div Pediat, Naples, Italy; [Pasquier, Laurent] Ctr Hosp Univ Rennes, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Unite Fonctionnelle Genet Medicale, Rennes, France; [Loget, Philippe] Ctr Hosp Univ Rennes, Lab Anat Pathol, Rennes, France; [Gigot, Nadege; Aral, Bernard; St-Onge, Judith; Riviere, Jean-Baptiste] Ctr Hosp Univ Dijon, Lab Genet Mol Plateau Tech Biol, Dijon, France; [Lopes, Carla A. M.; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, Inst IMAGINE, INSERM U781, Paris, France; [Alby, Caroline; Munnich, Arnold; Vekemans, Michel; Saunier, Sophie; Attie-Bitach, Tania] Paris Descartes Sorbonne Paris Cite Univ, Inst IMAGINE, Paris, France; [Munnich, Arnold; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Saunier, Sophie] INSERM, Lab Inherited Kidney Dis, UMRS 1163, Paris, France; [Megarbane, Andre] St Josephs Univ, Fac Med, Unite Genet Med, Beirut, Lebanon	Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Stanford University; CIBERNED; University of Valencia; University of Valencia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; CHU Rennes; Universite de Rennes 1; CHU Rennes; Universite de Rennes 1; CHU Dijon Bourgogne; University of Leicester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cell Physiol, Stanford, CA 94305 USA.	nachury@stanford.edu	Saunier, Sophie/G-6044-2015; García-Verdugo, José Manuel/L-8421-2017; Ye, Fan/K-1620-2015; Nachury, Maxence/A-8759-2008; Pasquier, Laurent/AAN-4081-2020; ATTIE-BITACH, Tania/K-1453-2017; Megarbane, Andre/ABD-5574-2021; Herranz-Pérez, Vicente/AAE-9196-2021; Nachury, Maxence/H-3695-2019; González-Granero, Susana/Q-3861-2018; Herranz-Pérez, Vicente/A-4605-2012; FRANCO, Brunella/S-2882-2018	Saunier, Sophie/0000-0002-1069-0047; García-Verdugo, José Manuel/0000-0001-9872-6499; Ye, Fan/0000-0002-5777-001X; Nachury, Maxence/0000-0003-4918-1562; Pasquier, Laurent/0000-0003-3985-1286; ATTIE-BITACH, Tania/0000-0002-1155-3626; Herranz-Pérez, Vicente/0000-0002-1969-1214; Nachury, Maxence/0000-0003-4918-1562; González-Granero, Susana/0000-0003-1531-550X; Herranz-Pérez, Vicente/0000-0002-1969-1214; Frederic, HUET/0000-0002-4510-7093; FRANCO, Brunella/0000-0001-5588-4569; Faivre, Laurence/0000-0001-9770-444X; Lopes, Carla A. M./0000-0003-3182-8305	NIGMS [GM089933]; GIS-Institut des Maladies Rares (HTS); French Ministry of Health [PHRC national 2010-A01014-35]; Regional Council of Burgundy; Wellcome Trust; Kidney Research UK; Fondazione Telethon [TGM11CB3]; European Community's Seventh Framework Programme (FP7) [241955]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative (Will) Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Kidney Research UK [RP2/2013] Funding Source: researchfish; Worldwide Cancer Research [13-0042] Funding Source: researchfish	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); GIS-Institut des Maladies Rares (HTS); French Ministry of Health; Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Wellcome Trust(Wellcome TrustEuropean Commission); Kidney Research UK(Kidney Research UK (KRUK)); Fondazione Telethon(Fondazione TelethonEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); Lung GO Sequencing Project; Women's Health Initiative (Will) Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Kidney Research UK(Kidney Research UK (KRUK)); Worldwide Cancer Research	We thank L. Pelletier (Lunenfeld Institute, University of Toronto), M. Bornens (Institut Curie, Paris), C. Janke (Institut Curie, Orsay), T. Stearns (Stanford University) and A. Merdes (CNRS, Universite de Toulouse) for antibodies against SASS6, ninein, glutamylated tubulin, CEP164 and PCM-1, respectively, A. Liu for the C2cd3-mutant MEFs and C2cd3 cDNA, J. Reiter for Ofd1 cDNA, S. Munro for pRFP-PACT, V. Meyer (Genoscope, Centre National de Genotypage), T. Hardy (University of Leicester) and N. Elkhartoufi (Necker, Paris) for technical support, F. Collman (Stanford University) for help with serial alignment, members of the Nachury laboratory for helpful discussions, and the patients and their families for their participation. This work was supported by grants from NIGMS (GM089933 to M.V.N.), the GIS-Institut des Maladies Rares (HTS), the French Ministry of Health (PHRC national 2010-A01014-35), the Regional Council of Burgundy (to C.T.-R.), the Wellcome Trust and Kidney Research UK (to A.M.F.), and the Fondazione Telethon (TGM11CB3) and the European Community's Seventh Framework Programme (FP7/2007-2013; 241955) (to ER). We also thank the National Heart, Lung, and Blood Institute (NHLBI) Grand Opportunity (GO) Exome Sequencing Project (see URLs) and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative (Will) Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Hoover AN, 2008, DEVELOPMENT, V135, P4049, DOI 10.1242/dev.029835; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Lopez E, 2014, HUM GENET, V133, P367, DOI 10.1007/s00439-013-1385-1; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Poretti A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-4; Reddick LE, 2012, JOVE-J VIS EXP, DOI 10.3791/3650; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Zhang DP, 2012, CELL CYCLE, V11, P3861, DOI 10.4161/cc.22068; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	34	80	85	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					905	911		10.1038/ng.3031	http://dx.doi.org/10.1038/ng.3031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24997988	Green Accepted			2022-12-17	WOS:000339704400023
J	Germain, M; Eyries, M; Montani, D; Poirier, O; Girerd, B; Dorfmuller, P; Coulet, F; Nadaud, S; Maugenre, S; Guignabert, C; Carpentier, W; Vonk-Noordegraaf, A; Levy, M; Chaouat, A; Lambert, JC; Bertrand, M; Dupuy, AM; Letenneur, L; Lathrop, M; Amouyel, P; de Ravel, TJL; Delcroix, M; Austin, ED; Robbins, IM; Hemnes, AR; Loyd, JE; Berman-Rosenzweig, E; Barst, RJ; Chung, WK; Simonneau, G; Tregouet, DA; Humbert, M; Soubrier, F				Germain, Marine; Eyries, Melanie; Montani, David; Poirier, Odette; Girerd, Barbara; Dorfmueller, Peter; Coulet, Florence; Nadaud, Sophie; Maugenre, Svetlana; Guignabert, Christophe; Carpentier, Wassila; Vonk-Noordegraaf, Anton; Levy, Marilyne; Chaouat, Ari; Lambert, Jean-Charles; Bertrand, Marion; Dupuy, Anne-Marie; Letenneur, Luc; Lathrop, Mark; Amouyel, Philippe; de Ravel, Thomy J. L.; Delcroix, Marion; Austin, Eric D.; Robbins, Ivan M.; Hemnes, Anna R.; Loyd, James E.; Berman-Rosenzweig, Erika; Barst, Robyn J.; Chung, Wendy K.; Simonneau, Gerald; Tregouet, David A.; Humbert, Marc; Soubrier, Florent			Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension	NATURE GENETICS			English	Article							EXPRESSION	Pulmonary arterial hypertension (PAH) is a rare, severe disease resulting from progressive obliteration of small-caliber pulmonary arteries by proliferating vascular cells. PAH can occur without recognized etiology (idiopathic PAH), be associated with a systemic disease or occur as a heritable form, with BMPR2 mutated in approximately 80% of familial and 15% of idiopathic PAH cases(1-3). We conducted a genome-wide association study (GWAS) based on 2 independent case-control studies for idiopathic and familial PAH (without BMPR2 mutations), including a total of 625 cases and 1,525 healthy individuals. We detected a significant association at the CBLN2 locus mapping to 18q22.3, with the risk allele conferring an odds ratio for PAH of 1.97 (1.59-2.45; P = 7.47 x 10(-10)). CBLN2 is expressed in the lung, and its expression is higher in explanted lungs from individuals with PAH and in endothelial cells cultured from explanted PAH lungs.	[Germain, Marine; Tregouet, David A.] Univ Paris 06, UMRS 937, Paris, France; [Germain, Marine; Eyries, Melanie; Poirier, Odette; Nadaud, Sophie; Maugenre, Svetlana; Bertrand, Marion; Tregouet, David A.; Soubrier, Florent] INSERM, Paris, France; [Germain, Marine; Eyries, Melanie; Poirier, Odette; Nadaud, Sophie; Maugenre, Svetlana; Tregouet, David A.; Soubrier, Florent] Inst Hosp Univ IHU Cardiometab & Nutr ICAN, Paris, France; [Eyries, Melanie; Poirier, Odette; Nadaud, Sophie; Maugenre, Svetlana; Soubrier, Florent] Univ Paris 06, UMRS 956, Paris, France; [Eyries, Melanie; Coulet, Florence; Soubrier, Florent] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Montani, David; Girerd, Barbara; Dorfmueller, Peter; Guignabert, Christophe; Simonneau, Gerald; Humbert, Marc] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Montani, David; Girerd, Barbara; Dorfmueller, Peter; Guignabert, Christophe; Simonneau, Gerald; Humbert, Marc] Hop Bicetre, AP HP, Ctr Natl Reference Hypertens Pulm Severe, Dept Hosp Univ DHU Thorax Innovat,Serv Pneumol, Le Kremlin Bicetre, France; [Montani, David; Girerd, Barbara; Dorfmueller, Peter; Guignabert, Christophe; Simonneau, Gerald; Humbert, Marc] INSERM, UMRS 999, Le Plessis Robinson, France; [Montani, David; Girerd, Barbara; Dorfmueller, Peter; Guignabert, Christophe; Simonneau, Gerald; Humbert, Marc] Univ Paris Sud, Lab Excellence LabEx Rech Medicament & Innovat Th, Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [Dorfmueller, Peter] Ctr Chirurg Marie Lannelongue, Dept Pathol, Le Plessis Robinson, France; [Carpentier, Wassila] Univ Paris 06, Postgen Platform P3S, Paris, France; [Vonk-Noordegraaf, Anton] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Med, Amsterdam, Netherlands; [Levy, Marilyne] Hop Necker Enfants Malad, AP HP, Dept Cardiac Surg, Paris, France; [Levy, Marilyne] INSERM, UMRS 765, Paris, France; [Levy, Marilyne] Univ Paris 05, Paris, France; [Chaouat, Ari] CHU Brabois, Resp Dis Dept, Vandoeuvre Les Nancy, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, UMRS 744, Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Inst Pasteur, INSERM, F-59019 Lille, France; [Bertrand, Marion] Univ Paris 06, UMRS 708, Paris, France; [Dupuy, Anne-Marie] Univ Montpellier, UMRS 888, F-34059 Montpellier, France; [Dupuy, Anne-Marie] INSERM, Montpellier, France; [Letenneur, Luc] Univ Bordeaux, U897, Bordeaux, France; [Letenneur, Luc] Inst Sante Publ Epidemiol & Dev, INSERM, Bordeaux, France; [Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Amouyel, Philippe] Ctr Hosp Reg Univ Lille, Lille, France; [de Ravel, Thomy J. L.] Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; [Delcroix, Marion] Catholic Univ Leuven KU Leuven, Dept Pneumol, B-3000 Louvain, Belgium; [Delcroix, Marion] Univ Hosp Gasthuisberg, Dept Pneumol, B-3000 Louvain, Belgium; [Austin, Eric D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pulm Allergy & Immunol Med, Nashville, TN 37232 USA; [Robbins, Ivan M.; Hemnes, Anna R.; Loyd, James E.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Berman-Rosenzweig, Erika; Barst, Robyn J.; Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10027 USA	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Hopital Marie Lannelongue; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; UDICE-French Research Universities; Sorbonne Universite; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Vanderbilt University; Vanderbilt University; Columbia University	Soubrier, F (corresponding author), Inst Hosp Univ IHU Cardiometab & Nutr ICAN, Paris, France.	florent.soubrier@upmc.fr	Chaouat, Ari/AAP-9249-2021; Nadaud, Sophie/A-7063-2013; LETENNEUR, Luc/T-4424-2019; Nadaud, Sophie/GXV-0505-2022; David, Montani/I-6885-2019; GUIGNABERT, Christophe/AGI-2488-2022; Simonneau, Gerald/ABE-6614-2020; Humbert, Marc/ABD-5112-2021; Trégouët, David-Alexandre/P-9210-2019; Delcroix, Marion/AAE-2712-2022; Chaouat, Ari/AAP-6784-2021; lambert, jean-charles/F-8787-2013; EYRIES, melanie/ABF-1034-2020; GUIGNABERT, Christophe/G-3873-2013; Humbert, Marc/AAC-8459-2019; Lambert, jean-charles/A-9553-2014; Tregouet, David-Alexandre/E-3961-2016	Nadaud, Sophie/0000-0002-1452-6009; LETENNEUR, Luc/0000-0002-3274-937X; David, Montani/0000-0002-9358-6922; GUIGNABERT, Christophe/0000-0002-8545-4452; Trégouët, David-Alexandre/0000-0001-9084-7800; Delcroix, Marion/0000-0001-8394-9809; Chaouat, Ari/0000-0001-6056-202X; lambert, jean-charles/0000-0003-0829-7817; GUIGNABERT, Christophe/0000-0002-8545-4452; Humbert, Marc/0000-0003-0703-2892; Lambert, jean-charles/0000-0003-0829-7817; Amouyel, Philippe/0000-0001-9088-234X; dupuy, anne marie/0000-0001-6538-3944; de Ravel, Thomy/0000-0002-3361-3781; Loyd, James/0000-0002-5042-7390; Rosenzweig, Erika B./0000-0003-4849-214X; Dorfmuller, Peter/0000-0003-2499-6829; Germain, Marine/0000-0002-8489-8916	Agence Nationale pour la Recherche [ANR-07-MRAR-021]; PHRC [AOM07-041]; INSERM; UPMC; Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; regional government of Aquitaine; regional government of Bourgogne; regional government of Languedoc-Roussillon; Fondation de France; Ministry of Research-INSERM Programme Cohorts and Collection of Biological Material; Eisai; Agence Nationale pour la Recherche (Project PHAAR) [ANR-07-MRAR-021]; Program Hospitalier de Recherche Clinique (PHRC2009 RENOVA-TV); Region Ile de France; US NIH [P01 HL072058, K23 HL0987431, R01 HL060056]; Vanderbilt General Clinical Research Center (GCRC) [RR000095]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072058, P01HL108800, K23HL098743, R01HL060056] Funding Source: NIH RePORTER	Agence Nationale pour la Recherche(French National Research Agency (ANR)); PHRC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; regional government of Aquitaine; regional government of Bourgogne(Region Bourgogne-Franche-Comte); regional government of Languedoc-Roussillon(Region Occitanie); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme Cohorts and Collection of Biological Material; Eisai(Eisai Co Ltd); Agence Nationale pour la Recherche (Project PHAAR)(French National Research Agency (ANR)); Program Hospitalier de Recherche Clinique (PHRC2009 RENOVA-TV); Region Ile de France(Region Ile-de-France); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt General Clinical Research Center (GCRC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Fadel and O. Mercier from the Centre Medico-Chirurgical Marie-Lannelongue for their help in lung sample collection. The Pulmonary Hypertension Allele-Associated Risk (PHAAR) project was financially supported by the Agence Nationale pour la Recherche (Project ANR-07-MRAR-021) and by PHRC AOM07-041, INSERM and UPMC. The 3C Study is conducted under a partnership agreement between INSERM, the Victor Segalen-Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and first phase of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, the Direction Generale de la Sante, the Mutuelle Generale de l'Education Nationale, the Institut de la Longevite, the Agence Francaise de Securite Sanitaire des Produits de Sante, the regional governments of Aquitaine, Bourgogne and Languedoc-Roussillon and the Fondation de France, and the Ministry of Research-INSERM Programme Cohorts and Collection of Biological Material. The Lille Genopole received an unconditional grant from Eisai. The financial supporters had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. M. G. was funded by a grant from the Agence Nationale pour la Recherche (Project PHAAR, ANR-07-MRAR-021) and the Program Hospitalier de Recherche Clinique (PHRC2009 RENOVA-TV). Statistical analyses used the C2BIG computing centre funded by the Fondation pour la Recherche Medicale and Region Ile de France. Collection and management of samples from Vanderbilt University were supported by US NIH grants P01 HL072058 and K23 HL0987431 and Vanderbilt General Clinical Research Center (GCRC) RR000095. Collection of the samples from Columbia University was supported by US NIH grant R01 HL060056.	Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis M, 2004, CIRCULATION, V110, P867, DOI 10.1161/01.CIR.0000138850.72900.FE; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Eyries M, 2012, CLIN GENET, V82, P173, DOI 10.1111/j.1399-0004.2011.01727.x; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Nilsson A, 2012, NEUROPHARMACOLOGY, V62, P347, DOI 10.1016/j.neuropharm.2011.08.004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; YIANGOU Y, 1989, J NEUROCHEM, V53, P886, DOI 10.1111/j.1471-4159.1989.tb11787.x	31	80	85	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2013	45	5					518	U82		10.1038/ng.2581	http://dx.doi.org/10.1038/ng.2581			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23502781	Green Accepted			2022-12-17	WOS:000318158200013
J	Golubchik, T; Brueggemann, AB; Street, T; Gertz, RE; Spencer, CCA; Ho, T; Giannoulatou, E; Link-Gelles, R; Harding, RM; Beall, B; Peto, TEA; Moore, MR; Donnelly, P; Crook, DW; Bowden, R				Golubchik, Tanya; Brueggemann, Angela B.; Street, Teresa; Gertz, Robert E., Jr.; Spencer, Chris C. A.; Ho, Thien; Giannoulatou, Eleni; Link-Gelles, Ruth; Harding, Rosalind M.; Beall, Bernard; Peto, Tim E. A.; Moore, Matthew R.; Donnelly, Peter; Crook, Derrick W.; Bowden, Rory			Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event	NATURE GENETICS			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; HAEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; DISEASE; CHILDREN; TRANSFORMATION; REPLACEMENT; PREVENTION	Streptococcus pneumoniae ('pneumococcus') causes an estimated 14.5 million cases of serious disease and 826,000 deaths annually in children under 5 years of age(1). The highly effective introduction of the PCV7 pneumococcal vaccine in 2000 in the United States(2,3) provided an unprecedented opportunity to investigate the response of an important pathogen to widespread, vaccine-induced selective pressure. Here, we use array-based sequencing of 62 isolates from a US national monitoring program to study five independent instances of vaccine escape recombination(4), showing the simultaneous transfer of multiple and often large (up to at least 44 kb) DNA fragments. We show that one such new strain quickly became established, spreading from east to west across the United States. These observations clarify the roles of recombination and selection in the population genomics of pneumococcus and provide proof of principle of the considerable value of combining genomic and epidemiological information in the surveillance and enhanced understanding of infectious diseases.	[Golubchik, Tanya; Street, Teresa; Ho, Thien; Donnelly, Peter; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Brueggemann, Angela B.; Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3TG, England; [Gertz, Robert E., Jr.; Link-Gelles, Ruth; Beall, Bernard; Moore, Matthew R.] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Spencer, Chris C. A.; Giannoulatou, Eleni; Donnelly, Peter; Bowden, Rory] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 3TG, England; [Peto, Tim E. A.; Crook, Derrick W.; Bowden, Rory] Univ Oxford, Nuffield Dept Med, Oxford Biomed Res Ctr, Oxford OX1 3TG, England	University of Oxford; University of Oxford; Centers for Disease Control & Prevention - USA; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	peter.donnelly@well.ox.ac.uk	Ho, Thien X/A-7209-2012; Golubchik, Tanya/B-4226-2018	Ho, Thien X/0000-0003-0914-306X; Golubchik, Tanya/0000-0003-2765-9828; Giannoulatou, Eleni/0000-0002-7084-6736; peto, tim/0000-0003-3477-8307; Donnelly, Peter/0000-0001-9495-3408; Brueggemann, Angela/0000-0002-2329-1934	Wellcome Trust [079126/Z/06/Z, 090532/Z/09/Z]; UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR; Wolfson Royal Society; NHS NIHR Oxford Biomedical Research Centre; UK Clinical Research Collaboration (UKCRC) (MRC UK) [G0800778]; UK Clinical Research Collaboration (UKCRC) (Wellcome Trust) [087646/2/08/Z]; Medical Research Council [G0800778] Funding Source: researchfish; MRC [G0800778] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR(National Institute for Health Research (NIHR)); Wolfson Royal Society(Royal Society of London); NHS NIHR Oxford Biomedical Research Centre; UK Clinical Research Collaboration (UKCRC) (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Clinical Research Collaboration (UKCRC) (Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge the clinicians, microbiologists and investigators of the ABCs program of the Emerging Infections Program Network. We thank X. Didelot for contributions to the analysis of Illumina genomic data. This work was funded by the Wellcome Trust (079126/Z/06/Z). T. E. A. P. and D. W. C. are funded by the UK National Health Service (NHS) National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and NIHR Senior Investigator Awards. P. D. is funded by a Wellcome Trust Core Award Grant (090532/Z/09/Z) and is supported, in part, by a Wolfson Royal Society Merit Award. R. B. is supported by the NHS NIHR Oxford Biomedical Research Centre and the UK Clinical Research Collaboration (UKCRC) (MRC UK G0800778 and Wellcome Trust 087646/2/08/Z). A. B. B. is a Wellcome Trust Career Development Fellow (083511/Z/07/Z). Genetic and epidemiological data are available from the authors.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004; Feil EJ, 2000, GENETICS, V154, P1439; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Perkins BA, 2000, JAMA-J AM MED ASSOC, V283, P2842, DOI 10.1001/jama.283.21.2842; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; R Development Core Team, 2007, R LANG ENV STAT COMP; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Trzcinski K, 2004, J BACTERIOL, V186, P3447, DOI 10.1128/JB.186.11.3447-3452.2004; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	27	80	81	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2012	44	3					352	U168		10.1038/ng.1072	http://dx.doi.org/10.1038/ng.1072			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22286217	Green Accepted, Green Submitted			2022-12-17	WOS:000300843600026
J	Sales, KU; Masedunskas, A; Bey, AL; Rasmussen, AL; Weigert, R; List, K; Szabo, R; Overbeek, PA; Bugge, TH				Sales, Katiuchia Uzzun; Masedunskas, Andrius; Bey, Alexandra L.; Rasmussen, Amber L.; Weigert, Roberto; List, Karin; Szabo, Roman; Overbeek, Paul A.; Bugge, Thomas H.			Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome	NATURE GENETICS			English	Article							SERINE-PROTEASE INHIBITOR; HUMAN STRATUM-CORNEUM; HEPATOCYTE GROWTH-FACTOR; BARRIER FUNCTION; TRYPSIN-LIKE; PROTEOLYTIC CASCADE; RECEPTORS PARS; EXPRESSION; DESQUAMATION; FILAGGRIN	Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation. Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade. Auto-activation of pro-inflammatory pro-kallikrein-related peptidases that are associated with stratum corneum detachment was either low or undetectable, but they were efficiently activated by matriptase. Ablation of matriptase from LEKTI-deficient mice dampened inflammation, eliminated aberrant protease activity, prevented detachment of the stratum corneum, and improved the barrier function of the epidermis. These results uncover a pathogenic matriptase-pro-kallikrein pathway that could operate in several human skin and inflammatory diseases.	[Sales, Katiuchia Uzzun; Bey, Alexandra L.; Rasmussen, Amber L.; List, Karin; Szabo, Roman; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Masedunskas, Andrius; Weigert, Roberto] Natl Inst Dent & Craniofacial Res, Intracellular Membrane Trafficking Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Baylor College of Medicine	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Masedunskas, Andrius/0000-0002-4533-5467; sales, katiuchia/0000-0002-3768-5790; Overbeek, Paul/0000-0001-9784-2084	NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000717, ZIADE000699] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank D. Martin, L. Fisher and L. Wahl for technical assistance, and J. Silvio Gutkind and M. J. Danton for reviewing this manuscript. Support for this study was provided by the NIDCR Intramural Research Program.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, AM J HUM GENET, V66, P914, DOI 10.1086/302824; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen LM, 2006, AM J PHYSIOL-RENAL, V291, pF567, DOI 10.1152/ajprenal.00047.2006; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Dreher F, 1998, ACTA DERM-VENEREOL, V78, P186; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kishi K, 2001, J BIOCHEM-TOKYO, V130, P425, DOI 10.1093/oxfordjournals.jbchem.a003002; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Marttin E, 1996, SKIN PHARMACOL, V9, P69; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; SMITH DL, 1995, J ALLERGY CLIN IMMUN, V95, P116, DOI 10.1016/S0091-6749(95)70159-1; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	49	80	82	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					676	U54		10.1038/ng.629	http://dx.doi.org/10.1038/ng.629			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20657595	Green Accepted			2022-12-17	WOS:000280524000011
J	Sebat, J				Sebat, Jonathan			Major changes in our DNA lead to major changes in our thinking	NATURE GENETICS			English	Editorial Material							COPY NUMBER POLYMORPHISM; GENOMIC REARRANGEMENTS; MOLECULAR-GENETICS; ARRAY; MAP; SUSCEPTIBILITY; DUPLICATIONS; DISORDERS; DELETIONS; AUTISM	Variability in the human genome has far exceeded expectations. In the course of the past three years, we have learned that much of our naturally occurring genetic variation consists of large-scale differences in genome structure, including copy-number variants (CNVs) and balanced rearrangements such as inversions. Recent studies have begun to reveal that structural variants are an important contributor to disease risk; however, structural variants as a class may not conform well to expectations of current methods for gene mapping. New approaches are needed to understand the contribution of structural variants to disease.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Sebat, J (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	sebat@cshl.edu		Sebat, Jonathan/0000-0002-9087-526X				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; HIGGS DR, 1989, BLOOD, V73, P1081; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs P A, 1977, Prog Med Genet, V2, P251; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; PICKLES A, 1995, AM J HUM GENET, V57, P717; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	39	80	86	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S3	S5		10.1038/ng2095	http://dx.doi.org/10.1038/ng2095			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597778				2022-12-17	WOS:000253974400002
J	Tong, JJY; Schriner, SE; McCleary, D; Day, BJ; Wallace, DC				Tong, James Jiayuan; Schriner, Samuel E.; McCleary, David; Day, Brian J.; Wallace, Douglas C.			Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster	NATURE GENETICS			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; ADENYLYL-CYCLASE; CAMP CASCADE; COMPLEX-I; SPAN; OVEREXPRESSION; MUTATIONS; PHOSPHORYLATION; EXPRESSION	We investigated the pathophysiology of neurofibromatosis-1 (NF1) in Drosophila melanogaster by inactivation or overexpression of the NF1 gene. NF1 gene mutants had shortened life spans and increased vulnerability to heat and oxidative stress in association with reduced mitochondrial respiration and elevated reactive oxygen species (ROS) production. Flies overexpressing NF1 had increased life spans, improved reproductive fitness, increased resistance to oxidative and heat stress in association with increased mitochondrial respiration and a 60% reduction in ROS production. These phenotypic effects proved to be modulated by the adenylyl cyclase/cyclic AMP (cAMP)/protein kinase A pathway, not the Ras/Raf pathway. Treatment of wild-type D. melanogaster with cAMP analogs increased their life span, and treatment of NF1 mutants with metalloporphyrin catalytic antioxidant compounds restored their life span. Thus, neurofibromin regulates longevity and stress resistance through cAMP regulation of mitochondrial respiration and ROS production, and NF1 may be treatable using catalytic antioxidants.	Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Univ Calif Irvine, Multidisciplinary Exercise Program, Irvine, CA 92697 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Jewish Health	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS041850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001751, R01AG024373, R01AG013154] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-47752] Funding Source: Medline; NIA NIH HHS [AG13154, AG24373, AG01751] Funding Source: Medline; NIDDK NIH HHS [DK73691] Funding Source: Medline; NIEHS NIH HHS [U54 ES015678] Funding Source: Medline; NINDS NIH HHS [NS41850, NS21328] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arun D, 2004, CURR OPIN NEUROL, V17, P101, DOI 10.1097/00019052-200404000-00004; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; BEAUCHAMP C, 1987, ANAL BIOCHEM, V44, P276; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bellomo F, 2006, ANTIOXID REDOX SIGN, V8, P495, DOI 10.1089/ars.2006.8.495; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Day BJ, 2004, DRUG DISCOV TODAY, V9, P557, DOI 10.1016/S1359-6446(04)03139-3; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Friedman JM, 1999, AM J MED GENET, V89, P1; GERSHMAN B, 2006, PHYSL GENOMICS; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Harrisingh MC, 2004, CELL CYCLE, V3, P1255, DOI 10.4161/cc.3.10.1182; Kachadourian R, 2004, BIOCHEM PHARMACOL, V67, P77, DOI 10.1016/j.bcp.2003.08.036; Korf B R, 2000, Oncologist, V5, P477, DOI 10.1634/theoncologist.5-6-477; Kurtz A, 2004, MOL CANCER RES, V2, P433; Li QY, 2001, J NEUROCHEM, V78, P746, DOI 10.1046/j.1471-4159.2001.00457.x; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Papa S, 2002, BIOSCIENCE REP, V22, P3, DOI 10.1023/A:1016004921277; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Patel M, 1999, TRENDS PHARMACOL SCI, V20, P359, DOI 10.1016/S0165-6147(99)01336-X; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Phillips JP, 2000, EXP GERONTOL, V35, P1157, DOI 10.1016/S0531-5565(00)00117-0; Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085; Pocsfalvi G, 2007, MOL CELL PROTEOMICS, V6, P231, DOI 10.1074/mcp.M600268-MCP200; Sun JT, 2004, MECH AGEING DEV, V125, P341, DOI 10.1016/j.mad.2004.01.009; Sun JT, 2002, GENETICS, V161, P661; Technikova-Dobrova Z, 2001, BIOCHEMISTRY-US, V40, P13941, DOI 10.1021/bi011066p; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; Velsor LW, 2004, TOXICOL APPL PHARM, V199, P10, DOI 10.1016/j.taap.2004.03.005; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yohay Kaleb H, 2006, Semin Pediatr Neurol, V13, P21, DOI 10.1016/j.spen.2006.01.007; ZHONG Y, 1992, J NEUROSCI, V12, P644	44	80	84	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					476	485		10.1038/ng2004	http://dx.doi.org/10.1038/ng2004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369827				2022-12-17	WOS:000245271200017
J	Peisajovich, SG; Rockah, L; Tawfik, DS				Peisajovich, SG; Rockah, L; Tawfik, DS			Evolution of new protein topologies through multistep gene rearrangements	NATURE GENETICS			English	Article							RESTRICTION-MODIFICATION SYSTEM; RANDOM CIRCULAR PERMUTATION; DNA-METHYLTRANSFERASE; MOLECULAR EVOLUTION; SEQUENCES; DOMAINS; ENZYMES; FOLD		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	dan.tawfik@weizmann.ac.il	Peisajovich, Sergio/C-6641-2011					Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jeltsch A, 1999, J MOL EVOL, V49, P161, DOI 10.1007/PL00006529; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KITA K, 1989, J BIOL CHEM, V264, P5751; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; Leismann O, 1998, EUR J BIOCHEM, V251, P899, DOI 10.1046/j.1432-1327.1998.2510899.x; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P179, DOI 10.1016/S0968-0004(00)89003-9; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROODVELDT C, 2005, PROTEIN ENG DES SEL; SUGISAKI H, 1989, J BIOL CHEM, V264, P5757; SZOMOLANYI E, 1980, GENE, V10, P219, DOI 10.1016/0378-1119(80)90051-7; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063	30	80	84	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					168	174		10.1038/ng1717	http://dx.doi.org/10.1038/ng1717			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415885				2022-12-17	WOS:000234953200010
J	Schimenti, J				Schimenti, J			Synapsis or silence	NATURE GENETICS			English	Editorial Material								The XY chromosome pair in mammalian males is sequestered into a transcriptionally dormant chromatin domain before the first meiotic division. New work shows that all chromosomes can suffer the same fate if they don't pair during meiosis, and that this may be part of a surveillance mechanism to protect against aneuploid gametes.	Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Schimenti, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	jcs92@cornell.edu						Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; EWULONU UK, 1993, DEVELOPMENT, V117, P89; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484	9	80	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					11	13		10.1038/ng0105-11	http://dx.doi.org/10.1038/ng0105-11			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15624015				2022-12-17	WOS:000225997500008
J	DePinho, RA; Polyak, K				DePinho, RA; Polyak, K			Cancer chromosomes in crisis	NATURE GENETICS			English	Editorial Material							TELOMERE DYSFUNCTION; BREAST; CARCINOMA; MICE	The benign-to-malignant transition in human breast cancer is associated with a marked increase in chromosomal aberrations. A new study suggests that telomere dysfunction and its associated bridge-fusion-breakage cycles may drive this episodic instability, thereby providing aspiring cancer cells with the multiple genetic aberrations needed to achieve a fully malignant state.	Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Boecker W, 2001, J PATHOL, V195, P415, DOI 10.1002/path.982; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Porter D, 2003, MOL CANCER RES, V1, P362; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X	11	80	83	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2004	36	9					932	934		10.1038/ng0904-932	http://dx.doi.org/10.1038/ng0904-932			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340427	Bronze			2022-12-17	WOS:000223658100008
J	Vermeulen, W; Rademakers, S; Jaspers, NGJ; Appeldoorn, E; Raams, A; Klein, B; Kleijer, WJ; Hansen, LK; Hoeijmakers, JHJ				Vermeulen, W; Rademakers, S; Jaspers, NGJ; Appeldoorn, E; Raams, A; Klein, B; Kleijer, WJ; Hansen, LK; Hoeijmakers, JHJ			A temperature-sensitive disorder in basal transcription and DNA repair in humans	NATURE GENETICS			English	Letter							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-D; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; TRICHOTHIODYSTROPHY; TFIIH; GENE; MUTATIONS; MECHANISM	The xeroderma pigmentosum group D (XPD) helicase subunit of TFIIH functions in DNA repair and transcription initiation(1,2). Different mutations in XPD give rise to th ree ultraviolet-sensitive syndromes: the skin cancer-prone disorder xeroderma pigmentosum (XP). in which repair of ultraviolet damage is affected; and the severe neurodevelopmental conditions Cockayne syndrome (CS) and trichothiodystrophy (TTD). In the latter two, the basal transcription function of TFIIH is also presumed to be affected(3-5). Here we report four unusual TTD patients with fever-dependent reversible deterioration of TTD features such as brittle hair. Cells from these patients show an in vivo temperature-sensitive defect of transcription and DNA repair due to thermo-instability of TFIIH. Our findings reveal the clinical consequences of impaired basal transcription and mutations in very fundamental processes in humans, which previously were only known in lower organisms.	Erasmus Univ, Ctr Biomed Genet, Dept Cell Biol & Genet, MGC, Rotterdam, Netherlands; Leiden Univ, Sylvius Labs, Dept Radiat Genet & Chem Mutagenesis, MGC, Leiden, Netherlands; Odense Univ Hosp, Dept Pediat, DK-5000 Odense, Denmark	Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Southern Denmark; Odense University Hospital	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Ctr Biomed Genet, Dept Cell Biol & Genet, MGC, POB 1738, Rotterdam, Netherlands.		Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; 				BOOTSMA D, 1998, NUCLEOTIDE EXCISION, P245; Broughton BC, 1996, MUTAT RES-DNA REPAIR, V362, P209, DOI 10.1016/0921-8777(95)00054-2; BRUCE D, 1994, J CLIN INVEST, V94, P2265, DOI 10.1172/JCI117589; Citterio E, 2000, CELL, V101, P447, DOI 10.1016/S0092-8674(00)80854-5; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Hanawalt PC, 2000, NATURE, V405, P415, DOI 10.1038/35013197; Hansen L K, 1993, Ugeskr Laeger, V155, P1949; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KLEIJER WJ, 1994, AM J MED GENET, V52, P227, DOI 10.1002/ajmg.1320520220; KLEIN B, 1990, EXP CELL RES, V191, P256, DOI 10.1016/0014-4827(90)90012-Y; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lehmann AR, 1998, BIOESSAYS, V20, P146, DOI 10.1002/(SICI)1521-1878(199802)20:2<146::AID-BIES7>3.3.CO;2-5; Lind H, 1999, BLOOD PRESSURE, V8, P9, DOI 10.1080/080370599438338; Powell B., 1994, KERATINOCYTE HDB, P401; Satoh MS, 1997, BBA-GENE STRUCT EXPR, V1354, P241, DOI 10.1016/S0167-4781(97)00102-4; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Takayama K, 1996, AM J HUM GENET, V58, P263; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; ZINKHAM WH, 1979, JOHNS HOPKINS MED J, V144, P109	25	80	81	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					299	303		10.1038/85864	http://dx.doi.org/10.1038/85864			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242112				2022-12-17	WOS:000167304200022
J	Sidow, A; Bulotsky, MS; Kerrebrock, AW; Birren, BW; Altshuler, D; Jaenisch, R; Johnson, KR; Lander, ES				Sidow, A; Bulotsky, MS; Kerrebrock, AW; Birren, BW; Altshuler, D; Jaenisch, R; Johnson, KR; Lander, ES			A novel member of the F-box/WD40 gene family, encoding dactylin, is disrupted in the mouse dactylaplasia mutant	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; F-BOX; UBIQUITIN-LIGASE; LIMB; PROTEOLYSIS; MUTATION; COMPLEX; LOCUS; RNA	Early outgrowth of the vertebrate embryonic limb requires signalling by the apical ectodermal ridge (AER) to the progress zone (PZ), which in response proliferates and lays down the pattern of the presumptive limb in a proximal to distal progression(1). Signals from the PZ maintain the AER until the anlagen for the distal phalanges have been formed(2). The semidominant mouse mutant dactylaplasia (Dac) disrupts the maintenance of the AER, leading to truncation of distal structures of the developing footplate, or autopod(3-5). Adult Dac homozygotes thus lack hands and feet except for malformed single digits, whereas heterozygotes lack phalanges of the three middle digits. Dac resembles the human autosomal dominant split hand/foot malformation (SHFM) diseases. One of these, SHFM3, maps to chromosome 10q24 (refs 6,7), which is syntenic to the Dac region on chromosome 19, and may disrupt the orthologue of Dac. We report here the positional cloning of Dac and show that it belongs to the F-box/WD40 gene family, which encodes adapters that target specific proteins for destruction by presenting them to the ubiquitination machinery(8). In conjuction with recent biochemical studies(9-12), this report demonstrates the importance of this gene family in vertebrate embryonic development.	Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Jackson Laboratory	Sidow, A (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, R248B, Stanford, CA 94305 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107				Altabef M, 1997, DEVELOPMENT, V124, P4547; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; CHAI CK, 1981, J HERED, V72, P234, DOI 10.1093/oxfordjournals.jhered.a109486; Crackower M, 1998, DEV BIOL, V201, P78, DOI 10.1006/dbio.1998.8938; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; Ji W, 1994, PCR Methods Appl, V4, P109; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; JOHNSON KR, 1995, GENOMICS, V29, P457, DOI 10.1006/geno.1995.9981; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; KELLER SA, 1994, GENOMICS, V23, P309, DOI 10.1006/geno.1994.1506; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Loomis CA, 1998, DEVELOPMENT, V125, P1137; LYONS KM, 1990, DEVELOPMENT, V109, P833; McKusick V.A., 1998, MENDELIAN INHERITANC; Michaud JL, 1997, DEVELOPMENT, V124, P1453; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SAUNDERS JW, 1963, DEV BIOL, V7, P64, DOI 10.1016/0012-1606(63)90107-6; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; WOLF DA, IN PRESS CURR BIOL; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	30	80	83	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					104	107		10.1038/12709	http://dx.doi.org/10.1038/12709			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471509				2022-12-17	WOS:000082337300026
J	Brown, PO; Hartwell, L				Brown, PO; Hartwell, L			Genomics and human disease - variations on variation	NATURE GENETICS			English	Editorial Material									Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Stanford University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Brown, PO (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA.							CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Freimer NB, 1997, NAT GENET, V17, P371, DOI 10.1038/ng1297-371; Harding RM, 1997, AM J HUM GENET, V60, P772; Kruglyak L, 1997, AM J HUM GENET, V61, P810, DOI 10.1086/514893; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; NICKERSON DA, 1997, AM J HUM GENET, V61, P115; PLOMIN R, 1994, J CHILD PSYCHOL PSYC, V35, P817, DOI 10.1111/j.1469-7610.1994.tb02297.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516	13	80	94	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					91	93		10.1038/ng0298-91	http://dx.doi.org/10.1038/ng0298-91			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462728				2022-12-17	WOS:000071779500002
J	DEsposito, M; Ciccodicola, A; Gianfrancesco, F; Esposito, T; Flagiello, L; Mazzarella, R; Schlessinger, D; DUrso, M				DEsposito, M; Ciccodicola, A; Gianfrancesco, F; Esposito, T; Flagiello, L; Mazzarella, R; Schlessinger, D; DUrso, M			A synaptobrevin-like gene in the Xq28 pseudoautosomal region undergoes X inactivation	NATURE GENETICS			English	Letter							POSITION-EFFECT VARIEGATION; CHROMOSOME INACTIVATION; Y-CHROMOSOME; TELOMERES; SEQUENCES; PROBES		CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; UNIV MODENA,SEZ ISTOL EMBRIOL & GENET,DIPARTIMENTO SCI MORFOL & MEDICOLEGALI,I-41100 MODENA,ITALY; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita di Modena e Reggio Emilia; Washington University (WUSTL)			D'Esposito, Maurizio/AAY-6376-2020; Esposito, Teresa/AAA-5488-2019; Gianfrancesco, Fernando/P-6853-2014	Esposito, Teresa/0000-0002-7879-8441; Ciccodicola, Alfredo/0000-0002-9924-1482; Gianfrancesco, Fernando/0000-0002-3812-2471	Telethon [E.0344] Funding Source: Medline	Telethon(Fondazione Telethon)		BICKMORE WA, 1987, NUCLEIC ACIDS RES, V15, P6261, DOI 10.1093/nar/15.15.6261; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; COOKE HJ, 1984, NATURE, V311, P259, DOI 10.1038/311259a0; DESPOSITO M, 1994, NUCLEIC ACIDS RES, V22, P4806, DOI 10.1093/nar/22.22.4806; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; FREIJE D, 1992, AM J HUM GENET, V51, P66; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRAUSZ JD, 1993, GENOMICS, V17, P530, DOI 10.1006/geno.1993.1366; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HENDRICH BD, 1995, HUM MOL GENET, V4, P1765, DOI 10.1093/hmg/4.suppl_1.1765; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; INCERTI B, 1992, NAT GENET, V2, P311, DOI 10.1038/ng1292-311; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; KOZAK M, 1983, MICROBIOL REV, V47, P1; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; KVALOY K, 1994, HUM MOL GENET, V3, P771, DOI 10.1093/hmg/3.5.771; LI L, 1995, HUM MOL GENET, V4, P2013, DOI 10.1093/hmg/4.11.2013; LYON MF, 1988, AM J HUM GENET, V42, P8; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385	30	80	81	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					227	229		10.1038/ng0696-227	http://dx.doi.org/10.1038/ng0696-227			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640232				2022-12-17	WOS:A1996UN39500025
J	Dieken, ES; Epner, EM; Fiering, S; Fournier, REK; Groudine, M				Dieken, ES; Epner, EM; Fiering, S; Fournier, REK; Groudine, M			Efficient modification of human chromosomal alleles using recombination-proficient chicken human microcell hybrids	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; B-CELL LINES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; GENE-EXPRESSION; CONTROL REGION; DNA-SEQUENCES; HYBRIDIZATION; ACTIVATION; MUTATIONS	Targeted modification of human chromosomal alleles by homologous recombination is a powerful approach to study gene function, but gene targeting in mammalian cells is an inefficient process. In contrast, gene targeting in a chicken pre-B cell line, DT40, is highly efficient. We have transferred human chromosome 11 into DT40 cells by microcell fusion, and find that the resulting hybrids are recombination-proficient. In these cells, targeting efficiencies into the chicken ovalbumin locus were >90% and into the human beta-globin and Ha-ras loci were 10-15%. These modified human chromosomes can be transferred subsequently to mammalian cells for functional tests. This chromosome shuttle system allows for the efficient homologous modification of human chromosomal genes, and for subsequent phenotypic analyses of the modified alleles in different mammalian cell types.	FRED HUTCHINSON CANC RES CTR, DIV MOLEC MED, SEATTLE, WA 98104 USA; FRED HUTCHINSON CANC RES CTR, DIV BASIC SCI, SEATTLE, WA 98104 USA; UNIV WASHINGTON, SCH MED, DEPT MOLEC BIOTECHNOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT RADIAT ONCOL, SEATTLE, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Fiering, Steven/0000-0003-0624-974X	NATIONAL CANCER INSTITUTE [R01CA054337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026449] Funding Source: NIH RePORTER; NCI NIH HHS [CA54337] Funding Source: Medline; NIDDK NIH HHS [DK44746] Funding Source: Medline; NIGMS NIH HHS [GM26449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BAUTISTA D, 1993, J IMMUNOL, V151, P1950; BRANDRIFF B, 1991, GENOMICS, V10, P75, DOI 10.1016/0888-7543(91)90486-X; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHARRON J, 1990, MOL CELL BIOL, V10, P1799, DOI 10.1128/MCB.10.4.1799; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; EPNER E, 1992, Current Biology, V2, P262, DOI 10.1016/0960-9822(92)90379-O; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; FIERING S, IN PRESS GENES DEV; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GEBHARD W, 1983, J MOL BIOL, V170, P567, DOI 10.1016/S0022-2836(83)80161-2; GOURDEAU H, 1990, ANNU REV CELL BIOL, V6, P69, DOI 10.1146/annurev.cb.06.110190.000441; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; KAO FT, 1973, P NATL ACAD SCI USA, V70, P2893, DOI 10.1073/pnas.70.10.2893; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; LAI EC, 1980, P NATL ACAD SCI-BIOL, V77, P244, DOI 10.1073/pnas.77.1.244; LANGSTON AA, 1993, METHODS MOL GENET, V1, P115; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LI YK, 1992, POULTRY SCI, V71, P151, DOI 10.3382/ps.0710151; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PAPAYANNOPOULOU T, 1988, SCIENCE, V242, P1056, DOI 10.1126/science.2461587; RAICH N, 1989, J BIOL CHEM, V264, P10186; Ringertz N R, 1974, Int Rev Exp Pathol, V13, P83; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SAUER B, 1990, New Biologist, V2, P441; SHAPERO MH, 1994, SOMAT CELL MOLEC GEN, V20, P215, DOI 10.1007/BF02254761; SHESELY EG, 1991, P NATL ACAD SCI USA, V88, P4294, DOI 10.1073/pnas.88.10.4294; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STUBBLEFIELD E, 1992, SOMAT CELL MOLEC GEN, V18, P485, DOI 10.1007/BF01232645; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TEREILE H, 1990, NATURE, V348, P649; THEUNE S, 1991, GENOMICS, V9, P511, DOI 10.1016/0888-7543(91)90418-E; TRASK BJ, 1991, AM J HUM GENET, V48, P1; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	42	80	85	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					174	182		10.1038/ng0296-174	http://dx.doi.org/10.1038/ng0296-174			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563756				2022-12-17	WOS:A1996TU07900018
J	GURRIERI, F; TRASK, BJ; VANDENENGH, G; KRAUSS, CM; SCHINZEL, A; PETTENATI, MJ; SCHINDLER, D; DIETZBAND, J; VERGNAUD, G; SCHERER, SW; TSUI, LC; MUENKE, M				GURRIERI, F; TRASK, BJ; VANDENENGH, G; KRAUSS, CM; SCHINZEL, A; PETTENATI, MJ; SCHINDLER, D; DIETZBAND, J; VERGNAUD, G; SCHERER, SW; TSUI, LC; MUENKE, M			PHYSICAL MAPPING OF THE HOLOPROSENCEPHALY CRITICAL REGION ON CHROMOSOME-7Q36	NATURE GENETICS			English	Article							UNBALANCED SEGREGATION; FAMILIAL TRANSLOCATION; POLYMORPHIC LOCI; DNA FRAGMENTS; LINKAGE MAP; CLONING; GENE; CYCLOPIA; MARKERS; PERSPECTIVES	Holoprosencephaly (HPE) is a developmental field defect involving the brain and face. Cytogenetic deletions in patients with HPE have localized one of the HPE genes to chromosomal region 7q36. We have characterized the 7q deletions in thirteen HPE patients. The result is the construction of a high resolution physical map of 7q32-qter. As a first step towards cloning an HPE gene crucial for normal brain development, we have defined the HPE minimal critical region in 7q36 between D7S292 and D7S392.	CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550; HARVARD COMMUNITY HLTH PLAN,BOSTON,MA 02116; INST MED GENET,ZURICH,SWITZERLAND; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,DIV MED GENET,WINSTON SALEM,NC 27103; INST HUMAN GENET & ANTHROPOL,WURZBURG,GERMANY; ONCOR INC,GAITHERSBURG,MD 20884; CTR ETUD BOUCHET,F-91710 VERT LE PETIT,FRANCE; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Wake Forest University; Wake Forest Baptist Medical Center; University of Wurzburg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Gurrieri, Fiorella/K-3214-2016; Tsui, Lap-chee/A-1081-2010; Vergnaud, Gilles/AAC-1162-2020; Scherer, Stephen W./B-3785-2013; Vergnaud, Gilles/P-1304-2015	Gurrieri, Fiorella/0000-0002-6775-5972; Vergnaud, Gilles/0000-0003-0913-194X; Scherer, Stephen W./0000-0002-8326-1999; Vergnaud, Gilles/0000-0003-0913-194X; Muenke, Maximilian/0000-0002-7719-6545				BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; COHEN MM, 1989, AM J MED GENET, V34, P271, DOI 10.1002/ajmg.1320340232; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DIETZBAND J, 1990, GENOMICS, V8, P168, DOI 10.1016/0888-7543(90)90240-U; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; HATZIIOANNOU AG, 1991, AM J MED GENET, V40, P201, DOI 10.1002/ajmg.1320400216; ISOBE M, 1985, SCIENCE, V228, P580, DOI 10.1126/science.3983641; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; KRAUSS CM, 1989, AM J MED GENET, V34, P514, DOI 10.1002/ajmg.1320340412; KURTZMAN DN, 1987, AM J MED GENET, V27, P33, DOI 10.1002/ajmg.1320270105; LATHROP GM, 1989, GENOMICS, V5, P866, DOI 10.1016/0888-7543(89)90128-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAUTHIER V, 1992, HUM MOL GENET, V1, P64, DOI 10.1093/hmg/1.1.64; LOGAN C, 1989, GENOMICS, V4, P206, DOI 10.1016/0888-7543(89)90301-7; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P544; MUNKE M, 1988, AM J MED GENET, V30, P929, DOI 10.1002/ajmg.1320300409; MUNKE M, 1989, AM J MED GENET, V34, P237, DOI 10.1002/ajmg.1320340222; PUNNETT HH, 1979, CYTOGENET CELL GENET, V24, P126, DOI 10.1159/000131366; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; SCHINZEL A, 1984, AM J MED GENET, V18, P153, DOI 10.1002/ajmg.1320180119; SCHINZEL A, 1986, AM J MED GENET, V24, P205, DOI 10.1002/ajmg.1320240128; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART EA, 1990, AM J HUM GENET, V46, P795; TAYSI K, 1982, ANN GENET-PARIS, V25, P159; TRASK B, 1989, AM J HUM GENET, V45, P739; TRASK B, 1990, CYTOMETRY, V11, P184, DOI 10.1002/cyto.990110121; VERGNAUD G, 1989, NUCLEIC ACIDS RES, V17, P7623, DOI 10.1093/nar/17.19.7623; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; ZACKOWSKI JL, 1990, ANN GENET-PARIS, V33, P113; SCIENCE, V258, P67	36	80	81	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					247	251		10.1038/ng0393-247	http://dx.doi.org/10.1038/ng0393-247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485580				2022-12-17	WOS:A1993KP79000015
J	Ly, P; Brunner, SF; Shoshani, O; Kim, DH; Lan, WJ; Pyntikova, T; Flanagan, AM; Behjati, S; Page, DC; Campbell, PJ; Cleveland, DW				Ly, Peter; Brunner, Simon F.; Shoshani, Ofer; Kim, Dong Hyun; Lan, Weijie; Pyntikova, Tatyana; Flanagan, Adrienne M.; Behjati, Sam; Page, David C.; Campbell, Peter J.; Cleveland, Don W.			Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements	NATURE GENETICS			English	Article							DNA-DAMAGE; SOMATIC REARRANGEMENT; CHROMOTHRIPSIS; MECHANISMS; EVOLUTION; REPAIR; BREAKAGE; SYSTEM; PHOSPHORYLATION; IDENTIFICATION	Cancer genomes are frequently characterized by numerical and structural chromosomal abnormalities. Here we integrated a centromere-specific inactivation approach with selection for a conditionally essential gene, a strategy termed CEN-SELECT, to systematically interrogate the structural landscape of mis-segregated chromosomes. We show that single-chromosome mis-segregation into a micronucleus can directly trigger a broad spectrum of genomic rearrangement types. Cytogenetic profiling revealed that mis-segregated chromosomes exhibit 120-fold-higher susceptibility to developing seven major categories of structural aberrations, including translocations, insertions, deletions, and complex reassembly through chromothripsis coupled to classical non-homologous end joining. Whole-genome sequencing of clonally propagated rearrangements identified random patterns of clustered breakpoints with copy-number alterations resulting in interspersed gene deletions and extrachromosomal DNA amplification events. We conclude that individual chromosome segregation errors during mitotic cell division are sufficient to drive extensive structural variations that recapitulate genomic features commonly associated with human disease.	[Ly, Peter; Shoshani, Ofer; Kim, Dong Hyun; Lan, Weijie; Cleveland, Don W.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Brunner, Simon F.; Behjati, Sam; Campbell, Peter J.] Wellcome Sanger Inst, Hinxton, England; [Pyntikova, Tatyana; Page, David C.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Flanagan, Adrienne M.] UCL, Canc Inst, London, England; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp NHS Trust, Dept Histopathol, Stanmore, Middx, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England; [Page, David C.] Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge, MA USA; [Page, David C.] MIT, Dept Biol, Cambridge, MA USA; [Ly, Peter] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Wellcome Trust Sanger Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of Cambridge; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Southwestern Medical Center Dallas	Ly, P; Cleveland, DW (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Ly, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	peter.ly@utsouthwestern.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Flanagan, Adrienne/0000-0002-2832-1303; /0000-0001-9920-3411; Ly, Peter/0000-0001-8946-7069; Shoshani, Ofer/0000-0001-8918-9935; Cleveland, Don/0000-0002-1934-3682; Kim, Dong Hyun/0000-0002-8762-1496	UCSD School of Medicine Microscopy Core [P30 NS047101]; US National Institutes of Health [K99 CA218871, R35 GM122476]; Wellcome Trust [WT088340MA, 110104/Z/15/Z]; Hope Funds for Cancer Research [HFCR-14-06-06]; Swiss National Science Foundation [P2SKP3171753, P400PB-180790]; St. Baldricks Foundation (Robert J. Arceci Innovation Award); NIHR UCLH Biomedical Research Centre; UCL Experimental Cancer Centre; RNOH NHS Trust; Howard Hughes Medical Institute; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [R00CA218871, K99CA218871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	UCSD School of Medicine Microscopy Core; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Hope Funds for Cancer Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); St. Baldricks Foundation (Robert J. Arceci Innovation Award); NIHR UCLH Biomedical Research Centre; UCL Experimental Cancer Centre; RNOH NHS Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Skaletsky for advice on targeting the Y chromosome, P. Rao and T. Senaratne for assistance with initial cytogenetic experiments, P. Mischel for helpful discussions, J. Santini and M. Erb for assistance with super-resolution imaging, the UCSD School of Medicine Microscopy Core (grant no. P30 NS047101) and A. Shiau for shared use of equipment, and the UCSD Animal Care Program for irradiator use. This work was supported by the US National Institutes of Health (grant no. K99 CA218871 to P.L. and no. R35 GM122476 to D.W.C.); the Wellcome Trust (grant no. WT088340MA to P.J.C. and no. 110104/Z/15/Z to S.B.); Hope Funds for Cancer Research (grant no. HFCR-14-06-06 to P.L.); the Swiss National Science Foundation (grant no. P2SKP3171753 and no. P400PB-180790 to S.F.B.); St. Baldricks Foundation (Robert J. Arceci Innovation Award to S.B.); the NIHR UCLH Biomedical Research Centre, the UCL Experimental Cancer Centre, and the RNOH NHS Trust (to A.M.F., who is an NIHR Senior Investigator); and the Howard Hughes Medical Institute (to D.C.P.). D.W.C. receives salary support from the Ludwig Institute for Cancer Research.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Behjati S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15936; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; COGEN PH, 1990, GENOMICS, V8, P279, DOI 10.1016/0888-7543(90)90283-Z; Cortes-Ciriano I., 2018, COMPREHENSIVE ANAL C; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; deCarvalho AC, 2018, NAT GENET, V50, P708, DOI 10.1038/s41588-018-0105-0; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dixon JR, 2018, NAT GENET, V50, P1388, DOI 10.1038/s41588-018-0195-8; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Henssen AG, 2017, NAT GENET, V49, P1005, DOI 10.1038/ng.3866; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; KATO H, 1968, J NATL CANCER I, V40, P165; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu PF, 2017, CELL, V168, P830, DOI 10.1016/j.cell.2017.01.037; Liu SW, 2018, NATURE, V561, P551, DOI 10.1038/s41586-018-0534-z; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Ly P, 2017, TRENDS CELL BIOL, V27, P917, DOI 10.1016/j.tcb.2017.08.005; Ly P, 2017, CELL CYCLE, V16, P1252, DOI 10.1080/15384101.2017.1325047; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; NOWELL P C, 1962, Blut, V8, P65; Raine Keiran M, 2016, Curr Protoc Bioinformatics, V56, DOI 10.1002/cpbi.17; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shankaran Sunita S, 2013, Methods Mol Biol, V931, P111, DOI 10.1007/978-1-62703-056-4_6; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soto M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214742; Soto M, 2017, CELL REP, V19, P2423, DOI 10.1016/j.celrep.2017.05.055; Stancu MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01343-4; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Weckselblatt B, 2015, GENOME RES, V25, P937, DOI 10.1101/gr.191247.115; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Willis NA, 2017, NATURE, V551, P590, DOI 10.1038/nature24477; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	76	79	81	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					705	+		10.1038/s41588-019-0360-8	http://dx.doi.org/10.1038/s41588-019-0360-8			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30833795	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000462767500017
J	Assi, SA; Imperato, MR; Coleman, DJL; Pickin, A; Potluri, S; Ptasinska, A; Chin, PS; Blair, H; Cauchy, P; James, SR; Zacarias-Cabeza, J; Gilding, LN; Beggs, A; Clokie, S; Loke, JC; Jenkin, P; Uddin, A; Delwel, R; Richards, SJ; Raghavan, M; Griffiths, MJ; Heidenreich, O; Cockerill, PN; Bonifer, C				Assi, Salam A.; Imperato, Maria Rosaria; Coleman, Daniel J. L.; Pickin, Anna; Potluri, Sandeep; Ptasinska, Anetta; Chin, Paulynn Suyin; Blair, Helen; Cauchy, Pierre; James, Sally R.; Zacarias-Cabeza, Joaquin; Gilding, L. Niall; Beggs, Andrew; Clokie, Sam; Loke, Justin C.; Jenkin, Phil; Uddin, Ash; Delwel, Ruud; Richards, Stephen J.; Raghavan, Manoj; Griffiths, Michael J.; Heidenreich, Olaf; Cockerill, Peter N.; Bonifer, Constanze			Subtype-specific regulatory network rewiring in acute myeloid leukemia	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTORS; EPIGENETIC REGULATORS; CHROMATIN-STRUCTURE; PROMOTER CONTACTS; T(8/21) AML; BINDING; DIFFERENTIATION; EXPRESSION; AML1-ETO	Acute myeloid leukemia (AML) is a heterogeneous disease caused by a variety of alterations in transcription factors, epigenetic regulators and signaling molecules. To determine how different mutant regulators establish AML subtype-specific transcriptional networks, we performed a comprehensive global analysis of cis-regulatory element activity and interaction, transcription factor occupancy and gene expression patterns in purified leukemic blast cells. Here, we focused on specific subgroups of subjects carrying mutations in genes encoding transcription factors (RUNX1, CEBP alpha), signaling molecules (FTL3-ITD, RAS) and the nuclear protein NPM1). Integrated analysis of these data demonstrates that each mutant regulator establishes a specific transcriptional and signaling network unrelated to that seen in normal cells, sustaining the expression of unique sets of genes required for AML growth and maintenance.	[Assi, Salam A.; Imperato, Maria Rosaria; Coleman, Daniel J. L.; Pickin, Anna; Potluri, Sandeep; Ptasinska, Anetta; Chin, Paulynn Suyin; Cauchy, Pierre; Zacarias-Cabeza, Joaquin; Gilding, L. Niall; Beggs, Andrew; Loke, Justin C.; Raghavan, Manoj; Cockerill, Peter N.; Bonifer, Constanze] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Blair, Helen; Heidenreich, Olaf] Univ Newcastle, Northern Inst Canc Res, Newcastle, England; [James, Sally R.] Univ Leeds, Sect Expt Haematol, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Clokie, Sam; Griffiths, Michael J.] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham, W Midlands, England; [Jenkin, Phil; Uddin, Ash] CMT Lab NHS Blood & Transplant, Birmingham, W Midlands, England; [Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Delwel, Ruud] Erasmus Univ, Oncode Inst, Erasmus MC, Med Ctr, Rotterdam, Netherlands; [Richards, Stephen J.] St James Univ Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [Raghavan, Manoj] Queen Elizabeth Hosp, Ctr Clin Haematol, Birmingham, W Midlands, England; [Heidenreich, Olaf] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	University of Birmingham; Newcastle University - UK; University of Leeds; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Saint James's University Hospital; University of Birmingham	Cockerill, PN; Bonifer, C (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England.	p.n.cockerill@bham.ac.uk; c.bonifer@bham.ac.uk	Beggs, Andrew D/A-6912-2013; Heidenreich, Olaf/AAP-5045-2021	Beggs, Andrew D/0000-0003-0784-2967; Heidenreich, Olaf/0000-0001-5404-6483; Raghavan, Manoj/0000-0002-5464-2602; Richards, Stephen/0000-0002-8421-5353; James, Sally/0000-0003-2701-9724; Cockerill, Peter/0000-0002-4410-8174; Gilding, Niall/0000-0002-3540-0712; Coleman, Daniel/0000-0001-9416-7028; Bonifer, Constanze/0000-0002-4267-0825; Zacarias Cabeza, Joaquin/0000-0002-0919-7044; Clokie, Samuel/0000-0002-0025-3652; Loke, Justin/0000-0002-0725-069X; Cauchy, Pierre/0000-0002-0659-0799; Chin, Paulynn Suyin/0000-0003-1600-3508	Bloodwise [15001]; Cancer Research UK; Kay Kendall Clinical Training Fellowship; MRC/Leuka Clinical Training Fellowship; MRC [MR/M009157/1, MR/P019609/1] Funding Source: UKRI	Bloodwise; Cancer Research UK(Cancer Research UK); Kay Kendall Clinical Training Fellowship; MRC/Leuka Clinical Training Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a program grant from Bloodwise (15001) to C.B. and P.N.C., as well as studentship awards from Cancer Research UK and Bloodwise to A. Pickin and N.G., respectively, a Kay Kendall Clinical Training Fellowship for J.L. and a MRC/Leuka Clinical Training Fellowship for S.P.	Bert AG, 2007, MOL CELL BIOL, V27, P2870, DOI 10.1128/MCB.02323-06; Bonifer C, 2015, TRENDS CANCER, V1, P157, DOI 10.1016/j.trecan.2015.10.003; Bonifer C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001377; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cauchy P, 2015, CELL REP, V12, P821, DOI 10.1016/j.celrep.2015.06.069; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chasman Deborah, 2017, Curr Opin Syst Biol, V2, P130, DOI 10.1016/j.coisb.2017.04.001; Cockerill Peter N., 2016, Yale Journal of Biology and Medicine, V89, P591; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunne J, 2010, CANCER RES, V70, P3985, DOI 10.1158/0008-5472.CAN-09-3604; Essig A, 2014, LEUKEMIA RES, V38, P340, DOI 10.1016/j.leukres.2013.12.014; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gerloff D, 2015, LEUKEMIA, V29, P535, DOI 10.1038/leu.2014.231; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Goyama S, 2016, LEUKEMIA, V30, P728, DOI 10.1038/leu.2015.275; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kesarwani M, 2017, NAT MED, V23, P472, DOI 10.1038/nm.4310; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin S, 2017, BLOOD, V130, P1213, DOI 10.1182/blood-2016-11-750976; Lin S, 2017, ADV EXP MED BIOL, V962, P151, DOI 10.1007/978-981-10-3233-2_11; Loke J, 2017, CELL REP, V19, P1654, DOI 10.1016/j.celrep.2017.05.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandoli A, 2014, LEUKEMIA, V28, P770, DOI 10.1038/leu.2013.257; Martens JHA, 2012, BLOOD, V120, P4038, DOI 10.1182/blood-2012-05-429050; Martinez-Soria N, 2018, CANCER CELL, V34, P626, DOI 10.1016/j.ccell.2018.08.015; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; McKeown MR, 2017, CANCER DISCOV, V7, P1136, DOI 10.1158/2159-8290.CD-17-0399; Mifsud B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174744; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; O'Connor C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120102; Obier N, 2016, DEVELOPMENT, V143, P4324, DOI 10.1242/dev.139857; Obier N, 2016, FEBS LETT, V590, P4105, DOI 10.1002/1873-3468.12343; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Parikh C, 2006, BLOOD, V108, P2349, DOI 10.1182/blood-2004-08-009498; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; Ptasinska A, 2014, CELL REP, V8, P1974, DOI 10.1016/j.celrep.2014.08.024; Pulikkan JA, 2017, LEUKEMIA, V31, P2279, DOI 10.1038/leu.2017.229; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Somerville TDD, 2015, CANCER CELL, V28, P329, DOI 10.1016/j.ccell.2015.07.017; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trop-Steinberg S, 2017, AM J MED SCI, V353, P474, DOI 10.1016/j.amjms.2017.01.019; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	79	80	4	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					151	+		10.1038/s41588-018-0270-1	http://dx.doi.org/10.1038/s41588-018-0270-1			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30420649	Green Accepted, Green Published			2022-12-17	WOS:000454108800022
J	Styrkarsdottir, U; Lund, SH; Thorleifsson, G; Zink, F; Stefansson, OA; Sigurdsson, JK; Juliusson, K; Bjarnadottir, K; Sigurbjornsdottir, S; Jonsson, S; Norland, K; Stefansdottir, L; Sigurdsson, A; Sveinbjornsson, G; Oddsson, A; Bjornsdottir, G; Gudmundsson, RL; Halldorsson, GH; Rafnar, T; Jonsdottir, I; Steingrimsson, E; Norddahl, GL; Masson, G; Sulem, P; Jonsson, H; Ingvarsson, T; Gudbjartsson, DF; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Lund, Sigrun H.; Thorleifsson, Gudmar; Zink, Florian; Stefansson, Olafur A.; Sigurdsson, Jon K.; Juliusson, Kristinn; Bjarnadottir, Kristbjorg; Sigurbjornsdottir, Sara; Jonsson, Stefan; Norland, Kristjan; Stefansdottir, Lilja; Sigurdsson, Asgeir; Sveinbjornsson, Gardar; Oddsson, Asmundur; Bjornsdottir, Gyda; Gudmundsson, Reynir L.; Halldorsson, Gisli H.; Rafnar, Thorunn; Jonsdottir, Ingileif; Steingrimsson, Eirikur; Norddahl, Gudmundur L.; Masson, Gisli; Sulem, Patrick; Jonsson, Helgi; Ingvarsson, Thorvaldur; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari			Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TOTAL HIP-REPLACEMENT; BONE-MINERAL DENSITY; BODY-MASS INDEX; SEQUENCE VARIANTS; FUNCTIONAL POLYMORPHISM; SUSCEPTIBILITY LOCI; COMMON VARIANTS; INCREASED RISK; KNEE	Osteoarthritis has a highly negative impact on quality of life because of the associated pain and loss of joint function. Here we describe the largest meta-analysis so far of osteoarthritis of the hip and the knee in samples from Iceland and the UK Biobank (including 17,151 hip osteoarthritis patients, 23,877 knee osteoarthritis patients, and more than 562,000 controls). We found 23 independent associations at 22 loci in the additive meta-analyses, of which 16 of the loci were novel: 12 for hip and 4 for knee osteoarthritis. Two associations are between rare or low-frequency missense variants and hip osteoarthritis, affecting the genes SMO (rs143083812, frequency 0.11%, odds ratio (OR) = 2.8, P = 7.9 x 10(-12), p.Arg173Cys) and IL11 (rs4252548, frequency 2.08%, OR = 1.30, P = 2.1 x 10(-11), p. Arg112His). A common missense variant in the COL11A1 gene also associates with hip osteoarthritis (rs3753841, frequency 61%, P = 5.2 x 10(-10), OR = 1.08, p. Pro1284Leu). In addition, using a recessive model, we confirm an association between hip osteoarthritis and a variant of CHADL1 (rs117018441, P = 1.8 x 10(-25), OR = 5.9). Furthermore, we observe a complex relationship between height and risk of osteoarthritis.	[Styrkarsdottir, Unnur; Lund, Sigrun H.; Thorleifsson, Gudmar; Zink, Florian; Stefansson, Olafur A.; Sigurdsson, Jon K.; Juliusson, Kristinn; Bjarnadottir, Kristbjorg; Jonsson, Stefan; Norland, Kristjan; Stefansdottir, Lilja; Sigurdsson, Asgeir; Sveinbjornsson, Gardar; Oddsson, Asmundur; Bjornsdottir, Gyda; Gudmundsson, Reynir L.; Halldorsson, Gisli H.; Rafnar, Thorunn; Jonsdottir, Ingileif; Norddahl, Gudmundur L.; Masson, Gisli; Sulem, Patrick; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Lund, Sigrun H.; Jonsdottir, Ingileif; Jonsson, Helgi; Ingvarsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sigurbjornsdottir, Sara; Steingrimsson, Eirikur] Univ Iceland, Biomed Ctr, Biochem & Mol Biol, Fac Med, Reykjavik, Iceland; [Jonsdottir, Ingileif] Landspitali, Dept Immunol, Reykjavik, Iceland; [Jonsson, Helgi] Landspitali, Dept Med, Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthoped Surg, Akureyri, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, Akureyri, Iceland; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland	University of Iceland; University of Iceland; University of Akureyri; University of Iceland	Styrkarsdottir, U; Stefansson, K (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kstefans@decode.is	Lund, Sigrun Helga/K-9144-2015; Stefansson, Kari/AAE-7187-2019; Lund, Sigrún Helga/AAG-6042-2019	Lund, Sigrun Helga/0000-0002-3806-2296; Lund, Sigrún Helga/0000-0002-3806-2296; Bjornsdottir, Gyda/0000-0002-8100-0306; Sigurbjornsdottir, Sara/0000-0002-3030-8888; Steingrimsson, Eirikur/0000-0001-5826-7486; Sveinbjornsson, Gardar/0000-0003-2429-9468; Styrkarsdottir, Unnur/0000-0001-8146-8278; Jonsson, Helgi/0000-0003-0187-8985	Medical Research Council [MC_QA137853, MC_PC_17228] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alman BA, 2015, NAT REV RHEUMATOL, V11, P552, DOI 10.1038/nrrheum.2015.84; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Cao Q, 2017, NAT GENET, V49, P1428, DOI 10.1038/ng.3950; Casalone E, 2018, ANN RHEUM DIS, V77, P620, DOI 10.1136/annrheumdis-2017-211848; Chantry A, 2011, CELL CYCLE, V10, P2437, DOI 10.4161/cc.10.15.16874; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; den Hollander W, 2017, ANN RHEUM DIS, V76, P2046, DOI 10.1136/annrheumdis-2017-211214; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elmberg M, 2013, ARTHRIT CARE RES, V65, P678, DOI 10.1002/acr.21883; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evangelou E, 2014, ANN RHEUM DIS, V73, P2130, DOI 10.1136/annrheumdis-2012-203114; Evangelou E, 2013, ANN RHEUM DIS, V72, P1264, DOI 10.1136/annrheumdis-2012-203182; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Franklin J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3033; Gudbjartsson DF, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.11; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Hackinger S, 2017, HUM MOL GENET, V26, P3850, DOI 10.1093/hmg/ddx285; Haro E, 2017, DEVELOPMENT, V144, P2009, DOI 10.1242/dev.146332; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; HOLM S, 1979, SCAND J STAT, V6, P65; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingvarsson T, 1999, ACTA ORTHOP SCAND, V70, P229, DOI 10.3109/17453679908997798; Jonsson H, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.115; Kerkhof HJM, 2011, OSTEOARTHR CARTILAGE, V19, P254, DOI 10.1016/j.joca.2010.10.027; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Liu B, 2007, RHEUMATOLOGY, V46, P861, DOI 10.1093/rheumatology/kel434; Liu YF, 2017, J RHEUMATOL, V44, P1652, DOI 10.3899/jrheum.161488; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lokau J, 2018, BBA-MOL CELL RES, V1865, P496, DOI 10.1016/j.bbamcr.2017.12.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mio F, 2007, AM J HUM GENET, V81, P1271, DOI 10.1086/522377; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nakoshi Y, 2010, J ORTHOP SCI, V15, P666, DOI 10.1007/s00776-010-1513-x; Ramos YFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103056; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez-Fontenla C, 2014, ARTHRITIS RHEUMATOL, V66, P940, DOI 10.1002/art.38300; Schiphof D, 2011, ANN RHEUM DIS, V70, P1422, DOI 10.1136/ard.2010.147520; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; Sigurdsson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15789; Sims NA, 2016, INT J BIOCHEM CELL B, V79, P14, DOI 10.1016/j.biocel.2016.08.003; Styrkarsdottir U, 2017, NAT GENET, V49, P801, DOI 10.1038/ng.3816; Styrkarsdottir U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10129; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wang Y, 2012, SEMIN ARTHRITIS RHEU, V41, P872, DOI 10.1016/j.semarthrit.2011.11.003; Welling M, 2017, INT J RHEUM DIS, V20, P1095, DOI 10.1111/1756-185X.13059; Welsh S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3391-x; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Xu X, 2018, BONE RES, V6, DOI 10.1038/s41413-017-0005-4; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zengini E, 2018, NAT GENET, V50, P549, DOI 10.1038/s41588-018-0079-y	80	79	81	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1681	+		10.1038/s41588-018-0247-0	http://dx.doi.org/10.1038/s41588-018-0247-0			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30374069				2022-12-17	WOS:000451434400015
J	Jiang, Y; Loh, YHE; Rajarajan, P; Hirayama, T; Liao, W; Kassim, BS; Javidfar, B; Hartley, BJ; Kleofas, L; Park, RB; Labonte, B; Ho, SM; Chandrasekaran, S; Do, C; Ramirez, BR; Peter, CJ; Julia, TCW; Safaie, BM; Morishita, H; Roussos, P; Nestler, EJ; Schaefer, A; Tycko, B; Brennand, KJ; Yagi, T; Shen, L; Akbarian, S				Jiang, Yan; Loh, Yong-Hwee Eddie; Rajarajan, Prashanth; Hirayama, Teruyoshi; Liao, Will; Kassim, Bibi S.; Javidfar, Behnam; Hartley, Brigham J.; Kleofas, Lisa; Park, Royce B.; Labonte, Benoit; Ho, Seok-Man; Chandrasekaran, Sandhya; Do, Catherine; Ramirez, Brianna R.; Peter, Cyril J.; Julia, T. C. W.; Safaie, Brian M.; Morishita, Hirofumi; Roussos, Panos; Nestler, Eric J.; Schaefer, Anne; Tycko, Benjamin; Brennand, Kristen J.; Yagi, Takeshi; Shen, Li; Akbarian, Schahram			The methyltransferase SETDB1 regulates a large neuron-specific topological chromatin domain	NATURE GENETICS			English	Article							CLUSTERED PROTOCADHERIN GENES; DNA METHYLATION; GENOME-WIDE; STOCHASTIC EXPRESSION; IMPRINTED LOCI; HUMAN BRAIN; CTCF; ALPHA; IDENTIFICATION; ELEMENTS	We report locus-specific disintegration of megabase-scale chromosomal conformations in brain after neuronal ablation of Setdb1 (also known as Kmt1e; encodes a histone H3 lysine 9 methyltransferase), including a large topologically associated 1.2-Mb domain conserved in humans and mice that encompasses >70 genes at the clustered protocadherin locus (hereafter referred to as cPcdh). The cPcdh topologically associated domain (TAD(cPcdh)) in neurons from mutant mice showed abnormal accumulation of the transcriptional regulator and three-dimensional (3D) genome organizer CTCF at cryptic binding sites, in conjunction with DNA cytosine hypomethylation, histone hyperacetylation and upregulated expression. Genes encoding stochastically expressed protocadherins were transcribed by increased numbers of cortical neurons, indicating relaxation of single-cell constraint. SETDB1-dependent loop formations bypassed 0.2-1 Mb of linear genome and radiated from the TAD(cPcdh) fringes toward cis-regulatory sequences within the cPcdh locus, counterbalanced shorter-range facilitative promoter-enhancer contacts and carried loop-bound polymorphisms that were associated with genetic risk for schizophrenia. We show that the SETDB1 repressor complex, which involves multiple KRAB zinc finger proteins, shields neuronal genomes from excess CTCF binding and is critically required for structural maintenance of TAD(cPcdh).	[Jiang, Yan; Rajarajan, Prashanth; Kassim, Bibi S.; Javidfar, Behnam; Hartley, Brigham J.; Kleofas, Lisa; Park, Royce B.; Ho, Seok-Man; Chandrasekaran, Sandhya; Peter, Cyril J.; Safaie, Brian M.; Morishita, Hirofumi; Roussos, Panos; Brennand, Kristen J.; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Jiang, Yan; Rajarajan, Prashanth; Kassim, Bibi S.; Javidfar, Behnam; Hartley, Brigham J.; Kleofas, Lisa; Park, Royce B.; Ho, Seok-Man; Chandrasekaran, Sandhya; Safaie, Brian M.; Morishita, Hirofumi; Roussos, Panos; Brennand, Kristen J.; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Loh, Yong-Hwee Eddie; Labonte, Benoit; Ramirez, Brianna R.; Julia, T. C. W.; Nestler, Eric J.; Schaefer, Anne; Shen, Li] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Loh, Yong-Hwee Eddie; Labonte, Benoit; Ramirez, Brianna R.; Julia, T. C. W.; Nestler, Eric J.; Schaefer, Anne; Shen, Li] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hirayama, Teruyoshi; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Kokoro Biol Grp, Labs Integrated Biol, Suita, Osaka, Japan; [Liao, Will] New York Genome Ctr, New York, NY USA; [Do, Catherine; Tycko, Benjamin] Columbia Univ, Dept Pathol & Cell Biol, Inst Canc Genet, New York, NY USA; [Do, Catherine; Tycko, Benjamin] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roussos, Panos] James J Peters Virginia Med Ctr, Mental Illness Res Educ & Clin Ctr, New York, NY USA; [Hartley, Brigham J.] VL39 Inc, Cambridge, MA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Osaka University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Akbarian, S (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Akbarian, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.	schahram.akbarian@mssm.edu	Brennand, Kristen J/J-8704-2012; Brennand, Kristen J/U-5470-2019; Morishita, Hirofumi/J-9619-2015; Labonte, Benoit/GPF-5629-2022	Brennand, Kristen J/0000-0003-0993-5956; Morishita, Hirofumi/0000-0002-1045-1337; Labonte, Benoit/0000-0002-1251-5605; Chandrasekaran, Sandhya/0000-0003-1730-293X; Liao, Willey/0000-0001-7574-4694; Peter, Cyril/0000-0001-9190-8724; do, catherine/0000-0002-9796-4345; Park, Royce/0000-0002-4698-9278	US National Institutes of Health (NIH) [R01MH106056, P50MH096890, R01MH101454, T32-AG049688, 1F30MH113330]; NIA [U01P50AG005138-30-1, U01AG046170, R01AG050986, R01MH109677, R01NS091574]; Japan-US Brain Research Cooperation Program; Veterans Affairs Merit grant [BX002395]; Brain and Behavior Research Foundation; Alzheimer's Association; New York Stem Cell Foundation; Brain Research Foundation; NATIONAL EYE INSTITUTE [R01EY024918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, T32MH087004, R01MH109677, R01MH106056, R01MH101454, R21MH106919, F30MH113330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG049688, P50AG005138, U01AG046170, R01AG050986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Japan-US Brain Research Cooperation Program; Veterans Affairs Merit grant(US Department of Veterans Affairs); Brain and Behavior Research Foundation; Alzheimer's Association(Alzheimer's Association); New York Stem Cell Foundation; Brain Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank J. Gonzalez-Maeso (Virginia Commonwealth University) for kindly providing the Camk2a promoter plasmid. The work was supported by US National Institutes of Health (NIH) grants R01MH106056 (S.A.), P50MH096890 (E.J.N.), R01MH101454 (K.J.B.), NIA U01P50AG005138-30-1 (K.J.B.), U01AG046170 (K.J.B.), R01AG050986 (P. Roussos), R01MH109677, (P. Roussos) and R01NS091574 (A.S.), NIH training grant T32-AG049688 (S.C.) and NIH fellowship award 1F30MH113330 (P. Rajarajan). Additional support was provided by a Grant-in-Aid for AMED-CREST, AMED, Japan (T.Y.), the Japan-US Brain Research Cooperation Program (T.Y.), the Veterans Affairs Merit grant BX002395 (P. Roussos), the Brain and Behavior Research Foundation (Y.J. and P. Roussos), the Alzheimer's Association (P. Roussos), the New York Stem Cell Foundation (K.J.B.) and the Brain Research Foundation (S.A.).	Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Chakravarthy S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003059; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cubenas-Potts C, 2015, NUCLEUS-PHILA, V6, P430, DOI 10.1080/19491034.2015.1096467; Cukier HN, 2012, AUTISM RES, V5, P385, DOI 10.1002/aur.1251; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Garafola CS, 2014, BRAIN RES, V1593, P55, DOI 10.1016/j.brainres.2014.08.071; Golan-Mashiach M, 2012, NUCLEIC ACIDS RES, V40, P3378, DOI 10.1093/nar/gkr1260; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Isbel L, 2016, ELIFE, V5, DOI 10.7554/eLife.15082; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; Keeler AB, 2015, CELL ADHES MIGR, V9, P214, DOI 10.1080/19336918.2014.1000069; Kehayova P, 2011, P NATL ACAD SCI USA, V108, P17195, DOI 10.1073/pnas.1114357108; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kundakovic M, 2017, BIOL PSYCHIAT, V81, P162, DOI 10.1016/j.biopsych.2016.03.1048; Labonte B., NAT MED IN PRESS; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung D, 2014, P NATL ACAD SCI USA, V111, P6690, DOI 10.1073/pnas.1322273111; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Paliwal A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003622; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rowe HM, 2013, DEVELOPMENT, V140, P519, DOI 10.1242/dev.087585; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Tan SL, 2012, DEVELOPMENT, V139, P3806, DOI 10.1242/dev.082198; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thu CA, 2014, CELL, V158, P1045, DOI 10.1016/j.cell.2014.07.012; Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Xu J., 2016, MOL PSYCHIAT; Xu Q, 2016, PEDIATR RES, V80, P371, DOI 10.1038/pr.2016.101; Yagi T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00045; Yokota S, 2011, J BIOL CHEM, V286, P31885, DOI 10.1074/jbc.M111.245605; Zhan YX, 2017, GENOME RES, V27, P479, DOI 10.1101/gr.212803.116	71	79	80	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1239	+		10.1038/ng.3906	http://dx.doi.org/10.1038/ng.3906			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FB8OI	28671686	Green Accepted			2022-12-17	WOS:000406397900014
J	Sun, RP; Hu, Z; Sottoriva, A; Graham, TA; Harpak, A; Ma, ZC; Fischer, JM; Shibata, D; Curtis, C				Sun, Ruping; Hu, Zheng; Sottoriva, Andrea; Graham, Trevor A.; Harpak, Arbel; Ma, Zhicheng; Fischer, Jared M.; Shibata, Darryl; Curtis, Christina			Between-region genetic divergence reflects the mode and tempo of tumor evolution	NATURE GENETICS			English	Article							INTERPRETING F-ST; WHOLE-GENOME; CELL-POPULATIONS; INTRATUMOR HETEROGENEITY; PASSENGER MUTATIONS; NEUTRAL MUTATIONS; CANCER; SELECTION; INFERENCE; RECONSTRUCTION	Given the implications of tumor dynamics for precision medicine, there is a need to systematically characterize the mode of evolution across diverse solid tumor types. In particular, methods to infer the role of natural selection within established human tumors are lacking. By simulating spatial tumor growth under different evolutionary modes and examining patterns of between-region subclonal genetic divergence from multiregion sequencing (MRS) data, we demonstrate that it is feasible to distinguish tumors driven by strong positive subclonal selection from those evolving neutrally or under weak selection, as the latter fail to dramatically alter subclonal composition. We developed a classifier based on measures of between-region subclonal genetic divergence and projected patient data into model space, finding different modes of evolution both within and between solid tumor types. Our findings have broad implications for how human tumors progress, how they accumulate intratumoral heterogeneity, and ultimately how they may be more effectively treated.	[Sun, Ruping; Hu, Zheng; Ma, Zhicheng; Curtis, Christina] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Sun, Ruping; Hu, Zheng; Ma, Zhicheng; Curtis, Christina] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Sun, Ruping; Hu, Zheng; Ma, Zhicheng; Curtis, Christina] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Sottoriva, Andrea] Inst Canc Res, Ctr Evolut & Canc, London, England; [Graham, Trevor A.] Queen Mary Univ London, Barts Canc Inst, Evolut & Canc Lab, London, England; [Harpak, Arbel] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fischer, Jared M.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Shibata, Darryl] Univ Southern Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Queen Mary University London; Stanford University; Oregon Health & Science University; University of Southern California	Curtis, C (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.	cncurtis@stanford.edu	Fischer, Jared/HCH-8013-2022	Harpak, Arbel/0000-0002-3655-748X; Hu, Zheng/0000-0003-1552-0060; Graham, Trevor/0000-0001-9582-1597; Fischer, Jared/0000-0002-0062-0870; Sottoriva, Andrea/0000-0001-6709-9533	NIH [R01CA182514, R01CA185016, P30 CA124435]; Susan G. Komen Foundation [IIR13260750]; Breast Cancer Research Foundation [BCRF-16-032]; Innovative Genomics Initiative (IGI); Chris Rokos Fellowship; Cancer Research UK; NATIONAL CANCER INSTITUTE [K99CA181679, R21CA185016, R01CA182514, P30CA124435] Funding Source: NIH RePORTER; Cancer Research UK [19771] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Innovative Genomics Initiative (IGI); Chris Rokos Fellowship; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was funded by awards from the NIH (R01CA182514), the Susan G. Komen Foundation (IIR13260750), and the Breast Cancer Research Foundation (BCRF-16-032) to C.C. and an award from the NIH (R01CA185016) to D.S. Z.H. is supported by an Innovative Genomics Initiative (IGI) Postdoctoral Fellowship. A.S. is supported by the Chris Rokos Fellowship. T.A.G. was supported by Cancer Research UK. This work was supported in part by NIH P30 CA124435 using the Genetics Bioinformatics Service Center within the Stanford Cancer Institute Shared Resource. The results are in part based upon data generated from the following studies: EGAD00001001394, EGAD00001000714, EGAD00001000900, EGAD00001000984, and EGAD00001001113. We thank members of the Curtis laboratory for helpful discussions.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bozic I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004731; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bustamante CD, 2001, GENETICS, V159, P1779; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hu Z., 2017, BIOCH BIOPHYS ACTA; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; KIMURA M, 1979, P NATL ACAD SCI USA, V76, P3440, DOI 10.1073/pnas.76.7.3440; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Ling SP, 2015, P NATL ACAD SCI USA, V112, pE6496, DOI 10.1073/pnas.1519556112; Lloyd MC, 2016, CANCER RES, V76, P3136, DOI 10.1158/0008-5472.CAN-15-2962; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Ostrow SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004239; Popic V, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0647-8; Qiao Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0443-x; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Rowan A, 2005, CLIN GASTROENTEROL H, V3, P1115, DOI 10.1016/S1542-3565(05)00618-X; Siegmund K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2202-8; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Suzuki Y, 2017, MOL ONCOL, V11, P124, DOI 10.1002/1878-0261.12012; TAJIMA F, 1989, GENETICS, V123, P585; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wand MP, 1997, AM STAT, V51, P59, DOI 10.2307/2684697; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wu CI, 2016, ANNU REV GENET, V50, P347, DOI 10.1146/annurev-genet-112414-054842; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zou L.S., 2016, GUT	55	79	79	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1015	+		10.1038/ng.3891	http://dx.doi.org/10.1038/ng.3891			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28581503	Green Accepted, Green Submitted			2022-12-17	WOS:000404253300010
J	Mondal, M; Casals, F; Xu, T; Dall'Olio, GM; Pybus, M; Netea, MG; Comas, D; Laayouni, H; Li, QB; Majumder, PP; Bertranpetit, J				Mondal, Mayukh; Casals, Ferran; Xu, Tina; Dall'Olio, Giovanni M.; Pybus, Marc; Netea, Mihai G.; Comas, David; Laayouni, Hafid; Li, Qibin; Majumder, Partha P.; Bertranpetit, Jaume			Genomic analysis of Andamanese provides insights into ancient human migration into Asia and adaptation	NATURE GENETICS			English	Article							POPULATION HISTORY; POSITIVE SELECTION; GENETIC-VARIATION; WIDE ASSOCIATION; SEQUENCE; NEANDERTHAL; COMPONENTS; ADMIXTURE; DISTINCT; MODEL	To shed light on the peopling of South Asia and the origins of the morphological adaptations found there, we analyzed whole-genome sequences from 10 Andamanese individuals and compared them with sequences for 60 individuals from mainland Indian populations with different ethnic histories and with publicly available data from other populations. We show that all Asian and Pacific populations share a single origin and expansion out of Africa, contradicting an earlier proposal of two independent waves of migration(1-4). We also show that populations from South and Southeast Asia harbor a small proportion of ancestry from an unknown extinct hominin, and this ancestry is absent from Europeans and East Asians. The footprints of adaptive selection in the genomes of the Andamanese show that the characteristic distinctive phenotypes of this population (including very short stature) do not reflect an ancient African origin but instead result from strong natural selection on genes related to human body size.	[Mondal, Mayukh; Pybus, Marc; Comas, David; Laayouni, Hafid; Bertranpetit, Jaume] Univ Pompeu Fabra, Inst Biol Evolutiva UPF CSIC, Barcelona, Spain; [Casals, Ferran] Univ Pompeu Fabra, Serv Genom, Barcelona, Spain; [Xu, Tina] BGI Shenzhen, Shenzhen, Peoples R China; [Dall'Olio, Giovanni M.] GlaxoSmithKline, GSK R&D, Computat Biol Target Sci, Stevenage, Herts, England; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Laayouni, Hafid] Univ Autonoma Barcelona, Dept Genet Microbiol, Bellaterra, Spain; [Majumder, Partha P.] Natl Inst BioMed Gen, Kalyani, W Bengal, India; [Bertranpetit, Jaume] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulrne Ctr Human Evolutionary Studies, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Pompeu Fabra University; Beijing Genomics Institute (BGI); GlaxoSmithKline; Radboud University Nijmegen; Autonomous University of Barcelona; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); University of Cambridge	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Inst Biol Evolutiva UPF CSIC, Barcelona, Spain.; Majumder, PP (corresponding author), Natl Inst BioMed Gen, Kalyani, W Bengal, India.; Bertranpetit, J (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Leverhulrne Ctr Human Evolutionary Studies, Cambridge, England.	jaume.bertanpetit@upf.edu; ppm1@nibrng.ac.in	Mondal, Mayukh/M-5476-2015; Laayouni, Hafid/AAA-9254-2019; Netea, Mihai/N-5155-2014; Bertranpetit, Jaume/F-8550-2012; Casals, Ferran/H-4347-2015; Comas, David/D-5382-2014	Mondal, Mayukh/0000-0003-0122-0323; Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Casals, Ferran/0000-0002-8941-0369; Comas, David/0000-0002-5075-0956; Pybus, Marc/0000-0002-6195-5738	Ministerio de Economia y Competitividad (Spain) [PRI-PIBIN-2011-0942, FU2013-43726-P]; Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2014 SGR866]	Ministerio de Economia y Competitividad (Spain); Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	J. Nye and C. Tyler-Smith kindly corrected the manuscript in depth. Thanks are given to R.A. Foley for discussion and inspiring input for Figure 3. Our main funding was provided by the joint Spain-India bilateral grant PRI-PIBIN-2011-0942 from the Ministerio de Economia y Competitividad (Spain). Complementary funding was provided by grant BFU2013-43726-P from the Ministerio de Economia y Competitividad (Spain), with the support of Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2014 SGR866).	Abbi A, 2009, LANG SCI, V31, P791, DOI 10.1016/j.langsci.2008.02.002; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brown, 1922, ANDAMAN ISLANDERS ST; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Coon C. S., 1966, LIVING RACES MAN; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dass F. A. M., 1937, THE ANDAMAN ISLANDS; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huxley T. H, 1870, J ETHNOLOGICAL SOC L, V2, P404, DOI DOI 10.2307/3014371; Juyal G, 2014, HUM GENET, V133, P1273, DOI 10.1007/s00439-014-1462-0; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Molnar Stephen., 2015, HUMAN VARIATION RACE; Montgomery SH, 2013, J HUM EVOL, V65, P750, DOI 10.1016/j.jhevol.2013.08.006; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2015, BIOINFORMATICS, V31, P3946, DOI 10.1093/bioinformatics/btv493; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; TAJIMA F, 1989, GENETICS, V123, P585; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zoledziewska M, 2015, NAT GENET, V47, P1352, DOI 10.1038/ng.3403	53	79	79	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1066	+		10.1038/ng.3621	http://dx.doi.org/10.1038/ng.3621			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	DU7MQ	27455350	Green Accepted			2022-12-17	WOS:000382398800019
J	Zhou, WY; Machiela, MJ; Freedman, ND; Rothman, N; Malats, N; Dagnall, C; Caporaso, N; Teras, LT; Gaudet, MM; Gapstur, SM; Stevens, VL; Jacobs, KB; Sampson, J; Albanes, D; Weinstein, S; Virtamo, J; Berndt, S; Hoover, RN; Black, A; Silverman, D; Figueroa, J; Garcia-Closas, M; Real, FX; Earl, J; Marenne, G; Rodriguez-Santiago, B; Karagas, M; Johnson, A; Schwenn, M; Wu, XF; Gu, J; Ye, YQ; Hutchinson, A; Tucker, M; Perez-Jurado, LA; Dean, M; Yeager, M; Chanock, SJ				Zhou, Weiyin; Machiela, Mitchell J.; Freedman, Neal D.; Rothman, Nathaniel; Malats, Nuria; Dagnall, Casey; Caporaso, Neil; Teras, Lauren T.; Gaudet, Mia M.; Gapstur, Susan M.; Stevens, Victoria L.; Jacobs, Kevin B.; Sampson, Joshua; Albanes, Demetrius; Weinstein, Stephanie; Virtamo, Jarmo; Berndt, Sonja; Hoover, Robert N.; Black, Amanda; Silverman, Debra; Figueroa, Jonine; Garcia-Closas, Montserrat; Real, Francisco X.; Earl, Julie; Marenne, Gaelle; Rodriguez-Santiago, Benjamin; Karagas, Margaret; Johnson, Alison; Schwenn, Molly; Wu, Xifeng; Gu, Jian; Ye, Yuanqing; Hutchinson, Amy; Tucker, Margaret; Perez-Jurado, Luis A.; Dean, Michael; Yeager, Meredith; Chanock, Stephen J.			Mosaic loss of chromosome Y is associated with common variation near TCL1A	NATURE GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; BONE-MARROW-CELLS; CONFERS SUSCEPTIBILITY; JAK2 HAPLOTYPE; AGE; RISK; HEMATOPOIESIS; LEUKEMIA; BLOOD; SNP	Mosaic loss of chromosome Y (mLOY) leading to gonosomal XY/XO commonly occurs during aging, particularly in smokers. We investigated whether mLOY was associated with non-hematological cancer in three prospective cohorts (8,679 cancer cases and 5,110 cancer-free controls) and genetic susceptibility to mLOY. Overall, mLOY was observed in 7% of men, and its prevalence increased with age (per-year odds ratio (OR) = 1.13, 95% confidence interval (CI) = 1.12-1.15; P < 2 x 10(-16)), reaching 18.7% among men over 80 years old. mLOY was associated with current smoking (OR = 2.35, 95% CI = 1.82-3.03; P = 5.55 x 10(-11)), but the association weakened with years after cessation. mLOY was not consistently associated with overall or specific cancer risk (for example, bladder, lung or prostate cancer) nor with cancer survival after diagnosis (multivariate-adjusted hazard ratio = 0.87, 95% CI = 0.73-1.04; P = 0.12). In a genome-wide association study, we observed the first example of a common susceptibility locus for genetic mosaicism, specifically mLOY, which maps to TCL1A at 14q32.13, marked by rs2887399 (OR = 1.55, 95% CI = 1.36-1.78; P = 1.37 x 10(-10)).	[Zhou, Weiyin; Machiela, Mitchell J.; Freedman, Neal D.; Rothman, Nathaniel; Dagnall, Casey; Caporaso, Neil; Sampson, Joshua; Albanes, Demetrius; Weinstein, Stephanie; Berndt, Sonja; Hoover, Robert N.; Black, Amanda; Silverman, Debra; Figueroa, Jonine; Garcia-Closas, Montserrat; Hutchinson, Amy; Tucker, Margaret; Dean, Michael; Yeager, Meredith; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Zhou, Weiyin; Dagnall, Casey; Jacobs, Kevin B.; Hutchinson, Amy; Yeager, Meredith] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Malats, Nuria; Real, Francisco X.; Earl, Julie; Marenne, Gaelle] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Teras, Lauren T.; Gaudet, Mia M.; Gapstur, Susan M.; Stevens, Victoria L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Jacobs, Kevin B.] Bioinformed LLC, Gaithersburg, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Real, Francisco X.; Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin] QGenomics, Quantitat Genom Med Lab, Barcelona, Spain; [Karagas, Margaret] Dartmouth Med Sch, Biostat & Epidemiol Sect, Lebanon, NH USA; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Wu, Xifeng; Gu, Jian; Ye, Yuanqing] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Perez-Jurado, Luis A.] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Dean, Michael] NCI, Lab Expt Immunol, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); American Cancer Society; Finland National Institute for Health & Welfare; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Dartmouth College; University of Texas System; UTMD Anderson Cancer Center; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yeager, M; Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA.; Yeager, M (corresponding author), Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA.	yeagerm@mail.nih.gov; chanocks@mail.nih.gov	Weinstein, Stephanie J/P-1627-2017; Arribas, Francisco X Real/H-5275-2015; Gu, Jian/Q-4780-2018; Figueroa, Jonine/AFK-2752-2022; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Machiela, Mitchell J/H-7335-2019; Figueroa, Jonine/AAG-1065-2022; Figueroa, Jonine/GWD-1322-2022; Marenne, Gaelle/AAU-8338-2020; Yeager, Meredith/AAA-5322-2020; Freedman, Neal David/B-9741-2015; Berndt, Sonja I/J-8423-2016; Garcia-Closas, Montserrat/AAZ-6930-2021; Malats, Nuria/H-7041-2015	Weinstein, Stephanie J/0000-0002-3834-1535; Arribas, Francisco X Real/0000-0001-9501-498X; Gu, Jian/0000-0003-3499-0973; Figueroa, Jonine/0000-0002-5100-623X; Dean, Michael C/0000-0003-2234-0631; Machiela, Mitchell J/0000-0001-6538-9705; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Marenne, Gaelle/0000-0002-4363-7170; Freedman, Neal David/0000-0003-0074-1098; Garcia-Closas, Montserrat/0000-0003-1033-2650; Malats, Nuria/0000-0003-2538-3784; Dagnall, Casey/0000-0001-7334-4718; Earl, Julie/0000-0001-9360-4716; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852	National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [R01CA057494, ZICCP010178] Funding Source: NIH RePORTER	National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	ABELIOVICH D, 1994, CANCER GENET CYTOGEN, V76, P70, DOI 10.1016/0165-4608(94)90075-2; Chanock S, 2014, WORLD CANC REPORT 20, P193; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Fernandez LC, 2016, NAT REV CANCER, V16, P43, DOI 10.1038/nrc.2015.1; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; GRIFFITHS MJ, 1992, GENE CHROMOSOME CANC, V5, P83; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Herens C, 1999, CLIN LAB HAEMATOL, V21, P17, DOI 10.1046/j.1365-2257.1999.00173.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; Machiela MJ, 2013, SEMIN HEMATOL, V50, P348, DOI 10.1053/j.seminhematol.2013.09.001; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Olcaydu D, 2009, LEUKEMIA, V23, P1924, DOI 10.1038/leu.2009.110; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.3.CO;2-9; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	35	79	80	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					563	+		10.1038/ng.3545	http://dx.doi.org/10.1038/ng.3545			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064253	Green Accepted			2022-12-17	WOS:000374834100017
J	Han, YC; Vidigal, JA; Mu, P; Yao, E; Singh, I; Gonzalez, AJ; Concepcion, CP; Bonetti, C; Ogrodowski, P; Carver, B; Selleri, L; Betel, D; Leslie, C; Ventura, A				Han, Yoon-Chi; Vidigal, Joana A.; Mu, Ping; Yao, Evelyn; Singh, Irtisha; Gonzalez, Alvaro J.; Concepcion, Carla P.; Bonetti, Ciro; Ogrodowski, Paul; Carver, Brett; Selleri, Licia; Betel, Doron; Leslie, Christina; Ventura, Andrea			An allelic series of miR-17 similar to 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron	NATURE GENETICS			English	Article							CHROMOSOMAL-ANOMALIES; GENE; CLUSTER; MUTATIONS; LIMB; AMPLIFICATION; DEFECTS; TARGET; CARCINOMA; MIR-17-92	Polycistronic microRNA (miRNA) clusters are a common feature of vertebrate genomes. The coordinated expression of miRNAs belonging to different seed families from a single transcriptional unit suggests functional cooperation, but this hypothesis has not been experimentally tested. Here we report the characterization of an allelic series of genetically engineered mice harboring selective targeted deletions of individual components of the miR-17 similar to 92 cluster. Our results demonstrate the coexistence of functional cooperation and specialization among members of this cluster, identify a previously undescribed function for the miR-17 seed family in controlling axial patterning in vertebrates and show that loss of miR-19 selectively impairs Myc-driven tumorigenesis in two models of human cancer. By integrating phenotypic analysis and gene expression profiling, we provide a genome-wide view of how the components of a polycistronic miRNA cluster affect gene expression in vivo. The reagents and data sets reported here will accelerate exploration of the complex biological functions of this important miRNA cluster.	[Han, Yoon-Chi; Vidigal, Joana A.; Mu, Ping; Yao, Evelyn; Concepcion, Carla P.; Bonetti, Ciro; Ogrodowski, Paul; Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Han, Yoon-Chi] Pfizer Inc, Oncol Res Unit, Pearl River, NY USA; [Mu, Ping; Yao, Evelyn; Concepcion, Carla P.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Singh, Irtisha; Gonzalez, Alvaro J.; Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Selleri, Licia] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Betel, Doron] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Betel, Doron] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Memorial Sloan Kettering Cancer Center; Pfizer; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Ventura, A (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	venturaa@mskcc.org	Singh, Irtisha/W-6182-2019	Ventura, Andrea/0000-0003-4320-9907; Mu, Ping/0000-0003-0955-0896; Singh, Irtisha/0000-0002-9460-3587; Betel, Doron/0000-0002-8006-7752; A. Vidigal, Joana/0000-0003-2765-6985	US National Institutes of Health/National Cancer Institute [R01CA149707, P30CA008748]; STARR Consortium; Geoffrey Beene Cancer Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society; American Italian Cancer Foundation; US National Institutes of Health [F31CA168356]; NATIONAL CANCER INSTITUTE [F31CA168356, P30CA008748, R01CA182503, R01CA149707] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); STARR Consortium; Geoffrey Beene Cancer Foundation; Gabrielle's Angel Foundation; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); American Italian Cancer Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Hollenstein for editing the manuscript and members of the Ventura laboratory for helpful discussions. The authors greatly acknowledge the contribution of the Weill Cornell Epigenomics Core. This work was funded by grants from the US National Institutes of Health/National Cancer Institute (R01CA149707 to A.V. and Core grant P30CA008748), the STARR Consortium (to A.V. and D.B.), the Geoffrey Beene Cancer Foundation (to A.V.), the Gabrielle's Angel Foundation (to A.V.), the Leukemia Lymphoma Society (to Y.-C.H.), the American Italian Cancer Foundation (to C.B.) and a US National Institutes of Health training grant (F31CA168356 to C.P.C.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feingold M, 1997, AM J MED GENET, V69, P245, DOI 10.1002/(SICI)1096-8628(19970331)69:3<245::AID-AJMG7>3.3.CO;2-U; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Jenkins RB, 1997, CANCER RES, V57, P524; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumps C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052321; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Meneghini V, 2006, EUR J MED GENET, V49, P151, DOI 10.1016/j.ejmg.2005.04.021; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Qian JQ, 1997, MODERN PATHOL, V10, P1113; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400	65	79	80	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					766	+		10.1038/ng.3321	http://dx.doi.org/10.1038/ng.3321			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029871	Green Accepted, Green Published			2022-12-17	WOS:000357090300014
J	Merrell, AJ; Ellis, BJ; Fox, ZD; Lawson, JA; Weiss, JA; Kardon, G				Merrell, Allyson J.; Ellis, Benjamin J.; Fox, Zachary D.; Lawson, Jennifer A.; Weiss, Jeffrey A.; Kardon, Gabrielle			Muscle connective tissue controls development of the diaphragm and is a source of congenital diaphragmatic hernias	NATURE GENETICS			English	Article							HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; MET RECEPTOR; LIMB BUD; C-MET; GATA4; DEFECTS; MOUSE	The diaphragm is an essential mammalian skeletal muscle, and defects in diaphragm development are the cause of congenital diaphragmatic hernias (CDHs), a common and often lethal birth defect. The diaphragm is derived from multiple embryonic sources, but how these give rise to the diaphragm is unknown, and, despite the identification of many CDH-associated genes, the etiology of CDH is incompletely understood. Using mouse genetics, we show that the pleuroperitoneal folds (PPFs), which are transient embryonic structures, are the source of the diaphragm's muscle connective tissue and regulate muscle development, and we show that the striking migration of PPF cells controls diaphragm morphogenesis. Furthermore, Gata4 mosaic mutations in PPF-derived muscle connective tissue fibroblasts result in the development of localized amuscular regions that are biomechanically weaker and more compliant, leading to CDH. Thus, the PPFs and muscle connective tissue are critical for diaphragm development, and mutations in PPF-derived fibroblasts are a source of CDH.	[Merrell, Allyson J.; Fox, Zachary D.; Lawson, Jennifer A.; Kardon, Gabrielle] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Ellis, Benjamin J.; Weiss, Jeffrey A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Ellis, Benjamin J.; Weiss, Jeffrey A.] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kardon, G (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	gkardon@genetics.utah.edu			University of Utah Graduate Fellowship; US National Institutes of Health (NIH) grant [R01GM083925]; US NIH grant [R01GM098151, R01HD053728]; Dimes grant [FY12-405]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083925] Funding Source: NIH RePORTER	University of Utah Graduate Fellowship; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dimes grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Rodesch at the University of Utah Imaging Core for help with microscopy, S. Merchant for help with microCT imaging, Y. Wan and C. Hansen for Fluorender analysis, M. Hockin and M.R. Capecchi for Cre protein, and M. Colasanto, N. Elde, L.B. Jorde, A. Keefe, A. Letsou, L.C. Murtaugh and C.J. Tabin for critical comments on the manuscript. A.J.M. was supported by a University of Utah Graduate Fellowship, FEBio analysis is supported by US National Institutes of Health (NIH) grant R01GM083925 to J.A.W. and G.A. Ateshian, and Fluorender analysis is supported by US NIH grant R01GM098151 to C. Hansen. This research was supported by US NIH grant R01HD053728 and March of Dimes grant FY12-405 to G.K.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Ackerman KG, 2007, AM J MED GENET C, V145C, P109, DOI 10.1002/ajmg.c.30128; Ackerman KG, 2012, PEDIATR DEVEL PATHOL, V15, P265, DOI 10.2350/11-05-1041-OA.1; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Allan DW, 1997, J COMP NEUROL, V382, P459, DOI 10.1002/(SICI)1096-9861(19970616)382:4<459::AID-CNE3>3.0.CO;2-1; Arrington CB, 2012, AM J MED GENET A, V158A, P3137, DOI 10.1002/ajmg.a.35664; Babiuk RP, 2003, J COMP NEUROL, V455, P477, DOI 10.1002/cne.10503; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bosch N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008269; Campbell E. J. M., 1970, RESP MUSCLES MECH NE; Clugston Robin D, 2007, Semin Pediatr Surg, V16, P94, DOI 10.1053/j.sempedsurg.2007.01.004; Clugston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL665, DOI 10.1152/ajplung.00027.2008; Coles GL, 2013, P NATL ACAD SCI USA, V110, pE1898, DOI 10.1073/pnas.1222797110; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Domyan ET, 2013, DEV CELL, V24, P52, DOI 10.1016/j.devcel.2012.11.018; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Greer JJ, 2000, J APPL PHYSIOL, V89, P2123, DOI 10.1152/jappl.2000.89.6.2123; Holder AM, 2007, AM J HUM GENET, V80, P825, DOI 10.1086/513442; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Kantarci S, 2010, AM J MED GENET A, V152A, P2493, DOI 10.1002/ajmg.a.33618; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Keijzer R, 2000, AM J PATHOL, V156, P1299, DOI 10.1016/S0002-9440(10)65000-6; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Longoni M, 2012, AM J MED GENET A, V158A, P3148, DOI 10.1002/ajmg.a.35665; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Merrell AJ, 2013, FEBS J, V280, P4026, DOI 10.1111/febs.12274; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura K, 2011, INT J CANCER, V128, P2613, DOI 10.1002/ijc.25606; Perry SF, 2010, RESP PHYSIOL NEUROBI, V171, P1, DOI 10.1016/j.resp.2010.01.004; Pober BR, 2007, AM J MED GENET C, V145C, P158, DOI 10.1002/ajmg.c.30126; Pober BR, 2005, AM J MED GENET A, V138A, P81, DOI 10.1002/ajmg.a.30904; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Raval MV, 2011, J PEDIATR SURG, V46, P617, DOI 10.1016/j.jpedsurg.2010.09.047; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Russell MK, 2012, P NATL ACAD SCI USA, V109, P2978, DOI 10.1073/pnas.1121621109; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STRUMPF RK, 1993, AM J PHYSIOL, V265, pH469, DOI 10.1152/ajpheart.1993.265.2.H469; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TORFS CP, 1992, TERATOLOGY, V46, P555, DOI 10.1002/tera.1420460605; Veenma DCM, 2012, PEDIATR PULM, V47, P534, DOI 10.1002/ppul.22553; Veenma D, 2012, EUR J HUM GENET, V20, P298, DOI 10.1038/ejhg.2011.194; Veenma D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015348; VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; Wan Y, 2009, IEEE T VIS COMPUT GR, V15, P1489, DOI 10.1109/TVCG.2009.118; Wat MJ, 2012, HUM MOL GENET, V21, P4115, DOI 10.1093/hmg/dds241; Wat MJ, 2009, AM J MED GENET A, V149A, P1661, DOI 10.1002/ajmg.a.32896; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Yamak A, 2012, AM J PHYSIOL-HEART C, V303, pH1057, DOI 10.1152/ajpheart.00250.2012; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; Yu L, 2013, HUM GENET, V132, P285, DOI 10.1007/s00439-012-1249-0; Zhang B, 2014, J CLIN INVEST, V124, P209, DOI 10.1172/JCI71090	62	79	81	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2015	47	5					496	U96		10.1038/ng.3250	http://dx.doi.org/10.1038/ng.3250			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CG9LE	25807280	Green Accepted			2022-12-17	WOS:000353635800012
J	Boztug, K; Jarvinen, PM; Salzer, E; Racek, T; Monch, S; Garncarz, W; Gertz, EM; Schaffer, AA; Antonopoulos, A; Haslam, SM; Schieck, L; Puchalka, J; Diestelhorst, J; Appaswamy, G; Lescoeur, B; Giambruno, R; Bigenzahn, JW; Elling, U; Pfeifer, D; Conde, CD; Albert, MH; Welte, K; Brandes, G; Sherkat, R; ten Bosch, JV; Rezaei, N; Etzioni, A; Bellanne-Chantelot, C; Superti-Furga, G; Penninger, JM; Bennett, KL; von Blume, J; Dell, A; Donadieu, J; Klein, C				Boztug, Kaan; Jaervinen, Paeivi M.; Salzer, Elisabeth; Racek, Tomas; Moench, Sebastian; Garncarz, Wojciech; Gertz, E. Michael; Schaeffer, Alejandro A.; Antonopoulos, Aristotelis; Haslam, Stuart M.; Schieck, Lena; Puchalka, Jacek; Diestelhorst, Jana; Appaswamy, Giridharan; Lescoeur, Brigitte; Giambruno, Roberto; Bigenzahn, Johannes W.; Elling, Ulrich; Pfeifer, Dietmar; Conde, Cecilia Dominguez; Albert, Michael H.; Welte, Karl; Brandes, Gudrun; Sherkat, Roya; ten Bosch, Jutte van der Werff; Rezaei, Nima; Etzioni, Amos; Bellanne-Chantelot, Christine; Superti-Furga, Giulio; Penninger, Josef M.; Bennett, Keiryn L.; von Blume, Julia; Dell, Anne; Donadieu, Jean; Klein, Christoph			JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia	NATURE GENETICS			English	Article							STIMULATING FACTOR-RECEPTOR; UNFOLDED PROTEIN RESPONSE; HERMANSKY-PUDLAK-SYNDROME; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; ELANE MUTATIONS; SEQUENCING DATA; COHEN-SYNDROME; GENE; ELASTASE	The analysis of individuals with severe congenital neutropenia (SCN) may shed light on the delicate balance of factors controlling the differentiation, maintenance and decay of neutrophils. We identify 9 distinct homozygous mutations in the JAGN1 gene encoding Jagunal homolog 1 in 14 individuals with SCN. JAGN1-mutant granulocytes are characterized by ultrastructural defects, a paucity of granules, aberrant N-glycosylation of multiple proteins and increased incidence of apoptosis. JAGN1 participates in the secretory pathway and is required for granulocyte colony-stimulating factor receptor-mediated signaling. JAGN1 emerges as a factor that is necessary in the differentiation and survival of neutrophils.	[Boztug, Kaan; Salzer, Elisabeth; Garncarz, Wojciech; Giambruno, Roberto; Bigenzahn, Johannes W.; Conde, Cecilia Dominguez; Superti-Furga, Giulio; Bennett, Keiryn L.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Jaervinen, Paeivi M.; Racek, Tomas; Moench, Sebastian; Puchalka, Jacek; Diestelhorst, Jana; Albert, Michael H.; Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Gertz, E. Michael; Schaeffer, Alejandro A.] US Natl Inst Hlth, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD USA; [Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Schieck, Lena; Diestelhorst, Jana; Appaswamy, Giridharan; Welte, Karl] Hannover Med Sch, Dept Pediat Hematol Oncol, Hannover, Germany; [Lescoeur, Brigitte] Hosp R Debre, Dept Hematol, Paris, France; [Elling, Ulrich] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Brandes, Gudrun] Hannover Med Sch, Dept Cell Biol, Hannover, Germany; [Sherkat, Roya] Isfahan Univ Med Sci, Acquired Immunodeficiency Res Ctr, Esfahan, Iran; [Conde, Cecilia Dominguez] Hosp Free Univ Brussels, Dept Pediat, Brussels, Belgium; [Rezaei, Nima] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran, Iran; [Etzioni, Amos] Technion Israel Inst Technol, Rappaport Sch Med, Div Pediat & Immunol, Haifa, Israel; [Bellanne-Chantelot, Christine] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [von Blume, Julia] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Donadieu, Jean] Armand Trousseau Childrens Hosp, AP HP, Reference Ctr Hereditary Immunodeficiencies, Neutropenia Registry, Paris, France	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Munich; National Institutes of Health (NIH) - USA; Imperial College London; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Freiburg; Hannover Medical School; Isfahan University Medical Science; Tehran University of Medical Sciences; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Klein, C (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany.	christoph.klein@med.uni-muenchen.de	Superti-Furga, Giulio/F-4755-2015; Boztug, Kaan/AAM-4161-2021; Rezaei, Nima/B-4245-2008; Penninger, Josef M/I-6860-2013; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Superti-Furga, Giulio/AAE-5681-2019; Giambruno, Roberto/W-4868-2017; von Blume, Julia/H-2120-2013; Giambruno, Roberto/AAI-6717-2021; Salzer, Elisabeth/G-8066-2017; Dominguez Conde, Cecilia/U-4890-2017	Superti-Furga, Giulio/0000-0002-0570-1768; Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Penninger, Josef M/0000-0002-8194-3777; Giambruno, Roberto/0000-0002-4566-261X; von Blume, Julia/0000-0001-6665-1592; Giambruno, Roberto/0000-0002-4566-261X; sherkat, Roya/0000-0001-6745-8161; Bennett, Keiryn L./0000-0001-9356-7708; Salzer, Elisabeth/0000-0002-8118-4934; Dominguez Conde, Cecilia/0000-0002-8684-4655; Dell, Anne/0000-0003-1380-2347; Bigenzahn, Johannes/0000-0002-5214-4570	CeMM; FWF (Austrian Science Fund) START Programme; European Research Council; European Program on Rare Diseases (E-RARE Neutro-Net); German Research Foundation (Gottfried-Wilhelm-Leibniz Program) [SFB914]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F0083091, BB/K016164/1]; Amgen; Chugai; Fondation Maladies Rares; Institut de Veille Sanitaire; INSERM; Association Sportive de Saint Quentin Fallavier; CEREDIH (Reference Center for Hereditary Immunodeficiencies); Societe d'Hemato-Immunologie Pediatrique; US National Institutes of Health; National Library of Medicine; DZIF (German Center for Infection Research); Care-for-Rare Foundation; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 595] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI	CeMM; FWF (Austrian Science Fund) START Programme(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); European Program on Rare Diseases (E-RARE Neutro-Net); German Research Foundation (Gottfried-Wilhelm-Leibniz Program)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Amgen(Amgen); Chugai; Fondation Maladies Rares; Institut de Veille Sanitaire; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Sportive de Saint Quentin Fallavier; CEREDIH (Reference Center for Hereditary Immunodeficiencies); Societe d'Hemato-Immunologie Pediatrique; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); DZIF (German Center for Infection Research); Care-for-Rare Foundation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the patients and their families for their participation in this study. The help of all contributing medical, technical and administrative staff is greatly appreciated. The authors thank J. Colinge for bioinformatics analysis of the mass spectrometry data. The authors thank G. Leverger, H. Ducou Lepointe, J. Levin, the association IRIS (Immunodeficience Primitive, Recherche, Information, Soutien) and V. Grosjean for their support. This study was supported by CeMM intramural funds and the FWF (Austrian Science Fund) START Programme (to K.B.) and by grants from the European Research Council (Advanced Grants to C.K. and J.P.; Starting Grant to K.B.), the European Program on Rare Diseases (E-RARE Neutro-Net) and the German Research Foundation (SFB914 and Gottfried-Wilhelm-Leibniz Program). The work at Imperial College was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; grants BB/F0083091 and BB/K016164/1). The French SCN registry is supported by grants from Amgen, Chugai, Fondation Maladies Rares, the Institut de Veille Sanitaire, INSERM, the Association Sportive de Saint Quentin Fallavier, CEREDIH (Reference Center for Hereditary Immunodeficiencies) and the Societe d'Hemato-Immunologie Pediatrique. This research is supported in part by the Intramural Research Program of the US National Institutes of Health, the National Library of Medicine, the DZIF (German Center for Infection Research) and the Care-for-Rare Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Boztug K, 2012, J PEDIATR-US, V160, P679, DOI 10.1016/j.jpeds.2011.09.019; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Bryant NJ, 2003, J CELL BIOL, V161, P691, DOI 10.1083/jcb.200212078; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DALE DC, 1993, BLOOD, V81, P2496; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Girish V, 2004, Indian J Cancer, V41, P47; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Horwitz MS, 2013, HEMATOL ONCOL CLIN N, V27, P19, DOI 10.1016/j.hoc.2012.10.004; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jun HS, 2010, BLOOD, V116, P2783, DOI 10.1182/blood-2009-12-258491; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LI JM, 1994, BIOCHEM BIOPH RES CO, V205, P238, DOI 10.1006/bbrc.1994.2655; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Pfeifer D, 2007, IMMUNOGENETICS, V59, P913, DOI 10.1007/s00251-007-0257-z; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Rudashevskaya EL, 2013, NAT PROTOC, V8, P75, DOI 10.1038/nprot.2012.133; Salzer E, 2013, HAEMATOLOGICA, V98, P473, DOI 10.3324/haematol.2012.068791; Seifert W, 2011, J BIOL CHEM, V286, P37665, DOI 10.1074/jbc.M111.267971; Stepensky P, 2013, BLOOD, V121, P5078, DOI 10.1182/blood-2012-12-475566; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070	51	79	83	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1021	+		10.1038/ng.3069	http://dx.doi.org/10.1038/ng.3069			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25129144	Green Accepted			2022-12-17	WOS:000341579400019
J	Herzog, VA; Lempradl, A; Trupke, J; Okulski, H; Altmutter, C; Ruge, F; Boidol, B; Kubicek, S; Schmauss, G; Aumayr, K; Ruf, M; Pospisilik, A; Dimond, A; Senergin, HB; Vargas, ML; Simon, JA; Ringrose, L				Herzog, Veronika A.; Lempradl, Adelheid; Trupke, Johanna; Okulski, Helena; Altmutter, Christina; Ruge, Frank; Boidol, Bernd; Kubicek, Stefan; Schmauss, Gerald; Aumayr, Karin; Ruf, Marius; Pospisilik, Andrew; Dimond, Andrew; Senergin, Hasene Basak; Vargas, Marcus L.; Simon, Jeffrey A.; Ringrose, Leonie			A strand-specific switch in noncoding transcription switches the function of a Polycomb/Trithorax response element	NATURE GENETICS			English	Article							POLYCOMB GROUP PROTEINS; EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; VESTIGIAL GENE; WING FORMATION; HOX LOCI; DROSOPHILA; RNAS; CHROMATIN	Polycomb/Trithorax response elements (PRE/TREs) can switch their function reversibly between silencing and activation by mechanisms that are poorly understood. Here we show that a switch in forward and reverse noncoding transcription from the Drosophila melanogaster vestigial (vg) PRE/TRE switches the status of the element between silencing (induced by the forward strand) and activation (induced by the reverse strand). In vitro, both noncoding RNAs inhibit PRC2 histone methyltransferase activity, but, in vivo, only the reverse strand binds PRC2. Overexpression of the reverse strand evicts PRC2 from chromatin and inhibits its enzymatic activity. We propose that the interaction of RNAs with PRC2 is differentially regulated in vivo, allowing regulated inhibition of local PRC2 activity. Genome-wide analysis shows that strand switching of noncoding RNAs occurs at several hundred Polycomb-binding sites in fly and vertebrate genomes. This work identifies a previously unreported and potentially widespread class of PRE/TREs that switch function by switching the direction of noncoding RNA transcription.	[Herzog, Veronika A.; Lempradl, Adelheid; Trupke, Johanna; Okulski, Helena; Altmutter, Christina; Ruge, Frank; Dimond, Andrew; Senergin, Hasene Basak; Ringrose, Leonie] IMBA Inst Mol Biotechnol, Vienna, Austria; [Lempradl, Adelheid; Ruf, Marius; Pospisilik, Andrew] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Boidol, Bernd; Kubicek, Stefan] CeMM Res Ctr Mol Med, Vienna, Austria; [Schmauss, Gerald; Aumayr, Karin] IMP, Vienna, Austria; [Dimond, Andrew] Babraham Inst, Cambridge, England; [Vargas, Marcus L.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Max Planck Society; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Minnesota System; University of Minnesota Twin Cities	Ringrose, L (corresponding author), IMBA Inst Mol Biotechnol, Vienna, Austria.	leonie.ringrose@imba.oeaw.ac.at	Lempradl, Adelheid/AAJ-2529-2021; Ringrose, Leonie/AAV-4734-2021; Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Trupke, Johanna/0000-0003-3144-5267; Okulski, Helena/0000-0002-2254-4282; Dimond, Andrew/0000-0002-2996-2479	Austrian Academy of Sciences; European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome'; European Union Framework Programme 7 Network of Excellence 'Epigenesys'; FWF Austrian Science Fund [P21525-B20]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850] Funding Source: NIH RePORTER	Austrian Academy of Sciences; European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome'; European Union Framework Programme 7 Network of Excellence 'Epigenesys'; FWF Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gasser for discussions and for critical reading of the manuscript. We thank M. Rehmsmeier and members of our laboratories for discussions, P. Pasierbek for advice and training on imaging, P.A. Steffen (IMBA) for the GFP and E(z) :: GFP constructs, C. Ehrhardt and E. Dworschak for technical assistance, B. Dickson (Janelia Farm) for the enGAL4 driver line, J.M. Dura (Institute of Human Genetics, Montpelier, France) for the daGAL4 driver line, I. Tamir (CSF Vienna) for the bioinformatics analysis of ChIP-seq data and sharing the 'Fuge' algorithm, F. Bantignies (Institute of Human Genetics, Montpelier, France) for advice on three-dimensional DNA FISH, R. Jones (Dedman College, Southern Methodist University) for providing antibody to E(Z) and the Vienna Campus Support Facility (CSF) for library preparation, deep sequencing and the purification of Drosophila PRC2. This work was funded by the Austrian Academy of Sciences, by European Community grants European Union Framework Programme 6 Network of Excellence 'The Epigenome' (to L.R.) and the European Union Framework Programme 7 Network of Excellence 'Epigenesys' (to L.R.), and by an FWF Austrian Science Fund grant (P21525-B20 to L.R.).	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aszodi A, 2012, BIOINFORMATICS, V28, P3318, DOI 10.1093/bioinformatics/bts607; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; BATE M, 1990, DEVELOPMENT, V110, P791; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; COHEN B, 1993, DEVELOPMENT, V117, P597; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Gemkow M. J., 1996, Bioimaging, V4, P107, DOI 10.1002/1361-6374(199606)4:2<107::AID-BIO8>3.3.CO;2-H; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; Guss KA, 2008, DEV DYNAM, V237, P2483, DOI 10.1002/dvdy.21664; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Katayama S, 2004, BRIEF BIOINFORM, V5, P249, DOI 10.1093/bib/5.3.249; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Okulski H, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-4; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Perez L, 2011, DEVELOPMENT, V138, P3125, DOI 10.1242/dev.065599; Rai AN, 2013, MOL CELL BIOL, V33, P4844, DOI 10.1128/MCB.00307-13; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Steffen PA, 2013, NUCLEIC ACIDS RES, V41, P5235, DOI 10.1093/nar/gkt217; Valouev A, 2008, NAT METHODS, V5, P829, DOI [10.1038/nmeth.1246, 10.1038/NMETH.1246]; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042102; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	54	79	81	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					973	+		10.1038/ng.3058	http://dx.doi.org/10.1038/ng.3058			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108384	Green Accepted			2022-12-17	WOS:000341579400011
J	Kong, A; Thorleifsson, G; Frigge, ML; Masson, G; Gudbjartsson, DF; Villemoes, R; Magnusdottir, E; Olafsdottir, SB; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Masson, Gisli; Gudbjartsson, Daniel F.; Villemoes, Rasmus; Magnusdottir, Erna; Olafsdottir, Stefania B.; Thorsteinsdottir, Unnur; Stefansson, Kari			Common and low-frequency variants associated with genome-wide recombination rate	NATURE GENETICS			English	Article							MAMMALIAN MEIOSIS; SEQUENCE VARIANTS; CROSSING-OVER; ZMM PROTEINS; RAD21L; MICE; CHROMOSOMES; IMPUTATION; REGULATOR; INVERSION	Meiotic recombination contributes to genetic diversity by yielding new combinations of alleles. Individuals vary with respect to the genome-wide recombination counts in their gametes. Exploiting data resources in Iceland, we compiled a data set consisting of 35,927 distinct parents and 71,929 parent-offspring pairs. Within this data set, we called over 2.2 million recombination events and imputed variants with sequence-level resolution from 2,261 whole genome-sequenced individuals into the parents to search for variants influencing recombination rate. We identified 13 variants in 8 regions that are associated with genome-wide recombination rate, 8 of which were previously unknown. Three of these variants associate with male recombination rate only, seven variants associate with female recombination rate only and three variants affect both. Two are low-frequency variants with large effects, one of which is estimated to increase the male and female genetic maps by 111 and 416 cM, respectively. This variant, located in an intron, would not be found by exome sequencing.	[Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Masson, Gisli; Gudbjartsson, Daniel F.; Villemoes, Rasmus; Olafsdottir, Stefania B.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Kong, Augustine; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Fac Phys Sci, Reykjavik, Iceland; [Magnusdottir, Erna; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Iceland	Kong, A (corresponding author), deCODE Genet Amgen Inc, Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Stefansson, Kari/AAE-7187-2019; Magnúsdóttir, Erna/H-5181-2013; Magnúsdóttir, Erna/T-8993-2019	Magnúsdóttir, Erna/0000-0002-3369-4390; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Frigge, Michael/0000-0003-2984-535X				Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chelysheva L., 2012, PLOS GENET, V8; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Gutierrez-Caballero C, 2011, CELL CYCLE, V10, P1477, DOI 10.4161/cc.10.9.15515; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kneitz B, 2000, GENE DEV, V14, P1085; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lee J, 2011, J CELL BIOL, V192, P263, DOI 10.1083/jcb.201008005; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Llano E, 2012, J CELL BIOL, V197, P877, DOI 10.1083/jcb.201201100; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nagel AC, 2012, J CELL SCI, V125, P5555, DOI 10.1242/jcs.113902; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Novak JE, 2001, GENETICS, V158, P1013; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Sleutels F, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-8; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139	41	79	80	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					11	+		10.1038/ng.2833	http://dx.doi.org/10.1038/ng.2833			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24270358				2022-12-17	WOS:000329113500006
J	Omberg, L; Ellrott, K; Yuan, Y; Kandoth, C; Wong, C; Kellen, MR; Friend, SH; Stuart, J; Liang, H; Margolin, AA				Omberg, Larsson; Ellrott, Kyle; Yuan, Yuan; Kandoth, Cyriac; Wong, Chris; Kellen, Michael R.; Friend, Stephen H.; Stuart, Josh; Liang, Han; Margolin, Adam A.			Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas	NATURE GENETICS			English	Editorial Material							WEB	The Cancer Genome Atlas Pan-Cancer Analysis Working Group collaborated on the Synapse software platform to share and evolve data, results and methodologies while performing integrative analysis of molecular profiling data from 12 tumor types. The group's work serves as a pilot case study that provides (i) a template for future large collaborative studies; (ii) a system to support collaborative projects; and (iii) a public resource of highly curated data, results and automated systems for the evaluation of community-developed models.	[Omberg, Larsson; Kellen, Michael R.; Friend, Stephen H.; Margolin, Adam A.] Sage Bionetworks, Seattle, WA USA; [Ellrott, Kyle; Wong, Chris; Stuart, Josh] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Yuan, Yuan; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Yuan, Yuan; Liang, Han] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Kandoth, Cyriac] Washington Univ, Genome Inst, St Louis, MO USA	University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Washington University (WUSTL)	Omberg, L (corresponding author), Sage Bionetworks, Seattle, WA USA.	larsson.omberg@sagebase.org; margolin@sagebase.org	wong, chris/GSN-0962-2022; Yuan, Yuan/H-4007-2013	Yuan, Yuan/0000-0003-4706-7897; Kandoth, Cyriac/0000-0002-1345-3573; Ellrott, Kyle/0000-0002-6573-5900; Omberg, Larsson/0000-0002-4719-9120; Stuart, Joshua/0000-0002-2171-565X	NATIONAL CANCER INSTITUTE [P30CA016672, U54CA149237, P50CA098258] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672, 5U54CA149237, U54 CA149237, U24 CA143858] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benkler Y, 2004, YALE LAW J, V114, P273, DOI 10.2307/4135731; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Derry JMJ, 2012, NAT GENET, V44, P127, DOI 10.1038/ng.1089; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolata G, 2010, NY TIMES; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Wolstencroft K, 2013, NUCLEIC ACIDS RES, V41, pW557, DOI 10.1093/nar/gkt328; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	23	79	80	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1121	1126		10.1038/ng.2761	http://dx.doi.org/10.1038/ng.2761			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	24071850	Green Accepted, hybrid, Green Published			2022-12-17	WOS:000324989600006
J	Arbiza, L; Gronau, I; Aksoy, BA; Hubisz, MJ; Gulko, B; Keinan, A; Siepel, A				Arbiza, Leonardo; Gronau, Ilan; Aksoy, Bulent A.; Hubisz, Melissa J.; Gulko, Brad; Keinan, Alon; Siepel, Adam			Genome-wide inference of natural selection on human transcription factor binding sites	NATURE GENETICS			English	Article							SLIGHTLY DELETERIOUS MUTATIONS; ADAPTIVE PROTEIN EVOLUTION; MOLECULAR EVOLUTION; BALANCING SELECTION; POPULATION-SIZE; MOUSE GENOME; DNA; ELEMENTS; DROSOPHILA; POLYMORPHISM	For decades, it has been hypothesized that gene regulation has had a central role in human evolution, yet much remains unknown about the genome-wide impact of regulatory mutations. Here we use whole-genome sequences and genome-wide chromatin immunoprecipitation and sequencing data to demonstrate that natural selection has profoundly influenced human transcription factor binding sites since the divergence of humans from chimpanzees 4-6 million years ago. Our analysis uses a new probabilistic method, called INSIGHT, for measuring the influence of selection on collections of short, interspersed noncoding elements. We find that, on average, transcription factor binding sites have experienced somewhat weaker selection than protein-coding genes. However, the binding sites of several transcription factors show clear evidence of adaptation. Several measures of selection are strongly correlated with predicted binding affinity. Overall, regulatory elements seem to contribute substantially to both adaptive substitutions and deleterious polymorphisms with key implications for human evolution and disease.	[Arbiza, Leonardo; Gronau, Ilan; Hubisz, Melissa J.; Keinan, Alon; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Aksoy, Bulent A.; Keinan, Alon; Siepel, Adam] Triinst Training Program Computat Biol & Med, New York, NY USA; [Gulko, Brad; Keinan, Alon; Siepel, Adam] Cornell Univ, Grad Field Comp Sci, Ithaca, NY USA	Cornell University; Cornell University	Siepel, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	acs4@cornell.edu		Hubisz, Melissa/0000-0002-9561-6830; Siepel, Adam/0000-0002-3557-7219; Keinan, Alon/0000-0002-9760-1122	Packard Fellowship, a Sloan Research Fellowship, US National Science Foundation [DBI-0644111]; US National Institutes of Health (National Institute of General Medical Sciences, NIGMS) [GM102192]; Cornell Center for Vertebrate Genomics; US National Institutes of Health [T32-GM083937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192, T32GM083937] Funding Source: NIH RePORTER	Packard Fellowship, a Sloan Research Fellowship, US National Science Foundation; US National Institutes of Health (National Institute of General Medical Sciences, NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cornell Center for Vertebrate Genomics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Blekhman, C. Danko, A. Boyko, K. Pollard, N. Goldman and A. Clark for comments on the manuscript. This research was supported by a Packard Fellowship, a Sloan Research Fellowship, US National Science Foundation grant DBI-0644111 and US National Institutes of Health (National Institute of General Medical Sciences, NIGMS) grant GM102192 (to A. S.). In addition, L. A. was supported in part by a postdoctoral fellowship award from the Cornell Center for Vertebrate Genomics, and B. A. A. was supported by US National Institutes of Health training grant T32-GM083937.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Charlesworth J, 2008, MOL BIOL EVOL, V25, P1007, DOI 10.1093/molbev/msn005; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Fay JC, 2001, GENETICS, V158, P1227; Gaffney DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000157; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gojobori J, 2007, P NATL ACAD SCI USA, V104, P3907, DOI 10.1073/pnas.0605565104; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2013, MOL BIOL EVOL, V30, P1159, DOI 10.1093/molbev/mst019; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JUKES T H, 1969, P21; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; Moses AM, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-19; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHNO S, 1972, J HUM EVOL, V1, P651, DOI 10.1016/0047-2484(72)90011-5; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; SAWYER SA, 1992, GENETICS, V132, P1161; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; Wilson DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002395; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	72	79	79	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					723	+		10.1038/ng.2658	http://dx.doi.org/10.1038/ng.2658			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23749186	Green Accepted			2022-12-17	WOS:000321005200006
J	Wu, C; Li, D; Jia, WH; Hu, ZB; Zhou, YF; Yu, DK; Tong, T; Wang, MR; Lin, DM; Qiao, Y; Zhou, YL; Chang, J; Zhai, K; Wang, MH; Wei, LX; Tan, W; Shen, HB; Zeng, YX; Lin, DX				Wu, Chen; Li, Dong; Jia, Weihua; Hu, Zhibin; Zhou, Yifeng; Yu, Dianke; Tong, Tong; Wang, Mingrong; Lin, Dongmei; Qiao, Yan; Zhou, Yuling; Chang, Jiang; Zhai, Kan; Wang, Menghan; Wei, Lixuan; Tan, Wen; Shen, Hongbing; Zeng, Yixin; Lin, Dongxin			Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC POLYMORPHISMS; SUSCEPTIBILITY LOCI; CANCER; ZINC; LIV-1; CHEMORADIOTHERAPY; PROGNOSIS; PLCE1; DNA	We conducted a genome-wide scan of SNPs to identify variants associated with length of survival in 1,331 individuals with esophageal squamous-cell carcinoma (ESCC), with associations validated in 2 independent sets including 1,962 individuals with this cancer. We identified rs1050631 in SLC39A6 as associated with the survival times of affected individuals, with the hazard ratio for death from ESCC in the combined sample being 1.30 (95% confidence interval (Cl) = 1.19-1.43; P = 3.77 x 10(-8)). rs7242481, located in the 5' UTR of SLC39A6, disturbs a transcriptional repressor binding site and results in upregulation of SLC39A6 expression. Immunohistochemical staining of ESCC tissues showed that higher expression of SLC39A6 protein was correlated with shorter length of survival in individuals with advanced ESCC (P = 0.013). Knockdown of SLC39A6 expression suppressed proliferation and invasion in ESCC cells. These results suggest that SLC39A6 has an important role in the prognosis of ESCC and may be a potential therapeutic target.	[Wu, Chen; Li, Dong; Yu, Dianke; Tong, Tong; Wang, Mingrong; Qiao, Yan; Zhou, Yuling; Chang, Jiang; Zhai, Kan; Wang, Menghan; Wei, Lixuan; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Li, Dong; Yu, Dianke; Tong, Tong; Wang, Mingrong; Lin, Dongmei; Qiao, Yan; Zhou, Yuling; Chang, Jiang; Zhai, Kan; Wang, Menghan; Wei, Lixuan; Tan, Wen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Chen; Yu, Dianke; Chang, Jiang; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Jia, Weihua; Zeng, Yixin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Peoples R China; [Lin, Dongmei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; State Key Lab Oncology South China; Sun Yat Sen University; Nanjing Medical University; Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Lin, DX (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	lindx72@cicams.ac.cn		Shen, Hongbing/0000-0002-2581-5906; wei, lixuan/0000-0001-7465-7513; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011	National Basic Research Program of China [2013CB910303, 2011CB504303]; National Natural Science Foundation of China [91229126]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge Y. Shimada (Hyogo College of Medicine) for providing the eight ESCC cell lines. This work was funded by the National Basic Research Program of China (2013CB910303 and 2011CB504303) and the National Natural Science Foundation of China (91229126).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Azzato EM, 2010, J NATL CANCER I, V102, P650, DOI 10.1093/jnci/djq057; Boonstra JJ, 2011, J GASTROINTEST SURG, V15, P48, DOI 10.1007/s11605-010-1358-9; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Innocenti F, 2012, CLIN CANCER RES, V18, P577, DOI 10.1158/1078-0432.CCR-11-1387; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; John E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-118; Kaneko K, 2010, FRONT BIOSCI-LANDMRK, V15, P65, DOI 10.2741/3607; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kuwahara A, 2010, J EXP CLIN CANC RES, V29, P1, DOI 10.1186/1756-9966-29-100; Lee PC, 2009, ANN THORAC SURG, V88, P186, DOI 10.1016/j.athoracsur.2009.03.079; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Liu JG, 2012, EUR J CARDIO-THORAC, V41, pE7, DOI 10.1093/ejcts/ezr240; Lopez V, 2010, EXP CELL RES, V316, P366, DOI 10.1016/j.yexcr.2009.10.011; Lu C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-91; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; Ma XL, 2009, MOL CANCER THER, V8, P3108, DOI 10.1158/1535-7163.MCT-08-0772; Okumura H, 2013, INT J CLIN ONCOL, V18, P329, DOI 10.1007/s10147-012-0383-y; Okuno T, 2007, AM J CLIN ONCOL-CANC, V30, P252, DOI 10.1097/01.coc.0000256059.88247.25; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Stiles BM, 2010, J THORAC CARDIOV SUR, V139, P387, DOI 10.1016/j.jtcvs.2009.10.003; Sun ZG, 2011, DIS ESOPHAGUS, V24, P182, DOI 10.1111/j.1442-2050.2010.01125.x; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thrift AP, 2012, INT J CANCER, V130, P2407, DOI 10.1002/ijc.26242; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang LS, 1999, AM J GASTROENTEROL, V94, P1933; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willis JA, 2012, CLIN CANCER RES, V18, P3942, DOI 10.1158/1078-0432.CCR-11-2856; Wu C, 2014, GUT, V63, P152, DOI 10.1136/gutjnl-2012-303477; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu C, 2010, CANCER RES, V70, P9721, DOI 10.1158/0008-5472.CAN-10-1493; Wu XF, 2011, J NATL CANCER I, V103, P817, DOI 10.1093/jnci/djr075; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; ZHANG DW, 1994, WORLD J SURG, V18, P347, DOI 10.1007/BF00316813; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	42	79	83	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					632	+		10.1038/ng.2638	http://dx.doi.org/10.1038/ng.2638			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23644492				2022-12-17	WOS:000319563900010
J	Wegmann, D; Kessner, DE; Veeramah, KR; Mathias, RA; Nicolae, DL; Yanek, LR; Sun, YV; Torgerson, DG; Rafaels, N; Mosley, T; Becker, LC; Ruczinski, I; Beaty, TH; Kardia, SLR; Meyers, DA; Barnes, KC; Becker, DM; Freimer, NB; Novembre, J				Wegmann, Daniel; Kessner, Darren E.; Veeramah, Krishna R.; Mathias, Rasika A.; Nicolae, Dan L.; Yanek, Lisa R.; Sun, Yan V.; Torgerson, Dara G.; Rafaels, Nicholas; Mosley, Thomas; Becker, Lewis C.; Ruczinski, Ingo; Beaty, Terri H.; Kardia, Sharon L. R.; Meyers, Deborah A.; Barnes, Kathleen C.; Becker, Diane M.; Freimer, Nelson B.; Novembre, John			Recombination rates in admixed individuals identified by ancestry-based inference	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; HUMAN GENOME; COPY NUMBER; INVERSION POLYMORPHISMS; POPULATION-STRUCTURE; ADMIXTURE; PATTERNS; LINKAGE; SELECTION; SEQUENCE	Studies of recombination and how it varies depend crucially on accurate recombination maps. We propose a new approach for constructing high-resolution maps of relative recombination rates based on the observation of ancestry switch points among admixed individuals. We show the utility of this approach using simulations and by applying it to SNP genotype data from a sample of 2,565 African Americans and 299 African Caribbeans and detecting several hundred thousand recombination events. Comparison of the inferred map with high-resolution maps from non-admixed populations provides evidence of fine-scale differentiation in recombination rates between populations. Overall, the admixed map is well predicted by the average proportion of admixture and the recombination rate estimates from the source populations. The exceptions to this are in areas surrounding known large chromosomal structural variants, specifically inversions. These results suggest that outside of structurally variable regions, admixture does not substantially disrupt the factors controlling recombination rates in humans.	[Wegmann, Daniel; Veeramah, Krishna R.; Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA; [Kessner, Darren E.; Novembre, John] Univ Calif Los Angeles, Interdept Program Bioinformat, Los Angeles, CA USA; [Mathias, Rasika A.; Yanek, Lisa R.; Becker, Lewis C.; Barnes, Kathleen C.; Becker, Diane M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Nicolae, Dan L.; Torgerson, Dara G.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Sun, Yan V.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Sun, Yan V.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Rafaels, Nicholas; Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Mosley, Thomas] Univ Mississippi, Dept Med, Jackson, MS 39216 USA; [Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Meyers, Deborah A.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; University of Chicago; University of Chicago; University of Chicago; University of Michigan System; University of Michigan; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Mississippi; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Los Angeles	Novembre, J (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA.	jnovembre@ucla.edu	Novembre, John/G-1339-2011; Wegmann, Daniel/K-2199-2012	Wegmann, Daniel/0000-0003-2866-6739; Nicolae, Dan/0000-0002-0918-4630	Searle Scholar Program; US National Institutes of Health (NIH) [R01HL087679, RL1MH083268]; NIH [HL072518, M01-RR00052, U01 HL49596, R01 HL072414, R01 HL087665, RC2 HL101651, HL087660, HL49612, AI50024, AI44840, HL075417, HL072433, AI41040, ES09606, RR03048]; US Environmental Protection Agency [83213901]; National Institute of General Medical Sciences (NIGMS) [S06GM08015]; Johns Hopkins University; NHLBI STAMPEED; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101651, U01HL049596, U01HL049612, R01HL087699, R01HL087665, R01HL087679, U01HL072518, U01HL075417, R01HL087660, R01HL072414, U01HL072433, RC1HL100245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R18AI044840, R01AI044840, R01AI041040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES009606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER	Searle Scholar Program; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Environmental Protection Agency(United States Environmental Protection Agency); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Johns Hopkins University(Johns Hopkins University); NHLBI STAMPEED(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J. N., D. W. and K. R. V. were funded by a Searle Scholar Program award to J. N. N. B. F. was supported by US National Institutes of Health (NIH) grants R01HL087679 and RL1MH083268. The sample assembled is compiled from the larger efforts and the generous sharing of data from four major consortiums. For the GeneSTAR consortium (L. C. B., D. R. B., L.R.Y. and R. A. M.), support came from NIH grants HL072518 and M01-RR00052. For the CAG-CSGA consortium (D. A. M., D. G. T. and D. L. N.), support came from NIH grants U01 HL49596, R01 HL072414, R01 HL087665 and RC2 HL101651, and special thanks is given to C. Ober. For the GENOA samples (Y.V.S. and S. L. R. K.), support came from NIH grants HL087660 and HL100245, and special thanks is given to E. Boerwinkle. For the GRAAD consortium (K. C. B., N. R., I. R., T. H. B. and R. A. M.), support came from NIH grants HL087699, HL49612, AI50024, AI44840, HL075417, HL072433, AI41040, ES09606, HL072433 and RR03048, US Environmental Protection Agency grant 83213901, and National Institute of General Medical Sciences (NIGMS) grant S06GM08015, and special thanks are given to A. V. Grant, L. Gao, C. Vergara, Y. J. Tsai, P. Gao, M. C. Liu, P. Breysse, M. B. Bracken, J. Hoh, E. W. Pugh, A. F. Scott, G. Abecasis, T. Murray, T. Hand, M. Yang, M. Campbell, C. Foster, J. B. Hetmanski, R. Ashworth, C. M. Ongaco, K. N. Hetrick and K. F. Doheny. K. C. B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. R. A. M. was supported in part by the Mosaic Initiative Award from Johns Hopkins University. We thank C. Jaquish and the NHLBI STAMPEED program for their support of this collaboration. We also acknowledge G. Coop, A. di Rienzo, K. Lohmueller, and M. Przeworski for helpful discussions and comments on a draft of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bansal V, 2007, GENOME RES, V17, P219, DOI 10.1101/gr.5774507; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daniels PR, 2004, AM J MED, V116, P676, DOI 10.1016/j.amjmed.2003.12.032; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Graffelman J, 2007, HUM GENET, V122, P301, DOI 10.1007/s00439-007-0391-6; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Ju YS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-554; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Laayouni H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017913; LONG JC, 1991, GENETICS, V127, P417; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Murray T, 2010, GENET EPIDEMIOL, V34, P561, DOI 10.1002/gepi.20512; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Serre D, 2005, GENOME RES, V15, P1547, DOI 10.1101/gr.4211905; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tang H, 2007, AM J HUM GENET, V81, P626, DOI 10.1086/520769; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zambelli-Weiner A, 2005, J ALLERGY CLIN IMMUN, V115, P1203, DOI 10.1016/j.jaci.2005.03.001; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	53	79	79	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					847	U53		10.1038/ng.894	http://dx.doi.org/10.1038/ng.894			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21775992	Green Published, Green Accepted			2022-12-17	WOS:000294325800009
J	Mons, B; van Haagen, H; Chichester, C; 't Hoen, PB; den Dunnen, JT; van Ommen, G; van Mulligen, E; Singh, B; Hooft, R; Roos, M; Hammond, J; Kiesel, B; Giardine, B; Velterop, J; Groth, P; Schultes, E				Mons, Barend; van Haagen, Herman; Chichester, Christine; 't Hoen, Peter-Bram; den Dunnen, Johan T.; van Ommen, Gertjan; van Mulligen, Erik; Singh, Bharat; Hooft, Rob; Roos, Marco; Hammond, Joel; Kiesel, Bruce; Giardine, Belinda; Velterop, Jan; Groth, Paul; Schultes, Erik			The value of data	NATURE GENETICS			English	Editorial Material								Data citation and the derivation of semantic constructs directly from datasets have now both found their place in scientific communication. The social challenge facing us is to maintain the value of traditional narrative publications and their relationship to the datasets they report upon while at the same time developing appropriate metrics for citation of data and data constructs.	[Mons, Barend; van Haagen, Herman; 't Hoen, Peter-Bram; den Dunnen, Johan T.; van Ommen, Gertjan; Roos, Marco; Schultes, Erik] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Mons, Barend; Chichester, Christine; Singh, Bharat; Hooft, Rob; Roos, Marco] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Mons, Barend; van Mulligen, Erik; Singh, Bharat] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Mons, Barend; Chichester, Christine; 't Hoen, Peter-Bram; van Ommen, Gertjan; van Mulligen, Erik; Hooft, Rob; Roos, Marco; Velterop, Jan; Groth, Paul; Schultes, Erik] Concept Web Alliance, Nijmegen, Netherlands; [Hammond, Joel; Kiesel, Bruce] Thomson Reuters, Philadelphia, PA USA; [Giardine, Belinda] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Velterop, Jan] Acad Concept Knowledge LTD, London, England; [Groth, Paul] Free Univ Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Clarivate; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vrije Universiteit Amsterdam	Mons, B (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	barend.mons@nbic.nl	dunnen, johan den/ABH-4228-2020; Hooft, Rob W.W./A-2906-2010; Hoen, Peter A 't/D-3950-2018; Kiesel, Bruce/A-1027-2007; 't Hoen, Peter/A-4857-2012; Groth, Paul T/F-1577-2010; Groth, Paul/AAI-2019-2021; Schultes, Erik/B-6035-2012	dunnen, johan den/0000-0002-6304-1710; Hooft, Rob W.W./0000-0001-6825-9439; Hoen, Peter A 't/0000-0003-4450-3112; Kiesel, Bruce/0000-0001-8593-0271; Groth, Paul T/0000-0003-0183-6910; Groth, Paul/0000-0003-0183-6910; van Mulligen, Erik/0000-0003-1377-9386; Schultes, Erik/0000-0001-8888-635X; Mons, Barend/0000-0003-3934-0072; Roos, Marco/0000-0002-8691-772X				[Anonymous], 2007, NAT GENET, V39, P423; Bizer C., 2009, INT J SEMANT WEB INF; den Dunnen JT, 2002, HUM MUTAT, V20, P403; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613; Mons B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-142; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; Mons Barend, 2009, CEUR WORKSHOP PROC, V523; van Haagen HHHBM, 2011, PROTEOMICS, V11, P843, DOI 10.1002/pmic.201000398; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894	10	79	81	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2011	43	4					281	283		10.1038/ng0411-281	http://dx.doi.org/10.1038/ng0411-281			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21445068				2022-12-17	WOS:000288903700002
J	Schramek, D; Kotsinas, A; Meixner, A; Wada, T; Elling, U; Pospisilik, JA; Neely, GG; Zwick, RH; Sigl, V; Forni, G; Serrano, M; Gorgoulis, VG; Penninger, JM				Schramek, Daniel; Kotsinas, Athanassios; Meixner, Arabella; Wada, Teiji; Elling, Ulrich; Pospisilik, J. Andrew; Neely, G. Gregory; Zwick, Ralf-Harun; Sigl, Verena; Forni, Guido; Serrano, Manuel; Gorgoulis, Vassilis G.; Penninger, Josef M.			The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DNA-DAMAGE RESPONSE; JUN NH2-TERMINAL KINASE; C-JUN; K-RAS; LUNG-CANCER; PRECANCEROUS LESIONS; INDUCED SENESCENCE; BREAST-CANCER; MICE	Most preneoplastic lesions are quiescent and do not progress to form overt tumors. It has been proposed that oncogenic stress activates the DNA damage response and the key tumor suppressor p53, which prohibits tumor growth. However, the molecular pathways by which cells sense a premalignant state in vivo are largely unknown. Here we report that tissue-specific inactivation of the stress signaling kinase MKK7 in KRas(G12D)-driven lung carcinomas and NeuT-driven mammary tumors markedly accelerates tumor onset and reduces overall survival. Mechanistically, MKK7 acts through the kinases JNK1 and JNK2, and this signaling pathway directly couples oncogenic and genotoxic stress to the stability of p53, which is required for cell cycle arrest and suppression of epithelial cancers. These results show that MKK7 functions as a major tumor suppressor in lung and mammary cancer in mouse and identify MKK7 as a vital molecular sensor to set a cellular anti-cancer barrier.	[Schramek, Daniel; Meixner, Arabella; Wada, Teiji; Elling, Ulrich; Pospisilik, J. Andrew; Sigl, Verena; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Kotsinas, Athanassios; Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; [Neely, G. Gregory] Garvan Inst Med Res, Sydney, NSW, Australia; [Zwick, Ralf-Harun] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria; [Forni, Guido] Univ Turin, Dept Clin & Biol Sci, Ctr Mol Biotechnol, Turin, Italy; [Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Athens Medical School; National & Kapodistrian University of Athens; Garvan Institute of Medical Research; University of Turin; Centro Nacional de Investigaciones Oncologicas (CNIO)	Penninger, JM (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Schramek, Daniel/J-5792-2014; Neely, Greg/AAB-4642-2020; Schramek, Daniel/AAL-1470-2020; Penninger, Josef M/I-6860-2013; Serrano, Manuel/H-2634-2015; Gorgoulis, Vassilis/AAD-3630-2019; neely, graham/A-6511-2011	Neely, Greg/0000-0002-1957-9732; Schramek, Daniel/0000-0001-9977-2104; Penninger, Josef M/0000-0002-8194-3777; Serrano, Manuel/0000-0001-7177-9312; Gorgoulis, Vassilis/0000-0001-9001-4112; 	EU INFLA-CARE network; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; EU	EU INFLA-CARE network; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)European Commission); EU(European Commission)	We thank all members of our laboratories for discussions; H. Scheuch and M. Radolf for microarray support; and E. Wagner for reading the manuscript. D. S. is supported by the EU INFLA-CARE network. J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse) and an EU ERC Advanced Grant. V. G. G. and A. K. are supported by the EU-grants INFLA-CARE and GENICA.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chen NY, 2001, CANCER RES, V61, P3908; COLES C, 1992, CANCER RES, V52, P5291; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Costa A, 2008, NAT CLIN PRACT ONCOL, V5, P700, DOI 10.1038/ncponc1239; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Efeyan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005475; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; LEHMAN TA, 1991, CANCER RES, V51, P4090; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; She QB, 2002, CANCER RES, V62, P1343; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	50	79	81	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					212	U55		10.1038/ng.767	http://dx.doi.org/10.1038/ng.767			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21317887				2022-12-17	WOS:000287693800011
J	Steiger, D; Furrer, M; Schwinkendorf, D; Gallant, P				Steiger, Dominik; Furrer, Michael; Schwinkendorf, Daniela; Gallant, Peter			Max-independent functions of Myc in Drosophila melanogaster	NATURE GENETICS			English	Article							POLYMERASE-III TRANSCRIPTION; C-MYC; CELL-GROWTH; FACTOR NETWORK; RIBOSOMAL DNA; DMYC; APOPTOSIS; PROTEIN; TRANSFORMATION; PROLIFERATION	Myc proteins are powerful proto-oncoproteins and important promoters of growth and proliferation during normal development. They are thought to exercise their effects upon binding to their partner protein Max, and their activities are largely antagonized by complexes of Max with Mnt or an Mxd family protein. Although the biological functions of Myc, Mxd and Mnt have been intensively studied, comparatively little is known about the in vivo role of Max. Here we generate Max loss-of-function and reduction-of-function mutations in Drosophila melanogaster to address the contribution of Max to Myc-dependent growth control. We find that many biological activities of Myc do not, or only partly, require the association with Max - for example, the control of endoreplication and cell competition - and that a Myc mutant that does not interact with Max retains substantial biological activity. We further show that Myc can control RNA polymerase III independently of Max, which explains some of Myc's observed biological activities. These studies show the ability of Myc to function independently of Max in vivo and thus change the current model of Max network function.	[Steiger, Dominik; Furrer, Michael; Schwinkendorf, Daniela; Gallant, Peter] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Zurich	Gallant, P (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gallant@zool.uzh.ch	Steiger, Dominik/F-1092-2010	Steiger, Dominik/0000-0003-2191-8091	Schweizerische Nationalfonds (SNF)	Schweizerische Nationalfonds (SNF)(Swiss National Science Foundation (SNSF))	We thank S. Pierce and R. Eisenman (Fred Hutchinson Cancer Research Center) for providing us with a dm Mnt recombinant chromosome before publication; K. Basler, J. Bischof (University of Zurich), E. Hafen, H. Stocker (ETH Zurich), S. Takada (MD Anderson) and D. Stein (University of Texas, Austin) for flies and antibodies; H. Stocker and C. Hugentobler for advice; N. Muller, R. Perez and other members of the lab for technical help and support; O. Carreno, L. Damerius, N. Arnold, N. Meier and S. Peterhans for help with fly work; and K. Basler and R. Eisenman for critical comments on the manuscript. This work was financially supported by a grant from the Schweizerische Nationalfonds (SNF).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bellosta P, 2005, P NATL ACAD SCI USA, V102, P11799, DOI 10.1073/pnas.0408945102; Benassayag C, 2005, MOL CELL BIOL, V25, P9897, DOI 10.1128/MCB.25.22.9897-9909.2005; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hong SL, 2000, GENE DEV, V14, P17; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Isogai Y, 2007, EMBO J, V26, P76, DOI 10.1038/sj.emboj.7601448; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; LAROCCA SA, 1994, ONCOGENE, V9, P3499; Loo LWM, 2005, MOL CELL BIOL, V25, P7078, DOI 10.1128/MCB.25.16.7078-7091.2005; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nilsson JA, 2004, MOL CELL BIOL, V24, P1560, DOI 10.1128/MCB.24.4.1560-1569.2004; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pierce SB, 2008, DEV BIOL, V315, P303, DOI 10.1016/j.ydbio.2007.12.026; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wert M, 2001, ONCOGENE, V20, P3746, DOI 10.1038/sj.onc.1204466	50	79	81	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1084	1091		10.1038/ng.178	http://dx.doi.org/10.1038/ng.178			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165923				2022-12-17	WOS:000258761200021
J	Delneri, D; Hoyle, DC; Gkargkas, K; Cross, EJM; Rash, B; Zeef, L; Leong, HS; Davey, HM; Hayes, A; Kell, DB; Griffith, GW; Oliver, SG				Delneri, Daniela; Hoyle, David C.; Gkargkas, Konstantinos; Cross, Emma J. M.; Rash, Bharat; Zeef, Leo; Leong, Hui-Sun; Davey, Hazel M.; Hayes, Andrew; Kell, Douglas B.; Griffith, Gareth W.; Oliver, Stephen G.			Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; HAPLOINSUFFICIENCY; ONTOLOGY; DELETION; STRAINS	Using competition experiments in continuous cultures grown in different nutrient environments (glucose limited, ammonium limited, phosphate limited and white grape juice), we identified genes that show haploinsufficiency phenotypes (reduced growth rate when hemizygous) or haploproficiency phenotypes (increased growth rate when hemizygous). Haploproficient genes (815, 1,194, 733 and 654 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) frequently show that phenotype in a specific environmental context. For instance, genes encoding components of the ubiquitination pathway or the proteasome show haploproficiency in nitrogen-limited conditions where protein conservation may be beneficial. Haploinsufficiency is more likely to be observed in all environments, as is the case with genes determining polar growth of the cell. Haploproficient genes seem randomly distributed in the genome, whereas haploinsufficient genes (685, 765, 1,277 and 217 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) are over-represented on chromosome III. This chromosome determines a yeast's mating type, and the concentration of haploinsufficient genes there may be a mechanism to prevent its loss.	Univ Manchester, Sch Med, NIBHI, Manchester M13 9PT, Lancs, England; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; Aberystwyth University; University of Manchester; University of Manchester; University of Manchester	Oliver, SG (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg,Tennis Court Rd, Cambridge, England.	steve.oliver@bioc.cam.ac.uk	Griffith, Gareth W./A-1970-2009; Kell, Douglas/E-8318-2011; Davey, Hazel/C-9055-2009; Oliver, Stephen/AAQ-5992-2021; Zeef, Leo/D-6922-2011	Griffith, Gareth W./0000-0001-6914-3745; Kell, Douglas/0000-0001-5838-7963; Oliver, Stephen/0000-0003-3410-6439; Delneri, Daniela/0000-0001-8070-411X; Hayes, Andy/0000-0002-9525-0306; Davey, Hazel/0000-0001-9185-0761; Hoyle, David/0000-0003-3483-5885	Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C505140/1, BB/C505140/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; OLIVER SG, 1991, BIOTECHNOLOGY HDB SA, P213; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Sherman F., 1981, METHODS YEAST GENETI; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	21	79	79	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					113	117		10.1038/ng.2007.49	http://dx.doi.org/10.1038/ng.2007.49			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157128				2022-12-17	WOS:000252118600027
J	Eichler, EE				Eichler, EE			Widening the spectrum of human genetic variation	NATURE GENETICS			English	Editorial Material							HUMAN GENOME; SEGMENTAL DUPLICATIONS	SNP genotyping platforms have been used to discover similar to 1,000 deletion structural variants within the human genome, with median lengths ranging from 500 bp to 10.5 kb. Analyses of a subset of these provide compelling evidence of linkage disequilibrium with flanking SNPs.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu						Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2003, COLD SPRING HARB SYM, V68, P445, DOI 10.1101/sqb.2003.68.445; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	14	79	87	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2006	38	1					9	11		10.1038/ng0106-9	http://dx.doi.org/10.1038/ng0106-9			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16380720				2022-12-17	WOS:000234227200003
J	Thilly, WG				Thilly, WG			Have environmental mutagens caused oncomutations in people?	NATURE GENETICS			English	Article							NITROSO-N-METHYLUREA; MUTATIONAL SPECTRA; UNITED-STATES; DNA-ADDUCTS; HPRT GENE; P53 GENE; MAMMARY CARCINOGENESIS; LAMINATION WORKERS; T-LYMPHOCYTES; COLON-CANCER	Age-specific cancer rates show large historical increases that indict environmental risk factors. But these environmental factors did not necessarily act by increasing oncomutation rates. Mathematical analyses suggest selective effects on preexisting oncomutants. The widely held hypothesis that environmental chemicals induce a substantial fraction of human point mutations has not been supported by observation. Direct measurement of the kinds and numbers of point mutations in human tissues have, in fact, found no clear relationship with exposure to environmental agents, save for sunlight in the skin. Alternative hypotheses that point mutations arise primarily as errors during turnover of undamaged DNA and that environmental conditions select rather than induce oncomutants seem to better explain the facts of environmental carcinogenesis in humans.	MIT, Biol Engn Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Thilly, WG (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Albertini RJ, 2001, CHEM-BIOL INTERACT, V135, P429, DOI 10.1016/S0009-2797(01)00181-8; ALBERTINI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6617, DOI 10.1073/pnas.79.21.6617; ALEXANDROV K, 1992, CANCER RES, V52, P6248; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; BENZER S, 1958, P NATL ACAD SCI USA, V44, P112, DOI 10.1073/pnas.44.2.112; Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brash DE, 1998, CANCER SURV, V32, P69; BurkhartSchultz KJ, 1996, CARCINOGENESIS, V17, P1871, DOI 10.1093/carcin/17.9.1871; BURNS FJ, 1976, CANCER RES, V36, P1422; Cariello NF, 1998, NUCLEIC ACIDS RES, V26, P198, DOI 10.1093/nar/26.1.198; CARIELLO NF, 1990, MUTAT RES, V231, P165, DOI 10.1016/0027-5107(90)90023-W; CHA RS, 1994, P NATL ACAD SCI USA, V91, P3749, DOI 10.1073/pnas.91.9.3749; Coller HA, 1998, CANCER RES, V58, P1268; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; COLLER HA, 1994, ENVIRON SCI TECHNOL, V28, P478; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Curry J, 1999, GENETICS, V152, P1065; Dong CH, 2001, INT J CANCER, V92, P144; DUNN JE, 1975, CANCER RES, V35, P3240; ERB LT, 2002, MATH MODEL PANCREATI; GRIVELL AR, 1975, J MOL BIOL, V98, P219, DOI 10.1016/S0022-2836(75)80110-0; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Herrero-Jimenez P, 1998, MUTAT RES-FUND MOL M, V400, P553, DOI 10.1016/S0027-5107(98)00067-0; HERREROJIMENEZ P, 2001, DETERMINATION HIST C; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V405, P155, DOI 10.1016/S0027-5107(98)00132-8; Jin ZA, 1996, CANCER RES, V56, P4927; KENSLER TW, 1996, IARC SCI PUBL, V139, P237; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219; Morley AA, 1999, MUTAT RES-FUND MOL M, V428, P11, DOI 10.1016/S1383-5742(99)00026-5; Muniappan BP, 2002, CANCER RES, V62, P3271; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; OLLER AR, 1992, J MOL BIOL, V228, P813, DOI 10.1016/0022-2836(92)90866-I; PELC SR, 1972, INT REV CYTOL, V32, P327, DOI 10.1016/S0074-7696(08)60344-7; Podlutsky A, 1999, MUTAT RES-FUND MOL M, V431, P325, DOI 10.1016/S0027-5107(99)00176-1; Rodin SN, 2000, P NATL ACAD SCI USA, V97, P12244, DOI 10.1073/pnas.180320897; THILLY WG, 1981, TECHNOL REV, V83, P37; TOMITAMITCHELL A, IN PRESS CANC RES; *US BUR CENS, 1900, MORT STAT; *US DEP HHS, 1937, VIT STAT US; VODICKA P, 1995, CARCINOGENESIS, V16, P1473, DOI 10.1093/carcin/16.7.1473; Vodicka P, 1999, MUTAT RES-GEN TOX EN, V445, P205, DOI 10.1016/S1383-5718(99)00127-8; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Yang K, 1998, MUTAT RES-FUND MOL M, V422, P285, DOI 10.1016/S0027-5107(98)00210-3; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198; ZIEGLER A, 1994, NATURE, V372, P730	55	79	85	1	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					255	259		10.1038/ng1205	http://dx.doi.org/10.1038/ng1205			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12833049				2022-12-17	WOS:000183815300009
J	Bachtrog, D				Bachtrog, D			Adaptation shapes patterns of genome evolution on sexual and asexual chromosomes in Drosophila	NATURE GENETICS			English	Article							NEO-Y CHROMOSOME; DEGENERATION; HYPOTHESIS; MIRANDA	What advantage might sexual recombination confer? Population genetics theory predicts that asexual genomes are less efficient at eliminating deleterious mutations and incorporating beneficial alleles(1,2). Here, I compare patterns of genome evolution in a 40-kb gene-rich region on homologous neo-sex chromosomes of Drosophila miranda(3). Genes on the non-recombining neo-Y show various signs of degeneration, including transposable-element insertions, frameshift mutations and a higher rate of amino-acid substitution. In contrast, loci on the recombining neo-X show intact open reading frames and generally low rates of amino-acid substitution. One exceptional gene on the neo-X shows evidence for adaptive protein evolution, affecting patterns of variability at neighboring regions along the chromosome. These findings illustrate the limits to natural selection in an asexual genome. Deleterious mutations, including repetitive DNA, accumulate on a non-recombining chromosome, whereas rapid protein evolution due to positive selection is confined to the recombining homolog.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Bachtrog, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Doris.Bachtrog@ed.ac.uk						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 1984, AM NAT; Bachtrog D, 2000, CURR BIOL, V10, P1025, DOI 10.1016/S0960-9822(00)00656-4; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; BACHTROG D, IN PRESS GENETICS; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; Bull J.J., 1983, EVOLUTION SEX DETERM; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; FELSENSTEIN J, 1974, GENETICS, V78, P737; HUDSON RR, 1987, GENETICS, V116, P153; Li W.H., 1997, MOL EVOLUTION; Macknight RH, 1939, GENETICS, V24, P180; Maynard Smith J, 1978, EVOLUTION SEX; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Ohno S., 1970, EVOLUTION GENE DUPLI; Orr HA, 1998, GENETICS, V150, P1693; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; TAJIMA F, 1989, GENETICS, V123, P585	28	79	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					215	219		10.1038/ng1164	http://dx.doi.org/10.1038/ng1164			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12754509				2022-12-17	WOS:000183200500030
J	Zenklusen, JC; Conti, CJ; Green, ED				Zenklusen, JC; Conti, CJ; Green, ED			Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31	NATURE GENETICS			English	Article							PRIMARY BREAST-CANCER; COMMONLY DELETED REGION; LONG ARM; PHYSICAL MAP; OVARIAN-CANCER; SQUAMOUS-CELL; FREQUENT LOSS; HETEROZYGOSITY; HUMAN-CHROMOSOME-7; CARCINOMAS	Loss of heterozygosity (LOH) of markers on human chromosome 7q31 is frequently encountered in a variety of human neoplasias, indicating the presence of a tumor-suppressor gene (TSC). By a combination of microcell-fusion and deletion-mapping studies, we previously established that this TSG resides within a critical region flanked by the genetic markers D7S522 and D7S677. Using a positional cloning strategy and aided by the availability of near-complete sequence of this genomic interval, we have identified a TSG within 7q31, named ST7 (for suppression of tumorigenicity 7; this same gene was recently reported in another context and called RAY1). ST7 is ubiquitously expressed in human tissues. Analysis of a series of cell lines derived from breast tumors and primary colon carcinomas revealed the presence of mutations in ST7. Introduction of the ST7 cDNA into the prostate-cancer-derived cell line PC3 had no effect on the in vitro proliferation of the cells, but abrogated their in vivo tumorigenicity. Our data indicate that ST7 is a TSG within chromosome 7q31 and may have an important role in the development of some types of human cancer.	NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; UTMD Anderson Cancer Center	Zenklusen, JC (corresponding author), NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA.							ABRAHAMSON GM, 1993, AM J HEMATOL, V42, P171, DOI 10.1002/ajh.2830420206; Achille A, 1996, CANCER RES, V56, P3808; BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; Bieche I, 1997, CLIN CANCER RES, V3, P1009; Black DM, 1999, BRIT J CANCER, V80, P42; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Cunningham JM, 1996, CANCER RES, V56, P4475; Dale TC, 1996, CANCER RES, V56, P4320; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; ElNaggar AK, 1997, AM J PATHOL, V151, P1767; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8449; Gupta PK, 1997, CANCER RES, V57, P1188; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.3.CO;2-M; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; Kaighn M E, 1978, Natl Cancer Inst Monogr, P17; KIBBELAAR RE, 1993, BLOOD, V82, P904; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Lin JC, 1996, ONCOGENE, V13, P2001; Matsuda T, 1997, ONCOGENE, V15, P2773, DOI 10.1038/sj.onc.1201461; Michaels JEA, 1996, P NATL ACAD SCI USA, V93, P14452, DOI 10.1073/pnas.93.25.14452; MOORE D, 1992, CURRENT PROTOCOLS MO; Myohanen SK, 1998, CANCER RES, V58, P591; NEUMAN WL, 1992, BLOOD, V79, P1501; Nishizuka S, 1997, BRIT J CANCER, V76, P1567, DOI 10.1038/bjc.1997.598; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; OGATA T, 1995, JPN J CANCER RES, V86, P35, DOI 10.1111/j.1349-7006.1995.tb02985.x; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Shridhar V, 1997, ONCOGENE, V15, P2727, DOI 10.1038/sj.onc.1201448; Sprenger CC, 1999, CANCER RES, V59, P2370; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Trovato M, 1999, J CLIN ENDOCR METAB, V84, P3235, DOI 10.1210/jcem.84.9.5986; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Vande Woude GF, 1997, CIBA F SYMP, V212, P119; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; XU Y, 1994, ISMB, V2, P376; ZENKLUSEN JC, 1994, ONCOGENE, V9, P2817; Zenklusen JC, 1996, MOL CARCINOGEN, V15, P167; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1994, P NATL ACAD SCI USA, V91, P12155, DOI 10.1073/pnas.91.25.12155; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zenklusen JC, 2000, ONCOGENE, V19, P1729, DOI 10.1038/sj.onc.1203488; Zenklusen Jean C., 1999, Neoplasia (New York), V1, P16, DOI 10.1038/sj.neo.7900011; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	50	79	86	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					392	398		10.1038/86891	http://dx.doi.org/10.1038/86891			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279520				2022-12-17	WOS:000167811200013
J	Lingenfelter, PA; Adler, DA; Poslinski, D; Thomas, S; Elliott, RW; Chapman, VM; Disteche, CM				Lingenfelter, PA; Adler, DA; Poslinski, D; Thomas, S; Elliott, RW; Chapman, VM; Disteche, CM			Escape from X inactivation of Smcx is preceded by silencing during mouse development	NATURE GENETICS			English	Letter							GENE; CHROMOSOME; HOMOLOG; TISSUE; RPS4		Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Roswell Pk Canc Ctr, Dept Cell & Mol Biol, Buffalo, NY USA	University of Washington; University of Washington Seattle; Roswell Park Cancer Institute	Lingenfelter, PA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.				PHS HHS [MG46883, MG33160] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; BRESSLER SL, 1993, SOMAT CELL MOLEC GEN, V19, P29, DOI 10.1007/BF01233952; Carrel L, 1996, HUM MOL GENET, V5, P1361, DOI 10.1093/hmg/5.9.1361; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; SINGERSAM J, 1993, METHOD ENZYMOL, V225, P334; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WU JS, 1994, NAT GENET, V7, P491, DOI 10.1038/ng0894-491; ZINN AR, 1991, GENOMICS, V11, P1097, DOI 10.1016/0888-7543(91)90037-F; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	13	79	79	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					212	213		10.1038/ng0398-212	http://dx.doi.org/10.1038/ng0398-212			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500539				2022-12-17	WOS:000072325000015
J	Bell, JI; Lathrop, GM				Bell, JI; Lathrop, GM			Multiple loci for multiple sclerosis	NATURE GENETICS			English	Editorial Material											Bell, JI (corresponding author), UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND.							Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EBERS GC, 1995, NATURE, V377, P260; EVERS GC, 1996, NAT GENET, V13, P472; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; PELTONEN L, 1996, NAT GENET, V13, P477; SAUREZ BK, 1994, GENETIC APPROACHES M, P23; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Tienari Pentti J., 1993, European Journal of Human Genetics, V1, P257; TIENARI PJ, 1992, LANCET, V340, P987, DOI 10.1016/0140-6736(92)93007-A	10	79	84	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					377	378		10.1038/ng0896-377	http://dx.doi.org/10.1038/ng0896-377			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696322				2022-12-17	WOS:A1996VB62000002
J	Estivill, X				Estivill, X			Complexity in a monogenic disease	NATURE GENETICS			English	Editorial Material							CYSTIC-FIBROSIS GENE; CONDUCTANCE REGULATOR GENE; CFTR CHLORIDE CHANNEL; MUTATIONS; MILD; IDENTIFICATION; PHENOTYPE		HOSP CLIN BARCELONA,GENET SERV,BARCELONA,CATALUNYA,SPAIN	University of Barcelona; Hospital Clinic de Barcelona	Estivill, X (corresponding author), HOSP LLOBREGAT,CANC RES INST,DEPT MOLEC GENET,BARCELONA,CATALUNYA,SPAIN.		Estivill, Xavier/A-3125-2013	Estivill, Xavier/0000-0002-0723-2256				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; COLLEDGE WH, 1995, NAT GENET, V10, P445, DOI 10.1038/ng0895-445; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; DAVIDSON DJ, 1995, NAT GENET, V9, P351, DOI 10.1038/ng0495-351; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DORK T, 1991, HUM GENET, V87, P441; ESTIVILL X, 1995, HUM GENET, V95, P331; GASPARINI P, 1992, J MED GENET, V29, P558, DOI 10.1136/jmg.29.8.558; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; JARVI K, 1995, LANCET, V345, P1578, DOI 10.1016/S0140-6736(95)91131-6; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; MERCIER B, 1995, AM J HUM GENET, V56, P272; NUNES V, 1993, HUM MOL GENET, V2, P79, DOI 10.1093/hmg/2.1.79; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; PIGNATI PF, IN PRESS AM J HUM GE; RATLIFF R, 1992, NAT GENET, V4, P35; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; WELCH MJ, 1995, METABOLIC BASIS INHE, P3799; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WILSCHANSKI M, 1995, J PEDIATR-US, V127, P705, DOI 10.1016/S0022-3476(95)70157-5; 1993, NEW ENGL J MED, V329, P1309	30	79	79	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					348	350		10.1038/ng0496-348	http://dx.doi.org/10.1038/ng0496-348			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630481				2022-12-17	WOS:A1996UC55300005
J	SOUDAIS, C; DEVILLARTAY, JP; LEDEIST, F; FISCHER, A; LISOWSKAGROSPIERRE, B				SOUDAIS, C; DEVILLARTAY, JP; LEDEIST, F; FISCHER, A; LISOWSKAGROSPIERRE, B			INDEPENDENT MUTATIONS OF THE HUMAN CD3-EPSILON GENE RESULTING IN A T-CELL RECEPTOR/CD3 COMPLEX IMMUNODEFICIENCY	NATURE GENETICS			English	Article							PRE-MESSENGER RNA; ANTIGEN RECEPTOR; CD3 COMPLEX; EPSILON-SUBUNITS; ALPHA-CHAIN; EXPRESSION; DEFICIENCY; REQUIREMENTS; ABNORMALITY; THALASSEMIA	The T-cell receptor (TCR) is composed of two glycoproteins (alpha and beta or gamma and delta) associated with four invariant polypeptides (CD3-gamma, delta, epsilon and zeta). The majority of TCR/CD3 complexes contain six polypeptide chains, and although there is some flexibility in the complex subunit stoichiometry the CD3-epsilon chain is central to CD3 core assembly and full complex formation. We have described previously defective expression of the TCR/CD3 complex in an immunodeficient child. We now report that two independent CD3-epsilon gene mutations present in the parents have segregated in the patient, leading to defective CD3-epsilon chain synthesis and preventing normal association and membrane expression of the TCR/CD3 complex.			SOUDAIS, C (corresponding author), HOP NECKER ENFANTS MALAD,INSERM,U132,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		de Villartay, jean pierre/H-9353-2017; soudais, claire/F-9756-2016	de Villartay, jean pierre/0000-0001-5987-0463; soudais, claire/0000-0002-4387-6649				AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; ARNAIZVILLENA A, 1991, LAB INVEST, V64, P675; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BACK AL, 1992, J BIOL CHEM, V267, P5482; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BLUMBERG RS, 1990, P NATL ACAD SCI USA, V87, P7220, DOI 10.1073/pnas.87.18.7220; BUFERNE M, 1992, J IMMUNOL, V148, P657; CLEVERS H, 1989, EMBO J, V8, P2527, DOI 10.1002/j.1460-2075.1989.tb08390.x; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; CLEVERS HC, 1988, P NATL ACAD SCI USA, V85, P8156, DOI 10.1073/pnas.85.21.8156; DIANZANI I, 1991, AM J HUM GENET, V48, P631; FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418; GOLD DP, 1986, NATURE, V321, P431, DOI 10.1038/321431a0; GOTODA T, 1991, J BIOL CHEM, V266, P24757; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; JIN YJ, 1990, J BIOL CHEM, V265, P15850; KAPES DJ, 1991, P NATL ACAD SCI USA, V88, P10619; KASHII S, 1991, J CELL BIOCHEM, V47, P49, DOI 10.1002/jcb.240470107; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; LEDEIST F, 1991, EUR J IMMUNOL, V21, P1641, DOI 10.1002/eji.1830210709; LIEBHABER SA, 1987, J CLIN INVEST, V80, P154, DOI 10.1172/JCI113041; MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0; OHNO K, 1988, J BIOL CHEM, V263, P18563; PEREZACIEGO P, 1991, J EXP MED, V174, P319, DOI 10.1084/jem.174.2.319; TA L, 1991, J EXP MED, V173, P1247; THOENES G, 1992, J BIOL CHEM, V267, P487; TUNNACLIFFE A, 1987, EMBO J, V6, P2953, DOI 10.1002/j.1460-2075.1987.tb02600.x; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973	36	79	84	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					77	81		10.1038/ng0193-77	http://dx.doi.org/10.1038/ng0193-77			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490660				2022-12-17	WOS:A1993KF37200017
J	CHARTIER, FL; KEER, JT; SUTCLIFFE, MJ; HENRIQUES, DA; MILEHAM, P; BROWN, SDM				CHARTIER, FL; KEER, JT; SUTCLIFFE, MJ; HENRIQUES, DA; MILEHAM, P; BROWN, SDM			CONSTRUCTION OF A MOUSE YEAST ARTIFICIAL CHROMOSOME LIBRARY IN A RECOMBINATION-DEFICIENT STRAIN OF YEAST	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE; DNA; VECTORS; CLONES; REGION; REPAIR; RAD52	We have constructed a new generation yeast artificial chromosome (YAC) library from female C57BL/10 mice in a recombination-deficient strain of Saccharomyces cerevisiae carrying a mutation in the RAD52 gene. The YAC library contains 41,568 clones with an average insert size of 240 kilobases, representing a greater than threefold coverage of the mouse genome. Currently, the library can be screened by polymerase chain reaction and we have isolated positive clones at a number of loci in the mouse genome. This rad52 library should enable a long-term assessment of the effect of one of the yeast recombination pathway genes on both, genome-wide YAC clone stability and the frequency of chimaeric clones.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND	Imperial College London								ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURGERS PMJ, 1987, ANAL BIOCHEM, V163, P391, DOI 10.1016/0003-2697(87)90240-5; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURKE DT, 1991, MAMM GENOME, V65; CAVANNA JS, 1990, GENOMICS, V7, P12, DOI 10.1016/0888-7543(90)90513-T; CHEN DS, 1988, P NATL ACAD SCI USA, V85, P6821, DOI 10.1073/pnas.85.18.6821; CLARK GJ, 1992, IMMUNOGENETICS, V35, P54; DIETRICH A, 1991, NUCLEIC ACIDS RES, V19, P2567, DOI 10.1093/nar/19.10.2567; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; HAMVAS RMJ, 1992, GENOMICS, V12, P363, DOI 10.1016/0888-7543(92)90386-7; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; KAI T, 1990, FEBS LETT, V275, P77, DOI 10.1016/0014-5793(90)81443-R; KOZHINA TN, 1988, GENETIKA+, V24, P993; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; MALONE RE, 1980, P NATL ACAD SCI-BIOL, V77, P503, DOI 10.1073/pnas.77.1.503; NASIR J, 1990, P NATL ACAD SCI USA, V87, P399, DOI 10.1073/pnas.87.1.399; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; OZENBERGER BA, 1991, MOL CELL BIOL, V11, P1222, DOI 10.1128/MCB.11.3.1222; PAVAN WJ, 1991, P NATL ACAD SCI USA, V8, P7788; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485	27	79	82	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					132	136		10.1038/ng0592-132	http://dx.doi.org/10.1038/ng0592-132			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302006				2022-12-17	WOS:A1992JC98000012
J	Shelton, JF; Shastri, AJ; Ye, C; Weldon, CH; Filshtein-Sonmez, T; Coker, D; Symons, A; Esparza-Gordillo, J; Aslibekyan, S; Auton, A				Shelton, Janie F.; Shastri, Anjali J.; Ye, Chelsea; Weldon, Catherine H.; Filshtein-Sonmez, Teresa; Coker, Daniella; Symons, Antony; Esparza-Gordillo, Jorge; Aslibekyan, Stella; Auton, Adam		23andMe COVID-19 Team	Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity	NATURE GENETICS			English	Article							INFECTION; RECEPTOR	A study of more than one million 23andMe research participants identifies genetic and nongenetic associations with COVID-19 susceptibility and severity. COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to fatal in others. Based on a study of 1,051,032 23andMe research participants, we report genetic and nongenetic associations with testing positive for SARS-CoV-2, respiratory symptoms and hospitalization. Using trans-ancestry genome-wide association studies, we identified a strong association between blood type and COVID-19 diagnosis, as well as a gene-rich locus on chromosome 3p21.31 that is more strongly associated with outcome severity. Hospitalization risk factors include advancing age, male sex, obesity, lower socioeconomic status, non-European ancestry and preexisting cardiometabolic conditions. While non-European ancestry was a significant risk factor for hospitalization after adjusting for sociodemographics and preexisting health conditions, we did not find evidence that these two primary genetic associations explain risk differences between populations for severe COVID-19 outcomes.	[Shelton, Janie F.; Shastri, Anjali J.; Ye, Chelsea; Weldon, Catherine H.; Filshtein-Sonmez, Teresa; Coker, Daniella; Symons, Antony; Aslibekyan, Stella; Auton, Adam] 23AndMe Inc, Sunnyvale, CA 94086 USA; [Esparza-Gordillo, Jorge] GSK Med Res Ctr, Target Sci R&D, Human Genet R&D, Stevenage, Herts, England	GlaxoSmithKline	Auton, A (corresponding author), 23AndMe Inc, Sunnyvale, CA 94086 USA.	aauton@23andme.com		Coker, Daniella/0000-0003-3780-067X				ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Amraei Razie, 2021, bioRxiv, DOI [10.1021/acscentsci.0c01537, 10.1101/2020.06.22.165803]; [Anonymous], 2020, COVID 19 PROJECTIONS; Band G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13480-z; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Bugert P, 2012, TRANSFUS MED HEMOTH, V39, P182, DOI 10.1159/000339235; Callaway E, 2020, NATURE, V585, P174, DOI 10.1038/d41586-020-02544-6; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chesmore K, 2018, HUM GENET, V137, P39, DOI 10.1007/s00439-017-1854-z; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Durand EY, 2014, BIORXIV; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Gao Chao, 2020, bioRxiv, DOI 10.1101/2020.07.29.227462; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Lopez-Pacheco C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3635809; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Mourant AE, 1976, DISTRIBUTION HUMAN B; Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434; Rodriguez-Diaz CE, 2020, ANN EPIDEMIOL, V52, P46, DOI 10.1016/j.annepidem.2020.07.007; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Valverde P, 2019, ACS CHEM BIOL, V14, P1660, DOI 10.1021/acschembio.9b00458; Wein AN, 2019, J EXP MED, V216, P2748, DOI 10.1084/jem.20181308; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zietz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19623-x	39	78	79	2	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2021	53	6					801	+		10.1038/s41588-021-00854-7	http://dx.doi.org/10.1038/s41588-021-00854-7		APR 2021	24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SO8WJ	33888907	Bronze			2022-12-17	WOS:000642389400005
J	Zhao, GW; Lian, Q; Zhang, ZH; Fu, QS; He, YH; Ma, S; Ruggieri, V; Monforte, AJ; Wang, PY; Julca, I; Wang, HS; Liu, JP; Xu, Y; Wang, RZ; Ji, JB; Xu, ZH; Kong, WH; Zhong, Y; Shang, JL; Pereira, L; Argyris, J; Zhang, J; Mayobre, C; Pujol, M; Oren, E; Out, D; Wang, JM; Sun, DX; Zhao, SJ; Zhu, YC; Li, N; Katzir, N; Gur, A; Dogimont, C; Schaefer, H; Fan, W; Bendahmane, A; Fei, Z; Pitrat, M; Gabaldon, T; Lin, T; Garcia-Mas, J; Xu, YY; Huang, SW				Zhao, Guangwei; Lian, Qun; Zhang, Zhonghua; Fu, Qiushi; He, Yuhua; Ma, Shuangwu; Ruggieri, Valentino; Monforte, Antonio J.; Wang, Pingyong; Julca, Irene; Wang, Huaisong; Liu, Junpu; Xu, Yong; Wang, Runze; Ji, Jiabing; Xu, Zhihong; Kong, Weihu; Zhong, Yang; Shang, Jianli; Pereira, Lara; Argyris, Jason; Zhang, Jian; Mayobre, Carlos; Pujol, Marta; Oren, Elad; Out, Diandian; Wang, Jiming; Sun, Dexi; Zhao, Shengjie; Zhu, Yingchun; Li, Na; Katzir, Nurit; Gur, Amit; Dogimont, Catherine; Schaefer, Hanno; Fan, Wei; Bendahmane, Abdelhafid; Fei, Zhangjun; Pitrat, Michel; Gabaldon, Toni; Lin, Tao; Garcia-Mas, Jordi; Xu, Yongyang; Huang, Sanwen			A comprehensive genome variation map of melon identifies multiple domestication events and loci influencing agronomic traits	NATURE GENETICS			English	Article							CUCUMBER CUCUMIS-SATIVUS; WIDE ASSOCIATION; POPULATION-STRUCTURE; TOMATO; GENE; L.; TOOL; DIVERSITY; CLONING; COLOR	Melon is an economically important fruit crop that has been cultivated for thousands of years; however, the genetic basis and history of its domestication still remain largely unknown. Here we report a comprehensive map of the genomic variation in melon derived from the resequencing of 1,175 accessions, which represent the global diversity of the species. Our results suggest that three independent domestication events occurred in melon, two in India and one in Africa. We detected two independent sets of domestication sweeps, resulting in diverse characteristics of the two subspecies melo and agrestis during melon breeding. Genome-wide association studies for 16 agronomic traits identified 208 loci significantly associated with fruit mass, quality and morphological characters. This study sheds light on the domestication history of melon and provides a valuable resource for genomics-assisted breeding of this important crop.	[Zhao, Guangwei; He, Yuhua; Ma, Shuangwu; Wang, Pingyong; Liu, Junpu; Xu, Zhihong; Kong, Weihu; Shang, Jianli; Zhang, Jian; Out, Diandian; Wang, Jiming; Sun, Dexi; Zhao, Shengjie; Zhu, Yingchun; Li, Na; Xu, Yongyang] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China; [Lian, Qun; Ji, Jiabing; Zhong, Yang; Fan, Wei; Lin, Tao; Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Minist Agr, Genome Anal Lab,Lingnan Guangdong Lab Modern Agr, Shenzhen, Peoples R China; [Zhang, Zhonghua; Fu, Qiushi; Wang, Huaisong] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sino Dutch Joint Lab Hort Genom, Key Lab Biol & Genet Improvement Hort Crops,Minis, Beijing, Peoples R China; [Zhang, Zhonghua] Qingdao Agr Univ, Coll Hort, Qingdao, Shandong, Peoples R China; [Ruggieri, Valentino; Pereira, Lara; Argyris, Jason; Mayobre, Carlos; Pujol, Marta; Garcia-Mas, Jordi] Ctr Res Agr Genom CSIC IRTA UAB UB, Barcelona, Spain; [Ruggieri, Valentino; Pereira, Lara; Argyris, Jason; Mayobre, Carlos; Pujol, Marta; Garcia-Mas, Jordi] IRTA, Barcelona, Spain; [Monforte, Antonio J.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Julca, Irene] UAB, Barcelona, Spain; [Julca, Irene; Gabaldon, Toni] Barcelona Inst Sci & Technol, CRG, Barcelona, Spain; [Julca, Irene; Gabaldon, Toni] UPF, Barcelona, Spain; [Xu, Yong] Beijing Acad Agr & Forestry Sci, Natl Watermelon & Melon Improvement Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Beijing Key Lab Vegetable Germplasm Improvement, Beijing, Peoples R China; [Wang, Runze] Nanjing Agr Univ, Ctr Pear Engn Technol Res, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Oren, Elad; Katzir, Nurit; Gur, Amit] Israeli Agr Res Org, Plant Sci Inst, NeweYaar Res Ctr, Ramat Yishay, Israel; [Dogimont, Catherine; Bendahmane, Abdelhafid; Pitrat, Michel] INRA, Genet & Ameliorat Fruits & Legumes, Montfavet, France; [Schaefer, Hanno] Tech Univ Munich, Dept Ecol & Ecosyst Management, Plant Biodivers Res, Freising Weihenstephan, Germany; [Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Gabaldon, Toni] ICREA, Barcelona, Spain; [Lin, Tao] China Agr Univ, Coll Hort, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Qingdao Agricultural University; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Beijing Academy of Agriculture & Forestry; Nanjing Agricultural University; INRAE; Technical University of Munich; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); ICREA; China Agricultural University	Xu, YY (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.; Huang, SW (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Minist Agr, Genome Anal Lab,Lingnan Guangdong Lab Modern Agr, Shenzhen, Peoples R China.; Garcia-Mas, J (corresponding author), Ctr Res Agr Genom CSIC IRTA UAB UB, Barcelona, Spain.; Garcia-Mas, J (corresponding author), IRTA, Barcelona, Spain.	Jordi.Garcia@irta.cat; xuyongyang@caas.cn; huangsanwen@caas.cn	Julca, Irene/AAE-9970-2021; Huang, Sanwen/ABE-9053-2020; Fei, Zhangjun/H-5152-2012; MONFORTE, Antonio José/B-4784-2009; Pujol, Marta/K-8061-2015; Pereira, Lara/AAF-7099-2019; Gur, Amit/AFT-6744-2022; Argyris, Jason M./E-1567-2011; ABAJO, MARTA PUJOL/AAD-4799-2019; Gabaldón, Toni/A-7336-2008; Garcia-Mas, Jordi/B-9694-2012	Julca, Irene/0000-0002-1332-7948; Huang, Sanwen/0000-0002-8547-5309; MONFORTE, Antonio José/0000-0003-3461-3094; Pujol, Marta/0000-0002-3595-5363; Argyris, Jason M./0000-0003-2685-9959; ABAJO, MARTA PUJOL/0000-0002-3595-5363; Gabaldón, Toni/0000-0003-0019-1735; Catherine, DOGIMONT/0000-0001-7399-768X; Oren, Elad/0000-0001-6821-4409; Lian, Qun/0000-0001-8734-8357; zhang, zhonghua/0000-0002-1034-227X; Pereira, Lara/0000-0001-5184-8587; Garcia-Mas, Jordi/0000-0001-7101-9049; Bendahmane, Abdelhafid/0000-0003-3246-868X; Li, Na/0000-0001-5311-2418	Agricultural Science and Technology Innovation Program; China Agriculture Research System [CARS-25]; Leading Talents of Guangdong Province Program [00201515]; Shenzhen Municipal (The Peacock Plan) [KQTD2016113010482651]; Dapeng district government; National Natural Science Foundation of China [31530066, 31772304]; Science and Technology Program of Guangdong [2018B020202007]; National Key R&D Program of China [2016YFD0101007]; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative [2015-51181-24285]; European Research Council (ERC-SEXYPARTH); Spanish Ministry of Economy and Competitiveness [AGL2015-64625-C2-1-R]; Severo Ochoa Programme for Centres of Excellence in RD 2016-2010 [SEV-2015-0533]; CERCA Programme/Generalitat de Catalunya; German Science Foundation [SPP1991]	Agricultural Science and Technology Innovation Program; China Agriculture Research System; Leading Talents of Guangdong Province Program; Shenzhen Municipal (The Peacock Plan); Dapeng district government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong; National Key R&D Program of China; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative; European Research Council (ERC-SEXYPARTH)(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Severo Ochoa Programme for Centres of Excellence in RD 2016-2010; CERCA Programme/Generalitat de Catalunya; German Science Foundation(German Research Foundation (DFG))	We thank B. S. Gaut (Department of Ecology and Evolutionary Biology, University of California Irvine), W. Lucas (University of California, Davis), J. Ruan (Agricultural Genome Institute at Shenzhen, Chinese Academy of Agricultural Sciences) and D. Wu (Kunming Institute of Zoology, Chinese Academy of Sciences) for critical comments. This work was supported by funding from the Agricultural Science and Technology Innovation Program (to Yongyang Xu, S.H., Z.Z. and H.W.), the China Agriculture Research System (CARS-25 to Yongyang Xu and H.W.), the Leading Talents of Guangdong Province Program (00201515 to S.H.), the Shenzhen Municipal (The Peacock Plan KQTD2016113010482651 to S.H.), the Dapeng district government, National Natural Science Foundation of China (31772304 to Z.Z.), the Science and Technology Program of Guangdong (2018B020202007 to S.H.), the National Natural Science Foundation of China (31530066 to S.H.), the National Key R&D Program of China (2016YFD0101007 to S.H.), USDA National Institute of Food and Agriculture Specialty Crop Research Initiative (2015-51181-24285 to Z.F.), the European Research Council (ERC-SEXYPARTH to A.B.), the Spanish Ministry of Economy and Competitiveness (AGL2015-64625-C2-1-R to J.G.-M.), Severo Ochoa Programme for Centres of Excellence in R&D 2016-2010 (SEV-2015-0533 to J.G.-M.), the CERCA Programme/Generalitat de Catalunya to J.G.-M. and the German Science Foundation (SPP1991 Taxon-OMICS to H.S.).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Argyris JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1196-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cohen S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5026; Darrigues A, 2008, J AM SOC HORTIC SCI, V133, P579, DOI 10.21273/JASHS.133.4.579; Dhillon NPS, 2007, GENET RESOUR CROP EV, V54, P1267, DOI 10.1007/s10722-006-9108-2; Diaz A, 2017, THEOR APPL GENET, V130, P1837, DOI 10.1007/s00122-017-2928-y; Dogra V, 2016, PLANTA, V244, P505, DOI 10.1007/s00425-016-2520-8; Du XM, 2018, NAT GENET, V50, P796, DOI 10.1038/s41588-018-0116-x; Endl J, 2018, AM J BOT, V105, P1662, DOI 10.1002/ajb2.1172; Falush D, 2003, GENETICS, V164, P1567; Feder A, 2015, PLANT PHYSIOL, V169, P1714, DOI 10.1104/pp.15.01008; Fujishita N., 1993, JAPAN J BREED S2, V43, P206; Galpaz N, 2018, PLANT J, V94, P169, DOI 10.1111/tpj.13838; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gawel NJ, 1991, MOL BIOL REP, V9, P262, DOI DOI 10.1007/BF02672076; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gur A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09987-4; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; He W, 2013, GENET MOL RES, V12, P6275, DOI 10.4238/2013.December.4.15; Hu ZH, 2014, J EXP BOT, V65, P1111, DOI 10.1093/jxb/ert463; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; JEFFREY C, 1980, BOT J LINN SOC, V81, P233, DOI 10.1111/j.1095-8339.1980.tb01676.x; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kato-Emori S, 2001, MOL GENET GENOMICS, V265, P135, DOI 10.1007/s004380000401; Kerje T, 2000, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.2000.510.5; Kuang JF, 2011, GENE, V485, P1, DOI 10.1016/j.gene.2011.05.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu H, 2016, THEOR APPL GENET, V129, P1247, DOI 10.1007/s00122-016-2700-8; Luan F, 2008, EUPHYTICA, V164, P445, DOI 10.1007/s10681-008-9699-0; Ma DeWei, 1996, Acta Horticulturae Sinica, V23, P255; Ma S., 2006, DESCRIPTORS DATA STA; Nardi CF, 2014, SCI HORTIC-AMSTERDAM, V165, P111, DOI 10.1016/j.scienta.2013.10.035; Oren E, 2019, J EXP BOT, V70, P3781, DOI 10.1093/jxb/erz182; Pan Y, 2013, PLANT PHYSIOL, V161, P1476, DOI 10.1104/pp.112.212654; Paris HS, 2012, ANN BOT-LONDON, V110, P23, DOI 10.1093/aob/mcs098; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pereira L, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1537-5; Perin C, 2002, THEOR APPL GENET, V104, P1017, DOI 10.1007/s00122-002-0864-x; PITRAT M, 2000, ACTA HORTIC, V510, P29; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Serres-Giardi L, 2012, CUCURBITACEAE 2012: PROCEEDINGS OF THE XTH EUCARPIA MEETING ON GENETICS AND BREEDING OF CUCURBITACEAE, P254; Shang Y, 2014, SCIENCE, V346, P1084, DOI 10.1126/science.1259215; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Staub JE, 2004, EUPHYTICA, V136, P151, DOI 10.1023/B:EUPH.0000030667.63614.bd; Tadmor Y, 2010, J AGR FOOD CHEM, V58, P10722, DOI 10.1021/jf1021797; TAJIMA F, 1983, GENETICS, V105, P437; Tanaka K, 2016, GENET RESOUR CROP EV, V63, P1237, DOI 10.1007/s10722-015-0314-7; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Tzuri G, 2015, PLANT J, V82, P267, DOI 10.1111/tpj.12814; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Zhou Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.183, 10.1038/nplants.2016.183]; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; Zhu GT, 2018, CELL, V172, P249, DOI 10.1016/j.cell.2017.12.019	68	78	84	28	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2019	51	11					1607	+		10.1038/s41588-019-0522-8	http://dx.doi.org/10.1038/s41588-019-0522-8			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JK2ZE	31676864	Green Submitted, Green Accepted			2022-12-17	WOS:000494714300009
J	Chakraborty, M; VanKuren, NW; Zhao, R; Zhang, XW; Kalsow, S; Emerson, JJ				Chakraborty, Mahul; VanKuren, Nicholas W.; Zhao, Roy; Zhang, Xinwen; Kalsow, Shannon; Emerson, J. J.			Hidden genetic variation shapes the structure of functional elements in Drosophila	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; MISSING HERITABILITY; SELECTIVE SWEEPS; READ ALIGNMENT; COMPLEX TRAITS; LARGE GENOMES; MELANOGASTER; EXPRESSION; NUMBER; IDENTIFICATION	Mutations that add, subtract, rearrange, or otherwise refashion genome structure often affect phenotypes, although the fragmented nature of most contemporary assemblies obscures them. To discover such mutations, we assembled the first new reference-quality genome of Drosophila melanogaster since its initial sequencing. By comparing this new genome to the existing D. melanogaster assembly, we created a structural variant map of unprecedented resolution and identified extensive genetic variation that has remained hidden until now. Many of these variants constitute candidates underlying phenotypic variation, including tandem duplications and a transposable element insertion that amplifies the expression of detoxification-related genes associated with nicotine resistance. The abundance of important genetic variation that still evades discovery highlights how crucial high-quality reference genomes are to deciphering phenotypes.	[Chakraborty, Mahul; Zhang, Xinwen; Kalsow, Shannon; Emerson, J. J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [VanKuren, Nicholas W.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Zhao, Roy; Zhang, Xinwen] Univ Calif Irvine, Grad Program Math Computat & Syst Biol, Irvine, CA USA; [Emerson, J. J.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of Chicago; University of California System; University of California Irvine; University of California System; University of California Irvine	Chakraborty, M; Emerson, JJ (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.; Emerson, JJ (corresponding author), Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA.	mchakrab@uci.edu; jje@uci.edu		Emerson, James/0000-0001-9474-0891; Chakraborty, Mahul/0000-0003-2414-9187	US National Institutes of Health (NIH) [R01GM123303-1]; University of California; Irvine setup funds; National Science Foundation (NSF) Graduate Research Fellowships [DGE-1321846, DGE-1144082]; NIH Genetics and Regulation Training Grant [T32-GM007197]; Genomics High-Throughput Facility Shared Resource of the Cancer Center Support at the University of California, Irvine [CA-62203]; NIH shared-instrumentation grant [1S10RR025496-01, 1S10OD010794-01, 1S10OD021718-01]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123303, T32GM007197] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021718] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Irvine setup funds; National Science Foundation (NSF) Graduate Research Fellowships(National Science Foundation (NSF)); NIH Genetics and Regulation Training Grant; Genomics High-Throughput Facility Shared Resource of the Cancer Center Support at the University of California, Irvine; NIH shared-instrumentation grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. T. Ngo, J. Yan, and A. Yue for help with fly maintenance and SV analysis, and J. Mohammed for providing the multiple-sequence alignment of the Drosophila species group. We thank A. Carrillo, E. Azizi, D. German, and M. McHenry for assistance in assembling the temperature-gradient instrument, N. Nirale for uploading the sequencing data and assembly, B. Gaut, G. C. G. Lee, A. Long, and K. Thornton for thoughtful comments on the manuscript, and M. Long for discussion and for permission to use the RNAi data. The work was supported by US National Institutes of Health (NIH) grant R01GM123303-1 (J. J. E.), University of California, Irvine setup funds (J. J. E), National Science Foundation (NSF) Graduate Research Fellowships (DGE-1321846 to R.Z. and DGE-1144082 to N.W.V.), and NIH Genetics and Regulation Training Grant T32-GM007197 (N.W.V.). This work was made possible, in part, through access to the Genomics High-Throughput Facility Shared Resource of the Cancer Center Support Grant CA-62203 at the University of California, Irvine, and NIH shared-instrumentation grants 1S10RR025496-01, 1S10OD010794-01, and 1S10OD021718-01.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; [Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; Bartoszewski S, 2004, MECH DEVELOP, V121, P1259, DOI 10.1016/j.mod.2004.05.006; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Chakraborty M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw654; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Cridland JM, 2015, GENETICS, V199, P85, DOI 10.1534/genetics.114.170837; Cridland JM, 2013, MOL BIOL EVOL, V30, P2311, DOI 10.1093/molbev/mst129; DeGiorgio M, 2016, BIOINFORMATICS, V32, P1895, DOI 10.1093/bioinformatics/btw051; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gamazon ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001292; Glendinning JI, 2002, ENTOMOL EXP APPL, V104, P15, DOI 10.1023/A:1021271717409; Green EW, 2014, NAT METHODS, V11, P222, DOI 10.1038/nmeth.2856; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Huber CD, 2016, MOL ECOL, V25, P142, DOI 10.1111/mec.13351; Huddleston J, 2016, GENETICS, V202, P1251, DOI 10.1534/genetics.115.180539; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; Khost D. E., 2016, PREPRINT; King EG, 2014, GENETICS, V198, P31, DOI 10.1534/genetics.114.161968; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Lam KK, 2015, BIOINFORMATICS, V31, P3207, DOI 10.1093/bioinformatics/btv280; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Long AD, 2000, GENETICS, V154, P1255; MacMillan HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28999; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marriage TN, 2014, GENETICS, V198, P45, DOI 10.1534/genetics.114.162107; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Petrov DA, 2011, MOL BIOL EVOL, V28, P1633, DOI 10.1093/molbev/msq337; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rogers RL, 2014, MOL BIOL EVOL, V31, P1750, DOI 10.1093/molbev/msu124; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saleem S, 2012, MECH DEVELOP, V129, P177, DOI 10.1016/j.mod.2012.04.002; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swinburne IA, 2008, DEV CELL, V14, P324, DOI 10.1016/j.devcel.2008.02.002; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Ye CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31900; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	58	78	78	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2018	50	1					20	+		10.1038/s41588-017-0010-y	http://dx.doi.org/10.1038/s41588-017-0010-y			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FT4XB	29255259	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-17	WOS:000423157400006
J	Marigorta, UM; Denson, LA; Hyams, JS; Mondal, K; Prince, J; Walters, TD; Griffiths, A; Noe, JD; Crandall, WV; Rosh, JR; Mack, DR; Kellermayer, R; Heyman, MB; Baker, SS; Stephens, MC; Baldassano, RN; Markowitz, JF; Kim, MO; Dubinsky, MC; Cho, J; Aronow, BJ; Kugathasan, S; Gibson, G				Marigorta, Urko M.; Denson, Lee A.; Hyams, Jeffrey S.; Mondal, Kajari; Prince, Jarod; Walters, Thomas D.; Griffiths, Anne; Noe, Joshua D.; Crandall, Wallace V.; Rosh, Joel R.; Mack, David R.; Kellermayer, Richard; Heyman, Melvin B.; Baker, Susan S.; Stephens, Michael C.; Baldassano, Robert N.; Markowitz, James F.; Kim, Mi-Ok; Dubinsky, Marla C.; Cho, Judy; Aronow, Bruce J.; Kugathasan, Subra; Gibson, Greg			Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; SUSCEPTIBILITY LOCI; COLOCALIZATION; INTESTINE; INFECTION; VARIANTS; CHILDREN	Gene expression profiling can be used to uncover the mechanisms by which loci identified through genome-wide association studies (GWAS) contribute to pathology(1,2). Given that most GWAS hits are in putative regulatory regions and transcript abundance is physiologically closer to the phenotype of interest(2), we hypothesized that summation of risk-allele-associated gene expression, namely a transcriptional risk score (TRS), should provide accurate estimates of disease risk. We integrate summary-level GWAS and expression quantitative trait locus (eQTL) data with RNA-seq data from the RISK study, an inception cohort of pediatric Crohn's disease(3,4). We show that TRSs based on genes regulated by variants linked to inflammatory bowel disease (IBD) not only outperform genetic risk scores (GRSs) in distinguishing Crohn's disease from healthy samples, but also serve to identify patients who in time will progress to complicated disease. Our dissection of eQTL effects may be used to distinguish genes whose association with disease is through promotion versus protection, thereby linking statistical association to biological mechanism. The TRS approach constitutes a potential strategy for personalized medicine that enhances inference from static genotypic risk assessment.	[Marigorta, Urko M.; Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Denson, Lee A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Hyams, Jeffrey S.] Connecticut Childrens Med Ctr, Div Digest Dis Hepatol & Nutr, Hartford, CT USA; [Mondal, Kajari; Prince, Jarod; Kugathasan, Subra] Emory Univ, Sch Med, Div Pediat Gastroenterol, Atlanta, GA USA; [Walters, Thomas D.; Griffiths, Anne] Univ Toronto, Hosp Sick Children, Div Pediat Gastroenterol Hepatol & Nutr, Dept Pediat, Toronto, ON, Canada; [Noe, Joshua D.] Med Coll Wisconsin, Dept Pediat Gastroenterol Hepatol & Nutr, Milwaukee, WI 53226 USA; [Crandall, Wallace V.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Dept Pediat Gastroenterol, Columbus, OH 43210 USA; [Rosh, Joel R.] Goryeb Childrens Hosp, Dept Pediat, Morristown, NJ USA; [Mack, David R.] Childrens Hosp Eastern Ontario, Dept Pediat, IBD Ctr, Ottawa, ON, Canada; [Mack, David R.] Univ Ottawa, Ottawa, ON, Canada; [Kellermayer, Richard] Texas Childrens Hosp, Baylor Coll Med, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Baker, Susan S.] Univ Buffalo, Dept Digest Dis, Buffalo, NY USA; [Baker, Susan S.] Univ Buffalo, Nutr Ctr, Buffalo, NY USA; [Stephens, Michael C.] Mayo Clin, Dept Pediat Gastroenterol, Rochester, MN USA; [Baldassano, Robert N.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Markowitz, James F.] Northwell Hlth, Dept Pediat, New York, NY USA; [Kim, Mi-Ok] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Dubinsky, Marla C.; Cho, Judy] Mt Sinai Hosp, Dept Pediat, New York, NY 10029 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	University System of Georgia; Georgia Institute of Technology; Cincinnati Children's Hospital Medical Center; Connecticut Children's Medical Center; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Medical College of Wisconsin; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Atlantic Health System; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Baylor College of Medicine; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Mayo Clinic; University of Pennsylvania; Northwell Health; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center	Gibson, G (corresponding author), Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA.	greg.gibson@biology.gatech.edu	; Marigorta, Urko M/L-9512-2014	Kim, Mi-Ok/0000-0002-7712-3653; Marigorta, Urko M/0000-0002-9087-6609	NIH [P01-GM0996568]; Crohn's and Colitis Foundation of America (CCFA), New York; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA), New York; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to B. Zeng, D. Arafat, H. Somineni, S. Venkateswaran, and colleagues from the Gibson and Kugathasan laboratories for their support and helpful comments. We also would like to thank I. Mendizabal, J. Lachance and K. Jordan for comments on the manuscript. This research was supported by Project 3 (G.G., PI) of the NIH program project "Statistical and Quantitative Genetics" grant P01-GM0996568 (B. Weir, University of Washington, Director) as well as research grants from the Crohn's and Colitis Foundation of America (CCFA), New York, to the individual study institutions participating in the RISK study.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Di Narzo AF, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.34; Fairfax BP, 2014, CURR OPIN IMMUNOL, V30, P63, DOI 10.1016/j.coi.2014.07.001; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gibson G, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0186-7; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kugathasan S, 2017, LANCET, V389, P1710, DOI 10.1016/S0140-6736(17)30317-3; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Ning K, 2015, HUM MOL GENET, V24, P4147, DOI 10.1093/hmg/ddv142; Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Petrillo MG, 2015, AUTOIMMUN REV, V14, P117, DOI 10.1016/j.autrev.2014.10.011; Reikvam DH, 2011, SCAND J GASTROENTERO, V46, P550, DOI 10.3109/00365521.2011.551887; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Singh T, 2015, INFLAMM BOWEL DIS, V21, P251, DOI 10.1097/MIB.0000000000000265; Walters TD, 2014, GASTROENTEROLOGY, V146, P383, DOI 10.1053/j.gastro.2013.10.027; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	45	78	80	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1517	+		10.1038/ng.3936	http://dx.doi.org/10.1038/ng.3936			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI3JD	28805827	Green Accepted, Green Submitted			2022-12-17	WOS:000411855800016
J	Seki, M; Kimura, S; Isobe, T; Yoshida, K; Ueno, H; Nakajima-Takagi, Y; Wang, CS; Lin, L; Kon, A; Suzuki, H; Shiozawa, Y; Kataoka, K; Fujii, Y; Shiraishi, Y; Chiba, K; Tanaka, H; Shimamura, T; Masuda, K; Kawamoto, H; Ohki, K; Kato, M; Arakawa, Y; Koh, K; Hanada, R; Moritake, H; Akiyama, M; Kobayashi, R; Deguchi, T; Hashii, Y; Imamura, T; Sato, A; Kiyokawa, N; Oka, A; Hayashi, Y; Takagi, M; Manabe, A; Ohara, A; Horibe, K; Sanada, M; Iwama, A; Mano, H; Miyano, S; Ogawa, S; Takita, J				Seki, Masafumi; Kimura, Shunsuke; Isobe, Tomoya; Yoshida, Kenichi; Ueno, Hiroo; Nakajima-Takagi, Yaeko; Wang, Changshan; Lin, Lin; Kon, Ayana; Suzuki, Hiromichi; Shiozawa, Yusuke; Kataoka, Keisuke; Fujii, Yoichi; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Shimamura, Teppei; Masuda, Kyoko; Kawamoto, Hiroshi; Ohki, Kentaro; Kato, Motohiro; Arakawa, Yuki; Koh, Katsuyoshi; Hanada, Ryoji; Moritake, Hiroshi; Akiyama, Masaharu; Kobayashi, Ryoji; Deguchi, Takao; Hashii, Yoshiko; Imamura, Toshihiko; Sato, Atsushi; Kiyokawa, Nobutaka; Oka, Akira; Hayashi, Yasuhide; Takagi, Masatoshi; Manabe, Atsushi; Ohara, Akira; Horibe, Keizo; Sanada, Masashi; Iwama, Atsushi; Mano, Hiroyuki; Miyano, Satoru; Ogawa, Seishi; Takita, Junko			Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							INTEGRATED MOLECULAR ANALYSIS; TRANSCRIPTION FACTOR PU.1; GENE-EXPRESSION; TUMOR-SUPPRESSOR; MUTATIONS; MLL; ACTIVATION; NETWORKS; NOTCH; DIMERIZATION	The outcome of treatment-refractory and/or relapsed pediatric T cell acute lymphoblastic leukemia (T-ALL) is extremely poor(1), and the genetic basis for this is not well understood. Here we report comprehensive profiling of 121 cases of pediatric TALL using transcriptome and/or targeted capture sequencing, through which we identified new recurrent gene fusions involving SPI1 (STMN1-SPI1 and TCF7-SPI1). Cases positive for fusions involving SPI1 (encoding PU.1), accounting for 3.9% (7/181) of the examined pediatric T-ALL cases, showed a double-negative (DN; CD4(-)CD8(-)) or CD8(+) single-positive (SP) phenotype and had uniformly poor overall survival. These cases represent a subset of pediatric T-ALL distinguishable from the known T-ALL subsets(2) in terms of expression of genes involved in T cell precommitment, establishment of T cell identity, and post-beta-selection maturation and with respect to mutational profile. PU.1 fusion proteins retained transcriptional activity and, when constitutively expressed in mouse stem/progenitor cells, induced cell proliferation and resulted in a maturation block. Our findings highlight a unique role of SPI1 fusions in high-risk pediatric T-ALL.	[Seki, Masafumi; Kimura, Shunsuke; Isobe, Tomoya; Shiozawa, Yusuke; Oka, Akira; Ohara, Akira; Takita, Junko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Kimura, Shunsuke] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Hiroshima, Japan; [Yoshida, Kenichi; Ueno, Hiroo; Kon, Ayana; Suzuki, Hiromichi; Kataoka, Keisuke; Fujii, Yoichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Nakajima-Takagi, Yaeko; Wang, Changshan; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Lin, Lin; Takagi, Masatoshi; Sanada, Masashi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Lab DNA Informat Anal, Tokyo, Japan; [Shimamura, Teppei] Nagoya Univ, Grad Sch Med, Div Syst Biol, Nagoya, Aichi, Japan; [Masuda, Kyoko; Kawamoto, Hiroshi] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Immunol, Kyoto, Japan; [Ohki, Kentaro; Kato, Motohiro; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Arakawa, Yuki; Koh, Katsuyoshi; Hanada, Ryoji] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Moritake, Hiroshi] Univ Miyazaki, Fac Med, Div Pediat, Miyazaki, Japan; [Akiyama, Masaharu] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Deguchi, Takao] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Hashii, Yoshiko] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Imamura, Toshihiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Sato, Atsushi] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Ohara, Akira] Toho Univ, Dept Pediat, Tokyo, Japan; [Horibe, Keizo; Sanada, Masashi] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Mano, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Cellular Signaling, Tokyo, Japan	University of Tokyo; Hiroshima University; Kyoto University; Chiba University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Nagoya University; Kyoto University; National Center for Child Health & Development - Japan; Saitama Children's Medical Center; University of Miyazaki; Jikei University; Mie University; Osaka University; Kyoto Prefectural University of Medicine; Gunma Children's Medical Centre; St. Luke's International Hospital; Toho University; Nagoya Medical Center; University of Tokyo	Takita, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan.; Ogawa, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan.	sogawa-tky@umin.ac.jp; jtakita-tky@umin.ac.jp	Kataoka, Keisuke/AAS-2546-2020; Seki, Masafumi/AAN-1025-2021; Kimura, Shunsuke/O-2037-2019; Suzuki, Hiromichi/AAO-4664-2021; Fujii, Yoichi/AAT-5533-2021; Lin, Lin/GXM-6308-2022; Ueno, Hiroo/AAJ-7175-2020; Ogawa, Seishi/AAE-7088-2019	Kataoka, Keisuke/0000-0002-8263-9902; Seki, Masafumi/0000-0003-4671-7026; Kimura, Shunsuke/0000-0002-2158-467X; Suzuki, Hiromichi/0000-0002-8858-0294; Fujii, Yoichi/0000-0001-5436-2259; Isobe, Tomoya/0000-0002-3487-3307; Yoshida, Kenichi/0000-0003-4612-2778; Shimamura, Teppei/0000-0003-2994-872X; Kato, Motohiro/0000-0001-5145-1774; Deguchi, Takao/0000-0001-9932-4299; Miyano, Satoru/0000-0002-1753-6616	KAKENHI from the Japan Society of Promotion of Science [17H04224, 26713037, 15H05909]; Japan Agency for Medical Research and Development (AMED) Practical Research for Innovative Cancer Control [16ck0106066h0003]; Project for Cancer Research and Therapeutic Evolution (P-CREATE) [16cm0106509h001]; Friends of Leukemia Research Fund [147100000868]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230, hp160219, hp150232]; Grants-in-Aid for Scientific Research [15H05909, 16K09870] Funding Source: KAKEN	KAKENHI from the Japan Society of Promotion of Science; Japan Agency for Medical Research and Development (AMED) Practical Research for Innovative Cancer Control(Japan Agency for Medical Research and Development (AMED)); Project for Cancer Research and Therapeutic Evolution (P-CREATE); Friends of Leukemia Research Fund; RIKEN Advanced Institute for Computational Science through the HPCI System Research project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We gratefully acknowledge the TCGA Consortium and all its members for making their invaluable data publically available. The results published here are in whole or part based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatment (TARGET) initiative managed by the NCI. Information about TARGET can be found at http://ocg.cancer.gov/programs/target. We are also grateful to M. Matsumura, N. Hoshino, K. Yin, F. Saito, Y. Mori, N. Mizota, and M. Nakamura for their excellent technical assistance. We also wish to express our appreciation to M.-J. Park (Gunma Children's Medical Hospital), K. Nomura (Toyama University), H. Kanegane (Tokyo Medical and Dental University), and K. Kato (Ibaraki Children's Hospital) for collecting samples and T. Yasuda, M. Takeyama, J. Mitsui, and S. Tsuji (University of Tokyo) for next-generation sequencing. This work was supported by KAKENHI (17H04224 (J.T.), 26713037 (M.K.), and 15H05909 (S.O.)) from the Japan Society of Promotion of Science; by Japan Agency for Medical Research and Development (AMED) Practical Research for Innovative Cancer Control (16ck0106066h0003 (M. Sanada)) and Project for Cancer Research and Therapeutic Evolution (P-CREATE) (16cm0106509h001 (J.T.)); and by the Friends of Leukemia Research Fund (147100000868 (M. Seki)). This research also used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (hp140230 (S.M.), hp160219 (S.M.), and hp150232 (S.M.)).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; Babusikova O, 2009, NEOPLASMA, V56, P508, DOI 10.4149/neo_2009_06_508; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; BARELI M, 1989, BRIT J HAEMATOL, V72, P36, DOI 10.1111/j.1365-2141.1989.tb07648.x; Belver L, 2016, NAT REV CANCER, V16, P494, DOI 10.1038/nrc.2016.63; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; DASTUGUE N, 1991, GENE CHROMOSOME CANC, V3, P411; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Grossmann V, 2011, HAEMATOL-HEMATOL J, V96, P1874, DOI 10.3324/haematol.2011.043919; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Herold R, 2004, J CLIN ONCOL, V22, P569, DOI 10.1200/JCO.2004.99.153; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Isoda T, 2012, BLOOD, V120, P789, DOI 10.1182/blood-2012-02-413195; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MOREAUGACHELIN F, 1990, LEUKEMIA, V4, P20; Neumann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053190; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; PRASAD R, 1994, P NATL ACAD SCI USA, V91, P8107, DOI 10.1073/pnas.91.17.8107; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191, DOI 10.1200/JCO.1999.17.1.191; Saiki R, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.955.955; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8557; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhou J, 2014, LEUKEMIA, V28, P1436, DOI 10.1038/leu.2013.384	63	78	80	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1274	+		10.1038/ng.3900	http://dx.doi.org/10.1038/ng.3900			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FB8OI	28671687	Green Submitted			2022-12-17	WOS:000406397900019
J	Yost, S; de Wolf, B; Hanks, S; Zachariou, A; Marcozzi, C; Clarke, M; de Voer, RM; Etemad, B; Uijttewaal, E; Ramsay, E; Wylie, H; Elliott, A; Picton, S; Smith, A; Smithson, S; Seal, S; Ruark, E; Houge, G; Pines, J; Kops, GJPL; Rahman, N				Yost, Shawn; de Wolf, Bas; Hanks, Sandra; Zachariou, Anna; Marcozzi, Chiara; Clarke, Matthew; de Voer, Richarda M.; Etemad, Banafsheh; Uijttewaal, Esther; Ramsay, Emma; Wylie, Harriet; Elliott, Anna; Picton, Susan; Smith, Audrey; Smithson, Sarah; Seal, Sheila; Ruark, Elise; Houge, Gunnar; Pines, Jonathon; Kops, Geert J. P. L.; Rahman, Nazneen			Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation	NATURE GENETICS			English	Article							MOSAIC VARIEGATED ANEUPLOIDY; AAA-ATPASE; PROTEIN	Through exome sequencing, we identified six individuals with biallelic loss-of-function mutations in TRIP13. All six developed Wilms tumor. Constitutional mosaic aneuploidies, microcephaly, developmental delay and seizures, which are features of mosaic variegated aneuploidy (MVA) syndrome1,2, were more variably present. Through functional studies, we show that TRIP13-mutant patient cells have no detectable TRIP13 and have substantial impairment of the spindle assembly checkpoint (SAC), leading to a high rate of chromosome missegregation. Accurate segregation, as well as SAC proficiency, is rescued by restoring TRIP13 function. Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors3, and here we show that their cells display severe SAC impairment. MVA due to biallelic CEP57 mutations4, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency. These data provide insights into the complex relationships between aneuploidy and carcinogenesis.	[Yost, Shawn; Hanks, Sandra; Zachariou, Anna; Clarke, Matthew; Ramsay, Emma; Wylie, Harriet; Elliott, Anna; Seal, Sheila; Ruark, Elise; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, London, England; [de Wolf, Bas; de Voer, Richarda M.; Etemad, Banafsheh; Uijttewaal, Esther; Kops, Geert J. P. L.] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Marcozzi, Chiara; Pines, Jonathon] Inst Canc Res, Div Canc Biol, London, England; [Marcozzi, Chiara; Pines, Jonathon] Univ Cambridge, Gurdon Inst, Cambridge, England; [Marcozzi, Chiara; Pines, Jonathon] Univ Cambridge, Dept Zool, Cambridge, England; [de Voer, Richarda M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Picton, Susan] Leeds Gen Infirm, Childrens & Adolescent Oncol & Haematol Unit, Leeds, W Yorkshire, England; [Smith, Audrey] Chapel Allerton Hosp, Yorkshire Reg Clin Genet Serv, Leeds, W Yorkshire, England; [Smithson, Sarah] St Michaels Hosp, Clin Genet Serv, Bristol, Avon, England; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet, Bergen, Norway; [Kops, Geert J. P. L.] Canc Genom Netherlands, Utrecht, Netherlands; [Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Rahman, Nazneen] Royal Marsden NHS Fdn Trust, Canc Genet Unit, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Cambridge; Radboud University Nijmegen; Leeds General Infirmary; University of Leeds; Chapel Allerton Hospital; University of Bergen; Haukeland University Hospital; Utrecht University; Utrecht University Medical Center; Royal Marsden NHS Foundation Trust	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, London, England.; Kops, GJPL (corresponding author), KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.; Kops, GJPL (corresponding author), Canc Genom Netherlands, Utrecht, Netherlands.; Kops, GJPL (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.; Rahman, N (corresponding author), Royal Marsden NHS Fdn Trust, Canc Genet Unit, London, England.	g.kops@hubrecht.eu; rahmanlab@icr.ac.uk	de Voer, Richarda M/ABD-1525-2021; de Voer, Richarda/P-5728-2015; Marcozzi, Chiara/AAC-8596-2022; de Voer, Richarda M/GSD-6097-2022; Marcozzi, Chiara/AAC-8547-2022	Marcozzi, Chiara/0000-0003-0038-5556; de Voer, Richarda M/0000-0002-8222-0343; Marcozzi, Chiara/0000-0003-0038-5556; de Wolf, Bas/0000-0002-1341-3555; Kops, Geert/0000-0003-3555-5295	NHS; Wellcome Trust [100210/Z/ 12/Z]; Netherlands Organisation for Scientific Research [NWO-ALW 823.02.004]; Dutch Cancer Society (KWF Kankerbestrijding) [KUN2014-6666]; Biotechnology and Biological Sciences Research Council [1221569] Funding Source: researchfish; Rosetrees Trust [M28-F2, M28-F1-CD2] Funding Source: researchfish	NHS; Wellcome Trust(Wellcome TrustEuropean Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Rosetrees Trust(Rosetrees Trust)	We thank the families for their participation and the researchers who recruited them, including K. Asakura-Hay, S. Bernardo de Sousa, P. Callier, D. Chitayat, J. Clayton-Smith, S. Fernandes, D. FitzPatrick, L. Florentin, J. Hurst, B. Isidor, S. Jacquemont, R. Marin Iglesias, M. Micale and J. Tolmie. We thank H. J. Snippert (UMC Utrecht) for providing the lentiviral H2B plasmid. We thank A. Renwick, S. Mahamdallie, C. Loveday and members of the Kops laboratory for helpful discussions and A. Strydom and B. Rex for assistance in preparing the manuscript. We acknowledge NHS funding to the Royal Marsden/ICR NIHR Biomedical Research Centre. This research was supported by the Wellcome Trust (100210/Z/ 12/Z), by the Netherlands Organisation for Scientific Research (NWO-ALW 823.02.004 to G.J.P.L.K.) and by the Dutch Cancer Society (KWF Kankerbestrijding to R.M.d.V., KUN2014-6666).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Garcia-Castillo H, 2008, AM J MED GENET A, V146A, P1687, DOI 10.1002/ajmg.a.32315; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jacquemont S, 2002, AM J MED GENET, V109, P17, DOI 10.1002/ajmg.10281; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Ma HT, 2016, CELL REP, V14, P1086, DOI 10.1016/j.celrep.2016.01.001; Mahamdallie SS, 2015, NAT GENET, V47, P1471, DOI 10.1038/ng.3440; Munz M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0195-6; Nelson CR, 2015, J CELL BIOL, V211, P503, DOI 10.1083/jcb.201505114; Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Ruark E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31029; Ruark Elise, 2015, F1000Res, V4, P883, DOI 10.12688/f1000research.7049.1; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Vader G, 2015, CHROMOSOMA, V124, P333, DOI 10.1007/s00412-015-0516-y; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; WARBURTON D, 1991, ANN GENET-PARIS, V34, P287; Ye QZ, 2015, ELIFE, V4, DOI 10.7554/eLife.07367	28	78	80	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1148	+		10.1038/ng.3883	http://dx.doi.org/10.1038/ng.3883			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28553959	Green Accepted			2022-12-17	WOS:000404253300027
J	Ansari, MA; Pedergnana, V; Ip, CLC; Magri, A; Von Delft, A; Bonsall, D; Chaturvedi, N; Bartha, I; Smith, D; Nicholson, G; McVean, G; Trebes, A; Piazza, P; Fellay, J; Cooke, G; Foster, GR; Hudson, E; McLauchlan, J; Simmonds, P; Bowden, R; Klenerman, P; Barnes, E; Spencer, CCA				Ansari, M. Azim; Pedergnana, Vincent; Ip, Camilla L. C.; Magri, Andrea; Von Delft, Annette; Bonsall, David; Chaturvedi, Nimisha; Bartha, Istvan; Smith, David; Nicholson, George; McVean, Gilean; Trebes, Amy; Piazza, Paolo; Fellay, Jacques; Cooke, Graham; Foster, Graham R.; Hudson, Emma; McLauchlan, John; Simmonds, Peter; Bowden, Rory; Klenerman, Paul; Barnes, Eleanor; Spencer, Chris C. A.		STOP-HCV Consortium	Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus	NATURE GENETICS			English	Article							GENOTYPES 1; GENETIC-VARIATION; WIDE ASSOCIATION; HCV CLEARANCE; INTERFERON; IL28B; RESISTANCE; HLA; EXPRESSION; SOFOSBUVIR	Outcomes of hepatitis C virus (HCV) infection and treatment depend on viral and host genetic factors. Here we use human genome-wide genotyping arrays and new whole-genome HCV viral sequencing technologies to perform a systematic genome-to-genome study of 542 individuals who were chronically infected with HCV, predominantly genotype 3. We show that both alleles of genes encoding human leukocyte antigen molecules and genes encoding components of the interferon lambda innate immune system drive viral polymorphism. Additionally, we show that IFNL4 genotypes determine HCV viral load through a mechanism dependent on a specific amino acid residue in the HCV NS5A protein. These findings highlight the interplay between the innate immune system and the viral genome in HCV control.	[Ansari, M. Azim; Pedergnana, Vincent; Ip, Camilla L. C.; McVean, Gilean; Trebes, Amy; Piazza, Paolo; Bowden, Rory; Spencer, Chris C. A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ansari, M. Azim] Univ Oxford, Oxford Martin Sch, Oxford, England; [Ansari, M. Azim; Ip, Camilla L. C.; Magri, Andrea; Von Delft, Annette; Bonsall, David; Smith, David; Hudson, Emma; Simmonds, Peter; Klenerman, Paul; Barnes, Eleanor] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Ansari, M. Azim; Ip, Camilla L. C.; Magri, Andrea; Von Delft, Annette; Bonsall, David; Smith, David; Hudson, Emma; Simmonds, Peter; Klenerman, Paul; Barnes, Eleanor] Univ Oxford, NIHR Oxford BRC, Oxford, England; [Chaturvedi, Nimisha; Bartha, Istvan; Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Nicholson, George] Univ Oxford, Dept Stat, Oxford, England; [McVean, Gilean] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England; [Cooke, Graham] Imperial Coll London, Wright Fleming Inst, London, England; [Foster, Graham R.] Queen Mary Univ London, London, England; [McLauchlan, John] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Oxford; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Oxford; University of Oxford; Imperial College London; University of London; Queen Mary University London; University of Glasgow	Spencer, CCA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Barnes, E (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.; Barnes, E (corresponding author), Univ Oxford, NIHR Oxford BRC, Oxford, England.	ellie.barnes@ndm.ox.ac.uk; chris.spencer@well.ox.ac.uk	Thomson, Emma C/M-8690-2017; Chaturvedi, Nimisha/X-8618-2019; Fellay, Jacques/A-6681-2009; Chaturvedi, Nimisha/AAY-2199-2020	Thomson, Emma C/0000-0003-1482-0889; Fellay, Jacques/0000-0002-8240-939X; klenerman, paul/0000-0003-4307-9161; Chaturvedi, Nimisha/0000-0002-3065-0202; Simmonds, Peter/0000-0002-7964-4700; bonsall, david/0000-0003-2187-0550; McKeating, Jane/0000-0002-7229-5886; Targett-Adams, Paul/0000-0003-4967-1668; ball, jonathan/0000-0001-5773-8733; Barnes, Eleanor/0000-0002-0860-0831; Smith, David/0000-0001-7778-7137; Ansari, M. Azim/0000-0003-2790-8353; Vickerman, Peter/0000-0002-8291-5890; Magri, Andrea/0000-0002-7143-7168; Bowden, Rory/0000-0001-8596-0366; von Delft, Annette/0000-0002-7699-8140; Dillon, John/0000-0002-2164-4476; Pedergnana, Vincent/0000-0002-7852-5339; Guha, Indra Neil/0000-0002-6940-5861; Nicholson, George/0000-0001-9588-6075; Irving, William/0000-0002-7268-3168; Foster, Graham/0000-0002-3704-386X	Medical Research Foundation; Medical Research Council (MRC) [MR/K01532X/1]; Wellcome Trust [090532/Z/09/Z, 109965MA, 097364/Z/11/Z, 100956/Z/13/Z]; MRC; NIHR Oxford BRC; Oxford Martin School; BRC of the Imperial College NHS Trust; US National Institutes of Health [U19AI082630]; MRC [MC.UU.12014/1]; Medical Research Foundation [C0365]; BBSRC [BB/N008553/1] Funding Source: UKRI; MRC [G0801976, MR/K01532X/1, MR/P025064/1, MC_UU_12014/1, G1100247, MC_UP_A390_1107, MC_EX_UU_G1000717, G0400802, G1001738] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12014/1, MC_EX_UU_G1000717, MR/P025064/1, MR/K01532X/1, MC_UP_A390_1107, G1001738] Funding Source: researchfish; National Institute for Health Research [RP-2016-07-012, 14/02/17, NF-SI-0515-10005] Funding Source: researchfish; Alan Turing Institute [TU/B/000062] Funding Source: researchfish	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford BRC; Oxford Martin School; BRC of the Imperial College NHS Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alan Turing Institute	We thank Gilead Sciences for providing samples and data from the BOSON clinical study for use in these analyses. We also thank HCV Research UK (funded by the Medical Research Foundation) for their assistance in handling and coordinating the release of samples for these analyses.; This work was funded by a grant from the Medical Research Council (MRC) (MR/K01532X/1; to the STOP-HCV Consortium). The work was supported by Core funding to the Wellcome Trust Centre for Human Genetics provided by the Wellcome Trust (090532/Z/09/Z; C.C.A.S. and R.B.). E.B. is funded by the MRC as an MRC Senior Clinical Fellow and received additional support from the NIHR Oxford BRC and the Oxford Martin School. M.A.A. is funded by the Oxford Martin School. G.C. is funded by the BRC of the Imperial College NHS Trust. P.K. is funded by the Oxford Martin School, the NIHR Oxford BRC, the Wellcome Trust (109965MA) and the US National Institutes of Health (U19AI082630). J.M. has funding support from the MRC (MC.UU.12014/1) and the Medical Research Foundation (C0365). C.C.A.S. is funded by Wellcome Trust grant 097364/Z/11/Z. G.M. is funded by Wellcome Trust grant 100956/Z/13/Z.	Ahmed A, 2015, VIRUSES-BASEL, V7, P6716, DOI 10.3390/v7122968; Ampuero J, 2014, ALIMENT PHARM THER, V39, P686, DOI 10.1111/apt.12646; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Ferraris P, 2016, AM J PATHOL, V186, P938, DOI 10.1016/j.ajpath.2015.11.027; Fitzmaurice K, 2011, GUT, V60, P1563, DOI 10.1136/gut.2010.228403; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heim MH, 2014, J HEPATOL, V61, pS14, DOI 10.1016/j.jhep.2014.06.035; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Magri A, 2015, BIOORG MED CHEM LETT, V25, P5372, DOI 10.1016/j.bmcl.2015.09.029; Malkki M, 2005, TISSUE ANTIGENS, V66, P114, DOI 10.1111/j.1399-0039.2005.00453.x; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Merani S, 2011, HEPATOLOGY, V53, P396, DOI 10.1002/hep.24076; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Neumann-Haefelin C, 2011, HEPATOLOGY, V54, P1157, DOI 10.1002/hep.24541; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pedergnana V, 2016, HEPATOLOGY, V64, P1377, DOI 10.1002/hep.28533; Peiffer KH, 2016, HEPATOLOGY, V63, P63, DOI 10.1002/hep.28255; Pol S, 2014, LIVER INT, V34, P18, DOI 10.1111/liv.12405; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; R Core Team, 2016, R LANG ENV STAT COMP; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Rojas A, 2014, J VIRAL HEPATITIS, V21, P19, DOI 10.1111/jvh.12209; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; Sarrazin C, 2016, GASTROENTEROLOGY, V151, P501, DOI 10.1053/j.gastro.2016.06.002; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16; von Delft A, 2016, GUT, V65, P112, DOI 10.1136/gutjnl-2014-308724; Witteveldt J, 2016, ANTIMICROB AGENTS CH, V60, P2981, DOI 10.1128/AAC.02932-15; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	64	78	79	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2017	49	5					666	+		10.1038/ng.3835	http://dx.doi.org/10.1038/ng.3835			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET1TI	28394351	Green Submitted, Green Accepted, Bronze			2022-12-17	WOS:000400051400006
J	Jenkinson, EM; Rodero, MP; Kasher, PR; Uggenti, C; Oojageer, A; Goosey, LC; Rose, Y; Kershaw, CJ; Urquhart, JE; Williams, SG; Bhaskar, SS; O'Sullivan, J; Baerlocher, GM; Haubitz, M; Aubert, G; Baranano, KW; Barnicoat, AJ; Battini, R; Berger, A; Blair, EM; Brunstrom-Hernandez, JE; Buckard, JA; Cassiman, DM; Caumes, R; Cordelli, DM; De Waele, LM; Fay, AJ; Ferreira, P; Fletcher, NA; Fryer, AE; Goel, H; Hemingway, CA; Henneke, M; Hughes, I; Jefferson, RJ; Kumar, R; Lagae, L; Landrieu, PG; Lourenco, CM; Malpas, TJ; Mehta, SG; Metz, I; Naidu, S; Ounap, K; Panzer, A; Prabhakar, P; Quaghebeur, G; Schiffmann, R; Sherr, EH; Sinnathuray, KR; Soh, C; Stewart, HS; Stone, J; Van Esch, H; Van Mol, CEG; Vanderver, A; Wakeling, EL; Whitney, A; Pavitt, GD; Griffiths-Jones, S; Rice, GI; Revy, P; van der Knaap, MS; Livingston, JH; O'Keefe, RT; Crow, YJ				Jenkinson, Emma M.; Rodero, Mathieu P.; Kasher, Paul R.; Uggenti, Carolina; Oojageer, Anthony; Goosey, Laurence C.; Rose, Yoann; Kershaw, Christopher J.; Urquhart, Jill E.; Williams, Simon G.; Bhaskar, Sanjeev S.; O'Sullivan, James; Baerlocher, Gabriela M.; Haubitz, Monika; Aubert, Geraldine; Baranano, Kristin W.; Barnicoat, Angela J.; Battini, Roberta; Berger, Andrea; Blair, Edward M.; Brunstrom-Hernandez, Janice E.; Buckard, Johannes A.; Cassiman, David M.; Caumes, Rosaline; Cordelli, Duccio M.; De Waele, Liesbeth M.; Fay, Alexander J.; Ferreira, Patrick; Fletcher, Nicholas A.; Fryer, Alan E.; Goel, Himanshu; Hemingway, Cheryl A.; Henneke, Marco; Hughes, Imelda; Jefferson, Rosalind J.; Kumar, Ram; Lagae, Lieven; Landrieu, Pierre G.; Lourenco, Charles M.; Malpas, Timothy J.; Mehta, Sarju G.; Metz, Imke; Naidu, Sakkubai; Ounap, Katrin; Panzer, Axel; Prabhakar, Prab; Quaghebeur, Gerardine; Schiffmann, Raphael; Sherr, Elliott H.; Sinnathuray, Kanaga R.; Soh, Calvin; Stewart, Helen S.; Stone, John; Van Esch, Hide; Van Mol, Christine E. G.; Vanderver, Adeline; Wakeling, Emma L.; Whitney, Andrea; Pavitt, Graham D.; Griffiths-Jones, Sam; Rice, Gillian I.; Revy, Patrick; van der Knaap, Marjo S.; Livingston, John H.; O'Keefe, Raymond T.; Crow, Yanick J.			Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts	NATURE GENETICS			English	Article							BOX-C/D; CEREBRORETINAL MICROANGIOPATHY; LSM PROTEINS; COMPONENT 1; U8 SNORNA; IDENTIFICATION; INVOLVEMENT; BIOGENESIS; RIBOSOMES; DISORDER	Although ribosomes are ubiquitous and essential for life, recent data indicate that monogenic causes of ribosomal dysfunction can confer a remarkable degree of specificity in terms of human disease phenotype. Box C/D small nucleolar RNAs (snoRNAs) are evolutionarily conserved non-protein-coding RNAs involved in ribosome biogenesis. Here we show that biallelic mutations in the gene SNORD118, encoding the box C/D snoRNA U8, cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts (LCC), presenting at any age from early childhood to late adulthood. These mutations affect U8 expression, processing and protein binding and thus implicate U8 as essential in cerebral vascular homeostasis.	[Jenkinson, Emma M.; Kasher, Paul R.; Oojageer, Anthony; Goosey, Laurence C.; Urquhart, Jill E.; Williams, Simon G.; Bhaskar, Sanjeev S.; O'Sullivan, James; Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester, Lancs, England; [Rodero, Mathieu P.; Uggenti, Carolina; Rose, Yoann; Crow, Yanick J.] Hop Necker Enfants Malad, INSERM UMR 1163, Inst Imagine, Lab Neurogenet & Neuroinflammat, Paris, France; [Kershaw, Christopher J.; Pavitt, Graham D.; Griffiths-Jones, Sam; O'Keefe, Raymond T.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Mol & Cellular Funct, Manchester, Lancs, England; [Baerlocher, Gabriela M.; Haubitz, Monika] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland; [Baerlocher, Gabriela M.; Haubitz, Monika] Univ Bern, Univ Hosp Bern, Inselspital, Dept Clin Res,Expt Hematol, Bern, Switzerland; [Aubert, Geraldine] Repeat Diagnost Inc, N Vancouver, BC, Canada; [Aubert, Geraldine] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Baranano, Kristin W.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Kennedy Krieger Inst, Div Neurogenet, Baltimore, MD USA; [Barnicoat, Angela J.] Great Ormond St Hosp NHS Fdn Trust, Dept Clin Genet, London, England; [Battini, Roberta] IRCCS Stella Maris, Dept Dev, Pisa, Italy; [Berger, Andrea] Klinikum Weiden, Dept Neuropediat, Weiden, Germany; [Berger, Andrea] Klinikum Harlaching, Dept Neuropediat, Munich, Germany; [Blair, Edward M.] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Dept Clin Genet, Oxford, England; [Brunstrom-Hernandez, Janice E.] CP Pl PLLC, Plano, TX USA; Washington Univ, St Louis Childrens Hosp, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Sozialpadiatr Zentrum EVK Dusseldorf, Dept Neuropediat, Dusseldorf, Germany; [Cassiman, David M.] Leuven Univ Hosp, Metab Ctr, Leuven, Belgium; [Cassiman, David M.] Katholieke Univ Leuven, Leuven, Belgium; [Caumes, Rosaline] Hop Roger Salengro, Dept Neuropediat, Lille, France; [Cordelli, Duccio M.] St Orsola Marcello Malpighi Hosp, Paediat Neurol Unit, Bologna, Italy; [De Waele, Liesbeth M.] Univ Hosp Leuven, Dept Paediat Neurol, Leuven, Belgium; [De Waele, Liesbeth M.; Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Paediat Neurol, Leuven, Belgium; [Ferreira, Patrick] Alberta Childrens Prov Gen Hosp, Div Med Genet, Calgary, AB, Canada; [Fletcher, Nicholas A.] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Fryer, Alan E.] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England; [Goel, Himanshu] Hunter Genet Hunter New England Local Hlth Dist, Waratah, NSW, Australia; [Goel, Himanshu] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Hemingway, Cheryl A.; Prabhakar, Prab] Great Ormond St Hosp NHS Fdn Trust, Dept Paediat Neurol, London, England; [Henneke, Marco] Georg August Univ, Univ Med Ctr, Dept Pediat & Adolescent Med, Gottingen, Germany; [Hughes, Imelda] Cent Manchester Univ Hosp NHS Fdn Trust, Pediat Neurol, Manchester, Lancs, England; [Jefferson, Rosalind J.] Royal Berkshire Hosp, Dingley Specialist Childrens Ctr, Reading, Berks, England; [Kumar, Ram] Alder Hey Childrens NHS Fdn Trust, Dept Paediat Neurol, Liverpool, Merseyside, England; [Landrieu, Pierre G.] CHU Paris Sud Bicetre, Dept Paediat Neurol, Le Kremlin Bicetre, France; [Lourenco, Charles M.] Univ Sao Paulo, Clin Hosp Ribeirao Preto, Neurogenet Div, Sao Paulo, Brazil; [Malpas, Timothy J.] Jersey Gen Hosp, Dept Pediat, St Helier, England; [Mehta, Sarju G.] Addenbrookes Hosp, East Anglian Reg Genet Serv, Cambridge, England; Georg August Univ, Univ Med Ctr, Dept Neuropathol, Gottingen, Germany; [Naidu, Sakkubai] Johns Hopkins Med Inst Neurol & Pediat, Kennedy Krieger Inst, Hugo Moser Res Inst, Baltimore, MD USA; [Ounap, Katrin] Tartu Univ Hosp, Dept Genet, Tartu, Estonia; [Ounap, Katrin] Univ Tartu, Inst Clin Med, Dept Pediat, Tartu, Estonia; [Panzer, Axel] DRK Kliniken BerlinWestend, Paediat Neurol, Epilepsy Ctr, Berlin, Germany; [Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford, England; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Sinnathuray, Kanaga R.] Wexham Pk Hosp, Dept Pediat, Slough, Berks, England; [Soh, Calvin] Salford Royal NHS Fdn Trust, Neuroradiol Dept, Salford, Lancs, England; [Stone, John] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Van Esch, Hide] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Van Mol, Christine E. G.] St Augustinusziekenhuis, Dept Pediat Neonatol, Antwerp, Belgium; [Vanderver, Adeline] George Washington Univ, Childrens Natl Hlth Syst, Sch Med, Dept Neurol, Washington, DC USA; [Vanderver, Adeline] George Washington Univ, Childrens Natl Hlth Syst, Sch Med, Ctr Genet Med Res, Washington, DC USA; [Wakeling, Emma L.] London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Harrow, Middx, England; [Whitney, Andrea] Univ Hosp Southampton NHS Trust, Dept Child Neurol, Southampton, Hants, England; [Revy, Patrick] Hop Necker Enfants Malad, Inst Imagine, INSERM UMR 1163, Lab Genome Dynam Immune Syst, Paris, France; [Revy, Patrick; Crow, Yanick J.] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Child Neurol & Amsterdam Neurosci, Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Funct Genom, Amsterdam, Netherlands; [Livingston, John H.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England	University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; British Columbia Cancer Agency; Johns Hopkins University; Kennedy Krieger Institute; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Fondazione Stella Maris; Munchen Klinik; Oxford University Hospitals NHS Foundation Trust; University of Oxford; St. Louis Children's Hospital; Washington University (WUSTL); KU Leuven; University Hospital Leuven; KU Leuven; Universite de Lille - ISITE; CHU Lille; IRCCS Azienda Ospedaliero-Universitaria di Bologna; KU Leuven; University Hospital Leuven; KU Leuven; Alberta Childrens Hospital; University of Calgary; Walton Centre; University of Newcastle; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Gottingen; University of Manchester; Royal Berkshire Hospital; Alder Hey Children's NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Sao Paulo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Gottingen; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; University of Tartu; Oxford University Hospitals NHS Foundation Trust; Baylor Scott & White Health; Baylor University Medical Center; University of California System; University of California San Francisco; Salford Royal NHS Foundation Trust; University of Edinburgh; KU Leuven; University Hospital Leuven; Children's National Health System; George Washington University; Children's National Health System; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leeds General Infirmary; University of Leeds	Crow, YJ (corresponding author), Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Evolut & Genom Sci, Manchester, Lancs, England.; Crow, YJ (corresponding author), Hop Necker Enfants Malad, INSERM UMR 1163, Inst Imagine, Lab Neurogenet & Neuroinflammat, Paris, France.; Crow, YJ (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France.	yanickcrow@mac.com	Crow, Yanick J/N-6120-2014; Uggenti, Carolina/G-9145-2017; Sander-Effron, Samuel/AAX-2231-2020; Van+Esch, Hilde/AAU-5688-2020; Stone, Jon/C-3119-2014; Revy, Patrick/H-8137-2017; Resource Center, NINDS Human Genetics/AGF-2474-2022; rodero, mathieu/C-8083-2011; Pavitt, Graham D/A-1363-2010; Vanderver, Adeline/CAG-5072-2022; Rice, Gillian I/G-3128-2015; battini, roberta/P-9095-2017; Ounap, Katrin/Q-1103-2016; Cordelli, Duccio Maria/Q-4983-2016; Cordelli, Duccio Maria/N-4725-2019; Cassiman, David/H-6813-2014; Griffiths-Jones, Sam/H-2998-2014	Crow, Yanick J/0000-0001-7211-7564; Uggenti, Carolina/0000-0003-2673-5120; Stone, Jon/0000-0001-9829-8092; rodero, mathieu/0000-0002-1300-0187; Pavitt, Graham D/0000-0002-8593-2418; Rice, Gillian I/0000-0002-4223-0571; battini, roberta/0000-0002-7889-1355; Ounap, Katrin/0000-0002-4594-6364; Cordelli, Duccio Maria/0000-0002-1367-6419; Cordelli, Duccio Maria/0000-0002-1367-6419; Cassiman, David/0000-0002-6154-0970; Van Esch, Hilde/0000-0002-9604-5726; Wakeling, Emma/0000-0001-5712-0044; Griffiths-Jones, Sam/0000-0001-6043-807X; Revy, Patrick/0000-0003-0758-8022; Kershaw, Christopher/0000-0001-6625-7894; Williams, Simon/0000-0001-7396-4108; Haubitz, Monika/0000-0001-7660-401X; van der Knaap, Marjo/0000-0001-8912-0954; Kasher, Paul/0000-0002-9213-502X; Vanderver, Adeline/0000-0002-6290-6751; Prabhakar, Prab/0000-0002-1641-8714	Newlife Foundation [14-15/15]; Great Ormond Street Hospital Children's Charity [V1212]; Investments for the Future [ANR-10-IAHU-01]; Wellcome Trust [104981, 097820/Z/11/B]; La Ligue (Equipe Lab Elisee); Centre National de la Recherche Scientifique (CNRS); BBSRC [BB/M006565/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M006565/1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1212] Funding Source: researchfish; Newlife [14-15/15] Funding Source: researchfish	Newlife Foundation; Great Ormond Street Hospital Children's Charity; Investments for the Future; Wellcome Trust(Wellcome TrustEuropean Commission); La Ligue (Equipe Lab Elisee); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital Childrens Charity; Newlife	We are very grateful to the affected families for their involvement in our research. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. DNA panels from the NINDS Human Genetics Resource Center DNA and Cell Line Repository were used in this study, as well as clinical data. The submitters who contributed samples are acknowledged in detailed descriptions of each panel: NDPT099 and NAPT095. Y.J.C. acknowledges funding from the Newlife Foundation (14-15/15), the Great Ormond Street Hospital Children's Charity (V1212) and a state subsidy managed by the National Research Agency (France) under 'Investments for the Future' (ANR-10-IAHU-01). R.T.O'K. acknowledges the Wellcome Trust (104981). This work was supported by Wellcome Trust funding (097820/Z/11/B) to Y.J.C. and R.T.O'K. P.R. has received research support from La Ligue (Equipe Lab Elisee) and the Centre National de la Recherche Scientifique (CNRS). This paper is dedicated to the memory of John L. Tolmie.	Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084; Briggs TA, 2008, AM J MED GENET A, V146A, P182, DOI 10.1002/ajmg.a.32080; Christopher KJ, 2012, DEV BIOL, V368, P382, DOI 10.1016/j.ydbio.2012.06.008; Corboy JR, 2006, NEUROLOGY, V67, P1890, DOI 10.1212/01.wnl.0000244470.06748.18; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Labrune P, 1996, NEUROLOGY, V46, P1297, DOI 10.1212/WNL.46.5.1297; Lafontaine DLJ, 2015, NAT STRUCT MOL BIOL, V22, P11, DOI 10.1038/nsmb.2939; Livingston JH, 2014, NEUROPEDIATRICS, V45, P175, DOI 10.1055/s-0033-1364180; Nagae-Poetscher LM, 2004, NEUROLOGY, V62, P1206, DOI 10.1212/01.WNL.0000119341.59445.CF; PECULIS BA, 1994, GENE DEV, V8, P2241, DOI 10.1101/gad.8.18.2241; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Peculis BA, 2001, GENE, V274, P83, DOI 10.1016/S0378-1119(01)00596-0; Polvi A, 2012, AM J HUM GENET, V90, P540, DOI 10.1016/j.ajhg.2012.02.002; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P269, DOI 10.1139/o92-042; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Shaheen R, 2015, HUM MOL GENET, V24, P5211, DOI 10.1093/hmg/ddv242; Takai H, 2016, GENE DEV, V30, P812, DOI 10.1101/gad.276873.115; Tomasevic N, 2002, MOL CELL BIOL, V22, P4101, DOI 10.1128/MCB.22.12.4101-4112.2002; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	27	78	81	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1185	1192		10.1038/ng.3661	http://dx.doi.org/10.1038/ng.3661			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27571260	Green Submitted, Green Accepted			2022-12-17	WOS:000384391600013
J	Day, FR; Helgason, H; Chasman, DI; Rose, LM; Loh, PR; Scott, RA; Helgason, A; Kong, A; Masson, G; Magnusson, OT; Gudbjartsson, D; Thorsteinsdottir, U; Buring, JE; Ridker, PM; Sulem, P; Stefansson, K; Ong, KK; Perry, JRB				Day, Felix R.; Helgason, Hannes; Chasman, Daniel I.; Rose, Lynda M.; Loh, Po-Ru; Scott, Robert A.; Helgason, Agnar; Kong, Augustine; Masson, Gisli; Magnusson, Olafur Th; Gudbjartsson, Daniel; Thorsteinsdottir, Unnur; Buring, Julie E.; Ridker, Paul M.; Sulem, Patrick; Stefansson, Kari; Ong, Ken K.; Perry, John R. B.			Physical and neurobehavioral determinants of reproductive onset and success	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXECUTIVE FUNCTION; AGE; SCHIZOPHRENIA; HEALTH; MENARCHE; BEHAVIOR; PUBERTY; INTERCOURSE; ESTROGENS	The ages of puberty, first sexual intercourse and first birth signify the onset of reproductive ability, behavior and success, respectively. In a genome-wide association study of 125,667 UK Biobank participants, we identify 38 loci associated (P < 5 x 10(-8)) with age at first sexual intercourse. These findings were taken forward in 241,910 men and women from Iceland and 20,187 women from the Women's Genome Health Study. Several of the identified loci also exhibit associations (P < 5 x 10(-8)) with other reproductive and behavioral traits, including age at first birth (variants in or near ESR1 and RBM6-SEMA3F), number of children (CADM2 and ESR1), irritable temperament (MSRA) and risk-taking propensity (CADM2). Mendelian randomization analyses infer causal influences of earlier puberty timing on earlier first sexual intercourse, earlier first birth and lower educational attainment. In turn, likely causal consequences of earlier first sexual intercourse include reproductive, educational, psychiatric and cardiometabolic outcomes.	[Day, Felix R.; Scott, Robert A.; Ong, Ken K.; Perry, John R. B.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Helgason, Hannes; Helgason, Agnar; Kong, Augustine; Masson, Gisli; Magnusson, Olafur Th; Gudbjartsson, Daniel; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Helgason, Hannes; Kong, Augustine; Gudbjartsson, Daniel] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Loh, Po-Ru] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Loh, Po-Ru] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland	University of Cambridge; University of Iceland; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland; University of Iceland	Ong, KK; Perry, JRB (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	ken.ong@mrc-epid.cam.ac.uk; john.perry@mrc-epid.cam.ac.uk	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kong, Augustine/0000-0001-8193-5438; Masson, Gisli/0000-0003-0493-8242; Day, Felix/0000-0003-3789-7651	Medical Research Council [MC_UU_12015/1, MC_UU_12015/2]; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; MRC [MC_UU_12015/1, MC_UU_12015/2, MC_U106179472] Funding Source: UKRI; Medical Research Council [MC_U106179472, MC_PC_13046, MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research has been conducted using the UK Biobank Resource. This work was supported by the Medical Research Council (Unit Programme numbers MC_UU_12015/1 and MC_UU_12015/2).	Allen JP, 2014, CHILD DEV, V85, P1866, DOI 10.1111/cdev.12250; Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Baams L, 2015, J ADOLESCENT HEALTH, V56, P586, DOI 10.1016/j.jadohealth.2014.11.019; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Carreau S, 2010, PHILOS T R SOC B, V365, P1517, DOI 10.1098/rstb.2009.0235; Charalampopoulos D, 2014, AM J EPIDEMIOL, V180, P29, DOI 10.1093/aje/kwu113; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9842; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; de Mattos CS, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0114-2; Dinzeo TJ, 2007, J NERV MENT DIS, V195, P421, DOI 10.1097/01.nmd.0000253795.69089.ec; Drummond AE, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-16; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Harden KP, 2011, CHILD DEV, V82, P1327, DOI 10.1111/j.1467-8624.2011.01607.x; Hawes ZC, 2010, J SEX RES, V47, P137, DOI 10.1080/00224490903509399; Hess RA, 1997, NATURE, V390, P509, DOI 10.1038/37352; Hochberg Z, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-2; Hoptman MJ, 2015, CNS SPECTRUMS, V20, P280, DOI 10.1017/S1092852915000206; Ibrahim-Verbaas CA, 2016, MOL PSYCHIATR, V21, P189, DOI 10.1038/mp.2015.37; INGHAM R, 1991, J COMMUNITY APPL SOC, V1, P117, DOI 10.1002/casp.2450010206; Lahat A, 2012, DEV PSYCHOPATHOL, V24, P847, DOI 10.1017/S0954579412000405; Lam TH, 2002, ARCH SEX BEHAV, V31, P359, DOI 10.1023/A:1016228427210; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lehmann A, 2010, ANTHROPOL ANZ, V68, P85, DOI 10.1127/0003-5548/2010/0086; Lenciauskiene I, 2008, SCAND J PUBLIC HEALT, V36, P607, DOI 10.1177/1403494807088460; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin AK, 2014, GENES BRAIN BEHAV, V13, P104, DOI 10.1111/gbb.12066; MARTIN NG, 1977, J BIOSOC SCI, V9, P91, DOI 10.1017/S0021932000000493; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sohn K., 2015, DISCUSSION PAPER SER, V1-34; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Waldron M, 2015, J ADOLESCENT HEALTH, V56, P550, DOI 10.1016/j.jadohealth.2015.01.011; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Waylen A, 2004, EUR J ENDOCRINOL, V151, pU151, DOI 10.1530/eje.0.151U151; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	52	78	78	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					617	+		10.1038/ng.3551	http://dx.doi.org/10.1038/ng.3551			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DN0HE	27089180	Green Submitted, Green Accepted			2022-12-17	WOS:000376744200008
J	Barak, T; Kwan, KY; Louvi, A; Demirbilek, V; Saygi, S; Tuysuz, B; Choi, M; Boyaci, H; Doerschner, K; Zhu, Y; Kaymakcalan, H; Yilmaz, S; Bakircioglu, M; Caglayan, AO; Ozturk, AK; Yasuno, K; Brunken, WJ; Atalar, E; Yalcinkaya, C; Dincer, A; Bronen, RA; Mane, S; Ozcelik, T; Lifton, RP; Sestan, N; Bilguvar, K; Gunel, M				Barak, Tanyeri; Kwan, Kenneth Y.; Louvi, Angeliki; Demirbilek, Veysi; Saygi, Serap; Tuysuz, Beyhan; Choi, Murim; Boyaci, Huseyin; Doerschner, Katja; Zhu, Ying; Kaymakcalan, Hande; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Brunken, William J.; Atalar, Ergin; Yalcinkaya, Cengiz; Dincer, Alp; Bronen, Richard A.; Mane, Shrikant; Ozcelik, Tayfun; Lifton, Richard P.; Sestan, Nenad; Bilguevar, Kaya; Guenel, Murat			Recessive LAMC3 mutations cause malformations of occipital cortical development	NATURE GENETICS			English	Article							HUMAN PREFRONTAL CORTEX; LAMININ GAMMA-3 CHAIN; EXPRESSION; NEURONS; POLYMICROGYRIA; MORPHOGENESIS; DIFFUSION; MIGRATION; MEMBRANE; ADULT	The biological basis for regional and inter-species differences in cerebral cortical morphology is poorly understood. We focused on consanguineous Turkish families with a single affected member with complex bilateral occipital cortical gyration abnormalities. By using whole-exome sequencing, we initially identified a homozygous 2-bp deletion in LAMC3, the laminin. 3 gene, leading to an immediate premature termination codon. In two other affected individuals with nearly identical phenotypes, we identified a homozygous nonsense mutation and a compound heterozygous mutation. In human but not mouse fetal brain, LAMC3 is enriched in postmitotic cortical plate neurons, localizing primarily to the somatodendritic compartment. LAMC3 expression peaks between late gestation and late infancy, paralleling the expression of molecules that are important in dendritogenesis and synapse formation. The discovery of the molecular basis of this unusual occipital malformation furthers our understanding of the complex biology underlying the formation of cortical gyrations.	[Barak, Tanyeri; Louvi, Angeliki; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Bronen, Richard A.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Barak, Tanyeri; Kwan, Kenneth Y.; Louvi, Angeliki; Zhu, Ying; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Sestan, Nenad; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Barak, Tanyeri; Choi, Murim; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Mane, Shrikant; Lifton, Richard P.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA; [Barak, Tanyeri; Choi, Murim; Yilmaz, Saliha; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Oeztuerk, Ali Kemal; Yasuno, Katsuhito; Mane, Shrikant; Lifton, Richard P.; Bilguevar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Kwan, Kenneth Y.; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Demirbilek, Veysi; Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Fac Med, Dept Neurol, Div Child Neurol, Istanbul, Turkey; [Saygi, Serap] Hacettepe Univ, Sch Med, Dept Neurol, Ankara, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat, Div Genet, Istanbul, Turkey; [Boyaci, Huseyin; Doerschner, Katja] Bilkent Univ, Dept Psychol, Ankara, Turkey; [Boyaci, Huseyin; Doerschner, Katja; Atalar, Ergin] Bilkent Univ, Natl Magnet Resonance Res Ctr, Ankara, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Fac Arts & Sci, Istanbul, Turkey; [Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Dincer, Alp] Acibadem Univ, Sch Med, Dept Radiol, Istanbul, Turkey; [Bronen, Richard A.] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Ozcelik, Tayfun] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Istanbul University; Istanbul University - Cerrahpasa; Hacettepe University; Istanbul University; Istanbul University - Cerrahpasa; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ministry of Energy & Natural Resources - Turkey; Bahcesehir University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Acibadem University; Yale University; Yale University; Ihsan Dogramaci Bilkent University; Howard Hughes Medical Institute; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	murat.gunel@yale.edu	Kaymakcalan, Hande/AFP-2191-2022; Dincer, Alp/D-3658-2015; Choi, Murim/AAP-9120-2021; Kwan, Kenneth Y/F-8489-2011; Yasuno, Katsuhito/E-1960-2012; Yalcinkaya, Cengiz/B-6288-2012; Kwan, Kenneth/AAI-2841-2021; Kaymakcalan, Hande/AAO-4208-2021; Atalar, Ergin/D-3184-2012; Boyaci, Huseyin/ABI-5769-2020; Zhu, Ying/T-2268-2019; Tüysüz, Beyhan/AAN-4858-2020; Caglayan, Ahmet O/D-1066-2012	Dincer, Alp/0000-0001-9158-8353; Kwan, Kenneth Y/0000-0003-4711-071X; Yasuno, Katsuhito/0000-0002-3606-532X; Yalcinkaya, Cengiz/0000-0002-3443-8524; Kwan, Kenneth/0000-0003-4711-071X; Kaymakcalan, Hande/0000-0001-7736-7634; Atalar, Ergin/0000-0002-6874-6103; Boyaci, Huseyin/0000-0003-3168-0654; Caglayan, Ahmet O/0000-0002-2332-322X; saygi, serap/0000-0002-7329-7138; Tuysuz, Beyhan/0000-0002-9620-5021; Barak, Tanyeri/0000-0002-8522-1552; Brunken, William J/0000-0001-7330-1814; Zhu, Ying/0000-0002-6594-3734	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; US National Institutes of Health [RC2NS070477, UL1RR024139NIH, UO1MH081896]; US National Institutes of Health Neuroscience Microarray Consortium [U24 NS051869-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070477, U24NS051869] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the subjects and families who have contributed to this study. We would like to thank M. State and J. Noonan for critical comments regarding the study and C. Camputaro for her help with the imaging studies. We acknowledge the use of Yale University Biomedical High Performance Computing Center for data analysis and storage. This study was supported by the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and US National Institutes of Health grants RC2NS070477 (to M. G.), UL1RR024139NIH (Yale Clinical and Translational Science Award) and UO1MH081896 (to N.S.). SNP genotyping was supported in part by a US National Institutes of Health Neuroscience Microarray Consortium award U24 NS051869-02S1 (to S.M.).	Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Ben Cheikh BOA, 2009, NEUROGENETICS, V10, P35, DOI 10.1007/s10048-008-0143-3; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; CAVINESS VS, 1975, SCIENCE, V189, P18; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FERRIE CD, 1995, NEUROLOGY, V45, P150, DOI 10.1212/WNL.45.1.150; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Louvi A, 2004, DEVELOPMENT, V131, P3093, DOI 10.1242/dev.01191; MRZLJAK L, 1992, J COMP NEUROL, V316, P485, DOI 10.1002/cne.903160408; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pinzon-Duarte G, 2010, INVEST OPHTH VIS SCI, V51, P1773, DOI 10.1167/iovs.09-4645; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200	35	78	82	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					590	U132		10.1038/ng.836	http://dx.doi.org/10.1038/ng.836			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21572413	Green Published, Green Accepted			2022-12-17	WOS:000291017000019
J	Harbison, ST; Carbone, MA; Ayroles, JF; Stone, EA; Lyman, RF; Mackay, TFC				Harbison, Susan T.; Carbone, Mary Anna; Ayroles, Julien F.; Stone, Eric A.; Lyman, Richard F.; Mackay, Trudy F. C.			Co-regulated transcriptional networks contribute to natural genetic variation in Drosophila sleep	NATURE GENETICS			English	Article							MUSHROOM BODIES; MELANOGASTER; MAINTENANCE; MODULATION; REGULATOR; EVOLUTION; MUTANTS; PROTEIN; AROUSAL; WAKING	Sleep disorders are common in humans, and sleep loss increases the risk of obesity and diabetes(1). Studies in Drosophila(2,3) have revealed molecular pathways(4-7) and neural tissues(8-10) regulating sleep; however, genes that maintain genetic variation for sleep in natural populations are unknown. Here, we characterized sleep in 40 wild-derived Drosophila lines and observed abundant genetic variation in sleep architecture. We associated sleep with genome-wide variation in gene expression(11) to identify candidate genes. We independently confirmed that molecular polymorphisms in Catsup (Catecholamines up) are associated with variation in sleep and that P-element mutations in four candidate genes affect sleep and gene expression. Transcripts associated with sleep grouped into biologically plausible genetically correlated transcriptional modules. We confirmed co-regulated gene expression using P-element mutants. Quantitative genetic analysis of natural phenotypic variation is an efficient method for revealing candidate genes and pathways.	[Harbison, Susan T.; Carbone, Mary Anna; Ayroles, Julien F.; Lyman, Richard F.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Harbison, Susan T.; Carbone, Mary Anna; Ayroles, Julien F.; Stone, Eric A.; Lyman, Richard F.; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	National Institutes of Health [R01 GM 45146, R01 GM 076083, R01 AA016560]; National Sleep Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146, R01GM076083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sleep Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants R01 GM 45146, R01 GM 076083 and R01 AA016560 to T. F. C. M. and the National Sleep Foundation Pickwick Fellowship to S. T. H. We thank D. Reif for assistance with Catsup permutation tests, K. Jordan for assistance with the genetic correlation data and R. Anholt for comments on the manuscript. This is a publication of the W. M. Keck Center for Behavioral Biology.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; ODONNELL JM, 2002, CHEM BIOL PTERIDINES, P211; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Sambandan D, 2006, GENETICS, V174, P1349, DOI 10.1534/genetics.106.060574; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Stathakis DG, 1999, GENETICS, V153, P361; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Zepelin H, 1994, PRINCIPLES PRACTICE, P69; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2	29	78	80	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					371	375		10.1038/ng.330	http://dx.doi.org/10.1038/ng.330			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19234472	Green Accepted			2022-12-17	WOS:000263640200021
J	Ozaki, K; Sato, H; Inoue, K; Tsunoda, T; Sakata, Y; Mizuno, H; Lin, TH; Miyamoto, Y; Aoki, A; Onouchi, Y; Sheu, SH; Ikegawa, S; Odashiro, K; Nobuyoshi, M; Juo, SHH; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, Kouichi; Sato, Hiroshi; Inoue, Katsumi; Tsunoda, Tatsuhiko; Sakata, Yasuhiko; Mizuno, Hiroya; Lin, Tsung-Hsien; Miyamoto, Yoshinari; Aoki, Asako; Onouchi, Yoshihiro; Sheu, Sheng-Hsiung; Ikegawa, Shiro; Odashiro, Keita; Nobuyoshi, Masakiyo; Juo, Suh-Hang H.; Hori, Masatsugu; Nakamura, Yusuke; Tanaka, Toshihiro			SNPs in BRAP associated with risk of myocardial infarction in Asian populations	NATURE GENETICS			English	Article							LYMPHOTOXIN-ALPHA GENE; SIGNAL-TRANSDUCTION; CONFERS RISK; POLYMORPHISMS; DISEASE; PROTEIN; SUSCEPTIBILITY; GENOME; FAMILY	Myocardial infarction is a common disease and among the leading causes of death in the world. We previously reported association of variants in LGALS2, encoding galectin-2, with myocardial infarction susceptibility in a case-control association study in a Japanese population(1). Here we identify BRAP (BRCA1-associated protein) as a galectin-2-binding protein. We report an association of SNPs in BRAP with myocardial infarction risk in a large Japanese cohort (P = 3.0 x 10(-18), OR = 1.48, 2,475 cases and 2,778 controls), with replication in additional Japanese and Taiwanese cohorts (P = 4.4 x 10(-6), 862 cases and 1,113 controls and P = 4.7 x 10(-3), 349 cases and 994 controls, respectively). BRAP expression was observed in smooth muscle cells (SMCs) and macrophages in human atherosclerotic lesions. BRAP knockdown by siRNA using cultured coronary endothelial cells suppressed activation of NF-kappa B, a central mediator of inflammation.	[Ozaki, Kouichi; Aoki, Asako; Onouchi, Yoshihiro; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan; [Sato, Hiroshi; Sakata, Yasuhiko; Mizuno, Hiroya; Hori, Masatsugu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Inoue, Katsumi; Odashiro, Keita; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8028555, Japan; [Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung 807, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung 807, Taiwan; [Miyamoto, Yoshinari; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Juo, Suh-Hang H.] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan; [Juo, Suh-Hang H.] Kaohsiung Med Univ, Grad Inst Med Genet, Kaohsiung 807, Taiwan; [Juo, Suh-Hang H.] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	RIKEN; Osaka University; Kokura Memorial Hospital; RIKEN; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; RIKEN; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Tanaka, T (corresponding author), RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Yokohama, Kanagawa 2300045, Japan.	toshitan@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Juo, Suh-Hang/A-1765-2010; Sheu, Sheng-Hsiung/C-7445-2009; Juo, Suh-Hang/C-9545-2009; Tanaka, Toshihiro/J-9310-2014; SAKATA, YASUHIKO/G-6661-2019; Ikegawa, Shiro/N-6895-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tanaka, Toshihiro/0000-0001-6201-9784; Ikegawa, Shiro/0000-0003-0316-2147; Ozaki, Kouichi/0000-0003-0028-1570; Odashiro, Keita/0000-0003-0347-6330; Lin, Tsung-Hsien/0000-0002-7226-8730	Takeda Science Foundation; Uehara Science Foundation; Japanese Millennium Project; Ministry of Education, Science, Sports, Culture and Technology of Japan [NHRI-Ex96-9607PI]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Science Foundation(Uehara Memorial Foundation); Japanese Millennium Project; Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Takahashi, M. Yoshii, S. Abiko, W. Yamanobe, R. Ohishi, M. Watabe and T. Furusho for their assistance. We also thank all the other members of Center for Genomic Medicine, RIKEN and OACIS for their contribution to the completion of our study. We are also grateful to members of The Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was supported in part by grants from the Takeda Science Foundation, the Uehara Science Foundation, the Japanese Millennium Project and the Ministry of Education, Science, Sports, Culture and Technology of Japan and NHRI-Ex96-9607PI (Taiwan).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Asselbergs FW, 2007, CLIN SCI, V112, P291, DOI 10.1042/CS20060200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Mangino M, 2007, ATHEROSCLEROSIS, V194, P112, DOI 10.1016/j.atherosclerosis.2006.10.004; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mizuno H, 2006, ATHEROSCLEROSIS, V185, P400, DOI 10.1016/j.atherosclerosis.2005.06.020; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Ozaki K, 2006, NAT GENET, V38, P921, DOI 10.1038/ng1846; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Watkins H, 2004, EUR J HUM GENET, V12, P770, DOI 10.1038/sj.ejhg.5201244	22	78	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					329	333		10.1038/ng.326	http://dx.doi.org/10.1038/ng.326			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198608				2022-12-17	WOS:000263640200014
J	Dutrow, N; Nix, DA; Holt, D; Milash, B; Dalley, B; Westbroek, E; Parnell, TJ; Cairns, BR				Dutrow, Natalie; Nix, David A.; Holt, Derick; Milash, Brett; Dalley, Brian; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.			Dynamic transcriptome of Schizosaccharomyces pombe shown by RNA-DNA hybrid mapping	NATURE GENETICS			English	Article							FISSION YEAST CENTROMERES; POLYMERASE-II; HUMAN GENOME; SEQUENCE; HETEROCHROMATIN; COMPLEX; IDENTIFICATION; ORGANIZATION; METHYLATION; TELOMERASE	We have determined the high-resolution strand-specific transcriptome of the fission yeast S. pombe under multiple growth conditions using a novel RNA-DNA hybridization mapping (HybMap) technique. HybMap uses an antibody against an RNA-DNA hybrid to detect RNA molecules hybridized to a high-density DNA oligonucleotide tiling microarray. HybMap showed exceptional dynamic range and reproducibility, and allowed us to identify strand-specific coding, noncoding and structural RNAs, as well as previously unknown RNAs conserved in distant yeast species. Notably, we found that virtually the entire euchromatic genome (including intergenics) is transcribed, with heterochromatin dampening intergenic transcription. We identified features including large numbers of condition-specific noncoding RNAs, extensive antisense transcription, new properties of antisense transcripts and induced divergent transcription. Furthermore, our HybMap data informed the efficiency and locations of RNA splicing genome-wide. Finally, we observed strand-specific transcription islands around tRNAs at heterochromatin boundaries inside centromeres. Here, we discuss these new features in terms of organism fitness and transcriptome evolution.	[Dutrow, Natalie; Holt, Derick; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Dutrow, Natalie; Holt, Derick; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Nix, David A.; Milash, Brett] Univ Utah, Sch Med, Huntsman Canc Inst, Bioinformat Core Facil, Salt Lake City, UT 84112 USA; [Dalley, Brian] Univ Utah, Sch Med, Huntsman Canc Inst, Microarray Core Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84132 USA.	brad.cairns@hci.utah.edu		Parnell, Timothy/0000-0002-3632-3691	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA24014] Funding Source: Medline; NIGMS NIH HHS [T32 GM007464] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLARKE L, 1986, P NATL ACAD SCI USA, V83, P8253, DOI 10.1073/pnas.83.21.8253; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; NAKASEKO Y, 1987, NUCLEIC ACIDS RES, V15, P4705, DOI 10.1093/nar/15.12.4705; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Steigele S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-25; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	38	78	79	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					977	986		10.1038/ng.196	http://dx.doi.org/10.1038/ng.196			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641648	Green Accepted			2022-12-17	WOS:000258026900014
J	Pravenec, M; Churchill, PC; Churchill, MC; Viklicky, O; Kazdova, L; Aitman, TJ; Petretto, E; Hubner, N; Wallace, CA; Zimdahl, H; Zidek, V; Landa, V; Dunbar, J; Bidani, A; Griffin, K; Qi, N; Maxova, M; Kren, V; Mlejnek, P; Wang, J; Kurtz, TW				Pravenec, Michal; Churchill, Paul C.; Churchill, Monique C.; Viklicky, Ondrej; Kazdova, Ludmila; Aitman, Timothy J.; Petretto, Enrico; Hubner, Norbert; Wallace, Caroline A.; Zimdahl, Heike; Zidek, Vaclav; Landa, Vladimir; Dunbar, Joseph; Bidani, Anil; Griffin, Karen; Qi, Nathan; Maxova, Martina; Kren, Vladimir; Mlejnek, Petr; Wang, Jiaming; Kurtz, Theodore W.			Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; DEFICIENCY; EXPRESSION; GENES; ACID; RATS	To identify renally expressed genes that influence risk for hypertension, we integrated expression quantitative trait locus (QTL) analysis of the kidney with genome-wide correlation analysis of renal expression profiles and blood pressure in recombinant inbred strains derived from the spontaneously hypertensive rat (SHR). This strategy, together with renal transplantation studies in SHR progenitor, transgenic and congenic strains, identified deficient renal expression of Cd36 encoding fatty acid translocase as a genetically determined risk factor for spontaneous hypertension.	[Wang, Jiaming; Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA; [Pravenec, Michal; Zidek, Vaclav; Landa, Vladimir; Kren, Vladimir; Mlejnek, Petr] Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic; Acad Sci Czech Republic, Ctr Appl Genom, Prague 14220, Czech Republic; [Pravenec, Michal; Kren, Vladimir] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800, Czech Republic; Charles Univ Prague, Gen Teaching Hosp, Prague 12800, Czech Republic; [Churchill, Paul C.; Churchill, Monique C.] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA; [Viklicky, Ondrej; Kazdova, Ludmila; Maxova, Martina] Inst Clin & Expt Med, Prague 14021, Czech Republic; [Aitman, Timothy J.; Petretto, Enrico; Wallace, Caroline A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London W12 ONN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W12 ONN, England; [Hubner, Norbert; Zimdahl, Heike] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bidani, Anil; Griffin, Karen] Loyola Univ, Dept Internal Med, Maywood, IL 60153 USA; Hines VA Hosp, Maywood, IL 60153 USA; [Qi, Nathan] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague; Wayne State University; Institute for Clinical & Experimental Medicine (IKEM); Imperial College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Michigan System; University of Michigan	Kurtz, TW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.	KurtzT@Labmed2.ucsf.edu	Pravenec, Michal/B-1666-2012; Mlejnek, Petr/C-2305-2012; Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012	Pravenec, Michal/0000-0001-9197-5871; Mlejnek, Petr/0000-0002-4218-8983; Aitman, Timothy/0000-0002-7875-4502; Viklicky, Ondrej/0000-0003-1049-2195	MRC [MC_U120061454] Funding Source: UKRI; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BORDESSOULE D, 1993, BRIT J HAEMATOL, V83, P370, DOI 10.1111/j.1365-2141.1993.tb04659.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kincer JF, 2002, J BIOL CHEM, V277, P23525, DOI 10.1074/jbc.M202465200; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Lifton Richard P, 2004, Harvey Lect, V100, P71; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Pravenec M, 2003, PHYSIOL RES, V52, P681; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200; Zou A P, 1999, Curr Hypertens Rep, V1, P178, DOI 10.1007/s11906-999-0016-7	15	78	81	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					952	954		10.1038/ng.164	http://dx.doi.org/10.1038/ng.164			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587397				2022-12-17	WOS:000258026900010
J	Li, JZ; Jiang, T; Mao, JH; Balmain, A; Peterson, L; Harris, C; Rao, PH; Havlak, P; Gibbs, R; Cai, WW				Li, JZ; Jiang, T; Mao, JH; Balmain, A; Peterson, L; Harris, C; Rao, PH; Havlak, P; Gibbs, R; Cai, WW			Genomic segmental polymorphisms in inbred mouse strains	NATURE GENETICS			English	Article							DUPLICATIONS; MICROARRAYS	By analyzing genomic copy-number differences using high-resolution mouse whole-genome BAC arrays, we uncover substantial differences in regional DNA content between inbred strains of mice. The identification of these apparently common segmental polymorphisms suggests that these differences can contribute to genetic variability and pathologic susceptibility.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine	Cai, WW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	wcai@bcm.tmc.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Peterson, Leif/0000-0002-1187-0883				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Peterson LE, 2002, COMPUT METH PROG BIO, V69, P179, DOI 10.1016/S0169-2607(01)00189-4; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100	12	78	79	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					952	954		10.1038/ng1417	http://dx.doi.org/10.1038/ng1417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322544	Bronze			2022-12-17	WOS:000223658100019
J	Takeuchi, A; Mishina, Y; Miyaishi, O; Kojima, E; Hasegawa, T; Isobe, K				Takeuchi, A; Mishina, Y; Miyaishi, O; Kojima, E; Hasegawa, T; Isobe, K			Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; BINDING PROTEIN; P53 PROTEIN; MICE; DISRUPTION; ZBP-89; GENE; EXPRESSION; DEFICIENT	Zfp148 belongs to a large family of C2H2-type zinc-finger transcription factors. Zfp148 is expressed in fetal germ cells in 13.5-d-old (E13.5) mouse embryos. Germ-line transmission of mutations were not observed in chimeric Zfp148(+/-) mice, and some of these mice completely lacked spermatogonia. The number of primordial germ cells in Zfp148(+/-) tetraploid embryos was normal until E11.5, but declined from E11.5 to E13.5 and continued to decline until few germ cells were present at E18.5. This phenotype was not rescued by wild-type Sertoli or stromal cells, and is therefore a cell-autonomous phenotype. These results indicate that two functional alleles of Zfp148 are required for the normal development of fetal germ cells. Recent studies have shown that Zfp148 activates p53, which has an important role in cell-cycle regulation(1). Primordial germ cells stop proliferating at approximately E13.5, which correlates with induction of phosphorylation of p53 and its translocation to the nucleus. Phosphorylation of p53 is impaired in Zfp(148+/-) embryonic stem cells and in fetal germ cells from chimeric Zfp148(+/-) embryos. Thus, Zfp148 may be required for regulating p53 in the development of germ cells.	Natl Inst Longev Sci, Dept Basic Gerontol, Obu, Aichi 4748522, Japan; Natl Inst Environm Hlth Studies, Mol Dev Biol Grp, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Isobe, K (corresponding author), Natl Inst Longev Sci, Dept Basic Gerontol, 36-3 Gengo,Morioka Cho, Obu, Aichi 4748522, Japan.		Takeuchi, Akihide/AAT-4675-2020; isobe, ken-ichi/A-6685-2011	Takeuchi, Akihide/0000-0002-2781-0180; isobe, ken-ichi/0000-0002-8150-2496	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; BUEHR M, 1993, METHOD ENZYMOL, V225, P58; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Hasegawa T, 1999, BIOCHEM BIOPH RES CO, V256, P249, DOI 10.1006/bbrc.1999.0275; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; HOGAN B, 1994, MANIPULATING MOUSE E, P373; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NAGY A, 1990, DEVELOPMENT, V110, P815; ROSAI J, 1996, ACKERMANS SURG PATHO, P1260; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Taniuchi T, 1997, BIOCHEM BIOPH RES CO, V233, P154, DOI 10.1006/bbrc.1997.6310; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; WONG TW, 1973, ARCH PATHOL, V95, P151; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; YOSHINAGA K, 1991, DIFFERENTIATION, V48, P75, DOI 10.1111/j.1432-0436.1991.tb00245.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	25	78	95	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					172	176		10.1038/ng1072	http://dx.doi.org/10.1038/ng1072			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524542				2022-12-17	WOS:000180773700015
J	Worth, PF; Houlden, H; Giunti, P; Davis, MB; Wood, NW				Worth, PF; Houlden, H; Giunti, P; Davis, MB; Wood, NW			Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia	NATURE GENETICS			English	Letter									Inst Neurol, Dept Clin Neurol, Neurogenet Sect, London WC1N 3BG, England	University of London; University College London	Wood, NW (corresponding author), Inst Neurol, Dept Clin Neurol, Neurogenet Sect, Queen Sq, London WC1N 3BG, England.		Giunti, Paola/E-5526-2012; Houlden, Henry J/C-1532-2008; Wood, Nicholas W/C-2505-2009	Giunti, Paola/0000-0003-3508-4788; Houlden, Henry J/0000-0002-2866-7777; Wood, Nicholas W/0000-0002-9500-3348				HARDING AE, 1984, J NEUROL NEUROSUR PS, V47, P853, DOI 10.1136/jnnp.47.8.853; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710	2	78	81	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					214	215		10.1038/73411	http://dx.doi.org/10.1038/73411			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700168				2022-12-17	WOS:000085590600007
J	Battey, J; Jordan, E; Cox, D; Dove, W				Battey, J; Jordan, E; Cox, D; Dove, W			An action plan for mouse genomics	NATURE GENETICS			English	Editorial Material								The mouse has become the leading animal model for studying biological processes in mammals. Creation of additional genomic and genetic resources will make the mouse an even more useful model for the research community. On the basis of recommendations from the scientific community, the National Institutes of Health (NIH) plans to support grants to generate a 'working draft' sequence of the mouse genome by 2003, systematic mutagenesis and phenotyping centres, repositories for mouse strain maintenance, distribution and cryopreservation and training fellowships in mouse pathobiology.	Natl Inst Deafness & Other Commun Disorders, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Univ Wisconsin, Sch Med, Mcardle Lab Canc Res, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Battey, J (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH Bldg 31,9000 Rockville Pike, Bethesda, MD 20892 USA.								0	78	80	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					73	75		10.1038/5012	http://dx.doi.org/10.1038/5012			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916794				2022-12-17	WOS:000077960700012
J	Moisan, MP; Courvoisier, H; Bihoreau, MT; Gauguier, D; Hendley, ED; Lathrop, M; James, MR; Mormede, P				Moisan, MP; Courvoisier, H; Bihoreau, MT; Gauguier, D; Hendley, ED; Lathrop, M; James, MR; Mormede, P			A major quantitative trait locus influences hyperactivity in the WKHA rat	NATURE GENETICS			English	Article							ATTENTION-DEFICIT DISORDER; CHILDHOOD HYPERACTIVITY; MICE	The syndrome of hyperactivity describes behavioural disorders existing mainly in children and characterized by increased levels of motor activity, inattention and impulsivity(1,2). Overall the aetiology is poorly understood due to the heterogeneity of the pathology although psychological, biological and social factors acting singly or in concert are generally thought to be involved. In animal studies the observed hyperactivity phenotype results from relative participation of exploration, emotionality and general activity(3). Studies using brain lesions(3), neuropharmacology(4) and gene knock-out strategies(5,6) have shown that specific elements of the brain dopaminergic system can subserve hyperactivity. Evidence of a genetic contribution comes from family(7,8) and twin studies(9) but also from the ability to select divergent animal lines on the basis of their differential activity. The Wistar-Kyoto (WKY) and Wistar-Kyoto hyperactive (WKHA) rats are such strains - distinct for their low and high activity scores in a novel environment, respectively(10). Here, we report the detection of a major hyperactivity-related QTL on chromosome 8, explaining 29% of the variance of an intercross between these strains. This study represents the first behavioural QTL analysis in rat and provides a new starting point for biologically categorizing different forms of hyperactivity.	WELLCOME TRUST CTR HUMAN GENET,OXFORD X3 7BN,ENGLAND; UNIV VERMONT,COLL MED,DEPT PHYSIOL & BIOPHYS,BURLINGTON,VT 05405	University of Oxford; Wellcome Centre for Human Genetics; University of Vermont	Moisan, MP (corresponding author), INST FRANCOIS MAGENDIE,INSERM,INRA,F-33077 BORDEAUX,FRANCE.		Mormede, Pierre/K-5537-2015; Gauguier, Dominique/G-2190-2016; Moisan, Marie-Pierre/AAO-9971-2021; Mormede, Pierre/N-3918-2019	Mormede, Pierre/0000-0003-0345-1432; Gauguier, Dominique/0000-0001-6156-9530; Moisan, Marie-Pierre/0000-0001-7315-5319; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BIHOREAU MT, UNPUB; CASTANON N, 1993, AM J PHYSIOL, V265, pR1304, DOI 10.1152/ajpregu.1993.265.6.R1304; CHURCHILL GA, 1994, GENETICS, V138, P963; COOK EH, 1995, AM J HUM GENET, V56, P993; COURVOISIER H, IN PRESS BRAIN RES; FARAONE SV, 1991, AM J PSYCHIAT, V148, P112; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; GIROS B, 1996, NATURE, V379, P303; HENDLEY ED, 1991, AM J PHYSIOL, V261, pH583, DOI 10.1152/ajpheart.1991.261.2.H583; HENDLEY ED, 1993, BRAIN RES, V586, P44; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; KELLEY AE, 1989, NEUROMETHODS, V13, P95; KNOTT SA, 1992, HEREDITY, V68, P313, DOI 10.1038/hdy.1992.45; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MOGENSON GJ, 1984, BEHAV NEURAL BIOL, V42, P52, DOI 10.1016/S0163-1047(84)90424-2; NELSON JC, 1995, PLANT GENOME, V4, pA315; SCHACHAR R, 1991, J CHILD PSYCHOL PSYC, V32, P155, DOI 10.1111/j.1469-7610.1991.tb00007.x; THAPAR A, 1995, BEHAV GENET, V25, P537, DOI 10.1007/BF02327577; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V51, P787, DOI 10.1016/0031-9384(92)90117-K; VOELLER KKS, 1991, J CHILD NEUROL, V6, pS2, DOI 10.1177/0883073891006001S01; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4	24	78	80	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					471	473		10.1038/ng1296-471	http://dx.doi.org/10.1038/ng1296-471			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944030				2022-12-17	WOS:A1996VV73000026
J	GRANT, M; ZUCCOTTI, M; MONK, M				GRANT, M; ZUCCOTTI, M; MONK, M			METHYLATION OF CPG SITES OF 2 X-LINKED GENES COINCIDES WITH X-INACTIVATION IN THE FEMALE MOUSE EMBRYO BUT NOT IN THE GERM LINE	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; DNA METHYLATION; CELLS; EXPRESSION; ISLAND; MICE	To further our understanding of initiation and imprinting of X-chromosome inactivation, we have examined methylation of specific CpG sites of X-linked Pgk-1 and G6pd genes throughout female mouse development. Methylation occurs around the time of inactivation and earlier for Pgk-1, which is closer to the X-inactivation centre. In female primordial germ cells, the inactive X chromosome escapes methylation; this may underly the reversibility of inactivation at meiosis. Similarly, the genes are unmethylated on the inactive X chromosome in sperm; hence, the imprint specifying preferential X-inactivation in extra-embryonic tissues must reside elsewhere.	UNIV PAVIA,CNR,CTR STUDIO ISTOCHIM,I-27100 PAVIA,ITALY; UNIV PAVIA,DIPARTIMENTO BIOL ANIM,I-27100 PAVIA,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia	GRANT, M (corresponding author), UNIV LONDON UNIV COLL,MRC,MAMMALIAN DEV UNIT,STEPHENSON WAY,LONDON NW1 2HE,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARLETT MH, 1991, SOMAT CELL MOLEC GEN, V17, P35; BECK BN, 1988, NUCLEIC ACIDS RES, V16, P9051, DOI 10.1093/nar/16.18.9051; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; GARTLER SM, 1980, CYTOGENET CELL GENET, V28, P203, DOI 10.1159/000131531; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HANSEN RS, 1988, MOL CELL BIOL, V8, P4962; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P964; JOHNSTON PG, 1981, GENET RES, V37, P317, DOI 10.1017/S0016672300020322; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1986, BIOESSAYS, V4, P204, DOI 10.1002/bies.950040505; MONK M, 1987, DEVELOPMENT, V99, P371; MONK M, 1987, MAMMALIAN DEV PRACTI; MONK M, 1990, GENOMIC IMPRINTING D, P55; PAPAIOANNOU VE, 1981, DEV GENET, V2, P305, DOI 10.1002/dvg.1020020308; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; SINGERSAM J, 1989, UCLA S MOL CELLULAR, V128; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TONIOLO D, 1991, GENE, V102, P197, DOI 10.1016/0378-1119(91)90078-P; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	37	78	78	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					161	166		10.1038/ng1092-161	http://dx.doi.org/10.1038/ng1092-161			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303266				2022-12-17	WOS:A1992JR08400019
J	Gozdecka, M; Meduri, E; Mazan, M; Tzelepis, K; Dudek, M; Knights, AJ; Pardo, M; Yu, L; Choudhary, JS; Metzakopian, E; Iyer, V; Yun, HY; Park, N; Varela, I; Bautista, R; Collord, G; Dovey, O; Garyfallos, DA; De Braekeleer, E; Kondo, S; Cooper, J; Gottgens, B; Bullinger, L; Northcott, PA; Adams, D; Vassiliou, GS; Huntly, BJP				Gozdecka, Malgorzata; Meduri, Eshwar; Mazan, Milena; Tzelepis, Konstantinos; Dudek, Monika; Knights, Andrew J.; Pardo, Mercedes; Yu, Lu; Choudhary, Jyoti S.; Metzakopian, Emmanouil; Iyer, Vivek; Yun, Haiyang; Park, Naomi; Varela, Ignacio; Bautista, Ruben; Collord, Grace; Dovey, Oliver; Garyfallos, Dimitrios A.; De Braekeleer, Etienne; Kondo, Saki; Cooper, Jonathan; Gottgens, Berthold; Bullinger, Lars; Northcott, Paul A.; Adams, David; Vassiliou, George S.; Huntly, Brian J. P.			UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; H3K27ME3 DEMETHYLASE UTX; EMBRYONIC STEM-CELLS; PEPTIDE IDENTIFICATION; TRANSCRIPTION FACTORS; CHROMOSOME Y; GENOME-WIDE; MOSAIC LOSS; THERAPEUTIC TARGETS; BETHESDA PROPOSALS	The histone H3 Lys27-specific demethylase UTX (or KDM6A) is targeted by loss-of-function mutations in multiple cancers. Here, we demonstrate that UTX suppresses myeloid leukemogenesis through noncatalytic functions, a property shared with its catalytically inactive Y-chromosome paralog, UTY (or KDM6C). In keeping with this, we demonstrate concomitant loss/mutation of KDM6A (UTX) and UTY in multiple human cancers. Mechanistically, global genomic profiling showed only minor changes in H3K27me3 but significant and bidirectional alterations in H3K27ac and chromatin accessibility; a predominant loss of H3K4me1 modifications; alterations in ETS and GATA-factor binding; and altered gene expression after Utx loss. By integrating proteomic and genomic analyses, we link these changes to UTX regulation of ATP-dependent chromatin remodeling, coordination of the COMPASS complex and enhanced pioneering activity of ETS factors during evolution to AML. Collectively, our findings identify a dual role for UTX in suppressing acute myeloid leukemia via repression of oncogenic ETS and upregulation of tumor-suppressive GATA programs.	[Gozdecka, Malgorzata; Mazan, Milena; Tzelepis, Konstantinos; Dudek, Monika; Collord, Grace; Dovey, Oliver; Garyfallos, Dimitrios A.; De Braekeleer, Etienne; Cooper, Jonathan; Vassiliou, George S.] Wellcome Trust Sanger Inst, Haematol Canc Genet, Hinxton, England; [Gozdecka, Malgorzata; Meduri, Eshwar; Mazan, Milena; Yun, Haiyang; Vassiliou, George S.; Huntly, Brian J. P.] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Biomed Campus, Cambridge, England; [Knights, Andrew J.] Wellcome Trust Sanger Inst, Genom Gene Regulat, Hinxton, England; [Pardo, Mercedes; Yu, Lu; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Prote Mass Spectrometry, Wellcome Trust Genome Campus, Hinxton, England; [Metzakopian, Emmanouil] Wellcome Trust Sanger Inst, Mouse Genom, Hinxton, England; [Iyer, Vivek; Adams, David] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, England; [Park, Naomi] Wellcome Trust Sanger Inst, Sequencing Res Grp, Cambridge, England; [Varela, Ignacio] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria CSIC UC Soderca, Santander, Spain; [Bautista, Ruben] Wellcome Trust Sanger Inst, New Pipeline Grp, Wellcome Trust Genome Campus, Hinxton, England; [Kondo, Saki] Univ Tokyo, Inst Med Sci, Lab Mol Genet, Tokyo, Japan; [Gottgens, Berthold; Huntly, Brian J. P.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gottgens, Berthold; Huntly, Brian J. P.] Univ Cambridge, Wellcome Trust Med Res Council, Stem Cell Inst, Cambridge, England; [Gottgens, Berthold; Huntly, Brian J. P.] Univ Cambridge, Dept Haematol, Cambridge, England; [Bullinger, Lars] Ulm Univ, Dept Internal Med 3, Med Ctr, Ulm, Germany; [Bullinger, Lars] Charite, Div Hematol Oncol & Tumour Immunol, Dept Med, Berlin, Germany; [Northcott, Paul A.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vassiliou, George S.; Huntly, Brian J. P.] Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Wellcome Trust Sanger Institute; University of Tokyo; University of Cambridge; University of Cambridge; University of Cambridge; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); St Jude Children's Research Hospital	Vassiliou, GS; Huntly, BJP (corresponding author), Wellcome Trust Sanger Inst, Haematol Canc Genet, Hinxton, England.; Vassiliou, GS; Huntly, BJP (corresponding author), Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Biomed Campus, Cambridge, England.; Huntly, BJP (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.; Huntly, BJP (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council, Stem Cell Inst, Cambridge, England.; Huntly, BJP (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.; Vassiliou, GS; Huntly, BJP (corresponding author), Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England.	gsv20@sanger.ac.uk; bjph2@cam.ac.uk	Varela, Ignacio/AAA-7680-2021; Bullinger, Lars/AAL-7965-2020; Varela, Ignacio/G-1699-2016; Adams, David H/C-9092-2009; Northcott, Paul A/N-4022-2018; huntly, brian/E-6725-2014; choudhary, jyoti/S-1232-2017	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Adams, David H/0000-0001-6776-0336; Northcott, Paul A/0000-0002-1220-5252; Gottgens, Berthold/0000-0001-6302-5705; Collord, Grace/0000-0003-1924-4411; Bullinger, Lars/0000-0002-5890-5510; , Malgorzata/0000-0002-3134-1276; huntly, brian/0000-0003-0312-161X; choudhary, jyoti/0000-0003-0881-5477; Adams, David/0000-0001-9490-0306; Pardo, Mercedes/0000-0002-3477-9695; Yun, Haiyang/0000-0001-8714-205X; Vassiliou, George/0000-0003-4337-8022; Meduri, Eshwar/0000-0002-3821-312X; Tzelepis, Konstantinos/0000-0002-4865-7648; De Braekeleer, Etienne/0000-0003-4659-023X	Bloodwise Program [17006]; ERC consolidator award [647685 COMAL]; Cancer Research UK program award; Medical Research Council, (MRC); Wellcome Trust (WT); Cambridge NIHR BRC; WT/MRC Center grant [097922/Z/11/Z]; WT strategic award [100140]; Cancer Research UK Senior Cancer Research Fellowship [C22324/A23015]; Kay Kendall Leukemia Fund; Sanger Institute [WT098051]; MRC [MR/R009708/1, MR/M010392/1] Funding Source: UKRI	Bloodwise Program; ERC consolidator award; Cancer Research UK program award; Medical Research Council, (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (WT)(Wellcome Trust); Cambridge NIHR BRC(National Institute for Health Research (NIHR)); WT/MRC Center grant; WT strategic award; Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK); Kay Kendall Leukemia Fund; Sanger Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was primarily funded by a joint Bloodwise Program Grant (17006) to B.J.P.H. and G.S.V. Work in the laboratory of B.J.P.H. is also funded by an ERC consolidator award (grant 647685 COMAL), a Cancer Research UK program award, the Medical Research Council, (MRC) the Wellcome Trust (WT) and the Cambridge NIHR BRC. We acknowledge the WT/MRC Center grant (097922/Z/11/Z) and support from WT strategic award 100140. G.S.V. is funded by a Cancer Research UK Senior Cancer Research Fellowship (C22324/A23015). The laboratory of G.S.V. is also supported by the Kay Kendall Leukemia Fund and core funding from the Sanger Institute (WT098051).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Beyaz S, 2017, NAT IMMUNOL, V18, P184, DOI 10.1038/ni.3644; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cho Y. W., J BIOL CHEM, V282; Ciau-Uitz A, 2013, BLOOD CELL MOL DIS, V51, P248, DOI 10.1016/j.bcmd.2013.07.010; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gao JH, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0024-z; Goldberg L, 2013, BLOOD, V122, P2694, DOI 10.1182/blood-2013-01-477133; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Greif PA, 2012, BLOOD, V120, P395, DOI 10.1182/blood-2012-01-403220; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones D, 2016, CURR PROTOC BIOINFOR, V56; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kumasaka N, 2016, NAT GENET, V48, P206, DOI 10.1038/ng.3467; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raine K.M., 2015, CURR PROTOC BIOINFOR, V52; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Wilson NK, 2016, BLOOD, V127, pE12, DOI 10.1182/blood-2015-10-677393; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wouters BJ, 2016, BLOOD, V127, P42, DOI 10.1182/blood-2015-07-604512; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoo KH, 2016, MOL CELL BIOL, V36, P2108, DOI 10.1128/MCB.00089-16; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou WY, 2016, NAT GENET, V48, P563, DOI 10.1038/ng.3545	73	77	82	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					883	+		10.1038/s41588-018-0114-z	http://dx.doi.org/10.1038/s41588-018-0114-z			27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29736013	Green Submitted, Green Accepted			2022-12-17	WOS:000433621000016
J	Mayran, A; Khetchoumian, K; Hariri, F; Pastinen, T; Gauthier, Y; Balsalobre, A; Drouin, J				Mayran, Alexandre; Khetchoumian, Konstantin; Hariri, Fadi; Pastinen, Tomi; Gauthier, Yves; Balsalobre, Aurelio; Drouin, Jacques			Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; CHROMATIN; GENOME; BINDING; FOXA1; RECRUITMENT; MACROPHAGE; EXPRESSION; LANDSCAPE	Pioneer transcription factors establish new cell-fate competence by triggering chromatin remodeling. However, many features of pioneer action, such as their kinetics and stability, remain poorly defined. Here, we show that Pax7, by opening a unique repertoire of enhancers, is necessary and sufficient for specification of one pituitary lineage. Pax7 binds its targeted enhancers rapidly, but chromatin remodeling and gene activation are slower. Enhancers opened by Pax7 show a loss of DNA methylation and acquire stable epigenetic memory, as evidenced by binding of nonpioneer factors after Pax7 withdrawal. This work shows that transient Pax7 expression is sufficient for stable specification of cell identity.	[Mayran, Alexandre; Khetchoumian, Konstantin; Gauthier, Yves; Balsalobre, Aurelio; Drouin, Jacques] IRCM, Lab Genet Mol, Montreal, PQ, Canada; [Mayran, Alexandre; Drouin, Jacques] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Hariri, Fadi; Pastinen, Tomi] McGill Univ, McGill Genome Innovat Ctr, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University	Drouin, J (corresponding author), IRCM, Lab Genet Mol, Montreal, PQ, Canada.; Drouin, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jacques.drouin@ircm.qc.ca		Mayran, Alexandre/0000-0002-1228-0308; Drouin, Jacques/0000-0001-8226-5691	IRCM Challenge fellowship; Canadian Institutes of Health Research	IRCM Challenge fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to our colleagues N. Francis for critical comments on the manuscript; L. Budry and S. Nemec for profiling data and Pitx1 ChIP-seq, respectively; O. Neyret for NGS analyses; E. Massicotte for FACS sorting; A. Blanchet-Cohen for WGBS data analysis; and E. Joyal for expert secretarial assistance. A.M. was supported by an IRCM Challenge fellowship. This work was supported by grants to J.D. from the Canadian Institutes of Health Research.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Almouzni G, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019372; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Drouin J, 2017, PITUITARY, 4TH EDITION, P3, DOI 10.1016/B978-0-12-804169-7.00001-5; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Langlais D, 2013, MOL ENDOCRINOL, V27, P1103, DOI 10.1210/me.2012-1407; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavoie PL, 2008, MOL ENDOCRINOL, V22, P1647, DOI 10.1210/me.2007-0567; Lerdrup M, 2016, NAT STRUCT MOL BIOL, V23, P349, DOI 10.1038/nsmb.3180; Liu F, 2016, NAT REV CANCER, V16, P359, DOI 10.1038/nrc.2016.41; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Pataskar A, 2016, EMBO J, V35, P24, DOI 10.15252/embj.201591206; Pulichino AM, 2003, GENE DEV, V17, P738, DOI 10.1101/gad.1065703; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rizzoti K, 2015, J MOL ENDOCRINOL, V54, pR55, DOI 10.1530/JME-14-0237; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Sheng HZ, 1999, TRENDS GENET, V15, P236, DOI 10.1016/S0168-9525(99)01742-4; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Zaret KS, 2016, MOL CELL, V62, P665, DOI 10.1016/j.molcel.2016.05.024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	77	78	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					259	+		10.1038/s41588-017-0035-2	http://dx.doi.org/10.1038/s41588-017-0035-2			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29358650				2022-12-17	WOS:000424519200017
J	Lu, HC; Tan, QM; Rousseaux, MWC; Wang, W; Kim, JY; Richman, R; Wan, YW; Yeh, SY; Patel, JM; Liu, XY; Lin, T; Lee, Y; Fryer, JD; Han, J; Chahrour, M; Finnell, RH; Lei, YP; Zurita-Jimenez, ME; Ahimaz, P; Anyane-Yeboa, K; Van Maldergem, L; Lehalle, D; Jean-Marcais, N; Mosca-Boidron, AL; Thevenon, J; Cousin, MA; Bro, DE; Lanpher, BC; Klee, EW; Alexander, N; Bainbridge, MN; Orr, HT; Sillitoe, RV; Ljungberg, MC; Liu, ZD; Schaaf, CP; Zoghbi, HY				Lu, Hsiang-Chih; Tan, Qiumin; Rousseaux, Maxime W. C.; Wang, Wei; Kim, Ji-Yoen; Richman, Ronald; Wan, Ying-Wooi; Yeh, Szu-Ying; Patel, Jay M.; Liu, Xiuyun; Lin, Tao; Lee, Yoontae; Fryer, John D.; Han, Jing; Chahrour, Maria; Finnell, Richard H.; Lei, Yunping; Zurita-Jimenez, Maria E.; Ahimaz, Priyanka; Anyane-Yeboa, Kwame; Van Maldergem, Lionel; Lehalle, Daphne; Jean-Marcais, Nolwenn; Mosca-Boidron, Anne-Laure; Thevenon, Julien; Cousin, Margot A.; Bro, Della E.; Lanpher, Brendan C.; Klee, Eric W.; Alexander, Nora; Bainbridge, Matthew N.; Orr, Harry T.; Sillitoe, Roy V.; Ljungberg, M. Cecilia; Liu, Zhandong; Schaaf, Christian P.; Zoghbi, Huda Y.			Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans	NATURE GENETICS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TIME PCR DATA; INTELLECTUAL DISABILITY; SCA1 NEUROPATHOLOGY; REPRESSOR CAPICUA; SOCIAL-BEHAVIOR; CAG REPEAT; NEURONS; AUTISM; ATAXIN-1	Gain-of-function mutations in some genes underlie neurodegenerative conditions, whereas loss-of-function mutations in the same genes have distinct phenotypes. This appears to be the case with the protein ataxin 1 (ATXN1), which forms a transcriptional repressor complex with capicua (CIC). Gain of function of the complex leads to neurodegeneration, but ATXN1-CIC is also essential for survival. We set out to understand the functions of the ATXN1-CIC complex in the developing forebrain and found that losing this complex results in hyperactivity, impaired learning and memory, and abnormal maturation and maintenance of upper-layer cortical neurons. We also found that CIC activity in the hypothalamus and medial amygdala modulates social interactions. Informed by these neurobehavioral features in mouse mutants, we identified five individuals with de novo heterozygous truncating mutations in CIC who share similar clinical features, including intellectual disability, attention deficit/hyperactivity disorder (ADHD), and autism spectrum disorder. Our study demonstrates that loss of ATXN1-CIC complexes causes a spectrum of neurobehavioral phenotypes.	[Lu, Hsiang-Chih; Yeh, Szu-Ying; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lu, Hsiang-Chih; Tan, Qiumin; Rousseaux, Maxime W. C.; Wang, Wei; Kim, Ji-Yoen; Richman, Ronald; Wan, Ying-Wooi; Yeh, Szu-Ying; Liu, Xiuyun; Lin, Tao; Lee, Yoontae; Fryer, John D.; Han, Jing; Sillitoe, Roy V.; Ljungberg, M. Cecilia; Liu, Zhandong; Schaaf, Christian P.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Tan, Qiumin; Rousseaux, Maxime W. C.; Wang, Wei; Kim, Ji-Yoen; Richman, Ronald; Wan, Ying-Wooi; Liu, Xiuyun; Lee, Yoontae; Fryer, John D.; Han, Jing; Chahrour, Maria; Bainbridge, Matthew N.; Schaaf, Christian P.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tan, Qiumin; Rousseaux, Maxime W. C.; Wang, Wei; Kim, Ji-Yoen; Richman, Ronald; Wan, Ying-Wooi; Liu, Xiuyun; Lee, Yoontae; Fryer, John D.; Han, Jing; Chahrour, Maria; Bainbridge, Matthew N.; Schaaf, Christian P.; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Richman, Ronald; Liu, Xiuyun; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Patel, Jay M.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Sillitoe, Roy V.] Univ Texas, Dell Med Sch, Dell Pediat Res Inst, Dept Pediat, Austin, TX USA; [Finnell, Richard H.; Lei, Yunping; Zurita-Jimenez, Maria E.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Ahimaz, Priyanka; Anyane-Yeboa, Kwame] Univ Franche Comte, Ctr Human Genet, Besancon, France; [Van Maldergem, Lionel] Dijon Univ Hosp, Univ Hosp Federat, Translat Med Congenital Anomal TRANSLAD, Dijon, France; [Lehalle, Daphne; Jean-Marcais, Nolwenn; Mosca-Boidron, Anne-Laure; Thevenon, Julien] Dijon Univ Hosp, Genet Ctr & Reference Ctr Congenital Anomal, Dijon, France; [Lehalle, Daphne; Jean-Marcais, Nolwenn; Thevenon, Julien] Burgundy Univ, Res Unit 4271, Genet Congenital Anomal, Dijon, France; [Lehalle, Daphne; Mosca-Boidron, Anne-Laure; Thevenon, Julien] Dijon Univ Hosp, Ctr Biol, Chromosomal & Mol Genet Lab, Dijon, France; [Mosca-Boidron, Anne-Laure] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Cousin, Margot A.; Bro, Della E.; Lanpher, Brendan C.; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Cousin, Margot A.; Klee, Eric W.] Mayo Clin, Dept Clin Gen, Rochester, MN USA; [Bro, Della E.; Lanpher, Brendan C.; Klee, Eric W.] GeneDx, Gaithersburg, MD USA; [Alexander, Nora] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX USA; [Bainbridge, Matthew N.] LLC, Codified Gen, Houston, TX USA; [Bainbridge, Matthew N.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA; [Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA; [Orr, Harry T.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Ljungberg, M. Cecilia; Liu, Zhandong; Zoghbi, Huda Y.] Texas Childrens Hosp, Houston, TX USA; [Schaaf, Christian P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Lu, Hsiang-Chih; Lee, Yoontae; Fryer, John D.; Chahrour, Maria; Bro, Della E.] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Lu, Hsiang-Chih; Tan, Qiumin] Mayo Clin, Dept Neurosci, Jacksonville, FL USA; [Lu, Hsiang-Chih; Lee, Yoontae; Fryer, John D.; Han, Jing; Chahrour, Maria; Bro, Della E.] MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX USA; [Lu, Hsiang-Chih; Lee, Yoontae; Fryer, John D.; Chahrour, Maria; Bro, Della E.] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev Neurosci, Dallas, TX 75390 USA; [Lu, Hsiang-Chih; Lee, Yoontae; Fryer, John D.; Han, Jing; Chahrour, Maria; Bro, Della E.] Virginia Piper Canc Inst Allina Hlth, Minneapolis, MN USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Austin; Columbia University; Universite de Franche-Comte; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Mayo Clinic; Mayo Clinic; Mayo Clinic; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Pohang University of Science & Technology (POSTECH); Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Allina Health System	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Schaaf, Christian P/AAJ-7318-2021; Lei, Yunping/B-6322-2009; Cousin, Margot/AAD-4591-2019; Finnell, Richard/D-8174-2018	Schaaf, Christian P/0000-0002-2148-7490; Lei, Yunping/0000-0003-1504-0884; Cousin, Margot/0000-0002-6119-9346; Anyane-Yeboa, Kwame/0000-0002-4977-9719; Finnell, Richard/0000-0002-5962-8754; Patel, Jay/0000-0003-2746-5716; Orr, Harry/0000-0001-6118-741X; Tan, Qiumin/0000-0003-2266-3238; Rousseaux, Maxime/0000-0002-2737-6193; Zoghbi, Huda/0000-0002-0700-3349; Liu, Zhandong/0000-0002-7608-0831; Chahrour, Maria/0000-0002-3174-1480; Yeh, Szu-Ying/0000-0003-4506-5652	Genomic and RNA Profiling Core at Baylor College of Medicine; Mayo Clinic Center for Individualized Medicine Investigative and Functional Genomics Program; NIH/NICHD [R01 HD081216, HD083809]; NIH/NHGRI [1UM1 HG008898-01]; NIH/NINDS [R37 NS22920, R01 NS089664, R01 NS027699-26, R37 NS027699-28, F32 NS083091]; NIH/NIGMS [R01 GM120033]; NSF [DMS-1263932]; CPRIT [RP170387]; Canadian Institutes of Health Research [201210MFE-290072-173743]; Shared Instrumentation grant [1S10OD016167]; Microscopy Core; Neuropathology Core at Baylor College or Medicine; NIH IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD083092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083809, P01HD067244, U54HD083092, R01HD081216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699, R01NS027699, R01NS089664, F32NS083091, R37NS022920] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016167] Funding Source: NIH RePORTER	Genomic and RNA Profiling Core at Baylor College of Medicine; Mayo Clinic Center for Individualized Medicine Investigative and Functional Genomics Program; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); CPRIT; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shared Instrumentation grant; Microscopy Core; Neuropathology Core at Baylor College or Medicine; NIH IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families for their articipation in the study and H. Zheng (Baylor College of Medicine) for providing Neurod6-Cre (NEX-Cre) mice. This project was partly supported by the Genomic and RNA Profiling Core at Baylor College of Medicine and the expert assistance of the core director, L.D. White. We would like to thank the Mayo Clinic Center for Individualized Medicine Investigative and Functional Genomics Program for funding and support. The project was supported by grants NIH/NICHD R01 HD081216 and HD083809 to R.H.F.; NIH/NHGRI 1UM1 HG008898-01 to M.N.B.; NIH/NINDS R37 NS22920 to H.T.O.; NIH/NINDS R01 NS089664 to R.V.S.; NIH/NIGMS R01 GM120033, NSF DMS-1263932 and CPRIT RP170387 to Z.L.; and NIH/NINDS R01 NS027699-26 and R37 NS027699-28 to H.Y.Z. Q.T. was supported by NIH/NINDS F32 NS083091, and M.W.C.R. received support from Canadian Institutes of Health Research Fellowship 201210MFE-290072-173743. H.Y.Z. is an investigator or the Howard IIughes Medical Institute. We thank the RNA Irr Situ I lybridization Core (supported by Shared Instrumentation grant 1S10OD016167), the Microscopy Core, and the Neuropathology Core at Baylor College or Medicine. All three cores are supported by NIH IDDRC grant U54 HD083092 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Alvarez-Bolado G, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00083; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Asher M, 2016, NEUROSCIENCE, V322, P54, DOI 10.1016/j.neuroscience.2016.02.011; Athanasakis E, 2014, AM J MED GENET A, V164, P170, DOI 10.1002/ajmg.a.36274; Baroy T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-3; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Celestino-Soper PBS, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-17; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Di Benedetto D, 2012, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-4; Diaz C, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00162; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fryer JD, 2011, SCIENCE, V334, P690, DOI 10.1126/science.1212673; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Jonas P, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00107; Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1147, DOI 10.1007/s00213-014-3464-y; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sotnikoca T.D., 2014, BEHAV GENETICS MOUSE, V2, P164; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Yi-Han Lee, 2011, Proceedings of International MultiConference of Engineers and Computer Scientists 2011 (IMECS 2011), P1; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P15395, DOI 10.1073/pnas.1304124110	50	77	79	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2017	49	4					527	+		10.1038/ng.3808	http://dx.doi.org/10.1038/ng.3808			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EP8CO	28288114	Green Accepted			2022-12-17	WOS:000397603700016
J	Reinius, B; Mold, JE; Ramskold, D; Deng, QL; Johnsson, P; Michaelsson, J; Frisen, J; Sandberg, R				Reinius, Bjorn; Mold, Jeff E.; Ramskold, Daniel; Deng, Qiaolin; Johnsson, Per; Michaelsson, Jakob; Frisen, Jonas; Sandberg, Rickard			Analysis of allelic expression patterns in clonal somatic cells by single-cell RNA-seq	NATURE GENETICS			English	Article							RANDOM MONOALLELIC EXPRESSION; STOCHASTIC GENE-EXPRESSION; EMBRYONIC STEM-CELLS; MAMMALIAN-CELLS; MOUSE; MECHANISMS; NANOG; TRANSCRIPTOME; PLURIPOTENCY; DYNAMICS	Cellular heterogeneity can emerge from the expression of only one parental allele. However, it has remained controversial whether, or to what degree, random monoallelic expression of autosomal genes (aRME) is mitotically inherited (clonal) or stochastic (dynamic) in somatic cells, particularly in vivo. Here we used allele-sensitive single-cell RNA-seq on clonal primary mouse fibroblasts and freshly isolated human CD8(+) T cells to dissect clonal and dynamic monoallelic expression patterns. Dynamic aRME affected a considerable portion of the cells' transcriptomes, with levels dependent on the cells' transcriptional activity. Notably, clonal aRME was detected, but it was surprisingly scarce (<1 % of genes) and mainly affected the most weakly expressed genes. Consequently, the overwhelming majority of aRME occurs transiently within individual cells, and patterns of aRME are thus primarily scattered throughout somatic cell populations rather than, as previously hypothesized, confined to patches of clonally related cells.	[Reinius, Bjorn; Mold, Jeff E.; Ramskold, Daniel; Deng, Qiaolin; Frisen, Jonas; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Reinius, Bjorn; Ramskold, Daniel; Johnsson, Per; Sandberg, Rickard] Ludwig Inst Canc Res, Stockholm, Sweden; [Michaelsson, Jakob] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital	Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Sandberg, R (corresponding author), Ludwig Inst Canc Res, Stockholm, Sweden.	rickard.sandberg@ki.se	Deng, Qiaolin/AAD-6905-2020	Deng, Qiaolin/0000-0001-5934-7816; Sandberg, Rickard/0000-0001-6473-1740; Mold, Jeffrey/0000-0003-2195-2978; Reinius, Bjorn/0000-0002-7021-5248; Ramskold, Daniel/0000-0003-2892-673X	Human Frontiers Science Program Long-Term Fellowship [LT-000231/2011-1]; Swedish Research Council, the European Research Council [648842]; Swedish Foundation for Strategic Research; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); Knut och Alice Wallenbergs Stiftelse; Torsten Soderbergs Stiftelse	Human Frontiers Science Program Long-Term Fellowship; Swedish Research Council, the European Research Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Torsten Soderbergs Stiftelse	We thank D. Edsgard for assistance in handling sequence data and members of the Sandberg laboratory for their input. J.M. was supported by a Human Frontiers Science Program Long-Term Fellowship (LT-000231/2011-1), and the work was supported by grants from the Swedish Research Council, the European Research Council (648842), the Swedish Foundation for Strategic Research, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, the Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), Knut och Alice Wallenbergs Stiftelse, and Torsten Soderbergs Stiftelse.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Borel C, 2015, AM J HUM GENET, V96, P70, DOI 10.1016/j.ajhg.2014.12.001; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Filipczyk A, 2013, CELL STEM CELL, V13, P12, DOI 10.1016/j.stem.2013.04.025; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ohlsson R, 1999, DEV GENES EVOL, V209, P113, DOI 10.1007/s004270050233; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Paul W., 2012, FUNDAMENTAL IMMUNOLO, V7th; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Pinter SF, 2015, GENETICS, V200, P537, DOI 10.1534/genetics.115.176263; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	34	77	81	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1430	1435		10.1038/ng.3678	http://dx.doi.org/10.1038/ng.3678			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668657	Green Accepted			2022-12-17	WOS:000386543400021
J	Davies, RW; Flint, J; Myers, S; Mott, R				Davies, Robert W.; Flint, Jonathan; Myers, Simon; Mott, Richard			Rapid genotype imputation from sequence without reference panels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; DISCOVERY; FRAMEWORK	Inexpensive genotyping methods are essential for genetic studies requiring large sample sizes. In human studies, array-based microarrays and high-density haplotype reference panels allow efficient genotype imputation for this purpose. However, these resources are typically unavailable in non-human settings. Here we describe a method ( STITCH) for imputation based only on sequencing read data, without requiring additional reference panels or array data. We demonstrate its applicability even in settings of extremely low sequencing coverage, by accurately imputing 5.7 million SNPs at a mean r(2) value of 0.98 in 2,073 outbred laboratory mice ( 0.15x sequencing coverage). In a sample of 11,670 Han Chinese ( 1.7x coverage), we achieve accuracy similar to that of alternative approaches that require a reference panel, demonstrating that our approach can work for genetically diverse populations. Our method enables straightforward progression from low-coverage sequence to imputed genotypes, overcoming barriers that at present restrict the application of genome-wide association study technology outside humans.	[Davies, Robert W.; Myers, Simon; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA; [Myers, Simon] Univ Oxford, Dept Stat, Oxford, England; [Mott, Richard] UCL, UCL Genet Inst, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California Los Angeles; University of Oxford; University of London; University College London	Davies, RW (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	rwdavies@well.ox.ac.uk	Myers, Simon R/A-6792-2015	Myers, Simon R/0000-0002-2585-9626; Mott, Richard/0000-0002-1022-9330	Wellcome Trust [097308/Z/11/Z, WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z, WT098387/Z/12/Z];  [098387/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); 	R.W.D. is supported by a grant from the Wellcome Trust (097308/Z/11/Z). S.M. is supported by Investigator Award 098387/Z/12/Z. This work was funded by the Wellcome Trust (WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z and WT098387/Z/12/Z).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Didion JP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-34; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang BE, 2011, BIOINFORMATICS, V27, P727, DOI 10.1093/bioinformatics/btq719; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nicod J, 2016, NAT GENET, V48, P912, DOI 10.1038/ng.3595; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; VanRaden PM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0243-7; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085	27	77	81	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					965	+		10.1038/ng.3594	http://dx.doi.org/10.1038/ng.3594			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376236	Green Accepted, Green Submitted			2022-12-17	WOS:000380755100023
J	Nicod, J; Davies, RW; Cai, N; Hassett, C; Goodstadt, L; Cosgrove, C; Yee, BK; Lionikaite, V; McIntyre, RE; Remme, CA; Lodder, EM; Gregory, JS; Hough, T; Joynson, R; Phelps, H; Nell, B; Rowe, C; Wood, J; Walling, A; Bopp, N; Bhomra, A; Hernandez-Pliego, P; Callebert, J; Aspden, RM; Talbot, NP; Robbins, PA; Harrison, M; Fray, M; Launay, JM; Pinto, YM; Blizard, DA; Bezzina, CR; Adams, DJ; Franken, P; Weaver, T; Wells, S; Brown, SDM; Potter, PK; Klenerman, P; Lionikas, A; Mott, R; Flint, J				Nicod, Jerome; Davies, Robert W.; Cai, Na; Hassett, Carl; Goodstadt, Leo; Cosgrove, Cormac; Yee, Benjamin K.; Lionikaite, Vikte; McIntyre, Rebecca E.; Remme, Carol Ann; Lodder, Elisabeth M.; Gregory, Jennifer S.; Hough, Tertius; Joynson, Russell; Phelps, Hayley; Nell, Barbara; Rowe, Clare; Wood, Joe; Walling, Alison; Bopp, Nasrin; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Callebert, Jacques; Aspden, Richard M.; Talbot, Nick P.; Robbins, Peter A.; Harrison, Mark; Fray, Martin; Launay, Jean-Marie; Pinto, Yigal M.; Blizard, David A.; Bezzina, Connie R.; Adams, David J.; Franken, Paul; Weaver, Tom; Wells, Sara; Brown, Steve D. M.; Potter, Paul K.; Klenerman, Paul; Lionikas, Arimantas; Mott, Richard; Flint, Jonathan			Genome-wide association of multiple complex traits in outbred mice by ultra-low-coverage sequencing	NATURE GENETICS			English	Article							B-CELL DEVELOPMENT; C-MET; MOUSE; GENOTYPE; MODEL; PHENOTYPES; FRAMEWORK; RECEPTOR; LACKING	Two bottlenecks impeding the genetic analysis of complex traits in rodents are access to mapping populations able to deliver gene-level mapping resolution and the need for population-specific genotyping arrays and haplotype reference panels. Here we combine low-coverage ( 0.15x) sequencing with a new method to impute the ancestral haplotype space in 1,887 commercially available outbred mice. We mapped 156 unique quantitative trait loci for 92 phenotypes at a 5% false discovery rate. Gene-level mapping resolution was achieved at about one-fifth of the loci, implicating Unc13c and Pgc1a at loci for the quality of sleep, Adarb2 for home cage activity, Rtkn2 for intensity of reaction to startle, Bmp2 for wound healing, Il15 and Id2 for several T cell measures and Prkca for bone mineral content. These findings have implications for diverse areas of mammalian biology and demonstrate how genome-wide association studies can be extended via low-coverage sequencing to species with highly recombinant outbred populations.	[Nicod, Jerome; Davies, Robert W.; Cai, Na; Goodstadt, Leo; Bopp, Nasrin; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Hassett, Carl; Hough, Tertius; Joynson, Russell; Phelps, Hayley; Nell, Barbara; Rowe, Clare; Wood, Joe; Walling, Alison; Harrison, Mark; Fray, Martin; Weaver, Tom; Wells, Sara] MRC Harwell, Mary Lyon Ctr, Harwell Sci & Innovat Campus, Harwell, Berks, England; [Cosgrove, Cormac; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Yee, Benjamin K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Lionikaite, Vikte; Gregory, Jennifer S.; Aspden, Richard M.; Lionikas, Arimantas] Univ Aberdeen, Sch Med Med Sci & Nutr, Coll Life Sci & Med, Aberdeen, Scotland; [McIntyre, Rebecca E.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, England; [Remme, Carol Ann; Lodder, Elisabeth M.; Pinto, Yigal M.; Bezzina, Connie R.] Acad Med Ctr, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, AP HP, Dept Biochem, INSERM U942, Paris, France; [Talbot, Nick P.; Robbins, Peter A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Blizard, David A.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Brown, Steve D. M.; Potter, Paul K.] MRC Harwell, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Harwell, Berks, England; [Mott, Richard] UCL, UCL Genet Inst, London, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	University of Oxford; Wellcome Centre for Human Genetics; MRC Harwell; University of Oxford; Hong Kong Polytechnic University; University of Aberdeen; Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Lausanne; MRC Harwell; University of London; University College London; University of California System; University of California Los Angeles	Mott, R; Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.; Mott, R (corresponding author), UCL, UCL Genet Inst, London, England.; Flint, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	r.mott@ucl.ac.uk; jflint@mednet.ucla.edu	callebert, jacques/L-4569-2017; Cai, Na/I-2977-2019; Lodder, Elisabeth/X-5385-2019; Franken, Paul/A-9633-2018; Potter, Paul Keith/GWU-6398-2022; Yee, Benjamin K/AAW-6048-2021	Cai, Na/0000-0001-7496-2075; Lodder, Elisabeth/0000-0001-6017-3796; Franken, Paul/0000-0002-2500-2921; Potter, Paul Keith/0000-0003-2689-2361; Yee, Benjamin K/0000-0002-3220-9162; Gregory, Jennifer/0000-0002-6328-4560; Aspden, Richard/0000-0002-0693-1194; , yigal/0000-0002-2836-571X; Adams, David/0000-0001-9490-0306; klenerman, paul/0000-0003-4307-9161; Mott, Richard/0000-0002-1022-9330; BHOMRA, AMARJIT/0000-0002-0439-0128; Talbot, Nick/0000-0002-9186-8950; Bezzina, Connie/0000-0002-0633-3514	Wellcome Trust [090532/Z/09/Z, 097308/Z/11/Z]; Mary Lyon Centre; Mammalian Genetics Unit (Medical Research Council, UK) [G0900747 91070, MC U142684172]; NIH [R01AR056280]; state of Vaud (Switzerland); Swiss National Science Foundation [SNF 14694, 136201]; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences; PREDICT project, InterUniversity Cardiology Institute of the Netherlands [061.02]; Agency of Science, Technology and Research (A*STAR) Graduate Academy; Medical Research Council [MR/L007428/1, MC_UP_1502/1, MC_U142684172] Funding Source: researchfish; National Institute for Health Research [ACF-2009-13-013, NF-SI-0515-10005] Funding Source: researchfish; MRC [MC_U142684172, MR/L007428/1, MC_UP_1502/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056280] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Mary Lyon Centre; Mammalian Genetics Unit (Medical Research Council, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; PREDICT project, InterUniversity Cardiology Institute of the Netherlands; Agency of Science, Technology and Research (A*STAR) Graduate Academy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors wish to acknowledge excellent technical assistance from A. Kurioka, L. Swadling, C. de Lara, J. Ussher, R. Townsend, S. Lionikaite, A.S. Lionikiene, R. Wolswinkel and I. van der Made. We would like to thank T.M. Keane and A.G. Doran for their help in annotating variants and adding the FVB/NJ strain to the MGP. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics and the Wellcome Trust Sanger Institute for the generation of the sequencing data. This work was funded by Wellcome Trust grant 090532/Z/09/Z (J.F.). Primary phenotyping of the mice was supported by the Mary Lyon Centre and Mammalian Genetics Unit (Medical Research Council, UK Hub grant G0900747 91070 and Medical Research Council, UK grant MC U142684172). D.A.B. acknowledges support from NIH R01AR056280. The sleep work was supported by the state of Vaud (Switzerland) and the Swiss National Science Foundation (SNF 14694 and 136201 to P.F.). The ECG work was supported by the Netherlands CardioVascular Research Initiative (Dutch Heart Foundation, Dutch Federation of University Medical Centres, Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences) PREDICT project, InterUniversity Cardiology Institute of the Netherlands (ICIN; 061.02; C.A.R. and C.R.B.). N.C. is supported by the Agency of Science, Technology and Research (A*STAR) Graduate Academy. R.W.D. is supported by a grant from the Wellcome Trust (097308/Z/11/Z).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Cheng RY, 2013, G3-GENES GENOM GENET, V3, P1861, DOI 10.1534/g3.113.007948; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Collier FM, 2004, BIOCHEM BIOPH RES CO, V324, P1360, DOI 10.1016/j.bbrc.2004.09.205; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Davies R.W., 2016, NAT GENET; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Dougherty SE, 2014, NEUROSCIENCE, V271, P137, DOI 10.1016/j.neuroscience.2014.04.023; Duprez DM, 1996, DEV BIOL, V174, P448, DOI 10.1006/dbio.1996.0087; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Galea GL, 2014, J BIOL CHEM, V289, P25509, DOI 10.1074/jbc.M114.580365; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2003, GENETICS, V165, P2213; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Munoz-Bravo JL, 2013, DEVELOPMENT, V140, P3669, DOI 10.1242/dev.091256; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Ma PC, 2003, CANCER RES, V63, P6272; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mittaz L, 1997, HUM GENET, V100, P398, DOI 10.1007/s004390050523; Nakura A, 2011, BONE, V48, P476, DOI 10.1016/j.bone.2010.09.238; Pallares LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005607; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; R Foundation for Statistical Computing, 2021, R LANG ENV STAT COMP; Ramos-Quiroga JA, 2014, J PSYCHIATR RES, V49, P60, DOI 10.1016/j.jpsychires.2013.10.022; Reddy SY, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0061-1; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Zaffaroni D, 2005, ONCOGENE, V24, P1084, DOI 10.1038/sj.onc.1208324; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	57	77	80	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					912	+		10.1038/ng.3595	http://dx.doi.org/10.1038/ng.3595			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376238	Green Submitted, Green Accepted			2022-12-17	WOS:000380755100015
J	Xu, H; Robinson, GW; Huang, J; Lim, JYS; Zhang, H; Bass, JK; Broniscer, A; Chintagumpala, M; Bartels, U; Gururangan, S; Hassall, T; Fisher, M; Cohn, R; Yamashita, T; Teitz, T; Zuo, J; Onar-Thomas, A; Gajjar, A; Stewart, CF; Yang, JJ				Xu, Heng; Robinson, Giles W.; Huang, Jie; Lim, Joshua Yew-Suang; Zhang, Hui; Bass, Johnnie K.; Broniscer, Alberto; Chintagumpala, Murali; Bartels, Ute; Gururangan, Sri; Hassall, Tim; Fisher, Michael; Cohn, Richard; Yamashita, Tetsuji; Teitz, Tal; Zuo, Jian; Onar-Thomas, Arzu; Gajjar, Amar; Stewart, Clinton F.; Yang, Jun J.			Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss	NATURE GENETICS			English	Article							PLATINUM-INDUCED OTOTOXICITY; GENETIC-VARIANTS; INTERNATIONAL SOCIETY; RISK MEDULLOBLASTOMA; GRADING SCALES; AVERAGE-RISK; HAIR-CELLS; CHILDREN; CANCER; NEUROBLASTOMA	Taking a genome-wide association study approach, we identified inherited genetic variations in ACYP2 associated with cisplatin-related ototoxicity (rs1872328: P = 3.9 x 10(-8), hazard ratio = 4.5) in 238 children with newly diagnosed brain tumors, with independent replication in 68 similarly treated children. The ACYP2 risk variant strongly predisposed these patients to precipitous hearing loss and was related to ototoxicity severity. These results point to new biology underlying the ototoxic effects of platinum agents.	[Xu, Heng; Lim, Joshua Yew-Suang; Zhang, Hui; Stewart, Clinton F.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Xu, Heng] Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Collaborat Innovat Ctr,Dept Lab Med, Chengdu 610064, Peoples R China; [Xu, Heng] Sichuan Univ, West China Hosp, Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China; [Robinson, Giles W.; Broniscer, Alberto; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Huang, Jie; Onar-Thomas, Arzu] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Lim, Joshua Yew-Suang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Bass, Johnnie K.] St Jude Childrens Res Hosp, Rehabil Serv, Memphis, TN 38105 USA; [Chintagumpala, Murali] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Bartels, Ute] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Gururangan, Sri] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hassall, Tim] Royal Childrens Hosp, Dept Oncol, Parkville, Vic 3052, Australia; [Fisher, Michael] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Cohn, Richard] Univ New S Wales, Sch Womens & Childrens Hlth, Kensington, NSW 2033, Australia; [Yamashita, Tetsuji; Teitz, Tal; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Sichuan University; Sichuan University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National University of Singapore; St Jude Children's Research Hospital; Baylor College of Medicine; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Duke University; Royal Children's Hospital Melbourne; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New South Wales Sydney; St Jude Children's Research Hospital	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	clinton.stewart@stjude.org; jun.yang@stjude.org	Robinson, Giles W/N-8095-2018; Xu, Heng/AAS-3465-2021; Yang, Jun J./ABG-5646-2020; Onar-Thomas, Arzu/M-9356-2018; Stewart, Clinton/N-3822-2018; Gajjar, Amar/N-8059-2018	Robinson, Giles W/0000-0001-7441-9486; Xu, Heng/0000-0002-7748-2621; Yang, Jun J./0000-0002-0770-9659; Stewart, Clinton/0000-0002-1546-9720; Cohn, Richard/0000-0002-2400-1353; Zhang, Hui/0000-0001-6825-5649; Hassall, Timothy/0000-0002-7883-3710; Bass, Johnnie/0000-0001-7432-3863	US National Institutes of Health [P30 CA21765-34, U01GM92666]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA154619, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC013879] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Throm for coordinating patient samples, S. Hughes for curating the ototoxicity data, all patients and their parents who participated in the St. Jude protocols included in this study, G. Koh (National University of Singapore) for her assistance in genome-wide genotyping, and L. Robison and K. Ness (St. Jude Children's Research Hospital) for insightful discussions. This work was supported by the US National Institutes of Health (P30 CA21765-34 and U01GM92666) and the American Lebanese Syrian Associated Charities (ALSAC).	Bass JK, 2014, PEDIATR BLOOD CANCER, V61, P601, DOI 10.1002/pbc.24830; Boddy AV, 2013, CLIN PHARMACOL THER, V94, P198, DOI 10.1038/clpt.2013.116; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Chang KW, 2010, J CLIN ONCOL, V28, P1788, DOI 10.1200/JCO.2009.24.4228; Chen WC, 2006, CANCER-AM CANCER SOC, V106, P820, DOI 10.1002/cncr.21683; CHEUNG NKV, 1991, J CLIN ONCOL, V9, P1050, DOI 10.1200/JCO.1991.9.6.1050; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Dean JB, 2008, J PEDIAT HEMATOL ONC, V30, P130, DOI 10.1097/MPH.0b013e31815d1d83; Degl'Innocenti D, 1999, BIOCHIMIE, V81, P1031, DOI 10.1016/S0300-9084(99)00333-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fouladi M, 2008, J CLIN ONCOL, V26, P3749, DOI 10.1200/JCO.2007.14.3974; Fuchs PA, 2014, J PHYSIOL-LONDON, V592, P3393, DOI 10.1113/jphysiol.2013.267914; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Gurney JG, 2014, NEURO-ONCOLOGY, V16, P848, DOI 10.1093/neuonc/not241; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Kushner BH, 2006, CANCER-AM CANCER SOC, V107, P417, DOI 10.1002/cncr.22004; Landier W, 2014, J CLIN ONCOL, V32, P527, DOI 10.1200/JCO.2013.51.2038; Langer T, 2013, TRENDS PHARMACOL SCI, V34, P458, DOI 10.1016/j.tips.2013.05.006; Lanvers-Kaminsky C, 2014, CLIN PHARMACOL THER, V96, P156, DOI 10.1038/clpt.2014.67; Li Y, 2004, EUR J CANCER, V40, P2445, DOI 10.1016/j.ejca.2003.08.009; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Mukherjea D, 2011, PHARMACOGENOMICS, V12, P1039, DOI [10.2217/PGS.11.48, 10.2217/pgs.11.48]; Oguri T, 2013, INT J CLIN PHARM TH, V51, P475, DOI 10.5414/CP201851; Oldenburg J, 2007, J CLIN ONCOL, V25, P708, DOI 10.1200/JCO.2006.08.9599; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perilongo G, 2009, NEW ENGL J MED, V361, P1662, DOI 10.1056/NEJMoa0810613; Potter DM, 2005, STAT MED, V24, P693, DOI 10.1002/sim.1931; Pussegoda K, 2013, CLIN PHARMACOL THER, V94, P243, DOI 10.1038/clpt.2013.80; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; Ratain MJ, 2013, CLIN PHARMACOL THER, V94, P631, DOI 10.1038/clpt.2013.178; Ross CJD, 2009, NAT GENET, V41, P1345, DOI 10.1038/ng.478; Thomas AJ, 2013, J NEUROSCI, V33, P4405, DOI 10.1523/JNEUROSCI.3940-12.2013; Travis LB, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju044; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614; Yang JJ, 2013, CLIN PHARMACOL THER, V94, P252, DOI 10.1038/clpt.2013.121	36	77	80	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					263	+		10.1038/ng.3217	http://dx.doi.org/10.1038/ng.3217			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665007	Green Accepted			2022-12-17	WOS:000350327900018
J	Nakajima, M; Takahashi, A; Tsuji, T; Karasugi, T; Baba, H; Uchida, K; Kawabata, S; Okawa, A; Shindo, S; Takeuchi, K; Taniguchi, Y; Maeda, S; Kashii, M; Seichi, A; Nakajima, H; Kawaguchi, Y; Fujibayashi, S; Takahata, M; Tanaka, T; Watanabe, K; Kida, K; Kanchiku, T; Ito, Z; Mori, K; Kaito, T; Kobayashi, S; Yamada, K; Takahashi, M; Chiba, K; Matsumoto, M; Furukawa, KI; Kubo, M; Toyama, Y; Ikegawa, S				Nakajima, Masahiro; Takahashi, Atsushi; Tsuji, Takashi; Karasugi, Tatsuki; Baba, Hisatoshi; Uchida, Kenzo; Kawabata, Shigenori; Okawa, Atsushi; Shindo, Shigeo; Takeuchi, Kazuhiro; Taniguchi, Yuki; Maeda, Shingo; Kashii, Masafumi; Seichi, Atsushi; Nakajima, Hideaki; Kawaguchi, Yoshiharu; Fujibayashi, Shunsuke; Takahata, Masahiko; Tanaka, Toshihiro; Watanabe, Kei; Kida, Kazunobu; Kanchiku, Tsukasa; Ito, Zenya; Mori, Kanji; Kaito, Takashi; Kobayashi, Sho; Yamada, Kei; Takahashi, Masahito; Chiba, Kazuhiro; Matsumoto, Morio; Furukawa, Ken-Ichi; Kubo, Michiaki; Toyama, Yoshiaki; Ikegawa, Shiro		Genetic Study Grp Invest Comm	A genome-wide association study identifies susceptibility loci for ossification of the posterior longitudinal ligament of the spine	NATURE GENETICS			English	Article							LINKAGE; GENE; VISUALIZATION; COMPONENTS; NPPS	Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common spinal disorder among the elderly that causes myelopathy and radiculopathy. To identify genetic factors for OPLL, we performed a genome-wide association study (GWAS) in similar to 8,000 individuals followed by a replication study using an additional similar to 7,000 individuals. We identified six susceptibility loci for OPLL: 20p12.3 (rs2423294: P = 1.10 x 10(-13)), 8q23.1 (rs374810: P = 1.88 x 10(-13)), 12p11.22 (rs1979679: P = 4.34 x 10(-12)), 12p12.2 (rs11045000: P = 2.95 x 10(-11)), 8q23.3 (rs13279799: P = 1.28 x 10(-10)) and 6p21.1 (rs927485: P = 9.40 x 10(-9)). Analyses of gene expression in and around the loci suggested that several genes are involved in OPLL etiology through membranous and/or endochondral ossification processes. Our results bring new insight to the etiology of OPLL.	[Nakajima, Masahiro; Karasugi, Tatsuki; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Tokyo, Japan; [Tsuji, Takashi; Chiba, Kazuhiro; Matsumoto, Morio; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Karasugi, Tatsuki] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed & Neuromusculoskeletal Surg, Kumamoto, Japan; [Baba, Hisatoshi; Uchida, Kenzo; Nakajima, Hideaki] Univ Fukui, Fac Med Sci, Dept Orthopaed & Rehabil Med, Fukui 910, Japan; [Kawabata, Shigenori; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Tokyo, Japan; [Shindo, Shigeo] Kudanzaka Hosp, Dept Orthoped, Tokyo, Japan; [Takeuchi, Kazuhiro] Natl Okayama Med Ctr, Dept Orthopaed Surg, Okayama, Japan; [Taniguchi, Yuki] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Maeda, Shingo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Joint Mat, Kagoshima 890, Japan; [Kashii, Masafumi] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan; [Seichi, Atsushi] Jichi Med Univ, Dept Orthoped, Shimotsuke, Japan; [Kawaguchi, Yoshiharu] Toyama Univ, Dept Orthopaed Surg, Toyama 930, Japan; [Fujibayashi, Shunsuke] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Takahata, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan; [Tanaka, Toshihiro] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan; [Watanabe, Kei] Niigata Univ, Med & Dent Gen Hosp, Dept Orthopaed Surg, Niigata, Japan; [Kida, Kazunobu] Kochi Med Sch, Dept Orthopaed Surg, Kochi, Japan; [Kanchiku, Tsukasa] Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Ube, Yamaguchi 755, Japan; [Ito, Zenya] Nagoya Univ, Grad Sch Med, Dept Orthoped, Nagoya, Aichi 4648601, Japan; [Mori, Kanji] Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga 52021, Japan; [Kaito, Takashi] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthopaed Surg, Osaka, Japan; [Kobayashi, Sho] Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Hamamatsu, Shizuoka 4313192, Japan; [Yamada, Kei] Kurume Univ, Sch Med, Dept Orthopaed Surg, Kurume, Fukuoka 830, Japan; [Takahashi, Masahito] Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Furukawa, Ken-Ichi] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; Keio University; Kumamoto University; University of Fukui; Tokyo Medical & Dental University (TMDU); University of Tokyo; Kagoshima University; Osaka University; Jichi Medical University; University of Toyama; Kyoto University; Hokkaido University; Hirosaki University; Niigata University; Kochi University; Yamaguchi University; Nagoya University; Shiga University of Medical Science; Hamamatsu University School of Medicine; Kurume University; Kyorin University; Hirosaki University; RIKEN	Ikegawa, S (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Furukawa, Ken-Ichi/N-9244-2014; Kashii, Masafumi/AAV-7959-2021; Takahata, Masahiko/E-1929-2012; Kubo, Michiaki/N-7947-2015; Yamada, Kei/AAY-8398-2020	Ikegawa, Shiro/0000-0003-0316-2147; Furukawa, Ken-Ichi/0000-0002-5680-007X; Kashii, Masafumi/0000-0002-7552-0356; Takahata, Masahiko/0000-0002-2436-2175; , Takashi/0000-0002-0878-3623	Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament [H23-Nanchi-Ippan-032]; Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament [H26-Itaku(Nan)-Ippan-053]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament; Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the individuals with OPLL and their families who participated in this study and the Japan OPLL Network (Zen-Sekichu-Ren), including Ishikawa prefecture OPLL Tomo-no-kai. We also thank Y. Takahashi and T. Oguma for technical assistance. The work reported in this article was supported by grants from the Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament (H23-Nanchi-Ippan-032) and Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament (H26-Itaku(Nan)-Ippan-053).	Abed E, 2011, ARTHRITIS RHEUM-US, V63, P3865, DOI 10.1002/art.30625; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Breslow N E, 1987, IARC Sci Publ, P1; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Harada Y, 2014, BIOCHEM BIOPH RES CO, V443, P1014, DOI 10.1016/j.bbrc.2013.12.080; Horikoshi T, 2006, HUM GENET, V119, P611, DOI 10.1007/s00439-006-0170-9; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Karasugi T, 2013, J BONE MINER METAB, V31, P136, DOI 10.1007/s00774-012-0404-y; Kawaguchi H., 2006, OPLL OSSIFICATION PO, P71; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Koga H, 1996, SPINE, V21, P469, DOI 10.1097/00007632-199602150-00011; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Matsunaga S, 2002, J NEUROSURG, V96, P168, DOI 10.3171/spi.2002.96.2.0168; Matsunaga S., 2006, OPLL OSSIFICATION PO, DOI 10.1007/978-4-431-32563-5_3; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Sato R, 2007, J NEUROSURG-SPINE, V7, P174, DOI 10.3171/SPI-07/08/174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; TAKETOMI E, 1992, SPINE, V17, pS55; Tanaka T, 2003, AM J HUM GENET, V73, P812, DOI 10.1086/378593; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yu JM, 1998, GENOMICS, V53, P90, DOI 10.1006/geno.1998.5500; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	39	77	83	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1012	+		10.1038/ng.3045	http://dx.doi.org/10.1038/ng.3045			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25064007				2022-12-17	WOS:000341579400017
J	Liang, Y; Jansen, M; Aronow, B; Geiger, H; Van Zant, G				Liang, Ying; Jansen, Michael; Aronow, Bruce; Geiger, Hartmut; Van Zant, Gary			The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice	NATURE GENETICS			English	Article							MAMMALIAN CARBOXYPEPTIDASE INHIBITOR; TAZAROTENE-INDUCED GENE-1; RETINOID RESPONSE GENE; IN-VIVO; REGIONAL SPECIFICATION; PROGENITOR CELLS; LIFE-SPAN; EXPRESSION; TIG1; FREQUENCY	We mapped quantitative trait loci that accounted for the variation in hematopoietic stem cell ( HSC) numbers between young adult C57BL/6 ( B6) and DBA/ 2 ( D2) mice. In reciprocal chromosome 3 congenic mice, introgressed D2 alleles increased HSC numbers owing to enhanced proliferation and self-renewal and reduced apoptosis, whereas B6 alleles had the opposite effects. Using oligonucleotide arrays, real-time PCR and protein blots, we identified latexin ( Lxn), a gene whose differential transcription and expression was associated with the allelic differences. Expression was inversely correlated with the number of HSCs; therefore, ectopic expression of Lxn using a retroviral vector decreased stem cell population size. We identified clusters of SNPs upstream of the Lxn transcriptional start site, at least two of which are associated with potential binding sites for transcription factors regulating stem cells. Thus, promoter polymorphisms between the B6 and D2 alleles may affect Lxn gene expression and consequently influence the population size of hematopoietic stem cells.	Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Expt Hematol, Cincinnati, OH 45229 USA	University of Kentucky; University of Kentucky; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Van Zant, G (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA.	gvzant1@uky.edu	Aronow, Bruce J/F-8438-2012		NIA NIH HHS [AG024950, AG022859, AG020917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024950, R01AG022859, R01AG020917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; ARIMATSU Y, 1994, J NEUROSCI, V14, P2020; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; ARIMATSU Y, 1994, NEUROSCI RES, V20, P131, DOI 10.1016/0168-0102(94)90030-2; BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; CALLAHAN G, 1999, FASEB J, pF637; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Henckaerts E, 2002, BLOOD, V99, P3947, DOI 10.1182/blood.V99.11.3947; Jin MH, 1997, GENOMICS, V39, P419, DOI 10.1006/geno.1996.4469; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Liang Y, 2003, CURR OPIN HEMATOL, V10, P195, DOI 10.1097/00062752-200305000-00001; Liu Q, 2000, MOL BIOL REP, V27, P241, DOI 10.1023/A:1010971219806; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; VANDERSLUIJS JP, 1990, EXP HEMATOL, V18, P893; VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	42	77	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					178	188		10.1038/ng1938	http://dx.doi.org/10.1038/ng1938			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220891				2022-12-17	WOS:000244063900015
J	Zeggini, E; Rayner, W; Morris, AP; Hattersley, AT; Walker, M; Hitman, GA; Deloukas, P; Cardon, LR; McCarthy, MI				Zeggini, E; Rayner, W; Morris, AP; Hattersley, AT; Walker, M; Hitman, GA; Deloukas, P; Cardon, LR; McCarthy, MI			An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; MAPS	A substantial investment has been made in the generation of large public resources designed to enable the identification of tag SNP sets, but data establishing the adequacy of the sample sizes used are limited. Using large-scale empirical and simulated data sets, we found that the sample sizes used in the HapMap project are sufficient to capture common variation, but that performance declines substantially for variants with minor allele frequencies of < 5%.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Peninsula Med Sch, Ctr Mol Genet, Exeter, Devon, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Barts & London Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London, England; Wellcome Trust Sanger Inst, Hinxton, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Exeter; Newcastle University - UK; University of London; Queen Mary University London; Wellcome Trust Sanger Institute	Zeggini, E (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	elez@well.ox.ac.uk	Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X; Zeggini, Eleftheria/0000-0003-4238-659X				Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Halldorsson BV, 2004, HUM HERED, V58, P190, DOI 10.1159/000083546; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Nordborg M., 2001, HDB STAT GENETICS, P179	12	77	85	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1320	1322		10.1038/ng1670	http://dx.doi.org/10.1038/ng1670			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258542				2022-12-17	WOS:000233657300010
J	Lim, JE; Jin, O; Bennett, C; Morgan, K; Wang, FD; Trenor, CC; Fleming, MD; Andrews, NC				Lim, JE; Jin, O; Bennett, C; Morgan, K; Wang, FD; Trenor, CC; Fleming, MD; Andrews, NC			A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice	NATURE GENETICS			English	Article							TRANSFERRIN RECEPTOR; RAT RETICULOCYTES; EPITHELIAL-CELLS; EXOCYST COMPLEX; RAB11; MEMBRANE; DELIVERY; PATHWAY; MOUSE; IRON	Hemoglobin deficit (hbd) mice carry a spontaneous mutation that impairs erythroid iron assimilation but does not cause other defects. Normal delivery of iron to developing erythroid precursors is highly dependent on the transferrin cycle. Through genetic mapping and complementation experiments, we show that the hbd mutation is an in-frame deletion of a conserved exon of the mouse gene Sec15l1, encoding one of two Sec15 proteins implicated in the mammalian exocyst complex. Sec15l1 is linked to the transferrin cycle through its interaction with Rab11, a GTPase involved in vesicular trafficking. We propose that inactivation of Sec15l1 alters recycling of transferrin cycle endosomes and increases the release of transferrin receptor exocytic vesicles. This in turn decreases erythroid iron uptake. Determining the molecular basis of the hbd phenotype provides new insight into the intricate mechanisms necessary for normal erythroid iron uptake and the function of a mammalian exocyst protein.	Childrens Hosp, Div Hematol Oncol, Karp Family Res Labs RM 8 125, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Andrews, NC (corresponding author), Childrens Hosp, Div Hematol Oncol, Karp Family Res Labs RM 8 125, Boston, MA 02115 USA.	nancy_andrews@hms.harvard.edu	Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Andrews, Nancy/0000-0003-0243-4462; Fleming, Mark/0000-0003-0948-4024				Andrews HK, 2002, TRAFFIC, V3, P906, DOI 10.1034/j.1600-0854.2002.31206.x; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; BANNERMAN RM, 1986, P SOC EXP BIOL MED, V182, P52, DOI 10.3181/00379727-182-42307; Bloom ML, 1998, MAMM GENOME, V9, P666, DOI 10.1007/s003359900841; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Chen J, 2005, BLOOD, V106, P328, DOI 10.1182/blood-2004-09-3686; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GARRICK LM, 1987, EXP HEMATOL, V15, P671; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HARDING C, 1984, EUR J CELL BIOL, V35, P256; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2002, J CELL SCI, V115, P2505; SCHEUFLER VH, 1969, Z VERSUCHSTIERKD, V11, P348; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; TORRANCE J, 1980, TISSUE IRON STORES; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	29	77	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1270	1273		10.1038/ng1659	http://dx.doi.org/10.1038/ng1659			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227995				2022-12-17	WOS:000233045200029
J	Ting, AH; Jair, KW; Suzuki, H; Yen, RWC; Baylin, SB; Schuebel, KE				Ting, AH; Jair, KW; Suzuki, H; Yen, RWC; Baylin, SB; Schuebel, KE			CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1	NATURE GENETICS			English	Article							METHYLATION; GENES; PROTEIN	The role of the primary mammalian DNA methyltransferase, DNMT1, in maintaining CpG island methylation in human colon cancer cells has recently been questioned. This controversy has arisen from discrepancies between genetic knockout and RNA interference-mediated knockdown studies. Here, we re-examined the RNA interference-based approach and found that hypermethylation of single-copy genes is maintained in cells transiently and stably depleted of DNMT1.	Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Baylin, SB (corresponding author), Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu; kornels@jhmi.edu						Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Myohanen SK, 1998, CANCER RES, V58, P591; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; SEDIVY JM, 1999, SCIENCE, V283, P9, DOI DOI 10.1126/SCIENCE.283.5398.9A); Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892	15	77	79	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					582	584		10.1038/ng1365	http://dx.doi.org/10.1038/ng1365			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15156141	Bronze			2022-12-17	WOS:000221763700014
J	Joosten, PHLJ; Toepoel, M; Mariman, ECM; Van Zoelen, EJJ				Joosten, PHLJ; Toepoel, M; Mariman, ECM; Van Zoelen, EJJ			Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects	NATURE GENETICS			English	Article							SPINA-BIFIDA OCCULTA; BINDING PROTEIN; TRANSCRIPTION; PREVALENCE; EXPRESSION; PAX1	Neural tube defects (NTDs), including anencephaly and spina bifida, are multifactorial diseases that occur with an incidence of 1 in 300 births in the United Kingdom(1). Mouse models have indicated that deregulated expression of the gene encoding the platelet-derived growth factor alpha -receptor (Pdgfra) causes congenital NTDs (refs. 2-4), whereas mutant forms of Pax-1 that have been associated with NTDs cause deregulated activation of the human PDGFRA promoter(2,5). There is an increasing awareness that genetic polymorphisms may have an important role in the susceptibility for NTDs (ref. 6). Here we identify five different haplotypes in the human PDGFRA promoter, of which the two most abundant ones, designated H1 and H2 alpha, differ in at least six polymorphic sites. In a transient transfection assay in human bone cells, the five haplotypes differ strongly in their ability to enhance reporter gene activity. In a group of patients with sporadic spina bifida, haplotypes with low transcriptional activity, including H1, were under-represented, whereas those with high transcriptional activity, including H2 alpha, were over-represented. When testing for haplotype combinations, HI homozygotes were fully absent from the group of sporadic patients, whereas H1/H2 alpha heterozygotes were over-represented in the groups of both sporadic and familial spina bifida patients, but strongly underrepresented in unrelated controls. Our data indicate that specific combinations of naturally occurring PDGFRA promoter haplotypes strongly affect NTD genesis.	Univ Nijmegen, Dept Cell Biol, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Joosten, PHLJ (corresponding author), Univ Nijmegen, Dept Cell Biol, Nijmegen, Netherlands.		van Zoelen, Everardus J./D-9192-2012					AFINK GB, 1995, ONCOGENE, V10, P1667; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Barber RC, 1999, MOL GENET METAB, V66, P1, DOI 10.1006/mgme.1998.2787; BOONE D, 1985, CLIN RADIOL, V36, P159, DOI 10.1016/S0009-9260(85)80100-8; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; Copp Andrew J., 1994, Current Opinion in Pediatrics, V6, P624, DOI 10.1097/00008480-199412000-00002; DOLK H, 1991, TERATOLOGY, V44, P547, DOI 10.1002/tera.1420440508; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; FIDAS A, 1987, CLIN RADIOL, V38, P537, DOI 10.1016/S0009-9260(87)80150-2; Fleming A, 2000, HUM MOL GENET, V9, P575, DOI 10.1093/hmg/9.4.575; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; HELWIG U, 1995, NAT GENET, V11, P60, DOI 10.1038/ng0995-60; Herrmann SM, 2000, J MOL MED-JMM, V78, P287, DOI 10.1007/s001090000111; Hol FA, 1996, J MED GENET, V33, P655, DOI 10.1136/jmg.33.8.655; Joosten PHLJ, 1998, P NATL ACAD SCI USA, V95, P14459, DOI 10.1073/pnas.95.24.14459; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Payne J, 1997, DEV DYNAM, V209, P105; Peters H, 1999, DEVELOPMENT, V126, P5399; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; ROUSSET F, 1995, GENETICS, V140, P1413; Sambrook J, 1989, MOL CLONING LAB MANU; Shimizu-Nishikawa K, 1999, DEV GROWTH DIFFER, V41, P731; Soriano P, 1997, DEVELOPMENT, V124, P2691; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wang CY, 1996, MOL CELL BIOL, V16, P712; Zhang XQ, 1998, MECH DEVELOP, V70, P167, DOI 10.1016/S0925-4773(97)00190-1	28	77	79	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					215	217		10.1038/84867	http://dx.doi.org/10.1038/84867			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175793				2022-12-17	WOS:000166839200026
J	Koob, MD; Benzow, KA; Bird, TD; Day, JW; Moseley, ML; Ranum, LPW				Koob, MD; Benzow, KA; Bird, TD; Day, JW; Moseley, ML; Ranum, LPW			Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; DOMINANT CEREBELLAR-ATAXIA; GENE; EXPANSION; DISEASE; LOCUS; MAP	Trinucleotide repeat expansions have been shown to cause a number of neurodegenerative diseases(1-6). A hallmark of most of these diseases is the presence of anticipation, a decrease in the age at onset in consecutive generations due to the tendency of the unstable trinucleotide repeat to lengthen when passed from one generation to the next(1). The involvement of trinucleotide repeat expansions in a number of other diseases -including familial spastic paraplegia(7), schizophrenia(8), bipolar affective disorder(9) and spinocerebellar ataxia type 7 (SCA7; ref. 10)-is suggested both by the presence of anticipation and by repeat expansion detection (RED)(10-12) analysis of genomic DNA samples. The involvement of trinucleotide expansions in these diseases, however, can be conclusively confirmed only by the isolation of the expansions present in these populations and detailed analysis to assess each expansion as a possible pathogenic mutation. We describe a novel procedure for quick isolation of expanded trinucleotide repeats and the corresponding flanking nucleotide sequence directly from small amounts of genomic DNA by a process of Repeat Analysis, Pooled isolation and Detection of individual clones containing expanded trinucleotide repeats (RAPID cloning). We have used this technique to clone the pathogenic SCA7 CAG expansion from an archived DNA sample of an individual affected with ataxia and retinal degeneration.	Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Vet Affairs Med Ctr, Seattle, WA 98108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Koob, MD (corresponding author), Univ Minnesota, Dept Neurol, Box 295 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.			Day, John/0000-0002-0086-9529	NINDS NIH HHS [P01 NS33718, R01 NS35870] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870, P01NS033718] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1996, J BIOL, V215, P403; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; David G, 1996, AM J HUM GENET, V59, P1328; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; LINDBLAD K, 1994, NAT GENET, V7, P124, DOI 10.1038/ng0694-124; MARX JL, 1985, SCIENCE, V229, P150, DOI 10.1126/science.2990043; NEILSEN JE, 1997, HUM MOL GENET, V6, P1811; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ORUC L, 1997, AM J HUM GENET, V60, P732; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	22	77	83	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					72	75		10.1038/ng0198-72	http://dx.doi.org/10.1038/ng0198-72			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425905				2022-12-17	WOS:000071259600026
J	Easton, D				Easton, D			Breast cancer genes - What are the real risks?	NATURE GENETICS			English	Editorial Material											Easton, D (corresponding author), INST PUBL HLTH,CRC,GENET EPIDEMIOL UNIT,FORVIE SITE,ROBINSON WAY,CAMBRIDGE CB2 2SR,ENGLAND.							EASTON DF, 1995, AM J HUM GENET, V56, P265; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001	5	77	79	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					210	211		10.1038/ng0797-210	http://dx.doi.org/10.1038/ng0797-210			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207777				2022-12-17	WOS:A1997XG60900003
J	Bedell, MA; Jenkins, NA; Copeland, NG				Bedell, MA; Jenkins, NA; Copeland, NG			Good genes in bad neighbourhoods	NATURE GENETICS			English	Editorial Material							POSITION-EFFECT VARIEGATION; BETA-GLOBIN GENE; MURINE LEUKEMIA-VIRUS; T-CELL LYMPHOMAS; HEREDITARY PERSISTENCE; FETAL HEMOGLOBIN; C-MYC; REGION; EXPRESSION; ACTIVATION				Bedell, MA (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA.							AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; AXELSON H, 1991, ONCOGENE, V6, P2263; BARTHOLOMEW C, 1991, MOL CELL BIOL, V11, P1820, DOI 10.1128/MCB.11.4.1820; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CLARK SH, 1986, GENETICS, V114, P819; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; DUTTLINGER R, 1995, P NATL ACAD SCI USA, V92, P3754, DOI 10.1073/pnas.92.9.3754; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; EISSENBERG JC, 1989, BIOESSAYS, V11, P14, DOI 10.1002/bies.950110105; ELDER JT, 1990, MOL CELL BIOL, V10, P1382, DOI 10.1128/MCB.10.4.1382; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FEINGOLD EA, 1989, BLOOD, V74, P2178; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; HENGLEIN B, 1989, MOL CELL BIOL, V9, P2105, DOI 10.1128/MCB.9.5.2105; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; HORTNAGEL K, 1995, ONCOGENE, V10, P1393; KWOK C, 1995, AM J HUM GENET, V57, P1028; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; LAMMIE GA, 1992, ONCOGENE, V7, P2381; LAVAL SH, 1995, P NATL ACAD SCI USA, V92, P10403, DOI 10.1073/pnas.92.22.10403; LEVY ER, 1994, BLOOD, V83, P1348; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; LIMADEFARIA A, 1983, MOL EVOLUTION ORG CH, P531; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MINTZ B, 1991, P NATL ACAD SCI USA, V88, P9643, DOI 10.1073/pnas.88.21.9643; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; PETERS G, 1994, J CELL SCI, P89; POTTER M, 1990, CARCINOGENESIS, V11, P1, DOI 10.1093/carcin/11.1.1; ROBERTSON G, 1995, P NATL ACAD SCI USA, V92, P5371, DOI 10.1073/pnas.92.12.5371; ROMAO L, 1991, BLOOD, V78, P1589; RUSSELL LB, 1970, GENETICS, V64, P281; SHAUGHNESSY J, 1994, ONCOGENE, V9, P247; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; SUZUKAWA K, 1994, BLOOD, V84, P2681; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TSICHLIS PN, 1990, J VIROL, V64, P2236, DOI 10.1128/JVI.64.5.2236-2244.1990; TSICHLIS PN, 1989, P NATL ACAD SCI USA, V86, P5487, DOI 10.1073/pnas.86.14.5487; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408	49	77	80	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					229	232		10.1038/ng0396-229	http://dx.doi.org/10.1038/ng0396-229			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589709				2022-12-17	WOS:A1996TY18300007
J	BERRY, R; STEVENS, TJ; WALTER, NAR; WILCOX, AS; RUBANO, T; HOPKINS, JA; WEBER, J; GOOLD, R; SOARES, MB; SIKELA, JM				BERRY, R; STEVENS, TJ; WALTER, NAR; WILCOX, AS; RUBANO, T; HOPKINS, JA; WEBER, J; GOOLD, R; SOARES, MB; SIKELA, JM			GENE-BASED SEQUENCE-TAGGED-SITES (STSS) AS THE BASIS FOR A HUMAN GENE MAP	NATURE GENETICS			English	Article							BRAIN CDNA LIBRARY; HUMAN GENOME; CAENORHABDITIS-ELEGANS; TAGS; CHROMOSOMES; ASSIGNMENT; EXPRESSION	Using our data set of 3,143 single pass sequences from human brain cDNA libraries, we have developed a strategy in which gene-based sequence-tagged-sites (STSs), derived from 3'untranslated regions of human cDNAs, are rapidly assigned to megabase-insert yeast artificial chromosomes and somatic cell hybrids to generate regional gene mapping data, Employing this approach, we have mapped 318 cDNAs, representing 308 human genes. Ninety-two of these mapped to regions implicated in human genetic diseases, identifying them as candidate genes. Extension of this strategy has the potential to result in virtually every human gene having, at its 3'end, its own associated STS, with each STS in turn specifying both a corresponding genomic clone and a specific regional location in the genome.	UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,PROGRAM MOLEC BIOL,DENVER,CO 80262; VET ADM SCHIZOPHRENIA CTR,DENVER,CO 80262; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449; STANFORD UNIV,CTR HUMAN GENOME MAPPING,STANFORD,CA 94305; COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Stanford University; Columbia University; New York State Psychiatry Institute				Walter, Nicole/0000-0003-0431-8078				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BELLANNECHANTEL.C, 1992, CELL, V70, P1059; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; GOOLD RD, 1993, HUM MOL GENET, V2, P1271, DOI 10.1093/hmg/2.8.1271; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; Lincoln S.E., 1991, PRIMER COMPUTER PROG; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLSEN M, 1989, SCIENCE, V245, P1434; POLYMEROPOULOS MH, 1993, NAT GENET, V4, P381, DOI 10.1038/ng0893-381; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; REID T, 1992, P NATL ACAD SCI USA, V89, P1388; SIKELA JM, 1993, NAT GENET, V3, P189, DOI 10.1038/ng0393-189; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837	24	77	81	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					415	423		10.1038/ng0895-415	http://dx.doi.org/10.1038/ng0895-415			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670491				2022-12-17	WOS:A1995RM37500014
J	ARMITAGE, MM; KIVLIN, JD; FERRELL, RE				ARMITAGE, MM; KIVLIN, JD; FERRELL, RE			A PROGRESSIVE EARLY-ONSET CATARACT GENE MAPS TO HUMAN-CHROMOSOME 17Q24	NATURE GENETICS			English	Article							INTRINSIC POLYPEPTIDE MIP; LINKAGE ANALYSIS; LENS; GALACTOKINASE; ENZYMES; FAMILY; LOCUS	Cerulean cataract is an autosomal dominant, early onset, progressive cataract characterized by blue or white opacifications in the nucleus and cortex of the lens. A large four-generation pedigree in which cerulean cataract segregates was studied for linkage analysis. A genome wide search was undertaken after the plausible candidate genes were excluded and the cerulean cataract phenotype was mapped to chromosome 17q24. The three markers closest to the disease gene are D17S802 (Z(theta)=9.46 at (theta)=0.085), D17S836 (Z(theta)=5.26 at (theta)=0.031) and AFMa238yb5 (Z(theta)=7.11 at (theta)=0.032). Multipoint linkage analyses yielded a maximum lod score of Z(theta)=13.71, placing the cerulean cataract gene between D17S802 and D17S836 at (theta)=0.048 and (theta)=0.013, respectively.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; MED COLL WISCONSIN,INST EYE,MILWAUKEE,WI 53226	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin								BEUTLER E, 1973, New England Journal of Medicine, V288, P1203, DOI 10.1056/NEJM197306072882303; BODKER FS, 1990, AM J MED GENET, V37, P54, DOI 10.1002/ajmg.1320370113; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BROEKHUYSE RM, 1976, EXP EYE RES, V23, P365, DOI 10.1016/0014-4835(76)90135-4; EIBERG H, 1988, CLIN GENET, V34, P272; ELSEVIER SM, 1974, NATURE, V251, P633, DOI 10.1038/251633a0; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KIVLIN J, 1985, CYTOGENET CELL GENET, V40, P669; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MAUMENEE IH, 1979, OPHTHALMOLOGY, V86, P1554; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; REESE PD, 1987, ARCH OPHTHALMOL-CHIC, V105, P1382; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P269; STAMBOLIAN D, 1986, INVEST OPHTH VIS SCI, V27, P429; TOMAREV SI, 1988, NATURE, V336, P86, DOI 10.1038/336086a0; VOGT A, 1922, A VONGRAEFES ARCH CL, V108, P219; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; YANCEY SB, 1988, J CELL BIOL, V106, P705, DOI 10.1083/jcb.106.3.705	22	77	80	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					37	40		10.1038/ng0195-37	http://dx.doi.org/10.1038/ng0195-37			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704021				2022-12-17	WOS:A1995PZ91300012
J	Kinker, GS; Greenwald, AC; Tal, R; Orlova, Z; Cuoco, MS; McFarland, JM; Warren, A; Rodman, C; Roth, JA; Bender, SA; Kumar, B; Rocco, JW; Fernandes, PACM; Mader, CC; Keren-Shaul, H; Plotnikov, A; Barr, H; Tsherniak, A; Rozenblatt-Rosen, O; Krizhanovsky, V; Puram, SV; Regev, A; Tirosh, I				Kinker, Gabriela S.; Greenwald, Alissa C.; Tal, Rotem; Orlova, Zhanna; Cuoco, Michael S.; McFarland, James M.; Warren, Allison; Rodman, Christopher; Roth, Jennifer A.; Bender, Samantha A.; Kumar, Bhavna; Rocco, James W.; Fernandes, Pedro A. C. M.; Mader, Christopher C.; Keren-Shaul, Hadas; Plotnikov, Alexander; Barr, Haim; Tsherniak, Aviad; Rozenblatt-Rosen, Orit; Krizhanovsky, Valery; Puram, Sidharth V.; Regev, Aviv; Tirosh, Itay			Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity	NATURE GENETICS			English	Article							DNA-PK; SECRETORY PHENOTYPE; SENESCENCE; HEAD; NECK; INHIBITION; INTERFERON; MELANOMA; PATHWAY; DAMAGE	Single-cell RNA-seq of a collection of 200 cancer cell lines finds common, recurrent heterogeneous expression programs, which also are found in patient samples and are linked to cell state and drug sensitivity. Cultured cell lines are the workhorse of cancer research, but the extent to which they recapitulate the heterogeneity observed among malignant cells in tumors is unclear. Here we used multiplexed single-cell RNA-seq to profile 198 cancer cell lines from 22 cancer types. We identified 12 expression programs that are recurrently heterogeneous within multiple cancer cell lines. These programs are associated with diverse biological processes, including cell cycle, senescence, stress and interferon responses, epithelial-mesenchymal transition and protein metabolism. Most of these programs recapitulate those recently identified as heterogeneous within human tumors. We prioritized specific cell lines as models of cellular heterogeneity and used them to study subpopulations of senescence-related cells, demonstrating their dynamics, regulation and unique drug sensitivities, which were predictive of clinical response. Our work describes the landscape of heterogeneity within diverse cancer cell lines and identifies recurrent patterns of heterogeneity that are shared between tumors and specific cell lines.	[Kinker, Gabriela S.; Greenwald, Alissa C.; Tal, Rotem; Orlova, Zhanna; Krizhanovsky, Valery; Tirosh, Itay] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Kinker, Gabriela S.; Fernandes, Pedro A. C. M.] Univ Sao Paulo, Inst Biosci, Sao Paulo, Brazil; [Cuoco, Michael S.; Rodman, Christopher; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [McFarland, James M.; Warren, Allison; Roth, Jennifer A.; Bender, Samantha A.; Mader, Christopher C.; Tsherniak, Aviad] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Kumar, Bhavna; Rocco, James W.] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Keren-Shaul, Hadas; Plotnikov, Alexander; Barr, Haim] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel; [Keren-Shaul, Hadas] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel; [Puram, Sidharth V.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA; [Regev, Aviv] Genentech Inc, San Francisco, CA USA	Weizmann Institute of Science; Universidade de Sao Paulo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Ohio State University; Weizmann Institute of Science; Weizmann Institute of Science; Washington University (WUSTL); Roche Holding; Genentech	Tirosh, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	itay.tirosh@weizmann.ac.il	Fernandes, Pedro/HGF-1507-2022; Rozenblatt-Rosen, Orit/HDN-4182-2022; Greenwald, Alissa/AAA-6592-2021	McFarland, James/0000-0001-9978-480X; Carlos Magno Fernandes, Pedro Augusto/0000-0002-4871-8201; Cuoco, Michael/0000-0003-2163-5120	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [K08 CA237732] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-David U, 2018, NATURE, V560, P325, DOI 10.1038/s41586-018-0409-3; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Bossi P, 2016, CLIN CANCER RES, V22, P3961, DOI 10.1158/1078-0432.CCR-15-2547; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Hanzelmann S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0057-5; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Izar B, 2020, NAT MED, V26, P1271, DOI 10.1038/s41591-020-0926-0; Jang DH, 2015, J GERONTOL A-BIOL, V70, P20, DOI 10.1093/gerona/glt212; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kim KT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0945-9; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; McFarland JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17440-w; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Musiani D, 2020, CELL REP, V30, P1208, DOI 10.1016/j.celrep.2019.12.061; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; O'Brien PS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050611; Parikh AS, 2019, ORAL ONCOL, V99, DOI 10.1016/j.oraloncology.2019.104458; Park YM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203069; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pawlikowski JS, 2013, P NATL ACAD SCI USA, V110, P16009, DOI 10.1073/pnas.1303491110; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; te Poele RH, 2002, CANCER RES, V62, P1876; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yang LX, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.49; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460	50	76	77	5	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2020	52	11					1208	+		10.1038/s41588-020-00726-6	http://dx.doi.org/10.1038/s41588-020-00726-6			30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OL8FK	33128048	Green Accepted, Green Submitted			2022-12-17	WOS:000585568300012
J	Pomerantz, MM; Qiu, XT; Zhu, YY; Takeda, DY; Pan, WT; Baca, SC; Gusev, A; Korthauer, KD; Severson, TM; Ha, G; Viswanathan, SR; Seo, JH; Nguyen, HM; Zhang, BH; Pasaniuc, B; Giambartolomei, C; Alaiwi, SA; Bell, CA; O'Connor, EP; Chabot, MS; Stillman, DR; Lis, R; Font-Tello, A; Li, L; Cejas, P; Bergman, AM; Sanders, J; van der Poel, HG; Gayther, SA; Lawrenson, K; Fonseca, MAS; Reddy, J; Corona, RI; Martovetsky, G; Egan, B; Choueiri, T; Ellis, L; Garraway, IP; Lee, GSM; Corey, E; Long, HW; Zwart, W; Freedman, ML				Pomerantz, Mark M.; Qiu, Xintao; Zhu, Yanyun; Takeda, David Y.; Pan, Wenting; Baca, Sylvan C.; Gusev, Alexander; Korthauer, Keegan D.; Severson, Tesa M.; Ha, Gavin; Viswanathan, Srinivas R.; Seo, Ji-Heui; Nguyen, Holly M.; Zhang, Baohui; Pasaniuc, Bogdan; Giambartolomei, Claudia; Alaiwi, Sarah A.; Bell, Connor A.; O'Connor, Edward P.; Chabot, Matthew S.; Stillman, David R.; Lis, Rosina; Font-Tello, Alba; Li, Lewyn; Cejas, Paloma; Bergman, Andries M.; Sanders, Joyce; van der Poel, Henk G.; Gayther, Simon A.; Lawrenson, Kate; Fonseca, Marcos A. S.; Reddy, Jessica; Corona, Rosario, I; Martovetsky, Gleb; Egan, Brian; Choueiri, Toni; Ellis, Leigh; Garraway, Isla P.; Lee, Gwo-Shu Mary; Corey, Eva; Long, Henry W.; Zwart, Wilbert; Freedman, Matthew L.			Prostate cancer reactivates developmental epigenomic programs during metastatic progression	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; CHROMATIN STATES; TRANSCRIPTION; DIFFERENTIATION; ZEB1; CELLS; SEQ; HERITABILITY; EPIGENETICS	Analyses of epigenomic datasets spanning transitions from normal prostate epithelium to localized prostate cancer to metastases show that latent developmental programs are reactivated in metastatic disease and that prostate lineage-specific regulatory elements are strongly enriched for prostate cancer risk heritability. Epigenetic processes govern prostate cancer (PCa) biology, as evidenced by the dependency of PCa cells on the androgen receptor (AR), a prostate master transcription factor. We generated 268 epigenomic datasets spanning two state transitions-from normal prostate epithelium to localized PCa to metastases-in specimens derived from human tissue. We discovered that reprogrammed AR sites in metastatic PCa are not created de novo; rather, they are prepopulated by the transcription factors FOXA1 and HOXB13 in normal prostate epithelium. Reprogrammed regulatory elements commissioned in metastatic disease hijack latent developmental programs, accessing sites that are implicated in prostate organogenesis. Analysis of reactivated regulatory elements enabled the identification and functional validation of previously unknown metastasis-specific enhancers atHOXB13,FOXA1andNKX3-1. Finally, we observed that prostate lineage-specific regulatory elements were strongly associated with PCa risk heritability and somatic mutation density. Examining prostate biology through an epigenomic lens is fundamental for understanding the mechanisms underlying tumor progression.	[Pomerantz, Mark M.; Qiu, Xintao; Takeda, David Y.; Pan, Wenting; Baca, Sylvan C.; Gusev, Alexander; Viswanathan, Srinivas R.; Seo, Ji-Heui; Alaiwi, Sarah A.; Bell, Connor A.; O'Connor, Edward P.; Chabot, Matthew S.; Stillman, David R.; Lis, Rosina; Font-Tello, Alba; Li, Lewyn; Cejas, Paloma; Choueiri, Toni; Lee, Gwo-Shu Mary; Long, Henry W.; Freedman, Matthew L.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhu, Yanyun; Severson, Tesa M.; Bergman, Andries M.; Zwart, Wilbert] Netherlands Canc Inst, Oncode Inst, Div Oncogen, Amsterdam, Netherlands; [Takeda, David Y.; Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Korthauer, Keegan D.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ha, Gavin] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Nguyen, Holly M.; Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Zhang, Baohui; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Zhang, Baohui; Garraway, Isla P.] Greater Los Angeles VA Healthcare Syst, Los Angeles, CA USA; [Pasaniuc, Bogdan; Giambartolomei, Claudia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan; Giambartolomei, Claudia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Bergman, Andries M.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Bergman, Andries M.; van der Poel, Henk G.] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands; [Sanders, Joyce] Netherlands Canc Inst, Div Pathol, Amsterdam, Netherlands; [Gayther, Simon A.; Lawrenson, Kate; Fonseca, Marcos A. S.; Reddy, Jessica; Corona, Rosario, I] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Lawrenson, Kate; Fonseca, Marcos A. S.; Reddy, Jessica; Corona, Rosario, I] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Martovetsky, Gleb; Egan, Brian] Act Motif Inc, Carlsbad, CA USA; [Ellis, Leigh] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA; [Zwart, Wilbert] Eindhoven Univ Technol, Lab Chem Biol, Eindhoven, Netherlands; [Zwart, Wilbert] Eindhoven Univ Technol, Inst Complex Mol Syst, Dept Biomed Engn, Eindhoven, Netherlands	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Netherlands Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Dana-Farber Cancer Institute; Eindhoven University of Technology; Eindhoven University of Technology	Freedman, ML (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Zwart, W (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Oncogen, Amsterdam, Netherlands.; Freedman, ML (corresponding author), Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	w.zwart@nki.nl; mfreedman@partners.org	Ha, Gavin/N-1984-2019; Choueiri, Toni/K-5238-2019; Korthauer, Keegan/I-5740-2019	Ha, Gavin/0000-0001-7578-7272; Choueiri, Toni/0000-0002-9201-3217; Korthauer, Keegan/0000-0002-4565-1654; /0000-0003-4914-1157; Takeda, David/0000-0002-5986-1169; Lawrenson, Kate/0000-0002-6469-2515; Qiu, Xintao/0000-0002-8560-7017	R. and N. Milikowsky; Prostate Cancer Foundation Challenge Award; NIH [R01GM107427, R01CA193910, K08 13 CA218530]; H.L. Snyder Medical Research Foundation; Department of Defense (DOD) [W81XWH-19-1-0565, W81XWH-14-1-0273]; VIDI grant from the Netherlands Organisation for Scientific Research; Dutch Cancer Society/Alpe d'HuZes [10084]; Oncode Institute; Jean Perkins Foundation; Prostate Cancer Foundation; STOP Cancer Foundation; National Cancer Institute/NIH [P50CA092131]; PNW Prostate Cancer SPORE [P50 CA097186]; DOD [W81XWH-17-1-0415];  [P01 CA163227]	R. and N. Milikowsky; Prostate Cancer Foundation Challenge Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H.L. Snyder Medical Research Foundation; Department of Defense (DOD)(United States Department of Defense); VIDI grant from the Netherlands Organisation for Scientific Research; Dutch Cancer Society/Alpe d'HuZes; Oncode Institute; Jean Perkins Foundation; Prostate Cancer Foundation; STOP Cancer Foundation; National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PNW Prostate Cancer SPORE; DOD(United States Department of Defense); 	We thank M. Brown (DFCI) and members of the Center for Functional Cancer Epigenetics at DFCI for useful discussions and technical assistance. We also thank the NKI Core Facility Molecular Pathology and Biobanking for technical assistance and tissue processing, and the NKI Genomics Core Facility for the Illumina sequencing analyses. We thank K. Schuurman, D. Sondheim and J. Conner for technical support. We also thank P. Nelson and C. Pritchard for their contributions to the dataset. This work was supported by R. and N. Milikowsky (to M.M.P.); a Prostate Cancer Foundation Challenge Award (to M.M.P. and M.L.F.); NIH grant nos. R01GM107427 and R01CA193910 (to M.L.F.); the H.L. Snyder Medical Research Foundation (to M.L.F.); Department of Defense (DOD) grant no.W81XWH-19-1-0565 (to M.L.F., M.M.P. and W.Z.); a VIDI grant from the Netherlands Organisation for Scientific Research (to W.Z.); the Dutch Cancer Society/Alpe d'HuZes (10084) and Oncode Institute (to W.Z.); NIH grant no. K08 13 CA218530 (to D. Y.T.); the Jean Perkins Foundation; the Prostate Cancer Foundation; the STOP Cancer Foundation; Department of Defense (DOD) grant no. W81XWH-14-1-0273; National Cancer Institute/NIH grant no. P50CA092131 (to I.P.G.); the PNW Prostate Cancer SPORE no. P50 CA097186; DOD grant no. W81XWH-17-1-0415; and grant no. P01 CA163227. The IPCR supported the establishment and generation of the LuCaP PDXs models. We thank the patients who generously donated the tissue that made this research possible.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beard J, 1902, LANCET, V1, P1758; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Branam AM, 2013, TOXICOL SCI, V133, P42, DOI 10.1093/toxsci/kft027; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cato L, 2019, CANCER CELL, V35, P401, DOI 10.1016/j.ccell.2019.01.008; Chen A, 2015, SCIENCE, V347, P713, DOI 10.1126/science.aaa6119; Chen H, 2018, CELL, V173, P386, DOI 10.1016/j.cell.2018.03.027; Chen Z, 2018, P NATL ACAD SCI USA, V115, P6810, DOI 10.1073/pnas.1718811115; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dai YH, 2019, THERANOSTICS, V9, P6063, DOI 10.7150/thno.36735; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; de The H, 2018, NAT REV CANCER, V18, P117, DOI 10.1038/nrc.2017.103; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Figiel S, 2017, HUM PATHOL, V61, P26, DOI 10.1016/j.humpath.2016.10.013; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gusev A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10979; Hankey W, 2020, CANCER RES, V80, P2427, DOI 10.1158/0008-5472.CAN-19-3447; Hanrahan K, 2017, MOL ONCOL, V11, P251, DOI 10.1002/1878-0261.12030; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R83, 10.1186/gb-2012-13-10-r83]; Hollander M, 1973, NONPARAMETRIC STAT M; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang LW, 2009, DEV BIOL, V328, P188, DOI 10.1016/j.ydbio.2009.01.003; Huang YK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14425-7; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Korthauer K, 2019, BIOSTATISTICS, V20, P367, DOI 10.1093/biostatistics/kxy007; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kruithof-de Julio M, 2013, DEV DYNAM, V242, P1160, DOI 10.1002/dvdy.24008; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kunz M, 2018, ONCOGENE, V37, P6136, DOI 10.1038/s41388-018-0385-y; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Lee SH, 2015, STEM CELLS, V33, P3356, DOI 10.1002/stem.2096; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Marchal C, 2018, NAT PROTOC, V13, P819, DOI 10.1038/nprot.2017.148; MARKERT CL, 1968, CANCER RES, V28, P1908; Mazrooei P, 2019, CANCER CELL, V36, P674, DOI 10.1016/j.ccell.2019.10.005; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Montanari M, 2017, ONCOTARGET, V8, P35376, DOI 10.18632/oncotarget.15686; Morova T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14644-y; Morrow JJ, 2018, NAT MED, V24, P176, DOI 10.1038/nm.4475; Morton AR, 2019, CELL, V179, P1330, DOI 10.1016/j.cell.2019.10.039; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Patten DK, 2018, NAT MED, V24, P1469, DOI 10.1038/s41591-018-0091-x; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Qin Q, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1274-4; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schumacher FR, 2018, NAT GENET, V50, P928, DOI 10.1038/s41588-018-0142-8; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; Singh AA, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800115; Stelloo S, 2019, ENDOCR-RELAT CANCER, V26, pR267, DOI 10.1530/ERC-19-0032; Stelloo S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07270-2; Stelloo S, 2015, EMBO MOL MED, V7, P1450, DOI 10.15252/emmm.201505424; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Toivanen R, 2017, DEVELOPMENT, V144, P1382, DOI 10.1242/dev.148270; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Waddington C H, 1957, STRATEGY GENES DISCU; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Yang JK, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1572-4; Yu YP, 2013, AM J PATHOL, V183, P1960, DOI 10.1016/j.ajpath.2013.08.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	97	76	78	2	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2020	52	8					790	+		10.1038/s41588-020-0664-8	http://dx.doi.org/10.1038/s41588-020-0664-8		JUL 2020	24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV1BD	32690948				2022-12-17	WOS:000550623300002
J	Lopez, S; Lim, EL; Horswell, S; Haase, K; Huebner, A; Dietzen, M; Mourikis, TP; Watkins, TBK; Rowan, A; Dewhurst, SM; Birkbak, NJ; Wilson, GA; Van Loo, P; Jamal-Hanjani, M; Swanton, C; McGranahan, N				Lopez, Saioa; Lim, Emilia L.; Horswell, Stuart; Haase, Kerstin; Huebner, Ariana; Dietzen, Michelle; Mourikis, Thanos P.; Watkins, Thomas B. K.; Rowan, Andrew; Dewhurst, Sally M.; Birkbak, Nicolai J.; Wilson, Gareth A.; Van Loo, Peter; Jamal-Hanjani, Mariam; Swanton, Charles; McGranahan, Nicholas		TRACERx Consortium	Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution	NATURE GENETICS			English	Article							MULLERS RATCHET; PASSENGER MUTATIONS; SOMATIC MUTATIONS; PATTERNS; GENES; DRIVER; HETEROGENEITY; ESSENTIALITY; INSTABILITY; POLYPLOIDY	Whole-genome doubling (WGD) is a prevalent event in cancer, involving a doubling of the entire chromosome complement. However, despite its prevalence and prognostic relevance, the evolutionary selection pressures for WGD in cancer have not been investigated. Here, we combine evolutionary simulations with an analysis of cancer sequencing data to explore WGD during cancer evolution. Simulations suggest that WGD can be selected to mitigate the irreversible, ratchet-like, accumulation of deleterious somatic alterations, provided that they occur at a sufficiently high rate. Consistent with this, we observe an enrichment for WGD in tumor types with extensive loss of heterozygosity, including lung squamous cell carcinoma and triple-negative breast cancers, and we find evidence for negative selection against homozygous loss of essential genes before, but not after, WGD. Finally, we demonstrate that loss of heterozygosity and temporal dissection of mutations can be exploited to identify novel tumor suppressor genes and to obtain a deeper characterization of known cancer genes. Analysis of whole-genome doubling (WGD) by using cancer sequencing data combined with simulations of tumor evolution suggests that there is negative selection against homozygous loss of essential genes before WGD but not after.	[Lopez, Saioa; Huebner, Ariana; Dietzen, Michelle; Mourikis, Thanos P.; McGranahan, Nicholas] UCL, Canc Inst, Canc Genome Evolut Res Grp, London, England; [Lopez, Saioa; Lim, Emilia L.; Huebner, Ariana; Dietzen, Michelle; Mourikis, Thanos P.; Swanton, Charles; McGranahan, Nicholas] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London, England; [Lim, Emilia L.; Huebner, Ariana; Dietzen, Michelle; Watkins, Thomas B. K.; Rowan, Andrew; Birkbak, Nicolai J.; Wilson, Gareth A.; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Lim, Emilia L.; Huebner, Ariana; Dietzen, Michelle; Watkins, Thomas B. K.; Rowan, Andrew; Birkbak, Nicolai J.; Wilson, Gareth A.; Swanton, Charles] UCL, Canc Inst, London, England; [Horswell, Stuart] Francis Crick Inst, Bioinformat & Biostat Grp, London, England; [Haase, Kerstin; Van Loo, Peter] Francis Crick Inst, Canc Genom Lab, London, England; [Dewhurst, Sally M.] Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10021 USA; [Birkbak, Nicolai J.] Aarhus Univ, Dept Mol Med, Aarhus, Denmark; [Van Loo, Peter] Univ Leuven, Dept Human Genet, Leuven, Belgium; [Jamal-Hanjani, Mariam] Univ Coll London Hosp NHS Fdn Trust, Dept Med Oncol, London, England	University of London; University College London; Cancer Research UK; University of London; University College London; Francis Crick Institute; University of London; University College London; Francis Crick Institute; Francis Crick Institute; Rockefeller University; Aarhus University; KU Leuven; University College London Hospitals NHS Foundation Trust; University of London; University College London	McGranahan, N (corresponding author), UCL, Canc Inst, Canc Genome Evolut Res Grp, London, England.; Swanton, C; McGranahan, N (corresponding author), UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London, England.; Swanton, C (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.; Swanton, C (corresponding author), UCL, Canc Inst, London, England.	charles.swanton@crick.ac.uk; nicholas.mcgranahan.10@ucl.ac.uk	Csabai, Istvan/F-6045-2011; McGranahan, Nicholas/ABD-6561-2021; Aerts, Hugo/ABF-2821-2020; Haase, Kerstin/AAQ-2768-2020; Scarci, Marco/AAD-5166-2020; Blackhall, Fiona/N-2186-2015; Ottensmeier, Christian/E-8131-2012	Csabai, Istvan/0000-0001-9232-9898; McGranahan, Nicholas/0000-0001-9537-4045; Aerts, Hugo/0000-0002-2122-2003; Haase, Kerstin/0000-0002-0944-5618; Scarci, Marco/0000-0002-4459-7721; Navani, Neal/0000-0002-6412-7516; READING, JAMES/0000-0001-5381-978X; Edwards, John/0000-0002-7935-5327; Birkbak, Nicolai/0000-0003-1613-9587; Le Quesne, John/0000-0003-3552-7446; Stone, Richard/0000-0001-8059-3800; Rothwell, Dominic/0000-0002-8757-3893; , Colin/0000-0001-8167-5461; Lowe, Helen/0000-0001-8630-378X; Escudero, Mickael/0000-0002-1336-815X; Blackhall, Fiona/0000-0001-8716-3395; Priest, Lynsey/0000-0003-3780-8508; De Sousa, Paulo/0000-0003-3011-4116; Ottensmeier, Christian/0000-0003-3619-1657; Herrero, Javier/0000-0001-7313-717X; Shackcloth, Michael/0000-0002-6494-9907; Middleton, Gary/0000-0001-5695-3474; Litchfield, Kevin/0000-0002-3725-0914; Chemi, Francesca/0000-0002-6652-5243; Dive, Caroline/0000-0002-1726-8850; naidu, babu/0000-0003-1576-230X; Johnson, Diana/0000-0003-0479-1228; Hynds, Robert/0000-0002-2170-8791	MRC [MR/P014712/1] Funding Source: UKRI; The Francis Crick Institute [10233] Funding Source: researchfish; Cancer Research UK [FC001202, FC001169] Funding Source: Medline; Cancer Research UK (CRUK) [FC001169, FC001202] Funding Source: Medline; European Research Council [835297, 617844] Funding Source: Medline; Medical Research Council [FC001169, MR/P014712/2, MC_UP_1203/1, MR/P014712/1, FC001202, FC001169, FC001202] Funding Source: Medline; Wellcome Trust [FC001202, FC001169] Funding Source: Medline; Wellcome Trust (Wellcome) [FC001169, FC001202, 211179/Z/18/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; Cancer Research UK(Cancer Research UK); Cancer Research UK (CRUK)(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust (Wellcome)		Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; [Anonymous], EVOLUTION MODERN SYN; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Bertrand D, 2018, CANCER RES, V78, P290, DOI 10.1158/0008-5472.CAN-17-1345; Bielski CM, 2018, NAT GENET, V50, P1189, DOI 10.1038/s41588-018-0165-1; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Chen HY, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00113; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Engelstadter J, 2008, GENETICS, V180, P957, DOI 10.1534/genetics.108.092379; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hazawa M, 2017, ONCOGENE, V36, P2243, DOI 10.1038/onc.2016.377; Hurst LD, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1337-5; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Laughney AM, 2015, CELL REP, V12, P809, DOI 10.1016/j.celrep.2015.06.065; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Loewe L, 2006, GENET RES, V87, P133, DOI 10.1017/S0016672306008123; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-125; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-88; Maciver SK, 2016, TRENDS PARASITOL, V32, P855, DOI 10.1016/j.pt.2016.08.006; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McFarland CD, 2014, P NATL ACAD SCI USA, V111, P15138, DOI 10.1073/pnas.1404341111; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Van den Eynden J, 2019, NAT GENET, V51, P1741, DOI 10.1038/s41588-019-0532-6; Van den Eynden J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006506; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vorontsov IE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2728-9; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zapata L, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1434-0	47	76	76	1	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2020	52	3					283	+		10.1038/s41588-020-0584-7	http://dx.doi.org/10.1038/s41588-020-0584-7			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KS5DL	32139907	Green Submitted, Green Accepted			2022-12-17	WOS:000518329000008
J	Gayden, T; Sepulveda, FE; Khuong-Quang, DA; Pratt, J; Valera, ET; Garrigue, A; Kelso, S; Sicheri, F; Mikael, LG; Hamel, N; Bajic, A; Dali, R; Deshmukh, S; Dervovic, D; Schramek, D; Guerin, F; Taipale, M; Nikbakht, H; Majewski, J; Moshous, D; Charlebois, J; Abish, S; Bole-Feysot, C; Nitschke, P; Bader-Meunier, B; Mitchell, D; Thieblemont, C; Battistella, M; Gravel, S; Nguyen, VH; Conyers, R; Diana, JS; McCormack, C; Prince, HM; Besnard, M; Blanche, S; Ekert, PG; Fraitag, S; Foulkes, WD; Fischer, A; Neven, B; Michonneau, D; de Saint Basile, G; Jabado, N				Gayden, Tenzin; Sepulveda, Fernando E.; Dong-Anh Khuong-Quang; Pratt, Jonathan; Valera, Elvis T.; Garrigue, Alexandrine; Kelso, Susan; Sicheri, Frank; Mikael, Leonie G.; Hamel, Nancy; Bajic, Andrea; Dali, Rola; Deshmukh, Shriya; Dervovic, Dzana; Schramek, Daniel; Guerin, Frederic; Taipale, Mikko; Nikbakht, Hamid; Majewski, Jacek; Moshous, Despina; Charlebois, Janie; Abish, Sharon; Bole-Feysot, Christine; Nitschke, Patrick; Bader-Meunier, Brigitte; Mitchell, David; Thieblemont, Catherine; Battistella, Maxime; Gravel, Simon; Van-Hung Nguyen; Conyers, Rachel; Diana, Jean-Sebastien; McCormack, Chris; Prince, H. Miles; Besnard, Marianne; Blanche, Stephane; Ekert, Paul G.; Fraitag, Sylvie; Foulkes, William D.; Fischer, Alain; Neven, Benedicte; Michonneau, David; de Saint Basile, Genevieve; Jabado, Nada			Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome	NATURE GENETICS			English	Article							GENOME; CLASSIFICATION; ACTIVATION; AUTOIMMUNE; RESPONSES	Subcutaneous panniculitis-like T cell lymphoma (SPTCL), a non-Hodgkin lymphoma, can be associated with hemophagocytic lymphohistiocytosis (HLH), a life-threatening immune activation that adversely affects survival(1,2). T cell immunoglobulin mucin 3 (TIM-3) is a modulator of immune responses expressed on subgroups of T and innate immune cells. We identify in similar to 60% of SPTCL cases germline, loss-of-function, missense variants altering highly conserved residues of TIM-3, c. 245A>G (p. Tyr82Cys) and c. 291A>G (p. Ile97Met), each with specific geographic distribution. The variant encoding p. Tyr82Cys TIM-3 occurs on a potential founder chromosome in patients with East Asian and Polynesian ancestry, while p. Ile97Met TIM-3 occurs in patients with European ancestry. Both variants induce protein misfolding and abrogate TIM-3's plasma membrane expression, leading to persistent immune activation and increased production of inflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1 beta, promoting HLH and SPTCL. Our findings highlight HLH-SPTCL as a new genetic entity and identify mutations causing TIM-3 alterations as a causative genetic defect in SPTCL. While HLH-SPTCL patients with mutant TIM-3 benefit from immunomodulation, therapeutic repression of the TIM-3 checkpoint may have adverse consequences.	[Gayden, Tenzin; Pratt, Jonathan; Valera, Elvis T.; Mikael, Leonie G.; Bajic, Andrea; Nikbakht, Hamid; Majewski, Jacek; Foulkes, William D.; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sepulveda, Fernando E.; Garrigue, Alexandrine; Guerin, Frederic; de Saint Basile, Genevieve] Inst Imagine, Lab Normal & Pathol Homeostasis Immune Syst, INSERM, U1163, Paris, France; [Sepulveda, Fernando E.; Garrigue, Alexandrine; Guerin, Frederic; Fischer, Alain; Neven, Benedicte; de Saint Basile, Genevieve] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Dong-Anh Khuong-Quang; Conyers, Rachel; Ekert, Paul G.] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia; [Dong-Anh Khuong-Quang; Conyers, Rachel; Ekert, Paul G.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Dong-Anh Khuong-Quang; Conyers, Rachel; Ekert, Paul G.] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia; [Valera, Elvis T.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Sao Paulo, Brazil; [Kelso, Susan; Sicheri, Frank; Dervovic, Dzana; Schramek, Daniel] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Kelso, Susan; Sicheri, Frank; Schramek, Daniel; Taipale, Mikko] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Canc Res Program, Montreal, PQ, Canada; [Dali, Rola; Nikbakht, Hamid] Canadian Ctr Computat Genom, Montreal, PQ, Canada; [Deshmukh, Shriya] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Majewski, Jacek; Gravel, Simon] McGill Univ, Montreal, PQ, Canada; [Majewski, Jacek; Gravel, Simon] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Moshous, Despina; Bader-Meunier, Brigitte; Diana, Jean-Sebastien; Blanche, Stephane; Fischer, Alain; Neven, Benedicte] Hop Necker Enfants Malad, AP HP, Dept Pediat Immunol & Hematol, Paris, France; [Charlebois, Janie; Abish, Sharon; Mitchell, David] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Hematol & Oncol, Montreal, PQ, Canada; [Bole-Feysot, Christine] Inst Imagine, Plateforme Genom, Paris, France; [Nitschke, Patrick] Univ Sorbonne Paris Cite, Univ Paris Descartes, Plateforme Bioinformat, Paris, France; [Thieblemont, Catherine] St Louis Hosp, Hematol & Oncol Unit, Paris, France; [Thieblemont, Catherine; Battistella, Maxime; Michonneau, David] Univ Sorbonne Paris Cite, Paris Diderot Univ, Paris, France; [Battistella, Maxime] St Louis Hosp, Cytol & Pathol Lab, Paris, France; [Van-Hung Nguyen] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pathol, Montreal, PQ, Canada; [McCormack, Chris] Univ Melbourne, Peter MacCallum Canc Inst, Dept Surg Oncol, Melbourne, Vic, Australia; [McCormack, Chris] St Vincents Hosp, Dept Dermatol, Fitzroy, Vic, Australia; [Prince, H. Miles] Epworth Healthcare, Melbourne, Vic, Australia; [Prince, H. Miles] Sir Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; [Prince, H. Miles] Univ Melbourne, Melbourne, Vic, Australia; [Besnard, Marianne] Ctr Hosp Polynesie Francaise, Dept Neonatol, Papeete, French Polynesi, France; [Fraitag, Sylvie] CHU Paris, Hop Necker Enfants Malad, Dept Anat & Cytol Pathol, Paris, France; [Fischer, Alain] Coll France, Paris, France; [Fischer, Alain; Neven, Benedicte] Inst Imagine, INSERM, U1163, Paris, France; [Michonneau, David] St Louis Hosp, Hematol & Transplantat Unit, Paris, France; [de Saint Basile, Genevieve] CHU Paris, Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, Paris, France; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; McGill University; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; Peter Maccallum Cancer Center; University of Melbourne; St Vincent's Hospital Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University	Jabado, N (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; de Saint Basile, G (corresponding author), Inst Imagine, Lab Normal & Pathol Homeostasis Immune Syst, INSERM, U1163, Paris, France.; de Saint Basile, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; de Saint Basile, G (corresponding author), CHU Paris, Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, Paris, France.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	genevieve.de-saint-basile@inserm.fr; nada.jabado@mcgill.ca	Valera, Elvis Terci/C-5226-2012; Michonneau, David/AGY-7745-2022; Schramek, Daniel/AAL-1470-2020; Moshous, Despina/B-7507-2017; Foulkes, William D./AAR-9586-2021; Jabado, Nada/AAN-4026-2020; Battistella, Maxime/K-2949-2012; Ekert, Paul/Q-1842-2015; Hamel, Nancy/L-5122-2016; Michonneau, David/L-1805-2017; Valera, Elvis/AAL-9414-2020; Thieblemont, Catherine/AAZ-8423-2020; Sepulveda, Fernando/O-7803-2016	Valera, Elvis Terci/0000-0002-4434-429X; Michonneau, David/0000-0003-4553-3065; Schramek, Daniel/0000-0001-9977-2104; Moshous, Despina/0000-0001-6719-3693; Foulkes, William D./0000-0001-7427-4651; Battistella, Maxime/0000-0002-7053-7431; Ekert, Paul/0000-0002-2976-8617; Hamel, Nancy/0000-0001-8971-0428; Michonneau, David/0000-0003-4553-3065; Valera, Elvis/0000-0002-4434-429X; Thieblemont, Catherine/0000-0002-9941-2448; Sepulveda, Fernando/0000-0001-5865-4929; Nguyen, Van-Hung/0000-0001-5318-2416; Dervovic, Dzana/0000-0002-0481-8542; Conyers, Rachel/0000-0002-2344-1365; Gayden, Tenzin/0000-0003-0138-8038; Bajic, Andrea/0000-0002-7177-5757; Guerin, Frederic/0000-0001-5723-4439; Nikbakht, Hamid/0000-0003-0209-5667; Khuong Quang, Dong Anh/0000-0001-6305-7790	Foundation of Stars; Fonds de la Recherche du Quebec en Sante; Institut Imagine, Paris [INSERM U1163]; Kids Cancer Project; Canadian Institute for Health Research [FDN-148390]; Fondation pour la Recherche Medicale [FRM: DEQ20150734354]; l'Agence Nationale de la Recherche [ANR-12-BSV1-0020-01]; Fondation Imagine; College de France; Canadian Institutes of Health Research; Fonds de Recherche du Quebec; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/20142-0/Brazil]	Foundation of Stars; Fonds de la Recherche du Quebec en Sante; Institut Imagine, Paris; Kids Cancer Project; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); l'Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Imagine; College de France; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded in part by the Foundation of Stars. N.J. is a member of the Penny Cole Laboratory and the recipient of a Chercheur Boursier, Chaire de Recherche Award from the Fonds de la Recherche du Quebec en Sante. D.-A.K.-Q. is a Herman Clinical Fellow. We thank N. Brousse and the Groupe Francais d'Etude des Lymphomes Cutanes for their valuable contributions. We also thank S. Lade from the Peter MacCallum Cancer Centre and the Victorian Comprehensive Cancer Centre, Melbourne; P. McKelvie from the Department of Pathology at St. Vincent's Hospital Melbourne; D. MacGregor from the Department of Pathology at the Royal Children's Hospital (RCH) Melbourne; L. Dalla-Pozza from the Cancer Center for Children at The Children's Hospital at Westmead, Sydney; C. Picard from the Study Center of Immunodeficiencies (CEDI) at Hopital-Necker Enfants Malades, Paris; and G. Menasche from INSERM U1163 at Institut Imagine, Paris. The Children's Cancer Centre Tissue Bank at RCH Melbourne runs thanks to the generous support of Cancer in Kids @ RCH, Leukaemia Auxiliary at RCH, the Murdoch Children's Research Institute, and the RCH Foundation. The Tumour Bank at the Children's Hospital at Westmead is generously supported by the Kids Cancer Project. W.D.F. is funded by the Canadian Institute for Health Research (FDN-148390). The G.d.S.B.lab (INSERM 1163 at Institut Imagine) is Equipe labelisee Fondation pour la Recherche Medicale (FRM: DEQ20150734354) and is supported by l'Agence Nationale de la Recherche (ANR-12-BSV1-0020-01 and the Investissements d'Avenir program) and by the Fondation Imagine. A.F. is supported by College de France. T. G. and J. P. are recipients of Canadian Institutes of Health Research and Fonds de Recherche du Quebec postdoctoral fellowships, respectively. A.B. is a recipient of a Fonds de Recherche du Quebec doctoral studentship. E.T.V. was granted funding by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant no. 2015/20142-0/Brazil), as part of a research fellowship abroad program to participate in this project. We thank M.Fu and S.-B. Feng of the Molecular Imaging facility at the Research Institute of the McGill University Health Centre for their assistance with the confocal microscope.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Berg KD, 2001, NEW ENGL J MED, V345, P1458, DOI 10.1056/NEJMoa010041; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; Gau JP, 2009, INT J HEMATOL, V89, P63, DOI 10.1007/s12185-008-0202-4; Gautron AS, 2014, EUR J IMMUNOL, V44, P2703, DOI 10.1002/eji.201344392; GONZALEZ CL, 1991, AM J SURG PATHOL, V15, P17, DOI 10.1097/00000478-199101000-00002; Greil R, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0155-9; Hamel N, 2011, EUR J HUM GENET, V19, P300, DOI 10.1038/ejhg.2010.203; Hudjashov G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20026-8; Huppmann AR, 2013, PEDIATR BLOOD CANCER, V60, P1165, DOI 10.1002/pbc.24462; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michonneau D, 2017, ACTA DERM-VENEREOL, V97, P358, DOI 10.2340/00015555-2543; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Oschlies I, 2015, BRIT J DERMATOL, V172, P793, DOI 10.1111/bjd.13440; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pincus LB, 2009, AM J DERMATOPATH, V31, P520, DOI 10.1097/DAD.0b013e3181a84f32; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Schmid JP, 2010, IMMUNOL REV, V235, P10, DOI 10.1111/j.0105-2896.2010.00890.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sepulveda FE, 2017, CURR OPIN IMMUNOL, V49, P20, DOI 10.1016/j.coi.2017.08.004; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Takada H, 2003, CLIN EXP IMMUNOL, V133, P448, DOI 10.1046/j.1365-2249.2003.02237.x; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Wang W, 2018, IMMUNOLOGY, V153, P71, DOI 10.1111/imm.12812; Willemze R, 2008, BLOOD, V111, P838, DOI 10.1182/blood-2007-04-087288; Willemze R, 2017, SEMIN DIAGN PATHOL, V34, P36, DOI 10.1053/j.semdp.2016.11.009	34	76	82	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1650	+		10.1038/s41588-018-0251-4	http://dx.doi.org/10.1038/s41588-018-0251-4			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30374066				2022-12-17	WOS:000451434400011
J	Guallar, D; Bi, XJ; Pardavila, JA; Huang, X; Saenz, C; Shi, XL; Zhou, HW; Faiola, F; Ding, JJ; Haruehanroengra, P; Yang, F; Li, D; Sanchez-Priego, C; Saunders, A; Pan, F; Valdes, VJ; Kelley, K; Blanco, MG; Chen, LY; Wang, HY; Sheng, J; Xu, MJ; Fidalgo, M; Shen, XH; Wang, JL				Guallar, Diana; Bi, Xianju; Pardavila, Jose Angel; Huang, Xin; Saenz, Carmen; Shi, Xianle; Zhou, Hongwei; Faiola, Francesco; Ding, Junjun; Haruehanroengra, Phensinee; Yang, Fan; Li, Dan; Sanchez-Priego, Carlos; Saunders, Arven; Pan, Feng; Valdes, Victor Julian; Kelley, Kevin; Blanco, Miguel G.; Chen, Lingyi; Wang, Huayan; Sheng, Jia; Xu, Mingjiang; Fidalgo, Miguel; Shen, Xiaohua; Wang, Jianlong			RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells	NATURE GENETICS			English	Article							ENHANCER ACTIVITY; DNA METHYLATION; DISTINCT ROLES; NONCODING RNA; 5-HYDROXYMETHYLCYTOSINE; GENOME; ELEMENTS; PROTEIN; GENES; HYDROXYMETHYLCYTOSINE	Ten-eleven translocation (TET) proteins play key roles in the regulation of DNA-methylation status by oxidizing 5-methylcytosine (5mC) to generate 5-hydroxymethylcytosine (5hmC), which can both serve as a stable epigenetic mark and participate in active demethylation. Unlike the other members of the TET family, TET2 does not contain a DNA-binding domain, and it remains unclear how it is recruited to chromatin. Here we show that TET2 is recruited by the RNA-binding protein Paraspeckle component 1 (PSPC1) through transcriptionally active loci, including endogenous retroviruses (ERVs) whose long terminal repeats (LTRs) have been co-opted by mammalian genomes as stage-and tissue-specific transcriptional regulatory modules. We found that PSPC1 and TET2 contribute to ERVL and ERVL-associated gene regulation by both transcriptional repression via histone deacetylases and post-transcriptional destabilization of RNAs through 5hmC modification. Our findings provide evidence for a functional role of transcriptionally active ERVs as specific docking sites for RNA epigenetic modulation and gene regulation.	[Guallar, Diana; Huang, Xin; Saenz, Carmen; Shi, Xianle; Zhou, Hongwei; Faiola, Francesco; Ding, Junjun; Yang, Fan; Li, Dan; Sanchez-Priego, Carlos; Saunders, Arven; Kelley, Kevin; Wang, Jianlong] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Guallar, Diana; Huang, Xin; Saenz, Carmen; Shi, Xianle; Zhou, Hongwei; Faiola, Francesco; Ding, Junjun; Yang, Fan; Li, Dan; Sanchez-Priego, Carlos; Saunders, Arven; Kelley, Kevin; Wang, Jianlong] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Guallar, Diana; Pardavila, Jose Angel; Blanco, Miguel G.; Fidalgo, Miguel] Univ Santiago de Compostela, Hlth Res Inst IDIS, CiMUS, Santiago De Compostela, Coruna, Spain; [Bi, Xianju; Shen, Xiaohua] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Shi, Xianle; Chen, Lingyi] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Shi, Xianle; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Haruehanroengra, Phensinee] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Haruehanroengra, Phensinee] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Yang, Fan; Wang, Huayan] Northwest A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Xianyang, Peoples R China; [Li, Dan; Sanchez-Priego, Carlos; Saunders, Arven; Wang, Jianlong] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Pan, Feng; Xu, Mingjiang] Univ Miami, Dept Biochem & Mol Biol, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [Valdes, Victor Julian] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Cell Biol & Dev, Mexico City, DF, Mexico	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universidade de Santiago de Compostela; Tsinghua University; Nankai University; Nankai University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Northwest A&F University - China; Icahn School of Medicine at Mount Sinai; University of Miami; Universidad Nacional Autonoma de Mexico	Wang, JL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.; Wang, JL (corresponding author), Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.; Wang, JL (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.	jianlong.wang@mssm.edu	Fidalgo, Miguel/I-7006-2019; Guallar, Diana/AAJ-1812-2020; Wang, Jianlong/AAG-9425-2020; Valdes, Julian/C-1840-2017; Wang, Jianlong/GQR-1191-2022; Faiola, Francesco/Q-4218-2018; Blanco, Miguel González/J-6424-2012; Bi, Xianju/Z-4056-2019; Blanco, Miguel González/R-5754-2017	Fidalgo, Miguel/0000-0003-1134-2674; Guallar, Diana/0000-0001-5834-7507; Valdes, Julian/0000-0001-6157-1358; Wang, Jianlong/0000-0002-1317-6457; Faiola, Francesco/0000-0002-3512-8253; Blanco, Miguel González/0000-0002-2883-7326; Blanco, Miguel González/0000-0002-2883-7326; Li, Dan/0000-0002-6332-1093; Ding, Junjun/0000-0002-9936-882X; Bi, Xianju/0000-0001-9061-2622; Yang, Fan/0000-0002-4269-128X	US National Institutes of Health (NIH) [1R01-GM095942, R21HD087722, R01HL112294]; Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM) [C028103, C028121]; Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award; Ministerio de Economia y Competitividad of Spain [2014-16779]; National Natural Science Foundation of China [31471219, 31428010]; Center for Life Sciences (CLS) at Tsinghua University; Agencia Estatal de Investigacion [BFU2016-80899-P]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [ED431F 2016/016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095942] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM); Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award; Ministerio de Economia y Competitividad of Spain(Spanish Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Life Sciences (CLS) at Tsinghua University; Agencia Estatal de Investigacion; Conselleria de Cultura, Educacion e Ordenacion Universitaria; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Kurihara for PSPC1 constructs, T. Macfarlan for the Zfp352-luciferase reporter construct, R. Jaenisch for the Tet-TKO ESC line, D. Trono for the Trim28-cKO line, and D.M. Gilbert and Y. Shinkai for the Ehmt2-cKO line. We also thank the medical illustrator J. Gregory from Icahn School of Medicine at Mount Sinai for the model drawing. This research was funded by the US National Institutes of Health (NIH) (grants 1R01-GM095942 and R21HD087722 to J.W.; grant R01HL112294 to M.X.) and the Empire State Stem Cell Fund through the New York State Department of Health (NYSTEM) (grants C028103 and C028121 to J.W.). J. W. is a recipient of an Irma T. Hirschl and Weill-Caulier Trusts Career Scientist Award, and M.F. is a recipient of a Ramon y Cajal contract (RYC-2014-16779) from the Ministerio de Economia y Competitividad of Spain. The research from the Shen laboratory is supported by the National Natural Science Foundation of China (31471219 and 31428010) and the Center for Life Sciences (CLS) at Tsinghua University. Additional support was provided by the Agencia Estatal de Investigacion (BFU2016-80899-P to M.F.) (AEI/FEDER, UE) and the Conselleria de Cultura, Educacion e Ordenacion Universitaria (ED431F 2016/016 to M.F.).	Amort T, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1139-1; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; de la Rica L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1096-8; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.e05-06-0587; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Frye M, 2016, DEVELOPMENT, V143, P3871, DOI 10.1242/dev.136556; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Gerdes P, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1124-8; Gilbert SL, 2000, J BIOL CHEM, V275, P36491, DOI 10.1074/jbc.C000409200; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Huber SM, 2015, CHEMBIOCHEM, V16, P752, DOI 10.1002/cbic.201500013; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kowalska E, 2012, MOL CELL BIOL, V32, P4585, DOI 10.1128/MCB.00334-12; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Ma C, 2016, CELL REP, V17, P997, DOI 10.1016/j.celrep.2016.09.078; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maksakova IA, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-15; Masiello I, 2017, CELL MOL LIFE SCI, V74, P3057, DOI 10.1007/s00018-017-2521-1; Miao ZG, 2016, BRAIN RES, V1642, P546, DOI 10.1016/j.brainres.2016.04.055; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhang HY, 2016, CHEM COMMUN, V52, P737, DOI 10.1039/c5cc07354e; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692	60	76	78	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					443	451		10.1038/s41588-018-0060-9	http://dx.doi.org/10.1038/s41588-018-0060-9			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29483655	Green Accepted			2022-12-17	WOS:000427933400020
J	Han, LS; Ren, C; Li, L; Li, XY; Ge, J; Wang, HC; Miao, YL; Guo, XJ; Moley, KH; Shu, WJ; Wang, Q				Han, Longsen; Ren, Chao; Li, Ling; Li, Xiaoyan; Ge, Juan; Wang, Haichao; Miao, Yi-Liang; Guo, Xuejiang; Moley, Kelle H.; Shu, Wenjie; Wang, Qiang			Embryonic defects induced by maternal obesity in mice derive from Stella insufficiency in oocytes	NATURE GENETICS			English	Article							DIET-INDUCED OBESITY; HIGH-FAT-DIET; DNA METHYLATION; MITOCHONDRIAL DYSFUNCTION; GROWTH-FACTOR; TET3; GENOME; PGC7; KINASE; STRESS	Maternal obesity can impair embryo development and offspring health, yet the mechanisms responsible remain poorly understood. In a high-fat diet (HFD)-based female mouse model of obesity, we identified a marked reduction of Stella (also known as DPPA3 or PGC7) protein in oocytes. Starting with this clue, we found that the establishment of pronuclear epigenetic asymmetry in zygotes from obese mice was severely disrupted, inducing the accumulation of maternal 5-hydroxymethylcytosine modifications and DNA lesions. Furthermore, methylome-wide sequencing analysis detected global hypomethylation across the zygote genome in HFD-fed mice, with a specific enrichment in transposon elements and unique regions. Notably, overexpression of Stella in the oocytes of HFD-fed mice not only restored the epigenetic remodeling in zygotes but also partly ameliorated the maternal-obesity-associated developmental defects in early embryos and fetal growth. Thus, Stella insufficiency in oocytes may represent a critical mechanism that mediates the phenotypic effects of maternal obesity in embryos and offspring.	[Han, Longsen; Li, Ling; Ge, Juan; Wang, Haichao; Guo, Xuejiang; Wang, Qiang] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Ren, Chao; Shu, Wenjie] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China; [Li, Xiaoyan] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Miao, Yi-Liang] Huazhong Agr Univ, Inst Stem Cell & Regenerat Biol, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China; [Miao, Yi-Liang] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Nanjing Medical University; Academy of Military Medical Sciences - China; Nanjing Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Washington University (WUSTL)	Wang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.; Shu, WJ (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	shuwj@bmi.ac.cn; qwang2012@njmu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705; Shu, Wenjie/0000-0001-9044-2352	National Key Scientific Research Projects of China [2014CB943200]; National Key Research and Development Program of China [2017YFC1001500]; National Natural Science Foundation of China [31571543]; Major Research Plan of the National Natural Science Foundation of China [U1435222]; Major Research Plan of the National Key R&D Program of China [2016YFC0901600]; National High Technology Research and Development Program of China [2015AA020108]	National Key Scientific Research Projects of China; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Key R&D Program of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	We are grateful to T. Schedl (Washington University in St. Louis School of Medicine) for a valuable discussion that led to the experiment design reported in this paper and his critical reading of the manuscript. We also thank Q.-Y. Sun and Z.-B. Wang (Chinese Academy of Sciences) for providing plasmids and Y.-S. Guo (Nanjing Medical University) for help with the proteomic assay. This work was supported by National Key Scientific Research Projects of China (2014CB943200 to Q.W.), the National Key Research and Development Program of China (2017YFC1001500 to Q.W.), the National Natural Science Foundation of China (no. 31571543 to Q.W.), a Major Research Plan of the National Natural Science Foundation of China (no. U1435222 to W.S.), a Major Research Plan of the National Key R&D Program of China (no. 2016YFC0901600 to W.S.), and the National High Technology Research and Development Program of China (no. 2015AA020108 to W.S.).	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Anderson NH, 2013, AUST NZ J OBSTET GYN, V53, P136, DOI 10.1111/ajo.12016; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Bermejo-Alvarez P, 2012, HUM REPROD, V27, P3513, DOI 10.1093/humrep/des327; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bian CJ, 2014, NUCLEIC ACIDS RES, V42, P2893, DOI 10.1093/nar/gkt1261; Bortvin Alex, 2004, BMC Developmental Biology, V4; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Faulk C, 2016, EPIGENETICS-US, V11, P489, DOI 10.1080/15592294.2016.1183856; Fernandez-Twinn DS, 2015, SEMIN CELL DEV BIOL, V43, P85, DOI 10.1016/j.semcdb.2015.06.006; Finger BJ, 2015, HUM REPROD, V30, P2084, DOI 10.1093/humrep/dev142; Funaki S, 2014, BIOCHEM BIOPH RES CO, V453, P455, DOI 10.1016/j.bbrc.2014.09.101; Ge ZJ, 2014, ENVIRON HEALTH PERSP, V122, P159, DOI 10.1289/ehp.1307047; Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hou XJ, 2015, J CELL SCI, V128, P2319, DOI 10.1242/jcs.167049; Hou YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18858; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.22345; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Inoue A, 2015, CELL REP, V10, P463, DOI 10.1016/j.celrep.2014.12.049; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kafer GR, 2016, CELL REP, V14, P1283, DOI 10.1016/j.celrep.2016.01.035; Kang J, 2013, CELL RES, V23, P6, DOI 10.1038/cr.2012.117; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Ladstatter S, 2016, CELL, V167, P1774, DOI 10.1016/j.cell.2016.11.009; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Luke B, 2011, FERTIL STERIL, V96, P820, DOI 10.1016/j.fertnstert.2011.07.1100; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Mahizir D, 2016, MOL NUTR FOOD RES, V60, P8, DOI 10.1002/mnfr.201500289; McPherson NO, 2015, AM J PHYSIOL-ENDOC M, V309, pE568, DOI 10.1152/ajpendo.00230.2015; Nagy A., 2003, MANIPULATING MOUSE E; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nakatani T, 2015, EMBO REP, V16, P582, DOI 10.15252/embr.201439427; Neri C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026591; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Qi L, 2014, MOL CELL PROTEOMICS, V13, P3626, DOI 10.1074/mcp.M114.039073; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sasson IE, 2015, DIABETOLOGIA, V58, P615, DOI 10.1007/s00125-014-3466-7; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Sun M, 2016, HUM MOL GENET, V25, P2208, DOI 10.1093/hmg/ddw089; Tenenbaum-Gavish K, 2013, FETAL DIAGN THER, V34, P1, DOI 10.1159/000350170; Tsukada Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15876; Wang J, 2015, MOL CELL PROTEOMICS, V14, P1104, DOI 10.1074/mcp.M114.045468; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu LL, 2015, DEVELOPMENT, V142, P681, DOI 10.1242/dev.114850; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273; Yu C, 2013, SCIENCE, V342, P1518, DOI 10.1126/science.1244587; Zhang L, 2015, CELL CYCLE, V14, P2959, DOI 10.1080/15384101.2015.1026517	64	76	78	1	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					432	+		10.1038/s41588-018-0055-6	http://dx.doi.org/10.1038/s41588-018-0055-6			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29459681				2022-12-17	WOS:000427933400019
J	Borges, F; Parent, JS; van Ex, F; Wolff, P; Martinez, G; Kohler, C; Martienssen, RA				Borges, Filipe; Parent, Jean-Sebastien; van Ex, Frederic; Wolff, Philip; Martinez, German; Kohler, Claudia; Martienssen, Robert A.			Transposon-derived small RNAs triggered by miR845 mediate genome dosage response in Arabidopsis	NATURE GENETICS			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; SEED DEVELOPMENT; GENE-EXPRESSION; POLLEN; PLANTS; DEMETHYLATION; THALIANA; ELEMENTS; HYBRIDIZATION	Chromosome dosage has substantial effects on reproductive isolation and speciation in both plants and animals, but the underlying mechanisms are largely obscure(1). Transposable elements in animals can regulate hybridity through maternal small RNA(2), whereas small RNAs in plants have been postulated to regulate dosage response via neighboring imprinted genes(3,4). Here we show that a highly conserved microRNA in plants, miR845, targets the tRNA(Met) primer-binding site (PBS) of long terminal repeat (LTR) retrotransposons in Arabidopsis pollen, and triggers the accumulation of 21-22-nucleotide (nt) small RNAs in a dose-dependent fashion via RNA polymerase IV. We show that these epigenetically activated small interfering RNAs (easiRNAs) mediate hybridization barriers between diploid seed parents and tetraploid pollen parents (the 'triploid block'), and that natural variation for miR845 may account for 'endosperm balance' allowing the formation of triploid seeds. Targeting of the PBS with small RNA is a common mechanism for transposon control in mammals and plants, and provides a uniquely sensitive means to monitor chromosome dosage and imprinting in the developing seed.	[Borges, Filipe; Parent, Jean-Sebastien; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [van Ex, Frederic; Martienssen, Robert A.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Wolff, Philip; Martinez, German; Kohler, Claudia] Swedish Univ Agr Sci, Dept Plant Biol, Uppsala, Sweden; [Wolff, Philip; Martinez, German; Kohler, Claudia] Linnean Ctr Plant Biol, Uppsala, Sweden; [van Ex, Frederic] Bayer CropSci NV, Ghent, Belgium; [Wolff, Philip] John Innes Ctr, Norwich, Norfolk, England	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Bayer AG; Bayer CropScience; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.; Martienssen, RA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Köhler, Claudia/G-9668-2011; Martínez, Germán/ABE-7261-2020	Köhler, Claudia/0000-0002-2619-4857; Martínez, Germán/0000-0002-5215-0866; Parent, Jean-Sebastien/0000-0001-7859-7415; Wolff, Philip/0000-0002-8915-553X; Van Ex, Frederic/0000-0003-2481-0115; Borges, Filipe/0000-0002-7388-2118	US National Institutes of Health (NIH) [R01 GM067014]; National Science Foundation Plant Genome Research Program; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation; Cancer Center (Support Grant) [5PP30CA045508]; European Research Council Starting Independent Researcher grant; Swedish Science Foundation; Knut and Alice Wallenberg Foundation; Marie Curie IOF Postdoctoral Fellowship [PIOF-GA-2012-330069]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020122] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cancer Center (Support Grant); European Research Council Starting Independent Researcher grant; Swedish Science Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Marie Curie IOF Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all members of the Martienssen laboratory for discussions. Research in the Martienssen laboratory is supported by the US National Institutes of Health (NIH; grant R01 GM067014), the National Science Foundation Plant Genome Research Program, and the Howard Hughes Medical Institute and Gordon and Betty Moore Foundation. The authors acknowledge assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded in part by the Cancer Center (Support Grant 5PP30CA045508). The osd1-1 mutant was kindly provided by R. Mercier (Institut Jean-Pierre Bourgin, INRA Versailles-Grignon, Versailles, France). Research in the Kohler laboratory was supported by a European Research Council Starting Independent Researcher grant, the Swedish Science Foundation and the Knut and Alice Wallenberg Foundation (to C.K.). G.M. was supported by a Marie Curie IOF Postdoctoral Fellowship (PIOF-GA-2012-330069). Sequencing for the Kohler laboratory was performed by the SNP&SEQ Technology Platform, Science for Life Laboratory at Uppsala University, a national infrastructure supported by the Swedish Research Council (VRRFI) and the Knut and Alice Wallenberg Foundation.	Birchler JA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00281; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Borges F, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-44; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Creasey KM, 2014, NATURE, V508, P411, DOI 10.1038/nature13069; d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Dresselhaus T, 2016, CURR BIOL, V26, pR125, DOI 10.1016/j.cub.2015.12.032; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hsieh PH, 2016, P NATL ACAD SCI USA, V113, P15132, DOI 10.1073/pnas.1619074114; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jullien PE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000885; Kato A, 2006, J HERED, V97, P39, DOI 10.1093/jhered/esj007; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Kirkbride RC, 2015, MOL PLANT, V8, P1766, DOI 10.1016/j.molp.2015.09.009; Kohler C, 2010, TRENDS GENET, V26, P142, DOI 10.1016/j.tig.2009.12.006; Kradolfer D, 2013, DEV CELL, V26, P525, DOI 10.1016/j.devcel.2013.08.006; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lu J, 2012, P NATL ACAD SCI USA, V109, P5529, DOI 10.1073/pnas.1203094109; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; Martinez G., 2018, ARABIDOPSIS NAT GENE; Martinez G, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.30, 10.1038/nplants.2016.30]; Mozgova I, 2015, PLANT J, V83, P121, DOI 10.1111/tpj.12828; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; Pignatta D, 2014, ELIFE, V3, DOI 10.7554/eLife.03198; Pumplin N, 2016, PLANT CELL, V28, P2786, DOI 10.1105/tpc.16.00554; Quadrana L, 2016, ELIFE, V5, DOI [10.7554/eLife.15716, 10.7554/elife.15716]; Rathore P, 2016, PLANT SCI, V247, P35, DOI 10.1016/j.plantsci.2016.03.002; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schalk C, 2017, P NATL ACAD SCI USA, V114, pE2965, DOI 10.1073/pnas.1618834114; Schatlowski N, 2014, PLANT CELL, V26, P3556, DOI 10.1105/tpc.114.130120; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Schoft VK, 2015, PLANT REPROD, V28, P61, DOI 10.1007/s00497-015-0258-2; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Surbanovski N, 2016, PLANT J, V85, P70, DOI 10.1111/tpj.13090; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Willing EM, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.23, 10.1038/nplants.2014.23]; Wolff P, 2015, ELIFE, V4, DOI [10.7554/eLife.10074.001, 10.7554/eLife.10074]; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	50	76	78	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					186	+		10.1038/s41588-017-0032-5	http://dx.doi.org/10.1038/s41588-017-0032-5			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29335544	Green Accepted, Green Submitted			2022-12-17	WOS:000424519200009
J	Sheehan, H; Moser, M; Klahre, U; Esfeld, K; Dell'Olivo, A; Mandel, T; Metzger, S; Vandenbussche, M; Freitas, L; Kuhlemeier, C				Sheehan, Hester; Moser, Michel; Klahre, Ulrich; Esfeld, Korinna; Dell'Olivo, Alexandre; Mandel, Therese; Metzger, Sabine; Vandenbussche, Michiel; Freitas, Loreta; Kuhlemeier, Cris			MYB-FL controls gain and loss of floral UV absorbance, a key trait affecting pollinator preference and reproductive isolation	NATURE GENETICS			English	Article							FLOWER COLOR; ANTHOCYANIN PIGMENTATION; EVOLUTIONARY HISTORY; ULTRAVIOLET VISION; PETUNIA SOLANACEAE; FLAVONOL SYNTHASE; GENUS PETUNIA; MANDUCA-SEXTA; SPECIATION; GENETICS	Adaptations to new pollinators involve multiple floral traits, each requiring coordinated changes in multiple genes. Despite this genetic complexity, shifts in pollination syndromes have happened frequently during angiosperm evolution. Here we study the genetic basis of floral UV absorbance, a key trait for attracting nocturnal pollinators. In Petunia, mutations in a single gene, MYB-FL, explain two transitions in UV absorbance. A gain of UV absorbance in the transition from bee to moth pollination was determined by a cis-regulatory mutation, whereas a frameshift mutation caused subsequent loss of UV absorbance during the transition from moth to hummingbird pollination. The functional differences in MYB-FL provide insight into the process of speciation and clarify phylogenetic relationships between nascent species.	[Sheehan, Hester; Moser, Michel; Klahre, Ulrich; Esfeld, Korinna; Dell'Olivo, Alexandre; Mandel, Therese; Kuhlemeier, Cris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Metzger, Sabine] Univ Cologne, Cologne Bioctr, Cluster Excellence Plant Sci, Mass Spectrometry Platform, D-50931 Cologne, Germany; [Vandenbussche, Michiel] Ecole Normale Super Lyon, UMR 5667, ENS Lyon, CNRS,INRA,UCBL, F-69364 Lyon, France; [Freitas, Loreta] Univ Fed Rio Grande do Sul, Dept Genet, Lab Mol Evolut, Porto Alegre, RS, Brazil	University of Bern; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Universidade Federal do Rio Grande do Sul	Kuhlemeier, C (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	cris.kuhlemeier@ips.unibe.ch	Freitas, Loreta B/D-9948-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Moser, Michel/AAD-5093-2019; Sheehan, Hester/AAB-2321-2021; Freitas, Loreta B/E-7366-2010	Freitas, Loreta B/0000-0002-0728-4945; Sheehan, Hester/0000-0002-2169-5206; Freitas, Loreta B/0000-0002-0728-4945; VANDENBUSSCHE, Michiel/0000-0002-4192-7369	ATIP-AVENIR (CNRS); ANR-BLANC grant; Science without Borders, CNPq; National Centre of Competence in Research; Swiss National Science Foundation; University of Bern	ATIP-AVENIR (CNRS); ANR-BLANC grant(French National Research Agency (ANR)); Science without Borders, CNPq; National Centre of Competence in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern	We thank C. Ball, J. Sekulovski, N. Signer and R. Zimmermann for expert care of our plants; M. Saxenhofer and A. Feller for help with genotyping and screening transposon populations; P. Morel and J. Zethof for help with the amplification and sequencing of dTph1 transposon-flanking sequences; A.L. Caze for help with phenotyping hybrid progeny plants; and A.L. Segatto and C. Turchetto for field collections and DNA extraction. K. Snowden, A. Amrad, K. Hermann, H. Summers and S. Robinson provided constructive comments on manuscript drafts; A. Amrad, R. Koes, J. Stuurman and T. Gerats provided advice and suggestions throughout the project; and R. Kopfli assisted with figures. M.V. was financially supported by an ATIP-AVENIR (CNRS) and ANR-BLANC grant. L.F. was financed by Science without Borders, CNPq. The remaining authors were financed by the National Centre of Competence in Research "Plant Survival" and grants from the Swiss National Science Foundation and the University of Bern.	Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Ando T, 2001, ANN BOT-LONDON, V88, P403, DOI 10.1006/anbo.2001.1485; Segatto ALA, 2014, MOL PHYLOGENET EVOL, V70, P504, DOI 10.1016/j.ympev.2013.10.011; Bouck A, 2007, EVOLUTION, V61, P2308, DOI 10.1111/j.1558-5646.2007.00214.x; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Bradshaw HD, 1998, GENETICS, V149, P367; Brothers AN, 2013, J HERED, V104, P853, DOI 10.1093/jhered/est059; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; CHARLESWORTH D, 1979, GENETICS, V91, P581; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooley AM, 2011, CURR BIOL, V21, P700, DOI 10.1016/j.cub.2011.03.028; Cronk Q, 2008, J EXP BOT, V59, P715, DOI 10.1093/jxb/ern009; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Dell'Olivo A, 2013, EVOLUTION, V67, P3023, DOI 10.1111/evo.12178; Dell'Olivo A, 2011, EVOLUTION, V65, P1979, DOI 10.1111/j.1558-5646.2011.01279.x; Dziedzioch C, 2003, PLANT BIOLOGY, V5, P331, DOI 10.1055/s-2003-40802; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faegri K., 1979, PRINCIPLES POLLINATI; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Galliot C, 2006, PLANTA, V225, P203, DOI 10.1007/s00425-006-0342-9; Gegear RJ, 2007, AM NAT, V170, P551, DOI 10.1086/521230; GOLDSMITH TH, 1980, SCIENCE, V207, P786, DOI 10.1126/science.7352290; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Guebitz Thomas, 2009, P29, DOI 10.1007/978-0-387-84796-2_2; GULDBERG LD, 1975, AM MIDL NAT, V93, P35, DOI 10.2307/2424103; Hermann K, 2015, PLANTA, V241, P1241, DOI 10.1007/s00425-015-2251-2; Hermann K, 2013, CURR BIOL, V23, P873, DOI 10.1016/j.cub.2013.03.069; Herrera G, 2008, J COMP PHYSIOL A, V194, P785, DOI 10.1007/s00359-008-0349-8; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; HOLTON TA, 1993, PLANT J, V4, P1003, DOI 10.1046/j.1365-313X.1993.04061003.x; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Kay KM, 2003, BIOTROPICA, V35, P198, DOI 10.1111/j.1744-7429.2003.tb00279.x; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; Kevan P, 1996, TRENDS PLANT SCI, V1, P280; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Knapp S, 2010, PHILOS T R SOC B, V365, P449, DOI 10.1098/rstb.2009.0236; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lorenz-Lemke AP, 2006, MOL ECOL, V15, P4487, DOI 10.1111/j.1365-294X.2006.03100.x; Lorenz-Lemke AP, 2010, MOL ECOL, V19, P5240, DOI 10.1111/j.1365-294X.2010.04871.x; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Reck-Kortmann M, 2014, MOL PHYLOGENET EVOL, V81, P19, DOI 10.1016/j.ympev.2014.08.022; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Stehmann Joao Renato, 2009, P1, DOI 10.1007/978-0-387-84796-2_1; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Streisfeld MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003385; Stuurman J, 2004, GENETICS, V168, P1585, DOI 10.1534/genetics.104.031138; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Venail J, 2010, PHILOS T R SOC B, V365, P461, DOI 10.1098/rstb.2009.0242; Watanabe H, 2001, J JPN SOC HORTIC SCI, V70, P33, DOI 10.2503/jjshs.70.33; Wessinger CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0349; WHITE RH, 1994, BIOTROPICA, V26, P427, DOI 10.2307/2389237; WHITE RH, 1983, J COMP PHYSIOL, V150, P153, DOI 10.1007/BF00606365; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; WIJSMAN HJW, 1983, ACTA BOT NEERL, V32, P97, DOI 10.1111/j.1438-8677.1983.tb01681.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Yuan YW, 2013, CURR OPIN PLANT BIOL, V16, P422, DOI 10.1016/j.pbi.2013.05.004; Yuan YW, 2013, GENETICS, V194, P255, DOI 10.1534/genetics.112.146852	74	76	77	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					159	166		10.1038/ng.3462	http://dx.doi.org/10.1038/ng.3462			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656847				2022-12-17	WOS:000369043900013
J	Hobbs, RP; DePianto, DJ; Jacob, JT; Han, MC; Chung, BM; Batazzi, AS; Poll, BG; Guo, YJ; Han, JN; Ong, SF; Zheng, WX; Taube, JM; Cihakova, D; Wan, FY; Coulombe, PA				Hobbs, Ryan P.; DePianto, Daryle J.; Jacob, Justin T.; Han, Minerva C.; Chung, Byung-Min; Batazzi, Adriana S.; Poll, Brian G.; Guo, Yajuan; Han, Jingnan; Ong, SuFey; Zheng, Wenxin; Taube, Janis M.; Cihakova, Daniela; Wan, Fengyi; Coulombe, Pierre A.			Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes	NATURE GENETICS			English	Article							NF-KAPPA-B; AUTOIMMUNE REGULATOR; HNRNP K; PROTEIN; CANCER; RNA	Expression of the intermediate filament protein keratin 17 (K17) is robustly upregulated in inflammatory skin diseases and in many tumors originating in stratified and pseudostratified epithelia(1-3). We report that autoimmune regulator (Aire), a transcriptional regulator, is inducibly expressed in human and mouse tumor keratinocytes in a K17-dependent manner and is required for timely onset of Gli2-induced skin tumorigenesis in mice. The induction of Aire mRNA in keratinocytes depends on a functional interaction between K17 and the heterogeneous nuclear ribonucleoprotein hnRNP K-4. Further, K17 colocalizes with Aire protein in the nucleus of tumor-prone keratinocytes, and each factor is bound to a specific promoter region featuring an NF-kappa B consensus sequence in a relevant subset of K17-and Aire-dependent proinflammatory genes. These findings provide radically new insight into keratin intermediate filament and Aire function, along with a molecular basis for the K17-dependent amplification of inflammatory and immune responses in diseased epithelia.	[Hobbs, Ryan P.; DePianto, Daryle J.; Jacob, Justin T.; Han, Minerva C.; Chung, Byung-Min; Batazzi, Adriana S.; Poll, Brian G.; Guo, Yajuan; Han, Jingnan; Zheng, Wenxin; Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Ong, SuFey; Cihakova, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Taube, Janis M.; Cihakova, Daniela] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Taube, Janis M.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Wan, Fengyi; Coulombe, Pierre A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	coulombe@jhu.edu	Cihakova, Daniela/A-9821-2017; Poll, Brian/GQH-9509-2022; Chung, Byung Min/H-6219-2019	Cihakova, Daniela/0000-0002-8713-2860; Poll, Brian/0000-0001-7523-626X; Chung, Byung Min/0000-0003-1262-5107; Guo, Yajuan/0000-0002-6344-5248	US National Institutes of Health [CA160255, AR044232, GM111682, CA009110]; NATIONAL CANCER INSTITUTE [R01CA160255, T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111682] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Coulombe laboratory for support, P. Peterson (Aire constructs; Tartu University), R. Foisner (subcellular fractionation), M. Vladut-Talor (central tolerance study) and J. Folmer (electron microscopy) for advice and assistance. These studies were supported by research grants CA160255 and AR044232 (to P.A.C.) and GM111682 (to F.W.) and by training grant CA009110 (to R.P.H.), all from the US National Institutes of Health.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Adamson KA, 2004, J PATHOL, V202, P180, DOI 10.1002/path.1493; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Chen RY, 2014, ONCOTARGET, V5, P4406, DOI 10.18632/oncotarget.2030; Chung BM, 2015, J CELL BIOL, V208, P613, DOI 10.1083/jcb.201408026; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Fu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2916; Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kisand K, 2011, ANN NY ACAD SCI, V1246, P77, DOI 10.1111/j.1749-6632.2011.06308.x; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kumar V, 2011, AM J PATHOL, V178, P983, DOI 10.1016/j.ajpath.2010.12.007; Kumeta M, 2013, EXP CELL RES, V319, P3226, DOI 10.1016/j.yexcr.2013.07.021; Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LIAO J, 1995, J BIOL CHEM, V270, P915, DOI 10.1074/jbc.270.2.915; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichelt J, 2010, METHODS MOL BIOL, V585, P59, DOI 10.1007/978-1-60761-380-0_5; Sankar S, 2013, MOL CELL BIOL, V33, P4448, DOI 10.1128/MCB.00241-13; Sillanpaa N, 2004, MOL IMMUNOL, V41, P1185, DOI 10.1016/j.molimm.2004.06.004; Tong XM, 2004, J INVEST DERMATOL, V122, P965, DOI 10.1111/j.0022-202X.2004.22422.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Woodworth CD, 2004, CARCINOGENESIS, V25, P1771, DOI 10.1093/carcin/bgh170	42	76	76	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					933	U135		10.1038/ng.3355	http://dx.doi.org/10.1038/ng.3355			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26168014	Green Accepted			2022-12-17	WOS:000358674100020
J	Viana, D; Comos, M; McAdam, PR; Ward, MJ; Selva, L; Guinane, CM; Gonzalez-Munoz, BM; Tristan, A; Foster, SJ; Fitzgerald, JR; Penades, JR				Viana, David; Comos, Maria; McAdam, Paul R.; Ward, Melissa J.; Selva, Laura; Guinane, Caitriona M.; Gonzalez-Munoz, Beatriz M.; Tristan, Anne; Foster, Simon J.; Fitzgerald, J. Ross; Penades, Jose R.			A single natural nucleotide mutation alters bacterial pathogen host tropism	NATURE GENETICS			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; LISTERIA-MONOCYTOGENES; AMINO-ACID; ADAPTATION; PROTEIN; VIRUS; GENOMICS; ORIGIN; RANGE; TRANSMISSION	The capacity of microbial pathogens to alter their host tropism leading to epidemics in distinct host species populations is a global public and veterinary health concern. To investigate the molecular basis of a bacterial host-switching event in a tractable host species, we traced the evolutionary trajectory of the common rabbit clone of Staphylococcus aureus. We report that it evolved through a likely human-to-rabbit host jump over 40 years ago and that only a single naturally occurring nucleotide mutation was required and sufficient to convert a human-specific S. aureus strain into one that could infect rabbits. Related mutations were identified at the same locus in other rabbit strains of distinct clonal origin, consistent with convergent evolution. This first report of a single mutation that was sufficient to alter the host tropism of a microorganism during its evolution highlights the capacity of some pathogens to readily expand into new host species populations.	[Viana, David; Selva, Laura] Univ CEU Cardenal Herrera, Biomed Res Inst, Valencia, Spain; [Comos, Maria] Inst Valenciano Invest Agr, Ctr Invest & Tecnol Anim, Segorbe, Spain; [McAdam, Paul R.; Guinane, Caitriona M.; Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Ward, Melissa J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Gonzalez-Munoz, Beatriz M.; Foster, Simon J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Tristan, Anne] Univ Lyon, Ctr Natl Reference Staphylocoques, Lyon, France; [Penades, Jose R.] CSIC, Inst Biomed Valencia, Valencia, Spain; [Penades, Jose R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Universidad CEU Cardenal Herrera; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Glasgow	Penades, JR (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	ross.fitzgerald@ed.ac.uk; joser.penades@glasgow.ac.uk	Tristan, Anne/L-9464-2014; Martínez, Laura Selva/E-7018-2017; Penadés, José R/W-9685-2019; TRISTAN, Anne/GSN-8306-2022; Viana, David/L-3701-2014	Penadés, José R/0000-0002-6439-5262; TRISTAN, Anne/0000-0001-9471-2655; Viana, David/0000-0002-5813-0356; Fitzgerald, Ross/0000-0002-9233-8468; Guinane, Caitriona/0000-0001-8215-1387; Selva Martinez, Laura/0000-0002-7920-1918; McAdam, Paul/0000-0001-6465-9910	Ministerio de Ciencia e Innovacion (Spain) [BIO2011-30503-C02-01, PIM2010EPA-00606, CSD2009-00006]; University of Glasgow; Biotechnology and Biological Sciences Research Council (UK) [BB/I013873/1]; Medical Research Council (UK); Ministerio de Ciencia e Innovacion, Spain [AGL2011-30170-CO2-02]; Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana [GV2013-077]; BBSRC [BBS/E/D/20231761, BBS/E/D/20310000, BB/I013873/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I013873/1, BBS/E/D/20231761, BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1, G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Glasgow; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Etienne for helpful advice, O. Schneewind, M. Woolhouse and I. Lasa for comments on the manuscript, C. Cervera and E. Blas for their support with the in vivo experiments, and R. Cartwright for excellent technical assistance. We are grateful to Edinburgh Genomics (Roslin Institute) for sequencing services. This work was supported by grants BIO2011-30503-C02-01, Eranetpathogenomics PIM2010EPA-00606 and Consolider-Ingenio CSD2009-00006 from Ministerio de Ciencia e Innovacion (Spain) and strategic grant funding from the University of Glasgow to J.R.P.; by a project grant (BB/I013873/1) and institute strategic grant funding from the Biotechnology and Biological Sciences Research Council (UK) to J.R.F., in addition to a doctoral training grant from the Medical Research Council (UK) to J.R.F.; and by grants AGL2011-30170-CO2-02 (Ministerio de Ciencia e Innovacion, Spain) and GV2013-077 (Conselleria d'Educacio, Cultura i Esport, Generalitat Valenciana) to D.V.	Tormo-Mas MA, 2013, MOL CELL, V49, P947, DOI 10.1016/j.molcel.2012.12.013; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bertsche U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067398; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Etienne L, 2013, CELL HOST MICROBE, V14, P85, DOI 10.1016/j.chom.2013.06.002; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Iqbal Z, 2013, BIOINFORMATICS, V29, P275, DOI 10.1093/bioinformatics/bts673; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Marano N, 2007, EMERG INFECT DIS, V13, P1807, DOI 10.3201/eid1312.071276; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Ubeda C, 2003, MOL MICROBIOL, V49, P193, DOI 10.1046/j.1365-2958.2003.03577.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vancraeynest D, 2006, J VET MED B, V53, P418, DOI 10.1111/j.1439-0450.2006.00977.x; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	42	76	77	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					361	U195		10.1038/ng.3219	http://dx.doi.org/10.1038/ng.3219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25685890	Green Accepted, Green Submitted			2022-12-17	WOS:000351922900011
J	Fakiola, M; Strange, A; Cordell, HJ; Miller, EN; Pirinen, M; Su, Z; Mishra, A; Mehrotra, S; Monteiro, GR; Band, G; Bellenguez, C; Dronov, S; Edkins, S; Freeman, C; Giannoulatou, E; Gray, E; Hunt, SE; Lacerda, HG; Langford, C; Pearson, R; Pontes, NN; Rai, M; Singh, SP; Smith, L; Sousa, O; Vukcevic, D; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Jankowski, J; Markus, HS; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, NW; Wilson, ME; Deloukas, P; Peltonen, L; Christiansen, F; Witt, C; Jeronimo, SMB; Sundar, S; Spencer, CCA; Blackwell, JM; Donnelly, P				Fakiola, Michaela; Strange, Amy; Cordell, Heather J.; Miller, E. Nancy; Pirinen, Matti; Su, Zhan; Mishra, Anshuman; Mehrotra, Sanjana; Monteiro, Gloria R.; Band, Gavin; Bellenguez, Celine; Dronov, Serge; Edkins, Sarah; Freeman, Colin; Giannoulatou, Eleni; Gray, Emma; Hunt, Sarah E.; Lacerda, Henio G.; Langford, Cordelia; Pearson, Richard; Pontes, Nubia N.; Rai, Madhukar; Singh, Shri P.; Smith, Linda; Sousa, Olivia; Vukcevic, Damjan; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Markus, Hugh S.; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas W.; Wilson, Mary E.; Deloukas, Panos; Peltonen, Leena; Christiansen, Frank; Witt, Campbell; Jeronimo, Selma M. B.; Sundar, Shyam; Spencer, Chris C. A.; Blackwell, Jenefer M.; Donnelly, Peter		LeishGEN Consortium; Wellcome Trust Case Control	Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFECTION; POLYMORPHISM; CHAGASI; GENES; MODEL	To identify susceptibility loci for visceral leishmaniasis, we undertook genome-wide association studies in two populations: 989 cases and 1,089 controls from India and 357 cases in 308 Brazilian families (1,970 individuals). The HLA-DRB1-HLA-DQA1 locus was the only region to show strong evidence of association in both populations. Replication at this region was undertaken in a second Indian population comprising 941 cases and 990 controls, and combined analysis across the three cohorts for rs9271858 at this locus showed P-combined = 2.76 x 10(-17) and odds ratio (OR) = 1.41, 95% confidence interval (Cl) = 1.30-1.52. A conditional analysis provided evidence for multiple associations within the HLA-DRB1-HLA-DQA1 region, and a model in which risk differed between three groups of haplotypes better explained the signal and was significant in the Indian discovery and replication cohorts. In conclusion, the HLA-DRB1-HLA-DQA1 HLA class II region contributes to visceral leishmaniasis susceptibility in India and Brazil, suggesting shared genetic risk factors for visceral leishmaniasis that cross the epidemiological divides of geography and parasite species.	[Fakiola, Michaela; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Sch Clin Med, Cambridge CB2 2QQ, England; [Pirinen, Matti; Su, Zhan; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Giannoulatou, Eleni; Pearson, Richard; Vukcevic, Damjan; Rautanen, Anna; Spencer, Chris C. A.; Donnelly, Peter; LeishGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Cordell, Heather J.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mishra, Anshuman; Mehrotra, Sanjana; Rai, Madhukar; Singh, Shri P.; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Monteiro, Gloria R.; Pontes, Nubia N.; Sousa, Olivia; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Ctr Biosci, BR-59072970 Natal, RN, Brazil; [Dronov, Serge; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil; [Smith, Linda; Christiansen, Frank; Witt, Campbell] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia; [Bramon, Elvira] S London & Maudsley Natl Hlth Serv NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr Mental Hlt, London, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Univ Oxford, Dept Oncol, Oxford, England; [Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Grp, London, England; [Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London WC2R 2LS, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Trembath, Richard C.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary E.] Vet Affairs VA Med Ctr, Iowa City, IA USA; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; Banaras Hindu University (BHU); Universidade Federal do Rio Grande do Norte; Wellcome Trust Sanger Institute; Universidade Federal do Rio Grande do Norte; Royal Perth Hospital; University of Western Australia; South London & Maudsley NHS Trust; University of London; King's College London; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; University of Oxford; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Telethon Kids Institute; University of Western Australia; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	jblackwell@ichr.uwa.edu.au; donnelly@well.ox.ac.uk	Mathew, Christopher G/G-3434-2015; Blackwell, Jenefer M/H-3015-2015; Belllenguez, Céline/Y-3183-2018; Jeronimo, Selma M.B./M-8672-2014; Bramon, Elvira/HHC-3809-2022; Bellenguez, Céline/X-4004-2019; Jeronimo, Selma/AAY-4033-2020; Bramon, Elvira/A-9463-2011; Jankowski, Janusz/H-2706-2012; Brown, Matthew A/E-5749-2010; Deloukas, Panos/B-2922-2013; Palmer, Colin NA/C-7053-2008; Wood, Nicholas W/C-2505-2009	Mathew, Christopher G/0000-0003-4178-1838; Belllenguez, Céline/0000-0002-1240-7874; Jeronimo, Selma M.B./0000-0002-4784-9904; Bramon, Elvira/0000-0003-1369-5983; Bellenguez, Céline/0000-0002-1240-7874; Jeronimo, Selma/0000-0002-4784-9904; Jankowski, Janusz/0000-0003-2130-9181; Brown, Matthew A/0000-0003-0538-8211; Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin NA/0000-0002-6415-6560; Wood, Nicholas W/0000-0002-9500-3348; Walters, James/0000-0002-6980-4053; Hunt, Sarah/0000-0002-8350-1235; Pirinen, Matti/0000-0002-1664-1350; Plomin, Robert/0000-0002-0756-3629; Giannoulatou, Eleni/0000-0002-7084-6736; Wilson, Mary/0000-0001-8680-7275; Corvin, Aiden/0000-0001-6717-4089; Mishra, Anshuman/0000-0002-9390-9971; Cordell, Heather/0000-0002-1879-5572; Trembath, Richard/0000-0003-0550-3400; Vukcevic, Damjan/0000-0001-7780-9586; Fakiola, Michaela/0000-0001-9071-4709	Wellcome Trust, WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Wellcome Senior Fellowship in Basic Biomedical Science [087436/Z/10/Z]; Royal Society Wolfson Merit Award; Wellcome Trust Centre for Human Genetics core grants [090532/Z/09/Z, 075491/Z/04/B]; Wellcome Trust [085475/Z/08/Z, 074196/Z/04/Z]; US National Institutes of Health (Tropical Medicine Research Center) in Brazil [P50AI074321, P50 AI-30639, 1201 AI076233, R01 AI048822]; Medical Research Council [G9817803B, MC_G1000735] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321, R01AI076233, P50AI030639, R01AI048822] Funding Source: NIH RePORTER	Wellcome Trust, WTCCC2 project; Wellcome Senior Fellowship in Basic Biomedical Science; Royal Society Wolfson Merit Award(Royal Society of London); Wellcome Trust Centre for Human Genetics core grants; Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health (Tropical Medicine Research Center) in Brazil(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The principal funding for this study was provided by the Wellcome Trust, as part of the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z). We thank S. Bertrand, J. Bryant, S.L. Clark, J.S. Conquer, T. Dibling, J.C. Eldred, S. Gamble, C. Hind, M.L. Perez, C.R. Stribling, S. Taylor and A. Wilk of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We thank D. Davison for making available his Shellfish program for calculating principal components in large genetic data sets. C.C.A.S. is supported by a Wellcome Trust Fellowship (097364/Z/11/Z). H.J.C. is supported by a Wellcome Senior Fellowship in Basic Biomedical Science (087436/Z/10/Z). P. Donnelly is supported in part by a Royal Society Wolfson Merit Award, and work was supported in part by Wellcome Trust Centre for Human Genetics core grants 090532/Z/09/Z and 075491/Z/04/B. Collection of samples and epidemiological data, sample preparation and sequence-based HLA typing were supported by grants from the Wellcome Trust (074196/Z/04/Z and 085475/Z/08/Z to J.M.B., S.S., S.M.B.J. and M.E.W.) and the US National Institutes of Health (Tropical Medicine Research Center award P50AI074321 to S.S. in India; Tropical Medicine Research Center award P50 AI-30639 to E.M. Carvalho and S.M.B.J. in Brazil; and 1201 AI076233 to M.E.W. and J.M.B.; R01 AI048822 to MEW, S.M.B.J. and J.M.B.). We give special thanks to all subjects who contributed samples and to clinicians and field staff in India and Brazil who helped with the recruitment of study subjects.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x; Fakiola M, 2011, J INFECT DIS, V204, P467, DOI 10.1093/infdis/jir284; HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357; Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3; Mehrotra S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-162; Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089; Olivo-Diaz A, 2004, HUM IMMUNOL, V65, P255, DOI 10.1016/j.humimm.2003.12.008; Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8; PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q; SACKS DL, 1987, J IMMUNOL, V138, P908; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	36	76	77	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					208	213		10.1038/ng.2518	http://dx.doi.org/10.1038/ng.2518			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23291585	Green Submitted, Green Accepted			2022-12-17	WOS:000314333000018
J	Orr, N; Lemnrau, A; Cooke, R; Fletcher, O; Tomczyk, K; Jones, M; Johnson, N; Lord, CJ; Mitsopoulos, C; Zvelebil, M; McDade, SS; Buck, G; Blancher, C; Trainer, AH; James, PA; Bojesen, SE; Bokmand, S; Nevanlinna, H; Mattson, J; Friedman, E; Laitman, Y; Palli, D; Masala, G; Zanna, I; Ottini, L; Giannini, G; Hollestelle, A; van den Ouweland, AMW; Novakovic, S; Krajc, M; Gago-Dominguez, M; Castelao, JE; Olsson, H; Hedenfalk, I; Easton, DF; Pharoah, PDP; Dunning, AM; Bishop, DT; Neuhausen, SL; Steele, L; Houlston, RS; Garcia-Closas, M; Ashworth, A; Swerdlow, AJ				Orr, Nick; Lemnrau, Alina; Cooke, Rosie; Fletcher, Olivia; Tomczyk, Katarzyna; Jones, Michael; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; McDade, Simon S.; Buck, Gemma; Blancher, Christine; Trainer, Alison H.; James, Paul A.; Bojesen, Stig E.; Bokmand, Susanne; Nevanlinna, Heli; Mattson, Johanna; Friedman, Eitan; Laitman, Yael; Palli, Domenico; Masala, Giovanna; Zanna, Ines; Ottini, Laura; Giannini, Giuseppe; Hollestelle, Antoinette; van den Ouweland, Ans M. W.; Novakovic, Srdjan; Krajc, Mateja; Gago-Dominguez, Manuela; Castelao, Jose Esteban; Olsson, Hakan; Hedenfalk, Ingrid; Easton, Douglas F.; Pharoah, Paul D. P.; Dunning, Alison M.; Bishop, D. Timothy; Neuhausen, Susan L.; Steele, Linda; Houlston, Richard S.; Garcia-Closas, Montserrat; Ashworth, Alan; Swerdlow, Anthony J.		KConFab Consortium	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; CONFER SUSCEPTIBILITY; LOCUS; BRCA1	We conducted a genome-wide association study of male breast cancer comprising 823 cases and 2,795 controls of European ancestry, with validation in independent sample sets totaling 438 cases and 474 controls. A SNP in RAD51B at 14q24.1 was significantly associated with male breast cancer risk (P = 3.02 x 10(-13); odds ratio (OR) = 1.57). We also refine association at 16q12.1 to a SNP within TOX3 (P = 3.87 x 10(-15); OR = 1.50).	[Orr, Nick; Lemnrau, Alina; Fletcher, Olivia; Tomczyk, Katarzyna; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; Garcia-Closas, Montserrat; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Orr, Nick; Lemnrau, Alina; Cooke, Rosie; Fletcher, Olivia; Tomczyk, Katarzyna; Jones, Michael; Johnson, Nichola; Lord, Christopher J.; Mitsopoulos, Costas; Zvelebil, Marketa; Garcia-Closas, Montserrat; Ashworth, Alan; Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, Sutton, Surrey, England; [Cooke, Rosie; Jones, Michael; Houlston, Richard S.; Garcia-Closas, Montserrat; Swerdlow, Anthony J.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [McDade, Simon S.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Buck, Gemma; Blancher, Christine] Wellcome Trust Ctr Human Genet, High Throughput Genom Grp, Oxford, England; [KConFab Consortium] Peter MacCallum Canc Ctr, Res Dept, Kathleen Cuningham Consortium Res Familial Breast, Melbourne, Vic, Australia; [Trainer, Alison H.; James, Paul A.] Peter MacCallum Canc Ctr, Familial Canc Clin, Melbourne, Vic, Australia; [Bojesen, Stig E.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bokmand, Susanne] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Mattson, Johanna] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Friedman, Eitan; Laitman, Yael] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Tel Aviv, Israel; [Friedman, Eitan; Laitman, Yael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Palli, Domenico; Masala, Giovanna; Zanna, Ines] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Ottini, Laura; Giannini, Giuseppe] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Hollestelle, Antoinette] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [van den Ouweland, Ans M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Novakovic, Srdjan] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana, Slovenia; [Krajc, Mateja] Inst Oncol Ljubljana, Canc Genet Clin, Epidemiol & Canc Registry, Ljubljana, Slovenia; [Gago-Dominguez, Manuela] CHUS, Galician Fdn Genom Med, Serv Galego Saude SERGAS, Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Castelao, Jose Esteban] Complexo Hosp Univ Vigo CHUVI, SERGAS, Genet Oncol Unit, Vigo, Spain; [Olsson, Hakan; Hedenfalk, Ingrid] Lund Univ, Dept Oncol, Lund, Sweden; [Easton, Douglas F.; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Easton, Douglas F.; Pharoah, Paul D. P.; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Bishop, D. Timothy] Univ Leeds, Leeds Inst Mol Med, Div Canc Studies & Pathol, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Neuhausen, Susan L.; Steele, Linda] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Queens University Belfast; University of Oxford; Wellcome Centre for Human Genetics; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Sapienza University Rome; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Institute of Oncology - Slovenia; Institute of Oncology - Slovenia; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; Lund University; University of Cambridge; University of Cambridge; University of Leeds; City of Hope; Beckman Research Institute of City of Hope	Orr, N (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	nicholas.orr@icr.ac.uk	James, Paul/G-2943-2014; Pharoah, Paul/V-6658-2019; Giannini, Giuseppe/B-5672-2013; Zanna, Ines/AAC-5596-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; McDade, Simon S/E-5730-2017; Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012; Garcia-Closas, Montserrat/F-3871-2015; McDade, Simon/AAE-5031-2020; Gago-Dominguez, Manuela/AAP-6611-2021; Masala, Giovanna/AAC-5474-2022	Pharoah, Paul/0000-0001-8494-732X; Giannini, Giuseppe/0000-0003-0299-4056; Zanna, Ines/0000-0002-5710-6506; Garcia-Closas, Montserrat/0000-0003-1033-2650; McDade, Simon S/0000-0002-3024-4773; Lord, Christopher J/0000-0002-3226-0515; Garcia-Closas, Montserrat/0000-0003-1033-2650; McDade, Simon/0000-0002-3024-4773; Masala, Giovanna/0000-0002-5758-9069; Nevanlinna, Heli/0000-0002-0916-2976; Hollestelle, Antoinette/0000-0003-1166-1966; Fletcher, Olivia/0000-0001-9387-7116; tumino, rosario/0000-0003-2666-414X; OTTINI, LAURA/0000-0001-8030-0449; Buck, Gemma/0000-0001-5289-1050; Houlston, Richard/0000-0002-5268-0242; Hedenfalk, Ingrid/0000-0002-6840-3397; PALLI, Domenico/0000-0002-5558-2437; Olsson, Hakan/0000-0002-8794-9635; Castelao, Jose E/0000-0001-7110-1376; Thorne, Heather/0000-0003-3610-2511; James, Paul/0000-0002-4361-4657; Mitsopoulos, Costas/0000-0002-9116-5921; Dunning, Alison Margaret/0000-0001-6651-7166; Novakovic, Srdjan/0000-0002-8888-4810; Jones, Michael/0000-0001-7479-3451; Zvelebil, Marketa/0000-0001-8018-5591; Swerdlow, Anthony/0000-0001-5550-4159; Bojesen, Stig/0000-0002-4061-4133; Bishop, Tim/0000-0002-8752-8785; Gago, Manuela/0000-0001-6713-4351	Australian National Health & Medical Research Council (NHMRC); National Breast Cancer Foundation; Cancer Australia [628333]; Breakthrough Breast Cancer, Movember; Institute of Cancer Research; Wellcome Trust [090532/Z/09/Z, 068545/Z/02]; UK Medical Research Council (MRC) [G0900747 91070]; UK MRC [G0000934]; Finnish Breast Cancer Group; Finnish Oncology Association; Salonoja Foundation; Italian Association for Cancer Research (AIRC) [IG 8713]; Istituto Toscano Tumori, Florence, Italy; Cancer Research UK [C490/A10124, CA8197/A10865, C588/A10589]; University of Cambridge NIHR Biomedical Research Centre; Joseph Mitchell Fund; Department of Pathology of the CHUS Santiago Hospital; Galician Foundation of Genomic Medicine; Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III; Swedish Cancer Society; Swedish Medical Research Council; US ARMY [DAMD-17-96-I-6266]; US National Institutes of Health (NIH) [R01CA74415]; City of Hope; MRC [G0000934] Funding Source: UKRI; Cancer Research UK [10118, 10589, 11022] Funding Source: researchfish; Medical Research Council [G0000934] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA074415] Funding Source: NIH RePORTER	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Cancer Australia; Breakthrough Breast Cancer, Movember; Institute of Cancer Research; Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Finnish Breast Cancer Group; Finnish Oncology Association; Salonoja Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori, Florence, Italy; Cancer Research UK(Cancer Research UK); University of Cambridge NIHR Biomedical Research Centre; Joseph Mitchell Fund; Department of Pathology of the CHUS Santiago Hospital; Galician Foundation of Genomic Medicine; Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); US ARMY(United States Department of DefenseUnited States Army); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the men who participated in the study. For ICR sample collection, we are grateful to B. Smith, D. Hogben, R. McCann, J. Melia, S. Squires, M. Snigorska, J. Micic and K. Sibley for administrative help and advice; to the research nurses A. Butlin, M. Pelerin, J. Wood and T. Gardener for collection of blood samples and questionnaire data from participants; to D. Thomas and her team front the Breakthrough Generations Study for coordinating collection of controls; and to the cancer registries of England and Wales for providing information on eligible participants. The Study of Epidemiology and Risk Factors in Cancer Heredity (SEARCH) thanks the SEARCH team. We wish to thank H. Thorne, E. Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics and the Clinical Follow Up Study (funded from 2001-2009 by the Australian National Health & Medical Research Council (NHMRC) and currently by the National Breast Cancer Foundation and Cancer Australia; 628333) for their contributions to this resource and the many families who contribute to kConFab. We thank G. Wilhoite for preparing the US samples for this study. We thank A. Jukkola-Vuorinen, V. Kataja and P. Auvinen, as well as S. Hallamies and S. Rants, for their contributions to the Finnish Male Breast Cancer Study. We thank J. Forteza, M. Fraga, C. Celeiro and the staff of the Department of Pathology of CHUS Santiago and A. Carracedo and C.M. Redondo for their contributions to the Spanish study. Finally, we thank the consultants who cared for the study participants for their advice and help. The Breakthrough Male Breast Cancer Study was approved by the South Eastern Research Ethics Committee. Participants gave informed consent for all aspects of the study.; This work was supported by Breakthrough Breast Cancer, Movember and the Institute of Cancer Research who acknowledge National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics is funded by Wellcome Trust grant 090532/Z/09/Z and UK Medical Research Council (MRC) Hub grant G0900747 91070. This work made use of data and samples generated by the 1958 British Birth Cohort under grant G0000934 from the UK MRC and grant 068545/Z/02 from the Wellcome Trust. The Finnish Male Breast Cancer Study acknowledges funding from the Finnish Breast Cancer Group, the Finnish Oncology Association and the Salonoja Foundation. L.O. acknowledges funding from the Italian Association for Cancer Research (AIRC, IG 8713). D.P. acknowledges funding from the Istituto Toscano Tumori, Florence, Italy. SEARCH is funded by a grant from Cancer Research UK (C490/A10124) and is supported by the University of Cambridge NIHR Biomedical Research Centre. A.M.D. has been funded by Cancer Research UK grant CA8197/A10865 and by the Joseph Mitchell Fund. D.T.B. acknowledges funding by Cancer Research UK (Programme Award C588/A10589). M.G.-D. and J.E.C. acknowledge the support of the Department of Pathology of the CHUS Santiago Hospital, the Galician Foundation of Genomic Medicine and the Program Grupos Emergentes, Cancer Genetics Unit of CHUVI, Instituto de Salud Carlos III. H.O. and I.H. acknowledge funding from the Swedish Cancer Society and The Swedish Medical Research Council. The collection of samples and epidemiological data for the US cases was supported by US ARMY Grant DAMD-17-96-I-6266 and US National Institutes of Health (NIH) grant R01CA74415. S.L.N. was partially supported by the Morris and Horowitz Families Endowed Professorship at the City of Hope.	Basham VM, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr419; Bevier M, 2012, BREAST CANCER RES TR, V132, P723, DOI 10.1007/s10549-011-1915-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Orr N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002290; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037	15	76	77	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1182	1184		10.1038/ng.2417	http://dx.doi.org/10.1038/ng.2417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23001122	Green Submitted, Green Accepted			2022-12-17	WOS:000310495800006
J	Saison, C; Helias, V; Ballif, BA; Peyrard, T; Puy, H; Miyazaki, T; Perrot, S; Vayssier-Taussat, M; Waldner, M; Le Pennec, PY; Cartron, JP; Arnaud, L				Saison, Carole; Helias, Virginie; Ballif, Bryan A.; Peyrard, Thierry; Puy, Herve; Miyazaki, Toru; Perrot, Sebastien; Vayssier-Taussat, Muriel; Waldner, Mauro; Le Pennec, Pierre-Yves; Cartron, Jean-Pierre; Arnaud, Lionel			Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior	NATURE GENETICS			English	Article							FUNCTIONAL ASSESSMENT; MULTIDRUG-RESISTANCE; HEMOLYTIC-DISEASE; TRANSPORTER ABCG2; HUMAN PLACENTA; POLYMORPHISMS; EXPRESSION; GENE; IDENTIFICATION; POPULATION	The breast cancer resistance protein, also known as ABCG2, is one of the most highly studied ATP-binding cassette (ABC) transporters because of its ability to confer multidrug resistance(1,2). The lack of information on the physiological role of ABCG2 in humans severely limits cancer chemotherapeutic approaches targeting this transporter. We report here that ABCG2 comprises the molecular basis of a new blood group system (Junior, Jr) and that individuals of the Jr(a) blood type have inherited two null alleles of ABCG2. We identified five frameshift and three nonsense mutations in ABCG2. We also show that the prevalence of the Jr(a) blood type in the Japanese and European Gypsy populations is related to the p.Gln126* and p.Arg236* protein alterations, respectively. The identification of ABCG2(-/-) (Jr(a-)) individuals who appear phenotypically normal is an essential step toward targeting ABCG2 in cancer and also in understanding the physiological and pharmacological roles of this promiscuous transporter in humans.	[Saison, Carole; Helias, Virginie; Peyrard, Thierry; Le Pennec, Pierre-Yves; Cartron, Jean-Pierre; Arnaud, Lionel] Natl Inst Blood Transfus INTS, Paris, France; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT USA; [Peyrard, Thierry; Le Pennec, Pierre-Yves] Natl Reference Ctr Blood Grp CNRGS, Paris, France; [Puy, Herve] Univ Paris 07, Assistance Publ Hop Paris, Ctr Francais Porphyries, INSERM,Ctr Rech Biomed Bichat Beaujon,U 773, Paris, France; [Miyazaki, Toru] Japanese Red Cross Hokkaido Blood Ctr, Sapporo, Hokkaido, Japan; [Perrot, Sebastien] Univ Paris Est, Enva, Maisons Alfort, France; [Vayssier-Taussat, Muriel] Inst Sci Rech Agron Inra, Unite Contrat Bartonella, Maisons Alfort, France; [Waldner, Mauro] SIT Osped Santa Chiara, Lab Immunoematologia, Trento, Italy	University of Vermont; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Santa Chiara Hospital	Arnaud, L (corresponding author), Natl Inst Blood Transfus INTS, Paris, France.	larnaud@ints.fr	PUY, HERVE/O-1785-2017; Perrot, Sébastien/HDO-4475-2022	PUY, HERVE/0000-0003-3362-2634; Perrot, Sébastien/0000-0003-3217-8375; PEYRARD, THIERRY/0000-0002-7715-568X; Saison, Carole/0000-0001-5898-7176	INTS; Inserm; Paris Diderot University (Paris 7); Vermont Genetics Network through the US National Institutes of Health/National Center for Research Resources [P20 RR16462]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	INTS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Diderot University (Paris 7); Vermont Genetics Network through the US National Institutes of Health/National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to all present and past members of the CNRGS for identifying and conserving Jr(a-) blood samples and extracting genomic DNA. We greatly appreciate M. Le Gall for her thoughtful comments on the manuscript. This study was supported in part by the INTS, Inserm and Paris Diderot University (Paris 7). B.A.B. was funded by the Vermont Genetics Network through a grant from the US National Institutes of Health/National Center for Research Resources (P20 RR16462).	Allikmets R, 1998, CANCER RES, V58, P5337; Cusatis G, 2008, PHARMACOGENOMICS, V9, P1005, DOI 10.2217/14622416.9.8.1005; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Helms V., 2012, NAT GENET, DOI [10.1038/mg.1069, DOI 10.1038/MG.1069]; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Imai Y, 2002, MOL CANCER THER, V1, P611; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kwon MY, 2004, TRANSFUSION, V44, P197, DOI 10.1111/j.1537-2995.2004.00643.x; Lee SS, 2007, DRUG METAB DISPOS, V35, P623, DOI 10.1124/dmd.106.012302; Maliepaard M, 2001, CANCER RES, V61, P3458; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Miyake K, 1999, CANCER RES, V59, P8; MIYAZAKI T, 1994, VOX SANG, V66, P51, DOI 10.1111/j.1423-0410.1994.tb00277.x; NAKAJIMA H, 1978, VOX SANG, V35, P265, DOI 10.1111/j.1423-0410.1978.tb02932.x; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Peyrard T, 2008, TRANSFUSION, V48, P1906, DOI 10.1111/j.1537-2995.2008.01787.x; Pisacka M, 2000, P 26 C INT SOC BLOOD, V78, P146; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	27	76	80	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					174	177		10.1038/ng.1070	http://dx.doi.org/10.1038/ng.1070			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246505	Green Accepted			2022-12-17	WOS:000299664400015
J	Germino, GG				Germino, GG			Linking cilia to Wnts	NATURE GENETICS			English	Editorial Material							RIGHT DETERMINANT INVERSIN; ANKYRIN REPEAT; PATHWAY; DISEASE; COMPLEX; MOUSE; GENE; INV	Inversin is a component of a poorly understood cilia-based mechanism responsible for specifying the left-right axis during development and for maintaining normal kidney architecture throughout life. A new study now suggests that inversin might act as a flow-regulated molecular switch between canonical and noncanonical Wnt pathways, providing insights into the mechanisms underlying cilia-based signaling processes.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	ggermino@jhmi.edu		Germino, Gregory/0000-0002-3609-5588				Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Perantoni AO, 2003, SEMIN CELL DEV BIOL, V14, P201, DOI 10.1016/S1084-9521(03)00022-3; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	13	76	78	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					455	457		10.1038/ng0505-455	http://dx.doi.org/10.1038/ng0505-455			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15858588				2022-12-17	WOS:000228862300004
J	Van Driessche, N; Demsar, J; Booth, EO; Hill, P; Juvan, P; Zupan, B; Kuspa, A; Shaulsky, G				Van Driessche, N; Demsar, J; Booth, EO; Hill, P; Juvan, P; Zupan, B; Kuspa, A; Shaulsky, G			Epistasis analysis with global transcriptional phenotypes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; GENE-EXPRESSION PATTERNS; DEPENDENT PROTEIN-KINASE; HUNCHBACK MESSENGER-RNA; DICTYOSTELIUM DEVELOPMENT; CELL-DIFFERENTIATION; DROSOPHILA EMBRYOS; DISCOIDEUM; CAMP; PUMILIO	Classical epistasis analysis can determine the order of function of genes in pathways using morphological, biochemical and other phenotypes. It requires knowledge of the pathway's phenotypic output and a variety of experimental expertise and so is unsuitable for genome-scale analysis. Here we used microarray profiles of mutants as phenotypes for epistasis analysis. Considering genes that regulate activity of protein kinase A in Dictyostelium, we identified known and unknown epistatic relationships and reconstructed a genetic network with microarray phenotypes alone. This work shows that microarray data can provide a uniform, quantitative tool for large-scale genetic network analysis.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Ljubljana; Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gadi@bcm.tmc.edu	Zupan, Blaz/L-1595-2019	Shaulsky, Gad/0000-0002-0532-0551; Juvan, Peter/0000-0003-2873-5247; Kuspa, Adam/0000-0002-9156-149X; Zupan, Blaz/0000-0002-5864-7056	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD039691] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABE K, 1983, DEV BIOL, V95, P200, DOI 10.1016/0012-1606(83)90018-0; Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; ANJARD C, 1992, DEVELOPMENT, V115, P785; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; DEGUNZBURG J, 1986, EMBO J, V5, P363, DOI 10.1002/j.1460-2075.1986.tb04220.x; DEMSAR J, 2001, MEDINFO, V10, P956; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Katoh M, 2004, P NATL ACAD SCI USA, V101, P7005, DOI 10.1073/pnas.0306983101; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Kniesmeijer Joke, 1987, PAROOL 1109; Loomis WF, 1998, MICROBIOL MOL BIOL R, V62, P684, DOI 10.1128/MMBR.62.3.684-694.1998; Loomis WF., 1975, DICTYOSTELIUM DISCOI; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shaulsky G, 2002, PROTIST, V153, P93, DOI 10.1078/1434-4610-00087; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Souza GM, 1998, DEVELOPMENT, V125, P2291; Souza GM, 1999, DEVELOPMENT, V126, P3263; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wang B, 2002, EUKARYOT CELL, V1, P126, DOI 10.1128/EC.1.1.126-136.2002; Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251; WETTERAUER BW, 1995, BBA-MOL CELL RES, V1265, P97, DOI 10.1016/0167-4889(94)00241-6; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zupan B, 2003, BIOINFORMATICS, V19, P383, DOI 10.1093/bioinformatics/btf871	47	76	80	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					471	477		10.1038/ng1545	http://dx.doi.org/10.1038/ng1545			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821735				2022-12-17	WOS:000228862300015
J	Bennett, D; Alphey, L				Bennett, D; Alphey, L			PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster	NATURE GENETICS			English	Article							TGF-BETA RECEPTOR; PROTEIN PHOSPHATASE-1; STRUCTURAL BASIS; KINASE; RECOGNITION; EXPRESSION; ACTIVATION; POSITION; GRADIENT; MITOSIS	In signaling involving the transforming growth factor-beta (TGF-beta) superfamily of proteins, ligand binding brings the constitutively active type II receptor kinase into close proximity to its substrate, the type I receptor kinase, which it then activates by phosphorylation(1). The type I receptor kinase in turn phosphorylates one of the Smad family of transcription factors, which translocates to the nucleus and regulates gene expression(2-5). Smads are recruited to the receptor complex by an anchor protein, SARA (Smad anchor for receptor activation)(6). Although several protein kinases in this pathway were known, including the receptors themselves, the relevant phosphatases had not previously been identified. Here we report the isolation of a Drosophila melanogaster homolog of SARA (Sara) in a screen for proteins that bind the catalytic subunit of type I serine/threonine protein phosphatase (PP1c). We identified a PP1c-binding motif in Sara, disruption of which reduced the ability of Sara to bind PP1c. Expression of this non-PP1c- binding mutant resulted in hyperphosphorylation of the type I receptor and stimulated expression of a target of TGF-beta signaling. Reducing PP1c activity enhanced the increase in the basal level of expression of genes responsive to Dpp (Decapentaplegic) caused by ectopic expression of the type II receptor Punt. Together these data suggest that PP1c is targeted to Dpp receptor complexes by Sara, where it acts as a negative regulator of Dpp signaling by affecting the phosphorylation state of the type I receptor.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Alphey, L (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Bennett, Daimark/E-2701-2014	Bennett, Daimark/0000-0002-0014-2290; Alphey, Luke/0000-0002-2916-3802				Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Alphey L, 1997, J CELL BIOL, V138, P395, DOI 10.1083/jcb.138.2.395; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; BAKSA K, 1993, GENETICS, V135, P117; Bennett D, 1999, BIOCHEMISTRY-US, V38, P16276, DOI 10.1021/bi9917028; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Cohen PTW, 2002, J CELL SCI, V115, P241; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Haerry TE, 1998, DEVELOPMENT, V125, P3977; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Moustakas A, 2001, J CELL SCI, V114, P4359; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Parker L, 2001, BIOTECHNIQUES, V31, P1280, DOI 10.2144/01316st01; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92	29	76	87	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					419	423		10.1038/ng938	http://dx.doi.org/10.1038/ng938			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134149				2022-12-17	WOS:000177147100020
J	Biesecker, LG				Biesecker, LG			Strike three for GLI3	NATURE GENETICS			English	Editorial Material							MULTIPLE				Biesecker, LG (corresponding author), NATL HUMAN GENOME RES INST,LAB GENET DIS RES,NIH,BETHESDA,MD, USA.		Biesecker, Leslie/AAG-2526-2021					Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Mo R, 1997, DEVELOPMENT, V124, P113; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979	11	76	76	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					259	260		10.1038/ng1197-259	http://dx.doi.org/10.1038/ng1197-259			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354780				2022-12-17	WOS:A1997YD66700007
J	Tuteja, N; Tuteja, R				Tuteja, N; Tuteja, R			DNA helicases: The long unwinding road	NATURE GENETICS			English	Editorial Material							HELA-CELLS; XERODERMA-PIGMENTOSUM; BINDING; REPAIR; PROTEINS; ENZYME				Tuteja, N (corresponding author), INT CTR GENET ENGN & BIOTECHNOL,ARUNA ASAF ALI MARG,NEW DELHI 110067,INDIA.							ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P441, DOI 10.1111/j.1432-1033.1976.tb10359.x; DAILEY L, 1990, MOL CELL BIOL, V10, P6225, DOI 10.1128/MCB.10.12.6225; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GOTTLIEB TM, 1994, TRENDS BIOCHEM SCI, V19, P500, DOI 10.1016/0968-0004(94)90138-4; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SEKI M, 1994, J BIOCHEM-TOKYO, V115, P523, DOI 10.1093/oxfordjournals.jbchem.a124369; SEO YS, 1991, J BIOL CHEM, V266, P13161; SEO YS, 1993, J BIOL CHEM, V268, P10282; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; THOMMES P, 1992, CHROMOSOMA, V101, P467, DOI 10.1007/BF00352468; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TUTEJA N, 1990, NUCLEIC ACIDS RES, V18, P6785, DOI 10.1093/nar/18.23.6785; TUTEJA N, 1995, NUCLEIC ACIDS RES, V23, P2457, DOI 10.1093/nar/23.13.2457; TUTEJA N, 1993, NUCLEIC ACIDS RES, V21, P2323, DOI 10.1093/nar/21.10.2323; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	22	76	77	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					11	12		10.1038/ng0596-11	http://dx.doi.org/10.1038/ng0596-11			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673087				2022-12-17	WOS:A1996UH43000004
J	Hurst, LD; McVean, G; Moore, T				Hurst, LD; McVean, G; Moore, T			Imprinted genes have few and small introns	NATURE GENETICS			English	Letter							GROWTH FACTOR-II; HUMAN CHORIONIC-GONADOTROPIN; EXPRESSION; IDENTIFICATION; ENDOSPERM; EVOLUTION; PRODUCT		BABRAHAM INST,DEPT DEV & SIGNALLING,CAMBRIDGE CB2 4AT,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Hurst, LD (corresponding author), UNIV CAMBRIDGE,DEPT GENET,DOWNING ST,CAMBRIDGE CB2 3EH,ENGLAND.		Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054				BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; DEGROOT N, 1993, PRENATAL DIAG, V13, P1159, DOI 10.1002/pd.1970131214; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; DURET L, 1995, MOL EVOL, V40, P308; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; ELLSWORTH DL, 1994, MOL BIOL EVOL, V11, P875; GOHSEN R, 1994, AM J OBSTET GYNECOL, V170, P700; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HAIG D, 1991, CELL, V64, P1045; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; HAIG D, 1993, PRENATAL DIAG, V13, P151, DOI 10.1002/pd.1970130214; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; HOLTHUIZEN P, 1990, BIOCHIM BIOPHYS ACTA, V1087, P341, DOI 10.1016/0167-4781(90)90010-Y; HURST L, IN PRESS GENOMIC IMP; HURST LD, 1992, GENETICS, V130, P229; HURST LD, IN PRESS GENETICS; METZGER R, 1995, FEBS LETT, V357, P27, DOI 10.1016/0014-5793(94)01292-9; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PALDI A, 1995, CURR BIOL, V5, P1030, DOI 10.1016/S0960-9822(95)00207-7; POLICASTRO P, 1983, J BIOL CHEM, V258, P1492; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SOLTER D, 1988, ANNU REV GENET, V22, P127; SZEBENYI G, 1994, GENOMICS, V19, P120, DOI 10.1006/geno.1994.1021; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	35	76	80	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					234	237		10.1038/ng0396-234	http://dx.doi.org/10.1038/ng0396-234			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589711				2022-12-17	WOS:A1996TY18300009
J	CHOI, TK; HOLLENBACH, PW; PEARSON, BE; UEDA, RM; WEDDELL, GN; KURAHARA, CG; WOODHOUSE, CS; KAY, RM; LORING, JF				CHOI, TK; HOLLENBACH, PW; PEARSON, BE; UEDA, RM; WEDDELL, GN; KURAHARA, CG; WOODHOUSE, CS; KAY, RM; LORING, JF			TRANSGENIC MICE CONTAINING A HUMAN HEAVY-CHAIN IMMUNOGLOBULIN GENE FRAGMENT CLONED IN A YEAST ARTIFICIAL CHROMOSOME	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; PHYSICAL MAP; MOUSE CELLS; DNA; SEGMENTS; REGION; LOCUS; PROTOONCOGENE; ORGANIZATION; EXPRESSION	We have developed a method for the introduction of yeast artificial chromosomes (YACs) into transgenic mice. An 85 kilobase (kb) fragment of the human heavy chain immunoglobulin gene was cloned as a YAC, and embryonic stem cell lines carrying intact, integrated YACs were derived by co-lipofection of the YAC with an unlinked selectable marker. Chimaeric founder animals were produced by blastocyst injection, and offspring transgenic for the YAC were obtained. Analysis of serum from these offspring for human heavy chain antibody subunits demonstrated expression of the YAC-borne immunoglobulin gene fragment. Co-lipofection may prove to be a highly-successful means of producing transgenic mice containing large gene fragments in YACs.			CHOI, TK (corresponding author), GENPHARM INT, 297 N BERNARDO AVE, Mountain View, CA 94043 USA.		Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI032285, R43AI032285] Funding Source: NIH RePORTER; NIAID NIH HHS [RA43 AI32285-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BERMAN JE, 1991, EUR J IMMUNOL, V21, P1311, DOI 10.1002/eji.1830210532; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BROWN SDM, 1991, BIOESSAYS, V13, P607, DOI 10.1002/bies.950131112; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHEN J, IN PRESS INT IMMUN; DAVIES NP, 1992, NUCLEIC ACIDS RES, V20, P2693, DOI 10.1093/nar/20.11.2693; DELALUNA S, 1988, GENE, V62, P121; ELICEIRI B, 1991, P NATL ACAD SCI USA, V88, P2179, DOI 10.1073/pnas.88.6.2179; FOX T, 1991, GUIDE YEAST GENETICS; GNIRKE A, 1991, EMBO J, V10, P1629, DOI 10.1002/j.1460-2075.1991.tb07685.x; GNIRKE A, 1991, SOMAT CELL MOLEC GEN, V17, P573, DOI 10.1007/BF01233622; Guise J. W., 1989, Immunoglobulin genes., P275; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; HUXLEY C, 1991, GENOMICS, V9, P742, DOI 10.1016/0888-7543(91)90369-P; ICHIHARA Y, 1988, EMBO J, V7, P4141, DOI 10.1002/j.1460-2075.1988.tb03309.x; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LUBIN I, 1991, SCIENCE, V252, P427, DOI 10.1126/science.1826797; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; PACHNIS V, 1990, P NATL ACAD SCI USA, V87, P5109, DOI 10.1073/pnas.87.13.5109; PAVAN WJ, 1990, MOL CELL BIOL, V10, P4163, DOI 10.1128/MCB.10.8.4163; PAVAN WJ, 1991, P NATL ACAD SCI USA, V88, P7788, DOI 10.1073/pnas.88.17.7788; RAMIREZSOILS R, IN PRESS METHODS ENZ; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; RILEY JH, 1992, NUCLEIC ACIDS RES, V20, P2971, DOI 10.1093/nar/20.12.2971; SCHEDL A, 1992, NUCLEIC ACIDS RES, V20, P3073, DOI 10.1093/nar/20.12.3073; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; SMITH DR, 1990, P NATL ACAD SCI USA, V87, P8242, DOI 10.1073/pnas.87.21.8242; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRAUSS WM, 1992, EMBO J, V11, P417, DOI 10.1002/j.1460-2075.1992.tb05070.x; STRAUSS WM, 1992, MAMM GENOME, V2, P150, DOI 10.1007/BF00302873; TRAVER CN, 1989, P NATL ACAD SCI USA, V86, P5898, DOI 10.1073/pnas.86.15.5898; TYBULEWICZ VLJ, 1991, CELL, V40, P271; Word C J, 1989, Int Immunol, V1, P296, DOI 10.1093/intimm/1.3.296	41	76	135	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1993	4	2					117	123		10.1038/ng0693-117	http://dx.doi.org/10.1038/ng0693-117			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348148				2022-12-17	WOS:A1993LF81600008
J	BATES, GP; VALDES, J; HUMMERICH, H; BAXENDALE, S; LEPASLIER, DL; MONACO, AP; TAGLE, D; MACDONALD, ME; ALTHERR, M; ROSS, M; BROWNSTEIN, BH; BENTLEY, D; WASMUTH, JJ; GUSELLA, JF; COHEN, D; COLLINS, F; LEHRACH, H				BATES, GP; VALDES, J; HUMMERICH, H; BAXENDALE, S; LEPASLIER, DL; MONACO, AP; TAGLE, D; MACDONALD, ME; ALTHERR, M; ROSS, M; BROWNSTEIN, BH; BENTLEY, D; WASMUTH, JJ; GUSELLA, JF; COHEN, D; COLLINS, F; LEHRACH, H			CHARACTERIZATION OF A YEAST ARTIFICIAL CHROMOSOME CONTIG SPANNING THE HUNTINGTONS-DISEASE GENE CANDIDATE REGION	NATURE GENETICS			English	Article							DNA MARKERS; LIBRARY; CONSTRUCTION; TELOMERE; CLONES; LOCUS; D4S95; G8	The Huntington's disease (HD) gene has been localized by recombination events to a region covering 2.2 megabases (Mb) DNA within chromosome 4p16.3. We have screened three yeast artificial chromosome (YAC) libraries in order to isolate and characterize 44 YAC clones mapping to this region. Approximately 50% of the YACs were chimaeric. Unstable YACs were identified across the whole region, but were particularly prevalent around the D4S183 and D4S43 loci. The YACs have been assembled into a contig extending from D4S126 to D4S98 covering roughly 2 Mb DNA except for a gap of about 250 kilobases (kb). The establishment of a YAC contig which spans the region most likely to contain the HD mutation is an essential step in the isolation of the HD gene.	CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED & HUMAN GENET,ANN ARBOR,MI 48109; JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND,HUMAN GENET LAB,OXFORD OX3 9DU,ENGLAND; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oxford; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Irvine; Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust	BATES, GP (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Monaco, Anthony P/A-4495-2010; Bates, Gillian P/E-1146-2012	Monaco, Anthony P/0000-0001-7480-3197; Bates, Gillian P/0000-0002-4041-6305; Le Paslier, Denis/0000-0003-4335-9956; Baxendale, Sarah/0000-0002-6760-9457				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BARRON L, 1991, J MED GENET, V28, P520, DOI 10.1136/jmg.28.8.520; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BRONSON SK, 1991, P NATL ACAD SCI USA, V88, P1676, DOI 10.1073/pnas.88.5.1676; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUCAN M, 1990, GENOMICS, V6, P1; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1989, TRENDS GENET, V5, P41, DOI 10.1016/0168-9525(89)90019-X; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1992, GENOMICS, V13, P75, DOI 10.1016/0888-7543(92)90204-6; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MONACO AP, 1991, NUCLEIC ACIDS RES, V19, P3315, DOI 10.1093/nar/19.12.3315; NELSON DL, 1990, GENET ANAL-BIOMOL E, V7, P100, DOI 10.1016/0735-0651(90)90014-7; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; PERLINO E, 1985, NUCLEIC ACIDS RES, V9, P8399; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBBINS C, 1989, AM J HUM GENET, V44, P422; Ross M. T., 1992, Techniques for the analysis of complex genomes., P137; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1992, IN PRESS AM J HUM GE; TAGLE DA, IN PRESS HUM MOL GEN; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207	48	76	80	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					180	187		10.1038/ng0692-180	http://dx.doi.org/10.1038/ng0692-180			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303232				2022-12-17	WOS:A1992JC98200009
J	Klarin, D; Busenkell, E; Judy, R; Lynch, J; Levin, M; Haessler, J; Aragam, K; Chaffin, M; Haas, M; Lindstrom, S; Assimes, TL; Huang, J; Lee, KM; Shao, Q; Huffman, JE; Kabrhel, C; Huang, YF; Sun, YV; Vujkovic, M; Saleheen, D; Miller, DR; Reaven, P; DuVal, S; Boden, WE; Pyarajan, S; Reiner, AP; Tregouet, DA; Henke, P; Kooperberg, C; Gaziano, JM; Concato, J; Rader, DJ; Cho, K; Chang, KM; Wilson, PWF; Smith, NL; O'Donnell, CJ; Tsao, PS; Kathiresan, S; Obi, A; Damrauer, SM; Natarajan, P				Klarin, Derek; Busenkell, Emma; Judy, Renae; Lynch, Julie; Levin, Michael; Haessler, Jeffery; Aragam, Krishna; Chaffin, Mark; Haas, Mary; Lindstrom, Sara; Assimes, Themistocles L.; Huang, Jie; Lee, Kyung Min; Shao, Qing; Huffman, Jennifer E.; Kabrhel, Christopher; Huang, Yunfeng; Sun, Yan, V; Vujkovic, Marijana; Saleheen, Danish; Miller, Donald R.; Reaven, Peter; DuVal, Scott; Boden, William E.; Pyarajan, Saiju; Reiner, Alex P.; Tregouet, David-Alexandre; Henke, Peter; Kooperberg, Charles; Gaziano, J. Michael; Concato, John; Rader, Daniel J.; Cho, Kelly; Chang, Kyong-Mi; Wilson, Peter W. F.; Smith, Nicholas L.; O'Donnell, Christopher J.; Tsao, Philip S.; Kathiresan, Sekar; Obi, Andrea; Damrauer, Scott M.; Natarajan, Pradeep		INVENT Consortium; Vet Affairs Million Vet Program	Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease	NATURE GENETICS			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BIOBANK; METAANALYSIS; THROMBOSIS; FIBROSIS; GWAS; ROSUVASTATIN; EPIDEMIOLOGY; INDIVIDUALS; RESOLUTION	Venous thromboembolism is a significant cause of mortality(1), yet its genetic determinants are incompletely defined. We performed a discovery genome-wide association study in the Million Veteran Program and UK Biobank, with testing of approximately 13 million DNA sequence variants for association with venous thromboembolism (26,066 cases and 624,053 controls) and meta-analyzed both studies, followed by independent replication with up to 17,672 venous thromboembolism cases and 167,295 controls. We identified 22 previously unknown loci, bringing the total number of venous thromboembolism-associated loci to 33, and subsequently fine-mapped these associations. We developed a genome-wide polygenic risk score for venous thromboembolism that identifies 5% of the population at an equivalent incident venous thromboembolism risk to carriers of the established factor V Leiden p.R506Q and prothrombin G20210A mutations. Our data provide mechanistic insights into the genetic epidemiology of venous thromboembolism and suggest a greater overlap among venous and arterial cardiovascular disease than previously thought.	[Klarin, Derek; O'Donnell, Christopher J.; Natarajan, Pradeep] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA; [Klarin, Derek; Aragam, Krishna; Kathiresan, Sekar; Natarajan, Pradeep] Harvard Med Sch, Ctr Genom Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Klarin, Derek; Aragam, Krishna; Chaffin, Mark; Haas, Mary; Kathiresan, Sekar; Natarajan, Pradeep] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Klarin, Derek] Univ Florida, Div Vasc Surg & Endovasc Therapy, Sch Med, Gainesville, FL USA; [Busenkell, Emma; Natarajan, Pradeep] Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Judy, Renae; Levin, Michael; Vujkovic, Marijana; Saleheen, Danish; Chang, Kyong-Mi; Damrauer, Scott M.] Corporal Michael Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Judy, Renae; Levin, Michael; Rader, Daniel J.; Chang, Kyong-Mi] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lynch, Julie; Lee, Kyung Min; DuVal, Scott] Vet Affairs Salt Lake City Hlth Care Syst, Vet Affairs Informat & Comp Infrastruct, Salt Lake City, UT USA; [Lynch, Julie] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Haessler, Jeffery; Lindstrom, Sara; Reiner, Alex P.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Lindstrom, Sara; Smith, Nicholas L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Assimes, Themistocles L.; Tsao, Philip S.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Assimes, Themistocles L.; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Huang, Jie; Huffman, Jennifer E.; Boden, William E.; Pyarajan, Saiju; Gaziano, J. Michael; Cho, Kelly; O'Donnell, Christopher J.] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Lee, Kyung Min; Shao, Qing; Miller, Donald R.] Edith Nourse Rogers Mem Vet Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Lee, Kyung Min; Miller, Donald R.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Kabrhel, Christopher] Massachusetts Gen Hosp, Dept Emergency Med, Ctr Vasc Emergencies, Boston, MA 02114 USA; [Kabrhel, Christopher] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Huang, Yunfeng; Sun, Yan, V] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Biomed Informat,Dept Epidemiol, Atlanta, GA USA; [Huang, Yunfeng; Sun, Yan, V; Wilson, Peter W. F.] Atlanta Vet Affairs Hlth Care Syst, Decatur, GA USA; [Vujkovic, Marijana; Saleheen, Danish] Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA; [Reaven, Peter] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [DuVal, Scott] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA; [Pyarajan, Saiju; Gaziano, J. Michael; Cho, Kelly] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Tregouet, David-Alexandre] Univ Bordeaux, INSERM UMR S 1219, Bordeaux Populat Hlth Res Ctr, Bordeaux, France; [Henke, Peter; Obi, Andrea] Univ Michigan, Dept Surg, Sect Vasc Surg, Ann Arbor, MI 48109 USA; [Concato, John] Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [Smith, Nicholas L.] Dept Vet Affairs, Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [O'Donnell, Christopher J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Med Div, Boston, MA 02115 USA; [Kathiresan, Sekar] Verve Therapeut, Cambridge, MA USA; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; University of Massachusetts System; University of Massachusetts Boston; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University; Rollins School Public Health; University of Pennsylvania; Pennsylvania Medicine; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UDICE-French Research Universities; Universite de Bordeaux; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Kaiser Permanente; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Natarajan, P (corresponding author), Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA.; Natarajan, P (corresponding author), Harvard Med Sch, Ctr Genom Med, Massachusetts Gen Hosp, Boston, MA 02115 USA.; Natarajan, P (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Natarajan, P (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02115 USA.	pnatarajan@mgh.harvard.edu	Levin, Michael/AAV-2382-2021; Natarajan, Pradeep/H-9764-2019; Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Assimes, Themistocles Leonard/D-9696-2015; Vujković, Marijana/S-9414-2019; Huang, Yunfeng/AAE-5589-2022	Levin, Michael/0000-0002-9937-9932; Natarajan, Pradeep/0000-0001-8402-7435; Trégouët, David-Alexandre/0000-0001-9084-7800; Assimes, Themistocles Leonard/0000-0003-2349-0009; Vujković, Marijana/0000-0003-4924-5714; Chaffin, Mark/0000-0002-1234-5562; Lee, Kyung Min/0000-0001-8995-0448; Chang, Kyong-Mi/0000-0001-6811-9364; DuVall, Scott/0000-0002-4898-3865; Ballantyne, Christie/0000-0002-6432-1730; Lynch, Julie/0000-0003-0108-2127; Klarin, Derek/0000-0002-4636-5780	Department of Veterans Affairs Office of Research and Development, Million Veteran Program [MVP000]; Department of Veterans Affairs [I01-01BX03340, I01-BX003362, I01-CX001025]; VA Informatics and Computing Infrastructure [VA HSR RES 13-457]; Veterans Administration [IK2-CX001780]; Massachusetts General Hospital; Donovan Family Foundation; National Institutes of Health (NIH) [R01HL127564]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [K08HL140203, R01HL142711]; EPIDEMIOM-VTE Senior Chair from the Initiative of Excellence of the University of Bordeaux; NIH [HL116854]; NHLBI, NIH; US Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127564, R01HL116854, R01HL142711, K08HL140203] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001780, I01BX003362, I01BX003340, I01CX001025] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of Research and Development, Million Veteran Program(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); VA Informatics and Computing Infrastructure; Veterans Administration(US Department of Veterans Affairs); Massachusetts General Hospital(General Electric); Donovan Family Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EPIDEMIOM-VTE Senior Chair from the Initiative of Excellence of the University of Bordeaux; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Funding was received from the Department of Veterans Affairs Office of Research and Development, Million Veteran Program (grant no. MVP000). This publication does not represent the views of the Department of Veterans Affairs or the US Government. This research was also supported by three additional Department of Veterans Affairs awards (no. I01-01BX03340 to K.C. and P.W.; no I01-BX003362 to P.T. and K.M.C.; and no. I01-CX001025 to P.W.) and used the resources and facilities at the VA Informatics and Computing Infrastructure (no. VA HSR RES 13-457). S.M.D. is supported by the Veterans Administration (no. IK2-CX001780). S.K. is supported by a Research Scholar award from the Massachusetts General Hospital, the Donovan Family Foundation and the National Institutes of Health (NIH) (no. R01HL127564). P.N. is supported by the NIH/National Heart, Lung, and Blood Institute (NHLBI) (nos. K08HL140203 and R01HL142711). D.T. was financially supported by the EPIDEMIOM-VTE Senior Chair from the Initiative of Excellence of the University of Bordeaux. C.K. is supported by the NIH (grant no. HL116854). Data on coronary artery disease have been contributed by the CARDIoGRAMplusC4D investigators. Data on large artery stroke have been contributed by the MEGASTROKE investigators. The MEGASTROKE project received funding from sources specified at http://www.megastroke.org/acknowledgements.html. The WHI program is funded by the NHLBI, NIH and the US Department of Health and Human Services (contract nos. HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C and HHSN268201600004C). For a list of all the investigators who have contributed to WHI science, see https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20 Long%20List.pdf. This research has been conducted using the UK Biobank resource, application no. 7089.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bahl V, 2010, ANN SURG, V251, P344, DOI 10.1097/SLA.0b013e3181b7fca6; Baldwin JF, 2012, J VASC SURG, V56, P1089, DOI 10.1016/j.jvs.2012.02.054; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Fogo AB, 2003, J CLIN INVEST, V112, P326, DOI 10.1172/JCI200319375; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Hernandez W, 2016, BLOOD, V127, P1923, DOI 10.1182/blood-2015-09-668525; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Klarin D, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001643; Laser A, 2014, ARTERIOSCL THROM VAS, V34, P377, DOI 10.1161/ATVBAHA.113.302428; Lindstrom S, 2019, BLOOD, V134, P1645, DOI 10.1182/blood.2019000435; Liu BX, 2019, NAT GENET, V51, P768, DOI 10.1038/s41588-019-0404-0; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Obi AT, 2014, J THROMB HAEMOST, V12, P1353, DOI 10.1111/jth.12644; Obi AT, 2017, THROMB HAEMOSTASIS, V117, P339, DOI 10.1160/TH16-03-0218; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wassel CL, 2015, THROMB RES, V136, P966, DOI 10.1016/j.thromres.2015.09.016; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wojcik BM, 2011, ANN VASC SURG, V25, P229, DOI 10.1016/j.avsg.2010.09.003	49	75	76	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2019	51	11					1574	+		10.1038/s41588-019-0519-3	http://dx.doi.org/10.1038/s41588-019-0519-3			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JK2ZE	31676865	Green Accepted, Green Submitted			2022-12-17	WOS:000494714300005
J	Frigola, J; Sabarinathan, R; Mularoni, L; Muinos, F; Gonzalez-Perez, A; Lopez-Bigas, N				Frigola, Joan; Sabarinathan, Radhakrishnan; Mularoni, Loris; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria			Reduced mutation rate in exons due to differential mismatch repair	NATURE GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; HUMAN GENOME; SOMATIC MUTATIONS; HUMAN CANCER; CHROMATIN ORGANIZATION; DNA-REPAIR; TUMOR TYPES; GENES; MECHANISMS; SIGNATURES	While recent studies have identified higher than anticipated heterogeneity of mutation rate across genomic regions, mutations in exons and introns are assumed to be generated at the same rate. Here we find fewer somatic mutations in exons than expected from their sequence content and demonstrate that this is not due to purifying selection. Instead, we show that it is caused by higher mismatch-repair activity in exonic than in intronic regions. Our findings have important implications for understanding of mutational and DNA repair processes and knowledge of the evolution of eukaryotic genes, and they have practical ramifications for the study of evolution of both tumors and species.	[Frigola, Joan; Sabarinathan, Radhakrishnan; Mularoni, Loris; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Frigola, Joan; Sabarinathan, Radhakrishnan; Mularoni, Loris; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Res Program Biomed Informat, Barcelona, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; ICREA	Lopez-Bigas, N (corresponding author), BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Lopez-Bigas, N (corresponding author), Univ Pompeu Fabra, Res Program Biomed Informat, Barcelona, Spain.; Lopez-Bigas, N (corresponding author), ICREA, Barcelona, Spain.	nuria.lopez@irbbarcelona.org	Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988; Gonzalez-Perez, Abel/0000-0002-8582-4660; Muinos, Ferran/0000-0002-4651-4168	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER, UE) [SAF2015-66084-R]; La Fundacio la Marato de TV3; EU H2020 Programme [634143]; European Research Council [682398]; Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain); CERCA (Generalitat de Catalunya); EMBO Long-Term Fellowship [ALTF 568-2014]; European Commission (EMBOCOFUND) [GA-2012-600394]; Marie Curie Actions; Spanish Ministry of Economy and Competitiveness [RYC-2013-14554]	Spanish Ministry of Economy and Competitiveness (MINECO/FEDER, UE)(Spanish Government); La Fundacio la Marato de TV3; EU H2020 Programme; European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain); CERCA (Generalitat de Catalunya); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); European Commission (EMBOCOFUND)(European Commission); Marie Curie Actions(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	We acknowledge funding from the Spanish Ministry of Economy and Competitiveness (SAF2015-66084-R, MINECO/FEDER, UE), La Fundacio la Marato de TV3, EU H2020 Programme 2014-2020 under grant agreements 634143 (MedBioinformatics) and by the European Research Council (Consolidator Grant 682398). IRB Barcelona is the recipient of a Severo Ochoa Centre of Excellence Award from the Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain) and is supported by CERCA (Generalitat de Catalunya). R.S. is supported by an EMBO Long-Term Fellowship (ALTF 568-2014) cofunded by the European Commission (EMBOCOFUND2012, GA-2012-600394) with support from Marie Curie Actions. A. G.-P. is supported by a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (RYC-2013-14554). We acknowledge the contribution of I. Reyes-Salazar to refactoring and cleaning all code produced in the study for publication. We are grateful to B. Campbell and U. Tabori for help in obtaining the mutation calls for bMMRD samples sequenced by the International BMMRD Consortium. The results published here are in part based upon data generated by the TCGA Research Network (http://cancergenome.nih.gov/).	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Kim S, 2011, P NATL ACAD SCI USA, V108, P13564, DOI 10.1073/pnas.1109475108; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lanzos A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41544; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004583; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Martincorena I., 2017, CELL; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012	48	75	76	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1684	+		10.1038/ng.3991	http://dx.doi.org/10.1038/ng.3991			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29106418	Green Accepted			2022-12-17	WOS:000416480600007
J	Chu, AY; Deng, X; Fisher, VA; Drong, A; Zhang, Y; Feitosa, MF; Liu, CT; Weeks, O; Choh, AC; Duan, Q; Dyer, TD; Eicher, JD; Guo, XQ; Heard-Costa, NL; Kacprowski, T; Kent, JW; Lange, LA; Liu, XG; Lohman, K; Lu, LY; Mahajan, A; O'Connell, JR; Parihar, A; Peralta, JM; Smith, AV; Zhang, Y; Homuth, G; Kissebah, AH; Kullberg, J; Laqua, R; Launer, LJ; Nauck, M; Olivier, M; Peyser, PA; Terry, JG; Wojczynski, MK; Yao, J; Bielak, LF; Blangero, J; Borecki, IB; Bowden, DW; Carr, JJ; Czerwinski, SA; Ding, JZ; Friedrich, N; Gudnason, V; Harris, TB; Ingelsson, E; Johnson, AD; Kardia, SLR; Langefeld, CD; Lind, L; Liu, YM; Mitchell, BD; Morris, AP; Mosley, TH; Rotter, JI; Shuldiner, AR; Towne, B; Volzke, H; Wallaschofski, H; Wilson, JG; Allison, M; Lindgren, CM; Goessling, W; Cupples, LA; Steinhauser, ML; Fox, CS				Chu, Audrey Y.; Deng, Xuan; Fisher, Virginia A.; Drong, Alexander; Zhang, Yang; Feitosa, Mary F.; Liu, Ching-Ti; Weeks, Olivia; Choh, Audrey C.; Duan, Qing; Dyer, Thomas D.; Eicher, John D.; Guo, Xiuqing; Heard-Costa, Nancy L.; Kacprowski, Tim; Kent, Jack W., Jr.; Lange, Leslie A.; Liu, Xinggang; Lohman, Kurt; Lu, Lingyi; Mahajan, Anubha; O'Connell, Jeffrey R.; Parihar, Ankita; Peralta, Juan M.; Smith, Albert V.; Zhang, Yi; Homuth, Georg; Kissebah, Ahmed H.; Kullberg, Joel; Laqua, Rene; Launer, Lenore J.; Nauck, Matthias; Olivier, Michael; Peyser, Patricia A.; Terry, James G.; Wojczynski, Mary K.; Yao, Jie; Bielak, Lawrence F.; Blangero, John; Borecki, Ingrid B.; Bowden, Donald W.; Carr, John Jeffrey; Czerwinski, Stefan A.; Ding, Jingzhong; Friedrich, Nele; Gudnason, Vilmunder; Harris, Tamara B.; Ingelsson, Erik; Johnson, Andrew D.; Kardia, Sharon L. R.; Langefeld, Carl D.; Lind, Lars; Liu, Yongmei; Mitchell, Braxton D.; Morris, Andrew P.; Mosley, Thomas H., Jr.; Rotter, Jerome I.; Shuldiner, Alan R.; Towne, Bradford; Voelzke, Henry; Wallaschofski, Henri; Wilson, James G.; Allison, Matthew; Lindgren, Cecilia M.; Goessling, Wolfram; Cupples, L. Adrienne; Steinhauser, Matthew L.; Fox, Caroline S.			Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation	NATURE GENETICS			English	Article							INCIDENT CARDIOVASCULAR-DISEASE; METABOLIC RISK-FACTORS; ALL-CAUSE MORTALITY; CARDIOMETABOLIC RISK; VISCERAL ADIPOSITY; SUBCUTANEOUS FAT; SUSCEPTIBILITY; HYPERTENSION; QUALITY; BIOLOGY	Variation in body fat distribution contributes to the metabolic sequelae of obesity. The genetic determinants of body fat distribution are poorly understood. The goal of this study was to gain new insights into the underlying genetics of body fat distribution by conducting sample-size-weighted fixed-effects genome-wide association meta-analyses in up to 9,594 women and 8,738 men of European, African, Hispanic and Chinese ancestry, with and without sex stratification, for six traits associated with ectopic fat (hereinafter referred to as ectopicfat traits). In total, we identified seven new loci associated with ectopic-fat traits (ATXN1, UBE2E2, EBF1, RREB1, GSDMB, GRAMD3 and ENSA; P < 5 x 10(-8); false discovery rate < 1 %). Functional analysis of these genes showed that loss of function of either Atxn1 or Ube2e2 in primary mouse adipose progenitor cells impaired adipocyte differentiation, suggesting physiological roles for ATXN1 and UBE2E2 in adipogenesis. Future studies are necessary to further explore the mechanisms by which these genes affect adipocyte biology and how their perturbations contribute to systemic metabolic disease.	[Chu, Audrey Y.; Eicher, John D.; Johnson, Andrew D.; Cupples, L. Adrienne; Fox, Caroline S.] NHLBIs Framingham Heart Study, Framingham, MA USA; [Chu, Audrey Y.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chu, Audrey Y.; Zhang, Yang; Weeks, Olivia; Goessling, Wolfram; Steinhauser, Matthew L.; Fox, Caroline S.] Harvard Med Sch, Boston, MA 02115 USA; [Deng, Xuan; Fisher, Virginia A.; Liu, Ching-Ti; Heard-Costa, Nancy L.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Drong, Alexander; Mahajan, Anubha; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Zhang, Yang; Steinhauser, Matthew L.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Zhang, Yang; Weeks, Olivia; Goessling, Wolfram; Steinhauser, Matthew L.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Feitosa, Mary F.; Wojczynski, Mary K.; Borecki, Ingrid B.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Choh, Audrey C.; Towne, Bradford] Wright State Univ, Boonshoft Sch Med, Dept Populat & Publ Hlth Sci, Div Epidemiol & Biostat, Dayton, OH 45435 USA; [Duan, Qing; Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Dyer, Thomas D.; Peralta, Juan M.; Blangero, John] Univ Texas Hlth Sci Ctr San Antonio, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Dyer, Thomas D.; Peralta, Juan M.; Blangero, John] Univ Texas Rio Grande Valley, Brownsville, TX USA; [Guo, Xiuqing; Yao, Jie; Rotter, Jerome I.] UCLA Med Ctr, Dept Pediat, Inst Translat Genom & Populat Sci, LABioMed Harbor, Torrance, CA USA; [Kacprowski, Tim; Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Kacprowski, Tim; Nauck, Matthias; Friedrich, Nele; Voelzke, Henry] German Ctr Cardiovasc Res DZHK, Greifswald, Germany; [Kent, Jack W., Jr.; Olivier, Michael] Texas Biomed Res Inst, Dept Genet, TOPS Nutr & Obes Res Ctr, San Antonio, TX USA; [Liu, Xinggang; O'Connell, Jeffrey R.; Parihar, Ankita; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Lohman, Kurt; Ding, Jingzhong; Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC USA; [Lohman, Kurt; Lu, Lingyi; Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Smith, Albert V.; Gudnason, Vilmunder] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmunder] Univ Iceland, Fac Med, Reykjavik, Iceland; [Zhang, Yi; Kissebah, Ahmed H.; Olivier, Michael] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, TOPS Obes & Metab Res Ctr, Dept Psychol, Milwaukee, WI 53226 USA; [Kullberg, Joel; Lind, Lars] Uppsala Univ, Sect Radiol, Dept Surg Sci, Uppsala, Sweden; [Laqua, Rene] Univ Hosp Berne, Dept Neuroradiol, Bern, Switzerland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Nauck, Matthias; Friedrich, Nele; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Peyser, Patricia A.; Bielak, Lawrence F.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Terry, James G.; Carr, John Jeffrey] Vanderbilt Univ, Med Ctr, Dept Cardiovasc Med, Dept Radiol & Radiol Sci, Nashville, TN USA; [Terry, James G.; Carr, John Jeffrey] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Bowden, Donald W.] Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Bowden, Donald W.] Wake Forest Univ, Sch Med, Ctr Diabet Res, Dept Biochem, Winston Salem, NC 27109 USA; [Bowden, Donald W.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27109 USA; [Czerwinski, Stefan A.] Univ Texas Hlth Sci Ctr UTHealth, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Brownsville Campus, Brownsville, TX USA; [Ding, Jingzhong] Wake Forest Sch Med, Gerontol & Geriatr Med, Winston Salem, NC USA; [Ingelsson, Erik] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Mitchell, Braxton D.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Voelzke, Henry] German Ctr Diabet Res DZD, Greifswald, Germany; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Allison, Matthew] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, Div Prevent Med, San Diego, CA 92103 USA; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA; [Goessling, Wolfram] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA USA; [Goessling, Wolfram] Dana Farber Canc Inst, Boston, MA 02115 USA; [Goessling, Wolfram; Steinhauser, Matthew L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Steinhauser, Matthew L.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA; [Chu, Audrey Y.; Fox, Caroline S.] Merck Res Labs, Boston, MA 02115 USA	Framingham Heart Study; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Washington University (WUSTL); University System of Ohio; Wright State University Dayton; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Rio Grande Valley; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Greifswald Medical School; German Centre for Cardiovascular Research; Texas Biomedical Research Institute; University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University; Icelandic Heart Association; University of Iceland; Medical College of Wisconsin; Uppsala University; University of Bern; University Hospital of Bern; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Rio Grande Valley; Wake Forest University; Uppsala University; Stanford University; Wake Forest University; Geriatric Research Education & Clinical Center; University of Liverpool; University of Mississippi; University of Mississippi Medical Center; Greifswald Medical School; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California San Diego; University of Oxford; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Merck & Company		audrey.chu@nih.gov; msteinhauser@partners.org; foxca@nhlbi.nih.gov	Rotter, Jerome/AAY-6598-2021; Carr, John/AAN-7531-2021; Kacprowski, Tim/N-9692-2019; Johnson, Andrew D/G-6520-2013; Mitchell, Braxton/CAF-0876-2022; Kacprowski, Tim/K-8650-2013; Drong, Alexander/AAG-1115-2020; Steinhauser, Matthew L./GVT-6393-2022; Blangero, John/ABA-7175-2021; Gudnason, Vilmundur/AAE-7126-2019; Carr, John Jeffrey/A-1938-2012; Kullberg, Joel/ABE-3997-2021; Feitosa, Mary F/K-8044-2012; Smith, Albert Vernon/K-5150-2015	Carr, John/0000-0002-4398-8237; Kacprowski, Tim/0000-0002-5393-2413; Johnson, Andrew D/0000-0001-6369-5178; Kacprowski, Tim/0000-0002-5393-2413; Steinhauser, Matthew L./0000-0001-5287-9246; Gudnason, Vilmundur/0000-0001-5696-0084; Carr, John Jeffrey/0000-0002-4398-8237; Feitosa, Mary F/0000-0002-0933-2410; Allison, Matthew/0000-0003-0777-8272; Heard-Costa, Nancy/0000-0001-9730-0306; Mitchell, Braxton/0000-0003-4920-4744; Liu, Ching-Ti/0000-0002-0703-0742; Peralta, Juan Manuel/0000-0002-8811-5579; Weeks, Olivia/0000-0003-1177-4848; Deng, Xuan/0000-0003-0918-817X; Lindgren, Cecilia/0000-0002-4903-9374; Blangero, John/0000-0001-6250-5723; Shuldiner, Alan/0000-0001-9921-4305; Mahajan, Anubha/0000-0001-5585-3420; Cupples, L. Adrienne/0000-0003-0273-7965; Terry, James/0000-0001-6659-3441; Smith, Albert Vernon/0000-0003-1942-5845	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095160, N01HC095166, N01HC095168, N01HC095165, N01HC095159, N01HC095163, N01HC095169, N01HC095164, N01HC095161, N01HC095167] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012252] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053685] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR001881, UL1TR000040, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122, M01RR016500, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119443, ZIAHL006170, R01HL074168, R01HL071205, R01HL085323, R01HL064278, R01HL065226, R01HL087660, R01HL088451, R01HL085571, R01HL105756, R01HL069313, R01HL117078, U01HL084756, U01HL067897, U01HL072515, R01HL067348] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048797, R01AR046838, R01AR052147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, R01DK106236, R01DK089256, R01DK064391, R03DK106477, R01DK071895, K08DK090147, P30DK063491, R01DK071891, R01DK065598, R01DK054026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, N01AG062103, R01AG032098, N01AG012100, R01AG028288, ZIAAG006000, N01AG062106, ZIAAG007480] Funding Source: NIH RePORTER; MRC [MR/N015355/1] Funding Source: UKRI; Medical Research Council [MR/N015355/1] Funding Source: Medline; NCATS NIH HHS [UL1 TR000124, UL1 TR001079, UL1 TR001881, UL1 TR000040] Funding Source: Medline; NCRR NIH HHS [M01 RR007122, UL1 RR024156, M01 RR016500] Funding Source: Medline; NEI NIH HHS [ZIA EY000401] Funding Source: Medline; NHGRI NIH HHS [HHSN268200782096C, P50 HG004952] Funding Source: Medline; NHLBI NIH HHS [HHSN268201300046C, R01 HL069313, R01 HL067348, N01 HC095168, N01 HC095169, N01HC65226, U01 HL084756, HHSN268201300047C, R01 HL085323, U01 HL067897, R01 HL074168, N01 HC095166, N01 HC095161, R01 HL088451, HHSN268201300048C, N01 HC095159, N01 HC095165, R01 HL119443, HHSN268201500001I, R01 HL105756, N01 HC095167, R01 HL085571, N02HL64278, R01 HL087660, HHSN268201300049C, N01 HC095163, R01 HL117078, R01 HL071205, N01 HC095164, U01 HL072515, HHSN268201300050C, N01 HC095162, N01 HC095160] Funding Source: Medline; NIAMS NIH HHS [R01 AR046838, R01 AR048797, R01 AR052147] Funding Source: Medline; NIA NIH HHS [R01 AG028288, N01 AG062103, N01 AG062106, N01 AG012100, R01 AG032098, N01 AG062101] Funding Source: Medline; NICHD NIH HHS [R01 HD012252, R01 HD053685] Funding Source: Medline; NIDDK NIH HHS [R01 DK071895, R01 DK071891, R01 DK054026, P30 DK072488, P30 DK063491, R01 DK065598, R03 DK106477, R01 DK106236, R01 DK064391, R01 DK089256, K08 DK090147] Funding Source: Medline; Wellcome Trust [098017, WT090532, WT064890] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		Abraham TM, 2015, CIRCULATION, V132, P1639, DOI 10.1161/CIRCULATIONAHA.114.015000; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Alvey NJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000788; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002705; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hayashi T, 2004, ANN INTERN MED, V140, P992, DOI 10.7326/0003-4819-140-12-200406150-00008; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hu HH, 2011, J COMPUT ASSIST TOMO, V35, P65, DOI 10.1097/RCT.0b013e3181fc2150; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413; Rosenquist KJ, 2015, J CLIN ENDOCR METAB, V100, P227, DOI 10.1210/jc.2013-4296; Rosenquist KJ, 2013, JACC-CARDIOVASC IMAG, V6, P762, DOI 10.1016/j.jcmg.2012.11.021; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Stouffer S, 1949, ADJUSTMENT ARMY LIFE; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660	27	75	75	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					125	130		10.1038/ng.3738	http://dx.doi.org/10.1038/ng.3738			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918534	Green Submitted, Green Accepted			2022-12-17	WOS:000390976600018
J	Lim, HN; van Oudenaarden, A				Lim, Han N.; van Oudenaarden, Alexander			A multistep epigenetic switch enables the stable inheritance of DNA methylation states	NATURE GENETICS			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; DEPENDENT PHASE VARIATION; MU MOM OPERON; ADENINE METHYLATION; COLONY MORPHOLOGY; GENE-EXPRESSION; DAM; OXYR; MECHANISM	In many prokaryotes and eukaryotes, DNA methylation at cis-regulatory sequences determines whether gene expression is on or off. Stable inheritance of these expression states is required in bacterial pathogenesis, cancer and developmental pathways(1,2). Here we delineate the factors that control the stability of these states by using the agn43 gene in Escherichia coli as a model system. Systematic disruption of this system shows that a functional switch requires the presence of several, rarely occupied, intermediate states that separate the 'on' and 'off' states. Cells that leave the on and off state enter different intermediate states, where there is a strong bias that drives cells back to their original state. The intermediate states therefore act as buffers that prevent back and forth switching. This mechanism of generating multiple states is an alternative to feedback regulation(3-5), and its general principle should be applicable to the analysis of other epigenetic switches and the design of synthetic circuits.	MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Lim, HN (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hanlim@berkeley.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM077183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMPBELL JL, 1988, GENE, V74, P189, DOI 10.1016/0378-1119(88)90283-1; Correnti J, 2002, MOL MICROBIOL, V44, P521, DOI 10.1046/j.1365-2958.2002.02918.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Haagmans W, 2000, MOL MICROBIOL, V35, P877, DOI 10.1046/j.1365-2958.2000.01762.x; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Henderson IR, 1997, ADV EXP MED BIOL, V412, P349; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KLOSE RJ, 2006, TRENDS BIOCH SCI; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Oehler S, 2006, NUCLEIC ACIDS RES, V34, P606, DOI 10.1093/nar/gkj453; OWEN P, 1987, J BACTERIOL, V169, P3770, DOI 10.1128/jb.169.8.3770-3777.1987; Owen P, 1996, FEMS IMMUNOL MED MIC, V16, P63; Stancheva I, 1999, EMBO J, V18, P6542, DOI 10.1093/emboj/18.22.6542; Sun WY, 1996, NUCLEIC ACIDS RES, V24, P4042, DOI 10.1093/nar/24.20.4042; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	75	77	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					269	275		10.1038/ng1956	http://dx.doi.org/10.1038/ng1956			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220888				2022-12-17	WOS:000244063900028
J	Wang, W; Yu, HJ; Long, MY				Wang, W; Yu, HJ; Long, MY			Duplication-degeneration as a mechanism of gene fission and the origin of new genes in Drosophila species	NATURE GENETICS			English	Article							EVOLUTION; MELANOGASTER; FUSION; RETROPOSONS; SELECTION; MUTATIONS; PROTEINS; JINGWEI; EXONS; LOCUS	Gene fission and fusion, the processes by which a single gene is split into two separate genes and two adjacent genes are fused into a single gene, respectively, are among the primary processes that generate new genes(1-4). Despite their seeming reversibility(4,5), nothing is known about the mechanism of gene fission. Because the nucleotide sequences of fission genes record little about their origination process, conventional analysis of duplicate genes may not be powerful enough to unravel the underlying mechanism. In a survey for young genes in species of the Drosophila melanogaster subgroup using fluorescence in situ hybridization, we identified a young gene family, monkey king, whose genesis sheds light on the evolutionary process of gene fission. Its members originated 1-2 million years ago as retroposed duplicates and evolved into fission genes that separately encode protein domains from a multidomain ancestor. The mechanism underlying this process is gene duplication with subsequent partial degeneration.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Chinese Acad Sci, Kunming Inst Zool, CAS Max Planck Jr Sci Grp, Key Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China; Yunnan Univ, Sch Life Sci, Kunming 650091, Yunnan, Peoples R China	University of Chicago; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	mlong@midway.uchicago.edu	Wang, Wen/AAP-9873-2020	Wang, Wen/0000-0002-7801-2066				ABRINK M, 1995, DNA CELL BIOL, V14, P125, DOI 10.1089/dna.1995.14.125; Altschmied J, 2002, GENETICS, V161, P259; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fay JC, 2000, GENETICS, V155, P1405; Finta C, 2000, GENE, V260, P13, DOI 10.1016/S0378-1119(00)00470-4; Force A, 1999, GENETICS, V151, P1531; FU YH, 1993, GENETICS, V133, P6934; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kumar S., 2001, MEGA2 MOL EVOLUTIONA; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Li W.H., 1997, MOL EVOLUTION; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Powell J.R., 1997, PROGR PROSPECTS EVOL; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Sokal R. R., 2000, BIOMETRY; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; TAJIMA F, 1989, GENETICS, V123, P585; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399	30	75	79	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					523	527		10.1038/ng1338	http://dx.doi.org/10.1038/ng1338			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15064762	Bronze			2022-12-17	WOS:000221183000028
J	Guillon, H; de Massy, B				Guillon, H; de Massy, B			An initiation site for meiotic crossing-over and gene conversion in the mouse	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SACCHAROMYCES-CEREVISIAE; RECOMBINATION HOTSPOT; CHROMOSOMES; SEQUENCE; MEIOSIS; REPAIR; LOCUS; MLH1	During meiosis, the reductional segregation of homologous chromosomes at the first meiotic division requires reciprocal exchange (crossing over) between homologs(1). The number of crossovers is tightly regulated (one to two per homolog in mice 2), and their distribution in the genome is not random-recombination 'hot' and 'cold' regions can be identified(3,4). We developed a molecular assay to study these events directly in mouse germ cells. This analysis was developed with reference to the proteosome subunit beta type 9 (Psmb9, previously called Lmp2) hot-spot region identified through genetic analysis(5,6). Here we show that this hot spot is an initiation site of meiotic recombination on the basis of two observations: (i) crossover density is maximal in an interval of 210 bp and decreases on both sides of this region; (ii) a high frequency of gene conversion is found in the region of highest crossover density. We then used this strategy to carry out the first temporal analysis of meiotic recombination in mouse spermatogenesis and demonstrate that crossover events occur during the pachytene stage of meiotic prophase.	Inst Genet Humaine, CNRS, UPR 1142, F-34396 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	de Massy, B (corresponding author), Inst Genet Humaine, CNRS, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 05, France.							Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BORTS RH, 1989, GENETICS, V123, P69; Cobb J, 1999, DEV BIOL, V205, P49, DOI 10.1006/dbio.1998.9101; DETLOFF P, 1992, GENETICS, V132, P113; GOETZ P, 1984, J CELL SCI, V65, P249; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; LAWRIE NM, 1995, CHROMOSOMA, V104, P308, DOI 10.1007/BF00352262; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Mizuno K, 1996, MAMM GENOME, V7, P490, DOI 10.1007/s003359900149; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHULTES NP, 1990, GENETICS, V126, P813; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; SYMINGTON LS, 1991, GENETICS, V128, P717; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8	21	75	76	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					296	299		10.1038/ng990	http://dx.doi.org/10.1038/ng990			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244318				2022-12-17	WOS:000178311100020
J	Arya, R; Duggirala, R; Almasy, L; Rainwater, DL; Mahaney, MC; Cole, S; Dyer, TD; Williams, K; Leach, RJ; Hixson, JE; MacCluer, JW; O'Connell, P; Stern, MP; Blangero, J				Arya, R; Duggirala, R; Almasy, L; Rainwater, DL; Mahaney, MC; Cole, S; Dyer, TD; Williams, K; Leach, RJ; Hixson, JE; MacCluer, JW; O'Connell, P; Stern, MP; Blangero, J			Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans	NATURE GENETICS			English	Article							COMPLEX TRAITS; SUSCEPTIBILITY LOCUS; RISK-FACTORS; GENE; ATHEROSCLEROSIS; DISEASE; LOCALIZATION; REPLICATION; MUTATIONS; LOCATION	High-density lipoproteins (HDLs) are anti-atherogenic lipoproteins that have a major role in transporting cholesterol from peripheral tissues to the liver, where it is removed(1,2). Epidemiologic studies have shown that low levels of high-density lipoprotein-cholesterol (HDL-C) are associated with an increased incidence of coronary heart disease and an increased mortality rate(3,4), indicating a protective role of high concentrations of HDL-C against atherogenesis and the development of coronary heart disease. HDL-C level is influenced by several genetic and nongenetic factors(3,5). Nongenetic factors include smoking, which has been shown to decrease the HDL-C level. Exercise and alcohol have been shown to increase HDL-C levels(6,7). Decreased HDL-C is often associated with other coronary heart disease risk factors such as obesity, hyperinsulinemia and insulin resistance, hyper-triglyceridemia and hypertension(3). Although several genes have been identified for rare forms of dyslipidemia, the genes accounting for major variation in HDL-C levels have yet to be identified(8). Using a multipoint variance components linkage approach, we found strong evidence of linkage (lod score=3.4; P=0.00004) of a quantitative trait locus (QTL) for HDL-C level to a genetic location between markers D9S925 and D9S741 on chromosome 9p in Mexican Americans. A replication study in an independent set of Mexican American families confirmed the existence of a QTL on chromosome 9p.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, San Antonio, TX 78284 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Baylor Coll Med, Baylor Breast Ctr, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Arya, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021	Leach, Robin/0000-0002-3201-5579; Hixson, James/0000-0002-0849-9315				Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Calabresi L, 1997, CURR OPIN LIPIDOL, V8, P219, DOI 10.1097/00041433-199708000-00005; Duggirala R, 2000, AM J HUM GENET, V66, P1237, DOI 10.1086/302849; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Dupuis J, 1999, GENETICS, V151, P373; FERNANDEZRUIZ E, 1993, GENOMICS, V17, P759, DOI 10.1006/geno.1993.1401; Fong IW, 2000, CAN MED ASSOC J, V163, P49; Gordon DJ, 1998, ENDOCRIN METAB CLIN, V27, P699, DOI 10.1016/S0889-8529(05)70034-7; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hegele RA, 2001, AM J HUM GENET, V69, P1161, DOI 10.1086/324647; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Imperatore G, 2000, ARTERIOSCL THROM VAS, V20, P2651, DOI 10.1161/01.ATV.20.12.2651; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; KLINGER KW, 1987, P NATL ACAD SCI USA, V84, P8548, DOI 10.1073/pnas.84.23.8548; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luoma PV, 1997, PHARMACOL TOXICOL, V81, P57, DOI 10.1111/j.1600-0773.1997.tb00032.x; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; OKA K, 1994, GENOMICS, V20, P298, DOI 10.1006/geno.1994.1171; OWERBACH D, 1981, P NATL ACAD SCI-BIOL, V78, P3123, DOI 10.1073/pnas.78.5.3123; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Rosenson RS, 1996, ARCH INTERN MED, V156, P1278, DOI 10.1001/archinte.156.12.1278; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; THOMPSON PD, 1991, CIRCULATION, V84, P140, DOI 10.1161/01.CIR.84.1.140; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; WEIDNER G, 1991, CIRCULATION, V83, P176, DOI 10.1161/01.CIR.83.1.176; WHITMORE TE, 1995, GENOMICS, V28, P599, DOI 10.1006/geno.1995.1198; WILT VM, 1996, ANN PHARMACOTHER, V31, P89	31	75	76	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					102	105		10.1038/ng810	http://dx.doi.org/10.1038/ng810			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743583				2022-12-17	WOS:000173105600022
J	Rudrasingham, V; Wavrant-De Vrieze, F; Lambert, JC; Chakraverty, S; Kehoe, P; Crook, R; Amouyel, P; Wu, W; Rice, F; Perez-Tur, J; Frigard, B; Morris, JC; Carty, S; Petersen, R; Cottel, D; Tunstall, N; Holmans, P; Lovestone, S; Chartier-Harlin, MC; Goate, A; Hardy, J; Owen, MJ; Williams, J				Rudrasingham, V; Wavrant-De Vrieze, F; Lambert, JC; Chakraverty, S; Kehoe, P; Crook, R; Amouyel, P; Wu, W; Rice, F; Perez-Tur, J; Frigard, B; Morris, JC; Carty, S; Petersen, R; Cottel, D; Tunstall, N; Holmans, P; Lovestone, S; Chartier-Harlin, MC; Goate, A; Hardy, J; Owen, MJ; Williams, J			alpha-2 macroglobulin gene and Alzheimer disease	NATURE GENETICS			English	Letter									Mayo Clin Jacksonville, Jacksonville, FL 32084 USA; Inst Pasteur, INSERM, F-59019 Lille, France; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Inst Psychiat, Sect Old Age Psychiat, London SE5 8AF, England	Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Mayo Clinic; University of London; King's College London	Williams, J (corresponding author), Univ Wales, Coll Med, Dept Psychol Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Holmans, Peter/F-4518-2015; Morris, John C/A-1686-2012; Hardy, John/C-2451-2009; Chartier-Harlin, Marie-Christine/L-4527-2018; lambert, jean-charles/F-8787-2013; Lovestone, Simon/E-8725-2010; Perez-Tur, Jordi/A-2143-2010; Lambert, jean-charles/A-9553-2014; Kehoe, Patrick/P-8760-2018	Holmans, Peter/0000-0003-0870-9412; Hardy, John/0000-0002-3122-0423; Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; lambert, jean-charles/0000-0003-0829-7817; Perez-Tur, Jordi/0000-0002-9111-1712; Lambert, jean-charles/0000-0003-0829-7817; Kehoe, Patrick/0000-0002-7542-1139; Lovestone, Simon/0000-0003-0473-4565; Williams, Julie/0000-0002-4069-0259; Rice, Frances/0000-0002-9484-1729; Amouyel, Philippe/0000-0001-9088-234X	NATIONAL INSTITUTE ON AGING [U24AG021886] Funding Source: NIH RePORTER; NIA NIH HHS [U24 AG021886] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619	6	75	76	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					17	19		10.1038/8726	http://dx.doi.org/10.1038/8726			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319854				2022-12-17	WOS:000080096300014
J	Smith, L; Liu, SJ; Goodrich, L; Jacobson, D; Degnin, C; Bentley, N; Carr, A; Flaggs, G; Keegan, K; Hoekstra, M; Thayer, MJ				Smith, L; Liu, SJ; Goodrich, L; Jacobson, D; Degnin, C; Bentley, N; Carr, A; Flaggs, G; Keegan, K; Hoekstra, M; Thayer, MJ			Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SQUAMOUS-CELL CARCINOMAS; ALVEOLAR RHABDOMYOSARCOMA; P53; EXPRESSION; PROTEIN; LOOP; GENE; DIFFERENTIATION; TRANSCRIPTION	Chromosome Sq alterations occur frequently in many types of tumours. In a genetic screen for loci present in rhabdomyosarcomas, we identified an isochromosome 3q [i(3q)], which inhibits muscle differentiation when transferred into myoblasts. The i(3q) inhibits MyoD function, resulting in a non-differentiating phenotype. Furthermore, the i(3q) induces a 'cut' phenotype, abnormal centrosome amplification, aneuploidy and loss of G1 arrest following gamma-irradiation, Testing candidate genes within this region reveals that forced expression of ataxia-telangiectasia and rad3-related (ATR) results in a phenocopy of the i(3q). Thus, genetic alteration of ATR leads to loss of differentiation as well as cell-cycle abnormalities.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA; Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England; ICOS Corp, Bothell, WA 98021 USA	Oregon Health & Science University; Oregon Health & Science University; University of Sussex; Icos Corporation	Thayer, MJ (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	thayerm@ohsu.edu		Carr, Antony Michael/0000-0002-2028-2389; Smith, Leslie/0000-0001-6452-6624				BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CAREY TE, 1993, J CELL BIOCHEM, P213; Carr AM, 1997, CURR OPIN GENET DEV, V7, P93, DOI 10.1016/S0959-437X(97)80115-3; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; DAVIS RJ, 1994, CANCER RES, V54, P2869; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DIAS P, 1990, AM J PATHOL, V137, P1283; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Favaloro J, 1980, Methods Enzymol, V65, P718; Fiddler TA, 1996, MOL CELL BIOL, V16, P5048; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HARDY S, 1993, MOL CELL BIOL, V13, P5943, DOI 10.1128/MCB.13.10.5943; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; JIN YS, 1993, CANCER RES, V53, P2140; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MITCHELL CD, 1991, ONCOGENE, V6, P89; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; PETERSON CA, 1990, CELL, V62, P493, DOI 10.1016/0092-8674(90)90014-6; RABBITTS P, 1990, GENE CHROMOSOME CANC, V2, P231, DOI 10.1002/gcc.2870020312; RAO PH, 1994, CANCER GENET CYTOGEN, V77, P60, DOI 10.1016/0165-4608(94)90150-3; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RIED T, 1994, CANCER RES, V54, P1801; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCRABLE HJ, 1990, P NATL ACAD SCI USA, V87, P2182, DOI 10.1073/pnas.87.6.2182; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; SPEICHER MR, 1995, CANCER RES, V55, P1010; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Trask B, 1990, FLOW CYTOMETRY; WeberHall SR, 1996, CANCER RES, V56, P3220; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yunis J J, 1978, Prog Clin Pathol, V7, P267	51	75	78	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					39	46		10.1038/ng0598-39	http://dx.doi.org/10.1038/ng0598-39			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590286				2022-12-17	WOS:000073346700014
J	Bolk, S; Angrist, M; Xie, J; Yanagisawa, M; Silvestri, JM; WeeseMayer, DE; Chakravarti, A				Bolk, S; Angrist, M; Xie, J; Yanagisawa, M; Silvestri, JM; WeeseMayer, DE; Chakravarti, A			Endothelin-3 frameshift mutation in congenital central hypoventilation syndrome	NATURE GENETICS			English	Letter							DISEASE		CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235; RUSH UNIV,RUSH PRESBYTERIAN ST LUKES MED CTR,COLL MED,DEPT PEDIAT,CHICAGO,IL 60612	Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Rush University	Bolk, S (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106, USA.			Xie, Jian/0000-0001-9454-1358				AMIEL J, 1995, AM J HUM GENET, V57, P1189; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; BOLK S, IN PRESS AM J MED GE; BOWER RJ, 1980, CLIN PEDIATR, V19, P665, DOI 10.1177/000992288001901004; Chakravarti A, 1996, HUM MOL GENET, V5, P303; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; GUILLEMINAULT C, 1982, PEDIATRICS, V70, P684; HADDAD GG, 1978, MEDICINE, V57, P517, DOI 10.1097/00005792-197811000-00003; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; KOSEKI C, 1989, NEUROSCI RES, V6, P581, DOI 10.1016/0168-0102(89)90047-3; KRSMANOVIC LZ, 1991, P NATL ACAD SCI USA, V88, P11124, DOI 10.1073/pnas.88.24.11124; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SWAMINATHAN S, 1989, CHEST, V96, P423, DOI 10.1378/chest.96.2.423; WEESEMAYER DE, 1992, J PEDIATR-US, V120, P381, DOI 10.1016/S0022-3476(05)80901-1; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	16	75	80	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					395	396		10.1038/ng0896-395	http://dx.doi.org/10.1038/ng0896-395			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696331				2022-12-17	WOS:A1996VB62000017
J	Villard, L; Gecz, J; Mattei, JF; Fontes, M; SaugierVeber, P; Munnich, A; Lyonnet, S				Villard, L; Gecz, J; Mattei, JF; Fontes, M; SaugierVeber, P; Munnich, A; Lyonnet, S			XNP mutation in a large family with Juberg-Marsidi syndrome	NATURE GENETICS			English	Letter							LINKED MENTAL-RETARDATION; GROWTH-RETARDATION; DEAFNESS; YEAST		HOP NECKER ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS 15,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Villard, L (corresponding author), FAC MED MARSEILLE,INSERM U406,27 BD J MOULIN,F-13385 MARSEILLE 5,FRANCE.		Gecz, Jozef/X-3469-2019; Lyonnet, Stanislas/H-5483-2017; Villard, Laurent/E-3941-2016	Gecz, Jozef/0000-0002-7884-6861; Lyonnet, Stanislas/0000-0001-5426-9417; Villard, Laurent/0000-0001-6657-5008; Saugier-Veber, Pascale/0000-0002-8045-6432				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; GECZ J, 1994, HUM MOL GENET, V3, P39, DOI 10.1093/hmg/3.1.39; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; JUBERG RC, 1980, AM J HUM GENET, V32, P714; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; MATTEI JF, 1983, CLIN GENET, V23, P70; SAUGIERVEBER P, 1993, AM J HUM GENET, V52, P1040; SAUGIERVEBER P, 1995, AM J MED GENET, V55, P300, DOI 10.1002/ajmg.1320550310; SAUGIERVEBER P, 1994, NAT GENET, V6, P357; SCHWARTZ CE, 1991, BIOL PSYCHIAT, V2; STAYTON CL, 1994, HUM MOL GENET, V3, P1957, DOI 10.1093/hmg/3.11.1957	14	75	79	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					359	360		10.1038/ng0496-359	http://dx.doi.org/10.1038/ng0496-359			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630485				2022-12-17	WOS:A1996UC55300010
J	TOTH, M; GRIMSBY, J; BUZSAKI, G; DONOVAN, GP				TOTH, M; GRIMSBY, J; BUZSAKI, G; DONOVAN, GP			EPILEPTIC SEIZURES CAUSED BY INACTIVATION OF A NOVEL GENE, JERKY, RELATED TO CENTROMERE-BINDING PROTEIN-B IN TRANSGENIC MICE	NATURE GENETICS			English	Article							MYOCLONIC EPILEPSY; CENP-B; LINKAGE; CHROMOSOME-15; LOCUS; MOUSE	Epidemiological data and genetic studies indicate that certain forms of human epilepsy are inherited. Based on the similarity between the human and mouse genomes, mouse models of epilepsy could facilitate the discovery of genes associated with epilepsy syndromes. Here, we report an insertional murine mutation that inactivates a novel gene and results in whole body jerks, generalized clonic seizures, and epileptic brain activity in transgenic mice. The gene, named jerky, encodes a putative 41.7 kD protein displaying homology to a number of nuclear regulatory proteins, suggesting that perhaps the jerky protein is able to bind DNA.	UNIV SO CALIF,DEPT MOLEC PHARMACOL & TOXICOL,LOS ANGELES,CA 90033; RUTGERS STATE UNIV,CTR MOLEC & BEHAV NEUROSCI,NEWARK,NJ 07102	University of Southern California; Rutgers State University Newark; Rutgers State University New Brunswick	TOTH, M (corresponding author), CORNELL UNIV,COLL MED,DEPT PHARMACOL,NEW YORK,NY 10021, USA.		Toth, Miklos/O-3343-2017	Buzsaki, Gyorgy/0000-0002-3100-4800				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beck C, 1994, Neurobiol Dis, V1, P95, DOI 10.1006/nbdi.1994.0012; Delgado-Escueta A V, 1986, Adv Neurol, V44, P3; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; GAREY CE, 1994, NAT GENET, V6, P426, DOI 10.1038/ng0494-426; GREENBERG DA, 1993, EPILEPSIA, V34, pS12; HOHMANN S, 1993, MOL GEN GENET, V241, P657, DOI 10.1007/BF00279908; LABOW MA, 1990, MOL CELL BIOL, V10, P3343, DOI 10.1128/MCB.10.7.3343; LEHESJOKI AE, 1992, NEUROLOGY, V42, P1545, DOI 10.1212/WNL.42.8.1545; LOSSIE AC, 1993, MAMM GENOME, V4, P621, DOI 10.1007/BF00361398; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; NOEBELS JL, 1984, NATURE, V310, P409, DOI 10.1038/310409a0; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TOTH M, IN PRESS J NEUROSCI, V41; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	23	75	78	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					71	75		10.1038/ng0995-71	http://dx.doi.org/10.1038/ng0995-71			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550318				2022-12-17	WOS:A1995RR72800018
J	RUGARLI, EI; ADLER, DA; BORSANI, G; TSUCHIYA, K; FRANCO, B; HAUGE, X; DISTECHE, C; CHAPMAN, V; BALLABIO, A				RUGARLI, EI; ADLER, DA; BORSANI, G; TSUCHIYA, K; FRANCO, B; HAUGE, X; DISTECHE, C; CHAPMAN, V; BALLABIO, A			DIFFERENT CHROMOSOMAL LOCALIZATION OF THE CLCN4 GENE IN MUS-SPRETUS AND C57BL/6J MICE	NATURE GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; MOUSE X-CHROMOSOME; PSEUDOAUTOSOMAL REGION; CHLORIDE CHANNEL; INTERSPECIFIC HYBRIDS; ALPHA-SUBUNIT; HALDANE RULE; MALE MEIOSIS; DNA; EXPRESSION	We report the unprecedented finding of a gene with a different map position in two mouse strains. The Clcn4 gene was found to map to the X chromosome in the wild Mediterrean mouse, Mus spretus but to chromosome 7 in the inbred strain of laboratory mouse C57BL/6J. These data indicate that a recent evolutionary rearrangement occurred on the mouse sex chromosomes, very close to the pseudoautosomal region, Our data provide molecular evidence for a major divergence near the pseudoautosomal region, consistent with the hypothesis that hybrid sterility in these species results from abnormal pairing of sex chromosomes during male meiosis.	TELETHON INST GENET & MED,MILAN,ITALY; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; ROSWELL PK CANC INST,DEPT MOLEC & CELL BIOL,BUFFALO,NY 14263; UNIV SIENA,DEPT MOLEC BIOL,SIENA,ITALY	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Washington; University of Washington Seattle; Baylor College of Medicine; Roswell Park Cancer Institute; University of Siena			Borsani, Giuseppe/B-1709-2010; BALLABIO, Andrea/AAL-2672-2020; FRANCO, Brunella/S-2882-2018	Borsani, Giuseppe/0000-0003-0110-1148; BALLABIO, Andrea/0000-0003-1381-4604; Rugarli, Elena/0000-0002-5782-1067; FRANCO, Brunella/0000-0001-5588-4569	Telethon [TGM94000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		ADLER DA, 1991, P NATL ACAD SCI USA, V88, P4592, DOI 10.1073/pnas.88.11.4592; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; CHAPMAN VM, 1991, GENOMICS, V10, P23, DOI 10.1016/0888-7543(91)90479-X; COYNE JA, 1985, NATURE, V314, P736, DOI 10.1038/314736a0; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; EICHER EM, 1992, P NATL ACAD SCI USA, V89, P2160, DOI 10.1073/pnas.89.6.2160; FERRIS SD, 1983, GENETICS, V107, P681; FISHER SE, 1994, HUM MOL GENET, V3, P2053; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HALE DW, 1993, CYTOGENET CELL GENET, V63, P221, DOI 10.1159/000133539; HARBERS K, 1990, CYTOGENET CELL GENET, V53, P129, DOI 10.1159/000132912; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEE K, 1994, MAMM GENOME, V5, P612, DOI 10.1007/BF00411455; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; Maniatis T., 1982, MOL CLONING; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; MATSUDA Y, 1992, CHROMOSOMA, V101, P483, DOI 10.1007/BF00352471; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; Ohno S., 1967, SEX CHROMOSOMES SEX, DOI [10.1007/978-3-642-88178-7, DOI 10.1007/978-3-642-88178-7]; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547	31	75	77	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					466	471		10.1038/ng0895-466	http://dx.doi.org/10.1038/ng0895-466			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670496				2022-12-17	WOS:A1995RM37500021
J	STAMBOLIAN, D; AI, YJ; SIDJANIN, D; NESBURN, K; SATHE, G; ROSENBERG, M; BERGSMA, DJ				STAMBOLIAN, D; AI, YJ; SIDJANIN, D; NESBURN, K; SATHE, G; ROSENBERG, M; BERGSMA, DJ			CLONING OF THE GALACTOKINASE CDNA AND IDENTIFICATION OF MUTATIONS IN 2 FAMILIES WITH CATARACTS	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GAL OPERON; DEFICIENCY; GENE; SEQUENCE; ENZYMES; REGION; KINASE	Galactokinase is an essential enzyme for the metabolism of galactose and its deficiency causes congenital cataracts during infancy and presenile cataracts in the adult population. We have cloned the human galactokinase cDNA, which maps to chromosome 17q24, and show that the isolated cDNA expresses galactokinase activity in bacteria and mammalian cells. We also describe two different mutations in this gene in unrelated families with galactokinase deficiency and cataracts. The availability of the cloned galactokinase gene provides an important reference to identify mutations in patients with galactokinase deficiency and cataracts.	UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; SMITH KLINE BEECHAM PHARMACEUT,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19046	University of Pennsylvania	STAMBOLIAN, D (corresponding author), UNIV PENN,INST HUMAN GENE THERAPY,DEPT OPHTHALMOL,BRB-1,ROOM 305,422 CURIE BLVD,PHILADELPHIA,PA 19104, USA.				NEI NIH HHS [R01 EY09 404] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009404] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMS CW, 1988, J BACTERIOL, V170, P203, DOI 10.1128/jb.170.1.203-212.1988; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; AIJAR N, 1994, MOL CELL BIOCHEM, V131, P75; BEST S, 1994, TECHNIQUES PROTEIN C, V5, P205; CALTABIANO MM, 1989, GENE, V85, P479, DOI 10.1016/0378-1119(89)90442-3; CITRON BA, 1984, J BACTERIOL, V158, P269, DOI 10.1128/JB.158.1.269-278.1984; DEBOUCK C, 1985, NUCLEIC ACIDS RES, V13, P1841, DOI 10.1093/nar/13.6.1841; ELSEVIER SM, 1974, NATURE, V251, P633, DOI 10.1038/251633a0; FOSTER A, 1990, INT OPHTHALMOL, V14, P135, DOI 10.1007/BF00158310; GITZELMANN R, 1965, LANCET, V2, P670; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARLEY JD, 1974, LANCET, V2, P259; LEE RT, 1992, P NATL ACAD SCI USA, V89, P10887, DOI 10.1073/pnas.89.22.10887; LEVY NS, 1972, AM J OPHTHALMOL, V74, P41, DOI 10.1016/0002-9394(72)91123-3; MAGNANI M, 1982, HUM HERED, V32, P329, DOI 10.1159/000153319; MAGNANI M, 1983, ENZYME, V29, P58, DOI 10.1159/000469604; McKenney K, 1981, Gene Amplif Anal, V2, P383; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; MOLLET B, 1991, J BACTERIOL, V173, P4464, DOI 10.1128/JB.173.14.4464-4473.1991; MONTELEO.JA, 1971, AM J MED, V50, P403, DOI 10.1016/0002-9343(71)90230-0; OLAMBIWONNU NO, 1974, PEDIATRICS, V53, P314; PICKERING WR, 1972, J PEDIATR-US, V81, P50, DOI 10.1016/S0022-3476(72)80373-1; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Sambrook J., 1989, MOL CLONING LAB MANU; SEGAL S, 1979, J PEDIATR-US, V95, P750, DOI 10.1016/S0022-3476(79)80729-5; SEGAL S, 1989, METABOLIC BASIS INHE, V1, P453; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P269; STAMBOLIAN D, 1988, SURV OPHTHALMOL, V32, P333, DOI 10.1016/0039-6257(88)90095-1; STAMBOLIAN D, 1986, INVEST OPHTH VIS SCI, V27, P429; STAMBOLIAN D, 1985, BIOCHIM BIOPHYS ACTA, V831, P306, DOI 10.1016/0167-4838(85)90112-8; STAMBOLIAN D, 1984, EXP EYE RES, V38, P231, DOI 10.1016/0014-4835(84)90161-1; STEPHENSON C, 1991, BIOCHEM GENET, V29, P135; TEDESCO TA, 1975, AM J HUM GENET, V27, P737; TEDESCO TA, 1977, AM J HUM GENET, V29, P240; TEDESCO TA, 1973, PEDIATR RES, V7, P394; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620	36	75	79	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					307	312		10.1038/ng0795-307	http://dx.doi.org/10.1038/ng0795-307			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670469				2022-12-17	WOS:A1995RG38600014
J	MCDOWELL, GA; GAHL, WA; STEPHENSON, LA; SCHNEIDER, JA; WEISSENBACH, J; POLYMEROPOULOS, MH; TOWN, MM; VANTHOFF, W; FARRALL, M; MATHEW, CG				MCDOWELL, GA; GAHL, WA; STEPHENSON, LA; SCHNEIDER, JA; WEISSENBACH, J; POLYMEROPOULOS, MH; TOWN, MM; VANTHOFF, W; FARRALL, M; MATHEW, CG			LINKAGE OF THE GENE FOR CYSTINOSIS TO MARKERS ON THE SHORT ARM OF CHROMOSOME-17	NATURE GENETICS			English	Note							NEPHROPATHIC CYSTINOSIS; CYSTEAMINE; CHILDREN		INST CHILD HLTH,LONDON WC1N 1EH,ENGLAND; WELLCOME TRUST CTR HUMAN GENET,NUFFIELD ORTHOPAED CTR,OXFORD OX3 7LD,ENGLAND; NICHHD,HUMAN GENET BRANCH,HUMAN BIOCHEM GENET SECT,BETHESDA,MD 20892; UNIV CALIF SAN DIEGO,SCH MED,DEPT PEDIAT,LA JOLLA,CA 92093; GENETHON,HUMAN GENOME RES CTR,F-91002 EVRY,FRANCE; NIH,NATL CTR HUMAN GENOME RES,GENET DIS RES LAB,BETHESDA,MD 20892	University of London; University College London; Nuffield Orthopaedic Centre; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	MCDOWELL, GA (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND.		Beckmann, Jacques S/A-9772-2008; MERLINI, LUCIANO/O-2944-2013	Beckmann, Jacques S/0000-0002-9741-1900; Campbell, Kevin/0000-0003-2066-5889; MERLINI, LUCIANO/0000-0002-1108-1198				GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; HAATAJA L, 1994, AM J HUM GENET, V54, P1042; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; Ott J., 1991, ANAL HUMAN GENETIC L; PELLETT OL, 1988, P NATL ACAD SCI USA, V85, P3531, DOI 10.1073/pnas.85.10.3531; POLYMEROPOULOS MH, 1992, PSYCHIAT RES, V48, P27; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; THEODOROPOULOS DS, 1993, JAMA-J AM MED ASSOC, V270, P2200, DOI 10.1001/jama.270.18.2200; THOENE JG, 1992, PATHOPHYSIOLOGY LYSO; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	14	75	76	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					246	248		10.1038/ng0695-246	http://dx.doi.org/10.1038/ng0695-246			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857					2022-12-17	WOS:A1995RA85700028
J	BAXENDALE, S; MACDONALD, ME; MOTT, R; FRANCIS, F; LIN, C; KIRBY, SF; JAMES, M; ZEHETNER, G; HUMMERICH, H; VALDES, J; COLLINS, FS; DEAVEN, LJ; GUSELLA, JF; LEHRACH, H; BATES, GP				BAXENDALE, S; MACDONALD, ME; MOTT, R; FRANCIS, F; LIN, C; KIRBY, SF; JAMES, M; ZEHETNER, G; HUMMERICH, H; VALDES, J; COLLINS, FS; DEAVEN, LJ; GUSELLA, JF; LEHRACH, H; BATES, GP			A COSMID CONTIG AND HIGH-RESOLUTION RESTRICTION MAP OF THE 2 MEGABASE REGION CONTAINING THE HUNTINGTONS-DISEASE GENE	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; REFERENCE LIBRARIES; RECOMBINATION; D4S10; LOCALIZATION; CHROMOSOME-4; ASSOCIATION; TELOMERE; SEGMENT; MARKER	The quest for the mutation responsible for Huntington's disease (HD) has required an exceptionally detailed analysis of a large part of 4p16.3 by molecular genetic techniques, making this stretch of 2.2 megabases one of the best characterized regions of the human genome. Here we describe the construction of a cosmid and Pl clone contig spanning the region containing the HD gene, and the establishment of a detailed, high resolution restriction map. This ordered clone library has allowed the identification of several genes from the region, and has played a vital role in the recent identification of the Huntington's disease gene. The restriction map provides the framework for the detailed analysis of a region extremely rich in coding sequences. This study also exemplifies many of the strategies to be used in the analysis of larger regions of the human genome.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114; UNIV MICHIGAN,DEPT INTERNAL MED & HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; LOS ALAMOS NATL LAB,LOS ALAMOS,NM 87545	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Los Alamos National Laboratory	BAXENDALE, S (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Francis, Fiona/B-5854-2016; Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Francis, Fiona/0000-0001-8542-7537; Baxendale, Sarah/0000-0002-6760-9457; Mott, Richard/0000-0002-1022-9330	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, P50NS016367] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00169] Funding Source: Medline; NINDS NIH HHS [NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAM S, 1991, AM J HUM GENET, V48, P595; ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; BARRON L, 1991, J MED GENET, V28, P520, DOI 10.1136/jmg.28.8.520; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BUCAN M, 1990, GENOMICS, V6, P1; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GRIBBIN TE, 1989, LEUKEMIA, V3, P643; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HOHEISEL JD, 1991, J MOL BIOL, V220, P903, DOI 10.1016/0022-2836(91)90362-A; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOHEISEL JD, 1989, TECHNIQUE, V1, P21; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LEHRACH H., 1990, GENOME ANAL, P39; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; LINSAY S, 1987, NATURE, V327, P336; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Melmer Georg, 1992, Human Molecular Genetics, V1, P433, DOI 10.1093/hmg/1.6.433; MOTT R, IN PRESS NUCL ACIDS; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; PIERCE JC, 1992, P NATL ACAD SCI USA, V89, P2056, DOI 10.1073/pnas.89.6.2056; PRITCHARD C, 1992, AM J HUM GENET, V50, P1218; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Sambrook J., 1989, MOL CLONING LAB MANU; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1992, AM J HUM GENET, V51, P357; STERNBERG N, 1990, New Biologist, V2, P151; TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0; TAYLOR SAM, 1992, NAT GENET, V2, P223, DOI 10.1038/ng1192-223; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; YOUNGMAN S, 1992, GENOMICS, V14, P350, DOI 10.1016/S0888-7543(05)80225-3; ZEHETNER G, 1986, NUCLEIC ACIDS RES, V14, P335, DOI 10.1093/nar/14.1.335; 1993, CELL, V72, P971	53	75	77	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					181	&		10.1038/ng0693-181	http://dx.doi.org/10.1038/ng0693-181			0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348156				2022-12-17	WOS:A1993LF81600020
J	BROCKINGTON, M; SWEENEY, MG; HAMMANS, SR; MORGANHUGHES, JA; HARDING, AE				BROCKINGTON, M; SWEENEY, MG; HAMMANS, SR; MORGANHUGHES, JA; HARDING, AE			A TANDEM DUPLICATION IN THE D-LOOP OF HUMAN MITOCHONDRIAL-DNA IS ASSOCIATED WITH DELETIONS IN MITOCHONDRIAL MYOPATHIES	NATURE GENETICS			English	Article							SEQUENCE; TRANSCRIPTION; DOMINANT; REGION	About 40 per cent of patients with mitochondrial myopathies have two populations of mitochondrial DNA (mtDNA) in muscle, one of which is deleted. All patients with single mtDNA deletions and neurological disease are sporadic cases, suggesting that deletions arise as fresh mutational events. We have detected a low abundance heteroplasmic tandem duplication involving the displacement loop of mtDNA in 18 of 58 patients with deletions and 5/5 of their mothers, but not in normal subjects. The location of the duplication to a region that controls both replication and transcription of mtDNA could explain features suggesting mild mitochondrial dysfunction in the muscle biopsies of three patients' mothers, and a predisposition to deletion.	UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND	University of London; University College London								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BUROKER NE, 1990, GENETICS, V124, P157; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5; HAMMANS SR, 1992, BRAIN, V115, P343, DOI 10.1093/brain/115.2.343; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HAYASAKA H, 1990, MOL BIOL EVOL, V8, P339; HIXSON JE, 1985, P NATL ACAD SCI USA, V82, P2660, DOI 10.1073/pnas.82.9.2660; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; HOLT IJ, 1989, ANN NEUROL, V29, P600; HORAI S, 1990, AM J HUM GENET, V46, P828; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1992, NAT GENET, V1, P9; POULTON J, 1991, AM J HUM GENET, V48, P649; POULTON J, 1989, LANCET, V1, P236; PULTON J, 1993, GENET, P23; ROTIG A, 1992, AM J HUM GENET, V50, P364; SANDY MS, 1993, MOVEMENT DISORD, V8, P74, DOI 10.1002/mds.870080114; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; TOPPER JN, 1989, MOL CELL BIOL, V9, P1200, DOI 10.1128/MCB.9.3.1200; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604	26	75	76	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					67	71		10.1038/ng0593-67	http://dx.doi.org/10.1038/ng0593-67			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513327				2022-12-17	WOS:A1993LA33700016
J	WU, CL; MELTON, DW				WU, CL; MELTON, DW			PRODUCTION OF A MODEL FOR LESCH-NYHAN SYNDROME IN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE-DEFICIENT MICE	NATURE GENETICS			English	Article							MOUSE MODEL; MUSCULAR-DYSTROPHY; DOPAMINE AGONISTS; BRAIN; IDENTIFICATION; AMPHETAMINE; MUTATIONS; RATS; INVOLVEMENT; CLONIDINE	The inherited disease Lesch-Nyhan syndrome, which is caused by a deficiency of the enzyme hypoxanthine phosphoribosyltransferase (HPRT), is characterized by behavioural alterations, including self-injurious behaviour and mental retardation. Although HPRT-deficient mice have been generated using the embryonic stem cell system, no spontaneous behavioural abnormalities had been reported. We examined whether mice were more tolerant of HPRT deficiency because they were more reliant on adenine phosphoribosyltransferase (APRT) than HPRT for their purine salvage. The administration of an APRT inhibitor to HPRT-deficient mice induced persistent self-injurious behaviour. This combined genetic and biochemical model will facilitate the study of Lesch-Nyhan syndrome and the evaluation of novel therapies.	UNIV EDINBURGH,INST CELL & MOLEC BIOL,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Wu, Chao-Liang/K-5272-2013	Wu, Chao-Liang/0000-0001-7821-9406				BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343; BREESE GR, 1990, BRAIN RES BULL, V25, P477, DOI 10.1016/0361-9230(90)90240-Z; BROSH S, 1990, J NEUROCHEM, V54, P1776, DOI 10.1111/j.1471-4159.1990.tb01233.x; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DUNNETT SB, 1989, BRAIN RES, V501, P401, DOI 10.1016/0006-8993(89)90659-8; FINGER S, 1988, J NEUROL SCI, V86, P203, DOI 10.1016/0022-510X(88)90099-8; FRAY PJ, 1980, PSYCHOPHARMACOLOGY, V69, P253, DOI 10.1007/BF00433091; FUJIMORI S, 1989, J CLIN INVEST, V83, P11, DOI 10.1172/JCI113846; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GOLDSTEIN M, 1989, PSYCHOPHARMACOL BULL, V25, P349; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JINNAH HA, 1990, BRAIN RES BULL, V25, P467, DOI 10.1016/0361-9230(90)90239-V; JINNAH HA, 1991, BEHAV NEUROSCI, V105, P1004, DOI 10.1037/0735-7044.105.6.1004; KEOUGH DT, 1988, J INHERIT METAB DIS, V11, P229, DOI 10.1007/BF01800364; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAKE CR, 1977, SCIENCE, V196, P905, DOI 10.1126/science.860124; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEESE HJ, 1991, J REPROD FERTIL, V91, P197; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LEWIS MH, 1985, PSYCHOPHARMACOLOGY, V85, P204, DOI 10.1007/BF00428415; LLOYD HGE, 1981, PHARMACOL BIOCHEM BE, V14, P827, DOI 10.1016/0091-3057(81)90368-3; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; MINANA MD, 1984, J NEUROCHEM, V43, P1556, DOI 10.1111/j.1471-4159.1984.tb06078.x; MOORE TF, 1992, DEVELOPMENT, V1152, P1011; MOYER JD, 1983, CAN J BIOCHEM CELL B, V61, P1153, DOI 10.1139/o83-148; MUELLER K, 1982, PHARMACOL BIOCHEM BE, V17, P613, DOI 10.1016/0091-3057(82)90332-X; PETERS JM, 1967, ARCH INT PHARMACOD T, V169, P139; RAZZAK A, 1977, JPN J PHARMACOL, V27, P145, DOI 10.1254/jjp.27.145; ROSENBLOOM FM, 1967, J AMER MED ASSOC, V202, P175, DOI 10.1001/jama.202.3.175; SIMMONDS HA, 1986, CLIN CHIM ACTA, V160, P1003; SINNETT D, 1988, HUM GENET, V81, P4, DOI 10.1007/BF00283719; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; USHIJIMA I, 1984, PSYCHOPHARMACOLOGY, V83, P335, DOI 10.1007/BF00428541; WILLIAMSON DJ, 1992, J INHERIT METAB DIS, V15, P665, DOI 10.1007/BF01799622; WILLIAMSON DJ, 1991, ADV EXP MED BIOL, V309, P269	44	75	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					235	240		10.1038/ng0393-235	http://dx.doi.org/10.1038/ng0393-235			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485579				2022-12-17	WOS:A1993KP79000013
J	Morgan, MAJ; Shilatifard, A				Morgan, Marc A. J.; Shilatifard, Ali			Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE ACTIVITY; COMPASS FAMILY; LYSINE 9; H3K4 MONOMETHYLATION; BIVALENT PROMOTERS; H2A UBIQUITYLATION; ACTIVE CHROMATIN; RNA-SYNTHESIS; POLYCOMB	Recent progress relating to the catalytic and non-catalytic functions of histone modifying complexes warrants a fresh look at the role of histone modifications and the "histone code" model. Histone-modifying enzymes are implicated in the control of diverse DNA-templated processes including gene expression. Here, we outline historical and current thinking regarding the functions of histone modifications and their associated enzymes. One current viewpoint, based largely on correlative evidence, posits that histone modifications are instructive for transcriptional regulation and represent an epigenetic 'code'. Recent studies have challenged this model and suggest that histone marks previously associated with active genes do not directly cause transcriptional activation. Additionally, many histone-modifying proteins possess non-catalytic functions that overshadow their enzymatic activities. Given that much remains unknown regarding the functions of these proteins, the field should be cautious in interpreting loss-of-function phenotypes and must consider both cellular and developmental context. In this Perspective, we focus on recent progress relating to the catalytic and non-catalytic functions of the Trithorax-COMPASS complexes, Polycomb repressive complexes and Clr4/Suv39 histone-modifying machineries.	[Morgan, Marc A. J.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Simpson Querrey Inst Epigenet, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Simpson Querrey Inst Epigenet, Chicago, IL 60611 USA.	ASH@Northwestern.edu		Morgan, Marc/0000-0002-0141-6273	National Cancer Institute through Outstanding Investigator Award [R35CA197569]	National Cancer Institute through Outstanding Investigator Award	We thank N. Ethen for scientific illustrations and A. Piunti for critical reading and input on this manuscript. Studies in the laboratory of A.S. are supported by generous funding from the National Cancer Institute through Outstanding Investigator Award R35CA197569.	Acquaviva L, 2013, EPIGENETICS-US, V8, P355, DOI 10.4161/epi.24295; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Armache A, 2020, NATURE, V583, P852, DOI 10.1038/s41586-020-2533-0; Ashokkumar D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186999; Bajusz I, 2001, GENETICS, V159, P1135; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blackledge NP, 2020, MOL CELL, V77, P857, DOI 10.1016/j.molcel.2019.12.001; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Boyle S, 2020, GENE DEV, V34, P931, DOI 10.1101/gad.336487.120; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Burton A, 2020, NAT CELL BIOL, V22, P767, DOI 10.1038/s41556-020-0536-6; Cao KX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8747; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deevy O, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.181354; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Douillet D, 2020, NAT GENET, V52, P615, DOI 10.1038/s41588-020-0618-1; Eagen KP, 2017, P NATL ACAD SCI USA, V114, P8764, DOI 10.1073/pnas.1701291114; Erdel F, 2020, MOL CELL, V78, P236, DOI 10.1016/j.molcel.2020.02.005; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gehre M, 2020, NAT GENET, V52, P273, DOI 10.1038/s41588-020-0586-5; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Howe FS, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600095; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Hubner JM, 2019, NEURO-ONCOLOGY, V21, P878, DOI 10.1093/neuonc/noz058; Iglesias N, 2018, NATURE, V560, P504, DOI 10.1038/s41586-018-0398-2; Iglesias N, 2017, ELIFE, V6, DOI 10.7544/eLife.29503; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jain SU, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09981-6; Jang SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13808-9; Jang SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05177-6; Jang YH, 2017, J MOL BIOL, V429, P2046, DOI 10.1016/j.jmb.2016.12.016; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; Kassis JA, 2017, GENETICS, V206, P1699, DOI 10.1534/genetics.115.185116; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kusevic D, 2017, BIOCHIMIE, V135, P83, DOI 10.1016/j.biochi.2017.01.013; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leatham-Jensen M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007932; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee CH, 2018, MOL CELL, V70, P422, DOI 10.1016/j.molcel.2018.03.020; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lui JC, 2018, J CLIN ENDOCR METAB, V103, P1470, DOI 10.1210/jc.2017-01948; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martire S, 2019, NAT GENET, V51, P941, DOI 10.1038/s41588-019-0428-5; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Morgan MAJ, 2017, GENE DEV, V31, P2003, DOI 10.1101/gad.305201.117; Morgan MA, 2013, SCIENCE, V340, P823, DOI 10.1126/science.1239223; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Oksuz O, 2018, MOL CELL, V70, P1149, DOI 10.1016/j.molcel.2018.05.023; Pajtler KW, 2018, ACTA NEUROPATHOL, V136, P211, DOI 10.1007/s00401-018-1877-0; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Penke TJR, 2018, GENETICS, V208, P229, DOI [10.1534/genetics.117.300292, 10.1534/genetics.117.300480]; Penke TJR, 2016, GENE DEV, V30, P1866, DOI 10.1101/gad.286278.116; Perez-Lluch S, 2015, NAT GENET, V47, P1158, DOI 10.1038/ng.3381; Perino M, 2018, NAT GENET, V50, P1002, DOI 10.1038/s41588-018-0134-8; Piunti A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2887; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Plys AJ, 2019, GENE DEV, V33, P799, DOI 10.1101/gad.326488.119; Poepsel S, 2018, NAT STRUCT MOL BIOL, V25, P154, DOI 10.1038/s41594-018-0023-y; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; Ragazzini R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11800-x; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rickels R, 2020, GENE DEV, V34, P1493, DOI 10.1101/gad.339762.120; Rickels R, 2018, TRENDS CELL BIOL, V28, P608, DOI 10.1016/j.tcb.2018.04.003; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sanulli S, 2019, NATURE, V575, P390, DOI 10.1038/s41586-019-1669-2; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shan CM, 2016, ELIFE, V5, DOI 10.7554/eLife.17903; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sitbon D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15084-4; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Stepanik VA, 2012, DEV BIOL, V364, P249, DOI 10.1016/j.ydbio.2011.12.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Sze CC, 2017, GENE DEV, V31, P1732, DOI 10.1101/gad.303768.117; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tatton-Brown K, 2017, AM J HUM GENET, V100, P725, DOI 10.1016/j.ajhg.2017.03.010; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; TIDWELL T, 1968, J BIOL CHEM, V243, P707; Tsuboi M, 2018, DEV CELL, V47, P758, DOI 10.1016/j.devcel.2018.11.018; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2019, MOL CELL, V76, P646, DOI 10.1016/j.molcel.2019.08.019; Wani AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10291; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; Weinert BT, 2018, CELL, V174, P231, DOI 10.1016/j.cell.2018.04.033; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yu R, 2018, NATURE, V558, P615, DOI 10.1038/s41586-018-0239-3; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang TT, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01957-w; Zhang WM, 2019, DEV CELL, V48, P406, DOI 10.1016/j.devcel.2018.11.047	143	74	77	3	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2020	52	12					1271	1281		10.1038/s41588-020-00736-4	http://dx.doi.org/10.1038/s41588-020-00736-4		NOV 2020	11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA2UH	33257899				2022-12-17	WOS:000595285500002
J	Nativio, R; Lan, YM; Donahue, G; Sidoli, S; Berson, A; Srinivasan, AR; Shcherbakova, O; Amlie-Wolf, A; Nie, J; Cui, XL; He, C; Wang, LS; Garcia, BA; Trojanowski, JQ; Bonini, NM; Berger, SL				Nativio, Raffaella; Lan, Yemin; Donahue, Greg; Sidoli, Simone; Berson, Amit; Srinivasan, Ananth R.; Shcherbakova, Oksana; Amlie-Wolf, Alexandre; Nie, Ji; Cui, Xiaolong; He, Chuan; Wang, Li-San; Garcia, Benjamin A.; Trojanowski, John Q.; Bonini, Nancy M.; Berger, Shelley L.			An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease	NATURE GENETICS			English	Article							RUBINSTEIN-TAYBI-SYNDROME; S-PHASE ENTRY; HISTONE H3; TRANSCRIPTION FACTOR; BINDING PROTEIN; ACETYLATION; TAU; CBP; METHYLATION; EXPRESSION	Protein aggregation is the hallmark of neurodegeneration, but the molecular mechanisms underlying late-onset Alzheimer's disease (AD) are unclear. Here we integrated transcriptomic, proteomic and epigenomic analyses of postmortem human brains to identify molecular pathways involved in AD. RNA sequencing analysis revealed upregulation of transcription- and chromatin-related genes, including the histone acetyltransferases for H3K27ac and H3K9ac. An unbiased proteomic screening singled out H3K27ac and H3K9ac as the main enrichments specific to AD. In turn, epigenomic profiling revealed gains in the histone H3 modifications H3K27ac and H3K9ac linked to transcription, chromatin and disease pathways in AD. Increasing genome-wide H3K27ac and H3K9ac in a fly model of AD exacerbated amyloid-beta 42-driven neurodegeneration. Together, these findings suggest that AD involves a reconfiguration of the epigenome, wherein H3K27ac and H3K9ac affect disease pathways by dysregulating transcription- and chromatin-gene feedback loops. The identification of this process highlights potential epigenetic strategies for early-stage disease treatment. Multi-omic profiling of brain tissue from patients with Alzheimer's disease (AD) identifies gains in H3K27ac and H3K9ac linked to transcription and disease pathways. Increasing H3K27ac and H3K9ac in a fly model of AD exacerbates neurodegeneration.	[Nativio, Raffaella; Donahue, Greg; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nativio, Raffaella; Lan, Yemin; Donahue, Greg; Sidoli, Simone; Garcia, Benjamin A.; Berger, Shelley L.] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Berson, Amit; Srinivasan, Ananth R.; Shcherbakova, Oksana; Bonini, Nancy M.; Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Amlie-Wolf, Alexandre; Wang, Li-San; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Nie, Ji; Cui, Xiaolong; He, Chuan] Univ Chicago, Dept Chem, Dept Biochem & Mol Biol, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Nie, Ji; Cui, Xiaolong; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Berger, Shelley L.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sidoli, Simone] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Albert Einstein College of Medicine	Berger, SL (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bonini, NM; Berger, SL (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu; bergers@pennmedicine.upenn.edu	CUI, XIAOLONG/GRF-0957-2022	CUI, XIAOLONG/0000-0002-1345-2271; Berger, Shelley/0000-0001-5398-4400; Amlie-Wolf, Alexandre/0000-0002-2073-1519; Shcherbakova, Oksana/0000-0001-7940-3256	National Institutes of Health (NIH)/National Institute on Aging [P01-AG031862]; Kleber foundation; NIH/National Institute of Neurological Disorders and Stroke [R35-NS097275]; NIAGADS [U24-AG041689]; Global Alliance for Chronic Diseases [U54-AG052427]; NIH [R01-NS111997, AI118891];  [R01-HG006827];  [T32-AG00255];  [AG10124]	National Institutes of Health (NIH)/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kleber foundation; NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAGADS; Global Alliance for Chronic Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; 	We thank A. Shilatifard for the histone H3.3WT and the histone mutants H3.3K27M and H3.3K9M. We thank members of the Berger laboratory for comments on the data analyses and P. Ortega for insightful scientific discussions. This work was supported by the Kleber foundation (S.L.B. and N.M.B.), a National Institutes of Health (NIH)/National Institute on Aging grant no. P01-AG031862 (S.L.B.) and an NIH/National Institute of Neurological Disorders and Stroke grant no. R35-NS097275 (N.M.B.). C.H. is supported by grant no. R01-HG006827. C.H. is a Howard Hughes Medical Institute Investigator. L.W. is supported by grant nos. U24-AG041689 (NIAGADS) and U54-AG052427 (Global Alliance for Chronic Diseases). A.A.-W. is supported by training grant no. T32-AG00255. B.A.G. is supported by NIH grant nos. R01-NS111997 and AI118891. J.Q.T. is supported by grant no. AG10124.	Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Anderson KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126592; Banzhaf-Strathmann J, 2014, EMBO J, V33, P1667, DOI 10.15252/embj.201387576; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; BENHATTAR J, 1988, GENE, V65, P219, DOI 10.1016/0378-1119(88)90458-1; Berson A, 2018, TRENDS NEUROSCI, V41, P587, DOI 10.1016/j.tins.2018.05.005; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chien HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047481; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cummings J, 2018, CTS-CLIN TRANSL SCI, V11, P147, DOI 10.1111/cts.12491; Cutler T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137691; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; De Ferrari GV, 2014, CNS NEUROL DISORD-DR, V13, P745; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; GABRIELLI F, 1984, MOL CELL BIOCHEM, V65, P57, DOI 10.1007/BF00226019; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Han D, 2016, MOL CELL, V63, P711, DOI 10.1016/j.molcel.2016.06.028; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaimori JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24318; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein HU, 2019, NAT NEUROSCI, V22, P37, DOI 10.1038/s41593-018-0291-1; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee YF, 2011, AM J PHYSIOL-ENDOC M, V301, pE91, DOI 10.1152/ajpendo.00701.2010; Liu BY, 2013, J BIOL CHEM, V288, P24581, DOI 10.1074/jbc.M113.467506; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Marzi SJ, 2018, NAT NEUROSCI, V21, P1618, DOI 10.1038/s41593-018-0253-7; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; Mitxelena J, 2018, NUCLEIC ACIDS RES, V46, P4546, DOI 10.1093/nar/gky218; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Nagy Z, 1998, NEUROSCIENCE, V87, P731; Nativio R, 2018, NAT NEUROSCI, V21, P497, DOI 10.1038/s41593-018-0101-9; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P139, DOI 10.4137/GRSB.S13204; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Sidoli S, 2015, ANAL CHEM, V87, P11448, DOI 10.1021/acs.analchem.5b03009; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sun WJ, 2014, GENOMICS, V104, P347, DOI 10.1016/j.ygeno.2014.08.021; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tate CM, 2010, FEBS J, V277, P210, DOI 10.1111/j.1742-4658.2009.07475.x; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Toledo JB, 2014, ALZHEIMERS DEMENT, V10, P477, DOI 10.1016/j.jalz.2013.06.003; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Vaeth Martin, 2018, F1000Res, V7, P260, DOI 10.12688/f1000research.13426.1; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; Vincent-Fabert C, 2016, BLOOD, V127, P1881, DOI 10.1182/blood-2015-09-666974; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weinert BT, 2018, CELL, V174, P231, DOI 10.1016/j.cell.2018.04.033; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Wu YL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00114; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Xu K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/143269; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yuan ZF, 2018, J PROTEOME RES, V17, P2533, DOI 10.1021/acs.jproteome.8b00133; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245; Zhang P, 2014, CELL REP, V6, P1110, DOI 10.1016/j.celrep.2014.02.011; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	114	74	76	11	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2020	52	10					1024	+		10.1038/s41588-020-0696-0	http://dx.doi.org/10.1038/s41588-020-0696-0		SEP 2020	31	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NV5GP	32989324	Green Submitted, Green Accepted			2022-12-17	WOS:000573500100003
J	Jessa, S; Blanchet-Cohen, A; Krug, B; Vladoiu, M; Coutelier, M; Faury, D; Poreau, B; De Jay, N; Hebert, S; Monlong, J; Farmer, WT; Donovan, LK; Hu, YX; McConechy, MK; Cavalli, FMG; Mikael, LG; Ellezam, B; Richer, M; Allaire, A; Weil, AG; Atkinson, J; Farmer, JP; Dudley, RWR; Larouche, V; Crevier, L; Albrecht, S; Filbin, MG; Sartelet, H; Lutz, PE; Nagy, C; Turecki, G; Costantino, S; Dirks, PB; Murai, KK; Bourque, G; Ragoussis, J; Garzia, L; Taylor, MD; Jabado, N; Kleinman, CL				Jessa, Selin; Blanchet-Cohen, Alexis; Krug, Brian; Vladoiu, Maria; Coutelier, Marie; Faury, Damien; Poreau, Brice; De Jay, Nicolas; Hebert, Steven; Monlong, Jean; Farmer, W. Todd; Donovan, Laura K.; Hu, Yixing; McConechy, Melissa K.; Cavalli, Florence M. G.; Mikael, Leonie G.; Ellezam, Benjamin; Richer, Maxime; Allaire, Andrea; Weil, Alexander G.; Atkinson, Jeffrey; Farmer, Jean-Pierre; Dudley, Roy W. R.; Larouche, Valerie; Crevier, Louis; Albrecht, Steffen; Filbin, Mariella G.; Sartelet, Herve; Lutz, Pierre-Eric; Nagy, Corina; Turecki, Gustavo; Costantino, Santiago; Dirks, Peter B.; Murai, Keith K.; Bourque, Guillaume; Ragoussis, Jiannis; Garzia, Livia; Taylor, Michael D.; Jabado, Nada; Kleinman, Claudia L.			Stalled developmental programs at the root of pediatric brain tumors	NATURE GENETICS			English	Article							HIGH-GRADE; PATHWAY ACTIVATION; HISTONE H3.3; RHOMBIC LIP; STEM-CELLS; EXPRESSION; MEDULLOBLASTOMA; MUTATIONS; SUBGROUPS; LANDSCAPE	Childhood brain tumors have suspected prenatal origins. To identify vulnerable developmental states, we generated a single-cell transcriptome atlas of >65,000 cells from embryonal pons and forebrain, two major tumor locations. We derived signatures for 191 distinct cell populations and defined the regional cellular diversity and differentiation dynamics. Projection of bulk tumor transcriptomes onto this dataset shows that WNT medulloblastomas match the rhombic lip-derived mossy fiber neuronal lineage and embryonal tumors with multilayered rosettes fully recapitulate a neuronal lineage, while group 2a/b atypical teratoid/rhabdoid tumors may originate outside the neuroectoderm. Importantly, single-cell tumor profiles reveal highly defined cell hierarchies that mirror transcriptional programs of the corresponding normal lineages. Our findings identify impaired differentiation of specific neural progenitors as a common mechanism underlying these pediatric cancers and provide a rational framework for future modeling and therapeutic interventions.	[Jessa, Selin] McGill Univ, Quantitat Life Sci, Montreal, PQ, Canada; [Jessa, Selin; Blanchet-Cohen, Alexis; Coutelier, Marie; De Jay, Nicolas; Hebert, Steven; Hu, Yixing; Kleinman, Claudia L.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Blanchet-Cohen, Alexis; Krug, Brian; Coutelier, Marie; De Jay, Nicolas; Hebert, Steven; Monlong, Jean; Hu, Yixing; McConechy, Melissa K.; Bourque, Guillaume; Ragoussis, Jiannis; Jabado, Nada; Kleinman, Claudia L.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Vladoiu, Maria; Donovan, Laura K.; Cavalli, Florence M. G.; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Vladoiu, Maria; Donovan, Laura K.; Cavalli, Florence M. G.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Faury, Damien; Poreau, Brice; Mikael, Leonie G.; Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Faury, Damien; Poreau, Brice; Mikael, Leonie G.; Jabado, Nada] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Poreau, Brice] Ctr Hosp Univ, Serv Genet & Procreat, Grenoble, France; [Monlong, Jean] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Farmer, W. Todd; Murai, Keith K.] McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Hlth Ctr,Brain Repair & Integrat Neurosci Program, Montreal, PQ, Canada; [Farmer, W. Todd; Murai, Keith K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Ellezam, Benjamin] Univ Montreal, Dept Pathol, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Richer, Maxime; Allaire, Andrea] Univ Sherbrooke, Dept Pathol, CHU Sherbrooke, Sherbrooke, PQ, Canada; [Weil, Alexander G.] Univ Montreal, Dept Pediat Neurosurg, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Atkinson, Jeffrey; Farmer, Jean-Pierre; Dudley, Roy W. R.] McGill Univ, Montreal Childrens Hosp, Dept Pediat Surg, Div Neurosurg, Montreal, PQ, Canada; [Larouche, Valerie] Univ Laval, Dept Pediat, CHU Quebec, Ctr Mere Enfant Soleil, Quebec City, PQ, Canada; [Crevier, Louis] Univ Laval, Dept Surg, Quebec City, PQ, Canada; [Albrecht, Steffen] McGill Univ, Montreal Childrens Hosp, Dept Pathol, Hlth Ctr, Montreal, PQ, Canada; [Filbin, Mariella G.] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA USA; [Sartelet, Herve] CHU Grenoble, Dept Pathol, Grenoble, France; [Lutz, Pierre-Eric] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, Federat Med Translat Strasbourg, CNRS, Strasbourg, France; [Lutz, Pierre-Eric; Nagy, Corina; Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Lutz, Pierre-Eric; Nagy, Corina; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Costantino, Santiago] Maisonneuve Rosemt Hosp Res Ctr, Montreal, PQ, Canada; [Costantino, Santiago] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Dirks, Peter B.; Taylor, Michael D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Dirks, Peter B.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bourque, Guillaume; Ragoussis, Jiannis] McGill Univ, Montreal, PQ, Canada; [Bourque, Guillaume; Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Bourque, Guillaume] Canadian Ctr Computat Genom, Montreal, PQ, Canada; [Garzia, Livia] McGill Univ, Canc Res Program, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Garzia, Livia] McGill Univ, Fac Surg, Div Orthoped Surg, Montreal, PQ, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of California System; University of California Santa Cruz; McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Laval University; Laval University; McGill University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University; McGill University; Universite de Montreal; University of Toronto; University of Toronto; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Kleinman, CL (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Jabado, N; Kleinman, CL (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada.; Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Taylor, MD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	mdt.cm@gmail.com; nada.jabado@mcgill.ca; claudia.kleinman@mcgill.ca	Bourque, Guillaume/AFR-2927-2022; Costantino, Santiago/ABD-5472-2020; Jabado, Nada/AAN-4026-2020; Ragoussis, Ioannis/AAD-9790-2022; Monlong, Jean/AAZ-8589-2020	Bourque, Guillaume/0000-0002-3933-9656; Costantino, Santiago/0000-0002-2454-2635; Monlong, Jean/0000-0002-9737-5516; Donovan, Laura/0000-0001-5557-5539; Cavalli, Florence M. G./0000-0002-4409-9642; Jessa, Selin/0000-0003-4192-6523; Ragoussis, Ioannis/0000-0002-8515-0934; Weil, Alexander/0000-0003-4162-6096; Coutelier, Marie/0000-0002-0261-7210	Large-Scale Applied Research Project grant from Genome Quebec; Genome Canada; Government of Canada; Ministere de l'Economie, de la Science et de l'Innovation du Quebec; Ontario Research Fund through Government of Ontario; Canadian Institutes for Health Research (CIHR) [PJT-156086, MOP-286756, FDN-154307]; US National Institutes of Health (NIH) [P01-CA196539, R01CA148699, R01CA159859]; Canadian Cancer Society (CCSRI) [705182]; NSERC [RGPIN-2016-04911]; Fonds de Recherche du Quebec en Sante (FRQS); National Sciences and Engineering Research Council [NSERC-448167-2013]; FRQS [25348]; CFI Leaders Opportunity Fund [32557, 33902]; Genome Canada Science Technology Innovation Centre; Compute Canada Resource Allocation Project [WST-164-AB]; Genome Canada Genome Innovation Node [244819]; Fondation Charles-Bruneau; Chaire de Recherche Award from the FRQS; Stand Up to Cancer (SU2C) Canada Cancer Stem Cell Dream Team Research Funding [SU2C-AACR-DT-19-15]; SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; Genome Quebec; Pediatric Brain Tumour Foundation; Canadian Institutes of Health Research; Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Genome BC; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Cancer Research UK Brain Tumour Award; Canadian Cancer Society Research Institute Impact grant; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto; CIHR; TD/LDI; RMGA; CIHR Banting postdoctoral fellowship; FRQS; NATIONAL CANCER INSTITUTE [R01CA159859, P01CA196539] Funding Source: NIH RePORTER	Large-Scale Applied Research Project grant from Genome Quebec; Genome Canada(Genome Canada); Government of Canada(CGIAR); Ministere de l'Economie, de la Science et de l'Innovation du Quebec; Ontario Research Fund through Government of Ontario; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society (CCSRI); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec en Sante (FRQS); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQS; CFI Leaders Opportunity Fund(Canada Foundation for Innovation); Genome Canada Science Technology Innovation Centre(Genome Canada); Compute Canada Resource Allocation Project; Genome Canada Genome Innovation Node; Fondation Charles-Bruneau; Chaire de Recherche Award from the FRQS; Stand Up to Cancer (SU2C) Canada Cancer Stem Cell Dream Team Research Funding; SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant; Genome Quebec; Pediatric Brain Tumour Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cure Search Foundation; b.r.a.i.n.child; Meagan's Walk; SWIFTY Foundation; Genome BC; Ontario Research Fund; Worldwide Cancer Research; V-Foundation for Cancer Research; Cancer Research UK Brain Tumour Award; Canadian Cancer Society Research Institute Impact grant; Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children; University of Toronto(University of Toronto); CIHR(Canadian Institutes of Health Research (CIHR)); TD/LDI; RMGA; CIHR Banting postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); FRQS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from: a Large-Scale Applied Research Project grant from Genome Quebec, Genome Canada, the Government of Canada and the Ministere de l'Economie, de la Science et de l'Innovation du Quebec, with the support of the Ontario Research Fund through funding provided by the Government of Ontario to N.J., M.D.T., C.L.K., P.B.D., G.B., J.R. and L.G.; the Canadian Institutes for Health Research (CIHR grant nos. PJT-156086, to C.L.K., and MOP-286756 and FDN-154307, to N.J.); the US National Institutes of Health (NIH grant nos. P01-CA196539, to N.J., R01CA148699 and R01CA159859, to M.D.T.); the Canadian Cancer Society (CCSRI grant no. 705182), NSERC (grant no. RGPIN-2016-04911) and the Fonds de Recherche du Quebec en Sante (FRQS) salary award to C.L.K.; National Sciences and Engineering Research Council (grant no. NSERC-448167-2013) and FRQS (grant no. 25348) to G.B.; CFI Leaders Opportunity Fund (grant nos. 32557, to J.R., and 33902, to C.L.K.), Genome Canada Science Technology Innovation Centre, Compute Canada Resource Allocation Project (grant no. WST-164-AB) and Genome Canada Genome Innovation Node (grant no. 244819) to J.R.; and the Fondation Charles-Bruneau. Data analyses were enabled by computer and storage resources provided by Compute Canada and Calcul Quebec. N.J. is a member of the Penny Cole Laboratory and the recipient of a Chercheur Boursier, Chaire de Recherche Award from the FRQS. This work was performed within the context of the International Childhood Astrocytoma Integrated Genomic and Epigenomic (ICHANGE) consortium, and the Stand Up to Cancer (SU2C) Canada Cancer Stem Cell Dream Team Research Funding (grant no. SU2C-AACR-DT-19-15, to M.D.T. and N.J.) and SU2C St. Baldrick's Pediatric Dream Team Translational Research Grant (no. SU2C-AACR-DT1113, to M.D.T.), with funding from Genome Canada and Genome Quebec. Stand Up to Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.D.T. is supported by The Pediatric Brain Tumour Foundation, The Canadian Institutes of Health Research, The Cure Search Foundation, b.r.a.i.n.child, Meagan's Walk, SWIFTY Foundation, Genome Canada, Genome BC, Genome Quebec, the Ontario Research Fund, Worldwide Cancer Research, V-Foundation for Cancer Research, Cancer Research UK Brain Tumour Award, Canadian Cancer Society Research Institute Impact grant and the Garron Family Chair in Childhood Cancer Research at the Hospital for Sick Children and the University of Toronto. S.J. is supported by a fellowship from CIHR. A.B.-C. is supported by a fellowship from FRQS and TD/LDI. N.D.J. is a recipient of a fellowship from FRQS and RMGA. M.K.M. is funded by a CIHR Banting postdoctoral fellowship. We thank K. Mann, S. Spira and J. Di Noia for critical reading of the manuscript, and S. Krumholtz for graphical editing of figures. We are especially grateful for the generous philanthropic donations of the Fondation Charles-Bruneau, and the Kat D-DIPG, Poppies for Irina and We Love You Connie Foundations.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; [Anonymous], 2014, GENOME BIOL, DOI DOI 10.1186/S13059-014-0550-8; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Dipietrantonio HJ, 2009, NEUROSCIENCE, V162, P560, DOI 10.1016/j.neuroscience.2009.02.082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fan XY, 2018, CELL RES, V28, P730, DOI 10.1038/s41422-018-0053-3; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Fontebasso AM, 2014, ACTA NEUROPATHOL, V128, P615, DOI 10.1007/s00401-014-1325-8; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10421; Harutyunyan AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09140-x; Hidalgo-Sanchez M, 2012, DEV BIOL, V371, P215, DOI 10.1016/j.ydbio.2012.08.019; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Jacob K, 2011, CLIN CANCER RES, V17, P4650, DOI 10.1158/1078-0432.CCR-11-0127; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kieran MW, 2010, J CLIN ONCOL, V28, P4783, DOI 10.1200/JCO.2010.28.3481; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Krug B, 2019, CANCER CELL, V35, P782, DOI [10.1016/j.ccell.2019.04.004, 10.1016/j.ccell.2019.08.012]; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Lu JQ, 2012, CAN J NEUROL SCI, V39, P605, DOI 10.1017/S031716710001533X; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; Mi D, 2018, SCIENCE, V360, P81, DOI 10.1126/science.aar6821; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Morales D, 2006, J NEUROSCI, V26, P12226, DOI 10.1523/JNEUROSCI.3493-06.2006; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Nagy C., 2019, BIORXIV, DOI [DOI 10.1101/384479, 10.1101/384479]; Neumann JE, 2017, NAT MED, V23, P1191, DOI 10.1038/nm.4402; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nguyen QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04334-1; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Pathania M, 2017, CANCER CELL, V32, P684, DOI 10.1016/j.ccell.2017.09.014; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torchia J, 2016, CANCER CELL, V30, P891, DOI 10.1016/j.ccell.2016.11.003; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Valdora F, 2013, INT J MOL SCI, V14, P7492, DOI 10.3390/ijms14047492; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vitte J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00346-5; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yuzwa SA, 2017, CELL REP, V21, P3970, DOI 10.1016/j.celrep.2017.12.017; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	78	74	75	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2019	51	12					1702	+		10.1038/s41588-019-0531-7	http://dx.doi.org/10.1038/s41588-019-0531-7			30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR5XD	31768071	Green Accepted			2022-12-17	WOS:000499696700007
J	McFaline-Figueroa, JL; Hill, AJ; Qiu, XJ; Jackson, D; Shendure, J; Trapnell, C				McFaline-Figueroa, Jose L.; Hill, Andrew J.; Qiu, Xiaojie; Jackson, Dana; Shendure, Jay; Trapnell, Cole			A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition	NATURE GENETICS			English	Article							EXPRESSION; CANCER; TRANSDIFFERENTIATION; MECHANISMS; INTEGRITY; CIRCUITS; REVEALS	Integrating single-cell trajectory analysis with pooled genetic screening could reveal the genetic architecture that guides cellular decisions in development and disease. We applied this paradigm to probe the genetic circuitry that controls epithelial-to-mesenchymal transition (EMT). We used single-cell RNA sequencing to profile epithelial cells undergoing a spontaneous spatially determined EMT in the presence or absence of transforming growth factor-beta. Pseudospatial trajectory analysis identified continuous waves of gene regulation as opposed to discrete 'partial' stages of EMT. KRAS was connected to the exit from the epithelial state and the acquisition of a fully mesenchymal phenotype. A pooled single-cell CRISPR-Cas9 screen identified EMT-associated receptors and transcription factors, including regulators of KRAS, whose loss impeded progress along the EMT. Inhibiting the KRAS effector MEK and its upstream activators EGFR and MET demonstrates that interruption of key signaling events reveals regulatory 'checkpoints' in the EMT continuum that mimic discrete stages, and reconciles opposing views of the program that controls EMT.	[McFaline-Figueroa, Jose L.; Hill, Andrew J.; Qiu, Xiaojie; Jackson, Dana; Shendure, Jay; Trapnell, Cole] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qiu, Xiaojie] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Shendure, Jay; Trapnell, Cole] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA USA; [Shendure, Jay; Trapnell, Cole] Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Trapnell, C (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Trapnell, C (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.; Trapnell, C (corresponding author), Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA USA.	coletrap@uw.edu	Horwitz, Marshall/AAE-8376-2021; Shendure, Jay/AAU-3684-2021	Trapnell, Cole/0000-0002-8105-4347; Shendure, Jay/0000-0002-1516-1865; McFaline-Figueroa, Jose L./0000-0003-4387-1511	NIH [T32HL007828, T32HG000035, U54DK107979, DP2HD088158, RC2DK114777, R01HL118342, DP1HG007811, R01HG006283]; NSF; Paul G. Allen Frontiers Group; Alfred P. Sloan Foundation Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL145611, T32HL007828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK114777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Paul G. Allen Frontiers Group; Alfred P. Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Trapnell and Shendure laboratories for helpful discussions during the course of this study and feedback on our manuscript, particularly S. Srivatsan, L. Saunders, H. Pliner and J. Packer. We thank N. M. Cruz for feedback on our manuscript. J.L.M.F. thanks S.V. McFaline-Cruz for support. J.L.M.F. was supported by NIH grants T32HL007828 and T32HG000035. A.J.H. was supported by an NSF Graduate Research Fellowship. J.S. and C.T. are supported by NIH grant no. U54DK107979 and the Paul G. Allen Frontiers Group. C.T. is supported by NIH grant nos. DP2HD088158, RC2DK114777 and R01HL118342 and is partly supported by an Alfred P. Sloan Foundation Research Fellowship. J.S. is supported by NIH grant nos. DP1HG007811 and R01HG006283 and is an investigator of the Howard Hughes Medical Institute.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Aiello NM, 2018, DEV CELL, V45, P681, DOI 10.1016/j.devcel.2018.05.027; Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Alpert A, 2018, NAT METHODS, V15, P267, DOI [10.1038/NMETH.4628, 10.1038/nmeth.4628]; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cacchiarelli D, 2018, CELL SYST, V7, P258, DOI 10.1016/j.cels.2018.07.006; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; George JT, 2017, CANCER RES, V77, P6415, DOI 10.1158/0008-5472.CAN-16-3521; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hill AJ, 2018, NAT METHODS, V15, P271, DOI [10.1038/NMETH.4604, 10.1038/nmeth.4604]; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Huang RYJ, 2012, J CELL SCI, V125, P4417, DOI 10.1242/jcs.099697; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Krishnaswamy S., 2017, BIORXIV, DOI [10.1101/155028, DOI 10.1101/155028]; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li MR, 2016, EXP BIOL MED, V241, P1, DOI 10.1177/1535370215597194; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Rabiner L., 1993, FUNDAMENTALS SPEECH; Reed NI, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5094; Rodriguez Luis G., 2004, V294, P23; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Shaul YD, 2014, CELL, V158, P1094, DOI 10.1016/j.cell.2014.07.032; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Vintsyuk T.K., 1968, CYBERNETICS, V4, P52, DOI [10.1007/bf01074755, DOI 10.1007/BF01074755, 10.1007/BF01074755]; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304	64	74	74	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2019	51	9					1389	+		10.1038/s41588-019-0489-5	http://dx.doi.org/10.1038/s41588-019-0489-5			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV1AX	31477929	Green Accepted			2022-12-17	WOS:000484010800015
J	Davies, MR; McIntyre, L; Mutreja, A; Lacey, JA; Lees, JA; Towers, RJ; Duchene, S; Smeesters, PR; Frost, HR; Price, DJ; Holden, MTG; David, S; Giffard, PM; Worthing, KA; Seale, AC; Berkley, JA; Harris, SR; Rivera-Hernandez, T; Berking, O; Cork, AJ; Torres, RSLA; Lithgow, T; Strugnell, RA; Bergmann, R; Nitsche-Schmitz, P; Chhatwal, GS; Bentley, SD; Fraser, JD; Moreland, NJ; Carapetis, JR; Steer, AC; Parkhill, J; Saul, A; Williamson, DA; Currie, BJ; Tong, SYC; Dougan, G; Walker, MJ				Davies, Mark R.; McIntyre, Liam; Mutreja, Ankur; Lacey, Jake A.; Lees, John A.; Towers, Rebecca J.; Duchene, Sebastian; Smeesters, Pierre R.; Frost, Hannah R.; Price, David J.; Holden, Matthew T. G.; David, Sophia; Giffard, Philip M.; Worthing, Kate A.; Seale, Anna C.; Berkley, James A.; Harris, Simon R.; Rivera-Hernandez, Tania; Berking, Olga; Cork, Amanda J.; Torres, Rosangela S. L. A.; Lithgow, Trevor; Strugnell, Richard A.; Bergmann, Rene; Nitsche-Schmitz, Patric; Chhatwal, Gusharan S.; Bentley, Stephen D.; Fraser, John D.; Moreland, Nicole J.; Carapetis, Jonathan R.; Steer, Andrew C.; Parkhill, Julian; Saul, Allan; Williamson, Deborah A.; Currie, Bart J.; Tong, Steven Y. C.; Dougan, Gordon; Walker, Mark J.			Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics	NATURE GENETICS			English	Article							PHYLOGENETIC ANALYSIS; SCARLET FEVER; EMM TYPE; PYOGENES; PROTEIN; DISEASE; RECOMBINATION; EPIDEMIC; IMMUNOGENICITY; IMMUNIZATION	Group A Streptococcus (GAS; Streptococcus pyogenes) is a bacterial pathogen for which a commercial vaccine for humans is not available. Employing the advantages of high-throughput DNA sequencing technology to vaccine design, we have analyzed 2,083 globally sampled GAS genomes. The global GAS population structure reveals extensive genomic heterogeneity driven by homologous recombination and overlaid with high levels of accessory gene plasticity. We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility. To determine vaccine candidate coverage, we investigated all of the previously described GAS candidate antigens for gene carriage and gene sequence heterogeneity. Only 15 of 28 vaccine antigen candidates were found to have both low naturally occurring sequence variation and high (>99%) coverage across this diverse GAS population. This technological platform for vaccine coverage determination is equally applicable to prospective GAS vaccine antigens identified in future studies.	[Davies, Mark R.; McIntyre, Liam; Duchene, Sebastian; Worthing, Kate A.; Strugnell, Richard A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Davies, Mark R.; McIntyre, Liam; Lacey, Jake A.; Duchene, Sebastian; Price, David J.; Worthing, Kate A.; Strugnell, Richard A.; Williamson, Deborah A.; Tong, Steven Y. C.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Davies, Mark R.; Mutreja, Ankur; Holden, Matthew T. G.; David, Sophia; Harris, Simon R.; Bentley, Stephen D.; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Davies, Mark R.; Rivera-Hernandez, Tania; Berking, Olga; Cork, Amanda J.; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Davies, Mark R.; Rivera-Hernandez, Tania; Berking, Olga; Cork, Amanda J.; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Mutreja, Ankur; Saul, Allan] GSK Vaccines Inst Global Hlth, Siena, Italy; [Lacey, Jake A.; Tong, Steven Y. C.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Doherty Dept, Melbourne, Vic, Australia; [Lees, John A.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Towers, Rebecca J.; Giffard, Philip M.; Currie, Bart J.; Tong, Steven Y. C.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Duchene, Sebastian] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Smeesters, Pierre R.; Frost, Hannah R.] Univ Libre Bruxelles, Mol Bacteriol Lab, Brussels, Belgium; [Smeesters, Pierre R.; Frost, Hannah R.] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Dept Pediat, Brussels, Belgium; [Smeesters, Pierre R.; Frost, Hannah R.; Steer, Andrew C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Price, David J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Price, David J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic, Australia; [Holden, Matthew T. G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Seale, Anna C.] Wellcome Trust Res Ctr, Kilifi, Kenya; [Berkley, James A.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Torres, Rosangela S. L. A.] Lab Cent Estado Parana, Lab Bacteriol, Epidemiol Lab, Curitiba, Parana, Brazil; [Torres, Rosangela S. L. A.] Lab Cent Estado Parana, Dis Control Div, Curitiba, Parana, Brazil; [Torres, Rosangela S. L. A.] Univ Posit, Dept Med, Curitiba, Parana, Brazil; [Lithgow, Trevor] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Lithgow, Trevor] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia; [Bergmann, Rene; Nitsche-Schmitz, Patric; Chhatwal, Gusharan S.] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Fraser, John D.; Moreland, Nicole J.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Carapetis, Jonathan R.] Perth Childrens Hosp, Perth, WA, Australia; [Williamson, Deborah A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Microbiol Diagnost Unit,Publ Hlth Lab, Melbourne, Vic, Australia; [Tong, Steven Y. C.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Dougan, Gordon] Univ Cambridge, Dept Med, Cambridge, England	University of Melbourne; Royal Melbourne Hospital; Wellcome Trust Sanger Institute; University of Queensland; University of Queensland; GlaxoSmithKline; University of Melbourne; New York University; Charles Darwin University; Menzies School of Health Research; University of Melbourne; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Victorian Infectious Diseases Reference Laboratory; University of St Andrews; University of Oxford; Monash University; Monash University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Auckland; Telethon Kids Institute; University of Western Australia; University of Melbourne; Royal Melbourne Hospital; University of Cambridge	Davies, MR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Davies, MR (corresponding author), Royal Melbourne Hosp, Melbourne, Vic, Australia.; Davies, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.; Davies, MR; Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.; Davies, MR; Walker, MJ (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	mark.davies1@unimelb.edu.au; mark.walker@uq.edu.au	Rivera-Hernandez, Tania/AAG-7511-2020; Tong, Steven/N-2353-2013; Davies, Mark R/J-2128-2014; Worthing, Kate/AAG-4907-2019; Saul, Allan/ABH-2091-2020; Parkhill, Julian/G-4703-2011; Lacey, Jake/AAV-6910-2020; Carapetis, Jonathan R/H-8933-2014; Holden, Matthew TG/K-6449-2014; Smeesters, Pierre/I-7723-2012	Tong, Steven/0000-0002-1368-8356; Davies, Mark R/0000-0001-6141-5179; Saul, Allan/0000-0003-0665-4091; Parkhill, Julian/0000-0002-7069-5958; Lacey, Jake/0000-0002-6492-6983; Carapetis, Jonathan R/0000-0002-1182-9792; Holden, Matthew TG/0000-0002-4958-2166; Seale, Anna/0000-0002-0129-3146; Worthing, Kate/0000-0001-8713-7189; Moreland, Nicole/0000-0001-6548-637X; Smeesters, Pierre/0000-0002-2642-9919; Strugnell, Richard/0000-0003-0614-5641; Frost, Hannah/0000-0002-1543-2805; Berkley, James/0000-0002-1236-849X; Rivera-Hernandez, Tania/0000-0002-3582-9973; Price, David/0000-0003-0076-3123; Duchene, Sebastian/0000-0002-2863-0907; Walker, Mark/0000-0001-7423-2769; Lees, John/0000-0001-5360-1254; Williamson, Deborah/0000-0001-7363-6665; Giffard, Phil/0000-0002-3030-9127	National Health and Medical Research Council; Wellcome Trust, UK; National Health and Medical Research Council postdoctoral training fellowship [635250]; European Union's Seventh Framework Programme FP7/2007-2013/under REA grant [251522]; Coalition to Accelerate New Vaccines Against Streptococcus (CANVAS; an Australian and New Zealand joint initiative)	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK(Wellcome Trust); National Health and Medical Research Council postdoctoral training fellowship; European Union's Seventh Framework Programme FP7/2007-2013/under REA grant; Coalition to Accelerate New Vaccines Against Streptococcus (CANVAS; an Australian and New Zealand joint initiative)	This work was supported by National Health and Medical Research Council project and program grants for: Protein Glycan Interactions in Infectious Diseases and Cellular Microbiology; the Coalition to Accelerate New Vaccines Against Streptococcus (CANVAS; an Australian and New Zealand joint initiative); and The Wellcome Trust, UK. For part of this study, M. R. D. was supported by a National Health and Medical Research Council postdoctoral training fellowship (635250) and A. M. was a GENDRIVAX fellow funded by the European Union's Seventh Framework Programme FP7/2007-2013/under REA grant agreement number 251522. We acknowledge assistance from the sequencing and pathogen informatics core teams at The Wellcome Trust Sanger Institute. We acknowledge and thank the database curators of the S. pyogenes MLST and emm databases (especially D. Bessen). We dedicate this work to the memory of our friend and colleague Gusharan Singh Chhatwal.	Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Athey TBT, 2014, J CLIN MICROBIOL, V52, P1871, DOI 10.1128/JCM.00029-14; Bao YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36644; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Bergmann R, 2014, INT J MED MICROBIOL, V304, P370, DOI 10.1016/j.ijmm.2013.12.001; Brandt ER, 2000, NAT MED, V6, P455, DOI 10.1038/74719; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaguza C, 2016, MBIO, V7, DOI 10.1128/mBio.01053-16; Chalker V, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3603-z; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Chochua S, 2017, MBIO, V8, DOI [10.1128/mBio.01422-17, 10.1128/mbio.01422-17]; Corander J, 2017, NAT ECOL EVOL, V1, P1950, DOI 10.1038/s41559-017-0337-x; Coscolla M, 2007, ENVIRON MICROBIOL, V9, P643, DOI 10.1111/j.1462-2920.2006.01184.x; Courtney HS, 2017, CLIN EXP VACCINE RES, V6, P45, DOI [10.7774/cevr.2017.6.1.45, 10.7774/cevr.2017.6.1.45.]; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; David S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006855; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Driebe EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130955; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Feil SC, 2014, J MOL BIOL, V426, P785, DOI 10.1016/j.jmb.2013.11.020; Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Henningham A, 2018, MBIO, V9, DOI 10.1128/mBio.02294-17; Henningham A, 2013, CURR TOP MICROBIOL, V368, P207, DOI 10.1007/82_2012_284; Henningham A, 2012, J MOL MED, V90, P1197, DOI 10.1007/s00109-012-0897-9; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ibrahim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168177; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; Kagawa TF, 2009, J MOL BIOL, V386, P754, DOI 10.1016/j.jmb.2008.12.074; Kapatai G, 2017, PEERJ, V5, DOI 10.7717/peerj.3226; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lees JA, 2019, GENOME RES, V29, P304, DOI 10.1101/gr.241455.118; Lees JA, 2018, BIOINFORMATICS, V34, P4310, DOI 10.1093/bioinformatics/bty539; Lees JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12797; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; McIver KS, 1996, INFECT IMMUN, V64, P2548, DOI 10.1128/IAI.64.7.2548-2555.1996; McNally A, 2018, SIGNATURES NEGATIVE, DOI [10.1101/400374, DOI 10.1101/400374]; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Mostowy R, 2017, MOL BIOL EVOL, V34, P1167, DOI 10.1093/molbev/msx066; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000083; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pandey M, 2016, J IMMUNOL, V196, P3364, DOI 10.4049/jimmunol.1501994; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rivera-Hernandez T, 2019, MBIO, V10, DOI 10.1128/mBio.00693-19; Sabharwal H, 2006, J INFECT DIS, V193, P129, DOI 10.1086/498618; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Souvorov A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1540-z; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Turner CE, 2015, MBIO, V6, DOI 10.1128/mBio.00622-15; VALENTINWEIGAND P, 1994, MICROB PATHOGENESIS, V17, P111, DOI 10.1006/mpat.1994.1057; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693; Wescombe PA, 2009, FUTURE MICROBIOL, V4, P819, DOI [10.2217/fmb.09.61, 10.2217/FMB.09.61]; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Woodbury RL, 2008, ANTIMICROB AGENTS CH, V52, P1140, DOI 10.1128/AAC.01352-07; Wyres KL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008114; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; You YH, 2018, EBIOMEDICINE, V28, P128, DOI 10.1016/j.ebiom.2018.01.010	79	74	76	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2019	51	6					1035	+		10.1038/s41588-019-0417-8	http://dx.doi.org/10.1038/s41588-019-0417-8			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB1AY	31133745	Green Accepted, Green Submitted, Bronze			2022-12-17	WOS:000469996900015
J	Millet, EJ; Kruijer, W; Coupel-Ledru, A; Prado, SA; Cabrera-Bosquet, L; Lacube, S; Charcosset, A; Welcker, C; van Eeuwijk, F; Tardieu, F				Millet, Emilie J.; Kruijer, Willem; Coupel-Ledru, Aude; Prado, Santiago Alvarez; Cabrera-Bosquet, Llorenc; Lacube, Sebastien; Charcosset, Alain; Welcker, Claude; van Eeuwijk, Fred; Tardieu, Francois			Genomic prediction of maize yield across European environmental conditions	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; WATER-DEFICIT; CROP PRODUCTION; DROUGHT; MODEL; WHEAT; SENSITIVITIES; IDENTIFICATION; CLIMATE; STRESS	The development of germplasm adapted to changing climate is required to ensure food security(1,2). Genomic prediction is a powerful tool to evaluate many genotypes but performs poorly in contrasting environmental scenarios(3-7) (genotype x environment interaction), in spite of promising results for flowering time(8). New avenues are opened by the development of sensor networks for environmental characterization in thousands of fieldes(9,10). We present a new strategy for germplasm evaluation under genotype x environment interaction. Yield was dissected in grain weight and number and genotype x environment interaction in these components was modeled as genotypic sensitivity to environmental drivers. Environments were characterized using genotype-specific indices computed from sensor data in each field and the progression of phenology calibrated for each genotype on a phenotyping platform. A whole-genome regression approach for the genotypic sensitivities led to accurate prediction of yield under genotype x environment interaction in a wide range of environmental scenarios, outperforming a benchmark approach.	[Millet, Emilie J.; Kruijer, Willem; van Eeuwijk, Fred] WUR, Biometris, Wageningen, Netherlands; [Millet, Emilie J.; Coupel-Ledru, Aude; Prado, Santiago Alvarez; Cabrera-Bosquet, Llorenc; Lacube, Sebastien; Welcker, Claude; Tardieu, Francois] Univ Montpellier, INRA, SupAgro, LEPSE, Montpellier, France; [Charcosset, Alain] Univ Paris Saclay, Univ Paris Sud, AgroParisTech, GQE Le Moulon,INRA,CNRS, Gif Sur Yvette, France; [Coupel-Ledru, Aude] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Prado, Santiago Alvarez] IFEVA, Buenos Aires, DF, Argentina; [Prado, Santiago Alvarez] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Wageningen University & Research; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Bristol; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Tardieu, F (corresponding author), Univ Montpellier, INRA, SupAgro, LEPSE, Montpellier, France.	francois.tardieu@inra.fr	Coupel-Ledru, Aude/AAB-9540-2019; Kruijer, Willem/AAJ-7245-2020; Coupel-Ledru, Aude/AAK-8168-2021; Cabrera-Bosquet, Llorenc/B-5032-2010	Coupel-Ledru, Aude/0000-0003-2097-5924; WELCKER, Claude/0000-0002-8275-1259; Millet, Emilie/0000-0002-2913-4892; van Eeuwijk, Fred/0000-0003-3672-2921; Lacube, Sebastien/0000-0002-7934-1822; Alvarez Prado, Santiago/0000-0003-0433-5222; Tardieu, Francois/0000-0002-7287-0094; Cabrera-Bosquet, Llorenc/0000-0002-2147-2846	EU [H2020 731013, FP7-244374]; Agence Nationale de la Recherche [ANR-10-BTBR-01, ANR-11-INBS-0012]; Netherlands Scientific Organisation for Research NWO-STW project [11145]	EU(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Netherlands Scientific Organisation for Research NWO-STW project	We are grateful to A. Grau, B. Suard, C. Check, P. Sidawy and T. Laisne for technical assistance in the Phenoarch experiments, as well as to key persons from the 2014 field experiments at Arvalis, Euralis and KWS. We are also grateful to S. Nicolas and S. Negro for the genotyping (imputation and quality check) and to R. Rincent for advice on the use of the BGLR package. This work was supported by the EU project FP7-244374 (DROPS), the Agence Nationale de la Recherche projects ANR-10-BTBR-01 (Amaizing) and ANR-11-INBS-0012 (Phenome), the Netherlands Scientific Organisation for Research NWO-STW project 11145 Learning from Nature and the EU project H2020 731013 (EPPN<SUP>2020</SUP>).	Andrade FH, 1999, CROP SCI, V39, P453, DOI 10.2135/cropsci1999.0011183X0039000200026x; Bonneau J, 2013, THEOR APPL GENET, V126, P747, DOI 10.1007/s00122-012-2015-3; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Bustos-Korts D, 2016, G3-GENES GENOM GENET, V6, P3733, DOI 10.1534/g3.116.035410; Cabrera-Bosquet L, 2016, NEW PHYTOL, V212, P269, DOI 10.1111/nph.14027; Chapuis R, 2012, EUR J AGRON, V42, P59, DOI 10.1016/j.eja.2011.12.006; Chenu K, 2013, NEW PHYTOL, V198, P801, DOI 10.1111/nph.12192; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; FISCHER RA, 1975, CROP SCI, V15, P607, DOI 10.2135/cropsci1975.0011183X001500050002x; Fuad-Hassan A, 2008, PLANT CELL ENVIRON, V31, P1349, DOI 10.1111/j.1365-3040.2008.01839.x; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Girardin P, 2000, ECOPHYSIOLOGIE MAIS; Guilioni L, 2000, AGR FOREST METEOROL, V100, P213, DOI 10.1016/S0168-1923(99)00130-6; Hammer GL, 2010, J EXP BOT, V61, P2185, DOI 10.1093/jxb/erq095; Harrison MT, 2014, GLOBAL CHANGE BIOL, V20, P867, DOI 10.1111/gcb.12381; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Jarquin D, 2014, THEOR APPL GENET, V127, P595, DOI 10.1007/s00122-013-2243-1; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Li X, 2018, P NATL ACAD SCI USA, V115, P6679, DOI 10.1073/pnas.1718326115; Ly D, 2018, FIELD CROP RES, V216, P32, DOI 10.1016/j.fcr.2017.08.020; Maiorano A, 2014, EUR J AGRON, V59, P86, DOI 10.1016/j.eja.2014.05.011; Malosetti M, 2016, CROP SCI, V56, P2210, DOI 10.2135/cropsci2015.05.0311; Messina CD, 2018, EUR J AGRON, V100, P151, DOI 10.1016/j.eja.2018.01.007; Millet E. J, 2019, MULTISITE EXPT NETWO, DOI [10.15454/IASSTN, DOI 10.15454/IASSTN]; Millet EJ, 2016, PLANT PHYSIOL, V172, P749, DOI 10.1104/pp.16.00621; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Negro S. S, 2018, GENOTYPING BY SEQUEN, DOI [10.1101/476598V1, DOI 10.1101/476598V1]; Neveu P, 2019, NEW PHYTOL, V221, P588, DOI 10.1111/nph.15385; Oury V, 2016, PLANT PHYSIOL, V171, P986, DOI 10.1104/pp.15.00268; Pachauri R.K., 2014, CLIMATE CHANGE 2014; Parent B, 2018, P NATL ACAD SCI USA, V115, P10642, DOI 10.1073/pnas.1720716115; Parent B, 2017, PLANT PHYSIOL, V174, P1669, DOI 10.1104/pp.17.00372; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Prado SA, 2018, PLANT CELL ENVIRON, V41, P314, DOI 10.1111/pce.13083; R Core Team, 2019, R LANG ENV STAT COMP; Ribaut JM, 1997, THEOR APPL GENET, V94, P887, DOI 10.1007/BF00221905; Rio S, 2019, THEOR APPL GENET, V132, P81, DOI 10.1007/s00122-018-3196-1; Roorkiwal M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30027-2; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Slafer G. A., 1994, FIELD CROPS RES, V27, P85; Steinbach D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat058; Tardieu F, 2018, ANNU REV PLANT BIOL, V69, P733, DOI 10.1146/annurev-arplant-042817-040218; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Welcker C, 2011, PLANT PHYSIOL, V157, P718, DOI 10.1104/pp.111.176479; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, P1, DOI 10.1007/978-3-319-24277-4	49	74	77	5	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2019	51	6					952	+		10.1038/s41588-019-0414-y	http://dx.doi.org/10.1038/s41588-019-0414-y			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB1AY	31110353				2022-12-17	WOS:000469996900007
J	Young, AI; Frigge, ML; Gudbjartsson, DF; Thorleifsson, G; Bjornsdottir, G; Sulem, P; Masson, G; Thorsteinsdottir, U; Stefansson, K; Kong, A				Young, Alexander I.; Frigge, Michael L.; Gudbjartsson, Daniel F.; Thorleifsson, Gudmar; Bjornsdottir, Gyda; Sulem, Patrick; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari; Kong, Augustine			Relatedness disequilibrium regression estimates heritability without environmental bias	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEQUENCE VARIANTS; EDUCATIONAL-ATTAINMENT; HUMAN TRAITS; TWIN; METAANALYSIS; HEIGHT; LOCI; MENARCHE; DESCENT	Heritability measures the proportion of trait variation that is due to genetic inheritance. Measurement of heritability is important in the nature-versus-nurture debate. However, existing estimates of heritability may be biased by environmental effects. Here, we introduce relatedness disequilibrium regression (RDR), a novel method for estimating heritability. RDR avoids most sources of environmental bias by exploiting variation in relatedness due to random Mendelian segregation. We used a sample of 54,888 Icelanders who had both parents genotyped to estimate the heritability of 14 traits, including height (55.4%, s.e. 4.4%) and educational attainment (17.0%, s.e. 9.4%). Our results suggest that some other estimates of heritability may be inflated by environmental effects.	[Young, Alexander I.; Frigge, Michael L.; Gudbjartsson, Daniel F.; Thorleifsson, Gudmar; Bjornsdottir, Gyda; Sulem, Patrick; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari; Kong, Augustine] Amgen Inc, DeCODE Genet, Reykjavik, Iceland; [Young, Alexander I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Young, Alexander I.; Kong, Augustine] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Gudbjartsson, Daniel F.; Kong, Augustine] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Iceland; University of Iceland	Young, AI; Kong, A (corresponding author), Amgen Inc, DeCODE Genet, Reykjavik, Iceland.; Young, AI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Young, AI; Kong, A (corresponding author), Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.; Kong, A (corresponding author), Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland.	alexander.young@bdi.ox.ac.uk; augustine.kong@bdi.ox.ac.uk	Stefansson, Kari/AAE-7187-2019	Gudbjartsson, Daniel/0000-0002-5222-9857; Young, Alexander/0000-0001-9930-989X; Kong, Augustine/0000-0001-8193-5438; Masson, Gisli/0000-0003-0493-8242; Bjornsdottir, Gyda/0000-0002-8100-0306; Frigge, Michael/0000-0003-2984-535X	Wellcome Trust Doctoral Studentship [099670/Z/12/Z]; Li Ka Shing Foundation	Wellcome Trust Doctoral Studentship; Li Ka Shing Foundation	A.I.Y. was supported by a Wellcome Trust Doctoral Studentship (099670/Z/12/Z) for part of this project. A.I.Y. and A. K. were supported by the Li Ka Shing Foundation for part of this project.	Arpegard J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001467; Baker JH, 2012, J ADOLESCENT HEALTH, V51, P491, DOI 10.1016/j.jadohealth.2012.02.013; Baud A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006498; Bijma P, 2010, GENETICS, V186, P1013, DOI 10.1534/genetics.110.120493; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; CAREY G, 1986, BEHAV GENET, V16, P319, DOI 10.1007/BF01071314; Carlsson S, 2013, DIABETOLOGIA, V56, P1031, DOI 10.1007/s00125-013-2859-3; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Heckerman D, 2016, P NATL ACAD SCI USA, V113, P7377, DOI 10.1073/pnas.1510497113; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; Hill W. D., 2018, GENOMIC ANAL FAMILY, DOI [10.1038/s41380-017-0005-1, DOI 10.1038/S41380-017-0005-1]; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2018, SCIENCE, V359, P424, DOI 10.1126/science.aan6877; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krapohl E, 2016, MOL PSYCHIATR, V21, P437, DOI 10.1038/mp.2015.2; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pedersen NL, 2002, TWIN RES, V5, P427, DOI 10.1375/twin.5.5.427; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Rahman I, 2009, TWIN RES HUM GENET, V12, P286, DOI 10.1375/twin.12.3.286; Sesardic N., 2005, MAKING SENSE HERITAB; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Sofer T, 2017, STAT APPL GENET MOL, V16, P259, DOI 10.1515/sagmb-2016-0076; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stoolmiller M, 1999, PSYCHOL BULL, V125, P392, DOI 10.1037/0033-2909.125.4.392; THOMSON G, 1995, AM J HUM GENET, V57, P487; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tuvblad C, 2006, J CHILD PSYCHOL PSYC, V47, P734, DOI 10.1111/j.1469-7610.2005.01552.x; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Young AI, 2014, GENETICS, V198, P1405, DOI 10.1534/genetics.114.170795; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	40	74	74	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2018	50	9					1304	+		10.1038/s41588-018-0178-9	http://dx.doi.org/10.1038/s41588-018-0178-9			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GS0CH	30104764	Green Submitted, Green Accepted			2022-12-17	WOS:000443151300022
J	Whitington, T; Gao, P; Song, W; Ross-Adams, H; Lamb, AD; Yang, YH; Svezia, I; Klevebring, D; Mills, IG; Karlsson, R; Halim, S; Dunning, MJ; Egevad, L; Warren, AY; Neal, DE; Gronberg, H; Lindberg, J; Wei, GH; Wiklund, F				Whitington, Thomas; Gao, Ping; Song, Wei; Ross-Adams, Helen; Lamb, Alastair D.; Yang, Yuehong; Svezia, Ilaria; Klevebring, Daniel; Mills, Ian G.; Karlsson, Robert; Halim, Silvia; Dunning, Mark J.; Egevad, Lars; Warren, Anne Y.; Neal, David E.; Gronberg, Henrik; Lindberg, Johan; Wei, Gong-Hong; Wiklund, Fredrik			Gene regulatory mechanisms underpinning prostate cancer susceptibility	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; RECEPTOR; BINDING; GENOME; ENHANCER; LOCI; STRATIFICATION; ASSOCIATION; DISCOVERY	Molecular characterization of genome-wide association study (GWAS) loci can uncover key genes and biological mechanisms underpinning complex traits and diseases. Here we present deep, high-throughput characterization of gene regulatory mechanisms underlying prostate cancer risk loci. Our methodology integrates data from 295 prostate cancer chromatin immunoprecipitation and sequencing experiments with genotype and gene expression data from 602 prostate tumor samples. The analysis identifies new gene regulatory mechanisms affected by risk locus SNPs, including widespread disruption of ternary androgen receptor (AR)-FOXA1 and AR-HOXB13 complexes and competitive binding mechanisms. We identify 57 expression quantitative trait loci at 35 risk loci, which we validate through analysis of allele-specific expression. We further validate predicted regulatory SNPs and target genes in prostate cancer cell line models. Finally, our integrated analysis can be accessed through an interactive visualization tool. This analysis elucidates how genome sequence variation affects disease predisposition via gene regulatory mechanisms and identifies relevant genes for downstream biomarker and drug development.	[Whitington, Thomas; Klevebring, Daniel; Karlsson, Robert; Gronberg, Henrik; Lindberg, Johan; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gao, Ping; Song, Wei; Yang, Yuehong; Svezia, Ilaria; Wei, Gong-Hong] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Gao, Ping; Song, Wei; Yang, Yuehong; Svezia, Ilaria; Wei, Gong-Hong] Univ Oulu, Bioctr, Oulu, Finland; [Ross-Adams, Helen; Lamb, Alastair D.; Halim, Silvia; Dunning, Mark J.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Lamb, Alastair D.] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England; [Mills, Ian G.] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, Prostate Canc Res Grp, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Inst Canc Res, Dept Mol Oncol, Oslo, Norway; [Mills, Ian G.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Movember Ctr Excellence Prostate Canc Res, Prostate Canc UK, Belfast, Antrim, North Ireland; [Halim, Silvia] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Egevad, Lars] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Warren, Anne Y.] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Neal, David E.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	Karolinska Institutet; University of Oulu; University of Oulu; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oslo; University of Oslo; University of Oslo; Queens University Belfast; Beatson Institute; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Whitington, T (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	thomas.whitington@ki.se	Lamb, Alastair/AAD-6375-2019; Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Karlsson, Robert/0000-0002-8949-2587; Ross-Adams, Helen/0000-0003-1338-742X; Wei, Gong-Hong/0000-0001-6546-9334; Klevebring, Daniel/0000-0002-9810-3838; Dunning, Mark/0000-0002-8853-9435; gao, ping/0000-0003-1383-3290; Lindberg, Johan/0000-0003-3610-6774	Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2013051]; National Cancer Research Institute (National Institute of Health Research (NIHR) [G0500966/75466]; Addenbrooke's Hospital Human Research Tissue bank; NIHR Cambridge Biomedical Research Centre; Cancer Research UK [C5047/A14835]; Swedish Cancer Society [CAN 2012/823, 09-0677]; Linnaeus grant [70867902]; Swedish Research Council [2010/3674]; Cancer Risk Prediction (CRisP) Center; Academy of Finland [284618, 279760]; Jane and Aatos Erkko Foundation; Chinese Scholarship Council [201206300074]; Academy of Medical Sciences (AMS) [AMS-SGCL11-Lamb] Funding Source: researchfish; Cancer Research UK [22310] Funding Source: researchfish; National Institute for Health Research [CL-2012-14-003] Funding Source: researchfish	Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); National Cancer Research Institute (National Institute of Health Research (NIHR); Addenbrooke's Hospital Human Research Tissue bank; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Swedish Cancer Society(Swedish Cancer Society); Linnaeus grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Risk Prediction (CRisP) Center; Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Chinese Scholarship Council(China Scholarship Council); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the authors of all the ChIP-seq data used in this study; a full listing of the original publications and corresponding accession codes is provided in Supplementary Table 1. We acknowledge the ENCODE Consortium and the Stamatoyannopoulos laboratory for generating the DNase-seq data considered here. The RNA-seq data analyzed here were generated by the TCGA Research Network (see URLs). Computations were performed using resources provided by the Swedish National Infrastructure for Computing (SNIC), through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project b2013051. We acknowledge the National Cancer Research Institute (National Institute of Health Research (NIHR)) collaborative study Prostate Cancer: Mechanisms of Progression and Treatment (ProMPT) collaborative (grant G0500966/75466) (see URLs) and the Addenbrooke's Hospital Human Research Tissue bank, NIHR Cambridge Biomedical Research Centre, which funded tissue collections in Cambridge. This work was funded by a Cancer Research UK program grant, C5047/A14835, awarded to D.E.N., Swedish Cancer Society grants CAN 2012/823 and 09-0677, a Linnaeus grant (contract 70867902), Swedish Research Council grant 2010/3674 and the Cancer Risk Prediction (CRisP) Center (see URLs). Academy of Finland (284618 and 279760) and Jane and Aatos Erkko Foundation grants were awarded to G.-H.W., and a Chinese Scholarship Council fellowship (201206300074) was awarded to P.G.	Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Feng JJ, 2011, CANCER EPIDEM BIOMAR, V20, P2396, DOI 10.1158/1055-9965.EPI-11-0523; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Nguyen HH, 2012, HUM MOL GENET, V21, P2076, DOI 10.1093/hmg/dds025; Hartmann H, 2013, GENOME RES, V23, P181, DOI 10.1101/gr.139881.112; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hazelett DJ, 2013, CELL CYCLE, V12, P379, DOI 10.4161/cc.23201; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Jankowski A, 2013, GENOME RES, V23, P1307, DOI 10.1101/gr.154922.113; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Mills IG, 2014, NAT REV CANCER, V14, P187, DOI 10.1038/nrc3678; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pedersen SF, 2013, CANCER RES, V73, P1658, DOI 10.1158/0008-5472.CAN-12-4188; Penney KL, 2015, CANCER EPIDEM BIOMAR, V24, P255, DOI 10.1158/1055-9965.EPI-14-0694-T; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross-Adams H, 2015, EBIOMEDICINE, V2, P1133, DOI 10.1016/j.ebiom.2015.07.017; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Szarvas T, 2011, INT J CANCER, V128, P1486, DOI 10.1002/ijc.25454; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Warren AY, 2013, PROSTATE, V73, P194, DOI 10.1002/pros.22556; Whitington T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr341; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Xu X, 2014, EUR J HUM GENET, V22, P558, DOI 10.1038/ejhg.2013.195; Yokoyama Y, 2008, CLIN CANCER RES, V14, P5503, DOI 10.1158/1078-0432.CCR-07-4041; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	66	74	75	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					387	+		10.1038/ng.3523	http://dx.doi.org/10.1038/ng.3523			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950096				2022-12-17	WOS:000372908800010
J	Chetaille, P; Preuss, C; Burkhard, S; Cote, JM; Houde, C; Castilloux, J; Piche, J; Gosset, N; Leclerc, S; Wunnemann, F; Thibeault, M; Gagnon, C; Galli, A; Tuck, E; Hickson, GR; El Amine, N; Boufaied, I; Lemyre, E; Barbara, PDS; Faure, S; Jonzon, A; Cameron, M; Dietz, HC; Gallo-McFarlane, E; Benson, DW; Moreau, C; Labuda, D; Zhan, SH; Shen, YQ; Jomphe, M; Jones, SJM; Bakkers, J; Andelfinger, G				Chetaille, Philippe; Preuss, Christoph; Burkhard, Silja; Cote, Jean-Marc; Houde, Christine; Castilloux, Julie; Piche, Jessica; Gosset, Natacha; Leclerc, Severine; Wuennemann, Florian; Thibeault, Maryse; Gagnon, Carmen; Galli, Antonella; Tuck, Elizabeth; Hickson, Gilles R.; El Amine, Nour; Boufaied, Ines; Lemyre, Emmanuelle; Barbara, Pascal de Santa; Faure, Sandrine; Jonzon, Anders; Cameron, Michel; Dietz, Harry C.; Gallo-McFarlane, Elena; Benson, D. Woodrow; Moreau, Claudia; Labuda, Damian; Zhan, Shing H.; Shen, Yaoqing; Jomphe, Michele; Jones, Steven J. M.; Bakkers, Jeroen; Andelfinger, Gregor		FORGE Canada Consortium	Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm	NATURE GENETICS			English	Article							DE-LANGE-SYNDROME; IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION; SICK SINUS SYNDROME; CARDIAC-ARRHYTHMIA	The pacemaking activity of specialized tissues in the heart and gut results in lifelong rhythmic contractions. Here we describe a new syndrome characterized by Chronic Atrial and Intestinal Dysrhythmia, termed CAID syndrome, in 16 French Canadians and 1 Swede. We show that a single shared homozygous founder mutation in SGOL1, a component of the cohesin complex, causes CAID syndrome. Cultured dermal fibroblasts from affected individuals showed accelerated cell cycle progression, a higher rate of senescence and enhanced activation of TGF-beta signaling. Karyotypes showed the typical railroad appearance of a centromeric cohesion defect. Tissues derived from affected individuals displayed pathological changes in both the enteric nervous system and smooth muscle. Morpholino-induced knockdown of sgol1 in zebrafish recapitulated the abnormalities seen in humans with CAID syndrome. Our findings identify CAID syndrome as a novel generalized dysrhythmia, suggesting a new role for SGOL1 and the cohesin complex in mediating the integrity of human cardiac and gut rhythm.	[Chetaille, Philippe; Cote, Jean-Marc; Houde, Christine; Castilloux, Julie] Ctr Hosp Univ CHU Quebec, Ctr Mere Enfants Soleil, Dept Pediat, Quebec City, PQ, Canada; [Preuss, Christoph; Piche, Jessica; Gosset, Natacha; Leclerc, Severine; Wuennemann, Florian; Thibeault, Maryse; Gagnon, Carmen; Cameron, Michel; Andelfinger, Gregor] Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Burkhard, Silja] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Burkhard, Silja] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Galli, Antonella; Tuck, Elizabeth] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Hickson, Gilles R.; El Amine, Nour; Boufaied, Ines; Lemyre, Emmanuelle; Moreau, Claudia; Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Barbara, Pascal de Santa; Faure, Sandrine] INSERM U1046, Montpellier, France; [Jonzon, Anders] Uppsala Univ, Astrid Lindgrens Childrens Hosp, Sect Pediat, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Dietz, Harry C.; Gallo-McFarlane, Elena] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Benson, D. Woodrow] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Zhan, Shing H.; Shen, Yaoqing; Jones, Steven J. M.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Jomphe, Michele] Univ Quebec Chicoutimi, Projet BALSAC, Chicoutimi, PQ, Canada; [Andelfinger, Gregor] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Uppsala University; Howard Hughes Medical Institute; Johns Hopkins University; Medical College of Wisconsin; British Columbia Cancer Agency; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal	Andelfinger, G (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada.	gregor.andelfinger@recherche-ste-justine.qc.ca	FAURE, Sandrine/N-6506-2018; de Santa Barbara, Pascal/N-6426-2015; de Santa Barbara, Pascal/AAO-5969-2021; Scherer, Stephen W./B-3785-2013; Jones, Steven J/C-3621-2009; Bakkers, Jeroen/H-5551-2011; Wünnemann, Florian/K-9613-2019	FAURE, Sandrine/0000-0002-8902-8274; de Santa Barbara, Pascal/0000-0001-9040-2481; de Santa Barbara, Pascal/0000-0001-9040-2481; Scherer, Stephen W./0000-0002-8326-1999; Jones, Steven J/0000-0003-3394-2208; Bakkers, Jeroen/0000-0002-9418-0422; Zhan, Shing/0000-0002-6351-8873; Hickson, Gilles/0000-0001-7670-9815	Canadian government through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; Foundation Nussia; Andre Aisenstadt; La Fondation du Grand defi Pierre Lavoie; Fondation CHU Sainte-Justine; Fondation Leducq; Association des Pseudo Obstructions Intestinales Chroniques (France); Netherlands Organization for Scientific Research (NWO); ZonMw [91212086]; Fonds de Recherche du Quebec-Sante	Canadian government through Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; Foundation Nussia; Andre Aisenstadt; La Fondation du Grand defi Pierre Lavoie; Fondation CHU Sainte-Justine; Fondation Leducq(Leducq Foundation); Association des Pseudo Obstructions Intestinales Chroniques (France); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMw(Netherlands Organization for Health Research and Development); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	We are deeply indebted to all participating families and patients. We thank L. Gosselin, L. fEcuyer, M.-F. Boudreault, C. Faure, F. LeDeist, L. D'Aoust and the McGill Genome Quebec Innovation Centre (D. Vincent) for expert assistance. We gratefully acknowledge the contribution of all referring physicians and supporting staff to this project. We would like to thank J. Marcadier (clinical coordinator) and C. Beaulieu (project manager) for their contributions to the infrastructure of the FORGE Canada Consortium. The FORGE (Finding of Rare Disease Genes) Consortium Steering Committee includes Kym Boycott (University of Ottawa), Jan Friedman (University of British Columbia), Jacques Michaud (Universite de Montreal), Francois Bernier (University of Calgary), Michael Brudno (University of Toronto), Bridget Fernandez (Memorial University), Bartha Knoppers (McGill University) and Steve Scherer (University of Toronto). FORGE Canada was funded by the Canadian government through Genome Canada, the Canadian Institutes of Health Research and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec, Genome British Columbia, Foundation Nussia and Andre Aisenstadt, La Fondation du Grand defi Pierre Lavoie, Fondation CHU Sainte-Justine, Fondation Leducq, Association des Pseudo Obstructions Intestinales Chroniques (France), the Netherlands Organization for Scientific Research (NWO) and ZonMw (91212086). G.A. holds a Senior Scholarship from the Fonds de Recherche du Quebec-Sante and holds the Banque Nationale Research Chair in Cardiovascular Genetics. We thank G. Rouleau for sharing whole-exome data for control purposes and M. Samuels for critical reading of the manuscript.	Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bouchard G, 1989, Hist Mes, V4, P39, DOI 10.3406/hism.1989.874; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Deglincerti A, 2007, EUR J HUM GENET, V15, P889, DOI 10.1038/sj.ejhg.5201844; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Gargiulo A, 2007, AM J HUM GENET, V80, P751, DOI 10.1086/513321; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Heijman J, 2013, J MOL CELL CARDIOL, V64, P90, DOI 10.1016/j.yjmcc.2013.09.006; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kline AD, 2007, AM J MED GENET A, V143A, P1287, DOI 10.1002/ajmg.a.31757; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RODRIGUEZ RD, 1990, GERIATRICS, V45, P26; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Thompson EA, 2013, GENETICS, V194, P301, DOI 10.1534/genetics.112.148825; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	30	74	73	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1245	1249		10.1038/ng.3113	http://dx.doi.org/10.1038/ng.3113			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25282101	Green Published			2022-12-17	WOS:000344131900017
J	Hakimi, AA; Pham, CG; Hsieh, JJ				Hakimi, A. Ari; Pham, Can G.; Hsieh, James J.			A clear picture of renal cell carcinoma	NATURE GENETICS			English	Editorial Material							KIDNEY CANCER; MUTATIONS; PBRM1; GENE; BAP1	Two recent studies describe the largest molecular profiling analyses to date of clear-cell renal cell carcinoma (ccRCC) and report remarkably similar findings. The recurrent pathway alterations identified in these studies open new avenues for therapeutic advances in this chemotherapy- and radiation-resistant disease.	[Hakimi, A. Ari; Pham, Can G.; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Hakimi, AA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	hsiehj@mskcc.org						Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	15	74	76	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					849	850		10.1038/ng.2708	http://dx.doi.org/10.1038/ng.2708			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23892664				2022-12-17	WOS:000322374900005
J	Weinhold, N; Johnson, DC; Chubb, D; Chen, BW; Forsti, A; Hosking, FJ; Broderick, P; Ma, YP; Dobbins, SE; Hose, D; Walker, BA; Davies, FE; Kaiser, MF; Li, NL; Gregory, WA; Jackson, GH; Witzens-Harig, M; Neben, K; Hoffmann, P; Nothen, MM; Muhleisen, TW; Eisele, L; Ross, FM; Jauch, A; Goldschmidt, H; Houlston, RS; Morgan, GJ; Hemminki, K				Weinhold, Niels; Johnson, David C.; Chubb, Daniel; Chen, Bowang; Foersti, Asta; Hosking, Fay J.; Broderick, Peter; Ma, Yussanne P.; Dobbins, Sara E.; Hose, Dirk; Walker, Brian A.; Davies, Faith E.; Kaiser, Martin F.; Li, Ni L.; Gregory, Walter A.; Jackson, Graham H.; Witzens-Harig, Mathias; Neben, Kai; Hoffmann, Per; Noethen, Markus M.; Muehleisen, Thomas W.; Eisele, Lewin; Ross, Fiona M.; Jauch, Anna; Goldschmidt, Hartmut; Houlston, Richard S.; Morgan, Gareth J.; Hemminki, Kari			The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma	NATURE GENETICS			English	Article							CYCLIN D1; GENE-EXPRESSION; HUMAN GENOME; CANCER-RISK; PATHOGENESIS; ASSOCIATION; STRATIFICATION; CYTOGENETICS; METAANALYSIS; LYMPHOCYTES	A number of specific chromosomal abnormalities define the subgroups of multiple myeloma. In a meta-analysis of two genome-wide association studies of multiple myeloma including a total of 1,661 affected individuals, we investigated risk for developing a specific tumor karyotype. The t(11;14)(q13;q32) translocation in which CCND1 is placed under the control of the immunoglobulin heavy chain enhancer was strongly associated with the CCND1 c.870G>A polymorphism (P = 7.96 x 10(-11)). These results provide a model in which a constitutive genetic factor is associated with risk of a specific chromosomal translocation.	[Weinhold, Niels; Hose, Dirk; Witzens-Harig, Mathias; Neben, Kai; Goldschmidt, Hartmut] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Johnson, David C.; Walker, Brian A.; Davies, Faith E.; Kaiser, Martin F.; Li, Ni L.; Morgan, Gareth J.] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, Sutton, Surrey, England; [Chubb, Daniel; Hosking, Fay J.; Broderick, Peter; Ma, Yussanne P.; Dobbins, Sara E.; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Chen, Bowang; Foersti, Asta; Hemminki, Kari] German Canc Res Ctr, Heidelberg, Germany; [Foersti, Asta; Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Hose, Dirk; Goldschmidt, Hartmut] Natl Ctr Tumour Dis, Heidelberg, Germany; [Gregory, Walter A.] Univ Leeds, Leeds Inst Mol Med, Sect Clin Trials Res, Leeds, W Yorkshire, England; [Jackson, Graham H.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hoffmann, Per; Noethen, Markus M.; Muehleisen, Thomas W.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Eisele, Lewin] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Ross, Fiona M.] Wessex Reg Cytogenet Lab, Cytogenet Grp, Salisbury, Wilts, England; [Jauch, Anna] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Leeds; Newcastle University - UK; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Duisburg Essen; Ruprecht Karls University Heidelberg	Houlston, RS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	richard.houlston@icr.ac.uk; kari.hemminki@icr.ac.uk	Hoffmann, Per/A-5149-2010; Jackson, Graham/GMW-7638-2022; Goldschmidt, Hartmut/AAL-8069-2021; Witzens-Harig, Mathias/N-1790-2017	Hoffmann, Per/0000-0002-6573-983X; Jackson, Graham/0000-0003-0756-969X; morgan, gareth/0000-0002-4271-6360; Walker, Brian/0000-0002-8615-6254; Davies, Faith/0000-0002-3971-2393; Hosking, Fay/0000-0002-1101-039X; Broderick, Peter/0000-0002-8348-5829; Nothen, Markus/0000-0002-8770-2464; Witzens-Harig, Mathias/0000-0002-2799-4661; Houlston, Richard/0000-0002-5268-0242	Myeloma UK; Leukaemia and Lymphoma Research [LLR 10021, LLR 11006]; Cancer Research UK [C1298/A8362]; Bobby Moore Fund; National Health Service (NHS) via the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust; Dietmar-Hopp-Stiftung Walldorf; University Hospital Heidelberg; Heinz-Nixdorf Foundation; German Federal Ministry of Education and Research (BMBF)	Myeloma UK; Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Bobby Moore Fund; National Health Service (NHS) via the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust; Dietmar-Hopp-Stiftung Walldorf; University Hospital Heidelberg; Heinz-Nixdorf Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We are grateful to all the subjects and investigators at the individual centers for their participation. V.J. Forster is acknowledged for sample preparation. We also thank the staff of the CTRU (Clinical Trials Research Unit) University of Leeds and the NCRI (National Cancer Research Institute) Haematology Clinical Studies Group. In the UK, funding was provided by Myeloma UK, Leukaemia and Lymphoma Research (LLR 10021), Cancer Research UK (C1298/A8362, supported by the Bobby Moore Fund) and the National Health Service (NHS) via the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust. Leukaemia and Lymphoma Research provided funding for the Newcastle Myeloma Study (LLR 11006). In Germany, funding was provided by Dietmar-Hopp-Stiftung Walldorf, University Hospital Heidelberg and the German Cancer Aid. The HNR study was funded by the Heinz-Nixdorf Foundation (chairman M. Nixdorf) and the German Federal Ministry of Education and Research (BMBF).	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Broderick P, 2012, NAT GENET, V44, P58, DOI 10.1038/ng.993; Chiecchio L, 2006, LEUKEMIA, V20, P1610, DOI 10.1038/sj.leu.2404304; Chng WJ, 2007, BEST PRACT RES CL HA, V20, P571, DOI 10.1016/j.beha.2007.08.004; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Leveque C, 2007, EXP CELL RES, V313, P2719, DOI 10.1016/j.yexcr.2007.04.018; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Marsaud V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-103; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neben K, 2010, HAEMATOL-HEMATOL J, V95, P1150, DOI 10.3324/haematol.2009.016436; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Pabalan N, 2008, CANCER EPIDEM BIOMAR, V17, P2773, DOI 10.1158/1055-9965.EPI-08-0169; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Pettiti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Slotta-Huspenina J, 2012, HAEMATOL-HEMATOL J, V97, P1422, DOI 10.3324/haematol.2011.055715; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496	35	74	74	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2013	45	5					522	U87		10.1038/ng.2583	http://dx.doi.org/10.1038/ng.2583			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23502783	Green Accepted			2022-12-17	WOS:000318158200014
J	Buck, MJ; Lieb, JD				Buck, Michael J.; Lieb, Jason D.			A chromatin-mediated mechanism for specification of conditional transcription factor targets	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; DNA-BINDING; HDA1 DEACETYLASE; OSMOTIC-STRESS; REPRESSION; YEAST; COMPLEX; GENES; IDENTIFICATION	Organisms respond to changes in their environment, and many such responses are initiated at the level of gene transcription. Here, we provide evidence for a previously undiscovered mechanism for directing transcriptional regulators to new binding targets in response to an environmental change. We show that repressor-activator protein 1 (Rap1), a master regulator of yeast metabolism, binds to an expanded target set after glucose depletion despite decreasing protein levels and no evidence of posttranslational modification. Computational analysis predicts that proteins capable of recruiting the chromatin regulator Tup1 act to restrict the binding distribution of Rap1 in the presence of glucose. Deletion of the gene(s) encoding Tup1, recruiters of Tup1 or chromatin regulators recruited by Tup1 cause Rap1 to bind specifically and inappropriately to low-glucose targets. These data, combined with whole-genome measurements of nucleosome occupancy and Tup1 distribution, provide evidence for a mechanism of dynamic target specification that coordinates the genome-wide distribution of intermediate-affinity DNA sequence motifs with chromatin-mediated regulation of accessibility to those sites.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu		Lieb, Jason/0000-0001-7601-8061	NHGRI NIH HHS [HG0029989] Funding Source: Medline; NIGMS NIH HHS [R01 GM072518-01A1, R01 GM072518-02, GM072518, R01 GM072518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Park SH, 1999, MOL CELL BIOL, V19, P2044; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Regnacq M, 2001, MOL MICROBIOL, V40, P1085, DOI 10.1046/j.1365-2958.2001.02450.x; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	30	74	75	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1446	1451		10.1038/ng1917	http://dx.doi.org/10.1038/ng1917			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17099712	Green Submitted, Green Accepted			2022-12-17	WOS:000242404200024
J	Vieland, VJ				Vieland, VJ			The replication requirement	NATURE GENETICS			English	Editorial Material								Human geneticists withhold judgment on any report of linkage or allelic association until it is independently replicated. But the independent replication criterion has become harder to meet. Does this signal the demise of the reverse genetics paradigm or a problem with the replication requirement itself?	Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Vieland, VJ (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA 52242 USA.							Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MCKUSICK VA, 1975, CYTOGENET CELL GENET, V14, P196, DOI 10.1159/000130344; MCKUSICK VA, 1974, CYTOGENET CELL GENET, V13, P63, DOI 10.1159/000130233; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	6	74	75	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2001	29	3					244	245		10.1038/ng1101-244	http://dx.doi.org/10.1038/ng1101-244			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687787				2022-12-17	WOS:000171911000004
J	Dow, DJ; Lindsey, N; Cairns, NJ; Brayne, C; Robinson, D; Huppert, FA; Paykel, ES; Xuereb, J; Wilcock, G; Whittaker, JL; Rubinsztein, DC				Dow, DJ; Lindsey, N; Cairns, NJ; Brayne, C; Robinson, D; Huppert, FA; Paykel, ES; Xuereb, J; Wilcock, G; Whittaker, JL; Rubinsztein, DC			alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK	NATURE GENETICS			English	Letter									Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; Inst Psychiat, Dept Neuropathol, MRC, Brain Bank, London SE5 8AF, England; Univ Forvie Site, Inst Publ Hlth, Cambridge CB2 2SR, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; Univ Bristol, Frenchay Hosp, Dept Care Elderly, Day Hosp Lab, Bristol BS16 1LE, Avon, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Dept Med Genet, Hills Rd, Cambridge CB2 2QQ, England.		Brayne, Carol/AAA-4285-2020; Cairns, Nigel/AAB-9713-2020; Rubinsztein, David C/C-3472-2011	Brayne, Carol/0000-0001-5307-663X; Cairns, Nigel/0000-0001-9858-3344; Huppert, Felicia/0000-0003-2696-2286				Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Brayne C, 1998, PSYCHOL MED, V28, P319; BRESLOW NE, 1980, STAT METHODS CORE RE; HESTON LL, 1992, GENETIC BASIS COMMON, P792; Tysoe C, 1998, DEMENT GERIATR COGN, V9, P191, DOI 10.1159/000017046	5	74	75	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					16	17		10.1038/8724	http://dx.doi.org/10.1038/8724			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319853				2022-12-17	WOS:000080096300013
J	Hodge, SE; Boehnke, M; Spence, MA				Hodge, SE; Boehnke, M; Spence, MA			Loss of information due to ambiguous haplotyping of SNPs	NATURE GENETICS			English	Letter									Columbia Univ, Dept Psychiat, New York State Psychiat Inst, Unit 24, New York, NY 10032 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Calif Irvine, Irvine Med Ctr, Dept Pediat, Orange, CA 92868 USA	Columbia University; New York State Psychiatry Institute; University of Michigan System; University of Michigan; University of California System; University of California Irvine	Hodge, SE (corresponding author), Columbia Univ, Dept Psychiat, New York State Psychiat Inst, Unit 24, 1051 Riverside Dr, New York, NY 10032 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK031813, R01DK031813, R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-31813, DK-31775] Funding Source: Medline; NIMH NIH HHS [MH-48858] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; LONG JC, 1995, AM J HUM GENET, V56, P799; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3	8	74	81	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					360	361		10.1038/7687	http://dx.doi.org/10.1038/7687			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192383				2022-12-17	WOS:000079439700014
J	Phimister, B				Phimister, B			Going global	NATURE GENETICS			English	Editorial Material																			0	74	80	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21			S			1	1		10.1038/4423	http://dx.doi.org/10.1038/4423			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU		Bronze			2022-12-17	WOS:000078008200001
J	Reilly, PR; Boshar, MF; Holtzman, SH				Reilly, PR; Boshar, MF; Holtzman, SH			Ethical issues in genetic research: Disclosure and informed consent	NATURE GENETICS			English	Editorial Material							SAMPLES	As research to correlate genetic status with predisposition to disease has accelerated, so has the concern that participation in such studies creates the risk of genetic discrimination and emotional distress. There is a need to broaden disclosure during the consent process to ensure that potential subjects understand these risks and other issues and to address them in the consent form. We describe the broad approach that we have taken in regard to disclosure and consent in gene mapping studies.	MILLENNIUM PHARMACEUT INC,CAMBRIDGE,MA 02139	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Reilly, PR (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA 02154, USA.							*AAAS DIR SCI POL, 1993, C ETH LEG ASP PED RE; *AM SOC HUM GEN, 1994, AM J HUM GENET, V55, pR1; *AM SOC HUM GEN, 1996, AM J HUM GENET, V59, P471; *AM SOC HUM GEN BO, 1995, AM J HUM GENET, V57, P1233; Bernstein T, 1994, RADON RENTAL HOUSING; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BLATT R, 1993, GENET RESOUR, V7, P32; BLOCH M, 1990, AM J HUM GENET, V46, P1; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; EARLEY CL, 1995, AM J HUM GENET, V57, P727; *HOUS COMM, 1995, HUM GEN SCI ITS CONS; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Juengst Eric T, 1995, Genome Sci Technol, V1, P21, DOI 10.1089/gst.1995.1.21; KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806; *NAT ACT PLAN BREA, 1996, POS PAP HER SUSC TES; *NIH DOE WORK GROU, 1990, 933686 NIH NAT CTR H; *NIH OFF PROT RES, 1993, HUM GEN RES PROT HUM; *PRES COMM STUD ET, 1981, PROT HUM SUBJ	18	74	74	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					16	20		10.1038/ng0197-16	http://dx.doi.org/10.1038/ng0197-16			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988163				2022-12-17	WOS:A1997WA37300015
J	GOLDMAN, MJ; YANG, YP; WILSON, JM				GOLDMAN, MJ; YANG, YP; WILSON, JM			GENE-THERAPY IN A XENOGRAFT MODEL OF CYSTIC-FIBROSIS LUNG CORRECTS CHLORIDE TRANSPORT MORE EFFECTIVELY THAN THE SODIUM DEFECT	NATURE GENETICS			English	Article							HUMAN BRONCHIAL EPITHELIA; INVIVO; CFTR	We have developed a model of gene therapy for cystic fibrosis (CF) lung disease, based on growth of human CF bronchial xenografts in nu/nu mice. We now report an evaluation of the primary abnormalities in CF lung epithelia - defective CI secretion and Na hyperabsorption - in xenografts following adenovirus-mediated gene transfer. In vivo infection of CF xenografts with a cystic fibrosis transmembrane regulator (CFTR) recombinant adenovirus, at a multiplicity of infection equal to 100, was sufficient to reconstitute near normal levels of cAMP-stimulated CI transport, despite transducing only 5% of cells in the pseudostratified epithelium. Correction in sodium hyperabsorption was partial and variable. These experiments define aspects of adenovirus-mediated gene therapy relevant to CF protocols based on intrapulmonary genetic reconstitution.	UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1994, HUM GENE THER, V5, P615, DOI 10.1089/hum.1994.5.5-615; BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169, DOI 10.1152/jappl.1980.48.1.169; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; ENGELHARDT JF, 1992, J CLIN INVEST, V90, P2598, DOI 10.1172/JCI116155; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; WELSH MJ, 1987, J CLIN INVEST, V80, P1523, DOI 10.1172/JCI113237; WHITSETT JA, 1994, HUM GENE THERA, V5, P1019; WILLUMSEN NJ, 1991, AM J PHYSIOL, V30, pC332; WILSON JM, 1994, HUM GENE THER, V5, P501, DOI 10.1089/hum.1994.5.4-501; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	22	74	78	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					126	131		10.1038/ng0295-126	http://dx.doi.org/10.1038/ng0295-126			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719338				2022-12-17	WOS:A1995QE67200012
J	LOBACCARO, JM; LUMBROSO, S; BELON, C; GALTIERDEREURE, F; BRINGER, J; LESIMPLE, T; HERON, JF; PUJOL, H; SULTAN, C				LOBACCARO, JM; LUMBROSO, S; BELON, C; GALTIERDEREURE, F; BRINGER, J; LESIMPLE, T; HERON, JF; PUJOL, H; SULTAN, C			MALE BREAST-CANCER AND THE ANDROGEN RECEPTOR GENE	NATURE GENETICS			English	Letter							MEN; DNA		HOP LAPEYRONIE, SERV ENDOCRINOL, UNITE BEDR, MONTPELLIER, FRANCE; SERV ONCOL MED, RENNES, FRANCE; CTR REG FRANCOIS BACLESSE, CAEN, FRANCE; CTR REG LUTTE CONTRE CANC, MONTPELLIER, FRANCE; SERV PEDIAT 1, MONTPELLIER, FRANCE	Universite de Montpellier; CHU de Montpellier; UNICANCER; Centre Francois Baclesse; Universite de Montpellier	LOBACCARO, JM (corresponding author), INSERM, U58, UNITE BEDR, 60 RUE NAVACELLES, F-34090 MONTPELLIER, FRANCE.		Lobaccaro, Jean-Marc A./U-1928-2019; Lobaccaro, Jean-Marc/Q-3926-2019; Lumbroso, Serge/AFS-0438-2022	Lobaccaro, Jean-Marc/0000-0001-9890-2392; 				COUTURE P, 1993, ENDOCRINOLOGY, V132, P179, DOI 10.1210/en.132.1.179; CRICHLOW RW, 1990, SURG CLIN N AM, V70, P1165; HACKENBERG R, 1991, CANCER RES, V51, P5722; KING MC, 1992, NAT GENET, V2, P89, DOI 10.1038/ng1092-89; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; SAUNDERS PTK, 1992, CLIN ENDOCRINOL, V37, P214, DOI 10.1111/j.1365-2265.1992.tb02313.x; SCHWARTZ RM, 1980, CANCER, V46, P2697, DOI 10.1002/1097-0142(19801215)46:12<2697::AID-CNCR2820461227>3.0.CO;2-4; SMITH SA, 1992, J NATURE GENET, V2, P128; SULTAN C, IN PRESS J STEROID B; THOMAS DB, 1992, AM J EPIDEMIOL, V135, P734, DOI 10.1093/oxfordjournals.aje.a116360; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132	12	74	74	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1993	5	2					109	110		10.1038/ng1093-109	http://dx.doi.org/10.1038/ng1093-109			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252034				2022-12-17	WOS:A1993MA05600005
J	PRIOR, TW; PAPP, AC; SNYDER, PJ; BURGHES, AHM; BARTOLO, C; SEDRA, MS; WESTERN, LM; MENDELL, JR				PRIOR, TW; PAPP, AC; SNYDER, PJ; BURGHES, AHM; BARTOLO, C; SEDRA, MS; WESTERN, LM; MENDELL, JR			A MISSENSE MUTATION IN THE DYSTROPHIN GENE IN A DUCHENNE MUSCULAR-DYSTROPHY PATIENT	NATURE GENETICS			English	Article							GLYCOPROTEIN COMPLEX; NONSENSE MUTATION; POINT MUTATIONS; DMD GENE; POLYMORPHISMS; DELETIONS; REGION; DNA; IDENTIFICATION; ORGANIZATION	About two thirds of Duchenne muscular dystrophy (DMD) patients have either gene deletions or duplications. The other DMD cases are most likely the result of point mutations that cannot be easily identified by current strategies. Utilizing a heteroduplex technique and direct sequencing of amplified products, we screened our nondeletion/duplication DMD population for point mutations. We now describe what we believe to be the first dystrophin missense mutation in a DMD patient. The mutation results in the substitution of an evolutionarily conserved leucine to arginine in the actin-binding domain. The patient makes a dystrophin protein which is properly localized and is present at a higher level than is observed in DMD patients. This suggests that an intact actin-binding domain is necessary for protein stability and essential for function.	OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	PRIOR, TW (corresponding author), OHIO STATE UNIV,DEPT PATHOL,COLUMBUS,OH 43210, USA.			Burghes, Arthur/0000-0001-9031-1555				BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BURROW K, 1991, NEUROLOGY, V41, P662; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; CLEMENS PR, 1992, NEUROLOGY, V42, P1775, DOI 10.1212/WNL.42.9.1775; DARRAS BT, 1988, AM J HUM GENET, V43, P620; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FEENER CA, 1991, AM J HUM GENET, V48, P621; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HU XY, 1990, AM J HUM GENET, V46, P682; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KILIMANN MW, 1992, HUM GENET, V89, P253; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEVINE BA, 1992, FEBS LETT, V298, P44, DOI 10.1016/0014-5793(92)80019-D; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MATSUO M, 1990, BIOCHEM BIOPH RES CO, V170, P963, DOI 10.1016/0006-291X(90)92185-3; NIGRO V, 1992, HUM MOL GENET, V1, P517, DOI 10.1093/hmg/1.7.517; OUDET C, 1991, AM J HUM GENET, V49, P311; PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345; Soto D, 1992, PCR Methods Appl, V2, P96; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; VAINZOF M, 1993, HUM MOL GENET, V2, P39, DOI 10.1093/hmg/2.1.39; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WINNARD AV, 1992, HUM MOL GENET, V1, P645, DOI 10.1093/hmg/1.8.645; WINNARD AV, IN PRESS HUM MOL GEN; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	36	74	78	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					357	360		10.1038/ng0893-357	http://dx.doi.org/10.1038/ng0893-357			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401582				2022-12-17	WOS:A1993LQ17800012
J	Xu, GT; Chhangawala, S; Cocco, E; Razavi, P; Cai, YY; Otto, JE; Ferrando, L; Selenica, P; Ladewig, E; Chan, CM; Paula, AD; Witkin, M; Cheng, YM; Park, J; Serna-Tamayo, C; Zhao, HY; Wu, F; Sallaku, M; Qu, X; Zhao, A; Collings, CK; D'Avino, AR; Jhaveri, K; Koche, R; Levine, RL; Reis-Filho, JS; Kadoch, C; Scaltriti, M; Leslie, CS; Baselga, J; Toska, E				Xu, Guotai; Chhangawala, Sagar; Cocco, Emiliano; Razavi, Pedram; Cai, Yanyan; Otto, Jordan E.; Ferrando, Lorenzo; Selenica, Pier; Ladewig, Erik; Chan, Carmen; Paula, Arnaud Da Cruz; Witkin, Matthew; Cheng, Yuanming; Park, Jane; Serna-Tamayo, Cristian; Zhao, HuiYong; Wu, Fan; Sallaku, Mirna; Qu, Xuan; Zhao, Alison; Collings, Clayton K.; D'Avino, Andrew R.; Jhaveri, Komal; Koche, Richard; Levine, Ross L.; Reis-Filho, Jorge S.; Kadoch, Cigall; Scaltriti, Maurizio; Leslie, Christina S.; Baselga, Jose; Toska, Eneda			ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer	NATURE GENETICS			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; TRANSCRIPTION FACTORS; SOMATIC MUTATIONS; GENE-EXPRESSION; CHROMATIN; FOXA1; LANDSCAPE; BINDING; RESISTANCE; CARCINOMAS	Mutations in ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, are the most common alterations of the SWI/SNF complex in estrogen-receptor-positive (ER+) breast cancer. We identify that ARID1A inactivating mutations are present at a high frequency in advanced endocrine-resistant ER+ breast cancer. An epigenome CRISPR-CAS9 knockout (KO) screen identifies ARID1A as the top candidate whose loss determines resistance to the ER degrader fulvestrant. ARID1A inactivation in cells and in patients leads to resistance to ER degraders by facilitating a switch from ER-dependent luminal cells to ER-independent basal-like cells. Cellular plasticity is mediated by loss of ARID1A-dependent SWI/SNF complex targeting to genomic sites of the luminal lineage-determining transcription factors including ER, forkhead box protein A1 (FOXA1) and GATA-binding factor 3 (GATA3). ARID1A also regulates genome-wide ER-FOXA1 chromatin interactions and ER-dependent transcription. Altogether, we uncover a critical role for ARID1A in maintaining luminal cell identity and endocrine therapeutic response in ER+ breast cancer. A CRISPR-CAS9 screen, analysis of patient data, and functional in vivo and in vitro experiments identify a critical role for ARID1A in determining breast luminal cell identity and endocrine therapeutic response in estrogen-receptor-positive breast cancer.	[Xu, Guotai; Cocco, Emiliano; Razavi, Pedram; Ladewig, Erik; Chan, Carmen; Wu, Fan; Sallaku, Mirna; Qu, Xuan; Zhao, Alison; Levine, Ross L.; Scaltriti, Maurizio; Baselga, Jose; Toska, Eneda] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Chhangawala, Sagar; Ladewig, Erik; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Chhangawala, Sagar] Weill Cornell Grad Sch, Physiol Biophys & Syst Biol Program, New York, NY USA; [Razavi, Pedram; Serna-Tamayo, Cristian; Jhaveri, Komal; Levine, Ross L.; Baselga, Jose] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Cai, Yanyan; Ferrando, Lorenzo; Selenica, Pier; Paula, Arnaud Da Cruz; Reis-Filho, Jorge S.; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Otto, Jordan E.; Collings, Clayton K.; D'Avino, Andrew R.; Kadoch, Cigall] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Otto, Jordan E.; Ferrando, Lorenzo; Collings, Clayton K.; D'Avino, Andrew R.; Kadoch, Cigall] Harvard Med Sch, Boston, MA 02115 USA; [Ferrando, Lorenzo] Univ Genoa, Dept Internal Med, Genoa, Italy; [Witkin, Matthew; Park, Jane; Koche, Richard; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Cheng, Yuanming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Serna-Tamayo, Cristian] Icahn Sch Med Mt Sinai, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Zhao, HuiYong; Kadoch, Cigall] Mem Sloan Kettering Canc Ctr, Tumor Assessment Core, 1275 York Ave, New York, NY 10021 USA; [Collings, Clayton K.; D'Avino, Andrew R.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Baselga, Jose] AstraZeneca, Res & Dev Oncol, Gaithersburg, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Genoa; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; AstraZeneca	Baselga, J; Toska, E (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA.; Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Baselga, J (corresponding author), AstraZeneca, Res & Dev Oncol, Gaithersburg, MD USA.	cleslie@cbio.mskcc.org; Jose.Baselga@astrazeneca.com; toskae@mskcc.org	Selenica, Pier/GQY-8678-2022; Ferrando, Lorenzo/AAA-9281-2022; Cheng, Yuanming/AFQ-2871-2022; Toska, Eneda/AAO-1711-2020; Toska, Eneda/AAQ-4369-2020	Ferrando, Lorenzo/0000-0002-4025-7930; Toska, Eneda/0000-0002-8974-9792; Chhangawala, Sagar/0000-0001-9626-1034; Zhao, Alison/0000-0002-5479-2686; Da Cruz Paula, Arnaud/0000-0001-7694-8760; Xu, Guotai/0000-0001-5265-3407; Razavi, Pedram/0000-0003-4236-0576; Cai, Yanyan/0000-0002-2779-6163; Wu, Fan/0000-0002-3960-320X	National Institutes of Health [P30 CA008748, RO1CA190642-01A1]; Breast Cancer Research Foundation [BCRF-17-013]; Stand Up to Cancer (Cancer Drug Combination Convergence Team) grant [SU2C 2015-004]; V Foundation [D2015-036]; National Science Foundation [PHY1545853]; U54 award [CA209975-01]; MSK Society Scholar Prize;  [NCI K00CA212478]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Stand Up to Cancer (Cancer Drug Combination Convergence Team) grant; V Foundation; National Science Foundation(National Science Foundation (NSF)); U54 award; MSK Society Scholar Prize; 	We thank the Center for Epigenetics Research at MSKCC for help with the ATACseq and ChIP-seq assays, and E. de Stanchina and the Antitumor Assessment Core Facility for help with xenografts establishment. We also thank the Baselga and Scaltriti laboratory members for helpful advice and discussions. We thank A. Del from the Department of Pathology at MSKCC for the procurement of the FFPE slides. This work has been supported by National Institutes of Health grant nos. P30 CA008748 and RO1CA190642-01A1, the Breast Cancer Research Foundation grant no. BCRF-17-013. E.T. and M. Scaltriti are supported by a kind gift from B. Smith. E.L. is supported by grant no. NCI K00CA212478. This work was also supported by grants from Stand Up to Cancer (Cancer Drug Combination Convergence Team) grant no. SU2C 2015-004, the V Foundation grant no. D2015-036 and the National Science Foundation grant no. PHY1545853 (G.X. and M. Scaltriti). This work was also funded by a U54 award grant no. CA209975-01 to C.S.L. E.C. is a recipient of an MSK Society Scholar Prize.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Caumanns JJ, 2018, BBA-REV CANCER, V1870, P176, DOI 10.1016/j.bbcan.2018.07.005; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dravis C, 2018, CANCER CELL, V34, P466, DOI 10.1016/j.ccell.2018.08.001; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kelso TWR, 2017, ELIFE, V6, DOI [10.7554/eLife.30506, 10.7554/eLife.30506.001]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nakayama RT, 2017, NAT GENET, V49, P1613, DOI 10.1038/ng.3958; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Pan J, 2018, CELL SYST, V6, P555, DOI 10.1016/j.cels.2018.04.011; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Sandoval GJ, 2018, MOL CELL, V71, P554, DOI 10.1016/j.molcel.2018.06.040; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sun XX, 2017, CANCER CELL, V32, P574, DOI 10.1016/j.ccell.2017.10.007; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Toska E, 2019, CELL REP, V27, P294, DOI 10.1016/j.celrep.2019.02.111; Toska E, 2017, SCIENCE, V355, P1324, DOI 10.1126/science.aah6893; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Weinreb I, 2014, NAT GENET, V46, P1166, DOI 10.1038/ng.3096; Wuidart A, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0095-2; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	65	73	74	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2020	52	2					198	+		10.1038/s41588-019-0554-0	http://dx.doi.org/10.1038/s41588-019-0554-0		JAN 2020	25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KM6MD	31932695	Green Accepted			2022-12-17	WOS:000508165900002
J	Iotchkova, V; Ritchie, GRS; Geihs, M; Morganella, S; Min, JL; Walter, K; Timpson, NJ; Dunham, I; Birney, E; Soranzo, N				Iotchkova, Valentina; Ritchie, Graham R. S.; Geihs, Matthias; Morganella, Sandro; Min, Josine L.; Walter, Klaudia; Timpson, Nicholas John; Dunham, Ian; Birney, Ewan; Soranzo, Nicole		UK10K Consortium	GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals	NATURE GENETICS			English	Article							WIDE ASSOCIATION; COMMON VARIANTS; LOCI; INSIGHTS; PATHOPHYSIOLOGY; LANDSCAPE; PROVIDES; GLUCOSE	Loci discovered by genome-wide association studies predominantly map outside protein-coding genes. The interpretation of the functional consequences of non-coding variants can be greatly enhanced by catalogs of regulatory genomic regions in cell lines and primary tissues. However, robust and readily applicable methods are still lacking by which to systematically evaluate the contribution of these regions to genetic variation implicated in diseases or quantitative traits. Here we propose a novel approach that leverages genome-wide association studies' findings with regulatory or functional annotations to classify features relevant to a phenotype of interest. Within our framework, we account for major sources of confounding not offered by current methods. We further assess enrichment of genome-wide association studies for 19 traits within Encyclopedia of DNA Elements- and Roadmap-derived regulatory regions. We characterize unique enrichment patterns for traits and annotations driving novel biological insights. The method is implemented in standalone software and an R package, to facilitate its application by the research community.	[Iotchkova, Valentina; Ritchie, Graham R. S.; Geihs, Matthias; Walter, Klaudia; Soranzo, Nicole] Wellcome Sanger Inst, Human Genet, Hinxton, England; [Iotchkova, Valentina; Ritchie, Graham R. S.; Morganella, Sandro; Dunham, Ian; Birney, Ewan] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England; [Min, Josine L.; Timpson, Nicholas John] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Min, Josine L.; Timpson, Nicholas John] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [UK10K Consortium] Univ Cambridge, Cambridge, England; [Soranzo, Nicole] Univ Cambridge, Dept Haematol, Cambridge, England; [Soranzo, Nicole] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Unit NIHR B, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Bristol; University of Bristol; University of Cambridge; University of Cambridge; University of Cambridge	Soranzo, N (corresponding author), Wellcome Sanger Inst, Human Genet, Hinxton, England.; Birney, E (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England.; Soranzo, N (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.; Soranzo, N (corresponding author), Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Unit NIHR B, Cambridge, England.	birney@ebi.ac.uk; ns6@sanger.ac.uk	Timpson, Nicholas John/O-7548-2015	Timpson, Nicholas John/0000-0002-7141-9189; Kelly, Kirsten/0000-0003-4234-543X; Dunham, Ian/0000-0003-2525-5598; Walter, Klaudia/0000-0003-4448-0301; Iotchkova, Valentina/0000-0001-5057-0210; Soranzo, Nicole/0000-0003-1095-3852; Birney, Ewan/0000-0001-8314-8497; Wilson, Scott/0000-0002-0357-1373	Wellcome Trust [WT091310, WT098051, 202802/Z/16/Z, MRC & WT 102215/2/13/2]; University of Bristol NIHR Biomedical Research Centre [BRC-1215-20011]; MRC Integrative Epidemiology Unit [MC_UU_12013/3]; CRUK Integrative Cancer Epidemiology Programme [C18281/A19169]; European Molecular Biology Laboratory-Wellcome Trust Sanger Institute postdoctoral fellowships; MRC [MC_UU_00011/5, MC_UU_12013/3, MC_UU_12013/2] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol NIHR Biomedical Research Centre; MRC Integrative Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK Integrative Cancer Epidemiology Programme; European Molecular Biology Laboratory-Wellcome Trust Sanger Institute postdoctoral fellowships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study made use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org/.Funding for UK10K was provided by the Wellcome Trust under award no. WT091310. Research by N.S. is supported by the Wellcome Trust (grants WT098051 and WT091310). N.J.T. is supported as a Wellcome Trust Investigator (no. 202802/Z/16/Z), is supported as the principal investigator of the Avon Longitudinal Study of Parents and Children (no. MRC & WT 102215/2/13/2), is supported by the University of Bristol NIHR Biomedical Research Centre (no. BRC-1215-20011) and the MRC Integrative Epidemiology Unit (no. MC_UU_12013/3), and works within the CRUK Integrative Cancer Epidemiology Programme (no. C18281/A19169). G.R.S.R. and V.I. are supported by European Molecular Biology Laboratory-Wellcome Trust Sanger Institute postdoctoral fellowships.	Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Chung DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004787; Dunham I., 2015, F1000 RES, V4, DOI [10.12688/f1000research.6032.1, DOI 10.12688/F1000RESEARCH.6032.1]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Shen HM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057055, 10.1371/journal.pone.0057746]; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962	36	73	73	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2019	51	2					343	+		10.1038/s41588-018-0322-6	http://dx.doi.org/10.1038/s41588-018-0322-6			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HJ6PM	30692680	Green Accepted, Green Submitted			2022-12-17	WOS:000457314300021
J	Nakatsuka, N; Moorjani, P; Rai, N; Sarkar, B; Tandon, A; Patterson, N; Bhavani, GS; Girisha, KM; Mustak, MS; Srinivasan, S; Kaushik, A; Vahab, SA; Jagadeesh, SM; Satyamoorthy, K; Singh, L; Reich, D; Thangaraj, K				Nakatsuka, Nathan; Moorjani, Priya; Rai, Niraj; Sarkar, Biswanath; Tandon, Arti; Patterson, Nick; Bhavani, Gandham SriLakshmi; Girisha, Katta Mohan; Mustak, Mohammed S.; Srinivasan, Sudha; Kaushik, Amit; Vahab, Saadi Abdul; Jagadeesh, Sujatha M.; Satyamoorthy, Kapaettu; Singh, Lalji; Reich, David; Thangaraj, Kumarasamy			The promise of discovering population-specific disease-associated genes in South Asia	NATURE GENETICS			English	Article							INDIA; COMMUNITY; HISTORY; COMPONENTS; MUTATIONS; DIVERSITY; GENOMES; WISP3	The more than 1.5 billion people who live in South Asia are correctly viewed not as a single large population but as many small endogamous groups. We assembled genome-wide data from over 2,800 individuals from over 260 distinct South Asian groups. We identified 81 unique groups, 14 of which had estimated census sizes of more than 1 million, that descend from founder events more extreme than those in Ashkenazi Jews and Finns, both of which have high rates of recessive disease due to founder events. We identified multiple examples of recessive diseases in South Asia that are the result of such founder events. This study highlights an underappreciated opportunity for decreasing disease burden among South Asians through discovery of and testing for recessive disease-associated genes.	[Nakatsuka, Nathan; Tandon, Arti; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Nakatsuka, Nathan] Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Moorjani, Priya] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Moorjani, Priya; Tandon, Arti; Patterson, Nick; Reich, David] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Rai, Niraj; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Sarkar, Biswanath] Anthropol Survey India, Kolkata, India; [Bhavani, Gandham SriLakshmi; Girisha, Katta Mohan] Manipal Univ, Kasturba Med Coll, Dept Med Genet, Manipal, Karnataka, India; [Mustak, Mohammed S.] Mangalore Univ, Dept Appl Zool, Mangalore, India; [Srinivasan, Sudha] Ctr Human Genet, Bangalore, Karnataka, India; [Kaushik, Amit] Amity Univ, Amity Inst Biotechnol, Noida, India; [Vahab, Saadi Abdul; Satyamoorthy, Kapaettu] Manipal Univ, Sch Life Sci, Manipal, Karnataka, India; [Jagadeesh, Sujatha M.] Fetal Care Res Fdn, Madras, Tamil Nadu, India; [Singh, Lalji] Genome Fdn, Hyderabad, Andhra Pradesh, India; [Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA USA; [Rai, Niraj] Birbal Sahni Inst Palaeosci, Lucknow, Uttar Pradesh, India	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Mangalore University; Amity University Noida; Manipal Academy of Higher Education (MAHE); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Reich, D (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.; Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA USA.	reich@genetics.med.harvard.edu; thangs@ccmb.res.in	KM, Girisha/AAK-6867-2020; Rai, Niraj/AAO-7618-2021; kaushik, amit/AAD-4457-2022	KM, Girisha/0000-0002-0139-8239; Rai, Niraj/0000-0002-1251-9390; Bhavani, Gandham/0000-0001-5284-8909; Satyamoorthy, Kapaettu/0000-0002-2368-5490; Srinivasan, Sudha/0000-0003-0777-4044; Kaushik, Amit/0000-0001-9380-7011	NIGMS [GM007753, 115006]; Translational Seed Fund grant from the Dean's Office of Harvard Medical School; Council of Scientific and Industrial Research, Government of India; TIFAC-CORE; Department of Biotechnology, Government of India [BT/PR4224/MED/97/60/2011]; Department of Science and Technology, Government of India [SR/WOS-A/LS-83/2011]; Indian Council of Medical Research [BMS 54/2/2013];  [HG006399]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM100233] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Translational Seed Fund grant from the Dean's Office of Harvard Medical School; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); TIFAC-CORE; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to the many Indian, Pakistani, Bangladeshi, Sri Lankan, and Nepalese individuals who contributed the DNA samples analyzed here, including the patients with PPD and MPS IVA. We are grateful to A. Basu and P.P. Majumder (National Institute of Biomedical Genomics, Kalyani, India) for early sharing of data. Funding was provided by an NIGMS (GM007753) fellowship to N.N.; a Translational Seed Fund grant from the Dean's Office of Harvard Medical School, and grant HG006399 to D.R.; a Council of Scientific and Industrial Research, Government of India grant to K.T.; support from TIFAC-CORE to S.A.V. and K.S.; and NIGMS grant 115006 to P.M. The study of MPS IVA patients was funded by grants from the Department of Biotechnology, Government of India (BT/PR4224/MED/97/60/2011 to S.S. and S.M.J.) and the Department of Science and Technology, Government of India (SR/WOS-A/LS-83/2011 to S.S.). Funding for the mutation analysis of Indian patients with PPD was provided by the Indian Council of Medical Research (BMS 54/2/2013) to K.M.G. D.R. is supported as an Investigator of the Howard Hughes Medical Institute.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bhavani GS, 2015, AM J MED GENET A, V167, P2481, DOI 10.1002/ajmg.a.37164; Bidchol AM, 2014, AM J MED GENET A, V164, P2793, DOI 10.1002/ajmg.a.36735; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dalal A, 2012, AM J MED GENET A, V158A, P2820, DOI 10.1002/ajmg.a.35620; Durand EY, 2014, MOL BIOL EVOL, V31, P2212, DOI 10.1093/molbev/msu151; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hoaglin D.C., 1993, DETECT HANDLE OUTLIE; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Manoharan I, 2006, PHARMACOGENET GENOM, V16, P461; Mastana SS, 2014, ANN HUM BIOL, V41, P287, DOI 10.3109/03014460.2014.922615; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Palamara PF, 2016, BIOINFORMATICS, V32, P3032, DOI 10.1093/bioinformatics/btw355; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Rajasimha HK, 2014, GENET RES, V96, DOI 10.1017/S0016672314000111; Raz AE, 2009, J GENET COUNS, V18, P114, DOI 10.1007/s10897-008-9209-5; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Shukla A, 2017, J HUM GENET, V62, P723, DOI 10.1038/jhg.2017.35; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761	30	73	73	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2017	49	9					1403	+		10.1038/ng.3917	http://dx.doi.org/10.1038/ng.3917			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FF1PS	28714977	Green Accepted, Green Submitted			2022-12-17	WOS:000408672000020
J	Robinson, MR; English, G; Moser, G; Lloyd-Jones, LR; Triplett, MA; Zhu, ZH; Nolte, IM; van Vliet-Ostaptchouk, JV; Snieder, H; Esko, T; Milani, L; Magi, R; Metspalu, A; Magnusson, PKE; Pedersen, NL; Ingelsson, E; Johannesson, M; Yang, J; Cesarini, D; Visscher, PM				Robinson, Matthew R.; English, Geoffrey; Moser, Gerhard; Lloyd-Jones, Luke R.; Triplett, Marcus A.; Zhu, Zhihong; Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold; Esko, Tonu; Milani, Lili; Magi, Reedik; Metspalu, Andres; Magnusson, Patrik K. E.; Pedersen, Nancy L.; Ingelsson, Erik; Johannesson, Magnus; Yang, Jian; Cesarini, David; Visscher, Peter M.		LifeLines Cohort Study	Genotype-covariate interaction effects and the heritability of adult body mass index	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; MISSING HERITABILITY; SEX-DIFFERENCES; FTO GENOTYPE; HUMAN HEIGHT; TRAITS; VARIANTS; TWIN; ASSOCIATION; VARIABILITY	Obesity is a worldwide epidemic, with major health and economic costs. Here we estimate heritability for body mass index (BMI) in 172,000 sibling pairs and 150,832 unrelated individuals and explore the contribution of genotype-covariate interaction effects at common SNP loci. We find evidence for genotype-age interaction (likelihood ratio test (LRT) = 73.58, degrees of freedom (df) = 1, P = 4.83 x 10(-18)), which contributed 8.1% (1.4% s.e.) to BMI variation. Across eight self-reported lifestyle factors, including diet and exercise, we find genotype-environment interaction only for smoking behavior (LRT = 19.70, P = 5.03 x 10(-5) and LRT = 30.80, P = 1.42 x 10(-8)), which contributed 4.0% (0.8% s.e.) to BMI variation. Bayesian association analysis suggests that BMI is highly polygenic, with 75% of the SNP heritability attributable to loci that each explain <0.01% of the phenotypic variance. Our findings imply that substantially larger sample sizes across ages and lifestyles are required to understand the full genetic architecture of BMI.	[Robinson, Matthew R.; English, Geoffrey; Moser, Gerhard; Lloyd-Jones, Luke R.; Zhu, Zhihong; Yang, Jian; Visscher, Peter M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Robinson, Matthew R.] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Triplett, Marcus A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Nolte, Ilja M.; van Vliet-Ostaptchouk, Jana V.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Esko, Tonu; Milani, Lili; Magi, Reedik; Metspalu, Andres] Univ Tartu, Estonia Genome Ctr, Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Esko, Tonu] Harvard Med Sch, Dept Genet, Boston, MA USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Johannesson, Magnus] Stockholm Sch Econ, Stockholm, Sweden; [Cesarini, David] NYU, Dept Econ, Ctr Expt Social Sci, 550 1St Ave, New York, NY 10003 USA	University of Queensland; University of Lausanne; University of Queensland; University of Groningen; University of Groningen; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Tartu; Karolinska Institutet; Uppsala University; Stanford University; Stockholm School of Economics; New York University	Robinson, MR; Visscher, PM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.; Robinson, MR (corresponding author), Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland.	matthew.robinson@unil.ch; peter.visscher@uq.edu.au	Johannesson, Magnus/E-9680-2011; Visscher, Peter/ABB-6151-2020; Milani, Lili/N-1097-2019; Yang, Jian/A-5852-2010; Mägi, Reedik/AAJ-9679-2021; Magnusson, Patrik KE/C-4458-2017; Zhu, Zhihong/F-8720-2015; Lloyd-Jones, Luke R/F-1237-2013; Moser, Gerhard/H-7054-2012	Johannesson, Magnus/0000-0001-8759-6393; Visscher, Peter/0000-0002-2143-8760; Milani, Lili/0000-0002-5323-3102; Yang, Jian/0000-0003-2001-2474; Magnusson, Patrik KE/0000-0002-7315-7899; Zhu, Zhihong/0000-0002-6783-3037; Lloyd-Jones, Luke R/0000-0002-0229-0625; Pedersen, Nancy/0000-0001-8057-3543; Robinson, Matthew/0000-0001-8982-8813; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; English, Geoffrey/0000-0003-3103-9322; Moser, Gerhard/0000-0003-3104-5730	UK Biobank Resource [12505]; Australian Research Council [160103860]; Australian National Health and Medical Research Council [1080157, 1078037, 1048853, 1050218, 1113400]; NIH [R21ESO25052-01, PO1GMO99568, DK U01-066134]; Charles and Sylvia Viertel Senior Medical Research Fellowship; University of Lausanne; Swedish Research Council [421-2013-1061, M-2005-1112]; Ragnar Soderberg Foundation [E9/11]; Jan Wallander and Tom Hedelius Foundation [P2015-0001:1]; US National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; EU [692145, 676550, 654248]; Estonian Research Council [IUT20-60]; NIASC; EIT-Health; NIH BMI grant [2R01DK075787-06A1]; European Regional Development Fund [2014-2020.4.01.15-0012 GENTRANSMED]; US National Institute on Aging (NIA) [U01AG009740]; NIA [RC2 AG036495, RC4 AG039029]; Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; NIH Genes, Environment and Health Initiative (GEI) [U01HG004399]; National Institutes of Health [CA87969, CA55075, DK58845]; NIH GEI [U01HG004424]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; Swedish Foundation for Strategic Research (SSF); Heart and Lung Foundation [20070481]	UK Biobank Resource; Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Sylvia Viertel Senior Medical Research Fellowship; University of Lausanne; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Jan Wallander and Tom Hedelius Foundation; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EU(European Commission); Estonian Research Council(Estonian Research Council); NIASC; EIT-Health; NIH BMI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Regional Development Fund(European Commission); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; NIH Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; GenomEUtwin; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The UK Biobank research was conducted using the UK Biobank Resource under project 12505. The University of Queensland group is supported by the Australian Research Council (Discovery Project 160103860), the Australian National Health and Medical Research Council (1080157, 1078037, 1048853, 1050218, and 1113400), and the NIH (R21ESO25052-01 and PO1GMO99568). J.Y. is supported by a Charles and Sylvia Viertel Senior Medical Research Fellowship. M.R.R. is supported by the University of Lausanne. D.C. and M.J. were supported by the Swedish Research Council (421-2013-1061), the Ragnar Soderberg Foundation (E9/11), and the Jan Wallander and Tom Hedelius Foundation (P2015-0001:1). The ARIC study is carried out as a collaborative study supported by the US National Heart, Lung, and Blood Institute (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The Estonian Genome Centre of University of Tartu Study was supported by EU Horizon 2020 grants 692145, 676550, and 654248; Estonian Research Council Grant IUT20-60, NIASC, EIT-Health; NIH BMI grant 2R01DK075787-06A1; and the European Regional Development Fund (project 2014-2020.4.01.15-0012 GENTRANSMED). The Health and Retirement Study is supported by the US National Institute on Aging (NIA; U01AG009740). The genotyping was funded separately by the NIA (RC2 AG036495 and RC4 AG039029) and was conducted by the NIH Center for Inherited Disease Research (CIDR) at Johns Hopkins University. Genotyping quality control and final preparation of the HRS data were performed by the Genetics Coordinating Center at the University of Washington. The LifeLines Cohort Study and generation and management of GWAS genotype data for the LifeLines Cohort Study were supported by the Netherlands Organization of Scientific Research NWO (175.010.2007.006); the Economic Structure Enhancing Fund of the Dutch government; the Ministry of Economic Affairs; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; and the Dutch Diabetes Research Foundation. The Nurses Health Study (NHS) and Health Professionals Follow-up Studies (HPFS) received funding support for the GWAS of Gene and Environment Initiatives in Type 2 Diabetes through the NIH Genes, Environment and Health Initiative (GEI) (U01HG004399). The human subjects participating in the GWAS derived from NHS and HPFS and these studies are supported by National Institutes of Health grants CA87969, CA55075 and DK58845. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the Gene Environment Association Studies, GENEVA Coordinating Center (U01 HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard, was provided by the NIH GEI (U01HG004424). The Swedish Twin Registry (TWINGENE) was supported by the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254; QLG2-CT-2002-01254), NIH DK U01-066134, the Swedish Foundation for Strategic Research (SSF), and the Heart and Lung Foundation (20070481).	Bjorklund A, 2005, UNEQUAL CHANCES: FAMILY BACKGROUND AND ECONOMIC SUCCESS, P145; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Coady SA, 2002, OBES RES, V10, P675, DOI 10.1038/oby.2002.91; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Fischer TM, 2004, GENET SEL EVOL, V36, P363, DOI 10.1051/gse:2004006; Fusi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5890; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Haberstick BC, 2010, BEHAV GENET, V40, P495, DOI 10.1007/s10519-009-9327-3; Hemani G, 2013, AM J HUM GENET, V93, P865, DOI 10.1016/j.ajhg.2013.10.005; KIRKPATRICK M, 1990, GENETICS, V124, P979; KIRKPATRICK M, 1994, GENET RES, V64, P57, DOI 10.1017/S0016672300032559; Lee SH, 2016, BIOINFORMATICS, V32, P1420, DOI 10.1093/bioinformatics/btw012; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch Michael, 1998; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Meyer K, 1998, GENET SEL EVOL, V30, P221, DOI 10.1051/gse:19980302; Meyer K, 2005, PHILOS T R SOC B, V360, P1443, DOI 10.1098/rstb.2005.1681; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Robinson MR, 2008, CURR BIOL, V18, P751, DOI 10.1016/j.cub.2008.04.059; Robinson MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0016; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Silventoinen K, 2000, BEHAV GENET, V30, P477, DOI 10.1023/A:1010202902159; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Traglia M, 2017, GENETICS, V205, P979, DOI 10.1534/genetics.116.193623; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2015, HUM MOL GENET, V24, P7445, DOI 10.1093/hmg/ddv443; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young AI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12724; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001	55	73	73	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1174	+		10.1038/ng.3912	http://dx.doi.org/10.1038/ng.3912			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FB8OI	28692066				2022-12-17	WOS:000406397900006
J	Acemel, RD; Tena, JJ; Irastorza-Azcarate, I; Marletaz, F; Gomez-Marin, C; de la Calle-Mustienes, E; Bertrand, S; Diaz, SG; Aldea, D; Aury, JM; Mangenot, S; Holland, PWH; Devos, DP; Maeso, I; Escriva, H; Gomez-Skarmeta, JL				Acemel, Rafael D.; Tena, Juan J.; Irastorza-Azcarate, Ibai; Marletaz, Ferdinand; Gomez-Marin, Carlos; de la Calle-Mustienes, Elisa; Bertrand, Stephanie; Diaz, Sergio G.; Aldea, Daniel; Aury, Jean-Marc; Mangenot, Sophie; Holland, Peter W. H.; Devos, Damien P.; Maeso, Ignacio; Escriva, Hector; Luis Gomez-Skarmeta, Jose			A single three-dimensional chromatin compartment in amphioxus indicates a stepwise evolution of vertebrate Hox bimodal regulation	NATURE GENETICS			English	Article							TOPOLOGICALLY ASSOCIATING DOMAINS; GENES; TRANSCRIPTION; DUPLICATION; LANDSCAPES; EXPRESSION; ENHANCERS; CLUSTERS; PROTEINS; LOCI	The HoxA and HoxD gene clusters of jawed vertebrates are organized into bipartite three-dimensional chromatin: structures that separate long-range regulatory inputs coming from the anterior and posterior Hox-neighboring regionsl. This architecture is instrumental in allowing vertebrate Hox genes to pattern disparate parts of the body, including limbs2. Almost nothing is known about how these three-dimensional topologies originated. Here we perform extensive 4C-seq profiling of the Hox cluster in embryos of amphioxus, an invertebrate chordate. We find that, in contrast to the architecture in vertebrates, the amphioxus Hox cluster is organized into a single chromatin interaction domain that includes long-range contacts mostly from the anterior side, bringing distant cis-regulatory elements into contact with Hox genes. We infer that the vertebrate Hox bipartite regulatory system is an evolutionary novelty generated by combining ancient long-range regulatory contacts from DNA in the anterior Hox neighborhood with new regulatory inputs from the posterior side.	[Acemel, Rafael D.; Tena, Juan J.; Irastorza-Azcarate, Ibai; Gomez-Marin, Carlos; de la Calle-Mustienes, Elisa; Diaz, Sergio G.; Devos, Damien P.; Maeso, Ignacio; Luis Gomez-Skarmeta, Jose] Univ Pablo de Olavide, CSIC, CABD, Seville, Spain; [Marletaz, Ferdinand; Holland, Peter W. H.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Bertrand, Stephanie; Aldea, Daniel; Escriva, Hector] Univ Paris 06, CNRS, UMR 7232, BIOM,Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France; [Aury, Jean-Marc; Mangenot, Sophie] CEA, Inst Genom, Evry, France	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Devos, DP; Maeso, I; Gomez-Skarmeta, JL (corresponding author), Univ Pablo de Olavide, CSIC, CABD, Seville, Spain.; Escriva, H (corresponding author), Univ Paris 06, CNRS, UMR 7232, BIOM,Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France.	damienpdevos@gmail.com; nacho.maeso@gmail.com; hescriva@obs-banyuls.fr; jlgomska@upo.es	Escriva, Hector/K-8325-2013; Tena, Juan J./Q-5995-2019; Irastorza, Ibai/ABI-7349-2020; Maeso, Ignacio/F-7659-2012; Aury, Jean-Marc/N-1621-2019; Acemel, Rafael Dominguez/AAM-1957-2020; Bertrand, Stephanie/D-8482-2014; Aldea, Daniel/L-4040-2015; Tena, Juan J/M-2265-2014; Gomez-Skarmeta, Jose Luis/B-5268-2014; Gómez-Marín, Carlos/AAX-2173-2021; devos, damien/ABH-5348-2020; Marlétaz, Ferdinand/H-3018-2019	Escriva, Hector/0000-0001-7577-5028; Tena, Juan J./0000-0001-8165-7984; Irastorza, Ibai/0000-0001-5245-2322; Maeso, Ignacio/0000-0002-6440-8457; Aury, Jean-Marc/0000-0003-1718-3010; Acemel, Rafael Dominguez/0000-0003-4120-0140; Bertrand, Stephanie/0000-0002-0689-0126; Aldea, Daniel/0000-0001-5101-0194; Tena, Juan J/0000-0001-8165-7984; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Marlétaz, Ferdinand/0000-0001-8124-4266; Gomez-Marin, Carlos/0000-0001-9724-2919; Devos, Damien/0000-0002-9453-4753; Holland, Peter/0000-0003-1533-9376; de la Calle-Mustienes, Elisa/0000-0002-8975-6503	Ministerio de Economia y Competitividad [BFU2013-41322-P]; Juan de la Cierva postdoctoral [BFU2014-58449-JIN]; Andalusian government [BIO-396]; C2A [EE: 2013/2506]; European Research Council (ERC) [268513]; European Molecular Biology Organization (EMBO); Universidad Pablo de Olavide; Conicyt 'Becas Chile'	Ministerio de Economia y Competitividad(Spanish Government); Juan de la Cierva postdoctoral; Andalusian government; C2A; European Research Council (ERC)(European Research Council (ERC)European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Universidad Pablo de Olavide; Conicyt 'Becas Chile'(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	We specially thank J. Pascual-Anaya for helping with some figures and helpful discussions. We would also like to thank F. Casares, I. Almudi and J.R. Martinez Morales for fruitful discussions. Work was funded by grants from the Ministerio de Economia y Competitividad (BFU2013-41322-P to J.L.G.-S.; Juan de la Cierva postdoctoral contract to I.M.; BFU2014-58449-JIN to J.J.T.); the Andalusian government (BIO-396 to J.L.G.-S.; C2A (EE: 2013/2506) to D.P.D. and I.I.-A.); the European Research Council (ERC; grant 268513) to P.W.H.H. and F.M.; a European Molecular Biology Organization (EMBO) short fellowship to I.M.; the Universidad Pablo de Olavide to J.J.T.; and Conicyt 'Becas Chile' to D.A.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; Holland LZ, 2012, WIRES DEV BIOL, V1, P167, DOI 10.1002/wdev.11; Lehoczky JA, 2004, EVOL DEV, V6, P423, DOI 10.1111/j.1525-142X.2004.04050.x; Lonfat N, 2015, FEBS LETT, V589, P2869, DOI 10.1016/j.febslet.2015.04.024; Lonfat N, 2014, SCIENCE, V346, P1004, DOI 10.1126/science.1257493; Maeso I, 2012, GENOME RES, V22, P642, DOI 10.1101/gr.132233.111; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Pascual-Anaya J, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-28; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773	25	73	73	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					336	341		10.1038/ng.3497	http://dx.doi.org/10.1038/ng.3497			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829752	Green Submitted			2022-12-17	WOS:000370902600020
J	Izumi, K; Nakato, R; Zhang, Z; Edmondson, AC; Noon, S; Dulik, MC; Rajagopalan, R; Venditti, CP; Gripp, K; Samanich, J; Zackai, EH; Deardorff, MA; Clark, D; Allen, JL; Dorsett, D; Misulovin, Z; Komata, M; Bando, M; Kaur, M; Katou, Y; Shirahige, K; Krantz, ID				Izumi, Kosuke; Nakato, Ryuichiro; Zhang, Zhe; Edmondson, Andrew C.; Noon, Sarah; Dulik, Matthew C.; Rajagopalan, Ramakrishnan; Venditti, Charles P.; Gripp, Karen; Samanich, Joy; Zackai, Elaine H.; Deardorff, Matthew A.; Clark, Dinah; Allen, Julian L.; Dorsett, Dale; Misulovin, Ziva; Komata, Makiko; Bando, Masashige; Kaur, Maninder; Katou, Yuki; Shirahige, Katsuhiko; Krantz, Ian D.			Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin	NATURE GENETICS			English	Article							DE-LANGE-SYNDROME; BROMODOMAIN PROTEIN BRD4; TRANSCRIPTION ELONGATION; NOVO MUTATIONS; P-TEFB; GENE; LEUKEMIA; CELLS; AF4; ACETYLATION	Transcriptional elongation is critical for gene expression regulation during embryogenesis. The super elongation complex (SEC) governs this process by mobilizing paused RNA polymerase II (RNAP2). Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia). Transcriptome and chromatin immunoprecipitation sequencing (ChIP-seq) analyses demonstrated similar alterations of genome-wide binding of AFF4, cohesin and RNAP2 in CdLS and CHOPS syndrome. Direct molecular interaction of the SEC, cohesin and RNAP2 was demonstrated. These data support a common molecular pathogenesis for CHOPS syndrome and CdLS caused by disturbance of transcriptional elongation due to alterations in genome-wide binding of AFF4 and cohesin.	[Izumi, Kosuke; Edmondson, Andrew C.; Noon, Sarah; Zackai, Elaine H.; Deardorff, Matthew A.; Clark, Dinah; Kaur, Maninder; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Izumi, Kosuke; Nakato, Ryuichiro; Komata, Makiko; Bando, Masashige; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo, Japan; [Zhang, Zhe] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Dulik, Matthew C.; Rajagopalan, Ramakrishnan] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Venditti, Charles P.] NHGRI, US NIH, Bethesda, MD 20892 USA; [Gripp, Karen] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE USA; [Samanich, Joy] Montefiore Med Ctr, Dept Pediat, Div Genet, Bronx, NY 10467 USA; [Zackai, Elaine H.; Deardorff, Matthew A.; Allen, Julian L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Allen, Julian L.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Dorsett, Dale; Misulovin, Ziva] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Shirahige, Katsuhiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Tokyo; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Nemours Alfred I. duPont Hospital for Children; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Saint Louis University; Japan Science & Technology Agency (JST)	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	kshirahi@iam.u-tokyo.ac.jp; ian2@mail.med.upenn.edu	Rajagopalan, Ramakrishnan/I-4349-2019; Nakato, Ryuichiro/AAV-6405-2020; Rajagopalan, Ramakrishnan/Q-9018-2016	Nakato, Ryuichiro/0000-0003-3019-5817; Shirahige, Katsuhiko/0000-0002-7862-1144; Edmondson, Andrew/0000-0003-0313-0743; Dorsett, Dale/0000-0002-0507-2762; Rajagopalan, Ramakrishnan/0000-0002-5751-9239	MEXT (Ministry of Education, Culture, Sports, Science and Technology); CdLS Foundation; Children's Hospital of Philadelphia; US National Institutes of Health (NIH)/National Institute of Child Health and Development (NICHD) [PO1 HD052860]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008638] Funding Source: NIH RePORTER	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CdLS Foundation; Children's Hospital of Philadelphia; US National Institutes of Health (NIH)/National Institute of Child Health and Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Nakagawa, S. Watanabe and E. Rappaport for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research (S) and for innovative science from MEXT (Ministry of Education, Culture, Sports, Science and Technology) (K.S.) and by research grants from the CdLS Foundation, development funds from the Children's Hospital of Philadelphia and grant PO1 HD052860 from the US National Institutes of Health (NIH)/National Institute of Child Health and Development (NICHD) (I.D.K.).	Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komata M, 2014, METHODS MOL BIOL, V1164, P33, DOI 10.1007/978-1-4939-0805-9_4; Komori T, 2012, J BIOL CHEM, V287, P19985, DOI 10.1074/jbc.M112.367854; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Taki T, 1999, P NATL ACAD SCI USA, V96, P14535, DOI 10.1073/pnas.96.25.14535; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tzschach A, 2006, AM J MED GENET A, V140A, P496, DOI 10.1002/ajmg.a.31105; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	42	73	74	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					338	U82		10.1038/ng.3229	http://dx.doi.org/10.1038/ng.3229			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730767	Green Accepted			2022-12-17	WOS:000351922900008
J	Geller, F; Feenstra, B; Carstensen, L; Pers, TH; van Rooij, IALM; Korberg, IB; Choudhry, S; Karjalainen, JM; Schnack, TH; Hollegaard, MV; Feitz, WFJ; Roeleveld, N; Hougaard, DM; Hirschhorn, JN; Franke, L; Baskin, LS; Nordenskjold, A; van der Zanden, LFMD; Melbye, M				Geller, Frank; Feenstra, Bjarke; Carstensen, Lisbeth; Pers, Tune H.; van Rooij, Iris A. L. M.; Korberg, Izabella Baranowska; Choudhry, Shweta; Karjalainen, Juha M.; Schnack, Tine H.; Hollegaard, Mads V.; Feitz, Wout F. J.; Roeleveld, Nel; Hougaard, David M.; Hirschhorn, Joel N.; Franke, Lude; Baskin, Laurence S.; Nordenskjold, Agneta; van der Zanden, Loes F. M.; Melbye, Mads			Genome-wide association analyses identify variants in developmental genes associated with hypospadias	NATURE GENETICS			English	Article							LOCI; METAANALYSIS; DISEASE; EXPRESSION; IDENTIFICATION; PRESSURE; ETIOLOGY; REVEALS; NETWORK; BMP7	Hypospadias is a common congenital condition in boys in which the urethra opens on the underside of the penis. We performed a genome-wide association study on 1,006 surgery-confirmed hypospadias cases and 5,486 controls from Denmark. After replication genotyping of an additional 1,972 cases and 1,812 controls from Denmark, the Netherlands and Sweden, 18 genomic regions showed independent association with P < 5 x 10(-8). Together, these loci explain 9% of the liability to developing this condition. Several of the identified regions harbor genes with key roles in embryonic development (including HOXA4, IRX5, IRX6 and EYA1). Subsequent pathway analysis with GRAIL and DEPICT provided additional insight into possible genetic mechanisms causing hypospadias.	[Geller, Frank; Feenstra, Bjarke; Carstensen, Lisbeth; Schnack, Tine H.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Pers, Tune H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Pers, Tune H.; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA USA; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [van Rooij, Iris A. L. M.; Roeleveld, Nel] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Korberg, Izabella Baranowska; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Korberg, Izabella Baranowska; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Choudhry, Shweta; Baskin, Laurence S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Karjalainen, Juha M.; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Feitz, Wout F. J.] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Roeleveld, Nel] Radboud Univ Nijmegen, Amalia Childrens Hosp, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA	Statens Serum Institut; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Technical University of Denmark; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; University of California System; University of California San Francisco; University of Groningen; Statens Serum Institut; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Harvard Medical School; Stanford University	Geller, F (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	fge@ssi.dk	Karjalainen, Juha/P-8624-2016; van der Zanden, Loes/M-4795-2015; Franke, Lude/P-7036-2016; Iris ALM Rooij, van/A-5705-2014; Hougaard, David/AAD-6368-2019; Roeleveld, Nel/B-4242-2008; Feitz, W.F.J./H-8028-2014	van der Zanden, Loes/0000-0003-3914-7491; Franke, Lude/0000-0002-5159-8802; Iris ALM Rooij, van/0000-0002-9519-966X; Roeleveld, Nel/0000-0002-3390-4466; Pers, Tune/0000-0003-0207-4831; Geller, Frank/0000-0002-9238-3269; Nordenskjold, Agneta/0000-0001-6638-4631; melbye, mads/0000-0001-8264-6785; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; Feenstra, Bjarke/0000-0003-1478-649X	Radboud University Medical Center; Oak Foundation fellowship; Danish Council for Independent Research Medical Sciences (FSS); Alfred Benzon Foundation; FSS grant [0602-01455B]; Novo Nordisk Foundation; Lundbeck Foundation [421/06]; Swedish Research Council; Foundation Frimurare Barnhuset Stockholm; Stockholm City Council; Swedish Society for Medical Research and Karolinska Institutet; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5K12DK083021]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083021] Funding Source: NIH RePORTER	Radboud University Medical Center; Oak Foundation fellowship; Danish Council for Independent Research Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Alfred Benzon Foundation; FSS grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation Frimurare Barnhuset Stockholm; Stockholm City Council; Swedish Society for Medical Research and Karolinska Institutet; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all study participants (as well as their parents) in Denmark, the Netherlands, Sweden and the United States for their cooperation in this study. We would also like to thank everyone involved in data collection and biological material handling in the four study groups (C.H.W. Wijers, S. van der Velde-Visser, K. Kwak, J. Knoll, R. de Gier, B. Kortmann, A. Paauwen, H.G. Kho, J. Driessen and the anesthesiologists of OR 18 for the Dutch group; data collection in the Netherlands was performed as part of a PhD project supported by the Radboud University Medical Center).; B.F. is supported by an Oak Foundation fellowship. T.H.P. is supported by the Danish Council for Independent Research Medical Sciences (FSS) and the Alfred Benzon Foundation. The study was supported by an FSS grant (0602-01455B), the Novo Nordisk Foundation, the Lundbeck Foundation (421/06), the Swedish Research Council, Foundation Frimurare Barnhuset Stockholm, the Stockholm City Council, the Swedish Society for Medical Research and Karolinska Institutet. Funding support for expression analysis performed at the University of California, San Francisco came from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-sponsored K12 Urologic Research (KURe) program (5K12DK083021). The funders had no role in study design, execution or analysis or in manuscript writing.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bult CJ, 2013, NUCLEIC ACIDS RES, V41, pD885, DOI 10.1093/nar/gks1115; Carmichael SL, 2013, J UROLOGY, V189, P305, DOI 10.1016/j.juro.2012.09.002; Chen TJ, 2007, EUR J HUM GENET, V15, P23, DOI 10.1038/sj.ejhg.5201722; Chiu HS, 2010, DEV BIOL, V344, P1071, DOI 10.1016/j.ydbio.2010.05.495; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Cvejic A, 2013, NAT GENET, V45, P542, DOI 10.1038/ng.2603; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Geller F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002275; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalfa N, 2009, INT J ANDROL, V32, P187, DOI 10.1111/j.1365-2605.2008.00899.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang C, 2011, DEV BIOL, V360, P186, DOI 10.1016/j.ydbio.2011.09.020; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	56	73	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					957	+		10.1038/ng.3063	http://dx.doi.org/10.1038/ng.3063			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108383				2022-12-17	WOS:000341579400009
J	Bonnefond, A; Skrobek, B; Lobbens, S; Eury, E; Thuillier, D; Cauchi, S; Lantieri, O; Balkau, B; Riboli, E; Marre, M; Charpentier, G; Yengo, L; Froguel, P				Bonnefond, Amelie; Skrobek, Boris; Lobbens, Stephane; Eury, Elodie; Thuillier, Dorothee; Cauchi, Stephane; Lantieri, Olivier; Balkau, Beverley; Riboli, Elio; Marre, Michel; Charpentier, Guillaume; Yengo, Loic; Froguel, Philippe			Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications	NATURE GENETICS			English	Article							GENETIC-VARIATION; DRUG DISCOVERY; GENOME; CANCER; OBESITY; INSULIN; AGE	Large chromosomal clonal mosaic events (CMEs) have been suggested to be linked to aging(1-3) and to predict cancer(2,3). Type 2 diabetes (T2D) has been conceptualized as an accelerated-aging disease(4-6) and is associated with higher prevalence of cancers(7-11). Here we aimed to assess the association between T2D and CME occurrence in blood. We evaluated the presence of CMEs in 7,659 individuals (including 2,208 with T2D) using DNA arrays. A significant association between CME occurrence and T2D was found (odds ratio (OR) = 5.3; P = 5.1 x 10(-5)) and was stronger when we only considered non-obese individuals with T2D (OR = 5.6; P = 4.9 x 10(-5)). Notably, CME carriers with T2D had higher prevalence of vascular complications than non-carriers with T2D (71.4% versus 37.1%, respectively; P = 7.7 x 10(-4)). In CME carriers, we found an increase in the percentage of abnormal cells over 6 years (P = 8.60 x 10(-3)). In conclusion, given the increased risk of cancer in CME carriers(2,3), our results may have profound clinical implications in patients with severe T2D.	[Bonnefond, Amelie; Skrobek, Boris; Lobbens, Stephane; Eury, Elodie; Thuillier, Dorothee; Cauchi, Stephane; Yengo, Loic; Froguel, Philippe] CNRS, Lille Pasteur Inst, UMR 8199, Lille, France; [Bonnefond, Amelie; Skrobek, Boris; Lobbens, Stephane; Eury, Elodie; Thuillier, Dorothee; Cauchi, Stephane; Yengo, Loic; Froguel, Philippe] Univ Lille, Lille, France; [Bonnefond, Amelie; Skrobek, Boris; Lobbens, Stephane; Eury, Elodie; Thuillier, Dorothee; Cauchi, Stephane; Yengo, Loic; Froguel, Philippe] EGID, Lille, France; [Lantieri, Olivier] Inst Inter Reg Sante IRSA, La Riche, France; [Balkau, Beverley] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Villejuif, France; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Paris 07, INSERM U695, Paris, France; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Dept Endocrinol & Diabetol, Essonnes, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Froguel, Philippe] QBRI, Doha, Qatar	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Sud Francilien; Imperial College London; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI)	Froguel, P (corresponding author), CNRS, Lille Pasteur Inst, UMR 8199, Lille, France.	p.froguel@imperial.ac.uk	FROGUEL, Philippe/O-6799-2017; Yengo, Loic/D-2692-2017; Bonnefond, Amélie/O-2784-2017	FROGUEL, Philippe/0000-0003-2972-0784; Yengo, Loic/0000-0002-4272-9305; Bonnefond, Amélie/0000-0001-9976-3005; Riboli, Elio/0000-0001-6795-6080; Marre, Michel/0000-0002-3071-1837	Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER Axe Cardio-Diabete); Delegation Regionale a la Recherche et a la Technologie de la Region Nord-Pas-De-Calais (DRRT); European Union (Fonds Europeen de Developpement Regional (FEDER)); Centre National de la Recherche Scientifique (CNRS); Medical Research Council [G1002084] Funding Source: researchfish; MRC [G1002084] Funding Source: UKRI	Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER Axe Cardio-Diabete)(Region Hauts-de-France); Delegation Regionale a la Recherche et a la Technologie de la Region Nord-Pas-De-Calais (DRRT)(Region Hauts-de-France); European Union (Fonds Europeen de Developpement Regional (FEDER)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are sincerely indebted to all participants in the genetic study. We thank M. Deweirder and F. Allegaert for their technical assistance and their invaluable management of DNA samples. This study was supported by the Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER Axe Cardio-Diabete to P. F.), the Delegation Regionale a la Recherche et a la Technologie de la Region Nord-Pas-De-Calais (DRRT), the European Union (Fonds Europeen de Developpement Regional (FEDER)) and the Centre National de la Recherche Scientifique (CNRS).	Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002; Castillo JJ, 2012, BLOOD, V119, P4845, DOI 10.1182/blood-2011-06-362830; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dumanski JP, 2012, METHODS MOL BIOL, V838, P249, DOI 10.1007/978-1-61779-507-7_12; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Geesaman BJ, 2006, AM J CLIN NUTR, V83, p466S; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kirkman MS, 2009, DIABETES CARE, V32, pS1, DOI 10.2337/dc09-S001; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Martin LJ, 2002, DIABETES, V51, P3568, DOI 10.2337/diabetes.51.12.3568; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Morley JE, 2008, CLIN GERIATR MED, V24, P395, DOI 10.1016/j.cger.2008.03.005; Murphy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039361; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	24	73	74	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1040	+		10.1038/ng.2700	http://dx.doi.org/10.1038/ng.2700			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23852171				2022-12-17	WOS:000323748200013
J	van Ommen, GJB				van Ommen, GJB			Frequency of new copy number variation in humans	NATURE GENETICS			English	Letter							RECENT SEGMENTAL DUPLICATIONS; HUMAN GENOME; DMD GENE; SEQUENCE; DELETIONS; MUTATION		Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Med Syst Biol, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Ommen, GJB (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, POB 9503, NL-2300 RA Leiden, Netherlands.	gjvo@lumc.nl						Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BLONDEN LAJ, 1991, GENOMICS, V10, P631, DOI 10.1016/0888-7543(91)90445-K; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; EMERY AEH, 1993, OXFORD MONOGRAPHS ME, V24; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOFKER MH, 1986, AM J HUM GENET, V39, P438; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942	15	73	76	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					333	334		10.1038/ng0405-333	http://dx.doi.org/10.1038/ng0405-333			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15800641				2022-12-17	WOS:000228040000004
J	Gilbertson, RJ; Clifford, SC				Gilbertson, RJ; Clifford, SC			PDGFRB is overexpressed in metastatic medulloblastoma	NATURE GENETICS			English	Letter									St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	St Jude Children's Research Hospital; Newcastle University - UK	Gilbertson, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.Gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021	Gilbertson, Richard James/0000-0001-7539-9472; Clifford, Steve/0000-0003-4893-2184				Ellison DW, 2003, EUR J PAEDIATR NEURO, V7, P53, DOI 10.1016/S1090-3798(03)00014-X; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731	2	73	75	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					197	198		10.1038/ng1103-197	http://dx.doi.org/10.1038/ng1103-197			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14593398				2022-12-17	WOS:000186273300002
J	Hunter, K; Welch, DR; Liu, ET				Hunter, K; Welch, DR; Liu, ET			Genetic background is an important determinant of metastatic potential	NATURE GENETICS			English	Letter							BREAST-CANCER; MOUSE MODELS; PROGRESSION; EXPRESSION		NCI, Lab Populat Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; Genome Inst Singapore, Singapore 117528, Singapore	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Hunter, K (corresponding author), NCI, Lab Populat Genet, Ctr Canc Res, NIH, Bldg 41,Room D702,41 Lib Dr, Bethesda, MD 20892 USA.		Welch, Danny R/B-7310-2009; Liu, Edison/C-4141-2008	Welch, Danny R/0000-0002-1951-4947; 	NATIONAL CANCER INSTITUTE [Z01CP010146] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Herzig M, 2002, BBA-REV CANCER, V1602, P97, DOI 10.1016/S0304-419X(02)00039-2; Hunter KW, 2001, CANCER RES, V61, P8866; Ingram DK, 1999, NEUROBIOL AGING, V20, P137, DOI 10.1016/S0197-4580(99)00033-0; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Raineri I, 2001, FREE RADICAL BIO MED, V31, P1018, DOI 10.1016/S0891-5849(01)00686-4; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	9	73	79	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					23	24		10.1038/ng0503-23b	http://dx.doi.org/10.1038/ng0503-23b			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12721549				2022-12-17	WOS:000182667900008
J	Anderson, KV; Ingham, PW				Anderson, KV; Ingham, PW			The transformation of the model organism: a decade of developmental genetics	NATURE GENETICS			English	Review							FUNCTIONAL GENOMIC ANALYSIS; LONG-RANGE ACTION; C-ELEGANS; CELL POLARITY; ASYMMETRIC LOCALIZATION; SIGNALING PATHWAYS; PROTEIN-KINASE; HEDGEHOG; WINGLESS; EXPRESSION	The past decade has seen the development of powerful techniques to dissect the molecular processes that regulate development. New tools have been used to reveal the basis of cell polarity, morphogen gradients and regulation of signaling in developing animals. Cell biology and developmental biology have become closely intertwined, and many genes that had been thought of as regulators of general cell biological (housekeeping) functions have been shown to act as specific developmental regulators. Vertebrate developmental genetics is now flourishing, with forward and reverse genetics in both zebrafish and the mouse providing new dimensions to our understanding of development.	Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; Univ Sheffield, Dept Biomed Sci, Ctr Dev Genet, Sheffield S10 2TN, S Yorkshire, England	Memorial Sloan Kettering Cancer Center; University of Sheffield	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-avderson@ski.mskcc.org	Ingham, Philip W/E-6710-2010; Ingham, Philip W/G-9903-2011; Ingham, Philip William/AAH-5884-2020	Ingham, Philip W/0000-0001-8224-9958; Ingham, Philip William/0000-0001-8224-9958; Anderson, Kathryn/0000-0003-1657-2161				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Karim FD, 1996, GENETICS, V143, P315; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mellitzer G, 2002, MECH DEVELOP, V118, P57, DOI 10.1016/S0925-4773(02)00191-0; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moustakas A, 2001, J CELL SCI, V114, P4359; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Sen J, 2000, DEVELOPMENT, V127, P5541; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WILSON V, 1993, DEVELOPMENT, V117, P1321; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707; XU T, 1993, DEVELOPMENT, V117, P1223; Ye YH, 2000, SEMIN CELL DEV BIOL, V11, P211, DOI 10.1006/scdb.2000.0167; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	78	73	77	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			285	293		10.1038/ng1105	http://dx.doi.org/10.1038/ng1105			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610538				2022-12-17	WOS:000181390900009
J	Haigis, KM; Dove, WF				Haigis, KM; Dove, WF			A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity	NATURE GENETICS			English	Article							WILD HOUSE MICE; MITOTIC RECOMBINATION; INTESTINAL NEOPLASIA; HOMOLOGOUS RECOMBINATION; MOUSE; ADENOMAS; CHROMOSOMES; CANCER; PREDISPOSITION; MULTIPLICITY	In mammals, loss of APC/Apc gatekeeper function initiates intestinal tumorigenesis. Several different mechanisms have been shown or proposed to mediate functional loss of APC/Apc: mutation in APC/Apc, non-disjunction, homologous somatic recombination and epigenetic silencing. The demonstration that, in the C57BL/6 (B6) Apc(Min/+) mouse model of inherited intestinal cancer, loss of Apc function can occur by loss of heterozygosity (LOH) through somatic recombination between homologs presents an opportunity to search for polymorphisms in the homologous somatic recombination pathway. We report that the Robertsonian translocation Rb(7.18)9Lub (Rb9) suppresses the multiplicity of intestinal adenomas in this mouse model. As the copy number of Rb9 increases, the association with the interphase nucleolus of the rDNA repeats centromeric to the Apc locus on Chromosome 18 is increasingly disrupted. Our analysis shows that homologous somatic recombination is the principal pathway for LOH in adenomas in B6 Apc(Min/+) mice. These studies provide additional evidence that neoplastic growth can initiate in the complete absence of canonical genomic instability.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Dove, WF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.							BRASCH JM, 1979, CYTOGENET CELL GENET, V24, P122, DOI 10.1159/000131365; Bridger JM, 1998, J CELL SCI, V111, P1241; Cormier RT, 2000, CANCER RES, V60, P3965; DAVISSON MT, 1987, CYTOGENET CELL GENET, V45, P70, DOI 10.1159/000132432; DAVISSON MT, 1993, GENETICS, V133, P649; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; EPPIG JT, 1988, J HERED, V79, P425, DOI 10.1093/oxfordjournals.jhered.a110545; Falconer DS, 1996, INTRO QUANTITATIVE G; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Frydman N, 2001, HUM REPROD, V16, P2274, DOI 10.1093/humrep/16.11.2274; GARCIABELLIDO A, 1978, MOL GEN GENET, V161, P317, DOI 10.1007/BF00331007; Gould KA, 1996, GENETICS, V144, P1769; GROPP A, 1982, CYTOGENET CELL GENET, V34, P67, DOI 10.1159/000131794; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Harbour JW, 2001, ARCH OPHTHALMOL-CHIC, V119, P1699; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LANE PW, 1985, J HERED, V76, P476, DOI 10.1093/oxfordjournals.jhered.a110152; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; LUONGO C, 1994, CANCER RES, V54, P5947; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; MERRIAM JR, 1972, MOL GEN GENET, V115, P294, DOI 10.1007/BF00333168; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Robertson WRB, 1916, J MORPHOL, V27, P179, DOI 10.1002/jmor.1050270202; Rothstein R, 2000, GENE DEV, V14, P1; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shao CS, 2000, P NATL ACAD SCI USA, V97, P7405, DOI 10.1073/pnas.97.13.7405; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Shoemaker AR, 1998, P NATL ACAD SCI USA, V95, P10826, DOI 10.1073/pnas.95.18.10826; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; SILVER LM, 1981, NATURE, V290, P68, DOI 10.1038/290068a0; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tucker M, 2000, J NATL CANCER I, V92, P530, DOI 10.1093/jnci/92.7.530; Turker MS, 1999, CANCER RES, V59, P4781; WALLACE BMN, 1992, CYTOGENET CELL GENET, V61, P211, DOI 10.1159/000133410	43	73	75	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					33	39		10.1038/ng1055	http://dx.doi.org/10.1038/ng1055			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12447373				2022-12-17	WOS:000180136100014
J	Streicher, J; Donat, MA; Strauss, B; Sporle, R; Schughart, K; Muller, GB				Streicher, J; Donat, MA; Strauss, B; Sporle, R; Schughart, K; Muller, GB			Computer-based three-dimensional visualization of developmental gene expression	NATURE GENETICS			English	Article							SERIAL SECTIONS; 3D RECONSTRUCTION; 3-DIMENSIONAL RECONSTRUCTION; MOUSE EMBRYOS; SYSTEM; SEGMENTATION; DERIVATIVES; DATABASE; DESIGN; MUTANT	A broad understanding of the relationship between gene activation, pattern formation and morphogenesis will require adequate tools for three-dimensional and, perhaps four-dimensional, representation and analysis of molecular developmental processes. We present a novel, computer-based method for the 3D visualization of embryonic gene expression and morphological structures from serial sections. The information from these automatically aligned 3D reconstructions exceeds that from single-section and whole-mount visualizations of in situ hybridizations. In addition, these 3D models of gene-expression patterns can become a central component of a future developmental database designed for the collection and presentation of digitized, morphological and gene-expression data. This work is accompanied by a web site (http://www. univie.ac.at/GeneEMAC).	Univ Vienna, Dept Anat, Integrat Morphol Grp, Vienna, Austria; GSF, Natl Res Ctr Environm & Hlth Neuherberg, Inst Mammalian Genet, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 1947, Dept Mol Biol, F-75724 Paris 15, France; Transgene SA, Dept Mol & Cellular Biol, Strasbourg, France	University of Vienna; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Transgene SA	Streicher, J (corresponding author), Univ Vienna, Dept Anat, Integrat Morphol Grp, Vienna, Austria.	johannes.streicher@univie.ac.at		Streicher, Johannes/0000-0002-4114-2246; Schughart, Klaus/0000-0002-6824-7523				ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; ARNOLDS WJA, 1978, STAIN TECHNOL, V53, P287; ARRAEZAYBAR LA, 1994, SURG RADIOL ANAT, V16, P419, DOI 10.1007/BF01627664; Born G, 1883, ARCH MIKROSK ANAT, V22, P584, DOI 10.1007/bf02952679; BRANDLE K, 1989, COMPUT BIOMED RES, V22, P52, DOI 10.1016/0010-4809(89)90015-3; BRAVERMAN MS, 1986, J INVEST DERMATOL, V86, P290, DOI 10.1111/1523-1747.ep12285445; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; HIBBARD LS, 1988, J NEUROSCI METH, V26, P55, DOI 10.1016/0165-0270(88)90129-X; His W., 1887, ANAT ANZEIGER, V2, P382; Holland Linda Z., 1996, P267; HOSONO M, 1995, J DIGIT IMAGING, V8, P105, DOI 10.1007/BF03168084; HUIJSMANS DP, 1986, ANAT RECORD, V216, P449, DOI 10.1002/ar.1092160402; IWAMOTO Y, 1995, ACTA ORTHOP SCAND, V66, P80, DOI 10.3109/17453679508994646; KERI C, 1991, J NEUROSCI METH, V37, P241, DOI 10.1016/0165-0270(91)90030-4; KNOX CK, 1990, P E MULT SOC COMP SI, P12; Krams R, 1997, ARTERIOSCL THROM VAS, V17, P2061, DOI 10.1161/01.ATV.17.10.2061; MITCHIE A, 1983, COMPUTER GRAPHICS IM, V22, P296; MOSS VA, 1990, J MICROSC-OXFORD, V158, P187, DOI 10.1111/j.1365-2818.1990.tb02992.x; Muller GB, 1996, AM ZOOL, V36, P4; OTT MO, 1991, DEVELOPMENT, V111, P1097; PROTHERO JS, 1986, COMPUT BIOMED RES, V19, P361, DOI 10.1016/0010-4809(86)90048-0; RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224; Roush W, 1997, SCIENCE, V278, P1397, DOI 10.1126/science.278.5342.1397; RYDMARK M, 1992, J MICROSC-OXFORD, V165, P29, DOI 10.1111/j.1365-2818.1992.tb04303.x; Scarborough J, 1997, J ANAT, V191, P117, DOI 10.1046/j.1469-7580.1997.19110117.x; Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; SKOGLUND TS, 1995, J NEUROSCI METH, V61, P105, DOI 10.1016/0165-0270(94)00031-B; Smith BR, 1999, SCI AM, V280, P76, DOI 10.1038/scientificamerican0399-76; Sporle R, 1996, DEVELOPMENT, V122, P79; Sporle R, 1998, DEV GENET, V22, P359, DOI 10.1002/(SICI)1520-6408(1998)22:4<359::AID-DVG6>3.0.CO;2-5; Sporle R, 1997, DEV DYNAM, V210, P216; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Stevens J. K., 1994, 3 DIMENSIONAL CONFOC; Streicher J, 1997, ANAT REC, V248, P583; Tajbakhsh S, 1998, CELL, V92, P9, DOI 10.1016/S0092-8674(00)80894-6; Theiler K., 1972, P1; Vazquez MD, 1998, ANAT HISTOL EMBRYOL, V27, P283, DOI 10.1111/j.1439-0264.1998.tb00194.x; VERBEEK FJ, 1995, MICROSC RES TECHNIQ, V30, P496, DOI 10.1002/jemt.1070300607; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209	40	73	76	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					147	152		10.1038/75989	http://dx.doi.org/10.1038/75989			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835627				2022-12-17	WOS:000087459200011
J	Risch, N				Risch, N			Haemochromatosis, HFE and genetic complexity	NATURE GENETICS			English	Letter							HEREDITARY HEMOCHROMATOSIS; MUTATION ANALYSIS				Risch, N (corresponding author), STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.							Ajioka RS, 1997, AM J HUM GENET, V60, P1439, DOI 10.1086/515466; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Calandro L, 1996, BLOOD CELL MOL DIS, V22, pA194; Carella M, 1997, AM J HUM GENET, V60, P828; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1997, HUM GENET, V100, P544, DOI 10.1007/s004390050549; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251	8	73	74	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					375	376		10.1038/ng1297-375	http://dx.doi.org/10.1038/ng1297-375			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398831				2022-12-17	WOS:A1997YJ92400010
J	Salido, EC; Li, XM; Yen, PH; Martin, N; Mohandas, TK; Shapiro, LJ				Salido, EC; Li, XM; Yen, PH; Martin, N; Mohandas, TK; Shapiro, LJ			Cloning and expression of the mouse pseudoautosomal steroid sulphatase gene (Sts)	NATURE GENETICS			English	Letter							HUMAN SEX-CHROMOSOMES; SULFATASE GENE; X-CHROMOSOME; LINKAGE; REGION; LOCUS; CDNA		UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF LOS ANGELES,MED CTR,DIV MED GENET,TORRANCE,CA 90509; UNIV LA LAGUNA,DEPT PATHOL,E-38071 TENERIFE,SPAIN	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Universidad de la Laguna			Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854	NICHD NIH HHS [HD28009, HD121781GM54907] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028009, R01HD012178] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1993, MEGA MOL EVOLUTIONAR; BALAZS I, 1982, CYTOGENET CELL GENET, V32, P251; BALLABIO A, 1995, METABOLIC MOL BASES, P2999; CATTANACH BM, 1986, MOUSE NEWS LETT, V74, P94; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; ERICKSON RP, 1983, GENETICS, V105, P181; GARTLER SM, 1983, GENETICS, V103, P137; GROMPE M, 1992, GENOMICS, V12, P755, DOI 10.1016/0888-7543(92)90306-D; KAWANO J, 1989, BIOCHIM BIOPHYS ACTA, V997, P199, DOI 10.1016/0167-4838(89)90187-8; KEINANEN BM, 1983, GENETICS, V105, P191; KEITGES E, 1985, NATURE, V315, P226, DOI 10.1038/315226a0; KEITGES EA, 1987, GENETICS, V116, P465; LAU EC, 1981, GENOMICS, V10, P971; LI X, IN PRESS MAMM GENOME; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MORTAUD S, 1995, J STEROID BIOCHEM, V52, P91, DOI 10.1016/0960-0760(94)00143-A; NAGAMINE CM, 1987, NUCLEIC ACIDS RES, V15, P9227, DOI 10.1093/nar/15.22.9227; Ohno S., 1967, SEX CHROMOSOMES SEX; PETERS C, 1990, J BIOL CHEM, V265, P3374; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SALIDO EC, 1993, SOMAT CELL MOLEC GEN, V19, P65, DOI 10.1007/BF01233955; Sambrook J, 1989, MOL CLONING LAB MANU; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	27	73	75	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					83	86		10.1038/ng0596-83	http://dx.doi.org/10.1038/ng0596-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673109				2022-12-17	WOS:A1996UH43000020
J	MOWRY, BJ; NANCARROW, DJ; LENNON, DP; SANDKUIJL, LA; CROWE, RR; SILVERMAN, JM; MOHS, RC; SIEVER, LJ; ENDICOTT, J; SHARPE, L; WALTERS, MK; HAYWARD, NK; LEVINSON, DF				MOWRY, BJ; NANCARROW, DJ; LENNON, DP; SANDKUIJL, LA; CROWE, RR; SILVERMAN, JM; MOHS, RC; SIEVER, LJ; ENDICOTT, J; SHARPE, L; WALTERS, MK; HAYWARD, NK; LEVINSON, DF			SCHIZOPHRENIA SUSCEPTIBILITY AND CHROMOSOME 6P24-22	NATURE GENETICS			English	Letter							MULTILOCUS LINKAGE ANALYSIS; DIAGNOSTIC INTERVIEW; DISORDERS; SCHEDULE; HUMANS		WOLSTON PK HOSP,CLIN STUDIES UNIT,BRISBANE,QLD 4076,AUSTRALIA; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,ROTTERDAM,NETHERLANDS; LEIDEN UNIV,DEPT GENET,LEIDEN,NETHERLANDS; UNIV GRONINGEN,DEPT MED GENET,GRONINGEN,NETHERLANDS; UNIV IOWA,SCH MED,DEPT PSYCHIAT,IOWA CITY,IA 52242; CUNY MT SINAI SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10029; COLUMBIA UNIV,NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032; QUEENSLAND INST MED RES,HERSTON,QLD 4029,AUSTRALIA; MED COLL PENN,DEPT PSYCHIAT,PHILADELPHIA,PA 19129; HAHNEMAN UNIV HOSP,PHILADELPHIA,PA 19129	Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen; University of Iowa; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; New York State Psychiatry Institute; QIMR Berghofer Medical Research Institute; Drexel University; Drexel University	MOWRY, BJ (corresponding author), UNIV QUEENSLAND,DEPT PSYCHIAT,BRISBANE,QLD 4076,AUSTRALIA.		hayward, nick/AAV-8802-2020; Silverman, Jeremy M./AAO-4268-2020; Mowry, Bryan/G-5046-2010	Mowry, Bryan/0000-0002-4115-5645	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-45097, MH-43212] Funding Source: Medline; PHS HHS [K00735] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDREASON NC, 1987, COMPREHENSIVE ASSESS; BARON M, 1981, PSYCHIAT RES, V4, P213, DOI 10.1016/0165-1781(81)90024-X; BARON M, 1980, SCHEDULE INTERVIEWIN; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; DIEHL SR, 1994, AM J HUM GENET S, V55, P867; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVINSON D, IN PRESS GENET EPIDE; LEVINSON DF, 1991, SCHIZOPHRENIA BULL, V17, P491, DOI 10.1093/schbul/17.3.491; MCGUE M, 1983, AM J HUM GENET, V35, P1161; Ott J., 1991, ANAL HUMAN GENETIC L; Shields J, 1982, SCHIZOPHRENIA EPIGEN; STANGL D, 1985, ARCH GEN PSYCHIAT, V42, P591; STRAUB R, NAT GENET, P287; SU Y, 1993, ARCH GEN PSYCHIAT, V50, P205; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEEKS DE, 1992, AM J HUM GENET, V50, P859; 1987, DSM 3 R DIAGNOSTIC S	21	73	73	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					233	234		10.1038/ng1195-233	http://dx.doi.org/10.1038/ng1195-233			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581441				2022-12-17	WOS:A1995TC63900006
J	KUMARAMANICKAVEL, G; MAW, M; DENTON, MJ; JOHN, S; SRIKUMARI, CRS; ORTH, U; OEHLMANN, R; GAL, A				KUMARAMANICKAVEL, G; MAW, M; DENTON, MJ; JOHN, S; SRIKUMARI, CRS; ORTH, U; OEHLMANN, R; GAL, A			MISSENSE RHODOPSIN MUTATION IN A FAMILY WITH RECESSIVE RP	NATURE GENETICS			English	Letter							RETINITIS-PIGMENTOSA; GENE; TRANSDUCIN		MED RES FDN,MADRAS 600006,TAMIL NADU,INDIA; INST BASIC MED SCI,DEPT GENET,MADRAS 600113,TAMIL NADU,INDIA; UNIV LUBECK,INST HUMANGENET,D-23538 LUBECK,GERMANY	University of Lubeck	KUMARAMANICKAVEL, G (corresponding author), UNIV OTAGO,DEPT BIOCHEM,POB 56,DUNEDIN,NEW ZEALAND.		KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021	KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301				BUNGE S, 1993, GENOMICS, V17, P230, DOI 10.1006/geno.1993.1309; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; FARRAR GJ, 1993, RETINAL DEGENERATION, P63; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; MACKE JP, 1993, AM J HUM GENET, V53, P80; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209	8	73	74	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					10	11		10.1038/ng0994-10	http://dx.doi.org/10.1038/ng0994-10			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987385				2022-12-17	WOS:A1994PE15700005
J	SUN, TQ; FENSTERMACHER, DA; VOS, JMH				SUN, TQ; FENSTERMACHER, DA; VOS, JMH			HUMAN ARTIFICIAL EPISOMAL CHROMOSOMES FOR CLONING LARGE DNA FRAGMENTS IN HUMAN-CELLS	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; MAMMALIAN REPLICATION ORIGIN; POLYMERASE CHAIN-REACTION; STABLE REPLICATION; ESCHERICHIA-COLI; TRANSGENIC MICE; HUMAN GENOME; MOUSE CELLS; YEAST; GENE	We have developed a human artificial episomal chromosome (HAEC) system, based on the latent replication origin of the large herpes Epstein-Barr virus, for the propagation and stable maintenance of DNA as circular minichromosomes in human cells. Individual HAECs carried human genomic inserts ranging from 60-330 kb and appeared genetically stable. An HAEC library of 1,500 independent clones carrying random human genomic fragments with average sizes of 150-200 kb was established and allowed recovery of the HAEC DNA. Our autologous HAEC system, with human DNA cloned directly in human cells, provides an important tool for functional study of large mammalian DNA regions and gene therapy.	UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CURRICULUM GENET & MOLEC BIOL, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BENTLEY DR, 1992, GENOMICS, V12, P534, DOI 10.1016/0888-7543(92)90445-X; BURKE DT, 1991, METHOD ENZYMOL, V194, P251; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARROLL SM, 1987, MOL CELL BIOL, V7, P1740, DOI 10.1128/MCB.7.5.1740; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COLLINS A, 1987, J TISS CULT METHODS, V10, P209; CURIEL D, 1994, VIRUSES HUMAN GENE T, P164; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ECKHARDT T, 1978, PLASMID, V1, P584, DOI 10.1016/0147-619X(78)90016-1; FEATHERSTONE T, 1993, GENOMICS, V17, P267, DOI 10.1006/geno.1993.1321; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GLASER R, 1974, J VIROL, V14, P174, DOI 10.1128/JVI.14.1.174-176.1974; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; HENNESSY K, 1983, SCIENCE, V220, P1396, DOI 10.1126/science.6304878; HOSODA F, 1990, NUCLEIC ACIDS RES, V18, P3863, DOI 10.1093/nar/18.13.3863; HUXLEY C, 1991, GENOMICS, V9, P742, DOI 10.1016/0888-7543(91)90369-P; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JANKELEVICH S, 1992, EMBO J, V11, P1165, DOI 10.1002/j.1460-2075.1992.tb05157.x; KIOUSSIS D, 1987, EMBO J, V6, P355, DOI 10.1002/j.1460-2075.1987.tb04762.x; KLAMAN LD, 1991, VIROLOGY, V185, P883, DOI 10.1016/0042-6822(91)90565-S; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; LAWRENCE JB, 1988, CELL, V52, P51; LIU P, 1993, CANCER GENET CYTOGEN, V65, P93, DOI 10.1016/0165-4608(93)90213-6; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; MCKUSICK VA, 1989, NEW ENGL J MED, V320, P910, DOI 10.1056/NEJM198904063201406; MICKEL S, 1977, NUCLEIC ACIDS RES, V4, P1465, DOI 10.1093/nar/4.5.1465; MIDDLETON T, 1994, J VIROL, V68, P4067, DOI 10.1128/JVI.68.6.4067-4071.1994; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NONET GH, 1993, SOMAT CELL MOLEC GEN, V19, P171, DOI 10.1007/BF01233532; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; PAVAN WJ, 1990, MOL CELL BIOL, V10, P4163, DOI 10.1128/MCB.10.8.4163; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rooney D E, 1986, HUMAN CYTOGENETICS P, VFirst; RUIZ JC, 1989, MOL CELL BIOL, V9, P109, DOI 10.1128/MCB.9.1.109; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; STRAUSS WM, 1992, EMBO J, V11, P417, DOI 10.1002/j.1460-2075.1992.tb05070.x; SUN TQ, 1992, INT J GENOME RES, V1, P45; VOS JMH, 1994, VIRUSES HUMAN GENE T, P109; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WINOCOUR E, 1980, P NATL ACAD SCI-BIOL, V77, P4861, DOI 10.1073/pnas.77.8.4861; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	57	73	99	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1994	8	1					33	41		10.1038/ng0994-33	http://dx.doi.org/10.1038/ng0994-33			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987390				2022-12-17	WOS:A1994PE15700013
J	CATTANACH, BM; BURTENSHAW, MD; RASBERRY, C; EVANS, EP				CATTANACH, BM; BURTENSHAW, MD; RASBERRY, C; EVANS, EP			LARGE DELETIONS AND OTHER GROSS FORMS OF CHROMOSOME IMBALANCE COMPATIBLE WITH VIABILITY AND FERTILITY IN THE MOUSE	NATURE GENETICS			English	Article							LOCI	Large deletions and other gross forms of chromosome imbalance are known in man but have rarely been found in the mouse. By screening progeny of spermatogonially irradiated male mice for a combination of runting and other phenotypic effects, we have identified animals that have large deletions comprising from 2.5-30 percent of the length of individual chromosomes, or other major chromosome changes, which are compatible with viability and fertility. Certain chromosome regions appear particularly susceptible to the generation of viable deletions and this has implications for radiation mutagenesis studies. Correlations with human deletions are also indicated.			CATTANACH, BM (corresponding author), MRC,DIV GENET,RADIOBIOL UNIT,DIDCOT OX11 0RD,OXON,ENGLAND.							Beechey CV, 1986, MOUSE NEWS LETT, V75, P28; CACHEIRO NLA, 1975, GENET RES, V25, P193, DOI 10.1017/S0016672300015597; CATTANACH BM, 1991, CYTOGENET CELL GENET, V56, P137, DOI 10.1159/000133070; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P157; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P156; CATTANACH BM, 1992, MOUSE GENOME, V90, P87; DAVISSON MT, 1991, CYTOGENET CELL GENET, V58, P1152, DOI 10.1159/000133726; DIGNAN PSJ, 1979, HUM GENET, V48, P151, DOI 10.1007/BF00286898; EVANS EP, 1990, MOUSE GENOME, V86, P230; EVANS EP, 1988, MOUSE NEWS LETT, V81, P66; FRANCO B, 1991, HUM GENET, V87, P269, DOI 10.1007/BF00200903; HOO JJ, 1986, HUM GENET, V73, P230, DOI 10.1007/BF00401233; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; Lyon M. F., 1992, Mouse Genome, V90, P22; Lyon ME, 1986, MOUSE NEWS LETT, V74, P96; LYON MF, 1984, GENET RES, V44, P161, DOI 10.1017/S0016672300026367; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Rinchik E.M., 1990, GENOME ANAL, P121; SARDA P, 1992, J MED GENET, V29, P259, DOI 10.1136/jmg.29.4.259; SCHINZEL A, 1988, PROGR TOPICS CYTOGEN, V8, P725; SEARLE AG, 1974, ADV RAD BIOL, V4; SEARLE AG, 1989, GENETIC VARIANTS STR, P582; VAUX C, 1991, J MED GENET, V29, P256; WINKING H, 1984, GENETICS, V108, P1013; 1985, NIH852011 PUBL	26	73	73	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					56	61		10.1038/ng0193-56	http://dx.doi.org/10.1038/ng0193-56			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490655				2022-12-17	WOS:A1993KF37200013
J	SCHIEBEL, K; WEISS, B; WOHRLE, D; RAPPOLD, G				SCHIEBEL, K; WEISS, B; WOHRLE, D; RAPPOLD, G			A HUMAN PSEUDOAUTOSOMAL GENE, ADP ATP TRANSLOCASE, ESCAPES X-INACTIVATION WHEREAS A HOMOLOG ON XQ IS SUBJECT TO X-INACTIVATION	NATURE GENETICS			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; RANGE RESTRICTION MAP; HUMAN Y-CHROMOSOME; SHORT ARM; MOLECULAR-CLONING; STEROID SULFATASE; ADP/ATP CARRIER; DNA-SEQUENCES; MESSENGER-RNA; LINKAGE MAP	We report the cloning of a highly conserved pseudoautosomal gene on the human sex chromosomes. A cDNA clone was selected by crosshybridization with a microdissected clone from the chromosomal subregion Xp22.3. It encodes a previously characterized member of the ADP/ATP translocase family and plays a fundamental role in cellular energy metabolism. This gene, ANT3, is located approximately 1,300 kilobases from the telomere, proximal to the pseudoautosomal gene CSF2RA, and escapes X-inactivation. Interestingly, a homologue of ANT3, ANT2, maps to Xq and is subject to X-inactivation. These genes provide the first evidence of two closely related X-chromosomal genes, which show striking differences in their X-inactivation behaviour.	UNIV ULM,DEPT CLIN GENET,W-7900 ULM,GERMANY	Ulm University	SCHIEBEL, K (corresponding author), UNIV HEIDELBERG,INST HUMAN GENET,W-6900 HEIDELBERG,GERMANY.							BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BISACCIA F, 1988, BIOCHIM BIOPHYS ACTA, V933, P229, DOI 10.1016/0005-2728(88)90030-8; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BURK RD, 1985, MOL CELL BIOL, V5, P576, DOI 10.1128/MCB.5.3.576; CHEN ST, 1990, SOMAT CELL MOLEC GEN, V16, P143, DOI 10.1007/BF01233044; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; FAN YS, 1992, CYTOGENET CELL GENET, V60, P29, DOI 10.1159/000133288; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FRASER N, 1987, DEVELOPMENT, V101, P127; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; HENKE A, 1991, AM J HUM GENET, V49, P811; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; KLINGEBERG M, 1990, TRENDS BIOCHEM SCI, V5, P18; KU DH, 1990, J BIOL CHEM, V265, P16060; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LI K, 1989, J BIOL CHEM, V264, P13998; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; MACKINNON RN, 1990, AM J HUM GENET, V47, P181; MONDELLO C, 1987, ANN HUM GENET, V51, P137, DOI 10.1111/j.1469-1809.1987.tb01055.x; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PETIT C, 1990, P NATL ACAD SCI USA, V87, P3680, DOI 10.1073/pnas.87.10.3680; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; RAPPOLD G, 1992, GENOMICS, V14, P455, DOI 10.1016/S0888-7543(05)80241-1; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; ROPERS HH, 1985, CYTOGENET CELL GENET, V40, P736; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; SALIDO EC, 1992, AM J HUM GENET, V50, P303; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SCHULTHEISS HP, 1985, ARCH BIOCHEM BIOPHYS, V239, P273, DOI 10.1016/0003-9861(85)90836-7; SPENCER JA, 1991, GENOMICS, V11, P339, DOI 10.1016/0888-7543(91)90141-Z; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WOHRLE D, 1990, HUM GENET, V85, P659; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YEN PH, 1992, HUM MOL GENET, V1, P47	53	73	76	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					82	87		10.1038/ng0193-82	http://dx.doi.org/10.1038/ng0193-82			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490661				2022-12-17	WOS:A1993KF37200018
J	Mbatchou, J; Barnard, L; Backman, J; Marcketta, A; Kosmicki, JA; Ziyatdinov, A; Benner, C; O'Dushlaine, C; Barber, M; Boutkov, B; Habegger, L; Ferreira, M; Baras, A; Reid, J; Abecasis, G; Maxwell, E; Marchini, J				Mbatchou, Joelle; Barnard, Leland; Backman, Joshua; Marcketta, Anthony; Kosmicki, Jack A.; Ziyatdinov, Andrey; Benner, Christian; O'Dushlaine, Colm; Barber, Mathew; Boutkov, Boris; Habegger, Lukas; Ferreira, Manuel; Baras, Aris; Reid, Jeffrey; Abecasis, Goncalo; Maxwell, Evan; Marchini, Jonathan			Computationally efficient whole-genome regression for quantitative and binary traits	NATURE GENETICS			English	Article							MIXED-MODEL ANALYSIS; WIDE ASSOCIATION; EXPRESSION; PREDICTION; INFERENCE; RESOURCE; TOOL	Genome-wide association analysis of cohorts with thousands of phenotypes is computationally expensive, particularly when accounting for sample relatedness or population structure. Here we present a novel machine-learning method called REGENIE for fitting a whole-genome regression model for quantitative and binary phenotypes that is substantially faster than alternatives in multi-trait analyses while maintaining statistical efficiency. The method naturally accommodates parallel analysis of multiple phenotypes and requires only local segments of the genotype matrix to be loaded in memory, in contrast to existing alternatives, which must load genome-wide matrices into memory. This results in substantial savings in compute time and memory usage. We introduce a fast, approximate Firth logistic regression test for unbalanced case-control phenotypes. The method is ideally suited to take advantage of distributed computing frameworks. We demonstrate the accuracy and computational benefits of this approach using the UK Biobank dataset with up to 407,746 individuals. REGENIE is a whole-genome regression method based on ridge regression that enables highly parallelized analysis of quantitative and binary traits in biobank-scale data with reduced computational requirements.	[Mbatchou, Joelle; Barnard, Leland; Backman, Joshua; Marcketta, Anthony; Kosmicki, Jack A.; Ziyatdinov, Andrey; Benner, Christian; O'Dushlaine, Colm; Barber, Mathew; Boutkov, Boris; Habegger, Lukas; Ferreira, Manuel; Baras, Aris; Reid, Jeffrey; Abecasis, Goncalo; Maxwell, Evan; Marchini, Jonathan] Regeneron Genet Ctr, Tarrytown, NY 10591 USA	Regeneron	Marchini, J (corresponding author), Regeneron Genet Ctr, Tarrytown, NY 10591 USA.	jonathan.marchini@regeneron.com		Mbatchou, Joelle/0000-0002-2245-3743	Medical Research Council [MC_PC_17228, MC_QA137853] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Breiman L, 1996, MACH LEARN, V24, P49; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chib S, 1998, BIOMETRIKA, V85, P347, DOI 10.1093/biomet/85.2.347; Dahl A, 2016, NAT GENET, V48, P466, DOI 10.1038/ng.3513; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; Dutta D, 2019, GENET EPIDEMIOL, V43, P4, DOI 10.1002/gepi.22156; Horowitz J E, 2021, medRxiv, DOI 10.1101/2020.12.14.20248176; Jiang LD, 2019, NAT GENET, V51, P1749, DOI 10.1038/s41588-019-0530-8; Jostins L, 2016, BIOINFORMATICS, V32, P1898, DOI 10.1093/bioinformatics/btw075; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Kerin M, 2020, AM J HUM GENET, V107, P698, DOI 10.1016/j.ajhg.2020.08.009; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kunert-Graf J., 2020, ALLELE FREQUENCY MIS, DOI [10.1101/2020.08.03.235150, DOI 10.1101/2020.08.03.235150]; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Logsdon BA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-58; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Meuwissen THE, 2001, GENETICS, V157, P1819; Morris AP, 2010, GENET EPIDEMIOL, V34, P335, DOI 10.1002/gepi.20486; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2019, R LANG ENV STAT COMP; Rizvi AA, 2019, BIOINFORMATICS, V35, P1968, DOI 10.1093/bioinformatics/bty920; Robinson GK., 1991, STAT SCI, V6, P15, DOI [10.1214/ss/1177011926, DOI 10.1214/SS/1177011926]; Shang LL, 2020, AM J HUM GENET, V106, P496, DOI 10.1016/j.ajhg.2020.03.002; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Young AI, 2018, NAT GENET, V50, P1608, DOI 10.1038/s41588-018-0225-6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou W, 2020, NAT GENET, V52, P634, DOI 10.1038/s41588-020-0621-6; Zhou W, 2018, NAT GENET, V50, P1335, DOI 10.1038/s41588-018-0184-y; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	41	72	72	4	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2021	53	7					1097	+		10.1038/s41588-021-00870-7	http://dx.doi.org/10.1038/s41588-021-00870-7		MAY 2021	20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH4XS	34017140	Green Submitted, Bronze			2022-12-17	WOS:000652463200001
J	Rodriguez-Leal, D; Xu, C; Kwon, CT; Soyars, C; Demesa-Arevalo, E; Man, J; Liu, L; Lemmon, ZH; Jones, DS; Van Eck, J; Jackson, DP; Bartlett, ME; Nimchuk, ZL; Lippman, ZB				Rodriguez-Leal, Daniel; Xu, Cao; Kwon, Choon-Tak; Soyars, Cara; Demesa-Arevalo, Edgar; Man, Jarrett; Liu, Lei; Lemmon, Zachary H.; Jones, Daniel S.; Van Eck, Joyce; Jackson, David P.; Bartlett, Madelaine E.; Nimchuk, Zachary L.; Lippman, Zachary B.			Evolution of buffering in a genetic circuit controlling plant stem cell proliferation	NATURE GENETICS			English	Article							ORGAN DEVELOPMENT; MERISTEM SIZE; SHOOT; ARABIDOPSIS; MECHANISMS; CLAVATA; MAINTENANCE; PERFORMANCE; MUTAGENESIS; IMPROVEMENT	Precise control of plant stem cell proliferation is necessary for the continuous and reproducible development of plant organs(1,2). The peptide ligand CLAVATA3 (CLV3) and its receptor protein kinase CLAVATA1 (CLV1) maintain stem cell homeostasis within a deeply conserved negative feedback circuit(1,2). In Arabidopsis, CLV1 paralogs also contribute to homeostasis,bycompensatingforthe loss of CLV1through transcriptional upregulation(3). Here, we show that compensation(4,5) operates in diverse lineages for both ligands and receptors, but while the core CLV signaling module is conserved, compensation mechanisms have diversified. Transcriptional compensation between ligand paralogs operates in tomato, facilitated by an ancient gene duplication that impacted the domestication of fruit size. In contrast, we found little evidence for transcriptional compensation between ligands in Arabidopsis and maize, and receptor compensation differs between tomato and Arabidopsis. Our findings show that compensation among ligand and receptor paralogs is critical for stem cell homeostasis, but that diverse genetic mechanisms buffer conserved developmental programs.	[Rodriguez-Leal, Daniel; Xu, Cao; Kwon, Choon-Tak; Demesa-Arevalo, Edgar; Liu, Lei; Lemmon, Zachary H.; Jackson, David P.; Lippman, Zachary B.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Soyars, Cara; Jones, Daniel S.; Nimchuk, Zachary L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Man, Jarrett; Bartlett, Madelaine E.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Van Eck, Joyce] Boyce Thompson Inst Plant Sci, Ithaca, NY USA; [Van Eck, Joyce] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA; [Lippman, Zachary B.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Rodriguez-Leal, Daniel; Lemmon, Zachary H.] Inari Agr, Cambridge, MA USA; [Xu, Cao] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Amherst; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Jackson, DP; Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.; Nimchuk, ZL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.; Bartlett, ME (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.; Lippman, ZB (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu; mbartlett@bio.umass.edu; zackn@email.unc.edu; lippman@cshl.edu	Leal, Daniel Rodriguez/AAI-8049-2021; Demesa-Arevalo, Edgar/AAX-8477-2020; Kwon, Choon-Tak/AHE-7146-2022	Leal, Daniel Rodriguez/0000-0003-1871-7432; Demesa-Arevalo, Edgar/0000-0002-2793-5928; Man, Jarrett/0000-0002-6412-8607; Van Eck, Joyce/0000-0002-8005-365X; Kwon, Choontak/0000-0002-3589-1662	Virginia Polytechnic Institute and State University; PEW Latin American Fellowship [29661]; NIGMS MIRA award from the National Institutes of Health [R35GM119614-01]; Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture [2016-67013-24572, 2015-67013-22823]; Next-Generation BioGreen 21 Program SSAC from the Rural Development Administration, Republic of Korea [PJ01322602]; National Science Foundation Plant Genome Research Program [IOS1732253, IOS-1546837]	Virginia Polytechnic Institute and State University; PEW Latin American Fellowship; NIGMS MIRA award from the National Institutes of Health; Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture; Next-Generation BioGreen 21 Program SSAC from the Rural Development Administration, Republic of Korea; National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank C. Brooks, A. Krainer and J. Dalrymple for their technical support; P. Keen for assistance with the tomato transformation; T. Mulligan, S. Vermylen and S. Qiao from the Cold Spring Harbor Laboratory, and staff from Cornell University's Long Island Horticultural Research and Extension Center, for assistance with plant care; and H. Shinohara and Y. Matsubayashi from Nagoya University for the tomato peptide binding assays. Initial work from Z.L.N. was supported by funds from the Virginia Polytechnic Institute and State University. The research for this study was supported by: a PEW Latin American Fellowship (no. 29661) to D.R.L.; a NIGMS MIRA award from the National Institutes of Health to Z.L.N. (award no. R35GM119614-01); an Agriculture and Food Research Initiative competitive grant no. 2016-67013-24572 of the USDA National Institute of Food and Agriculture and the Next-Generation BioGreen 21 Program SSAC (grant no. PJ01322602) from the Rural Development Administration, Republic of Korea to D. J.; an Agriculture and Food Research Initiative competitive grant no. 2015-67013-22823 of the USDA National Institute of Food and Agriculture to Z. B. L.; and the National Science Foundation Plant Genome Research Program (grant no. IOS1732253 to J.V.E. and Z.B.L., and grant no. IOS-1546837 to D.J., M.E.B., Z.L.N and Z.B.L.).	Abley K, 2016, ANN BOT-LONDON, V117, P733, DOI 10.1093/aob/mcw016; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Betsuyaku Shigeyuki, 2011, Arabidopsis Book, V9, pe0149, DOI 10.1199/tab.0149; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.74, 10.1038/nplants.2016.74]; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Depuydt S, 2013, P NATL ACAD SCI USA, V110, P7074, DOI 10.1073/pnas.1222314110; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Diss G, 2014, J EXP ZOOL PART B, V322, P488, DOI 10.1002/jez.b.22555; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Fletcher JC, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7040087; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goad DM, 2017, NEW PHYTOL, V216, P605, DOI 10.1111/nph.14348; Gregory EF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202595; Gupta S, 2016, PLANT CELL TISS ORG, V127, P417, DOI 10.1007/s11240-016-1063-9; Hoshino A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13295; Il Je B, 2016, NAT GENET, V48, P785, DOI 10.1038/ng.3567; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klepikova AV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1688-9; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Lemmon ZH, 2016, GENOME RES, V26, P1676, DOI 10.1101/gr.207837.116; Li H, 2016, J SYST EVOL, V54, P204, DOI 10.1111/jse.12206; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mandel T, 2016, DEVELOPMENT, V143, P1612, DOI 10.1242/dev.129973; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nimchuk ZL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006681; Nimchuk ZL, 2015, DEVELOPMENT, V142, P1043, DOI 10.1242/dev.119677; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; R Foundation for Statistical Computing, 2021, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Leal D, 2017, CELL, V171, P470, DOI 10.1016/j.cell.2017.08.030; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Somssich M, 2016, DEVELOPMENT, V143, P3238, DOI 10.1242/dev.133645; Soria PS, 2014, MOL BIOL EVOL, V31, P984, DOI 10.1093/molbev/msu050; Soyars CL, 2016, CURR OPIN PLANT BIOL, V29, P163, DOI 10.1016/j.pbi.2015.12.002; Suzaki T, 2008, PLANT CELL, V20, P2049, DOI 10.1105/tpc.107.057257; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Xu C, 2015, NAT GENET, V47, P784, DOI 10.1038/ng.3309; Yamaguchi YL, 2017, PLANT CELL PHYSIOL, V58, P1848, DOI 10.1093/pcp/pcx139; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	55	72	75	13	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					786	+		10.1038/s41588-019-0389-8	http://dx.doi.org/10.1038/s41588-019-0389-8			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK	30988512	Green Accepted			2022-12-17	WOS:000466842000006
J	Haney, MS; Bohlen, CJ; Morgens, DW; Ousey, JA; Barkal, AA; Tsui, CK; Ego, BK; Levin, R; Kamber, RA; Collins, H; Tucker, A; Li, A; Vorselen, D; Labitigan, L; Crane, E; Boyle, E; Jiang, LH; Chan, J; Rincon, E; Greenleaf, WJ; Li, B; Snyder, MP; Weissman, IL; Theriot, JA; Collins, SR; Barres, B; Bassik, MC				Haney, Michael S.; Bohlen, Christopher J.; Morgens, David W.; Ousey, James A.; Barkal, Amira A.; Tsui, C. Kimberly; Ego, Braeden K.; Levin, Roni; Kamber, Roarke A.; Collins, Hannah; Tucker, Andrew; Li, Amy; Vorselen, Daan; Labitigan, Lorenzo; Crane, Emily; Boyle, Evan; Jiang, Lihua; Chan, Joanne; Rincon, Esther; Greenleaf, William J.; Li, Billy; Snyder, Michael P.; Weissman, Irving L.; Theriot, Julie A.; Collins, Sean R.; Barres, Ben A.; Bassik, Michael C.			Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens	NATURE GENETICS			English	Article							PROTEIN; CELLS; ENGULFMENT; ACTIVATION; PLECKSTRIN; PHAGOSOMES; RECEPTOR; DYNAMICS; PLATFORM; LIGASE	Phagocytosis is required for a broad range of physiological functions, from pathogen defense to tissue homeostasis, but the mechanisms required for phagocytosis of diverse substrates remain incompletely understood. Here, we developed a rapid magnet- based phenotypic screening strategy, and performed eight genome-wide CRISPR screens in human cells to identify genes regulating phagocytosis of distinct substrates. After validating select hits in focused miniscreens, orthogonal assays and primary human macrophages, we show that (1) the previously uncharacterized gene NHLRC2 is a central player in phagocytosis, regulating RhoA-Rac1 signaling cascades that control actin polymerization and filopodia formation, (2) very-long-chain fatty acids are essential for efficient phagocytosis of certain substrates and (3) the previously uncharacterized Alzheimer's diseaseassociated gene TM2D3 can preferentially influence uptake of amyloid-beta aggregates. These findings illuminate new regulators and core principles of phagocytosis, and more generally establish an efficient method for unbiased identification of cellular uptake mechanisms across diverse physiological and pathological contexts.	[Haney, Michael S.; Morgens, David W.; Ousey, James A.; Tsui, C. Kimberly; Ego, Braeden K.; Kamber, Roarke A.; Li, Amy; Crane, Emily; Boyle, Evan; Jiang, Lihua; Chan, Joanne; Greenleaf, William J.; Li, Billy; Snyder, Michael P.; Bassik, Michael C.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Haney, Michael S.; Morgens, David W.; Ousey, James A.; Tsui, C. Kimberly; Ego, Braeden K.; Kamber, Roarke A.; Li, Amy; Crane, Emily; Boyle, Evan; Jiang, Lihua; Chan, Joanne; Greenleaf, William J.; Li, Billy; Snyder, Michael P.; Bassik, Michael C.] Stanford Univ, Stanford Univ Chem Engn & Med Human Hlth ChEM H, Sch Med, Stanford, CA 94305 USA; [Bohlen, Christopher J.; Collins, Hannah; Tucker, Andrew; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Barkal, Amira A.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol, Sch Med, Stanford, CA 94305 USA; [Levin, Roni] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Vorselen, Daan; Labitigan, Lorenzo; Theriot, Julie A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Rincon, Esther; Collins, Sean R.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Bohlen, Christopher J.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Toronto; Stanford University; University of California System; University of California Davis; Roche Holding; Genentech	Bassik, MC (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Stanford Univ Chem Engn & Med Human Hlth ChEM H, Sch Med, Stanford, CA 94305 USA.; Bohlen, CJ (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.; Bohlen, CJ (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	bohlenc@gene.com; bassik@stanford.edu	Theriot, Julie/HHN-2034-2022; Collins, Hannah/GSD-5229-2022	Tsui, C. Kimberly/0000-0002-3807-5329; Snyder, Michael/0000-0003-0784-7987; Theriot, Julie/0000-0002-2334-2535; Ego, Braeden/0000-0003-3018-1423	NICHD NIH HHS [DP2 HD084069, DP2 HD094656] Funding Source: Medline; NIDA NIH HHS [R01 DA015043] Funding Source: Medline; NIGMS NIH HHS [T32 GM007790, T32 GM007365] Funding Source: Medline; NIH HHS [T32-GM007365, DP2 HD094656, 1DP2HD084069-01, R01 DA015043] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD094656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365, T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brumell JH, 1999, J IMMUNOL, V163, P3388; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Collins SR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156027; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; ELLIS RE, 1991, GENETICS, V129, P79; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Horsthemke M, 2017, J BIOL CHEM, V292, P7258, DOI 10.1074/jbc.M116.766923; Jakobsdottir J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006327; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jongstra-Bilen J, 2006, IMMUNOL RES, V35, P65, DOI 10.1385/IR:35:1:65; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kajkowski EM, 2001, J BIOL CHEM, V276, P18748, DOI 10.1074/jbc.M011161200; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kramer NJ, 2018, NAT GENET, V50, P603, DOI 10.1038/s41588-018-0070-7; Larocca Jorge N, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0325s33; LARRICK JW, 1980, J IMMUNOL, V125, P6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Liu NA, 2018, NATURE, V553, P228, DOI 10.1038/nature25179; Logan MA, 2012, NAT NEUROSCI, V15, P722, DOI 10.1038/nn.3066; Ma AD, 1999, J BIOL CHEM, V274, P28730, DOI 10.1074/jbc.274.40.28730; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mosser DM, 2011, CURR PROTOC IMMUNOL; Nishi K, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0006-7; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rotty JD, 2017, DEV CELL, V42, P498, DOI 10.1016/j.devcel.2017.08.003; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen K, 2016, CELL REP, V14, P547, DOI 10.1016/j.celrep.2015.12.055; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Uusimaa J, 2018, ACTA NEUROPATHOL, V135, P727, DOI 10.1007/s00401-018-1817-z; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang LQ, 2017, CELL REP, V21, P773, DOI 10.1016/j.celrep.2017.09.085; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Ziegenfuss JS, 2012, NAT NEUROSCI, V15, P979, DOI 10.1038/nn.3135	63	72	73	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1716	+		10.1038/s41588-018-0254-1	http://dx.doi.org/10.1038/s41588-018-0254-1			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30397336	Green Accepted			2022-12-17	WOS:000451434400019
J	Hormozdiari, F; Gazal, S; van de Geijn, B; Finucane, HK; Ju, CJT; Loh, PR; Schoech, A; Reshef, Y; Liu, XY; O'Connor, L; Gusev, A; Eskin, E; Price, AL				Hormozdiari, Farhad; Gazal, Steven; van de Geijn, Bryce; Finucane, Hilary K.; Ju, Chelsea J. -T.; Loh, Po-Ru; Schoech, Armin; Reshef, Yakir; Liu, Xuanyao; O'Connor, Luke; Gusev, Alexander; Eskin, Eleazar; Price, Alkes L.			Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; PARTITIONING HERITABILITY; VARIANTS; COMMON; EXPRESSION; IDENTIFICATION; GWAS; SCHIZOPHRENIA; SIGNALS	There is increasing evidence that many risk loci found using genome-wide association studies are molecular quantitative trait loci (QTLs). Here we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTLs, using data from the Genotype-Tissue Expression (GTEx) and BLUEPRINT consortia. We show that these annotations are more strongly enriched for heritability (5.84x for eQTLs; P = 1.19 x 10(-31)) across 41 diseases and complex traits than annotations containing all significant molecular QTLs (1.80x for expression (e) QTLs). eQTL annotations obtained by meta-analyzing all GTEx tissues generally performed best, whereas tissue-specific eQTL annotations produced stronger enrichments for blood-and brain-related diseases and traits. eQTL annotations restricted to loss-of-function intolerant genes were even more enriched for heritability (17.06x; P = 1.20 x 10(-35)). All molecular QTLs except splicing QTLs remained significantly enriched in joint analysis, indicating that each of these annotations is uniquely informative for disease and complex trait architectures.	[Hormozdiari, Farhad; Gazal, Steven; van de Geijn, Bryce; Finucane, Hilary K.; Schoech, Armin; Reshef, Yakir; Liu, Xuanyao; O'Connor, Luke; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hormozdiari, Farhad; Gazal, Steven; van de Geijn, Bryce; Finucane, Hilary K.; Loh, Po-Ru; Schoech, Armin; Reshef, Yakir; Liu, Xuanyao; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ju, Chelsea J. -T.; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Loh, Po-Ru; Gusev, Alexander] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Loh, Po-Ru; Gusev, Alexander] Harvard Med Sch, Boston, MA USA; [O'Connor, Luke] Harvard Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Boston, MA USA; [Gusev, Alexander] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Eskin, Eleazar] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California Los Angeles	Hormozdiari, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Hormozdiari, F (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.	Hormozdiari@hsph.harvard.edu; aprice@hsph.harvard.edu	Gazal, Steven/AAK-3764-2020	Loh, Po-Ru/0000-0001-5542-9064; Gazal, Steven/0000-0003-4510-5730	NIH [U01 HG009379, R01 MH101244, R01 MH109978, T32 DK110919, R01 MH107649]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG009987, U01HG009379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK110919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109978, R01MH101244, R01MH101782, R01MH107649] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Raychaudhuri, N. Zaitlen, B. Pasaniuc, M. Nivard, J.-H. Sul and F. Hormozdiari for helpful discussions. This research was funded by NIH grants U01 HG009379, R01 MH101244, R01 MH109978, T32 DK110919 and R01 MH107649. This research was conducted using the UK Biobank Resource under application 16549.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Cassa CA, 2017, NAT GENET, V49, P806, DOI 10.1038/ng.3831; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gazal S., 2018, BIORXIV, DOI [10.1101/256412, DOI 10.1101/256412]; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2017, AM J HUM GENET, V100, P789, DOI 10.1016/j.ajhg.2017.04.005; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Hu XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004404; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Liu XY, 2017, AM J HUM GENET, V100, P605, DOI 10.1016/j.ajhg.2017.03.002; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Park Y., 2017, BIORXIV; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Urbut SM, 2016, BIORXIV, DOI [10.1101/096552, DOI 10.1101/096552]; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	66	72	72	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					1041	+		10.1038/s41588-018-0148-2	http://dx.doi.org/10.1038/s41588-018-0148-2			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29942083	Green Accepted, Green Submitted			2022-12-17	WOS:000437224400019
J	di Iulio, J; Bartha, I; Wong, EHM; Yu, HC; Lavrenko, V; Yang, DC; Jung, I; Hicks, MA; Shah, N; Kirkness, EF; Fabani, MM; Biggs, WH; Ren, B; Venter, JC; Telenti, A				di Iulio, Julia; Bartha, Istvan; Wong, Emily H. M.; Yu, Hung-Chun; Lavrenko, Victor; Yang, Dongchan; Jung, Inkyung; Hicks, Michael A.; Shah, Naisha; Kirkness, Ewen F.; Fabani, Martin M.; Biggs, William H.; Ren, Bing; Venter, J. Craig; Telenti, Amalio			The human noncoding genome defined by genetic diversity	NATURE GENETICS			English	Article							CLINVAR PUBLIC ARCHIVE; HUMAN-DISEASE; VARIANTS; FRAMEWORK; MUTATION; FEATURES; DATABASE; DOMAINS; MODEL	Understanding the significance of genetic variants in the non-coding genome is emerging as the next challenge in human genomics. We used the power of 11,257 whole-genome sequences and 16,384 heptamers (7-nt motifs) to build a map of sequence constraint for the human species. This build differed substantially from traditional maps of interspecies conservation and identified regulatory elements among the most constrained regions of the genome. Using new Hi-C experimental data, we describe a strong pattern of coordination over 2 Mb where the most constrained regulatory elements associate with the most essential genes. Constrained regions of the noncoding genome are up to 52-fold enriched for known pathogenic variants as compared to unconstrained regions (21-fold when compared to the genome average). This map of sequence constraint across thousands of individuals is an asset to help interpret noncoding elements in the human genome, prioritize variants and reconsider gene units at a larger scale.	[di Iulio, Julia; Bartha, Istvan; Wong, Emily H. M.; Yu, Hung-Chun; Lavrenko, Victor; Hicks, Michael A.; Shah, Naisha; Kirkness, Ewen F.; Fabani, Martin M.; Biggs, William H.; Venter, J. Craig] Human Longev Inc, San Diego, CA USA; [Yang, Dongchan; Jung, Inkyung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA USA; [Venter, J. Craig; Telenti, Amalio] J Craig Venter Inst, La Jolla, CA 92037 USA; [di Iulio, Julia; Telenti, Amalio] Scripps Res Inst, La Jolla, CA 92037 USA; [Bartha, Istvan] Swiss Fed Inst Technol, Lausanne, Switzerland; Verogen, San Diego, CA USA	Korea Advanced Institute of Science & Technology (KAIST); Ludwig Institute for Cancer Research; J. Craig Venter Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Telenti, A (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.; Telenti, A (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	atelenti@scripps.edu	Telenti, Amalio/AAY-1674-2021; Jung, Inkyung/CAJ-5773-2022; Jung, Inkyung/Q-2018-2016	Yu, Hung-Chun/0000-0002-4980-8508; Jung, Inkyung/0000-0002-5885-2754; Hicks, Michael/0000-0003-1045-2660; Lavrenko, Victor/0000-0002-2106-8173	Human Longevity, Inc.	Human Longevity, Inc.	We thank Human Longevity, Inc., for finnancial support.	Aggarwala V, 2016, NAT GENET, V48, P349, DOI 10.1038/ng.3511; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bartha I, 2018, NAT REV GENET, V19, P51, DOI 10.1038/nrg.2017.75; Bartha I, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004647; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fadista J, 2017, BIOINFORMATICS, V33, P471, DOI 10.1093/bioinformatics/btv602; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Gordon CT, 2014, NAT GENET, V46, P3, DOI 10.1038/ng.2861; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Huang YF, 2017, NAT GENET, V49, P618, DOI 10.1038/ng.3810; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knight JC, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0092-4; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Makrythanasis P, 2013, CLIN GENET, V84, P422, DOI 10.1111/cge.12272; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rackham OJL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1322; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schrider DR, 2015, GENOME BIOL EVOL, V7, P3511, DOI 10.1093/gbe/evv228; Shah N., AM J HUM GENET; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Ward LD, 2013, SCIENCE, V340, DOI [10.1126/science.1233195, 10.1126/science.1233366]; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	39	72	73	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					333	+		10.1038/s41588-018-0062-7	http://dx.doi.org/10.1038/s41588-018-0062-7			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29483654	Green Submitted			2022-12-17	WOS:000427933400006
J	Kotlarz, D; Marquardt, B; Baroy, T; Lee, WS; Konnikova, L; Hollizeck, S; Magg, T; Lehle, AS; Walz, C; Borggraefe, I; Hauck, F; Bufler, P; Conca, R; Wall, SM; Schumacher, EM; Misceo, D; Frengen, E; Bentsen, BS; Uhlig, HH; Hopfner, KP; Muise, AM; Snapper, SB; Stromme, P; Klein, C				Kotlarz, Daniel; Marquardt, Benjamin; Baroy, Tuva; Lee, Way S.; Konnikova, Liza; Hollizeck, Sebastian; Magg, Thomas; Lehle, Anna S.; Walz, Christoph; Borggraefe, Ingo; Hauck, Fabian; Bufler, Philip; Conca, Raffaele; Wall, Sarah M.; Schumacher, Eva M.; Misceo, Doriana; Frengen, Eirik; Bentsen, Beint S.; Uhlig, Holm H.; Hopfner, Karl-Peter; Muise, Aleixo M.; Snapper, Scott B.; Stromme, Petter; Klein, Christoph			Human TGF-beta 1 deficiency causes severe inflammatory bowel disease and encephalopathy	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; ANTISENSE OLIGONUCLEOTIDE; MUTATIONS; VARIANTS; SMAD7; GENE; POLYMORPHISMS; INHIBITION; DIAGNOSIS	Transforming growth factor (TGF)-beta 1 (encoded by TGFB1) is the prototypic member of the TGF-beta family of 33 proteins that orchestrate embryogenesis, development and tissue homeostasis(1,2). Following its discovery(3), enormous interest and numerous controversies have emerged about the role of TGF-beta in coordinating the balance of pro- and anti-oncogenic properties(4,5), pro-and anti-inflammatory effects(6), or pro- and anti-fibrinogenic characteristics(7). Here we describe three individuals from two pedigrees with biallelic loss-of-function mutations in the TGFB1 gene who presented with severe infantile inflammatory bowel disease (IBD) and central nervous system (CNS) disease associated with epilepsy, brain atrophy and posterior leukoencephalopathy. The proteins encoded by the mutated TGFB1 alleles were characterized by impaired secretion, function or stability of the TGF-beta 1-LAP complex, which is suggestive of perturbed bioavailability of TGF-beta 1. Our study shows that TGF-beta 1 has a critical and nonredundant role in the development and homeostasis of intestinal immunity and the CNS in humans.	[Kotlarz, Daniel; Marquardt, Benjamin; Hollizeck, Sebastian; Magg, Thomas; Lehle, Anna S.; Borggraefe, Ingo; Hauck, Fabian; Bufler, Philip; Conca, Raffaele; Klein, Christoph] Univ Hosp LMU Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Baroy, Tuva; Misceo, Doriana; Frengen, Eirik] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Baroy, Tuva; Misceo, Doriana; Frengen, Eirik; Stromme, Petter] Univ Oslo, Fac Med, Oslo, Norway; [Lee, Way S.] Univ Malaya, Med Ctr, Dept Pediat, Kuala Lumpur, Malaysia; [Konnikova, Liza; Wall, Sarah M.; Snapper, Scott B.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Konnikova, Liza; Snapper, Scott B.] Harvard Med Sch, Boston, MA USA; [Konnikova, Liza] Brigham & Womens Hosp, Dept Pediat & Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Walz, Christoph] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Schumacher, Eva M.; Bentsen, Beint S.; Stromme, Petter] Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway; [Bentsen, Beint S.] Oslo Univ Hosp, Pediat Liver Kidney Alimentary Nutr & Transplanta, Dept Pediat Res, Oslo, Norway; [Uhlig, Holm H.] Univ Oxford, Translat Gastroenterol Unit, Oxford, England; [Uhlig, Holm H.] Univ Oxford, Dept Pediat, Oxford, England; [Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Hopfner, Karl-Peter] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Muise, Aleixo M.] Hosp Sick Children, Res Inst, SickKids Inflammatory Bowel Dis Ctr, Toronto, ON, Canada; [Muise, Aleixo M.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON, Canada; [Muise, Aleixo M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Muise, Aleixo M.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	University of Munich; University of Oslo; University of Oslo; Universiti Malaya; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Munich; University of Oslo; University of Oslo; University of Oxford; University of Oxford; University of Munich; University of Munich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital	Klein, C (corresponding author), Univ Hosp LMU Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany.	christoph.klein@med.uni-muenchen.de	Borggraefe, Ingo/AAC-4966-2020; Misceo, Doriana/AAR-9085-2020; Hauck, Fabian/H-5556-2016; Hopfner, Karl-Peter/B-6864-2014; Kotlarz, Daniel/HGA-2077-2022; LEE, WAY SEAH/B-8844-2010	Misceo, Doriana/0000-0002-6594-5801; Hopfner, Karl-Peter/0000-0002-4528-8357; Kotlarz, Daniel/0000-0002-4576-6769; LEE, WAY SEAH/0000-0001-9163-2828; Marquardt, Benjamin/0000-0002-3872-4819; Frengen, Eirik/0000-0002-8387-2247; Hollizeck, Sebastian/0000-0002-9504-3497; Bufler, Philip/0000-0002-5742-8273; Uhlig, Holm/0000-0002-6111-7355; Hauck, Fabian/0000-0001-9644-2003	Research Council of Norway; Southeastern Regional Health Authorities; Leona M. and Harry B. Helmsley Charitable Trust; Collaborative Research Consortium [SFB1054]; PID-NET (BMBF); BioSysNet; European Research Council; Gottfried-Wilhelm-Leibniz Program (DFG); DAAD network on 'Rare Diseases and Personalized Therapies'; German Center for Infection Research (DZIF); Care-for-Rare Foundation; University Malaya High Impact Research [UM.C/625/HIR/MOHE/CHAN/13/1]; Else Kroner-Fresenius-Stiftung; Daimler und Benz Stiftung; Reinhard Frank-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities; Leona M. and Harry B. Helmsley Charitable Trust; Collaborative Research Consortium; PID-NET (BMBF)(Federal Ministry of Education & Research (BMBF)); BioSysNet; European Research Council(European Research Council (ERC)European Commission); Gottfried-Wilhelm-Leibniz Program (DFG)(German Research Foundation (DFG)); DAAD network on 'Rare Diseases and Personalized Therapies'; German Center for Infection Research (DZIF); Care-for-Rare Foundation; University Malaya High Impact Research; Else Kroner-Fresenius-Stiftung; Daimler und Benz Stiftung; Reinhard Frank-Stiftung; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are very grateful to our patients and their parents for allowing us to study their diseases. We thank the medical staff at the Dr. von Hauner Children's Hospital, Oslo University Hospital and University Malaya Medical Center. In particular, we would like to acknowledge pathologist D. Klotz (Oslo University Hospital) for the histology of colonic biopsies. Whole-exome sequencing of family A was conducted at the Next-Generation Sequencing facility at the Dr. von Hauner Children's Hospital under the supervision of M. Rohlfs. The sequencing service of family B was provided by the Norwegian Sequencing Centre, a national technology platform supported by the Functional Genomics and Infrastructure Programs of the Research Council of Norway and the Southeastern Regional Health Authorities, and the sequencing data of family B were analyzed by A. Holmgren. We acknowledge the assistance of the Flow Cytometry Core Facility at the Dr. von Hauner Children's Hospital and of the Harvard Medical School CyTOF Core. Samples from the patient with CED were provided with support of the Oxford Gastrointestinal Illness Biobank and Biomedical Research Center Oxford. We gratefully acknowledge our bioinformatician, J. Puchalka, who died in a tragic accident during the course of the investigations. This work has been supported by The Leona M. and Harry B. Helmsley Charitable Trust, the Collaborative Research Consortium SFB1054 (DFG), PID-NET (BMBF), BioSysNet, the European Research Council, the Gottfried-Wilhelm-Leibniz Program (DFG), the DAAD network on 'Rare Diseases and Personalized Therapies', the German Center for Infection Research (DZIF) and the Care-for-Rare Foundation. W.S.L. was partly funded by University Malaya High Impact Research (UM.C/625/HIR/MOHE/CHAN/13/1). D.K. has been a scholar funded by the Else Kroner-Fresenius-Stiftung, the Daimler und Benz Stiftung and the Reinhard Frank-Stiftung.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Arosio B, 2007, MECH AGEING DEV, V128, P553, DOI 10.1016/j.mad.2007.07.006; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Servi B, 2002, EXP GERONTOL, V37, P813, DOI 10.1016/S0531-5565(02)00018-9; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Koeglsperger T, 2013, GLIA, V61, P985, DOI 10.1002/glia.22490; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2015, NEW ENGL J MED, V372, P1104, DOI 10.1056/NEJMoa1407250; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SILBERSTEIN GB, 1987, SCIENCE, V237, P291, DOI 10.1126/science.3474783; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Vigeland MD, 2016, BIOINFORMATICS, V32, P1592, DOI 10.1093/bioinformatics/btw046; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012	39	72	76	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					344	+		10.1038/s41588-018-0063-6	http://dx.doi.org/10.1038/s41588-018-0063-6			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29483653	Green Submitted, Green Accepted			2022-12-17	WOS:000427933400008
J	Agnihotri, S; Jalali, S; Wilson, MR; Danesh, A; Li, M; Klironomos, G; Krieger, JR; Mansouri, A; Khan, O; Mamatjan, Y; Landon-Brace, N; Tung, T; Dowar, M; Li, TT; Bruce, JP; Burrell, KE; Tonge, PD; Alamsahebpour, A; Krischek, B; Agarwalla, PK; Bi, WL; Dunn, IF; Beroukhim, R; Fehlings, MG; Bril, V; Pagnotta, SM; Iavarone, A; Pugh, TJ; Aldape, KD; Zadeh, G				Agnihotri, Sameer; Jalali, Shahrzad; Wilson, Mark R.; Danesh, Arnavaz; Li, Mira; Klironomos, George; Krieger, Jonathan R.; Mansouri, Alireza; Khan, Osaama; Mamatjan, Yasin; Landon-Brace, Natalie; Tung, Takyee; Dowar, Mark; Li, Tiantian; Bruce, Jeffrey P.; Burrell, Kelly E.; Tonge, Peter D.; Alamsahebpour, Amir; Krischek, Boris; Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen; Fehlings, Michael G.; Bril, Vera; Pagnotta, Stefano M.; Iavarone, Antonio; Pugh, Trevor J.; Aldape, Kenneth D.; Zadeh, Gelareh			The genomic landscape of schwannoma	NATURE GENETICS			English	Article							DRIVER MUTATIONS; GENE-EXPRESSION; CANCER; TUMORS; CLASSIFICATION; ADENOCARCINOMA; ESTABLISHMENT; COMPLEXITY; RESISTANCE; INHIBITORS	Schwannomas are common peripheral nerve sheath tumors that can cause debilitating morbidities. We performed an integrative analysis to determine genomic aberrations common to sporadic schwannomas. Exome sequence analysis with validation by targeted DNA sequencing of 125 samples uncovered, in addition to expected NF2 disruption, recurrent mutations in ARID1A, ARID1B and DDR1. RNA sequencing identified a recurrent in-frame SH3PXD2A-HTRA1 fusion in 12/125 (10%) cases, and genomic analysis demonstrated the mechanism as resulting from a balanced 19-Mb chromosomal inversion on chromosome 10q. The fusion was associated with male gender predominance, occurring in one out of every six men with schwannoma. Methylation profiling identified distinct molecular subgroups of schwannomas that were associated with anatomical location. Expression of the SH3PXD2A-HTRA1 fusion resulted in elevated phosphorylated ERK, increased proliferation, increased invasion and in vivo tumorigenesis. Targeting of the MEK-ERK pathway was effective in fusion-positive Schwann cells, suggesting a possible therapeutic approach for this subset of tumors.	[Agnihotri, Sameer; Jalali, Shahrzad; Wilson, Mark R.; Li, Mira; Klironomos, George; Mansouri, Alireza; Khan, Osaama; Mamatjan, Yasin; Landon-Brace, Natalie; Tung, Takyee; Burrell, Kelly E.; Tonge, Peter D.; Alamsahebpour, Amir; Aldape, Kenneth D.; Zadeh, Gelareh] Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Ctr Neurooncol Res, Toronto, ON, Canada; [Danesh, Arnavaz; Dowar, Mark; Li, Tiantian; Bruce, Jeffrey P.; Pugh, Trevor J.; Aldape, Kenneth D.; Zadeh, Gelareh] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Krieger, Jonathan R.] Hosp Sick Children, SPARC Bioctr, Toronto, ON, Canada; [Krischek, Boris] Univ Hosp Cologne, Dept Neurosurg, Cologne, Germany; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen] Harvard Med Sch, Boston, MA USA; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Beroukhim, Rameen] Broad Inst MIT & Harvard, Cambridge, MA USA; [Agarwalla, Pankaj Kumar] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Agarwalla, Pankaj Kumar; Bi, Wenya Linda; Beroukhim, Rameen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bi, Wenya Linda; Dunn, Ian F.; Beroukhim, Rameen] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fehlings, Michael G.; Zadeh, Gelareh] Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada; [Bril, Vera] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Bril, Vera] Univ Toronto, Elizabeth Raab Neurofibromatosis Program, Toronto, ON, Canada; [Pagnotta, Stefano M.] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Pagnotta, Stefano M.; Iavarone, Antonio] Columbia Univ, Dept Pathol & Cell Biol & Neurol, New York, NY USA; [Pugh, Trevor J.; Aldape, Kenneth D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Aldape, Kenneth D.] Maryland Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Aldape, Kenneth D.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cologne; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Sannio; Columbia University; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Toronto	Aldape, KD; Zadeh, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, MacFeeters Hamilton Ctr Neurooncol Res, Toronto, ON, Canada.; Aldape, KD; Zadeh, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Zadeh, G (corresponding author), Univ Hlth Network, Dept Neurosurg, Toronto, ON, Canada.; Aldape, KD (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Aldape, KD (corresponding author), Maryland Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.; Aldape, KD (corresponding author), Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada.	kaldape@uhnresearch.ca; gelareh.zadeh@uhn.ca	Pugh, Trevor/Y-2535-2019; Mamatjan, Yasin/ABD-2527-2021; BRIL, vera/ABA-6509-2020	Pugh, Trevor/0000-0002-8073-5888; Mamatjan, Yasin/0000-0002-8807-2927; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Fehlings, Michael/0000-0002-5722-6364; LANDON-BRACE, NATALIE/0000-0001-7021-8716; PAGNOTTA, Stefano Maria/0000-0002-8298-9777; Iavarone, Antonio/0000-0002-0683-4634; Mansouri, Alireza/0000-0002-7442-7539	Canadian Institute of Health Research (CIHR); Princess Margaret Cancer Foundation; Wilkins Family Chair in Brain Tumor Research; CIHR; Terry Fox Research Institute; MacFeeters-Hamilton Neuro-Oncology Research Program	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Princess Margaret Cancer Foundation(University of Toronto); Wilkins Family Chair in Brain Tumor Research; CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; MacFeeters-Hamilton Neuro-Oncology Research Program	This work was supported by the Canadian Institute of Health Research (CIHR) post-doctoral fellowship (S.A.). The contributions of T.J.P., K.D.A. and G.Z. to this project were supported by the Princess Margaret Cancer Foundation. We thank the staff of the Princess Margaret Genomics Centre (N. Winegarden, J. Tsao and N. Khuu) and Bioinformatics Services (C. Virtanen and Z. Lu) for their expertise in generating the sequencing data used in this study. G.Z. is supported by the Wilkins Family Chair in Brain Tumor Research, CIHR grants, and The Terry Fox Research Institute. K.D.A. is supported by funding from the MacFeeters-Hamilton Neuro-Oncology Research Program. The human immortalized Schwann cells were a gift from A. Hoke (The Johns Hopkins School of Medicine, Baltimore, Maryland, USA).	Abul-Kasim K, 2008, NEURORADIOLOGY, V50, P301, DOI 10.1007/s00234-007-0345-7; Agnihotri S, 2014, J NEUROSURG, V121, P1434, DOI 10.3171/2014.6.JNS131433; AL-Shudifat AR, 2014, J NEUROL NEUROSUR PS, V85, P106, DOI 10.1136/jnnp-2013-305168; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blakeley JO, 2016, NEURO-ONCOLOGY, V18, P624, DOI 10.1093/neuonc/nov200; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cleven AHG, 2016, MODERN PATHOL, V29, P582, DOI 10.1038/modpathol.2016.45; DAIMARU Y, 1985, AM J SURG PATHOL, V9, P434, DOI 10.1097/00000478-198506000-00005; Dallas PB, 1998, MOL CELL BIOL, V18, P3596, DOI 10.1128/MCB.18.6.3596; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gu L, 2010, ENDOCR-RELAT CANCER, V17, P481, DOI 10.1677/ERC-09-0328; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hung G, 2002, INT J ONCOL, V20, P475; Hung G, 1999, INT J ONCOL, V14, P409; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Milligan BD, 2012, J NEUROSURG, V116, P598, DOI 10.3171/2011.11.JNS11811; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Nigro A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.98; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rohrich M, 2016, ACTA NEUROPATHOL, V131, P877, DOI 10.1007/s00401-016-1540-6; Sabha N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039412; Sim JCH, 2015, INTRACTABLE RARE DIS, V4, P17, DOI 10.5582/irdr.2014.01021; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	58	72	73	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1339	1348		10.1038/ng.3688	http://dx.doi.org/10.1038/ng.3688			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27723760				2022-12-17	WOS:000386543400010
J	McCarroll, SA; Bradner, JE; Turpeinen, H; Volin, L; Martin, PJ; Chilewski, SD; Antin, JH; Lee, SJ; Ruutu, T; Storer, B; Warren, EH; Zhang, B; Zhao, LP; Ginsburg, D; Soiffer, RJ; Partanen, J; Hansen, JA; Ritz, J; Palotie, A; Altshuler, D				McCarroll, Steven A.; Bradner, James E.; Turpeinen, Hannu; Volin, Liisa; Martin, Paul J.; Chilewski, Shannon D.; Antin, Joseph H.; Lee, Stephanie J.; Ruutu, Tapani; Storer, Barry; Warren, Edus H.; Zhang, Bo; Zhao, Lue Ping; Ginsburg, David; Soiffer, Robert J.; Partanen, Jukka; Hansen, John A.; Ritz, Jerome; Palotie, Aarno; Altshuler, David			Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease	NATURE GENETICS			English	Article							MINOR HISTOCOMPATIBILITY ANTIGEN; H-Y; RISK-FACTOR; CELL; UGT2B17; TRANSPLANTATION; IDENTIFICATION	Transplantation and pregnancy, in which two diploid genomes reside in one body, can each lead to diseases in which immune cells from one individual target antigens encoded in the other's genome. One such disease, graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT, or bone marrow transplant), is common even after transplants between HLA-identical siblings, indicating that cryptic histocompatibility loci exist outside the HLA locus. The immune system of an individual whose genome is homozygous for a gene deletion could recognize epitopes encoded by that gene as alloantigens. Analyzing common gene deletions in three HSCT cohorts (1,345 HLA-identical sibling donor-recipient pairs), we found that risk of acute GVHD was greater (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.4-4.6) when donor and recipient were mismatched for homozygous deletion of UGT2B17, a gene expressed in GVHD-affected tissues and giving rise to multiple histocompatibility antigens. Human genome structural variation merits investigation as a potential mechanism in diseases of alloimmunity.	[McCarroll, Steven A.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [McCarroll, Steven A.; Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [McCarroll, Steven A.; Bradner, James E.; Chilewski, Shannon D.; Palotie, Aarno; Altshuler, David] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Bradner, James E.; Antin, Joseph H.; Lee, Stephanie J.; Soiffer, Robert J.; Ritz, Jerome] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Bradner, James E.; Antin, Joseph H.; Lee, Stephanie J.; Soiffer, Robert J.; Ritz, Jerome] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Turpeinen, Hannu; Partanen, Jukka] Finnish Red Cross Blood Serv, Dept Res & Dev, Helsinki, Finland; [Volin, Liisa; Ruutu, Tapani] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Martin, Paul J.; Lee, Stephanie J.; Storer, Barry; Warren, Edus H.; Zhang, Bo; Zhao, Lue Ping; Hansen, John A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Martin, Paul J.; Warren, Edus H.; Hansen, John A.] Univ Washington, Dept Med, Seattle, WA USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Palotie, Aarno] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Helsinki; Helsinki University Central Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Helsinki; Wellcome Trust Sanger Institute	McCarroll, SA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	mccarroll@genetics.med.harvard.edu	Pillay, Nischalan/F-9536-2012; Altshuler, David M/A-4476-2009; Partanen, Jukka/B-7207-2014	Altshuler, David M/0000-0002-7250-4107; Partanen, Jukka/0000-0001-6681-4734; McCarroll, Steven/0000-0002-6954-8184; Palotie, Aarno/0000-0002-2527-5874; Volin, Liisa/0000-0002-9731-8335; Warren, Edus/0000-0002-9570-2755	Broad Institute of MIT and Harvard; Academy of Finland; Helsinki University Central Hospital Research Fund; Fred Hutchinson Cancer Research Center; Lilly Life Sciences Research fellowship; S. Juselius Foundation; Center of Excellence Program of the Finnish Academy; National Institutes of Health [HA070149, AI29530, AI33484, CA18029, HL087690]; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087690, P01HL070149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484, P01AI029530, U19AI029530] Funding Source: NIH RePORTER	Broad Institute of MIT and Harvard; Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Fund; Fred Hutchinson Cancer Research Center; Lilly Life Sciences Research fellowship; S. Juselius Foundation; Center of Excellence Program of the Finnish Academy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank the patients, donors and clinical care teams at Helsinki University Central Hospital, the Dana-Farber Cancer Institute and the Fred Hutchinson Cancer Research Center. We also wish to thank D. Sese and colleagues at the Brigham and Women's Hospital Tissue Typing Laboratory; the Ted and Eileen Pasquarello Tissue Bank; Q. Yang and colleagues at the Quality Assurance Office for Clinical Trials at Dana-Farber Cancer Institute; E. Lander, Y. Ofran, J. Chien and M. Daly for helpful conversations on the project and data; and B. Blazar, C. KeeverTaylor and D. Senitzer for providing patient samples for the Nichols et al. cohort further studied here. This work was supported by the Broad Institute of MIT and Harvard (D. A., S. A. M.), the Academy of Finland (L. V., H. T., J. P.), the Helsinki University Central Hospital Research Fund (L. V.), the Fred Hutchinson Cancer Research Center, a Lilly Life Sciences Research fellowship (S. A. M.), the S. Juselius Foundation (J. P.), the Center of Excellence Program of the Finnish Academy (A. P.) and the National Institutes of Health (HA070149 to J. H. A.; AI29530 to J. R.; AI33484, CA18029 and HL087690 to J. A. H.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; COLIN Y, 1991, BLOOD, V78, P2747; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutler C, 2006, BLOOD, V108, P756, DOI 10.1182/blood-2006-01-0233; GALE RP, 1984, LANCET, V2, P28, DOI 10.1016/S0140-6736(84)92009-9; GALE RP, 1994, ANN INTERN MED, V120, P646, DOI 10.7326/0003-4819-120-8-199404150-00004; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivanov R, 2005, CLIN CANCER RES, V11, P1694, DOI 10.1158/1078-0432.CCR-04-1772; Kamei M, 2009, BLOOD, V113, P5041, DOI 10.1182/blood-2008-07-171678; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P320, DOI 10.1016/j.bbmt.2003.12.304; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Miklos DB, 2004, BLOOD, V103, P353, DOI 10.1182/blood-2003-03-0984; Murata M, 2003, J EXP MED, V197, P1279, DOI 10.1084/jem.20030044; Nichols WC, 1996, BLOOD, V88, P4429, DOI 10.1182/blood.V88.12.4429.bloodjournal88124429; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Schulze JJ, 2008, J CLIN ENDOCR METAB, V93, P2500, DOI 10.1210/jc.2008-0218; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Terakura S, 2005, BRIT J HAEMATOL, V129, P221, DOI 10.1111/j.1365-2141.2005.05427.x; Terakura S, 2007, TRANSPLANTATION, V83, P1242, DOI 10.1097/01.tp.0000259931.72622.d1; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Warren EH, 2000, J IMMUNOL, V164, P2807, DOI 10.4049/jimmunol.164.5.2807; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zorn E, 2004, J EXP MED, V199, P1133, DOI 10.1084/jem.20031560	32	72	74	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1341	U112		10.1038/ng.490	http://dx.doi.org/10.1038/ng.490			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19935662	Green Accepted			2022-12-17	WOS:000272144900018
J	Ozaki, K; Sato, H; Iida, A; Mizuno, H; Nakamura, T; Miyamoto, Y; Takahashi, A; Tsunoda, T; Ikegawa, S; Kamatani, N; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, Kouichi; Sato, Hiroshi; Iida, Aritoshi; Mizuno, Hiroya; Nakamura, Takahiro; Miyamoto, Yoshinari; Takahashi, Atsushi; Tsunoda, Tatsuhiko; Ikegawa, Shiro; Kamatani, Naoyuki; Hori, Masatsugu; Nakamura, Yusuke; Tanaka, Toshihiro			A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; NF-KAPPA-B; LINKAGE ANALYSIS; HUMAN GENOME; PROTEASOME INHIBITION; GENE; ATHEROSCLEROSIS; STRATIFICATION; SUSCEPTIBILITY; CHROMOSOME-2	Inflammation is now considered critical in the pathogenesis of myocardial infarction. One of the mechanisms regulating the inflammatory process is the ubiquitin-proteasome system. We investigated whether variants of the 20S proteasome are associated with susceptibility to myocardial infarction and found a common SNP (minor allele frequency of 0.35) in the proteasome subunit a type 6 gene (PSMA6) conferring risk of myocardial infarction in the Japanese population (chi(2) = 21.1, P = 0.0000044, 2,592 affected individuals versus 2,851 controls). We replicated this association in another panel of myocardial infarction and control subjects, although its relevance to other ethnic groups remains to be clarified. The SNP, located in the 5' untranslated region of exon 1 in this gene, enhanced the transcription of PSMA6. Moreover, suppression of PSMA6 expression using short interfering RNA in cultured cells reduced activation of the transcription factor NF-kappa B by stabilizing phosphorylated I kappa B. Our results implicate this PSMA6 SNP as a previously unknown genetic risk factor for myocardial infarction.	RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, SNP Res Ctr,Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; RIKEN, Inst Phys & Chem Res, Lab Bone & Joint Dis, SNP Res Ctr,Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	RIKEN; Osaka University; RIKEN; RIKEN	Tanaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, SNP Res Ctr,Minato Ku, 4-6-1,Shirokanedai, Tokyo 1088639, Japan.	toshitan@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Iida, Aritoshi/CAA-1373-2022; Tsunoda, Tatsuhiko/K-2061-2014; Tanaka, Toshihiro/J-9310-2014	Ikegawa, Shiro/0000-0003-0316-2147; Iida, Aritoshi/0000-0001-7538-1651; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Maki CG, 1996, CANCER RES, V56, P2649; Meiners S, 2002, CIRCULATION, V105, P483, DOI 10.1161/hc0402.102951; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445	30	72	81	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					921	925		10.1038/ng1846	http://dx.doi.org/10.1038/ng1846			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845397				2022-12-17	WOS:000239325700022
J	Hunter, N; Borner, GV; Lichten, M; Kleckner, N				Hunter, N; Borner, GV; Lichten, M; Kleckner, N			gamma-H2AX illuminates meiosis	NATURE GENETICS			English	Editorial Material							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; MECHANISM; REPAIR; SPO11	The temporal and functional relationships between the DNA events of meiotic recombination and the synaptonemal complex (SC). a meiosis-specific structure formed between homolog axes, are subjects of intense discussion and investigation. A new study provides evidence that initiation of recombination (through programmed double-strand breaks (DSBs)) precedes initiation of SC formation, and further suggests that progression of recombination is required for formation of SC on a region-by-region basis. These conclusions derive from immunocytological analysis of a phosphorylated histone variant. gamma -H2AX, previously found to be characteristic of DSB repair in mitotic cells, and shown here to be recruited for specialized use during meiosis.	Harvard Univ, Cambridge, MA 02138 USA; NCI, Div Basic Sci, Biochem Lab, Bethesda, MD 20892 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, N (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.		Lichten, Michael/C-5795-2013	Lichten, Michael/0000-0001-9707-2956				BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, IN PRESS CURR TOPICS; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McCLINTOCK BARBARA, 1933, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V19, P191, DOI 10.1007/BF02462870; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Plug AW, 1998, J CELL SCI, V111, P413; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	16	72	72	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2001	27	3					236	238		10.1038/85781	http://dx.doi.org/10.1038/85781			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242097				2022-12-17	WOS:000167304200006
J	Gilad, Y; Segre, D; Skorecki, K; Nachman, MW; Lancet, D; Sharon, D				Gilad, Y; Segre, D; Skorecki, K; Nachman, MW; Lancet, D; Sharon, D			Dichotomy of single-nucleotide polymorphism haplotypes in olfactory receptor genes and pseudogenes	NATURE GENETICS			English	Letter							HUMAN LIPOPROTEIN-LIPASE; STATISTICAL TESTS; DNA POLYMORPHISM; DIVERSITY; EVOLUTION; CLUSTER; HUMAN-CHROMOSOME-17; RECOMBINATION; NEUTRALITY; ANCESTRY	Substantial efforts are focused on identifying single-nucleotide polymorphisms (SNPs) throughout the human genome, particularly in coding regions (cSNPs), for both linkage disequilibrium and association studies(1,2). Less attention, however, has been directed to the clarification of evolutionary processes that are responsible for the variability in nucleotide diversity among different regions of the genome(3). We report here the population sequence diversity of genomic segments within a 450-kb cluster(4,5) of olfactory receptor (OR) genes(6,7) on human chromosome 17. We found a dichotomy in the pattern of nucleotide diversity between OR pseudogenes and introns on the one hand and the closely interspersed intact genes on the other. We suggest that weak positive selection is responsible for the observed patterns of genetic variation. This is inferred from a lower ratio of polymorphism to divergence in genes compared with pseudogenes or introns, high non-synonymous substitution rates in OR genes. and a small but significant overall reduction in variability in the entire OR gene cluster compared with other genomic regions. The dichotomy among functionally different segments within a short genomic distance requires high recombination rates within this OR cluster. Our work demonstrates the impact of weak positive selection on human nucleotide diversity, and has implications for the evolution of the olfactory repertoire.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, Fac Med, Mol Med Lab, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Dept Nephrol, Haifa, Israel; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Weizmann Institute of Science; Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Arizona	Lancet, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.		Sharon, Dror/P-4539-2015; Segrè, Daniel/A-1993-2009	Sharon, Dror/0000-0002-1789-5811; Segrè, Daniel/0000-0003-4859-1914	NIDCD NIH HHS [DC00305] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; FU YX, 1993, GENETICS, V133, P693; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HUDSON RR, 1987, GENETICS, V116, P153; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LI WH, 1991, GENETICS, V129, P513; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nachman MW, 1998, GENETICS, V150, P1133; NACHMAN MW, IN PRESS GENETICS; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; PAYSEUR BA, IN PRESS GENETICS; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Sherry ST, 1999, GENOME RES, V9, P677; SIMONSEN KL, 1995, GENETICS, V141, P413; TAJIMA F, 1989, GENETICS, V123, P585; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	30	72	76	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					221	224		10.1038/79957	http://dx.doi.org/10.1038/79957			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017082				2022-12-17	WOS:000089638800023
J	Rogner, UC; Spyropoulos, DD; Le Novere, N; Changeux, JP; Avner, P				Rogner, UC; Spyropoulos, DD; Le Novere, N; Changeux, JP; Avner, P			Control of neurulation by the nucleosome assembly protein-1-like 2	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; NEURAL-TUBE DEFECTS; HISTONE CHAPERONE; MUTANT MOUSE; IN-VITRO; PROLIFERATION; NEURONS; GENE; DIFFERENTIATION; INHERITANCE	Neurulation is a complex process of histogenesis involving the precise temporal and spatial organization of gene expression(1,2) Genes influencing neurulation include proneural genes determining primary cell fate, neurogenic genes involved in lateral inhibition pathways and genes controlling the frequency of mitotic events. This is reflected in the aetiology and genetics of human and mouse neural tube defects, which are of both multifactorial and multigenic origin(3). The X-linked gene Nap1l2, specifically expressed in neurons, encodes a protein that is highly similar to the nucleosome assembly (NAP) and SET proteins. We inactivated Nap1l2 in mice by gene targeting, leading to embryonic lethality from mid-gestation onwards. Surviving mutant chimaeric embryos showed extensive surface ectoderm defects as well as the presence of open neural tubes and exposed brains similar to those observed in human spina bifida and anencephaly. These defects correlated with an overproduction of neuronal precursor cells. Protein expression studies showed that the Nap1l2 protein binds to condensing chromatin during S phase and in apoptotic cells, but remained cytoplasmic during G1 phase. Nap1l2 therefore likely represents a class of tissue-specific factors interacting with chromatin to regulate neuronal cell proliferation.	Inst Pasteur, CNRS, URA 1947, Paris 15, France; Inst Pasteur, CNRS, URA 1284, Paris 15, France; Med Univ S Carolina, Ctr Mol & Struct Biol, Charleston, SC USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Medical University of South Carolina	Rogner, UC (corresponding author), Inst Pasteur, CNRS, URA 1947, Paris 15, France.	urogner@pasteur.fr	Le Novère, Nicolas/F-9973-2010	Le Novère, Nicolas/0000-0002-6309-7327; Rogner, Ute Christine/0000-0001-9993-269X				Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; EMERY AEH, 1986, METHODOLOGY MED GENE, V58; FRAICHARD A, 1995, J CELL SCI, V108, P3181; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; HOGAN B, 1994, MANIPULATING MOUSE E, P373; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ito T, 1996, MOL CELL BIOL, V16, P3112; JENSSON O, 1988, J MED GENET, V25, P227, DOI 10.1136/jmg.25.4.227; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Kerszberg M, 1998, BIOESSAYS, V20, P758, DOI 10.1002/(SICI)1521-1878(199809)20:9<758::AID-BIES9>3.0.CO;2-C; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NARUSE I, 1995, PROG NEUROBIOL, V47, P135, DOI 10.1016/0301-0082(95)00024-P; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; Papenbrock T, 1998, DEV DYNAM, V212, P540, DOI 10.1002/(SICI)1097-0177(199808)212:4<540::AID-AJA7>3.0.CO;2-H; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; ROUGEULLE C, 1994, MAMM GENOME, V5, P416, DOI 10.1007/BF00357001; Rougeulle C, 1996, HUM MOL GENET, V5, P41, DOI 10.1093/hmg/5.1.41; SIMON HU, 1994, BIOCHEM J, V297, P389, DOI 10.1042/bj2970389; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; WILSON DB, 1974, J COMP NEUROL, V154, P249, DOI 10.1002/cne.901540303; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582; YOUNG WS, 1986, P NATL ACAD SCI USA, V83, P9827, DOI 10.1073/pnas.83.24.9827	30	72	74	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2000	25	4					431	435		10.1038/78124	http://dx.doi.org/10.1038/78124			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932189				2022-12-17	WOS:000088615000020
J	Gustavsson, P; Willig, TN; vanHaeringen, A; Tchernia, G; Dianzani, I; Donner, M; Elinder, G; Henter, JI; Nilsson, PG; Gordon, L; Skeppner, G; vantVeerKorthof, L; Kreuger, A; Dahl, N				Gustavsson, P; Willig, TN; vanHaeringen, A; Tchernia, G; Dianzani, I; Donner, M; Elinder, G; Henter, JI; Nilsson, PG; Gordon, L; Skeppner, G; vantVeerKorthof, L; Kreuger, A; Dahl, N			Diamond-Blackfan anaemia: Genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb	NATURE GENETICS			English	Article							CONGENITAL HYPOPLASTIC-ANEMIA; HYBRIDIZATION; MUTATIONS	Diamond-Blackfan anaemia (DEA; MIM#205900) is a rare disorder manifested as a pure red-cell aplasia in the neonatal period or in infancy(1-3). The clinical hallmark of DBA is a selective decrease in erythroid precursors and anaemia. Other lineages are usually normal and the peripheral white blood cell count is normal. In approximately one-third of cases, the disease is associated with a wide variety of congenital anomalies and malformations(3-7). Most cases are sporadic, but 10-20% of them follow a recessive or a dominant inheritance pattern(5). A female with DBA and a chromosomal translocation involving chromosome 19q was recently identified(8). We undertook a linkage analysis with chromosome 19 markers in multiplex DBA families of Swedish, French, Dutch, Arabic and Italian origin. Significant linkage to chromosome 19q13 was established for dominant and recessive inherited DBA with a peak rod score at D19S197 (Z(max)=7.08, theta=0.00). Within this region, a submicroscopic de novo deletion of 3.3 Mb was identified in a patient with DBA. The deletion coincides with the translocation break-point and, together with key recombinations, restricts the DBA gene to a 1.8-Mb region. The results suggest that, despite its clinical heterogeneity, DBA is genetically homogeneous for a gene in 19q13.	UNIV UPPSALA,CHILDRENS HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN; HOP BICETRE,DEPT HEMATOL,LE KREMLIN BICETR,FRANCE; HOP BICETRE,DEPT PAEDIAT,LE KREMLIN BICETR,FRANCE; LEIDEN UNIV HOSP,DEPT CLIN GENET,LEIDEN,NETHERLANDS; UNIV TURIN,DEPT PAEDIAT,I-10124 TURIN,ITALY; UNIV TURIN,DEPT GENET,I-10124 TURIN,ITALY; UNIV LUND HOSP,ASTRID LINDGREN CHILD CTR,LUND,SWEDEN; UNIV LUND HOSP,DEPT MED,LUND,SWEDEN; LAWRENCE LIVERMORE NATL LAB,LIVERMORE,CA 94551; OREBRO REG HOSP,DEPT PAEDIAT,OREBRO,SWEDEN; UNIV UPPSALA,CHILDRENS HOSP,DEPT PAEDIAT,S-75185 UPPSALA,SWEDEN	Uppsala University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Leiden University; Leiden University Medical Center (LUMC); University of Turin; University of Turin; Lund University; Skane University Hospital; Lund University; Skane University Hospital; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Uppsala University				Henter, Jan-Inge/0000-0002-0629-2126				ALTER BP, 1980, AM J PEDIAT HEMATOL, V2, P121; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BAL SE, 1996, BRIT J HAEMATOL, V94, P645; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVANZO M, 1994, PEDIATR HEMAT ONCOL, V11, P189, DOI 10.3109/08880019409141655; Diamond L K, 1976, Adv Pediatr, V22, P349; Diamond L. K., 1938, AM J DIS CHILD, V56, P464; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; GLADER BE, 1988, BRIT J HAEMATOL, V68, P165, DOI 10.1111/j.1365-2141.1988.tb06184.x; GOJIC V, 1994, AM J MED GENET, V50, P87, DOI 10.1002/ajmg.1320500119; GREINIX HT, 1993, BRIT J HAEMATOL, V84, P515, DOI 10.1111/j.1365-2141.1993.tb03109.x; GUSTAVSSON P, IN PRESS J MED GENET; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LITTLE M, 1995, HUM MOL GENET, V4, P351, DOI 10.1093/hmg/4.3.351; Mohrenweiser Harvey, 1996, Cytogenetics and Cell Genetics, V74, P161, DOI 10.1159/000134408; Ott J., 1991, ANAL HUMAN GENETIC L; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Young N. S., 1994, APLASTIC ANEMIA ACQU	23	72	72	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					368	371		10.1038/ng0897-368	http://dx.doi.org/10.1038/ng0897-368			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241274				2022-12-17	WOS:A1997XM90900019
J	WANG, T; LAWLER, AM; STEEL, G; SIPILA, I; MILAM, AH; VALLE, D				WANG, T; LAWLER, AM; STEEL, G; SIPILA, I; MILAM, AH; VALLE, D			MICE LACKING ORNITHINE-DELTA-AMINO-TRANSFERASE HAVE PARADOXICAL NEONATAL HYPOORNITHINAEMIA AND RETINAL DEGENERATION	NATURE GENETICS			English	Article							GYRATE ATROPHY; MOUSE INTESTINE; ARGININE; AMINOTRANSFERASE; MUTATIONS; GLUTAMATE; GENE; PYRROLINE-5-CARBOXYLATE; METABOLISM; ACID	Deficiency of ornithine-delta-aminotransferase (OAT) in humans causes hyperornithinaemia and gyrate atrophy (GA), a blinding chorioretinal degeneration. Surprisingly, OAT-deficient mice produced by gene targeting exhibit neonatal hypoornithinaemia and lethality, rescuable by short-term arginine supplementation. Post-weaning, these mice develop hyperornithinaemia similar to human GA patients. Subsequent studies in one human GA infant also showed transient hypoornithinaemia. Thus, the OAT reaction plays opposite roles in neonatal and adult mammals. Over several months, OAT-deficient mice develop a retinal degeneration with involvement of photoreceptors and pigment epithelium. OAT-deficient mice appear to be an excellent model of human GA.	JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT OBSTET & GYNECOL, BALTIMORE, MD 21205 USA; AURORA HOSP, DEPT PEDIAT, SF-00250 HELSINKI, FINLAND; UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle					NEI NIH HHS [EY01730, EY01311, EY02948] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001311, R01EY002948, P30EY001730] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTMAN PL, 1972, BIOL DATA BOOK, P195; BRODY LC, 1992, J BIOL CHEM, V267, P3302; Brusilow SW, 1991, TECHNIQUES DIAGNOSTI, P345; CAREY GP, 1987, J NUTR, V117, P1734, DOI 10.1093/jn/117.10.1734; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; HAUSER ER, 1990, NEW ENGL J MED, V322, P1641, DOI 10.1056/NEJM199006073222305; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; JONES ME, 1985, J NUTR, V115, P509, DOI 10.1093/jn/115.4.509; KERWIN JF, 1994, MED RES REV, V14, P23, DOI 10.1002/med.2610140103; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MIGCHIELSEN AAJ, 1995, NAT GENET, V10, P279, DOI 10.1038/ng0795-279; MITCHELL GA, 1988, J CLIN INVEST, V81, P630, DOI 10.1172/JCI113365; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MORRIS JG, 1978, SCIENCE, V199, P431, DOI 10.1126/science.619464; MORRIS JG, 1978, J NUTR, V108, P1944, DOI 10.1093/jn/108.12.1944; PATEJUNAS G, 1994, SOMAT CELL MOLEC GEN, V20, P55, DOI 10.1007/BF02257486; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; RIBY JE, 1990, PEDIATR RES, V28, P261, DOI 10.1203/00006450-199009000-00022; STEWART PM, 1981, AM J PHYSIOL, V241, pE310, DOI 10.1152/ajpendo.1981.241.4.E310; Valle D, 1995, METABOLIC MOL BASES, V1, P1147; WAKABAYASHI Y, 1991, ARCH BIOCHEM BIOPHYS, V291, P1, DOI 10.1016/0003-9861(91)90097-3; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WILSON DJ, 1991, AM J OPHTHALMOL, V111, P24, DOI 10.1016/S0002-9394(14)76892-8; WINDMUELLER HG, 1975, ARCH BIOCHEM BIOPHYS, V171, P662, DOI 10.1016/0003-9861(75)90078-8	29	72	74	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1995	11	2					185	190		10.1038/ng1095-185	http://dx.doi.org/10.1038/ng1095-185			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550347				2022-12-17	WOS:A1995RX80600021
J	LI, X; PARK, WJ; PYERITZ, RE; JABS, EW				LI, X; PARK, WJ; PYERITZ, RE; JABS, EW			EFFECT ON SPLICING OF A SILENT FGFR2 MUTATION IN CROUZON SYNDROME	NATURE GENETICS			English	Letter									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,BALTIMORE,MD 21287; ALLEGHENY SINGER RES INST,DEPT MED GENET,PITTSBURGH,PA 15212	Johns Hopkins University; Johns Hopkins University	LI, X (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,CTR MED GENET,CMSC 1004,BALTIMORE,MD 21287, USA.		Pyeritz, Reed/A-1364-2010	Jabs, Ethylin/0000-0001-8983-5466	NCRR NIH HHS [RR00052] Funding Source: Medline; NIDCR NIH HHS [DE11131, DE10180] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131, R01DE010180] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; MULVIHILL JT, 1995, NAT GENET, V9, P101, DOI 10.1038/ng0295-101; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155	4	72	73	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					232	233		10.1038/ng0395-232	http://dx.doi.org/10.1038/ng0395-232			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773284				2022-12-17	WOS:A1995QL23200010
J	ELLIS, NA; YE, TZ; PATTON, S; GERMAN, J; GOODFELLOW, PN; WELLER, P				ELLIS, NA; YE, TZ; PATTON, S; GERMAN, J; GOODFELLOW, PN; WELLER, P			CLONING OF PBDX, AN MIC2-RELATED GENE THAT SPANS THE PSEUDOAUTOSOMAL BOUNDARY ON CHROMOSOME XP	NATURE GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; Y-CHROMOSOME; REGION; DNA; SEQUENCES; HOMOLOGY; MAP; TRANSLOCATION; RECOMBINATION; POLYMERASE	The pseudoautosomal boundaries are the interface between pseudoautosomal and sex chromosome-specific DNA sequences. We have isolated a gene, PBDX, from the human pseudoautosomal boundary region of Xp. The three exons at the 5' end of PBDX are situated in the pseudoautosomal region immediately downstream of MIC2, whereas the other seven exons are in the X-specific region. Hence, PBDX is inherited in two modes: its 5' end is pseudoautosomally inherited and its 3' end is X-linked. The predicted amino acid sequence of the 540 bp coding region is 48% homologous to 12E7, the product of MIC2. By virtue of its position, PBDX becomes an excellent candidate for the XG blood group gene.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND	University of Cambridge	ELLIS, NA (corresponding author), NEW YORK BLOOD CTR,HUMAN GENET LAB,310 E 67TH ST,NEW YORK,NY 10021, USA.							AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5353, DOI 10.1093/nar/14.13.5353; ANDREWS PW, 1984, LAB INVEST, V50, P147; BANTING GS, 1989, MOL IMMUNOL, V26, P181, DOI 10.1016/0161-5890(89)90100-4; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; Davis R W, 1980, Methods Enzymol, V65, P404; DRACOPOLI NC, 1985, AM J HUM GENET, V37, P199; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; ELLIS N, 1990, CELL, V63, P977, DOI 10.1016/0092-8674(90)90501-5; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P273; FISHER EMC, 1990, GENOMICS, V7, P625, DOI 10.1016/0888-7543(90)90209-D; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; GABRIELROBEZ O, 1990, CYTOGENET CELL GENET, V54, P38, DOI 10.1159/000132951; GELIN C, 1989, EMBO J, V8, P3235; GOODFELLOW PJ, 1987, ANN HUM GENET, V51, P161, DOI 10.1111/j.1469-1809.1987.tb01058.x; GOODFELLOW PN, 1981, NATURE, V289, P404, DOI 10.1038/289404a0; GROSSBERGER D, 1987, NUCLEIC ACIDS RES, V15, P6737, DOI 10.1093/nar/15.16.6737; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KREITMAN M, 1989, GENE ANAL TECH, V6, P84, DOI 10.1016/0735-0651(89)90021-6; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; MARCUS M, 1976, NATURE, V262, P65; MOHANDAS TK, 1992, CELL, V51, P526; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PRITCHARD CA, 1987, NATURE, V328, P273, DOI 10.1038/328273a0; PRITCHARD CA, 1987, NUCLEIC ACIDS RES, V15, P6159, DOI 10.1093/nar/15.15.6159; RACE RR, 1975, BLOOD GROUPS MAN, P578; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Sambrook J., 1989, MOL CLONING LAB MANU; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WAHLE E, 1992, BIOESSAYS, V14, P113, DOI 10.1002/bies.950140208; YATES J R W, 1987, Genomics, V1, P52, DOI 10.1016/0888-7543(87)90104-2; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7	44	72	77	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					394	400		10.1038/ng0494-394	http://dx.doi.org/10.1038/ng0494-394			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054981				2022-12-17	WOS:A1994ND87000020
J	VANCAMP, G; VITS, L; COUCKE, P; LYONNET, S; SCHRANDERSTUMPEL, C; DARBY, J; HOLDEN, J; MUNNICH, A; WILLEMS, PJ				VANCAMP, G; VITS, L; COUCKE, P; LYONNET, S; SCHRANDERSTUMPEL, C; DARBY, J; HOLDEN, J; MUNNICH, A; WILLEMS, PJ			A DUPLICATION IN THE L1CAM GENE ASSOCIATED WITH X-LINKED HYDROCEPHALUS	NATURE GENETICS			English	Article							ADHESION MOLECULE L1; AQUEDUCTAL STENOSIS; CYTOPLASMIC REGION; XQ28; MIGRATION; NEURONS; DXS52; RNA	Recently, a mutation in the gene for the neural cell adhesion molecule L1CAM, located at chromosome Xq28, was found in a family with X-linked hydrocephalus (HSAS). However, as the L1CAM mutation could only be identified in one HSAS family, it remained unclear whether or not L1CAM was the gene responsible for HSAS. We have conducted a mutation analysis of L1CAM in 25 HSAS families. The mutation reported previously was not found in any of these families. In one family, however, a 1.3 kilobases (kb) genomic duplication was identified, cosegregating with HSAS and significantly changing the intracellular domain of the L1CAM protein. These results confirm that L1CAM is the HSAS gene.	UNIV ANTWERP,UIA,DEPT MED GENET,B-2610 ANTWERP,BELGIUM; HOP NECKER ENFANTS MALAD,INSERM,UNITE RECH HANDICAPS GENET ENFANT 12,F-75743 PARIS 15,FRANCE; STATE UNIV UMBURG,DEPT GENET & CELL BIOL,6201 BX MAASTRICHT,NETHERLANDS; DEPT PSYCHIAT,SAN MATEO,CA 94403; CYTOGENET & DNA RES LAB,KINGSTON K7M 8A6,ON,CANADA	University of Antwerp; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University			Van Camp, Guy/F-3386-2013; Lyonnet, Stanislas/H-5483-2017	Van Camp, Guy/0000-0001-5105-9000; Lyonnet, Stanislas/0000-0001-5426-9417				ASOU H, 1992, NEUROSCI LETT, V144, P221, DOI 10.1016/0304-3940(92)90754-U; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BURTON BK, 1979, CLIN GENET, V16, P47; CASSIE R, 1977, J MED GENET, V14, P72, DOI 10.1136/jmg.14.1.72; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRIED K, 1972, CLIN GENET, V3, P258; FRIEDMAN KJ, 1991, 23RD P ANN MARCH DIM; HALLIDAY J, 1986, J MED GENET, V23, P23, DOI 10.1136/jmg.23.1.23; HARPER JR, 1991, J NEUROCHEM, V56, P797, DOI 10.1111/j.1471-4159.1991.tb01994.x; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOLDEN JJA, 1990, AM J HUM GENET S, V47, pA183; JOUET M, 1993, J MED GENET, V30, P214, DOI 10.1136/jmg.30.3.214; LANDRIEU P, 1979, DEV MED CHILD NEUROL, V21, P637; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MIURA M, 1992, J BIOL CHEM, V267, P10752; ORTH U, 1991, CYTOGENET CELL GENET, V58, P2079; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; RENIER WO, 1982, CLIN NEUROL NEUROSUR, V84, P113, DOI 10.1016/0303-8467(82)90064-6; ROSENTHAL A, 1991, NUCLEIC ACIDS RES, V19, P5395, DOI 10.1093/nar/19.19.5395; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Schachner M., 1992, NERVE GROWTH CONE; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; VARADI V, 1987, J MED GENET, V24, P207, DOI 10.1136/jmg.24.4.207; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883	30	72	72	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					421	425						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401593				2022-12-17	WOS:A1993LQ17800023
J	BURGLIN, TR; RUVKUN, G				BURGLIN, TR; RUVKUN, G			NEW MOTIF IN PBX GENES	NATURE GENETICS			English	Letter									MASSACHUSETTS GEN HOSP, DEPT MOLEC BIOL, WELLMAN 8, BOSTON, MA 02114 USA; HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT GENET, BOSTON, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital								BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KASSIS JA, 1986, EMBO J, V5, P3583, DOI 10.1002/j.1460-2075.1986.tb04686.x; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5	15	72	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1992	1	5					319	320		10.1038/ng0892-319	http://dx.doi.org/10.1038/ng0892-319			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1363814				2022-12-17	WOS:A1992JJ12100004
J	Kelleher, J; Wong, Y; Wohns, AW; Fadil, C; Albers, PK; McVean, G				Kelleher, Jerome; Wong, Yan; Wohns, Anthony W.; Fadil, Chaimaa; Albers, Patrick K.; McVean, Gil			Inferring whole-genome histories in large population datasets	NATURE GENETICS			English	Article							PHYLOGENETIC NETWORKS; RECOMBINATION RATES; TREES; SEQUENCES; AGE	Inferring the full genealogical history of a set of DNA sequences is a core problem in evolutionary biology, because this history encodes information about the events and forces that have influenced a species. However, current methods are limited, and the most accurate techniques are able to process no more than a hundred samples. As datasets that consist of millions of genomes are now being collected, there is a need for scalable and efficient inference methods to fully utilize these resources. Here we introduce an algorithm that is able to not only infer whole-genome histories with comparable accuracy to the stateof-the-art but also process four orders of magnitude more sequences. The approach also provides an 'evolutionary encoding' of the data, enabling efficient calculation of relevant statistics. We apply the method to human data from the 1000 Genomes Project, Simons Genome Diversity Project and UK Biobank, showing that the inferred genealogies are rich in biological signal and efficient to process.	[Kelleher, Jerome; Wong, Yan; Wohns, Anthony W.; Fadil, Chaimaa; Albers, Patrick K.; McVean, Gil] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England	University of Oxford	Kelleher, J (corresponding author), Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.	jerome.kelleher@bdi.ox.ac.uk		McVean, Gil/0000-0002-5012-4162; Wohns, Anthony Wilder/0000-0001-7353-1177; Wong, Yan/0000-0002-3536-6411; Albers, Patrick/0000-0003-2770-3729; Fadil, Chaimaa/0000-0003-3759-7835; Kelleher, Jerome/0000-0002-7894-5253	Wellcome Trust [100956/Z/13/Z]; Rhodes Trust; Health Data Research UK; NIHR Oxford Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust; Health Data Research UK; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust grant 100956/Z/13/Z to G. M. A. W. W. and C. F. thank the Rhodes Trust for their support. We thank J. Novembre and P. Ralph for comments on earlier drafts of this manuscript; P. Ralph and K. Thornton for many useful discussions on tree sequence algorithms. Computation used the Oxford Biomedical Research Computing (BMRC) facility, a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Albers PK., 2018, BIORXIV, DOI [10.1101/416610, DOI 10.1101/416610]; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ane C, 2005, SYST BIOL, V54, P146, DOI 10.1080/10635150590905984; Arenas Miguel, 2013, Frontiers in Genetics, V4, P206, DOI 10.3389/fgene.2013.00206; Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bordewich M., 2005, ANN COMB, V8, P409, DOI [10.1007/s00026-004-0229-z, DOI 10.1007/S00026-004-0229-Z]; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cardona G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-532; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; EUROSTAT, 2011, REG EUR UN NOM TERR; Fearnhead P, 2001, GENETICS, V159, P1299; Felsenstein J, 2004, INFERRING PHYLOGENIE; FISHER RA, 1954, HEREDITY, V8, P187, DOI 10.1038/hdy.1954.17; Griffiths R., 1991, IMS LECT NOTES MONOG, P100, DOI DOI 10.1214/LNMS/1215459289; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Gusfield D, 2014, RECOMBINATORICS: THE ALGORITHMICS OF ANCESTRAL RECOMBINATION GRAPHS AND EXPLICIT PHYLOGENETIC NETWORKS, P1; Gusfield D, 2007, J COMPUT BIOL, V14, P1247, DOI 10.1089/cmb.2006.0137; Gusfield Dan, 2004, J Bioinform Comput Biol, V2, P173, DOI 10.1142/S0219720004000521; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; HAECKEL E, 1866, GENERELLE MORPHOLOGI, V2; Haller BC, 2019, MOL ECOL RESOUR, V19, P552, DOI 10.1111/1755-0998.12968; Haller BC, 2019, MOL BIOL EVOL, V36, P632, DOI 10.1093/molbev/msy228; HEIN J, 1990, MATH BIOSCI, V98, P185, DOI 10.1016/0025-5564(90)90123-G; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jombart T, 2017, MOL ECOL RESOUR, V17, P1385, DOI 10.1111/1755-0998.12676; Keightley PD, 2018, GENETICS, V209, P897, DOI 10.1534/genetics.118.301120; Kelleher J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006581; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Kendall M, 2016, MOL BIOL EVOL, V33, P2735, DOI 10.1093/molbev/msw124; KIMURA M, 1973, GENETICS, V75, P199; Kuhner MK, 2000, GENETICS, V156, P1393; Li N, 2003, GENETICS, V165, P2213; Lunter G, 2019, BIOINFORMATICS, V35, P798, DOI 10.1093/bioinformatics/bty735; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McGill James R., 2013, Frontiers in Genetics, V4, P146, DOI 10.3389/fgene.2013.00146; McKinney W., 2010, P 9 PYTH SCI C, P51, DOI [DOI 10.25080/MAJORA-92BF1922-00A, 10.25080/majora-92bf1922-00a]; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Mirzaei S, 2017, BIOINFORMATICS, V33, P1021, DOI 10.1093/bioinformatics/btw735; Morrison DA, 2016, EVOL BIOL, V43, P456, DOI 10.1007/s11692-016-9376-5; Nakagome S, 2016, MOL BIOL EVOL, V33, P657, DOI 10.1093/molbev/msv256; O'Fallon BD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-40; Oliphant T.E., 2006, A GUIDE TO NUMPY, VVol. 1; Ormond L, 2016, MOL ECOL, V25, P157, DOI 10.1111/mec.13478; Parida L, 2008, J COMPUT BIOL, V15, P1133, DOI 10.1089/cmb.2008.0065; Pedersen BS, 2017, BIOINFORMATICS, V33, P1867, DOI 10.1093/bioinformatics/btx057; Ragan MA, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-43; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shchur V., 2019, BIORXIV, DOI [10.1101/542035, DOI 10.1101/542035]; Smith J, 2018, MOL BIOL EVOL, V35, P1003, DOI 10.1093/molbev/msy006; Song YS, 2005, BIOINFORMATICS, V21, pI413, DOI 10.1093/bioinformatics/bti1033; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Speidel L, 2019, NAT GENET, V51, P1321, DOI 10.1038/s41588-019-0484-x; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Wang LS, 2001, J COMPUT BIOL, V8, P69, DOI 10.1089/106652701300099119; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	60	71	71	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2019	51	9					1330	+		10.1038/s41588-019-0483-y	http://dx.doi.org/10.1038/s41588-019-0483-y			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV1AX	31477934	Green Accepted, Green Submitted			2022-12-17	WOS:000484010800009
J	Eslam, M; McLeod, D; Kelaeng, KS; Mangia, A; Berg, T; Thabet, K; Irving, WL; Dore, GJ; Sheridan, D; Gronbk, H; Abate, ML; Hartmann, R; Bugianesi, E; Spengler, U; Rojas, A; Booth, DR; Weltman, M; Mollison, L; Cheng, W; Riordan, S; Mahajan, H; Fischer, J; Nattermann, J; Douglas, MW; Liddle, C; Powell, E; Romero-Gomez, M; George, J				Eslam, Mohammed; McLeod, Duncan; Kelaeng, Kebitsaone Simon; Mangia, Alessandra; Berg, Thomas; Thabet, Khaled; Irving, William L.; Dore, Gregory J.; Sheridan, David; Gronbk, Henning; Abate, Maria Lorena; Hartmann, Rune; Bugianesi, Elisabetta; Spengler, Ulrich; Rojas, Angela; Booth, David R.; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Mahajan, Hema; Fischer, Janett; Nattermann, Jacob; Douglas, Mark W.; Liddle, Christopher; Powell, Elizabeth; Romero-Gomez, Manuel; George, Jacob		Int Liver Dis Genetics Consortium	IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis	NATURE GENETICS			English	Article							INTERFERON-STIMULATED GENES; GENOME-WIDE-ASSOCIATION; LIVER FIBROSIS; HCV CLEARANCE; C PATIENTS; LAMBDA 4; IL28B; IFNL3; EXPRESSION; GENOTYPE	Genetic variation in the IFNL3-IFNL4 (interferon-lambda 3-interferon-lambda 4) region is associated with hepatic inflammation and fibrosis1-4. Whether IFN-lambda 3 or IFN-lambda 4 protein drives this association is not known. We demonstrate that hepatic inflammation, fibrosis stage, fibrosis progression rate, hepatic infiltration of immune cells, IFN-lambda 3 expression, and serum sCD163 levels (a marker of activated macrophages) are greater in individuals with the IFNL3-IFNL4 risk haplotype that does not produce IFN-lambda 4, but produces IFN-lambda 3. No difference in these features was observed according to genotype at rs117648444, which encodes a substitution at position 70 of the IFN-lambda 4 protein and reduces IFN-lambda 4 activity, or between patients encoding functionally defective IFN-lambda 4 (IFN-lambda 4-Ser70) and those encoding fully active IFN-lambda 4-Pro70. The two proposed functional variants (rs368234815 and rs4803217) 5,6 were not superior to the discovery SNP rs12979860 with respect to liver inflammation or fibrosis phenotype. IFN-lambda 3 rather than IFN-lambda 4 likely mediates IFNL3-IFNL4 haplotypedependent hepatic inflammation and fibrosis.	[Eslam, Mohammed; Kelaeng, Kebitsaone Simon; Thabet, Khaled; Douglas, Mark W.; Liddle, Christopher; George, Jacob] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia; [Eslam, Mohammed; Kelaeng, Kebitsaone Simon; Thabet, Khaled; Douglas, Mark W.; Liddle, Christopher; George, Jacob] Univ Sydney, Sydney, NSW, Australia; [McLeod, Duncan; Mahajan, Hema] Westmead Hosp, ICPMR, Dept Anat Pathol, Sydney, NSW, Australia; [Mangia, Alessandra] Osped Casa Sollievo Sofferenza, IRCCS, Div Hepatol, San Giovanni Rotondo, Italy; [Berg, Thomas; Fischer, Janett] Univ Clin Leipzig, Clin Gastroenterol & Rheumatol, Sect Hepatol, Leipzig, Germany; [Thabet, Khaled] Minia Univ, Fac Pharm, Dept Biochem, Al Minya, Egypt; [Irving, William L.] Univ Nottingham, NIHR Biomed Res Unit Gastroenterol & Liver, Nottingham, England; [Dore, Gregory J.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Sheridan, David] Plymouth Univ, Inst Translat & Stratified Med, Plymouth, Devon, England; [Gronbk, Henning] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark; [Abate, Maria Lorena; Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol & Hepatol, Turin, Italy; [Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 2, Bonn, Germany; [Rojas, Angela; Romero-Gomez, Manuel] Univ Hosp Virgen del Rocio, Inst Biomed Seville, UCM IC Digest Dis, Seville, Spain; [Rojas, Angela; Romero-Gomez, Manuel] Univ Hosp Virgen del Rocio, Inst Biomed Seville, Ciberehd, Seville, Spain; [Booth, David R.] Westmead Hosp, Inst Immunol & Allergy Res, Sydney, NSW, Australia; [Booth, David R.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW, Australia; [Weltman, Martin] Nepean Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia; [Mollison, Lindsay] Fremantle Hosp, Dept Gastroenterol & Hepatol, Fremantle, WA, Australia; [Cheng, Wendy] Royal Perth Hosp, Dept Gastroenterol & Hepatol, Perth, WA, Australia; [Riordan, Stephen] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Riordan, Stephen] Univ New South Wales, Sydney, NSW, Australia; [Douglas, Mark W.] Univ Sydney, Westmead Hosp, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Powell, Elizabeth] Univ Queensland, Princess Alexandra Hosp, Sch Med, Woolloongabba, Qld, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; IRCCS Casa Sollievo Della Sofferenza; Leipzig University; Egyptian Knowledge Bank (EKB); Minia University; University of Nottingham; University of New South Wales Sydney; Kirby Institute; University of Plymouth; Aarhus University; University of Turin; Aarhus University; University of Bonn; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sydney; University of Sydney; Westmead Institute for Medical Research; Nepean Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of New South Wales Sydney; University of Sydney; University of Queensland	George, J (corresponding author), Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia.; George, J (corresponding author), Univ Sydney, Sydney, NSW, Australia.	jacob.george@sydney.edu.au	Powell, Elizabeth/B-4455-2011; Mangia, A/AAL-5357-2020; Romero-Gomez, Manuel/L-8030-2014; Dore, Gregory John/ABD-5665-2021; Gronbaek, Henning/AAJ-3202-2020; Douglas, Mark/D-5513-2011	Powell, Elizabeth/0000-0001-5008-8061; Mangia, A/0000-0002-2600-3555; Romero-Gomez, Manuel/0000-0001-8494-8947; Dore, Gregory John/0000-0002-4741-2622; Gronbaek, Henning/0000-0001-8998-7910; Douglas, Mark/0000-0003-4621-3485; Hartmann, Rune/0000-0003-1159-066X; Matthews, Gail/0000-0002-1048-6396; Berg, Thomas/0000-0003-0003-6241; Gallego-Duran, Rocio/0000-0002-9452-1661; Irving, William/0000-0002-7268-3168; Applegate, Tanya/0000-0002-8657-4261; Sheridan, David/0000-0001-5100-814X; Thabet, khaled/0000-0002-5937-2058	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC) [1053206]; NHMRC [APP1107178, APP1108422, 1028432]; Medical Research Council [MR/N005953/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002082, NNF10OC1013267, NNF15OC0017902] Funding Source: researchfish; MRC [MR/N005953/1] Funding Source: UKRI	Robert W. Storr Bequest; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all the patients for their participation in this study. M.E., M.D., and J.G. are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, and by a National Health and Medical Research Council of Australia (NHMRC) Program Grant (1053206) and NHMRC Project Grants (APP1107178 and APP1108422). G.D. is supported by an NHMRC Fellowship (1028432).	Aboulnasr F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141655; Aoki Y, 2015, J GASTROENTEROL, V50, P894, DOI 10.1007/s00535-014-1023-2; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Chandra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108616; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Dolganiuc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044915; Eslam M, 2016, J HEPATOL, V64, P390, DOI 10.1016/j.jhep.2015.11.008; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Eslam M, 2014, J HEPATOL, V61, P235, DOI 10.1016/j.jhep.2014.03.039; Friborg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121734; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lauber C, 2015, GENES IMMUN, V16, P414, DOI 10.1038/gene.2015.23; Lu YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16037; Lu YF, 2015, VIROLOGY, V476, P334, DOI 10.1016/j.virol.2014.12.020; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Murata K, 2014, J GASTROENTEROL, V49, P126, DOI 10.1007/s00535-013-0814-1; O'Brien TR, 2015, J HEPATOL, V63, P1103, DOI 10.1016/j.jhep.2015.06.035; Onabajo OO, 2015, J INTERF CYTOK RES, V35, P888, DOI 10.1089/jir.2014.0161; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rallon NI, 2012, J ANTIMICROB CHEMOTH, V67, P1246, DOI 10.1093/jac/dkr598; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terczynska-Dyla E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6699; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Thompson AJ, 2010, HEPATOLOGY, V52, p1220A; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Watanabe T, 2013, GUT, V62, P1340, DOI 10.1136/gutjnl-2012-302553; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182	44	71	74	2	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2017	49	5					795	+		10.1038/ng.3836	http://dx.doi.org/10.1038/ng.3836			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET1TI	28394349	Green Submitted			2022-12-17	WOS:000400051400020
J	Ma, HS; Xu, H; O'Farrell, PH				Ma, Hansong; Xu, Hong; O'Farrell, Patrick H.			Transmission of mitochondrial mutations and action of purifying selection in Drosophila melanogaster	NATURE GENETICS			English	Article							RAPID SEGREGATION; DNA HETEROPLASMY; INHERITANCE; MORPHOGENESIS; REDUCTION; EXPLAINS; GENETICS; DRIFT	It is not known how selection affects mutations in the multiple copies of the mitochondrial genome(1-11). We transferred cytoplasm between D. melanogaster embryos carrying mitochondrial mutations to create heteroplasmic lines transmitting two mitochondrial genotypes. Increased temperature imposed selection against a temperature-sensitive mutation affecting cytochrome oxidase, driving decreases in the abundance of the mutant genome over successive generations. Selection did not influence the health or fertility of the flies but acted during midoogenesis to influence competition between the genomes. Mitochondria might incur an advantage through selective localization, survival or proliferation, yet timing and insensitivity to park mutation suggest that preferential proliferation underlies selection. Selection drove complete replacement of the temperature-sensitive mitochondrial genome by a wild-type genome but also stabilized the multigenerational transmission of two genomes carrying complementing detrimental mutations. While they are so balanced, these stably transmitted mutations have no detrimental phenotype, but their segregation could contribute to disease phenotypes and somatic aging.	[Ma, Hansong; Xu, Hong; O'Farrell, Patrick H.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	O'Farrell, PH (corresponding author), Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA.	ofarrell@cgl.ucsf.edu	Xu, Hong/H-9997-2016; Ma, Hansong/A-7794-2012; Ma, Hansong/O-7736-2019	Xu, Hong/0000-0003-1049-1184; Ma, Hansong/0000-0002-2705-1970; Ma, Hansong/0000-0002-2705-1970; O'Farrell, Patrick/0000-0003-0011-2734	US National Institutes of Health [GM086854, ES020725]; United Mitochondrial Disease Foundation; Human Frontiers Science Program [LT000138/2010-l]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086854, R01GM120005] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Martinez for helping perform the park RNAi experiment and G. Mardon (Baylor College of Medicine) for kindly providing the dpk<SUP>Delta 21</SUP> strain. This research was supported by the US National Institutes of Health (GM086854 and ES020725) and by United Mitochondrial Disease Foundation funding to P.H.O. H.M. was supported by the Human Frontiers Science Program (LT000138/2010-l).	Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DeLuca SZ, 2012, DEV CELL, V22, P660, DOI 10.1016/j.devcel.2011.12.021; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; King R. C., 1970, OVARIAN DEV DROSOPHI; MATSUURA ET, 1989, GENETICS, V122, P663; Ogienko AA, 2007, RUSS J GENET+, V43, P1120, DOI 10.1134/S1022795407100055; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; SOLIGNAC M, 1987, GENETICS, V117, P687; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wright S., 1984, EVOLUTION GENETICS P, V2; Xu H, 2008, SCIENCE, V321, P575, DOI 10.1126/science.1160226	24	71	71	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					393	+		10.1038/ng.2919	http://dx.doi.org/10.1038/ng.2919			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24614071	Green Accepted			2022-12-17	WOS:000334510100018
J	Zimdahl, B; Ito, T; Blevins, A; Bajaj, J; Konuma, T; Weeks, J; Koechlein, CS; Kwon, HY; Arami, O; Rizzieri, D; Broome, HE; Chuah, C; Oehler, VG; Sasik, R; Hardiman, G; Reya, T				Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Rizzieri, David; Broome, H. Elizabeth; Chuah, Charles; Oehler, Vivian G.; Sasik, Roman; Hardiman, Gary; Reya, Tannishtha			Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia	NATURE GENETICS			English	Article							DRIVE TRANSGENE EXPRESSION; SELF-RENEWAL; SPINDLE ORIENTATION; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; MURINE MODEL; CANCER; DIFFERENTIATION; PROLIFERATION; SEGREGATION	Cell fate can be controlled through asymmetric division and segregation of protein determinants, but the regulation of this process in the hematopoietic system is poorly understood. Here we show that the dynein-binding protein Lis1 is critically required for hematopoietic stem cell function and leukemogenesis. Conditional deletion of Lis1 (also known as Pafah1b1) in the hematopoietic system led to a severe bloodless phenotype, depletion of the stem cell pool and embryonic lethality. Further, real-time imaging revealed that loss of Lis1 caused defects in spindle positioning and inheritance of cell fate determinants, triggering accelerated differentiation. Finally, deletion of Lis1 blocked the propagation of myeloid leukemia and led to a marked improvement in survival, suggesting that Lis1 is also required for oncogenic growth. These data identify a key role for Lis1 in hematopoietic stem cells and mark its directed control of asymmetric division as a critical regulator of normal and malignant hematopoietic development.	[Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Zimdahl, Bryan; Ito, Takahiro; Blevins, Allen; Bajaj, Jeevisha; Konuma, Takaaki; Weeks, Joi; Koechlein, Claire S.; Kwon, Hyog Young; Arami, Omead; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Zimdahl, Bryan; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Rizzieri, David] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy, Durham, NC 27710 USA; [Broome, H. Elizabeth] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Broome, H. Elizabeth; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Chuah, Charles] Singapore Gen Hosp, Dept Hematol, Singapore, Singapore; [Chuah, Charles] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA	University of California System; University of California San Diego; Duke University; Duke University; University of California System; University of California San Diego; University of California System; University of California San Diego; Singapore General Hospital; National University of Singapore; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Reya, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	treya@ucsd.edu	Ito, Takahiro/F-5006-2011; Kwon, Hyog/T-7915-2019	Ito, Takahiro/0000-0001-7165-0412; Kwon, Hyog/0000-0003-1663-5118; Konuma, Takaaki/0000-0002-1953-8463; Hardiman, Gary/0000-0003-4558-0400	US National Institutes of Health (NIH) Cancer Biology Training Grant [T32 CA 59365-18]; NIH Pharmacological Sciences Training Program [T32 GM007752]; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science; Leukemia and Lymphoma Society Scholar Award; University of California San Diego Moores Cancer Center National Cancer Institute Core Grant [P30CA23100]; NIH [DK63031, HL097767, DP1 CA174422]; NATIONAL CANCER INSTITUTE [DP1CA174422, P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Cancer Biology Training Grant; NIH Pharmacological Sciences Training Program; California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); University of California San Diego Moores Cancer Center National Cancer Institute Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to B. Hogan, J. Chang, A. Desai, J. Gleeson, J.E. Lee, M.F. Wu, M. Sander and J. Koop for experimental advice and reagents. We would also like to thank M. Kritzik for advice and comments on the manuscript; M. Nakamura for experimental help; M. Cook, L. Matinek, B. Harvat, E. O'Conner and K. Marquez for cell sorting; and W. Pear (University of Pennsylvania) and A.M. Pendergast (Duke University) for the BCR-ABL construct, D.G. Gilliland (University of Pennsylvania) for the NUP98-HOXA9 construct, S. Armstrong (Memorial Sloan-Kettering Cancer Center) for the MLL-AF9 construct, C. Counter (Duke University) for NRAS<SUP>G12V</SUP>, S. Russell (Peter MacCallum Cancer Centre) for the mCherry-alpha-tubulin construct, G. Wahl (Salk Institute) for the H2B-GFP (pEGFPN1) vector and D. Kioussis (Medical Research Council National Institute for Medical Research) for the Vav1-cre transgenic line. B.Z. and C.S.K. received support from US National Institutes of Health (NIH) Cancer Biology Training Grant (T32 CA 59365-18) and NIH Pharmacological Sciences Training Program (T32 GM007752), respectively. T.I. is a recipient of a California Institute for Regenerative Medicine interdisciplinary stem cell training program fellowship, and T.K. is supported by a postdoctoral fellowship from the Japanese Society for the Promotion of Science. This work was also supported by a Leukemia and Lymphoma Society Scholar Award, the University of California San Diego Moores Cancer Center National Cancer Institute Core Grant, P30CA23100, as well as by NIH grants DK63031, HL097767 and DP1 CA174422 awarded to T.R.	Almarza E, 2004, EXP HEMATOL, V32, P360, DOI 10.1016/j.exphem.2004.01.005; Arnold B.C., 1992, 1 COURSE ORDER STAT; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bonaccorsi S, 2007, DEVELOPMENT, V134, P2183, DOI 10.1242/dev.02848; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Ogilvy S, 1999, BLOOD, V94, P1855; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	55	71	75	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					245	+		10.1038/ng.2889	http://dx.doi.org/10.1038/ng.2889			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24487275	Green Accepted			2022-12-17	WOS:000332036700008
J	Dokshin, GA; Baltus, AE; Eppig, JJ; Page, DC				Dokshin, Gregoriy A.; Baltus, Andrew E.; Eppig, John J.; Page, David C.			Oocyte differentiation is genetically dissociable from meiosis in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR FOXL2; PRIMORDIAL GERM-CELLS; DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; MOUSE OOCYTE; SUPPRESSES MEIOSIS; MEIOTIC CHROMOSOME; OVARIAN STRUCTURES; SEX DETERMINATION	Oogenesis is the process by which ovarian germ cells undertake meiosis and differentiate to become eggs. In mice, Stra8 is required for the chromosomal events of meiosis to occur, but its role in differentiation remains unknown. Here we report Stra8-deficient ovarian germ cells that grow and differentiate into oocyte-like cells that synthesize zonae pellucidae, organize surrounding somatic cells into follicles, are ovulated in response to hormonal stimulation, undergo asymmetric cell division to produce a polar body and cleave to form two-cell embryos upon fertilization. These events occur without premeiotic chromosomal replication, sister chromatid cohesion, synapsis or recombination. Thus, oocyte growth and differentiation are genetically dissociable from the chromosomal events of meiosis. These findings open to study the independent contributions of meiosis and oocyte differentiation to the making of a functional egg.	[Dokshin, Gregoriy A.; Baltus, Andrew E.; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Dokshin, Gregoriy A.; Baltus, Andrew E.; Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Dokshin, Gregoriy A.; Baltus, Andrew E.; Page, David C.] MIT, Dept Biol, Cambridge, MA USA; [Eppig, John J.] Jackson Lab, Bar Harbor, ME 04609 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Jackson Laboratory	Page, DC (corresponding author), Whitehead Inst, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu		Dokshin, Gregoriy/0000-0002-8780-7143	Howard Hughes Medical Institute; US National Institutes of Health [HD23839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023839] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank C. Heyting (Agricultural University, Wageningen) for antiserum to REC8, N. Watson and L. Bechtold for assistance with electron microscopy and A. Amon, D. Bellott, M. Carmell, I. Cheeseman, D. de Rooij, R. Desgraz, T. Endo, G. Fink, M. A. Handel, T. Hassold, S. Hawley, A. Hochwagen, Y. Hu, J. Hughes, B. Lesch, J. Mueller, L. Okumura, T. Orr-Weaver, S. Repping, K. Romer and S. Soh for advice and comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the US National Institutes of Health (HD23839).	Adams IR, 2002, DEVELOPMENT, V129, P1155; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bannister LA, 2004, GENESIS, V40, P184, DOI 10.1002/gene.20085; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bowles J, 2010, REPRODUCTION, V139, P943, DOI 10.1530/REP-10-0075; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; DONAHUE RP, 1968, J EXP ZOOL, V169, P237, DOI 10.1002/jez.1401690210; EPPIG JJ, 1993, DEV BIOL, V158, P400, DOI 10.1006/dbio.1993.1198; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031; KLAR AJS, 1980, GENETICS, V94, P597; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Krentz AD, 2011, DEV BIOL, V356, P63, DOI 10.1016/j.ydbio.2011.05.658; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Morgan CT, 2013, P NATL ACAD SCI USA, V110, P3411, DOI 10.1073/pnas.1300928110; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Oatley J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100297; Page AW, 1997, CURR OPIN GENET DEV, V7, P23, DOI 10.1016/S0959-437X(97)80105-0; Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ravi M, 2008, NATURE, V451, P1121, DOI 10.1038/nature06557; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Salvador LM, 2008, METHODS, V45, P172, DOI 10.1016/j.ymeth.2008.03.004; Scherthan H, 2003, CYTOGENET GENOME RES, V103, P235, DOI 10.1159/000076809; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Susiarjo M, 2009, METHODS MOL BIOL, V558, P339, DOI 10.1007/978-1-60761-103-5_20; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Von Stetina JR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005553; WASSARMAN PM, 1978, J MORPHOL, V156, P209, DOI 10.1002/jmor.1051560206; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wojtasz L, 2012, GENE DEV, V26, P958, DOI 10.1101/gad.187559.112; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	54	71	71	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2013	45	8					877	U289		10.1038/ng.2672	http://dx.doi.org/10.1038/ng.2672			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23770609	Green Accepted, Green Submitted			2022-12-17	WOS:000322374900009
J	Wijnker, E; van Dun, K; de Snoo, CB; Lelivelt, CLC; Keurentjes, JJB; Naharudin, NS; Ravi, M; Chan, SWL; de Jong, H; Dirks, R				Wijnker, Erik; van Dun, Kees; de Snoo, C. Bastiaan; Lelivelt, Cilia L. C.; Keurentjes, Joost J. B.; Naharudin, Nazatul Shima; Ravi, Maruthachalam; Chan, Simon W. L.; de Jong, Hans; Dirks, Rob			Reverse breeding in Arabidopsis thaliana generates homozygous parental lines from a heterozygous plant	NATURE GENETICS			English	Article							GENOME; DNA; CONSTRUCTION; MEIOSIS; GENES; RFLP; MAP	Traditionally, hybrid seeds are produced by crossing selected inbred lines. Here we provide a proof of concept for reverse breeding, a new approach that simplifies meiosis such that homozygous parental lines can be generated from a vigorous hybrid individual. We silenced DMC1, which encodes the meiotic recombination protein DISRUPTED MEIOTIC cDNA1, in hybrids of A. thaliana, so that non-recombined parental chromosomes segregate during meiosis. We then converted the resulting gametes into adult haploid plants, and subsequently into homozygous diploids, so that each contained half the genome of the original hybrid. From 36 homozygous lines, we selected 3 (out of 6) complementing parental pairs that allowed us to recreate the original hybrid by intercrossing. In addition, this approach resulted in a complete set of chromosome-substitution lines. Our method allows the selection of a single choice offspring from a segregating population and preservation of its heterozygous genotype by generating homozygous founder lines.	[Wijnker, Erik; Keurentjes, Joost J. B.; de Jong, Hans] Wageningen Univ, Genet Lab, Wageningen, Netherlands; [van Dun, Kees; de Snoo, C. Bastiaan; Lelivelt, Cilia L. C.; Dirks, Rob] Rijk Zwaan R&D Fijnaart, Fijnaart, Netherlands; [Keurentjes, Joost J. B.] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Naharudin, Nazatul Shima] Univ Putra Malaysia, Dept Crop Sci, Fac Agr, Serdang, Malaysia; [Ravi, Maruthachalam; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Chan, Simon W. L.] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA	Wageningen University & Research; Wageningen University & Research; Universiti Putra Malaysia; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis	Wijnker, E (corresponding author), Wageningen Univ, Genet Lab, Wageningen, Netherlands.	erik.wijnker@wur.nl	Wijnker, Erik/H-4816-2011; Naharudin, Nazatul Shima/I-4909-2016	Naharudin, Nazatul Shima/0000-0003-2524-9382; Maruthachalam, Ravi/0000-0003-0036-3330; Keurentjes, Joost/0000-0001-8918-0711				Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dirks R, 2009, PLANT BIOTECHNOL J, V7, P837, DOI 10.1111/j.1467-7652.2009.00450.x; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Forster BP, 2007, TRENDS PLANT SCI, V12, P368, DOI 10.1016/j.tplants.2007.06.007; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hartung F, 2007, PLANT CELL, V19, P3090, DOI 10.1105/tpc.107.054817; HAUGE BM, 1993, PLANT J, V3, P745, DOI 10.1111/j.1365-313X.1993.00745.x; Koumproglou R, 2002, PLANT J, V31, P355, DOI 10.1046/j.1365-313X.2002.01353.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Ma Hong, 2006, Arabidopsis Book, V4, pe0095, DOI 10.1199/tab.0095; Marimuthu MPA, 2011, SCIENCE, V331, P876, DOI 10.1126/science.1199682; Mercier R, 2008, CYTOGENET GENOME RES, V120, P281, DOI 10.1159/000121077; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Ross KJ, 1997, CHROMOSOME RES, V5, P551, DOI 10.1023/A:1018497804129; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tang XM, 2008, GENETICS, V180, P1319, DOI 10.1534/genetics.108.093211; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Toyota M, 2011, PLANT J, V65, P589, DOI 10.1111/j.1365-313X.2010.04440.x; van Dijk P, 2000, TRENDS PLANT SCI, V5, P81, DOI 10.1016/S1360-1385(99)01545-9; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428	28	71	80	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2012	44	4					467	U156		10.1038/ng.2203	http://dx.doi.org/10.1038/ng.2203			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22406643				2022-12-17	WOS:000302130600025
J	Antonacci, F; Kidd, JM; Marques-Bonet, T; Teague, B; Ventura, M; Girirajan, S; Alkan, C; Campbell, CD; Vives, L; Malig, M; Rosenfeld, JA; Ballif, BC; Shaffer, LG; Graves, TA; Wilson, RK; Schwartz, DC; Eichler, EE				Antonacci, Francesca; Kidd, Jeffrey M.; Marques-Bonet, Tomas; Teague, Brian; Ventura, Mario; Girirajan, Santhosh; Alkan, Can; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.; Graves, Tina A.; Wilson, Richard K.; Schwartz, David C.; Eichler, Evan E.			A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISMS; GENOME ARCHITECTURE; COMMON INVERSION; DNA-SEQUENCE; DISORDERS; REARRANGEMENTS; DISCOVERY; DELETIONS; SELECTION	There is a complex relationship between the evolution of segmental duplications and rearrangements associated with human disease. We performed a detailed analysis of one region on chromosome 16p12.1 associated with neurocognitive disease and identified one of the largest structural inconsistencies in the human reference assembly. Various genomic analyses show that all examined humans are homozygously inverted relative to the reference genome for a 1.1-Mb region on 16p12.1. We determined that this assembly discrepancy stems from two common structural configurations with worldwide frequencies of 17.6% (S1) and 82.4% (S2). This polymorphism arose from the rapid integration of segmental duplications, precipitating two local inversions within the human lineage over the last 10 million years. The two human haplotypes differ by 333 kb of additional duplicated sequence present in S2 but not in S1. Notably, we show that the S2 configuration harbors directly oriented duplications, specifically predisposing this chromosome to disease-associated rearrangement.	[Antonacci, Francesca; Kidd, Jeffrey M.; Marques-Bonet, Tomas; Girirajan, Santhosh; Alkan, Can; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas] Inst Biol Evolut UPF CSIC, Barcelona, Catalonia, Spain; [Teague, Brian] Univ Wisconsin, Dept Chem, Lab Mol & Computat Genom, Genet Lab, Madison, WI 53706 USA; [Teague, Brian] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Ventura, Mario; Schwartz, David C.] Univ Bari, Dept Genet & Microbiol, Bari, Italy; [Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA USA; [Graves, Tina A.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA	University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universita degli Studi di Bari Aldo Moro; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Marques-Bonet, Tomas/I-4618-2014; Antonacci, Francesca/F-5457-2013; Marques-Bonet, Tomas/ABF-3734-2020; Wilson, Richard K./AAF-4139-2019; Ventura, Mario/E-6420-2011; Alkan, Can/D-2982-2009	Marques-Bonet, Tomas/0000-0002-5597-3075; Antonacci, Francesca/0000-0002-5833-6186; Marques-Bonet, Tomas/0000-0002-5597-3075; Wilson, Richard K./0000-0002-1992-1358; Ventura, Mario/0000-0001-7762-8777; Alkan, Can/0000-0002-5443-0706; Kidd, Jeffrey/0000-0002-9631-1465; /0000-0002-9833-2817	US National Science Foundation; US National Institutes of Health [T32 GM07215, 5T15 LM007359, HG000225, HG002385]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000225, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank P. Sudmant for useful discussions, G. M. Cooper and T. Brown for critical review of the manuscript and L. Zhou, Y. Fu, R. Shi, J. Wu, S. Shaull and B. A. Roe for sequencing of clone AC120780. This work was supported by a US National Science Foundation Graduate Research Fellowship (to J. M. K.) and a Marie Curie fellowship (FP7 to T.M.-B.), and by the US National Institutes of Health (grants T32 GM07215 and 5T15 LM007359 to B. T., HG000225 to D. C. S. and HG002385 to E. E. E.). E. E. E. is an investigator of the Howard Hughes Medical Institute.	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	52	71	72	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					745	U29		10.1038/ng.643	http://dx.doi.org/10.1038/ng.643			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729854	Green Accepted			2022-12-17	WOS:000281388400007
J	Tomida, S; Mamiya, T; Sakamaki, H; Miura, M; Aosaki, T; Masuda, M; Niwa, M; Kameyama, T; Kobayashi, J; Iwaki, Y; Imai, S; Ishikawa, A; Abe, K; Yoshimura, T; Nabeshima, T; Ebihara, S				Tomida, Shigeru; Mamiya, Takayoshi; Sakamaki, Hirotake; Miura, Masami; Aosaki, Toshihiko; Masuda, Masao; Niwa, Minae; Kameyama, Tsutomu; Kobayashi, Junya; Iwaki, Yuka; Imai, Saki; Ishikawa, Akira; Abe, Kuniya; Yoshimura, Takashi; Nabeshima, Toshitaka; Ebihara, Shizufumi			Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests	NATURE GENETICS			English	Article							PREPULSE INHIBITION; MICE LACKING; QTL ANALYSIS; RECEPTOR; DEPRESSION; MODEL; GABA; DISSECTION; PLASTICITY; ATTENTION	The tail suspension test (TST) and forced swimming test (FST) are widely used for assessing antidepressant activity and depression-like behavior. We found that CS mice show negligible immobility in inescapable situations. Quantitative trait locus (QTL) mapping using CS and C57BL/6J mice revealed significant QTLs on chromosomes 4 (FST) and 5 (TST and FST). To identify the quantitative trait gene on chromosome 5, we narrowed the QTL interval to 0.5 Mb using several congenic and subcongenic strains. Ubiquitin-specific peptidase 46 (Usp46) with a lysine codon deletion was located in this region. This deletion affected nest building, muscimol-induced righting reflex and anti-immobility effects of imipramine. The muscimol-induced current in the hippocampal CA1 pyramidal neurons and hippocampal expression of the 67-kDa isoform of glutamic acid decarboxylase were significantly decreased in the Usp46 mutant mice compared to control mice. These phenotypes were rescued in transgenic mice with bacterial artificial chromosomes containing wild-type Usp46. Thus, Usp46 affects the immobility in the TST and FST, and it is implicated in the regulation of GABA action.	[Tomida, Shigeru; Sakamaki, Hirotake; Kobayashi, Junya; Iwaki, Yuka; Imai, Saki; Yoshimura, Takashi; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mamiya, Takayoshi; Niwa, Minae; Nabeshima, Toshitaka] Meijo Univ, Fac Pharm, Dept Chem Pharmacol, Tempaku Ku, Nagoya, Aichi 468, Japan; [Miura, Masami; Aosaki, Toshihiko; Masuda, Masao] Tokyo Metropolitan Inst Gerontol, Neural Circuits Dynam Res Grp, Itabashi Ku, Tokyo, Japan; [Kameyama, Tsutomu] Japan Inst Psychopharmacol, Higashi Ku, Nagoya, Aichi, Japan; [Ishikawa, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Div Appl Genet & Physiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Abe, Kuniya] RIKEN, Bioresource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki, Japan	Nagoya University; Meijo University; Tokyo Metropolitan Institute of Gerontology; Nagoya University; RIKEN	Ebihara, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp	Niwa, Minae/G-5469-2011; Niwa, Minae/AAV-2639-2021; Ishikawa, Akira/I-6856-2014; Yoshimura, Takashi/C-8306-2012	Niwa, Minae/0000-0002-8784-7815; Niwa, Minae/0000-0002-8784-7815; Ishikawa, Akira/0000-0002-8275-4230; Yoshimura, Takashi/0000-0001-7018-9652	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the late M. Ukai (Meijo University) for his helpful suggestions and for providing the facilities for the behavioral experiments, A. Yoshiki (RIKEN BRC) for his useful suggestions regarding the rescue experiment with transgenic mice, S. Yasuo (Johann Wolfgang Goethe-University Frankfurt) for her guidance on the in situ hybridization experiment, RIKEN BRC for providing the mice and the Nagoya University Radio-isotope Center for allowing us to use their facilities. This research was supported in part by a Grant-in-Aid for Scientific Research to S. E. and by the Academic Frontier Project for Private Universities (2007-2011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. M and T. N.	Abe H, 1999, J COMP PHYSIOL A, V184, P243, DOI 10.1007/s003590050322; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Abe K, 2004, GENOME RES, V14, P2439, DOI 10.1101/gr.2899304; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Belknap JK, 2001, BEHAV GENET, V31, P5, DOI 10.1023/A:1010249607128; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; CHURCHILL GA, 1994, GENETICS, V138, P963; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Crowley JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2433, DOI 10.1038/sj.npp.1301065; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; Ebihara S, 2003, BRAIN RES, V980, P121, DOI 10.1016/S0006-8993(03)02947-0; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Galeotti N, 2003, NEUROPSYCHOPHARMACOL, V28, P888, DOI 10.1038/sj.npp.1300111; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kuwahara M, 1999, BLOOD, V94, P1149, DOI 10.1182/blood.V94.4.1149.416k18_1149_1155; Lad HV, 2007, MAMM GENOME, V18, P482, DOI 10.1007/s00335-007-9029-1; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Mamiya T, 2004, BIOL PHARM BULL, V27, P1041, DOI 10.1248/bpb.27.1041; Mamiya T, 1998, BRAIN RES, V783, P236, DOI 10.1016/S0006-8993(97)01406-6; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MEIER E, 1987, NEUROTROPHIC ACTIVIT, P139; Miura M, 2007, J NEUROSCI, V27, P9721, DOI 10.1523/JNEUROSCI.2993-07.2007; Miyamoto Y, 2002, J NEUROSCI, V22, P2335, DOI 10.1523/JNEUROSCI.22-06-02335.2002; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Ukai M, 2004, EUR J PHARMACOL, V492, P183, DOI 10.1016/j.ejphar.2004.03.066; Ukai M, 1998, PHARMACOL BIOCHEM BE, V61, P247, DOI 10.1016/S0091-3057(98)00093-8; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	49	71	80	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					688	695		10.1038/ng.344	http://dx.doi.org/10.1038/ng.344			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19465912				2022-12-17	WOS:000266411700017
J	Ahn, J; Berndt, SI; Wacholder, S; Kraft, P; Kibel, AS; Yeager, M; Albanes, D; Giovannucci, E; Stampfer, MJ; Virtamo, J; Thun, MJ; Feigelson, HS; Cancel-Tassin, G; Cussenot, O; Thomas, G; Hunter, DJ; Fraumeni, JF; Hoover, RN; Chanock, SJ; Hayes, RB				Ahn, Jiyoung; Berndt, Sonja I.; Wacholder, Sholom; Kraft, Peter; Kibel, Adam S.; Yeager, Meredith; Albanes, Demetrius; Giovannucci, Edward; Stampfer, Meir J.; Virtamo, Jarmo; Thun, Michael J.; Feigelson, Heather Spencer; Cancel-Tassin, Geraldine; Cussenot, Olivier; Thomas, Gilles; Hunter, David J.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hayes, Richard B.			Variation in KLK genes, prostate-specific antigen and risk of prostate cancer	NATURE GENETICS			English	Letter							POLYMORPHISM; ASSOCIATION; PROMOTER		[Ahn, Jiyoung; Berndt, Sonja I.; Wacholder, Sholom; Yeager, Meredith; Albanes, Demetrius; Thomas, Gilles; Hunter, David J.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Chanock, Stephen J.; Hayes, Richard B.] Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Dept Epidemiol, Boston, MA 02115 USA; [Kibel, Adam S.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Giovannucci, Edward; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward; Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Giovannucci, Edward; Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Virtamo, Jarmo] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-0030 Helsinki, Finland; [Thun, Michael J.; Feigelson, Heather Spencer] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier] CeRePP Hop Tenon, AP HP, F-75020 Paris, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Finland National Institute for Health & Welfare; American Cancer Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Hayes, RB (corresponding author), Natl Canc Inst, Natl Inst Hlth, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	Hayesr@mail.nih.gov	Berndt, Sonja I/J-8423-2016; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020	cussenot, olivier/0000-0002-9912-0533; Hayes, Richard/0000-0002-0918-661X; Ahn, Jiyoung/0000-0002-2900-2304; Cancel-Tassin, Geraldine/0000-0002-9583-6382	NATIONAL CANCER INSTITUTE [Z01CP010152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036120] Funding Source: NIH RePORTER; CCR NIH HHS [N01RC37004, N01-RC-45035] Funding Source: Medline; Intramural NIH HHS [ZIA CP010152-11] Funding Source: Medline; NCI NIH HHS [N01CO12400, N01 CN045165, U01 CA098710, P01 CA055075, N01-CO-12400, R01CA112028, R01 CA112028, U01CA098233, CA55075, U01 CA098233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borgono CA, 2004, MOL CANCER RES, V2, P257; Cramer SD, 2003, JNCI-J NATL CANCER I, V95, P1044, DOI 10.1093/jnci/95.14.1044; de Koning HJ, 2002, INT J CANCER, V98, P268, DOI 10.1002/ijc.10188; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Nam RK, 2003, J CLIN ONCOL, V21, P2312, DOI 10.1200/JCO.2003.11.007; Pal P, 2007, HUM GENET, V122, P251, DOI 10.1007/s00439-007-0394-3; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107	10	71	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1032	1034		10.1038/ng0908-1032	http://dx.doi.org/10.1038/ng0908-1032			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165914	Green Accepted			2022-12-17	WOS:000258761200002
J	McBride, CM; Alford, SH; Reid, RJ; Larson, EB; Baxevanis, AD; Brody, LC				McBride, Colleen M.; Alford, Sharon Hensley; Reid, Robert J.; Larson, Eric B.; Baxevanis, Andreas D.; Brody, Lawrence C.			Putting science over supposition in the arena of personalized genomics	NATURE GENETICS			English	Editorial Material							HEALTH BEHAVIOR-CHANGE; MEDICINE; DISEASES	We explore the process of going from genome discovery to evaluation of medical impact and discuss emerging challenges faced by the scientific community. the need to confront these challenges is heightened in a climate where unregulated genetic tests are being marketed directly to the general public(1,2). Specifically, we characterize the delicate balance involved in deciding when genomic discoveries such as gene-disease associations are 'ready' to be evaluated as potential tools to improve health. We recommend that a considerable research commitment be made now in order to successfully bridge the rapidly widening gap between gene-disease association research and the critical (but slower and more involved) investigations into public health and clinical utility. Lastly, we describe a large, ongoing, early-phase research project, the multiplex Initiative, which is examining issues related to the utility of genetic susceptibility testing for common health conditions.	[McBride, Colleen M.] Natl Genome Res Inst, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA; [Alford, Sharon Hensley] Henry Ford Hosp, Detroit, MI 48202 USA; [Reid, Robert J.; Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Baxevanis, Andreas D.; Brody, Lawrence C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Henry Ford Health System; Henry Ford Hospital; Group Health Cooperative; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	McBride, CM (corresponding author), Natl Genome Res Inst, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA.	cmcbride@mail.nih.gov; lbrody@helix.nih.gov		Baxevanis, Andy/0000-0002-5370-0014	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200344, Z01HG200345] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG200344-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baird PA, 2002, PERSPECT BIOL MED, V45, P516, DOI 10.1353/pbm.2002.0061; Baker M, 2008, NATURE, V451, P516, DOI 10.1038/451516a; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; COOKEDEEGAN R, 1994, GENE WARS SCI POLITI; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Institute of Medicine, 2004, HLTH LIT; Katsanis SH, 2008, SCIENCE, V320, P53, DOI 10.1126/science.1156604; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Lunshof JE, 2006, PHARMACOGENOMICS, V7, P237, DOI 10.2217/14622416.7.2.237; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Ory MG, 2002, HEALTH EDUC RES, V17, P500, DOI 10.1093/her/17.5.500; Roberts L, 2001, SCIENCE, V291, P1182; Satia JA, 2005, J AM DIET ASSOC, V105, P392, DOI 10.1016/j.jada.2004.12.006; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Thrasher JF, 2007, ADDICT BEHAV, V32, P2916, DOI 10.1016/j.addbeh.2007.05.018; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	18	71	71	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					939	942		10.1038/ng0808-939	http://dx.doi.org/10.1038/ng0808-939			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18665132	Green Accepted			2022-12-17	WOS:000258026900006
J	Bhangale, TR; Stephens, M; Nickerson, DA				Bhangale, Tushar R.; Stephens, Matthew; Nickerson, Deborah A.			Automating resequencing-based detection of insertion-deletion polymorphisms	NATURE GENETICS			English	Article							HUMAN GENOME; LINKAGE-DISEQUILIBRIUM; STRUCTURAL VARIATION; SEQUENCE VARIATION; SNPS; RISK; GENE; TOOL; IDENTIFICATION; PROMOTER	Structural and insertion-deletion (indel) variants have received considerable recent attention, partly because of their phenotypic consequences. Among these variants, the most common are small indels (similar to 1-30 bp). Identifying and genotyping indels using sequence traces obtained from diploid samples requires extensive manual review, which makes large-scale studies inconvenient. We report a new algorithm, implemented in available software (PolyPhred version 6.0), to help automate detection and genotyping of indels from sequence traces. The algorithm identifies heterozygous individuals, which permits the discovery of low-frequency indels. It finds 80% of all indel polymorphisms with almost no false positives and finds 97% with a false discovery rate of 10%. Additionally, genotyping accuracy exceeds 99%, and it correctly infers indel length in 96% of the cases. Using this approach, we identify indels in the HapMap ENCODE regions, providing the first report of these polymorphisms in this data set.	Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bhangale, TR (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	tushar@u.washington.edu; debnick@u.washington.edu			NHGRI NIH HHS [HG/LM02585] Funding Source: Medline; NHLBI NIH HHS [HL66682] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P5669, DOI 10.1210/jc.2004-0398; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lin SC, 2004, J ORAL PATHOL MED, V33, P323, DOI 10.1111/j.1600-0714.2004.00214.x; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Othman M, 2005, BLOOD, V105, P4330, DOI 10.1182/blood-2002-09-2942; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	32	71	76	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1457	1462		10.1038/ng1925	http://dx.doi.org/10.1038/ng1925			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115056				2022-12-17	WOS:000242404200026
J	Shiba, H; Kakizaki, T; Iwano, M; Tarutani, Y; Watanabe, M; Isogai, A; Takayama, S				Shiba, H; Kakizaki, T; Iwano, M; Tarutani, Y; Watanabe, M; Isogai, A; Takayama, S			Dominance relationships between self-incompatibility alleles controlled by DNA methylation	NATURE GENETICS			English	Article							NUCLEOLAR DOMINANCE; BRASSICA; TRANSCRIPTION; PROMOTER; BINDING; HYBRID; POLLEN	In crucifers, the pollen S-determinant gene, SP11, is sporophytically expressed in the anther tapetum, and the pollen self-incompatibility phenotype is determined by the dominance relationships between the two S-haplotypes it carries. We report here that 5' promoter sequences of recessive SP11 alleles are specifically methylated in the tapetum before the initiation of SP11 transcription. These results suggest that tissue-specific monoallelic de novo DNA methylation is involved in determining the dominance interactions that determine the cruciferous self-incompatibility phenotype.	Grad Sch Biol Sci, Nara Inst Sci & Technol, Ikoma 6300101, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Tohoku 9808577, Japan	Nara Institute of Science & Technology; Iwate University; Tohoku University	Shiba, H (corresponding author), Grad Sch Biol Sci, Nara Inst Sci & Technol, 8916-5 Takayama, Ikoma 6300101, Japan.	hshiba@salk.edu; takayama@bs.naist.jp	KAKIZAKI, Tomohiro/E-6304-2011; Watanabe, Masao/E-6300-2011; Isogai, Akira/O-8897-2017; Watanabe, Masao/N-1465-2019	KAKIZAKI, Tomohiro/0000-0002-3636-6616; Watanabe, Masao/0000-0002-9419-5149; Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149				Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brennan AC, 2003, PHILOS T ROY SOC B, V358, P1047, DOI 10.1098/rstb.2003.1300; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Frieman M, 1999, GENETICS, V152, P451; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Kakizaki T, 2003, PLANT CELL PHYSIOL, V44, P70, DOI 10.1093/pcp/pcg009; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	15	71	77	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					297	299		10.1038/ng1734	http://dx.doi.org/10.1038/ng1734			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444272				2022-12-17	WOS:000235589600009
J	Liu, PT; Jenkins, NA; Copeland, NG				Liu, PT; Jenkins, NA; Copeland, NG			Efficient Cre-IoxP-induced mitotic recombination in mouse embryonic stem cells	NATURE GENETICS			English	Article							GENETIC MOSAICS; PRADER-WILLI; DROSOPHILA; MICE; SEGREGATION; CHROMOSOMES; REGION; MODEL	FLP/FRT-induced mitotic recombination provides a powerful method for creating genetic mosaics in Drosophila and for discerning the function of recessive genes in a heterozygous individual. Here we show that mitotic recombination can be reproducibly induced in mouse embryonic stem (ES) cells, by Cre/loxP technology, at frequencies ranging from 4.2 x 10(-5) (Snrpn) to 7.0 x 10(-3) (D7Mit178) for single allelic loxP sites, and to 5.0 x 10(-2) (D7Mit178) for multiple allelic lox sites, after transient Cre expression. Notably, much of the recombination occurs in G2 and is followed by X segregation, where the recombinant chromatids segregate away from each other during mitosis. It is X segregation that is useful for genetic mosaic analysis because it produces clones of homozygous mutant daughter cells from heterozygous mothers. Our studies confirm the predictions made from studies in Drosophila(1) that suggest that X segregation will not be limited to organisms with strong mitotic pairing, because the forces (sister-chromatid cohesion) responsible for X segregation are an elemental feature of mitosis in all eukaryotes. Our studies also show that genetic mosaic analysis in mice is feasible, at least for certain chromosomal regions.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Copeland, NG (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.							Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; BATEMAN AJ, 1967, GENET RES, V9, P375, DOI 10.1017/S001667230001065X; BAUBONIS W, 1993, NUCLEIC ACIDS RES, V21, P2025, DOI 10.1093/nar/21.9.2025; Beumer KJ, 1998, GENETICS, V150, P173; CATTANACH BM, 1994, J INHERIT METAB DIS, V17, P403, DOI 10.1007/BF00711356; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FAVOR J, 1994, ANNU REV GENET, V28, P27, DOI 10.1146/annurev.ge.28.120194.000331; FISHER G, 1986, MUTAT RES, V164, P381, DOI 10.1016/0165-1161(86)90031-2; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; PANTHIER JJ, 1990, GENETICS, V125, P175; PIMPINELLI S, 1986, P NATL ACAD SCI USA, V83, P3900, DOI 10.1073/pnas.83.11.3900; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Riesselmann L, 1999, CYTOGENET CELL GENET, V86, P39, DOI 10.1159/000015426; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Stevens N. M., 1908, Journal of Experimental Zoology Philadelphia, V5, DOI 10.1002/jez.1400050304; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	31	71	76	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					66	72		10.1038/ng788	http://dx.doi.org/10.1038/ng788			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11740496				2022-12-17	WOS:000173105600015
J	Weil, CF; Kunze, R				Weil, CF; Kunze, R			Transposition of maize Ac/Ds transposable elements in the yeast Saccharomyces cerevisiae	NATURE GENETICS			English	Article							ACTIVATOR AC TRANSPOSASE; DNA TRANSPOSITION; IN-VIVO; EXCISION; EXPRESSION; GENE; ARABIDOPSIS; TOBACCO; RECOMBINATION; DISSOCIATION	Excision by transposons is associated with chromosome breaks; generally, host-cell proteins repair this damage, often introducing mutations. Many transposons also use host proteins in the transposition mechanism or in regulation(1-4). Transposition in systems lacking host factors that influence the behaviour of these transpositions is useful in determining what those factors are and how they work. In addition, features of transposition and regulation intrinsic to the element itself can be determined. Maize Activator/Dissociation (Ac/Ds) elements transpose in a wide variety of heterologous plants, but their characteristics in these other systems differ from those in maize, including their response to increasing genetic dosage(5,6) and the types of repair products recovered following excision(7). Two Arabidopsis thaliana mutants (iae1 and iae2) show increased Ac transposition frequencies(8). These mutants, and the differences mentioned above, suggest the involvement of host proteins in Ac/Ds activity and potential differences between these proteins among plant species. Here we report that Ac/Ds elements, members of the hAT (hobo, Ac, Tam3) superfamily, transpose in the yeast Saccharomyces cerevisiae, an organism lacking class II ('cut and paste') transposons. This demonstrates that plant-specific proteins are not essential for Ac/Ds transposition. The yeast system is valuable for dissecting the Ac/Ds transposition mechanism and identifying host factors that can influence transposition and the repair of DNA damage induced by Ac/Ds. Mutations caused by Ds excision in yeast suggest formation of a DNA-hairpin intermediate, and reinsertions occur throughout the genome with a frequency similar to that in plants. The high proportion of Ac/Ds reinsertions also makes this system an in vivo mutagenesis and reverse genetics tool in yeast and, presumably, other eukaryotic systems.	Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; Univ Munich, Inst Genet & Mikrobiol, D-8000 Munich, Germany	Idaho; University of Idaho; University of Munich	Kunze, R (corresponding author), Univ Cologne, Bot Inst 2, Cologne, Germany.			Kunze, Reinhard/0000-0002-3304-5550				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; COEN ES, 1989, MOBILE DNA; Colot V, 1998, MOL CELL BIOL, V18, P4337, DOI 10.1128/MCB.18.7.4337; DABOUSSI MJ, 1994, GENETICA, V93, P1; ESSER SL, 2000, PLANT CELL, V12, P211; FELDMAR S, 1991, EMBO J, V10, P4003, DOI 10.1002/j.1460-2075.1991.tb04975.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HEINLEIN M, 1994, PLANT J, V5, P705, DOI 10.1111/j.1365-313X.1994.00705.x; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; HOUBAHERIN N, 1990, MOL GEN GENET, V224, P17, DOI 10.1007/BF00259446; Jarvis P, 1997, PLANT J, V11, P907; KELLER J, 1993, PLANT MOL BIOL, V21, P157, DOI 10.1007/BF00039626; Kempken F, 1996, MOL CELL BIOL, V16, P6563; Kunze R, 1997, ADV BOT RES, V27, P331; KUNZE R, 1995, PLANT J, V8, P45, DOI 10.1046/j.1365-313X.1995.08010045.x; KUNZE R, 1993, P NATL ACAD SCI USA, V90, P7094, DOI 10.1073/pnas.90.15.7094; LAUFS J, 1990, P NATL ACAD SCI USA, V87, P7752, DOI 10.1073/pnas.87.19.7752; MAKRIS JC, 1990, J BACTERIOL, V172, P1368, DOI 10.1128/jb.172.3.1368-1373.1990; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Rinehart TA, 1997, PLANT J, V12, P1419, DOI 10.1046/j.1365-313x.1997.12061419.x; SCOFIELD SR, 1993, CELL, V75, P507, DOI 10.1016/0092-8674(93)90385-4; SIGNON L, 1995, GENE DEV, V9, P1123, DOI 10.1101/gad.9.9.1123; SURETTE MG, 1989, EMBO J, V8, P3483, DOI 10.1002/j.1460-2075.1989.tb08513.x; SWINBURNE J, 1992, PLANT CELL, V4, P583, DOI 10.1105/tpc.4.5.583; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	28	71	79	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					187	190		10.1038/82827	http://dx.doi.org/10.1038/82827			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017074				2022-12-17	WOS:000089638800015
J	Hayashi, T; Motulsky, AG; Deeb, SS				Hayashi, T; Motulsky, AG; Deeb, SS			Position of a 'green-red' hybrid gene in the visual pigment array determines colour-vision phenotype	NATURE GENETICS			English	Article							MOLECULAR-GENETICS; TANDEM ARRAY; EXPRESSION; DEFECTS; SEVERITY; LOCUS; XQ28; BLUE	The X-linked red- and green-pigment genes are arranged in a head-to-tail tandem array(1-3). The colour-vision defect of deuteranomaly (in 5% of males of European descent) is associated with a 5'-green-red-3' visual-pigment hybrid gene(4,5), which may also exist in males with normal colour vision(5-7). To explain why males with a normal red, a normal green and a green-red hybrid gene may have either normal or deutan colour vision, we hypothesized that only the first two genes are expressed(8,9) and deuteranomaly results only if the green-red hybrid gene occupies the second position and is expressed preferentially over normal green-pigment genes occupying more distal positions. We used long-range PCR amplification and studied 10 deutan males (8 deuteranomalous and 2 deuteranopic) with 3 visual pigment genes (red, green and green-red hybrid) to investigate whether position of the hybrid gene in the array determined gene expression. The green-red hybrid gene was always at the second position land the first position was always occupied by the red gene). Conversely, in two men with red, green and green-red hybrid genes and normal colour vision, the hybrid gene occupied the third position. When pigment gene mRNA expression was assessed in post-mortem retinae of three men with the red, green and green-red genotype, the green-red hybrid gene was expressed only when located in the second position. We conclude that the green-red hybrid gene will only cause deutan defects when it occupies the second position of the pigment gene array.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Deeb, SS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.				NEI NIH HHS [EY08395] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008395] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Crognale MA, 1998, VISION RES, V38, P3377, DOI 10.1016/S0042-6989(97)00425-2; DEEB SS, 1992, AM J HUM GENET, V51, P687; DILLON N, 1991, NATURE, V350, P252, DOI 10.1038/350252a0; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; FARRELL DF, 1993, NEUROLOGY, V43, P1518, DOI 10.1212/WNL.43.8.1518; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; Hanna MC, 1997, GENOMICS, V43, P384, DOI 10.1006/geno.1997.4830; HANSCOMBE O, 1989, GENE DEV, V3, P1572, DOI 10.1101/gad.3.10.1572; Kitahara Kenji, 1998, Nippon Ganka Gakkai Zasshi, V102, P837; Macke JP, 1997, INVEST OPHTH VIS SCI, V38, P1040; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MILER SA, 1988, NUCLEIC ACIDS RES, V16, P1215; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Sanocki E, 1997, VISION RES, V37, P1897, DOI 10.1016/S0042-6989(97)00005-9; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Shevell SK, 1997, VISION RES, V37, P1115, DOI 10.1016/S0042-6989(96)00270-2; Sjoberg SA, 1998, VISION RES, V38, P3213, DOI 10.1016/S0042-6989(97)00367-2; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WINDERICKX J, 1992, P NATL ACAD SCI USA, V89, P9710, DOI 10.1073/pnas.89.20.9710; Yamaguchi T, 1997, HUM MOL GENET, V6, P981, DOI 10.1093/hmg/6.7.981	26	71	72	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					90	93		10.1038/8798	http://dx.doi.org/10.1038/8798			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319869				2022-12-17	WOS:000080096300030
J	Tsai, TF; Armstrong, D; Beaudet, AL				Tsai, TF; Armstrong, D; Beaudet, AL			Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome	NATURE GENETICS			English	Letter							MOUSE MODEL; GENE; EXPRESSION; REGION; FAMILY		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.tmc.edu			NICHD NIH HHS [HD 37283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; DABOVIC B, 1995, MAMM GENOME, V6, P571, DOI 10.1007/BF00352360; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	15	71	73	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1999	22	1					15	16		10.1038/8722	http://dx.doi.org/10.1038/8722			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319852				2022-12-17	WOS:000080096300012
J	Montoya, SE; Aston, CE; DeKosky, ST; Kamboh, MI; Lazo, JS; Ferrell, RE				Montoya, SE; Aston, CE; DeKosky, ST; Kamboh, MI; Lazo, JS; Ferrell, RE			Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease	NATURE GENETICS			English	Letter							EXPRESSION; PROTEASE; CLONING		Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Alzheimers Dis Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ferrell, RE (corresponding author), Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA.			Kamboh, M. Ilyas/0000-0002-3453-1438; DeKosky, Steven/0000-0003-3743-2758	NCI NIH HHS [CA43917] Funding Source: Medline; NIA NIH HHS [AG13672, U24 AG021886, P30 AG10133] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013672, U24AG021886, P30AG010133] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; Chang TE, 1996, ANN NY ACAD SCI, V777, P183, DOI 10.1111/j.1749-6632.1996.tb34417.x; Ferrando AA, 1997, J BIOL CHEM, V272, P33298, DOI 10.1074/jbc.272.52.33298; Ferrando AA, 1996, CANCER RES, V56, P1746; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; KOLDAMOVA R, IN PRESS BIOCHEMISTR; LAZO JS, 1983, P NATL ACAD SCI-BIOL, V80, P3064, DOI 10.1073/pnas.80.10.3064; LevyLahad E, 1996, ANN NEUROL, V40, P829, DOI 10.1002/ana.410400604; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; Montoya SE, 1997, CANCER RES, V57, P4191; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; ZHENG W, 1997, FASEB J, V11, P3148; Zheng WJ, 1997, J BIOL CHEM, V272, P30350, DOI 10.1074/jbc.272.48.30350	15	71	72	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					211	212		10.1038/ng0398-211	http://dx.doi.org/10.1038/ng0398-211			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500538				2022-12-17	WOS:000072325000014
J	Cossee, M; Campuzano, V; Koutnikova, H; Fischbeck, K; Mandel, JL; Koenig, M; Bidichandani, SI; Patel, PI; Molte, MD; Canizares, J; DeFrutos, R; Pianese, L; Cavalcanti, F; Monticelli, A; Cocozza, S; Montermini, L; Pandolfo, M				Cossee, M; Campuzano, V; Koutnikova, H; Fischbeck, K; Mandel, JL; Koenig, M; Bidichandani, SI; Patel, PI; Molte, MD; Canizares, J; DeFrutos, R; Pianese, L; Cavalcanti, F; Monticelli, A; Cocozza, S; Montermini, L; Pandolfo, M			Frataxin fracas	NATURE GENETICS			English	Letter									INSERM,CNRS,INST GENET & BIOL MOL & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; UNIV VALENCIA,DEPT GENET,E-46100 BURJASSOT,SPAIN; UNIV NAPLES FEDERICO II,DIPARTIMENTO BIOL & PATOL CELLULARE & MOL,I-80131 NAPLES,ITALY; CNR,CEOS,I-80131 NAPLES,ITALY; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT NEUROL & NEUROSURG,MONTREAL,PQ H2L 4M1,CANADA; MCGILL UNIV,CTR RECH LOIUS CHARLES SIMARD,MONTREAL,PQ H2L 4M1,CANADA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Valencia; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); McGill University; McGill University; McGill University			Koutnikova, Hana/I-7758-2017; Campuzano, Victoria/ABG-7429-2020; Canizares, Joaquin/M-3255-2014; Canizares, Joaquin/X-9702-2019; Campuzano, V/G-1826-2014; CAMPUZANO, VICTORIA/K-7883-2019; Pandolfo, Massimo/B-2853-2010; Cocozza, Sergio/F-6488-2010; CAVALCANTI, FRANCESCA/I-3651-2014; Cavalcanti, Francesca/N-3901-2019; Patel, Pragna/H-9129-2017	Campuzano, Victoria/0000-0001-8128-2641; Canizares, Joaquin/0000-0001-9002-5516; Canizares, Joaquin/0000-0001-9002-5516; Campuzano, V/0000-0001-8128-2641; CAVALCANTI, FRANCESCA/0000-0001-5769-4582; Cavalcanti, Francesca/0000-0001-5769-4582; Bidichandani, Sanjay/0000-0001-6191-6475; Patel, Pragna/0000-0003-3584-1072	NINDS NIH HHS [NS34192] Funding Source: Medline; Telethon [722] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034192] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	71	71	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					337	338		10.1038/ng0497-337	http://dx.doi.org/10.1038/ng0497-337			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090376				2022-12-17	WOS:A1997WQ38900008
